PT J
AU Xiong, CL
   Huang, X
   Chen, SB
   Li, Y
AF Xiong, Chenlu
   Huang, Xuan
   Chen, Shibiao
   Li, Yong
TI Role of Extracellular microRNAs in Sepsis-Induced Acute Lung Injury
SO JOURNAL OF IMMUNOLOGY RESEARCH
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; ENDOTHELIAL PROGENITOR CELLS;
   RESPIRATORY-DISTRESS-SYNDROME; VESICLES; MICROPARTICLES; COMMUNICATION;
   MICROVESICLES; SURVIVAL; RNAS
AB Acute lung injury (ALI) is a life-threatening pathological disease characterized by the damage of pulmonary endothelial cells and epithelial cell barriers by uncontrolled inflammation. During sepsis-induced ALI, multiple cells cooperate and communicate with each other to respond to the stimulation of inflammatory factors. However, the underlying mechanisms of action have not been fully identified, and the modes of communication therein are also being investigated. Extracellular vesicles (EVs) are a heterogeneous population of spherical membrane structures released by almost all types of cells, containing various cellular components. EVs are primary transport vehicles for microRNAs (miRNAs), which play essential roles in physiological and pathological processes in ALI. EV miRNAs from different sources participated in regulating the biological function of pulmonary epithelial cells, endothelial cells, and phagocytes by transferring miRNA through EVs during ALI induced by sepsis, which has great potential diagnostic and therapeutic values. This study aims to summarize the role and mechanism of extracellular vesicle miRNAs from different cells in the regulation of sepsis-induced ALI. It provides ideas for further exploring the role of extracellular miRNA secreted by different cells in the ALI induced by sepsis, to make up for the deficiency of current understanding, and to explore the more optimal scheme for diagnosis and treatment of ALI.
C1 [Xiong, Chenlu; Chen, Shibiao; Li, Yong] Nanchang Univ, Med Ctr Anesthesiol & Pain, Dept Anesthesiol, Affiliated Hosp 1, Nanchang, China.
   [Huang, Xuan] Nanchang Univ, Inst Translat Med, Natl Engn Res Ctr Bioengn Drugs & Technol, Nanchang, China.
C3 Nanchang University; Nanchang University
RP Chen, SB; Li, Y (corresponding author), Nanchang Univ, Med Ctr Anesthesiol & Pain, Dept Anesthesiol, Affiliated Hosp 1, Nanchang, Peoples R China.
EM 401440920004@email.ncu.edu.cn; huangxuan@ncu.edu.cn;
   chenlaoshi1111@163.com; liyong@ncu.edu.cn
RI 李, 勇/GWV-7423-2022
OI 李, 勇/0000-0002-4108-0989
FU National Natural Science Foundation of China [82060023, 31960147,
   82160133]; Jiangxi Provincial Natural Science Foundation
   [20202ACBL206015, 20224BAB206007, 20212ACB216005, 20212BAB206086]
FX AcknowledgmentsThis work was supported by grants from the National
   Natural Science Foundation of China (82060023, 31960147, and 82160133),
   Jiangxi Provincial Natural Science Foundation (20202ACBL206015,
   20224BAB206007, 20212ACB216005, and 20212BAB206086).
CR Bayraktar R, 2017, MOL ONCOL, V11, P1673, DOI 10.1002/1878-0261.12144
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Cao JP, 2012, ANESTHESIOLOGY, V116, P1278, DOI 10.1097/ALN.0b013e3182567f84
   Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857
   Cheng LS, 2022, NAT REV DRUG DISCOV, V21, P379, DOI 10.1038/s41573-022-00410-w
   Cheng L, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23743
   Cocozza F, 2020, CELL, V182, P262, DOI 10.1016/j.cell.2020.04.054
   Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326
   da Silva CG, 2020, CHEM PHYS LIPIDS, V232, DOI 10.1016/j.chemphyslip.2020.104964
   Dengler V, 2013, AM J RESP CELL MOL, V49, P1, DOI 10.1165/rcmb.2012-0472TR
   Divangahi M, 2015, TRENDS IMMUNOL, V36, P307, DOI 10.1016/j.it.2015.03.005
   Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004
   Fan HK, 2014, AM J RESP CRIT CARE, V189, P1509, DOI 10.1164/rccm.201312-2163OC
   Fan Q, 2018, CANCER LETT, V414, P107, DOI 10.1016/j.canlet.2017.10.040
   Gon Y, 2020, RESPIROLOGY, V25, P149, DOI 10.1111/resp.13756
   Gupta N, 2012, THORAX, V67, P533, DOI 10.1136/thoraxjnl-2011-201176
   Gurung S, 2021, CELL COMMUN SIGNAL, V19, DOI 10.1186/s12964-021-00730-1
   Hao Q, 2019, J IMMUNOL, V203, P1961, DOI 10.4049/jimmunol.1801534
   Hao Q, 2015, STEM CELL TRANSL MED, V4, P832, DOI 10.5966/sctm.2015-0006
   Hao Y, 2022, CURR ISSUES MOL BIOL, V44, P2217, DOI 10.3390/cimb44050150
   Vasconcelos MH, 2019, DRUG RESIST UPDATE, V47, DOI 10.1016/j.drup.2019.100647
   Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209
   Iraci N, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020171
   Jean-Toussaint R, 2021, BRAIN BEHAV IMMUN, V94, P210, DOI 10.1016/j.bbi.2021.02.005
   Jiang LJ, 2021, INFLAMM RES, V70, P205, DOI 10.1007/s00011-020-01415-0
   Jin Y, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1079-3
   Joffe AM, 2020, NAT PROTOC, V15, P2230, DOI 10.1038/s41596-020-0330-8
   Joffre J, 2020, AM J RESP CRIT CARE, V202, P361, DOI 10.1164/rccm.201910-1911TR
   Johnston LK, 2012, AM J RESP CELL MOL, V47, P417, DOI 10.1165/rcmb.2012-0090OC
   Khalaj K, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2020.1795365
   Kim KM, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1413
   Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052
   Kourtzelis I, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00553
   Krasnodembskaya A, 2012, AM J PHYSIOL-LUNG C, V302, pL1003, DOI 10.1152/ajplung.00180.2011
   Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544
   Kronstadt SM, 2021, ADV THER-GERMANY, V4, DOI 10.1002/adtp.202000259
   Lan JQ, 2019, CANCER RES, V79, P146, DOI 10.1158/0008-5472.CAN-18-0014
   Lee H, 2018, J IMMUNOL, V201, P1500, DOI 10.4049/jimmunol.1800264
   Lee H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00924
   Lee H, 2017, J IMMUNOL, V199, P1453, DOI 10.4049/jimmunol.1700165
   Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106
   Li J, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12055
   Liu F, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.646546
   Ma L, 2015, CELL RES, V25, P24, DOI 10.1038/cr.2014.135
   Martire S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22062875
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Mizuta Y, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-02015-9
   Monsel A, 2015, AM J RESP CRIT CARE, V192, P324, DOI 10.1164/rccm.201410-1765OC
   Neudecker V, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5360
   PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5
   Park J, 2019, THORAX, V74, P43, DOI 10.1136/thoraxjnl-2018-211576
   Quan C, 2021, INT IMMUNOPHARMACOL, V100, DOI 10.1016/j.intimp.2021.108118
   Rajasekaran S, 2016, J CELL PHYSIOL, V231, P2097, DOI 10.1002/jcp.25316
   Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253
   Saha S, 2018, BIOMED PHARMACOTHER, V104, P485, DOI 10.1016/j.biopha.2018.05.007
   Ibanez-Cabellos JS, 2018, BBA-MOL BASIS DIS, V1864, P3234, DOI 10.1016/j.bbadis.2018.07.010
   Sevransky JE, 2009, CRIT CARE, V13, DOI 10.1186/cc8048
   Silk E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.52
   Stapleton RD, 2005, CHEST, V128, P525, DOI 10.1378/chest.128.2.525
   Sun R, 2020, INFLAMM RES, V69, P1, DOI 10.1007/s00011-019-01299-9
   Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   van Niel G, 2022, NAT REV MOL CELL BIO, V23, P369, DOI 10.1038/s41580-022-00460-3
   van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125
   Wang JM, 2020, CRIT CARE MED, V48, pE599, DOI 10.1097/CCM.0000000000004315
   Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614
   Wang W, 2016, AM J PHYSIOL-LUNG C, V311, pL494, DOI 10.1152/ajplung.00001.2016
   Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288
   Wei XX, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02857-4
   Welsh JA, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00078
   Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7
   Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045
   Wu X, 2018, EXP CELL RES, V370, P13, DOI 10.1016/j.yexcr.2018.06.003
   Xu ZH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/205054
   Yi XM, 2019, EXP CELL RES, V383, DOI 10.1016/j.yexcr.2019.05.035
   Youn YJ, 2021, THERANOSTICS, V11, P2770, DOI 10.7150/thno.51756
   Yuan ZH, 2018, JOVE-J VIS EXP, DOI 10.3791/57737
   Zaborowski MP, 2015, BIOSCIENCE, V65, P783, DOI 10.1093/biosci/biv084
   Zhang D, 2019, THORAX, V74, P865, DOI 10.1136/thoraxjnl-2018-212994
   Zhou Y, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2339-3
   Zhu YG, 2014, STEM CELLS, V32, P116, DOI 10.1002/stem.1504
   Zhu YG, 2013, RESPIROLOGY, V18, P744, DOI 10.1111/resp.12093
NR 82
TC 0
Z9 0
U1 1
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-8861
EI 2314-7156
J9 J IMMUNOL RES
JI J Immunol. Res.
PD JUN 19
PY 2023
VL 2023
AR 5509652
DI 10.1155/2023/5509652
PG 8
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA L3AA9
UT WOS:001022006400002
PM 37378068
OA gold
DA 2023-08-21
ER

PT J
AU Zhao, CQ
   Wang, C
   Liu, MM
   Cao, M
   Peng, J
   Kong, DQ
   Ren, XT
   Liu, R
   Hai, CX
   Zhang, XD
AF Zhao, Chen-qian
   Wang, Chong
   Liu, Meng-meng
   Cao, Meng
   Peng, Jie
   Kong, De-qin
   Ren, Xiao-ting
   Liu, Rui
   Hai, Chun-xu
   Zhang, Xiao-di
TI Single-cell transcriptomes reveal heterogeneity of chlorine-induced mice
   acute lung injury and the inhibitory effect of pentoxifylline on
   ferroptosis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PULMONARY INFLAMMATION
AB To investigate the effect of pentoxifylline (PTX) on Chlorine (Cl-2)-induced acute lung injury (ALI) by single-cell RNA sequencing (scRNA-seq). Female BALB/c mice were exposed to Cl-2 at 400 ppm for 15 min. H&E staining was used to observe the degree of lung injury. scRNA-seq was conducted to analysis of normal and Cl-2-exposed mice lung tissues. Immunofluorescence was used to observe genes of interest. Thirty-two mice were randomly divided into four groups: Control, Cl-2, Cl-2+Fer-1, Cl-2+PTX. TEM, WB and ELISA were used to detect ferroptosis-related indicators. The 5, 8, 10, 12, 16, 20 clusters were epithelial cells and 4, 15, 18, 19, 21 clusters were endothelial cells. Pseudo-time analysis revealed the differentiation trajectory of epithelial cells and key regulatory genes (Gclc, Bpifa1, Dnah5 and Dnah9) during the process of injury. Cell-cell communication analysis identified several important receptor-ligand complexes (Nrp1-Vegfa, Nrp2-Vegfa, Flt1-Vegfa and Flt4-Vegfa). Ferroptosis were found up-regulated in epithelial and endothelial cells by GSVA analysis. Highly expressed genes to which closely related ferroptosis were found by SCENIC analysis. PTX could significantly decrease the levels of MDA and abnormal high expression of solute carrier family 7 member 11 (SLC7A11, the key transporter of cystine) as well as increase the expression of GSH/GSSG and glutathione peroxidase 4 (GPX4) (p < 0.05). This study revealed novel molecular features of Cl-2-induced ALI. PTX may be a potential specific drug by inhibiting the process of ferroptosis in epithelial and endothelial cells.
C1 [Zhao, Chen-qian; Wang, Chong] Shaanxi Univ Chinese Med, Dept Med Expt Ctr, Xianyang 712046, China.
   [Zhao, Chen-qian; Cao, Meng; Peng, Jie; Kong, De-qin; Ren, Xiao-ting; Liu, Rui; Hai, Chun-xu; Zhang, Xiao-di] Air Force Med Univ, Sch Publ Hlth, Dept Toxicol, Shaanxi Key Lab Free Rad Biol & Med,Minist Educ,Ke, Xian 710032, China.
   [Liu, Meng-meng] Logist Univ Chinese Peoples Armed Police Force, Dept Hlth Serv, Tianjin 300309, China.
C3 Shaanxi University of Chinese Medicine; Air Force Military Medical
   University
RP Hai, CX; Zhang, XD (corresponding author), Air Force Med Univ, Sch Publ Hlth, Dept Toxicol, Shaanxi Key Lab Free Rad Biol & Med,Minist Educ,Ke, Xian 710032, Peoples R China.
EM cx-hai@fmmu.edu.cn; zhangxiaodi@fmmu.edu.cn
OI Zhao, Chen-qian/0000-0002-8443-9429
FU Military Medical Innovation [16CXZ021]
FX <STRONG> </STRONG>The work was supported by grants from the project of
   Military Medical Innovation (16CXZ021).
CR Achanta S, 2021, TOXICOL MECH METHOD, V31, P244, DOI 10.1080/15376516.2019.1669244
   Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]
   Annamaraju P., 2022, PENTOXIFYLLINE
   Aprea I, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009306
   Brune K, 2015, AM J PHYSIOL-LUNG C, V308, pL731, DOI 10.1152/ajplung.00309.2014
   Bukowy-Bieryllo Z, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23084122
   Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096
   Chavarria AP, 2021, COMPUT STRUCT BIOTEC, V19, P1379, DOI 10.1016/j.csbj.2021.02.009
   Chen J, 2013, TOXICOL APPL PHARM, V272, P408, DOI 10.1016/j.taap.2013.06.009
   Chen X, 2021, AUTOPHAGY, V17, P2054, DOI 10.1080/15548627.2020.1810918
   Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042
   Endesfelder S, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/3840124
   Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7
   Hendry BM, 2020, PHARMACOL RES PERSPE, V8, DOI 10.1002/prp2.631
   Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003
   Hoyle GW, 2010, TOXICOL SCI, V118, P696, DOI 10.1093/toxsci/kfq264
   Kang YP, 2021, CELL METAB, V33, P174, DOI 10.1016/j.cmet.2020.12.007
   Konrad FM, 2013, FASEB J, V27, P3524, DOI 10.1096/fj.13-228122
   Koppula P, 2021, PROTEIN CELL, V12, P599, DOI 10.1007/s13238-020-00789-5
   Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0
   Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5
   Liu MM., 2022, J AIR FORCE MILIT U, V43, P1
   Liu X, 2022, MOL CELL BIOCHEM, V477, P1453, DOI 10.1007/s11010-021-04327-7
   Liu Y, 2019, J SURG RES, V238, P175, DOI 10.1016/j.jss.2019.01.020
   Ma TY, 2022, CELL DEATH DISCOV, V8, DOI 10.1038/s41420-022-01212-0
   McCarty MF, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2015-000365
   Monji F, 2020, EUR J PHARMACOL, V887, DOI 10.1016/j.ejphar.2020.173561
   Radbel J, 2020, ANN NY ACAD SCI, V1480, P14, DOI 10.1111/nyas.14438
   Saferali A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227067
   Sun YT, 2020, BIOMED PHARMACOTHER, V127, DOI 10.1016/j.biopha.2020.110108
   Suo SB, 2018, CELL REP, V25, P1436, DOI 10.1016/j.celrep.2018.10.045
   van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536
   Watkins R, 2021, TOXICOL MECH METHOD, V31, P257, DOI 10.1080/15376516.2021.1906808
   Windmeier C, 1997, GEN PHARMACOL-VASC S, V29, P181, DOI 10.1016/S0306-3623(96)00314-X
   Wu GS, 2016, SCI REP-UK, V6, DOI 10.1038/srep30067
   Zellner T, 2020, TOXICOL LETT, V320, P73, DOI 10.1016/j.toxlet.2019.12.005
   Zhang JH, 2021, PHYTOTHER RES, V35, P494, DOI 10.1002/ptr.6829
   Zhang XD, 2010, INHAL TOXICOL, V22, P889, DOI 10.3109/08958378.2010.493900
   Zhang YL, 2022, RESP RES, V23, DOI 10.1186/s12931-022-01932-y
   Zhou T, 2018, CHINESE MED J-PEKING, V131, P1214, DOI 10.4103/0366-6999.231515
NR 40
TC 0
Z9 0
U1 1
U2 1
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 26
PY 2023
VL 13
IS 1
DI 10.1038/s41598-023-32093-7
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA F7XF1
UT WOS:000984431900073
PM 37100790
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Madenspacher, JH
   Wurfel, MM
   Fessler, MB
   Madenspacher, JH
   Morrell, ED
   McDonald, JG
   Thompson, BM
   Li, Y
   Birukov, KG
   Birukova, AA
   Stapleton, RD
   Alejo, A
   Karmaus, PW
   Meacham, JM
   Rai, P
   Mikacenic, C
   Wurfel, MM
   Fessler, MB
AF Madenspacher, Jennifer H.
   Wurfel, Mark M.
   Fessler, Michael B.
   Madenspacher, Jennifer H.
   Morrell, Eric D. .
   McDonald, Jeffrey G. .
   Thompson, Bonne M. .
   Li, Yue
   Birukov, Konstantin G.
   Birukova, Anna A.
   Stapleton, Renee D. .
   Alejo, Aidin
   Karmaus, Peer W. .
   Meacham, Julie M. .
   Rai, Prashant
   Mikacenic, Carmen
   Wurfel, Mark M.
   Fessler, Michael B.
TI 25-Hydroxycholesterol exacerbates vascular leak during acute lung injury
SO JCI INSIGHT
LA English
DT Article
ID ENDOPLASMIC-RETICULUM STRESS; ENDOTHELIAL-CELLS; HOST-DEFENSE; ER
   STRESS; INFLAMMATION; MOUSE; MACROPHAGES; EXPRESSION; AGONIST
AB Cholesterol-25-hydroxylase (CH25H), the biosynthetic enzyme for 25-hydroxycholesterol (25HC), is most highly expressed in the lung, but its role in lung biology is poorly defined. Recently, we reported that Ch25h is induced in monocyte-derived macrophages recruited to the airspace during resolution of lung inflammation and that 25HC promotes liver X receptor-dependent (LXRdependent) clearance of apoptotic neutrophils by these cells. Ch25h and 25HC are, however, also robustly induced by lung-resident cells during the early hours of lung inflammation, suggesting additional cellular sources and targets. Here, using Ch25h-/- mice and exogenous 25HC in lung injury models, we provide evidence that 25HC sustains proinflammatory cytokines in the airspace and augments lung injury, at least in part, by inducing LXR-independent endoplasmic reticulum stress and endothelial leak. Suggesting an autocrine effect in endothelium, inhaled LPS upregulates pulmonary endothelial Ch25h, and non-hematopoietic Ch25h deletion is sufficient to confer lung protection. In patients with acute respiratory distress syndrome, airspace 25HC and alveolar macrophage CH25H were associated with markers of microvascular leak, endothelial activation, endoplasmic reticulum stress, inflammation, and clinical severity. Taken together, our findings suggest that 25HC deriving from and acting on different cell types in the lung communicates distinct, temporal LXR-independent and -dependent signals to regulate inflammatory homeostasis.
C1 [Madenspacher, Jennifer H.; Alejo, Aidin; Karmaus, Peer W. .; Meacham, Julie M. .; Rai, Prashant; Fessler, Michael B. .] NIEHS, Immun Inflammat & Dis Lab, NIH, Res Triangle Pk, NC 27709, United States.
   [Morrell, Eric D. .; Mikacenic, Carmen; Wurfel, Mark M. .] Harborview Med Ctr, Sect Pulm Crit Care & Sleep Med, Seattle, WA, United States.
   [Madenspacher, Jennifer H. .; Thompson, Bonne M. .] Texas Southwestern Med Ctr, Ctr Human Nutr, Dallas, TX, United States.
   [Madenspacher, Jennifer H. .] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX, United States.
   [Birukov, Konstantin G. .; Birukova, Anna A. .] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD, United States.
   [Stapleton, Renee D. .] Univ Vermont, Larner Coll Med, Dept Med, Burlington, VT, United States.
   [Fessler, Michael B. .] NIEHS, 111 TW Alexander Dr,POB 12233,MD D2-01, Res Triangle Pk, NC 27709, United States.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS); Harborview Medical Center;
   University of Texas System; University of Texas Southwestern Medical
   Center Dallas; University System of Maryland; University of Maryland
   Baltimore; University of Vermont; National Institutes of Health (NIH) -
   USA; NIH National Institute of Environmental Health Sciences (NIEHS)
RP Fessler, MB (corresponding author), NIEHS, 111 TW Alexander Dr,POB 12233,MD D2-01, Res Triangle Pk, NC 27709 USA.
EM fesslerm@niehs.nih.gov
OI Morrell, Eric/0000-0001-9900-3604
FU Intramural Research Program of the NIH National Institute of
   Environmental Health Sciences [Z01ES102005]; NIH National Heart, Lung,
   and Blood Institute [P50HL073996, K23HL144916, HL087823]; National
   Institute of General Medical Sciences [5P01HL160487, 1P30DK127984,
   GM122940]; National Institute of General Medical Sciences; 
   [UL1TR003163]
FX The authors thank Ligon Perrow for assistance with animal husbandry,
   Seddon Thomas and Maria Sifre for assistance with FACS, and Min Shi for
   help with statistical analysis. This research was supported by the
   Intramural Research Program of the NIH National Institute of
   Environmental Health Sciences (Z01ES102005) and by the NIH National
   Heart, Lung, and Blood Institute (P50HL073996, K23HL144916, and
   HL087823) and National Institute of General Medical Sciences (GM122940)
   , as well as UL1TR003163, 5P01HL160487, and 1P30DK127984.
CR Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106
   Chalubinski M, 2013, INFLAMM RES, V62, P1015, DOI 10.1007/s00011-013-0660-x
   Choi SH, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120519
   Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200
   Draper DW, 2010, AM J RESP CRIT CARE, V182, P404, DOI 10.1164/rccm.200910-1580OC
   Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224
   Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159
   Fessler MB, 2018, PHARMACOL THERAPEUT, V181, P1, DOI 10.1016/j.pharmthera.2017.07.010
   Furnkranz A, 2005, ARTERIOSCL THROM VAS, V25, P633, DOI 10.1161/01.ATV.0000153106.03644.a0
   Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419
   Gold ES, 2014, P NATL ACAD SCI USA, V111, P10666, DOI 10.1073/pnas.1404271111
   Gowdy KM, 2015, MUCOSAL IMMUNOL, V8, P559, DOI 10.1038/mi.2014.88
   Jia J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708349
   Karki P, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040981
   Ke YB, 2019, FASEB J, V33, P3887, DOI 10.1096/fj.201800981R
   Kim HJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01142
   Kimura T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13130
   Li JW, 2016, J LIPID RES, V57, P1845, DOI 10.1194/jlr.M069906
   Li Z, 2017, CIRCULATION, V136, P1315, DOI 10.1161/CIRCULATIONAHA.117.027462
   Lin WC, 2020, J CLIN INVEST, V130, P157, DOI 10.1172/JCI127144
   Luchetti F, 2017, REDOX BIOL, V13, P581, DOI 10.1016/j.redox.2017.07.014
   Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316
   Madenspacher JH, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137189
   Maurya MR, 2013, J LIPID RES, V54, P2525, DOI 10.1194/jlr.M040212
   McDonald JG, 2007, METHOD ENZYMOL, V432, P145, DOI 10.1016/S0076-6879(07)32006-5
   Morello F, 2009, ATHEROSCLEROSIS, V207, P38, DOI 10.1016/j.atherosclerosis.2009.04.001
   Morrell ED, 2018, AM J RESP CRIT CARE, V197, P528, DOI 10.1164/rccm.201703-0614LE
   MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720
   Nakano H, 2018, METHODS MOL BIOL, V1799, P59, DOI 10.1007/978-1-4939-7896-0_6
   Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294
   Ou ZJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE781, DOI 10.1152/ajpendo.00218.2016
   Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790
   Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002
   Shibata N, 2013, J BIOL CHEM, V288, P35812, DOI 10.1074/jbc.M113.519637
   Smoak K, 2008, J IMMUNOL, V180, P3305, DOI 10.4049/jimmunol.180.5.3305
   Stapleton RD, 2011, CRIT CARE MED, V39, P1655, DOI 10.1097/CCM.0b013e318218669d
   Sugiura H, 2012, RESPIROLOGY, V17, P533, DOI 10.1111/j.1440-1843.2012.02136.x
   Ware LB, 2001, CRIT CARE MED, V29, P2325, DOI 10.1097/00003246-200112000-00016
   Watanabe Y, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100989
   Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200
   Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203
   Zinter MS, 2016, AM J PHYSIOL-LUNG C, V310, pL224, DOI 10.1152/ajplung.00336.2015
NR 44
TC 1
Z9 1
U1 1
U2 1
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD APR 10
PY 2023
VL 8
IS 7
AR e155448
DI 10.1172/jci.insight.155448
PG 16
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA D6CV8
UT WOS:000969600300001
PM 36821369
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Xavier, PH
   Fonseca, ACF
   Goncalves, LA
   de Sousa, GC
   da Silva, MC
   Sacramento, RFD
   Samary, CD
   Medeiros, M
   Cruz, FF
   Capelozzi, VL
   Felix, NS
   Pelosi, P
   Marini, JJ
   Rocco, PRM
   Silva, PL
AF Xavier, Paulo Henrique
   Fonseca, Ana Carolina Fernandes
   Goncalves, Leonardo Alves
   de Sousa, Giselle Cavalho
   da Silva, Mariana Coelho
   Sacramento, Raquel Ferreira de Magalhaes
   Samary, Cynthia dos Santos
   Medeiros, Mayck
   Cruz, Fernanda Ferreira
   Capelozzi, Vera Luiza
   Felix, Nathane Satanna
   Pelosi, Paolo
   Marini, John J.
   Rocco, Patricia Rieken Macedo
   Silva, Pedro Leme
TI Lung Injury Is Induced by Abrupt Increase in Respiratory Rate but
   Prevented by Recruitment Maneuver in Mild Acute Respiratory Distress
   Syndrome in Rats
SO ANESTHESIOLOGY
LA English
DT Article
ID VENTILATOR-INDUCED LUNG; EXPERIMENTAL PULMONARY; DRIVING PRESSURE; CELL;
   FREQUENCY; STRAIN; IMPACT; EDEMA; FLUID; FLOW
AB Background:Gradually changing respiratory rate (RR) during time to reduce ventilation-induced lung injury has not been investigated. The authors hypothesized that gradual, compared with abrupt, increments in RR would mitigate ventilation-induced lung injury and that recruitment maneuver before abruptly increasing RR may prevent injurious biologic impact. Methods:Twenty-four hours after intratracheal administration of Escherichia coli lipopolysaccharide, 49 male Wistar rats were anesthetized and mechanically ventilated (tidal volume, 6 ml/kg; positive end-expiratory pressure, 3 cm H2O) with RR increase patterns as follows (n = 7 per group): (1) control 1, RR = 70 breaths/min for 2 h; (2) and (3) abrupt increases of RR for 1 and 2 h, respectively, both for 2 h; (4) shorter RR adaptation, gradually increasing RR (from 70 to 130 breaths/min during 30 min); (5) longer RR adaptation, more gradual increase in RR (from 70 to 130 breaths/min during 60 min), both for 2 h; (6) control 2, abrupt increase of RR maintained for 1 h; and (7) control 3, recruitment maneuver (continuous positive airway pressure, 30 cm H2O for 30 s) followed by control-2 protocol. Results:At the end of 1 h of mechanical ventilation, cumulative diffuse alveolar damage scores were lower in shorter (11.0 [8.0 to 12.0]) and longer (13.0 [11.0 to 14.0]) RR adaptation groups than in animals with abrupt increase of RR for 1 h (25.0 [22.0 to 26.0], P = 0.035 and P = 0.048, respectively) and 2 h (35.0 [32.0 to 39.0], P = 0.003 and P = 0.040, respectively); mechanical power and lung heterogeneity were lower, and alveolar integrity was higher, in the longer RR adaptation group compared with abruptly adjusted groups; markers of lung inflammation (interleukin-6), epithelial (club cell secretory protein [CC-16]) and endothelial cell damage (vascular cell adhesion molecule 1 [VCAM-1]) were higher in both abrupt groups, but not in either RR adaptation group, compared with controls. Recruitment maneuver prevented the increase in VCAM-1 and CC-16 gene expressions in the abruptly increased RR groups. Conclusions:In mild experimental acute respiratory distress syndrome in rats, gradually increasing RR, compared with abruptly doing so, can mitigate the development of ventilation-induced lung injury. In addition, recruitment maneuver prevented the injurious biologic impact of abrupt increases in RR.
C1 [Xavier, Paulo Henrique; Fonseca, Ana Carolina Fernandes; Goncalves, Leonardo Alves; de Sousa, Giselle Cavalho; da Silva, Mariana Coelho; Sacramento, Raquel Ferreira de Magalhaes; Samary, Cynthia dos Santos; Medeiros, Mayck; Cruz, Fernanda Ferreira] Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, Lab Pulm Invest, Rio De Janeiro, RJ, Brazil.
   [Samary, Cynthia dos Santos] Univ Fed Rio de Janeiro, Fac Physiotherapy, Dept Cardioresp & Musculoskeletal Physiotherapy, Rio De Janeiro, Brazil.
   [Capelozzi, Vera Luiza; Felix, Nathane Satanna] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil.
   [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy.
   [Pelosi, Paolo] San Martino Policlin Hosp, Anesthesia & Crit Care, IRCCS Oncol & Neurosci, Genoa, Italy.
   [Marini, John J.; Rocco, Patricia Rieken Macedo; Silva, Pedro Leme] Reg Hosp, St Paul, MN, United States.
   [Marini, John J.; Rocco, Patricia Rieken Macedo; Silva, Pedro Leme] Univ Minnesota, St Paul, MN, United States.
C3 Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de
   Janeiro; Universidade de Sao Paulo; University of Genoa; University of
   Minnesota System; University of Minnesota Twin Cities
RP Silva, PL (corresponding author), Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, Ctr Ciencias Saude, Lab Pulm Invest, Ave Carlos Chagas Filho S-N,Bloco G 014, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM phxavier@msn.com; anacarolfernandesf@gmail.com; leoalvesphn@hotmail.com;
   maevesettasilva@gmail.com; ftraquelmagalhaes@gmail.com;
   cynthiasamary@biof.ufrj.br; medeirosmayck@biof.ufrj.br;
   ffcruz@biof.ufrj.br; vera.capelozzi@fm.usp.br; ppelosi@hotmail.com;
   marin002@umn.edu; prmrocco@biof.ufrj.br; Pedro.leme@gmail.com
OI Silva, Pedro/0000-0001-5838-4949; Rieken Macedo Rocco,
   Patricia/0000-0003-1412-7136
FU Brazilian Council for Scientific and Technological Development (CNPq);
   Rio de Janeiro State Research Foundation [FAPERJ E-26/202.766/2018,
   E-26/010.001488/2019]; Sao Paulo State Research Foundation (FAPESP)
   [2018/20403-6]; Coordination for the Improvement of Higher Education
   Personnel (CAPES) [88881.371450/2019-01]; Department of Science and
   Technology - Brazilian Ministry of Health (DECIT/MS)
FX This study was supported by the Brazilian Council for Scientific and
   Technological Development (CNPq), the Rio de Janeiro State Research
   Foundation (FAPERJ E-26/202.766/2018, E-26/010.001488/2019), the Sao
   Paulo State Research Foundation (FAPESP 2018/20403-6), the Coordination
   for the Improvement of Higher Education Personnel (CAPES,
   88881.371450/2019-01), and the Department of Science and Technology -
   Brazilian Ministry of Health (DECIT/MS).
CR Akamine R, 2007, J BIOCHEM BIOPH METH, V70, P481, DOI 10.1016/j.jbbm.2006.11.008
   Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a
   Conrad SA, 2005, CRIT CARE MED, V33, P835, DOI 10.1097/01.CCM.0000159532.56865.8A
   Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522
   Costa ELV, 2021, AM J RESP CRIT CARE, V204, P303, DOI 10.1164/rccm.202009-3467OC
   Cressoni M, 2016, ANESTHESIOLOGY, V124, P1100, DOI 10.1097/ALN.0000000000001056
   Del Sorbo L, 2019, INTENS CARE MED, V45, P1436, DOI 10.1007/s00134-019-05734-7
   du Sert NP, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000410
   Faffe DS, 2009, PHYSIOL REV, V89, P759, DOI 10.1152/physrev.00019.2007
   Felix NS, 2019, ANESTHESIOLOGY, V130, P767, DOI 10.1097/ALN.0000000000002630
   Fernandes MVS, 2022, J APPL PHYSIOL, V132, P375, DOI 10.1152/japplphysiol.00613.2021
   Gattinoni L, 2016, INTENS CARE MED, V42, P1567, DOI 10.1007/s00134-016-4505-2
   Hotchkiss JR, 2000, AM J RESP CRIT CARE, V161, P463, DOI 10.1164/ajrccm.161.2.9811008
   Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST
   Katira BH, 2017, AM J RESP CRIT CARE, V196, P1411, DOI 10.1164/rccm.201611-2268OC
   Kiss T, 2016, BRIT J ANAESTH, V116, P708, DOI 10.1093/bja/aew093
   Kropski JA, 2009, CHEST, V135, P1440, DOI 10.1378/chest.08-2465
   Lopez-Alonso I, 2019, INTENS CARE MED EXP, V7, DOI 10.1186/s40635-019-0222-9
   Marini JJ, 2018, ANESTHESIOLOGY, V128, P1062, DOI 10.1097/ALN.0000000000002203
   Marini JJ, 2016, INTENS CARE MED, V42, P1597, DOI 10.1007/s00134-016-4534-x
   Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST
   Moraes L, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00318
   Moriondo A, 2012, RESP PHYSIOL NEUROBI, V181, P308, DOI 10.1016/j.resp.2012.03.013
   MORTOLA JP, 1983, J APPL PHYSIOL, V55, P250, DOI 10.1152/jappl.1983.55.1.250
   Motta-Ribeiro GC, 2018, AM J RESP CRIT CARE, V198, P891, DOI 10.1164/rccm.201710-2038OC
   Parameswaran H, 2006, J APPL PHYSIOL, V100, P186, DOI 10.1152/japplphysiol.00424.2005
   Paula LF, 2016, J APPL PHYSIOL, V121, P1335, DOI 10.1152/japplphysiol.00861.2015
   Pinto EF, 2020, ANESTHESIOLOGY, V132, P307, DOI 10.1097/ALN.0000000000003060
   Protti A, 2016, CRIT CARE MED, V44, pE838, DOI 10.1097/CCM.0000000000001718
   Retamal J, 2016, ACTA ANAESTH SCAND, V60, P1131, DOI 10.1111/aas.12735
   Rich PB, 2000, J TRAUMA, V49, P903, DOI 10.1097/00005373-200011000-00019
   Riva DR, 2008, CRIT CARE MED, V36, P1900, DOI 10.1097/CCM.0b013e3181760e5d
   Samary CS, 2016, CRIT CARE MED, V44, pE553, DOI 10.1097/CCM.0000000000001611
   Samary CS, 2015, ANESTHESIOLOGY, V123, P423, DOI 10.1097/ALN.0000000000000716
   Santos RS, 2018, ANESTHESIOLOGY, V128, P1193, DOI 10.1097/ALN.0000000000002143
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Neto AS, 2018, INTENS CARE MED, V44, P1914, DOI 10.1007/s00134-018-5375-6
   Silva PL, 2013, CRIT CARE MED, V41, pE256, DOI 10.1097/CCM.0b013e31828a3c13
   Silva PL, 2019, INTENS CARE MED EXP, V7, DOI 10.1186/s40635-019-0243-4
   Uhlig C, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-56
   Vaporidi K, 2008, CRIT CARE MED, V36, P1277, DOI 10.1097/CCM.0b013e318169f30e
   Wallace MJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-19
   WEBB HH, 1974, AM REV RESPIR DIS, V110, P556
   Weber A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51024-z
   Wierzchon CGRS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01071
NR 47
TC 2
Z9 2
U1 2
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0003-3022
EI 1528-1175
J9 ANESTHESIOLOGY
JI Anesthesiology
PD APR
PY 2023
VL 138
IS 4
BP 420
EP 435
DI 10.1097/ALN.0000000000004479
PG 16
WC Anesthesiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology
GA 9R9EY
UT WOS:000945951300012
PM 36571572
DA 2023-08-21
ER

PT J
AU Chen, XR
   Qi, D
   Fan, SL
   He, YR
   Jing, HK
   Wang, DX
AF Chen, Xiaorui
   Qi, Di
   Fan, Shulei
   He, Yirui
   Jing, Hekun
   Wang, Daoxin
TI Interferon regulatory factor 1 (IRF1) inhibits lung endothelial
   regeneration following inflammation-induced acute lung injury
SO CLINICAL SCIENCE
LA English
DT Article
ID STEM-CELLS; LIPOPOLYSACCHARIDE; EXPRESSION; STAT1; PHOSPHORYLATION;
   PROLIFERATION; RESPONSES; GAMMA
AB Background: Acute respiratory distress syndrome (ARDS) is a respiratory condition caused by severe endothelial barrier dysfunction within the lung. In ARDS, excessive inflammation, tissue edema, and immune cell influx prevents endothelial cell regeneration that is crucial in repairing the endothelial barrier. However, little is known about the molecular mechanism that underpin endothelial cell regeneration in ARDS.Methods: R-based bioinformatics tools were used to analyze microarray-derived tran-scription profiles in human lung microvascular endothelial cells (HLMVECs) subjected to non-treatment or lipopolysaccharide (LPS) exposure. We generated endothelial cell-specific interferon regulatory factor 1 (Irf1) knockout (Irf1EC-/-) and Irf1fl/fl control mice for use in an endotoxemic murine model of acute lung injury (ALI). In vitro studies (qPCR, immunoblotting, and ChIP-qPCR) were conducted in mouse lung endothelial cells (MLECs) and HLMVECs. Dual-luciferase promoter reporter assays were performed in HLMVECs.Results: Bioinformatics analyses identified IRF1 as a key up-regulated gene in HLMVECs post-LPS exposure. Endothelial-specific knockout of Irf1 in ALI mice resulted in enhanced regeneration of lung endothelium, while liposomal delivery of endothelial-specific Irf1 to wild-type ALI mice inhibited lung endothelial regeneration in a leukemia inhibitory factor (Lif)-dependent manner. Mechanistically, we demonstrated that LPS-induced Stat1Ser727 phosphorylation promotes Irf1 transactivation, resulting in downstream up-regulation of Lif that inhibits endothelial cell proliferation.Conclusions: These results demonstrate the existence of a p-Stat1Ser727-Irf1-Lif axis that inhibits lung endothelial cell regeneration post-LPS injury. Thus, direct inhibition of IRF1 or LIF may be a promising strategy for enhancing endothelial cell regeneration and improving clinical outcomes in ARDS patients.
C1 [Chen, Xiaorui; Qi, Di; Fan, Shulei; Jing, Hekun; Wang, Daoxin] Chongqing Med Univ, Affiliated Hosp 2, Dept Resp & Crit Care Med, Chongqing, China.
   [He, Yirui] Chongqing Med Univ, Affiliated Hosp 2, Dept Endocrinol, Chongqing, China.
C3 Chongqing Medical University; Chongqing Medical University
RP Chen, XR; Wang, DX (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Resp & Crit Care Med, Chongqing, Peoples R China.
EM cherrycxr123456@qq.com; wangdaoxin@hospital.cqmu.edu.cn
FU National Natural Science Foundation of China [81670071]
FX Funding This work was supported by the National Natural Science
   Foundation of China [grant number 81670071 (to Daoxin Wang) ] .
CR Abe J, 2016, ARTERIOSCL THROM VAS, V36, P1717, DOI 10.1161/ATVBAHA.116.308131
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Buttmann M, 2007, J VASC RES, V44, P51, DOI 10.1159/000097977
   Chang JC, 2019, CLIN APPL THROMB-HEM, V25, DOI 10.1177/1076029619887437
   Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495
   CRAPO JD, 1982, AM REV RESPIR DIS, V126, P332
   Curley GF, 2015, CURR OPIN CRIT CARE, V21, P42, DOI 10.1097/MCC.0000000000000171
   Curley GF, 2013, ANESTHESIOLOGY, V118, P924, DOI 10.1097/ALN.0b013e318287ba08
   Ribeiro LND, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18573-7
   Erdmann J, 2011, J INTERF CYTOK RES, V31, P451, DOI 10.1089/jir.2009.0103
   Gory S, 1999, BLOOD, V93, P184, DOI 10.1182/blood.V93.1.184.401a20_184_192
   Gu MX, 2012, CIRC RES, V111, P882, DOI 10.1161/CIRCRESAHA.112.269001
   Hogan NT, 2017, ELIFE, V6, DOI 10.7554/eLife.22536
   Huang H, 2004, MOL PHARMACOL, V66, P302, DOI 10.1124/mol.66.2.302
   Huang W, 2008, J NEUROCHEM, V107, P497, DOI 10.1111/j.1471-4159.2008.05626.x
   Jambusaria A, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2190-6
   Jia HY, 2018, THROMB RES, V163, P105, DOI 10.1016/j.thromres.2018.01.039
   Johnsen BKB, 2019, J CONTROL RELEASE, V295, P237, DOI 10.1016/j.jconrel.2019.01.005
   Kreft L, 2017, NUCLEIC ACIDS RES, V45, pW490, DOI 10.1093/nar/gkx376
   Lee JH, 2008, BBA-MOL CELL RES, V1783, P1654, DOI 10.1016/j.bbamcr.2008.04.006
   Lin ZS, 2016, PHYTOTHER RES, V30, P663, DOI 10.1002/ptr.5576
   Liu ML, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10134-y
   Liu YG, 2019, TISSUE CELL, V61, P61, DOI 10.1016/j.tice.2019.09.004
   Ma HT, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1109
   Matthay MA, 2010, CHEST, V138, P965, DOI 10.1378/chest.10-0518
   McColm JR, 2006, EXP EYE RES, V83, P438, DOI 10.1016/j.exer.2006.01.027
   Michalska A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01135
   Miyawaki-Shimizu K, 2006, AM J PHYSIOL-LUNG C, V290, pL405, DOI 10.1152/ajplung.00292.2005
   Negishi H, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028423
   Nicole M, 2013, J CARCINOG MUTAGEN, pS6, DOI [10.4172/2157-2518.S6-009, DOI 10.4172/2157-2518.S6-009]
   Park JA, 2006, ONCOL REP, V16, P1253
   Payne S, 2018, ARTERIOSCL THROM VAS, V38, P2550, DOI 10.1161/ATVBAHA.118.309669
   Peng K, 2020, J MOL CELL CARDIOL, V140, P30, DOI 10.1016/j.yjmcc.2020.02.006
   Piaszyk-Borychowska A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01253
   Putz EM, 2013, CELL REP, V4, P437, DOI 10.1016/j.celrep.2013.07.012
   Qin S, 2020, AM J REPROD IMMUNOL, V83, DOI 10.1111/aji.13234
   Su VYF, 2019, STEM CELLS, V37, P1516, DOI 10.1002/stem.3093
   Thomson SJP, 2009, P NATL ACAD SCI USA, V106, P11564, DOI 10.1073/pnas.0904477106
   Twohig JP, 2019, NAT IMMUNOL, V20, P458, DOI 10.1038/s41590-019-0350-0
   Wu J, 2015, J CELL MOL MED, V19, P544, DOI 10.1111/jcmm.12464
   Xu M, 2015, ACTA PHARMACOL SIN, V36, P179, DOI 10.1038/aps.2014.112
   Yamauchi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep38336
   Zhou MY, 1998, J CLIN INVEST, V101, P2427, DOI 10.1172/JCI407
   Zhu LL, 2020, J PHYSIOL BIOCHEM, V76, P147, DOI 10.1007/s13105-020-00729-1
NR 44
TC 0
Z9 0
U1 6
U2 6
PU PORTLAND PRESS LTD
PI LONDON
PA 1ST FLR, 10 QUEEN STREET PLACE, LONDON, ENGLAND
SN 0143-5221
EI 1470-8736
J9 CLIN SCI
JI Clin. Sci.
PD MAR
PY 2023
VL 137
IS 5
BP 367
EP 383
DI 10.1042/CS20220876
PG 17
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA E7LQ8
UT WOS:000977320500002
PM 36857175
OA hybrid, Green Published
DA 2023-08-21
ER

PT J
AU Wang, XY
   Lin, FX
   Guo, LS
AF Wang, Xiaoyu
   Lin, Feixue
   Guo, Lisha
TI TILRR Aggravates Sepsis-Induced Acute Lung Injury by Suppressing the
   PI3K/Akt Pathway
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
AB Acute lung injury (ALI) is a life-threatening lung change, and 40% of ALI cases result from sepsis. However, the effective treatment for sepsis-induced ALI is limited. It is urgent to explore novel therapeutic targets for ALI caused by sepsis. Anti-inflammatory therapy is a potential effective treatment for sepsis-induced ALI. Toll-like/Interleukin-1 receptor regulator (TILRR) could trigger aberrant inflammatory responses. Nevertheless, the role of TILRR in sepsis-induced ALI remains unknown. Besides, the phosphatidylinositol 3 ' kinase/protein kinase B (PI3K/Akt) pathway exerts protective effect on sepsis-induced ALI. Thus, the primary aim of the current study was to investigate whether TILRR contributed to sepsis-induced ALI by the PI3K/Akt pathway. To construct the sepsis-induced ALI model, human pulmonary microvascular endothelial cells (HPMVECs) were treated with lipopolysaccharide (LPS). Besides, the mRNA levels and protein levels were determined by quantitative reverse transcription-PCR (qPCR) and Western blot (WB), respectively. Moreover, cell proliferation was identified by the Cell Counting Kit-8 (CCK-8) assay and Annexin V was utilized to detect apoptosis. Furthermore, levels of proinflammatory cytokines and oxidative stress were tested by the enzyme-linked immunosorbent assay (ELISA) while reactive oxygen species (ROS) was determined by the flow cytometer. Results indicated that TILRR was upregulated to suppress the proliferation and induce apoptosis of HPMVECs under LPS treatment. Besides, TILRR induced aberrant inflammatory responses and oxidative stress in HPMVECs under LPS treatment. Mechanistically, TILRR regulated proliferation, apoptosis, inflammatory responses, and oxidative stress in LPS-treated HPMVECs through inactivating the PI3K/Akt pathway. In summary, TILRR aggravated sepsis-induced ALI by suppressing the PI3K/Akt pathway. These results could provide novel therapy targets for sepsis-induced ALI.
C1 [Wang, Xiaoyu; Guo, Lisha] Binzhou Med Univ Hosp, Dept Emergency, Binzhou 256600, Shandong, China.
   [Lin, Feixue] Binzhou Welf Inst, Binzhou 256600, Shandong, China.
C3 Binzhou Medical University
RP Guo, LS (corresponding author), Binzhou Med Univ Hosp, Dept Emergency, Binzhou 256600, Shandong, Peoples R China.
EM 707301334@qq.com; xzfcc@126.com; ssa.ak@163.com
RI LI, XIAO/IQV-9318-2023
FU Binzhou Medical University "Clinical + X" Scientific and Technological
   Innovation Project;  [BY2021LCX14]
FX AcknowledgmentsThis work was supported by the Binzhou Medical University
   "Clinical + X" Scientific and Technological Innovation Project
   (BY2021LCX14).
CR Abul Kashem M, 2021, J INFLAMM RES, V14, P4927, DOI 10.2147/JIR.S325553
   Abul Kashem M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22157825
   Butt Y, 2016, ARCH PATHOL LAB MED, V140, P345, DOI 10.5858/arpa.2015-0519-RA
   Cecconi M, 2018, LANCET, V392, P75, DOI 10.1016/S0140-6736(18)30696-2
   Huang XT, 2020, FREE RADICAL BIO MED, V146, P222, DOI 10.1016/j.freeradbiomed.2019.11.011
   Jia XQ, 2019, J BUON, V24, P1985
   Kashem MA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00272
   Lee S, 2018, EUR J PHARM SCI, V114, P275, DOI 10.1016/j.ejps.2017.12.019
   Li RR, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5240898
   Li T, 2020, MOL IMMUNOL, V120, P13, DOI 10.1016/j.molimm.2020.01.014
   Lv MC, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-02397-7
   Mokra D, 2015, RESP PHYSIOL NEUROBI, V209, P52, DOI 10.1016/j.resp.2014.10.006
   Qiu N, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-1084-3
   Qiu YL, 2018, BIOCHEM BIOPH RES CO, V503, P436, DOI 10.1016/j.bbrc.2018.04.079
   Rahimi VB, 2019, MOLECULES, V24, DOI 10.3390/molecules24010139
   Salomao R, 2019, BRAZ J MED BIOL RES, V52, DOI [10.1590/1414-431x20198595, 10.1590/1414-431X20198595]
   Shi J, 2019, LAB INVEST, V99, P1795, DOI 10.1038/s41374-019-0286-x
   Smith Sarah A, 2017, JACC Basic Transl Sci, V2, P398, DOI 10.1016/j.jacbts.2017.03.014
   Tang QY, 2020, J BIOL REG HOMEOS AG, V34, P1679, DOI 10.23812/20-252-A
   Wang RH, 2020, EUR REV MED PHARMACO, V24, P5618, DOI 10.26355/eurrev_202005_21349
   Wang YM, 2019, DRUG DES DEV THER, V13, P3391, DOI 10.2147/DDDT.S222296
   Zha LH, 2020, J CELL PHYSIOL, V235, P9557, DOI 10.1002/jcp.29763
   Zhang BH, 2016, ONCOL REP, V35, P1807, DOI 10.3892/or.2015.4479
   Zhang X, 2021, J BIOL REG HOMEOS AG, V35, P59, DOI 10.23812/20-258-A
   Zhang X, 2010, J BIOL CHEM, V285, P7222, DOI 10.1074/jbc.M109.073429
NR 25
TC 2
Z9 2
U1 1
U2 12
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PD AUG 26
PY 2022
VL 2022
AR 7341504
DI 10.1155/2022/7341504
PG 10
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA 4N5ZX
UT WOS:000854099400004
PM 36065264
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Zhang, L
   Li, B
   Zhang, DG
   Zhao, Y
   Yu, Q
AF Zhang, Lei
   Li, Bin
   Zhang, Degang
   Zhao, Ye
   Yu, Qin
TI lncRNA SNHG12 Inhibition Based on Microsystem Cell Imaging Technology
   Protects the Endothelium from LPS-Induced Inflammation by Inhibiting the
   Expression of miR-140-3p Target Gene fndc5
SO CONTRAST MEDIA & MOLECULAR IMAGING
LA English
DT Article
ID ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; DOWN-REGULATION;
   APOPTOSIS; PROLIFERATION; MICRORNA-206; MIGRATION; CYTOKINES; PULMONARY;
   MICE
AB Acute lung injury (ALI) is a serious disease with a high incidence rate, characterized by uncontrolled inflammation and apoptosis. At present, long-chain noncoding RNA (lncRNA) is a noncoding RNA with a length of more than 200 nucleotides. It plays an important role in ALI, cell cycle regulation, cell differentiation regulation, and many other life activities. Therefore, the current focus is to identify and evaluate the possible functions and potential molecular mechanisms of lncRNA small nuclear host gene 12 (SNHG12). Lipopolysaccharide (LPS)-induced mice model and in vitro cell model were established. Gene knockout is to use the principle of DNA homologous recombination to replace the target gene fragment with the designed homologous fragment, so as to achieve the purpose of gene knockout. The relationship between lncRNA SNHG12 expression and ALI was studied through knockdown and overexpression experiments. The qRT-PCR, ROS, immunohistochemistry, histopathology, TUNEL, and cell permeability tests were performed to further verify the possible targets and mechanisms of action. The expression of lncRNA SNHG12 in lung tissue was lower than that in normal tissue. The results showed that lncRNA SNHG12 could reduce lung cell injury and inflammatory cytokines induced by ALI. Bioinformatics analysis showed that lncRNA SNHG12 interacted with miR-140-3p. Subsequent experiments confirmed the link between lncRNA SNHG12, miR-140-3p, and fndc5. Furthermore, this study indicates that lncRNA SNHG12 has a key function in ALI. The results of this study demonstrated the role of lncRNA SNHG12 in the pathological process of ALI and provided a reference for developing novel anti-ALI treatments so that patients can get timely treatment, avoid causing multiple organ failure, and will not endanger their life safety.
C1 [Zhang, Lei; Li, Bin; Zhao, Ye] Lanzhou Univ, Sch Clin Med 1, Dept Crit Care Med, Hosp 1, Lanzhou 730000, Gansu, China.
   [Zhang, Degang] Lanzhou Univ, Dept Resp, Hosp 2, Lanzhou 730000, China.
   [Yu, Qin] Lanzhou Univ, Sch Clin Med 1, Hosp 1, Lanzhou 730000, Gansu, China.
C3 Lanzhou University; Lanzhou University; Lanzhou University
RP Yu, Q (corresponding author), Lanzhou Univ, Sch Clin Med 1, Hosp 1, Lanzhou 730000, Gansu, Peoples R China.
EM yuqin@lzu.edu.cn
CR Backofen R, 2018, METHODS MOL BIOL, V1704, P363, DOI 10.1007/978-1-4939-7463-4_14
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Brandenberger C, 2018, AGING DIS, V9, P553, DOI 10.14336/AD.2017.0902
   Chen CS, 2016, CELL BIOL TOXICOL, V32, P169, DOI 10.1007/s10565-016-9322-4
   Cheng XW, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00263
   Eveillard M, 2010, J INFECTION, V60, P154, DOI 10.1016/j.jinf.2009.09.004
   Fang L, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/283939
   Fang Y, 2017, AM J TRANSL RES, V9, P1287
   Fu XD, 2016, BIOCHEM BIOPH RES CO, V477, P167, DOI 10.1016/j.bbrc.2016.06.038
   Huang JL, 2014, CARCINOGENESIS, V35, P507, DOI 10.1093/carcin/bgt405
   Lan T, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0486-9
   Li B, 2021, FASEB J, V35, DOI 10.1096/fj.201900076RRRRR
   Li WQ, 2016, BIOMED PHARMACOTHER, V84, P1375, DOI 10.1016/j.biopha.2016.10.065
   Liu XB, 2018, MOL THER-NUCL ACIDS, V10, P142, DOI 10.1016/j.omtn.2017.12.001
   Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158
   Mendez JL, 2005, CURR OPIN CRIT CARE, V11, P29, DOI 10.1097/00075198-200502000-00005
   Parsey MV, 1998, J IMMUNOL, V160, P1007
   Peng WX, 2017, ONCOGENE, V36, P5661, DOI 10.1038/onc.2017.184
   Rajasekaran S, 2016, J CELL PHYSIOL, V231, P2097, DOI 10.1002/jcp.25316
   Song L, 2017, INFLAMMATION, V40, P927, DOI 10.1007/s10753-017-0537-1
   Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621
   Stapleton RD, 2005, CHEST, V128, P525, DOI 10.1378/chest.128.2.525
   Su ZQ, 2014, INT IMMUNOPHARMACOL, V22, P371, DOI 10.1016/j.intimp.2014.06.043
   Sun CC, 2015, ONCOTARGET, V6, P25533, DOI 10.18632/oncotarget.4575
   Tang RR, 2016, BIOTECHNOL LETT, V38, P1277, DOI 10.1007/s10529-016-2107-2
   Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368
   Wang OC, 2017, AM J TRANSL RES, V9, P533
   Wu CT, 2018, INT J BIOCHEM CELL B, V101, P1, DOI 10.1016/j.biocel.2018.04.019
   Zhai W, 2015, INT J ONCOL, V46, P2125, DOI 10.3892/ijo.2015.2897
   Zhang HY, 2018, MOL MED REP, V17, P2743, DOI 10.3892/mmr.2017.8143
   Zhao G, 2017, ONCOTARGET, V8, P68153, DOI 10.18632/oncotarget.19249
   Zhou S, 2018, BIOCHEM BIOPH RES CO, V495, P1822, DOI 10.1016/j.bbrc.2017.12.047
NR 32
TC 2
Z9 2
U1 0
U2 0
PU WILEY-HINDAWI
PI LONDON
PA ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 1555-4309
EI 1555-4317
J9 CONTRAST MEDIA MOL I
JI Contrast Media Mol. Imaging
PD AUG 13
PY 2022
VL 2022
AR 1681864
DI 10.1155/2022/1681864
PG 12
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA 3Y8MJ
UT WOS:000843975800006
PM 36034208
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Jonigk, D
   Werlein, C
   Lee, PD
   Kauczor, HU
   Langer, F
   Ackermann, M
AF Jonigk, Danny
   Werlein, Christopher
   Lee, Peter D.
   Kauczor, Hans-Ulrich
   Laenger, Florian
   Ackermann, Maximilian
TI Pulmonary and Systemic Pathology in COVID-19
SO DEUTSCHES ARZTEBLATT INTERNATIONAL
LA English
DT Review
AB Background: The COVID-19 pandemic is the third worldwide coronavirus-associated disease outbreak in the past 20 years. Lung involvement, with acute respiratory distress syndrome (ARDS) in severe cases, is the main clinical feature of this disease; the cardiovascular system, the central nervous system, and the gastrointestinal tract can also be affected. The pathophysiology of both pulmonary and extrapulmonary organ damage was almost completely unknown when the pandemic began.Methods: This review is based on pertinent publications retrieved by a selective search concerning the structural changes and pathophysiology of COVID-19, with a focus on imaging techniques. Results: Immunohistochemical, electron-microscopic and molecular pathological analyses of tissues obtained by autopsy have improved our understanding of COVID-19 pathophysiology, including molecular regulatory mechanisms. Intussusceptive angio-genesis (IA) has been found to be a prominent pattern of damage in the affected organs of COVID-19 patients. In IA, an existing vessel changes by invagination of the endothelium and formation of an intraluminal septum, ultimately giving rise to two new lumina. This alters hemodynamics within the vessel, leading to a loss of laminar flow and its replacement by turbulent, inhomo-geneous flow. IA, which arises because of ischemia due to thrombosis, is itself a risk factor for the generation of further micro -thrombi; these have been detected in the lungs, heart, liver, kidneys, brain, and placenta of COVID-19 patients.Conclusion: Studies of autopsy material from various tissues of COVID-19 patients have revealed ultrastructural evidence of altered microvascularity, IA, and multifocal thrombi. These changes may contribute to the pathophysiology of post-acute intersti-tial fibrotic organ changes as well as to the clinical picture of long COVID.
C1 [Jonigk, Danny; Werlein, Christopher; Laenger, Florian] Hannover Med Sch, Inst Pathol, Carl Neuberg Str 1, D-30625 Hannover, Germany.
   [Jonigk, Danny; Laenger, Florian] German Ctr Lung Res DZL, Biomed Res Endstage & Obstructive Lung Dis, Hannover Site, Hannover, Germany.
   [Lee, Peter D.] UCL, Fac Engn Sci, Dept Mech Engn, London, England, United Kingdom.
   [Kauczor, Hans-Ulrich] Heidelberg Univ Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.
   [Kauczor, Hans-Ulrich] Heidelberg Univ Hosp, Translat Lung Res Ctr Heidelberg, Heidelberg, Germany.
   [Ackermann, Maximilian] Univ Hosp Witten Herdecke, Helios Univ Hosp Wuppertal, Inst Pathol & Mol Pathol, Wuppertal, Germany.
   [Ackermann, Maximilian] Univ Med Ctr Mainz, Inst Funct & Clin Anat, Mainz, Germany.
C3 Hannover Medical School; University of London; University College
   London; Ruprecht Karls University Heidelberg; Ruprecht Karls University
   Heidelberg; Johannes Gutenberg University of Mainz
RP Jonigk, D (corresponding author), Hannover Med Sch, Inst Pathol, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM Jonigk.danny@mh-hannover.de
FU Royal Academy of Engineering [PDL - CiET1819/10]; UK Medical Research
   Council [MR/R025673/1]; Chan Zuckerberg Initiative DAF, an advised fund
   of Silicon Valley Community Foundation from the Chan Zuckerberg
   Initiative Foundation [CZIF2021-006424, 2020-225394]; European
   Synchrotron Research Facility
FX Prof. Lee received financial support from the Royal Academy of
   Engineering (PDL - CiET1819/10), the UK Medical Research Council
   (MR/R025673/1), grant number 2020-225394 from the Chan Zuckerberg
   Initiative DAF, an advised fund of Silicon Valley Community Foundation
   (grant number CZIF2021-006424) from the Chan Zuckerberg Initiative
   Foundation, and the European Synchrotron Research Facility, proposals
   md1252 and md1290.
CR Ackermann M, 2022, AM J RESP CRIT CARE, V205, P121, DOI 10.1164/rccm.202103-0594IM
   Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Alsaad KO, 2018, HISTOPATHOLOGY, V72, P516, DOI 10.1111/his.13379
   Chen Jie, 2003, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V25, P360
   Eckermann M, 2020, ELIFE, V9, DOI 10.7554/eLife.60408
   Groff D, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.28568
   Jonigk D, 2021, INTENS CARE MED, V47, P86, DOI 10.1007/s00134-020-06302-0
   Jud P, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.750887
   Kamp JC, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23031583
   Kamp JC, 2022, INT J MOL SCI, V23, P1
   Lang M, 2020, RADIOL-CARDIOTHORAC, V2, DOI 10.1148/ryct.2020200277
   Mentzer SJ, 2014, ANGIOGENESIS, V17, P499, DOI 10.1007/s10456-014-9428-3
   Reichardt M, 2021, ELIFE, V10, DOI [10.7554/eLife.71359, 10.7554/eLife.71359.sa0, 10.7554/eLife.71359.sa1, 10.7554/eLife.71359.sa2]
   Ribatti D, 2012, CANCER LETT, V316, P126, DOI 10.1016/j.canlet.2011.10.040
   Tzankov A, 2020, VIRCHOWS ARCH, V477, P331, DOI 10.1007/s00428-020-02887-5
   Verleden SE, 2016, AM J TRANSPLANT, V16, P3262, DOI 10.1111/ajt.13945
   von Stillfried S, 2021, PATHOLOGE, V42, P216, DOI 10.1007/s00292-020-00891-9
   von Stillfried S, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012885
   Yeahia R, 2022, CLIN IMAG, V81, P107, DOI 10.1016/j.clinimag.2021.10.003
   Zhang D, 2021, EUR RADIOL, V31, P7172, DOI 10.1007/s00330-021-07799-9
NR 20
TC 4
Z9 4
U1 2
U2 3
PU DEUTSCHER AERZTE-VERLAG GMBH
PI COLOGNE
PA DIESELSTRABE 2, POSTFACH 400265, D-50859 COLOGNE, GERMANY
SN 1866-0452
J9 DTSCH ARZTEBL INT
JI Dtsch. Arztebl. Int.
PD JUN 24
PY 2022
VL 119
IS 25
BP 429
EP +
DI 10.3238/arztebl.m2022.0231
PG 16
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 6R3NQ
UT WOS:000892214600001
PM 35698804
OA Green Published, Green Submitted
DA 2023-08-21
ER

PT J
AU Qian, YS
   Wang, ZW
   Lin, HR
   Lei, TH
   Zhou, Z
   Huang, WL
   Wu, XH
   Zuo, L
   Wu, J
   Liu, Y
   Wang, LF
   Guan, XH
   Deng, KY
   Fu, MG
   Xin, HB
AF Qian, Yisong
   Wang, Ziwei
   Lin, Hongru
   Lei, Tianhua
   Zhou, Zhou
   Huang, Weilu
   Wu, Xuehan
   Zuo, Li
   Wu, Jie
   Liu, Yu
   Wang, Ling-Fang
   Guan, Xiao-Hui
   Deng, Ke-Yu
   Fu, Mingui
   Xin, Hong-Bo
TI TRIM47 is a novel endothelial activation factor that aggravates
   lipopolysaccharide-induced acute lung injury in mice via K63-linked
   ubiquitination of TRAF2
SO SIGNAL TRANSDUCTION AND TARGETED THERAPY
LA English
DT Article
ID SEVERE SEPSIS; DEGRADATION; PROTEIN; DYSFUNCTION; PROGRESSION; PROMOTES;
   IMMUNITY; CANCER; GENE
AB Endothelial activation plays an essential role in the pathogenesis of sepsis-induced acute lung injury, however, the detailed regulatory mechanisms remain largely unknown. Here, we reported that TRIM47, an E3 ubiquitin ligase of the tripartite motif-containing protein family, was highly expressed in vascular endothelial cells. TRIM47-deficient mice were effectively resistant to lipopolysaccharide (LPS)-induced acute lung injury and death by attenuating pulmonary inflammation. TRIM47 was upregulated during TNF alpha-induced endothelial activation in vitro. Knockdown of TRIM47 in endothelial cells inhibited the transcription of multiple pro-inflammatory cytokines, reduced monocyte adhesion and the expression of adhesion molecules, and suppressed the secretion of IL-1 beta and IL-6 in endothelial cells. By contrast, overexpression of TRIM47 promoted inflammatory response and monocyte adhesion upon TNF alpha stimulation. In addition, TRIM47 was able to activate the NF-kappa B and MAPK signaling pathways during endothelial activation. Furthermore, our experiments revealed that TRIM47 resulted in endothelial activation by promoting the K63-linked ubiquitination of TRAF2, a key component of the TNF alpha signaling pathway. Taken together, our studies demonstrated that TRIM47 as a novel activator of endothelial cells, promoted LPS-induced pulmonary inflammation and acute lung injury through potentiating the K63-linked ubiquitination of TRAF2, which in turn activates NF-kappa B and MAPK signaling pathways to trigger an inflammatory response in endothelial cells.
C1 [Qian, Yisong; Wang, Ziwei; Lin, Hongru; Huang, Weilu; Wu, Xuehan; Zuo, Li; Wu, Jie; Liu, Yu; Wang, Ling-Fang; Guan, Xiao-Hui; Deng, Ke-Yu; Xin, Hong-Bo] Nanchang Univ, Natl Engn Res Ctr Bioengn Drugs & Technol, Inst Translat Med, 1299 Xuefu Rd, Nanchang 330031, Jiangxi, China.
   [Qian, Yisong; Lei, Tianhua; Zhou, Zhou; Fu, Mingui] Univ Missouri, Sch Med, Dept Biomed Sci, 2411 Holmes St, Kansas City, MO 64108, United States.
C3 Nanchang University; University of Missouri System; University of
   Missouri Kansas City
RP Xin, HB (corresponding author), Nanchang Univ, Natl Engn Res Ctr Bioengn Drugs & Technol, Inst Translat Med, 1299 Xuefu Rd, Nanchang 330031, Jiangxi, Peoples R China.; Fu, MG (corresponding author), Univ Missouri, Sch Med, Dept Biomed Sci, 2411 Holmes St, Kansas City, MO 64108 USA.
EM fum@umkc.edu; xinhb@ncu.edu.cn
RI wang, ziqi/IQS-5011-2023; wang, ziwei/HQY-9921-2023; Wang,
   Zhiquan/HHS-6768-2022; Wang, Zilong/IQV-2260-2023
FU National Natural Science Foundation of China [82070080, 81860020,
   81873659, 81760140, 81970256]; Foundation for the National Institutes of
   Health [1R15AI138116]; China Scholarship Council [201906825031]
FX This work was supported by the National Natural Science Foundation of
   China (82070080 and 81860020 to Y.Q., 81873659 to H.-B.X., and 81760140
   and 81970256 to K.Y.D.), Foundation for the National Institutes of
   Health (1R15AI138116 to M.F.), and the financial support provided by
   China Scholarship Council (201906825031 to Y.Q.).
CR Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887
   Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004
   Chen JX, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-01831-0
   Dou SJ, 2021, ELIFE, V10, DOI 10.7554/eLife.66501
   Fornage M, 2011, ANN NEUROL, V69, P928, DOI 10.1002/ana.22403
   Gleeson EM, 2012, CELL MOL LIFE SCI, V69, P717, DOI 10.1007/s00018-011-0825-0
   Han YD, 2017, ONCOTARGET, V8, P22730, DOI 10.18632/oncotarget.15188
   Hao MQ, 2019, BIOCHEM BIOPH RES CO, V515, P651, DOI 10.1016/j.bbrc.2019.05.065
   Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002
   Hoffpauir CT, 2020, J IMMUNOL, V205, P153, DOI 10.4049/jimmunol.1901511
   Huang X, 2020, J MOL CELL BIOL, V12, P176, DOI 10.1093/jmcb/mjz040
   Ince C, 2016, SHOCK, V45, P259, DOI 10.1097/SHK.0000000000000473
   Ji YX, 2018, NAT MED, V24, P213, DOI 10.1038/nm.4461
   Jiang MX, 2017, SCI REP-UK, V7, DOI 10.1038/srep42781
   Li L, 2021, PHARMACOL RES, V166, DOI 10.1016/j.phrs.2021.105429
   Li L, 2020, LIFE SCI, V256, DOI 10.1016/j.lfs.2020.117893
   Li Y, 2020, J MOL CELL BIOL, V12, P190, DOI 10.1093/jmcb/mjz077
   Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641
   Liang Q, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1143-x
   Liu YC, 2020, J IMMUNOL, V204, P1499, DOI 10.4049/jimmunol.1900482
   Luo DH, 2006, AM J PATHOL, V169, P1886, DOI 10.2353/ajpath.2006.060603
   Maarifi G, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax3511
   Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009
   Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x
   Park ES, 2015, J BIOL CHEM, V290, P9660, DOI 10.1074/jbc.M114.609685
   Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976
   Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11
   Vallet B, 2003, CRIT CARE, V7, P130, DOI 10.1186/cc1864
   van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323
   Vandeputte DAA, 2001, BIOCHEM BIOPH RES CO, V286, P574, DOI 10.1006/bbrc.2001.5431
   Versteeg GA, 2014, CYTOKINE GROWTH F R, V25, P563, DOI 10.1016/j.cytogfr.2014.08.001
   Wang YQ, 2020, CHEM-BIOL INTERACT, V317, DOI 10.1016/j.cbi.2020.108960
   Wang YD, 2017, GENE, V627, P188, DOI 10.1016/j.gene.2017.06.017
   Wang YF, 2017, FASEB J, V31, P2026, DOI 10.1096/fj.201600988RR
   Wei HM, 2020, ONCOTARGETS THER, V13, P13401, DOI 10.2147/OTT.S264459
   Xing Y, 2017, J IMMUNOL, V199, P1561, DOI 10.4049/jimmunol.1700175
   Yang LL, 2014, MOLECULES, V19, P2390, DOI 10.3390/molecules19022390
   Yu T, 2020, J BIOL CHEM, V295, P8846, DOI 10.1074/jbc.RA119.012043
   Zhao W, 2012, J IMMUNOL, V188, P2567, DOI 10.4049/jimmunol.1103255
NR 39
TC 9
Z9 9
U1 4
U2 14
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2095-9907
EI 2059-3635
J9 SIGNAL TRANSDUCT TAR
JI Signal Transduct. Target. Ther.
PD MAY 6
PY 2022
VL 7
IS 1
AR 148
DI 10.1038/s41392-022-00953-9
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 0Z7XF
UT WOS:000791285800001
PM 35513381
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Qi, D
   Deng, W
   Chen, XR
   Fan, SL
   Peng, JN
   Tang, XM
   Wang, DX
   Yu, Q
AF Qi, Di
   Deng, Wang
   Chen, Xiaorui
   Fan, Shulei
   Peng, Junnan
   Tang, Xumao
   Wang, Daoxin
   Yu, Qian
TI Adipose-Derived Circulating Exosomes Promote Protection of the Pulmonary
   Endothelial Barrier by Inhibiting EndMT and Oxidative Stress through
   Down-Regulation of the TGF-beta Pathway: A Potential Explanation for the
   Obesity Paradox in ARDS
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; FATTY LIVER-DISEASE; INTENSIVE-CARE;
   MIRNAS; MECHANISM; HEALTH; SERUM; RNAS
AB The "obesity paradox in acute respiratory distress syndrome" (ARDS) refers to the phenomenon in which obesity is associated with higher morbidity but lower mortality in patients with ARDS. Endothelial-to-mesenchymal transition (EndMT) represents a key link in the interaction between endothelial disruption and mesenchymal fibrosis under inflammatory and oxidative conditions, which represent the intersectional pathophysiology of ARDS. Adipose tissue is considered to constitute the major source of circulating exosomal microRNAs (miRNAs), which act as genetic forms of adipokines for cell-cell crosstalk. We aimed to demonstrate the regulation and mechanism of adipose-derived exosomes in the obesity paradox in ARDS. High-fat-induced obese mice and lean control mice were subjected to ARDS insult to investigate the effects of obesity on ARDS and microarray analysis was performed to screen for differences in circulating miRNAs. In addition, mice and pulmonary endothelial cells were administered with adipose-derived exosomal miR-122-5p to investigate the underlying molecular mechanisms. We found high-fat diet-induced obesity protected against ARDS in mice by reinforcing endothelial barrier and attenuating fibroproliferation. Circulating exosomes produced in the obese state mediated these protective effects by inhibiting EndMT and oxidative stress. Mechanistically, adipose-derived exosomal miR-122-5p promoted the integrity and function of pulmonary endothelial barrier and alleviated fibrogenesis by suppressing EndMT and oxidative stress through down-regulation of the transforming growth factor beta 1 (TGF-beta 1)/TGF-beta receptor 1 (TGF-beta R1)/Smad2 pathway in vivo and in vitro. In conclusion, adipose-derived circulating exosomal miR-122-5p protects against ARDS by reinforcing pulmonary endothelial barrier through inhibition of EndMT and oxidative stress via down-regulation of the TGF-beta pathway, which propose a potential explanation for the obesity paradox in ARDS and indicate promising prospects for adipose-derived exosomes in cell-free therapies for ARDS.
C1 [Qi, Di; Deng, Wang; Chen, Xiaorui; Fan, Shulei; Peng, Junnan; Tang, Xumao; Wang, Daoxin; Yu, Qian] Chongqing Med Univ, Dept Resp Med, Affiliated Hosp 2, Chongqing, China.
C3 Chongqing Medical University
RP Wang, DX; Yu, Q (corresponding author), Chongqing Med Univ, Dept Resp Med, Affiliated Hosp 2, Chongqing, Peoples R China.
EM qidi@hospital.cqmu.edu.cn; dengwang@hospital.cqmu.edu.cn;
   chenxiaorui@stu.cqmu.edu.cn; fsl0311@163.com; pengjn@stu.cqmu.edu.cn;
   darktxm@163.com; wangdaoxin@hospital.cqmu.edu.cn;
   yuqian@hospital.cqmu.edu.cn
RI Yu, Qian/I-1460-2018
OI Yu, Qian/0000-0002-2066-6681
FU National Natural Science Foundation for Young Scholars of China
   [81800083]; Postdoctoral Science Foundation of China [2019M653832XB];
   Natural Science Foundation of Chongqing [cstc2019jcyj-zdxmX0031]
FX We thank all the members of Wang's laboratory for full cooperation. We
   appreciate Enago for providing language assistance. This work was
   supported by the National Natural Science Foundation for Young Scholars
   of China (Grant NO. 81800083), Postdoctoral Science Foundation of China
   (Grant NO. 2019M653832XB), Natural Science Foundation of Chongqing
   (Grant NO. cstc2019jcyj-zdxmX0031), and special funding for postdoctoral
   research of Chongqing.
CR Ball L, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1682-5
   Baranova A, 2019, OBES REV, V20, P108, DOI 10.1111/obr.12765
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Bischoff J, 2019, CIRC RES, V124, P1163, DOI 10.1161/CIRCRESAHA.119.314813
   Brandt S, 2018, PEDIATR OBES, V13, P175, DOI 10.1111/ijpo.12261
   Cho JG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00294
   Cooley BC, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006927
   Crewe C, 2021, CELL METAB, V33, P1853, DOI 10.1016/j.cmet.2021.08.002
   Deng ZB, 2009, DIABETES, V58, P2498, DOI 10.2337/db09-0216
   Fan XF, 2015, CHEST, V147, P969, DOI 10.1378/chest.14-1426
   Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014
   Fatima F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00545
   Ferrante SC, 2015, PEDIATR RES, V77, P447, DOI 10.1038/pr.2014.202
   Flaherty SE, 2019, SCIENCE, V363, P989, DOI 10.1126/science.aaw2586
   Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743
   Guervilly C, 2011, CRIT CARE, V15, DOI 10.1186/cc9978
   Heneghan HM, 2011, J CLIN ENDOCR METAB, V96, pE846, DOI 10.1210/jc.2010-2701
   Ji CB, 2019, NAT REV ENDOCRINOL, V15, P731, DOI 10.1038/s41574-019-0260-0
   Kubo H, 2018, CHEST, V153, P210, DOI 10.1016/j.chest.2017.06.026
   Li XR, 2019, CELL METAB, V30, P414, DOI 10.1016/j.cmet.2019.08.011
   Miyaaki H, 2014, LIVER INT, V34, pE302, DOI 10.1111/liv.12429
   Ni YN, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1615-3
   Nseir S, 2021, CHEST, V159, P2309, DOI 10.1016/j.chest.2021.01.081
   Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162
   Pepper DJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1360-z
   Perez L, 2017, CYTOKINE GROWTH F R, V33, P41, DOI 10.1016/j.cytogfr.2016.09.002
   Pirola CJ, 2015, GUT, V64, P800, DOI 10.1136/gutjnl-2014-306996
   Qi D, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.265
   Rho SS, 2017, J NIPPON MED SCH, V84, P148, DOI 10.1272/jnms.84.148
   Sakr Y, 2008, INTENS CARE MED, V34, P1999, DOI 10.1007/s00134-008-1243-0
   Sakr Y, 2015, CRIT CARE MED, V43, P2623, DOI 10.1097/CCM.0000000000001310
   Schetz M, 2019, INTENS CARE MED, V45, P757, DOI 10.1007/s00134-019-05594-1
   Shah D, 2019, FASEB J, V33, P13617, DOI 10.1096/fj.201901123R
   Shah R, 2017, DIABETES CARE, V40, P546, DOI 10.2337/dc16-1354
   Thille AW, 2013, LANCET RESP MED, V1, P395, DOI 10.1016/S2213-2600(13)70053-5
   Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365
   Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]
   Villar J, 2019, CHEST, V155, P587, DOI 10.1016/j.chest.2018.10.022
   Wilson MR, 2017, CRIT CARE MED, V45, pE831, DOI 10.1097/CCM.0000000000002403
   Yin SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11012
   Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035
   Yu Q, 2020, AM J PHYSIOL-LUNG C, V318, pL723, DOI 10.1152/ajplung.00255.2019
NR 42
TC 4
Z9 4
U1 1
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD MAY 5
PY 2022
VL 2022
AR 5475832
DI 10.1155/2022/5475832
PG 25
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 1J1JV
UT WOS:000797681500006
PM 35571250
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Tang, WF
   Li, M
   Yangzhong, XT
   Zhang, XF
   Zu, AN
   Hou, YJ
   Li, L
   Sun, SB
AF Tang, Weifeng
   Li, Min
   Yangzhong, Xiaoting
   Zhang, Xifeng
   Zu, Anju
   Hou, Yunjiao
   Li, Lin
   Sun, Shibo
TI Hippo signaling pathway and respiratory diseases
SO CELL DEATH DISCOVERY
LA English
DT Review
ID PULMONARY ARTERIAL-HYPERTENSION; AIRWAY SMOOTH-MUSCLE; FIBROBLAST
   ACTIVATION; CELL PROLIFERATION; YAP; INJURY; HOMEOSTASIS;
   SPHINGOSINE-1-PHOSPHATE; DIFFERENTIATION; INFLAMMATION
AB The hippo signaling pathway is a highly conserved evolutionary signaling pathway that plays an important role in regulating cell proliferation, organ size, tissue development, and regeneration. Increasing evidences consider that the hippo signaling pathway is involved in the process of respiratory diseases. Hippo signaling pathway is mainly composed of mammalian STE20-like kinase 1/2 (MST1/2), large tumor suppressor 1/2 (LATS1/2), WW domain of the Sav family containing protein 1 (SAV1), MOB kinase activator 1 (MOB1), Yes-associated protein (YAP) or transcriptional coactivator with PDZ-binding motif (TAZ), and members of the TEA domain (TEAD) family. YAP is the cascade effector of the hippo signaling pathway. The activation of YAP promotes pulmonary arterial vascular smooth muscle cells (PAVSMCs) proliferation, which leads to pulmonary vascular remodeling; thereby the pulmonary arterial hypertension (PAH) is aggravated. While the loss of YAP leads to high expression of inflammatory genes and the accumulation of inflammatory cells, the pneumonia is consequently exacerbated. In addition, overexpressed YAP promotes the proliferation of lung fibroblasts and collagen deposition; thereby the idiopathic pulmonary fibrosis (IPF) is promoted. Moreover, YAP knockout reduces collagen deposition and the senescence of adult alveolar epithelial cells (AECs); hence the IPF is slowed. In addition, hippo signaling pathway may be involved in the repair of acute lung injury (ALI) by promoting the proliferation and differentiation of lung epithelial progenitor cells and intervening in the repair of pulmonary capillary endothelium. Moreover, the hippo signaling pathway is involved in asthma. In conclusion, the hippo signaling pathway is involved in respiratory diseases. More researches are needed to focus on the molecular mechanisms by which the hippo signaling pathway participates in respiratory diseases.
C1 [Tang, Weifeng; Li, Min; Yangzhong, Xiaoting; Zhang, Xifeng; Zu, Anju; Hou, Yunjiao; Li, Lin; Sun, Shibo] Kunming Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Kunming, Yunnan, China.
   [Tang, Weifeng] Kunming Med Univ, Seven Class, Clin Med, 2019 Grade, Kunming, Yunnan, China.
   [Yangzhong, Xiaoting] Kunming Med Univ, First Class, Pediat, 2020 Grade, Kunming, Yunnan, China.
C3 Kunming Medical University; Kunming Medical University; Kunming Medical
   University
RP Sun, SB (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Kunming, Yunnan, Peoples R China.
EM shibosunky@126.com
OI Sun, shibo/0000-0001-9287-1820
FU National Natural Science Foundation of China [82160007]; Yunnan
   Provincial Science and Technology Department [2019FE001 (-058)]
FX The present study was funded by the National Natural Science Foundation
   of China (No. 82160007) and the Yunnan Provincial Science and Technology
   Department [Nos. 2019FE001 (-058)].
CR Aspal M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093188
   Bae SJ, 2020, ELIFE, V9, DOI 10.7554/eLife.54863
   Bandaru P, 2020, SMALL, V16, DOI 10.1002/smll.202001837
   Banerjee P, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93845-x
   Bian S, 2021, INT J NANOMED, V16, P2247, DOI 10.2147/IJN.S300594
   Boopathy GTK, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00049
   Bridgeman MB, 2021, J PHARM PRACT, V34, P149, DOI 10.1177/0897190020927274
   Chanda D, 2019, MOL ASPECTS MED, V65, P56, DOI 10.1016/j.mam.2018.08.004
   Chen HH, 2021, AM J HUM GENET, V108, P194, DOI 10.1016/j.ajhg.2020.12.010
   Chen Q, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107828
   Chen YZ, 2019, CELL DEATH DIFFER, V26, P1832, DOI 10.1038/s41418-018-0250-0
   Cheng JB, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00281
   Choi YJ, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.02226-2020
   Chun J, 2021, DRUGS, V81, P207, DOI 10.1007/s40265-020-01431-8
   Dasgupta I, 2019, J BIOL CHEM, V294, P17693, DOI 10.1074/jbc.REV119.007963
   Davis JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180329
   Dong L, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/4851431
   Dong LY, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-020-02072-0
   Driskill JH, 2021, ANNU REV PATHOL-MECH, V16, P299, DOI 10.1146/annurev-pathol-030420-105050
   Flinn MA, 2020, SEMIN CELL DEV BIOL, V100, P11, DOI 10.1016/j.semcdb.2019.09.004
   Fodor LE, 2017, ALLERGY ASTHMA IMMUN, V9, P247, DOI 10.4168/aair.2017.9.3.247
   Fu Siling, 2017, Yichuan, V39, P597, DOI 10.16288/j.yczz.17-056
   Gokey JJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98738
   Hammad H, 2020, NAT IMMUNOL, V21, P1313, DOI 10.1038/s41590-020-0797-z
   Han ZY, 2020, J BIOL CHEM, V295, P8596, DOI 10.1074/jbc.AC120.013171
   Harb H, 2020, NAT IMMUNOL, V21, P1359, DOI 10.1038/s41590-020-0777-3
   He JL, 2018, BRIT J PHARMACOL, V175, P1354, DOI 10.1111/bph.13806
   Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014
   Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59
   Hoxha S, 2020, CANCER RES, V80, P2512, DOI 10.1158/0008-5472.CAN-19-2415
   Nguyen HT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169587
   Ibar C, 2020, DEV CELL, V54, P256, DOI 10.1016/j.devcel.2020.06.025
   Islam MS, 2021, CLIN TRANSL MED, V11, DOI 10.1002/ctm2.475
   Jeong JH, 2021, ARCH PHARM RES, V44, P1, DOI 10.1007/s12272-020-01287-2
   Jia XX, 2021, INT J MOL MED, V47, P195, DOI 10.3892/ijmm.2020.4791
   Ju MJ, 2018, CELL CYCLE, V17, P2001, DOI 10.1080/15384101.2018.1509635
   Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025
   Kudryashova TV, 2016, AM J RESP CRIT CARE, V194, P866, DOI 10.1164/rccm.201510-2003OC
   LaCanna R, 2019, J CLIN INVEST, V129, P2107, DOI 10.1172/JCI125014
   Landry NM, 2021, BASIC RES CARDIOL, V116, DOI 10.1007/s00395-021-00865-9
   Lange AW, 2015, J MOL CELL BIOL, V7, P35, DOI 10.1093/jmcb/mju046
   Li FW, 2017, FEBS OPEN BIO, V7, P1880, DOI 10.1002/2211-5463.12322
   Li SY, 2019, THERANOSTICS, V9, P4993, DOI 10.7150/thno.35665
   Li YC, 2020, CELL DEATH DIFFER, V27, P2635, DOI 10.1038/s41418-020-0528-x
   Lin L, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01337
   Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014
   Liu J, 2020, J CELL MOL MED, V24, P5786, DOI 10.1111/jcmm.15241
   Liu L, 2018, AM J PHYSIOL-LUNG C, V315, pL609, DOI 10.1152/ajplung.00554.2017
   Liu PF, 2021, REDOX BIOL, V38, DOI 10.1016/j.redox.2020.101766
   Liu Y, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8871476
   Luo JQ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050426
   Luo Q, 2020, J INFLAMM RES, V13, P1279, DOI 10.2147/JIR.S288244
   Ma SH, 2019, ANNU REV BIOCHEM, V88, P577, DOI 10.1146/annurev-biochem-013118-111829
   Mammoto T, 2019, AM J RESP CELL MOL, V60, P117, DOI 10.1165/rcmb.2018-0105OC
   Mana-Capelli S, 2018, J BIOL CHEM, V293, P18230, DOI 10.1074/jbc.RA118.004187
   Masliantsev K, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010184
   Matthaios D, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9121949
   Meliambro K, 2017, J BIOL CHEM, V292, P21137, DOI 10.1074/jbc.M117.819029
   Meng ZP, 2018, NATURE, V560, P655, DOI 10.1038/s41586-018-0444-0
   Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115
   Michalski JE, 2020, J INFLAMM RES, V13, P1305, DOI 10.2147/JIR.S280958
   Miller AJ, 2017, PHYSIOLOGY, V32, P246, DOI 10.1152/physiol.00041.2016
   Misra JR, 2018, ANNU REV GENET, V52, P65, DOI 10.1146/annurev-genet-120417-031621
   Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111
   Mo JS, 2017, BMB REP, V50, P71, DOI 10.5483/BMBRep.2017.50.2.199
   Moleirinho S, 2017, ELIFE, V6, DOI 10.7554/eLife.23966
   Moon S, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101184
   Morris HE, 2019, CLIN SCI, V133, P2481, DOI 10.1042/CS20190835
   Mussell Ashley L, 2018, Oncotarget, V9, P29975, DOI 10.18632/oncotarget.25724
   Ng-Blichfeldt JP, 2018, EBIOMEDICINE, V36, P461, DOI 10.1016/j.ebiom.2018.09.002
   Nguyen AV, 2014, WORLD J GASTROENTERO, V20, P10279, DOI 10.3748/wjg.v20.i30.10279
   Nguyen CDK, 2019, TRENDS CANCER, V5, P283, DOI 10.1016/j.trecan.2019.02.010
   Nishimura T, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01494
   Noguchi S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113674
   Pahal P., 2021, STATPEARLS
   Principi N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020447
   Rojek KO, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000253
   Saito A, 2015, AM J PHYSIOL-LUNG C, V309, pL756, DOI 10.1152/ajplung.00238.2015
   Salem O, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040370
   Santos DM, 2020, AM J RESP CELL MOL, V62, P479, DOI 10.1165/rcmb.2019-0296OC
   Emami SS, 2020, CANCERS, V12, DOI 10.3390/cancers12092438
   Sattar SBA, 2021, STATPEARLS
   Shen YF, 2019, EBIOMEDICINE, V40, P210, DOI 10.1016/j.ebiom.2018.12.038
   Stamm DR, 2021, STATPEARLS
   Suo T, 2018, BIOMED PHARMACOTHER, V108, P783, DOI 10.1016/j.biopha.2018.09.046
   Taha Z, 2018, CANCERS, V10, DOI 10.3390/cancers10040094
   Tran THY, 2019, J MOL CELL BIOL, V11, P1006, DOI 10.1093/jmcb/mjz013
   Phan THG, 2021, CELL MOL LIFE SCI, V78, P2031, DOI 10.1007/s00018-020-03693-7
   Tocci P, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-021-01827-8
   Totaro A, 2019, P NATL ACAD SCI USA, V116, P17848, DOI 10.1073/pnas.1908228116
   Vishnupriya S, 2020, LIFE SCI, V260, DOI 10.1016/j.lfs.2020.118308
   Volckaert T, 2017, DEV CELL, V43, P48, DOI 10.1016/j.devcel.2017.09.003
   Vonk MC, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13453
   Wang DY, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03069-6
   Wang JL, 2021, CHINESE J PHYSIOL, V64, P115, DOI 10.4103/cjp.cjp_25_21
   Wang J, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100599
   Wang LL, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2005590118
   Wang S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00323
   Wang ZL, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.03033
   Wei HL, 2017, CANCER SCI, V108, P478, DOI 10.1111/cas.13138
   Wu ZM, 2021, TRENDS BIOCHEM SCI, V46, P51, DOI 10.1016/j.tibs.2020.08.008
   Xiao K, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03034-3
   Xie SZ, 2021, BLOOD CANCER DISCOV, V2, P32, DOI 10.1158/2643-3230.BCD-20-0155
   Xu L, 2021, MOL MED REP, V23, DOI 10.3892/mmr.2020.11734
   Xu W, 2021, CANCER GENOM PROTEOM, V18, P451, DOI 10.21873/cgp.20271
   Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558
   Yamauchi T, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050398
   Yao JM, 2021, MOL MED REP, V23, DOI 10.3892/mmr.2020.11726
   Yasuda S, 2021, LAB INVEST, V101, P245, DOI 10.1038/s41374-020-00505-1
   Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044
   Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037
   Yuan T, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00418
   Zhang C, 2018, ONCOTARGET, V9, P2175, DOI [10.18632/oncotarget.23299, 10.18632/oncotarget.25667]
   Zhang L, 2014, CELL SIGNAL, V26, P1392, DOI 10.1016/j.cellsig.2014.02.023
   Zhang YL, 2018, CANCER RES, V78, P2305, DOI 10.1158/0008-5472.CAN-17-2867
   Zhao XG, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041118
   Zheng YG, 2019, DEV CELL, V50, P264, DOI 10.1016/j.devcel.2019.06.003
   Zhou BY, 2018, J CLIN INVEST, V128, P970, DOI 10.1172/JCI90429
   Zhou J, 2015, INT J CLIN EXP PATHO, V8, P11132
   Zinatizadeh MR, 2021, GENES DIS, V8, P48, DOI 10.1016/j.gendis.2019.11.003
   Zuo WY, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.663551
NR 121
TC 11
Z9 13
U1 1
U2 9
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2058-7716
J9 CELL DEATH DISCOV
JI Cell Death Discov.
PD APR 20
PY 2022
VL 8
IS 1
AR 213
DI 10.1038/s41420-022-01020-6
PG 10
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 0P4CW
UT WOS:000784168000003
PM 35443749
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Xu, JH
   Xu, L
   Sui, PF
   Chen, JY
   Moya, EA
   Hume, P
   Janssen, WJ
   Duran, JM
   Thistlethwaite, P
   Carlin, A
   Gulleman, P
   Banaschewski, B
   Goldy, MK
   Yuan, JXJ
   Malhotra, A
   Pryhuber, G
   Crotty-Alexander, L
   Deutsch, G
   Young, LR
   Sun, X
AF Xu, Jinhao
   Xu, Le
   Sui, Pengfei
   Chen, Jiyuan
   Moya, Esteban A.
   Hume, Patrick
   Janssen, William J.
   Duran, Jason M.
   Thistlethwaite, Patricia
   Carlin, Aaron
   Gulleman, Peter
   Banaschewski, Brandon
   Goldy, Mary Kate
   Yuan, Jason X-J.
   Malhotra, Atul
   Pryhuber, Gloria
   Crotty-Alexander, Laura
   Deutsch, Gail
   Young, Lisa R.
   Sun, Xin
TI Excess neuropeptides in lung signal through endothelial cells to impair
   gas exchange
SO DEVELOPMENTAL CELL
LA English
DT Article
ID GENE-RELATED PEPTIDE; MUCUS OVERPRODUCTION; SENSORY NEURONS;
   NEUROENDOCRINE; HYPERPLASIA; INFANCY; DIFFERENTIATION; FOREGUT; SYSTEM;
   EDEMA
AB Although increased neuropeptides are often detected in lungs that exhibit respiratory distress, whether they contribute to the condition is unknown. Here, we show in a mouse model of neuroendocrine cell hyperplasia of infancy, a pediatric disease with increased pulmonary neuroendocrine cells (PNECs), excess PNECderived neuropeptides are responsible for pulmonary manifestations including hypoxemia. In mouse postnatal lung, prolonged signaling from elevated neuropeptides such as calcitonin gene-related peptide (CGRP) activate receptors enriched on endothelial cells, leading to reduced cellular junction gene expression, increased endothelium permeability, excess lung fluid, and hypoxemia. Excess fluid and hypoxemia were effectively attenuated by either prevention of PNEC formation, inactivation of CGRP gene, endothelium-specific inactivation of CGRP receptor gene, or treatment with CGRP receptor antagonist. Neuropeptides were increased in human lung diseases with excess fluid such as acute respiratory distress syndrome. Our findings suggest that restricting neuropeptide function may limit fluid and improve gas exchange in these conditions.
C1 [Xu, Jinhao; Xu, Le; Sun, Xin] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093, United States.
   [Xu, Jinhao; Sun, Xin] Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093, United States.
   [Sui, Pengfei] Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, 320 Yueyang Rd, Shanghai 200031, China.
   [Chen, Jiyuan; Yuan, Jason X-J; Malhotra, Atul; Crotty-Alexander, Laura] Univ Calif San Diego, Sch Med, Div Pulm Crit Care & Sleep Med, La Jolla, CA 92121, United States.
   [Moya, Esteban A.] Univ Calif San Diego, Dept Med, Div Physiol, La Jolla, CA 92121, United States.
   [Moya, Esteban A.] Univ Calif San Diego, Dept Med, Div Physiol, La Jolla, CA 92093, United States.
   [Hume, Patrick; Janssen, William J.] Natl Jewish Hlth, Dept Med, Denver, CO 80206, United States.
   [Duran, Jason M.] Univ Calif San Diego, Dept Internal Med, Div Cardiol, Med Ctr, La Jolla, CA 92037, United States.
   [Thistlethwaite, Patricia] Univ Calif San Diego, Div Cardiothorac Surg, La Jolla, CA 92093, United States.
   [Carlin, Aaron] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093, United States.
   [Gulleman, Peter; Young, Lisa R.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232, United States.
   [Banaschewski, Brandon; Goldy, Mary Kate; Young, Lisa R.] Childrens Hosp Philadelphia, Dept Pediat, Div Pulm & Sleep Med, Philadelphia, PA 16104, United States.
   [Pryhuber, Gloria] Univ Rochester, Sch Med & Dent, Med Ctr, Rochester, NY 14642, United States.
   [Crotty-Alexander, Laura] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92161, United States.
   [Deutsch, Gail] Univ Washington, Seattle Childrens Hosp, Dept Labs, Seattle, WA 98105, United States.
C3 University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   Chinese Academy of Sciences; Shanghai Institutes for Biological
   Sciences, CAS; University of California System; University of California
   San Diego; University of California System; University of California San
   Diego; University of California System; University of California San
   Diego; National Jewish Health; University of California System;
   University of California San Diego; University of California System;
   University of California San Diego; University of California System;
   University of California San Diego; Vanderbilt University; University of
   Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia;
   University of Rochester; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); VA San Diego Healthcare System; Seattle
   Children's Hospital; University of Washington; University of Washington
   Seattle
RP Sun, X (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.; Sun, X (corresponding author), Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA.
EM xinsun@health.ucsd.edu
RI Xu, Le/AHD-3304-2022; Carlin, Aaron/AAK-3806-2021; Xu, Le/IST-7864-2023
OI Xu, Le/0000-0001-6321-5023; Xu, Le/0000-0001-6321-5023; Deutsch,
   Gail/0000-0002-0571-0285; XU, JINHAO/0000-0003-4018-2825
FU NIH [OT2OD023857, R01HL146141]; ATS Research Foundation [2019-1059];
   Orphan Disease Center [MDBR-21-115-NEHI]; AHA pre-doctoral fellowship
   [828448]; National Institutes of Health SIG [S10 OD026929]; UCSD School
   of Medicine Micro-scopy Core (National Institute of Neurological
   Disorders and Stroke) [P30 NS047101]
FX The authors would like to thank members of the Sun lab for inputs and
   discus-sions. This work was supported by NIH R01HL146141 (to X.S. and
   L.R.Y.) , NIH OT2OD023857 (to X.S.) , ATS Research Foundation 2019-1059
   (to X.S.) , Orphan Disease Center MDBR-21-115-NEHI (to X.S. and L.R.Y) ,
   and AHA pre-doctoral fellowship 828448 (to J.X.) . Single-cell RNA-seq
   was performed using the service of UC San Diego IGM Genomics Center
   utilizing an Illumina Nova-Seq 6000 that was purchased with funding from
   a National Institutes of Health SIG grant (#S10 OD026929) . Cell sorting
   was performed using the Flow Cy-tometry Core at the San Diego Center for
   AIDS Research (P30 AI036214) , the VA San Diego Health Care System, and
   the San Diego Veterans Medical Research Foundation. We also thank the
   UCSD School of Medicine Micro-scopy Core (National Institute of
   Neurological Disorders and Stroke grant P30 NS047101) for assistance
   with imaging and analysis.
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Aiyar N, 1996, J BIOL CHEM, V271, P11325, DOI 10.1074/jbc.271.19.11325
   Aubdool AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6732
   Baral P, 2018, NAT MED, V24, P417, DOI 10.1038/nm.4501
   Barrios J, 2019, AM J RESP CELL MOL, V60, P687, DOI 10.1165/rcmb.2018-0179OC
   Barrios J, 2017, FASEB J, V31, P4117, DOI 10.1096/fj.201700115R
   Brain SD, 2004, PHYSIOL REV, V84, P903, DOI 10.1152/physrev.00037.2003
   BRAIN SD, 1985, NATURE, V313, P54, DOI 10.1038/313054a0
   Breen ID, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.7934
   Chintagari NR, 2012, CRIT CARE, V16, DOI 10.1186/cc11298
   Cutz E, 2007, PEDIATR DEVEL PATHOL, V10, P419, DOI 10.2350/07-04-0267.1
   D'Agnillo F, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abj7790
   Deterding RR, 2005, PEDIATR PULM, V40, P157, DOI 10.1002/ppul.20243
   Domyan ET, 2011, DEVELOPMENT, V138, P971, DOI 10.1242/dev.053694
   Du YN, 2017, THORAX, V72, P481, DOI 10.1136/thoraxjnl-2016-209598
   ESPIRITU RF, 1992, INFLAMMATION, V16, P509, DOI 10.1007/BF00918976
   Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5
   Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302
   Gotts JE, 2019, AM J PHYSIOL-LUNG C, V317, pL717, DOI 10.1152/ajplung.00132.2019
   Hennessy ML, 2017, J NEUROSCI, V37, P1807, DOI 10.1523/JNEUROSCI.2316-16.2016
   Huppert LA, 2019, SEMIN RESP CRIT CARE, V40, P31, DOI 10.1055/s-0039-1683996
   Ito T, 2000, DEVELOPMENT, V127, P3913
   Jang AS, 2011, AM J RESP CELL MOL, V44, P483, DOI 10.1165/rcmb.2009-0391OC
   Jin SQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21246-9
   Kaelberer MM, 2018, SCIENCE, V361, P1219, DOI 10.1126/science.aat5236
   Kuo CS, 2015, CELL, V163, P394, DOI 10.1016/j.cell.2015.09.021
   Kusakabe T, 2006, MOL ENDOCRINOL, V20, P1796, DOI 10.1210/me.2005-0327
   Li CG, 2013, DEV BIOL, V378, P13, DOI 10.1016/j.ydbio.2013.03.018
   Liptzin DR, 2020, ANN AM THORAC SOC, V17, P724, DOI 10.1513/AnnalsATS.201908-617OC
   MaassenVanDenBrink A, 2016, TRENDS PHARMACOL SCI, V37, P779, DOI 10.1016/j.tips.2016.06.002
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234
   Moitra J, 2007, TRANSL RES, V150, P253, DOI 10.1016/j.trsl.2007.03.013
   Nevel RJ, 2018, PEDIATR PULM, V53, P656, DOI 10.1002/ppul.23958
   NEWBOLD P, 1993, BRIT J PHARMACOL, V108, P705, DOI 10.1111/j.1476-5381.1993.tb12865.x
   Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC
   Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505
   Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018
   Perrot CY, 2018, FASEB J, V32, P5793, DOI 10.1096/fj.201700818RRR
   Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Smith P, 2019, ALCOHOL, V80, P81, DOI 10.1016/j.alcohol.2018.08.007
   Su YJ, 2022, AM J PHYSIOL-LUNG C, V322, pL50, DOI 10.1152/ajplung.00376.2021
   Sui PF, 2018, SCIENCE, V360, P1086, DOI 10.1126/science.aan8546
   Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752
   Travaglini KJ, 2020, NATURE, V587, DOI 10.1038/s41586-020-2922-4
   Wang A, 2020, ELIFE, V9, DOI 10.7554/eLife.62522
   Xiang YY, 2007, NAT MED, V13, P862, DOI 10.1038/nm1604
   Xiong MM, 2021, PULM CIRC, V11, DOI 10.1177/20458940211041512
   Xu JH, 2020, DEV CELL, V55, P123, DOI 10.1016/j.devcel.2020.09.024
   Xu X, 2014, GENE DEV, V28, P1929, DOI 10.1101/gad.243717.114
   Young LR, 2013, CHEST, V144, P1199, DOI 10.1378/chest.13-0811
   Young LR, 2011, CHEST, V139, P1060, DOI 10.1378/chest.10-1304
   Zhu ZK, 2020, PULM CIRC, V10, DOI 10.1177/2045894020922129
NR 54
TC 10
Z9 9
U1 4
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD APR 11
PY 2022
VL 57
IS 7
BP 839
EP +
DI 10.1016/j.devcel.2022.02.023
EA APR 2022
PG 22
WC Cell Biology; Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology
GA 0W4TT
UT WOS:000789021800002
PM 35303432
OA Green Published, hybrid, Green Accepted
DA 2023-08-21
ER

PT J
AU Lamers, MM
   Haagmans, BL
AF Lamers, Mart M.
   Haagmans, Bart L.
TI SARS-CoV-2 pathogenesis
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Review
ID RESPIRATORY-DISTRESS-SYNDROME; CORONAVIRUS DISEASE 2019; PLASMACYTOID
   DENDRITIC CELLS; DIPEPTIDYL PEPTIDASE 4; ACUTE LUNG INJURY;
   TISSUE-FACTOR; COVID-19 INFECTIONS; FUNCTIONAL RECEPTOR;
   VIRAL-INFECTIONS; I INTERFERON
AB The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating pandemic. Although most people infected with SARS-CoV-2 develop a mild to moderate disease with virus replication restricted mainly to the upper airways, some progress to having a life-threatening pneumonia. In this Review, we explore recent clinical and experimental advances regarding SARS-CoV-2 pathophysiology and discuss potential mechanisms behind SARS-CoV-2-associated acute respiratory distress syndrome (ARDS), specifically focusing on new insights obtained using novel technologies such as single-cell omics, organoid infection models and CRISPR screens. We describe how SARS-CoV-2 may infect the lower respiratory tract and cause alveolar damage as a result of dysfunctional immune responses. We discuss how this may lead to the induction of a 'leaky state' of both the epithelium and the endothelium, promoting inflammation and coagulation, while an influx of immune cells leads to overexuberant inflammatory responses and immunopathology. Finally, we highlight how these findings may aid the development of new therapeutic interventions against COVID-19.
   In this Review, Lamers and Haagmans explore recent clinical and experimental advances in understanding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogenesis, interactions with host cells and the involvement of the immune system in the development of severe disease. Specifically, they focus on mechanisms underlying the development of COVID-19-associated acute respiratory distress syndrome.
C1 [Lamers, Mart M.; Haagmans, Bart L.] Erasmus MC, Virosci Dept, Rotterdam, Netherlands.
C3 Erasmus University Rotterdam; Erasmus MC
RP Haagmans, BL (corresponding author), Erasmus MC, Virosci Dept, Rotterdam, Netherlands.
EM b.haagmans@erasmusmc.nl
RI Haagmans, Bart L/E-9791-2015
OI Haagmans, Bart L/0000-0001-6221-2015
CR ACTIV-3 TICO LY-CoV555 Study Grp, 2021, NEW ENGL J MED, V384, P905, DOI 10.1056/NEJMoa2033130
   Ader F, 2022, LANCET INFECT DIS, V22, P209, DOI 10.1016/S1473-3099(21)00485-0
   Agrawal A, 2013, GERONTOLOGY, V59, P421, DOI 10.1159/000350536
   Ahn JH, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI148517
   Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520
   Arribas, 2021, NEJM EVID, DOI 10.1056/EVIDoa2100044
   Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261
   Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348
   Bailey AL, 2021, CELL, V184, P15, DOI 10.1016/j.cell.2020.12.003
   Bange Erin M, 2021, Res Sq, DOI 10.21203/rs.3.rs-162289/v1
   Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782
   Bastard P, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4340
   Bauernfried S, 2021, SCIENCE, V371, P482, DOI 10.1126/science.abd0811
   Berlin DA, 2020, NEW ENGL J MED, V383, P2451, DOI 10.1056/NEJMcp2009575
   Bernal AJ, 2022, NEW ENGL J MED, V386, P509, DOI 10.1056/NEJMoa2116044
   Beumer J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25729-7
   Bhatnagar J, 2021, J INFECT DIS, V223, P752, DOI 10.1093/infdis/jiab039
   Blair RV, 2021, AM J PATHOL, V191, P274, DOI 10.1016/j.ajpath.2020.10.016
   Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026
   Bonaventura A, 2021, NAT REV IMMUNOL, V21, P319, DOI 10.1038/s41577-021-00536-9
   Bove PF, 2014, AM J RESP CELL MOL, V50, P767, DOI 10.1165/rcmb.2013-0071OC
   Bradley BT, 2020, LANCET, V396, P320, DOI 10.1016/S0140-6736(20)31305-2
   Camprubi-Rimblas M, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.01.08
   Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985
   Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645
   Cardinal-Fernandez P, 2017, ANN AM THORAC SOC, V14, P844, DOI 10.1513/AnnalsATS.201609-728PS
   Carroll T, 2022, PLOS PATHOG, V18, DOI 10.1371/journal.ppat.1009914
   Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5
   Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770
   Chan JFW, 2020, CLIN INFECT DIS, V71, P2428, DOI 10.1093/cid/ciaa325
   Chandra A, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2020-237207
   Channappanavar R, 2019, J CLIN INVEST, V129, P3625, DOI 10.1172/JCI126363
   Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007
   Chen JY, 2020, CELL RES, V30, P708, DOI 10.1038/s41422-020-0369-7
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chen YF, 2020, J MED VIROL, V92, P833, DOI 10.1002/jmv.25825
   Choi J, 2020, CELL STEM CELL, V27, P366, DOI 10.1016/j.stem.2020.06.020
   Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4
   Costa MFD, 2020, STEM CELL REP, V15, P1015, DOI 10.1016/j.stemcr.2020.09.006
   Creech CB, 2021, JAMA-J AM MED ASSOC, V325, P1318, DOI 10.1001/jama.2021.3199
   Daly James L, 2020, Science, V370, P861, DOI 10.1126/science.abd3072
   Daniloski Z, 2021, CELL, V184, P92, DOI 10.1016/j.cell.2020.10.030
   De Michele S, 2020, AM J CLIN PATHOL, V154, P748, DOI 10.1093/ajcp/aqaa156
   del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095
   Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]
   Delorey TM, 2021, NATURE, V595, P107, DOI 10.1038/s41586-021-03570-8
   Dinnon Kenneth H, 2020, bioRxiv, DOI 10.1101/2020.05.06.081497
   Dittmann M, 2015, CELL, V160, P631, DOI 10.1016/j.cell.2015.01.040
   Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10
   Doran AC, 2020, NAT REV IMMUNOL, V20, P254, DOI 10.1038/s41577-019-0240-6
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283
   Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345
   Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211
   Feng E, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030708
   Ferreira AC, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00428-w
   Fielding BC, 2011, FUTURE MICROBIOL, V6, P153, DOI [10.2217/fmb.10.166, 10.2217/FMB.10.166]
   Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609
   Galani IE, 2015, J LEUKOCYTE BIOL, V98, P557, DOI 10.1189/jlb.4VMR1114-555R
   Georg P, 2022, CELL, V185, P493, DOI [10.1016/j.cel.2021.12.040, 10.1016/j.cell.2021.12.040]
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Giannis D, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104362
   Goh KJ, 2020, ANN ACAD MED SINGAP, V49, P108
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Gralinski LE, 2013, MBIO, V4, DOI 10.1128/mBio.00271-13
   Grant RA, 2021, NATURE, V590, P635, DOI 10.1038/s41586-020-03148-w
   Grasselli G, 2020, LANCET RESP MED, V8, P1201, DOI 10.1016/S2213-2600(20)30370-2
   Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031
   Gu HJ, 2020, SCIENCE, V369, P1603, DOI 10.1126/science.abc4730
   Gu J, 2007, AM J PATHOL, V170, P1136, DOI 10.2353/ajpath.2007.061088
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI [10.1056/NEJMc2005203, 10.1056/NEJMoa2002032]
   Haagmans BL, 2004, NAT MED, V10, P290, DOI 10.1038/nm1001
   Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027
   Halfmann PJ, 2022, NATURE, V603, P687, DOI 10.1038/s41586-022-04441-6
   Han LL, 2021, J MED VIROL, V93, P5376, DOI 10.1002/jmv.27050
   Herold T, 2020, J ALLERGY CLIN IMMUN, V146, P128, DOI 10.1016/j.jaci.2020.05.008
   Hewitson JP, 2020, J IMMUNOL, V204, P2949, DOI 10.4049/jimmunol.1900940
   Hoffmann M, 2021, EBIOMEDICINE, V65, DOI 10.1016/j.ebiom.2021.103255
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hoffmann M, 2020, NATURE, V585, P588, DOI 10.1038/s41586-020-2575-3
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7
   Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0
   Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042
   Huang Jessie, 2020, Cell Stem Cell, V27, P962, DOI [10.1101/2020.06.30.175695, 10.1016/j.stem.2020.09.013]
   Hui KPY, 2020, LANCET RESP MED, V8, P687, DOI 10.1016/S2213-2600(20)30193-4
   Hulswit RJG, 2016, ADV VIRUS RES, V96, P29, DOI 10.1016/bs.aivir.2016.08.004
   Huynh J, 2012, J VIROL, V86, P12816, DOI 10.1128/JVI.00906-12
   Iba T, 2020, J THROMB HAEMOST, V18, P2103, DOI 10.1111/jth.14975
   Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117
   Jia HP, 2005, J VIROL, V79, P14614, DOI 10.1128/JVI.79.23.14614-14621.2005
   JONES T, 2021, SCIENCE, V373
   Kambas K, 2008, J IMMUNOL, V180, P7368, DOI 10.4049/jimmunol.180.11.7368
   Kanegai CM, 2016, AM J RESP CELL MOL, V55, P613, DOI 10.1165/rcmb.2015-0387LE
   Karagiannidis C, 2021, LANCET RESP MED, V9, pE47, DOI 10.1016/S2213-2600(21)00101-6
   Karagiannidis C, 2020, LANCET RESP MED, V8, P853, DOI 10.1016/S2213-2600(20)30316-7
   Karki Rajendra, 2020, bioRxiv, DOI [10.1016/j.cell.2020.11.025, 10.1101/2020.10.29.361048]
   Katsura H, 2020, CELL STEM CELL, V27, P890, DOI 10.1016/j.stem.2020.10.005
   Katzenstein A L, 1976, Am J Pathol, V85, P209
   Kawase M, 2012, J VIROL, V86, P6537, DOI 10.1128/JVI.00094-12
   Kayesh MEH, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13112302
   Kenawy HI, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00215
   Khan M, 2021, CELL, V184, P5932, DOI 10.1016/j.cell.2021.10.027
   Khanmohammadi S, 2021, J MED VIROL, V93, P2735, DOI 10.1002/jmv.26826
   Kim YI, 2020, CELL HOST MICROBE, V27, P704, DOI 10.1016/j.chom.2020.03.023
   Klimstra William B, 2020, bioRxiv, DOI 10.1101/2020.06.19.154930
   Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]
   Kluge S, 2021, DTSCH ARZTEBL INT, V118, P1, DOI 10.3238/arztebl.m2021.0110
   Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226
   Kobayashi Y, 2020, NAT CELL BIOL, V22, P934, DOI 10.1038/s41556-020-0542-8
   Koning R, 2021, INTENS CARE MED, V47, P704, DOI 10.1007/s00134-021-06392-4
   Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0
   Lamers MM, 2021, ELIFE, V10, DOI 10.7554/eLife.66815
   Lamers MM, 2021, EMBO J, V40, DOI 10.15252/embj.2020105912
   Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669
   Lamers MM., SARS COV 2 OMICRON E, DOI 10.1101/2022.01.19.476898
   Lau SY, 2020, EMERG MICROBES INFEC, V9, P837, DOI 10.1080/22221751.2020.1756700
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Leist SR, 2020, CELL, V183, P1070, DOI 10.1016/j.cell.2020.09.050
   Li JY, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198074
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9
   Lindner D, 2020, JAMA CARDIOL, V5, P1281, DOI 10.1001/jamacardio.2020.3551
   Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022
   Little DR, 2019, P NATL ACAD SCI USA, V116, P20545, DOI 10.1073/pnas.1906663116
   Lokugamage KG, 2020, J VIROL, V94, DOI 10.1128/JVI.01410-20
   Loske J, 2022, NAT BIOTECHNOL, V40, P319, DOI 10.1038/s41587-021-01037-9
   Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y
   Mackman N, 2020, ARTERIOSCL THROM VAS, V40, P2033, DOI 10.1161/ATVBAHA.120.314514
   Mahajan S, 2021, AM J MED, V134, P812, DOI 10.1016/j.amjmed.2021.01.020
   Major J, 2020, SCIENCE, V369, P712, DOI 10.1126/science.abc2061
   Marconi VC, 2021, LANCET RESP MED, V9, P1407, DOI 10.1016/S2213-2600(21)00331-3
   Galvan-Roman JM, 2021, J ALLERGY CLIN IMMUN, V147, P72, DOI 10.1016/j.jaci.2020.09.018
   Maucourant C, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6832
   Meinhardt J, 2021, NAT NEUROSCI, V24, P168, DOI 10.1038/s41593-020-00758-5
   Melms JC, 2021, NATURE, V595, P114, DOI 10.1038/s41586-021-03569-1
   Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134
   Meyer NJ, 2021, LANCET, V398, P622, DOI 10.1016/S0140-6736(21)00439-6
   Meyerholz DK, 2016, AM J PATHOL, V186, P78, DOI 10.1016/j.ajpath.2015.09.014
   Millar FR, 2016, THORAX, V71, P462, DOI 10.1136/thoraxjnl-2015-207461
   Mulay A, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109055
   Munoz-Fontela C, 2020, NATURE, V586, P509, DOI 10.1038/s41586-020-2787-6
   Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]
   Muus C, 2021, NAT MED, V27, P546, DOI 10.1038/s41591-020-01227-z
   Mykytyn AZ, 2021, ELIFE, V10, DOI 10.7554/eLife.64508
   Netea MG, 2020, CELL, V181, P969, DOI 10.1016/j.cell.2020.04.042
   Niemi MEK, 2021, NATURE, V600, P472, DOI 10.1038/s41586-021-03767-x
   O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0
   Ogando NS, 2020, J GEN VIROL, V101, P925, DOI 10.1099/jgv.0.001453
   Osterrieder N, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12070779
   Ouwendijk WJD, 2021, J INFECT DIS, V223, P1512, DOI 10.1093/infdis/jiab050
   Owens AP, 2010, THROMB HAEMOSTASIS, V104, P432, DOI 10.1160/TH09-11-0771
   Page G, 2013, INT IMMUNOPHARMACOL, V17, P1176, DOI 10.1016/j.intimp.2013.06.004
   Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y
   Parasa S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11335
   Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2
   Petersen E, 2020, LANCET INFECT DIS, V20, pE238, DOI 10.1016/S1473-3099(20)30484-9
   Pfizer, 2021, PFIZERS NOVEL
   Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Ramakrishnan S, 2021, LANCET RESP MED, V9, P763, DOI 10.1016/S2213-2600(21)00160-0
   RANE CK, 2019, AM J PHYSIOL-LUNG C, V316
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Rebendenne A., 2021, BIDIRECTIONAL GENOME, DOI 10.1101/2021.05.19.444823
   Redondo N, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.708264
   Rendeiro AF, 2021, NATURE, V593, P564, DOI 10.1038/s41586-021-03475-6
   Rentsch CT, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n311
   Richard M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17367-2
   Robinot R, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24521-x
   Rockx B, 2020, SCIENCE, V368, P1012, DOI 10.1126/science.abb7314
   Sachs N, 2019, EMBO J, V38, DOI 10.15252/embj.2018100300
   Salahudeen AA, 2020, NATURE, V588, P670, DOI 10.1038/s41586-020-3014-1
   Sampaio NG, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92940-3
   Sang YQ, 2021, BLOOD REV, V46, DOI 10.1016/j.blre.2020.100733
   Sariol A, 2021, NAT IMMUNOL, V22, P801, DOI 10.1038/s41590-021-00962-w
   Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001
   Sebag SC, 2011, CURR PHARM BIOTECHNO, V12, P1481
   Sims AC, 2005, J VIROL, V79, P15511, DOI 10.1128/JVI.79.24.15511-15524.2005
   Skendros P, 2020, J CLIN INVEST, V130, P6151, DOI 10.1172/JCI141374
   Smits SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000756
   Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023
   Strunz M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17358-3
   Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x
   Swieringa F, 2018, RES PRACT THROMB HAE, V2, P450, DOI 10.1002/rth2.12107
   Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768
   Totura AL, 2012, CURR OPIN VIROL, V2, P264, DOI 10.1016/j.coviro.2012.04.004
   Trimpert J, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108488
   Tsang TK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26709-7
   Tsukui T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15647-5
   V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6
   van den Brand JMA, 2015, J PATHOL, V235, P175, DOI 10.1002/path.4458
   van der Vaart J, 2021, DIS MODEL MECH, V14, DOI 10.1242/dmm.049060
   Vanderheiden A, 2021, MBIO, V12, DOI 10.1128/mBio.02749-21
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112
   Venet F, 2021, ANN NY ACAD SCI, V1499, P3, DOI 10.1111/nyas.14333
   Venet M., 2021, SARS COV 2 INFECT CE, DOI 10.1101/2021.09.01.21262969
   Vora SM, 2021, NAT REV IMMUNOL, V21, P694, DOI 10.1038/s41577-021-00588-x
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang DW, 2020, J COASTAL RES, P1, DOI 10.2112/JCR-SI109-001.1
   Wang R, 2021, CELL, V184, P106, DOI 10.1016/j.cell.2020.12.004
   Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786
   Wei J, 2021, CELL, V184, P76, DOI 10.1016/j.cell.2020.10.028
   Weinreich DM, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMoa2108163
   Wendisch D, 2021, CELL, V184, P6243, DOI 10.1016/j.cell.2021.11.033
   Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839
   Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]
   Williamson EJ., 2020, NATURE, V584, P430, DOI [10.1101/2020.05.06.20092999, DOI 10.1101/2020.05.06.20092999]
   Wong LYR, 2022, NAT REV IMMUNOL, V22, P47, DOI 10.1038/s41577-021-00656-2
   Woolsey C, 2021, NAT IMMUNOL, V22, P86, DOI 10.1038/s41590-020-00835-8
   World Health Organization, 2003, CONS DOC EP SEV AC R
   Wu J, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108761
   Wu P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24482-1
   Xie XP, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01270-4, 10.1101/2021.01.27.427998]
   Yin X, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108628
   Youk J, 2020, CELL STEM CELL, V27, P905, DOI 10.1016/j.stem.2020.10.004
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhang JH, 2021, CELL MOL IMMUNOL, V18, P1305, DOI 10.1038/s41423-021-00665-0
   Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570
   Zhang Z, 2017, P NATL ACAD SCI USA, V114, P3903, DOI 10.1073/pnas.1621177114
   Zheng J, 2021, J INFECT DIS, V223, P785, DOI 10.1093/infdis/jiaa753
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou J, 2020, NAT MED, V26, P1077, DOI 10.1038/s41591-020-0912-6
   Zhou J, 2018, P NATL ACAD SCI USA, V115, P6822, DOI 10.1073/pnas.1806308115
   Zhou P, 2020, NATURE, V579, P270, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Ziegler Carly G K, 2021, bioRxiv, DOI [10.1016/j.cell.2021.07.023, 10.1101/2021.02.20.431155]
   Zuo Yu, 2020, medRxiv, DOI 10.1101/2020.08.29.20184358
NR 231
TC 161
Z9 163
U1 40
U2 114
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD MAY
PY 2022
VL 20
IS 5
BP 270
EP 284
DI 10.1038/s41579-022-00713-0
EA MAR 2022
PG 15
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA 0N1LD
UT WOS:000775742300001
PM 35354968
OA Bronze
DA 2023-08-21
ER

PT J
AU Fukatsu, M
   Ohkawara, H
   Wang, XT
   Alkebsi, L
   Furukawa, M
   Mori, H
   Fukami, M
   Fukami, S
   Sano, T
   Takahashi, H
   Harada-Shirado, K
   Kimura, S
   Sugimoto, K
   Ogawa, K
   Ikezoe, T
AF Fukatsu, Masahiko
   Ohkawara, Hiroshi
   Wang, Xintao
   Alkebsi, Lobna
   Furukawa, Miki
   Mori, Hirotaka
   Fukami, Miwa
   Fukami, Shin-ichi
   Sano, Takahiro
   Takahashi, Hiroshi
   Harada-Shirado, Kayo
   Kimura, Satoshi
   Sugimoto, Koichi
   Ogawa, Kazuei
   Ikezoe, Takayuki
TI The suppressive effects of Mer inhibition on inflammatory responses in
   the pathogenesis of LPS-induced ALI/ARDS
SO SCIENCE SIGNALING
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; TYROSINE KINASE
   RECEPTOR; PLASMA-LEVELS; PROTEIN-S; TNF-ALPHA; GAS6; EXPRESSION;
   THROMBOMODULIN; IL-6
AB The pathogenesis of sepsis-induced acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) has not yet been fully elucidated. Growth arrest-specific 6 (Gas6) has marked effects on hemostasis and reduces inflammation through its interaction with receptor tyrosine kinases of the TAM family: Tyro3, Axl, and Mer. Here, we found that plasma concentrations of Gas6 and soluble Mer were greater in patients with severe sepsis or septic ALI/ARDS compared with those in normal healthy donors. To determine whether the Gas6-Mer axis was critical in the pathogenesis of ALI/ARDS, we investigated the effects of intravenous administration of the selective Mer inhibitor UNC2250 on lipopolysaccharide (LPS)-induced ALI in mouse models subjected to inhalation of LPS. UNC2250 markedly inhibited the infiltration into the lungs of neutrophils and monocytes with increased amounts of Gas6 and Mer proteins, severe lung damage, and increased amounts of reactive oxygen species (ROS) in LPS-induced ALI in mice. In human pulmonary aortic endothelial cells, LPS induced decreases in the amounts of endothelial nitric oxide synthase, thrombomodulin, and vascular endothelial-cadherin, which was blocked by treatment with UNC2250. UNC2250 also inhibited the LPS-dependent increases in cell proliferation and enhanced apoptosis in HL-60 cells, a human neutrophil-like cell line, and RAW264.7 cells, a mouse monocyte/macrophage cell line. These data provide insights into the potential multiple beneficial effects of the Mer inhibitor UNC2250 as a therapeutic reagent to treat inflammatory responses in ALI/ARDS.
C1 [Fukatsu, Masahiko; Ohkawara, Hiroshi; Wang, Xintao; Alkebsi, Lobna; Furukawa, Miki; Mori, Hirotaka; Fukami, Miwa; Fukami, Shin-ichi; Sano, Takahiro; Takahashi, Hiroshi; Harada-Shirado, Kayo; Kimura, Satoshi; Ogawa, Kazuei; Ikezoe, Takayuki] Fukushima Med Univ, Dept Hematol, Fukushima, Japan.
   [Sugimoto, Koichi] Fukushima Med Univ, Dept Cardiovasc Med, Fukushima, Japan.
C3 Fukushima Medical University; Fukushima Medical University
RP Ohkawara, H (corresponding author), Fukushima Med Univ, Dept Hematol, Fukushima, Japan.
EM ohkawara@fmu.ac.jp
RI Fukatsu, Masahiko/AAE-9638-2020
OI Fukatsu, Masahiko/0000-0002-7957-0000; Alkebsi,
   Lobna/0000-0002-0689-4717; Ohkawara, Hiroshi/0000-0002-3129-1977
FU Fukushima Medical University Research Project; Japan Society for the
   Promotion of Science [16K19583, 19K17837, 18H02844]; Grants-in-Aid for
   Scientific Research [16K19583, 18H02844, 19K17837] Funding Source: KAKEN
FX This work was supported by the Fukushima Medical University Research
   Project and Grants-in-Aid for Scientific Research from the Japan Society
   for the Promotion of Science (16K19583, 19K17837, and 18H02844). The
   funders had no role in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alciato F, 2010, J LEUKOCYTE BIOL, V87, P869, DOI 10.1189/jlb.0909610
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491
   Branchford BR, 2018, J THROMB HAEMOST, V16, P352, DOI 10.1111/jth.13875
   Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p
   Chow CW, 2003, AM J RESP CELL MOL, V29, P427, DOI 10.1165/rcmb.F278
   Dellinger RP, 1998, CRIT CARE MED, V26, P15, DOI 10.1097/00003246-199801000-00011
   Diehl JL, 2013, RESP CARE, V58, P1886, DOI 10.4187/respcare.02129
   Ekman C, 2010, CRIT CARE, V14, DOI 10.1186/cc9233
   Evans CE, 2017, AM J PHYSIOL-LUNG C, V312, pL441, DOI 10.1152/ajplung.00441.2016
   Fan E, 2018, JAMA-J AM MED ASSOC, V319, P698, DOI 10.1001/jama.2017.21907
   Fujimori T, 2015, MUCOSAL IMMUNOL, V8, P1021, DOI 10.1038/mi.2014.129
   FUJISHIMA S, 1993, J CELL PHYSIOL, V154, P478, DOI 10.1002/jcp.1041540305
   Furukawa M, 2019, BLOOD ADV, V3, P2128, DOI 10.1182/bloodadvances.2019000222
   Furukawa M, 2017, J BIOL CHEM, V292, P4280, DOI 10.1074/jbc.M116.733030
   Gheita TA, 2012, J CLIN IMMUNOL, V32, P1279, DOI 10.1007/s10875-012-9743-7
   Giangola MD, 2013, SHOCK, V40, P485, DOI 10.1097/SHK.0b013e3182a588c1
   Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301
   Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138
   Gross CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119918
   Han SH, 2015, J IMMUNOL, V194, P855, DOI 10.4049/jimmunol.1402513
   Helfinger V, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3264858
   Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065
   Huang XF, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/1264913
   Hui LL, 2017, INT J CLIN EXP PATHO, V10, P7401
   Ihle BU, 2001, ANAESTH INTENS CARE, V29, P155, DOI 10.1177/0310057X0102900210
   Jiang ZL, 2017, AM J PHYSIOL-LUNG C, V312, pL231, DOI 10.1152/ajplung.00389.2016
   Kaku S, 2020, J INTENSIVE CARE MED, V35, P723, DOI 10.1177/0885066619855021
   Kellner M, 2017, ADV EXP MED BIOL, V967, P105, DOI 10.1007/978-3-319-63245-2_8
   Kushimoto S, 2012, CRIT CARE, V16, DOI 10.1186/cc11898
   Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011
   Loghmani H, 2018, BLOOD, V132, P148, DOI 10.1182/blood-2017-12-768994
   Lowinus T, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-018-0317-z
   Martin FA, 2013, AM J PHYSIOL-HEART C, V304, pH1585, DOI 10.1152/ajpheart.00096.2013
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   Millar FR, 2016, THORAX, V71, P462, DOI 10.1136/thoraxjnl-2015-207461
   Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149
   Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647
   Qi D, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.265
   Salmi L, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030602
   Sapru A, 2015, INTENS CARE MED, V41, P470, DOI 10.1007/s00134-015-3648-x
   Sarma JV, 2011, COMPR PHYSIOL, V1, P1365, DOI 10.1002/cphy.c100068
   Sawant DA, 2011, MICROCIRCULATION, V18, P46, DOI 10.1111/j.1549-8719.2010.00067.x
   Silversides JA, 2017, INTENS CARE MED, V43, P155, DOI 10.1007/s00134-016-4573-3
   Stalder G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163542
   STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0
   Takahashi Y, 2016, J TRAUMA ACUTE CARE, V81, P868, DOI 10.1097/TA.0000000000001208
   Tecchio C, 2016, SEMIN IMMUNOL, V28, P119, DOI 10.1016/j.smim.2016.04.003
   Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]
   Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020
   Tjwa M, 2008, BLOOD, V111, P4096, DOI 10.1182/blood-2007-05-089565
   Tsantes A, 2013, CLIN CHEM LAB MED, V51, P1535, DOI 10.1515/cclm-2012-0562
   van der Meer JHM, 2014, BLOOD, V123, P2460, DOI 10.1182/blood-2013-09-528752
   Vassiliou AG, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228793
   VESCONI S, 1988, CRIT CARE MED, V16, P111, DOI 10.1097/00003246-198802000-00002
   Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7
   Whitman SP, 2014, LEUKEMIA, V28, P1252, DOI 10.1038/leu.2013.371
   Yadav H, 2016, CRIT CARE MED, V44, P1082, DOI 10.1097/CCM.0000000000001617
   Yeh LC, 2017, TOHOKU J EXP MED, V243, P187, DOI 10.1620/tjem.243.187
   Zhang WH, 2013, J MED CHEM, V56, P9683, DOI 10.1021/jm401387j
NR 63
TC 3
Z9 5
U1 4
U2 24
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1945-0877
EI 1937-9145
J9 SCI SIGNAL
JI Sci. Signal.
PD MAR 8
PY 2022
VL 15
IS 724
AR eabd2533
DI 10.1126/scisignal.abd2533
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA ZP1ST
UT WOS:000766206100002
PM 35258998
DA 2023-08-21
ER

PT J
AU Sercundes, MK
   Ortolan, LS
   Julio, VD
   Bella, LM
   Quirino, TD
   Debone, D
   Carneiro-Ramos, MS
   Christoffolete, MA
   Martins, JO
   Lima, MRD
   Alvarez, JM
   Amarante-Mendes, GP
   Goncalves, LA
   Marinho, CRF
   Epiphanio, S
AF Sercundes, Michelle Klein
   Ortolan, Luana dos Santos
   Julio, Viviane da Silva
   Bella, Leonardo M.
   Quirino, Thatyane de Castro
   Debone, Daniela
   Carneiro-Ramos, Marcela S.
   Christoffolete, Marcelo A.
   Martins, Joilson O.
   D'Imperio Lima, Maria Regina
   Alvarez, Jose M.
   Amarante-Mendes, Gustavo P.
   Goncalves, Ligia Antunes
   Marinho, Claudio R. F.
   Epiphanio, Sabrina
TI Blockade of caspase cascade overcomes malaria-associated acute
   respiratory distress syndrome in mice
SO CELL DEATH & DISEASE
LA English
DT Article
ID ACUTE LUNG INJURY; PULMONARY-EDEMA; CELL APOPTOSIS; DEATH; INFLAMMATION;
   EXPRESSION; FALCIPARUM; FLUID; PATHOGENESIS; MECHANISMS
AB Malaria is an enormous burden on global health that caused 409,000 deaths in 2019. Severe malaria can manifest in the lungs, an illness known as acute respiratory distress syndrome (ARDS). Not much is known about the development of malaria-associated ARDS (MA-ARDS), especially regarding cell death in the lungs. We had previously established a murine model that mimics various human ARDS aspects, such as pulmonary edema, hemorrhages, pleural effusion, and hypoxemia, using DBA/2 mice infected with Plasmodium berghei ANKA. Here, we explored the mechanisms and the involvement of apoptosis in this syndrome. We found that apoptosis contributes to the pathogenesis of MA-ARDS, primarily as facilitators of the alveolar-capillary barrier breakdown. The protection of pulmonary endothelium by inhibiting caspase activation could be a promising therapeutic strategy to prevent the pathogenicity of MA-ARDS. Therefore, intervention in the programmed death cell mechanism could help patients not to develop severe malaria.
C1 [Sercundes, Michelle K.; Julio, Viviane da Silva; Bella, Leonardo M.; Quirino, Thatyane de Castro; Debone, Daniela; Martins, Joilson O.; Epiphanio, Sabrina] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil.
   [Ortolan, Luana S.; D'Imperio Lima, Maria Regina; Alvarez, Jose M.; Amarante-Mendes, Gustavo P.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Sao Paulo, Brazil.
   [Carneiro-Ramos, Marcela S.; Christoffolete, Marcelo A.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil.
   [Amarante-Mendes, Gustavo P.] Inst Nacl Ciencia & Tecnol INCT III, Inst Invest Imunol, Sao Paulo, Brazil.
   [Goncalves, Ligia Antunes; Marinho, Claudio R. F.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Sao Paulo, Brazil.
   [Ortolan, Luana S.] Seattle Childrens Res Inst, Ctr Global Infect Dis, Seattle, WA, United States.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade
   Federal do ABC (UFABC); Universidade de Sao Paulo; Seattle Children's
   Hospital
RP Epiphanio, S (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil.
EM sabrinae@usp.br
RI Alvarez, Jose M/I-6181-2012; Gonçalves, Lígia Antunes/F-6242-2014;
   Marinho, Claudio Romero Farias/F-7507-2012; Carneiro-Ramos,
   Marcela/AAP-6258-2021; Mendes, Gustavo P Amarante/C-8187-2012; D'Império
   Lima, Maria Regina/I-4747-2012; Epiphanio, Sabrina/C-7572-2012; Ramos,
   Marcela Sorelli Carneiro/I-6191-2017; Martins, Joilson O./G-4367-2011
OI Alvarez, Jose M/0000-0002-9711-4914; Gonçalves, Lígia
   Antunes/0000-0001-9804-6899; Marinho, Claudio Romero
   Farias/0000-0002-1227-3845; Mendes, Gustavo P
   Amarante/0000-0002-7851-6205; D'Império Lima, Maria
   Regina/0000-0002-4683-7709; Epiphanio, Sabrina/0000-0001-6094-9750;
   Ramos, Marcela Sorelli Carneiro/0000-0003-2666-1280; Martins, Joilson
   O./0000-0003-2630-7038; dos Santos Ortolan, Luana/0000-0003-1153-9987
FU Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo: FAPESP, Brazil); Coordination of Improvement of Higher
   Level Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior: CAPES); National Council for Scientific and Technological
   Development (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico: CNPq, Brazil); CNPq [131431/2017-0, 302917/2019-5,
   310993/2020-2, 428838/2018-9]; CAPES; FAPESP [2013/20718-3,
   2015/06106-0, 2020/06747-4, 2020/03175-0, 2020/03163-1]; CAPES/PNPD
FX Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo: FAPESP, Brazil), the Coordination of Improvement of Higher
   Level Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior: CAPES), and the National Council for Scientific and
   Technological Development (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico: CNPq, Brazil) supported this research. TCQ
   (CNPq 131431/2017-0), LSO (CAPES and FAPESP 2013/20718-3), MKS
   (CAPES/PNPD), LAG (FAPESP 2015/06106-0), CRFM (CNPq 302917/2019-5 and
   FAPESP 2020/06747-4), JOM (CNPq 310993/2020-2 and FAPESP 2020/03175-0),
   and SE (CNPq 428838/2018-9 and FAPESP 2020/03163-1) received fellowship
   grants. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0
   Amarante-Mendes GP, 1999, BRAZ J MED BIOL RES, V32, P1053, DOI 10.1590/S0100-879X1999000900001
   Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305
   Ashley SL, 2016, AM J RESP CELL MOL, V54, P482, DOI 10.1165/rcmb.2015-0148OC
   Bhatia M, 2012, AM J RESP CELL MOL, V46, P566, DOI 10.1165/rcmb.2011-0392TR
   Estevanez IC, 2016, MED CLIN-BARCELONA, V146, P354, DOI 10.1016/j.medcli.2015.11.043
   CHEN SF, 1995, MICROVASC RES, V50, P119, DOI 10.1006/mvre.1995.1044
   Chopra M, 2009, EXP BIOL MED, V234, P361, DOI 10.3181/0811-MR-318
   Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634
   de Souza MC, 2016, CURRENT TOPICS IN MALARIA, P85, DOI 10.5772/65348
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Eugenin EA, 2019, BRAIN RES, V1720, DOI 10.1016/j.brainres.2019.146317
   Galani V, 2010, PATHOL RES PRACT, V206, P145, DOI 10.1016/j.prp.2009.12.002
   Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4
   Guinee D, 1997, AM J PATHOL, V151, P999
   Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53
   Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063
   Kawahara R, 2019, MOL CELL PROTEOMICS, V18, P182, DOI 10.1074/mcp.RA118.000907
   Lau YL., 2013, MALARIA J, V12, P8, DOI [10.1186/1475-2875-12-1, DOI 10.1186/1475-2875-12-1]
   Le Berre R, 2004, INTENS CARE MED, V30, P1204, DOI 10.1007/s00134-004-2165-0
   Lee KS, 2008, RESP MED, V102, P464, DOI 10.1016/j.rmed.2007.10.001
   Lima FA., 2019, PLOS ONE, V14, P1
   Liu MD, 2016, PANCREATOLOGY, V16, P733, DOI 10.1016/j.pan.2016.06.002
   Maknitikul S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181674
   Martin TR, 2003, CRIT CARE MED, V31, pS184, DOI 10.1097/01.CCM.0000057841.33876.B1
   Mata-Cantero L, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-112
   Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158
   McGready R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-191
   Mohan Alladi, 2008, Journal of Vector Borne Diseases, V45, P179
   Moschonas IC, 2019, ATHEROSCLEROSIS, V288, P9, DOI 10.1016/j.atherosclerosis.2019.06.919
   Mungunsukh O, 2010, AM J PHYSIOL-LUNG C, V298, pL696, DOI 10.1152/ajplung.00322.2009
   Nadesalingam A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00359
   Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001
   O'Reilly MA, 2000, LAB INVEST, V80, P1845, DOI 10.1038/labinvest.3780195
   Ortolan LD, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/3105817
   Ortolan LS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/872464
   Pereira MLM, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4158698
   Perl M, 2008, MOL MED, V14, P465, DOI 10.2119/2008-00011.Perl
   Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992
   Pinzon-Charry A, 2013, J EXP MED, V210, P1635, DOI [10.1084/jem., 10.1084/jem.20121972]
   Punsawad C, 2015, INT J CLIN EXP PATHO, V8, P10002
   Rajahram GS, 2016, EMERG INFECT DIS, V22, P41, DOI 10.3201/eid2201.151305
   Reis AS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax6346
   SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970
   Sena-dos-Santos C, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020479
   Sercundes MK, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006054
   Suzuki H, 2011, ACTA NEUROCHIR SUPPL, V111, P129, DOI 10.1007/978-3-7091-0693-8_21
   Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659
   THUMWOOD CM, 1988, PARASITOLOGY, V96, P579, DOI 10.1017/S0031182000080203
   Tseng CY, 2017, CARDIOVASC TOXICOL, V17, P384, DOI 10.1007/s12012-016-9364-0
   Viriyavejakul P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-106
   Wang LR, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/7059304
   World Health Organization, 2020, WORLD MALARIA REPORT, P238
   Xu XF, 2016, CHINESE MED J-PEKING, V129, P2357, DOI 10.4103/0366-6999.190669
   Xu XB, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20180992
NR 55
TC 2
Z9 2
U1 4
U2 14
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD FEB 10
PY 2022
VL 13
IS 2
AR 144
DI 10.1038/s41419-022-04582-6
PG 10
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA YX2YZ
UT WOS:000753974900010
PM 35145061
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU dos Santos, CC
   Amatullah, H
   Vaswani, CM
   Maron-Gutierrez, T
   Kim, M
   Mei, SHJ
   Szaszi, K
   Monteiro, APT
   Varkouhi, AK
   Herreroz, R
   Lorente, JA
   Tsoporis, JN
   Gupta, S
   Ektesabi, A
   Kavantzas, N
   Salpeas, V
   Marshall, JC
   Rocco, PRM
   Marsden, PA
   Weiss, DJ
   Stewart, DJ
   Hu, PZ
   Liles, WC
AF dos Santos, Claudia C.
   Amatullah, Hajera
   Vaswani, Chirag M.
   Maron-Gutierrez, Tatiana
   Kim, Michael
   Mei, Shirley H. J.
   Szaszi, Katalin
   Monteiro, Ana Paula Teixeira
   Varkouhi, Amir K.
   Herreroz, Raquel
   Angel Lorente, Jose
   Tsoporis, James N.
   Gupta, Sahil
   Ektesabi, Amin
   Kavantzas, Nikolaos
   Salpeas, Vasileios
   Marshall, John C.
   Rocco, Patricia Rieken Macedo
   Marsden, Philip A.
   Weiss, Daniel J.
   Stewart, Duncan J.
   Hu, Pingzhao
   Liles, W. Conrad
TI Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression
   to attenuate sepsis-induced acute lung injury
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Article
ID OCCLUDIN; EPIDEMIOLOGY; PREVENTION; MORTALITY; SURVIVAL; MICE; LPS
AB Although mesenchymal stromal (stem) cell (MSC) administration attenuates sepsis-induced lung injury in pre-clinical models, the mechanism(s) of action and host immune system contributions to its therapeutic effects remain elusive. We show that treatment with MSCs decreased expression of host-derived microRNA (miR)-193b-5p and increased expression of its target gene, the tight junctional protein occludin (Ocln), in lungs from septic mice. Mutating the Ocln 3' untranslated region miR-193b-5p binding sequence impaired binding to Ocln mRNA. Inhibition of miR-193b-5p in human primary pulmonary microvascular endothelial cells prevents tumour necrosis factor (TNF)-induced decrease in Ocln gene and protein expression and loss of barrier function. MSC-conditioned media mitigated TNF-induced miR-193b-5p upregulation and Ocln downregulation in vitro When administered in vivo, MSC-conditioned media recapitulated the effects of MSC administration on pulmonary miR-193b-5p and Ocln expression. MiR-193b-deficient mice were resistant to pulmonary inflammation and injury induced by lipopolysaccharide (LPS) instillation. Silencing of Ocln in miR-193b-deficient mice partially recovered the susceptibility to LPS-induced lung injury. In vivo inhibition of miR-193b-5p protected mice from endotoxin-induced lung injury. Finally, the clinical significance of these results was supported by the finding of increased miR-193b-5p expression levels in lung autopsy samples from acute respiratory distress syndrome patients who died with diffuse alveolar damage.
C1 [dos Santos, Claudia C.; Amatullah, Hajera; Vaswani, Chirag M.; Kim, Michael; Szaszi, Katalin; Monteiro, Ana Paula T.; Varkouhi, Amir K.; Tsoporis, James N.; Gupta, Sahil; Ektesabi, Amin; Marshall, John C.; Marsden, Philip A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada.
   [dos Santos, Claudia C.; Vaswani, Chirag M.] Univ Toronto, Temerty Fac Med, Dept Physiol, Toronto, ON, Canada.
   [dos Santos, Claudia C.; Gupta, Sahil; Ektesabi, Amin; Marshall, John C.] Univ Toronto, Temerty Fac Med, Inst Med Sci, Toronto, ON, Canada.
   [dos Santos, Claudia C.; Gupta, Sahil; Ektesabi, Amin; Marshall, John C.] Univ Toronto, Temerty Fac Med, Interdept Div Crit Care, Toronto, ON, Canada.
   [Maron-Gutierrez, Tatiana] Fundacao Oswaldo Cruz, FIOCRUZ, Inst Oswaldo Cruz IOC, Rio De Janeiro, Brazil.
   [Mei, Shirley H. J.; Stewart, Duncan J.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada.
   [Szaszi, Katalin; Marshall, John C.] Univ Toronto, Dept Surg, Toronto, ON, Canada.
   [Herreroz, Raquel; Angel Lorente, Jose] Univ Hosp Getafe, Crit Care Dept, Madrid, Spain.
   [Angel Lorente, Jose] Ctr Invest Biomed Red CIBER Enfermedades Resp, Madrid, Spain.
   [Angel Lorente, Jose] Univ Europea Madrid, Madrid, Spain.
   [Kavantzas, Nikolaos; Salpeas, Vasileios] Natl & Kapodistrian Univ Athens, Sch Med, Dept Pathol 1, Athens, Greece.
   [Rocco, Patricia R. M.] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Lab Pulm Invest, Rio De Janeiro, Brazil.
   [Weiss, Daniel J.] Univ Vermont, Dept Med, Burlington, VT, United States.
   [Hu, Pingzhao] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada.
   [Liles, W. Conrad] Univ Washington, Dept Med, Seattle, WA, United States.
C3 University of Toronto; Saint Michaels Hospital Toronto; University of
   Toronto; University of Toronto; University of Toronto; Fundacao Oswaldo
   Cruz; University of Ottawa; Ottawa Hospital Research Institute;
   University of Toronto; Hospital Universitario de Getafe; CIBER - Centro
   de Investigacion Biomedica en Red; CIBERES; European University of
   Madrid; Athens Medical School; National & Kapodistrian University of
   Athens; Universidade Federal do Rio de Janeiro; University of Vermont;
   University of Manitoba; University of Washington; University of
   Washington Seattle
RP dos Santos, CC (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada.; dos Santos, CC (corresponding author), Univ Toronto, Temerty Fac Med, Dept Physiol, Toronto, ON, Canada.; dos Santos, CC (corresponding author), Univ Toronto, Temerty Fac Med, Inst Med Sci, Toronto, ON, Canada.; dos Santos, CC (corresponding author), Univ Toronto, Temerty Fac Med, Interdept Div Crit Care, Toronto, ON, Canada.
EM claudia.dossantos@unityhealth.to
RI Marsden, Philip A/B-1441-2012
OI Varkouhi, Amir Khashayar/0000-0002-1794-7546; dos Santos,
   Claudia/0000-0002-6446-8791; Maron-Gutierrez,
   Tatiana/0000-0002-6905-2007; Szaszi, Katalin/0000-0002-2490-8422; Mei,
   Shirley/0000-0003-4727-1177; Rieken Macedo Rocco,
   Patricia/0000-0003-1412-7136; Vaswani, Chirag/0000-0002-6877-4999
FU Canadian Institutes of Health Research [MOP-130331, MPO-106545]; Canada
   Research Chair in Infectious Diseases and Inflammation; Ontario Research
   Fund [RE07-086]; Ontario Graduate Scholarship; St. Michael's Hospital Li
   Ka Shing Knowledge Institute Graduate Scholarship; Mary J. Santalo
   Fellowship
FX This work was supported by the Canadian Institutes of Health Research
   (grant number MOP-130331, MPO-106545 to C.C. dos Santos), the Canada
   Research Chair in Infectious Diseases and Inflammation to W.C. Liles,
   and the Ontario Research Fund (grant number RE07-086 to D.J. Stewart,
   S.H.J. Mei, W.C. Liles and C.C. dos Santos). H. Amatullah was the
   recipient of the Ontario Graduate Scholarship, St. Michael's Hospital Li
   Ka Shing Knowledge Institute Graduate Scholarship and Mary J. Santalo
   Fellowship. Funding information for this article has been deposited with
   the Crossref Funder Registry.
CR Baglio SR, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0116-z
   Baldassarre A, 2020, EPIGENOMICS-UK, V12, DOI 10.2217/epi-2020-0162
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857
   Choi KH, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190634
   Chow MYT, 2020, TRENDS PHARMACOL SCI, V41, P715, DOI 10.1016/j.tips.2020.08.002
   Coletta C, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0511-3
   Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11
   Dammes N, 2020, TRENDS PHARMACOL SCI, V41, P755, DOI 10.1016/j.tips.2020.08.004
   dos Santos CC, 2004, PHYSIOL GENOMICS, V19, P331, DOI 10.1152/physiolgenomics.00153.2004
   dos Santos CC, 2012, AM J PATHOL, V181, P1681, DOI 10.1016/j.ajpath.2012.08.009
   Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009
   Feuermann Y, 2013, RNA BIOL, V10, P1807, DOI 10.4161/rna.27239
   Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC
   Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855
   Hanna J, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00478
   Hawiger J, 2015, J THROMB HAEMOST, V13, P1743, DOI 10.1111/jth.13061
   Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043
   Herrero R, 2019, THORAX, V74, P69, DOI 10.1136/thoraxjnl-2018-211535
   Hu S, 2020, J CANCER, V11, P260, DOI 10.7150/jca.35067
   Krasnodembskaya A, 2012, AM J PHYSIOL-LUNG C, V302, pL1003, DOI 10.1152/ajplung.00180.2011
   Lee JW, 2013, AM J RESP CRIT CARE, V187, P751, DOI 10.1164/rccm.201206-0990OC
   Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106
   Li RR, 2019, MOL CARCINOGEN, V58, P2316, DOI 10.1002/mc.23120
   Maron-Gutierrez T, 2013, CRIT CARE MED, V41, pE319, DOI 10.1097/CCM.0b013e31828a663e
   Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139
   McCarter SD, 2007, AM J RESP CRIT CARE, V175, P1014, DOI 10.1164/rccm.200609-1370OC
   Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269
   Mei SHJ, 2010, AM J RESP CRIT CARE, V182, P1047, DOI 10.1164/rccm.201001-0010OC
   Moll G, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01091
   Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905
   Paik M., 2004, APPL GENET MOL BIOL, V3, DOI [10.2202/1544-6115.1054, DOI 10.2202/1544-6115.1027]
   Phelps J, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/9415367
   Richter JF, 2019, TISSUE BARRIERS, V7, DOI 10.1080/21688370.2019.1608759
   Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Varkouhi AK, 2020, STEM CELL REV REP, V16, P812, DOI 10.1007/s12015-020-10000-1
   Vizoso FJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091852
   Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226
   Zhang CY, 2019, J CELL BIOCHEM, V120, P12775, DOI 10.1002/jcb.28545
   Zhou T, 2020, P NATL ACAD SCI USA, V117, P4758, DOI 10.1073/pnas.1909731117
   Zhu YG, 2014, STEM CELLS, V32, P116, DOI 10.1002/stem.1504
NR 42
TC 20
Z9 20
U1 7
U2 36
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD JAN 1
PY 2022
VL 59
IS 1
SI SI
AR 2004216
DI 10.1183/13993003.04216-2020
PG 15
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA YW4CS
UT WOS:000753363000001
PM 34112731
DA 2023-08-21
ER

PT J
AU Gao, P
   Wu, BR
   Ding, Y
   Yin, BR
   Gu, HX
AF Gao, Pei
   Wu, Beirong
   Ding, Ying
   Yin, Bingru
   Gu, Haoxiang
TI circEXOC5 promotes acute lung injury through the PTBP1/ Skp2/Runx2 axis
   to activate autophagy
SO LIFE SCIENCE ALLIANCE
LA English
DT Article
ID IMPROVES SURVIVAL; OXIDATIVE STRESS; INFLAMMATION; EXPRESSION; SEPSIS;
   RUNX2; EPIDEMIOLOGY; MECHANISMS; MORTALITY; APOPTOSIS
AB To understand the pathogenesis of acute lung injury (ALI), we focused on circEXOC5, a significantly up-regulated circular RNA in ALI. Using the in vivo cecal ligation and puncture (CLP)-induced ALI mouse model and in vitro LPS-challenged mouse pulmonary microvascular endothelial cell (MPVEC) model, we examined the impacts of knockdown circEXOC5 on lung injury, inflammation, and autophagy. The regulation between circEXOC5, polypyrimidine tract-binding protein 1 (PTBP1), S-phase kinase-associated protein 2 (Skp2), and Runt-related transcription factor 2 (Runx2) was in-vestigated by combining RNA immunoprecipitation, qRT-PCR, mRNA stability, and ubiquitination assays. The significance of PTBP1 in circEXOC5-induced ALI phenotypes was examined both in vitro and in vivo. circEXOC5 was up-regulated and associated with increased inflammation and activated autophagy in cecal ligation and puncture-induced ALI lung tissues and LPS-challenged MPVECs. Through the interaction with PTBP1, circEXOC5 accelerated Skp2 mRNA decay, an E3 ubiquitin ligase for Runx2, and therefore in-creased Runx2 expression. Functionally, overexpressing PTBP1 reversed shcircEXOC5-inhibited ALI, inflammation, or autophagy. The signaling cascade circEXOC5/PTBP1/Skp2/Runx2, by essentially regulating in-flammation and autophagy in MPVECs, aggravates sepsis-induced ALI.
C1 [Gao, Pei; Wu, Beirong; Ding, Ying; Yin, Bingru; Gu, Haoxiang] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Sch Med, Dept Resp, Shanghai, China.
C3 Shanghai Jiao Tong University
RP Gu, HX (corresponding author), Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Sch Med, Dept Resp, Shanghai, Peoples R China.
EM guxianghaoo4513@163.com
CR Bao XW, 2019, J CELL MOL MED, V23, P7111, DOI 10.1111/jcmm.14577
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Bhandari V, 2008, FRONT BIOSCI-LANDMRK, V13, P6653, DOI 10.2741/3179
   Busch CJL, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3302
   Chen C, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.602605
   Chopra M, 2009, EXP BIOL MED, V234, P361, DOI 10.3181/0811-MR-318
   Fanelli Vito, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS3, DOI 10.1513/AnnalsATS.201407-340MG
   Hu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.274
   Hui Z, 2021, MED SCI MONITOR, V27, DOI 10.12659/MSM.930429
   Jiang JY, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101638
   Jiang L, 2021, ONCOL LETT, V21, DOI 10.3892/ol.2020.12370
   Jiang Y, 2020, EXP THER MED, V20, P227, DOI 10.3892/etm.2020.8686
   Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775
   Khandia R, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070674
   Kim WJ, 2020, EXP MOL MED, V52, P1178, DOI 10.1038/s12276-020-0471-4
   Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426
   Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529
   Li PB, 2021, INNATE IMMUN-LONDON, V27, P41, DOI 10.1177/1753425920971347
   Li T, 2020, MOL IMMUNOL, V120, P13, DOI 10.1016/j.molimm.2020.01.014
   Li XH, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/354087
   Li XO, 2019, J CELL BIOCHEM, V120, P16658, DOI 10.1002/jcb.28924
   Lin CW, 2014, SHOCK, V41, P241, DOI 10.1097/SHK.0000000000000111
   Lo S, 2013, ANN SURG, V257, P352, DOI 10.1097/SLA.0b013e318269d0e2
   Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008
   Mokra D, 2015, RESP PHYSIOL NEUROBI, V209, P52, DOI 10.1016/j.resp.2014.10.006
   Nosaka N, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00207
   Peng W, 2021, LIFE SCI, V265, DOI 10.1016/j.lfs.2020.118833
   Qin H, 2018, ARCH ORAL BIOL, V95, P74, DOI 10.1016/j.archoralbio.2018.07.016
   Qiu ZM, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00448-6
   Ren C, 2022, BIOENGINEERED, V13, P5262, DOI 10.1080/21655979.2022.2037881
   Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214
   Rosenfeldt MT, 2012, AUTOPHAGY, V8, P963, DOI 10.4161/auto.20186
   Shao L, 2017, BIOCHEM BIOPH RES CO, V487, P194, DOI 10.1016/j.bbrc.2017.04.020
   Slavin SA, 2018, AM J PHYSIOL-LUNG C, V314, pL388, DOI 10.1152/ajplung.00555.2016
   Su L, 2016, TUMOR BIOL, V37, P3925, DOI 10.1007/s13277-015-4151-2
   Sun Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001931
   Sun YM, 2019, BLOOD, V134, P1533, DOI 10.1182/blood.2019000802
   Tandon M, 2018, J CELL PHYSIOL, V233, P559, DOI 10.1002/jcp.25916
   Thacker G, 2016, BBA-MOL CELL RES, V1863, P510, DOI 10.1016/j.bbamcr.2016.01.010
   Tian FQ, 2021, J GENE MED, V23, DOI 10.1002/jgm.3329
   VILLAR J, 1994, CRIT CARE MED, V22, P914
   Vishnupriya S, 2020, LIFE SCI, V260, DOI 10.1016/j.lfs.2020.118308
   Wang SH, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1078-z
   Wang W, 2023, MOL CELL BIOCHEM, V478, P743, DOI 10.1007/s11010-022-04521-1
   Wang W, 2022, IMMUNOBIOLOGY, V227, DOI 10.1016/j.imbio.2022.152219
   Wu L, 2019, J CELL BIOCHEM, V120, P12075, DOI 10.1002/jcb.26660
   Yang CL, 2021, GENE, V766, DOI 10.1016/j.gene.2020.145153
   Yao L, 2017, J CELL BIOCHEM, V118, P4708, DOI 10.1002/jcb.26137
   Yuan CY, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04532
   Zhang S, 2021, CHEM RES TOXICOL, V34, P857, DOI 10.1021/acs.chemrestox.0c00493
   Zhao HY, 2019, INFLAMMATION, V42, P426, DOI 10.1007/s10753-018-00952-5
   Zhou MH, 2018, EUR REV MED PHARMACO, V22, P8438, DOI 10.26355/eurrev_201812_16543
   Zhu QT, 2017, MOL MED REP, V15, P1272, DOI 10.3892/mmr.2017.6118
   Zhu W, 2020, J ZHEJIANG UNIV-SC B, V21, P122, DOI 10.1631/jzus.B1900422
   Zou ZJ, 2020, J GENE MED, V22, DOI 10.1002/jgm.3261
NR 55
TC 0
Z9 0
U1 0
U2 2
PU LIFE SCIENCE ALLIANCE LLC
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
EI 2575-1077
J9 LIFE SCI ALLIANCE
JI Life Sci. Alliance
PD JAN
PY 2022
VL 6
IS 1
AR e202201468
DI 10.26508/lsa.202201468
PG 14
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA 5X6XT
UT WOS:000878743400001
PM 36302650
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Xu, JX
   Xu, D
   Yu, ZZ
   Fu, ZH
   Lv, Z
   Meng, L
   Zhao, X
AF Xu, Jiaxin
   Xu, Dan
   Yu, Zhizhong
   Fu, Zhaohui
   Lv, Zheng
   Meng, Lei
   Zhao, Xin
TI Exosomal miR-150 partially attenuated acute lung injury by mediating
   microvascular endothelial cells and MAPK pathway
SO BIOSCIENCE REPORTS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; STROMAL CELLS; DIFFERENTIATION; BMSCS;
   LIPOPOLYSACCHARIDE; PROLIFERATION; EXPRESSION; THERAPY
AB Background: Acute lung injury (ALI) is a respiratory disease with high morbidity and mortality rates. Currently, there is no effective treatment to complement mechanical ventilation. Exo-somes and microRNAs (miRNAs) are promising agents for the management of this disease.
   Methods: Exosomes were isolated from mouse bone marrow stromal stem cells (BMSCs). The levels of two miRNAs, miR-542-3P and miR-150, in exosomes were determined using RT-PCR, and miR-150 was selected for further study. ALI model was established in mice using lipopolysaccharides, and then, they were treated with saline, exosomes, miRNA agomirs, or miRNA antagomirs. The concentrations of TNF-alpha,IL-6, and IL-1 beta and the number of neutrophils and macrophages in the bronchoalveolar lavage fluid were measured. The wet/dry weight ratio of the lung tissue was calculated, and tissue pathology and apoptosis were observed using hematoxylin and eosin and terminal deoxynucleotidyl transferase dUTP nick-end labeling staining. CD34 and VE-cadherin expression was detected using immunofluorescence. Proteins associated with apoptosis and MAPK signaling were detected using Western blotting, and miR-150 expression in lung tissue was evaluated using RT-PCR.
   Results: We successfully isolated BMSCs and exosomes and showed that the level of miR-150 was significantly higher than that of miR-542-3p. Exosomes and miR-150 reduced inflammation and lung edema while maintaining the integrity of the alveolar structure. They also mitigated microvascular endothelial cell injury by regulating the caspase-3, Bax/Bcl-2, and MAPK signaling.
   Conclusions: Exosomal miR-150 attenuates lipopolysaccharide-induced ALI through the MAPK pathway.
C1 [Xu, Jiaxin; Xu, Dan; Yu, Zhizhong; Fu, Zhaohui; Lv, Zheng; Meng, Lei; Zhao, Xin] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Crit Care Med, Wuhan 430022, China.
C3 Huazhong University of Science & Technology
RP Yu, ZZ; Fu, ZH (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Crit Care Med, Wuhan 430022, Peoples R China.
EM 634315431@qq.com; 1334485308@qq.com
RI Xu, Jiaxin/GPS-4486-2022
OI Xu, Jiaxin/0000-0003-3297-7118
FU Nature Science Foundation of Hubei Province [2019CFB723]
FX This work was supported by the Nature Science Foundation of Hubei
   Province [grant number 2019CFB723] .
CR Amarnath S, 2015, STEM CELLS, V33, P1200, DOI 10.1002/stem.1934
   Barile L, 2018, CARDIOVASC RES, V114, P992, DOI 10.1093/cvr/cvy055
   Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95
   Dong F, 2012, CIRCULATION, V126, P314, DOI 10.1161/CIRCULATIONAHA.111.082453
   Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296
   Gan L, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/8101359
   Gao Y, 2014, TISSUE CELL, V46, P450, DOI 10.1016/j.tice.2014.08.006
   Garcia-Garcia A, 2015, IMMUNOL LETT, V168, P129, DOI 10.1016/j.imlet.2015.06.020
   Gill SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088501
   Guang LG, 2013, INT J BIOCHEM CELL B, V45, P1813, DOI 10.1016/j.biocel.2013.05.034
   Haldar D, 2016, FASEB J, V30, P3905, DOI 10.1096/fj.201600433R
   He T, 2014, J PATHOL, V232, P499, DOI 10.1002/path.4324
   He ZG, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/761091
   Jansen FH, 2009, MOL CELL PROTEOMICS, V8, P1192, DOI 10.1074/mcp.M800443-MCP200
   Kanehira M, 2014, MOL CELL BIOL, V34, P2848, DOI 10.1128/MCB.00871-13
   Li PB, 2019, INT IMMUNOPHARMACOL, V75, DOI 10.1016/j.intimp.2019.105794
   Lo BC, 2017, AM J RESP CELL MOL, V57, P651, DOI 10.1165/rcmb.2016-0386OC
   Ma HC, 2016, CHINESE MED J-PEKING, V129, P967, DOI 10.4103/0366-6999.179794
   Ma QQ, 2014, CLIN RES HEPATOL GAS, V38, P689, DOI 10.1016/j.clinre.2014.06.001
   Miao C, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0697-9
   Montemurro T, 2011, J CELL MOL MED, V15, P796, DOI 10.1111/j.1582-4934.2010.01047.x
   Munir H, 2015, STEM CELLS DEV, V24, P2091, DOI 10.1089/scd.2015.0008
   Ono M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005231
   Qu J.M., STEM CELLS
   Rajput C, 2016, ARTERIOSCL THROM VAS, V36, P380, DOI 10.1161/ATVBAHA.115.306997
   San ZH, 2014, INT IMMUNOPHARMACOL, V19, P342, DOI 10.1016/j.intimp.2014.01.031
   Tang Y, 2014, EUR J PHARMACOL, V723, P494, DOI 10.1016/j.ejphar.2013.10.019
   Wang DD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4520
   Yan DM, 2019, ONCOTARGETS THER, V12, P9685, DOI 10.2147/OTT.S209937
   Yang C, 2015, BIOL TRACE ELEM RES, V168, P453, DOI 10.1007/s12011-015-0374-8
   Ye XC, 2013, INT J MOL SCI, V14, P22221, DOI 10.3390/ijms141122221
   Young JA, 2013, BLOOD, V122, P2911, DOI 10.1182/blood-2012-12-473017
   Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001
   Zhu XH, 2013, GASTRIC CANCER, V16, P155, DOI 10.1007/s10120-012-0166-1
NR 34
TC 10
Z9 10
U1 2
U2 10
PU PORTLAND PRESS LTD
PI LONDON
PA 1ST FLR, 10 QUEEN STREET PLACE, LONDON, ENGLAND
SN 0144-8463
EI 1573-4935
J9 BIOSCIENCE REP
JI Biosci. Rep.
PD JAN
PY 2022
VL 42
IS 1
AR BSR20203363
DI 10.1042/BSR20203363
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA XX4SC
UT WOS:000736286500001
PM 34750610
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Wu, L
   Cheng, Y
   Peng, SX
   Zhang, WS
   Zhang, CX
AF Wu, Lan
   Cheng, Yan
   Peng, Shunxiang
   Zhang, Wensheng
   Zhang, Chaoxiong
TI Sphingosine Kinase 1 Plays an Important Role in Atorvastatin-Mediated
   Anti-Inflammatory Effect against Acute Lung Injury
SO MEDIATORS OF INFLAMMATION
LA English
DT Article
ID SPHINGOSINE-1-PHOSPHATE RECEPTORS; MECHANICAL VENTILATION;
   MOLECULAR-MECHANISMS; PERMEABILITY; 1-PHOSPHATE; STATINS; ACTIVATION;
   VOLUME
AB Atorvastatin is a 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) inhibitor and inhibits cholesterol synthesis. Recently, atorvastatin also showed anti-inflammatory effect in acute lung injury, ameliorating pulmonary gas-blood exchanging function. Sphingosine kinase 1 plays a central role in endothelial (EC) cytoskeleton rearrangement and EC barrier integrity regulation. In this study, the role of sphingosine kinase 1 in atorvastatin anti-inflammatory effect against acute lung injury was investigated. Both wild-type (WT) and SphK1(-/-) mice were challenged with high tidal volume ventilation (40 ml/kg body weight, 65 breathing/min, 4 hours). The acute lung injury was evaluated and the mechanisms were explored. In WT mice, atorvastatin treatment significantly decreased acute lung injury responding to high tidal volume ventilation (HT), including protein, cellular infiltration, and cytokine releasing; comparing to WT mice, SphK1(-/-) mice showed significantly worsen pulmonary injuries on HT model. Moreover, the atorvastatin-mediated anti-inflammatory effect was diminished in SphK1(-/-) mice. To further confirm the role of SphK1 in VILI, we then compared the inflammatory response of endothelial cells that were isolated from WT and SphK1(-/-) mice to cyclic stretching. Similarly, atorvastatin significantly decreased cytokine generation from WT EC responding to cyclic stretching. Atorvastatin also significantly preserved endothelial junction integrity in WT EC against thrombin challenge. However, the inhibitory effect of atorvastatin on cytokine generation induced by cyclic stretching was abolished on SphK1(-/-) mice EC. The endothelial junction integrity effects of atorvastatin also diminished on SphK1(-/-) mouse EC. Signal analysis indicated that atorvastatin inhibited JNK activation induced by cyclic stretch. SphK1 knockout also blocked atorvastatin-mediated VE-cadherin junction enhancement. In summary, by inhibition of MAPK activity and maintenance of EC junction homeostasis, SphK1 plays a critical role in atorvastatin-mediated anti-inflammatory effects in both cellular and in vivo model. This study also offers an insight into mechanical stress-mediated acute lung injury and potential therapy in the future.
C1 [Wu, Lan] Sichuan Univ, West China Univ Hosp 2, Dept Anesthesiol, Chengdu 610041, Sichuan, China.
   [Wu, Lan] Sichuan Univ, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu 610041, Sichuan, China.
   [Cheng, Yan; Peng, Shunxiang; Zhang, Wensheng] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Dept Anesthesiol,Lab Anesthesia & Crit Care Med, Chengdu 610041, Sichuan, China.
   [Zhang, Chaoxiong] Sichuan Univ, West China Sch Publ Hlth, Dept Ctr Dis Prevent & Control, Sichuan University 610041, Sichuan, China.
   [Zhang, Chaoxiong] Sichuan Univ, West China Hosp 4, Sichuan University 610041, Sichuan, China.
   [Zhang, Chaoxiong] Univ Illinois, Coll Med, Dept Med, Chicago, IL, United States.
C3 Sichuan University; Sichuan University; Sichuan University; Sichuan
   University; Sichuan University; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital
RP Zhang, WS (corresponding author), Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Dept Anesthesiol,Lab Anesthesia & Crit Care Med, Chengdu 610041, Sichuan, Peoples R China.
EM lancy12@163.com; 880517chengyan@163.com; 1473051689@qq.com;
   zhang_ws@scu.edu.cn; zcx7792@163.com
FU Science and Technology Department of Sichuan Province, China
   [2018sz0236]
FX AcknowledgmentsThis study was supported by Science and Technology
   Department of Sichuan Province, China (No. 2018sz0236).
CR Adams DR, 2016, TRENDS BIOCHEM SCI, V41, P395, DOI 10.1016/j.tibs.2016.02.007
   Ball L, 2015, BEST PRACT RES-CLIN, V29, P285, DOI 10.1016/j.bpa.2015.08.003
   Beitler JR, 2016, CLIN CHEST MED, V37, P633, DOI 10.1016/j.ccm.2016.07.004
   Bryan AM, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12836
   Cheifetz IM, 2013, PEDIATR CLIN N AM, V60, P621, DOI 10.1016/j.pcl.2013.02.015
   Chen L, 2018, CHINESE MED J-PEKING, V131, P1225, DOI 10.4103/0366-6999.226840
   Chen W, 2016, INT J MOL MED, V38, P1030, DOI 10.3892/ijmm.2016.2731
   Chen WG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16529
   Chen WG, 2014, AM J RESP CELL MOL, V50, P328, DOI 10.1165/rcmb.2013-0058OC
   Chen WG, 2012, AM J PHYSIOL-LUNG C, V303, pL279, DOI 10.1152/ajplung.00361.2011
   Chen WG, 2010, J CELL BIOCHEM, V110, P718, DOI 10.1002/jcb.22582
   Cheon S, 2008, BIOCHEM BIOPH RES CO, V374, P74, DOI 10.1016/j.bbrc.2008.06.091
   Choudhury S, 2015, EUR J PHARMACOL, V765, P447, DOI 10.1016/j.ejphar.2015.09.009
   Davies JD, 2016, RESP CARE, V61, P774, DOI 10.4187/respcare.04651
   Di AK, 2010, J BIOL CHEM, V285, P15848, DOI 10.1074/jbc.M109.075549
   Ebenezer David L., 2017, Advances in Biological Regulation, V63, P156, DOI 10.1016/j.jbior.2016.09.007
   Estenssoro E, 2016, MEDICINA-BUENOS AIRE, V76, P235
   Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450
   Gattinoni L, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1750-x
   Grin'kina NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036475
   Guo J, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-01307-3
   Healy LM, 2016, CURR DRUG TARGETS, V17, P1841, DOI 10.2174/1389450116666151001112710
   Hess DR, 2014, SEMIN RESP CRIT CARE, V35, P418, DOI 10.1055/s-0034-1382154
   Huang LS, 2013, FASEB J, V27, P1749, DOI 10.1096/fj.12-219634
   Huo ZH, 2019, VASC PHARMACOL, V117, P7, DOI 10.1016/j.vph.2018.06.003
   Kawasaki T, 2018, AM J PHYSIOL-LUNG C, V315, pL834, DOI 10.1152/ajplung.00031.2018
   Keszler M, 2015, CLIN PERINATOL, V42, P781, DOI 10.1016/j.clp.2015.08.006
   Keszler M, 2015, AM J PERINAT, V32, P23, DOI 10.1055/s-0034-1371713
   Koushki K, 2021, CLIN REV ALLERG IMMU, V60, P175, DOI 10.1007/s12016-020-08791-9
   Li X, 2008, BLOOD, V111, P3489, DOI 10.1182/blood-2007-05-092148
   Maceyka M, 2008, MOL CELL BIOL, V28, P5687, DOI 10.1128/MCB.00465-08
   Mager Diana R, 2016, Home Healthc Now, V34, P388, DOI 10.1097/NHH.0000000000000426
   Marsolais D, 2009, NAT REV DRUG DISCOV, V8, P297, DOI 10.1038/nrd2356
   Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST
   Natarajan V, 2013, AM J RESP CELL MOL, V49, P6, DOI 10.1165/rcmb.2012-0411TR
   Obinata H, 2019, INT IMMUNOL, V31, P617, DOI 10.1093/intimm/dxz037
   Oesterle A, 2017, CIRC RES, V120, P229, DOI 10.1161/CIRCRESAHA.116.308537
   Pinal-Fernandez I, 2018, MED CLIN-BARCELONA, V150, P398, DOI [10.1016/j.medcli.2017.11.030, 10.1016/j.medcle.2018.03.001]
   Qiang GH, 2019, HEPATOB PANCREAT DIS, V18, P255, DOI 10.1016/j.hbpd.2019.04.001
   Radigan KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035788
   Ren Y, 2015, BIOCHEM BIOPH RES CO, V459, P94, DOI 10.1016/j.bbrc.2015.02.076
   Santus P, 2019, CAN RESPIR J, V2019, DOI 10.1155/2019/3546056
   Siempos II, 2010, CRIT CARE MED, V38, P1321, DOI 10.1097/CCM.0b013e3181d9dad6
   Song SL, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9090759
   Suryadevara V, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010114
   Taguchi Y, 2016, J BIOL CHEM, V291, P12029, DOI 10.1074/jbc.M116.728170
   Tamashiro PM, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0076-x
   Taniguti EH, 2019, BRAIN RES BULL, V146, P279, DOI 10.1016/j.brainresbull.2019.01.018
   Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51
   Toth Peter P, 2019, Methodist Debakey Cardiovasc J, V15, P23, DOI 10.14797/mdcj-15-1-23
   Tremoulet AH, 2015, AUTOIMMUNITY, V48, P177, DOI 10.3109/08916934.2015.1027818
   Tulbah AS, 2020, SAUDI PHARM J, V28, P1353, DOI 10.1016/j.jsps.2020.08.025
   Uhlig U, 2011, COMPR PHYSIOL, V1, P635, DOI 10.1002/cphy.c100004
   Wang T, 2017, AM J PHYSIOL-LUNG C, V312, pL452, DOI 10.1152/ajplung.00231.2016
   Zhang XW, 2018, AM J PHYSIOL-RENAL, V315, pF752, DOI 10.1152/ajprenal.00596.2017
NR 55
TC 2
Z9 2
U1 2
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0962-9351
EI 1466-1861
J9 MEDIAT INFLAMM
JI Mediat. Inflamm.
PD DEC 21
PY 2021
VL 2021
AR 9247285
DI 10.1155/2021/9247285
PG 14
WC Cell Biology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Immunology
GA YB3PF
UT WOS:000738927900002
PM 34970075
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Liu, J
   Dean, DA
AF Liu, Jing
   Dean, David A.
TI Gene transfer of MRCK alpha rescues lipopolysaccharide-induced acute
   lung injury by restoring alveolar capillary barrier function
SO SCIENTIFIC REPORTS
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; NONMUSCLE MYOSIN-II; LIGHT-CHAIN KINASE;
   FLUID CLEARANCE; PULMONARY-EDEMA; MEDIATED TRANSFER; TIGHT JUNCTIONS;
   K-ATPASE; ELECTROPORATION; NA+
AB Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS) is characterized by alveolar edema accumulation with reduced alveolar fluid clearance (AFC), alveolar-capillary barrier disruption, and substantial inflammation, all leading to acute respiratory failure. Enhancing AFC has long been considered one of the primary therapeutic goals in gene therapy treatments for ARDS. We previously showed that electroporation-mediated gene delivery of the Na+, K+-ATPase beta 1 subunit not only increased AFC, but also restored alveolar barrier function through upregulation of tight junction proteins, leading to treatment of LPS-induced ALI in mice. We identified MRCK alpha as an interaction partner of beta 1 which mediates this upregulation in cultured alveolar epithelial cells. In this study, we investigate whether electroporation-mediated gene transfer of MRCK alpha to the lungs can attenuate LPS-induced acute lung injury in vivo. Compared to mice that received a non-expressing plasmid, those receiving the MRCK alpha plasmid showed attenuated LPS-increased pulmonary edema and lung leakage, restored tight junction protein expression, and improved overall outcomes. Interestingly, gene transfer of MRCK alpha did not alter AFC rates. Studies using both cultured microvascular endothelial cells and mice suggest that beta 1 and MRCK alpha upregulate junctional complexes in both alveolar epithelial and capillary endothelial cells, and that one or both barriers may be positively affected by our approach. Our data support a model of treatment for ALI/ARDS in which improvement of alveolar-capillary barrier function alone may be of more benefit than improvement of alveolar fluid clearance.
C1 [Liu, Jing; Dean, David A.] Univ Rochester, Sch Med & Dent, Dept Pediat, 601 Elmwood Ave,Box 850, Rochester, NY 14642, United States.
   [Liu, Jing; Dean, David A.] Univ Rochester, Sch Med & Dent, Dept Pharmacol & Physiol, Rochester, NY 14642, United States.
C3 University of Rochester; University of Rochester
RP Dean, DA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pediat, 601 Elmwood Ave,Box 850, Rochester, NY 14642 USA.; Dean, DA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pharmacol & Physiol, Rochester, NY 14642 USA.
EM david_dean@urmc.rochester.edu
FU NIH [HL148825]; American Heart Association [20PRE35200159]
FX We would like to thank Michael Barravecchia, Rosemary Norman, Rui Zhou,
   Gillian Schiralli-Lester, Haiqing Bai, Jennifer Young, and Xin Lin for
   advice and technical assistance on these studies. We would also like to
   thank Arshad Rahman, Mohammad Shadab, Rauf Najar, and Michelle Millar
   for help with VE-cadherin staining and experiments with MVECs. This work
   was supported in part by NIH Grant HL148825 and a predoctoral fellowship
   from the American Heart Association (20PRE35200159).
CR Ando K, 2013, J CELL BIOL, V202, P901, DOI 10.1083/jcb.201301115
   Bai HQ, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.134881
   Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756
   Dean DA, 2003, GENE THER, V10, P1608, DOI 10.1038/sj.gt.3302053
   Dumasius V, 2001, CIRC RES, V89, P907, DOI 10.1161/hh2201.100204
   Emr BM, 2015, SHOCK, V43, P16, DOI 10.1097/SHK.0000000000000228
   Factor P, 2000, HUM GENE THER, V11, P2231, DOI 10.1089/104303400750035753
   Gagliardi PA, 2014, J CELL BIOL, V206, P415, DOI 10.1083/jcb.201312090
   GORIN AB, 1979, J APPL PHYSIOL, V47, P1315, DOI 10.1152/jappl.1979.47.6.1315
   He WQ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030993
   Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325
   Huppert LA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00371
   Itoh M, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24221
   Leonard A, 2019, CELL SIGNAL, V61, P120, DOI 10.1016/j.cellsig.2019.04.013
   Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130
   Lin X, 2016, GENE THER, V23, P489, DOI 10.1038/gt.2016.19
   Machado-Aranda D, 2005, AM J RESP CRIT CARE, V171, P204, DOI 10.1164/rccm.200403-313OC
   Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028
   Mammoto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2774
   Marston DJ, 2016, CURR BIOL, V26, P2079, DOI 10.1016/j.cub.2016.06.010
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Matthay MA, 2014, AM J RESP CRIT CARE, V189, P1301, DOI 10.1164/rccm.201403-0535OE
   Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST
   Mutlu G, 2005, CIRC RES, V96, P999, DOI 10.1161/01.RES.0000164554.21993.AC
   Mutlu GM, 2005, AM J PHYSIOL-LUNG C, V289, pL685, DOI 10.1152/ajplung.00247.2005
   Mutlu GM, 2004, CIRC RES, V94, P1091, DOI 10.1161/01.RES.0000125623.56442.20
   Mutlu GM, 2007, AM J RESP CRIT CARE, V176, P582, DOI 10.1164/rccm.200608-1246OC
   Natarajan V, 2013, AM J RESP CELL MOL, V49, P6, DOI 10.1165/rcmb.2012-0411TR
   Newell-Litwa KA, 2015, DIS MODEL MECH, V8, P1495, DOI 10.1242/dmm.022103
   Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC
   Rajasekaran AK, 2003, AM J PHYSIOL-RENAL, V285, pF388, DOI 10.1152/ajprenal.00439.2002
   Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279
   Ridge KM, 2003, CIRC RES, V92, P453, DOI 10.1161/01.RES.0000059414.10360.F2
   Rokkam D, 2011, AM J PATHOL, V179, P1081, DOI 10.1016/j.ajpath.2011.05.017
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144
   Smith FG, 2012, LANCET, V379, P229, DOI 10.1016/S0140-6736(11)61623-1
   Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403
   STANDIFORD TJ, 1995, J IMMUNOL, V155, P1515
   Stern M, 2000, GENE THER, V7, P960, DOI 10.1038/sj.gt.3301193
   Szilagyi KL, 2017, TRANSL RES, V180, P12, DOI 10.1016/j.trsl.2016.07.020
   Tan I, 2011, FEBS LETT, V585, P1260, DOI 10.1016/j.febslet.2011.03.054
   Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]
   Unbekandt M, 2014, J MOL MED, V92, P217, DOI 10.1007/s00109-014-1133-6
   Vadasz I, 2007, INTENS CARE MED, V33, P1243, DOI 10.1007/s00134-007-0661-8
   Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035
   Yang X, 2020, LANCET RESP MED, V8, pE26
   Zemans RL, 2004, CRIT CARE, V8, P469, DOI 10.1186/cc2906
   Zhou QQ, 2017, CHEST, V151, P658, DOI 10.1016/j.chest.2016.10.030
   Zihni C, 2017, NAT CELL BIOL, V19, P1049, DOI 10.1038/ncb3592
NR 54
TC 5
Z9 6
U1 0
U2 1
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 21
PY 2021
VL 11
IS 1
AR 20862
DI 10.1038/s41598-021-99897-3
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA WK7VO
UT WOS:000709931300024
PM 34675326
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Meng, SS
   Guo, FM
   Huang, LL
   Huang, YZ
   Xie, JF
   Yang, CS
   Qiu, HB
   Yang, Y
AF Meng, Shanshan
   Guo, Fengmei
   Huang, Li-Li
   Huang, Yingzi
   Xie, Jian-Feng
   Yang, Cong-Shan
   Qiu, Haibo
   Yang, Yi
TI mTORC2 Activation Mediated by Mesenchymal Stem Cell-Secreted Hepatocyte
   Growth Factors for the Recovery of Lipopolysaccharide-Induced Vascular
   Endothelial Barrier
SO STEM CELLS INTERNATIONAL
LA English
DT Article
ID PROLIFERATION; RICTOR; RAPTOR
AB Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is characterized by pulmonary microvascular endothelial barrier dysfunction. Mesenchymal stem cell-secreted hepatocyte growth factor (HGF) has positive effects of lipopolysaccharide(LPS-) induced pulmonary endothelial barrier. Studies have exhibited the mammalian TORC1 (mTORC1) signaling is of potent angiogenesis effects. The mTOR protein kinase has two distinct multiprotein complexes mTORC1 and mTORC2 that regulate different branches of the mTOR network. However, detailed mTORC2 mechanisms of HGF protective effects remain poorly defined. Therefore, the aim of this study was to determine whether mTORC2 mediated protective effects of MSC-secreted HGF against LPS-induced pulmonary microvascular endothelial barrier dysfunction activated like mTORC1 activation. We introduced MSC-PMVEC coculture transwell system and recombinant murine HGF on LPS-induced endothelial cell barrier dysfunction in vitro and then explored potential mechanisms by lentivirus vector-mediated HGF, mTORC1 (raptor), and mTORC2 (rictor) gene knockdown modification. Endothelial paracellular and transcellular permeability, adherent junction protein (VE-Cadherin), cell proliferation, apoptosis, and mTOR-associated proteins were tested. These revealed that HGF could promote quick reestablishment of adherent junction VE-cadherin and decrease endothelial paracellular and transcellular permeability during LSP-induced endothelial dysfunction with the involvement of mTORC2 (rictor) and mTORC1 (raptor) pathways. Raptor and rictor knockdown in LPS-induced PMEVECs with stimulation of HGF increased apoptosis ratio, activated Cleaved-Caspase-3 expression, and downregulated cell proliferation. Moreover, mTORC2/Akt but not mTORC2/PKC had significance on HGF endothelial protective effects. Taken together, these highlight activation mTORC2 pathway could also contribute to vascular endothelial barrier recovery by MSC-secreted HGF in LPS stimulation.
C1 [Meng, Shan-Shan; Guo, Feng-Mei; Huang, Li-Li; Huang, Ying-Zi; Xie, Jian-Feng; Yang, Cong-Shan; Qiu, Hai-Bo; Yang, Yi] Southeast Univ, Jiangsu Prov Key Lab Crit Care Med, Zhongda Hosp, Dept Crit Care Med,Sch Med, Nanjing 210009, China.
C3 Southeast University - China
RP Yang, Y (corresponding author), Southeast Univ, Jiangsu Prov Key Lab Crit Care Med, Zhongda Hosp, Dept Crit Care Med,Sch Med, Nanjing 210009, Peoples R China.
EM yiyiyang2004@163.com
RI Qiu, Haibo/AAS-9047-2021
OI Qiu, Haibo/0000-0001-8589-4717; Guo, Fengmei/0000-0002-7279-2946
FU National Natural Science Foundation of China [81671892, 81971888,
   81971812, 82102300]; Jiangsu Natural Science Foundation [BK20200367,
   BK20161433, BK20191264]; Jiangsu Province's Medical Key Talent
   [ZDRCA2016082]; Jiangsu Province Key Medical Discipline (laboratory)
   [ZDXKA2016025]; Jiangsu Entrepreneurship and Innovation Doctors
FX This study is supported by the following: contract grant sponsor:
   National Natural Science Foundation of China, contract grant numbers:
   81671892, 81971888, 81971812 and 82102300; contract grant sponsor:
   Jiangsu Natural Science Foundation, contract grant numbers: BK20200367,
   BK20161433, and BK20191264; contract grant sponsor: Jiangsu Province's
   Medical Key Talent, contract grant number: ZDRCA2016082; contract grant
   sponsor: Jiangsu Province Key Medical Discipline (laboratory), contract
   grant number: ZDXKA2016025; contract grant sponsor: Jiangsu
   Entrepreneurship and Innovation Doctors.
CR Armstrong SM, 2012, AM J PATHOL, V180, P1308, DOI 10.1016/j.ajpath.2011.12.002
   Bardita C, 2013, APOPTOSIS, V18, P57, DOI 10.1007/s10495-012-0762-x
   Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020
   Birukova AA, 2009, AM J RESP CELL MOL, V40, P99, DOI 10.1165/rcmb.2008-0099OC
   Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679
   Ding Y, 2018, CELL PHYSIOL BIOCHEM, V46, P520, DOI 10.1159/000488619
   Goncharov DA, 2014, CIRCULATION, V129, P864, DOI 10.1161/CIRCULATIONAHA.113.004581
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704
   Hu SL, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0320-5
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jaffre S, 2002, AM J PHYSIOL-LUNG C, V282, pL310, DOI 10.1152/ajplung.00121.2001
   Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73
   Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460
   Mac Sweeney R, 2016, LANCET, V388, P2416, DOI 10.1016/S0140-6736(16)00578-X
   Nakao T, 2007, J PHARMACOL SCI, V105, P334, DOI 10.1254/jphs.FP0070682
   Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003
   Quesnel C, 2008, AM J PHYSIOL-LUNG C, V294, pL334, DOI 10.1152/ajplung.00096.2007
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Stoeltzing O, 2006, CANCER CELL, V10, P89, DOI 10.1016/j.ccr.2006.07.013
   Wang H, 2013, HUM GENE THER, V24, P343, DOI 10.1089/hum.2012.177
   Wang S, 2015, MOL CELL BIOL, V35, P1299, DOI 10.1128/MCB.00306-14
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yamada T, 2000, AM J RESP CRIT CARE, V162, P707, DOI 10.1164/ajrccm.162.2.9908064
   Yang C, 2014, INT J BIOCHEM CELL B, V50, P93, DOI 10.1016/j.biocel.2014.02.020
   Yang Y, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0257-0
   Yu Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0356-9
   Yuan T, 2018, J MOL BIOL, V430, P904, DOI 10.1016/j.jmb.2018.02.013
NR 30
TC 3
Z9 3
U1 1
U2 7
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-966X
EI 1687-9678
J9 STEM CELLS INT
JI Stem Cells Int.
PD OCT 18
PY 2021
VL 2021
AR 9981589
DI 10.1155/2021/9981589
PG 12
WC Cell & Tissue Engineering
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA ZW5GT
UT WOS:000771241900001
PM 34707661
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Bayat, B
   Nielsen, KR
   Bein, G
   Traum, A
   Burg-Roderfeld, M
   Sachs, UJ
AF Bayat, Behnaz
   Nielsen, Kaspar Rene
   Bein, Gregor
   Traum, Annalena
   Burg-Roderfeld, Monika
   Sachs, Ulrich J. H.
TI Transfusion of target antigens to preimmunized recipients: a new
   mechanism in transfusion-related acute lung injury
SO BLOOD ADVANCES
LA English
DT Article
ID LINKED-IMMUNOSORBENT-ASSAY; RED-BLOOD-CELLS; IN-VIVO; TNF-ALPHA;
   ACTIVATION; ANTIBODIES; GAMMA; PATHOGENESIS; INFLAMMATION; NEUTROPHILS
AB Transfusion-related lung injury (TRALI) is a serious side effect of blood transfusion. Exclusion of antibody carriers from the donor pool has significantly decreased the number of cases, but TRALI remains the leading cause of transfusion-related morbidity and mortality in industrialized countries. Here, we show that proteins released from donor cells during processing of blood components are capable of inducing a new type of reverse TRALI when transfused to preimmunized recipients. First, we show that soluble neutrophil surface protein CD177 in complex with proteinase 3 (sCD177/PR3) is not only present in human plasma but also in packed red blood cell (PRBC) supernatant. Filtration or storage enhances the concentration of sCD177/PR3 in PRBCs. Second, we show that sCD177/PR3 specifically binds to PECAM-1 on stimulated (but not on unstimulated) endothelial cells (ECs). Third, we provide evidence that the sCD177/PR3/PECAM-1 complex is functional. In the presence of monoclonal or human antibodies against CD177 or PR3, ECs produce reactive oxygen species and become apoptotic. Albumin flux through an EC monolayer increases significantly whenever antibodies and the cognate antigens are present. Finally, we describe a clinical case in which anti-CD177 present in a transfusion recipient precipitated TRALI after the transfusion of CD177-positive, but not CD177-negative, PRBCs. In conclusion, we introduce a new TRALI mechanism based on the specific binding of transfused, soluble antigens to activated ECs in preimmunized recipients. We suggest that further studies and clinical work-up of TRALI should also include antibody investigation of the recipient.
C1 [Bayat, Behnaz; Bein, Gregor; Traum, Annalena; Sachs, Ulrich J.] Justus Liebig Univ, Inst Clin Immunol & Transfus Med, Langhansstr 7, D-35392 Giessen, Germany.
   [Nielsen, Kaspar Rene] Aalborg Univ Hosp, Clin Immunol, Aalborg, Denmark.
   [Burg-Roderfeld, Monika] Fresenius Univ Appl Sci, Fac Biol & Chem, Idstein, Germany.
C3 Justus Liebig University Giessen; Aalborg University; Aalborg University
   Hospital
RP Sachs, UJ (corresponding author), Justus Liebig Univ, Inst Clin Immunol & Transfus Med, Langhansstr 7, D-35392 Giessen, Germany.
EM behnaz.bayat@immunologie.med.uni-giessen.de;
   ulrich.sachs@med.uniessen.de
RI Sachs, Ulrich/GSI-7824-2022
OI Burg-Roderfeld, Monika/0000-0003-3455-9171; Bein,
   Gregor/0000-0002-7571-8362; Sachs, Ulrich/0000-0001-5486-5542
CR Al-Tamimi AS, 2019, INT J RES PHARM SCI, V10, P1448
   Alexander PE, 2016, BLOOD, V127, P400, DOI 10.1182/blood-2015-09-670950
   Andreu G, 2018, TRANSFUS MED REV, V32, P16, DOI 10.1016/j.tmrv.2017.07.001
   Bayat B, 2013, ARTERIOSCL THROM VAS, V33, P2538, DOI 10.1161/ATVBAHA.113.301206
   Bayat B, 2010, J IMMUNOL, V184, P3889, DOI 10.4049/jimmunol.0903136
   Bayat B, 2009, TRANSFUSION, V49, P1819, DOI 10.1111/j.1537-2995.2009.02229.x
   Ben Mkaddem S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00811
   Bianchi M, 2016, BLOOD TRANSFUS-ITALY, V14, P214, DOI 10.2450/2015.0154-15
   Bux J, 2007, BRIT J HAEMATOL, V136, P788, DOI 10.1111/j.1365-2141.2007.06492.x
   De Clippel D, 2019, TRANSFUSION, V59, P2788, DOI 10.1111/trf.15431
   Finlayson J, 2011, INTERN MED J, V41, P638, DOI 10.1111/j.1445-5994.2010.02366.x
   Gajic O, 2007, AM J RESP CRIT CARE, V176, P886, DOI 10.1164/rccm.200702-271OC
   Groger M, 1996, J IMMUNOL, V156, P1549
   Ilmakunnas M, 2005, J THORAC CARDIOV SUR, V129, P851, DOI 10.1016/j.jtcvs.2004.07.061
   Jerke U, 2017, SCI REP-UK, V7, DOI 10.1038/srep43328
   Kapur R, 2017, BLOOD, V129, P2557, DOI 10.1182/blood-2016-12-758185
   Kelher MR, 2009, BLOOD, V113, P2079, DOI 10.1182/blood-2008-09-177857
   Khan SY, 2006, BLOOD, V108, P2455, DOI 10.1182/blood-2006-04-017251
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   Looney MR, 2014, CRIT CARE MED, V42, P1676, DOI 10.1097/CCM.0000000000000323
   Lundblad LKA, 2005, AM J RESP CRIT CARE, V171, P1363, DOI 10.1164/rccm.200410-1349OC
   McVey MJ, 2019, ANESTHESIOLOGY, V131, P693, DOI 10.1097/ALN.0000000000002687
   Middelburg RA, 2008, TRANSFUSION, V48, P2167, DOI 10.1111/j.1537-2995.2008.01810.x
   Muller MCA, 2015, TRANSFUSION, V55, P164, DOI 10.1111/trf.12816
   ODIN JA, 1991, SCIENCE, V254, P1785, DOI 10.1126/science.1837175
   Pan LF, 1998, CLIN EXP IMMUNOL, V112, P533
   Peters A, 2017, ISBT SCI SER, V12, P260
   Peters AL, 2016, CRIT CARE MED, V44, pE412, DOI 10.1097/CCM.0000000000001614
   ROMER LH, 1995, J IMMUNOL, V154, P6582
   Roubinian NH, 2015, TRANSFUSION, V55, P1838, DOI 10.1111/trf.13021
   Sachs UJ, 2003, TRANSFUSION, V43, P1683, DOI 10.1111/j.0041-1132.2003.00568.x
   Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200
   Schmickl CN, 2015, CRIT CARE MED, V43, P205, DOI 10.1097/CCM.0000000000000675
   Semple JW, 2019, BLOOD, V133, P1840, DOI 10.1182/blood-2018-10-860809
   Silliman CC, 2006, CRIT CARE MED, V34, pS124, DOI 10.1097/01.CCM.0000214292.62276.8E
   Strait RT, 2011, J EXP MED, V208, P2525, DOI 10.1084/jem.20110159
   Tariket S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49040-0
   Tuinman PR, 2011, CLIN EXP IMMUNOL, V165, P278, DOI 10.1111/j.1365-2249.2011.04422.x
   VANDENHERIKOUDIJK IE, 1995, BLOOD, V85, P2202, DOI 10.1182/blood.V85.8.2202.bloodjournal8582202
   Vlaar APJ, 2019, TRANSFUSION, V59, P2465, DOI 10.1111/trf.15311
   Vlaar APJ, 2011, BLOOD, V117, P4218, DOI 10.1182/blood-2010-10-313973
   Vlaar APJ, 2010, ANESTHESIOLOGY, V113, P92, DOI 10.1097/ALN.0b013e3181de6f25
   Werth S, 2013, TRANSFUSION, V53, P193, DOI 10.1111/j.1537-2995.2012.03675.x
   Woodfin A, 2009, BLOOD, V113, P6246, DOI 10.1182/blood-2008-11-188375
NR 44
TC 7
Z9 7
U1 1
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2473-9529
EI 2473-9537
J9 BLOOD ADV
JI Blood Adv.
PD OCT 26
PY 2021
VL 5
IS 20
BP 3975
EP 3985
DI 10.1182/bloodadvances.2020003843
EA OCT 2021
PG 11
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA WP3HX
UT WOS:000713028200007
PM 34438443
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Chen, DQ
   Shen, MJ
   Wang, H
   Li, Y
   Tang, AL
   Li, S
   Xiong, MC
   Guo, Y
   Zhang, GQ
AF Chen, Dan-Qian
   Shen, Mei-Jia
   Wang, Hui
   Li, Yan
   Tang, A-Ling
   Li, Shan
   Xiong, Meng-Chen
   Guo, Yan
   Zhang, Guo-Qiang
TI Sirt3 Maintains Microvascular Endothelial Adherens Junction Integrity to
   Alleviate Sepsis-Induced Lung Inflammation by Modulating the Interaction
   of VE-Cadherin and beta-Catenin
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID INJURY; DYSFUNCTION; PATHWAY
AB Inflammatory injury is a hallmark of sepsis-induced acute respiratory distress syndrome (ARDS)/acute lung injury (ALI). However, the mechanisms underlying inflammatory injury remain obscure. Here, we developed the novel strategy to suppress lung inflammation through maintaining microvascular endothelial barrier integrity. VE-cadherin is the main adherens junction protein that interacts with beta-catenin and forms a complex. We found that lung inflammation was accompanied by decreased VE-cadherin expression and increased beta-catenin activity in animal models and human pulmonary microvascular endothelial cells (HPMECs), illuminating the relationship among VE-cadherin/beta-catenin complex, microvascular endothelial barrier integrity, and inflammation. Furthermore, we showed that the VE-cadherin/beta-catenin complex dissociated upon lung inflammation, while Sirt3 promoted the stability of such a complex. Sirt3 was decreased during lung inflammation in vivo and in vitro. Sirt3 deficiency not only led to the downregulation of VE-cadherin but also enhanced the transcriptional activity of beta-catenin that further increased beta-catenin target gene MMP-7 expression, thereby promoting inflammatory factor COX-2 expression. Sirt3 overexpression promoted VE-cadherin expression, inhibited beta-catenin transcriptional activity, strengthened the stability of the VE-cadherin/beta-catenin complex, and suppressed inflammation in HPMECs. Notably, Sirt3 deficiency significantly damaged microvascular endothelial barrier integrity and intensified lung inflammation in animal model. These results demonstrated the role of Sirt3 in modulating microvascular endothelial barrier integrity to inhibit inflammation. Therefore, strategies that aim at enhancing the stability of endothelial VE-cadherin/beta-catenin complex are potentially beneficial for preventing sepsis-induced lung inflammation.
C1 [Chen, Dan-Qian; Shen, Mei-Jia; Wang, Hui; Li, Yan; Tang, A-Ling; Li, Shan; Xiong, Meng-Chen; Zhang, Guo-Qiang] China Japan Friendship Hosp, Dept Emergency, 2 Yinghua Dongjie, Beijing, China.
   [Wang, Hui] Weifang Hosp Tradit Chinese Med, Dept Crit Care Med, 1055 Weizhou Rd, Weifang 261041, Shandong, China.
   [Guo, Yan] Univ New Mexico, Dept Internal Med, 1700 Lomas Blvd NE, Albuquerque, NM 87131, United States.
C3 China-Japan Friendship Hospital; University of New Mexico
RP Chen, DQ; Zhang, GQ (corresponding author), China Japan Friendship Hosp, Dept Emergency, 2 Yinghua Dongjie, Beijing, Peoples R China.
EM chendanqian2013@163.com; 346803216@qq.com; 1243095974@qq.com;
   18600845518@163.com; tangaling1997@163.com; 1156028927@qq.com;
   879463966@qq.com; yaguo@salud.unm.edu; zhangchong2003@vip.sina.com
RI Chen, Dan-Qian/HCH-6571-2022
FU National Natural Science Foundation of China [81871600, 82104511];
   Postdoctoral Science Foundation of China [2021M693579]
FX AcknowledgmentsThis study was supported by the National Natural Science
   Foundation of China (Grant Nos. 81871600 and 82104511) and the project
   funded by the Postdoctoral Science Foundation of China (Grant No.
   2021M693579).
CR Abraham MN, 2018, CRIT CARE MED, V46, pE797, DOI 10.1097/CCM.0000000000003201
   Ali HR, 2019, J PROTEOME RES, V18, P1513, DOI 10.1021/acs.jproteome.8b00800
   Amado-Azevedo J, 2022, ANGIOGENESIS, V25, P145, DOI 10.1007/s10456-021-09808-3
   Barabutis N, 2017, CHEST, V152, P954, DOI 10.1016/j.chest.2017.07.014
   Bi JB, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.136277
   Botros L, 2020, J CELL SCI, V133, DOI 10.1242/jcs.240077
   Cecconi M, 2018, LANCET, V392, P75, DOI 10.1016/S0140-6736(18)30696-2
   Chen DQ, 2020, THER ADV CHRONIC DIS, V11, DOI 10.1177/2040622320962648
   Chen DQ, 2020, PHYTOMEDICINE, V72, DOI 10.1016/j.phymed.2020.153232
   Chen DQ, 2019, THER ADV CHRONIC DIS, V10, DOI 10.1177/2040622319869116
   Chen DQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09329-0
   Chen DQ, 2019, FREE RADICAL BIO MED, V134, P494, DOI 10.1016/j.freeradbiomed.2019.01.046
   Chen DQ, 2018, TRENDS PHARMACOL SCI, V39, P937, DOI 10.1016/j.tips.2018.09.002
   Chen DQ, 2017, REDOX BIOL, V12, P505, DOI 10.1016/j.redox.2017.03.017
   Chen L, 2017, CHEM-BIOL INTERACT, V273, P56, DOI 10.1016/j.cbi.2017.05.025
   David S, 2013, J PHARMACOL EXP THER, V345, P2, DOI 10.1124/jpet.112.201061
   Dong WJ, 2018, AUTOPHAGY, V14, P1677, DOI 10.1080/15548627.2018.1476811
   Filewod NC, 2019, AM J RESP CRIT CARE, V200, P1472, DOI 10.1164/rccm.201905-1011CP
   Friedrich EE, 2019, P NATL ACAD SCI USA, V116, P12980, DOI 10.1073/pnas.1902165116
   Graves JD, 2020, P NATL ACAD SCI USA, V117, P14958, DOI 10.1073/pnas.1921554117
   Grindel BJ, 2014, MATRIX BIOL, V36, P64, DOI 10.1016/j.matbio.2014.04.005
   Hong GL, 2018, FREE RADICAL BIO MED, V123, P125, DOI 10.1016/j.freeradbiomed.2018.05.073
   Hubner K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07302-x
   Jablonski RP, 2017, FASEB J, V31, P2520, DOI 10.1096/fj.201601077R
   Katoh M, 2018, INT J MOL MED, V42, P713, DOI 10.3892/ijmm.2018.3689
   Kim TS, 2019, AUTOPHAGY, V15, P1356, DOI 10.1080/15548627.2019.1582743
   Kurundkar D, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.120722
   Lee EH, 2020, THERANOSTICS, V10, P9913, DOI 10.7150/thno.46417
   Li XY, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109363
   Lilley E, 2020, BRIT J PHARMACOL, V177, P3611, DOI 10.1111/bph.15178
   Liu Y, 2018, AM J PHYSIOL-CELL PH, V314, pC449, DOI 10.1152/ajpcell.00173.2017
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST
   Qi ZL, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9821543
   Reitsema VA, 2019, ANTIOXID REDOX SIGN, V31, P134, DOI 10.1089/ars.2018.7537
   Sabbineni H, 2019, BIOCHEM PHARMACOL, V164, P205, DOI 10.1016/j.bcp.2019.04.016
   Schafer R, 2003, CIRCULATION, V108, P1585, DOI 10.1161/01.CIR.0000091085.12422.19
   Tafrihi M, 2017, NUTR CANCER, V69, P702, DOI 10.1080/01635581.2017.1320415
   Tian YG, 2018, MOL MED REP, V17, P5557, DOI 10.3892/mmr.2018.8469
   Tinsley JH, 2005, AM J PHYSIOL-LUNG C, V289, pL217, DOI 10.1152/ajplung.00248.2004
   Vachharajani VT, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8167273
   van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36
   Wang XF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092738
   Xiong SQ, 2020, J CLIN INVEST, V130, P3684, DOI 10.1172/JCI136908
   Yang XY, 2018, CARDIOVASC RES, V114, P1752, DOI 10.1093/cvr/cvy167
   Yu WK, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2315-y
   Zhou M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01612
   Zhu N, 2019, AM J PHYSIOL-LUNG C, V317, pL615, DOI 10.1152/ajplung.00425.2018
NR 48
TC 6
Z9 7
U1 1
U2 13
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD OCT 1
PY 2021
VL 2021
AR 8978795
DI 10.1155/2021/8978795
PG 18
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA XQ4BO
UT WOS:000731491500002
PM 34630854
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Sriram, K
   Insel, MB
   Insel, PA
AF Sriram, Krishna
   Insel, Michael B.
   Insel, Paul A.
TI Inhaled beta 2 Adrenergic Agonists and Other cAMP- Elevating Agents:
   Therapeutics for Alveolar Injury and Acute Respiratory Disease Syndrome?
SO PHARMACOLOGICAL REVIEWS
LA English
DT Review
ID ACUTE LUNG INJURY; BRONCHIAL EPITHELIAL-CELLS; ACTING
   BETA(2)-ADRENOCEPTOR AGONIST; OBSTRUCTIVE PULMONARY-DISEASE;
   PROTEIN-COUPLED RECEPTORS; ROFLUMILAST N-OXIDE; TRANSMEMBRANE
   CONDUCTANCE REGULATOR; PSEUDOMONAS-AERUGINOSA INFECTION;
   BETA-ADRENOCEPTOR AGONISTS; ENAC MESSENGER-RNA
AB long-acting fl-adrenergic agonists (LABAs) and short-acting fl-adrenergic agonists are approved for the treatment of obstructive lung disease via actions mediated by fl2 adrenergic receptors (fl2-ARs) that increase cellular cAMP synthesis. This review discusses the potential of fl2-AR agonists, in particular LABAs, for the treatment of acute respiratory distress syndrome (ARDS). We emphasize ARDS induced by pneumonia and focus on the pathobiology of ARDS and actions of LABAs and cAMP on pulmonary and immune cell types. fl2-AR agonists/cAMP have beneficial actions that include protection of epithelial and endothelial cells from injury, restoration of alveolar fluid clearance, and reduction of fibrotic remodeling. fl2-AR agonists/cAMP also exert antiinflammatory effects on the immune system by actions on several types of immune cells. Early administration is likely critical for optimizing efficacy of LABAs or other cAMP-elevating agents, such as agonists of other Gs-coupled G protein-coupled receptors or cyclic nucleotide phosphodiesterase inhibitors. Clinical studies that target lung injury early, prior to development of ARDS, are thus needed to further assess the use of inhaled LABAs, perhaps combined with inhaled corticosteroids and/or long-acting muscarinic cholinergic antagonists. Such agents may provide a multipronged, repurposing, and efficacious therapeutic approach while minimizing systemic toxicity. Significance Statement--Acute respiratory distress syndrome (ARDS) after pulmonary alveolar injury (e.g., certain viral infections) is associated with-40% mortality and in need of new therapeutic approaches. This review summarizes the pathobiology of ARDS, focusing on contributions of pulmonary and immune cell types and potentially beneficial actions of fl2 adrenergic receptors and cAMP. Early administration of inhaled fl2 adrenergic agonists and perhaps other cAMP-elevating agents after alveolar injury may be a prophylactic approach to prevent development of ARDS.
C1 [Sriram, Krishna; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093, United States.
   [Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093, United States.
   [Insel, Michael B.] Univ Arizona, Dept Med, Tucson, AZ, United States.
C3 University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of Arizona
RP Insel, PA (corresponding author), Dept Pharmacol, MC 0636,9500 Gilman Dr, La Jolla, CA 92093 USA.
EM pinsel@health.ucsd.edu
FU Academic Senate of the University of California, San Diego
FX Support was provided by Academic Senate of the University of California,
   San Diego. We thank Drs. Taylor Doherty and Jeffrey Jasper for their
   helpful comments prior to submission of this manuscript.
CR Aburima A, 2013, BLOOD, V122, P3533, DOI 10.1182/blood-2013-03-487850
   Agac D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00736
   Al-Wadei HAN, 2012, PHARMACOL RES, V66, P33, DOI 10.1016/j.phrs.2012.03.014
   Alagha K, 2014, THER ADV CHRONIC DIS, V5, P85, DOI 10.1177/2040622313518227
   Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5744, DOI 10.1111/bph.13348
   Altosaar K, 2019, ADRENOCEPTORS VERSIO, DOI [10.2218/gtopdb/F4/2019.4, DOI 10.2218/GTOPDB/F4/2019.4]
   ANDERSSON TLG, 1991, J CARDIOVASC PHARM, V18, P237, DOI 10.1097/00005344-199108000-00010
   Ando M, 2003, AM J RESP CELL MOL, V28, P582, DOI 10.1165/rcmb.2002-0162OC
   Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007
   Anfossi G, 1996, EUR J CLIN INVEST, V26, P353, DOI 10.1046/j.1365-2362.1996.150293.x
   [Anonymous], 2012, JAMA, DOI DOI 10.1001/JAMA.2012.5669
   Armstrong SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047323
   Artigas A, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.07.21
   Arumugham VB, 2017, J LEUKOCYTE BIOL, V101, P1301, DOI 10.1189/jlb.2RU1116-474R
   Atabai K, 2002, INTENS CARE MED, V28, P705, DOI 10.1007/s00134-002-1282-x
   AUSTIN CE, 1995, J AUTON PHARMACOL, V15, P169, DOI 10.1111/j.1474-8673.1995.tb00301.x
   Ayabe S, 2013, J PHARMACOL SCI, V121, P312, DOI 10.1254/jphs.12275FP
   Aytemur ZA, 2012, REV PORT PNEUMOL, V18, P272, DOI 10.1016/j.rppneu.2012.04.010
   Azzam ZS, 2015, RAMBAM MAIMONIDES ME, V6, DOI 10.5041/RMMJ.10210
   Azzam ZS, 2004, AM J RESP CRIT CARE, V170, P730, DOI 10.1164/rccm.200308-1127OC
   Baines DL, 2010, PFLUG ARCH EUR J PHY, V459, P451, DOI 10.1007/s00424-009-0717-4
   Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x
   BALUK P, 1994, AM J PHYSIOL, V266, pL461, DOI 10.1152/ajplung.1994.266.4.L461
   Banquet S, 2011, CELL SIGNAL, V23, P1136, DOI 10.1016/j.cellsig.2011.02.008
   Baouz S, 2005, INT IMMUNOL, V17, P1473, DOI 10.1093/intimm/dxh325
   Barlow CA, 2008, APOPTOSIS, V13, P681, DOI 10.1007/s10495-008-0203-z
   Barnes BJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200652
   Barnes MA, 2015, CYTOKINE, V72, P210, DOI 10.1016/j.cyto.2015.01.008
   Barnes NC, 2006, AM J RESP CRIT CARE, V173, P736, DOI 10.1164/rccm.200508-1321OC
   Barnes PJ, 2002, EUR RESPIR J, V19, P182, DOI 10.1183/09031936.02.00283202
   Bartis D, 2014, THORAX, V69, P760, DOI 10.1136/thoraxjnl-2013-204608
   Bartoszewski R, 2017, AM J PHYSIOL-LUNG C, V313, pL859, DOI 10.1152/ajplung.00285.2017
   BASRAN GS, 1986, EUR J NUCL MED, V12, P381
   Bassford CR, 2012, CRIT CARE, V16, DOI 10.1186/cc11221
   Batah SS, 2021, RESP MED, V176, DOI 10.1016/j.rmed.2020.106239
   Bathoorn E, 2008, COPD, V5, P282, DOI 10.1080/15412550802363360
   Battram C, 2006, J PHARMACOL EXP THER, V317, P762, DOI 10.1124/jpet.105.098251
   Bauman KA, 2010, J CLIN INVEST, V120, P1950, DOI 10.1172/JCI38369
   Beeh KM, 2017, AM J RESP CRIT CARE, V196, P139, DOI 10.1164/rccm.201609-1794CI
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Benlhabib H, 2015, J BIOL CHEM, V290, P22409, DOI 10.1074/jbc.M114.636068
   Bennett William D., 2002, Journal of Allergy and Clinical Immunology, V110, pS291, DOI 10.1067/mai.2002.129704
   Berthiaume Y, 2003, AM J PHYSIOL-LUNG C, V285, pL798, DOI 10.1152/ajplung.00166.2003
   Berthiaume Y, 2007, RESP PHYSIOL NEUROBI, V159, P350, DOI 10.1016/j.resp.2007.05.010
   Billington CK, 2017, HANDB EXP PHARMACOL, V237, P23, DOI 10.1007/164_2016_64
   BinMahfouz H, 2015, MOL PHARMACOL, V87, P64, DOI 10.1124/mol.114.093393
   Birukov KG, 2018, PULM CIRC, V8, DOI 10.1177/2045893217752660
   Birukova AA, 2013, EUR RESPIR J, V41, P165, DOI 10.1183/09031936.00148311
   Bloom CI, 2021, LANCET RESP MED, V9, P699, DOI 10.1016/S2213-2600(21)00013-8
   Bochkov YA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-98
   Bodor J, 2012, EUR J IMMUNOL, V42, P1375, DOI 10.1002/eji.201141578
   Boncoeur E, 2010, AM J PHYSIOL-LUNG C, V298, pL417, DOI 10.1152/ajplung.00170.2009
   Bosmann M, 2012, FASEB J, V26, P2137, DOI 10.1096/fj.11-201640
   Bourbeau J, 2007, THORAX, V62, P938, DOI 10.1136/thx.2006.071068
   Bozyk PD, 2011, AM J RESP CELL MOL, V45, P445, DOI 10.1165/rcmb.2011-0025RT
   Brand JD, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123467
   Brostjan C, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-0255-6
   Brudvik KW, 2012, BRIT J PHARMACOL, V166, P411, DOI 10.1111/j.1476-5381.2011.01800.x
   Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1
   Calebiro D, 2021, PHYSIOL REV, V101, P857, DOI 10.1152/physrev.00021.2020
   Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070
   Calverley PMA, 2017, COPD, V14, P648, DOI 10.1080/15412555.2017.1389875
   Calzetta L, 2018, CURR OPIN PHARMACOL, V40, P95, DOI 10.1016/j.coph.2018.03.011
   Carla A, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01337-9
   CARSTAIRS JR, 1985, AM REV RESPIR DIS, V132, P541
   Cates CJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010005.pub2
   Cazzola M, 2019, RESP MED, V156, P47, DOI 10.1016/j.rmed.2019.08.005
   Cazzola M, 2013, AM J RESP CRIT CARE, V187, P690, DOI 10.1164/rccm.201209-1739PP
   Chakraborty M, 2013, BREATHE, V9, P477, DOI 10.1183/20734735.006513
   Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x
   Chapman HA, 2011, ANNU REV PHYSIOL, V73, P413, DOI 10.1146/annurev-physiol-012110-142225
   Chen H, 2021, INT IMMUNOPHARMACOL, V93, DOI 10.1016/j.intimp.2021.107447
   Chen L, 2009, AM J RESP CELL MOL, V40, P588, DOI 10.1165/rcmb.2008-0034OC
   Chen XJ, 2004, AM J PHYSIOL-LUNG C, V287, pL366, DOI 10.1152/ajplung.00011.2004
   Chinn AM, 2020, BRIT J PHARMACOL, V177, P3363, DOI 10.1111/bph.15095
   Claesson-Welsh L, 2021, TRENDS MOL MED, V27, P314, DOI 10.1016/j.molmed.2020.11.006
   Cloutier MM, 2020, J ALLERGY CLIN IMMUN, V146, P1217, DOI 10.1016/j.jaci.2020.10.003
   Conti V, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00321
   Coraux C, 2004, AM J RESP CELL MOL, V30, P605, DOI 10.1165/rcmb.2003-0056OC
   Cortijo J, 2009, BRIT J PHARMACOL, V156, P534, DOI 10.1111/j.1476-5381.2008.00041.x
   Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009
   Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011
   Dagenais A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-2
   Dagenais A, 2004, AM J PHYSIOL-LUNG C, V286, pL301, DOI 10.1152/ajplung.00326.2002
   Dagenais A, 2006, AM J PHYSIOL-LUNG C, V291, pL1220, DOI 10.1152/ajplung.00511.2005
   Dahl R, 2010, THORAX, V65, P473, DOI 10.1136/thx.2009.125435
   Dale PR, 2014, CURR OPIN PHARMACOL, V16, P31, DOI 10.1016/j.coph.2014.03.003
   Davel AP, 2015, LIFE SCI, V125, P49, DOI 10.1016/j.lfs.2015.01.018
   de Prost N, 2008, INTENS CARE MED, V34, P763, DOI 10.1007/s00134-007-0954-y
   Decramer ML, 2013, INT J CHRONIC OBSTR, V8, P53, DOI 10.2147/COPD.S39018
   Dehdashtian M, 2016, ITAL J PEDIATR, V42, DOI 10.1186/s13052-016-0215-1
   Delaunay M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010069
   Descalzi D, 2008, ALLERGY, V63, P432, DOI 10.1111/j.1398-9995.2007.01582.x
   Di Marco F, 2012, PULM PHARMACOL THER, V25, P119, DOI 10.1016/j.pupt.2011.12.010
   Dormond O, 2003, THROMB HAEMOSTASIS, V90, P577, DOI 10.1160/TH03-03-0196
   Dorotea D, 2021, ARCH PHARM RES, V44, P49, DOI 10.1007/s12272-020-01280-9
   Dowling RB, 1999, EUR RESPIR J, V14, P363, DOI 10.1034/j.1399-3003.1999.14b21.x
   Dowling RB, 1997, AM J RESP CRIT CARE, V155, P327, DOI 10.1164/ajrccm.155.1.9001332
   Dumasius V, 2001, CIRC RES, V89, P907, DOI 10.1161/hh2201.100204
   Dunne AE, 2019, AM J RESP CELL MOL, V60, P445, DOI 10.1165/rcmb.2018-0065OC
   Edwards MR, 2007, J BIOL CHEM, V282, P15366, DOI 10.1074/jbc.M701325200
   Edwards MR, 2006, AM J RESP CELL MOL, V34, P616, DOI 10.1165/rcmb.2005-0385OC
   Ejioforl S, 2013, CLIN MED INSIGHTS-CI, V7, P17, DOI 10.4137/CCRPM.S7211
   Epa AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135266
   Evans DJ, 1998, AM J PHYSIOL-CELL PH, V275, pC1284, DOI 10.1152/ajpcell.1998.275.5.C1284
   Factor Phillip, 2002, Journal of Allergy and Clinical Immunology, V110, pS242, DOI 10.1067/mai.2002.129706
   Failla M, 2009, AM J RESP CELL MOL, V41, P50, DOI 10.1165/rcmb.2007-0438OC
   Fang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL242, DOI 10.1152/ajplung.00178.2005
   Feng EZ, 2013, EXP THER MED, V6, P747, DOI 10.3892/etm.2013.1192
   Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1
   Fessler MB, 2019, AM J RESP CELL MOL, V60, P382, DOI 10.1165/rcmb.2018-0370ED
   Festic E, 2016, AM J RESP CRIT CARE, V193
   Festic E, 2017, CRIT CARE MED, V45, P798, DOI 10.1097/CCM.0000000000002284
   Flori HR, 2005, AM J RESP CRIT CARE, V171, P995, DOI 10.1164/rccm.200404-544OC
   Folkesson HG, 2006, AM J RESP CELL MOL, V35, P10, DOI 10.1165/rcmb.2006-0080SF
   Folkesson HG, 2000, J APPL PHYSIOL, V88, P416, DOI 10.1152/jappl.2000.88.2.416
   Fouad MK, 2020, QJM SUPPL 1, V113
   Fragaki K, 2006, AM J PHYSIOL-LUNG C, V291, pL11, DOI 10.1152/ajplung.00488.2005
   Frank JA, 2000, J APPL PHYSIOL, V89, P1255, DOI 10.1152/jappl.2000.89.4.1255
   Frank JA, 2007, AM J PHYSIOL-LUNG C, V293, pL52, DOI 10.1152/ajplung.00256.2006
   Frantzeskaki F, 2017, RESPIRATION, V93, P212, DOI 10.1159/000453002
   FREDEN K, 1978, ACTA HAEMATOL-BASEL, V60, P310, DOI 10.1159/000207728
   Frerking I, 2001, INTENS CARE MED, V27, P1699, DOI 10.1007/s00134-001-1121-5
   Fuentes E, 2014, THROMB RES, V134, P221, DOI 10.1016/j.thromres.2014.04.027
   Galasso G, 2013, CIRC RES, V112, P1026, DOI 10.1161/CIRCRESAHA.111.300152
   Garbuzenko OB, 2017, NANOMED-NANOTECHNOL, V13, P1983, DOI 10.1016/j.nano.2017.04.005
   Gates S, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17380
   Gebistorf F, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002787.pub3
   Giacomelli C, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00054
   Giorgi M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155338
   Gladstone DE, 2020, ANN INTERN MED, V173, P852, DOI 10.7326/L20-0681
   Glasser JR, 2012, MICROBES INFECT, V14, P17, DOI 10.1016/j.micinf.2011.08.019
   Global Initiative for Asthma, 2020, 2020 GINA REP GLOB S
   Gonzales J N, 2015, Austin J Vasc Med, V2
   Gonzales LW, 2002, AM J PHYSIOL-LUNG C, V283, pL940, DOI 10.1152/ajplung.00127.2002
   Goulet S, 2007, J CELL PHYSIOL, V210, P167, DOI 10.1002/jcp.20836
   Griese M, 1999, EUR RESPIR J, V13, P1455, DOI 10.1034/j.1399-3003.1999.13f36.x
   Griffiths MJD, 2019, BMJ OPEN RESPIR RES, V6, DOI 10.1136/bmjresp-2019-000420
   Grootendorst DC, 2007, THORAX, V62, P1081, DOI 10.1136/thx.2006.075937
   Groshaus HE, 2004, CRIT CARE, V8, P234, DOI 10.1186/cc2875
   Gross CA, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-30
   Haak AJ, 2020, TRENDS PHARMACOL SCI, V41, P172, DOI 10.1016/j.tips.2019.12.008
   Haak AJ, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau6296
   Hamacher J, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01644
   Hamacher J, 2009, EXP LUNG RES, V35, P175, DOI 10.1080/01902140802488446
   Han S, 2015, ANN AM THORAC SOC, V12, P765, DOI 10.1513/AnnalsATS.201411-507FR
   Hanania NA, 2012, CHEST, V142, P119, DOI 10.1378/chest.11-2231
   Haque R, 2013, J ALLERGY CLIN IMMUN, V132, P1166, DOI 10.1016/j.jaci.2013.07.038
   Hasan S, 2018, FEBS J, V285, P4343, DOI 10.1111/febs.14582
   Hasan Z, 2021, AM J THER, V28, pE189, DOI 10.1097/MJT.0000000000001343
   HEEL RC, 1978, DRUGS, V15, P3, DOI 10.2165/00003495-197815010-00002
   Helbig C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65072-3
   Herold S, 2015, EUR RESPIR J, V45, P1463, DOI 10.1183/09031936.00186214
   Herrero R, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2017.12.18
   Herrero R, 2013, AM J PHYSIOL-LUNG C, V305, pL377, DOI 10.1152/ajplung.00271.2012
   Herrmann FE, 2017, BRIT J PHARMACOL, V174, P3848, DOI 10.1111/bph.13982
   Hiemstra PS, 2018, TOXICOL IN VITRO, V47, P137, DOI 10.1016/j.tiv.2017.11.005
   Hill Charlotte, 2019, J Lung Health Dis, V3, P31
   Hlapcic I, 2020, BIOCHEM MEDICA, V30, DOI 10.11613/BM.2020.010701
   Hodges RJ, 2004, AM J PATHOL, V165, P1663, DOI 10.1016/S0002-9440(10)63423-2
   Hohne K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038369
   Hohlfeld JM, 2008, PULM PHARMACOL THER, V21, P616, DOI 10.1016/j.pupt.2008.02.002
   Holden NS, 2010, BRIT J PHARMACOL, V160, P410, DOI 10.1111/j.1476-5381.2010.00708.x
   Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
   Horie S, 2020, INTENS CARE MED, V46, P2265, DOI 10.1007/s00134-020-06141-z
   Horvath G, 2006, EUR RESPIR J, V27, P172, DOI 10.1183/09031936.06.00048605
   Hoyle Gary W, 2010, Proc Am Thorac Soc, V7, P284, DOI 10.1513/pats.201001-002SM
   Hozawa S, 2014, PULM PHARMACOL THER, V27, P190, DOI 10.1016/j.pupt.2013.12.003
   Hu P, 2016, ONCOL REP, V36, P1757, DOI 10.3892/or.2016.4966
   Hu QS, 2020, J HYPERTENS, V38, P82, DOI 10.1097/HJH.0000000000002203
   Huang XW, 2011, AM J PATHOL, V179, P2751, DOI 10.1016/j.ajpath.2011.08.018
   Hufford MM, 2015, CURR TOP MICROBIOL, V386, P423, DOI 10.1007/82_2014_397
   Huppert LA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00371
   Hussain R, 2013, APMIS, V121, P814, DOI 10.1111/apm.12138
   Ikezono K, 2005, PHARMACOLOGY, V73, P209, DOI 10.1159/000083299
   Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x
   Insel PA, 2012, BRIT J PHARMACOL, V166, P447, DOI 10.1111/j.1476-5381.2012.01847.x
   Ippolito M, 2021, CELL SIGNAL, V80, DOI 10.1016/j.cellsig.2020.109905
   Irannejad R, 2017, NAT CHEM BIOL, V13, P799, DOI 10.1038/nchembio.2389
   Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000
   Itani OA, 2002, AM J PHYSIOL-LUNG C, V282, pL631, DOI 10.1152/ajplung.00085.2001
   Ivanova V, 2013, EUR J PHARM BIOPHARM, V84, P335, DOI 10.1016/j.ejpb.2012.11.023
   Nannini LJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006829.pub2
   Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775
   Johnson Malcolm, 2004, Proc Am Thorac Soc, V1, P200, DOI 10.1513/pats.200402-010MS
   Joshi T, 2015, BRIT J PHARMACOL, V172, P2634, DOI 10.1111/bph.13087
   Kage H, 2012, CURR OPIN PULM MED, V18, P517, DOI 10.1097/MCP.0b013e3283566721
   Kainuma K, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0563-4
   Kalfaoglu B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.589380
   Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029
   Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121
   Kay LJ, 2005, CHEM IMMUNOL ALLERGY, V87, P145, DOI 10.1159/000087641
   Kazi AS, 2010, AM J PHYSIOL-LUNG C, V299, pL794, DOI 10.1152/ajplung.00372.2009
   Ke X, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0335-y
   KERRY R, 1983, BRIT J PHARMACOL, V79, P681, DOI 10.1111/j.1476-5381.1983.tb10005.x
   Kersten ETG, 2017, PAEDIATR RESPIR REV, V21, P80, DOI 10.1016/j.prrv.2016.05.006
   Kew KM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010177.pub2
   Kohyama T, 2009, INFLAMMATION, V32, P387, DOI 10.1007/s10753-009-9147-x
   Kolmus K, 2015, BRAIN BEHAV IMMUN, V45, P297, DOI 10.1016/j.bbi.2014.10.007
   Kolosionek E, 2009, MOL BIOL CELL, V20, P4751, DOI 10.1091/mbc.E09-01-0019
   Kondo T, 2015, ANN THORAC SURG, V100, P480, DOI 10.1016/j.athoracsur.2015.02.136
   Korn SH, 2001, EUR RESPIR J, V17, P1070, DOI 10.1183/09031936.01.00073301
   KOUTOUZOV S, 1985, BIOCHEM BIOPH RES CO, V132, P1051, DOI 10.1016/0006-291X(85)91913-8
   Kunzelmann K, 2006, FASEB J, V20, P545, DOI 10.1096/fj.05-4454fje
   Lambers C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19294-1
   Lamyel F, 2011, N-S ARCH PHARMACOL, V384, P133, DOI 10.1007/s00210-011-0655-5
   Lang F, 2013, FASEB J, V27, P3, DOI 10.1096/fj.12-218230
   Larj Michael J, 2004, Chest, V126, p138S, DOI 10.1378/chest.126.2_suppl_1.138S
   LARSSON PT, 1992, THROMB HAEMOSTASIS, V68, P687
   LARSSON S, 1977, AM REV RESPIR DIS, V116, P861
   Lazrak A, 2000, AM J PHYSIOL-CELL PH, V279, pC762, DOI 10.1152/ajpcell.2000.279.3.C762
   Lazrak A, 2009, FASEB J, V23, P3829, DOI 10.1096/fj.09-135590
   Leblais V, 2008, CARDIOVASC RES, V77, P202, DOI 10.1093/cvr/cvm008
   Lee HW, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002958
   Leone V, 2007, AM J PHYSIOL-GASTR L, V293, pG673, DOI 10.1152/ajpgi.00584.2006
   Levitt JE, 2021, ANN AM THORAC SOC, V18, P698, DOI 10.1513/AnnalsATS.202009-1115SD
   Levitt JE, 2012, CRIT CARE, V16, DOI 10.1186/cc11144
   Lewis SR, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004477.pub3
   Li H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02080
   Li TB, 2006, AM J PHYSIOL-LUNG C, V290, pL649, DOI 10.1152/ajplung.00205.2005
   Liebler JM, 2004, J HISTOCHEM CYTOCHEM, V52, P759, DOI 10.1369/jhc.3A6184.2004
   Lin SH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01545
   LINDENSCHMIDT RC, 1985, J PHARMACOL EXP THER, V232, P346
   Litvan J, 2006, J BIOL CHEM, V281, P19892, DOI 10.1074/jbc.M602064200
   Liu BW, 2020, J AUTOIMMUN, V111, DOI 10.1016/j.jaut.2020.102452
   Liu H, 2015, INT IMMUNOPHARMACOL, V29, P937, DOI 10.1016/j.intimp.2015.10.010
   Liu XQ, 2010, AM J PHYSIOL-LUNG C, V298, pL819, DOI 10.1152/ajplung.00429.2009
   Liu XQ, 2004, AM J PHYSIOL-CELL PH, V286, pC1089, DOI 10.1152/ajpcell.00461.2003
   Liu Y, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0523-z
   Lo CY, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0678-7
   Loeh B, 2010, CELL PHYSIOL BIOCHEM, V25, P123, DOI 10.1159/000272057
   Londino JD, 2013, AM J PHYSIOL-LUNG C, V304, pL582, DOI 10.1152/ajplung.00314.2012
   Londino JD, 2017, AM J PHYSIOL-LUNG C, V313, pL845, DOI 10.1152/ajplung.00244.2017
   Londino JD, 2015, FASEB J, V29, P2712, DOI 10.1096/fj.14-268755
   Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653
   Lovgren AK, 2006, AM J PHYSIOL-LUNG C, V291, pL144, DOI 10.1152/ajplung.00492.2005
   Lu D, 2013, MOL PHARMACOL, V84, P787, DOI 10.1124/mol.113.087742
   Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC
   Maiolo G, 2018, AM J RESP CRIT CARE, V197, P1586, DOI 10.1164/rccm.201709-1804OC
   Mak JCW, 1996, EUR J PHARMACOL, V302, P215, DOI 10.1016/0014-2999(96)00104-5
   Mangi Asif Muhammad, 2015, Acta Med Acad, V44, P109, DOI 10.5644/ama2006-124.138
   Manocha S, 2006, CRIT CARE, V10, DOI 10.1186/cc3971
   Mapel DW, 2006, RESP MED, V100, P595, DOI 10.1016/j.rmed.2005.08.006
   Maqsood U, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012930.pub2
   Marino F, 2013, AMINO ACIDS, V45, P55, DOI 10.1007/s00726-011-1186-6
   Maris NA, 2005, AM J RESP CRIT CARE, V172, P878, DOI 10.1164/rccm.200503-451OC
   Maron MB, 2009, AM J PHYSIOL-LUNG C, V297, pL487, DOI 10.1152/ajplung.90629.2008
   Martin MC, 2001, J BIOL CHEM, V276, P45041, DOI 10.1074/jbc.M105197200
   Martinez FJ, 2018, AM J RESP CRIT CARE, V198, P1268, DOI 10.1164/rccm.201712-2493OC
   Matalon S, 2015, AM J PHYSIOL-LUNG C, V309, pL1229, DOI 10.1152/ajplung.00319.2015
   Matera MG, 2018, CURR OPIN PHARMACOL, V40, P142, DOI 10.1016/j.coph.2018.04.012
   Matthay Michael A, 2005, Proc Am Thorac Soc, V2, P206, DOI 10.1513/pats.200501-009AC
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC
   McAuley DF, 2004, CRIT CARE MED, V32, P1470, DOI 10.1097/01.CCM.0000129489.34416.0E
   McGraw DW, 2001, AM J PHYSIOL-LUNG C, V281, pL895, DOI 10.1152/ajplung.2001.281.4.L895
   McMahon AW, 2011, PEDIATRICS, V128, pE1147, DOI 10.1542/peds.2010-1720
   McTavish N, 2009, BIOCHEM J, V423, P189, DOI 10.1042/BJ20090366
   Migneault F, 2013, AM J PHYSIOL-LUNG C, V305, pL747, DOI 10.1152/ajplung.00023.2013
   Milara J, 2012, BRIT J PHARMACOL, V166, P2243, DOI 10.1111/j.1476-5381.2012.01929.x
   Milara J, 2015, COPD, V12, P320, DOI 10.3109/15412555.2014.948995
   Milara J, 2014, PULM PHARMACOL THER, V28, P138, DOI 10.1016/j.pupt.2014.02.001
   Millar FR, 2016, THORAX, V71, P462, DOI 10.1136/thoraxjnl-2015-207461
   MINNEAR FL, 1986, J APPL PHYSIOL, V60, P266, DOI 10.1152/jappl.1986.60.1.266
   MINNEAR FL, 1993, J APPL PHYSIOL, V75, P1171, DOI 10.1152/jappl.1993.75.3.1171
   Mirastschijski U, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00254
   Molina-Molina M, 2006, THORAX, V61, P604, DOI 10.1136/thx.2005.051946
   Montuschi P, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00258
   Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829
   Morty RE, 2007, INTENS CARE MED, V33, P1229, DOI 10.1007/s00134-007-0662-7
   Mosenden R, 2011, CELL SIGNAL, V23, P1009, DOI 10.1016/j.cellsig.2010.11.018
   Mostafa MM, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-018-0467-2
   MOTULSKY HJ, 1982, NEW ENGL J MED, V307, P18, DOI 10.1056/NEJM198207013070104
   Moyron-Quiroz J, 2007, ADV EXP MED BIOL, V590, P55
   Mukherjee S, 2019, AM J PHYSIOL-LUNG C, V316, pL810, DOI 10.1152/ajplung.00403.2018
   Mutlu GM, 2004, CIRC RES, V94, P1091, DOI 10.1161/01.RES.0000125623.56442.20
   Mutlu GM, 2008, AM J RESP CELL MOL, V38, P127, DOI 10.1165/rcmb.2007-0198TR
   Nagy Z, 2018, RES PRACT THROMB HAE, V2, P558, DOI 10.1002/rth2.12122
   Nakai A, 2019, NEUROCHEM INT, V130, DOI 10.1016/j.neuint.2018.10.017
   Nakai A, 2014, J EXP MED, V211, P2583, DOI 10.1084/jem.20141132
   Nakamura K, 2002, AM J PHYSIOL-CELL PH, V283, pC762, DOI 10.1152/ajpcell.00029.2002
   Nakanishi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123895
   Namkoong S, 2005, EXP MOL MED, V37, P588, DOI 10.1038/emm.2005.72
   Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013
   Newton R, 2016, BRIT J PHARMACOL, V173, P3405, DOI 10.1111/bph.13628
   Nikitopoulou I, 2019, PULM CIRC, V9, DOI 10.1177/2045894019881954
   Nilsson MB, 2020, J NEUROIMMUNE PHARM, V15, P27, DOI 10.1007/s11481-019-09891-w
   Noe L, 2010, CURR MED CHEM, V17, P2897, DOI 10.2174/092986710792065018
   Nolte H, 2013, RESP MED, V107, P656, DOI 10.1016/j.rmed.2013.02.010
   O'Kane CM, 2009, CRIT CARE MED, V37, P2242, DOI 10.1097/CCM.0b013e3181a5506c
   O'Leary AP, 2015, J CELL PHYSIOL, V230, P356, DOI 10.1002/jcp.24716
   Oddera S, 1998, J ASTHMA, V35, P401, DOI 10.3109/02770909809048948
   ONEILL CA, 1992, J APPL TOXICOL, V12, P97, DOI 10.1002/jat.2550120206
   Ortega E, 2019, ENDOCR METAB IMMUNE, V19, P1089, DOI 10.2174/1871530319666190206124520
   Ortiz-Diaz E, 2013, SEMIN RESP CRIT CARE, V34, P448, DOI 10.1055/s-0033-1351118
   Padro CJ, 2014, SEMIN IMMUNOL, V26, P357, DOI 10.1016/j.smim.2014.01.003
   Page C, 2017, HANDB EXP PHARMACOL, V237, P1, DOI 10.1007/164_2016_61
   Pan JB, 2009, RESPIROLOGY, V14, P975, DOI 10.1111/j.1440-1843.2009.01606.x
   Paolillo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061877
   Pappova L, 2016, ADV EXP MED BIOL, V935, P25, DOI 10.1007/5584_2016_24
   Parker JC, 1997, J APPL PHYSIOL, V83, P1962, DOI 10.1152/jappl.1997.83.6.1962
   Pedersen LRE, 2012, ACTA PHYSIOL, V206, P142, DOI 10.1111/j.1748-1716.2012.02459.x
   Penke LRK, 2014, J BIOL CHEM, V289, P17151, DOI 10.1074/jbc.M114.558130
   Perkins GD, 2008, THORAX, V63, P215, DOI 10.1136/thx.2007.080382
   Perkins GD, 2004, CRIT CARE, V8, P25, DOI 10.1186/cc2417
   Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC
   Peteranderl C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00446
   Peteranderl C, 2016, J CLIN INVEST, V126, P1566, DOI 10.1172/JCI83931
   Peters DM, 2014, P NATL ACAD SCI USA, V111, pE374, DOI 10.1073/pnas.1306798111
   Phillips JE, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00259
   Piatti G, 2005, PHARMACOL RES, V51, P165, DOI 10.1016/j.phrs.2004.07.006
   Pini A, 2010, J PHARMACOL EXP THER, V335, P589, DOI 10.1124/jpet.110.170977
   Pirina P, 2018, RESP MED, V143, P74, DOI 10.1016/j.rmed.2018.08.013
   Qiao GX, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00164
   Queen LR, 2000, CIRC RES, V87, P39, DOI 10.1161/01.RES.87.1.39
   Rabe KF, 2018, LANCET RESP MED, V6, P827, DOI 10.1016/S2213-2600(18)30331-X
   Rahman MS, 2010, AM J PHYSIOL-LUNG C, V298, pL96, DOI 10.1152/ajplung.00158.2009
   Raker VK, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00123
   Ramakrishnan S, 2021, LANCET RESP MED, V9, P763, DOI 10.1016/S2213-2600(21)00160-0
   Randrianarison N, 2008, AM J PHYSIOL-LUNG C, V294, pL409, DOI 10.1152/ajplung.00307.2007
   Rauen T, 2013, TRENDS MOL MED, V19, P262, DOI 10.1016/j.molmed.2013.02.001
   Rezaee F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181876
   Richard C, 2019, RESP PHYSIOL NEUROBI, V259, P104, DOI 10.1016/j.resp.2018.08.006
   Rider CF, 2011, J PHARMACOL EXP THER, V338, P860, DOI 10.1124/jpet.111.181016
   Roberts OL, 2014, BIOCHEM SOC T, V42, P89, DOI 10.1042/BST20130253
   Robriquet L, 2011, EXP LUNG RES, V37, P453, DOI 10.3109/01902148.2011.593092
   Roca O, 2008, CRIT CARE, V12, DOI 10.1186/cc6911
   Rodrigo GJ, 2009, CHEST, V136, P1029, DOI 10.1378/chest.09-0821
   Romano M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00043
   Roth M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188010
   Roux J, 2013, FASEB J, V27, P1095, DOI 10.1096/fj.12-219295
   Roux J, 2010, J BIOL CHEM, V285, P4278, DOI 10.1074/jbc.M109.036731
   Rueda CM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00216
   Rudiger JJ, 2013, RESPIROLOGY, V18, P840, DOI 10.1111/resp.12104
   Sabatini F, 2003, RESP MED, V97, P1052, DOI 10.1016/S0954-6111(03)00137-9
   Sakuma T, 2006, CRIT CARE MED, V34, P676, DOI 10.1097/01.CCM.0000201403.70636.0F
   Salathe Matthias, 2002, Journal of Allergy and Clinical Immunology, V110, pS275, DOI 10.1067/mai.2002.129412
   Saldias FJ, 2000, AM J RESP CRIT CARE, V162, P282, DOI 10.1164/ajrccm.162.1.9809058
   Salton F, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55040083
   Samuelsen JT, 2007, AM J PHYSIOL-LUNG C, V292, pL232, DOI 10.1152/ajplung.00049.2006
   Sanders VM, 2012, BRAIN BEHAV IMMUN, V26, P195, DOI 10.1016/j.bbi.2011.08.001
   Santus P, 2018, PHARMACOL RES, V133, P160, DOI 10.1016/j.phrs.2018.05.010
   Santus P, 2012, PHARMACOL RES, V66, P343, DOI 10.1016/j.phrs.2012.05.007
   Sartori C, 2002, NEW ENGL J MED, V346, P1631, DOI 10.1056/NEJMoa013183
   Sassi Y, 2012, FASEB J, V26, P1009, DOI 10.1096/fj.11-194027
   Sayner SL, 2011, AM J PHYSIOL-LUNG C, V300, pL667, DOI 10.1152/ajplung.00433.2010
   Scanzano A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00171
   Scavone C, 2020, BRIT J PHARMACOL, V177, P4813, DOI 10.1111/bph.15072
   Schmeckebier S, 2013, TISSUE ENG PT A, V19, P938, DOI [10.1089/ten.TEA.2012.0066, 10.1089/ten.tea.2012.0066]
   Schousboe P, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03268-9
   Schultze A, 2020, LANCET RESP MED, V8, P1106, DOI 10.1016/S2213-2600(20)30415-X
   Scott A, 2019, CHEST, V156, p1668A, DOI 10.1016/j.chest.2019.08.1462
   Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR
   Sharma D, 2020, SEMIN IMMUNOPATHOL, V42, P709, DOI 10.1007/s00281-020-00829-6
   Sharma G, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.52
   Shirshev SV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P981, DOI 10.1134/S000629791109001X
   Silvestri M, 2001, EUR RESPIR J, V18, P139, DOI 10.1183/09031936.01.00067901
   Singam R, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-32
   Singh D, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1142-7
   Sisson TH, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13753
   Skuratovskaia D, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100400
   Slack RJ, 2013, J PHARMACOL EXP THER, V344, P218, DOI 10.1124/jpet.112.198481
   SMITH DM, 1988, HISTOL HISTOPATHOL, V3, P291
   Smith FG, 2012, LANCET, V379, P229, DOI 10.1016/S0140-6736(11)61623-1
   SMITH SKS, 1989, TOXICOL IN VITRO, V3, P129, DOI 10.1016/0887-2333(89)90055-6
   Smith SKS, 2002, IN VITRO CELL DEV-AN, V38, P298
   Song WF, 2011, AM J RESP CELL MOL, V45, P88, DOI 10.1165/rcmb.2010-0226OC
   Sorriento D, 2011, TRANSL MED UNISA, V1, P213
   Sriram K, 2020, P NATL ACAD SCI USA, V117, P29274, DOI 10.1073/pnas.2009875117
   Sriram K, 2021, PHYSIOL REV, V101, P545, DOI 10.1152/physrev.00035.2020
   Sriram K, 2020, BRIT J PHARMACOL, V177, P4971, DOI 10.1111/bph.15194
   Sriram K, 2020, BRIT J PHARMACOL, V177, P4825, DOI 10.1111/bph.15082
   Standiford TJ, 2016, TRANSL RES, V167, P183, DOI 10.1016/j.trsl.2015.04.015
   Stephen-Victor E, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02182-2020
   Stolz D, 2018, AM J RESP CRIT CARE, V197, P1136, DOI 10.1164/rccm.201709-1807OC
   Strandberg K, 2007, RESP MED, V101, P1132, DOI 10.1016/j.rmed.2006.11.014
   Su X, 2006, AM J PHYSIOL-LUNG C, V290, pL769, DOI 10.1152/ajplung.00334.2005
   Sun L, 2012, ACTA PHARMACOL SIN, V33, P342, DOI 10.1038/aps.2011.200
   Tamm M, 2012, RESP MED, V106, pS9, DOI 10.1016/S0954-6111(12)70005-7
   Tannheimer SL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-28
   Tarazan N, 2020, INTENS CARE MED EXP, V8, DOI 10.1186/s40635-020-00348-6
   Tashkin DP, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-149
   Tavares LP, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.105030
   Taylor BJ, 2017, J HEART LUNG TRANSPL, V36, P418, DOI 10.1016/j.healun.2016.09.008
   Taylor NE, 2016, CLIN MED INSIGHTS-CI, V10, P19, DOI 10.4137/CCRPRPM.S30251
   Theron AJ, 2013, DRUG DES DEV THER, V7, P1387, DOI 10.2147/DDDT.S50995
   Tricco AC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009183
   Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665
   Udalov S, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-26
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Unwalla HJ, 2015, AM J RESP CELL MOL, V52, P65, DOI 10.1165/rcmb.2013-0538OC
   Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723
   van den Berge M, 2014, THORAX, V69, P14, DOI 10.1136/thoraxjnl-2012-202878
   Vestbo J, 2016, LANCET, V387, P1817, DOI 10.1016/S0140-6736(16)30069-1
   Vivona ML, 2001, AM J RESP CELL MOL, V25, P554, DOI 10.1165/ajrcmb.25.5.4420
   Voelkel NF, 2007, CHEST, V131, P874, DOI 10.1378/chest.06-2453
   Volonaki E, 2006, CLIN EXP ALLERGY, V36, P1268, DOI 10.1111/j.1365-2222.2006.02566.x
   Wagener BM, 2015, ANESTHESIOLOGY, V122, P1084, DOI 10.1097/ALN.0000000000000595
   Wang MN, 2020, AM J PHYSIOL-LUNG C, V318, pL787, DOI 10.1152/ajplung.00195.2019
   WANG XL, 1985, J CYCLIC NUCL PROT, V10, P439
   Wedzicha JA, 2014, RESP MED, V108, P1498, DOI 10.1016/j.rmed.2014.07.011
   Wehbi VL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00222
   Wei B, 2014, MOLECULES, V19, P4967, DOI 10.3390/molecules19044967
   Wendell SG, 2020, PHARMACOL REV, V72, P1, DOI 10.1124/pr.118.016899
   Weston MC, 1998, GEN PHARMACOL-VASC S, V31, P715, DOI 10.1016/S0306-3623(98)00080-9
   Wettlaufer SH, 2016, AM J RESP CELL MOL, V54, P114, DOI 10.1165/rcmb.2014-0468OC
   WHELAN CJ, 1993, BRIT J PHARMACOL, V110, P613, DOI 10.1111/j.1476-5381.1993.tb13855.x
   Wichert PV, 1988, LUNG, P257
   Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007
   WINTHER K, 1985, THROMB RES, V40, P757, DOI 10.1016/0049-3848(85)90313-5
   Wolk KE, 2008, AM J RESP CRIT CARE, V178, P969, DOI 10.1164/rccm.200803-455OC
   Wolska N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215475
   Woulfe DS, 2005, J THROMB HAEMOST, V3, P2193, DOI 10.1111/j.1538-7836.2005.01338.x
   Wright CE, 2017, ERJ OPEN RES, V3
   WRIGHT JR, 1991, ANNU REV PHYSIOL, V53, P395, DOI 10.1146/annurev.ph.53.030191.002143
   Wright TW, 2001, INFECT IMMUN, V69, P758, DOI 10.1128/IAI.69.2.758-764.2001
   Wu LN, 2018, PROCEEDINGS OF THE FIRST WORKSHOP ON DATA ACQUISITION TO ANALYSIS (DATA '18), P9, DOI 10.1145/3277868.3277873
   Xu XT, 2018, AM J PHYSIOL-CELL PH, V315, pC558, DOI 10.1152/ajpcell.00294.2017
   Yamagata T, 2009, RESP PHYSIOL NEUROBI, V166, P16, DOI 10.1016/j.resp.2008.12.008
   Yamaya M, 2020, RESPIR INVESTIG, V58, P155, DOI 10.1016/j.resinv.2019.12.005
   Yamaya M, 2014, RESPIR INVESTIG, V52, P251, DOI 10.1016/j.resinv.2014.03.004
   Yamaya M, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.41
   Yamaya M, 2011, EUR J PHARMACOL, V650, P431, DOI 10.1016/j.ejphar.2010.09.056
   Yang JJ, 2015, INT J BIOL SCI, V11, P868, DOI 10.7150/ijbs.12045
   Yang L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00243-2
   Yang L, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-142
   Yang Y, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/862628
   Yoon YS, 2013, J LEUKOCYTE BIOL, V94, P1037, DOI 10.1189/jlb.0513255
   YU SK, 1977, THROMB HAEMOSTASIS, V37, P413, DOI 10.1055/s-0038-1649249
   Zahm JM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-6
   Zhang W, 2020, CLIN IMMUNOL, V214, DOI 10.1016/j.clim.2020.108393
   Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041
   Zhu YJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-34
   Zmajkovicova K, 2019, AM J RESP CELL MOL, V60, P578, DOI 10.1165/rcmb.2018-0142OC
   Zuo HX, 2019, BRIT J PHARMACOL, V176, P2402, DOI 10.1111/bph.14605
NR 435
TC 5
Z9 5
U1 1
U2 3
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0031-6997
EI 1521-0081
J9 PHARMACOL REV
JI Pharmacol. Rev.
PD OCT
PY 2021
VL 73
IS 4
BP 488
EP 526
DI 10.1124/pharmrev.121.000356
PG 39
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA YF0FW
UT WOS:000741493500004
PM 34795026
OA Bronze
DA 2023-08-21
ER

PT J
AU Zhang, LS
   Ge, SH
   He, WM
   Chen, QG
   Xu, CX
   Zeng, M
AF Zhang, Lishan
   Ge, Shanhui
   He, Wanmei
   Chen, Qingui
   Xu, Caixia
   Zeng, Mian
TI Ghrelin protects against lipopolysaccharide-induced acute respiratory
   distress syndrome through the PI3K/AKT pathway
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID ACUTE LUNG INJURY; INDUCED APOPTOSIS; CELL-PROLIFERATION;
   ENDOTHELIAL-CELLS; HIGH GLUCOSE; SEPSIS; ACTIVATION; MECHANISMS; AXIS
AB Pulmonary endothelial barrier dysfunction is a major pathophysiology observed in acute respiratory distress syndrome (ARDS). Ghrelin, a key regulator of metabolism, has been shown to play protective roles in the respiratory system. However, its effects on lipopolysaccharide (LPS)-induced pulmonary endothelial barrier injury are unknown. In this study, the effects of ghrelin on LPS-induced ARDS and endothelial cell injury were evaluated in vivo and in vitro. In vivo, mice treated with LPS (3 mg/kg intranasal application) were used to establish the ARDS model. Annexin V/propidium iodide apoptosis assay, scratch-wound assay, tube formation assay, transwell permeability assay, and Western blotting experiment were performed to reveal in vitro effects and underlying mechanisms of ghrelin on endothelial barrier function. Our results showed that ghrelin had protective effects on LPSinduced ARDS and endothelial barrier disruption by inhibiting apoptosis, promoting cell migration and tube formation, and activating the PI3K/AKT signaling pathway. Furthermore, ghrelin stabilized LPS-induced endothelial barrier function by decreasing endothelial permeability and increasing the expression of the intercellular junction protein vascular endothelial cadherin. LY294002, a specific inhibitor of the PI3K pathway, reversed the protective effects of ghrelin on the endothelial cell barrier. In conclusion, our findings indicated that ghrelin protected against LPS-induced ARDS by impairing the pulmonary endothelial barrier partly through activating the PI3K/AKT pathway. Thus, ghrelin may be a valuable therapeutic strategy for the prevention or treatment of ARDS.
C1 [Zhang, Lishan; Ge, Shanhui; He, Wanmei; Chen, Qingui; Zeng, Mian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Intens Care Unit, Guangzhou, China.
   [Zhang, Lishan; Ge, Shanhui; He, Wanmei; Chen, Qingui; Zeng, Mian] Sun Yat Sen Univ, Inst Pulm Dis, Guangzhou, China.
   [Xu, Caixia] Sun Yat Sen Univ, Res Ctr Translat Med, Affiliated Hosp 1, Guangzhou, China.
C3 Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University
RP Zeng, M (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Intens Care Unit, Guangzhou, Peoples R China.; Zeng, M (corresponding author), Sun Yat Sen Univ, Inst Pulm Dis, Guangzhou, Peoples R China.; Xu, CX (corresponding author), Sun Yat Sen Univ, Res Ctr Translat Med, Affiliated Hosp 1, Guangzhou, Peoples R China.
EM xucx3@mail.sysu.edu.cn; zengmian@mail.sysu.edu.cn
RI ZHOU, YUE/IZE-6277-2023; Chen, Qingui/AAQ-3123-2020
OI Chen, Qingui/0000-0001-9669-0007
FU National Natural Science Foundation of China [81670066, 81772302];
   Guangdong Basic and Applied Basic Research Foundation [2019A1515011198];
   Science and Technology Program of Guangzhou City
   [2014Y2-00136/201803010122]; Guangdong Science and Technology Program
   [2019A030317003]
FX This work was supported by the National Natural Science Foundation of
   China (Grant 81670066, 81772302), Guangdong Basic and Applied Basic
   Research Foundation (Grant 2019A1515011198), the Science and Technology
   Program of Guangzhou City (Grant 2014Y2-00136/201803010122), and the
   Guangdong Science and Technology Program (Grant 2019A030317003).
CR Chen HR, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2273
   Chen J, 2008, MED SCI MONITOR, V14, pBR141
   Chopin LK, 2012, ENDOCR REV, V33, P849, DOI 10.1210/er.2011-1007
   Chorny A, 2008, J IMMUNOL, V180, P8369, DOI 10.4049/jimmunol.180.12.8369
   Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020
   Imazu Y, 2011, EUR J PHARMACOL, V672, P153, DOI 10.1016/j.ejphar.2011.09.183
   Jeffery PL, 2005, ENDOCR-RELAT CANCER, V12, P839, DOI 10.1677/erc.1.00984
   Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641
   Katare R, 2016, ENDOCRINOLOGY, V157, P432, DOI 10.1210/en.2015-1799
   Koyuturk M, 2015, CELL BIOL INT, V39, P834, DOI 10.1002/cbin.10464
   Laakkonen JP, 2017, ANGIOGENESIS, V20, P109, DOI 10.1007/s10456-016-9532-7
   Li B, 2016, INT J MOL MED, V38, P794, DOI 10.3892/ijmm.2016.2668
   Li B, 2015, ENDOCRINOLOGY, V156, P203, DOI 10.1210/en.2014-1539
   Liao PZ, 2017, CELL PHYSIOL BIOCHEM, V44, P1842, DOI 10.1159/000485820
   Lin TC, 2015, J PATHOL, V237, P50, DOI 10.1002/path.4552
   Liu H, 2015, INT IMMUNOPHARMACOL, V29, P937, DOI 10.1016/j.intimp.2015.10.010
   Liu K, 2009, REGUL PEPTIDES, V155, P62, DOI 10.1016/j.regpep.2009.03.003
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158
   Medina-Tato DA, 2007, IMMUNOLOGY, V121, P448, DOI 10.1111/j.1365-2567.2007.02663.x
   Millar FR, 2016, THORAX, V71, P462, DOI 10.1136/thoraxjnl-2015-207461
   Muller-Redetzky HC, 2014, CELL TISSUE RES, V355, P657, DOI 10.1007/s00441-014-1821-0
   Narula T, 2015, AM J RESP CELL MOL, V53, P437, DOI 10.1165/rcmb.2014-0226TR
   Qi D, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.265
   Vila G, 2007, J CLIN ENDOCR METAB, V92, P3930, DOI 10.1210/jc.2007-1194
   Waseem T, 2014, PEPTIDES, V52, P113, DOI 10.1016/j.peptides.2013.11.021
   Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC
   Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed
   Yang D, 2013, PEPTIDES, V42, P112, DOI 10.1016/j.peptides.2013.01.012
   Yuan S. Y., 2011, REGULATION ENDOTHELI, P146
   Zeng M, 2015, INFLAMMATION, V38, P683, DOI 10.1007/s10753-014-9977-z
   Zhang RY, 2013, MOL BIOL REP, V40, P51, DOI 10.1007/s11033-012-1993-1
   Zheng X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28089-3
   Zhou XL, 2010, AM J MED SCI, V339, P49, DOI 10.1097/MAJ.0b013e3181b9c3d3
   Zhu JH, 2018, BIOCHEM BIOPH RES CO, V498, P616, DOI 10.1016/j.bbrc.2018.03.031
   Zhu JH, 2014, PEPTIDES, V52, P23, DOI 10.1016/j.peptides.2013.11.015
   李玉梅, 2009, [中国病理生理杂志, Chinese Journal of Pathophysiology], V25, P2235
NR 37
TC 7
Z9 7
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP
PY 2021
VL 297
IS 3
AR 101111
DI 10.1016/j.jbc.2021.101111
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA WF4MJ
UT WOS:000706280200009
PM 34437900
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Zemskov, EA
   Wu, XM
   Aggarwal, S
   Yegambaram, M
   Gross, C
   Lu, Q
   Wang, H
   Tang, HY
   Wang, T
   Black, SM
AF Zemskov, Evgeny A.
   Wu, Xiaomin
   Aggarwal, Saurabh
   Yegambaram, Mannivannan
   Gross, Christine M.
   Lu, Qing
   Wang, Hui
   Tang, Haiyang
   Wang, Ting
   Black, Stephen M.
TI Nitration of protein kinase G-I alpha modulates cyclic nucleotide
   crosstalk via phosphodiesterase 3A: Implications for acute lung injury
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SOLUBLE GUANYLYL CYCLASE; MOLECULAR-MECHANISMS; CAMP; ACTIVATION; CGMP;
   PHOSPHATASE; PKA; VASORELAXATION; ISOFORMS; RECEPTOR
AB Phosphodiesterase 3A (PDE3A) selectively cleaves the phosphodiester bond of cAMP and is inhibited by cGMP, making it an important regulator of cAMP-cGMP signaling crosstalk in the pulmonary vasculature. In addition, the nitric oxide-cGMP axis is known to play an important role in maintaining endothelial barrier function. However, the potential role of protein kinase G-I alpha (PKG-I alpha) in this protective process is unresolved and was the focus of our study. We describe here a novel mechanism regulating PDE3A activity, which involves a PKG-I alpha-dependent inhibitory phosphorylation of PDE3A at serine 654. We also show that this phosphorylation is critical for maintaining intracellular cAMP levels in the pulmonary endothelium and endothelial barrier integrity. In an animal model of acute lung injury (ALI) induced by challenging mice with lipopolysaccharide (LPS), an increase in PDE3 activity and a decrease in cAMP levels in lung tissue was associated with reduced PKG activity upon PKG-I alpha nitration at tyrosine 247. The peroxynitrite scavenger manganese (III) tetrakis(1-methyl-4-pyridyl)porphyrin prevented this increase in PDE3 activity in LPS-exposed lungs. In addition, site-directed mutagenesis of PDE3A to replace serine 654 with alanine yielded a mutant protein that was insensitive to PKG-dependent regulation. Taken together, our data demonstrate a novel functional link between nitrosative stress induced by LPS during ALI and the downregulation of barrier-protective intracellular cAMP levels. Our data also provide new evidence that PKG-I alpha is critical for endothelial barrier maintenance and that preservation of its catalytic activity may be efficacious in ALI therapy.
C1 [Zemskov, Evgeny A.; Wu, Xiaomin; Yegambaram, Mannivannan; Lu, Qing; Wang, Hui; Tang, Haiyang] Univ Arizona Hlth Sci, Dept Med, Tucson, AZ, United States.
   [Aggarwal, Saurabh; Gross, Christine] Augusta Univ, Vasc Biol Ctr, Augusta, GA, United States.
   [Wang, Hui; Tang, Haiyang] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, China.
   [Tang, Haiyang; Wang, Ting; Black, Stephen M.] Florida Int Univ, Ctr Translat Sci, Port St Lucie, FL 34987, United States.
   [Wang, Ting] Univ Arizona, Dept Internal Med, Phoenix, AZ, United States.
   [Wang, Ting; Black, Stephen M.] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Environm Hlth Sci, Miami, FL 33199, United States.
   [Black, Stephen M.] Florida Int Univ, Herbert Wertheim Coll Med, Cellular Biol & Pharmacol, Miami, FL 33199, United States.
   [Aggarwal, Saurabh] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL, United States.
   [Gross, Christine] Broward Hlth Med Ctr, Dept Med, Ft Lauderdale, FL, United States.
C3 University of Arizona; University of Arizona Health Sciences; University
   System of Georgia; Augusta University; Northwest A&F University - China;
   State University System of Florida; Florida International University;
   University of Arizona; State University System of Florida; Florida
   International University; State University System of Florida; Florida
   International University; University of Alabama System; University of
   Alabama Birmingham
RP Black, SM (corresponding author), Florida Int Univ, Ctr Translat Sci, Port St Lucie, FL 34987 USA.; Black, SM (corresponding author), Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Environm Hlth Sci, Miami, FL 33199 USA.; Black, SM (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Cellular Biol & Pharmacol, Miami, FL 33199 USA.
EM stblack@fiu.edu
OI Black, Stephen M./0000-0002-4524-6544; Lu, Qing/0000-0002-1000-3884;
   Yegambaram, Manivannan/0000-0003-4561-8608
FU Interdisciplinary Training in Cardiovascular Research [HL60190,
   HL137282, HL134610, HL142212, HL146369]; National Heart, Lung, and Blood
   Institute, Bethesda, MD, USA [T32 HL007249]
FX This research was supported in part by HL60190 (S. M. B.), HL137282 (S.
   M. B.), HL134610 (S. M. B.), HL142212 (S. M. B./E. A. Z.), HL146369 (S.
   M. B.), and the Interdisciplinary Training in Cardiovascular Research
   T32 HL007249 (X. W.), all from the National Heart, Lung, and Blood
   Institute, Bethesda, MD, USA.
CR Adderley SP, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00010
   Aggarwal S, 2014, J BIOL CHEM, V289, P7948, DOI 10.1074/jbc.M113.534313
   Aggarwal S, 2011, J CELL PHYSIOL, V226, P3104, DOI 10.1002/jcp.22692
   Aslam M, 2010, CARDIOVASC RES, V87, P375, DOI 10.1093/cvr/cvq065
   Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x
   Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911
   Birukova AA, 2010, AM J PHYSIOL-LUNG C, V299, pL652, DOI 10.1152/ajplung.00202.2009
   Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318
   Chung KF, 2006, EUR J PHARMACOL, V533, P110, DOI 10.1016/j.ejphar.2005.12.059
   Davel AP, 2015, LIFE SCI, V125, P49, DOI 10.1016/j.lfs.2015.01.018
   Garcia-Morales V, 2014, VASC PHARMACOL, V60, P95, DOI 10.1016/j.vph.2014.01.004
   Geoffroy V, 1999, EUR J BIOCHEM, V259, P892, DOI 10.1046/j.1432-1327.1999.00123.x
   Goeckeler ZM, 2005, J BIOL CHEM, V280, P33083, DOI 10.1074/jbc.M503173200
   Gonzales JN, 2014, AM J PHYSIOL-LUNG C, V306, pL497, DOI 10.1152/ajplung.00086.2013
   Guinzberg R, 2017, FEBS J, V284, P258, DOI 10.1111/febs.13969
   Hambleton R, 2005, J BIOL CHEM, V280, P39168, DOI 10.1074/jbc.M506760200
   Horai S, 2013, CELL MOL NEUROBIOL, V33, P291, DOI 10.1007/s10571-012-9896-1
   Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5
   Hwang TL, 2012, TOXICOL APPL PHARM, V260, P193, DOI 10.1016/j.taap.2012.02.011
   Joshi CN, 2011, J PHARMACOL EXP THER, V339, P394, DOI 10.1124/jpet.111.183400
   Kellner M, 2017, ADV EXP MED BIOL, V967, P105, DOI 10.1007/978-3-319-63245-2_8
   Kumar S, 2017, FREE RADICAL BIO MED, V102, P217, DOI 10.1016/j.freeradbiomed.2016.11.008
   Lincoln TM, 2006, FRONT BIOSCI-LANDMRK, V11, P356, DOI 10.2741/1803
   Liu H, 2015, INT IMMUNOPHARMACOL, V29, P937, DOI 10.1016/j.intimp.2015.10.010
   Liu S, 2012, J NEUROL SCI, V320, P45, DOI 10.1016/j.jns.2012.06.005
   Lubomirov LT, 2018, ACTA PHYSIOL, V224, DOI 10.1111/apha.13079
   Lynch MJ, 2007, BIOCHEM SOC T, V35, P938, DOI 10.1042/BST0350938
   Masciarelli S, 2004, J CLIN INVEST, V114, P196, DOI 10.1172/JCI2004210804
   Maurice DH, 2005, FRONT BIOSCI, V10, P1221, DOI 10.2741/1614
   Murthy KS, 2002, AM J PHYSIOL-CELL PH, V282, pC508, DOI 10.1152/ajpcell.00373.2001
   Nakane M, 2003, CLIN CHEM LAB MED, V41, P865, DOI 10.1515/CCLM.2003.131
   Palmer D, 2007, J BIOL CHEM, V282, P9411, DOI 10.1074/jbc.M606936200
   Pavlaki N, 2018, J CARDIOVASC DEV DIS, V5, DOI 10.3390/jcdd5010004
   Pooladanda V, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1247-9
   Rafikov R, 2014, J BIOL CHEM, V289, P4710, DOI 10.1074/jbc.M114.547596
   Ramos-Espiritu LS, 2011, J PHARMACOL EXP THER, V338, P925, DOI 10.1124/jpet.111.184135
   Ricciardolo FLM, 2015, RESPIRATION, V89, P572, DOI 10.1159/000381905
   Samuel S, 2017, CELL PHYSIOL BIOCHEM, V41, P1894, DOI 10.1159/000471938
   Schlegel N, 2009, CRIT CARE MED, V37, P1735, DOI 10.1097/CCM.0b013e31819deb6a
   Schlegel N, 2009, MICROCIRCULATION, V16, P521, DOI 10.1080/10739680902967427
   Seifert R, 2015, TRENDS BIOCHEM SCI, V40, P8, DOI 10.1016/j.tibs.2014.10.008
   Sharma S, 2008, AM J PHYSIOL-LUNG C, V294, pL46, DOI 10.1152/ajplung.00247.2007
   Sharma S, 2010, VASC PHARMACOL, V52, P182, DOI 10.1016/j.vph.2009.11.010
   Sheehe JL, 2018, J BIOL CHEM, V293, P16791, DOI 10.1074/jbc.RA118.004363
   SILVER P J, 1985, Reviews in Clinical and Basic Pharmacology, V5, P341
   Song P, 2007, CIRCULATION, V116, P1585, DOI 10.1161/CIRCULATIONAHA.107.716498
   Stangherlin A, 2012, AM J PHYSIOL-HEART C, V302, pH379, DOI 10.1152/ajpheart.00766.2011
   Stehlik Josef, 2006, Expert Opin Investig Drugs, V15, P733, DOI 10.1517/13543784.15.7.733
   Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007
   Takagi T, 2014, CURR NEUROVASC RES, V11, P302, DOI 10.2174/1567202611666140912113152
   Umapathy NS, 2010, VASC PHARMACOL, V52, P199, DOI 10.1016/j.vph.2009.12.008
   Umapathy NS, 2010, J CELL PHYSIOL, V223, P215, DOI 10.1002/jcp.22029
   Vandeput F, 2013, P NATL ACAD SCI USA, V110, P19778, DOI 10.1073/pnas.1305427110
   Vogel SM, 2012, COMPR PHYSIOL, V2, P449, DOI 10.1002/cphy.c100006
   Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH2427, DOI 10.1152/ajpheart.00556.2004
   Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501
   Zemskov Evgeny, 2011, J Cardiovasc Dis Res, V2, P14, DOI 10.4103/0975-3583.78582
   Zhao YDD, 2012, AM J PATHOL, V180, P2268, DOI 10.1016/j.ajpath.2012.02.016
   Zuo HX, 2018, BRIT J PHARMACOL, V175, P2988, DOI 10.1111/bph.14347
NR 59
TC 2
Z9 2
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD AUG
PY 2021
VL 297
IS 2
AR 100946
DI 10.1016/j.jbc.2021.100946
PG 11
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA UI8TB
UT WOS:000690871000011
PM 34252457
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Li, G
   Wang, B
   Ding, XC
   Zhang, XH
   Tang, J
   Lin, HQ
AF Li, Guang
   Wang, Bo
   Ding, Xiangchao
   Zhang, Xinghua
   Tang, Jian
   Lin, Huiqing
TI Plasma extracellular vesicle delivery of miR-210-3p by targeting ATG7 to
   promote sepsis-induced acute lung injury by regulating autophagy and
   activating inflammation
SO EXPERIMENTAL AND MOLECULAR MEDICINE
LA English
DT Article
ID DEGRADATION
AB Extracellular vesicles (EVs) can be used for intercellular communication by facilitating the transfer of miRNAs from one cell to a recipient cell. MicroRNA (miR)-210-3p is released into the blood during sepsis, inducing cytokine production and promoting leukocyte migration. Thus, the current study aimed to elucidate the role of plasma EVs in delivering miR-210-3p in sepsis-induced acute lung injury (ALI). Plasma EVs were isolated from septic patients, after which the expression of various inflammatory factors was measured using enzyme-linked immunosorbent assay. Cell viability and apoptosis were measured via cell counting kit-8 and flow cytometry. Transendothelial resistance and fluorescein isothiocyanate fluorescence were used to measure endothelial cell permeability. Matrigel was used to examine the tubulogenesis of endothelial cells. The targeting relationship between miR-210-3p and ATG7 was assessed by dual-luciferase reporter assays. The expression of ATG7 and autophagy-related genes was determined to examine autophagic activation. A sepsis mouse model was established by cecal ligation and puncture (CLP)-induced surgery. The level of miR-210-3p was highly enriched in septic EVs. MiR-210-3p enhanced THP-1 macrophage inflammation, BEAS-2B cell apoptosis, and HLMVEC permeability while inhibiting angiogenesis and cellular activity. MiR-210-3p overexpression reduced ATG7 and LC3II/LC3I expression and increased P62 expression. Improvements in vascular density and autophagosome formation, increased ATG7 expression, and changes in the ratio of LC3II/LC3I were detected, as well as reduced P62 expression, in adenovirus-anti-miR-210-3p treated mice after CLP injury. Taken together, the key findings of the current study demonstrate that plasma EVs carrying miR-210-3p target ATG7 to regulate autophagy and inflammatory activation in a sepsis-induced ALI model.
   Sepsis: The mechanism of acute lung injury A short non-coding microRNA carried in nanosized packets called extracellular vesicles (EVs) is a key factor in the acute lung injury (ALI) seen in sepsis, which occurs when the body's response to infection spirals out of control, leading to organ failure. ALI is one of the most common causes of sepsis-related fatality, but how sepsis causes ALI is unclear. Huiqing Lin at Wuhan University in China and co-workers investigated the role of miR-210-3p, thought to be involved in lung function, in sepsis-induced ALI. Sampling blood-borne EVs from sepsis patients showed increased miR-210-3p levels. Further research showed that miR-210-3p hyper-activates a gene involved in degradation of damaged cells, causing excessive degradation. Inhibiting miR-210-3p in a mouse model of sepsis decreased lung injury. Targeting this microRNA shows promise for protecting lung tissue against sepsis-induced damage.
C1 [Li, Guang] Wuhan Univ, Renmin Hosp, Dept Crit Care Med, Wuhan 430060, China.
   [Wang, Bo; Ding, Xiangchao; Zhang, Xinghua; Lin, Huiqing] Wuhan Univ, Renmin Hosp, Dept Thorac Surg, Wuhan 430060, China.
   [Tang, Jian] Nanchang Univ, Affiliated Hosp 1, Dept Thorac Surg, Nanchang 330006, Jiangxi, China.
C3 Wuhan University; Wuhan University; Nanchang University
RP Lin, HQ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Thorac Surg, Wuhan 430060, Peoples R China.
EM huiqing.lin@whu.edu.cn
CR Bomsztyk K, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0943-4
   Frudd K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02352-z
   Avila-Bonilla RG, 2017, VIRUS RES, V232, P139, DOI 10.1016/j.virusres.2017.03.005
   Herrera-Rivero M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29153-8
   Ho J, 2016, AUTOPHAGY, V12, P1073, DOI 10.1080/15548627.2016.1179410
   Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793
   Jaeger A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4070-2
   Jiang KF, 2019, MOL THER, V27, P1758, DOI 10.1016/j.ymthe.2019.07.003
   Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65
   Lei M, 2019, INFLAMM RES, V68, P665, DOI 10.1007/s00011-019-01250-y
   Lin YJ, 2019, BOSNIAN J BASIC MED, V19, P249, DOI 10.17305/bjbms.2019.4131
   Lin ZB, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-016-1087-2
   Mandelbaum Jonathan, 2015, Autophagy, P0
   Mei SQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22171
   Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004
   Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200
   Park I, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00786-2018
   Pu QQ, 2017, J IMMUNOL, V198, P3205, DOI 10.4049/jimmunol.1601196
   Ren D, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0688-6
   Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255
   Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Varkouhi AK, 2019, ANESTHESIOLOGY, V130, P778, DOI 10.1097/ALN.0000000000002655
   Wang LL, 2019, ANAL CHEM, V91, P16023, DOI 10.1021/acs.analchem.9b03539
   Xu JJ, 2018, J IMMUNOL, V201, P3392, DOI 10.4049/jimmunol.1801008
   Yin X, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01071
   Zhou Y, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2339-3
   Zou L, 2016, J IMMUNOL, V196, P2788, DOI 10.4049/jimmunol.1502106
NR 28
TC 12
Z9 12
U1 3
U2 21
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1226-3613
EI 2092-6413
J9 EXP MOL MED
JI Exp. Mol. Med.
PD JUL
PY 2021
VL 53
IS 7
BP 1180
EP 1191
DI 10.1038/s12276-021-00651-6
EA JUL 2021
PG 12
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA TU3LT
UT WOS:000678446200001
PM 34321587
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Silva, JD
   Su, Y
   Calfee, CS
   Delucchi, KL
   Weiss, D
   McAuley, DF
   O'Kane, C
   Krasnodembskaya, AD
AF Silva, Johnatas Dutra
   Su, Yue
   Calfee, Carolyn S.
   Delucchi, Kevin L.
   Weiss, Daniel
   McAuley, Danny F.
   O'Kane, Cecilia M.
   Krasnodembskaya, Anna D.
TI Mesenchymal stromal cell extracellular vesicles rescue mitochondrial
   dysfunction and improve barrier integrity in clinically relevant models
   of ARDS
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; PLASMA ANGIOPOIETIN-2;
   STEM-CELLS; MICROVESICLES; SUBPHENOTYPES; VALIDATION; REPAIR
AB Alveolar epithelial-capillary barrier disruption is a hallmark of acute respiratory distress syndrome (ARDS). Contribution of mitochondrial dysfunction to the compromised alveolar-capillary barrier in ARDS remains unclear. Mesenchymal stromal cells-derived extracellular vesicles (MSC-EVs) are considered as a cell-free therapy for ARDS. Mitochondrial transfer was shown to be important for the therapeutic effects of MSCs and MSC-EVs. Here we investigated the contribution of mitochondrial dysfunction to the injury of alveolar epithelial and endothelial barriers in ARDS and the ability of MSC-EVs to modulate alveolar-capillary barrier integrity through mitochondrial transfer.
   Primary human small airway epithelial and pulmonary microvascular endothelial cells and human precision cut lung slices (PCLSs) were stimulated with endotoxin or plasma samples from patients with ARDS and treated with MSC-EVs, barrier properties and mitochondrial functions were evaluated. Lipopolysaccharide (LPS)-injured mice were treated with MSC-EVs and degree of lung injury and mitochondrial respiration of the lung tissue were assessed.
   Inflammatory stimulation resulted in increased permeability coupled with pronounced mitochondrial dysfunction in both types of primary cells and PCLSs. Extracellular vesicles derived from normal MSCs restored barrier integrity and normal levels of oxidative phosphorylation while an extracellular vesicles preparation which did not contain mitochondria was not effective. In vivo, presence of mitochondria was critical for extracellular vesicles ability to reduce lung injury and restore mitochondrial respiration in the lung tissue.
   In the ARDS environment, MSC-EVs improve alveolar-capillary barrier properties through restoration of mitochondrial functions at least partially via mitochondrial transfer.
C1 [Silva, Johnatas Dutra; Su, Yue; McAuley, Danny F.; O'Kane, Cecilia; Krasnodembskaya, Anna D.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland, United Kingdom.
   [Calfee, Carolyn S.] Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA 94143, United States.
   [Calfee, Carolyn S.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA, United States.
   [Calfee, Carolyn S.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA, United States.
   [Delucchi, Kevin L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA, United States.
   [Weiss, Daniel] Univ Vermont, Dept Med, Larner Coll Med, Burlington, VT, United States.
C3 Queens University Belfast; University of California System; University
   of California San Francisco; University of California System; University
   of California San Francisco; University of California System; University
   of California San Francisco; University of California System; University
   of California San Francisco; University of Vermont
RP Krasnodembskaya, AD (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland.
EM a.krasnodembskaya@qub.ac.uk
RI Silva, Johnatas D/I-6478-2017; Krasnodembskaya, Anna/I-1225-2019
OI Silva, Johnatas D/0000-0003-4379-4237; Krasnodembskaya,
   Anna/0000-0002-2380-5069; McAuley, Daniel/0000-0002-3283-1947
FU UK Medical Research Council [MRC MR/R025096/1, MR/S009426/1]; MRC
   [MR/S009426/1, MR/R025096/1] Funding Source: UKRI
FX This work was supported by UK Medical Research Council Research Awards
   (MRC MR/R025096/1 and MR/S009426/1 - to AK) . Funding information for
   this article has been deposited with the Crossref Funder Registry.
CR Abraham A, 2020, STEM CELL TRANSL MED, V9, P28, DOI 10.1002/sctm.19-0205
   Agrawal A, 2013, AM J RESP CRIT CARE, V187, P736, DOI 10.1164/rccm.201208-1460OC
   Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030
   Apostolova N, 2015, ANTIOXID REDOX SIGN, V22, P686, DOI 10.1089/ars.2014.5952
   Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494
   Biswas S, 2013, CURR MED CHEM, V20, P1496, DOI 10.2174/0929867311320120004
   Bos LD, 2017, THORAX, V72, P876, DOI 10.1136/thoraxjnl-2016-209719
   Bos LDJ, 2019, AM J RESP CRIT CARE, V200, P42, DOI 10.1164/rccm.201809-1808OC
   Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X
   Calfee CS, 2018, LANCET RESP MED, V6, P691, DOI 10.1016/S2213-2600(18)30177-2
   Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9
   Calfee CS, 2012, CRIT CARE MED, V40, P1731, DOI 10.1097/CCM.0b013e3182451c87
   Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC
   Cho HY, 2020, ARCH PHARM RES, V43, P297, DOI 10.1007/s12272-019-01182-5
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dushianthan A, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012041.pub2
   Elahi FM, 2020, STEM CELLS, V38, P15, DOI 10.1002/stem.3061
   Famous KR, 2017, AM J RESP CRIT CARE, V195, P331, DOI 10.1164/rccm.201603-0645OC
   Fergie N, 2019, FASEB J, V33, P5585, DOI 10.1096/fj.201802056R
   Hao Q, 2019, J IMMUNOL, V203, P1961, DOI 10.4049/jimmunol.1801534
   Harrois A, 2009, CURR OPIN ANESTHESIO, V22, P143, DOI 10.1097/ACO.0b013e328328d1cc
   Hough RF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124329
   Hu SL, 2018, STEM CELL TRANSL MED, V7, P615, DOI 10.1002/sctm.17-0278
   Huppert LA, 2019, SEMIN RESP CRIT CARE, V40, P31, DOI 10.1055/s-0039-1683996
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Jackson MV, 2016, STEM CELLS, V34, P2210, DOI 10.1002/stem.2372
   Kozlov AV, 2017, REDOX BIOL, V13, P170, DOI 10.1016/j.redox.2017.05.017
   Laffey JG, 2018, LANCET RESP MED, V6, P659, DOI 10.1016/S2213-2600(18)30279-0
   Lee JH, 2019, TRANSFUSION, V59, P876, DOI 10.1111/trf.14838
   Lentz SI, 2010, J HISTOCHEM CYTOCHEM, V58, P207, DOI 10.1369/jhc.2009.954701
   Lewis SR, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004477.pub3
   Li XY, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-19
   Mahida RY, 2020, AM J RESP CELL MOL, V63, P15, DOI 10.1165/rcmb.2019-0447TR
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Matthay MA, 2019, LANCET RESP MED, V7, P154, DOI 10.1016/S2213-2600(18)30418-1
   McAuley DF, 2014, NEW ENGL J MED, V371, P1695, DOI 10.1056/NEJMoa1403285
   Monsel A, 2015, AM J RESP CRIT CARE, V192, P324, DOI 10.1164/rccm.201410-1765OC
   Morrison TJ, 2017, AM J RESP CRIT CARE, V196, P1275, DOI 10.1164/rccm.201701-0170OC
   Parikh SM, 2017, CURR OPIN HEMATOL, V24, P432, DOI 10.1097/MOH.0000000000000361
   Park J, 2019, THORAX, V74, P43, DOI 10.1136/thoraxjnl-2018-211576
   Phinney DG, 2017, STEM CELLS, V35, P851, DOI 10.1002/stem.2575
   Phinney DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9472
   Piantadosi CA, 2017, ANNU REV PHYSIOL, V79, P495, DOI 10.1146/annurev-physiol-022516-034322
   Puhm F, 2019, CIRC RES, V125, P43, DOI 10.1161/CIRCRESAHA.118.314601
   Riou M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051253
   Ryter SW, 2018, ANN AM THORAC SOC, V15, pS266, DOI 10.1513/AnnalsATS.201808-585MG
   Silva JD, 2020, CYTOTHERAPY, V22, pS25
   Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100
   Supinski GS, 2020, CHEST, V157, P310, DOI 10.1016/j.chest.2019.08.2182
   Tang XD, 2017, STEM CELLS, V35, P1849, DOI 10.1002/stem.2619
   Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750
   Uhl FE, 2015, EUR RESPIR J, V46, P1150, DOI 10.1183/09031936.00183214
   Varkouhi AK, 2019, ANESTHESIOLOGY, V130, P778, DOI 10.1097/ALN.0000000000002655
   Wiklander OPB, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav8521
   Zhu YG, 2014, STEM CELLS, V32, P116, DOI 10.1002/stem.1504
   Zinter MS, 2016, AM J PHYSIOL-LUNG C, V310, pL224, DOI 10.1152/ajplung.00336.2015
NR 56
TC 56
Z9 56
U1 6
U2 24
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD JUL 1
PY 2021
VL 58
IS 1
AR 2002978
DI 10.1183/13993003.02978-2020
PG 18
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA TH3KJ
UT WOS:000671991400006
PM 33334945
OA hybrid, Green Published
DA 2023-08-21
ER

PT J
AU Smadja, DM
   Mentzer, SJ
   Fontenay, M
   Laffan, MA
   Ackermann, M
   Helms, J
   Jonigk, D
   Chocron, R
   Pier, GB
   Gendron, N
   Pons, S
   Diehl, JL
   Margadant, C
   Guerin, C
   Huijbers, EJM
   Philippe, A
   Chapuis, N
   Nowak-Sliwinska, P
   Karagiannidis, C
   Sanchez, O
   Kumpers, P
   Skurnik, D
   Randi, AM
   Griffioen, AW
AF Smadja, David M.
   Mentzer, Steven J.
   Fontenay, Michaela
   Laffan, Mike A.
   Ackermann, Maximilian
   Helms, Julie
   Jonigk, Danny
   Chocron, Richard
   Pier, Gerald B.
   Gendron, Nicolas
   Pons, Stephanie
   Diehl, Jean-Luc
   Margadant, Coert
   Guerin, Coralie
   Huijbers, Elisabeth J. M.
   Philippe, Aurelien
   Chapuis, Nicolas
   Nowak-Sliwinska, Patrycja
   Karagiannidis, Christian
   Sanchez, Olivier
   Kuempers, Philipp
   Skurnik, David
   Randi, Anna M.
   Griffioen, Arjan W.
TI COVID-19 is a systemic vascular hemopathy: insight for mechanistic and
   clinical aspects
SO ANGIOGENESIS
LA English
DT Review
ID VON-WILLEBRAND-FACTOR; HEMATOPOIETIC STEM-CELLS; DISSEMINATED
   INTRAVASCULAR COAGULATION; PLASMINOGEN-ACTIVATOR INHIBITOR-1; SEPTIC
   SHOCK; SUBLINGUAL MICROCIRCULATION; ENDOTHELIAL GLYCOCALYX; CONVALESCENT
   PLASMA; POSTMORTEM FINDINGS; TISSUE DISTRIBUTION
AB Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with vascular inflammation and endothelial injury. Severe forms of SARS-CoV-2 infection induce acute respiratory distress syndrome (ARDS) and there is still an ongoing debate on whether COVID-19 ARDS and its perfusion defect differs from ARDS induced by other causes. Beside pro-inflammatory cytokines (such as interleukin-1 beta [IL-1 beta] or IL-6), several main pathological phenomena have been seen because of endothelial cell (EC) dysfunction: hypercoagulation reflected by fibrin degradation products called D-dimers, micro- and macrothrombosis and pathological angiogenesis. Direct endothelial infection by SARS-CoV-2 is not likely to occur and ACE-2 expression by EC is a matter of debate. Indeed, endothelial damage reported in severely ill patients with COVID-19 could be more likely secondary to infection of neighboring cells and/or a consequence of inflammation. Endotheliopathy could give rise to hypercoagulation by alteration in the levels of different factors such as von Willebrand factor. Other than thrombotic events, pathological angiogenesis is among the recent findings. Overexpression of different proangiogenic factors such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (FGF-2) or placental growth factors (PlGF) have been found in plasma or lung biopsies of COVID-19 patients. Finally, SARS-CoV-2 infection induces an emergency myelopoiesis associated to deregulated immunity and mobilization of endothelial progenitor cells, leading to features of acquired hematological malignancies or cardiovascular disease, which are discussed in this review. Altogether, this review will try to elucidate the pathophysiology of thrombotic complications, pathological angiogenesis and EC dysfunction, allowing better insight in new targets and antithrombotic protocols to better address vascular system dysfunction. Since treating SARS-CoV-2 infection and its potential long-term effects involves targeting the vascular compartment and/or mobilization of immature immune cells, we propose to define COVID-19 and its complications as a systemic vascular acquired hemopathy.
C1 [Smadja, David M.; Gendron, Nicolas; Diehl, Jean-Luc; Guerin, Coralie; Philippe, Aurelien] Univ Paris, Innovat Therapies Haemostasis, INSERM, Paris, France.
   [Smadja, David M.; Gendron, Nicolas; Philippe, Aurelien] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Hematol, Carpentier Fdn, Paris, France.
   [Smadja, David M.; Gendron, Nicolas; Philippe, Aurelien] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Biosurg Res Lab, Carpentier Fdn, Paris, France.
   [Smadja, David M.; Ackermann, Maximilian; Jonigk, Danny; Sanchez, Olivier] F CRIN INNOVTE Network, Paris, France.
   [Mentzer, Steven J.] Harvard Med Sch, Euro Amer COVID 19 Working Grp, Brigham & Womens Hosp, Boston, MA 02115, United States.
   [Mentzer, Steven J.] Harvard Med Sch, Lab Adapt & Regenerat Biol, Brigham & Womens Hosp, Boston, MA 02115, United States.
   [Fontenay, Michaela; Gendron, Nicolas] Univ Paris, Inst Cochin, INSERM, Paris, France.
   [Fontenay, Michaela; Jonigk, Danny; Gendron, Nicolas] Assistance Publ Hop Paris, Dept Hematol, Paris, France.
   [Laffan, Mike A.] Imperial Coll London, Ctr Hematol, London, England, United Kingdom.
   [Ackermann, Maximilian] Univ Witten Herdecke, Helios Univ Clin Wuppertal, Euro Amer COVID 19 Working Grp, Witten, Germany.
   [Ackermann, Maximilian] Univ Witten Herdecke, Helios Univ Clin Wuppertal, Inst Pathol, Witten, Germany.
   [Ackermann, Maximilian] Univ Witten Herdecke, Helios Univ Clin Wuppertal, Dept Mol Pathol, Witten, Germany.
   [Ackermann, Maximilian] Johannes Gutenberg Univ Mainz, Inst Funct & Clin Anat, Univ Med Ctr, Mainz, Germany.
   [Helms, Julie] Hop Univ Strasbourg, Serv Med Intens Reanimat, Nouvel Hop Civil, Strasbourg, France.
   [Helms, Julie] Univ Strasbourg UNISTRA, INSERM UMR S1109, LabEx TRANSPLANTEX, Ctr Rech Immunol & Hematol,Fac Med,Federat Hosp U, Strasbourg, France.
   [Jonigk, Danny] Biomed Res Endstage & Obstruct Lung Dis Hannover, German Ctr Lung Res, Hannover, Germany.
   [Chocron, Richard] Univ Paris, PARCC, INSERM, Paris, France.
   [Chocron, Richard] Assistance Publ Hop Paris, Emergency Dept, Paris, France.
   [Pier, Gerald B.; Skurnik, David] Harvard Med Sch, Div Infect Dis, Dept Med, Brigham & Womens Hosp, Boston, MA 02115, United States.
   [Pons, Stephanie] Pitie Salpetriere Univ Hosp, Assistance Publ Hop Paris, Dept Anesthesiol & Crit Care, Paris, France.
   [Diehl, Jean-Luc] Assistance Publ Hop Paris, Intens Care Unit, Carpentier Fdn, Paris, France.
   [Diehl, Jean-Luc; Sanchez, Olivier] Assistance Publ Hop Paris, Biosurg Res Lab, Carpentier Fdn, Paris, France.
   [Margadant, Coert; Huijbers, Elisabeth J. M.; Griffioen, Arjan W.] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Angiogenesis Lab, Dept Med Oncol,Canc Ctr Amsterdam, Amsterdam, Netherlands.
   [Guerin, Coralie] Inst Curie, Cytometry Platform, Paris, France.
   [Nowak-Sliwinska, Patrycja] Univ Geneva, Sch Pharmaceut Sci, Mol Pharmacol Grp, Geneva, Switzerland.
   [Nowak-Sliwinska, Patrycja] Univ Geneva, Inst Pharmaceut Sci Western Switzerland, Geneva, Switzerland.
   [Karagiannidis, Christian] Univ Witten Herdecke, ARDS & ECMO Ctr Cologne Merheim, Cologne, Germany.
   [Sanchez, Olivier] Assistance Publ Hop Paris, Dept Resp Dis, Carpentier Fdn, Paris, France.
   [Kuempers, Philipp] Univ Hosp Munster, Dept Med D, Div Gen Internal & Emergency Med Nephrol & Rheuma, Munster, Germany.
   [Skurnik, David] Univ Paris, INSERM, F-75015 Paris, France.
   [Skurnik, David] Assistance Publ Hop Paris, Dept Microbiol, Paris, France.
   [Randi, Anna M.] Imperial Coll London, Natl Heart & Lung Inst, London, England, United Kingdom.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   UDICE-French Research Universities; Universite Paris Cite; UDICE-French
   Research Universities; Aix-Marseille Universite; Assistance
   Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP;
   Universite Paris Cite; Hopital Universitaire Europeen Georges-Pompidou -
   APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research
   Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de
   Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Saint-Antoine - APHP; Universite Paris
   Cite; Hopital Universitaire Europeen Georges-Pompidou - APHP; Harvard
   University; Brigham & Women's Hospital; Harvard Medical School; Harvard
   University; Brigham & Women's Hospital; Harvard Medical School; Institut
   National de la Sante et de la Recherche Medicale (Inserm); UDICE-French
   Research Universities; Universite Paris Cite; UDICE-French Research
   Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de
   Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Saint-Antoine - APHP; Universite Paris
   Cite; Hopital Universitaire Robert-Debre - APHP; Imperial College
   London; Witten Herdecke University; Witten Herdecke University; Witten
   Herdecke University; Johannes Gutenberg University of Mainz; CHU
   Strasbourg; UDICE-French Research Universities; Universites de
   Strasbourg Etablissements Associes; Universite de Strasbourg; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Institut
   National de la Sante et de la Recherche Medicale (Inserm); UDICE-French
   Research Universities; Universite Paris Cite; UDICE-French Research
   Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de
   Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Saint-Antoine - APHP; Harvard University;
   Brigham & Women's Hospital; Harvard Medical School; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP;
   UDICE-French Research Universities; Aix-Marseille Universite; Assistance
   Publique-Hopitaux de Marseille; Sorbonne Universite; Hopital
   Universitaire Saint-Antoine - APHP; UDICE-French Research Universities;
   Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille;
   Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Saint-Antoine - APHP; UDICE-French Research Universities;
   Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille;
   Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Saint-Antoine - APHP; University of Amsterdam; Vrije
   Universiteit Amsterdam; UDICE-French Research Universities; Universite
   PSL; UNICANCER; Institut Curie; University of Geneva; University of
   Geneva; Witten Herdecke University; UDICE-French Research Universities;
   Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille;
   Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Saint-Antoine - APHP; University of Munster; Institut
   National de la Sante et de la Recherche Medicale (Inserm); UDICE-French
   Research Universities; Universite Paris Cite; UDICE-French Research
   Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de
   Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Saint-Antoine - APHP; Imperial College
   London
RP Smadja, DM (corresponding author), Univ Paris, Innovat Therapies Haemostasis, INSERM, Paris, France.; Smadja, DM (corresponding author), Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Hematol, Carpentier Fdn, Paris, France.; Smadja, DM (corresponding author), Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Biosurg Res Lab, Carpentier Fdn, Paris, France.; Smadja, DM (corresponding author), F CRIN INNOVTE Network, Paris, France.
EM david.smadja@aphp.fr
RI Pons, Stephanie/IRZ-9466-2023; Randi, Anna/HLP-5457-2023; Guerin,
   Coralie/HKV-6282-2023; Nowak-Sliwinska, Patrycja/T-7663-2018; Chapuis,
   nicolas/HIR-3009-2022; Gendron, Nicolas/AAB-8014-2022; Chocron,
   Richard/ABF-5825-2021
OI Nowak-Sliwinska, Patrycja/0000-0002-8299-0444; Chapuis,
   nicolas/0000-0003-0601-3948; Gendron, Nicolas/0000-0003-4852-4738; Pons,
   Stephanie/0000-0002-7372-3563; Skurnik, David/0000-0002-4205-9639;
   Guerin, Coralie/0000-0002-1840-4017; Laffan, Michael/0000-0002-8268-3268
FU French national agency for research ANR Flash-COVID SARCODO (Fondation
   de France); ANR AAP RA-COVID-19 VASCOV (CAPNET label "priorite nationale
   de recherche" by French Government); Mecenat Covid AP-HP; SARCODO-EP
   (Contrat de recherche clinique DRCI AP-HP) [COV21033]; French national
   agency for research ANR AAP RA-COVID-19 CALPRO; Site de Recherche
   Integre sur le Cancer CARPEM of the Institut National du Cancer; Dutch
   Cancer Society [KWF2018-11651]; European Research Council (ERC)
   [680209]; Swiss National Science Foundation [310030-197878]; British
   Heart Foundation (BHF); Imperial College COVID response Fund; Swiss
   National Science Foundation (SNF) [310030_197878] Funding Source: Swiss
   National Science Foundation (SNF); European Research Council (ERC)
   [680209] Funding Source: European Research Council (ERC)
FX We thank Maud BARRANDON for Fig. 1 design. DM SMADJA, O SANCHEZ and JL
   DIEHL are funded with grants from French national agency for research
   ANR Flash-COVID SARCODO (Fondation de France), ANR AAP RA-COVID-19
   VASCOV (CAPNET label "priorite nationale de recherche" by French
   Government), Mecenat Covid AP-HP and SARCODO-EP (COV21033-Contrat de
   recherche clinique DRCI AP-HP). M FONTENAY work is funded by the French
   national agency for research ANR AAP RA-COVID-19 CALPRO, the Mecenat
   Covid AP-HP and the Site de Recherche Integre sur le Cancer CARPEM of
   the Institut National du Cancer. AW GRIFFIOEN and EJM HUIJBERS are
   funded by the Dutch Cancer Society (KWF2018-11651). P NOWAK-SLIWINSKA is
   funded by the European Research Council (ERC-680209) and by the Swiss
   National Science Foundation (#310030-197878). AM RANDI is funded by the
   British Heart Foundation (BHF) and the Imperial College COVID response
   Fund.
CR Ackermann M, 2020, NEW ENGL J MED, V383, P888, DOI 10.1056/NEJMc2022068
   Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429
   AMADOAZEVEDO J, 2021, ANGIOGENESIS
   Aman J, 2021, IN PRESS
   Amrun SN, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102911
   Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359
   [Anonymous], 2020, BMJ, V371, pm4232, DOI 10.1136/bmj.m4232
   [Anonymous], 2012, JAMA, DOI DOI 10.1001/JAMA.2012.5669
   Arachchillage DJ, 2020, BRIT J HAEMATOL, V190, pE270, DOI 10.1111/bjh.17050
   Arachchillage DRJ, 2021, SEMIN THROMB HEMOST, V47, P436, DOI 10.1055/s-0040-1722309
   Bajou K, 2014, NAT MED, V20, P741, DOI 10.1038/nm.3552
   Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135
   Barrett TJ, 2020, CIRC RES, V127, P945, DOI 10.1161/CIRCRESAHA.120.317803
   Basiorka AA, 2016, BLOOD, V128, P2960, DOI 10.1182/blood-2016-07-730556
   Bassler K, 2019, ANNU REV IMMUNOL, V37, P269, DOI 10.1146/annurev-immunol-042718-041728
   Bazzan M, 2020, INTERN EMERG MED, V15, P861, DOI 10.1007/s11739-020-02394-0
   Beenen LFM, 2020, THROMB RES, V196, P135, DOI 10.1016/j.thromres.2020.08.026
   Beloncle FM, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00675-7
   Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011
   Bermejo-Martin JF, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03398-0
   Bernardes JP, 2020, IMMUNITY, V53, P1296, DOI 10.1016/j.immuni.2020.11.017
   Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026
   Blasi A, 2020, J THROMB HAEMOST, V18, P2646, DOI 10.1111/jth.15043
   Boettcher S, 2017, TRENDS IMMUNOL, V38, P345, DOI 10.1016/j.it.2017.01.004
   Boettcher S, 2012, J IMMUNOL, V188, P5824, DOI 10.4049/jimmunol.1103253
   Bolton Kelly L, 2020, medRxiv, DOI [10.1038/s41467-021-26138-6, 10.1101/2020.11.25.20233163]
   BORGEL D, 2021, CRIT CARE
   Bost P, 2020, CELL, V181, P1475, DOI 10.1016/j.cell.2020.05.006
   Bradley BT, 2020, LANCET, V396, P320, DOI 10.1016/S0140-6736(20)31305-2
   Brodsky SV, 2002, CIRCULATION, V106, P2372, DOI 10.1161/01.CIR.0000033972.90653.AF
   Buijsers B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.575047
   Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242
   Byzova TV, 2016, BLOOD, V128, P2283, DOI 10.1182/blood-2016-09-737023
   Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005
   CADUFF JH, 1986, ANAT RECORD, V216, P154, DOI 10.1002/ar.1092160207
   Cai ZG, 2018, CELL STEM CELL, V23, P833, DOI 10.1016/j.stem.2018.10.013
   Caputo ND, 2020, ACAD EMERG MED, V27, P375, DOI 10.1111/acem.13994
   Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5
   Carsetti A, 2020, MICROVASC RES, V132, DOI 10.1016/j.mvr.2020.104064
   Casadevall A, 2020, J CLIN INVEST, V130, P5112, DOI 10.1172/JCI139760
   Cattaneo M, 2020, THROMB HAEMOSTASIS, V120, P1230, DOI 10.1055/s-0040-1712097
   Caviedes I, 2021, AM J RESP CRIT CARE, V203, P258, DOI 10.1164/rccm.202009-3446LE
   Chapman DG, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03263-2020
   Chavkin NW, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00042
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078
   Chen LT, 2020, CELL MOL IMMUNOL, V17, P992, DOI 10.1038/s41423-020-0492-x
   Chen XH, 2013, J CLIN INVEST, V123, P4595, DOI 10.1172/JCI67580
   Cheng PY, 2019, LEUKEMIA, V33, P2034, DOI 10.1038/s41375-019-0397-9
   Chiumello D, 2020, INTENS CARE MED, V46, P2187, DOI 10.1007/s00134-020-06281-2
   CHOCRON R, 2021, ARCH CARDIOVASC DIS
   Chocron R, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.018624
   Chun SH, 2021, EUR RADIOL, V31, P1130, DOI 10.1007/s00330-020-07173-1
   Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000
   Couzin-Frankel J, 2020, SCIENCE, V368, P455, DOI 10.1126/science.368.6490.455
   Damiani E, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00680-w
   Darcy CJ, 2014, CRIT CARE, V18, DOI 10.1186/cc14003
   Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7
   Romualdo LGD, 2021, J INFECTION, V82, pE40, DOI 10.1016/j.jinf.2020.08.010
   Debuc B, 2021, STEM CELL REV REP, V17, P4, DOI 10.1007/s12015-020-09987-4
   Delabranche X, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0339-5
   Delabranche X, 2016, CRIT CARE MED, V44, pE930, DOI 10.1097/CCM.0000000000001836
   Denorme F, 2016, BLOOD, V127, P2337, DOI 10.1182/blood-2015-08-662650
   Dhawan RT, 2021, LANCET RESP MED, V9, P107, DOI 10.1016/S2213-2600(20)30407-0
   Dhont S, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01462-5
   Diehl JL, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00757-6
   Diehl JL, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00716-1
   Santo DAD, 2020, J THROMB THROMBOLYS, V50, P790, DOI 10.1007/s11239-020-02245-x
   Doevelaar AAN, 2021, CRIT CARE MED, V49, pE512, DOI 10.1097/CCM.0000000000004918
   Dolhnikoff M, 2020, J THROMB HAEMOST, V18, P1517, DOI 10.1111/jth.14844
   Drost CC, 2019, THROMB HAEMOSTASIS, V119, P1827, DOI 10.1055/s-0039-1695768
   Duployez N, 2020, CANCERS, V12, DOI 10.3390/cancers12071992
   Dupont A, 2021, ARTERIOSCL THROM VAS, V41, P1760, DOI 10.1161/ATVBAHA.120.315595
   Dupont V, 2021, CLIN INFECT DIS, V72, P1834, DOI 10.1093/cid/ciaa1007
   Dutt T, 2021, BLOOD, V137, P1731, DOI 10.1182/blood.2020007599
   Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283
   Escher R, 2020, THROMB RES, V192, P174, DOI 10.1016/j.thromres.2020.05.032
   Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815
   Fakhr BS, 2020, BRIT J ANAESTH, V125, pE434, DOI 10.1016/j.bja.2020.08.001
   Falasca L, 2020, J INFECT DIS, V222, P1807, DOI 10.1093/infdis/jiaa578
   Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1
   Filipovic N, 2009, MICROVASC RES, V78, P286, DOI 10.1016/j.mvr.2009.08.004
   Flevaris P, 2017, SEMIN THROMB HEMOST, V43, P169, DOI 10.1055/s-0036-1586228
   Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5
   Fraser Douglas D, 2020, Crit Care Explor, V2, pe0144, DOI 10.1097/CCE.0000000000000144
   Gattinoni L, 2020, AM J RESP CRIT CARE, V201, P1299, DOI 10.1164/rccm.202003-0817LE
   Gendron N, 2021, ARTHRITIS RHEUMATOL, V73, P1976, DOI 10.1002/art.41777
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Giardini V, 2020, AM J HEMATOL, V95, pE188, DOI 10.1002/ajh.25882
   Goldsmith CS, 2020, LANCET, V395, pE99, DOI 10.1016/S0140-6736(20)31188-0
   Goligher EC, 2021, INTENS CARE MED, V47, P83, DOI 10.1007/s00134-020-06320-y
   Goshua G, 2020, LANCET HAEMATOL, V7, pE575, DOI 10.1016/S2352-3026(20)30216-7
   Goudot G, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.586307
   Gowd V, 2016, WORLD J DIABETES, V7, P67, DOI 10.4239/wjd.v7.i4.67
   GREENE R, 1987, AM J ROENTGENOL, V148, P501, DOI 10.2214/ajr.148.3.501
   Greinacher A, 2021, NEW ENGL J MED, V384, P2092, DOI 10.1056/NEJMoa2104840
   Griffioen AW, 2000, PHARMACOL REV, V52, P237
   Grimmer B, 2017, J APPL PHYSIOL, V123, P1635, DOI 10.1152/japplphysiol.00120.2017
   Gue YX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091850
   Guerin CL, 2021, STEM CELL REV REP, V17, P639, DOI 10.1007/s12015-020-10062-1
   Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3
   Gupta N, 2019, THROMB RES, V181, P77, DOI 10.1016/j.thromres.2019.07.013
   Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007
   Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027
   Hakanpaa L, 2018, P NATL ACAD SCI USA, V115, pE6467, DOI 10.1073/pnas.1722317115
   Hakanpaa L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6962
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hardman N, 2020, TRANSPL INFECT DIS, V22, DOI 10.1111/tid.13264
   Hattori N, 1999, AM J PHYSIOL-LUNG C, V277, pL573, DOI 10.1152/ajplung.1999.277.3.L573
   He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5
   Helms J, 2021, ANN INTENSIVE CARE, V11, DOI 10.1186/s13613-021-00809-5
   Helms J, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00704-5
   Helms J, 2020, INTENS CARE MED, V46, P1502, DOI 10.1007/s00134-020-06082-7
   Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x
   Herault A, 2017, NATURE, V544, P53, DOI 10.1038/nature21693
   Herrmann J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18672-6
   Hu WT, 2020, EMERG INFECT DIS, V26, P2974, DOI 10.3201/eid2612.203334
   Hueso T, 2020, BLOOD, V136, P2290, DOI 10.1182/blood.2020008423
   Huijbers EJM, 2018, VACCINE, V36, P3054, DOI 10.1016/j.vaccine.2018.03.064
   Huijbers EJM, 2017, HUM VACC IMMUNOTHER, V13, P1112, DOI 10.1080/21645515.2016.1276140
   Iba T, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1468-1
   IDELL S, 1989, J CLIN INVEST, V84, P695, DOI 10.1172/JCI114217
   Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719
   Jimenez D, 2021, CHEST, V159, P1182, DOI 10.1016/j.chest.2020.11.005
   Jonigk D, 2021, INTENS CARE MED, V47, P86, DOI 10.1007/s00134-020-06302-0
   Jonmarker S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03375-7
   Kandalla PK, 2016, J EXP MED, V213, P2269, DOI 10.1084/jem.20151975
   Edul VSK, 2021, J CRIT CARE, V61, P73, DOI 10.1016/j.jcrc.2020.10.002
   Karagiannidis C, 2020, LANCET RESP MED, V8, P853, DOI 10.1016/S2213-2600(20)30316-7
   Karmaus PWF, 2017, J EXP MED, V214, P2629, DOI 10.1084/jem.20161855
   Karuppan MKM, 2021, MOL NEUROBIOL, V58, P2465, DOI 10.1007/s12035-020-02245-1
   KAWANO Y, 1991, BLOOD, V77, P2118
   Khider L, 2020, J THROMB HAEMOST, V18, P2391, DOI 10.1111/jth.14968
   Khinda J, 2021, J MED VIROL, V93, P1078, DOI 10.1002/jmv.26411
   Kim SY, 2020, ANTIVIR RES, V181, DOI 10.1016/j.antiviral.2020.104873
   Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]
   Kong YX, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03079-y
   Kraakman MJ, 2017, J CLIN INVEST, V127, P2133, DOI 10.1172/JCI92450
   Kruse JM, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03401-8
   Kumpers P, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1978-0
   Kumpers P, 2008, CRIT CARE, V12, DOI 10.1186/cc7130
   Kwaan HC, 2011, SEMIN THROMB HEMOST, V37, P960, DOI 10.1055/s-0031-1297375
   Lang M, 2020, LANCET INFECT DIS, V20, P1365, DOI 10.1016/S1473-3099(20)30367-4
   Lax SF, 2020, ANN INTERN MED, V173, P350, DOI 10.7326/M20-2566
   Lee D. -H., 2014, PLOS ONE, V9
   Lee GS, 2011, DEV DYNAM, V240, P1335, DOI 10.1002/dvdy.22618
   Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706
   Leimkuhler NB, 2021, CELL STEM CELL, V28, P637, DOI 10.1016/j.stem.2020.11.004
   Leppkes M, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102925
   Lerum TV, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03448-2020
   Li LL, 2021, J INFECT DIS, V223, P178, DOI 10.1093/infdis/jiaa642
   Liepelt A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010127
   Liu J, 2011, BLOOD, V117, P342, DOI 10.1182/blood-2010-06-287987
   LONG QX, 2020, NAT MED, V26, P845, DOI [DOI 10.1038/S41591-020-0897-1, 10.1101/2020.03.18.20038018]
   Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y
   LUO Y, 2020, CLIN INFECT DIS, V10, P2
   Lynch KL, 2021, CLIN INFECT DIS, V72, P301, DOI 10.1093/cid/ciaa979
   Maatman TK, 2020, CRIT CARE MED, V48, pE783, DOI 10.1097/CCM.0000000000004466
   Makowski L, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020146
   Malas MB, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100639
   Mancini I, 2021, J THROMB HAEMOST, V19, P513, DOI 10.1111/jth.15191
   Mancuso P, 2020, J THROMB HAEMOST, V18, P2744, DOI 10.1111/jth.15044
   Mann ER, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6197
   Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660
   Mauri T, 2020, CRIT CARE MED, V48, P1129, DOI 10.1097/CCM.0000000000004386
   Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189
   McAndrews KM, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.142386
   McCormack JJ, 2017, J CELL SCI, V130, P3611, DOI 10.1242/jcs.208033
   McCracken IR, 2021, CIRCULATION, V143, P865, DOI 10.1161/CIRCULATIONAHA.120.052824
   Medcalf RL, 2020, J THROMB HAEMOST, V18, P2118, DOI 10.1111/jth.14960
   Meduri GU, 2009, CHEST, V136, P1631, DOI 10.1378/chest.08-2408
   Meghraoui-Kheddar A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01117
   Mehra MR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMoa2007621
   Meizlish ML, 2021, AM J HEMATOL, V96, P471, DOI [10.1002/ajh.26102, 10.1101/2021.01.12.21249577]
   Meizlish Matthew L, 2020, medRxiv, DOI 10.1101/2020.06.29.20140376
   Mendoza M, 2020, BJOG-INT J OBSTET GY, V127, P1374, DOI 10.1111/1471-0528.16339
   Mengos AE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01147
   Mentzer SJ, 2014, ANGIOGENESIS, V17, P499, DOI 10.1007/s10456-014-9428-3
   Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888
   Miller SE, 2020, NEW ENGL J MED, V383, P2689, DOI 10.1056/NEJMc2030450
   Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034
   Mitroulis I, 2017, J CLIN INVEST, V127, P3624, DOI 10.1172/JCI92571
   Mo XN, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01217-2020
   Monneret G, 2016, CYTOM PART B-CLIN CY, V90, P376, DOI 10.1002/cyto.b.21270
   Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004
   Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008
   Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029
   Negro A, 2021, AM J HEMATOL, V96, pE41, DOI 10.1002/ajh.26037
   Noh JY, 2020, J INFECTION, V81, P816, DOI 10.1016/j.jinf.2020.05.035
   Nolte MA, 2021, TRENDS BIOCHEM SCI, V46, P124, DOI 10.1016/j.tibs.2020.09.001
   Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116
   Nougier C, 2020, J THROMB HAEMOST, V18, P2215, DOI 10.1111/jth.15016
   Nuckton TJ, 2002, NEW ENGL J MED, V346, P1281, DOI 10.1056/NEJMoa012835
   O'Sullivan JM, 2020, BRIT J HAEMATOL, V190, P27, DOI 10.1111/bjh.16845
   Oduro KA, 2012, BLOOD, V120, P2203, DOI 10.1182/blood-2011-11-391342
   Ospina-Tascon GA, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00651-1
   Oudemans-van Straaten HM, 2015, SEMIN THROMB HEMOST, V41, P91, DOI 10.1055/s-0034-1398384
   Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850
   Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001
   Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046
   Park EJ, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13040645
   Paschall AV, 2015, J IMMUNOL, V194, P2369, DOI 10.4049/jimmunol.1402412
   Patel BV, 2020, AM J RESP CRIT CARE, V202, P690, DOI 10.1164/rccm.202004-1412OC
   Pfaender S, 2020, NAT MICROBIOL, V5, P1330, DOI [10.1038/s41564-020-0769-y, 10.1101/2020.03.05.979260]
   Philippe A, 2021, ANGIOGENESIS, V24, P505, DOI 10.1007/s10456-020-09762-6
   Phipps WS, 2020, AM J CLIN PATHOL, V154, P459, DOI 10.1093/ajcp/aqaa123
   Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346
   Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003
   Pietras EM, 2014, J EXP MED, V211, P245, DOI 10.1084/jem.20131043
   Planquette B, 2021, THROMB RES, V197, P94, DOI 10.1016/j.thromres.2020.11.001
   Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430
   Polidoro RB, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01626
   Potje SR, 2021, LIFE SCI, V276, DOI 10.1016/j.lfs.2021.119376
   Psaila B, 2019, BLOOD, V133, P1427, DOI 10.1182/blood-2018-11-835371
   Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005
   Qu JX, 2020, CLIN INFECT DIS, V71, P2255, DOI 10.1093/cid/ciaa489
   Rahimi A, 2021, TRIALS, V22, DOI 10.1186/s13063-021-05242-4
   Ramjiawan RR, 2017, ANGIOGENESIS, V20, P185, DOI 10.1007/s10456-017-9552-y
   Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854
   Ratajczak MZ, 2017, CIRC RES, V120, P166, DOI 10.1161/CIRCRESAHA.116.309362
   Rauch A, 2020, CIRCULATION, V142, P1881, DOI 10.1161/CIRCULATIONAHA.120.050907
   Reglero-Real N, 2016, ARTERIOSCL THROM VAS, V36, P2048, DOI 10.1161/ATVBAHA.116.307610
   Remmelink M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03218-5
   Ren LL, 2021, CLIN INFECT DIS, V72, pE545, DOI 10.1093/cid/ciaa1247
   Reyes Miguel, 2020, bioRxiv, DOI 10.1101/2020.09.02.280180
   Reyes M, 2020, NAT MED, V26, P333, DOI 10.1038/s41591-020-0752-4
   Rodriguez MR, 2021, INT J LAB HEMATOL, V43, pE152, DOI 10.1111/ijlh.13476
   Roncati L, 2020, PLATELETS, V31, P1085, DOI 10.1080/09537104.2020.1810224
   Rovas A, 2021, ANGIOGENESIS, V24, P145, DOI 10.1007/s10456-020-09753-7
   Rovas A, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2542-2
   Sack KD, 2020, CRIT CARE CLIN, V36, P201, DOI 10.1016/j.ccc.2019.12.003
   Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152
   Salem S, 2020, GLOB MID EAST, P1, DOI [10.2214/AJR.20.23034, 10.1017/9781108868969, 10.2214/AJR.20.23034S.]
   Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474
   Schneider RK, 2016, NAT MED, V22, P288, DOI 10.1038/nm.4047
   Schurch CM, 2014, CELL STEM CELL, V14, P460, DOI 10.1016/j.stem.2014.01.002
   Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001
   Sela S, 2011, CIRC RES, V108, P1063, DOI 10.1161/CIRCRESAHA.110.239665
   Sella N, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03242-5
   Shah A, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03260-3
   Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783
   Shen QC, 2018, NATURE, V554, P123, DOI 10.1038/nature25434
   Shi H, 2021, J LEUKOCYTE BIOL, V109, P67, DOI [10.1002/JLB.3COVCRA0720-359R, 10.1101/2020.05.06.20093070]
   Si-Mohamed S, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02608-2020
   Silvin A, 2020, CELL, V182, P1401, DOI 10.1016/j.cell.2020.08.002
   Simonovich VA, 2021, NEW ENGL J MED, V384, P619, DOI 10.1056/NEJMoa2031304
   Sinha P, 2013, CRIT CARE, V17, DOI 10.1186/cc12541
   Slessarev M, 2020, CAN J ANESTH, V67, P1288, DOI 10.1007/s12630-020-01661-0
   Smadja DM, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.00956-2021
   Smadja DM, 2021, J THROMB HAEMOST, V19, P1823, DOI 10.1111/jth.15339
   Smadja DM, 2020, ANGIOGENESIS, V23, P611, DOI 10.1007/s10456-020-09730-0
   Smadja DM, 2009, CIRCULATION, V119, P374, DOI 10.1161/CIRCULATIONAHA.108.808246
   Song JW, 2017, J PHARMACOL EXP THER, V361, P115, DOI 10.1124/jpet.116.239509
   Spiezia L, 2020, THROMB HAEMOSTASIS, V120, P998, DOI 10.1055/s-0040-1710018
   Sreejit G, 2020, CIRCULATION, V141, P1080, DOI 10.1161/CIRCULATIONAHA.119.043833
   Stahl K, 2020, AM J RESP CRIT CARE, V202, P1178, DOI 10.1164/rccm.202007-2676LE
   Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824
   Susen S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03000-7
   Sylvester JT, 2012, PHYSIOL REV, V92, P367, DOI 10.1152/physrev.00041.2010
   Szwebel TA, 2021, STEM CELL REV REP, V17, P296, DOI 10.1007/s12015-020-10107-5
   Takizawa H, 2017, CELL STEM CELL, V21, P225, DOI 10.1016/j.stem.2017.06.013
   Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4
   Tandon R, 2021, J VIROL, V95, DOI [10.1128/JVI.01987-20, 10.1101/2020.06.08.140236]
   Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068
   Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0
   Thachil J, 2020, J THROMB HAEMOST, V18, P2138, DOI 10.1111/jth.15004
   Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725
   Tobin MJ, 2020, AM J RESP CRIT CARE, V202, P356, DOI 10.1164/rccm.202006-2157CP
   TOMASHEFSKI JF, 1983, AM J PATHOL, V112, P112
   Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726
   Turecek PL, 2021, THROMB RES, V201, P100, DOI 10.1016/j.thromres.2021.02.012
   Uchimido R, 2019, CRIT CARE, V23, DOI 10.1186/s13054-018-2292-6
   Ulas T, 2017, NAT IMMUNOL, V18, P622, DOI 10.1038/ni.3745
   Undas A, 2019, EXPERT REV HEMATOL, V12, P597, DOI 10.1080/17474086.2019.1627193
   Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002
   Valdivia-Mazeyra MF, 2021, VIRCHOWS ARCH, V478, P487, DOI 10.1007/s00428-020-02926-1
   van der Bijl I, 2020, MATRIX BIOL, V93, P60, DOI 10.1016/j.matbio.2020.05.005
   Vardhana SA, 2020, J EXP MED, V217, DOI 10.1084/jem.20200678
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Vassiliou AG, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010186
   Vincent JL, 2013, CRIT CARE MED, V41, P2069, DOI 10.1097/CCM.0b013e31828e9b03
   von Meijenfeldt FA, 2021, RES PRACT THROMB HAE, V5, P132, DOI 10.1002/rth2.12462
   Wang LM, 2012, J CLIN INVEST, V122, P4218, DOI 10.1172/JCI59176
   Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298
   Wang YQ, 2020, J CLIN INVEST, V130, P5235, DOI [10.1172/JCI138759, 10.1172/JCI138759.]
   Weber GF, 2015, SCIENCE, V347, P1260, DOI 10.1126/science.aaa4268
   Weinbaum S, 2021, CARDIOVASC ENG TECHN, V12, P37, DOI 10.1007/s13239-020-00485-9
   Weiss E, 2020, THROMB HAEMOSTASIS, V120, P1343, DOI 10.1055/s-0040-1713637
   Whyte CS, 2020, J THROMB HAEMOST, V18, P1548, DOI 10.1111/jth.14872
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   WRIGHT F, 2020, J AM COLL SURGEONS
   Wu SC, 2021, BLOOD ADV, V5, P1305, DOI 10.1182/bloodadvances.2020003259
   Wu Y, 2020, QJM-INT J MED, V113, P539, DOI 10.1093/qjmed/hcaa121
   Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648
   Yamamoto H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7429
   Yamamoto K, 1998, BLOOD, V92, P2791, DOI 10.1182/blood.V92.8.2791.420k24_2791_2801
   Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007
   Yan SF, 1999, ARTERIOSCL THROM VAS, V19, P2029, DOI 10.1161/01.ATV.19.9.2029
   Yang Lu-Lu, 2020, Chronic Dis Transl Med, V6, P79, DOI 10.1016/j.cdtm.2020.05.002
   Yang WJ, 2020, J INFECTION, V80, P388, DOI 10.1016/j.jinf.2020.02.016
   Yau JW, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0124-z
   Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9
   Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252
   ZHANG R, 2020, J VASC SURG VENOUS L
   Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575
   Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007
   Zhao JW, 2020, ADV POLYM SCI, V285, P1, DOI 10.1007/12_2020_62
   Zhao W, 2020, AM J ROENTGENOL, V214, P1072, DOI 10.2214/AJR.20.22976
   Zheng L, 2016, BLOOD ADV, V1, P75, DOI 10.1182/bloodadvances.2016000711
   Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI [10.1148/radiol.2020200463, 10.1056/NEJMc2001737]
   Zuo Yu, 2020, medRxiv, DOI 10.1101/2020.08.29.20184358
NR 313
TC 75
Z9 79
U1 3
U2 16
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-6970
EI 1573-7209
J9 ANGIOGENESIS
JI Angiogenesis
PD NOV
PY 2021
VL 24
IS 4
BP 755
EP 788
DI 10.1007/s10456-021-09805-6
EA JUN 2021
PG 34
WC Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA WA6NV
UT WOS:000667636900001
PM 34184164
OA Bronze, Green Published
DA 2023-08-21
ER

PT J
AU Surolia, R
   Li, FJ
   Wang, Z
   Kashyap, M
   Srivastava, RK
   Traylor, AM
   Singh, P
   Dsouza, KG
   Kim, H
   Pittet, JF
   Zmijewski, JW
   Agarwal, A
   Athar, M
   Ahmad, A
   Antony, VB
AF Surolia, Ranu
   Li, Fu Jun
   Wang, Zheng
   Kashyap, Mahendra
   Srivastava, Ritesh Kumar
   Traylor, Amie M.
   Singh, Pooja
   Dsouza, Kevin G.
   Kim, Harrison
   Pittet, Jean-Francois
   Zmijewski, Jaroslaw W.
   Agarwal, Anupam
   Athar, Mohammad
   Ahmad, Aftab
   Antony, Veena B.
TI NETosis in the pathogenesis of acute lung injury following cutaneous
   chemical burns
SO JCI INSIGHT
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; NEUTROPHIL EXTRACELLULAR TRAPS; NADPH
   OXIDASE; PHENYLARSINE OXIDE; PAD4; DNA; INFLAMMATION; TOXICITY;
   IMMUNITY; EXPOSURE
AB Despite the high morbidity and mortality among patients with extensive cutaneous burns in the intensive care unit due to the development of acute respiratory distress syndrome, effective therapeutics remain to be determined. This is primarily because the mechanisms leading to acute lung injury (ALI) in these patients remain unknown. We test the hypothesis that cutaneous chemical burns promote lung injury due to systemic activation of neutrophils, in particular, toxicity mediated by the deployment of neutrophil extracellular traps (NETs). We also demonstrate the potential benefit of a peptidyl arginine deiminase 4 (PAD4) inhibitor to prevent NETosis and to preserve microvascular endothelial barrier function, thus reducing the severity of ALI in mice. Our data demonstrated that phenylarsine oxide (PAO) treatment of neutrophils caused increased intracellular Ca2+-associated PAD4 activity. A dermal chemical burn by lewisite or PAO resulted in PAD4 activation, NETosis, and ALI. NETs disrupted the barrier function of endothelial cells in human lung microvascular endothelial cell spheroids. Citrullinated histone 3 alone caused ALI in mice. Pharmacologic or genetic abrogation of PAD4 inhibited lung injury following cutaneous chemical burns. Cutaneous burns by lewisite and PAO caused ALI by PAD4-mediated NETosis. PAD4 inhibitors may have potential as countermeasures to suppress detrimental lung injury after chemical burns.
C1 [Surolia, Ranu; Li, Fu Jun; Wang, Zheng; Singh, Pooja; Dsouza, Kevin G.; Zmijewski, Jaroslaw W.; Antony, Veena B.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care, Dept Med, Birmingham, AL, United States.
   [Kashyap, Mahendra; Srivastava, Ritesh Kumar; Athar, Mohammad] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL, United States.
   [Traylor, Amie M.; Agarwal, Anupam] Univ Alabama Birmingham, Div Nephrol, Dept Med, Birmingham, AL, United States.
   [Kim, Harrison] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL, United States.
   [Pittet, Jean-Francois; Ahmad, Aftab] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL, United States.
   [Agarwal, Anupam] Dept Vet Affairs, Birmingham, AL, United States.
C3 University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham
RP Antony, VB (corresponding author), 1530 3rd Ave South,THT-541, Birmingham, AL 35294 USA.
EM vantony@uabmc.edu
RI singh, pooja/HLQ-3856-2023
OI Pittet, Jean-Francois/0000-0002-2196-9289; singh,
   pooja/0000-0003-4167-5314; Ahmad, Aftab/0000-0003-0686-0987
FU CounterACT Program [U54ES030246]; National Institutes of Health Office
   of the Director [R01 ES029981]; National Institute of Environmental
   Health Sciences, NIH [P42ES027723]
FX This work was funded by grants from the CounterACT Program, grants
   U54ES030246 (to VBA, A Ahmad, A Agarwal, and MA); the National
   Institutes of Health Office of the Director, grant R01 ES029981 (to
   VBA); and the National Institute of Environmental Health Sciences, NIH,
   grant P42ES027723 (to VBA). We thank Yuanyuan Gao for technical
   assistance with the animal exposure experiments. We thank Weng Zhiping
   for communication assistance with MRIGlobal for the lewisite exposure
   experiments. We also thank Jada Bibb for technical assistance during
   neutrophil isolation. We thank Melissa Climanto and Edward Phillip for
   the electron microscopy sample preparations and imaging and Robert
   Grabski for confocal microscopy at the High Resolution Imaging Facility
   at the UAB.
CR Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8
   Afshar M, 2019, ANN SURG, V270, P1186, DOI 10.1097/SLA.0000000000002795
   Ainsworth CR, 2018, BURNS, V44, P1433, DOI 10.1016/j.burns.2018.05.008
   Allam R, 2013, EUR J IMMUNOL, V43, P3336, DOI 10.1002/eji.201243224
   Altrichter J, 2010, EUR J TRAUMA EMERG S, V36, P551, DOI 10.1007/s00068-010-0013-1
   *AM BURN ASS, BURN INC TREATM US
   Belenkiy SM, 2014, J TRAUMA ACUTE CARE, V76, P821, DOI 10.1097/TA.0b013e3182aa2d21
   Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035
   Biron BM, 2017, J INNATE IMMUN, V9, P22, DOI 10.1159/000448808
   Brahmajosyula M, 2013, ZYGOTE, V21, P314, DOI 10.1017/S0967199411000633
   Calum H, 2014, METHODS MOL BIOL, V1149, P793, DOI 10.1007/978-1-4939-0473-0_60
   Chiu TW, 2006, CLIN CHEM LAB MED, V44, P13, DOI 10.1515/CCLM.2006.003
   Cho CF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15623
   Clemens RA, 2015, J LEUKOCYTE BIOL, V98, P497, DOI 10.1189/jlb.2MR1114-573R
   DOERSCHUK CM, 1987, J APPL PHYSIOL, V63, P1806, DOI 10.1152/jappl.1987.63.5.1806
   Douda DN, 2015, P NATL ACAD SCI USA, V112, P2817, DOI 10.1073/pnas.1414055112
   Doussiere J, 1998, EUR J BIOCHEM, V251, P649, DOI 10.1046/j.1432-1327.1998.2510649.x
   Epelman S, 2015, NAT REV IMMUNOL, V15, P117, DOI 10.1038/nri3800
   Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107
   Garner H, 2017, SCIENCE, V358, P42, DOI 10.1126/science.aap8361
   Ghari F, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501257
   Grassle S, 2014, ARTERIOSCL THROM VAS, V34, P1382, DOI 10.1161/ATVBAHA.113.303016
   Greenberg MI, 2016, CLIN TOXICOL, V54, P79, DOI 10.3109/15563650.2015.1121272
   Hirano S, 2003, ARCH TOXICOL, V77, P305, DOI 10.1007/s00204-003-0447-x
   Huang H, 2015, HEPATOLOGY, V62, P600, DOI 10.1002/hep.27841
   Jorch SK, 2017, NAT MED, V23, P279, DOI 10.1038/nm.4294
   Kaufman T, 2017, CLIN IMMUNOL, V183, P254, DOI 10.1016/j.clim.2017.08.014
   Khan MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep41749
   Knuckley B, 2010, BIOCHEMISTRY-US, V49, P4852, DOI 10.1021/bi100363t
   Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399
   Koushik S, 2017, EXPERT OPIN THER TAR, V21, P433, DOI 10.1080/14728222.2017.1294160
   Krebs J, 2015, BIOCHEM BIOPH RES CO, V460, P114, DOI 10.1016/j.bbrc.2015.02.004
   Lee RC, 1996, BURNS, V22, P509, DOI 10.1016/0305-4179(96)00051-4
   Lewis HD, 2015, NAT CHEM BIOL, V11, P189, DOI 10.1038/nchembio.1735
   Li CZ, 2016, AM J PATHOL, V186, P2637, DOI 10.1016/j.ajpath.2016.06.012
   Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239
   Li YQ, 2014, SURGERY, V156, P229, DOI 10.1016/j.surg.2014.04.009
   Mackay LS, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-23
   Manzoor S, 2020, ANN NY ACAD SCI, V1479, P210, DOI 10.1111/nyas.14346
   Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498
   Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST
   Meegan JE, 2018, BIOCHEM BIOPH RES CO, V503, P1498, DOI 10.1016/j.bbrc.2018.07.069
   Moore FA, 1996, J TRAUMA, V40, P501, DOI 10.1097/00005373-199604000-00001
   Munro NB, 1999, ENVIRON HEALTH PERSP, V107, P933, DOI 10.1289/ehp.99107933
   Najmeh S, 2015, JOVE-J VIS EXP, DOI 10.3791/52687
   Oh Hana, 2008, J Vis Exp, DOI 10.3791/745
   Ojima M, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00444-5
   Oromendia C, 2018, ANN AM THORAC SOC, V15, P998, DOI 10.1513/AnnalsATS.201803-192RL
   Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105
   Peiseler M, 2019, J CLIN INVEST, V129, P2629, DOI 10.1172/JCI124616
   Reilly JP, 2019, SEMIN RESP CRIT CARE, V40, P19, DOI 10.1055/s-0039-1684049
   Rezoagli E, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.62
   Rodrigues SF, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.978720
   Roussin A, 1997, EUR J PHARMACOL, V322, P91, DOI 10.1016/S0014-2999(96)00988-0
   Sakuma M, 2019, FASEB J, V33, P13602
   Sanderson H, 2014, J HAZARD MATER, V279, P518, DOI 10.1016/j.jhazmat.2014.06.073
   Shin HJ, 2017, J THORAC DIS, V9, pE17, DOI 10.21037/jtd.2017.01.45
   Siemiatkowski A, 2000, HAEMOSTASIS, V30, P189
   Silva L, 2016, Ann Burns Fire Disasters, V29, P178
   Srivastava RK, 2016, SCI REP-UK, V6, DOI 10.1038/srep34865
   Sun B, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129687
   Surolia R, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123253
   Surolia R, 2015, AM J PHYSIOL-LUNG C, V309, pL280, DOI 10.1152/ajplung.00097.2015
   Villar J, 2014, CURR OPIN CRIT CARE, V20, P3, DOI 10.1097/MCC.0000000000000057
   Wang JP, 2005, BIOCHEM PHARMACOL, V69, P1225, DOI 10.1016/j.bcp.2005.01.013
   Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072
   Ward CM, 1997, THROMB RES, V86, P469, DOI 10.1016/S0049-3848(97)00096-0
   WATERS LL, 1945, SCIENCE, V102, P601, DOI 10.1126/science.102.2659.601
   Yoo DG, 2014, J IMMUNOL, V192, P4728, DOI 10.4049/jimmunol.1301589
   Zhao T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36696
NR 70
TC 16
Z9 16
U1 2
U2 4
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD MAY 24
PY 2021
VL 6
IS 10
AR e147564
DI 10.1172/jci.insight.147564
PG 18
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA SG5UU
UT WOS:000653507400024
PM 34027893
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Salimi, U
   Menden, HL
   Mabry, SM
   Xia, S
   Sampath, V
AF Salimi, Umar
   Menden, Heather L.
   Mabry, Sherry M.
   Xia, Sheng
   Sampath, Venkatesh
TI Angiopoietin-1 protects against endotoxin-induced neonatal lung injury
   and alveolar simplification in mice
SO PEDIATRIC RESEARCH
LA English
DT Article
ID MULTIPLE-ORGAN DYSFUNCTION; KAPPA-B; EXPRESSION; TIE2; CONTRIBUTE;
   SURVIVAL; INFANTS; SEPSIS
AB Background Sepsis in premature newborns is a risk factor for bronchopulmonary dysplasia (BPD), but underlying mechanisms of lung injury remain unclear. Aberrant expression of endothelial cell (EC) angiopoietin 2 (ANGPT2) disrupts angiopoietin 1 (ANGPT1)/TIE2-mediated endothelial quiescence, and is implicated in sepsis-induced acute respiratory distress syndrome in adults. We hypothesized that recombinant ANGPT1 will mitigate sepsis-induced ANGPT2 expression, inflammation, acute lung injury (ALI), and alveolar remodeling in the saccular lung. Methods Effects of recombinant ANGPT1 on lipopolysaccharide (LPS)-induced endothelial inflammation were evaluated in human pulmonary microvascular endothelial cells (HPMEC). ALI and long-term alveolar remodeling were assessed in newborn mice exposed to intraperitoneal LPS and recombinant ANGPT1 pretreatment. Results LPS dephosphorylated EC TIE2 in association with increased ANGPT2 in vivo and in vitro. ANGPT1 suppressed LPS and ANGPT2-induced EC inflammation in HPMEC. Neonatal mice treated with LPS had increased lung cytokine expression, neutrophilic influx, and cellular apoptosis. ANGPT1 pre-treatment suppressed LPS-induced lung Toll-like receptor signaling, inflammation, and ALI. LPS-induced acute increases in metalloproteinase 9 expression and elastic fiber breaks, as well as a long-term decrease in radial alveolar counts, were mitigated by ANGPT1. Conclusions In an experimental model of sepsis-induced BPD, ANGPT1 preserved endothelial quiescence, inhibited ALI, and suppressed alveolar simplification. Impact
   Key message: Angiopoietin 1 inhibits LPS-induced neonatal lung injury and alveolar remodeling. Additions to existing literature: Demonstrates dysregulation of angiopoietin-TIE2 axis is important for sepsis- induced acute lung injury and alveolar simplification in experimental BPD. Establishes recombinant Angiopoietin 1 as an anti-inflammatory therapy in BPD.
   Impact: Angiopoietin 1-based interventions may represent novel therapies for mitigating sepsis-induced lung injury and BPD in premature infants.
C1 [Salimi, Umar] Childrens Mercy Kansas City, Div Pediat Crit Care, Dept Pediat, Kansas City, MO, United States.
   [Menden, Heather L.; Mabry, Sherry M.; Xia, Sheng; Sampath, Venkatesh] Childrens Mercy Kansas City, Dept Pediat, Div Neonatol, Kansas City, KS 64108, United States.
   [Menden, Heather L.; Mabry, Sherry M.; Xia, Sheng; Sampath, Venkatesh] Childrens Mercy Res Inst, Neonatal Dis Res Program, Kansas City, KS 64108, United States.
C3 Children's Mercy Hospital
RP Sampath, V (corresponding author), Childrens Mercy Kansas City, Dept Pediat, Div Neonatol, Kansas City, KS 64108 USA.; Sampath, V (corresponding author), Childrens Mercy Res Inst, Neonatal Dis Res Program, Kansas City, KS 64108 USA.
EM vsampath@cmh.edu
OI Salimi, Umar/0000-0001-6124-9086
FU Little Giraffe Foundation; Little Giraffe Foundation pilot grant (US); 
   [1R01HL128374-01]
FX We thank Dr. Wei Yu and Dr. Chris Nitkin from Children's Mercy Kansas
   City for their support with histologic and molecular techniques. We
   thank Dr. Nitkin, Dr. Yong Yun Han, and Dr. Geoffrey Allen from
   Children's Mercy for their intellectual contributions. We wish to thank
   the Little Giraffe Foundation for grant support. Supported by
   1R01HL128374-01 (VS) and Little Giraffe Foundation pilot grant (US).
CR Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X
   Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494
   Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12
   Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004
   COONEY TP, 1982, THORAX, V37, P580, DOI 10.1136/thx.37.8.580
   David S, 2012, CRIT CARE MED, V40, P3034, DOI 10.1097/CCM.0b013e31825fdc31
   David S, 2011, CYTOKINE, V55, P251, DOI 10.1016/j.cyto.2011.04.005
   Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714
   Hakanpaa L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6962
   Hato T, 2009, BIOCHEM BIOPH RES CO, V381, P218, DOI 10.1016/j.bbrc.2009.02.030
   Hegeman MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015653
   Houghton AM, 2015, MATRIX BIOL, V44-46, P167, DOI 10.1016/j.matbio.2015.02.002
   Hughes DP, 2003, CIRC RES, V92, P630, DOI 10.1161/01.RES.0000063422.38690.DC
   Huppert LA, 2019, SEMIN RESP CRIT CARE, V40, P31, DOI 10.1055/s-0039-1683996
   Iosef C, 2012, AM J PHYSIOL-LUNG C, V302, pL1023, DOI 10.1152/ajplung.00230.2011
   Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24
   Kim M, 2016, J CLIN INVEST, V126, P3511, DOI 10.1172/JCI84871
   Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009
   Korhonen EA, 2016, J CLIN INVEST, V126, P3495, DOI 10.1172/JCI84923
   Kumpers P, 2009, CRIT CARE, V13, DOI 10.1186/cc7866
   Leligdowicz A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00838
   Liang Fei, 2011, Zhonghua Er Ke Za Zhi, V49, P834
   Lignelli E, 2019, AM J PHYSIOL-LUNG C, V317, pL832, DOI 10.1152/ajplung.00369.2019
   McCarter SD, 2007, AM J RESP CRIT CARE, V175, P1014, DOI 10.1164/rccm.200609-1370OC
   McKenna S, 2017, PEDIATR RES, V82, P1064, DOI 10.1038/pr.2017.182
   Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269
   Menden H, 2019, AM J PHYSIOL-LUNG C, V317, pL332, DOI 10.1152/ajplung.00247.2018
   Menden HL, 2016, AM J RESP CELL MOL, V55, P767, DOI 10.1165/rcmb.2016-0006OC
   Mofarrahi M, 2008, AM J PHYSIOL-LUNG C, V294, pL955, DOI 10.1152/ajplung.00449.2007
   OGDEN BE, 1983, CHEST, V83, pS31, DOI 10.1378/chest.83.5.31S
   Phanthanawiboon S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148564
   Sampath V, 2006, PEDIATR RES, V60, P663, DOI 10.1203/01.pdr.0000246071.50268.51
   Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653
   Shah J, 2015, AM J PERINAT, V32, P675, DOI 10.1055/s-0034-1393936
   Shahzad Tayyab, 2016, Mol Cell Pediatr, V3, P23, DOI 10.1186/s40348-016-0051-9
   Shrestha AK, 2019, AM J PHYSIOL-LUNG C, V316, pL229, DOI 10.1152/ajplung.00560.2017
   Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP
   Thomas W, 2011, PEDIATR PULM, V46, P777, DOI 10.1002/ppul.21435
   Thomas W, 2009, PEDIATR RES, V65, P468, DOI 10.1203/PDR.0b013e3181991f35
   Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E
   Wright JK, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1087-x
   Ying LH, 2018, AM J PHYSIOL-LUNG C, V315, pL66, DOI 10.1152/ajplung.00363.2017
NR 42
TC 4
Z9 4
U1 5
U2 12
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD MAY
PY 2022
VL 91
IS 6
BP 1405
EP 1415
DI 10.1038/s41390-021-01544-0
EA MAY 2021
PG 11
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 3Q1BU
UT WOS:000650068800001
PM 33980990
OA Green Accepted
DA 2023-08-21
ER

PT J
AU Quijada, H
   Bermudez, T
   Kempf, CL
   Valera, DG
   Garcia, AN
   Camp, SM
   Song, JH
   Franco, E
   Burt, JK
   Sun, B
   Mascarenhas, JB
   Burns, K
   Gaber, A
   Oita, RC
   Hernon, VR
   Barber, C
   Moreno-Vinasco, L
   Sun, XG
   Cress, AE
   Martin, D
   Liu, ZL
   Desai, AA
   Natarajan, V
   Jacobson, JR
   Dudek, SM
   Bime, C
   Sammani, S
   Garcia, JGN
AF Quijada, Hector
   Bermudez, Tadeo
   Kempf, Carrie L.
   Valera, Daniel G.
   Garcia, Alexander N.
   Camp, Sara M.
   Song, Jin H.
   Franco, Evelyn
   Burt, Jessica K.
   Sun, Belinda
   Mascarenhas, Joseph B.
   Burns, Kimberlie
   Gaber, Amir
   Oita, Radu C.
   Hernon, Vivian Reyes
   Barber, Christy
   Moreno-Vinasco, Liliana
   Sun, Xiaoguang
   Cress, Anne E.
   Martin, Diego
   Liu, Zhonglin
   Desai, Ankit A.
   Natarajan, Viswanathan
   Jacobson, Jeffrey R.
   Dudek, Steven M.
   Bime, Christian
   Sammani, Saad
   Garcia, Joe G. N.
TI Endothelial eNAMPT amplifies pre-clinical acute lung injury: efficacy of
   an eNAMPT-neutralising monoclonal antibody
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Article
ID COLONY-ENHANCING FACTOR; RESPIRATORY-DISTRESS-SYNDROME;
   MECHANICAL-STRESS; SPHINGOSINE 1-PHOSPHATE; MURINE MODELS; BIOMARKER;
   INFLAMMATION; EXPRESSION; CANDIDATE; MORTALITY
AB Rationale: The severe acute respiratory syndrome coronavirus 2/coronavirus disease 2019 pandemic has highlighted the serious unmet need for effective therapies that reduce acute respiratory distress syndrome (ARDS) mortality. We explored whether extracellular nicotinamide phosphoribosyltransferase (eNAMPT), a ligand for Toll-like receptor (TLR)4 and a master regulator of innate immunity and inflammation, is a potential ARDS therapeutic target. Methods: Wild-type C57BL/6J or endothelial cell (EC)-cNAMPT(-/-) knockout mice (targeted EC NAMPT deletion) were exposed to either a lipopolysaccharide (LPS)-induced ("one-hit") or a combined LPS/ ventilator ("two-hit")-induced acute inflammatory lung injury model. A NAMPT-specific monoclonal antibody (mAb) imaging probe (Tc-99m-ProNamptor) was used to detect NAMPT expression in lung tissues. Either an eNAMPT-neutralising goat polyclonal antibody (pAb) or a humanised monoclonal antibody (ALT-100 mAb) were used in vitro and in vivo. Results: Immunohistochemical, biochemical and imaging studies validated time-dependent increases in NAMPT lung tissue expression in both pre-clinical ARDS models. Intravenous delivery of either eNAMPTneutralising pAb or mAb significantly attenuated inflammatory lung injury (haematoxylin and eosin staining, bronchoalveolar lavage (BAL) protein, BAL polymorphonuclear cells, plasma interleukin-6) in both pre-clinical models. In vitro human lung EC studies demonstrated eNAMPT-neutralising antibodies (pAb, mAb) to strongly abrogate eNAMPT-induced TLR4 pathway activation and EC barrier disruption. In vivo studies in wild-type and EC-cNAMPT(-/-) mice confirmed a highly significant contribution of EC-derived NAMPT to the severity of inflammatory lung injury in both pre-clinical ARDS models. Conclusions: These findings highlight both the role of EC-derived eNAMPT and the potential for biologic targeting of the eNAMPT/TLR4 inflammatory pathway. In combination with predictive eNAMPT biomarker and NAMPT genotyping assays, this offers the opportunity to identify high-risk ARDS subjects for delivery of personalised medicine.
C1 [Quijada, Hector; Bermudez, Tadeo; Kempf, Carrie L.; Valera, Daniel G.; Camp, Sara M.; Song, Jin H.; Franco, Evelyn; Burt, Jessica K.; Mascarenhas, Joseph B.; Burns, Kimberlie; Gaber, Amir; Oita, Radu C.; Hernon, Vivian Reyes; Moreno-Vinasco, Liliana; Sun, Xiaoguang; Bime, Christian; Sammani, Saad; Garcia, Joe G. N.] Univ Arizona Hlth Sci, Dept Med, Tucson, AZ 85721, United States.
   [Garcia, Alexander N.] Univ Arizona Hlth Sci, Dept Radiat Oncol, Tucson, AZ 85721, United States.
   [Sun, Belinda] Univ Arizona Hlth Sci, Dept Pathol, Tucson, AZ 85721, United States.
   [Barber, Christy; Liu, Zhonglin] Univ Arizona Hlth Sci, Dept Med Imaging, Tucson, AZ 85721, United States.
   [Cress, Anne E.] Univ Arizona Hlth Sci, Dept Cellular & Mol Med, Tucson, AZ 85721, United States.
   [Martin, Diego] Houston Methodist Hosp, Res Inst, Houston, TX 77030, United States.
   [Desai, Ankit A.] Indiana Univ, Dept Med, Indianapolis, IN, United States.
   [Natarajan, Viswanathan; Jacobson, Jeffrey R.; Dudek, Steven M.] Univ Illinois, Dept Med, Chicago, IL, United States.
C3 University of Arizona; University of Arizona Health Sciences; University
   of Arizona; University of Arizona Health Sciences; University of
   Arizona; University of Arizona Health Sciences; University of Arizona;
   University of Arizona Health Sciences; University of Arizona; University
   of Arizona Health Sciences; The Methodist Hospital System; The Methodist
   Hospital - Houston; Indiana University System; Indiana University-Purdue
   University Indianapolis; University of Illinois System; University of
   Illinois Chicago; University of Illinois Chicago Hospital
RP Garcia, JGN (corresponding author), Univ Arizona Hlth Sci, 1295 N Martin Ave,Suite A274, Tucson, AZ 85721 USA.
EM skipgarcia@email.arizona.edu
RI SUN, XIAOGUANG/ACA-5558-2022
OI Gavilan-Martin, Diego/0000-0003-3712-8705; SONG,
   JIN/0000-0002-0123-2909; Cress, Anne/0000-0001-6194-0061
FU National Institutes of Health (NIH) /National Heart, Lung, and Blood
   Institute (NHLBI) [P01HL126609, R01HL094394, P01HL134610]
FX This work was supported by the National Institutes of Health (NIH)
   /National Heart, Lung, and Blood Institute (NHLBI) grants P01HL126609,
   R01HL094394 and P01HL134610. Funding information for this article has
   been deposited with the Crossref Funder Registry.
CR Adyshev DM, 2014, AM J RESP CELL MOL, V50, P409, DOI 10.1165/rcmb.2013-0292OC
   Bajwa EK, 2007, CRIT CARE MED, V35, P2484, DOI 10.1097/01.CCM.0000281852.36573.22
   Bajwa EK, 2007, CRIT CARE MED, V35, P1290, DOI 10.1097/01.CCM.0000260243.22758.4F
   Barber HB, 2014, P SPIE INT SOC OPT E, V9186
   Bime C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2697-x
   Camp SM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13135
   Denning NL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02536
   Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200
   Elangovan VR, 2016, PULM CIRC, V6, P539, DOI 10.1086/688761
   Fuller BM, 2014, SHOCK, V41, P378, DOI 10.1097/SHK.0000000000000142
   Gao L, 2007, TRANSL RES, V150, P18, DOI 10.1016/j.trsl.2007.02.007
   Garcia JGN, 2000, J APPL PHYSIOL, V89, P2333, DOI 10.1152/jappl.2000.89.6.2333
   Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450
   Geraci-Erck M, 2013, NAT SOC HIST 32 S PO, P1
   Goldman JL, 2014, PULM CIRC, V4, P280, DOI 10.1086/675991
   Gong T, 2020, NAT REV IMMUNOL, V20, P95, DOI 10.1038/s41577-019-0215-7
   Grigoryev DN, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r34
   Han L, 2014, PROC SPIE, V9214, DOI 10.1117/12.2066179
   Hong SB, 2008, AM J RESP CRIT CARE, V178, P605, DOI 10.1164/rccm.200712-1822OC
   Jagrosse ML, 2019, TRANSL RES, V214, P30, DOI 10.1016/j.trsl.2019.07.011
   Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641
   Kim EJ, 2010, MOL CARCINOGEN, V49, P672, DOI 10.1002/mc.20640
   Klohs J, 2008, STROKE, V39, P2845, DOI 10.1161/STROKEAHA.107.509844
   Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215
   Korhonen H, 2009, J EXP MED, V206, P411, DOI 10.1084/jem.20082150
   Lee KA, 2011, CHEST, V140, P382, DOI 10.1378/chest.10-3100
   Lee K, 2013, SCAND J INFECT DIS, V45, P760, DOI 10.3109/00365548.2013.797600
   Letsiou E, 2015, AM J PHYSIOL-LUNG C, V308, pL259, DOI 10.1152/ajplung.00323.2014
   Liu ZL, 2012, NUCL MED BIOL, V39, P905, DOI 10.1016/j.nucmedbio.2012.05.003
   Malaviya R, 2017, PHARMACOL THERAPEUT, V180, P90, DOI 10.1016/j.pharmthera.2017.06.008
   Malviya G, 2009, J NUCL MED, V50, P1683, DOI 10.2967/jnumed.108.059485
   Mathew G, 2015, INFLAMM RES, V64, P747, DOI 10.1007/s00011-015-0851-8
   Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS
   Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST
   Meyer NJ, 2009, FASEB J, V23, P1325, DOI 10.1096/fj.08-119073
   Miller BW, 2014, NUCL INSTRUM METH A, V767, P146, DOI 10.1016/j.nima.2014.05.070
   Mitra S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100169
   Moitra J, 2007, TRANSL RES, V150, P253, DOI 10.1016/j.trsl.2007.03.013
   Moreno-Vinasco L, 2014, AM J RESP CELL MOL, V51, P223, DOI 10.1165/rcmb.2012-0519OC
   O'Mahony DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051104
   Oakley C, 2019, THORAX, V74, P1120, DOI 10.1136/thoraxjnl-2019-213460
   Oita RC, 2018, AM J RESP CELL MOL, V59, P36, DOI 10.1165/rcmb.2017-0155OC
   Ouadi A, 2018, NUCL MED BIOL, V61, P21, DOI 10.1016/j.nucmedbio.2018.03.003
   Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC
   Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003
   Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f
   Rizzo AN, 2015, AM J PHYSIOL-LUNG C, V309, pL1294, DOI 10.1152/ajplung.00031.2015
   Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976
   Simon BA, 2006, AM J PHYSIOL-LUNG C, V291, pL851, DOI 10.1152/ajplung.00463.2005
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Sun XG, 2020, AM J RESP CELL MOL, V63, P92, DOI 10.1165/rcmb.2019-0164OC
   Sun XG, 2014, AM J RESP CELL MOL, V51, P660, DOI 10.1165/rcmb.2014-0117OC
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Ye SQ, 2005, MICROVASC RES, V70, P142, DOI 10.1016/j.mvr.2005.08.003
   Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC
   Zambon M, 2008, CHEST, V133, P1120, DOI 10.1378/chest.07-2134
   Zhang Q, 2015, ONCOL LETT, V9, P1231, DOI 10.3892/ol.2014.2807
NR 59
TC 40
Z9 40
U1 2
U2 7
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD MAY 1
PY 2021
VL 57
IS 5
AR 2002536
DI 10.1183/13993003.02536-2020
PG 15
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA RZ5QU
UT WOS:000648652300003
PM 33243842
OA hybrid, Green Published
DA 2023-08-21
ER

PT J
AU Feng, ZY
   Zhou, J
   Liu, YH
   Xia, RX
   Li, Q
   Yan, L
   Chen, Q
   Chen, XB
   Jiang, YX
   Chao, G
   Wang, M
   Zhou, GR
   Zhang, YJ
   Wang, YS
   Xia, HP
AF Feng, Zunyong
   Zhou, Jing
   Liu, Yinhua
   Xia, Ruixue
   Li, Qiang
   Yan, Liang
   Chen, Qun
   Chen, Xiaobing
   Jiang, Yuxin
   Chao, Gao
   Wang, Ming
   Zhou, Guoren
   Zhang, Yijie
   Wang, Yongsheng
   Xia, Hongping
TI Epithelium- and endothelium-derived exosomes regulate the alveolar
   macrophages by targeting RGS1 mediated calcium signaling-dependent
   immune response
SO CELL DEATH AND DIFFERENTIATION
LA English
DT Article
AB Alveolar macrophages (AM) maintain airway immune balance; however, the regulation of heterogeneity of AMs is incompletely understood. We demonstrate that RGS1 coregulates the immunophenotype of AM subpopulations, including pro- and anti-inflammatory, injury- and repair-associated, and pro- and antifibrotic phenotypes, through the PLC-IP3R signal-dependent intracellular Ca2+ response. Flt3(+) AMs and Tie2(+) AMs had different immune properties, and RGS1 expression in the cells was targeted by exosomes (EXOs) containing miR-223 and miR-27b-3p that were derived from vascular endothelial cells (EnCs) and type II alveolar epithelial cells (EpCs-II), respectively. Imbalance of AMs was correlated with acute lung injury/acute respiratory distress syndrome (ALI/ARDS) and pulmonary fibrosis (PF) caused a lack of secretion of CD31(+) and CD74(+) EXOs derived from EnCs and EpCs-II. Timely treatment with EXOs significantly improved endotoxin-induced ALI/ARDS and bleomycin-induced PF in mice. Thus, EnC- and EpC-II-derived EXOs regulate the immune balance of AMs and can be used as potential therapeutic drugs.
C1 [Feng, Zunyong; Xia, Hongping] Nanjing Med Univ, Sch Basic Med Sci, Dept Pathol, Nanjing, China.
   [Feng, Zunyong; Xia, Hongping] Nanjing Med Univ, Sir Run Run Hosp, Nanjing, China.
   [Feng, Zunyong; Xia, Hongping] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, China.
   [Feng, Zunyong; Xia, Hongping] Nanjing Med Univ, Key Lab Antibody Tech, Natl Hlth Commiss, Nanjing, China.
   [Feng, Zunyong; Zhou, Jing; Liu, Yinhua; Xia, Hongping] Warman Med Coll, Affiliated Yijishan Hosp 1, Dept Pathol, Wuhu, China.
   [Feng, Zunyong; Zhou, Jing; Liu, Yinhua; Xia, Hongping] Warman Med Coll, Anhui Higher Educ Inst, Key Lab Noncoding RNA Transformat Res, Wuhu, China.
   [Feng, Zunyong; Xia, Hongping] Southeast Univ Nanjing Med Univ, Interdisciplinary Innovat Inst Med & Engn, Nanjing, China.
   [Xia, Ruixue; Zhang, Yijie; Xia, Hongping] Henan Univ, Huaihe Hosp, Dept Resp & Crit Care Med, Kaifeng, China.
   [Li, Qiang] Wannan Med Coll, Dept Anat, Wuhu, China.
   [Yan, Liang] Wannan Med Coll, Dept Biochem & Mol Biol, Wuhu, China.
   [Chen, Qun] Wannan Med Coll, Affiliated Yijishan Hosp, Dept Intens Care Unit, Wuhu, China.
   [Chen, Xiaobing] Zhengzhou Univ, Affiliated Canc Hosp, Dept Med Oncol, Zhengzhou, China.
   [Jiang, Yuxin] Jiaxing Univ, Sch Med, Dept Pathogen Biol & Immunol, Jiaxing, China.
   [Chao, Gao] Xi An Jiao Tong Univ, Honghui Hosp, Dept Microsurg, Xian, China.
   [Wang, Ming] Cent South Univ, Xiangya Hosp 2, Dept Neurosurg, Changsha, China.
   [Zhou, Guoren; Xia, Hongping] Nanjing Med Univ, Jiangsu Canc Hosp, Affiliated Canc Hosp, Jiangsu Inst Canc Res, Nanjing, China.
   [Wang, Yongsheng] Nanjing Univ, Med Sch, Dept Resp Med, Affiliated Drum Tower Hosp, Nanjing, China.
C3 Nanjing Medical University; Nanjing Medical University; Nanjing Medical
   University; Nanjing Medical University; Henan University; Wannan Medical
   College; Wannan Medical College; Wannan Medical College; Zhengzhou
   University; Jiaxing University; Xi'an Jiaotong University; Central South
   University; Nanjing Medical University; Nanjing University
RP Xia, HP (corresponding author), Nanjing Med Univ, Sch Basic Med Sci, Dept Pathol, Nanjing, Peoples R China.; Xia, HP (corresponding author), Nanjing Med Univ, Sir Run Run Hosp, Nanjing, Peoples R China.; Xia, HP (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Peoples R China.; Xia, HP (corresponding author), Nanjing Med Univ, Key Lab Antibody Tech, Natl Hlth Commiss, Nanjing, Peoples R China.; Xia, HP (corresponding author), Warman Med Coll, Affiliated Yijishan Hosp 1, Dept Pathol, Wuhu, Peoples R China.; Xia, HP (corresponding author), Warman Med Coll, Anhui Higher Educ Inst, Key Lab Noncoding RNA Transformat Res, Wuhu, Peoples R China.; Xia, HP (corresponding author), Southeast Univ Nanjing Med Univ, Interdisciplinary Innovat Inst Med & Engn, Nanjing, Peoples R China.; Zhang, YJ; Xia, HP (corresponding author), Henan Univ, Huaihe Hosp, Dept Resp & Crit Care Med, Kaifeng, Peoples R China.; Zhou, GR; Xia, HP (corresponding author), Nanjing Med Univ, Jiangsu Canc Hosp, Affiliated Canc Hosp, Jiangsu Inst Canc Res, Nanjing, Peoples R China.; Wang, YS (corresponding author), Nanjing Univ, Med Sch, Dept Resp Med, Affiliated Drum Tower Hosp, Nanjing, Peoples R China.
EM zhouguoren888@126.com; 13903782431@163.com; dolphin8012@yahoo.com;
   xiahongping@njmu.edu.cn
RI zhang, shuai/IVU-7877-2023; wang, qiang/IZW-1751-2023; Lu,
   Jianhong/IYT-3322-2023
OI Zhou, Guoren/0000-0001-5344-8480
FU National Natural Science Foundation of China [81800082, 81802651,
   81172790, 81671586]; Recruitment Program of Overseas High-Level Young
   Talents, "Innovative and Entrepreneurial Team" [(2018)2015]; Science and
   Technology Grant of Jiangsu Province [BE2019758]; Six Talent Peaks
   Project of Jiangsu Province [TD-SWYY-007]; High-Level Talents Program of
   Nanjing Medical University; Nanjing Drum Tower Hospital; "Peak" Training
   Program for Scientific Research of Yijishan Hospital, Wannan Medical
   College [GF2019G19]; Medical Interdisciplinary Research Funding of Henan
   University [CJ1205A0240011]
FX This study was supported by the National Natural Science Foundation of
   China (81800082, 81802651, 81172790, and 81671586) and the grants from
   The Recruitment Program of Overseas High-Level Young Talents,
   "Innovative and Entrepreneurial Team" (No.(2018)2015), Science and
   Technology Grant (BE2019758) and the Six Talent Peaks Project
   (TD-SWYY-007) of Jiangsu Province and High-Level Talents Program of
   Nanjing Medical University; Funding of Postdoctoral Funding of Nanjing
   Drum Tower Hospital Affiliated to Medical School of Nanjing University,
   and "Peak" Training Program for Scientific Research of Yijishan
   Hospital, Wannan Medical College (No.GF2019G19); The Medical
   Interdisciplinary Research Funding of Henan University (No.
   CJ1205A0240011).
CR Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014
   *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00
   Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967
   Barnes PJ, 2016, J ALLERGY CLIN IMMUN, V138, P16, DOI 10.1016/j.jaci.2016.05.011
   Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675
   Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021
   Chen G, 2018, NATURE, V560, P382, DOI 10.1038/s41586-018-0392-8
   Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868
   Chevillet JR, 2014, P NATL ACAD SCI USA, V111, P14888, DOI 10.1073/pnas.1408301111
   Chin AC, 2007, ANNU REV PATHOL-MECH, V2, P111, DOI 10.1146/annurev.pathol.2.010506.091944
   Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075
   Dagvadorj J, 2015, IMMUNITY, V42, P640, DOI 10.1016/j.immuni.2015.03.007
   de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO
   EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978
   Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013
   Feng ZY, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.549
   Fricker M, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00196-2017
   Gibbings SL, 2015, BLOOD, V126, P1357, DOI 10.1182/blood-2015-01-624809
   Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637
   Greening DW, 2015, METHODS MOL BIOL, V1295, P179, DOI 10.1007/978-1-4939-2550-6_15
   Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199
   Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619
   Ha D, 2016, ACTA PHARM SIN B, V6, P287, DOI 10.1016/j.apsb.2016.02.001
   Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017
   Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028
   Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793
   Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999
   Laterre PF, 2007, CRIT CARE, V11, DOI 10.1186/cc6156
   Lee H, 2019, J CONTROL RELEASE, V294, P43, DOI 10.1016/j.jconrel.2018.12.008
   Lee H, 2018, J IMMUNOL, V201, P1500, DOI 10.4049/jimmunol.1800264
   Lee JH, 2013, AM J RESP CELL MOL, V48, P288, DOI 10.1165/rcmb.2011-0403OC
   Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647
   Liu SS, 2019, IMMUNITY, V51, P522, DOI 10.1016/j.immuni.2019.06.014
   Marsh LM, 2009, AM J PHYSIOL-LUNG C, V296, pL442, DOI 10.1152/ajplung.00525.2007
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x
   Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639
   Molyneaux PL, 2014, AM J RESP CRIT CARE, V190, P906, DOI 10.1164/rccm.201403-0541OC
   Mora AL, 2017, NAT REV DRUG DISCOV, V16, DOI [10.1038/nrd.2017.225, 10.1038/nrd.2017.170]
   Moratz C, 2004, MOL CELL BIOL, V24, P5767, DOI 10.1128/MCB.24.13.5767-5775.2004
   Neudecker V, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5360
   Nova Z, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040831
   Patel J, 2017, CIRCULATION, V135, P786, DOI 10.1161/CIRCULATIONAHA.116.024754
   Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989
   Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925
   PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711
   Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051
   Serrano-Mollar A, 2016, CHEST, V150, P533, DOI 10.1016/j.chest.2016.03.021
   Sinha Meenal, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.2013
   Squires KE, 2018, PHARMACOL REV, V70, P446, DOI 10.1124/pr.117.015354
   Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004
   Vannella KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004372
   Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015
   Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001
   Zhang D, 2018, MOL THER, V26, P2119, DOI 10.1016/j.ymthe.2018.06.007
NR 59
TC 20
Z9 21
U1 2
U2 32
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1350-9047
EI 1476-5403
J9 CELL DEATH DIFFER
JI Cell Death Differ.
PD JUL
PY 2021
VL 28
IS 7
BP 2238
EP 2256
DI 10.1038/s41418-021-00750-x
EA MAR 2021
PG 19
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA TE4MJ
UT WOS:000631489600001
PM 33753901
OA Green Published, Bronze
DA 2023-08-21
ER

PT J
AU Chen, Y
   Wei, D
   Zhao, J
   Xu, XN
   Chen, JY
AF Chen, Yin
   Wei, Dong
   Zhao, Jin
   Xu, Xiangnan
   Chen, Jingyu
TI Reduction of hyperoxic acute lung injury in mice by Formononetin
SO PLOS ONE
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; EXPRESSION; PROTECTS; SEPSIS; RATS
AB Background
   The antioxidant and anti-inflammatory features of Formononetin, an isoflavone constituent extracted from traditional Chinese medicine, have been reported. The present study investigated that whether Formononetin plays a benefit on hyperoxic ALI.
   Methods
   C57BL/6 mice were exposed to hyperoxia for 72 h to produce experimental hyperoxic ALI model. Formononetin or vehicle was administrated intraperitoneally. Samples from the lung were collected at 72 h post hyperoxia exposure for further study. Pulmonary microvascular endothelial cells isolated from the lung of C57BL/6 mice were used for in vitro study.
   Results
   Formononetin pretreatment notably attenuated hyperoxia-induced elevating pulmonary water content, upregulation of proinflammatory cytokine levels and increasing infiltration of neutrophil in the lung. Western blot analyses showed that Formononetin enhanced the expression of nuclear factor erythroid-2-related factor 2 (Nrf2) which is a key transcription factor regulating the expression of heme oxygenase-1 (HO-1). Formononetin increased HO-1 expression and activity compared with vehicle-treated animals. Moreover, Formononetin reversed hyperoxia-caused the reduction of M2 macrophage polarization. However, pretreatment of a HO-1 inhibitor reduced the protective effect of Formononetin on hyperoxic ALI. Cell study showed that the Formononetin-induced upregulation of HO-1 was abolished when the Nrf2 was silenced.
   Conclusions
   Formononetin pretreatment reduces hyperoxia-induced ALI via Nrf2/HO-1-mediated antioxidant and anti-inflammatory effects.
C1 [Chen, Yin; Wei, Dong; Zhao, Jin; Chen, Jingyu] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Thorac Surg, Wuxi, Jiangsu, China.
   [Chen, Yin; Xu, Xiangnan] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Thorac Surg, Shanghai, China.
C3 Jiangnan University; Nanjing Medical University; Shanghai Jiao Tong
   University
RP Chen, JY (corresponding author), Nanjing Med Univ, Wuxi Peoples Hosp, Dept Thorac Surg, Wuxi, Jiangsu, Peoples R China.
EM chenjingyu3332019@163.com
RI chen, jingyu/AAY-2275-2021
CR Aladaileh SH, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8100430
   Amata E, 2017, CLIN SCI, V131, P1701, DOI 10.1042/CS20170157
   Belchamber KBR, 2017, RESULTS PROBL CELL D, V62, P299, DOI 10.1007/978-3-319-54090-0_12
   Cheng C, 2007, MOL CELL BIOCHEM, V305, P1, DOI 10.1007/s11010-007-9521-7
   Cheng YY, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2060874
   Chi XJ, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0793-0
   COCHRANE CG, 1983, J CLIN INVEST, V71, P754, DOI 10.1172/JCI110823
   Constantin M, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/859235
   Fu XX, 2019, CNS NEUROL DISORD-DR, V18, P566, DOI 10.2174/1871527318666190807160137
   Gautam J, 2017, BRIT J NUTR, V117, P645, DOI 10.1017/S0007114517000149
   Jain D, 2008, AM J RESP CRIT CARE, V178, P805, DOI 10.1164/rccm.200804-582OC
   Jin F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170900
   Lee H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030813
   Li ZZ, 2018, BIOMED PHARMACOTHER, V106, P349, DOI 10.1016/j.biopha.2018.06.041
   Li ZZ, 2017, AM J TRANSL RES, V9, P5653
   Liang Y, 2019, PHYTOTHER RES, V33, P130, DOI 10.1002/ptr.6206
   Lu S, 2011, CHIN J INTEGR MED, V17, P473, DOI 10.1007/s11655-011-0756-5
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   Ma ZQ, 2013, INFLAMMATION, V36, P1560, DOI 10.1007/s10753-013-9700-5
   Mac Sweeney R, 2016, LANCET, V388, P2416, DOI 10.1016/S0140-6736(16)00578-X
   Montana G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167420
   Ryter SW, 2000, METH MOL B, V99, P369
   Safavian D, 2019, SHOCK, V51, P213, DOI 10.1097/SHK.0000000000001135
   Tao W, 2018, J TRAUMA ACUTE CARE, V85, P1102, DOI 10.1097/TA.0000000000002057
   Tao W, 2018, SHOCK, V50, P589, DOI 10.1097/SHK.0000000000001067
   Tao W, 2012, INFLAMMATION, V35, P150, DOI 10.1007/s10753-011-9300-1
   Wang LF, 2012, SHOCK, V37, P539, DOI 10.1097/SHK.0b013e31824dcb5a
   Wang Y, 2018, MED SCI MONITOR, V24, P3604, DOI 10.12659/MSM.910245
   Wu DC, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/3048532
   Wu YW, 2020, FASEB J, V34, P8028, DOI 10.1096/fj.202000313RR
   Xiong J, 2017, INT J MOL MED, V39, P113, DOI 10.3892/ijmm.2016.2809
   Yi L, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.533841
   Zhang M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120596
   Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834
   Zhang XC, 2006, FASEB J, V20, P2156, DOI 10.1096/fj.06-5668fje
   Zhao HL, 2017, AM J PHYSIOL-LUNG C, V312, pL155, DOI 10.1152/ajplung.00449.2016
NR 36
TC 7
Z9 7
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 7
PY 2021
VL 16
IS 1
AR e0245050
DI 10.1371/journal.pone.0245050
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA PS6NW
UT WOS:000608044300031
PM 33411783
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Evans, CE
   Iruela-Arispe, ML
   Zhao, YY
AF Evans, Colin E.
   Iruela-Arispe, M. Luisa
   Zhao, You-Yang
TI Mechanisms of Endothelial Regeneration and Vascular Repair and Their
   Application to Regenerative Medicine
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; ACUTE LUNG INJURY; BONE-MARROW; PROGENITOR
   CELLS; ADHERENS JUNCTIONS; BLOOD-FLOW; PROLIFERATION; INFLAMMATION;
   FIBROBLASTS; REENDOTHELIALIZATION
AB Endothelial barrier integrity is required for maintaining vascular homeostasis and fluid balance between the circulation and surrounding tissues and for preventing the development of vascular disease. Despite comprehensive understanding of the molecular mechanisms and signaling pathways that mediate endothelial injury, the regulatory mechanisms responsible for endothelial regeneration and vascular repair are incompletely understood and constitute an emerging area of research. Endogenous and exogenous reparative mechanisms serve to reverse vascular damage and restore endothelial barrier function through regeneration of a functional endothelium and re-engagement of endothelial junctions. In this review, mechanisms that contribute to endothelial regeneration and vascular repair are described. Targeting these mechanisms has the potential to improve outcome in diseases that are characterized by vascular injury, such as atherosclerosis, restenosis, peripheral vascular disease, sepsis, and acute respiratory distress syndrome. Future studies to further improve current understanding of the mechanisms that control endothelial regeneration and vascular repair are also highlighted.
C1 [Evans, Colin E.; Zhao, You-Yang] Ann & Robert H Lurie Childrens Hosp Chicago, Program Lung & Vasc Biol, Stanley Manne Childrens Res Inst, 225 E Chicago Ave,Box 205, Chicago, IL 60611, United States.
   [Evans, Colin E.; Zhao, You-Yang] Ann & Robert H Lurie Childrens Hosp Chicago, Sect Injury Repair & Regenerat, Stanley Manne Childrens Res Inst, Chicago, IL 60611, United States.
   [Evans, Colin E.; Zhao, You-Yang] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611, United States.
   [Iruela-Arispe, M. Luisa] Northwestern Univ, Feinberg Sch Med, Dept Cell & Dev Biol, Chicago, IL 60611, United States.
   [Iruela-Arispe, M. Luisa; Zhao, You-Yang] Northwestern Univ, Feinberg Cardiovasc & Renal Res Inst, Feinberg Sch Med, Chicago, IL 60611, United States.
   [Zhao, You-Yang] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611, United States.
   [Zhao, You-Yang] Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611, United States.
C3 Ann & Robert H. Lurie Children's Hospital of Chicago; Ann & Robert H.
   Lurie Children's Hospital of Chicago; Northwestern University; Feinberg
   School of Medicine; Northwestern University; Feinberg School of
   Medicine; Northwestern University; Feinberg School of Medicine;
   Northwestern University; Feinberg School of Medicine; Northwestern
   University; Feinberg School of Medicine
RP Zhao, YY (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Program Lung & Vasc Biol, Stanley Manne Childrens Res Inst, 225 E Chicago Ave,Box 205, Chicago, IL 60611 USA.
EM youyang.zhao@northwestern.edu
RI Iruela-Arispe, M. Luisa/AAJ-1297-2020
OI Iruela-Arispe, M. Luisa/0000-0002-3050-4168; ZHAO,
   YOU-YANG/0000-0002-0041-0339; Evans, Colin/0000-0002-9251-357X
FU NIH [R01HL148810, R01HL123957, R01HL133951, R01HL140409, R35HL140014];
   American Heart Association Career Development Award [19CDA34500000]
FX Supported in part by NIH grants R01HL148810 (Y.Y.Z.), R01HL123957
   (Y.Y.Z.), R01HL133951 (Y.Y.Z.), R01HL140409 (Y.Y.Z.), and R35HL140014
   (M.L.I.A); and American Heart Association Career Development Award
   19CDA34500000 (C.E.E.).
CR Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Bautch VL, 2011, NAT MED, V17, P1437, DOI 10.1038/nm.2539
   Bierhansl L, 2017, PHYSIOLOGY, V32, P126, DOI 10.1152/physiol.00031.2016
   Buchwald AB, 2006, J SURG RES, V136, P120, DOI 10.1016/j.jss.2006.06.011
   CALLOW AD, 1994, GROWTH FACTORS, V10, P223, DOI 10.3109/08977199409000240
   Cheung KCP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17329-8
   Cines DB, 1998, BLOOD, V91, P3527
   Creighton J, 2011, FASEB J, V25, P3356, DOI 10.1096/fj.10-179218
   De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC
   Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859
   Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709
   Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123
   Eyries M, 2008, CIRC RES, V103, P432, DOI 10.1161/CIRCRESAHA.108.179333
   Fang ST, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001407
   Fu PF, 2020, J BIOL CHEM, V295, P7669, DOI 10.1074/jbc.RA119.011801
   Galli D, 2005, ARTERIOSCL THROM VAS, V25, P692, DOI 10.1161/01.ATV.0000156402.52029.ce
   Ghani U, 2005, STROKE, V36, P151, DOI 10.1161/01.STR.0000149944.15406.16
   Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020
   Gold ES, 2012, J EXP MED, V209, P807, DOI 10.1084/jem.20111202
   Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011
   Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855
   Hagensen MK, 2012, CARDIOVASC RES, V93, P223, DOI 10.1093/cvr/cvr278
   Han JK, 2014, CIRCULATION, V130, P1168, DOI 10.1161/CIRCULATIONAHA.113.007727
   Huang XJ, 2019, AM J PATHOL, V189, P1664, DOI 10.1016/j.ajpath.2019.04.014
   Huang XJ, 2016, CIRCULATION, V133, P1093, DOI 10.1161/CIRCULATIONAHA.115.020918
   Huang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050094
   Huppert LA, 2019, TRANSFUSION, V59, P869, DOI 10.1111/trf.14835
   Hutter R, 2004, CIRCULATION, V110, P2430, DOI 10.1161/01.CIR.0000145120.37891.8A
   Imrie H, 2012, DIABETES, V61, P2359, DOI 10.2337/db11-1494
   Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057
   Ionescu L, 2012, AM J PHYSIOL-LUNG C, V303, pL967, DOI 10.1152/ajplung.00144.2011
   Isner JM, 2001, ANN NY ACAD SCI, V953, P75, DOI 10.1111/j.1749-6632.2001.tb02075.x
   Itoh Y, 2010, ARTERIOSCL THROM VAS, V30, P1725, DOI 10.1161/ATVBAHA.110.207365
   Iwasaki M, 2011, EUR HEART J, V32, P627, DOI 10.1093/eurheartj/ehq442
   Jansen F, 2013, CIRCULATION, V128, P2026, DOI 10.1161/CIRCULATIONAHA.113.001720
   Jian MY, 2016, AM J PHYSIOL-LUNG C, V310, pL71, DOI 10.1152/ajplung.00227.2015
   Jian MY, 2013, AM J PHYSIOL-LUNG C, V305, pL844, DOI 10.1152/ajplung.00173.2013
   Kaestner KH, 2000, GENE DEV, V14, P142
   Kalucka J, 2015, CELL CYCLE, V14, P3379, DOI 10.1080/15384101.2015.1090068
   Kawasaki T, 2015, AM J RESP CELL MOL, V53, P500, DOI 10.1165/rcmb.2014-0185OC
   Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652
   Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534
   Konishi H, 2007, J AM COLL CARDIOL, V49, P1099, DOI 10.1016/j.jacc.2006.10.068
   Kruse K, 2019, J CELL BIOL, V218, P299, DOI 10.1083/jcb.201802076
   Laurenzana A, 2015, J MOL MED, V93, P1145, DOI 10.1007/s00109-015-1292-0
   Lee JW, 2013, AM J RESP CRIT CARE, V187, P751, DOI 10.1164/rccm.201206-0990OC
   Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106
   Leroyer AS, 2008, J AM COLL CARDIOL, V52, P1302, DOI 10.1016/j.jacc.2008.07.032
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Liu ML, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10134-y
   Marcu R, 2018, ISCIENCE, V4, P20, DOI 10.1016/j.isci.2018.05.003
   Margariti A, 2012, P NATL ACAD SCI USA, V109, P13793, DOI 10.1073/pnas.1205526109
   Masoud AG, 2020, J CLIN INVEST, V130, P94, DOI 10.1172/JCI128469
   Matthay MA, 2019, LANCET RESP MED, V7, P154, DOI 10.1016/S2213-2600(18)30418-1
   McDonald AI, 2018, CELL STEM CELL, V23, P210, DOI 10.1016/j.stem.2018.07.011
   Medina RJ, 2017, STEM CELL TRANSL MED, V6, P1316, DOI 10.1002/sctm.16-0360
   Mei SHJ, 2010, AM J RESP CRIT CARE, V182, P1047, DOI 10.1164/rccm.201001-0010OC
   Mirza MK, 2010, J EXP MED, V207, P1675, DOI 10.1084/jem.20091857
   Miyagawa K, 2019, CIRC RES, V124, P211, DOI 10.1161/CIRCRESAHA.118.313374
   Morel O, 2009, HAEMATOL-HEMATOL J, V94, P313, DOI 10.3324/haematol.2009.003657
   Morita R, 2015, P NATL ACAD SCI USA, V112, P160, DOI 10.1073/pnas.1413234112
   Nakajima-Takagi Y, 2013, BLOOD, V121, P447, DOI 10.1182/blood-2012-05-431403
   Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905
   Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017
   Ohle SJ, 2012, AM J RESP CELL MOL, V47, P11, DOI 10.1165/rcmb.2011-0180OC
   Ostendorf T, 1999, J CLIN INVEST, V104, P913, DOI 10.1172/JCI6740
   Patel J, 2017, CIRCULATION, V135, P786, DOI 10.1161/CIRCULATIONAHA.116.024754
   Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105
   Rafat N, 2013, AM J RESP CELL MOL, V48, P399, DOI 10.1165/rcmb.2011-0132TR
   Rajput C, 2016, ARTERIOSCL THROM VAS, V36, P380, DOI 10.1161/ATVBAHA.115.306997
   Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005
   Ratcliffe P, 2017, HYPOXIA, V5, P11, DOI 10.2147/HP.S127042
   Ratcliffe PJ, 2007, J CLIN INVEST, V117, P862, DOI 10.1172/JCI31750
   Ren J, 2019, CIRC RES, V124, P1253, DOI 10.1161/CIRCRESAHA.118.314567
   Ross MD, 2018, CURR CARDIOL REV, V14, P233, DOI 10.2174/1573403X14666180726112303
   Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F
   Sandri M, 2016, EUR J PREV CARDIOL, V23, P349, DOI 10.1177/2047487315588391
   Schinkothe T, 2008, STEM CELLS DEV, V17, P199, DOI 10.1089/scd.2007.0175
   Schober A, 2014, NAT MED, V20, P368, DOI 10.1038/nm.3487
   Singhal M, 2018, J EXP MED, V215, P2497, DOI 10.1084/jem.20180008
   Slukvin II, 2018, CELL MOL LIFE SCI, V75, P3507, DOI 10.1007/s00018-018-2871-3
   Timmerman I, 2012, MOL BIOL CELL, V23, P4212, DOI 10.1091/mbc.E12-01-0038
   Torella D, 2004, AM J PHYSIOL-HEART C, V287, pH2850, DOI 10.1152/ajpheart.01119.2003
   Van der Heiden K, 2013, CARDIOVASC RES, V99, P269, DOI 10.1093/cvr/cvt090
   Vyalov S, 1996, AM J PATHOL, V149, P2107
   Wakabayashi T, 2018, CELL STEM CELL, V22, P384, DOI 10.1016/j.stem.2018.01.010
   Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c
   Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55
   Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002
   Wary KK, 2009, STEM CELLS, V27, P3112, DOI 10.1002/stem.241
   Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996
   Xu C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6758
   Yu BQ, 2016, STEM CELLS, V34, P2368, DOI 10.1002/stem.2410
   Zhang YM, 2009, FASEB J, V23, P1358, DOI 10.1096/fj.08-110296
   Zhao YDD, 2014, STEM CELLS, V32, P1855, DOI 10.1002/stem.1690
   Zhao YD, 2010, AM J PHYSIOL-LUNG C, V298, pL36, DOI 10.1152/ajplung.00064.2009
   Zhao YDD, 2009, CIRC RES, V105, P696, DOI 10.1161/CIRCRESAHA.109.199778
   Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154
NR 99
TC 41
Z9 44
U1 3
U2 39
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD JAN
PY 2021
VL 191
IS 1
BP 52
EP 65
DI 10.1016/j.ajpath.2020.10.001
PG 14
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA PL7GS
UT WOS:000603286100006
PM 33069720
OA Green Published, Bronze
DA 2023-08-21
ER

PT J
AU Gao, M
   Yu, TY
   Liu, D
   Shi, Y
   Yang, PL
   Zhang, J
   Wang, JZ
   Liu, Y
   Zhang, X
AF Gao, Min
   Yu, Tianyi
   Liu, Dan
   Shi, Yan
   Yang, Peilang
   Zhang, Jie
   Wang, Jizhuang
   Liu, Yan
   Zhang, Xiong
TI Sepsis plasma-derived exosomal miR-1-3p induces endothelial cell
   dysfunction by targeting SERP1
SO CLINICAL SCIENCE
LA English
DT Article
ID ACUTE LUNG INJURY; STRESS RESPONSES; PROLIFERATION; SUPPRESSES;
   CONTRIBUTES; MICRORNAS; MORTALITY; APOPTOSIS; INVASION; RECEPTOR
AB Acute lung injury (ALI) is the leading cause of death in sepsis patients. Exosomes participate in the occurrence and development of ALI by regulating endothelial cell inflammatory response, oxidative stress and apoptosis, causing serious pulmonary vascular leakage and interstitial edema. The current study investigated the effect of exosomal miRNAs on endothelial cells during sepsis. We found a significant increase in miR-1-3p expression in ce cal ligation and puncture (CLP) rats exosomes sequencing and sepsis patients' exosomes, and lipopolysaccharide (LPS)-stimulated human umbilical vein endothelial cells (HUVECs) in vitro. However, the specific biological function of miR-1-3p in ALI remains unknown. Therefore, mimics or inhibitors of miR-1-3p were transfected to modulate its expression in HUVECs. Cell proliferation, apoptosis, contraction, permeability, and membrane injury were examined via cell counting kit-8 (CCK-8), flow cytometry, phalloidin staining, Transwell assay, lactate dehydrogenase (LDH) activity, and Western blotting. The miR-1-3p target gene was predicted with miRNA-related databases and validated by luciferase reporter. Target gene expression was blocked by siRNA to explore the underlying mechanisms. The results illustrated increased miR-1-3p and decreased stress-associated endoplasmic reticulum protein 1 (SERP1) expression both in vivo and in vitro. SERP1 was a direct target gene of miR-1-3p. Up-regulated miR-1-3p inhibits cell proliferation, promotes apoptosis and cytoskeleton contraction, increases monolayer endothelial cell permeability and membrane injury by targeting SERP1, which leads to dysfunction of endothelial cells and weakens vascular barrier function involved in the development of ALI. MiR-1-3p and SERP1 may be promising therapeutic candidates for sepsis-induced lung injury.
C1 [Gao, Min; Yu, Tianyi; Liu, Dan; Shi, Yan; Yang, Peilang; Zhang, Jie; Wang, Jizhuang; Liu, Yan; Zhang, Xiong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Burns, Shanghai, China.
C3 Shanghai Jiao Tong University
RP Liu, Y; Zhang, X (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Burns, Shanghai, Peoples R China.
EM rjliuyan@126.com; xiong@medmail.com.cn
RI 刘, 琰/GVT-3050-2022
FU National Natural Science Foundation of China [81871564]; Shanghai
   Committee of Science and Technology, China [18ZR1423800]; Shanghai
   Collaborative Innovation Center for Translational Medical [TM201705];
   Clinical Key Specialty Project Foundation of Shanghai [shslczdzk02302]
FX This work was supported by the National Natural Science Foundation of
   China [grant number 81871564]; the Shanghai Committee of Science and
   Technology, China [grant number 18ZR1423800]; the Shanghai Collaborative
   Innovation Center for Translational Medical [grant number TM201705]; and
   the Clinical Key Specialty Project Foundation of Shanghai [grant number
   shslczdzk02302]. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abou El-Khier Noha T, 2019, Egypt J Immunol, V26, P105
   Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007
   Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bastida-Ruiz D, 2017, PLACENTA, V57, P163, DOI 10.1016/j.placenta.2017.07.004
   Buie JNJ, 2019, INFLAMMATION, V42, P170, DOI 10.1007/s10753-018-0882-8
   Cerutti C, 2017, EXP CELL RES, V358, P31, DOI 10.1016/j.yexcr.2017.06.003
   Chang CL, 2018, AM J TRANSL RES, V10, P1053
   Chevillet JR, 2014, MOLECULES, V19, P6080, DOI 10.3390/molecules19056080
   Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001
   Fang Y, 2017, AM J TRANSL RES, V9, P1287
   Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC
   Gao YS, 2021, COMPR PHYSIOL, V11, P1351, DOI 10.1002/cphy.c200006
   Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368
   Guan GP, 2019, N-S ARCH PHARMACOL, V392, P715, DOI 10.1007/s00210-019-01625-2
   Hashemian SM, 2020, MOL THER-NUCL ACIDS, V21, P51, DOI 10.1016/j.omtn.2020.05.012
   Im Y, 2020, J CELL MOL MED, V24, P9439, DOI 10.1111/jcmm.15606
   Jiang KF, 2019, MOL THER, V27, P1758, DOI 10.1016/j.ymthe.2019.07.003
   Jiao DM, 2018, J CELL MOL MED, V22, P3526, DOI 10.1111/jcmm.13629
   Ke J, 2019, EUR REV MED PHARMACO, V23, P8870, DOI 10.26355/eurrev_201910_19282
   Koole C, 2013, BIOCHEM SOC T, V41, P172, DOI 10.1042/BST20120236
   Li HX, 2015, EXP BIOL MED, V240, P1735, DOI 10.1177/1535370215591830
   Luo Q, 2020, INFLAMMATION, V43, P975, DOI 10.1007/s10753-020-01183-3
   Ma Q, 2017, INT J ONCOL, V51, P1104, DOI 10.3892/ijo.2017.4111
   Matsuyama H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010132
   McKelvey Kelly J, 2015, J Circ Biomark, V4, P7, DOI 10.5772/61186
   Meng L, 2019, FOLIA HISTOCHEM CYTO, V57, P168, DOI 10.5603/FHC.a2019.0019
   Mera S, 2011, APMIS, V119, P155, DOI 10.1111/j.1600-0463.2010.02705.x
   Miyashita T, 2016, IN VIVO, V30, P341
   Mori MA, 2019, CELL METAB, V30, P656, DOI 10.1016/j.cmet.2019.07.011
   Mucaj V, 2015, ONCOGENE, V34, P2204, DOI 10.1038/onc.2014.168
   Park EJ, 2019, CURR PHARM DESIGN, V25, P4486, DOI 10.2174/1381612825666191116125525
   Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862
   Raeven P, 2018, THERANOSTICS, V8, P3348, DOI 10.7150/thno.23453
   Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6
   Sevransky JE, 2009, CRIT CARE, V13, DOI 10.1186/cc8048
   Shang AQ, 2017, CELL PHYSIOL BIOCHEM, V41, P1179, DOI 10.1159/000464379
   Shapiro N, 2006, ANN EMERG MED, V48, P583, DOI 10.1016/j.annemergmed.2006.07.007
   Shi Q, 2017, TOXICOL APPL PHARM, V336, P8, DOI 10.1016/j.taap.2017.09.023
   Su G, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/5608382
   Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403
   Sysol JR, 2018, AM J PHYSIOL-LUNG C, V314, pL461, DOI 10.1152/ajplung.00057.2017
   Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855
   Thomas GW, 2012, BIOCHEM BIOPH RES CO, V421, P707, DOI 10.1016/j.bbrc.2012.04.066
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   Wang ZS, 2018, BIOCHEM CELL BIOL, V96, P355, DOI 10.1139/bcb-2017-0015
   Wu JJ, 2017, BBA-MOL BASIS DIS, V1863, P292, DOI 10.1016/j.bbadis.2016.10.024
   Xiao YY, 2017, J CELL BIOCHEM, V118, P3616, DOI 10.1002/jcb.26207
   Xu MY, 2020, LIFE SCI, V254, DOI 10.1016/j.lfs.2020.117746
   Zeng ZG, 2013, EXP LUNG RES, V39, P275, DOI 10.3109/01902148.2013.808285
   Zhan GH, 2019, ADV CLIN EXP MED, V28, P711, DOI 10.17219/acem/94163
   Zhang H, 2019, ONCOTARGETS THER, V12, P2149, DOI 10.2147/OTT.S197326
   Zhou Y, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2339-3
NR 53
TC 37
Z9 39
U1 1
U2 14
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FLR, 90 HIGH HOLBORN, LONDON WC1V 6LJ, ENGLAND
SN 0143-5221
EI 1470-8736
J9 CLIN SCI
JI Clin. Sci.
PD JAN
PY 2021
VL 135
IS 2
BP 347
EP 365
DI 10.1042/CS20200573
PG 19
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA QA5QM
UT WOS:000613498700005
PM 33416075
OA Green Published, hybrid
DA 2023-08-21
ER

PT J
AU Thompson, AF
   Moraes, L
   Rocha, NN
   Fernandes, MVS
   Antunes, MA
   Abreu, SC
   Santos, CL
   Capelozzi, VL
   Samary, CS
   de Abreu, MG
   Saddy, F
   Pelosi, P
   Silva, PL
   Rocco, PRM
AF Thompson, Alessandra F.
   Moraes, Lillian
   Rocha, Nazareth N.
   Fernandes, Marcos V. S.
   Antunes, Mariana A.
   Abreu, Soraia C.
   Santos, Cintia Lourenco
   Capelozzi, Vera Luiza
   Samary, Cynthia dos Santos
   de Abreu, Marcelo Gama
   Saddy, Felipe
   Pelosi, Paolo
   Silva, Pedro Leme
   Rocco, Patricia Rieken Macedo
TI Impact of different frequencies of controlled breath and
   pressure-support levels during biphasic positive airway pressure
   ventilation on the lung and diaphragm in experimental mild acute
   respiratory distress syndrome
SO PLOS ONE
LA English
DT Article
ID MECHANICAL VENTILATION; RELEASE VENTILATION; INJURY; ESOPHAGEAL;
   MORTALITY; PULMONARY; PERFUSION; ATROPHY
AB Background We hypothesized that a decrease in frequency of controlled breaths during biphasic positive airway pressure (BIVENT), associated with an increase in spontaneous breaths, whether pressure support (PSV)-assisted or not, would mitigate lung and diaphragm damage in mild experimental acute respiratory distress syndrome (ARDS). Materials and methods Wistar rats received Escherichia coli lipopolysaccharide intratracheally. After 24 hours, animals were randomly assigned to: 1) BIVENT-100+PSV0%: airway pressure (P-high) adjusted to V-T = 6 mL/kg and frequency of controlled breaths (f) = 100 bpm; 2) BIVENT-50+PSV0%: P-high adjusted to V-T = 6 mL/kg and f = 50 bpm; 3) BIVENT-50+PSV50% (PSV set to half the P-high reference value, i.e., PSV50%); or 4) BIVENT-50+PSV100% (PSV equal to P-high reference value, i.e., PSV100%). Positive end-expiratory pressure (P-low) was equal to 5 cmH(2)O. Nonventilated animals were used for lung and diaphragm histology and molecular biology analysis. Results BIVENT-50+PSV0%, compared to BIVENT-100+PSV0%, reduced the diffuse alveolar damage (DAD) score, the expression of amphiregulin (marker of alveolar stretch) and muscle atrophy F-box (marker of diaphragm atrophy). In BIVENT-50 groups, the increase in PSV (BIVENT-50+PSV50% versus BIVENT-50+PSV100%) yielded better lung mechanics and less alveolar collapse, interstitial edema, cumulative DAD score, as well as gene expressions associated with lung inflammation, epithelial and endothelial cell damage in lung tissue, and muscle ring finger protein 1 (marker of muscle proteolysis) in diaphragm. Transpulmonary peak pressure (Ppeak,L) and pressure-time product per minute (PTPmin) at P-high were associated with lung damage, while increased spontaneous breathing at P-low did not promote lung injury. Conclusion In the ARDS model used herein, during BIVENT, the level of PSV and the phase of the respiratory cycle in which the inspiratory effort occurs affected lung and diaphragm damage. Partitioning of inspiratory effort and transpulmonary pressure in spontaneous breaths at P-low and P-high is required to minimize VILI.
C1 [Thompson, Alessandra F.; Moraes, Lillian; Rocha, Nazareth N.; Fernandes, Marcos V. S.; Antunes, Mariana A.; Abreu, Soraia C.; Santos, Cintia L.; Samary, Cynthia S.; Saddy, Felipe; Silva, Pedro L.; Rocco, Patricia R. M.] Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, Lab Pulm Invest, Rio De Janeiro, RJ, Brazil.
   [Thompson, Alessandra F.; Saddy, Felipe] Copa DOr Hosp, Rio De Janeiro, Brazil.
   [Rocha, Nazareth N.] Fluminense Fed Univ, Biomed Inst, Dept Physiol & Pharmacol, Niteroi, RJ, Brazil.
   [Capelozzi, Vera L.] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil.
   [Samary, Cynthia S.] Univ Fed Rio de Janeiro, Dept Phys Therapy, Rio De Janeiro, RJ, Brazil.
   [de Abreu, Marcelo G.] Tech Univ Dresden, Univ Hosp Dresden, Dept Anesthesiol & Intens Care Therapy, Pulm Engn Grp, Dresden, Germany.
   [de Abreu, Marcelo G.] Outcomes Res Consortium, Cleveland, OH, United States.
   [Saddy, Felipe] Pro Cardiaco Hosp, Rio De Janeiro, Brazil.
   [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy.
   [Pelosi, Paolo] IRCCS Oncol & Neurosci, San Martino Policlin Hosp, Genoa, Italy.
C3 Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense;
   Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro;
   Technische Universitat Dresden; Carl Gustav Carus University Hospital;
   University of Genoa
RP Rocco, PRM (corresponding author), Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, Lab Pulm Invest, Rio De Janeiro, RJ, Brazil.
EM prmrocco@biof.ufrj.br
RI , Capelozzi/N-1737-2019; Silva, Pedro Leme/AAD-8236-2019; Antunes,
   Mariana/F-8994-2012
OI , Capelozzi/0000-0001-9732-5853; Silva, Pedro Leme/0000-0001-5838-4949;
   Antunes, Mariana/0000-0002-2004-3628; samary,
   cynthia/0000-0002-1860-4166; Rieken Macedo Rocco,
   Patricia/0000-0003-1412-7136
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   [421067/2016-0, 443894/2018-3]; Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro [E-26/210.910/2016,
   E-26/010.001488/2019]
FX This study was supported by Conselho Nacional de Desenvolvimento Cienti
   ' fico e Tecnolo ' gico in the form of grants awarded to PRMR
   (421067/2016-0) and PLS (443894/20183), and Fundacao Carlos Chagas Filho
   de Amparo a Pesquisa do Estado do Rio de Janeiro in the form of grants
   awarded to PRMR (E-26/210.910/2016, E-26/010.001488/2019).
CR Araujo MN, 2017, ANESTH ANALG, V125, P491, DOI 10.1213/ANE.0000000000001927
   Archer DP, 2007, ANESTH ANALG, V105, P993, DOI 10.1213/01.ane.0000282023.42639.b2
   Heil LBB, 2016, ANESTH ANALG, V122, P1015, DOI 10.1213/ANE.0000000000001114
   BAYDUR A, 1982, AM REV RESPIR DIS, V126, P788
   Brochard L, 2017, AM J RESP CRIT CARE, V195, P438, DOI 10.1164/rccm.201605-1081CP
   Carvalho AR, 2011, J APPL PHYSIOL, V110, P1083, DOI 10.1152/japplphysiol.00804.2010
   da Cruz DG, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246891
   de Abreu MG, 2010, CRIT CARE, V14, DOI 10.1186/cc8912
   Demoule A, 2013, AM J RESP CRIT CARE, V188, P213, DOI 10.1164/rccm.201209-1668OC
   Dolinay T, 2006, PHYSIOL GENOMICS, V26, P68, DOI 10.1152/physiolgenomics.00110.2005
   du Sert NP, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000411
   Engelberts D, 2012, INTENS CARE MED, V38, P879, DOI 10.1007/s00134-012-2512-5
   Esteban A, 1999, AM J RESP CRIT CARE, V159, P512, DOI 10.1164/ajrccm.159.2.9803106
   Esteban A, 2013, AM J RESP CRIT CARE, V188, P220, DOI 10.1164/rccm.201212-2169OC
   Felix NS, 2019, ANESTHESIOLOGY, V130, P767, DOI 10.1097/ALN.0000000000002630
   Goligher EC, 2018, AM J RESP CRIT CARE, V197, P204, DOI 10.1164/rccm.201703-0536OC
   Henzler D, 2019, INTENS CARE MED EXP, V7, DOI 10.1186/s40635-019-0272-z
   Hudson MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137693
   Kaplan LJ, 2001, CRIT CARE, V5, P221, DOI 10.1186/cc1027
   Kiss T, 2016, BRIT J ANAESTH, V116, P708, DOI 10.1093/bja/aew093
   Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447
   Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST
   McMullen SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040190
   Menezes SLS, 2005, J APPL PHYSIOL, V98, P1777, DOI 10.1152/japplphysiol.01182.2004
   Mireles-Cabodevila E, 2016, RESP CARE, V61, P761, DOI 10.4187/respcare.04653
   Moraes L, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0474-4
   MORTOLA JP, 1983, J APPL PHYSIOL, V55, P250, DOI 10.1152/jappl.1983.55.1.250
   Pinto EF, 2020, ANESTHESIOLOGY, V132, P307, DOI 10.1097/ALN.0000000000003060
   Putensen C, 2004, CRIT CARE, V8, P492, DOI 10.1186/cc2919
   Putensen C, 2001, AM J RESP CRIT CARE, V164, P43, DOI 10.1164/ajrccm.164.1.2001078
   Putensen C, 1999, AM J RESP CRIT CARE, V159, P1241, DOI 10.1164/ajrccm.159.4.9806077
   Rocco PRM, 2020, INTENS CARE MED, V46, P2377, DOI 10.1007/s00134-020-06143-x
   Saddy F, 2013, CRIT CARE, V17, DOI 10.1186/cc13051
   Saddy F, 2010, INTENS CARE MED, V36, P1417, DOI 10.1007/s00134-010-1808-6
   Samary CS, 2016, CRIT CARE MED, V44, pE553, DOI 10.1097/CCM.0000000000001611
   Samary CS, 2015, ANESTHESIOLOGY, V123, P423, DOI 10.1097/ALN.0000000000000716
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Slutsky AS, 2014, NEW ENGL J MED, V370, P980, DOI [10.1056/NEJMra1208707, 10.1056/NEJMc1400293]
   Spieth PM, 2009, AM J RESP CRIT CARE, V179, P684, DOI 10.1164/rccm.200806-975OC
   SUKI B, 1994, NATURE, V368, P615, DOI 10.1038/368615a0
   Thille AW, 2006, INTENS CARE MED, V32, P1515, DOI 10.1007/s00134-006-0301-8
   Uhlig C, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-56
   van Haren F, 2019, CRIT CARE MED, V47, P229, DOI 10.1097/CCM.0000000000003519
   Watson AC, 2001, CRIT CARE MED, V29, P1325, DOI 10.1097/00003246-200107000-00005
   Yoshida T, 2020, CURR OPIN CRIT CARE, V26, P59, DOI 10.1097/MCC.0000000000000691
   Zhang ZH, 2019, CRIT CARE MED, V47, P315, DOI 10.1097/CCM.0000000000003499
NR 46
TC 1
Z9 1
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PY 2021
VL 16
IS 8
AR e0256021
DI 10.1371/journal.pone.0256021
PG 20
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA UC9GQ
UT WOS:000686828600015
PM 34415935
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Zhong, LZ
   Gao, XR
   Chen, YL
   Yu, ZX
   Jin, S
   Zhu, CL
AF Zhong, Lizhe
   Gao, Xiurong
   Chen, Yongli
   Yu, Zhaoxiang
   Jin, Shuo
   Zhu, Chunlei
TI Roles of VE-Cadherin in Hypoxia Induced Injury of Pulmonary
   Microvascular Endothelial Barrier
SO HEART SURGERY FORUM
LA English
DT Article
ID APOPTOSIS; CELLS
AB Background: Hypoxia induced injury of pulmonary microvascular endothelial barrier is closely related to the pathogenesis of acute lung injury after lung transplantation. VE-cadherin is an important structural molecule for pulmonary microvascular endothelial barrier. In this study, we aim to investigate the roles of VE-cadherin in hypoxia induced injury of pulmonary microvascular endothelial barrier.
   Methods: Rat model of hypoxia and cultured pulmonary microvascular endothelial cells (PMVECs) were utilized. Determination of PMVECs apoptosis, skeleton combination was conducted to verify the effects of hypoxia on injury of pulmonary microvascular endothelial barrier. In addition, VE-cadherin expression was modulated by administration of siRNA in order to investigate the roles of VE-cadherin in hypoxia induced PMVECs apoptosis and skeleton recombination.
   Results: Our data indicated that expression of VE-cadherin was down-regulated in hypoxia-exposed PMVECs. Whereas, in the cells treated using siRNA, down-regulation of VE-cadherin did not trigger PMVECs apoptosis, but it increased the sensitivity of PMVECs to the hypoxia induced apoptosis. In cases of hypoxia, the expression of VE-cadherin was significantly down-regulated, together with endothelial skeleton recombination and increase of permeability, which then triggered endothelial barrier dysfunction.
   Conclusions: These data verify that VE-cadherin expression played an important role in hypoxia induced PMVECs apoptosis and cellular skeletal recombination.
C1 [Zhong, Lizhe; Chen, Yongli] Beihua Univ, Dept Thorac Surg, Affiliated Hosp, Jilin 132013, Jilin, China.
   [Gao, Xiurong] Qianguo Cty Hosp, Dept Cardiovasc 2, Songyuan 138000, China.
   [Yu, Zhaoxiang] Beihua Univ, Dept Anesthesiol, Affiliated Hosp, Jilin 132013, Jilin, China.
   [Jin, Shuo; Zhu, Chunlei] Beihua Univ, Dept Hand & Foot Surg, Affiliated Hosp, Jilin 132013, Jilin, China.
C3 Beihua University; Beihua University; Beihua University
RP Zhu, CL (corresponding author), Beihua Univ, Dept Hand & Foot Surg, Affiliated Hosp, Jilin 132013, Jilin, Peoples R China.
EM luckdhzcl@sina.com
FU Foundation of Jilin Provincial Department of Education, China
   [JJKH20170055K]; Foundation of Health Department of Jilin Province,
   China [2017J080]
FX This work was supported by grants from the Foundation of Jilin
   Provincial Department of Education, China (No. JJKH20170055K) , the
   Foundation of Health Department of Jilin Province, China (No. 2017J080)
   .
CR Abu Taha A, 2014, CELL ADHES MIGR, V8, P125, DOI 10.4161/cam.28243
   Audia JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081792
   Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697
   Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346
   Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7
   Elgharably H, 2015, THORAC SURG CLIN, V25, P35, DOI 10.1016/j.thorsurg.2014.09.011
   Guo HJ, 2015, SLEEP BREATH, V19, P969, DOI 10.1007/s11325-015-1128-8
   Huang YR, 2015, BIOCHEM BIOPH RES CO, V468, P119, DOI 10.1016/j.bbrc.2015.10.150
   Kandasamy K, 2015, AM J PHYSIOL-LUNG C, V309, pL584, DOI 10.1152/ajplung.00211.2014
   Kasa A, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974448
   O'Leary H, 2010, CANCER MICROENVIRON, V3, P67, DOI 10.1007/s12307-010-0035-6
   Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199
   Padmanabhan A, 2015, CURR OPIN CELL BIOL, V36, P32, DOI 10.1016/j.ceb.2015.06.008
   Requiao-Moura LR, 2011, TRANSPL P, V43, P70, DOI 10.1016/j.transproceed.2010.12.012
   Stevens Troy, 2011, Proc Am Thorac Soc, V8, P453, DOI 10.1513/pats.201101-004MW
   Takeda K, 2015, J REPROD DEVELOP, V61, P185, DOI 10.1262/jrd.2014-140
   Taveau JC, 2008, BIOCHEM SOC T, V36, P189, DOI 10.1042/BST0360189
   Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855
   Weidert E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108092
   Wu XM, 2018, J CELL BIOCHEM, V119, P6704, DOI 10.1002/jcb.26859
   Wu ZY, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017377
   Wu ZY, 2016, AM J TRANSL RES, V8, P4310
NR 22
TC 1
Z9 1
U1 1
U2 5
PU FORUM MULTIMEDIA PUBLISHING, LLC
PI CHARLOTTESVILLE
PA 375 GREENBRIER DR, CHARLOTTESVILLE, VA 22901 USA
SN 1098-3511
EI 1522-6662
J9 HEART SURG FORUM
JI Heart Surg. Forum
PY 2021
VL 24
IS 4
BP E764
EP E768
DI 10.1532/hsf.3405
PG 5
WC Cardiac & Cardiovascular Systems; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Surgery
GA UY7GK
UT WOS:000701687500026
PM 34473045
OA gold
DA 2023-08-21
ER

PT J
AU Wang, SW
   Sun, YF
   Bai, Y
   Zhou, NN
   Chen, N
   Miller, EJ
   Zhang, YJ
   Li, W
AF Wang, Shuaiwei
   Sun, Yafang
   Bai, Yu
   Zhou, Nannan
   Chen, Na
   Miller, Edmund J.
   Zhang, Yijie
   Li, Wei
TI Contribution of Connexin Hemichannels to the Pathogenesis of Acute Lung
   Injury
SO MEDIATORS OF INFLAMMATION
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; MEDIATOR; PERMEABILITY; RECRUITMENT;
   ACTIVATION; CHANNELS; STERILE; RELEASE; HMG-1; CELL
AB Connexin (Cx) family members form hemichannels (HCs) and gap junctions (GJs). Biological functions of Cx HCs have not been adequately characterized due to the inability to selectively target HCs or GJs. Recently, we developed a 6-mer peptide mimetic (P5) of the first extracellular loop of Cx43 and showed that it can block the permeability of HCs but not GJs formed by Cx43. In this study, we further characterized the HC blocking property of P5 and investigated the role of Cx HCs in acute lung injury (ALI). We found that P5 administration decreased HC permeability, in pulmonary microvascular endothelial cells, HepG2 cells, and even Cx43-deficient astrocytes, which express different sets of Cxs, suggesting that P5 is a broad spectrum Cx HC blocker. In addition, P5 reduced HC permeability of alveolar cells in vivo. Moreover, P5 decreased endotoxin-induced release, by vascular endothelial cells in vitro, of high mobility group box protein 1 (HMGB1), a critical mediator of acute lung injury (ALI), and reduced HMGB1 accumulation in bronchoalveolar lavage fluid (BALF) of mice subjected to intratracheal endotoxin instillation. Furthermore, P5 administration resulted in a significant decrease in the concentrations of ALT, AST, and LDH in the BALF, the accumulation of leukocytes in alveoli, and the mortality rate of mice subjected to ALI. Wright-Giemsa staining showed that P5 caused similar reductions of both neutrophils and monocytes in BALF of ALI mice. Together, these results suggest that Cx HCs mediate HMGB1 release, augment leukocyte recruitment, and contribute to ALI pathology.
C1 [Wang, Shuaiwei; Sun, Yafang; Bai, Yu; Zhang, Yijie; Li, Wei] Henan Univ, Huaihe Hosp, Ctr Translat Med, Sepsis Lab, Kaifeng, Henan, China.
   [Wang, Shuaiwei; Bai, Yu; Zhou, Nannan; Chen, Na; Zhang, Yijie; Li, Wei] Int Lab Sepsis Res, Kaifeng, Henan, China.
   [Wang, Shuaiwei; Bai, Yu; Zhou, Nannan; Chen, Na; Zhang, Yijie; Li, Wei] Engn & Res Ctr Sepsis, Kaifeng, Henan, China.
   [Sun, Yafang; Zhou, Nannan; Chen, Na] Henan Univ, Huaihe Hosp, Dept Pulm & Crit Care Med, Kaifeng, Henan, China.
   [Miller, Edmund J.] RDS2 Solut, 25 Hlth Sci Dr,Suite 208-B, Stony Brook, NY 11794, United States.
C3 Henan University; Henan University
RP Li, W (corresponding author), Henan Univ, Huaihe Hosp, Ctr Translat Med, Sepsis Lab, Kaifeng, Henan, Peoples R China.; Li, W (corresponding author), Int Lab Sepsis Res, Kaifeng, Henan, Peoples R China.; Li, W (corresponding author), Engn & Res Ctr Sepsis, Kaifeng, Henan, Peoples R China.
EM weionweb@yahoo.com
RI Shuaiwei, Wang/D-5773-2015
OI Shuaiwei, Wang/0000-0003-2409-9888; Li, Wei/0000-0002-7941-7022
FU National Natural Science Foundation of China [81671959, U1704171];
   Science and Technology Bureau of Kaifeng; Henan University
FX The authors wish to thank Ms. Huanhuan Zhang for her technical
   assistance and Dr. Haichao Wang at the Feinstein Institute for Medical
   Research of Northwell Health Inc. (Manhasset, NY, USA) for his
   suggestions during manuscript preparation. This study was supported by
   research grants (81671959 and U1704171) from the National Natural
   Science Foundation of China (WL), a key laboratory grant from the
   Science and Technology Bureau of Kaifeng (WL and NNZ), and a start-up
   grant from Henan University (WL).
CR Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950
   Abudara V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00306
   Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413
   Chen Hong, 2010, Expert Rev Respir Med, V4, P773, DOI 10.1586/ers.10.71
   Fan E, 2018, JAMA-J AM MED ASSOC, V319, P698, DOI 10.1001/jama.2017.21907
   Fanelli Vito, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS3, DOI 10.1513/AnnalsATS.201407-340MG
   Johnson LN, 2009, ANTIOXID REDOX SIGN, V11, P355, DOI 10.1089/ars.2008.2183
   Li W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18452-1
   Li W, 2013, MOL MED, V19, P203, DOI 10.2119/molmed.2013.00064
   Lohman AW, 2014, FEBS LETT, V588, P1379, DOI 10.1016/j.febslet.2014.02.004
   Losa D, 2011, EXPERT OPIN THER TAR, V15, P989, DOI 10.1517/14728222.2011.584875
   Lu B, 2014, EXPERT REV CLIN IMMU, V10, P713, DOI 10.1586/1744666X.2014.909730
   Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290
   MILLER EJ, 1992, AM REV RESPIR DIS, V146, P427, DOI 10.1164/ajrccm/146.2.427
   O'Donnell JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100931
   Parthasarathi K, 2006, J CLIN INVEST, V116, P2193, DOI 10.1172/JCI26605
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Sarieddine MZR, 2009, J CELL MOL MED, V13, P4560, DOI 10.1111/j.1582-4934.2008.00654.x
   Simon AM, 2002, DEV BIOL, V251, P206, DOI 10.1006/dbio.2002.0826
   Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626
   Tsung A, 2014, J INTERN MED, V276, P425, DOI 10.1111/joim.12276
   Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189
   Verselis VK, 2013, NEUROPHARMACOLOGY, V75, P517, DOI 10.1016/j.neuropharm.2013.03.020
   Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248
   Wang N, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0309-x
   Wang X, 2017, P NATL ACAD SCI USA, V114, P4483, DOI 10.1073/pnas.1616752114
   Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902
   Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100
   Yano T, 2001, CARCINOGENESIS, V22, P1593, DOI 10.1093/carcin/22.10.1593
   Yin J, 2019, AM J PHYSIOL-LUNG C, V316, pL35, DOI 10.1152/ajplung.00012.2018
   Zhang J, 2015, AM J PHYSIOL-LUNG C, V309, pL1323, DOI 10.1152/ajplung.00016.2015
   Zhou HS, 2018, MICROVASC RES, V115, P58, DOI 10.1016/j.mvr.2017.08.008
   Zhou M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01612
NR 33
TC 4
Z9 4
U1 1
U2 5
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0962-9351
EI 1466-1861
J9 MEDIAT INFLAMM
JI Mediat. Inflamm.
PD NOV 18
PY 2020
VL 2020
AR 8094347
DI 10.1155/2020/8094347
PG 10
WC Cell Biology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Immunology
GA PA7PR
UT WOS:000595823100001
PM 33293898
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Cleary, SJ
   Kwaan, N
   Tian, JJ
   Calabrese, DR
   Mallavia, B
   Magnen, M
   Greenland, JR
   Urisman, A
   Singer, JP
   Hays, SR
   Kukreja, J
   Hay, AM
   Howie, HL
   Toy, P
   Lowell, CA
   Morrell, CN
   Zimring, JC
   Looney, MR
AF Cleary, Simon J.
   Kwaan, Nicholas
   Tian, Jennifer J.
   Calabrese, Daniel R.
   Mallavia, Benat
   Magnen, Melia
   Greenland, John R.
   Urisman, Anatoly
   Singer, Jonathan P.
   Hays, Steven R.
   Kukreja, Jasleen
   Hay, Ariel M.
   Howie, Heather L.
   Toy, Pearl
   Lowell, Clifford A.
   Morrell, Craig N.
   Zimring, James C.
   Looney, Mark R.
TI Complement activation on endothelium initiates antibody-mediated acute
   lung injury
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID BRONCHIOLITIS OBLITERANS SYNDROME; DONOR-SPECIFIC ANTIBODIES;
   TRANSFUSION; CELLS; NEUTROPHILS; PLATELETS; TRALI; MOUSE; MACROPHAGES;
   DEFICIENT
AB Antibodies targeting human leukocyte antigen (HLA)/major histocompatibility complex (MHC) proteins limit successful transplantation and transfusion, and their presence in blood products can cause lethal transfusion-related acute lung injury (TRALI). It is unclear which cell types are bound by these anti-leukocyte antibodies to initiate an immunologic cascade resulting in lung injury. We therefore conditionally removed MHC class I (MHC I) from likely cellular targets in antibodymediated lung injury. Only the removal of endothelial MHC I reduced lung injury and mortality, related mechanistically to absent endothelial complement fixation and lung platelet retention. Restoration of endothelial MHC I rendered MHC !deficient mice susceptible to lung injury. Neutrophil responses, including neutrophil extracellular trap (NET) release, were intact in endothelial MHC I-deficient mice, whereas complement depletion reduced both lung injury and NETs. Human pulmonary endothelial cells showed high HLA class I expression, and posttransfusion complement activation was increased in clinical TRALI. These results indicate that the critical source of antigen for anti-leukocyte antibodies is in fact the endothelium, which reframes our understanding of TRALI as a rapid-onset vasculitis. Inhibition of complement activation may have multiple beneficial effects of reducing endothelial injury, platelet retention, and NET release in conditions where antibodies trigger these pathogenic responses.
C1 [Cleary, Simon J.; Kwaan, Nicholas; Tian, Jennifer J.; Calabrese, Daniel R.; Mallavia, Benat; Magnen, Melia; Greenland, John R.; Singer, Jonathan P.; Hays, Steven R.; Looney, Mark R.] UCSF, Dept Med, San Francisco, CA, United States.
   [Calabrese, Daniel R.; Greenland, John R.] Vet Affairs Healthcare Syst, San Francisco, CA, United States.
   [Urisman, Anatoly] UCSF, Dept Pathol, San Francisco, CA, United States.
   [Kukreja, Jasleen] UCSF, Dept Surg, San Francisco, CA, United States.
   [Hay, Ariel M.; Howie, Heather L.; Zimring, James C.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908, United States.
   [Toy, Pearl; Lowell, Clifford A.; Looney, Mark R.] UCSF, Dept Lab Med, San Francisco, CA, United States.
   [Morrell, Craig N.] Univ Rochester, Aab Cardiovasc Res Inst, Sch Med & Dent, New York, NY, United States.
C3 University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   University of Virginia; University of California System; University of
   California San Francisco; University of Rochester
RP Looney, MR (corresponding author), 513 Parnassus Ave,HSE 1355A, San Francisco, CA 94143 USA.
EM mark.looney@ucsf.edu
RI Greenland, John R/AAR-6030-2021
OI Greenland, John R/0000-0003-1422-8367; Calabrese,
   Daniel/0000-0002-0596-3434; Tian, Jennifer J./0000-0002-3850-439X;
   Urisman, Anatoly/0000-0001-8364-5303; Singer,
   Jonathan/0000-0003-0224-7472; Cleary, Simon/0000-0001-5573-6363; Magnen,
   Melia/0000-0001-5189-0072
FU NIH Diabetes Research Center grant [P30 DK063720]; NIH [HL107386,
   HL130324, HL138673]; International Society for Heart and Lung Transplant
   Joel D. Cooper Award
FX We acknowledge the UCSF BIDC for enabling imaging experiments, and the
   UCSF Parnassus Flow Core, supported in part by the NIH Diabetes Research
   Center grant P30 DK063720, for flow cytometry support, We thank Michael
   Matthay (UCSF, San Francisco), Donor Network West, the TRALI study
   group, and participating donors and clinicians for providing access to
   human samples, and Kirk D, Jones (UCSF, San Francisco) for providing
   lung AMR C4d images. SIC would like to thank Peter Baluk and Donald
   McDonald for training in immunofluorescence techniques, Emma Lefranyais
   for intravital training, and Clare Abram and Alexandre Boissonnas for
   insights into myeloid cell biology, This work was supported by NIH RO1
   grants HL107386 (to MRL), HL130324 (to MRL), HL138673 (to MRL and JCZ),
   and an International Society for Heart and Lung Transplant Joel D,
   Cooper Award (to DRC).
CR Abrahimi P, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85293
   Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009
   Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643
   Beutier H, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan5997
   Bouquegneau A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002572
   Brugiere O, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01898-2017
   Calabrese DR, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.133083
   Calabrese DR, 2019, TRANSPLANTATION, V103, P493, DOI 10.1097/TP.0000000000002450
   Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010
   Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303
   Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960
   Cleary SJ, 2019, AM J RESP CELL MOL, V61, P232, DOI 10.1165/rcmb.2018-0182OC
   del Conde I, 2005, J EXP MED, V201, P871, DOI 10.1084/jem.20041497
   Dykes A, 2000, BRIT J HAEMATOL, V109, P674, DOI 10.1046/j.1365-2141.2000.01999.x
   Hachem RR, 2018, AM J TRANSPLANT, V18, P2285, DOI 10.1111/ajt.14893
   Headley MB, 2016, NATURE, V531, P513, DOI 10.1038/nature16985
   Hechler B, 2016, J THROMB HAEMOST, V14, P1255, DOI 10.1111/jth.13335
   Hilt ZT, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122943
   HORI M, 1991, HYPERTENSION, V18, P565, DOI 10.1161/01.HYP.18.5.565
   Jongerius I, 2019, TRANSFUS MED REV, V33, P236, DOI 10.1016/j.tmrv.2019.09.002
   Kapur R, 2017, BLOOD, V129, P2557, DOI 10.1182/blood-2016-12-758185
   Koller BH, 2010, J IMMUNOL, V184, P4592
   Kulkarni Hrishikesh S, 2015, Curr Transplant Rep, V2, P316
   Lefrancais E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98178
   Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706
   Lobo LJ, 2013, J HEART LUNG TRANSPL, V32, P70, DOI 10.1016/j.healun.2012.10.007
   Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238
   Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432
   Mallavia B, 2020, AM J RESP CELL MOL, V62, P364, DOI 10.1165/rcmb.2019-0140OC
   McKenzie CGJ, 2014, BLOOD, V123, P3496, DOI 10.1182/blood-2013-11-536755
   McVey MJ, 2017, AM J PHYSIOL-LUNG C, V312, P1625, DOI 10.1152/ajplung.00317.2016
   Meyer KC, 2014, EUR RESPIR J, V44, P1479, DOI 10.1183/09031936.00107514
   Mnjoyan Z, 2008, PLATELETS, V19, P512, DOI 10.1080/09537100802238494
   Morrell CN, 2008, CIRC RES, V102, P777, DOI 10.1161/CIRCRESAHA.107.170332
   Morrell MR, 2014, J HEART LUNG TRANSPL, V33, P1288, DOI 10.1016/j.healun.2014.07.018
   Murata Kazunori, 2009, Transplant Rev (Orlando), V23, P139, DOI 10.1016/j.trre.2009.02.005
   Ortiz-Munoz G, 2014, BLOOD, V124, P2625, DOI 10.1182/blood-2014-03-562876
   OZATO K, 1982, TRANSPLANTATION, V34, P113, DOI 10.1097/00007890-198209000-00001
   Palmer LJ, 2016, J PERIODONTAL RES, V51, P70, DOI 10.1111/jre.12284
   POPOVSKY MA, 1983, AM REV RESPIR DIS, V128, P185, DOI 10.1164/arrd.1983.128.1.185
   Roux A, 2016, AM J TRANSPLANT, V16, P1216, DOI 10.1111/ajt.13589
   Sachs UJH, 2011, BLOOD, V117, P669, DOI 10.1182/blood-2010-05-286146
   Safavi S, 2014, J HEART LUNG TRANSPL, V33, P1273, DOI 10.1016/j.healun.2014.07.012
   Sauter RJ, 2018, CIRCULATION, V138, P1720, DOI 10.1161/CIRCULATIONAHA.118.034600
   Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811
   Semple JW, 2019, BLOOD, V133, P1840, DOI 10.1182/blood-2018-10-860809
   Silliman CC, 2007, BLOOD, V109, P1752, DOI 10.1182/blood-2006-05-025106
   Singh NRP, 2012, EUR J CLIN INVEST, V42, P1342, DOI 10.1111/j.1365-2362.2012.02720.x
   Sollberger G, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar6689
   Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478
   Strait RT, 2011, J EXP MED, V208, P2525, DOI 10.1084/jem.20110159
   Thomas GM, 2012, BLOOD, V119, P6335, DOI 10.1182/blood-2012-01-405183
   Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362
   Tikkanen JM, 2016, AM J RESP CRIT CARE, V194, P596, DOI 10.1164/rccm.201509-1857OC
   Torres-Ruiz J, 2020, TRANSPL IMMUNOL, V60, DOI 10.1016/j.trim.2020.101286
   Toy P, 2012, BLOOD, V119, P1757, DOI 10.1182/blood-2011-08-370932
   Vlaar APJ, 2019, TRANSFUSION, V59, P2465, DOI 10.1111/trf.15311
   Vossoughi S, 2019, TRANSFUSION, V59, P2567, DOI 10.1111/trf.15387
   Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001
   Yuan YP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam5861
   Yuen J, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00137
   ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0
NR 62
TC 22
Z9 26
U1 0
U2 2
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD NOV 2
PY 2020
VL 130
IS 11
BP 5909
EP 5923
DI 10.1172/JCI138136
PG 15
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA OO5JD
UT WOS:000587413700029
PM 32730229
OA Bronze, Green Published
DA 2023-08-21
ER

PT J
AU Lee, LK
   Medzikovic, L
   Eghbali, M
   Eltzschig, HK
   Yuan, XY
AF Lee, Lisa K.
   Medzikovic, Lejla
   Eghbali, Mansoureh
   Eltzschig, Holger K.
   Yuan, Xiaoyi
TI The Role of MicroRNAs in Acute Respiratory Distress Syndrome and Sepsis,
   From Targets to Therapies: A Narrative Review
SO ANESTHESIA AND ANALGESIA
LA English
DT Review
ID TUMOR-NECROSIS-FACTOR; OXIDE SYNTHASE INHIBITOR; PLACEBO-CONTROLLED
   TRIAL; FACTOR PATHWAY INHIBITOR; ACUTE LUNG INJURY; DOUBLE-BLIND;
   MONOCLONAL-ANTIBODY; PHASE-III; INFLAMMATORY RESPONSES; CIRCULATING
   MICRORNAS
AB Acute respiratory distress syndrome (ARDS) is a significant cause of morbidity and mortality in the intensive care unit (ICU) and is characterized by lung epithelial and endothelial cell injury, with increased permeability of the alveolar-capillary membrane, leading to pulmonary edema, severe hypoxia, and difficulty with ventilation. The most common cause of ARDS is sepsis, and currently, treatment of ARDS and sepsis has consisted mostly of supportive care because targeted therapies have largely been unsuccessful. The molecular mechanisms behind ARDS remain elusive. Recently, a number of microRNAs (miRNAs) identified through high-throughput screening studies in ARDS patients and preclinical animal models have suggested a role for miRNA in the pathophysiology of ARDS. miRNAs are small noncoding RNAs ranging from 18 to 24 nucleotides that regulate gene expression via inhibition of the target mRNA translation or by targeting complementary mRNA for early degradation. Unsurprisingly, some miRNAs that are differentially expressed in ARDS overlap with those important in sepsis. In addition, circulatory miRNA may be useful as biomarkers or as targets for pharmacologic therapy. This can be revolutionary in a syndrome that has neither a measurable indicator of the disease nor a targeted therapy. While there are currently no miRNA-based therapies targeted for ARDS, therapies targeting miRNA have reached phase II clinical trials for the treatment of a wide range of diseases. Further studies may yield a unique miRNA profile pattern that serves as a biomarker or as targets for miRNA-based pharmacologic therapy. In this review, we discuss miRNAs that have been found to play a role in ARDS and sepsis, the potential mechanism of how particular miRNAs may contribute to the pathophysiology of ARDS, and strategies for pharmacologically targeting miRNA as therapy.
C1 [Lee, Lisa K.; Medzikovic, Lejla; Eghbali, Mansoureh] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol & Perioperat Med, 757 Westwood Plaza,Suite 3325, Los Angeles, CA 90095, United States.
   [Eltzschig, Holger K.; Yuan, Xiaoyi] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Anesthesiol, Houston, TX 77030, United States.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of Texas System; University of Texas
   Health Science Center Houston
RP Lee, LK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol & Perioperat Med, 757 Westwood Plaza,Suite 3325, Los Angeles, CA 90095 USA.
EM lklee@mednet.ucla.edu
RI Lee, Lisa/ABE-7534-2020
OI Lee, Lisa/0000-0001-5857-9260
FU American Thoracic Society; American Heart Association Career Development
   Award [19CDA34660279]; American Lung Association Catalyst Award
   [CA-622265]; Center for Clinical and Translational Sciences, McGovern
   Medical School Pilot Award [1UL1TR003167-01]; Parker B. Francis
   Fellowship;  [R01-HL129051];  [R01-HL147586];  [R01-DK097075]; 
   [R01-HL098294];  [POI-HL114457];  [R01-DK082509];  [R01-HL109233]; 
   [R01-DK109574];  [R01-HL119837];  [R01-HL133900]
FX M.E. received grants from R01-HL129051 and R01-HL147586; and H.E.
   received grants from R01-DK097075, R01-HL098294, POI-HL114457,
   R01-DK082509, R01-HL109233, R01-DK109574, R01-HL119837, and
   R01-HL133900. X.Y. received grants from the American Thoracic Society
   Unrestricted Grant, American Heart Association Career Development Award
   (19CDA34660279), American Lung Association Catalyst Award (CA-622265),
   the Center for Clinical and Translational Sciences, McGovern Medical
   School Pilot Award (1UL1TR003167-01), and Parker B. Francis Fellowship.
CR ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934
   Abraham E, 1998, LANCET, V351, P929
   Abraham E, 1999, CRIT CARE MED, V27, P1478, DOI 10.1097/00003246-199908000-00013
   Abraham E, 2001, CRIT CARE MED, V29, P2081, DOI 10.1097/00003246-200111000-00007
   Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238
   Abraham E, 2001, CRIT CARE MED, V29, P503, DOI 10.1097/00003246-200103000-00006
   Avontuur JAM, 1999, CIRCULATION, V99, P271, DOI 10.1161/01.CIR.99.2.271
   Barta T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36625
   Bartoszewski R, 2019, CELL MOL BIOL LETT, V24, DOI 10.1186/s11658-019-0196-3
   Beg MS, 2017, INVEST NEW DRUG, V35, P180, DOI 10.1007/s10637-016-0407-y
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Benz F, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/384208
   Bernard GR, 1997, CHEST, V112, P164, DOI 10.1378/chest.112.1.164
   Biron BM, 2015, BIOMARK INSIGHTS, V10, P7, DOI 10.4137/BMI.S29519
   Bofill-De Ros X, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2160-6
   BONE RC, 1989, CHEST, V96, P114, DOI 10.1378/chest.96.1.114
   Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854
   Caserta S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28006
   Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028
   Cohen J, 1996, CRIT CARE MED, V24, P1431, DOI 10.1097/00003246-199609000-00002
   Connelly CM, 2014, METHODS MOL BIOL, V1095, P147, DOI 10.1007/978-1-62703-703-7_12
   Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522
   Cui LY, 2019, CARBONATE EVAPORITE, V34, P1, DOI 10.1007/s13146-017-0408-8
   Cui MY, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00626
   de Rie D, 2017, NAT BIOTECHNOL, V35, P872, DOI 10.1038/nbt.3947
   Dong GR, 2016, INT J CLIN EXP PATHO, V9, P7010
   Evankovich J, 2020, AM J RESP CELL MOL, V62, P157, DOI 10.1165/rcmb.2018-0373OC
   Eworuke E, 2018, J CRIT CARE, V47, P192, DOI 10.1016/j.jcrc.2018.07.002
   Faix JD, 2013, CRIT REV CL LAB SCI, V50, P23, DOI 10.3109/10408363.2013.764490
   Fan E, 2018, JAMA-J AM MED ASSOC, V319, P698, DOI 10.1001/jama.2017.21907
   Fein AM, 1997, JAMA-J AM MED ASSOC, V277, P482, DOI 10.1001/jama.277.6.482
   Feng ZY, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.549
   Gallant-Behm CL, 2019, J INVEST DERMATOL, V139, P1073, DOI 10.1016/j.jid.2018.11.007
   Gallant-Behm CL, 2018, WOUND REPAIR REGEN, V26, P311, DOI 10.1111/wrr.12660
   Gebert LFR, 2014, NUCLEIC ACIDS RES, V42, P609, DOI 10.1093/nar/gkt852
   Ginde AA, 2019, NEW ENGL J MED, V381, P2529, DOI 10.1056/NEJMoa1911124
   Godoy PM, 2018, CELL REP, V25, P1346, DOI 10.1016/j.celrep.2018.10.014
   Grover R, 1999, CRIT CARE MED, V27, P913, DOI 10.1097/00003246-199905000-00025
   Gumireddy K, 2008, ANGEW CHEM INT EDIT, V47, P7482, DOI 10.1002/anie.200801555
   Guo CR, 2016, MOL MED, V22, DOI 10.2119/molmed.2015.00240
   Han Y, 2016, CLIN LAB, V62, P2355, DOI 10.7754/Clin.Lab.2016.160511
   Hanna J, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00478
   Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722
   Hollensen AK, 2018, MOL THER-NUCL ACIDS, V13, P365, DOI 10.1016/j.omtn.2018.09.009
   How CK, 2015, SHOCK, V43, P121, DOI 10.1097/SHK.0000000000000282
   Huang CQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-46
   Huang GX, 2017, CELL MOL IMMUNOL, V14, P265, DOI 10.1038/cmi.2015.78
   Ishida Masaharu, 2013, Curr Anesthesiol Rep, V1, P63
   Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026
   Jayaraj GG, 2015, CHEM COMMUN, V51, P820, DOI 10.1039/c4cc04514a
   JEPSEN S, 1992, CRIT CARE MED, V20, P918, DOI 10.1097/00003246-199207000-00004
   Jiang J, 2018, MED SCI MONITOR, V24, P4330, DOI 10.12659/MSM.910316
   Jiang KF, 2019, MOL THER, V27, P1758, DOI 10.1016/j.ymthe.2019.07.003
   Kent OA, 2018, JOVE-J VIS EXP, DOI 10.3791/57845
   Kortylewski M, 2014, MOL THER, V22, P1070, DOI 10.1038/mt.2014.73
   Li PB, 2019, INT IMMUNOPHARMACOL, V75, DOI 10.1016/j.intimp.2019.105794
   Li Q, 2017, MOL MED REP, V16, P4119, DOI 10.3892/mmr.2017.7109
   Li SL, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23098
   Liau NPD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04013-1
   Lima JF, 2018, RNA BIOL, V15, P338, DOI 10.1080/15476286.2018.1445959
   Liu F, 2017, SHOCK, V48, P61, DOI 10.1097/SHK.0000000000000839
   Liu KD, 2008, AM J RESP CRIT CARE, V178, P618, DOI 10.1164/rccm.200803-419OC
   Liu X, 2018, MOL THER-NUCL ACIDS, V13, P312, DOI 10.1016/j.omtn.2018.09.010
   Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6
   Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012
   Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116
   Magna M, 2014, MOL MED, V20, P138, DOI 10.2119/molmed.2013.00164
   Maltby S, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00021
   Marti-Carvajal AJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004388.pub5
   Mashima R, 2015, IMMUNOLOGY, V145, P323, DOI 10.1111/imm.12468
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008
   McAuley DF, 2017, LANCET RESP MED, V5, P484, DOI 10.1016/S2213-2600(17)30171-6
   McAuley DF, 2014, NEW ENGL J MED, V371, P1695, DOI 10.1056/NEJMoa1403285
   Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68
   Mohnle P, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0056-z
   Mohnle P, 2015, EUR J IMMUNOL, V45, P260, DOI 10.1002/eji.201444667
   Moss M, 2019, NEW ENGL J MED, V380, P1997, DOI 10.1056/NEJMoa1901686
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Narute P, 2017, SHOCK, V47, P688, DOI 10.1097/SHK.0000000000000806
   Neudecker V, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5360
   Neudecker V, 2017, J MOL MED, V95, P935, DOI 10.1007/s00109-017-1568-7
   Neudecker V, 2016, ANESTHESIOLOGY, V124, P489, DOI 10.1097/ALN.0000000000000969
   Nguyen HB, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-6
   O'Brien J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00402
   Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010
   Park J, 2018, EXP THER MED, V15, P5495, DOI 10.3892/etm.2018.6118
   PETROS A, 1994, CARDIOVASC RES, V28, P34, DOI 10.1093/cvr/28.1.34
   Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370
   Puskarichl MA, 2015, J ACUTE DIS, V4, P101, DOI 10.1016/S2221-6189(15)30017-2
   Qu J, 2019, MOL THER-NUCL ACIDS, V14, P274, DOI 10.1016/j.omtn.2018.12.002
   Rajput C, 2016, ARTERIOSCL THROM VAS, V36, P380, DOI 10.1161/ATVBAHA.115.306997
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275
   Real JM, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2003-3
   Reid G, 2016, EPIGENOMICS-UK, V8, P1079, DOI 10.2217/epi-2016-0035
   Reithmair M, 2017, J CELL MOL MED, V21, P2403, DOI 10.1111/jcmm.13162
   Rezoagli E, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.62
   Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9
   Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612
   Rotllan N, 2013, ARTERIOSCL THROM VAS, V33, P1973, DOI 10.1161/ATVBAHA.113.301732
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Saguil A, 2012, AM FAM PHYSICIAN, V85, P352
   Schoonover LL, 2000, PHARMACOTHERAPY, V20, P1184, DOI 10.1592/phco.20.15.1184.34587
   Schult P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05053-3
   Seto AG, 2018, BRIT J HAEMATOL, V183, P428, DOI 10.1111/bjh.15547
   Standage SW, 2011, EXPERT REV ANTI-INFE, V9, P71, DOI [10.1586/eri.10.154, 10.1586/ERI.10.154]
   Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0
   Pham T, 2017, AM J RESP CRIT CARE, V195, P860, DOI 10.1164/rccm.201609-1773CP
   Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0
   Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029
   Testa Ugo, 2017, Non-Coding RNA, V3, P22, DOI 10.3390/ncrna3030022
   The ARDS Clinical Trials Network, 2002, CRIT CARE MED, V30, P1, DOI DOI 10.1023/A:1014292830216
   Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]
   Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20
   Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520
   van Zandwijk N, 2017, LANCET ONCOL, V18, P1386, DOI 10.1016/S1470-2045(17)30621-6
   Vasilescu C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183334
   Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405
   Vautrin A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37813-y
   Vergadi E, 2014, J IMMUNOL, V192, P394, DOI 10.4049/jimmunol.1300959
   Vincent JL, 2015, CRIT CARE MED, V43, P57, DOI 10.1097/CCM.0000000000000554
   Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]
   Wang HJ, 2014, CLIN CHEM LAB MED, V52, P927, DOI 10.1515/cclm-2013-0899
   Wang HJ, 2012, J TRAUMA ACUTE CARE, V73, P850, DOI 10.1097/TA.0b013e31825a7560
   Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145
   Wang LN, 2013, EXP THER MED, V5, P1101, DOI 10.3892/etm.2013.937
   Wang ZC, 2014, CELL IMMUNOL, V290, P190, DOI 10.1016/j.cellimm.2014.06.006
   Xie T, 2012, J IMMUNOL, V188, P2437, DOI 10.4049/jimmunol.1101070
   Xie W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157085
   Xu JJ, 2018, J IMMUNOL, V201, P3392, DOI 10.4049/jimmunol.1801008
   Yan YR, 2019, INT J MOL MED, V43, P1467, DOI 10.3892/ijmm.2019.4075
   Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218
   Ying HJ, 2015, J IMMUNOL, V194, P1239, DOI 10.4049/jimmunol.1402088
   Yuan XY, 2018, J LEUKOCYTE BIOL, V104, P515, DOI 10.1002/JLB.3MR0218-079R
   Yuan ZH, 2016, AM J PHYSIOL-LUNG C, V310, pL426, DOI 10.1152/ajplung.00195.2015
   Zeiher BG, 2004, CRIT CARE MED, V32, P1695, DOI 10.1097/01.CCM.0000133332.48386.85
   Zeng ZG, 2013, EXP LUNG RES, V39, P275, DOI 10.3109/01902148.2013.808285
   Zhang D, 2019, THORAX, V74, P865, DOI 10.1136/thoraxjnl-2018-212994
   Zhang JP, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2861-y
   Zheng Y, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0370-1
   Zhou Y, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2339-3
   Zhou Y, 2018, MOL THER, V26, P1375, DOI 10.1016/j.ymthe.2018.02.020
   Zollner H, 2014, METHODS MOL BIOL, V1095, P177, DOI 10.1007/978-1-62703-703-7_15
NR 144
TC 22
Z9 23
U1 1
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0003-2999
J9 ANESTH ANALG
JI Anesth. Analg.
PD NOV
PY 2020
VL 131
IS 5
BP 1471
EP 1484
DI 10.1213/ANE.0000000000005146
PG 14
WC Anesthesiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology
GA OA3OG
UT WOS:000577698500030
PM 33079870
OA Bronze, Green Accepted
DA 2023-08-21
ER

PT J
AU Zhao, G
   Weiner, AI
   Neupauer, KM
   Costa, MFD
   Palashikar, G
   Adams-Tzivelekidis, S
   Mangalmurti, NS
   Vaughan, AE
AF Zhao, Gan
   Weiner, Aaron, I
   Neupauer, Katherine M.
   Costa, Maria Fernanda de Mello
   Palashikar, Gargi
   Adams-Tzivelekidis, Stephanie
   Mangalmurti, Nilam S.
   Vaughan, Andrew E.
TI Regeneration of the pulmonary vascular endothelium after viral pneumonia
   requires COUP-TF2
SO SCIENCE ADVANCES
LA English
DT Article
ID ORPHAN NUCLEAR RECEPTOR; GROWTH-FACTOR VEGF; INTUSSUSCEPTIVE
   ANGIOGENESIS; LUNG REGENERATION; IN-VITRO; INFLUENZA; CELLS; TFII;
   NEUROPILIN-1; ACTIVATION
AB Acute respiratory distress syndrome is associated with a robust inflammatory response that damages the vascular endothelium, impairing gas exchange. While restoration of microcapillaries is critical to avoid mortality, therapeutic targeting of this process requires a greater understanding of endothelial repair mechanisms. Here, we demonstrate that lung endothelium possesses substantial regenerative capacity and lineage tracing reveals that native endothelium is the source of vascular repair after influenza injury. Ablation of chicken ovalbumin upstream promoter-transcription factor 2 (COUP-TF2) (Nr2f2), a transcription factor implicated in developmental angiogenesis, reduced endothelial proliferation, exacerbating viral lung injury in vivo. In vitro, COUP-TF2 regulates proliferation and migration through activation of cyclin D1 and neuropilin 1. Upon influenza injury, nuclear factor xB suppresses COUP-TF2, but surviving endothelial cells ultimately reestablish vascular homeostasis dependent on restoration of COUP-TF2. Therefore, stabilization of COUP-TF2 may represent a therapeutic strategy to enhance recovery from pathogens, including H1N1 influenza and SARS-CoV-2.
C1 [Zhao, Gan; Weiner, Aaron, I; Neupauer, Katherine M.; Costa, Maria Fernanda de Mello; Palashikar, Gargi; Adams-Tzivelekidis, Stephanie; Vaughan, Andrew E.] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104, United States.
   [Zhao, Gan; Weiner, Aaron, I; Costa, Maria Fernanda de Mello; Palashikar, Gargi; Adams-Tzivelekidis, Stephanie; Vaughan, Andrew E.] Univ Penn, Lung Biol Inst, Philadelphia, PA 19104, United States.
   [Zhao, Gan] Huazhong Agr Univ, Coll Vet Med, Dept Clin Vet Med, Wuhan 430070, China.
   [Mangalmurti, Nilam S.] Univ Penn, Perelman Sch Med, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104, United States.
   [Vaughan, Andrew E.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104, United States.
C3 University of Pennsylvania; University of Pennsylvania; Huazhong
   Agricultural University; University of Pennsylvania; Pennsylvania
   Medicine; University of Pennsylvania
RP Vaughan, AE (corresponding author), Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA.; Vaughan, AE (corresponding author), Univ Penn, Lung Biol Inst, Philadelphia, PA 19104 USA.; Vaughan, AE (corresponding author), Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA.
EM andrewva@vet.upenn.edu
RI De Mello Costa, Maria Fernanda/E-2721-2013; Costa, Maria Fernanda
   Furtado de Lima e/ABE-3779-2021
OI De Mello Costa, Maria Fernanda/0000-0001-5302-571X; Costa, Maria
   Fernanda Furtado de Lima e/0000-0002-3474-2980; Adams-Tzivelekidis,
   Stephanie/0000-0002-5642-7439; Zhao, Gan/0000-0002-8043-6036; Vaughan,
   Andrew/0000-0001-5740-643X; Weiner, Aaron/0000-0003-3618-5548
FU NIH [DK065988]; Margaret Q. Landenberger Research Foundation; Cystic
   Fibrosis Foundation [BOUCHE15R0]; China Scholarship Council
FX This work was supported by NIH grants R00-HL-131817 and the Margaret Q.
   Landenberger Research Foundation to A.E.V. The provision of cells by
   Randell was supported by a grant from the Cystic Fibrosis Foundation
   (BOUCHE15R0) and a grant from the NIH (DK065988). G.Z. acknowledges
   financial support (scholarship) from the China Scholarship Council.
CR Ackermann M, 2014, ANGIOGENESIS, V17, P541, DOI 10.1007/s10456-013-9399-9
   Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379
   Armstrong SM, 2013, VIRULENCE, V4, P537, DOI 10.4161/viru.25779
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   Buchweitz John P, 2007, Toxicol Pathol, V35, P424, DOI 10.1080/01926230701302558
   Ceni E, 2017, J HEPATOL, V66, P754, DOI 10.1016/j.jhep.2016.11.003
   Chen XP, 2012, MOL ENDOCRINOL, V26, P1268, DOI 10.1210/me.2011-1305
   CRAPO JD, 1982, AM REV RESPIR DIS, V126, P332
   Di Peppe SR, 2002, GENE THER, V9, P1271, DOI 10.1038/sj.gt.3301798
   Ellis LV, 2020, DEV CELL, V52, P617, DOI 10.1016/j.devcel.2020.01.009
   Fang B, 2012, NUCLEIC ACIDS RES, V40, P5343, DOI 10.1093/nar/gks190
   Fantin A, 2013, BLOOD, V121, P2352, DOI 10.1182/blood-2012-05-424713
   Feldmann A, 2000, J VIROL, V74, P8018, DOI 10.1128/JVI.74.17.8018-8027.2000
   Flory E, 2000, J BIOL CHEM, V275, P8307, DOI 10.1074/jbc.275.12.8307
   Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224
   Garcia GL, 2020, AM J PATHOL, V190, P543, DOI 10.1016/j.ajpath.2019.11.003
   Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016
   Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2
   He LJ, 2017, J CLIN INVEST, V127, P2968, DOI 10.1172/JCI93868
   Henke N, 2007, CIRC RES, V101, P268, DOI 10.1161/CIRCRESAHA.107.150474
   Herold S, 2015, EUR RESPIR J, V45, P1463, DOI 10.1183/09031936.00186214
   Hou YZ, 2018, IMMUNITY, V49, P490, DOI 10.1016/j.immuni.2018.07.008
   Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258
   Indalao IL, 2017, ARCH VIROL, V162, P201, DOI 10.1007/s00705-016-3093-3
   Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518
   Ishizawa K, 2004, FEBS LETT, V556, P249, DOI 10.1016/S0014-5793(03)01399-1
   Jubb AM, 2012, J PATHOL, V226, P50, DOI 10.1002/path.2989
   Katsura H, 2019, STEM CELL REP, V12, P657, DOI 10.1016/j.stemcr.2019.02.013
   Keeler SP, 2018, J IMMUNOL, V201, P2354, DOI 10.4049/jimmunol.1800671
   Kim KS, 2015, J MED VIROL, V87, P1104, DOI 10.1002/jmv.24138
   Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227
   Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001
   Lampropoulou A, 2014, BIOCHEM SOC T, V42, P1623, DOI 10.1042/BST20140244
   Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910
   Lin FJ, 2012, ARTERIOSCL THROM VAS, V32, pE135, DOI 10.1161/ATVBAHA.112.300255
   Lin SC, 2014, J CLIN ENDOCR METAB, V99, pE427, DOI 10.1210/jc.2013-3717
   LOOSLI CG, 1975, CHEST, V67, pS7, DOI 10.1378/chest.67.2_Supplement.7S
   Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467
   Mangalmurti NS, 2020, AM J RESP CRIT CARE, V202, P750, DOI 10.1164/rccm.202006-2598LE
   Mangalmurti NS, 2013, AM J PHYSIOL-LUNG C, V304, pL250, DOI 10.1152/ajplung.00278.2012
   McDonald A. I., CELL STEM CELL, V23
   Mentzer SJ, 2014, ANGIOGENESIS, V17, P499, DOI 10.1007/s10456-014-9428-3
   Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982
   Moutal A., 2020, 209288 BIORXIV
   Niethamer TK, 2020, ELIFE, V9, DOI 10.7554/eLife.53072
   Norlin M., 2010, ATLAS GENETICS CYTOG
   Oh H, 2002, P NATL ACAD SCI USA, V99, P383, DOI 10.1073/pnas.012074399
   Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624
   Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037
   Pi JJ, 2018, THERANOSTICS, V8, P1511, DOI 10.7150/thno.21986
   Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096
   Poulos MG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13829
   Prahst C, 2008, J BIOL CHEM, V283, P25110, DOI 10.1074/jbc.C800137200
   Qanadli SD, 2020, AM J ROENTGENOL, V215, pW15, DOI 10.2214/AJR.20.23185
   Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040
   Raimondi C, 2014, J EXP MED, V211, P1167, DOI 10.1084/jem.20132330
   Rane CK, 2019, AM J PHYSIOL-LUNG C, V316, pL1141, DOI 10.1152/ajplung.00032.2019
   Robinson CJ, 2001, J CELL SCI, V114, P853
   Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Shi XL, 2013, CRIT CARE, V17, DOI 10.1186/cc13171
   Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X
   Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508
   Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6
   Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140
   Starzec A, 2007, PEPTIDES, V28, P2397, DOI 10.1016/j.peptides.2007.09.013
   Su TY, 2018, NATURE, V559, P356, DOI 10.1038/s41586-018-0288-7
   Sugiyama MG, 2016, J VIROL, V90, P1812, DOI 10.1128/JVI.02599-15
   Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808
   Tang K, 2015, BBA-GENE REGUL MECH, V1849, P201, DOI 10.1016/j.bbagrm.2014.05.022
   Tang K, 2012, DEVELOPMENT, V139, P1630, DOI 10.1242/dev.075564
   Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015
   Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112
   Vogel AJ, 2014, VIRAL IMMUNOL, V27, P214, DOI 10.1089/vim.2013.0095
   Weiner AI, 2019, NPJ REGEN MED, V4, DOI 10.1038/s41536-019-0080-9
   Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498
   Wu SP, 2013, DEV CELL, V25, P417, DOI 10.1016/j.devcel.2013.04.017
   Xi Y, 2017, NAT CELL BIOL, V19, P904, DOI 10.1038/ncb3580
   Xie X, 2016, J CLIN INVEST, V126, P3929, DOI 10.1172/JCI87414
   Xie XZ, 2020, RADIOLOGY, V296, pE41, DOI 10.1148/radiol.2020200343
   Yalamanchili Hari Krishna, 2017, Curr Protoc Bioinformatics, V59, DOI 10.1002/cpbi.33
   Yang Y, 2016, CELL MOL IMMUNOL, V13, P432, DOI 10.1038/cmi.2016.1
   Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037
   You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511
   Zhong L, 2018, FASEB J, V32, P4070, DOI 10.1096/fj.201701536R
   Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6
NR 87
TC 17
Z9 17
U1 0
U2 8
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD NOV
PY 2020
VL 6
IS 48
AR eabc4493
DI 10.1126/sciadv.abc4493
PG 15
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA PA9DR
UT WOS:000595928400016
PM 33239293
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Li, JZ
   Meng, SS
   Xu, XP
   Huang, YB
   Mao, P
   Li, YM
   Yang, Y
   Qiu, HB
   Pan, C
AF Li, Jinze
   Meng, Shanshan
   Xu, Xiu-Ping
   Huang, Yongbo
   Mao, Pu
   Li, Yi-min
   Yang, Yi
   Qiu, Haibo
   Pan, Chun
TI Mechanically Stretched Mesenchymal Stem Cells Can Reduce the Effects of
   LPS-Induced Injury on the Pulmonary Microvascular Endothelium Barrier
SO STEM CELLS INTERNATIONAL
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; CRITICALLY-ILL ADULTS; ACUTE LUNG INJURY;
   MECHANISMS; THERAPY; EPIDEMIOLOGY; WORKSHOP; BIOLOGY; CARE
AB Mesenchymal stem cells (MSCs) may improve the treatment of acute respiratory distress syndrome (ARDS). However, few studies have investigated the effects of mechanically stretched -MSCs (MS-MSCs) in in vitro models of ARDS. The aim of this study was to evaluate the potential therapeutic effects of MS-MSCs on pulmonary microvascular endothelium barrier injuries induced by LPS. We introduced a cocultured model of pulmonary microvascular endothelial cell (EC) and MSC medium obtained from MSCs with or without mechanical stretch. We found that Wright-Giemsa staining revealed that MSC morphology changed significantly and cell plasma shrank separately after mechanical stretch. Cell proliferation of the MS-MSC groups was much lower than the untreated MSC group; expression of cell surface markers did not change significantly. Compared to the medium from untreated MSCs, inflammatory factors elevated statistically in the medium from MS-MSCs. Moreover, the paracellular permeability of endothelial cells treated with LPS was restored with a medium from MS-MSCs, while LPS-induced EC apoptosis decreased. In addition, protective effects on the remodeling of intercellular junctions were observed when compared to LPS-treated endothelial cells. These data demonstrated that the MS-MSC groups had potential therapeutic effects on the LPS-treated ECs; these results might be useful in the treatment of ARDS.
C1 [Li, Jin-ze; Meng, Shan-shan; Xu, Xiu-Ping; Yang, Yi; Qiu, Hai-bo; Pan, Chun] Southeast Univ, Jiangsu Prov Key Lab Crit Care Med, Zhongda Hosp, Dept Crit Care Med,Sch Med, Nanjing 210009, China.
   [Huang, Yong-bo; Mao, Pu; Li, Yi-min] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou Inst Resp Dis,Dept Crit Care Med, Guangzhou 510120, China.
C3 Southeast University - China; Guangzhou Medical University; State Key
   Laboratory of Respiratory Disease
RP Pan, C (corresponding author), Southeast Univ, Jiangsu Prov Key Lab Crit Care Med, Zhongda Hosp, Dept Crit Care Med,Sch Med, Nanjing 210009, Peoples R China.
EM jinzelee@163.com; mengshanshan0101@163.com; xiupxu@126.com;
   yongbo2046@163.com; maopu1981@126.com; dryiminli@vip.163.com;
   yiyiyang2004@163.com; haiboq2000@163.com; panchun1982@gmail.com
RI Qiu, Haibo/AAS-9047-2021
OI Qiu, Haibo/0000-0001-8589-4717; Pan, Chun/0000-0002-6077-5882; mao,
   pu/0000-0002-5017-1073
FU National Natural Science Foundation of China [81300043, 81571847];
   Jiangsu Province's Medical Key Discipline (laboratory) [ZDXKA2016025];
   Key Laboratory of Environmental Medicine Engineering [2020EME001]
FX The authors would like to thank Dr. Ruoyu Hu for his valuable support.
   The study was supported by the National Natural Science Foundation of
   China (Grant/Award Numbers: 81300043, 81571847), Jiangsu Province's
   Medical Key Discipline (laboratory) (Grant/Award Number: ZDXKA2016025),
   and Key Laboratory of Environmental Medicine Engineering (Grant/Award
   Number: 2020EME001).
CR Armstrong SM, 2012, AM J PATHOL, V180, P1308, DOI 10.1016/j.ajpath.2011.12.002
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Brooks D, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01298-2019
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Chen N, 2020, LANCET, V395, P507, DOI DOI 10.1016/S0140-6736(20)30211-7
   Chen QH, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0025-1
   Cummings Matthew J, 2020, Lancet, V395, P1763, DOI [10.1101/2020.04.15.20067157, 10.1016/S0140-6736(20)31189-2]
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Fan E, 2018, JAMA-J AM MED ASSOC, V319, P698, DOI 10.1001/jama.2017.21907
   Goetzke R, 2018, CELL MOL LIFE SCI, V75, P3297, DOI 10.1007/s00018-018-2830-z
   Greco A, 2020, INTENS CARE MED, V46, P854, DOI DOI 10.1007/s00134-020-06022-5
   Grune J, 2019, INTENS CARE MED EXP, V7, DOI 10.1186/s40635-019-0226-5
   Hu CX, 2019, J CELL MOL MED, V23, P1657, DOI 10.1111/jcmm.14115
   Hu SL, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0320-5
   Jozwiak M, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0081-9
   Knudsen L, 2018, HISTOCHEM CELL BIOL, V150, P661, DOI 10.1007/s00418-018-1747-9
   Laffey JG, 2017, AM J RESP CRIT CARE, V196, P266, DOI 10.1164/rccm.201701-0107CP
   Lane SW, 2014, NAT BIOTECHNOL, V32, P795, DOI 10.1038/nbt.2978
   Li CW, 2020, BIOMATERIALS, V258, DOI 10.1016/j.biomaterials.2020.120292
   Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589
   Matthay MA, 2019, LANCET RESP MED, V7, P154, DOI 10.1016/S2213-2600(18)30418-1
   Matthay MA, 2013, AM J RESP CRIT CARE, V188, P370, DOI 10.1164/rccm.201303-0522WS
   Matthay Michael A, 2008, Proc Am Thorac Soc, V5, P297, DOI 10.1513/pats.200708-141DR
   Maul TM, 2011, BIOMECH MODEL MECHAN, V10, P939, DOI 10.1007/s10237-010-0285-8
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Meng FY, 2015, AM J PHYSIOL-LUNG C, V308, pL452, DOI 10.1152/ajplung.00170.2014
   Meng SS, 2019, J CELL BIOCHEM, V120, P3637, DOI 10.1002/jcb.27642
   Mora Carpio AL., 2020, VENTILATOR MANAGEMEN
   MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221
   Nieponice A, 2007, J BIOMED MATER RES A, V81A, P523, DOI 10.1002/jbm.a.31041
   O'Cearbhaill ED, 2008, BIOMATERIALS, V29, P1610, DOI 10.1016/j.biomaterials.2007.11.042
   Parthasarathi K, 2012, AM J PHYSIOL-LUNG C, V303, pL33, DOI 10.1152/ajplung.00219.2011
   Pati S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025171
   Peired AJ, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4798639
   Radeva MY, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.12860
   Ryan AL, 2019, AM J RESP CELL MOL, V61, P429, DOI 10.1165/rcmb.2019-0286ST
   Saparov A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3924858
   Sohni A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/130763
   Spinelli E, 2020, INTENS CARE MED, V46, P606, DOI 10.1007/s00134-020-05942-6
   Steingen C, 2008, J MOL CELL CARDIOL, V44, P1072, DOI 10.1016/j.yjmcc.2008.03.010
   Walter J, 2014, LANCET RESP MED, V2, P1016, DOI 10.1016/S2213-2600(14)70217-6
   Yang ZY, 2014, J IMMUNOL, V193, P1931, DOI 10.4049/jimmunol.1302863
   Zayed Y., 2019, RESP DISTRESS SYNDRO
   Zhang R, 2015, AM J RESP CRIT CARE, V192, P315, DOI 10.1164/rccm.201412-2326OC
   Zheng GP, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-39
NR 45
TC 3
Z9 3
U1 1
U2 8
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-966X
EI 1687-9678
J9 STEM CELLS INT
JI Stem Cells Int.
PD OCT 30
PY 2020
VL 2020
AR 8861407
DI 10.1155/2020/8861407
PG 12
WC Cell & Tissue Engineering
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA OT6IR
UT WOS:000590948300001
PM 33178288
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Hojyo, S
   Uchida, M
   Tanaka, K
   Hasebe, R
   Tanaka, Y
   Murakami, M
   Hirano, T
AF Hojyo, Shintaro
   Uchida, Mona
   Tanaka, Kumiko
   Hasebe, Rie
   Tanaka, Yuki
   Murakami, Masaaki
   Hirano, Toshio
TI How COVID-19 induces cytokine storm with high mortality
SO INFLAMMATION AND REGENERATION
LA English
DT Review
ID ANGIOTENSIN-CONVERTING ENZYME-2; ACUTE RESPIRATORY SYNDROME; FUNCTIONAL
   RECEPTOR; SARS CORONAVIRUS; VIRAL LOAD; INFLAMMATION; TOCILIZUMAB;
   ACTIVATION; ACE2; INHIBITION
AB The newly emerging coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, but has rapidly spread all over the world. Some COVID-19 patients encounter a severe symptom of acute respiratory distress syndrome (ARDS) with high mortality. This high severity is dependent on a cytokine storm, most likely induced by the interleukin-6 (IL-6) amplifier, which is hyperactivation machinery that regulates the nuclear factor kappa B (NF-kappa B) pathway and stimulated by the simultaneous activation of IL-6-signal transducer and activator of transcription 3 (STAT3) and NF-kappa B signaling in non-immune cells including alveolar epithelial cells and endothelial cells. We hypothesize that IL-6-STAT3 signaling is a promising therapeutic target for the cytokine storm in COVID-19, because IL-6 is a major STAT3 stimulator, particularly during inflammation. We herein review the pathogenic mechanism and potential therapeutic targets of ARDS in COVID-19 patients.
C1 [Hojyo, Shintaro; Uchida, Mona; Tanaka, Kumiko; Hasebe, Rie; Tanaka, Yuki; Murakami, Masaaki; Hirano, Toshio] Hokkaido Univ, Inst Genet Med, Grad Sch Med, Mol Psychoimmunol, Sapporo, Hokkaido 0600815, Japan.
   [Hirano, Toshio] Natl Inst Quantum & Radiol Sci & Technol, Chiba 2638555, Japan.
C3 Hokkaido University; National Institutes for Quantum Science &
   Technology
RP Murakami, M; Hirano, T (corresponding author), Hokkaido Univ, Inst Genet Med, Grad Sch Med, Mol Psychoimmunol, Sapporo, Hokkaido 0600815, Japan.
EM murakami@igm.hokudai.ac.jp; hirano-toshio@qst.go.jp
RI Uchida, Mona/AAK-1828-2021; Hirano, Toshio/C-8194-2009
OI , Masaaki/0000-0001-7159-7279; HASEBE, Rie/0000-0003-2009-0595
CR [Anonymous], 2020, JAMA, DOI DOI 10.1038/s41422-020-0282-0
   [Anonymous], 2020, IMMUNITY, DOI DOI 10.1016/J.IMMUNI.2020.04.003
   [Anonymous], 2020, J KOREAN MED SCI
   Arima Y, 2017, ELIFE, V6, DOI 10.7554/eLife.25517
   Arima Y, 2015, ELIFE, V4, DOI 10.7554/eLife.08733
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chu KH, 2005, KIDNEY INT, V67, P698, DOI 10.1111/j.1523-1755.2005.67130.x
   De Benedetti F, 2012, NEW ENGL J MED, V367, P2385, DOI 10.1056/NEJMoa1112802
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   DeDiego ML, 2014, J VIROL, V88, P913, DOI 10.1128/JVI.02576-13
   Eguchi S, 2018, HYPERTENSION, V71, P804, DOI 10.1161/HYPERTENSIONAHA.118.10266
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Fujita M, 2019, J INVEST DERMATOL, V139, P333, DOI 10.1016/j.jid.2018.07.044
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI [10.1056/NEJMc2005203, 10.1056/NEJMoa2002032]
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Harada M, 2015, J IMMUNOL, V194, P1039, DOI 10.4049/jimmunol.1400562
   Herold T, 2020, J ALLERGY CLIN IMMUN, V146, P128, DOI 10.1016/j.jaci.2020.05.008
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Iwasaki A, 2020, NAT REV IMMUNOL, V20, P339, DOI 10.1038/s41577-020-0321-6
   Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2
   Kennedy GA, 2014, LANCET ONCOL, V15, P1451, DOI 10.1016/S1470-2045(14)71017-4
   Kim JY, 2020, J KOREAN MED SCI, V35
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Lamb YN, 2018, DRUGS, V78, P929, DOI 10.1007/s40265-018-0929-z
   Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504
   Lee J, 2013, INT IMMUNOL, V25, P319, DOI 10.1093/intimm/dxs158
   Levi M, 2008, SEMIN THROMB HEMOST, V34, P26, DOI 10.1055/s-2008-1066020
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Liu BW, 2020, J AUTOIMMUN, V111, DOI 10.1016/j.jaut.2020.102452
   Liu PP, 2020, CIRCULATION, V142, P68, DOI 10.1161/CIRCULATIONAHA.120.047549
   Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Luo P, 2020, J MED VIROL, V92, P814, DOI 10.1002/jmv.25801
   Magro G, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198070
   Mahmudpour M, 2020, CYTOKINE, V133, DOI 10.1016/j.cyto.2020.155151
   Matsuzawa Y, HYPERTENS RES
   McGonagle D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102537
   Meng J, 2020, EMERG MICROBES INFEC, V9, P757, DOI 10.1080/22221751.2020.1746200
   Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4
   Mogul A, 2019, ANN PHARMACOTHER, V53, P947, DOI 10.1177/1060028019839650
   Murakami M, 2019, IMMUNITY, V50, P812, DOI 10.1016/j.immuni.2019.03.027
   Murakami M, 2013, CELL REP, V3, P946, DOI 10.1016/j.celrep.2013.01.028
   Neelapu SS, 2018, NAT REV CLIN ONCOL, V15, P47, DOI 10.1038/nrclinonc.2017.148
   Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018
   Ota M, 2020, ARTHRITIS RHEUMATOL, V72, P931, DOI 10.1002/art.41182
   Pan Y, 2020, LANCET INFECT DIS, V20, P411, DOI 10.1016/S1473-3099(20)30113-4
   Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5
   Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272
   Qin C, 2020, CLIN INFECT DIS CHIN
   Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005
   Sheng F, 2016, PHARMAZIE, V71, P636, DOI 10.1691/ph.2016.6713
   Tang N., 2020, JAMA-J AM MED ASSOC, V18, P844, DOI [DOI 10.1001/JAMA.2020.7869, 10.1111/jth.14768]
   Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8
   Toniati P, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102568
   van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36
   Verdecchia Paolo, 2020, Eur J Intern Med, V76, P14, DOI 10.1016/j.ejim.2020.04.037
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wrapp D, 2020, BIORXIV
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yi XH, 2010, AM J RESP CRIT CARE, V182, P436, DOI 10.1164/ajrccm.182.3.436
   Zhang BC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235458
   Zhang P, 2020, CIRC RES, V126, P1671, DOI 10.1161/CIRCRESAHA.120.317134
   Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575
   Zhang YC, 2004, INFECT IMMUN, V72, P4410, DOI 10.1128/IAI.72.8.4410-4415.2004
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou P, 2020, NATURE, V579, P270, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI [10.1148/radiol.2020200463, 10.1056/NEJMc2001737]
NR 76
TC 356
Z9 362
U1 2
U2 23
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1880-8190
J9 INFLAMM REGEN
JI Inflamm. Regen.
PD OCT 1
PY 2020
VL 40
IS 1
AR 37
DI 10.1186/s41232-020-00146-3
PG 7
WC Immunology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Research & Experimental Medicine
GA NZ2DO
UT WOS:000576905800001
PM 33014208
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Acosta, MAT
   Singer, BD
AF Acosta, Manuel A. Torres
   Singer, Benjamin D.
TI Pathogenesis of COVID-19-induced ARDS: implications for an ageing
   population
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Article
ID MACROPHAGE ACTIVATION SYNDROME; RESPIRATORY-DISTRESS-SYNDROME;
   REGULATORY T-CELLS; INFLUENZA-VIRUS; LUNG INJURY; IN-VIVO; INTERFERON;
   INFECTION; CORONAVIRUS; SARS-COV-2
AB The coronavirus disease 2019 (COVID-19) pandemic has elicited a swift response by the scientific community to elucidate the pathogenesis of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)-induced lung injury and develop effective therapeutics. Clinical data indicate that severe COVID-19 most commonly manifests as viral pneumonia-induced acute respiratory distress syndrome (ARDS), a clinical entity mechanistically understood best in the context of influenza A virus-induced pneumonia. Similar to influenza, advanced age has emerged as the leading host risk factor for developing severe COVID-19. In this review we connect the current understanding of the SARS-CoV-2 replication cycle and host response to the clinical presentation of COVID-19, borrowing concepts from influenza A virus-induced ARDS pathogenesis and discussing how these ideas inform our evolving understanding of COVID-19-induced ARDS. We also consider important differences between COVID-19 and influenza, mainly the protean clinical presentation and associated lymphopenia of COVID-19, the contrasting role of interferon-gamma in mediating the host immune response to these viruses, and the tropism for vascular endothelial cells of SARS-CoV-2, commenting on the potential limitations of influenza as a model for COVID-19. Finally, we explore hallmarks of ageing that could explain the association between advanced age and susceptibility to severe COVID-19.
C1 [Acosta, Manuel A. Torres; Singer, Benjamin D.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Pulm & Crit Care Med, Chicago, IL 60611, United States.
   [Singer, Benjamin D.] Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611, United States.
   [Singer, Benjamin D.] Northwestern Univ, Feinberg Sch Med, Simpson Querrey Ctr Epigenet, Chicago, IL 60611, United States.
C3 Northwestern University; Feinberg School of Medicine; Northwestern
   University; Feinberg School of Medicine; Northwestern University;
   Feinberg School of Medicine
RP Singer, BD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med,Simpson Querrey Ctr Epigenet, Div Pulm & Crit Care Med,Dept Biochem & Mol Genet, Simpson Querrey,5th Floor, Chicago, IL 60611 USA.
EM benjamin-singer@northwestern.edu
FU NIH [K08HL128867, U19AI135964, R01HL149883, P01AG049665, T32GM008152]
FX M.A. Torres Acosta was supported by NIH award T32GM008152. B.D. Singer
   was supported by NIH awards K08HL128867, U19AI135964, R01HL149883, and
   P01AG049665. Funding information for this article has been deposited
   with the Crossref Funder Registry.
CR Abdul-Careem MF, 2012, J INFECT DIS, V206, P167, DOI 10.1093/infdis/jis340
   Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Aggarwal NR, 2014, J IMMUNOL, V192, P4453, DOI 10.4049/jimmunol.1400146
   Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106
   Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002
   [Anonymous], 2012, JAMA, DOI DOI 10.1001/JAMA.2012.5669
   [Anonymous], 2020, NAT MED, DOI [10.1038/s41591-020-0869-5, DOI 10.1038/S41591-020-0869-5]
   [Anonymous], 2020, LANCET, DOI [10.1016/S0140-6736(20)30211-7, DOI 10.1016/S0140-6736(20)30211-7]
   Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021
   Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026
   Broggi A, 2020, SCIENCE, V369, P706, DOI 10.1126/science.abc3545
   Cai YS, 2020, CELL RES, V30, P574, DOI 10.1038/s41422-020-0314-9
   Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9
   Camp JV, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00550
   Carlin LE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00781
   Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Crayne CB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00119
   D'Alessio FR, 2016, AM J PHYSIOL-LUNG C, V310, pL733, DOI 10.1152/ajplung.00419.2015
   D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498
   Davidson S, 2016, EMBO MOL MED, V8, P1099, DOI 10.15252/emmm.201606413
   De Felice FG, 2020, TRENDS NEUROSCI, V43, P355, DOI 10.1016/j.tins.2020.04.004
   Dial CF, 2017, AM J RESP CELL MOL, V57, P162, DOI 10.1165/rcmb.2017-0019OC
   Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101
   Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283
   Felgenhauer U, 2020, J BIOL CHEM, V295, P13958, DOI 10.1074/jbc.AC120.013788
   Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025
   Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2
   GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365
   Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Goshua George, 2020, Lancet Haematol, V7, pe575, DOI 10.1016/S2352-3026(20)30216-7
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x
   Hemann EA, 2019, NAT IMMUNOL, V20, P1035, DOI 10.1038/s41590-019-0408-z
   Herold S, 2015, EUR RESPIR J, V45, P1463, DOI 10.1183/09031936.00186214
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4
   Jain Juhi, 2020, VirusDisease, V31, P75, DOI 10.1007/s13337-020-00591-1
   Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927
   Khan SS, 2017, AGING CELL, V16, P624, DOI 10.1111/acel.12601
   Kim TS, 2011, TRENDS IMMUNOL, V32, P225, DOI 10.1016/j.it.2011.02.006
   Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312
   Lagunas-Rangel FA, 2020, J MED VIROL, V92, P1789, DOI 10.1002/jmv.25900
   Lerkvaleekul B, 2018, OPEN ACCESS RHEUMATO, V10, P117, DOI 10.2147/OARRR.S151013
   Li JY, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198074
   Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   McGrath-Morrow SA, 2018, J BIOL CHEM, V293, P11772, DOI 10.1074/jbc.RA118.003589
   Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134
   Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061
   Mock JR, 2014, MUCOSAL IMMUNOL, V7, P1440, DOI 10.1038/mi.2014.33
   Moitra VK, 2016, CRIT CARE MED, V44, P655, DOI 10.1097/CCM.0000000000001480
   Morales-Nebreda L, 2019, TRANSL RES, V204, P1, DOI 10.1016/j.trsl.2018.08.001
   Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013
   Nicol MQ, 2019, VIROLOGY, V526, P155, DOI 10.1016/j.virol.2018.10.017
   Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683
   Palmer DB, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00316
   Pothlichet J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003256
   Prabhu N, 2013, J VIROL, V87, P12510, DOI 10.1128/JVI.01776-13
   Proto JD, 2018, IMMUNITY, V49, P666, DOI 10.1016/j.immuni.2018.07.015
   Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623
   Schulert GS, 2016, J INFECT DIS, V213, P1180, DOI 10.1093/infdis/jiv550
   Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115
   Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Singer BD, 2019, J CLIN INVEST, V129, P2597, DOI 10.1172/JCI124613
   Singer BD, 2015, AM J RESP CELL MOL, V52, P641, DOI 10.1165/rcmb.2014-0327OC
   Sinha P, 2020, JAMA INTERN MED, V180, P1152, DOI 10.1001/jamainternmed.2020.3313
   Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4
   Tang X, 2020, CHEST, V158, P195, DOI 10.1016/j.chest.2020.03.032
   Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558
   To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1
   Topham DJ, 1997, J IMMUNOL, V159, P5197
   Tsioufis C, 2007, EUR HEART J, V28, P1162, DOI 10.1093/eurheartj/ehm089
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Voiriot G, 2020, INTERN EMERG MED, V15, P1333, DOI 10.1007/s11739-020-02356-6
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Walter JM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123287
   Wang JK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030209, 10.1371/journal.pone.0031048]
   Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z
   WORLD HEALTH ORGANIZATION, COR DIS COVID 19 PAN
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Yan Jun, 2010, Immun Ageing, V7, P4, DOI 10.1186/1742-4933-7-4
   Yang Xiaobo, 2020, Lancet Respir Med, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
   Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Ziehr DR, 2020, AM J RESP CRIT CARE, V201, P1560, DOI 10.1164/rccm.202004-1163LE
   Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI [10.1148/radiol.2020200463, 10.1056/NEJMc2001737]
   Zust R, 2007, PLOS PATHOG, V3, P1062, DOI 10.1371/journal.ppat.0030109
NR 91
TC 121
Z9 123
U1 1
U2 20
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD SEP 1
PY 2020
VL 56
IS 3
AR 2002049
DI 10.1183/13993003.02049-2020
PG 12
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA OR0NN
UT WOS:000589173000016
PM 32747391
OA Green Published, hybrid
DA 2023-08-21
ER

PT J
AU Ito, H
   Kimura, H
   Karasawa, T
   Hisata, S
   Sadatomo, A
   Inoue, Y
   Yamada, N
   Aizawa, E
   Hishida, E
   Kamata, R
   Komada, T
   Watanabe, S
   Kasahara, T
   Suzuki, T
   Horie, H
   Kitayama, J
   Sata, N
   Yamaji-Kegan, K
   Takahashi, M
AF Ito, Homare
   Kimura, Hiroaki
   Karasawa, Tadayoshi
   Hisata, Shu
   Sadatomo, Ai
   Inoue, Yoshiyuki
   Yamada, Naoya
   Aizawa, Emi
   Hishida, Erika
   Kamata, Ryo
   Komada, Takanori
   Watanabe, Sachiko
   Kasahara, Tadashi
   Suzuki, Takuji
   Horie, Hisanaga
   Kitayama, Joji
   Sata, Naohiro
   Yamaji-Kegan, Kazuyo
   Takahashi, Masafumi
TI NLRP3 Inflammasome Activation in Lung Vascular Endothelial Cells
   Contributes to Intestinal Ischemia/Reperfusion-Induced Acute Lung Injury
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID MICE DEFICIENT; ISCHEMIA; IL-1-BETA; MECHANISM; APOPTOSIS; PROTEIN; ASC
AB Intestinal ischemia/reperfusion (I/R) injury is a life-threatening complication that leads to inflammation and remote organ damage. The NLRP3 inflammasome regulates the caspase-1-dependent release of IL-1 beta, an early mediator of inflammation after I/R injury. In this study, we investigated the role of the NLRP3 inflammasome in mice with intestinal I/R injury. Deficiency of NLRP3, ASC, caspase-1/11, or IL-1 beta prolonged survival after intestinal I/R injury, but neither NLRP3 nor caspase-1/11 deficiency affected intestinal inflammation. Intestinal I/R injury caused acute lung injury (ALI) characterized by inflammation, reactive oxygen species generation, and vascular permeability, which was markedly improved by NLRP3 deficiency. Bone marrow chimeric experiments showed that NLRP3 in non-bone marrow-derived cells was the main contributor to development of intestinal I/R-induced ALI. The NLRP3 inflammasome in lung vascular endothelial cells is thought to be important to lung vascular permeability. Using mass spectrometry, we identified intestinal I/R-derived lipid mediators that enhanced NLRP3 inflammasome activation in lung vascular endothelial cells. Finally, we confirmed that serum levels of these lipid mediators were elevated in patients with intestinal ischemia. To our knowledge, these findings provide new insights into the mechanism underlying intestinal I/R-induced ALI and suggest that endothelial NLRP3 inflammasome-driven IL-1 beta is a novel potential target for treating and preventing this disorder.
C1 [Ito, Homare; Kimura, Hiroaki; Karasawa, Tadayoshi; Sadatomo, Ai; Inoue, Yoshiyuki; Yamada, Naoya; Aizawa, Emi; Hishida, Erika; Kamata, Ryo; Komada, Takanori; Watanabe, Sachiko; Kasahara, Tadashi; Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.
   [Ito, Homare; Sadatomo, Ai; Inoue, Yoshiyuki; Horie, Hisanaga; Kitayama, Joji; Sata, Naohiro] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi 3290498, Japan.
   [Hisata, Shu; Suzuki, Takuji] Jichi Med Univ, Dept Med, Div Pulm Med, Shimotsuke, Tochigi 3290498, Japan.
   [Yamaji-Kegan, Kazuyo] Univ Maryland, Dept Anesthesiol, Sch Med, Baltimore, MD 21201, United States.
C3 Jichi Medical University; Jichi Medical University; Jichi Medical
   University; University System of Maryland; University of Maryland
   Baltimore
RP Takahashi, M (corresponding author), Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.
EM masafumi2@jichi.ac.jp
RI sachiko, watanabe/AAM-8862-2021; Watanabe, Sachiko/GRE-6723-2022
OI sachiko, watanabe/0000-0002-6110-9603; Watanabe,
   Sachiko/0000-0002-6110-9603; Karasawa, Tadayoshi/0000-0002-6738-2360;
   Kamata, Ryo/0000-0001-6970-9657
FU Japan Society for the Promotion of Science [18K08112]; Private
   University Research Branding Project; Japan Agency for Medical Research
   and Development Core Research for Evolutional Science and Technology
   Grant [18gm0610012h0105]; Takeda Science Foundation; Jichi Medical
   University Graduate Student Start-up Award; Jichi Medical University
   Graduate Student Research Award; Grants-in-Aid for Scientific Research
   [18K08112] Funding Source: KAKEN
FX This work was supported by Japan Society for the Promotion of Science
   Grant-in-Aid for Scientific Research 18K08112 (to M.T.), a Private
   University Research Branding Project (to M.T.), Japan Agency for Medical
   Research and Development Core Research for Evolutional Science and
   Technology Grant 18gm0610012h0105 (to M.T.), the Takeda Science
   Foundation (to M.T.), a Jichi Medical University Graduate Student
   Start-up Award (to H.I.), and a Jichi Medical University Graduate
   Student Research Award (to H.I.).
CR Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849
   Chen YT, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-270
   Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495
   Clair DG, 2016, NEW ENGL J MED, V374, P959, DOI 10.1056/NEJMra1503884
   Cui TP, 2010, AM J RESP CRIT CARE, V181, P238, DOI 10.1164/rccm.200804-625OC
   Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859
   Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507
   Englert JA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124061
   Gonzalez LM, 2015, AM J PHYSIOL-GASTR L, V308, pG63, DOI 10.1152/ajpgi.00112.2013
   Gubernatorova EO, 2016, JOVE-J VIS EXP, DOI 10.3791/53881
   Guo YD, 2011, J BIOL CHEM, V286, P33832, DOI 10.1074/jbc.M110.216564
   He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002
   Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463
   Huang H, 2013, J IMMUNOL, V191, P2665, DOI 10.4049/jimmunol.1202733
   Inoue Y, 2014, J IMMUNOL, V192, P4342, DOI 10.4049/jimmunol.1302039
   Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106
   Jia YF, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101534
   Jin LL, 2017, J IMMUNOL, V198, P1253, DOI 10.4049/jimmunol.1601745
   Kamo N, 2013, HEPATOLOGY, V58, P351, DOI 10.1002/hep.26320
   Kannan L, 2013, P NATL ACAD SCI USA, V110, P14348, DOI 10.1073/pnas.1309393110
   Karasawa T, 2018, ARTERIOSCL THROM VAS, V38, P744, DOI 10.1161/ATVBAHA.117.310581
   Karasawa T, 2017, J ATHEROSCLER THROMB, V24, P443, DOI 10.5551/jat.RV17001
   Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777
   Kawashima A, 2017, J IMMUNOL, V199, P3614, DOI 10.4049/jimmunol.1700184
   Komada T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10901
   Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014
   KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475
   Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124
   Latchoumycandane C, 2007, HEPATOLOGY, V45, P412, DOI 10.1002/hep.21475
   Leaphart CL, 2007, SURGERY, V141, P563, DOI 10.1016/j.surg.2007.01.021
   Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039
   Lee S, 2017, AM J RESP CRIT CARE, V196, P713, DOI 10.1164/rccm.201604-0892OC
   Lopategi A, 2019, J LEUKOCYTE BIOL, V105, P25, DOI 10.1002/JLB.3HI0517-206RR
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST
   Mizushina Y, 2015, J BIOL CHEM, V290, P5065, DOI 10.1074/jbc.M114.603217
   Pelosi P, 2003, EUR RESPIR J, V42, P48, DOI DOI 10.1183/09031936.03.0042
   Perl M, 2011, EXPERT REV RESP MED, V5, P115, DOI [10.1586/ers.10.92, 10.1586/ERS.10.92]
   Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046
   Rossaint J, 2012, CRIT CARE, V16, DOI 10.1186/cc11518
   Sadatomo A, 2017, J IMMUNOL, V199, P3306, DOI 10.4049/jimmunol.1700717
   Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616
   Takahashi M, 2014, INT HEART J, V55, P101, DOI 10.1536/ihj.13-388
   Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]
   Tsutsui H, 1999, IMMUNITY, V11, P359, DOI 10.1016/S1074-7613(00)80111-9
   Tuboly E, 2016, MICROBIOL IMMUNOL, V60, P35, DOI 10.1111/1348-0421.12338
   Usui F, 2015, ARTERIOSCL THROM VAS, V35, P127, DOI 10.1161/ATVBAHA.114.303763
   Yajima N, 2008, CIRCULATION, V117, P3079, DOI 10.1161/CIRCULATIONAHA.107.746453
   Yamada M, 2015, J CHROMATOGR B, V995, P74, DOI 10.1016/j.jchromb.2015.05.015
   Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x
   Yan XX, 2014, CIRC RES, V114, P637, DOI 10.1161/CIRCRESAHA.114.302625
   Yang J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.274
   Yang WL, 2016, SCI REP-UK, V6, DOI 10.1038/srep26571
   Zarbock A, 2009, J IMMUNOL, V183, P4715, DOI 10.4049/jimmunol.0802592
   Zhang XJ, 2018, NAT MED, V24, P73, DOI 10.1038/nm.4451
   Zhu QW, 2016, EXP THER MED, V11, P978, DOI 10.3892/etm.2016.3018
NR 56
TC 22
Z9 25
U1 2
U2 15
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD SEP 1
PY 2020
VL 205
IS 5
BP 1393
EP 1405
DI 10.4049/jimmunol.2000217
PG 13
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA NE7ED
UT WOS:000562763400021
PM 32727891
OA Bronze
DA 2023-08-21
ER

PT J
AU Shadab, M
   Millar, MW
   Slavin, SA
   Leonard, A
   Fazal, F
   Rahman, A
AF Shadab, Mohammad
   Millar, Michelle Warren
   Slavin, Spencer A.
   Leonard, Antony
   Fazal, Fabeha
   Rahman, Arshad
TI Autophagy protein ATG7 is a critical regulator of endothelial cell
   inflammation and permeability
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NF-KAPPA-B; RELA/P65 NUCLEAR TRANSLOCATION; ICAM-1 EXPRESSION;
   TRANSCRIPTION FACTOR; MECHANISMS; ADHESION; KINASE; ACTIVATION;
   JUNCTIONS; PATHOGENESIS
AB Endothelial cell (EC) inflammation and permeability are critical pathogenic mechanisms in many inflammatory conditions including acute lung injury. In this study, we investigated the role of ATG7, an essential autophagy regulator with no autophagy-unrelated functions, in the mechanism of EC inflammation and permeability. Knockdown of ATG7 using si-RNA significantly attenuated thrombin-induced expression of proinflammatory molecules such as IL-6, MCP-1, ICAM-1 and VCAM-1. Mechanistic study implicated reduced NF-kappa B activity in the inhibition of EC inflammation in ATG7-silenced cells. Moreover, depletion of ATG7 markedly reduced the binding of RelA/p65 to DNA in the nucleus. Surprisingly, the thrombin-induced degradation of I kappa B alpha in the cytosol was not affected in ATG7-depleted cells, suggesting a defect in the translocation of released RelA/p65 to the nucleus in these cells. This is likely due to suppression of thrombin-induced phosphorylation and thereby inactivation of Cofilin1, an actin-depolymerizing protein, in ATG7-depleted cells. Actin stress fiber dynamics are required for thrombin-induced translocation of RelA/p65 to the nucleus, and indeed our results showed that ATG7 silencing inhibited this response via inactivation of Cofilin1. ATG7 silencing also reduced thrombin-mediated EC permeability by inhibiting the disassembly of VE-cadherin at adherens junctions. Together, these data uncover a novel function of ATG7 in mediating EC inflammation and permeability, and provide a mechanistic basis for the linkage between autophagy and EC dysfunction.
C1 [Shadab, Mohammad; Millar, Michelle Warren; Slavin, Spencer A.; Leonard, Antony; Fazal, Fabeha; Rahman, Arshad] Univ Rochester, Dept Pediat, Lung Biol & Dis Program, Sch Med & Dent, 601 Elmwood Ave,Box 850, Rochester, NY 14642, United States.
C3 University of Rochester
RP Rahman, A (corresponding author), Univ Rochester, Dept Pediat, Lung Biol & Dis Program, Sch Med & Dent, 601 Elmwood Ave,Box 850, Rochester, NY 14642 USA.
EM Arshad_Rahman@URMC.Rochester.edu
RI Shadab, Mohammad/AHD-3316-2022
OI Shadab, Mohammad/0000-0003-4148-0365; Millar,
   Michelle/0000-0001-6018-1307
FU NHLBI [HL130870, HL138538]; NIGMS [GM130463]; National Institute of
   Environmental Health Sciences Center (EHSC) [ES-01247]
FX This work was supported by NHLBI grants HL130870, and HL138538, and
   NIGMS grant GM130463. This work was also supported in part by National
   Institute of Environmental Health Sciences Center (EHSC) Grant ES-01247.
CR Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105
   Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200
   Bijli KM, 2007, AM J PHYSIOL-LUNG C, V292, pL396, DOI 10.1152/ajplung.00163.2006
   Bijli KM, 2012, AM J RESP CELL MOL, V47, P660, DOI 10.1165/rcmb.2012-0047OC
   Boteon YL, 2017, WORLD J GASTROENTERO, V23, P8443, DOI 10.3748/wjg.v23.i48.8443
   Brest P, 2010, CURR MOL MED, V10, P486, DOI 10.2174/156652410791608252
   Cahill PA, 2016, ATHEROSCLEROSIS, V248, P97, DOI 10.1016/j.atherosclerosis.2016.03.007
   Cerutti C, 2017, EXP CELL RES, V358, P31, DOI 10.1016/j.yexcr.2017.06.003
   Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004
   Deretic V, 2018, AUTOPHAGY, V14, P243, DOI 10.1080/15548627.2017.1402992
   DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493
   Dudek S.M, 2001, J APPL PHYSIOL, V91, P1487
   Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200
   Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444
   Gavard J, 2013, CELL ADHES MIGR, V7, P455, DOI 10.4161/cam.27330
   Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020
   Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697
   Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114
   Jin LL, 2017, J IMMUNOL, V198, P1253, DOI 10.4049/jimmunol.1601745
   Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191
   Ke YB, 2017, AM J PHYSIOL-LUNG C, V313, pL710, DOI 10.1152/ajplung.00519.2016
   Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245
   Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534
   LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933
   Leonard A, 2019, CELL SIGNAL, V61, P120, DOI 10.1016/j.cellsig.2019.04.013
   Leonard A, 2018, CELL SIGNAL, V44, P103, DOI 10.1016/j.cellsig.2018.01.011
   Leonard A, 2013, AM J PHYSIOL-LUNG C, V305, pL651, DOI 10.1152/ajplung.00071.2013
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Li Ning, 2016, BMC Physiology, V16, P7, DOI 10.1186/s12899-016-0027-y
   Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910
   Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H
   Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005
   Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23
   Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Mehta D, 2014, AM J PHYSIOL-LUNG C, V307, pL924, DOI 10.1152/ajplung.00318.2014
   Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207
   Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894
   Mondaca-Ruff D, 2019, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01553
   Neal MD, 2013, J IMMUNOL, V190, P3541, DOI 10.4049/jimmunol.1202264
   Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034
   Perl M, 2011, EXPERT REV RESP MED, V5, P115, DOI [10.1586/ers.10.92, 10.1586/ERS.10.92]
   Rahman A, 1999, J IMMUNOL, V162, P5466
   Rahman Arshad, 2011, Proc Am Thorac Soc, V8, P497, DOI 10.1513/pats.201101-009MW
   Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757
   Salio M, 2014, P NATL ACAD SCI USA, V111, pE5678, DOI 10.1073/pnas.1413935112
   Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993
   Slavin SA, 2018, AM J PHYSIOL-LUNG C, V314, pL388, DOI 10.1152/ajplung.00555.2016
   Sukriti S, 2014, PULM CIRC, V4, P535, DOI 10.1086/677356
   Sun YX, 2018, CIRCULATION, V138, P2247, DOI 10.1161/CIRCULATIONAHA.117.032821
   Swart C, 2016, EUR J CELL BIOL, V95, P598, DOI 10.1016/j.ejcb.2016.10.005
   TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301
   Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367
   Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4
   Tian YF, 2016, J BIOL CHEM, V291, P10032, DOI 10.1074/jbc.M115.690487
   Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347
   Trocoli A, 2011, AM J CANCER RES, V1, P629
   Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102
   Yang HF, 2017, ONCOTARGET, V8, P47296, DOI 10.18632/oncotarget.17624
   Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865
NR 60
TC 11
Z9 11
U1 1
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 13
PY 2020
VL 10
IS 1
AR 13708
DI 10.1038/s41598-020-70126-7
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA NF8MM
UT WOS:000563546900004
PM 32792588
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU James, J
   Srivastava, A
   Varghese, MV
   Eccles, CA
   Zemskova, M
   Rafikova, O
   Rafikov, R
AF James, Joel
   Srivastava, Anup
   Varghese, Mathews Valuparampil
   Eccles, Cody A.
   Zemskova, Marina A.
   Rafikova, Olga
   Rafikov, Ruslan
TI Heme induces rapid endothelial barrier dysfunction via the MKK3/p38MAPK
   axis
SO BLOOD
LA English
DT Article
ID JUNCTIONS; CELLS; ADHERENS
AB Several studies demonstrate that hemolysis and free heme in circulation cause endothelial barrier dysfunction and are associated with severe pathological conditions such as acute respiratory distress syndrome, acute chest syndrome, and sepsis. However, the precise molecular mechanisms involved in the pathology of heme-induced barrier disruption remain to be elucidated. In this study, we investigated the role of free heme in the endothelial barrier integrity and mechanisms of heme-mediated intracellular signaling of human lung micro-vascular endothelial cells (HLMVECs). Heme, in a dose-dependent manner, induced a rapid drop in the endothelial barrier integrity of HLMVECs. An investigation into barrier proteins revealed that heme primarily affected the tight junction proteins zona occludens-1, claudin-1, and claudin-5, which were significantly reduced after heme exposure. The p38MAPK/HSP27 pathway, involved in the regulation of endothelial cytoskeleton remodeling, was also sig-nificantly altered after heme treatment, both in HLMVECs and mice. By using a knockout (KO) mouse for MKK3, a key regulator of the p38MAPK pathway, we showed that this KO effectively decreased heme-induced endothelial barrier dysfunction. Taken together, our results indicate that targeting the p38MAPK pathway may represent a crucial treatment strategy in alleviating hemolytic diseases.
C1 [James, Joel; Srivastava, Anup; Varghese, Mathews Valuparampil; Eccles, Cody A.; Zemskova, Marina; Rafikova, Olga; Rafikov, Ruslan] Univ Arizona, Coll Med, Dept Med, Div Endocrinol, 1501 N Campbell Ave, Tucson, AZ 85721, United States.
C3 University of Arizona
RP Rafikov, R (corresponding author), Univ Arizona, Coll Med, Dept Med, Div Endocrinol, 1501 N Campbell Ave, Tucson, AZ 85721 USA.
EM ruslanrafikov@deptofmed.arizona.edu
RI Valuparampil Varghese, Mathews/R-1267-2019; James, Joel/X-8792-2019
OI Rafikov, Ruslan/0000-0001-5950-4076; Eccles, Cody/0000-0001-8364-0588
FU National Heart, Lung, and Blood Institute, National Institutes of Health
   [R01HL133085, R01HL132918, R01HL151447]; Arizona Area Heath and
   Education Center grant [RG2017-11]
FX Certain elements in Figure 2S and the visual abstract were derived from
   the image bank of Servier Medical Art (http://smart.servier.com/) under
   a Creative Commons Attribution 3.0 Unported License. This work was
   supported by National Heart, Lung, and Blood Institute, National
   Institutes of Health, grants R01HL133085 (O.R.), R01HL132918 (R.R.) and
   R01HL151447 (R.R.), and by Arizona Area Heath and Education Center grant
   RG2017-11 (A.S.).
CR Alayash AI, 2018, BLOOD CELL MOL DIS, V70, P78, DOI 10.1016/j.bcmd.2017.05.009
   Andrade J, 2004, BIOCHEM J, V384, P327, DOI 10.1042/BJ20040622
   Barry AK, 2015, J CELL SCI, V128, P1341, DOI 10.1242/jcs.159954
   Corre I, 2017, ONCOTARGET, V8, P55684, DOI 10.18632/oncotarget.18264
   Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012
   Higdon AN, 2012, AM J PHYSIOL-HEART C, V302, pH1394, DOI 10.1152/ajpheart.00584.2011
   Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200
   Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534
   Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009
   Rafikov R, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8050135
   Rafikova O, 2018, AM J RESP CELL MOL, V59, P334, DOI 10.1165/rcmb.2017-0308OC
   Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229
   Soni S, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1115-1
   Tornavaca O, 2015, J CELL BIOL, V208, P821, DOI 10.1083/jcb.201404140
   Wang JY, 2009, J CELL PHYSIOL, V219, P617, DOI 10.1002/jcp.21711
NR 15
TC 14
Z9 15
U1 1
U2 2
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD AUG 6
PY 2020
VL 136
IS 6
BP 749
EP 754
DI 10.1182/blood.2019003986
PG 6
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA MY7DI
UT WOS:000558573400016
PM 32548640
OA hybrid, Green Published
DA 2023-08-21
ER

PT J
AU Maekawa, T
   Tamura, H
   Domon, H
   Hiyoshi, T
   Isono, T
   Yonezawa, D
   Hayashi, N
   Takahashi, N
   Tabeta, K
   Maeda, T
   Oda, M
   Ziogas, A
   Alexaki, VI
   Chavakis, T
   Terao, Y
   Hajishengallis, G
AF Maekawa, Tomoki
   Tamura, Hikaru
   Domon, Hisanori
   Hiyoshi, Takumi
   Isono, Toshihito
   Yonezawa, Daisuke
   Hayashi, Naoki
   Takahashi, Naoki
   Tabeta, Koichi
   Maeda, Takeyasu
   Oda, Masataka
   Ziogas, Athanasios
   Alexaki, Vasileia Ismini
   Chavakis, Triantafyllos
   Terao, Yutaka
   Hajishengallis, George
TI Erythromycin inhibits neutrophilic inflammation and mucosal disease by
   upregulating DEL-1
SO JCI INSIGHT
LA English
DT Article
ID DEVELOPMENTAL ENDOTHELIAL LOCUS-1; MACROLIDE ANTIBIOTICS;
   CLINICAL-IMPLICATIONS; GHRELIN; HORMONE; EXACERBATIONS; PEPTIDE; CELLS;
   ELECTROPORATION; DIFFERENTIATION
AB Macrolide antibiotics exert antiinflammatory effects; however, little is known regarding their immunomodulatory mechanisms. In this study, using 2 distinct mouse models of mucosal inflammatory disease (LPS-induced acute lung injury and ligature-induced periodontitis), we demonstrated that the antiinflammatory action of erythromycin (ERM) is mediated through upregulation of the secreted homeostatic protein developmental endothelial locus-1 (DEL-1). Consistent with the anti-neutrophil recruitment action of endothelial cell-derived DEL-1, ERM inhibited neutrophil infiltration in the lungs and the periodontium in a DEL-1-dependent manner. Whereas ERM (but not other antibiotics, such as josamycin and penicillin) protected against lethal pulmonary inflammation and inflammatory periodontal bone loss, these protective effects of ERM were abolished in Dell-deficient mice. By interacting with the growth hormone secretagogue receptor and activating JAK2 in human lung microvascular endothelial cells, ERM induced DEL1 transcription that was mediated by MAPK p38 and was CCAAT/enhancer binding protein-beta dependent. Moreover, ERM reversed IL-17-induced inhibition of DEL-1 transcription, in a manner that was dependent not only on JAK2 but also on P13K/AKT signaling. Because DEL-1 levels are severely reduced in inflammatory conditions and with aging, the ability of ERM to upregulate DEL-1 may lead to a novel approach for the treatment of inflammatory and aging-related diseases.
C1 [Maekawa, Tomoki; Tamura, Hikaru; Domon, Hisanori; Hiyoshi, Takumi; Yonezawa, Daisuke; Maeda, Takeyasu; Terao, Yutaka] Niigata Univ, Ctr Adv Oral Sci, Grad Sch Med & Dent Sci, Niigata, Japan.
   [Maekawa, Tomoki; Tamura, Hikaru; Domon, Hisanori; Hiyoshi, Takumi; Isono, Toshihito; Terao, Yutaka] Niigata Univ, Div Microbiol & Infect Dis, Grad Sch Med & Dent Sci, Niigata, Japan.
   [Maekawa, Tomoki; Tamura, Hikaru; Takahashi, Naoki; Tabeta, Koichi] Niigata Univ, Grad Sch Med & Dent Sci, Div Periodontol, Niigata, Japan.
   [Yonezawa, Daisuke] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Sci Hlth Promot, Niigata, Japan.
   [Hayashi, Naoki; Oda, Masataka] Kyoto Pharmaceut Univ, Dept Microbiol & Infect Control Sci, Yamashina, Japan.
   [Maeda, Takeyasu] Univ Airlangga, Fac Dent Med, Surabaya, Indonesia.
   [Ziogas, Athanasios; Alexaki, Vasileia Ismini; Chavakis, Triantafyllos] Tech Univ Dresden, Inst Clin Chem & Lab Med, Fac Med, Dresden, Germany.
   [Ziogas, Athanasios; Alexaki, Vasileia Ismini; Chavakis, Triantafyllos] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Dresden, Germany.
   [Chavakis, Triantafyllos] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland, United Kingdom.
   [Hajishengallis, George] Univ Penn, Penn Dent Med, Dept Basic & Translat Sci, Lab Innate Immun & Inflammat, Philadelphia, PA, United States.
C3 Niigata University; Niigata University; Niigata University; Niigata
   University; Kyoto Pharmaceutical University; Airlangga University;
   Technische Universitat Dresden; Technische Universitat Dresden; Carl
   Gustav Carus University Hospital; University of Edinburgh; University of
   Pennsylvania
RP Maekawa, T (corresponding author), Niigata Univ, Div Microbiol & Infect Dis, Grad Sch Med & Dent Sci, Niigata, Japan.; Maekawa, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Periodontol, Niigata, Japan.; Maekawa, T (corresponding author), Ctr Adv Oral Sci, Grad Sch Med & Dent Sci, Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.
EM maekawa-t@dent.niigata-u.ac.jp
RI Maekawa, Tomoki/AAA-4673-2020; Ziogas, Athanasios/ABD-3505-2020; Oda,
   Masataka/ABG-6047-2020; Chavakis, Triantafyllos/ABE-8845-2020; Domon,
   H/ADQ-4045-2022
OI Domon, H/0000-0002-2911-826X; Maekawa, Tomoki/0000-0002-4597-1316;
   Maeda, Takeyasu/0000-0001-5317-7510; Alexaki, Vasileia
   Ismini/0000-0003-3935-8985; Isono, Toshihito/0000-0002-8676-3302; Terao,
   Yutaka/0000-0002-4450-5583
FU JSPS KAKENHI [16H06272E, 17KK0165, 17K19747, 19H03828, 19K22706]; Senri
   Life Science Foundation; Takeda Science Foundation; Nakajima Foundation;
   NIH [DE024716, DE028561, DE026152]; European Research Council; Deutsche
   Forschungsgemeinschaft [SFB-TR 205, SFB1181]; JSP; Grants-in-Aid for
   Scientific Research [19K22706, 19H03828, 17KK0165, 17K19747] Funding
   Source: KAKEN
FX This work was supported by grants from JSPS KAKENHI (16H06272E,
   17KK0165, 17K19747, 19H03828, 19K22706), the Senri Life Science
   Foundation, the Takeda Science Foundation, the Nakajima Foundation and
   young investigator research seed grant from JSP to TM, U.S. Public
   Health Service grants from the NIH (DE024716 to GH; DE028561 and
   DE026152 to GH and TC), a grant from the European Research Council
   (DEMETINL to TC), and grants from the Deutsche Forschungsgemeinschaft
   (SFB-TR 205 to TC and VIA and SFB1181 to TC).
CR Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623
   Banerjee Dev, 2004, Treat Respir Med, V3, P59, DOI 10.2165/00151829-200403010-00007
   Beiras-Fernandez A, 2010, PEPTIDES, V31, P2222, DOI 10.1016/j.peptides.2010.08.019
   Castillo R L, 2015, Open Respir Med J, V9, P83, DOI 10.2174/1874306401509010083
   Chapple ILC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2645
   Choi EY, 2015, MOL PSYCHIATR, V20, P880, DOI 10.1038/mp.2014.146
   Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218
   Chung H, 2013, J ENDOCRINOL, V218, P49, DOI 10.1530/JOE-13-0045
   COLBURN WA, 1977, J CLIN PHARMACOL, V17, P592, DOI 10.1177/009127007701701006
   Davidson R, 2002, J OTOLARYNGOL S1, V31, P38
   Domon H, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00161-18, 10.1128/aac.00161-18]
   Domon H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00732
   Dutzan N, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0797
   Dutzan N, 2016, JOVE-J VIS EXP, DOI 10.3791/53736
   Eskan MA, 2012, NAT IMMUNOL, V13, P465, DOI 10.1038/ni.2260
   Folwaczny M, 2017, EUR J ORAL SCI, V125, P258, DOI 10.1111/eos.12357
   Giamarellos-Bourboulis EJ, 2014, J ANTIMICROB CHEMOTH, V69, P1111, DOI 10.1093/jac/dkt475
   Hajishengallis G, 2008, J IMMUNOL, V181, P4141, DOI 10.4049/jimmunol.181.6.4141
   Hajishengallis G, 2019, TRENDS MOL MED, V25, P444, DOI 10.1016/j.molmed.2019.02.010
   Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785
   Hashimoto M, 2016, DEV BIOL, V418, P1, DOI 10.1016/j.ydbio.2016.07.017
   Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315
   He ZY, 2010, RESPIRATION, V80, P445, DOI 10.1159/000321374
   Ito T, 2009, J DERMATOL SCI, V54, P185, DOI 10.1016/j.jdermsci.2009.01.007
   Jeon SG, 2019, AGEING RES REV, V55, DOI 10.1016/j.arr.2019.100945
   JOHNSON KJ, 1974, J CLIN INVEST, V54, P349, DOI 10.1172/JCI107770
   Kabir K, 2002, SHOCK, V17, P300, DOI 10.1097/00024382-200204000-00010
   Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09
   Kassebaum NJ, 2014, J DENT RES, V93, P1045, DOI 10.1177/0022034514552491
   Kim C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030588
   Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230
   Kojima M, 2001, TRENDS ENDOCRIN MET, V12, P118, DOI 10.1016/S1043-2760(00)00362-3
   Kourtzelis I, 2019, NAT IMMUNOL, V20, P40, DOI 10.1038/s41590-018-0249-1
   Kovaleva A, 2012, J ANTIMICROB CHEMOTH, V67, P530, DOI 10.1093/jac/dkr520
   Lebel M, 1993, Can J Infect Dis, V4, P148
   Lin X, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-48
   Maekawa T, 2017, J DENT RES, V96, P571, DOI 10.1177/0022034516687248
   Maekawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9272
   Majima Y, 2004, AM J MED, V117, P20, DOI 10.1016/j.amjmed.2004.07.025
   Matsuura B, 2006, J BIOL CHEM, V281, P12390, DOI 10.1074/jbc.M511921200
   Mikacenic C, 2016, CRIT CARE MED, V44, P496, DOI 10.1097/CCM.0000000000001409
   Mitroulis I, 2017, J CLIN INVEST, V127, P3624, DOI 10.1172/JCI92571
   Moriyama C, 2010, AM J RESP CELL MOL, V42, P304, DOI 10.1165/rcmb.2009-0025OC
   Murray CDR, 2005, GUT, V54, P1693, DOI 10.1136/gut.2005.069088
   Nagai K, 2019, J INFECT CHEMOTHER, V25, P229, DOI 10.1016/j.jiac.2018.08.018
   Namkoong H, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006955
   Orlova EG, 2014, B EXP BIOL MED+, V156, P819, DOI 10.1007/s10517-014-2459-3
   Park YJ, 2008, MOL CELL ENDOCRINOL, V285, P19, DOI 10.1016/j.mce.2008.01.003
   Peres MA, 2019, LANCET, V394, P249, DOI 10.1016/S0140-6736(19)31146-8
   Pinheiro NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120441
   PLEWIG G, 1975, J INVEST DERMATOL, V65, P532, DOI 10.1111/1523-1747.ep12610281
   Reis BS, 2015, J IMMUNOL, V194, P5253, DOI 10.4049/jimmunol.1402996
   Righetti RF, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01021
   Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664
   Rollins DR, 2014, J ALLER CL IMM-PRACT, V2, P511, DOI 10.1016/j.jaip.2014.06.002
   Sanger GJ, 2016, NAT REV GASTRO HEPAT, V13, P38, DOI 10.1038/nrgastro.2015.163
   Sato Y, 2007, PROSTAG LEUKOTR ESS, V76, P181, DOI 10.1016/j.plefa.2006.12.005
   Seemungal TAR, 2008, AM J RESP CRIT CARE, V178, P1139, DOI 10.1164/rccm.200801-145OC
   Shin J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5380
   Simoens S, 2013, RESP MED, V107, P637, DOI 10.1016/j.rmed.2012.12.019
   Smith RG, 2005, TRENDS ENDOCRIN MET, V16, P436, DOI 10.1016/j.tem.2005.09.004
   Southern KW, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002203.pub4
   Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101
   Tamaoki J, 2004, AM J MED, V117, P5, DOI 10.1016/j.amjmed.2004.07.023
   Tomasetto C, 2000, GASTROENTEROLOGY, V119, P395, DOI 10.1053/gast.2000.9371
   Uchimura T, 2019, BIOCHEM PHARMACOL, V165, P79, DOI 10.1016/j.bcp.2019.03.014
   Wales D, 1999, THORAX, V54, pS58, DOI 10.1136/thx.54.2008.S58
   Walkey AJ, 2012, CHEST, V141, P1153, DOI 10.1378/chest.11-1908
   Westaway SM, 2009, PROGR MED CHEM, V48, P31, DOI 10.1016/S0079-6468(09)04802-4
   Xu YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117081
   Yan S, 2018, IMMUNOL CELL BIOL, V96, P526, DOI 10.1111/imcb.12023
   Yuh D, 2020, J BIOL CHEM, V295, P7261, DOI 10.1074/jbc.RA120.013024
   Zimmermann P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00302
   Ziogas A, 2020, J IMMUNOL, V204, P1214, DOI 10.4049/jimmunol.1900746
   Zuckerman JM, 2009, INFECT DIS CLIN N AM, V23, P997, DOI 10.1016/j.idc.2009.06.013
NR 75
TC 17
Z9 18
U1 1
U2 6
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD AUG 6
PY 2020
VL 5
IS 15
AR e136706
DI 10.1172/jci.insight.136706
PG 19
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA NN9KM
UT WOS:000569107100001
PM 32603314
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Wyman, AE
   Nguyen, TTT
   Karki, P
   Tulapurkar, ME
   Zhang, CO
   Kim, J
   Feng, TG
   Dabo, AJ
   Todd, NW
   Luzina, IG
   Geraghty, P
   Foronjy, RF
   Hasday, JD
   Birukova, AA
   Atamas, SP
   Birukov, KG
AF Wyman, Anne E.
   Nguyen, Trang T. T.
   Karki, Pratap
   Tulapurkar, Mohan E.
   Zhang, Chen-Ou
   Kim, Junghyun
   Feng, Theresa G.
   Dabo, Abdoulaye J.
   Todd, Nevins W.
   Luzina, Irina G.
   Geraghty, Patrick
   Foronjy, Robert F.
   Hasday, Jeffrey D.
   Birukova, Anna A.
   Atamas, Sergei P.
   Birukov, Konstantin G.
TI SIRT7 deficiency suppresses inflammation, induces EndoMT, and increases
   vascular permeability in primary pulmonary endothelial cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; SYSTEMIC-SCLEROSIS;
   SIRTUINS; AGE; EPIDEMIOLOGY; OUTCOMES; DYSFUNCTION; METABOLISM; FIBROSIS
AB Acute lung injury (ALI), a common condition in critically ill patients, has limited treatments and high mortality. Aging is a risk factor for ALI. Sirtuins (SIRTs), central regulators of the aging process, decrease during normal aging and in aging-related diseases. We recently showed decreased SIRT7 expression in lung tissues and fibroblasts from patients with pulmonary fibrosis compared to controls. To gain insight into aging-related mechanisms in ALI, we investigated the effects of SIRT7 depletion on lipopolysaccharide (LPS)-induced inflammatory responses and endothelial barrier permeability in human primary pulmonary endothelial cells. Silencing SIRT7 in pulmonary artery or microvascular endothelial cells attenuated LPS-induced increases in ICAM1, VCAM1, IL8, and IL6 and induced endomesenchymal transition (EndoMT) with decreases in VE-Cadherin and PECAM1 and increases in collagen, alpha-smooth muscle actin, TGF beta receptor 1, and the transcription factor Snail. Loss of endothelial adhesion molecules was accompanied by increased F-actin stress fibers and increased endothelial barrier permeability. Together, these results show that an aging phenotype induced by SIRT7 deficiency promotes EndoMT with impaired inflammatory responses and dysfunction of the lung vascular barrier.
C1 [Wyman, Anne E.] Baltimore VA Med Ctr, VA Maryland Hlth Care Syst, Geriatr Res Educ & Clin Ctr GRECC, Baltimore, MD 21201, United States.
   [Wyman, Anne E.; Nguyen, Trang T. T.; Karki, Pratap; Tulapurkar, Mohan E.; Zhang, Chen-Ou; Kim, Junghyun; Todd, Nevins W.; Luzina, Irina G.; Hasday, Jeffrey D.; Birukova, Anna A.; Atamas, Sergei P.; Birukov, Konstantin G.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201, United States.
   [Wyman, Anne E.; Todd, Nevins W.; Luzina, Irina G.; Hasday, Jeffrey D.; Atamas, Sergei P.] Baltimore VA Med Ctr, Res Serv, Baltimore, MD 21201, United States.
   [Wyman, Anne E.; Dabo, Abdoulaye J.; Geraghty, Patrick; Foronjy, Robert F.] SUNY Downstate Hlth Sci Univ, Dept Med, Brooklyn, NY 11203, United States.
   [Wyman, Anne E.; Dabo, Abdoulaye J.; Geraghty, Patrick; Foronjy, Robert F.] SUNY Downstate Hlth Sci Univ, Dept Cell Biol, Brooklyn, NY 11203, United States.
   [Feng, Theresa G.] SUNY Downstate Hlth Sci Univ, Dept Anesthesiol, Brooklyn, NY, United States.
C3 Geriatric Research Education & Clinical Center; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA
   Medical Center; University System of Maryland; University of Maryland
   Baltimore; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Baltimore VA Medical Center
RP Wyman, AE (corresponding author), Baltimore VA Med Ctr, VA Maryland Hlth Care Syst, Geriatr Res Educ & Clin Ctr GRECC, Baltimore, MD 21201 USA.; Wyman, AE (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.; Wyman, AE (corresponding author), Baltimore VA Med Ctr, Res Serv, Baltimore, MD 21201 USA.; Wyman, AE (corresponding author), SUNY Downstate Hlth Sci Univ, Dept Med, Brooklyn, NY 11203 USA.; Wyman, AE (corresponding author), SUNY Downstate Hlth Sci Univ, Dept Cell Biol, Brooklyn, NY 11203 USA.
EM Anne.Wyman@downstate.edu
RI Birukov, Konstantin/FJB-5755-2022; tulapurkar, mohan/F-1926-2015;
   Nguyen, Trang Thi Thu/CAI-9696-2022
OI tulapurkar, mohan/0000-0002-2476-5417; Nguyen, Trang Thi
   Thu/0000-0001-8747-9082; Geraghty, Patrick/0000-0003-1647-5505
FU Advanced Geriatrics Fellowship through GRECC at the Baltimore VA Medical
   Center; NIH [R01HL087823, R01GM122940, R01GM114171, R01HL107920]; NIH
   NHLBI [R01HL126897]; VA [I01BX002499, I01CX000101]; Scleroderma
   Foundation; Flight Attendant Medical Research Institute (FAMRI)
   [CIA160028]
FX This study was supported by an Advanced Geriatrics Fellowship through
   GRECC at the Baltimore VA Medical Center (AEW); NIH Grants R01GM114171
   and R01HL107920 (AAB); NIH Grants R01HL087823 and R01GM122940 (KGB), NIH
   NHLBI R01HL126897, VA I01BX002499, and research award from the
   Scleroderma Foundation (SPA); VA I01CX000101 (IGL); and the Flight
   Attendant Medical Research Institute (FAMRI) CIA160028 (RFF).
CR Akamata K, 2016, ONCOTARGET, V7, P69321, DOI 10.18632/oncotarget.12504
   Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Bindu S, 2017, AM J PHYSIOL-LUNG C, V312, pL68, DOI 10.1152/ajplung.00188.2016
   Birukova AA, 2005, J CELL PHYSIOL, V204, P934, DOI 10.1002/jcp.20359
   Bodas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015480
   Brandenberger C, 2018, AGING DIS, V9, P553, DOI 10.14336/AD.2017.0902
   Budinger GRS, 2017, J GERONTOL A-BIOL, V72, P1492, DOI 10.1093/gerona/glx090
   Bustos ML, 2014, AM J RESP CRIT CARE, V189, P787, DOI 10.1164/rccm.201306-1043OC
   Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027
   Chen L, 2018, LIFE SCI, V210, P86, DOI 10.1016/j.lfs.2018.08.064
   Choi JE, 2014, CURR OPIN GENET DEV, V26, P24, DOI 10.1016/j.gde.2014.05.005
   Clements RT, 2005, AM J PHYSIOL-LUNG C, V288, pL294, DOI 10.1152/ajplung.00213.2004
   Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021
   Donato AJ, 2011, J PHYSIOL-LONDON, V589, P4545, DOI 10.1113/jphysiol.2011.211219
   Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159
   Eachempati SR, 2007, J TRAUMA, V63, P344, DOI 10.1097/TA.0b013e3180eea5a1
   Ely EW, 2002, ANN INTERN MED, V136, P25, DOI 10.7326/0003-4819-136-1-200201010-00007
   Fan E, 2018, JAMA-J AM MED ASSOC, V319, P698, DOI 10.1001/jama.2017.21907
   Fu CP, 2019, ACTA PHARMACOL SIN, V40, P630, DOI 10.1038/s41401-018-0045-3
   Gill SE, 2017, CELL TISSUE RES, V367, P495, DOI 10.1007/s00441-016-2521-8
   Grabowska W, 2017, BIOGERONTOLOGY, V18, P447, DOI 10.1007/s10522-017-9685-9
   Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831
   Hall JA, 2013, J CLIN INVEST, V123, P973, DOI 10.1172/JCI64094
   He W, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/684242
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002
   Jiang L, 2016, BIOMED PHARMACOTHER, V84, P130, DOI 10.1016/j.biopha.2016.09.020
   Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775
   Johnston CJ, 2003, CHEST, V124, P653, DOI 10.1378/chest.124.2.653
   Karki P, 2019, J BIOL CHEM, V294, P3369, DOI 10.1074/jbc.RA118.004030
   Klingbeil LR, 2017, AM J RESP CELL MOL, V56, P585, DOI 10.1165/rcmb.2016-0118OC
   Kurundkar D, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.120722
   Li TX, 2013, MOL MED REP, V7, P1889, DOI 10.3892/mmr.2013.1444
   Lin JR, 2018, HYPERTENSION, V72, P350, DOI 10.1161/HYPERTENSIONAHA.118.10482
   Linge HM, 2015, IMMUNOL RES, V63, P209, DOI 10.1007/s12026-015-8684-7
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   Ng F, 2013, J CELL PHYSIOL, V228, P2262, DOI 10.1002/jcp.24399
   Palumbo S, 2017, AM J PHYSIOL-LUNG C, V312, P1297, DOI 10.1152/ajplung.00305.2016
   Pardali E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102157
   Piera-Velazquez S, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040045
   Rojas M, 2015, ANN AM THORAC SOC, V12, pS222, DOI 10.1513/AnnalsATS.201508-484PL
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sosulski ML, 2017, J GERONTOL A-BIOL, V72, P595, DOI 10.1093/gerona/glw151
   Starr ME, 2011, FREE RADICAL BIO MED, V50, P371, DOI 10.1016/j.freeradbiomed.2010.11.013
   Starr ME, 2010, BLOOD, V115, P4886, DOI 10.1182/blood-2009-10-246678
   Thannickal VJ, 2015, AM J RESP CRIT CARE, V191, P261, DOI 10.1164/rccm.201410-1876PP
   Tharakan B, 2012, SHOCK, V37, P306, DOI 10.1097/SHK.0b013e318240b564
   Tian YG, 2018, MOL MED REP, V17, P5557, DOI 10.3892/mmr.2018.8469
   Tian YF, 2016, J BIOL CHEM, V291, P10032, DOI 10.1074/jbc.M115.690487
   van de Ven RAH, 2017, TRENDS MOL MED, V23, P320, DOI 10.1016/j.molmed.2017.02.005
   Vazquez BN, 2016, EMBO J, V35, P1488, DOI 10.15252/embj.201593499
   Verin AD, 2001, AM J PHYSIOL-LUNG C, V281, pL565, DOI 10.1152/ajplung.2001.281.3.L565
   Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4
   Wang JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37130-4
   WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]
   Wei J, 2015, ARTHRITIS RHEUMATOL, V67, P1323, DOI 10.1002/art.39061
   Wyman AE, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0724-6
   Wyman AE, 2017, AM J PHYSIOL-LUNG C, V312, pL945, DOI 10.1152/ajplung.00473.2016
   Zhang WJ, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4082102
   Zhu XX, 2017, J DERMATOL SCI, V87, P149, DOI 10.1016/j.jdermsci.2017.04.013
NR 63
TC 10
Z9 12
U1 1
U2 8
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 27
PY 2020
VL 10
IS 1
AR 12497
DI 10.1038/s41598-020-69236-z
PG 17
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA MW2KN
UT WOS:000556872700030
PM 32719338
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Suzuki, K
   Okada, H
   Takemura, G
   Takada, C
   Tomita, H
   Yano, H
   Muraki, I
   Zaikokuji, R
   Kuroda, A
   Fukuda, H
   Nishio, A
   Takashima, S
   Suzuki, A
   Miyazaki, N
   Fukuta, T
   Yamada, N
   Watanabe, T
   Doi, T
   Yoshida, T
   Kumada, K
   Ushikoshi, H
   Yoshida, S
   Ogura, S
AF Suzuki, Kodai
   Okada, Hideshi
   Takemura, Genzou
   Takada, Chihiro
   Tomita, Hiroyuki
   Yano, Hirohisa
   Muraki, Isamu
   Zaikokuji, Ryogen
   Kuroda, Ayumi
   Fukuda, Hirotsugu
   Nishio, Ayane
   Takashima, Shigeo
   Suzuki, Akio
   Miyazaki, Nagisa
   Fukuta, Tetsuya
   Yamada, Noriaki
   Watanabe, Takatomo
   Doi, Tomoaki
   Yoshida, Takahiro
   Kumada, Keisuke
   Ushikoshi, Hiroaki
   Yoshida, Shozo
   Ogura, Shinji
TI Recombinant thrombomodulin protects against LPS-induced acute
   respiratory distress syndrome via preservation of pulmonary endothelial
   glycocalyx
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Article
ID LUNG INJURY; EXPRESSION; CAPILLARY; DAMAGE; MODEL; LAYER; INFLAMMATION;
   DYSFUNCTION; SEVERITY; ENDOCAN
AB Background and Purpose Disruption of the endothelial glycocalyx is causally related to microvascular endothelial dysfunction, a characteristic of sepsis-induced acute respiratory distress syndrome (ARDS). Recombinant human thrombomodulin (rhTM) attenuates vascular endothelial injuries, but the underlying mechanism remains elusive. Here, we investigated the structural basis and molecular mechanisms of rhTM effects on vascular endothelial injury in a model of sepsis. Experimental Approach LPS (20 mg center dot kg(-1)) was intraperitoneally injected into 10-week-old male C57BL6 mice, and saline or rhTM was intraperitoneally injected 3 and 24 h after LPS injection. Using serum and/or lung tissue, histological, ultrastructural, and microarray analyses were performed. Key Results Survival rate of rhTM-treated mice was significantly higher than that of control mice 48 h after LPS injection. Serum concentrations of IL-6 and high-mobility group box 1 were lower in the rhTM-treated group than in the control. Injury to the endothelial glycocalyx in pulmonary capillaries was attenuated by rhTM treatment. Gene set enrichment analysis revealed up-regulation of gene sets corresponding to cell proliferation/differentiation and anti-inflammation, such as the TGF-beta pathway, and negative regulation of IL-6, upon rhTM treatment. Gene expression of heparan sulfate 6-O-sulfotransferase 1 and endothelial cell-specific molecule 1 (components of the endothelial glycocalyx) was significantly preserved by rhTM treatment, and their protein expression levels were maintained in endothelial cells. Conclusion and Implications Our findings show that rhTM treatment affected inflammation, cell proliferation/differentiation, and glycocalyx synthesis in serum and lung tissue, subsequently attenuating ARDS caused by endothelial injury.
C1 [Suzuki, Kodai; Okada, Hideshi; Takada, Chihiro; Yano, Hirohisa; Muraki, Isamu; Zaikokuji, Ryogen; Kuroda, Ayumi; Fukuda, Hirotsugu; Nishio, Ayane; Fukuta, Tetsuya; Yamada, Noriaki; Doi, Tomoaki; Yoshida, Takahiro; Kumada, Keisuke; Ushikoshi, Hiroaki; Yoshida, Shozo; Ogura, Shinji] Gifu Univ, Dept Emergency & Disaster Med, Grad Sch Med, 1-1 Yanagido, Gifu 5011194, Japan.
   [Takemura, Genzou; Miyazaki, Nagisa] Asahi Univ, Dept Internal Med, Sch Dent, Mizuho, Japan.
   [Tomita, Hiroyuki] Gifu Univ, Dept Tumour Pathol, Grad Sch Med, Gifu, Japan.
   [Takashima, Shigeo] Gifu Univ, Life Sci Res Ctr, Div Genom Res, Gifu, Japan.
   [Suzuki, Akio] Gifu Univ Hosp, Dept Pharm, Gifu, Japan.
   [Watanabe, Takatomo] Gifu Univ Hosp, Div Clin Lab, Gifu, Japan.
C3 Gifu University; Asahi University; Gifu University; Gifu University;
   Gifu University; Gifu University
RP Okada, H (corresponding author), Gifu Univ, Dept Emergency & Disaster Med, Grad Sch Med, 1-1 Yanagido, Gifu 5011194, Japan.
EM hideshi@gifu-u.ac.jp
RI Watanabe, Takatomo/ITV-2150-2023; Tomita, Hiroyuki/L-5571-2019
OI Tomita, Hiroyuki/0000-0002-3291-0274; Okada, Hideshi/0000-0002-7775-4308
FU Asahi Kasei Pharma Corporation; Japan Society for the Promotion of
   Science [15K10973, 16H05497, 16K09509, 16K20381, 17K11569, 18K08884,
   18K08914, 18K16511, 19H03756, 19K09410, 19K18347]; Grants-in-Aid for
   Scientific Research [19K18347, 16K09509, 18K08914, 19H03756, 18K16511,
   19K09410, 16H05497, 18K08884, 16K20381, 17K11569, 15K10973] Funding
   Source: KAKEN
FX Asahi Kasei Pharma Corporation; Japan Society for the Promotion of
   Science, Grant/Award Numbers: 15K10973, 16H05497, 16K09509, 16K20381,
   17K11569, 18K08884, 18K08914, 18K16511, 19H03756, 19K09410, 19K18347
CR Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782
   Aitkenhead M, 2002, MICROVASC RES, V63, P159, DOI 10.1006/mvre.2001.2380
   Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS297, DOI [10.1111/bph.14752, 10.1111/bph.14749]
   Bechard D, 2000, J VASC RES, V37, P417, DOI 10.1159/000025758
   Becker BF, 2010, BASIC RES CARDIOL, V105, P687, DOI 10.1007/s00395-010-0118-z
   Bull TM, 2010, AM J RESP CRIT CARE, V182, P1123, DOI 10.1164/rccm.201002-0250OC
   Chan WK, 2017, BIOL OPEN, V6, P1933, DOI 10.1242/bio.028605
   Chelazzi C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0741-z
   Constantinescu SN, 2008, TRENDS BIOCHEM SCI, V33, P122, DOI 10.1016/j.tibs.2007.12.002
   Cross LJM, 2011, CRIT CARE CLIN, V27, P355, DOI 10.1016/j.ccc.2010.12.005
   Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x
   Frati-Munari Alberto C., 2013, Arch. Cardiol. Méx., V83, P303, DOI 10.1016/j.acmx.2013.04.015
   Fu J, 2016, INT IMMUNOPHARMACOL, V38, P267, DOI 10.1016/j.intimp.2016.06.010
   Fukuta T, 2020, SHOCK, V54, P386, DOI 10.1097/SHK.0000000000001482
   Gunst J, 2013, CRIT CARE MED, V41, P182, DOI 10.1097/CCM.0b013e3182676657
   Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013
   Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e
   Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200
   Hagiwara A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012850
   Harding SD, 2018, NUCLEIC ACIDS RES, V46, pD1091, DOI 10.1093/nar/gkx1121
   Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508
   Herpin A, 2007, FEBS J, V274, P2977, DOI 10.1111/j.1742-4658.2007.05840.x
   Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853
   Inagawa R, 2018, CHEST, V154, P317, DOI 10.1016/j.chest.2018.03.003
   Ito T, 2011, J THROMB HAEMOST, V9, P168, DOI 10.1111/j.1538-7836.2011.04319.x
   Ito T, 2008, ARTERIOSCL THROM VAS, V28, P1825, DOI 10.1161/ATVBAHA.107.150631
   Kadono K, 2017, AM J TRANSPLANT, V17, P69, DOI 10.1111/ajt.13991
   Kataoka H, 2016, MICROSC RES TECHNIQ, V79, P31, DOI 10.1002/jemt.22602
   Kearon C, 2005, J THROMB HAEMOST, V3, P962, DOI 10.1111/j.1538-7836.2005.01251.x
   Khorchidi Sascha, 2002, Curr Opin Investig Drugs, V3, P1196
   Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI [10.1038/jcbfm.2010.220, 10.1111/j.1476-5381.2010.00872.x]
   Knelson EH, 2014, TRENDS BIOCHEM SCI, V39, P277, DOI 10.1016/j.tibs.2014.03.001
   Langlois RA, 2010, ALCOHOL CLIN EXP RES, V34, P1425, DOI 10.1111/j.1530-0277.2010.01226.x
   Lassalle P, 1996, J BIOL CHEM, V271, P20458, DOI 10.1074/jbc.271.34.20458
   Liu XY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00102
   LUFT JH, 1966, FED PROC, V25, P1773
   Martin JV, 2017, AM J SURG, V214, P1166, DOI 10.1016/j.amjsurg.2017.09.018
   Mensah SA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186116
   Meyerholz DK, 2008, J IMMUNOL, V181, P641, DOI 10.4049/jimmunol.181.1.641
   Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623
   Okada H, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1841-8
   Orbegozo D, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0311-4
   Rehm M, 2004, ANESTHESIOLOGY, V100, P1211, DOI 10.1097/00000542-200405000-00025
   Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8
   Rennel E, 2007, EXP CELL RES, V313, P1285, DOI 10.1016/j.yexcr.2007.01.021
   Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843
   Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297
   Shao M, 2016, MOL MED REP, V13, P529, DOI 10.3892/mmr.2015.4521
   Suzuki K, 2019, AM J PATHOL, V189, P1526, DOI 10.1016/j.ajpath.2019.05.002
   Takahashi Y, 2016, J TRAUMA ACUTE CARE, V81, P868, DOI 10.1097/TA.0000000000001208
   Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295
   Tang L, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/625180
   Tawara S, 2016, THROMB RES, V147, P72, DOI 10.1016/j.thromres.2016.09.011
   Thille AW, 2013, LANCET RESP MED, V1, P395, DOI 10.1016/S2213-2600(13)70053-5
   Vincent JL, 2019, JAMA-J AM MED ASSOC, V321, P1993, DOI 10.1001/jama.2019.5358
   Vink H, 2000, AM J PHYSIOL-HEART C, V278, pH285, DOI 10.1152/ajpheart.2000.278.1.H285
   Wang LP, 2016, BIOCHEM BIOPH RES CO, V478, P669, DOI 10.1016/j.bbrc.2016.08.005
   Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515
   Yamakawa K, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1415-1
   Yang YM, 2017, AM J RESP CELL MOL, V56, P727, DOI 10.1165/rcmb.2016-0338OC
   Yoshihiro S, 2019, SHOCK, V51, P174, DOI 10.1097/SHK.0000000000001148
   Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734
   Zhang SM, 2012, BIOTECH HISTOCHEM, V87, P172, DOI 10.3109/10520295.2011.577754
NR 63
TC 18
Z9 23
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1188
EI 1476-5381
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PD SEP
PY 2020
VL 177
IS 17
BP 4021
EP 4033
DI 10.1111/bph.15153
EA JUL 2020
PG 13
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA NB5UP
UT WOS:000548226500001
PM 32497259
OA hybrid, Green Published
DA 2023-08-21
ER

PT J
AU Xia, WF
   Pan, Z
   Zhang, HM
   Zhou, QS
   Liu, Y
AF Xia, Wenfang
   Pan, Zhou
   Zhang, Huanming
   Zhou, Qingshan
   Liu, Yu
TI Inhibition of ERR alpha Aggravates Sepsis-Induced Acute Lung Injury in
   Rats via Provoking Inflammation and Oxidative Stress
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID ESTROGEN-RELATED RECEPTOR; TNF-ALPHA; EXPRESSION; CELLS
AB Inflammation and oxidative stress are critical pathologies that contribute to sepsis-induced acute lung injury (ALI). This study investigated the regulatory role of estrogen-related receptor alpha (ERR alpha) in an experimental model of sepsis-induced ALI. In vivo, a cecal ligation and puncture- (CLP-) induced ALI model was established in anesthetized rats. Animals were then randomly assigned to receive an intraperitoneal injection of vehicle or ERR alpha inverse agonist (XCT-790, 2.5 mg/kg). Administration of XCT-790 significantly aggravated a sepsis-induced increase in pathological damage of lung tissues, lung endothelial permeability, myeloperoxidase (MPO) activity in lung tissues, production of serum inflammatory factors, and inflammatory cell accumulation in bronchoalveolar lavage fluid. In addition, XCT-790 treatment exacerbated a CLP-induced decrease in lung superoxide dismutase and an increase in lung malondialdehyde levels. In vitro, the exposure of rat pulmonary microvascular endothelial cells (PMVECs) to lipopolysaccharide (LPS) resulted in increased endothelial permeability and reduced expression of tight junction protein ZO-1, Occludin, JAM-A, and adherens junction protein VE-cadherin, which were further deteriorated by knockdown of ERR alpha. In addition, LPS-triggered inflammatory factor production and increase in the expression of phosphorylated I kappa B alpha and NF-kappa B p65 were also exacerbated by silencing ERR alpha gene. Meanwhile, knockdown of ERR alpha dramatically promoted LPS-activated mitochondrial reactive oxygen species production and LPS-induced downregulation of Sirt3 protein levels in rat PMVECs. Taken together, our present study provides evidences that ERR alpha functions as a novel negative modulator of sepsis-induced ALI in rats. The underlying mechanisms responsible for ERR alpha-elicited effects are largely dependent on the regulation of inflammatory response and oxidative stress.
C1 [Xia, Wenfang; Pan, Zhou; Zhang, Huanming; Zhou, Qingshan] Wuhan Univ, Dept Crit Care Med, Renmin Hosp, Wuhan 430060, China.
   [Liu, Yu] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430060, China.
   [Liu, Yu] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430060, China.
   [Liu, Yu] Hubei Key Lab Cardiol, Wuhan 430060, China.
C3 Wuhan University; Wuhan University; Wuhan University
RP Liu, Y (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430060, Peoples R China.; Liu, Y (corresponding author), Wuhan Univ, Cardiovasc Res Inst, Wuhan 430060, Peoples R China.; Liu, Y (corresponding author), Hubei Key Lab Cardiol, Wuhan 430060, Peoples R China.
EM liuyuwuda@163.com
FU National Natural Science Foundation of China [81301620, 81671941]
FX This work was supported by the National Natural Science Foundation of
   China (No. 81301620 and No. 81671941).
CR Afonina IS, 2017, NAT IMMUNOL, V18, P861, DOI 10.1038/ni.3772
   Arbibe L, 1997, J IMMUNOL, V159, P391
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Boueiz A, 2009, MICROVASC RES, V77, P26, DOI 10.1016/j.mvr.2008.10.005
   Eskiocak B, 2014, BIOCHEMISTRY-US, V53, P4839, DOI 10.1021/bi500737n
   Fan J, 2001, AM J PHYSIOL-LUNG C, V281, pL1037, DOI 10.1152/ajplung.2001.281.5.L1037
   He MY, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4957646
   Hong EJ, 2013, P NATL ACAD SCI USA, V110, P17975, DOI 10.1073/pnas.1315319110
   Karki P, 2019, ANTIOXID REDOX SIGN, V31, P1009, DOI 10.1089/ars.2019.7798
   Kiyonari Y, 2000, CRIT CARE MED, V28, P484, DOI 10.1097/00003246-200002000-00033
   Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707
   Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112
   Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Nie YH, 2009, J CELL MOL MED, V13, P3051, DOI 10.1111/j.1582-4934.2008.00382.x
   Park J, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2747018
   Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101
   Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Tseng AHH, 2013, FREE RADICAL BIO MED, V63, P222, DOI 10.1016/j.freeradbiomed.2013.05.002
   Tsushida K, 2018, BIOCHEM BIOPH RES CO, V498, P918, DOI 10.1016/j.bbrc.2018.03.080
   Wang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079757
   Wei F, 2017, INT IMMUNOPHARMACOL, V46, P220, DOI 10.1016/j.intimp.2017.03.007
   Williams AE, 2014, AM J PHYSIOL-LUNG C, V306, pL217, DOI 10.1152/ajplung.00311.2013
   Wolthuis EK, 2009, SHOCK, V31, P262, DOI 10.1097/SHK.0b013e31817d42dd
   Xia WF, 2019, INT IMMUNOPHARMACOL, V72, P211, DOI 10.1016/j.intimp.2019.04.009
   Yang F, 2016, CELL PHYSIOL BIOCHEM, V39, P1369, DOI 10.1159/000447841
   Yuk JM, 2015, IMMUNITY, V43, P80, DOI 10.1016/j.immuni.2015.07.003
NR 28
TC 23
Z9 28
U1 0
U2 10
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD JUL 3
PY 2020
VL 2020
AR 2048632
DI 10.1155/2020/2048632
PG 9
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA MQ2ZW
UT WOS:000552767200005
PM 32714486
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Fattahi, F
   Grailer, JJ
   Parlett, M
   Lu, H
   Malan, EA
   Abe, E
   Russell, MW
   Frydrych, LM
   Delano, MJ
   Zetoune, FS
   Ward, PA
AF Fattahi, Fateme
   Grailer, Jamison J.
   Parlett, Michella
   Lu, Hope
   Malan, Elizabeth A.
   Abe, Elizabeth
   Russell, Mark W.
   Frydrych, Lynn M.
   Delano, Matthew J.
   Zetoune, Firas S.
   Ward, Peter A.
TI Requirement of Complement C6 for Intact Innate Immune Responses in Mice
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID NLRP3 INFLAMMASOME; EXTRACELLULAR HISTONES; C5A RECEPTOR; NEUTROPHIL
   ELASTASE; INDUCED ACTIVATION; CECAL LIGATION; CUTTING EDGE; SEPSIS;
   BLOCKADE; TRAPS
AB Over the first days of polymicrobial sepsis, there is robust activation of the innate immune system, causing the appearance of proinflammatory cytokines and chemokines, along with the appearance of extracellular histones, which are highly proinflammatory and prothrombotic. In the current study, we studied different innate immune responses in mice with knockout (KO) of complement protein 6 (C6). Polymorphonuclear neutrophils (PMNs) from these KO mice had defective innate immune responses, including defective expression of surface adhesion molecules, generation of superoxide anion, and appearance of reactive oxygen species and histone release after activation of PMNs, along with defective phagocytosis. In addition, in C6(-/-) mice, the NLRP3 inflammasome was defective both in PMNs and in macrophages. When these KO mice were subjected to polymicrobial sepsis, their survival was improved, associated with reduced levels in the plasma of proinflammatory cytokines and chemokines and lower levels of histones in plasma. In addition, sepsis-induced cardiac dysfunction was attenuated in these KO mice. In a model of acute lung injury induced by LPS, C6(-/-) mice showed reduced PMN buildup and less lung epithelial/endothelial cell dysfunction (edema and hemorrhage). These data indicate that C6(-/-) mice have reduced innate immune responses that result in less organ injury and improved survival after polymicrobial sepsis.
C1 [Fattahi, Fateme] Univ Michigan, Dept Internal Med, Div Allergy & Clin Immunol, Med Sch, Ann Arbor, MI 48109, United States.
   [Fattahi, Fateme; Grailer, Jamison J.; Parlett, Michella; Lu, Hope; Malan, Elizabeth A.; Abe, Elizabeth; Zetoune, Firas S.; Ward, Peter A.] Univ Michigan, Dept Pathol, Med Sch, 1150 W Med Ctr Dr,7520 MSRB 1,Box 5602, Ann Arbor, MI 48109, United States.
   [Russell, Mark W.] Univ Michigan, Dept Pediat & Communicable Dis, Med Sch, Ann Arbor, MI 48109, United States.
   [Frydrych, Lynn M.; Delano, Matthew J.] Univ Michigan, Dept Surg, Sch Med Sch, Ann Arbor, MI 48109, United States.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; University of Michigan System;
   University of Michigan; University of Michigan System; University of
   Michigan
RP Ward, PA (corresponding author), Univ Michigan, Dept Pathol, Med Sch, 1150 W Med Ctr Dr,7520 MSRB 1,Box 5602, Ann Arbor, MI 48109 USA.
EM pward@umich.edu
OI Delano, Matthew/0000-0001-7540-5166
FU National Institutes of Health [GM-29507, GM-61656]; Stobbe Endowment of
   the Department of Pathology at University of Michigan Medical School
FX This work was supported in part by National Institutes of Health Grants
   GM-29507 and GM-61656 and by the Stobbe Endowment of the Department of
   Pathology at University of Michigan Medical School.
CR Antalik P E, 1975, Trans Pa Acad Ophthalmol Otolaryngol, V28, P42
   Arvidsson I, 2016, J IMMUNOL, V197, P1276, DOI 10.4049/jimmunol.1502377
   Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829
   Bosmann M, 2013, FASEB J, V27, P5010, DOI 10.1096/fj.13-236380
   Bosmann M, 2013, TRENDS IMMUNOL, V34, P129, DOI 10.1016/j.it.2012.09.004
   Buras JA, 2004, IMMUNOBIOLOGY, V209, P629, DOI 10.1016/j.imbio.2004.09.004
   Chen R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.337
   Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512
   Doster RS, 2018, J INNATE IMMUN, V10, P3, DOI 10.1159/000480373
   Fattahi F, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4302726
   Fattahi F, 2018, MOL IMMUNOL, V102, P32, DOI 10.1016/j.molimm.2018.06.006
   Fattahi F, 2017, FASEB J, V31, P4129, DOI 10.1096/fj.201700140R
   Fattahi F, 2017, J INNATE IMMUN, V9, P300, DOI 10.1159/000452951
   Fattahi F, 2015, IMMUNOL RES, V61, P177, DOI 10.1007/s12026-015-8628-2
   Flierl MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002560
   Flierl MA, 2009, CRIT CARE, V13, DOI 10.1186/cc7710
   Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107
   Gold Ronald, 2002, Paediatr Child Health, V7, P622
   Grailer JJ, 2015, J IMMUNOL, V194, P868, DOI 10.4049/jimmunol.1401193
   Grailer JJ, 2014, J INNATE IMMUN, V6, P607, DOI 10.1159/000358524
   Grailer JJ, 2014, J INNATE IMMUN, V6, P695, DOI 10.1159/000362554
   Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368
   Haggadone MD, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/1340156
   Hoesel LM, 2005, SHOCK, V24, P40, DOI 10.1097/01.shk.0000170353.80318.d5
   Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496
   Huang H, 2013, J IMMUNOL, V191, P2665, DOI 10.4049/jimmunol.1202733
   Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193
   Huber-Lang M, 2016, SEMIN IMMUNOL, V28, P278, DOI 10.1016/j.smim.2016.04.005
   Huber-Lang MS, 2002, J IMMUNOL, V169, P3223, DOI 10.4049/jimmunol.169.6.3223
   Kalbitz M, 2016, FASEB J, V30, P3997, DOI 10.1096/fj.201600728R
   Kalbitz M, 2016, J IMMUNOL, V197, P2353, DOI 10.4049/jimmunol.1600091
   Kalbitz M, 2015, FASEB J, V29, P2185, DOI 10.1096/fj.14-268730
   Karasu E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00543
   Laudisi F, 2013, J IMMUNOL, V191, P1006, DOI 10.4049/jimmunol.1300489
   Markiewski MM, 2008, J CELL MOL MED, V12, P2245, DOI 10.1111/j.1582-4934.2008.00504.x
   Martin L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143583
   Martin L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00404
   Mazer M, 2019, J IMMUNOL, V203, P2088, DOI 10.4049/jimmunol.1900637
   Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044
   Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052
   Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387
   Ricklin D, 2018, NAT REV NEPHROL, V14, P26, DOI 10.1038/nrneph.2017.156
   Riedemann NC, 2003, FASEB J, V17, P370, DOI 10.1096/fj.03-0708fje
   Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1
   Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503
   Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409
   Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753
   Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214
   Schuerholz T, 2012, CRIT CARE, V16, DOI 10.1186/cc11220
   Schuerholz T, 2013, CRIT CARE, V17, DOI 10.1186/cc11920
   Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061
   Serhan CN, 2008, BRIT J PHARMACOL, V153, pS200, DOI 10.1038/sj.bjp.0707489
   Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409
   Stover CM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00491
   Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388
   Unnewehr H, 2013, J IMMUNOL, V190, P4215, DOI 10.4049/jimmunol.1200534
   Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269
   Ward PA, 2011, JAMA-J AM MED ASSOC, V306, P2618, DOI 10.1001/jama.2011.1831
   Ward PA, 2010, J INNATE IMMUN, V2, P439, DOI 10.1159/000317194
   Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053
NR 60
TC 12
Z9 12
U1 0
U2 4
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD JUL 1
PY 2020
VL 205
IS 1
BP 251
EP 260
DI 10.4049/jimmunol.1900801
PG 10
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA MC5IK
UT WOS:000543320100024
PM 32444389
OA Bronze
DA 2023-08-21
ER

PT J
AU Xiong, SQ
   Hong, ZG
   Huang, LS
   Tsukasaki, Y
   Nepal, S
   Di, AK
   Zhong, M
   Wu, W
   Ye, ZM
   Gao, XP
   Rao, GN
   Mehta, D
   Rehman, J
   Malik, AB
AF Xiong, Shiqin
   Hong, Zhigang
   Huang, Longshuang
   Tsukasaki, Yoshikazu
   Nepal, Saroj
   Di, Anke
   Zhong, Ming
   Wu, Wei
   Ye, Zhiming
   Gao, Xiaopei
   Rao, Gadiparthi N.
   Mehta, Dolly
   Rehman, Jalees
   Malik, Asrar B.
TI IL-1 beta suppression of VE-cadherin transcription underlies
   sepsis-induced inflammatory lung injury
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID SOLUBLE ADENYLYL-CYCLASE; ENDOTHELIAL PERMEABILITY; CODING VARIANT;
   GENE; PREVENTS; COMPARTMENTATION; MECHANISMS; EXPRESSION; REVEALS
AB Unchecked inflammation is a hallmark of inflammatory tissue injury in diseases such as acute respiratory distress syndrome (ARDS). Yet the mechanisms of inflammatory lung injury remain largely unknown. Here we showed that bacterial endotoxin lipopolysaccharide (LPS) and cecal ligation and puncture-induced (CLP-induced) polymicrobial sepsis decreased the expression of transcription factor cAMP response element binding (CREB) in lung endothelial cells. We demonstrated that endothelial CREB was crucial for VE-cadherin transcription and the formation of the normal restrictive endothelial adherens junctions. The inflammatory cytokine IL-1 beta reduced cAMP generation and CREB-mediated transcription of VE-cadherin. Furthermore, endothelial cell-specific deletion of CREB induced lung vascular injury whereas ectopic expression of CREB in the endothelium prevented the injury. We also observed that rolipram, which inhibits type 4 cyclic nucleotide phosphodiesterase-mediated (PDE4-mediated) hydrolysis of cAMP, prevented endotoxemia-induced lung vascular injury since it preserved CREB-mediated VE-cadherin expression. These data demonstrate the fundamental role of the endothelial cAMP-CREB axis in promoting lung vascular integrity and suppressing inflammatory injury. Therefore, strategies aimed at enhancing endothelial CREB-mediated VE-cadherin transcription are potentially useful in preventing sepsis-induced lung vascular injury in ARDS.
C1 [Xiong, Shiqin; Hong, Zhigang; Huang, Long Shuang; Tsukasaki, Yoshikazu; Nepal, Saroj; Di, Anke; Zhong, Ming; Wu, Wei; Gao, Xiaopei; Mehta, Dolly; Rehman, Jalees; Malik, Asrar B.] Univ Illinois, Dept Pharmacol & Regenerat Med, Coll Med, Chicago, IL 60612, United States.
   [Xiong, Shiqin; Hong, Zhigang; Huang, Long Shuang; Tsukasaki, Yoshikazu; Nepal, Saroj; Di, Anke; Zhong, Ming; Wu, Wei; Gao, Xiaopei; Mehta, Dolly; Rehman, Jalees; Malik, Asrar B.] Univ Illinois, Ctr Lung & Vasc Biol, Coll Med, Chicago, IL 60612, United States.
   [Ye, Zhiming] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Nephrol, Guangzhou, China.
   [Rao, Gadiparthi N.] Univ Tennessee, Dept Physiol, Hlth Sci Ctr, Memphis, TN, United States.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital;
   Guangdong Academy of Medical Sciences & Guangdong General Hospital;
   Southern Medical University - China; University of Tennessee System;
   University of Tennessee Health Science Center
RP Malik, AB (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 South Wolcott Ave, Chicago, IL 60612 USA.
EM abmalik@uic.edu
RI Rehman, Jalees/GVU-1981-2022
OI Rehman, Jalees/0000-0002-2787-9292; Malik, Asrar/0000-0002-8205-7128
FU NIH [P01-HL60678, P01-HL077806, T32-HL007829, R01-HL118068, R01-HL90152]
FX This work was supported by NIH grants P01-HL60678, P01-HL077806,
   T32-HL007829, R01-HL118068, and R01-HL90152.
CR Chaudhry H, 2013, IN VIVO, V27, P669
   Chava KR, 2012, BLOOD, V119, P308, DOI 10.1182/blood-2011-02-339473
   Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625
   Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495
   Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444
   Di AK, 2018, IMMUNITY, V49, P56, DOI 10.1016/j.immuni.2018.04.032
   Erdei J, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4310816
   Evavold CL, 2019, IMMUNITY, V51, P609, DOI 10.1016/j.immuni.2019.08.005
   Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013
   Fischmeister R, 2006, CIRC RES, V98, P582, DOI 10.1161/01.RES.0000215564.22445.7e
   FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836
   Fisher RK, 2017, J SURG RES, V219, P136, DOI 10.1016/j.jss.2017.05.111
   Friedrich EE, 2019, P NATL ACAD SCI USA, V116, P12980, DOI 10.1073/pnas.1902165116
   Gong HX, 2015, J CLIN INVEST, V125, P652, DOI 10.1172/JCI77701
   Hoyer FF, 2019, IMMUNITY, V51, P899, DOI 10.1016/j.immuni.2019.10.010
   Johnstone TB, 2018, MOL PHARMACOL, V93, P270, DOI 10.1124/mol.117.110825
   Kim SH, 2016, NUCLEIC ACIDS RES, V44, P9667, DOI 10.1093/nar/gkw643
   Kimmoun A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0896-7
   Kleinboelting S, 2014, P NATL ACAD SCI USA, V111, P3727, DOI 10.1073/pnas.1322778111
   Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534
   Korayem AH, 2017, AM J PHYSIOL-HEART C, V313, pH179, DOI 10.1152/ajpheart.00002.2017
   Lakhina V, 2015, NEURON, V85, P330, DOI 10.1016/j.neuron.2014.12.029
   Lampugnani MG, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029322
   Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320
   Lefkimmiatis K, 2014, PHARMACOL THERAPEUT, V143, P295, DOI 10.1016/j.pharmthera.2014.03.008
   Liu ML, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10134-y
   Liu XY, 2019, IMMUNITY, V50, P317, DOI [10.1016/j.immuni.2018.12.012, 10.1016/j.immuni.2019.02.012]
   Liu YC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01021
   London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678
   Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543
   Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   Meyer NJ, 2018, CRIT CARE MED, V46, P21, DOI 10.1097/CCM.0000000000002749
   Meyer NJ, 2014, AM J RESP CRIT CARE, V190, P656, DOI 10.1164/rccm.201403-0586OC
   Meyer NJ, 2013, AM J RESP CRIT CARE, V187, P950, DOI 10.1164/rccm.201208-1501OC
   Nanes BA, 2017, MOL BIOL CELL, V28, P30, DOI 10.1091/mbc.E16-06-0459
   Noval Rivas M, 2019, IMMUNITY, V51, P508, DOI 10.1016/j.immuni.2019.05.021
   Ohmura T, 2017, MOL BIOL CELL, V28, P1622, DOI 10.1091/mbc.E16-09-0639
   Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199
   Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017
   Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013
   Polat G, 2017, EURASIAN J MED, V49, P53, DOI 10.5152/eurasianjmed.2017.17062
   Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062
   Ramos CJ, 2018, J BIOL CHEM, V293, P717, DOI 10.1074/jbc.M117.815381
   Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914
   Ruhl S, 2018, SCIENCE, V362, P956, DOI 10.1126/science.aar7607
   Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e
   Schlegel N, 2009, MICROCIRCULATION, V16, P521, DOI 10.1080/10739680902967427
   Verma S, 2017, CELL METAB, V26, P703, DOI 10.1016/j.cmet.2017.09.022
   Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH2427, DOI 10.1152/ajpheart.00556.2004
   Wettschureck N, 2019, PHYSIOL REV, V99, P1467, DOI 10.1152/physrev.00037.2018
   Zhou MY, 1998, J CLIN INVEST, V101, P2427, DOI 10.1172/JCI407
   Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603
NR 53
TC 81
Z9 91
U1 0
U2 17
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD JUL 1
PY 2020
VL 130
IS 7
BP 3684
EP 3698
DI 10.1172/JCI136908
PG 15
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA OC8IT
UT WOS:000579400900001
PM 32298238
OA Bronze, Green Published
DA 2023-08-21
ER

PT J
AU Schaefer, IM
   Padera, RF
   Solomon, IH
   Kanjilal, S
   Hammer, MM
   Hornick, JL
   Sholl, LM
AF Schaefer, Inga-Marie
   Padera, Robert F.
   Solomon, Isaac H.
   Kanjilal, Sanjat
   Hammer, Mark M.
   Hornick, Jason L.
   Sholl, Lynette M.
TI In situ detection of SARS-CoV-2 in lungs and airways of patients with
   COVID-19
SO MODERN PATHOLOGY
LA English
DT Article
ID FOXJ1 EXPRESSION; CILIOGENESIS; INFECTION
AB Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has led to a global public health crisis. In elderly individuals and those with comorbidities, COVID-19 is associated with high mortality, frequently caused by acute respiratory distress syndrome. We examine in situ expression of SARS-CoV-2 in airways and lung obtained at autopsy of individuals with confirmed COVID-19 infection. Seven autopsy cases (male,N = 5; female,N = 2) with reverse transcriptase-polymerase chain reaction (RT-PCR)-confirmed SARS-CoV-2 infection and a median age of 66 years (range, 50-77 years) were evaluated using a rabbit polyclonal antibody against SARS Nucleocapsid protein in correlation with clinical parameters. The median time from symptom onset to death was 9 days (range, 6-31 days), from hospitalization 7 days (range, 1-21 days), from positive RT-PCR 7 days (range, 0-18 days), and from intensive care unit admission defining onset of respiratory failure 3 days (range, 1-18 days). Chest imaging identified diffuse airspace disease in all patients corresponding to acute and (N = 5) or organizing (N = 2) diffuse alveolar damage (DAD) on histologic examination. Among five patients with acute-phase DAD (<= 7 days from onset of respiratory failure), SARS-CoV-2 was detected in pulmonary pneumocytes and ciliated airway cells (N = 5), and in upper airway epithelium (N = 2). In two patients with organizing DAD (>14 days from onset of respiratory failure), no virus was detected in lungs or airways. No endothelial cell infection was observed. The findings suggest that SARS-CoV-2 infection of epithelial cells in lungs and airways of patients with COVID-19 who developed respiratory failure can be detected during the acute phase of lung injury and is absent in the organizing phase.
C1 [Schaefer, Inga-Marie; Padera, Robert F.; Solomon, Isaac H.; Hornick, Jason L.; Sholl, Lynette M.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115, United States.
   [Kanjilal, Sanjat] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115, United States.
   [Kanjilal, Sanjat] Harvard Med Sch, Dept Populat Med, Boston, MA 02115, United States.
   [Kanjilal, Sanjat] Harvard Pilgrim Healthcare Inst, Boston, MA, United States.
   [Hammer, Mark M.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115, United States.
C3 Harvard University; Brigham & Women's Hospital; Harvard Medical School;
   Harvard University; Brigham & Women's Hospital; Harvard University;
   Harvard Medical School; Harvard Pilgrim Health Care; Harvard University;
   Brigham & Women's Hospital; Harvard Medical School
RP Sholl, LM (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.
EM lmsholl@bwh.harvard.edu
RI Schaefer, Inga-Marie/ABA-3951-2020; Hammer, Mark/AAR-9625-2020
OI Schaefer, Inga-Marie/0000-0001-9710-5500; Hammer,
   Mark/0000-0002-1700-7984; Kanjilal, Sanjat/0000-0002-1221-5725; Padera,
   Robert/0000-0002-4571-5494; Solomon, Isaac/0000-0003-3432-0902
FU US National Institutes of Health (NIH/NCI) [K08-CA241085]; PhAST
   Diagnostics; Roche/Genentech
FX IMS was funded by US National Institutes of Health (NIH/NCI grant
   K08-CA241085). SK received funding support from PhAST Diagnostics. JLH
   is a consultant to Epizyme, Eli Lilly, Aadi Bioscience, and TRACON
   Pharmaceuticals. LMS reports consulting fees/honoraria from LOXO
   Oncology, EMD Serono, Foghorn Therapeutics, and Astra Zeneca and
   research funding to the institution from Roche/Genentech. The remaining
   authors have no conflicts to disclose.
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]
   Barton LM, 2020, AM J CLIN PATHOL, V153, P725, DOI [10.1093/AJCP/AQAA062, 10.1093/ajcp/aqaa062]
   Chandrashekar A, 2020, SCIENCE, V369, P812, DOI 10.1126/science.abc4776
   Coy S, 2016, MODERN PATHOL, V29, P1446, DOI 10.1038/modpathol.2016.153
   Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI [10.1056/NEJMc2005203, 10.1056/NEJMoa2002032]
   Guzik TJ, 2020, CARDIOVASC RES, V116, P1666, DOI 10.1093/cvr/cvaa106
   Harenberg J, 2020, CLIN CHEM LAB MED, V58, P1029, DOI 10.1515/cclm-2020-0502
   Lax SF, 2020, ANN INTERN MED, V173, P350, DOI 10.7326/M20-2566
   Li Y, 2020, EUR RADIOL, V30, P6186, DOI 10.1007/s00330-020-06969-5
   LONG QX, 2020, NAT MED, V26, P845, DOI [DOI 10.1038/S41591-020-0897-1, 10.1101/2020.03.18.20038018]
   Look DC, 2001, AM J PATHOL, V159, P2055, DOI 10.1016/S0002-9440(10)63057-X
   Martines RB, 2020, EMERG INFECT DIS, V26, P2005, DOI 10.3201/eid2609.202095
   Mata M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048037
   Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134
   Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4
   Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]
   Nicholls JM, 2006, PLOS MED, V3, P222, DOI 10.1371/journal.pmed.0030027
   Ottestad William, 2020, Tidsskr Nor Laegeforen, V140, DOI 10.4045/tidsskr.20.0299
   Pujadas E, 2020, J MED VIROL, V92, P1695, DOI 10.1002/jmv.25988
   Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259
   Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6
   Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010
   TOMASHEFSKI JF, 1983, AM J PATHOL, V112, P112
   Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5
   Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003
   Wilkerson RG, 2020, AM J EMERG MED, V38, DOI 10.1016/j.ajem.2020.05.044
   Wu CA, 2008, AM J PATHOL, V172, P714, DOI 10.2353/ajpath.2008.070462
   Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X
   Yang Xiaobo, 2020, Lancet Respir Med, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Zhang HL, 2020, ANN INTERN MED, V172, P629, DOI 10.7326/M20-0533
   Zhao R, 2020, CLIN INFECT DIS
NR 36
TC 190
Z9 194
U1 2
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0893-3952
EI 1530-0285
J9 MODERN PATHOL
JI Mod. Pathol.
PD NOV
PY 2020
VL 33
IS 11
BP 2104
EP 2114
DI 10.1038/s41379-020-0595-z
EA JUN 2020
PG 11
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA OF2UZ
UT WOS:000541317200002
PM 32561849
OA Bronze, Green Published
DA 2023-08-21
ER

PT J
AU Saguil, A
   Fargo, MV
AF Saguil, Aaron
   Fargo, Matthew, V
TI Acute Respiratory Distress Syndrome: Diagnosis and Management
SO AMERICAN FAMILY PHYSICIAN
LA English
DT Article
ID ACUTE LUNG INJURY; INTENSIVE-CARE UNITS; QUALITY-OF-LIFE; FUNCTIONAL
   DISABILITY; GUIDELINES; MORTALITY; OUTCOMES; EPIDEMIOLOGY; SURVIVORS;
   ARDS
AB Acute respiratory distress syndrome (ARDS) is noncardiogenic pulmonary edema that manifests as rapidly progressive dyspnea, tachypnea, and hypoxemia. Diagnostic criteria include onset within one week of a known insult or new or worsening respiratory symptoms, profound hypoxemia, bilateral pulmonary opacities on radiography, and inability to explain respiratory failure by cardiac failure or fluid overload. ARDS is thought to occur when a pulmonary or extrapulmonary insult causes the release of inflammatory mediators, promoting inflammatory cell accumulation in the alveoli and microcirculation of the lung. Inflammatory cells damage the vascular endothelium and alveolar epithelium, leading to pulmonary edema, hyaline membrane formation, decreased lung compliance, and decreased gas exchange. Most cases are associated with pneumonia or sepsis. ARDS is responsible for one in 10 admissions to intensive care units and one in four mechanical ventilations. In-hospital mortality for patients with severe ARDS ranges from 46% to 60%. ARDS often must be differentiated from pneumonia and congestive heart failure, which typically has signs of fluid overload. Treatment of ARDS is supportive and includes mechanical ventilation, prophylaxis for stress ulcers and venous thromboembolism, nutritional support, and treatment of the underlying injury. Low tidal volume and high positive end-expiratory pressure improve outcomes. Prone positioning is recommended for some moderate and all severe cases. As patients with ARDS improve and the underlying illness resolves, a spontaneous breathing trial is indicated to assess eligibility for ventilator weaning. Patients who survive ARDS are at risk of diminished functional capacity, mental illness, and decreased quality of life; ongoing care by a primary care physician is beneficial for these patients. Copyright (C) 2020 American Academy of Family Physicians.
C1 [Saguil, Aaron] Uniformed Serv Univ Hlth Sci, Dept Family Med, F Edward Hebert Sch Med, Bethesda, MD 20814, United States.
   [Fargo, Matthew, V] 8th Theater Sustainment Command, Ft Shafter, HI, United States.
C3 Uniformed Services University of the Health Sciences - USA
RP Saguil, A (corresponding author), Brooke Army Med Ctr, Dept Med, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.
EM aaron.saguil@usuhs.edu
CR Academy of Nutrition and Dietetics, 2012, CRIT ILLN EV BAS NUT
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706
   Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500
   Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6
   Burnham EL, 2014, EUR RESPIR J, V43, P276, DOI 10.1183/09031936.00196412
   Cavalcanti AB, 2017, JAMA-J AM MED ASSOC, V318, P1335, DOI 10.1001/jama.2017.14171
   Centers for Disease Control and Prevention, 2020, COR DIS 2019 COVID 2
   Combes A, 2018, NEW ENGL J MED, V378, P1965, DOI 10.1056/NEJMoa1800385
   Combes A, 2019, INTENS CARE MED, V45, P592, DOI 10.1007/s00134-019-05567-4
   COOK DJ, 1994, NEW ENGL J MED, V330, P377, DOI 10.1056/NEJM199402103300601
   Davydow DS, 2008, PSYCHOSOM MED, V70, P512, DOI 10.1097/PSY.0b013e31816aa0dd
   Engels PT, 2009, CAN J SURG, V52, P427
   Esan A, 2010, CHEST, V137, P1203, DOI 10.1378/chest.09-2415
   Eworuke E, 2018, J CRIT CARE, V47, P192, DOI 10.1016/j.jcrc.2018.07.002
   Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST
   Fitzgerald M, 2014, CRIT CARE, V18, DOI 10.1186/cc13875
   Frutos-Vivar Fernando, 2004, Curr Opin Crit Care, V10, P1, DOI 10.1097/00075198-200402000-00001
   Girard TD, 2017, AM J RESP CRIT CARE, V195, P120, DOI 10.1164/rccm.201610-2075ST
   Goodwin Corey M, 2011, J Pharm Pract, V24, P78, DOI 10.1177/0897190010393851
   Greco A, 2020, INTENS CARE MED, V46, P854, DOI DOI 10.1007/s00134-020-06022-5
   Griffiths MJD, 2019, BMJ OPEN RESPIR RES, V6, DOI 10.1136/bmjresp-2019-000420
   Griffiths RD, 2010, CRIT CARE MED, V38, P779, DOI 10.1097/CCM.0b013e3181cc4b53
   Guillamondegui OD, 2005, PRACTICE MANAGEMENT
   Halpern NA, 2019, CRIT CARE MED, V47, P517, DOI 10.1097/CCM.0000000000003615
   Heidemann SM, 2017, PEDIATR CLIN N AM, V64, P1017, DOI 10.1016/j.pcl.2017.06.004
   Herridge Margaret S, 2011, N Engl J Med, V364, P1293, DOI 10.1056/NEJMoa1011802
   Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8
   Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450
   Ike JD, 2018, CRIT CARE MED, V46, P764, DOI 10.1097/CCM.0000000000003015
   Irish Critical Care Trials Group, 2008, CRIT CARE, V12, P830
   Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553
   Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350
   Kahn Susan R, 2012, Chest, V141, pe195S, DOI 10.1378/chest.11-2296
   Khemani RG, 2015, PEDIATR CRIT CARE ME, V16, pS23, DOI 10.1097/PCC.0000000000000432
   Komiya K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1809-8
   Krag M, 2018, NEW ENGL J MED, V379, P2199, DOI 10.1056/NEJMoa1714919
   Lewis SR, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004477.pub3
   Lin PC, 2010, CRIT CARE MED, V38, P1197, DOI 10.1097/CCM.0b013e3181d69ccf
   Luo L, 2017, CHEST, V151, P755, DOI 10.1016/j.chest.2016.09.004
   Maca J, 2017, RESP CARE, V62, P113, DOI 10.4187/respcare.04716
   MATOS R, 2020, DOD COVID 19 PRACTIC
   Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158
   McClave SA, 2016, JPEN-PARENTER ENTER, V40, P159, DOI [10.1177/0148607115621863, 10.1097/CCM.0000000000001525]
   Morales-Quinteros L, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0551-6
   Mortelliti MP, 2002, AM FAM PHYSICIAN, V65, P1823
   Munshi L, 2017, ANN AM THORAC SOC, V14, pS280, DOI 10.1513/AnnalsATS.201704-343OT
   Myhren H, 2010, CRIT CARE MED, V38, P1554, DOI 10.1097/CCM.0b013e3181e2c8b1
   Nin N, 2017, INTENS CARE MED, V43, P200, DOI 10.1007/s00134-016-4611-1
   Oeyen SG, 2010, CRIT CARE MED, V38, P2386, DOI 10.1097/CCM.0b013e3181f3dec5
   Papazian L, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0540-9
   Parhar KKS, 2019, ANN AM THORAC SOC, V16, P1263, DOI 10.1513/AnnalsATS.201812-910OC
   Petrucci N, 2013, LUNG PROTECTIVE VENT
   Raimondi N, 2017, J CRIT CARE, V38, P304, DOI 10.1016/j.jcrc.2016.10.009
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Saguil A, 2012, AM FAM PHYS, V85, P4352
   Saguil A, 2012, AM FAM PHYSICIAN, V85, P352
   Shah RD, 2017, CLIN CHEST MED, V38, P113, DOI 10.1016/j.ccm.2016.11.013
   Society of Critical Care Medicine, US RES AV COVID 19
   Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]
   Villar J, 2020, LANCET RESP MED, V8, P267, DOI 10.1016/S2213-2600(19)30417-5
   WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]
   World Health Organization, 2020, PEDIATR MED RODZ, DOI DOI 10.15557/PiMR.2020.0003
   Zompatori M, 2014, EUR RESPIR REV, V23, P519, DOI 10.1183/09059180.00001314
NR 68
TC 45
Z9 49
U1 0
U2 8
PU AMER ACAD FAMILY PHYSICIANS
PI KANSAS CITY
PA 8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA
SN 0002-838X
EI 1532-0650
J9 AM FAM PHYSICIAN
JI Am. Fam. Physician
PD JUN 15
PY 2020
VL 101
IS 11
BP 730
EP 738
PG 9
WC Primary Health Care; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA LY2GN
UT WOS:000540338700005
PM 32538594
DA 2023-08-21
ER

PT J
AU Qiao, JJ
   He, R
   Yin, YH
   Tian, L
   Li, L
   Lian, ZQ
   Fang, P
   Liu, Z
AF Qiao, Jiajia
   He, Rui
   Yin, Yonghua
   Tian, Li
   Li, Ling
   Lian, Zhengqiu
   Fang, Peng
   Liu, Zhong
TI rIL-35 prevents murine transfusion-related acute lung injury by
   inhibiting the activation of endothelial cells
SO TRANSFUSION
LA English
DT Article
ID REGULATORY T-CELLS; INDUCED ARTHRITIS; IL-35; CONTRIBUTES; SUPPRESSION;
   EXPANSION; CYTOKINES; MODEL; TRALI
AB BACKGROUND Transfusion-related acute lung injury (TRALI) is an important cause of death associated with transfusion, and no specific clinical treatments are available. Endothelial cells are believed to play an important role in the development of TRALI. This study investigated whether IL-35, an endothelial stabilizing cytokine could regulate the severity of antibody-mediated TRALI in vivo.
   STUDY DESIGN AND METHODS Human microvascular endothelial cells (HMVECs) were cultured in vitro, rIL-35(2 mu g/mL) was added before HMVECs activation, and HMVECs were fully activated by LPS (0.5 mu g/mL). Then cells were collected for flow cytometry analysis. We used a previously established "two-event" mouse model of TRALI with naive and lipopolysaccharide (LPS)-injected mice as controls. rIL-35(100 mu g/kg) was injected into the tail vein for 3 consecutive days before the induction of the TRALI model. Samples were collected 2 hours after TRALI induction and tested for lung tissue myeloperoxidase activity, total protein levels, lung tissue histology, endothelial cell activation assay, and cytokine assay.
   RESULTS In vitro culture of HMVECs with rIL-35 verified that rIL-35 inhibited endothelial cells. In a mouse model, prophylactic administration of rIL-35 prevented pulmonary edema, increased lung protein levels, and reduced polymorphonuclear neutrophil accumulation in the lung.
   CONCLUSIONS This work suggests that antibody-mediated murine TRALI can be prevented by rIL-35, and that rIL-35 appears to work by inhibiting the activation of lung endothelial cells.
C1 [Qiao, Jiajia; He, Rui; Yin, Yonghua; Tian, Li; Li, Ling; Fang, Peng; Liu, Zhong] Chinese Acad Med Sci & Peking Union Med Coll, Inst Blood Transfus, 26 Huacai Rd, Chengdu 610052, Sichuan, China.
   [Qiao, Jiajia; He, Rui; Yin, Yonghua; Tian, Li; Li, Ling; Fang, Peng; Liu, Zhong] Chinese Acad Med Sci, Key Lab Transfus Adverse React, Beijing, China.
   [Lian, Zhengqiu] Third Peoples Hosp Chengdu, Chengdu, China.
   [Fang, Peng] Anhui Med Univ, Sch Publ Hlth, Hefei, China.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College;
   Institute of Blood Transfusion - CAMS; Peking Union Medical College;
   Chinese Academy of Medical Sciences - Peking Union Medical College;
   Anhui Medical University
RP Liu, Z (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Blood Transfus, 26 Huacai Rd, Chengdu 610052, Sichuan, Peoples R China.
EM liuz@ibt.pumc.edu.cn
RI Liu, Zhong/ABH-8584-2020
OI liu, zhong/0000-0001-8173-9656
FU CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-3-024,
   2017-I2M-1-009]; Non-profit Central Research Institute Fund of Chinese
   Academy of Medical Sciences [2018PT32016]
FX CAMS Innovation Fund for Medical Sciences (CIFMS; Grant No.
   2016-I2M-3-024 and No. 2017-I2M-1-009), Non-profit Central Research
   Institute Fund of Chinese Academy of Medical Sciences (No. 2018PT32016)
CR Bayat B, 2013, ARTERIOSCL THROM VAS, V33, P2538, DOI 10.1161/ATVBAHA.113.301206
   Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227
   Collison LW, 2009, J IMMUNOL, V182, P6121, DOI 10.4049/jimmunol.0803646
   Dykes A, 2000, BRIT J HAEMATOL, V109, P674, DOI 10.1046/j.1365-2141.2000.01999.x
   El Mdawar MB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41742-9
   Fung YL, 2010, BLOOD, V116, P3073, DOI 10.1182/blood-2010-05-284570
   Gajic O, 2007, AM J RESP CRIT CARE, V176, P886, DOI 10.1164/rccm.200702-271OC
   He R, 2019, TRANSFUSION, V59, P534, DOI 10.1111/trf.15064
   Kanters E, 2008, J BIOL CHEM, V283, P31830, DOI 10.1074/jbc.M804888200
   Kapur R, 2019, BLOOD, V134, P74, DOI 10.1182/blood.2019000972
   Kapur R, 2018, BLOOD ADV, V2, P1651, DOI 10.1182/bloodadvances.2018018903
   Kapur R, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.04.37
   Kapur R, 2017, BLOOD, V129, P2557, DOI 10.1182/blood-2016-12-758185
   Kapur R, 2015, BLOOD, V126, P2747, DOI 10.1182/blood-2015-09-672592
   Khan SY, 2010, BIOCHEM J, V432, P35, DOI 10.1042/BJ20091087
   Kleinman S, 2004, TRANSFUSION, V44, P1774, DOI 10.1111/j.0041-1132.2004.04347.x
   Knipe L, 2010, BLOOD, V116, P2183, DOI 10.1182/blood-2010-03-276170
   Kochetkova I, 2010, J IMMUNOL, V184, P7144, DOI 10.4049/jimmunol.0902739
   Li XY, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101373
   Li XY, 2018, ARTERIOSCL THROM VAS, V38, P599, DOI 10.1161/ATVBAHA.117.310626
   Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033628
   Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432
   Morsing KSH, 2018, BLOOD REV, V32, P1, DOI 10.1016/j.blre.2017.08.003
   Mulder HD, 2015, J CRIT CARE, V30, P55, DOI 10.1016/j.jcrc.2014.10.005
   Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810
   Olson BM, 2012, J IMMUNOL, V189, P5590, DOI 10.4049/jimmunol.1201744
   Peters AL, 2015, BRIT J HAEMATOL, V170, P597, DOI 10.1111/bjh.13459
   Rebetz J, 2018, TRANSFUS MED HEMOTH, V45, P290, DOI 10.1159/000492950
   Semple JW, 2019, BLOOD, V133, P1840, DOI 10.1182/blood-2018-10-860809
   Sha XJ, 2015, J BIOL CHEM, V290, P19307, DOI 10.1074/jbc.M115.663286
   Silliman CC, 2005, BLOOD, V105, P2266, DOI 10.1182/blood-2004-07-2929
   Silliman CC, 2003, BLOOD, V101, P454, DOI 10.1182/blood-2002-03-0958
   Tariket S, 2016, EXPERT REV HEMATOL, V9, P497, DOI 10.1586/17474086.2016.1152177
   Thomas GM, 2012, BLOOD, V119, P6335, DOI 10.1182/blood-2012-01-405183
   Toy P, 2012, BLOOD, V119, P1757, DOI 10.1182/blood-2011-08-370932
   van Rijssel J, 2012, MOL BIOL CELL, V23, P2831, DOI 10.1091/mbc.E11-11-0907
   Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366
   Vlaar APJ, 2010, INTENS CARE MED, V36, P879, DOI 10.1007/s00134-010-1802-z
   Vlaar APJ, 2013, LANCET, V382, P984, DOI 10.1016/S0140-6736(12)62197-7
   Vlaar APJ, 2011, BLOOD, V117, P4218, DOI 10.1182/blood-2010-10-313973
   Wang RX, 2012, J BIOL CHEM, V287, P36012, DOI 10.1074/jbc.M112.390625
   Wyman TH, 2002, AM J PHYSIOL-CELL PH, V283, pC1592, DOI 10.1152/ajpcell.00540.2001
   Yang L, 2006, CIRC RES, V98, P394, DOI 10.1161/01.RES.0000201958.59020.1a
   Yang L, 2006, J IMMUNOL, V177, P6440, DOI 10.4049/jimmunol.177.9.6440
   Zhang F, 2016, SCI REP-UK, V6, DOI 10.1038/srep21348
NR 45
TC 4
Z9 4
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JUL
PY 2020
VL 60
IS 7
BP 1434
EP 1442
DI 10.1111/trf.15805
EA MAY 2020
PG 9
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA ML7EE
UT WOS:000535191900001
PM 32452053
DA 2023-08-21
ER

PT J
AU van de Veerdonk, FL
   Netea, MG
   van Deuren, M
   van der Meer, JWM
   de Mast, Q
   Bruggemann, RJ
   van der Hoeven, H
AF van de Veerdonk, Frank L.
   Netea, Mihai G.
   van Deuren, Marcel
   van der Meer, Jos W. M.
   de Mast, Quirijn
   Brueggemann, Roger J.
   van der Hoeven, Hans
TI Kallikrein-kinin blockade in patients with COVID-19 to prevent acute
   respiratory distress syndrome
SO ELIFE
LA English
DT Article
ID RECEPTORS
AB COVID-19 patients can present with pulmonary edema early in disease. We propose that this is due to a local vascular problem because of activation of bradykinin 1 receptor (B1R) and B2R on endothelial cells in the lungs. SARS-CoV-2 enters the cell via ACE2 that next to its role in RAAS is needed to inactivate des-Arg9 bradykinin, the potent ligand of the B1R. Without ACE2 acting as a guardian to inactivate the ligands of B1R, the lung environment is prone for local vascular leakage leading to angioedema. Here, we hypothesize that a kinin-dependent local lung angioedema via B1R and eventually B2R is an important feature of COVID-19. We propose that blocking the B2R and inhibiting plasma kallikrein activity might have an ameliorating effect on early disease caused by COVID-19 and might prevent acute respiratory distress syndrome (ARDS). In addition, this pathway might indirectly be responsive to anti-inflammatory agents.
C1 [van de Veerdonk, Frank L.; Netea, Mihai G.; van Deuren, Marcel; van der Meer, Jos W. M.; de Mast, Quirijn] Radboudumc Ctr Infect Dis RCI, Dept Internal Med, Nijmegen, Netherlands.
   [Netea, Mihai G.] Univ Bonn, Life & Med Sci Inst LIMES, Dept Genom & Immunoregulat, Bonn, Germany.
   [Brueggemann, Roger J.] Radboudumc Ctr Infect Dis RCI, Dept Pharm, Nijmegen, Netherlands.
   [van der Hoeven, Hans] Radboudumc Ctr Infect Dis RCI, Intens Care, Nijmegen, Netherlands.
C3 University of Bonn
RP van de Veerdonk, FL (corresponding author), Radboudumc Ctr Infect Dis RCI, Dept Internal Med, Nijmegen, Netherlands.
EM frank.vandeveerdonk@radboudumc.nl
RI van de Veerdonk, Frank L/C-7256-2008
OI van de Veerdonk, Frank L/0000-0002-1121-4894; de Mast,
   Quirijn/0000-0001-6056-157X
CR [Anonymous], 2020, J CLIN MED, DOI DOI 10.3390/jcm9020538
   Batlle D, 2020, CLIN SCI, V134, P543, DOI 10.1042/CS20200163
   BHOOLA KD, 1992, PHARMACOL REV, V44, P1
   Ceravolo GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111117
   European Medicines Agency, 2014, ASS REP FIR INN IC
   Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8
   Fu Y, 2020, VIROL SIN, V85, P4006, DOI DOI 10.1007/212250-020-00207-4
   Gattinoni L, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02880-z
   Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2
   Glowacka I, 2010, J VIROL, V84, P1198, DOI 10.1128/JVI.01248-09
   Gralinski LE, 2018, MBIO, V9, DOI 10.1128/mBio.01753-18
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Kuduk SD, 2007, J MED CHEM, V50, P272, DOI 10.1021/jm061094b
   Levi M, 2019, RES PRACT THROMB HAE, V3, P38, DOI 10.1002/rth2.12175
   Marceau F, 2018, PEPTIDES, V105, P37, DOI 10.1016/j.peptides.2018.05.007
   Nasseri S, 2015, CRIT CARE MED, V43, pE499, DOI 10.1097/CCM.0000000000001268
   Passos GF, 2004, J IMMUNOL, V172, P1839, DOI 10.4049/jimmunol.172.3.1839
   Qadri F, 2018, EXPERT OPIN THER TAR, V22, P31, DOI 10.1080/14728222.2018.1409724
   Quitterer U, 2014, BIOCHEM PHARMACOL, V88, P284, DOI 10.1016/j.bcp.2014.01.019
   Sodhi CP, 2018, AM J PHYSIOL-LUNG C, V314, pL17, DOI 10.1152/ajplung.00498.2016
   Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]
   Zekayi Kutlubay, 2017, COMPREHENSIVE REV UR, P151, DOI DOI 10.5772/67704
NR 23
TC 189
Z9 193
U1 1
U2 9
PU eLIFE SCIENCES PUBL LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD APR 27
PY 2020
VL 9
AR e57555
DI 10.7554/eLife.57555
PG 9
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA LL9QT
UT WOS:000531890700001
PM 32338605
OA gold, Green Published, Green Submitted
DA 2023-08-21
ER

PT J
AU Goligorsky, MS
   Sun, D
AF Goligorsky, Michael S.
   Sun, Dong
TI Glycocalyx in Endotoxemia and Sepsis
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Review
ID ACUTE-RENAL-FAILURE; ENDOTHELIAL GLYCOCALYX; CAPILLARY GLYCOCALYX;
   POLYETHYLENE-GLYCOL; SEPTIC SHOCK; HYALURONAN; MATRIX; PERMEABILITY;
   DYSFUNCTION; EXOCYTOSIS
AB Along with the recognition of a crucial role played by endothelial dysfunction secondarily igniting cardiovascular, pulmonary, and renal complications, investigational focus has extended toward endothelial glycocalyx. This delicate coating of cells, including the vascular endothelium, regulates permeability, leukocyte traffic, nitric oxide production, and coagulation, and harbors diverse growth and survival factors. In this brief overview, we discuss the metabolic signatures of sepsis as they relate to the loss of glycocalyx integrity and highlight the contribution of several proteases, heparanase, and hyaluronidase to the shedding of glycocalyx. Clinical manifestations of glycocalyx degradation in unraveling acute respiratory distress syndrome and the cardiovascular, microcirculatory, and renal complications of sepsis are concisely presented. Finally, we list therapeutic strategies for preventing the degradation of, and for restoration of, the glycocalyx.
C1 [Goligorsky, Michael S.] New York Med Coll, Dept Med, Valhalla, NY 10595, United States.
   [Goligorsky, Michael S.] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595, United States.
   [Goligorsky, Michael S.; Sun, Dong] New York Med Coll, Dept Physiol, Valhalla, NY 10595, United States.
C3 New York Medical College; New York Medical College; New York Medical
   College
RP Goligorsky, MS (corresponding author), New York Med Coll, 15 Dana Rd,Basic Sci Bldg, Valhalla, NY 10595 USA.
EM michael_goligorsky@nymc.edu
FU NIH [HL144528]
FX Supported by NIH grant HL144528 (M.S.G. and D.S.).
CR Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887
   Annecke T, 2011, BRIT J ANAESTH, V107, P679, DOI 10.1093/bja/aer269
   Annecke T, 2010, BRIT J ANAESTH, V104, P414, DOI 10.1093/bja/aeq019
   Becker BF, 2010, BASIC RES CARDIOL, V105, P687, DOI 10.1007/s00395-010-0118-z
   Beesley SJ, 2018, CRIT CARE MED, V46, P625, DOI 10.1097/CCM.0000000000002851
   Bertuglia S, 2006, AM J PHYSIOL-HEART C, V291, pH1536, DOI 10.1152/ajpheart.01114.2005
   Cabric S, 2008, TISSUE ENG PT C-METH, V14, P141, DOI 10.1089/ten.tec.2007.0312
   Cancel LM, 2013, FASEB J, V27, P896
   Chiang ET, 2009, MICROVASC RES, V77, P174, DOI 10.1016/j.mvr.2008.11.007
   Cunningham PN, 2002, J IMMUNOL, V168, P5817, DOI 10.4049/jimmunol.168.11.5817
   De Gaudio AR, 2000, INTENS CARE MED, V26, P1364, DOI 10.1007/s001340000593
   Declves AE, 2012, NEPHROL DIAL TRANSPL, V27, P3771, DOI 10.1093/ndt/gfs098
   Freeman CG, 2013, BIOMATERIALS, V34, P5670, DOI 10.1016/j.biomaterials.2013.03.091
   Giantsos-Adams K, 2011, BIOMATERIALS, V32, P288, DOI 10.1016/j.biomaterials.2010.08.092
   Goldberg R, 2013, MATRIX BIOL, V32, P234, DOI 10.1016/j.matbio.2013.02.008
   Hawiger J, 2015, J THROMB HAEMOST, V13, P1743, DOI 10.1111/jth.13061
   Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508
   Holland NB, 1998, NATURE, V392, P799, DOI 10.1038/33894
   Huet O, 2014, CLIN SCI, V126, P31, DOI 10.1042/CS20120668
   Iba T, 2018, THROMB RES, V171, P1, DOI 10.1016/j.thromres.2018.09.042
   Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004
   Inagawa R, 2018, CHEST, V154, P317, DOI 10.1016/j.chest.2018.03.003
   Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558
   Kotecha A, 2018, J CRIT CARE, V43, P122, DOI 10.1016/j.jcrc.2017.08.044
   Kuo MC, 2008, J AM SOC NEPHROL, V19, P2321, DOI 10.1681/ASN.2007111200
   Levi M, 2013, INTENS CARE MED, V39, P1839, DOI 10.1007/s00134-013-3054-1
   Levin M, 2017, BBA-MOL CELL RES, V1864, P1927, DOI 10.1016/j.bbamcr.2017.06.009
   Lin JJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003374
   Lipowsky HH, 2013, MICROVASC RES, V90, P80, DOI 10.1016/j.mvr.2013.07.004
   Martin L, 2019, CHEST, V155, P427, DOI 10.1016/j.chest.2018.08.1037
   McGarrity S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25015-5
   Mishra HK, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00138
   MORRISON DC, 1978, AM J PATHOL, V93, P526
   Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003
   Nelson A, 2014, ACTA ANAESTH SCAND, V58, P36, DOI 10.1111/aas.12223
   Nordling S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21463-1
   Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194
   Oppert M, 2008, NEPHROL DIAL TRANSPL, V23, P904, DOI 10.1093/ndt/gfm610
   Powell JD, 2005, IMMUNOL RES, V31, P207, DOI 10.1385/IR:31:3:207
   Reitsma S, 2011, J VASC RES, V48, P297, DOI 10.1159/000322176
   Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9
   Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843
   Schreiber A, 2012, KIDNEY INT, V82, P53, DOI 10.1038/ki.2012.62
   Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565
   Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683
   Song JW, 2017, J PHARMACOL EXP THER, V361, P115, DOI 10.1124/jpet.116.239509
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tarbell JM, 2016, J INTERN MED, V280, P97, DOI 10.1111/joim.12465
   van den Berg Bernard M, 2006, Pharmacol Rep, V58 Suppl, P75
   Van Wyngene L, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708712
   Vanlaere I, 2009, CLIN MICROBIOL REV, V22, P224, DOI 10.1128/CMR.00047-08
   Vlodaysky I, 2016, DRUG RESIST UPDATE, V29, P54, DOI 10.1016/j.drup.2016.10.001
   Wilke S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-62
   Wodicka JR, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020036
   Xu C, 2014, KIDNEY INT, V85, P72, DOI 10.1038/ki.2013.286
   Yen WY, 2012, MICROVASC RES, V83, P337, DOI 10.1016/j.mvr.2012.02.005
   Zhang XH, 2018, MATRIX BIOL, V71-72, P421, DOI 10.1016/j.matbio.2018.01.026
   Zullo JA, 2016, AM J PATHOL, V186, P248, DOI 10.1016/j.ajpath.2015.10.001
NR 59
TC 44
Z9 51
U1 2
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD APR
PY 2020
VL 190
IS 4
BP 791
EP 798
DI 10.1016/j.ajpath.2019.06.017
PG 8
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA LG1DH
UT WOS:000527849900007
PM 32035882
OA Bronze, Green Published
DA 2023-08-21
ER

PT J
AU Jones, JH
   Minshall, RD
AF Jones, Joshua H.
   Minshall, Richard D.
TI Lung Endothelial Transcytosis
SO COMPREHENSIVE PHYSIOLOGY
LA English
DT Article
ID CAVEOLAE-MEDIATED ENDOCYTOSIS; PROTEIN-COUPLED RECEPTOR; SRC-DEPENDENT
   PHOSPHORYLATION; VESICULO-VACUOLAR ORGANELLE; TRANS-GOLGI-NETWORK;
   BLOOD-BRAIN-BARRIER; OXIDE SYNTHASE ENOS; TYROSINE PHOSPHORYLATION;
   IN-VIVO; ALBUMIN TRANSCYTOSIS
AB Transcytosis of macromolecules through lung endothelial cells is the primary route of transport from the vascular compartment into the interstitial space. Endothelial transcytosis is mostly a caveolae-dependent process that combines receptor-mediated endocytosis, vesicle trafficking via actin-cytoskeletal remodeling, and SNARE protein directed vesicle fusion and exocytosis. Herein, we review the current literature on caveolae-mediated endocytosis, the role of actin cytoskeleton in caveolae stabilization at the plasma membrane, actin remodeling during vesicle trafficking, and exocytosis of caveolar vesicles. Next, we provide a concise summary of experimental methods employed to assess transcytosis. Finally, we review evidence that transcytosis contributes to the pathogenesis of acute lung injury. (C) 2020 American Physiological Society.
C1 [Jones, Joshua H.; Minshall, Richard D.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612, United States.
   [Minshall, Richard D.] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680, United States.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital
RP Minshall, RD (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA.; Minshall, RD (corresponding author), Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680 USA.
EM rminsh@uic.edu
FU NIH [UL1 TR002003, 5T32 HL07829, P01 HL60678, HL083298, HL125356]
FX We would like to acknowledge expert electron microscopy conducted by Dan
   Predescu Ph.D. (formerly affiliated with the Department of Pharmacology
   at UIC) and the Research Resources Center Electron Microscopy Core.
   Figures 2 and 3 were created with Biorender. This work was supported in
   part by NIH CTSA UL1 TR002003 PECTS Fellowship, NIH 5T32 HL07829 (JJ),
   and NIH NHLBI grants P01 HL60678, HL083298, and HL125356 (RM).
CR Ahmed SM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07467-5
   Ahn S, 2002, J BIOL CHEM, V277, P26642, DOI 10.1074/jbc.M201499200
   Alexander LD, 2014, AM J PHYSIOL-RENAL, V307, pF287, DOI 10.1152/ajprenal.00094.2014
   Ali T, 2019, FASEB J, V33, P8504, DOI 10.1096/fj.201802635R
   ALPERN DB, 1983, EXP CELL RES, V149, P555, DOI 10.1016/0014-4827(83)90366-X
   Aman J, 2016, AM J PHYSIOL-LUNG C, V311, pL453, DOI 10.1152/ajplung.00393.2015
   Andreone BJ, 2017, NEURON, V94, P581, DOI 10.1016/j.neuron.2017.03.043
   Anguita E, 2018, ARCH BIOCHEM BIOPHYS, V650, P59, DOI 10.1016/j.abb.2018.05.005
   Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652
   Aranda JF, 2011, MOL BIOL CELL, V22, P1252, DOI 10.1091/mbc.E10-11-0910
   Ariotti N, 2015, J BIOL CHEM, V290, P24875, DOI 10.1074/jbc.M115.644336
   Bardita C, 2013, JOVE-J VIS EXP, DOI 10.3791/50316
   Bartolini F, 2012, MOL BIOL CELL, V23, P4032, DOI 10.1091/mbc.E12-05-0338
   Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053
   Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756
   Boopathy GTK, 2017, J BIOL CHEM, V292, P17760, DOI 10.1074/jbc.M117.794743
   Borza CM, 2010, J BIOL CHEM, V285, P40114, DOI 10.1074/jbc.M110.156729
   Bourseau-Guilmain E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11371
   Breen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034516
   Brown DA, 2015, METHODS MOL BIOL, V1232, P55, DOI 10.1007/978-1-4939-1752-5_5
   BRUNS RR, 1968, J CELL BIOL, V37, P244, DOI 10.1083/jcb.37.2.244
   Bryant SM, 2018, AM J PHYSIOL-HEART C, V315, pH1101, DOI 10.1152/ajpheart.00209.2018
   Burgalossi A, 2010, NEURON, V68, P473, DOI 10.1016/j.neuron.2010.09.019
   Busija AR, 2017, AM J PHYSIOL-CELL PH, V312, pC459, DOI 10.1152/ajpcell.00355.2016
   Butt Y, 2016, ARCH PATHOL LAB MED, V140, P345, DOI 10.5858/arpa.2015-0519-RA
   Capozza F, 2005, AM J PHYSIOL-CELL PH, V288, pC1317, DOI 10.1152/ajpcell.00489.2004
   Caraceni P, 2013, BLOOD TRANSFUS-ITALY, V11, pS18, DOI 10.2450/2013.005s
   Cerecedo D, 2015, J CELL BIOCHEM, V116, P2528, DOI 10.1002/jcb.25197
   Chabot F, 1998, EUR RESPIR J, V11, P745
   Chang SH, 2009, AM J PATHOL, V175, P1768, DOI 10.2353/ajpath.2009.090171
   Chatterjee M, 2017, CANCER RES, V77, P5925, DOI 10.1158/0008-5472.CAN-17-0604
   Chen BY, 2017, ELIFE, V6, DOI 10.7554/eLife.29795
   Chen F, 2000, CURR BIOL, V10, P758, DOI 10.1016/S0960-9822(00)00571-6
   Chen ZL, 2018, MOL BIOL CELL, V29, P1190, DOI 10.1091/mbc.E17-01-0049
   Chen ZL, 2012, MOL BIOL CELL, V23, P1388, DOI 10.1091/mbc.E11-09-0811
   Cheng JPX, 2016, TRENDS CELL BIOL, V26, P177, DOI 10.1016/j.tcb.2015.10.010
   Cheng ZJ, 2010, J BIOL CHEM, V285, P15119, DOI 10.1074/jbc.M109.069427
   Chettimada Sukrutha, 2015, World J Respirol, V5, P126, DOI 10.5320/wjr.v5.i2.126
   Choi E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09318-3
   Chow CW, 2003, AM J RESP CELL MOL, V29, P427, DOI 10.1165/rcmb.F278
   Chuang MC, 2019, J CELL BIOL, V218, P1670, DOI 10.1083/jcb.201809161
   de Almeida CJ, 2011, CELL CYCLE, V10, P2151, DOI 10.4161/cc.10.13.16234
   Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897
   del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293
   DeVries HE, 1996, J PHARMACOL EXP THER, V277, P1418
   Dewulf M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09405-5
   Ding SY, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91023
   Diring J, 2019, NAT CELL BIOL, V21, P845, DOI 10.1038/s41556-019-0337-y
   Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540
   Dreja K, 2002, ARTERIOSCL THROM VAS, V22, P1267, DOI 10.1161/01.ATV.0000023438.32585.A1
   Dvorak AM, 1996, J LEUKOCYTE BIOL, V59, P100, DOI 10.1002/jlb.59.1.100
   Dvorak AM, 2001, J HISTOCHEM CYTOCHEM, V49, P419, DOI 10.1177/002215540104900401
   Ellis S, 2000, TRENDS CELL BIOL, V10, P85, DOI 10.1016/S0962-8924(99)01710-9
   Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf
   Ewers H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004721
   Ferreira APA, 2018, TRENDS CELL BIOL, V28, P188, DOI 10.1016/j.tcb.2017.11.004
   Filippini A, 2018, J CELL BIOCHEM, V119, P5060, DOI 10.1002/jcb.26793
   Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445
   Fortin C, 2015, METHODS MOL BIOL, V1343, P1, DOI 10.1007/978-1-4939-2963-4_1
   Foster-Barber A, 1998, P NATL ACAD SCI USA, V95, P4673, DOI 10.1073/pnas.95.8.4673
   FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655
   Fujimoto T, 2000, J CELL SCI, V113, P3509
   Fung KRY, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00841
   Fung KYY, 2018, TRAFFIC, V19, P5, DOI 10.1111/tra.12533
   GABELLA G, 1978, J ULTRA MOL STRUCT R, V65, P135, DOI 10.1016/S0022-5320(78)90051-5
   Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200
   Galloway DA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00790
   Gao YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044150
   Garcia-Castillo MD, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a027912
   Genet G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10359-x
   Gerbod-Giannone MC, 2019, BBA-GEN SUBJECTS, V1863, P830, DOI 10.1016/j.bbagen.2019.01.005
   Ghetie V, 1996, EUR J IMMUNOL, V26, P690, DOI 10.1002/eji.1830260327
   Gingras D, 1998, BIOCHEM BIOPH RES CO, V247, P888, DOI 10.1006/bbrc.1998.8885
   Giusti AF, 1999, J BIOL CHEM, V274, P29318, DOI 10.1074/jbc.274.41.29318
   GLENNEY JR, 1989, J BIOL CHEM, V264, P20163
   Godlee C, 2013, J CELL BIOL, V203, P717, DOI 10.1083/jcb.201307100
   Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019
   Gonzalez-Jamett AM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04418-w
   Gottlieb-Abraham E, 2013, MOL BIOL CELL, V24, P3881, DOI 10.1091/mbc.E13-03-0163
   Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006
   GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253
   Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138
   GROTTE G, 1956, Acta Chir Scand Suppl, V211, P1
   Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249
   Gu YT, 2019, FASEB J, V33, P441, DOI 10.1096/fj.201800095RR
   Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887
   Hansen CG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2808
   Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319
   Hashad AM, 2018, ARTERIOSCL THROM VAS, V38, P2371, DOI 10.1161/ATVBAHA.118.311394
   He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834
   He J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21663
   Head BP, 2007, TRENDS CELL BIOL, V17, P51, DOI 10.1016/j.tcb.2006.11.008
   Heckel K, 2004, AM J PHYSIOL-LUNG C, V287, pL867, DOI 10.1152/ajplung.00078.2004
   Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85
   Hernandez VJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00905
   Hertzog M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052627
   Hezel M, 2010, MOL BIOL CELL, V21, P302, DOI 10.1091/mbc.E09-05-0381
   Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042
   Hinze C, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216804
   Hinze C, 2018, BIOCHEM SOC T, V46, P565, DOI 10.1042/BST20170355
   Hirama T, 2017, J BIOL CHEM, V292, P14292, DOI 10.1074/jbc.M117.791400
   Hoernke M, 2017, P NATL ACAD SCI USA, V114, pE4360, DOI 10.1073/pnas.1614066114
   Hoop CL, 2012, BIOCHEMISTRY-US, V51, P90, DOI 10.1021/bi201356v
   Hu G, 2008, CIRC RES, V102, pE120, DOI 10.1161/CIRCRESAHA.107.167486
   Huang LZ, 2019, NATURE, V569, P565, DOI 10.1038/s41586-019-1140-4
   Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671
   Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927
   Inaba T, 2016, P NATL ACAD SCI USA, V113, P7834, DOI 10.1073/pnas.1603513113
   Ivanciu L, 2006, BLOOD, V108, p514A, DOI 10.1182/blood.V108.11.1814.1814
   Ivaturi S, 2014, BIOCHEM BIOPH RES CO, V445, P422, DOI 10.1016/j.bbrc.2014.02.019
   Iwamoto DV, 2018, NAT STRUCT MOL BIOL, V25, P918, DOI 10.1038/s41594-018-0128-3
   Jiang Y, 2016, J BIOL CHEM, V291, P20729, DOI 10.1074/jbc.M116.752485
   Jiao H, 2013, J IMMUNOL, V191, P6191, DOI 10.4049/jimmunol.1300873
   JOHANSSON BR, 1979, MICROVASC RES, V17, P107, DOI 10.1016/0026-2862(79)90400-X
   John TA, 2003, AM J PHYSIOL-LUNG C, V284, pL187, DOI 10.1152/ajplung.00152.2002
   John TA, 2001, J PHYSIOL-LONDON, V533, P547, DOI 10.1111/j.1469-7793.2001.0547a.x
   Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775
   Joshi B, 2012, J CELL BIOL, V199, P425, DOI 10.1083/jcb.201207089
   Jufvas A, 2016, BIOCHEM J, V473, P3177, DOI 10.1042/BCJ20160581
   Kaksonen M, 2018, NAT REV MOL CELL BIO, V19, P313, DOI 10.1038/nrm.2017.132
   Kanai Y, 2014, J CELL BIOL, V204, P395, DOI 10.1083/jcb.201309066
   KEDEM O, 1989, BIOCHIM BIOPHYS ACTA, V1000, P411, DOI 10.1016/S0006-3002(89)80036-8
   Kellner M, 2017, ADV EXP MED BIOL, V967, P105, DOI 10.1007/978-3-319-63245-2_8
   Keshavarz M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25445-1
   Kimura A, 2002, J BIOL CHEM, V277, P30153, DOI 10.1074/jbc.M203375200
   Kimura T, 2013, MOL CELL BIOL, V33, P4834, DOI 10.1128/MCB.00895-13
   Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725
   Klein IK, 2009, J BIOL CHEM, V284, P25953, DOI 10.1074/jbc.M109.035071
   Knezevic I, 2011, J CELL MOL MED, V15, P2364, DOI 10.1111/j.1582-4934.2010.01226.x
   Kogo H, 2004, J BIOL CHEM, V279, P25574, DOI 10.1074/jbc.M310807200
   Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833
   Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534
   Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x
   Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866
   Kraehling JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13516
   Krishna A, 2019, BIOPHYS J, V116, P69, DOI 10.1016/j.bpj.2018.11.3127
   Kuebler WM, 2016, AM J PHYSIOL-LUNG C, V310, pL720, DOI 10.1152/ajplung.00157.2015
   KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003
   Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200
   Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9
   Lamaze C, 2017, CURR OPIN CELL BIOL, V47, P117, DOI 10.1016/j.ceb.2017.02.014
   LANKEN PN, 1985, J APPL PHYSIOL, V59, P580, DOI 10.1152/jappl.1985.59.2.580
   Lee H, 2001, J BIOL CHEM, V276, P35150, DOI 10.1074/jbc.M104530200
   Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750
   Lee HS, 2004, MICROVASC RES, V68, P231, DOI 10.1016/j.mvr.2004.07.005
   Lee MH, 2019, ARCH PHARM RES, V42, P481, DOI 10.1007/s12272-019-01153-w
   Lee WL, 2016, PHYSIOLOGY, V31, P336, DOI 10.1152/physiol.00010.2016
   Lefort CT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00157
   Levi M, 2017, THROMB RES, V149, P38, DOI 10.1016/j.thromres.2016.11.007
   Li HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081903
   Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182
   Li SW, 1996, J BIOL CHEM, V271, P3863
   Li WJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44659
   Li Y, 2019, ELIFE, V8, DOI 10.7554/eLife.44594
   Li Y, 2018, AM J PHYSIOL-RENAL, V315, pF1626, DOI 10.1152/ajprenal.00076.2018
   Lin ZX, 2008, CANCER SCI, V99, P2540, DOI 10.1111/j.1349-7006.2008.00974.x
   Liu DM, 2018, MOL BIOL CELL, V29, P736, DOI 10.1091/mbc.E17-08-0518
   Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008
   Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200
   Liu LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102935
   Liu SL, 2014, J BIOL CHEM, V289, P18163, DOI 10.1074/jbc.M113.521203
   Lockett AD, 2015, AM J PHYSIOL-LUNG C, V309, pL425, DOI 10.1152/ajplung.00376.2014
   Loeffler B, 2007, J LIPID RES, V48, P288, DOI 10.1194/jlr.M600292-JLR200
   Ludwig A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001640
   Lum AFH, 2002, J BIOL CHEM, V277, P20660, DOI 10.1074/jbc.M202223200
   Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637
   Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443
   Lutz SE, 2017, CELL REP, V21, P2104, DOI 10.1016/j.celrep.2017.10.094
   Machleidt T, 2000, J CELL BIOL, V148, P17, DOI 10.1083/jcb.148.1.17
   Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9
   Maniatis Nikolaos A, 2012, Pulm Circ, V2, P452, DOI 10.4103/2045-8932.105033
   Marsboom G, 2017, MOL BIOL CELL, V28, P1177, DOI 10.1091/mbc.E16-11-0790
   Martin-Urdiroz M, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00024
   MASTICK CC, 1995, J CELL BIOL, V129, P1523, DOI 10.1083/jcb.129.6.1523
   Mayor S, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016758
   McCall PM, 2019, P NATL ACAD SCI USA, V116, P12629, DOI 10.1073/pnas.1818808116
   McIntosh DP, 1999, AM J PHYSIOL-HEART C, V277, pH2222, DOI 10.1152/ajpheart.1999.277.6.H2222
   McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Meng F, 2017, MOL BIOL CELL, V28, P2190, DOI 10.1091/mbc.E17-05-0278
   Merlot AM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00299
   Mettlen M, 2018, ANNU REV BIOCHEM, V87, P871, DOI 10.1146/annurev-biochem-062917-012644
   Michaely PA, 1999, J BIOL CHEM, V274, P21430, DOI 10.1074/jbc.274.30.21430
   MILICI AJ, 1985, CIRC RES, V56, P709, DOI 10.1161/01.RES.56.5.709
   MILICI AJ, 1987, J CELL BIOL, V105, P2603, DOI 10.1083/jcb.105.6.2603
   Minamino T, 2006, J CLIN INVEST, V116, P2316, DOI 10.1172/JCI29637
   Minguet S, 2017, NAT IMMUNOL, V18, P1150, DOI 10.1038/ni.3813
   Minshall RD, 2002, HISTOCHEM CELL BIOL, V117, P105, DOI 10.1007/s00418-001-0367-x
   Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057
   Moissoglu K, 2014, J CELL SCI, V127, P2565, DOI 10.1242/jcs.149088
   MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911
   Monier S, 1996, FEBS LETT, V388, P143, DOI 10.1016/0014-5793(96)00519-4
   Moon H, 2014, ONCOGENE, V33, P3561, DOI 10.1038/onc.2013.315
   Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787
   Moreno-Vicente R, 2019, CELL REP, V26, P1679, DOI 10.1016/j.celrep.2019.01.090
   Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117
   Muradashvili N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00166
   MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339
   Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340
   Muriel O, 2011, J CELL SCI, V124, P2763, DOI 10.1242/jcs.080804
   Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401
   Nethe M, 2011, CELL ADHES MIGR, V5, P59, DOI 10.4161/cam.5.1.13702
   Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919
   Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200
   NOGUCHI Y, 1986, CELL TISSUE RES, V246, P487, DOI 10.1007/BF00215188
   Nomura R, 1999, MOL BIOL CELL, V10, P975, DOI 10.1091/mbc.10.4.975
   Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07
   Ogata T, 2014, P NATL ACAD SCI USA, V111, P3811, DOI 10.1073/pnas.1315359111
   Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685
   Oh P, 2007, NAT BIOTECHNOL, V25, P327, DOI 10.1038/nbt1292
   Oh P, 2012, J BIOL CHEM, V287, P17353, DOI 10.1074/jbc.M111.338897
   Okreglak V, 2007, J CELL BIOL, V178, P1251, DOI 10.1083/jcb.200703092
   Orlichenko L, 2006, J BIOL CHEM, V281, P4570, DOI 10.1074/jbc.M512088200
   Oshikawa J, 2004, P NATL ACAD SCI USA, V101, P12670, DOI 10.1073/pnas.0402053101
   Owczarek K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25640-0
   PALADE GE, 1953, J APPL PHYS, V24, P1424
   PAPPENHEIMER JR, 1951, AM J PHYSIOL, V167, P13, DOI 10.1152/ajplegacy.1951.167.1.13
   Parton RG, 2018, ANNU REV CELL DEV BI, V34, P111, DOI 10.1146/annurev-cellbio-100617-062737
   Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784
   PETERS KR, 1985, J CELL BIOL, V101, P2233, DOI 10.1083/jcb.101.6.2233
   Picco A, 2018, MOL BIOL CELL, V29, P1346, DOI 10.1091/mbc.E17-11-0688
   Picco A, 2017, CELL, V168, P400, DOI 10.1016/j.cell.2017.01.004
   Pilch PF, 2011, TRENDS ENDOCRIN MET, V22, P318, DOI 10.1016/j.tem.2011.04.001
   PORTER GA, 1987, AM J ANAT, V178, P116, DOI 10.1002/aja.1001780203
   Potje SR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43193-8
   Predescu D, 2004, AM J PHYSIOL-LUNG C, V287, pL895, DOI 10.1152/ajplung.00075.2004
   Predescu D, 1998, P NATL ACAD SCI USA, V95, P6175, DOI 10.1073/pnas.95.11.6175
   PREDESCU D, 1994, P NATL ACAD SCI USA, V91, P3014, DOI 10.1073/pnas.91.8.3014
   Predescu DN, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/672705
   Predescu SA, 1997, AM J PHYSIOL-HEART C, V272, pH937, DOI 10.1152/ajpheart.1997.272.2.H937
   Predescu SA, 2005, J BIOL CHEM, V280, P37130, DOI 10.1074/jbc.M505659200
   Predescu SA, 2003, MOL BIOL CELL, V14, P4997, DOI 10.1091/mbc.e03-01-0041
   Predescu SA, 2001, MOL BIOL CELL, V12, P1019, DOI 10.1091/mbc.12.4.1019
   Predescu SA, 2007, AM J PHYSIOL-LUNG C, V293, pL823, DOI 10.1152/ajplung.00436.2006
   Priya R, 2017, MOL BIOL CELL, V28, P12, DOI 10.1091/mbc.E16-04-0262
   Puy C, 2019, ARTERIOSCL THROM VAS, V39, P1390, DOI 10.1161/ATVBAHA.119.312619
   Raheel H, 2019, AM J PHYSIOL-LUNG C, V316, pL740, DOI 10.1152/ajplung.00127.2018
   Rangel L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38020-5
   Rantakari P, 2016, NATURE, V538, P392, DOI 10.1038/nature19814
   Rantakari P, 2015, NAT IMMUNOL, V16, P386, DOI 10.1038/ni.3101
   Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002
   Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200
   Razani B, 2001, J BIOL CHEM, V276, P38121
   Reeves VL, 2012, ADV EXP MED BIOL, V729, P3, DOI 10.1007/978-1-4614-1222-9_1
   Richter T, 2008, TRAFFIC, V9, P893, DOI 10.1111/j.1600-0854.2008.00733.x
   RIPPE B, 1994, PHYSIOL REV, V74, P163, DOI 10.1152/physrev.1994.74.1.163
   ROHLICH P, 1976, J ULTRA MOL STRUCT R, V57, P94, DOI 10.1016/S0022-5320(76)80059-7
   Root KT, 2015, CURR TOP MEMBR, V75, P305, DOI 10.1016/bs.ctm.2015.03.007
   Ross JA, 2011, BIOPHYS J, V100, pL15, DOI 10.1016/j.bpj.2010.12.3703
   ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z
   Sandoo A, 2010, OPEN CARDIOVASC MED, V4, P302, DOI 10.2174/1874192401004010302
   Sandvig K, 2018, HISTOCHEM CELL BIOL, V150, P107, DOI 10.1007/s00418-018-1678-5
   SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407
   Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337
   Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131
   Schlegel A, 1999, J BIOL CHEM, V274, P22660, DOI 10.1074/jbc.274.32.22660
   SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399
   SCHNITZER JE, 1995, AM J PHYSIOL-HEART C, V268, pH48, DOI 10.1152/ajpheart.1995.268.1.H48
   SCHNITZER JE, 1994, J BIOL CHEM, V269, P6072
   Schnitzer JE, 1996, SCIENCE, V274, P239, DOI 10.1126/science.274.5285.239
   Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200
   Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200
   SEEGER W, 1995, MICROVASC RES, V50, P1, DOI 10.1006/mvre.1995.1033
   Seemann E, 2017, ELIFE, V6, DOI 10.7554/eLife.29854
   Sengupta D, 2012, J PHYS CHEM B, V116, P14556, DOI 10.1021/jp3077886
   Senju Y, 2015, J CELL SCI, V128, P2766, DOI 10.1242/jcs.167775
   Senju Y, 2011, J CELL SCI, V124, P2032, DOI 10.1242/jcs.086264
   Shajahan AN, 2004, J BIOL CHEM, V279, P48055, DOI 10.1074/jbc.M405837200
   Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200
   Shang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32180
   Shitara A, 2019, MOL BIOL CELL, V30, P324, DOI 10.1091/mbc.E18-10-0615
   SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5
   Siddiqui MR, 2011, J CELL BIOL, V193, P841, DOI 10.1083/jcb.201012129
   SIFLINGERBIRNBOIM A, 1991, J CELL PHYSIOL, V149, P575, DOI 10.1002/jcp.1041490329
   SIMIONESCU M, 1974, J CELL BIOL, V60, P128, DOI 10.1083/jcb.60.1.128
   SIMIONESCU M, 1991, CELL BIOL REV, V25, P5
   Simionescu M., 1984, HDB PHYSL, P78
   SIMIONESCU N, 1973, J CELL BIOL, V57, P424, DOI 10.1083/jcb.57.2.424
   SINGER II, 1979, EXP CELL RES, V122, P251, DOI 10.1016/0014-4827(79)90302-1
   Skruzny M, 2012, P NATL ACAD SCI USA, V109, pE2533, DOI 10.1073/pnas.1207011109
   Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690
   Song KS, 1997, J BIOL CHEM, V272, P4398, DOI 10.1074/jbc.272.7.4398
   Soriano-Castell D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07130-x
   Sowa G, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00120
   Stan RV, 2007, J CELL MOL MED, V11, P621, DOI 10.1111/j.1582-4934.2007.00075.x
   Stan RV, 2012, DEV CELL, V23, P1203, DOI 10.1016/j.devcel.2012.11.003
   Stan RV, 1999, J CELL BIOL, V145, P1189, DOI 10.1083/jcb.145.6.1189
   Stan RV, 2004, MOL BIOL CELL, V15, P3615, DOI 10.1091/mbc.E03-08-0593
   Stan RV, 2004, AM J PHYSIOL-HEART C, V286, pH1347, DOI 10.1152/ajpheart.00909.2003
   Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203
   Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008
   Stapleton NM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40731-2
   Stateva SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128783
   Stoeber M, 2012, EMBO J, V31, P2350, DOI 10.1038/emboj.2012.98
   Sun SW, 2010, ACTA PHARMACOL SIN, V31, P1336, DOI 10.1038/aps.2010.87
   Sun Y, 2011, METHODS MOL BIOL, V763, P303, DOI 10.1007/978-1-61779-191-8_21
   Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673
   Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997
   Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200
   Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255
   Taniguchi T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162513
   Tiruppathi C, 1996, P NATL ACAD SCI USA, V93, P250, DOI 10.1073/pnas.93.1.250
   Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968
   Tiruppathi C, 2008, J BIOL CHEM, V283, P4210, DOI 10.1074/jbc.M703153200
   Tkachenko E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032655
   Toseland Christopher P, 2013, J Chem Biol, V6, P85, DOI 10.1007/s12154-013-0094-5
   Triacca V, 2017, CIRC RES, V120, P1440, DOI 10.1161/CIRCRESAHA.116.309828
   Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003
   Urra H, 2018, NAT CELL BIOL, V20, P942, DOI 10.1038/s41556-018-0141-0
   Urra H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033085
   Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016
   VILLASCHI S, 1986, MICROVASC RES, V32, P190, DOI 10.1016/0026-2862(86)90053-1
   Vogel SM, 2001, AM J PHYSIOL-LUNG C, V281, pL1512, DOI 10.1152/ajplung.2001.281.6.L1512
   WAGNER RC, 1991, MICROVASC RES, V42, P139, DOI 10.1016/0026-2862(91)90082-M
   Wang H, 2008, DIABETES, V57, P540, DOI 10.2337/db07-0967
   Wang H, 2019, J BIOL CHEM, V294, P10544, DOI 10.1074/jbc.RA119.008824
   Wang H, 2015, DIABETOLOGIA, V58, P1344, DOI 10.1007/s00125-015-3546-3
   Wang SP, 2016, J CLIN INVEST, V126, P4527, DOI 10.1172/JCI87343
   Wang Y, 2003, J AM SOC NEPHROL, V14, P28, DOI 10.1097/01.ASN.0000043180.18456.47
   Wettschureck N, 2019, PHYSIOL REV, V99, P1467, DOI 10.1152/physrev.00037.2018
   Williere Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19071-6
   Wu B, 2015, J CELL SCI, V128, P2957, DOI 10.1242/jcs.156398
   Xiang BG, 2012, J BIOL CHEM, V287, P41277, DOI 10.1074/jbc.M112.393124
   Xie LK, 2011, AM J PHYSIOL-CELL PH, V301, pC1161, DOI 10.1152/ajpcell.00486.2010
   Xie LK, 2010, AM J PHYSIOL-CELL PH, V298, pC693, DOI 10.1152/ajpcell.00401.2009
   Xie ZJ, 2005, MOL BIOL CELL, V16, P3236, DOI 10.1091/mbc.E05-02-0109
   YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445
   Yamaguchi T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10060
   Yamakuchi Munekazu, 2008, V440, P203, DOI 10.1007/978-1-59745-178-9_15
   Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942
   Yeow I, 2017, CURR BIOL, V27, P2951, DOI 10.1016/j.cub.2017.07.047
   Yoshida A, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004786
   Yu M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01745-4
   Zanoni P, 2018, ATHEROSCLEROSIS, V275, P273, DOI 10.1016/j.atherosclerosis.2018.06.881
   Zemans RL, 2017, THORAX, V72, P1, DOI 10.1136/thoraxjnl-2016-209170
   Zhang XB, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00130
   Zhang YN, 2018, J VIROL, V92, DOI [10.1128/JVI.00797-18, 10.1128/jvi.00797-18]
   Zhao TT, 2019, VIROLOGY, V529, P160, DOI 10.1016/j.virol.2019.01.009
   ZHAO YH, 1992, P NATL ACAD SCI USA, V89, P8298, DOI 10.1073/pnas.89.17.8298
   Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338
   Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799
   Zhou K, 2015, MOL BIOL CELL, V26, P1995, DOI 10.1091/mbc.E14-10-1481
   Zhu BY, 2017, CELL TISSUE RES, V368, P591, DOI 10.1007/s00441-017-2587-y
   Zhu QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118737
   Zimnicka AM, 2016, MOL BIOL CELL, V27, P2090, DOI 10.1091/mbc.E15-11-0756
NR 345
TC 13
Z9 13
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 2040-4603
J9 COMPR PHYSIOL
JI Compr. Physiol.
PD APR
PY 2020
VL 10
IS 2
BP 491
EP 508
DI 10.1002/cphy.c190012
PG 18
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA KU9FG
UT WOS:000520029400006
PM 32163197
OA Bronze, Green Accepted
DA 2023-08-21
ER

PT J
AU Trent, B
   Liang, YJ
   Xing, Y
   Esqueda, M
   Wei, Y
   Cho, NH
   Kim, HI
   Kim, YS
   Shelite, TR
   Cai, JY
   Sun, J
   Bouyer, DH
   Liu, JJ
   Soong, L
AF Trent, Brandon
   Liang, Yuejin
   Xing, Yan
   Esqueda, Marisol
   Wei, Yang
   Cho, Nam-Hyuk
   Kim, Hong-Il
   Kim, Yeon-Sook
   Shelite, Thomas R.
   Cai, Jiyang
   Sun, Jiaren
   Bouyer, Donald H.
   Liu, Jinjun
   Soong, Lynn
TI Polarized lung inflammation and Tie2/angiopoietin-mediated endothelial
   dysfunction during severe Orientia tsutsugamushi infection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MULTIPLE-ORGAN DYSFUNCTION; SCRUB TYPHUS; TYROSINE KINASE;
   ANGIOPOIETIN-2; CELLS; MANIFESTATIONS; VASCULATURE; RICKETTSIA;
   ACTIVATION; EXPRESSION
AB Orientia tsutsugamushi infection can cause acute lung injury and high mortality in humans; however, the underlying mechanisms are unclear. Here, we tested a hypothesis that dysregulated pulmonary inflammation and Tie2-mediated endothelial malfunction contribute to lung damage. Using a murine model of lethal O. tsutsugamushi infection, we demonstrated pathological characteristics of vascular activation and tissue damage: 1) a significant increase of ICAM-1 and angiopoietin-2 (Ang2) proteins in inflamed tissues and lung-derived endothelial cells (EC), 2) a progressive loss of endothelial quiescent and junction proteins (Ang1, VE-cadherin/CD144, occuludin), and 3) a profound impairment of Tie2 receptor at the transcriptional and functional levels. In vitro infection of primary human EC cultures and serum Ang2 proteins in scrub typhus patients support our animal studies, implying endothelial dysfunction in severe scrub typhus. Flow cytometric analyses of lung-recovered cells further revealed that pulmonary macrophages (M phi) were polarized toward an M1-like phenotype (CD80(+)CD64(+)CD11b(+)Ly6G(-)) during the onset of disease and prior to host death, which correlated with the significant loss of CD31(+)CD45(-) ECs and M2-like (CD206(+)CD64(+)CD11b(+)Ly6G(-)) cells. In vitro studies indicated extensive bacterial replication in M2-type, but not M1-type, M phi s, implying the protective and pathogenic roles of M1-skewed responses. This is the first detailed investigation of lung cellular immune responses during acute O. tsutsugamushi infection. It uncovers specific biomarkers for vascular dysfunction and M1-skewed inflammatory responses, highlighting future therapeutic research for the control of this neglected tropical disease.
   Author summary
   Scrub typhus is a life-threatening disease, infecting an estimated one million people yearly. Acute lung injury is a dangerous clinical development in severe cases; however, its pathogenic biomarkers and mechanisms of progression remain unknown. Here, we used a lethal infection mouse model that parallels certain aspects of severe scrub typhus, primary human endothelial cell cultures, and patient sera to define pathogenic biomarkers following Orientia tsutsugamushi infections. We found a significant increase in the levels of endothelial activation/stress markers (angiopoietins and ICAM-1) in infected mouse lungs and patient sera, but a progressive loss of endothelium-specific Tie2 receptor and junction proteins (VE-cadherin), at severe stages of disease. These signs of vasculature disruption positively correlated with the timing and magnitude of recruitment/activation of proinflammatory M phi subsets in infected lungs. Bacterial growth in vitro was favored in M2-like, but not in M1-like, M phi s. This study, for the first time, reveals endothelial malfunction and dysregulated inflammatory responses, suggesting potential therapeutic targets to ameliorate tissue damage and pathogenesis.
C1 [Trent, Brandon; Sun, Jiaren; Bouyer, Donald H.; Soong, Lynn] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555, United States.
   [Liang, Yuejin; Xing, Yan; Esqueda, Marisol; Wei, Yang; Shelite, Thomas R.; Sun, Jiaren; Soong, Lynn] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555, United States.
   [Cho, Nam-Hyuk] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea.
   [Cho, Nam-Hyuk; Kim, Hong-Il] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.
   [Kim, Yeon-Sook] Chungnam Natl Univ, Sch Med, Dept Internal Med, Div Infect Dis, Daejeon, South Korea.
   [Cai, Jiyang] Univ Texas Med Branch, Dept Ophthalmol & Visual Sci, Galveston, TX 77555, United States.
   [Liu, Jinjun] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Xian, China.
   [Xing, Yan] Peoples Hosp Henan Prov, Zhengzhou, Henan, China.
   [Wei, Yang] Xi An Jiao Tong Univ, Affiliated Hosp 2, Core Res Lab, Xian, China.
   [Shelite, Thomas R.] Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555, United States.
   [Cai, Jiyang] OUHSC, Dept Physiol, Oklahoma City, OK, United States.
C3 University of Texas System; University of Texas Medical Branch
   Galveston; University of Texas System; University of Texas Medical
   Branch Galveston; Seoul National University (SNU); Seoul National
   University (SNU); Chungnam National University; University of Texas
   System; University of Texas Medical Branch Galveston; Xi'an Jiaotong
   University; Zhengzhou University; Xi'an Jiaotong University; University
   of Texas System; University of Texas Medical Branch Galveston;
   University of Oklahoma System; University of Oklahoma Health Sciences
   Center
RP Soong, L (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Soong, L (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Liu, JJ (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Xian, Peoples R China.
EM jupet@163.com; lysoong@utmb.edu
OI Kim, Yeon-Sook/0000-0003-1142-5488; Esqueda,
   Marisol/0000-0002-2182-2105; Liang, Yuejin/0000-0002-9557-1847
FU NIH; NIAID [AI132674, AI126343]; T32 Biodefense Training Program Grant
   [AI060549]; T35 Infectious Diseases Training Grant [AI078878]; UTMB
   Infection and Immunity Data Generation Award; American Association of
   Immunologists as a 2018 AAI Careers in Immunology Fellowship
FX This work was supported by generous grant funding from the NIH and NIAID
   (grant numbers AI132674, AI126343 to LS, https://www.niaid.nih.gov/), a
   T32 Biodefense Training Program Grant (grant number AI060549, provided
   to BT, https://www.niaid.nih.gov/), and a T35 Infectious Diseases
   Training Grant (grant number AI078878 to LS and ME,
   https://www.niaid.nih.gov/). Funding was also provided from the UTMB
   Infection and Immunity Data Generation Award to LS
   (https://www.utmb.edu/ihii). Lastly, funding was provided by the
   American Association of Immunologists as a 2018 AAI Careers in
   Immunology Fellowship (grant to BT and LS, https://www.aai.org/). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013
   [Anonymous], 2013, MED LETT DRUGS THER, V55, P5
   [Anonymous], 2013, FAM LR, V49, P503
   [Anonymous], 2012, REGEN MED S3, V7, pS14
   Astrup E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002648
   Atri C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061801
   Bertani FR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08121-8
   BOOCKVAR KS, 1994, INFECT IMMUN, V62, P1089, DOI 10.1128/IAI.62.3.1089-1100.1994
   BRIELAND JK, 1995, INFECT IMMUN, V63, P3253, DOI 10.1128/IAI.63.9.3253-3258.1995
   BROWN GW, 1976, T ROY SOC TROP MED H, V70, P444, DOI 10.1016/0035-9203(76)90127-9
   Buchacher T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143593
   Cho NH, 2002, INFECT IMMUN, V70, P4841, DOI 10.1128/IAI.70.9.4841-4850.2002
   Cho NH, 2000, INFECT IMMUN, V68, P594, DOI 10.1128/IAI.68.2.594-602.2000
   Chu H, 2006, INFECT IMMUN, V74, P4246, DOI 10.1128/IAI.01620-05
   Curto P, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00080
   David S, 2011, CYTOKINE, V55, P251, DOI 10.1016/j.cyto.2011.04.005
   Diaz FE, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00076-17
   DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897
   Ehrentraut H, 2018, J INFLAMM-LOND, V15, DOI 10.1186/s12950-018-0188-5
   Feng HM, 2000, INFECT IMMUN, V68, P6729, DOI 10.1128/IAI.68.12.6729-6736.2000
   Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685
   Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351
   Garcia S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082088
   Ghosh CC, 2016, P NATL ACAD SCI USA, V113, P2472, DOI 10.1073/pnas.1519467113
   Gong B, 2013, P NATL ACAD SCI USA, V110, P19615, DOI 10.1073/pnas.1314400110
   Gonzales J., 2015, AUSTIN J VASC MED, V2, P1, DOI [10.1080/10590501.2015.1002999.A, DOI 10.1080/10590501.2015.1002999.A]
   Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138
   Hauptmann M, 2016, PLOS NEGLECT TROP D, V10, DOI [10.137, 10.1371/journal.pntd.0004991]
   Higgins SJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6812
   Hsu YH, 2008, PATHOLOGY, V40, P268, DOI 10.1080/00313020801911488
   Ikeda Y, 2010, APPL OPTICS, V49, pC95, DOI 10.1364/AO.49.000C95
   Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322
   Keller CA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003064
   Kim DM, 2010, CLIN MICROBIOL INFEC, V16, P447, DOI 10.1111/j.1469-0691.2009.02865.x
   Kim G, 2017, J PROSTHET DENT, V11, pe0005408, DOI 10.1371/journal.pntd.0005408
   Kim MK, 1999, MICROBIOL IMMUNOL, V43, P751, DOI 10.1111/j.1348-0421.1999.tb02466.x
   Ko Y, 2013, INFECT IMMUN, V81, P552, DOI 10.1128/IAI.00861-12
   Liu CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054841
   Lurchachaiwong W, 2012, EXP APPL ACAROL, V58, P23, DOI 10.1007/s10493-012-9563-8
   Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55
   Mendell NL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005453
   Milam KE, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688362.2014.957508
   Min CK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02022
   Moron CG, 2001, MODERN PATHOL, V14, P752, DOI 10.1038/modpathol.3880385
   Ogawa M, 2017, MICROB PATHOGENESIS, V107, P335, DOI 10.1016/j.micpath.2017.04.012
   Orfanos SE, 2007, CRIT CARE MED, V35, P199, DOI 10.1097/01.CCM.0000251640.77679.D7
   Otterdal K, 2014, J INFECTION, V69, P462, DOI 10.1016/j.jinf.2014.06.018
   Parikh SM, 2017, J AM SOC NEPHROL, V28, P1973, DOI 10.1681/ASN.2017010069
   Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046
   Paris DH, 2008, CLIN EXP IMMUNOL, V153, P63, DOI 10.1111/j.1365-2249.2008.03673.x
   Paris DH, 2013, AM J TROP MED HYG, V89, P301, DOI 10.4269/ajtmh.13-0064
   Paris DH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001466
   Petersen JEV, 2016, SCI REP-UK, V6, DOI 10.1038/srep35950
   Phanthanawiboon S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148564
   Phongmany S, 2006, EMERG INFECT DIS, V12, P256
   ROTHLEIN R, 1986, J IMMUNOL, V137, P1270
   Shelite TR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004467
   Shelite TR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002966
   Singer BD, 2016, AM J PHYSIOL-LUNG C, V310, pL796, DOI 10.1152/ajplung.00334.2015
   Soong L, 2018, J IMMUNOL, V200, P1233, DOI 10.4049/jimmunol.1701219
   Soong L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005765
   Soong L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004884
   Soong L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003191
   Stiehl T, 2014, CRIT CARE MED, V42, pE654, DOI 10.1097/CCM.0000000000000524
   Sunyakumthorn P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054570
   Tabruyn SP, 2010, AM J PATHOL, V177, P3233, DOI 10.2353/ajpath.2010.100059
   Tantibhedhyangkul W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001028
   Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725
   Trent B, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02065
   Varghese GM, 2013, INT J INFECT DIS, V17, pE981, DOI 10.1016/j.ijid.2013.05.017
   Wang CC, 2007, AM J TROP MED HYG, V76, P1148, DOI 10.4269/ajtmh.2007.76.1148
   WESTLIN WF, 1993, AM J PATHOL, V142, P117
   Xu G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006127
   Ying W, 2013, JOVE-J VIS EXP, DOI 10.3791/50323
NR 74
TC 11
Z9 11
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2020
VL 14
IS 3
AR e0007675
DI 10.1371/journal.pntd.0007675
PG 22
WC Infectious Diseases; Parasitology; Tropical Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Parasitology; Tropical Medicine
GA LH2YY
UT WOS:000528655400079
PM 32119672
OA Green Published, gold, Green Submitted
DA 2023-08-21
ER

PT J
AU Niethamer, TK
   Stabler, CT
   Leach, JP
   Zepp, JA
   Morley, MP
   Babu, A
   Zhou, S
   Morrisey, EE
AF Niethamer, Terren K.
   Stabler, Collin T.
   Leach, John P.
   Zepp, Jarod A.
   Morley, Michael P.
   Babu, Apoorva
   Zhou, Su
   Morrisey, Edward E.
TI Defining the role of pulmonary endothelial cell heterogeneity in the
   response to acute lung injury
SO ELIFE
LA English
DT Article
ID PROGENITOR CELLS; ANGIOCRINE SIGNALS; STEM-CELLS; EXPRESSION; VEGF;
   REGENERATION; PATHOGENESIS; INTEGRATION; MECHANISMS; EPITHELIUM
AB Pulmonary endothelial cells (ECs) are an essential component of the gas exchange machinery of the lung alveolus. Despite this, the extent and function of lung EC heterogeneity remains incompletely understood. Using single-cell analytics, we identify multiple EC populations in the mouse lung, including macrovascular endothelium (maEC), microvascular endothelium (miECs), and a new population we have termed Car4-high ECs. Car4-high ECs express a unique gene signature, and ligand-receptor analysis indicates they are primed to receive reparative signals from alveolar type I cells. After acute lung injury, they are preferentially localized in regenerating regions of the alveolus. Influenza infection reveals the emergence of a population of highly proliferative ECs that likely arise from multiple miEC populations and contribute to alveolar revascularization after injury. These studies map EC heterogeneity in the adult lung and characterize the response of novel EC subpopulations required for tissue regeneration after acute lung injury.
C1 [Niethamer, Terren K.; Stabler, Collin T.; Leach, John P.; Zepp, Jarod A.; Morley, Michael P.; Babu, Apoorva; Zhou, Su; Morrisey, Edward E.] Univ Penn, Dept Med, Philadelphia, PA 19104, United States.
   [Niethamer, Terren K.; Stabler, Collin T.; Leach, John P.; Zepp, Jarod A.; Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104, United States.
   [Niethamer, Terren K.; Stabler, Collin T.; Leach, John P.; Zepp, Jarod A.; Morley, Michael P.; Morrisey, Edward E.] Univ Penn, Penn Childrens Hosp, Philadelphia Lung Biol Inst, Philadelphia, PA 19104, United States.
   [Niethamer, Terren K.; Stabler, Collin T.; Leach, John P.; Zepp, Jarod A.; Morley, Michael P.; Babu, Apoorva; Zhou, Su; Morrisey, Edward E.] Univ Penn, Penn Cardiovasc Inst, Philadelphia, PA 19104, United States.
   [Morrisey, Edward E.] Univ Penn, Penn Inst Regenerat Med, Philadelphia, PA 19104, United States.
C3 University of Pennsylvania; University of Pennsylvania; University of
   Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia;
   University of Pennsylvania; University of Pennsylvania
RP Morrisey, EE (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.; Morrisey, EE (corresponding author), Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.; Morrisey, EE (corresponding author), Univ Penn, Penn Childrens Hosp, Philadelphia Lung Biol Inst, Philadelphia, PA 19104 USA.; Morrisey, EE (corresponding author), Univ Penn, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA.; Morrisey, EE (corresponding author), Univ Penn, Penn Inst Regenerat Med, Philadelphia, PA 19104 USA.
EM emorrise@pennmedicine.upenn.edu
OI Babu, Apoorva/0000-0003-3661-5261; Niethamer,
   Terren/0000-0002-0914-994X; Morley, Michael/0000-0002-0958-7376; Leach,
   John/0000-0002-0779-8583; Morrisey, Edward/0000-0001-5785-1939
FU National Institutes of Health [T32-HL7586-34, R01-HL087825,
   U01-HL134745-01, R01-HL132999, R01-HL132349]; NATIONAL HEART, LUNG, AND
   BLOOD INSTITUTE [F32HL152664] Funding Source: NIH RePORTER
FX R01-HL132999 National Institutes of Health R01-HL087825 Edward E
   Morriseyr National Institutes of Health U01-HL134745-01 Edward E
   Morriseyr National Institutes of Health R01-HL132999 Edward E Morriseyr
   National Institutes of Health R01-HL132349 Edward E Morriseyr National
   Institutes of Health T32-HL7586-34 Terren K Niethamer
CR ADAMSON IYR, 1974, AM J PATHOL, V77, P185
   ADAMSON IYR, 1976, ENVIRON HEALTH PERSP, V16, P119, DOI 10.2307/3428592
   Alvarez DF, 2008, AM J PHYSIOL-LUNG C, V294, pL419, DOI 10.1152/ajplung.00314.2007
   Armstrong SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047323
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964
   Aspalter IM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8264
   Basile DP, 2014, J CELL PHYSIOL, V229, P10, DOI 10.1002/jcp.24423
   Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314
   Berg S, 2019, NAT METHODS, V16, P1226, DOI 10.1038/s41592-019-0582-9
   Betz C, 2016, DEVELOPMENT, V143, P2249, DOI 10.1242/dev.135616
   Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569
   Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096
   Chao CM, 2019, HUM MOL GENET, V28, P1429, DOI 10.1093/hmg/ddy439
   Cohen M, 2018, CELL, V175, P1031, DOI 10.1016/j.cell.2018.09.009
   Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003
   Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493
   Ding J, 2018, GENOME RES, V28, P383, DOI 10.1101/gr.225979.117
   Ebina M, 2004, AM J RESP CRIT CARE, V169, P1203, DOI 10.1164/rccm.200308-1111OC
   FLEMING RE, 1993, AM J PHYSIOL, V265, pL627, DOI 10.1152/ajplung.1993.265.6.L627
   Gianni-Barrera R, 2011, BIOCHEM SOC T, V39, P1644, DOI 10.1042/BST20110650
   Gregory DJ, 2015, AM J PHYSIOL-LUNG C, V309, pL1041, DOI 10.1152/ajplung.00283.2015
   He LQ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.160
   Herold S, 2015, EUR RESPIR J, V45, P1463, DOI 10.1183/09031936.00186214
   Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103
   Kash JC, 2015, AM J PATHOL, V185, P1528, DOI 10.1016/j.ajpath.2014.08.030
   Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001
   Lacorre DA, 2004, BLOOD, V103, P4164, DOI 10.1182/blood-2003-10-3537
   Lee J.-K., 2014, SCI REP, V4, P1
   Lee JY, 2017, PULM CIRC, V7, P777, DOI 10.1177/2045893217731295
   Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071
   Londhe VA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-134
   McDonald AI, 2018, CELL STEM CELL, V23, P210, DOI 10.1016/j.stem.2018.07.011
   McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970
   Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7
   Moya IM, 2012, DEV CELL, V22, P501, DOI 10.1016/j.devcel.2012.01.007
   Nguyet NM, 2005, DEV BIOL, V282, P111, DOI 10.1016/j.ydbio.2005.02.031
   PIALI L, 1995, J EXP MED, V181, P811, DOI 10.1084/jem.181.2.811
   Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6
   Pociask DA, 2017, AM J PATHOL, V187, P851, DOI 10.1016/j.ajpath.2016.12.012
   Potente M, 2017, NAT REV MOL CELL BIO, V18, P477, DOI 10.1038/nrm.2017.36
   Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039
   Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105
   Reyfman PA, 2019, AM J RESP CRIT CARE, V199, P1517, DOI 10.1164/rccm.201712-2410OC
   Rojas-Quintero J, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99022
   Sabbagh MF, 2018, ELIFE, V7, DOI 10.7554/eLife.36187
   Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X
   Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87
   Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0
   Taha M, 2017, PULM CIRC, V7, P755, DOI 10.1177/2045893217743710
   Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434
   Topfer L, 2014, J CRIT CARE, V29, P340, DOI 10.1016/j.jcrc.2013.12.013
   Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173
   Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002
   Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112
   Wakabayashi T, 2018, CELL STEM CELL, V22, P384, DOI 10.1016/j.stem.2018.01.010
   White AC, 2007, DEVELOPMENT, V134, P3743, DOI 10.1242/dev.004879
   Xi Y, 2017, NAT CELL BIOL, V19, P904, DOI 10.1038/ncb3580
   Xie T, 2018, CELL REP, V22, P3625, DOI 10.1016/j.celrep.2018.03.010
   Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558
   Yamamoto K, 1998, BLOOD, V92, P2791, DOI 10.1182/blood.V92.8.2791.420k24_2791_2801
   Zacharias WJ, 2018, NATURE, V555, P251, DOI 10.1038/nature25786
   Zepp JA, 2017, CELL, V170, P1134, DOI 10.1016/j.cell.2017.07.034
NR 64
TC 84
Z9 84
U1 1
U2 16
PU eLIFE SCIENCES PUBL LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD FEB 24
PY 2020
VL 9
AR e53072
DI 10.7554/eLife.53072
PG 28
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA LI2UI
UT WOS:000529338700001
PM 32091393
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Yi, L
   Zhou, ZD
   Zheng, YJ
   Chang, ML
   Huang, XQ
   Guo, F
   Zhao, QM
   Huan, JN
AF Yi, Lei
   Zhou, Zengding
   Zheng, Yijuan
   Chang, Mengling
   Huang, Xiaoqin
   Guo, Feng
   Zhao, Quanming
   Huan, Jingning
TI Suppressive Effects of GSS on Lipopolysaccharide-Induced Endothelial
   Cell Injury and ALI via TNF-alpha and IL-6
SO MEDIATORS OF INFLAMMATION
LA English
DT Article
ID ACUTE LUNG INJURY; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; BARRIER
   DYSFUNCTION; ORGAN DYSFUNCTION; SIGNALING PATHWAY; SEVERE SEPSIS;
   ACTIVATION; GENISTEIN; PROLIFERATION
AB Background. Under septic conditions, LPS induced lung vascular endothelial cell (EC) injury, and the release of inflammatory mediator launches and aggravates acute lung injury (ALI). There are no effective therapeutic options for ALI. Genistein-3 '-sodium sulfonate (GSS) is a derivative of native soy isoflavone, which exhibits neuroprotective effects via its antiapoptosis property. However, whether GSS protect against sepsis-induced EC injury and release of inflammatory mediators has not been determined. In this study, we found that GSS not only downregulated the levels of TNF-alpha and IL-6 in the lung and serum of mice in vivo but also inhibited the expression and secretion of TNF-alpha and IL-6 in ECs. Importantly, we also found that GSS blocked LPS-induced TNF-alpha and IL-6 expression in ECs via the Myd88/NF-kappa B signaling pathway. Taken together, our results demonstrated that GSS might be a promising candidate for sepsis-induced ALI via its regulating effects on inflammatory response in lung ECs.
C1 [Yi, Lei; Zhou, Zengding; Chang, Mengling; Huang, Xiaoqin; Huan, Jingning] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Burn & Plast Surg, Shanghai, China.
   [Zheng, Yijuan] Fudan Univ, Zhongshan Hosp, Dept Crit Care Med, Shanghai, China.
   [Guo, Feng] Shanghai Jiao Tong Univ, Dept Plast Surg, Affiliated Peoples Hosp 6, Shanghai, China.
   [Zhao, Quanming] Nantong Univ, Affiliated Hosp 2, Dept Orthoped Surg, Nantong, Jiangsu, China.
C3 Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong
   University; Nantong University
RP Huan, JN (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Burn & Plast Surg, Shanghai, Peoples R China.; Guo, F (corresponding author), Shanghai Jiao Tong Univ, Dept Plast Surg, Affiliated Peoples Hosp 6, Shanghai, Peoples R China.; Zhao, QM (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Orthoped Surg, Nantong, Jiangsu, Peoples R China.
EM guofengbuni@aliyun.com; abc83859@163.com; jnhuan56542@163.com
RI Yi, Lei/AAI-6290-2020; huang, xiaoqin/HZL-4359-2023
FU National Natural Science Foundation of China [81772078, 81772077,
   81971832]; Shanghai Jiao Tong University [YG2015MS58]; Natural Science
   Foundation of Shanghai [19ZR1432100]
FX This study was supported by the National Natural Science Foundation of
   China (nos. 81772078, 81772077, and 81971832) and by a grant from
   Shanghai Jiao Tong University (No. YG2015MS58) and by the Natural
   Science Foundation of Shanghai (19ZR1432100).
CR Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887
   AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
   Bianchi AMA, 2016, LUNG, V194, P193, DOI 10.1007/s00408-016-9853-8
   Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002
   Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506
   Benavente-Garcia O, 2008, J AGR FOOD CHEM, V56, P6185, DOI 10.1021/jf8006568
   Bhatia M, 2009, FRONT BIOSCI-LANDMRK, V14, P4703, DOI 10.2741/3561
   Choi G, 2008, CRIT CARE MED, V36, P204, DOI 10.1097/01.CCM.0000292012.87482.F4
   Cui ZW, 2015, ACTA PHARMACOL SIN, V36, P1426, DOI 10.1038/aps.2015.90
   Del Gaudio P, 2017, PLANTA MED, V83, P426, DOI 10.1055/s-0042-110179
   Guo F, 2012, SHOCK, V37, P531, DOI 10.1097/SHK.0b013e31824caa96
   Guo F, 2012, MOL IMMUNOL, V50, P98, DOI 10.1016/j.molimm.2011.12.009
   Han R, 2018, CHEMOSPHERE, V200, P283, DOI 10.1016/j.chemosphere.2018.02.137
   Houschyar KS, 2018, INT J ARTIF ORGANS, V41, P247, DOI 10.1177/0391398818762357
   Jeong JW, 2014, CHEM-BIOL INTERACT, V212, P30, DOI 10.1016/j.cbi.2014.01.012
   Jimenez-Garcia L, 2016, BIOCHEM J, V473, P2061, DOI 10.1042/BCJ20160343
   Lan KC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12285-8
   Lee JW, 2018, INT IMMUNOPHARMACOL, V64, P123, DOI 10.1016/j.intimp.2018.08.015
   Li LD, 2017, NEUROSCI LETT, V646, P43, DOI 10.1016/j.neulet.2017.02.046
   Li X, 2012, CYTOKINE, V60, P114, DOI 10.1016/j.cyto.2012.06.008
   Lou J, 2019, ACTA PHARMACOL SIN, V40, P769, DOI 10.1038/s41401-018-0175-7
   Mirahmadi SMS, 2018, CYTOKINE, V104, P151, DOI 10.1016/j.cyto.2017.10.008
   Moitra J, 2007, TRANSL RES, V150, P253, DOI 10.1016/j.trsl.2007.03.013
   Mu ST, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0925-6
   Murakami K, 1996, BLOOD, V87, P642, DOI 10.1182/blood.V87.2.642.bloodjournal872642
   Opal SM, 2015, J INTERN MED, V277, P277, DOI 10.1111/joim.12331
   Reinhart K, 2002, CRIT CARE MED, V30, pS302, DOI 10.1097/00003246-200205001-00021
   Saha S, 2018, J NUTR BIOCHEM, V55, P26, DOI 10.1016/j.jnutbio.2017.11.010
   Sanaei M, 2018, INT J PREVENTIVE MED, V9, DOI 10.4103/ijpvm.IJPVM_249_16
   Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373
   Tian CL, 2019, BIOMED PHARMACOTHER, V109, P1024, DOI 10.1016/j.biopha.2018.10.197
   Varoni EM, 2012, CURR MED CHEM, V19, P1706
   Vincent JL, 2003, CRIT CARE MED, V31, pS296, DOI 10.1097/01.CCM.0000057906.89552.8F
   WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]
   Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288
   Wendel M, 2007, INTENS CARE MED, V33, P25, DOI 10.1007/s00134-006-0433-x
   Xu WJ, 2019, AM J PHYSIOL-LUNG C, V316, pL567, DOI 10.1152/ajplung.00190.2018
   YASUMOTO K, 1992, J BIOL CHEM, V267, P22506
   Yi L, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00357
   Yi L, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00133
   Yi L, 2016, SURGERY, V159, P1436, DOI 10.1016/j.surg.2015.12.008
   Yin J, 2019, AM J PHYSIOL-LUNG C, V316, pL35, DOI 10.1152/ajplung.00012.2018
   Zeuke S, 2002, CARDIOVASC RES, V56, P126, DOI 10.1016/S0008-6363(02)00512-6
   Zhang L, 2017, J LAB PRECIS MED, V2, P2, DOI DOI 10.1155/2017/2032697
NR 44
TC 12
Z9 13
U1 2
U2 18
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0962-9351
EI 1466-1861
J9 MEDIAT INFLAMM
JI Mediat. Inflamm.
PD DEC 30
PY 2019
VL 2019
AR 4251394
DI 10.1155/2019/4251394
PG 13
WC Cell Biology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Immunology
GA KC6GZ
UT WOS:000507275000004
PM 32082076
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Ortolan, LD
   Sercundes, MK
   Moura, GC
   Quirino, TD
   Debone, D
   Costa, DD
   Murillo, O
   Marinho, CRF
   Epiphanio, S
AF Ortolan, Luana dos Santos
   Sercundes, Michelle Klein
   Moura, Gabriel Candido
   Quirino, Thatyane de Castro
   Debone, Daniela
   Costa, Douglas de Sousa
   Murillo, Oscar
   Farias Marinho, Claudio Romero
   Epiphanio, Sabrina
TI Endothelial Protein C Receptor Could Contribute to Experimental
   Malaria-Associated Acute Respiratory Distress Syndrome
SO JOURNAL OF IMMUNOLOGY RESEARCH
LA English
DT Article
ID CEREBRAL MALARIA; INFECTED ERYTHROCYTES; DOUBLE-BLIND; LUNG INJURY;
   DEXAMETHASONE; ADHESION; BRAIN; CELLS; CYTOADHERENCE; PATHOGENESIS
AB The severity of Plasmodium falciparum malaria is associated with parasite cytoadherence, but there is limited knowledge about the effect of parasite cytoadherence in malaria-associated acute respiratory distress syndrome (ARDS). Our objective was to evaluate the cytoadherence of infected red blood cells (iRBCs) in a murine model of ARDS and to appraise a potential function of endothelial protein C receptor (EPCR) in ARDS pathogenesis. DBA/2 mice infected with P. berghei ANKA were classified as ARDS- or hyperparasitemia- (HP-) developing mice according to respiratory parameters and parasitemia. Lungs, blood, and bronchoalveolar lavage were collected for gene expression or protein analyses. Primary cultures of microvascular lung endothelial cells from DBA/2 mice were analyzed for iRBC interactions. Lungs from ARDS-developing mice showed evidence of iRBC accumulation along with an increase in EPCR and TNF concentrations. Furthermore, TNF increased iRBC adherence in vitro. Dexamethasone-treated infected mice showed low levels of TNF and EPCR mRNA expression and, finally, decreased vascular permeability, thus protecting mice from ARDS. In conclusion, we identified that increased iRBC cytoadherence in the lungs underlies malaria-associated ARDS in DBA/2-infected mice and that inflammation increased cytoadherence capacity, suggesting a participation of EPCR and a conceivable target for drug development.
C1 [Ortolan, Luana dos Santos; Epiphanio, Sabrina] Univ Sao Paulo, Dept Immunol, Biomed Sci Inst, 1730 Prof Lineu Prestes Ave, BR-05508900 Sao Paulo, SP, Brazil.
   [Sercundes, Michelle Klein; Moura, Gabriel Candido; Quirino, Thatyane de Castro; Debone, Daniela; Epiphanio, Sabrina] Univ Sao Paulo, Dept Clin & Toxicol Anal, Fac Pharmaceut Sci, 580 Prof Lineu Prestes Ave, BR-05508000 Sao Paulo, SP, Brazil.
   [Costa, Douglas de Sousa; Murillo, Oscar; Farias Marinho, Claudio Romero] Univ Sao Paulo, Dept Parasitol, Biomed Sci Inst, 1374 Prof Lineu Prestes Ave, BR-05508000 Sao Paulo, SP, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de
   Sao Paulo
RP Ortolan, LD; Epiphanio, S (corresponding author), Univ Sao Paulo, Dept Immunol, Biomed Sci Inst, 1730 Prof Lineu Prestes Ave, BR-05508900 Sao Paulo, SP, Brazil.; Epiphanio, S (corresponding author), Univ Sao Paulo, Dept Clin & Toxicol Anal, Fac Pharmaceut Sci, 580 Prof Lineu Prestes Ave, BR-05508000 Sao Paulo, SP, Brazil.
EM luana_ortolan@yahoo.com.br; sabrinae@usp.br
RI de Sousa Costa, Douglas/AAL-3344-2020; Debone, Daniela/E-6692-2019;
   DEBONE, DANIELA/AAF-8214-2019; Epiphanio, Sabrina/C-7572-2012; dos
   Santos Ortolan, Luana/AAU-3092-2021; Marinho, Claudio Romero
   Farias/F-7507-2012; Murillo, Oscar J/H-5039-2017
OI de Sousa Costa, Douglas/0000-0003-0859-5355; Debone,
   Daniela/0000-0001-5316-5130; DEBONE, DANIELA/0000-0001-5316-5130;
   Epiphanio, Sabrina/0000-0001-6094-9750; Marinho, Claudio Romero
   Farias/0000-0002-1227-3845; Murillo, Oscar J/0000-0003-1204-7984; dos
   Santos Ortolan, Luana/0000-0003-1153-9987
FU Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP), Brazil); Coordination of Improvement of Higher
   Level Personnel; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES); National Council for Scientific and Technological
   Development (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Brazil); CAPES; FAPESP [2013/20718-3, 2017/00077-4,
   2013/00981-1, 2016/07030-3, 2014/20451-0, 2017/05782-8]; CAPES/PNPD;
   CNPq [131431/2017-0, 162730/2014-4, 133890/2016-3, 455863/2014-8]
FX The authors thank Patricia Mendonca da Silva Amorim, Erika Paula Machado
   Peixoto, and Bernardo Paulo Albe for their technical assistance. This
   work was supported by the Sao Paulo Research Foundation (Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil), the
   Coordination of Improvement of Higher Level Personnel; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES); and the National
   Council for Scientific and Technological Development (Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil). LSO (CAPES
   and FAPESP 2013/20718-3), MKS (CAPES/PNPD), GCM (FAPESP 2017/00077-4),
   TCQ (CNPq 131431/2017-0), DD (CNPq 162730/2014-4), DSC (CNPq
   133890/2016-3), OM (FAPESP 2013/00981-1), CRFM (FAPESP 2016/07030-3), SE
   (FAPESP 2014/20451-0 and 2017/05782-8 and CNPQ 455863/2014-8) received
   fellowship grants.
CR Aird WC, 2014, BLOOD, V123, P163, DOI 10.1182/blood-2013-09-521005
   Aitken EH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-230
   Ampawong S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0922-x
   Azasi Y, 2018, P NATL ACAD SCI USA, V115, P1063, DOI 10.1073/pnas.1712879115
   Azoulay E, 2012, EUR RESPIR J, V39, P648, DOI 10.1183/09031936.00057711
   Beeson JG, 2002, CELL MOL LIFE SCI, V59, P258, DOI 10.1007/s00018-002-8421-y
   Besnard AG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004607
   Bhatia M, 2012, AM J RESP CELL MOL, V46, P566, DOI 10.1165/rcmb.2011-0392TR
   Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619
   CHEN SF, 1995, MICROVASC RES, V50, P119, DOI 10.1006/mvre.1995.1044
   Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836
   Craig AG, 2012, MALAYS J MED SCI, V19, P5
   Cunningham DA, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1834-8
   De las Salas B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-347
   El-Assaad F, 2013, INFECT IMMUN, V81, P3984, DOI 10.1128/IAI.00428-13
   Epiphanio S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000916
   Fonager J, 2012, J EXP MED, V209, P93, DOI 10.1084/jem.20110762
   Gao YJ, 2015, THROMB RES, V135, P1154, DOI 10.1016/j.thromres.2015.03.019
   Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996
   Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138
   Healy LD, 2017, J BIOL CHEM, V292, P8616, DOI 10.1074/jbc.M116.768309
   HOFFMAN SL, 1988, J INFECT DIS, V158, P325, DOI 10.1093/infdis/158.2.325
   Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475
   Kessler A, 2017, CELL HOST MICROBE, V22, P601, DOI 10.1016/j.chom.2017.09.009
   Lagasse HAD, 2016, J LEUKOCYTE BIOL, V99, P659, DOI 10.1189/jlb.4HI0315-130RRR
   LIN JJ, 2017, SCI REP, V7, P1, DOI DOI 10.1038/srep41722
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lovegrove FE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000068
   Maknitikul S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181674
   Matute-Bello G, 2003, CRIT CARE, V7, P355, DOI 10.1186/cc1861
   Meijvis SCA, 2011, LANCET, V377, P2023, DOI 10.1016/S0140-6736(11)60607-7
   Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a
   Mosnier LO, 2016, THROMB RES, V141, pS46, DOI 10.1016/S0049-3848(16)30364-4
   Moxon CA, 2013, BLOOD, V122, P842, DOI 10.1182/blood-2013-03-490219
   OCKENHOUSE CF, 1992, J EXP MED, V176, P1183, DOI 10.1084/jem.176.4.1183
   Ortolan LS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/872464
   Palomo J, 2015, EUR J IMMUNOL, V45, P1354, DOI 10.1002/eji.201445206
   Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013
   Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104
   Pasini EM, 2013, MOL CELL PROTEOMICS, V12, P426, DOI 10.1074/mcp.M112.021238
   Pasvol G, 2005, BRIT MED BULL, V75-76, P29, DOI 10.1093/bmb/ldh059
   Penha-Goncalves C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01771
   Pereira MLM, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4158698
   Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992
   Pouvelle B, 2000, NAT MED, V6, P1264, DOI 10.1038/81374
   Proudfoot A, 2018, THORAX, V73, P723, DOI 10.1136/thoraxjnl-2017-210305
   Rambhatla JS, 2019, J INFECT DIS, V219, P808, DOI 10.1093/infdis/jiy564
   Rao LVM, 2014, BLOOD, V124, P1553, DOI 10.1182/blood-2014-05-578328
   Renia L, 2012, VIRULENCE, V3, P193, DOI 10.4161/viru.19013
   Reverchon F, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006322
   Sampath S, 2015, CELL MICROBIOL, V17, P1868, DOI 10.1111/cmi.12478
   Sercundes MK, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006054
   Shabani E, 2016, SCI REP-UK, V6, DOI 10.1038/srep27084
   Shio MT, 2010, MICROBES INFECT, V12, P889, DOI 10.1016/j.micinf.2010.07.001
   Shu J., 2015, IMMUNOHISTOCHEMISTRY
   Storm J, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809164
   Takala A, 2002, SHOCK, V17, P252, DOI 10.1097/00024382-200204000-00002
   Pham TT, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00416
   THUMWOOD CM, 1988, PARASITOLOGY, V96, P579, DOI 10.1017/S0031182000080203
   TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840
   Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216
   Van den Steen PE, 2013, TRENDS PARASITOL, V29, P346, DOI 10.1016/j.pt.2013.04.006
   Van den Steen PE, 2010, AM J RESP CRIT CARE, V181, P957, DOI 10.1164/rccm.200905-0786OC
   WARRELL DA, 1982, NEW ENGL J MED, V306, P313, DOI 10.1056/NEJM198202113060601
   Wilson M., 2017, J VET SCI TECHNOL, V8, P1, DOI [10.4172/2157-7579.1000443, DOI 10.4172/2157-7579.1000443]
   Wilson MR, 2007, AM J PHYSIOL-LUNG C, V293, pL60, DOI 10.1152/ajplung.00284.2006
NR 66
TC 7
Z9 7
U1 0
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-8861
EI 2314-7156
J9 J IMMUNOL RES
JI J Immunol. Res.
PD DEC 4
PY 2019
VL 2019
AR 3105817
DI 10.1155/2019/3105817
PG 18
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA JX1KJ
UT WOS:000503501900001
PM 31871954
OA Green Published, gold, Green Submitted
DA 2023-08-21
ER

PT J
AU Ye, W
   Zheng, CL
   Yu, DL
   Zhang, F
   Pan, RG
   Ni, XF
   Shi, ZH
   Zhang, ZJ
   Xiang, YK
   Sun, HW
   Shi, KQ
   Chen, BC
   Zhang, QY
   Zhou, MT
AF Ye, Wen
   Zheng, Chenlei
   Yu, Dinglai
   Zhang, Fan
   Pan, Reguang
   Ni, Xiaofeng
   Shi, Zhehao
   Zhang, Zhongjing
   Xiang, Yukai
   Sun, Hongwei
   Shi, Keqing
   Chen, Bicheng
   Zhang, Qiyu
   Zhou, Mengtao
TI Lipoxin A4 Ameliorates Acute Pancreatitis-Associated Acute Lung Injury
   through the Antioxidative and Anti-Inflammatory Effects of the Nrf2
   Pathway
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID INFLAMMATION; EXPRESSION; CELLS; MACROPHAGES; ACTIVATION; APOPTOSIS;
   MICE
AB Acute lung injury (ALI) is a critical event involved in the pathophysiological process of acute pancreatitis (AP). Many methods have been widely used for the treatment of AP-ALI, but few are useful during early inflammation. Lipoxin A4 (LXA4), a potent available anti-inflammatory and novel antioxidant mediator, has been extensively studied in AP-ALI, but its underlying mechanism as a protective mediator is not clear. This research was conducted to identify the possible targets and mechanisms involved in the anti-AP-ALI effect of LXA4. First, we confirmed that LXA4 strongly inhibited AP-ALI in mice. Next, using ELISA, PCR, and fluorescence detection to evaluate different parameters, LXA4 was shown to reduce the inflammatory cytokine production induced by AP and block reactive oxygen species (ROS) generation in vivo and in vitro. In addition, TNF-alpha treatment activated the nuclear factor E2-related factor 2 (Nrf2) signaling pathway and its downstream gene heme oxygenase-1 (HO-1) in human pulmonary microvascular endothelial cells (HPMECs), and LXA4 further promoted their expression. This study also provided evidence that LXA4 phosphorylates Ser40 and triggers its nuclear translocation to activate Nrf2. Moreover, when Nrf2-knockout (Nrf2(-/-)) mice and cells were used to further assess the effect of the Nrf2/HO-1 pathway, we found that Nrf2 expression knockdown partially eliminated the effect of LXA4 on the reductions in inflammatory factor levels while abrogating the inhibitory effect of LXA4 on the ROS generation stimulated by AP-ALI. Overall, LXA4 attenuated the resolution of AP-induced inflammation and ROS generation to mitigate ALI, perhaps by modulating the Nrf2/HO-1 pathway. These findings have laid a foundation for the treatment of AP-ALI.
C1 [Ye, Wen; Zheng, Chenlei; Zhang, Fan; Pan, Reguang; Ni, Xiaofeng; Shi, Zhehao; Zhang, Zhongjing; Shi, Keqing; Chen, Bicheng; Zhou, Mengtao] Wenzhou Med Univ, Key Lab Diag & Treatment Severe Hepatopancreat Di, Affiliated Hosp 1, Wenzhou 325015, Zhejiang, China.
   [Yu, Dinglai; Xiang, Yukai; Sun, Hongwei; Chen, Bicheng; Zhang, Qiyu; Zhou, Mengtao] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou 325015, China.
   [Zhou, Mengtao] Wenzhou Med Univ, Affiliated Hosp 1, Pancreatitis Treatment Ctr, Wenzhou 325015, Zhejiang, China.
C3 Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical
   University
RP Zhou, MT (corresponding author), Wenzhou Med Univ, Key Lab Diag & Treatment Severe Hepatopancreat Di, Affiliated Hosp 1, Wenzhou 325015, Zhejiang, Peoples R China.; Zhang, QY; Zhou, MT (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou 325015, Peoples R China.; Zhou, MT (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Pancreatitis Treatment Ctr, Wenzhou 325015, Zhejiang, Peoples R China.
EM qiyuz@126.com; zhoumengtao@wmu.edu.cn
RI Shi, Keqing/GZK-5146-2022
OI Shi, Keqing/0000-0002-5070-3834; yu, dinglai/0000-0003-1006-1256
FU National Natural Sciences Foundation of China [81570583, 81770630,
   81800567, 81700568]
FX This work was supported by grants from the National Natural Sciences
   Foundation of China (81570583, 81770630, 81800567, and 81700568).
CR Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779
   Brennan EP, 2018, DIABETES, V67, P2657, DOI 10.2337/db17-1317
   Cao JP, 2012, ANESTHESIOLOGY, V116, P1278, DOI 10.1097/ALN.0b013e3182567f84
   Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943
   Chaudhuri L, 2010, ENVIRON INT, V36, P924, DOI 10.1016/j.envint.2010.01.001
   Chavez-Sanchez L, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-117
   Cheng X, 2016, FREE RADICAL BIO MED, V93, P52, DOI 10.1016/j.freeradbiomed.2016.01.026
   Crockett SD, 2018, GASTROENTEROLOGY, V154, P1096, DOI 10.1053/j.gastro.2018.01.032
   Dai YQ, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.101093
   Dombernowsky T, 2016, PANCREATOLOGY, V16, P756, DOI 10.1016/j.pan.2016.06.664
   Dong JK, 2018, THERANOSTICS, V8, P1808, DOI 10.7150/thno.23177
   Forsmark CE, 2016, NEW ENGL J MED, V375, P1972, DOI 10.1056/NEJMra1505202
   Gan N, 2019, BIOMED PHARMACOTHER, V112, DOI 10.1016/j.biopha.2019.01.056
   Gatliff J, 2014, AUTOPHAGY, V10, P2279, DOI 10.4161/15548627.2014.991665
   Gorelick FS, 2009, CLIN GASTROENTEROL H, V7, pS10, DOI 10.1016/j.cgh.2009.07.036
   Gukovskaya AS, 2017, GASTROENTEROLOGY, V153, P1212, DOI 10.1053/j.gastro.2017.08.071
   Guo H, 2016, EUR REV MED PHARMACO, V20, P873
   Jiang KF, 2018, INT IMMUNOPHARMACOL, V64, P140, DOI 10.1016/j.intimp.2018.08.023
   Jin FY, 2019, MOL PHARMACEUT, V16, P71, DOI 10.1021/acs.molpharmaceut.8b00861
   Jin MP, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1135-x
   Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266
   Kim J, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2746457
   Lee I, 2014, AM J PHYSIOL-LUNG C, V306, pL635, DOI 10.1152/ajplung.00374.2013
   Lee J, 2018, REDOX BIOL, V18, P6, DOI 10.1016/j.redox.2018.05.015
   Lerch MM, 2013, GUT, V62, P2, DOI 10.1136/gutjnl-2012-303724
   Levy BD, 2005, BRIT J PHARMACOL, V146, P344, DOI 10.1038/sj.bjp.0706338
   Li B, 2018, INT IMMUNOPHARMACOL, V57, P147, DOI 10.1016/j.intimp.2018.02.017
   Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467
   Lin CC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040436
   Liu YH, 2011, J IMMUNOL, V186, P3197, DOI 10.4049/jimmunol.1002016
   Luo HD, 2019, CHEM-BIOL INTERACT, V306, P10, DOI 10.1016/j.cbi.2019.04.007
   Lv HM, 2017, REDOX BIOL, V12, P311, DOI 10.1016/j.redox.2017.03.001
   Lv WZ, 2013, EXP BIOL MED, V238, P1388, DOI 10.1177/1535370213502611
   Mai JT, 2018, ATHEROSCLEROSIS, V278, P259, DOI 10.1016/j.atherosclerosis.2018.09.025
   Martinez R M, 2018, J Dermatol Sci, DOI 10.1016/j.jdermsci.2018.04.014
   Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3
   Pastor CM, 2003, CHEST, V124, P2341, DOI 10.1378/chest.124.6.2341
   Pavlidis P, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/897107
   Qu YL, 2018, CELL PHYSIOL BIOCHEM, V51, P1830, DOI 10.1159/000495684
   Raraty Michael G T, 2004, Curr Gastroenterol Rep, V6, P99, DOI 10.1007/s11894-004-0035-0
   Ren M, 2014, FOOD CHEM TOXICOL, V73, P140, DOI 10.1016/j.fct.2014.07.039
   Sacco P, 2017, MACROMOL BIOSCI, V17, DOI 10.1002/mabi.201700214
   SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007
   Shi ZH, 2018, MOL IMMUNOL, V103, P78, DOI 10.1016/j.molimm.2018.09.003
   Subedi L, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020194
   Teng Y, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0485-0
   Tsai Yung-Fong, 2018, Cell Physiol Biochem, V51, P2776, DOI 10.1159/000495970
   van Dijk SM, 2017, GUT, V66, P2024, DOI 10.1136/gutjnl-2016-313595
   Wang SG, 2019, AUTOPHAGY, V15, P1954, DOI 10.1080/15548627.2019.1596486
   Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7
   Wu J, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00019
   Xu J, 2019, LAB INVEST, V99, P577, DOI 10.1038/s41374-018-0170-0
   Xu JQ, 2019, INT IMMUNOPHARMACOL, V69, P289, DOI 10.1016/j.intimp.2019.02.005
   Yao J, 2019, BIOFACTORS, V45, P616, DOI 10.1002/biof.1507
   Yao LB, 2013, BLOOD, V122, P3832, DOI 10.1182/blood-2012-12-473835
   Yao WF, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/258567
   Yi L, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00357
   Zhang YP, 2018, THER APHER DIAL, V22, P649, DOI 10.1111/1744-9987.12720
   Zhang YT, 2019, CHEM-BIOL INTERACT, V305, P54, DOI 10.1016/j.cbi.2019.03.027
   Zhang YC, 2019, CHEMOSPHERE, V226, P463, DOI 10.1016/j.chemosphere.2019.03.167
   Zheng GZ, 2019, BIOMED PHARMACOTHER, V111, P733, DOI 10.1016/j.biopha.2018.12.073
NR 61
TC 32
Z9 36
U1 3
U2 18
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD NOV 6
PY 2019
VL 2019
AR 2197017
DI 10.1155/2019/2197017
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA JP9PY
UT WOS:000498590200002
PM 31781326
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Alam, MA
   Betal, SGN
   Aghai, ZH
   Bhandari, V
AF Alam, Mohammad Afaque
   Betal, Suhita Gayen Nee
   Aghai, Zubair H.
   Bhandari, Vineet
TI Hyperoxia causes miR199a-5p-mediated injury in the developing lung
SO PEDIATRIC RESEARCH
LA English
DT Article
ID CRITICAL REGULATOR; EXPRESSION; INFLAMMATION; PROTEIN; MICE; CAVEOLIN-1;
   APOPTOSIS
AB BACKGROUND: Hyperoxia-induced acute lung injury (HALI) is characterized by increased permeability and infiltration of inflammatory cells, impairment of alveolar development, and compromised lung function. Recent evidence has determined that microRNAs (miRs) are implicated in hyperoxia-induced lung injury, including bronchopulmonary dysplasia (BPD). However, the expression profile and functional role of miR199a-5p in developing lungs have not been reported.
   METHODS: The present study was undertaken to explore the role of miR199a-5p in developing mice lungs and human neonates. We exposed neonatal mice for 7 days, mouse lung epithelial cells (MLE12), mouse lung endothelial cells (MLECs), and macrophages (RAW246.7), to hyperoxia at different time points.
   RESULTS: Our results demonstrated enhanced miR199a-5p expression in hyperoxia-exposed mice lungs and cells, as well as in tracheal aspirates of infants developing BPD, with significant reduction in the expression of its target, caveolin-1. Next, we observed that miR199a-5p-mimic worsens HALI as evidenced by increased inflammatory cells, cytokines, and lung vascular markers. Conversely, miR199a-5p-inhibitor treatment attenuated HALI.
   CONCLUSION: Thus, our findings suggest that miR199a-5p is a potential target for attenuating HALI pathophysiology in the developing lung. Moreover, miR199a-5p-inhibitor could be part of a novel therapeutic strategy for improving BPD in preterm neonates.
C1 [Alam, Mohammad Afaque; Bhandari, Vineet] Drexel Univ, Coll Med, Div Neonatol, Dept Pediat, Philadelphia, PA 19104, United States.
   [Alam, Mohammad Afaque] Temple Univ, Lewis Katz Sch Med, Dept Neurosci, Philadelphia, PA, United States.
   [Betal, Suhita Gayen Nee; Aghai, Zubair H.] Thomas Jefferson Univ, Dept Pediat, Div Neonatol, Philadelphia, PA, United States.
C3 Drexel University; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Temple University; Jefferson University
RP Bhandari, V (corresponding author), Drexel Univ, Coll Med, Div Neonatol, Dept Pediat, Philadelphia, PA 19104 USA.
EM vineet.bhandari@drexel.edu
RI Bhandari, Vineet/AAS-3365-2020
OI Alam, Mohammad Afaque/0000-0001-5801-2512; Aghai,
   Zubair/0000-0001-5545-9706
FU Departmental Funds
FX The work was supported by Departmental Funds (V.B.).
CR Alphonse RS, 2011, AM J RESP CELL MOL, V44, P146, DOI 10.1165/rcmb.2009-0182OC
   Balany J, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00090
   Benlhabib H, 2015, J BIOL CHEM, V290, P22409, DOI 10.1074/jbc.M114.636068
   Bhandari A, 2009, PEDIATRICS, V123, P1562, DOI 10.1542/peds.2008-1962
   Bhandari V, 2010, SEMIN FETAL NEONAT M, V15, P223, DOI 10.1016/j.siny.2010.03.009
   Bhari, 2011, CLIN PULM MED, V18, P137, DOI [10.1097/CPM.0b013e318218a071, DOI 10.1097/CPM.0B013E318218A071]
   Chaubey S, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0903-4
   Chen XY, 2017, MICROMACHINES-BASEL, V8, DOI 10.3390/mi8030064
   Chen Y, 2015, EXP LUNG RES, V41, P344, DOI 10.3109/01902148.2015.1039668
   Choo-Wing R, 2007, AM J PHYSIOL-LUNG C, V293, pL142, DOI 10.1152/ajplung.00434.2006
   Choo-Wing R, 2013, AM J RESP CELL MOL, V48, P749, DOI 10.1165/rcmb.2012-0381OC
   Durrani-Kolarik S, 2017, AM J PHYSIOL-LUNG C, V313, pL339, DOI 10.1152/ajplung.00273.2016
   Galambos C, 2008, PATHOLOGY, V40, P124, DOI 10.1080/00313020701818981
   Go H, 2016, AM J PHYSIOL-LUNG C, V311, pL400, DOI 10.1152/ajplung.00428.2015
   Harijith A, 2011, AM J RESP CELL MOL, V44, P621, DOI 10.1165/rcmb.2010-0058OC
   Hassan T, 2014, AM J RESP CRIT CARE, V189, P263, DOI 10.1164/rccm.201306-1151OC
   Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010
   Li Z, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-54
   Lin CX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003231
   Mach WJ, 2011, NURS RES PRACT, V2011, DOI 10.1155/2011/260482
   Maniatis Nikolaos A, 2012, Pulm Circ, V2, P452, DOI 10.4103/2045-8932.105033
   Mizuno S, 2012, CHEST, V142, P663, DOI 10.1378/chest.11-2746
   Narasaraju T, 2015, AM J RESP CELL MOL, V52, P253, DOI 10.1165/rcmb.2013-0021OC
   Olave N, 2016, AM J PHYSIOL-LUNG C, V310, pL476, DOI 10.1152/ajplung.00145.2015
   Osei ET, 2015, EUR RESPIR J, V46, P807, DOI 10.1183/13993003.02139-2014
   Perrone S, 2017, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00143
   Ramsay PL, 1996, TOXICOL LETT, V87, P157, DOI 10.1016/0378-4274(96)03773-3
   Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83
   Sureshbabu A, 2016, AM J RESP CELL MOL, V55, P722, DOI 10.1165/rcmb.2015-0349OC
   Sureshbabu A, 2015, RESP RES, V16, DOI 10.1186/s12931-014-0162-6
   Syed M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01349-y
   Syed MA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/457189
   Syed MA, 2010, EXP CELL RES, V316, P3140, DOI 10.1016/j.yexcr.2010.08.009
   Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536
   Yao L, 2017, INT J MOL MED, V39, P1403, DOI 10.3892/ijmm.2017.2961
   Zhang PF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9446
   Zhang XY, 2011, RESP CARE, V56, P1009, DOI 10.4187/respcare.01032
NR 37
TC 11
Z9 12
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD NOV
PY 2019
VL 86
IS 5
BP 579
EP 588
DI 10.1038/s41390-019-0524-3
PG 10
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA JM9DI
UT WOS:000496506400010
PM 31390652
OA Bronze
DA 2023-08-21
ER

PT J
AU Li, CC
   Pan, JY
   Ye, LC
   Xu, HL
   Wang, BB
   Xu, HY
   Xu, LN
   Hou, TT
   Zhang, D
AF Li, Chichi
   Pan, Jingye
   Ye, Lechi
   Xu, Honglei
   Wang, Beibei
   Xu, Hanyan
   Xu, Lingna
   Hou, Tongtong
   Zhang, Dan
TI Autophagy regulates the therapeutic potential of adipose-derived stem
   cells in LPS-induced pulmonary microvascular barrier damage
SO CELL DEATH & DISEASE
LA English
DT Article
ID INDUCED LUNG INJURY; ENDOTHELIAL BARRIER; GROWTH-FACTOR;
   LIPOPOLYSACCHARIDE; METABOLISM; MAINTAINS; APOPTOSIS; PROMOTES;
   SURVIVAL; MODEL
AB Adipose-derived stem cells (ADSCs) have been shown to be beneficial in some pulmonary diseases, and the paracrine effect is the major mechanism underlying ADSC-based therapy. Autophagy plays a crucial role in maintaining stem cell homeostasis and survival. However, the role of autophagy in mediating ADSC paracrine effects has not been thoroughly elucidated. We examined whether ADSCs participate in lipopolysaccharide (LPS)-induced pulmonary microvascular endothelial cell (PMVEC) barrier damage in a paracrine manner and illuminated the role of autophagy in regulating ADSC paracrine effects. PMVECs and ADSCs with or without autophagy inhibition were cocultured without intercellular contact, and the microvascular barrier function was assessed after LPS treatment. ADSC paracrine function was evaluated by detecting essential growth factors for endothelial cells. For in vivo experiments, ADSCs with or without autophagy inhibition were transplanted into LPS-induced lung-injury mice, and lung injury was assessed. ADSCs significantly alleviated LPS-induced microvascular barrier injury. In addition, ADSC paracrine levels of VEGF, FGF, and EGF were induced by LPS treatment, especially in the coculture condition. Inhibiting autophagy weakened the paracrine function and the protective effects of ADSCs on microvascular barrier injury. Moreover, ADSC transplantation alleviated LPS-induced lung injury, and inhibiting autophagy markedly weakened the therapeutic effect of ADSCs on lung injury. Together, these findings show that ADSC paracrine effects play a vital protective role in LPS-induced pulmonary microvascular barrier injury. Autophagy is a positive mediating factor in the paracrine process. These results are helpful for illuminating the role and mechanism of ADSC paracrine effects and developing effective therapies in acute lung injury.
C1 [Li, Chichi] Wenzhou Med Univ, Affiliated Hosp 1, Plast Surg, Wenzhou, Zhejiang 325000, China.
   [Pan, Jingye] Wenzhou Med Univ, Affiliated Hosp 1, Dept Intens Care Unit, Wenzhou, Zhejiang 325000, China.
   [Ye, Lechi] Wenzhou Med Univ, Affiliated Hosp 1, Dept Colorectal & Anal Surg, Wenzhou, Zhejiang 325000, China.
   [Xu, Honglei] Wenzhou Med Univ, Affiliated Hosp 1, Emergency Dept, Wenzhou, Zhejiang 325000, China.
   [Wang, Beibei; Xu, Hanyan; Xu, Lingna; Hou, Tongtong; Zhang, Dan] Wenzhou Med Univ, Affiliated Hosp 1, Dept Resp Med, Wenzhou, Zhejiang 325000, China.
   Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang 325000, China.
C3 Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical
   University; Wenzhou Medical University; Wenzhou Medical University;
   Wenzhou Medical University
RP Zhang, D (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Resp Med, Wenzhou, Zhejiang 325000, Peoples R China.
EM zhangdan6250@yeah.net
OI Zhang, Dan/0000-0001-8174-1238
FU National Natural Science Foundation of China [81800075]; Wenzhou Science
   and Technology Project [Y20190116]
FX This work was financially supported by the National Natural Science
   Foundation of China (81800075), and the Wenzhou Science and Technology
   Project (Y20190116).
CR Aboul-Fotouh GI, 2015, INT J STEM CELLS, V8, P170, DOI 10.15283/ijsc.2015.8.2.170
   An Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0082-8
   [Anonymous], 2011, GUIDE CARE USE LAB A
   Asano J, 2017, CELL REP, V20, P1050, DOI 10.1016/j.celrep.2017.07.019
   Bake S, 2016, ENDOCRINOLOGY, V157, P61, DOI 10.1210/en.2015-1840
   Dalvi P, 2016, AUTOPHAGY, V12, P2420, DOI 10.1080/15548627.2016.1238551
   DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016
   Deveza L, 2013, STEM CELLS DEV, V22, P483, DOI 10.1089/scd.2012.0201
   Domigan CK, 2015, J CELL SCI, V128, P2236, DOI 10.1242/jcs.163774
   Frese L, 2016, TRANSFUS MED HEMOTH, V43, P268, DOI 10.1159/000448180
   Fujii S, 2012, ONCOIMMUNOLOGY, V1, P630, DOI 10.4161/onci.20297
   Gao LB, 2016, STEM CELL TRANSL MED, V5, P1496, DOI 10.5966/sctm.2015-0420
   Gopalakrishnan S, 2007, AM J PHYSIOL-CELL PH, V292, pC1094, DOI 10.1152/ajpcell.00099.2006
   Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388
   Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775
   Kuroda K, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0701-4
   Li CC, 2017, CELL PHYSIOL BIOCHEM, V44, P1762, DOI 10.1159/000485783
   Lin X, 2016, GENE THER, V23, P489, DOI 10.1038/gt.2016.19
   Liu K, 2016, AUTOPHAGY, V12, P2000, DOI 10.1080/15548627.2016.1212786
   Moon KM, 2012, INT J MOL SCI, V13, P1239, DOI 10.3390/ijms13011239
   Munshi N, 2002, J IMMUNOL, V168, P5860, DOI 10.4049/jimmunol.168.11.5860
   Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298
   Park MJ, 2015, CELL TRANSPLANT, V24, P2367, DOI 10.3727/096368914X685645
   Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016
   Qian J, 2016, STEM CELLS, V34, P1947, DOI 10.1002/stem.2337
   Qin LH, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/120641
   Raffaghello L, 2008, STEM CELLS, V26, P151, DOI 10.1634/stemcells.2007-0416
   RASHED SM, 1991, EUR J BIOCHEM, V197, P805, DOI 10.1111/j.1432-1033.1991.tb15975.x
   Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664
   Smith KM, 1997, CRIT CARE MED, V25, P1888, DOI 10.1097/00003246-199711000-00030
   Su G, 2007, AM J RESP CELL MOL, V36, P377, DOI 10.1165/rcmb.2006-0238OC
   Vinci MC, 2004, BIOCHEM PHARMACOL, V67, P277, DOI 10.1016/j.bcp.2003.09.007
   Wu YY, 2018, ANN PLAS SURG, V80, P572, DOI 10.1097/SAP.0000000000001355
   Xu LH, 2016, TUMOR BIOL, V37, P7835, DOI 10.1007/s13277-015-4664-8
   Zhang D, 2018, J CELL PHYSIOL, V233, P688, DOI 10.1002/jcp.25928
NR 35
TC 13
Z9 13
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD OCT 23
PY 2019
VL 10
AR 804
DI 10.1038/s41419-019-2037-8
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA JI3QU
UT WOS:000493383500002
PM 31645547
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Takei, Y
   Yamada, M
   Saito, K
   Kameyama, Y
   Sugiura, H
   Makiguchi, T
   Fujino, N
   Koarai, A
   Toyama, H
   Saito, K
   Ejima, Y
   Kawazoe, Y
   Kudo, D
   Kushimoto, S
   Yamauchi, M
   Ichinose, M
AF Takei, Yusuke
   Yamada, Mitsuhiro
   Saito, Koji
   Kameyama, Yoshinobu
   Sugiura, Hisatoshi
   Makiguchi, Tomonori
   Fujino, Naoya
   Koarai, Akira
   Toyama, Hiroaki
   Saito, Kazutomo
   Ejima, Yutaka
   Kawazoe, Yu
   Kudo, Daisuke
   Kushimoto, Shigeki
   Yamauchi, Masanori
   Ichinose, Masakazu
TI Increase in circulating ACE-positive endothelial microparticles during
   acute lung injury
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; PATHOGENESIS; DYSFUNCTION; INHIBITION;
   ANTIBODIES; ELEVATION; SEPSIS; RISK
AB Circulating endothelial microparticles (EMPs) are considered to be markers of endothelial injury, and lung microvascular endothelial cells express higher levels of angiotensin-converting enzyme (ACE). The aim of this study is to examine whether the number of ACE(+) microvascular EMPs could be a prognostic marker for the development of acute respiratory distress syndrome (ARDS) in septic patients.
   The numbers of EMPs and ACE(+) EMPs in the culture supernatant from human microvascular endothelial cells, as well as in the blood of mouse lung injury models and septic patients (n=82), were examined using flow cytometry. ACE(+) EMPs in the culture supernatant from pulmonary microvascular endothelial cells increased after exposure to an inflammatory stimulus. In the mouse lung injury models, the circulating
   ACE(+) EMPs and ACE(+) EMP/EMP ratio were higher than in the controls (p<0.001). The ACE(+) EMP/EMP ratio was correlated with the wet/dry lung ratio (rs=0.775, p<0.001). The circulating ACE(+) EMPs and ACE(+) EMP/ EMP ratio on admission were significantly increased in septic patients who developed ARDS compared with septic patients who did not (p<0.001).
   Therefore, circulating ACE(+) EMPs may be a prognostic marker for the development of ARDS in the septic patients.
C1 [Takei, Yusuke; Toyama, Hiroaki; Saito, Kazutomo; Ejima, Yutaka; Yamauchi, Masanori] Tohoku Univ, Grad Sch Med, Dept Anaesthesiol & Perioperat Med, Sendai, Miyagi, Japan.
   [Yamada, Mitsuhiro; Sugiura, Hisatoshi; Makiguchi, Tomonori; Fujino, Naoya; Koarai, Akira; Ichinose, Masakazu] Tohoku Univ, Grad Sch Med, Dept Resp Med, Sendai, Miyagi, Japan.
   [Saito, Koji; Kameyama, Yoshinobu] Tohoku Univ, Grad Sch Med, Dept Intens Care Unit, Sendai, Miyagi, Japan.
   [Kawazoe, Yu; Kudo, Daisuke; Kushimoto, Shigeki] Tohoku Univ, Grad Sch Med, Div Emergency & Crit Care Med, Sendai, Miyagi, Japan.
C3 Tohoku University; Tohoku University; Tohoku University; Tohoku
   University
RP Yamada, M (corresponding author), Tohoku Univ, Dept Resp Med, Grad Sch Med, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.
EM yamitsu@med.tohoku.ac.jp
RI YAMADA, MITSUHIRO/Q-8003-2016; koarai, akira/T-6382-2019; Kushimoto,
   Shigeki/AET-6785-2022; Fujino, Naoya/O-7031-2014; Toyama,
   Hiroaki/AAZ-3534-2021
OI YAMADA, MITSUHIRO/0000-0002-0832-1939; Kushimoto,
   Shigeki/0000-0001-9232-5782; Fujino, Naoya/0000-0003-3174-2632; Toyama,
   Hiroaki/0000-0002-4854-5187
FU Japan Society for the Promotion of Science (JSPS) [15K15562, 18K08907,
   15K09206, 18K08134]; Grants-in-Aid for Scientific Research [15K09206,
   18K08134, 15K15562, 18K08907] Funding Source: KAKEN
FX This work was supported by Grants-in-Aid for Scientific Research
   (15K15562 and 18K08907 to K. Saito, and 15K09206 and 18K08134 to M.
   Yamada) from the Japan Society for the Promotion of Science (JSPS).
   Funding information for this article has been deposited with the
   Crossref Funder Registry.
CR Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae
   Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535
   Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756
   Burger D, 2013, CLIN SCI, V124, P423, DOI 10.1042/CS20120309
   Calfee CS, 2015, CHEST, V147, P1539, DOI 10.1378/chest.14-2454
   Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495
   Coates D, 2003, INT J BIOCHEM CELL B, V35, P769, DOI 10.1016/S1357-2725(02)00309-6
   Curti AM, 2009, J THROMB HAEMOST, V7, P701, DOI 10.1111/j.1538-7836.2009.03304.x
   DANILOV S, 1994, J BIOL CHEM, V269, P26806
   Danilov SM, 2001, AM J PHYSIOL-LUNG C, V280, pL1335, DOI 10.1152/ajplung.2001.280.6.L1335
   Faure V, 2006, J THROMB HAEMOST, V4, P566, DOI 10.1111/j.1538-7836.2005.01780.x
   Feng B, 2010, ATHEROSCLEROSIS, V208, P264, DOI 10.1016/j.atherosclerosis.2009.06.037
   Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC
   Jung C, 2012, ATHEROSCLEROSIS, V221, P226, DOI 10.1016/j.atherosclerosis.2011.12.025
   Lan CC, 2017, J THORAC CARDIOV SUR, V153, P206, DOI 10.1016/j.jtcvs.2016.09.068
   Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305
   Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST
   Menezes SLS, 2005, J APPL PHYSIOL, V98, P1777, DOI 10.1152/japplphysiol.01182.2004
   Meziani F, 2010, CRIT CARE, V14, DOI 10.1186/cc9231
   Nie DM, 2016, AM J PHYSIOL-CELL PH, V310, pC821, DOI 10.1152/ajpcell.00372.2015
   Nozaki T, 2009, J AM COLL CARDIOL, V54, P601, DOI 10.1016/j.jacc.2009.05.022
   Pelosi P, 2003, EUR RESPIR J, V42, P48, DOI DOI 10.1183/09031936.03.0042
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Razavi HM, 2002, CRIT CARE MED, V30, P868, DOI 10.1097/00003246-200204000-00026
   Sanchez-Lopez V, 2015, TRANSL RES, V166, P733, DOI 10.1016/j.trsl.2015.08.006
   Schiro A, 2014, ATHEROSCLEROSIS, V234, P295, DOI 10.1016/j.atherosclerosis.2014.03.019
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Takahashi T, 2012, THORAX, V67, P1067, DOI 10.1136/thoraxjnl-2011-201395
   Tanaka K, 2017, AM J RESP CELL MOL, V56, P179, DOI 10.1165/rcmb.2016-0158OC
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Yamada M, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-95
   Yamada M, 2011, AM J RESP CRIT CARE, V183, P1391, DOI 10.1164/rccm.201004-0592OC
   Yun J Winny, 2016, Pathophysiology, V23, P265, DOI 10.1016/j.pathophys.2016.08.004
   Zhu ZY, 2017, AM J PHYSIOL-LUNG C, V313, pL104, DOI 10.1152/ajplung.00410.2016
NR 34
TC 21
Z9 21
U1 0
U2 5
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD OCT 1
PY 2019
VL 54
IS 4
AR 1801188
DI 10.1183/13993003.01188-2018
PG 12
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA NZ7NC
UT WOS:000577289300030
PM 31320458
OA Bronze
DA 2023-08-21
ER

PT J
AU Claser, C
   Nguee, SYT
   Balachander, A
   Howland, SW
   Becht, E
   Gunasegaran, B
   Hartimath, SV
   Lee, AWQ
   Ho, JTT
   Ong, CB
   Newell, EW
   Goggi, J
   Ng, LG
   Renia, L
AF Claser, Carla
   Nguee, Samantha Yee Teng
   Balachander, Akhila
   Howland, Shanshan Wu
   Becht, Etienne
   Gunasegaran, Bavani
   Hartimath, Siddesh V.
   Lee, Audrey W. Q.
   Ho, Jacqueline Theng Theng
   Ong, Chee Bing
   Newell, Evan W.
   Goggi, Julian
   Ng, Lai Guan
   Renia, Laurent
TI Lung endothelial cell antigen cross-presentation to CD8(+)T cells drives
   malaria-associated lung injury
SO NATURE COMMUNICATIONS
LA English
DT Article
ID EXPERIMENTAL CEREBRAL MALARIA; RESPIRATORY-DISTRESS-SYNDROME; IFN-GAMMA;
   FALCIPARUM-MALARIA; INTERFERON-GAMMA; VIVAX MALARIA; DOUBLE-BLIND;
   T-CELLS; BRAIN; DEXAMETHASONE
AB Malaria-associated acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) are life-threatening manifestations of severe malaria infections. The pathogenic mechanisms that lead to respiratory complications, such as vascular leakage, remain unclear. Here, we confirm that depleting CD8(+)T cells with anti-CD8 beta antibodies in C57BL/6 mice infected with P. berghei ANKA (PbA) prevent pulmonary vascular leakage. When we transfer activated parasite-specific CD8(+)T cells into PbA-infected TCR beta(-/-) mice (devoid of all T-cell populations), pulmonary vascular leakage recapitulates. Additionally, we demonstrate that PbA-infected erythrocyte accumulation leads to lung endothelial cell cross-presentation of parasite antigen to CD8(+)T cells in an IFN gamma-dependent manner. In conclusion, pulmonary vascular damage in ALI is a consequence of IFN gamma-activated lung endothelial cells capturing, processing, and cross-presenting malaria parasite antigen to specific CD8(+)T cells induced during infection. The mechanistic understanding of the immunopathogenesis in malaria-associated ARDS and ALI provide the basis for development of adjunct treatments.
C1 [Claser, Carla; Nguee, Samantha Yee Teng; Balachander, Akhila; Howland, Shanshan Wu; Becht, Etienne; Gunasegaran, Bavani; Lee, Audrey W. Q.; Ho, Jacqueline Theng Theng; Newell, Evan W.; Ng, Lai Guan; Renia, Laurent] ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Level 3&4 Immunos Bldg, Singapore 138648, Singapore.
   [Nguee, Samantha Yee Teng; Renia, Laurent] Natl Univ Singapore, Dept Microbiol & Immunol, Yong Loo Lin Sch Med, 5 Sci Dr 2 Blk MD4,Level 3, Singapore 117545, Singapore.
   [Hartimath, Siddesh V.; Goggi, Julian] ASTAR, Isotop Mol Imaging Lab, Singapore Bioimaging Consortium SBIC, 11 Biopolis Way,02-02 Helios, Singapore 138667, Singapore.
   [Ong, Chee Bing] ASTAR, Histolopathol Adv Mol Pathol Lab, IMCB, 61 Biopolis Dr,Level 6 Proteos Bldg, Singapore 138673, Singapore.
C3 Agency for Science Technology & Research (A*STAR); A*STAR - Singapore
   Immunology Network (SIgN); National University of Singapore; Agency for
   Science Technology & Research (A*STAR); A*STAR - Institute of
   Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging
   Consortium (SBIC); Agency for Science Technology & Research (A*STAR);
   A*STAR - Institute of Molecular & Cell Biology (IMCB)
RP Claser, C; Renia, L (corresponding author), ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Level 3&4 Immunos Bldg, Singapore 138648, Singapore.; Renia, L (corresponding author), Natl Univ Singapore, Dept Microbiol & Immunol, Yong Loo Lin Sch Med, 5 Sci Dr 2 Blk MD4,Level 3, Singapore 117545, Singapore.
EM carla_claser@immunol.a-star.edu.sg; renia_laurent@immunol.a-star.edu.sg
RI Newell, Evan W/F-9711-2012; Ng, Lai Guan/E-5673-2011; Claser,
   Carla/P-2736-2018; Hartimath, Siddesh/GPP-5423-2022; Renia,
   Laurent/E-2117-2011; Howland, Shanshan W/I-2245-2014
OI Newell, Evan W/0000-0002-2889-243X; Ng, Lai Guan/0000-0003-1905-3586;
   Claser, Carla/0000-0002-5395-9632; Hartimath,
   Siddesh/0000-0002-8248-0866; Renia, Laurent/0000-0003-0349-1557;
   Howland, Shanshan W/0000-0003-4794-1564; Ong, Chee
   Bing/0000-0002-0521-1646; Becht, Etienne/0000-0003-1859-9202;
   Gunasegaran, Bavani/0000-0002-4783-8404; Nguee, Samantha Yee
   Teng/0000-0001-5381-2377; Lee, Audrey/0000-0002-7395-5225
FU Yong Loo Lin School of Medicine, National University of Singapore;
   Agency for Science, Technology and Research (A*STAR); BMRC [IAF 311006,
   H16/99/b0/011]
FX The authors would like to thank the Benoist-Mathis laboratory (Harvard
   Medical School) for providing the pT<INF>beta</INF>cass cassette used to
   generate the BSL8.4 transgenic mice. We also thank Dr. Anis Larbi and
   the SIgN Flow Cytometry core for assistance with the sorting, the SIgN
   Mouse Core for support with mice, and BRC animal Gene Editing Laboratory
   for oocyte injection. The authors would like to thank Insight Editing
   London for editing the manuscript prior to submission. SN was supported
   by a postgraduate scholarship from the Yong Loo Lin School of Medicine,
   National University of Singapore. This project was funded by Agency for
   Science, Technology and Research (A*STAR) to a core grant to SIgN. The
   Flow cytometry core is part of the SIgN Immunomonitoring platform,
   supported by a BMRC IAF 311006 grant and BMRC transition funds
   #H16/99/b0/011 (A*STAR).
CR Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0
   Anstey NM, 2002, J INFECT DIS, V185, P1326, DOI 10.1086/339885
   Aursudkij Boonrut, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P541
   Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w
   Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006
   Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314
   Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369
   Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x
   Chang WL, 2001, INFECT IMMUN, V69, P7341, DOI 10.1128/IAI.69.12.7341-7348.2001
   CHEN SF, 1995, MICROVASC RES, V50, P119, DOI 10.1006/mvre.1995.1044
   Claser C, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12763
   Claser C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018720
   CORBETT CEP, 1989, J TROP MED HYG, V92, P112
   DUARTE MIS, 1985, AM J TROP MED HYG, V34, P31, DOI 10.4269/ajtmh.1985.34.31
   Dunst J, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00324
   Epiphanio S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000916
   Franke-Fayard B, 2006, NAT PROTOC, V1, P476, DOI 10.1038/nprot.2006.69
   Fruh K, 1999, CURR OPIN IMMUNOL, V11, P76, DOI 10.1016/S0952-7915(99)80014-4
   GACHOT B, 1995, CHEST, V108, P746, DOI 10.1378/chest.108.3.746
   Galvao B, 2019, MUCOSAL IMMUNOL, V12, P312, DOI 10.1038/s41385-018-0093-5
   GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572
   Gupta H, 2015, J INFECT DEV COUNTR, V9, P910, DOI 10.3855/jidc.6813
   HOFFMAN SL, 1988, J INFECT DIS, V158, P325, DOI 10.1093/infdis/158.2.325
   Howland SW, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004963
   Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273
   Hunt NH, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00113
   KAYE J, 1992, J IMMUNOL, V148, P3342
   KOUSKOFF V, 1995, J IMMUNOL METHODS, V180, P273, DOI 10.1016/0022-1759(95)00002-R
   Krupnick AS, 2012, NAT PROTOC, V7, P128, DOI 10.1038/nprot.2011.424
   Lacerda MVG, 2012, CLIN INFECT DIS, V55, pE67, DOI 10.1093/cid/cis615
   Lagasse HAD, 2016, J LEUKOCYTE BIOL, V99, P659, DOI 10.1189/jlb.4HI0315-130RRR
   Latourette MT, 2011, J DIGIT IMAGING, V24, P729, DOI 10.1007/s10278-010-9323-4
   Lovegrove FE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000068
   Maguire GP, 2005, J INFECT DIS, V192, P1966, DOI 10.1086/497697
   Mai JT, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-61
   Malleret B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00118
   Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-177
   Meager A, 1999, CYTOKINE GROWTH F R, V10, P27, DOI 10.1016/S1359-6101(98)00024-0
   Milner D, 2013, HUM PATHOL, V44, P2719, DOI 10.1016/j.humpath.2013.07.018
   Mohan Alladi, 2008, Journal of Vector Borne Diseases, V45, P179
   Nacer A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004528
   Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221
   Penet MF, 2007, J BIOL CHEM, V282, P14505, DOI 10.1074/jbc.M608035200
   Poh CM, 2014, INFECT IMMUN, V82, P4854, DOI 10.1128/IAI.02180-14
   Rasalkar DD, 2011, BRIT J RADIOL, V84, P380, DOI 10.1259/bjr/85759874
   Razakandrainibe R, 2012, TRENDS PARASITOL, V28, P151, DOI 10.1016/j.pt.2012.01.004
   Saggu R, 2011, AM J PATHOL, V179, P1104, DOI 10.1016/j.ajpath.2011.05.044
   Schmidt NW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000998
   Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686
   Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252
   SENALDI G, 1994, INFECT IMMUN, V62, P1144, DOI 10.1128/IAI.62.4.1144-1149.1994
   Sercundes MK, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006054
   Shackelford C, 2002, TOXICOL PATHOL, V30, P93, DOI 10.1080/01926230252824761
   Swanson PA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006022
   Taylor Walter R J, 2006, Treat Respir Med, V5, P419, DOI 10.2165/00151829-200605060-00007
   Taylor WRJ, 2012, CHEST, V142, P492, DOI 10.1378/chest.11-2655
   Teo TH, 2015, J VIROL, V89, P7955, DOI 10.1128/JVI.00909-15
   Pham TT, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00416
   Van den Steen PE, 2008, EUR J IMMUNOL, V38, P1082, DOI 10.1002/eji.200737906
   Van den Steen PE, 2013, TRENDS PARASITOL, V29, P346, DOI 10.1016/j.pt.2013.04.006
   Van den Steen PE, 2010, AM J RESP CRIT CARE, V181, P957, DOI 10.1164/rccm.200905-0786OC
   Villegas-Mendez A, 2011, J IMMUNOL, V187, P2885, DOI 10.4049/jimmunol.1100241
   WARRELL DA, 1982, NEW ENGL J MED, V306, P313, DOI 10.1056/NEJM198202113060601
   William T, 2011, EMERG INFECT DIS, V17, P1248, DOI 10.3201/eid1707.101017
   Wojtasiak M, 2010, J GEN VIROL, V91, P2158, DOI 10.1099/vir.0.021915-0
NR 65
TC 31
Z9 32
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD SEP 18
PY 2019
VL 10
AR 4241
DI 10.1038/s41467-019-12017-8
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA IY4PF
UT WOS:000486374800003
PM 31534124
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Punsawad, C
   Viriyavejakul, P
AF Punsawad, Chuchard
   Viriyavejakul, Parnpen
TI Expression of sphingosine kinase 1 and sphingosine 1-phosphate receptor
   3 in malaria-associated acute lung injury/acute respiratory distress
   syndrome in a mouse model
SO PLOS ONE
LA English
DT Article
ID RETRACTED ARTICLE. SEE; SPHINGOSINE-1-PHOSPHATE RECEPTORS; FUNCTIONAL
   ROLES; TNF-ALPHA; METABOLISM; APOPTOSIS; CELLS; S1P
AB This study aimed to investigate the expression of sphingosine kinase 1 (SphK-1) and sphingosine 1-phosphate receptor 3 (S1PR-3) in a mouse model of malaria-associated acute lung injury/acute respiratory distress syndrome (ALI/ARDS). DBA/2 mice were infected with Plasmodium berghei ANKA to generate an experimental model of malaria-associated ALI/ARDS. The infected mice were divided into 2 groups based on the histopathological study of lung tissues: those with and those without ALI/ARDS. The expression of the SphK-1 and S1PR-3 proteins in the lung tissues was investigated using immunohistochemical staining and Western blot analysis. In addition, the S1P level was quantified in plasma and lung tissues using an enzyme-linked immunosorbent assay (ELISA). The results demonstrated that the cellular expression of the SphK-1 and S1PR-3 proteins was significantly upregulated in endothelial cells, alveolar epithelial cells and alveolar macrophages in the lung tissues of malaria-infected mice with ALI/ARDS compared with those in the control groups. The increased expression of the SphK-1 and S1PR-3 proteins was confirmed using Western blot analysis. The concentration of S1P in plasma and lung tissues was significantly decreased in malaria-infected mice with ALI/ARDS compared with non-ALI/ARDS and control mice. Furthermore, increased expression of the SphK-1 and S1PR-3 proteins significantly correlated with lung injury scores and S1P concentrations in malaria-infected mice with ALI/ARDS. These findings highlight increased expression of SphK-1 and S1PR-3 in the lung tissues of malaria-infected mice with ALI/ARDS.
C1 [Punsawad, Chuchard] Walailak Univ, Sch Med, Nakhon Si Thammarat, Thailand.
   [Punsawad, Chuchard] Walailak Univ, Res Inst Hlth Sci, Trop Med Res Unit, Nakhon Si Thammarat, Thailand.
   [Viriyavejakul, Parnpen] Mahidol Univ, Fac Trop Med, Dept Trop Pathol, Bangkok, Thailand.
C3 Walailak University; Walailak University; Mahidol University
RP Punsawad, C (corresponding author), Walailak Univ, Sch Med, Nakhon Si Thammarat, Thailand.; Punsawad, C (corresponding author), Walailak Univ, Res Inst Hlth Sci, Trop Med Res Unit, Nakhon Si Thammarat, Thailand.
EM chuchard.pu@wu.ac.th
RI Punsawad, C/AAI-9258-2020
FU Thailand Research Fund [MRG5980054]; New Strategic Research (P2P)
   Project of Walailak University, Thailand [CGS-P2P-2562-011]
FX This work was supported by a research grant for new scholars to CP from
   the Thailand Research Fund (MRG5980054) and partially supported by the
   New Strategic Research (P2P) Project of Walailak University, Thailand
   (Contract number: CGS-P2P-2562-011).
CR Ahmed N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00312
   Aitken EH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-230
   Alemany R, 2007, N-S ARCH PHARMACOL, V374, P413, DOI 10.1007/s00210-007-0132-3
   Aoki S, 2005, J BIOCHEM, V138, P47, DOI 10.1093/jb/mvi100
   Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005
   Deroost K, 2013, AM J RESP CELL MOL, V48, P589, DOI 10.1165/rcmb.2012-0450OC
   Epiphanio S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000916
   Finney CAM, 2011, MOL MED, V17, P717, DOI 10.2119/molmed.2010.00214
   Fukuda Y, 2003, BIOCHEM BIOPH RES CO, V309, P155, DOI 10.1016/S0006-291X(03)01551-1
   Gon Y, 2005, P NATL ACAD SCI USA, V102, P9270, DOI 10.1073/pnas.0501997102
   Haddadi N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091891
   Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007
   Hatoum D, 2017, ONCOTARGET, V8, P36898, DOI 10.18632/oncotarget.16370
   Hisano Y, 2012, J BIOCHEM, V152, P305, DOI 10.1093/jb/mvs090
   Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005
   Li CY, 2009, AM J PATHOL, V175, P1464, DOI 10.2353/ajpath.2009.090037
   Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200
   Liu HY, 2016, PEERJ, V4, DOI 10.7717/peerj.2712
   Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003
   Marsolais D, 2009, NAT REV DRUG DISCOV, V8, P297, DOI 10.1038/nrd2356
   Mohammed S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00296
   Mohan Alladi, 2008, Journal of Vector Borne Diseases, V45, P179
   Natarajan V, 2013, AM J RESP CELL MOL, V49, P6, DOI 10.1165/rcmb.2012-0411TR
   Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663
   Ortolan LS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/872464
   Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC
   Punsawad C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180631
   Punsawad C, 2015, INT J CLIN EXP PATHO, V8, P10002
   Punsawad C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-260
   Sercundes MK, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006054
   Sun XG, 2013, AM J PHYSIOL-LUNG C, V305, pL467, DOI 10.1152/ajplung.00010.2013
   Sun XG, 2012, AM J RESP CELL MOL, V47, P628, DOI 10.1165/rcmb.2012-0048OC
   Swan DJ, 2010, J CELL MOL MED, V14, P2211, DOI 10.1111/j.1582-4934.2010.01136.x
   Taylor WRJ, 2012, CHEST, V142, P492, DOI 10.1378/chest.11-2655
   Thuy AV, 2014, CELL PHYSIOL BIOCHEM, V34, P158, DOI 10.1159/000362992
   Van den Steen PE, 2013, TRENDS PARASITOL, V29, P346, DOI 10.1016/j.pt.2013.04.006
   van Hooren KWEM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091346
   Visser BJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-442
   World Health Organization, 2017, MAL REP 2017
   Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200
   Zhi L, 2006, J CELL PHYSIOL, V208, P109, DOI 10.1002/jcp.20646
NR 41
TC 11
Z9 12
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 4
PY 2019
VL 14
IS 9
AR e0222098
DI 10.1371/journal.pone.0222098
PG 17
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA IY3SM
UT WOS:000486313000063
PM 31483837
OA gold, Green Submitted, Green Published
DA 2023-08-21
ER

PT J
AU Tariket, S
   Hamzeh-Cognasse, H
   Laradi, S
   Arthaud, CA
   Eyraud, MA
   Bourlet, T
   Berthelot, P
   Garraud, O
   Cognasse, F
AF Tariket, Sofiane
   Hamzeh-Cognasse, Hind
   Laradi, Sandrine
   Arthaud, Charles-Antoine
   Eyraud, Marie-Ange
   Bourlet, Thomas
   Berthelot, Philippe
   Garraud, Olivier
   Cognasse, Fabrice
TI Evidence of CD40L/CD40 pathway involvement in experimental
   transfusion-related acute lung injury
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SOLUBLE CD40 LIGAND; PLATELET-DERIVED CD40L; CD154; RECRUITMENT;
   COMPONENTS; NEUTROPHILS; ACTIVATION; PREVENTS; BLOCKADE; RELEASE
AB Platelet transfusions can cause adverse reactions in their recipients, including transfusion-related acute lung injury (TRALI). The pathophysiology of TRALI depends on a number of signaling pathways and the inflammatory role played by blood platelets remains controversial. Platelets are important in inflammation, particularly via the immunomodulator complex CD40/CD40L. We studied the specific function of the CD40/CD40L interaction in regulating an experimental TRALI Two-hit model. A mouse model of immune TRALI was triggered by injection of LPS and an anti-MHC I antibody, and the effect of injection of a neutralizing anti-CD40L antibody before induction of TRALI investigated. The characteristics of TRALI were decreased body temperature, pulmonary lesions, and immune cell infiltration into the alveolar space. Pulmonary infiltration was evaluated by blood counts of specific immune cells and their detection in lung sections. Inhibition of the CD40/CD40L immunomodulator interaction significantly reduced communication between immune and/or endothelial cells and the development of pulmonary edema. Hence, our results indicate that targeting of the CD40/CD40L interaction could be an important method to prevent TRALI. While considering that our work concerned a mouse model, we postulate that improvement of the conditions under which platelet concentrates are prepared/stored would assist in alleviating the risk of TRALI.
C1 [Tariket, Sofiane; Hamzeh-Cognasse, Hind; Laradi, Sandrine; Bourlet, Thomas; Berthelot, Philippe; Garraud, Olivier; Cognasse, Fabrice] Univ Lyon, GIMAP EA3064, St Etienne, France.
   [Tariket, Sofiane; Laradi, Sandrine; Arthaud, Charles-Antoine; Eyraud, Marie-Ange; Cognasse, Fabrice] Etab Francais Sang Auvergne Rhone Alpes, St Etienne, France.
   [Garraud, Olivier] Inst Natl Transfus Sanguine, Paris, France.
RP Cognasse, F (corresponding author), Univ Lyon, GIMAP EA3064, St Etienne, France.; Cognasse, F (corresponding author), Etab Francais Sang Auvergne Rhone Alpes, St Etienne, France.
EM fabrice.cognasse@univ-st-etienne.fr
RI , LARADI/AAD-4643-2020; COGNASSE, hind/HNP-2222-2023; Cognasse,
   Fabrice/Z-4401-2019
OI HAMZEH-COGNASSE, Hind/0000-0003-1462-3893; Berthelot,
   Philippe/0000-0001-9356-8081
FU French Blood Establishment (Grant APR), France; Agence Nationale de la
   Securite et du Medicament et des Produits de Sante (ANSM) [2012S055,
   AAP-2012-011]; French "Agence Nationale de la Recherche"
   [ANR-12-JSV1-0012-01]; Association " Les Amis de Remi" Savigneux, France
FX We would also like to thank the facility technical staff of the
   University of Saint-Etienne PLEXAN. This work was supported by grants
   from the French Blood Establishment (Grant APR), France; the Agence
   Nationale de la Securite et du Medicament et des Produits de Sante (ANSM
   -AAP-2012-011, Reference 2012S055); the French "Agence Nationale de la
   Recherche" (ANR-12-JSV1-0012-01); and the Association " Les Amis de
   Remi" Savigneux, France.
CR Adawi A, 1998, CLIN IMMUNOL IMMUNOP, V89, P222, DOI 10.1006/clin.1998.4606
   Adawi A, 1998, AM J PATHOL, V152, P651
   Aloui C, 2014, INT J MOL SCI, V15, P22342, DOI 10.3390/ijms151222342
   Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01
   Andrews RK, 2008, BLOOD, V112, P2174, DOI 10.1182/blood-2008-06-163063
   Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655
   Blumberg N, 2006, TRANSFUSION, V46, P1813, DOI 10.1111/j.1537-2995.2006.00979.x
   Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303
   Caudrillier A, 2012, CURR PHARM DESIGN, V18, P3260, DOI 10.2174/1381612811209023260
   Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726
   Cognasse F, 2006, TRANSFUSION, V46, P1184, DOI 10.1111/j.1537-2995.2006.00869.x
   Cognasse F, 2008, BLOOD, V112, P4779, DOI 10.1182/blood-2008-05-157578
   de Stoppelaar SF, 2014, THROMB HAEMOSTASIS, V112, P666, DOI 10.1160/TH14-02-0126
   Doerschuk CM, 2001, MICROCIRCULATION, V8, P71, DOI 10.1038/sj.mn.7300151
   Dunbar NM, 2015, CURR OPIN HEMATOL, V22, P554, DOI 10.1097/MOH.0000000000000187
   Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x
   Garraud O, 2013, CRIT CARE, V17, DOI 10.1186/cc12716
   Hamzeh-Cognasse H, 2014, TRANSFUSION, V54, P613, DOI 10.1111/trf.12378
   Hashimoto N, 2004, AM J RESP CELL MOL, V30, P808, DOI 10.1165/rcmb.2003-0197OC
   Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393
   Jin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064631
   Kapur R, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.04.37
   Kapur R, 2017, BLOOD, V129, P2557, DOI 10.1182/blood-2016-12-758185
   Kaufman J, 2007, J THROMB HAEMOST, V5, P788, DOI 10.1111/j.1538-7836.2007.02412.x
   Khan SY, 2006, BLOOD, V108, P2455, DOI 10.1182/blood-2006-04-017251
   Langer F, 2005, THROMB HAEMOSTASIS, V93, P1137, DOI 10.1160/TH04-12-0774
   Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706
   Li G, 2008, AM J PATHOL, V172, P1141, DOI 10.2353/ajpath.2008.070633
   Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432
   Lorente L, 2011, CRIT CARE, V15, DOI 10.1186/cc10104
   McKenzie CGJ, 2014, BLOOD, V123, P3496, DOI 10.1182/blood-2013-11-536755
   Middelburg RA, 2015, TRANSFUSION, V55, P953, DOI 10.1111/trf.12966
   P'ng SSY, 2008, THER APHER DIAL, V12, P78, DOI 10.1111/j.1744-9987.2007.00545.x
   Park Y, 2002, PLATELETS, V13, P301, DOI 10.1080/095371002220148332
   Peters AL, 2015, BRIT J HAEMATOL, V170, P597, DOI 10.1111/bjh.13459
   Rahman M, 2012, INFLAMM RES, V61, P571, DOI 10.1007/s00011-012-0446-6
   Rahman M, 2009, ANN SURG, V250, P783, DOI 10.1097/SLA.0b013e3181bd95b7
   Sahler J, 2012, TRANSFUS CLIN BIOL, V19, P98, DOI 10.1016/j.tracli.2012.02.003
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Semple JW, 2018, CRIT CARE MED, V46, pE452, DOI 10.1097/CCM.0000000000002989
   Silliman CC, 2006, CRIT CARE MED, V34, pS124, DOI 10.1097/01.CCM.0000214292.62276.8E
   Strait RT, 2011, J EXP MED, V208, P2525, DOI 10.1084/jem.20110159
   Tariket S, 2016, EXPERT REV HEMATOL, V9, P497, DOI 10.1586/17474086.2016.1152177
   Tuinman PR, 2011, CLIN EXP IMMUNOL, V165, P278, DOI 10.1111/j.1365-2249.2011.04422.x
   Tuinman Pieter R, 2011, Crit Care, V15, P429, DOI 10.1186/cc10237
   van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2
   Vanichakarn P, 2008, THROMB RES, V122, P346, DOI 10.1016/j.thromres.2007.12.019
   Vasilescu DM, 2013, J APPL PHYSIOL, V114, P716, DOI 10.1152/japplphysiol.00855.2012
   Vlaar APJ, 2013, LANCET, V382, P984, DOI 10.1016/S0140-6736(12)62197-7
   Wang X, 2014, BURNS TRAUMA, V2, DOI 10.4103/2321-3868.135487
   Weissmuller T, 2008, J CLIN INVEST, V118, P3682, DOI 10.1172/JCI35874
   West FB, 2013, EXPERT REV HEMATOL, V6, P265, DOI [10.1586/ehm.13.31, 10.1586/EHM.13.31]
   Zhang BK, 2013, IMMUNOL LETT, V153, P58, DOI 10.1016/j.imlet.2013.07.005
   Zuchtriegel G, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002459
NR 54
TC 18
Z9 18
U1 1
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 29
PY 2019
VL 9
AR 12536
DI 10.1038/s41598-019-49040-0
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA IT6WN
UT WOS:000483017100015
PM 31467410
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Huang, XJ
   Zhang, XM
   Zhao, DX
   Yin, J
   Hu, GC
   Evans, CE
   Zhao, YY
AF Huang, Xiaojia
   Zhang, Xianming
   Zhao, David X.
   Yin, Jun
   Hu, Guochang
   Evans, Colin E.
   Zhao, You-Yang
TI Endothelial Hypoxia-Inducible Factor-1 alpha Is Required for Vascular
   Repair and Resolution of Inflammatory Lung Injury through Forkhead Box
   Protein M1
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; PROLYL HYDROXYLASE INHIBITOR; SEVERE
   SEPSIS; SEPTIC SHOCK; CELLS; REGENERATION; MODELS; MICE; PROLIFERATION;
   HYPERTENSION
AB Endothelial barrier dysfunction is a central factor in the pathogenesis of persistent lung inflammation and protein-rich edema formation, the hallmarks of acute respiratory distress syndrome. However, little is known about the molecular mechanisms that are responsible for vascular repair and resolution of inflammatory injury after sepsis challenge. Herein, we show that hypoxia-inducible factor-1 alpha (HIF-1 alpha), expressed in endothelial cells (ECs), is the critical transcriptional factor mediating vascular repair and resolution of inflammatory lung injury. After sepsis challenge, HIF-1 alpha but not HIF-2 alpha expression was rapidly induced in lung vascular ECs, and mice with EC-restricted disruption of Hif1 alpha (Hif1 alpha(f/f)/Tie2Cre(+)) exhibited defective vascular repair, persistent inflammation, and increased mortality in contrast with the wild-type littermates after polymicrobial sepsis or endotoxemia challenge. Hif1 alpha(f/f)/Tie2Cre(+) lungs exhibited marked decrease of EC proliferation during recovery after sepsis challenge, which was associated with inhibited expression of forkhead box protein M1 (Foxm1), a reparative transcription factor. Therapeutic restoration of endothelial Foxm1 expression, via liposomal delivery of Foxm1 plasmid DNA to Hif1 alpha(f/f)/Tie2Cre(+) mice, resulted in reactivation of the vascular repair program and improved survival. Together, our studies, for the first time, delineate the essential rote of endothelial HIF-1 alpha in driving the vascular repair program. Thus, therapeutic activation of HIF-1 alpha dependent vascular repair may represent a novel and effective therapy to treat inflammatory vascular diseases, such as sepsis and acute respiratory distress syndrome.
C1 [Huang, Xiaojia; Zhang, Xianming; Evans, Colin E.; Zhao, You-Yang] Ann & Robert H Lurie Childrens Hosp Chicago, Program Lung & Vasc Biol, Stanley Manne Childrens Res Inst, 225 E Chicago Ave,Box 205, Chicago, IL 60611, United States.
   [Huang, Xiaojia; Zhang, Xianming; Evans, Colin E.; Zhao, You-Yang] Northwestern Univ, Feinberg Sch Med, Div Crit Care, Chicago, IL 60611, United States.
   [Zhao, You-Yang] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Dept Pharmacol, Chicago, IL 60611, United States.
   [Zhao, You-Yang] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611, United States.
   [Zhao, You-Yang] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611, United States.
   [Zhao, You-Yang] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611, United States.
   [Huang, Xiaojia; Zhang, Xianming; Zhao, David X.; Yin, Jun; Evans, Colin E.; Zhao, You-Yang] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL, United States.
   [Hu, Guochang] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL, United States.
   [Zhao, David X.] Univ Chicago, Dept Med, Chicago, IL 60637, United States.
C3 Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern
   University; Feinberg School of Medicine; Northwestern University;
   Feinberg School of Medicine; Northwestern University; Feinberg School of
   Medicine; Northwestern University; Feinberg School of Medicine;
   Northwestern University; Feinberg School of Medicine; University of
   Illinois System; University of Illinois Chicago; University of Illinois
   Chicago Hospital; University of Illinois System; University of Illinois
   Chicago; University of Illinois Chicago Hospital; University of Chicago
RP Zhao, YY (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Program Lung & Vasc Biol, Stanley Manne Childrens Res Inst, 225 E Chicago Ave,Box 205, Chicago, IL 60611 USA.; Zhao, YY (corresponding author), Northwestern Univ, Dept Pediat, Feinberg Sch Med, 225 E Chicago Ave,Box 205, Chicago, IL 60611 USA.
EM youyang.zhao@northwestern.edu
RI Zhang, XZ/HJA-4189-2022; zhang, xian/GYA-0290-2022
OI ZHAO, YOU-YANG/0000-0002-0041-0339; Zhao, David/0000-0002-6819-5794;
   Evans, Colin/0000-0002-9251-357X
FU NIH [R01HL123957, R01HL125350, R01HL133951, R01HL140409, P01HL077806]
FX Supported, in part, by NIH grants R01HL123957, R01HL125350, R01HL133951,
   R01HL140409, and P01HL077806 (Y.-Y.Z.).
CR Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887
   Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a
   Ariazi JL, 2017, J PHARMACOL EXP THER, V363, P336, DOI 10.1124/jpet.117.242503
   AUSTIN GE, 1985, J AM COLL CARDIOL, V6, P369, DOI 10.1016/S0735-1097(85)80174-1
   Bachmaier K, 2007, NAT MED, V13, P920, DOI 10.1038/nm1607
   Ball MK, 2014, AM J RESP CRIT CARE, V189, P314, DOI 10.1164/rccm.201302-0302OC
   Bartels K, 2013, P NATL ACAD SCI USA, V110, P18351, DOI 10.1073/pnas.1318345110
   Branco-Price C, 2012, CANCER CELL, V21, P52, DOI 10.1016/j.ccr.2011.11.017
   Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854
   Cines DB, 1998, BLOOD, V91, P3527
   Cowburn AS, 2016, P NATL ACAD SCI USA, V113, P8801, DOI 10.1073/pnas.1602978113
   Dai ZY, 2016, CIRCULATION, V133, P2447, DOI 10.1161/CIRCULATIONAHA.116.021494
   De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC
   De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602
   Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859
   Eckle T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001665
   Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750
   Fan E, 2018, JAMA-J AM MED ASSOC, V319, P698, DOI 10.1001/jama.2017.21907
   Fujita M, 1998, INT ARCH ALLERGY IMM, V117, P202, DOI 10.1159/000024011
   Gill SE, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0266-7
   Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011
   Gong HX, 2015, J CLIN INVEST, V125, P652, DOI 10.1172/JCI77701
   Han S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9260
   Huang XJ, 2016, CIRCULATION, V133, P1093, DOI 10.1161/CIRCULATIONAHA.115.020918
   Huang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050094
   Jiang XG, 2019, CIRCULATION, V139, P502, DOI 10.1161/CIRCULATIONAHA.118.036157
   Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009
   Kapitsinou PP, 2014, J CLIN INVEST, V124, P2396, DOI 10.1172/JCI69073
   Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106
   Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253
   Laffey JG, 2017, AM J RESP CRIT CARE, V196, P18, DOI 10.1164/rccm.201612-2415CI
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022
   Mao SZ, 2015, ARTERIOSCL THROM VAS, V35, P1635, DOI 10.1161/ATVBAHA.115.305519
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   McClendon J, 2017, AM J PATHOL, V187, P1772, DOI 10.1016/j.ajpath.2017.04.012
   McDonald AI, 2018, CELL STEM CELL, V23, P210, DOI 10.1016/j.stem.2018.07.011
   Minamino T, 2006, J CLIN INVEST, V116, P2316, DOI 10.1172/JCI29637
   Minamishima YA, 2010, SCIENCE, V329, P407, DOI 10.1126/science.1192811
   Mirza MK, 2010, J EXP MED, V207, P1675, DOI 10.1084/jem.20091857
   National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GLOBAL HLTH AGING, V8th, DOI [10.17226/12910, DOI 10.17226/12910]
   Ohle SJ, 2012, AM J RESP CELL MOL, V47, P11, DOI 10.1165/rcmb.2011-0180OC
   Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008
   Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516
   Provenzano R, 2016, CLIN J AM SOC NEPHRO, V11, P982, DOI 10.2215/CJN.06890615
   Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214
   Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905
   Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F
   SCHWARTZ RS, 1992, J AM COLL CARDIOL, V20, P1284, DOI 10.1016/0735-1097(92)90389-5
   Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720
   Stevens TC, 2014, AM J PHYSIOL-LUNG C, V306, pL915, DOI 10.1152/ajplung.00135.2013
   Trzeciak S, 2007, ANN EMERG MED, V49, P88, DOI 10.1016/j.annemergmed.2006.08.021
   Vohwinkel CU, 2015, J APPL PHYSIOL, V119, P1157, DOI 10.1152/japplphysiol.00226.2015
   WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510
   Wang HL, 2007, J IMMUNOL, V179, P1834, DOI 10.4049/jimmunol.179.3.1834
   WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2
   Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154
   Ziegler T, 2013, J CLIN INVEST, V123, P3436, DOI 10.1172/JCI66549
NR 60
TC 23
Z9 24
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD AUG
PY 2019
VL 189
IS 8
BP 1664
EP 1679
DI 10.1016/j.ajpath.2019.04.014
PG 16
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA IN5KE
UT WOS:000478713500017
PM 31121134
OA hybrid, Green Published
DA 2023-08-21
ER

PT J
AU Suzuki, K
   Okada, H
   Takemura, G
   Takada, C
   Kuroda, A
   Yano, H
   Zaikokuji, R
   Morishita, K
   Tomita, H
   Oda, K
   Matsuo, S
   Uchida, A
   Fukuta, T
   Sampei, S
   Miyazaki, N
   Kawaguchi, T
   Watanabe, T
   Yoshida, T
   Ushikoshi, H
   Yoshida, S
   Maekawa, Y
   Ogura, S
AF Suzuki, Kodai
   Okada, Hideshi
   Takemura, Genzou
   Takada, Chihiro
   Kuroda, Ayumi
   Yano, Hirohisa
   Zaikokuji, Ryogen
   Morishita, Kentaro
   Tomita, Hiroyuki
   Oda, Kazumasa
   Matsuo, Saori
   Uchida, Akihiro
   Fukuta, Tetsuya
   Sampei, So
   Miyazaki, Nagisa
   Kawaguchi, Tomonori
   Watanabe, Takatomo
   Yoshida, Takahiro
   Ushikoshi, Hiroaki
   Yoshida, Shozo
   Maekawa, Yoichi
   Ogura, Shinji
TI Neutrophil Elastase Damages the Pulmonary Endothelial Glycocalyx in
   Lipopolysaccharide-Induced Experimental Endotoxemia
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID COLONY-STIMULATING FACTOR; ACUTE LUNG INJURY; SEPTIC SHOCK; GRANULOCYTE;
   INHIBITION; SEPSIS; SIVELESTAT; RESPONSES
AB Neutrophil elastase (NE) is necessary for effective sterilization of phagocytosed bacterial and fungal pathogens; however, NE increases alveolocapillary permeability and induces proinflammatory cytokine production in sepsis-induced acute respiratory distress syndrome. Under septic conditions, the pulmonary endothelial glycocalyx covering on the healthy endothelium surface is injured, but the contribution of NE to this injury remains unknown. Our aim was to examine whether NE-induced pulmonary endothelial injury is associated with endotoxemia. Lipopolysaccharide (LPS; 20 mg/kg) was injected intraperitoneally into 9- to 12-week-old granulocyte colony-stimulating factor knockout (G-CSFKO) mice, which harbor few neutrophils, and littermate control mice; in a second assay, mice were injected with the NE-inhibitor sivelestat (0.2 mg/kg) at 3, 6, 9, and 12 hours after LPS administration. Subsequently, vascular endothelial injury was evaluated through ultrastructural analysis. At 48 hours after LPS injection, survival rate was more than threefold higher among G-CSFKO than control mice, and degradation of both thrombomodulin and syndecan-1 was markedly attenuated in G-CSFKO compared with control mice. Ultrastructural analysis revealed attenuated vascular endothelial injury and clear preservation of the endothelial glycocalyx in G-CSFKO mice. Moreover, after LPS exposure, survival rate was approximately ninefold higher among sivelestat-injected mice than control mice, and sivelestat treatment potently preserved vascular endothelial structures and the endothelial glycocalyx. In conclusion, NE is associated with pulmonary endothelial injury under LPS-induced endotoxemic conditions.
C1 [Suzuki, Kodai; Okada, Hideshi; Takada, Chihiro; Kuroda, Ayumi; Yano, Hirohisa; Zaikokuji, Ryogen; Morishita, Kentaro; Oda, Kazumasa; Matsuo, Saori; Uchida, Akihiro; Fukuta, Tetsuya; Sampei, So; Kawaguchi, Tomonori; Yoshida, Takahiro; Ushikoshi, Hiroaki; Yoshida, Shozo; Ogura, Shinji] Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Yanagido 1-1, Gifu 5011194, Japan.
   [Tomita, Hiroyuki] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan.
   [Maekawa, Yoichi] Gifu Univ, Grad Sch Med, Dept Parasitol & Infect Dis, Gifu, Japan.
   [Okada, Hideshi; Takemura, Genzou; Miyazaki, Nagisa] Asahi Univ, Sch Dent, Dept Internal Med, Mizuho Ku, Gifu, Japan.
   [Zaikokuji, Ryogen] Gifu Pharmaceut Univ, Dept Biofunct Anal, Lab Mol Biol, Gifu, Japan.
   [Watanabe, Takatomo] Gifu Univ Hosp, Dept Clin Lab, Gifu, Japan.
   [Maekawa, Yoichi] Gifu Univ, Ctr Highly Adv Integrat Nano & Life Sci G CHAIN, Domain Integrated Life Syst, Gifu, Japan.
C3 Gifu University; Gifu University; Gifu University; Asahi University;
   Gifu Pharmaceutical University; Gifu University; Gifu University
RP Okada, H (corresponding author), Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Yanagido 1-1, Gifu 5011194, Japan.
EM hideshi@gifu-u.ac.jp
RI Watanabe, Takatomo/ITV-2150-2023
OI Maekawa, Yoichi/0000-0002-3879-5713; Okada, Hideshi/0000-0002-7775-4308
FU Ministry of Education, Science and Culture of Japan [18K08914, 17K11569,
   16H05497, 16K20381, 15K10973]; Grants-in-Aid for Scientific Research
   [17K11569, 16K20381, 16H05497, 15K10973, 18K08914] Funding Source: KAKEN
FX Supported in part by the Ministry of Education, Science and Culture of
   Japan grants-in-aid for scientific research 18K08914 (K.S.), 17K11569
   (S.0.), 16H05497 (H.0.), 16K20381 (K.S.), and 15K10973 (T.Y.).
   Sivelestat, a neutrophil elastase competitive antagonist, was gifted
   from Ono Pharmaceutical Co., Ltd., Osaka, Japan.
CR Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8
   ADACHI T, 1993, BIOCHEM J, V289, P523, DOI 10.1042/bj2890523
   Ando Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35976-2
   [Anonymous], 2011, COMMITTEE UPDATE GUI, V8th
   Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615
   Chelazzi C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0741-z
   DONNELLY SC, 1995, AM J RESP CRIT CARE, V151, P1428, DOI 10.1164/ajrccm.151.5.7735596
   Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138
   Hagiwara S, 2008, INFLAMMATION, V31, P227, DOI 10.1007/s10753-008-9069-z
   Imaki K, 1996, BIOORGAN MED CHEM, V4, P2115, DOI 10.1016/S0968-0896(96)00216-7
   Inagawa R, 2018, CHEST, V154, P317, DOI 10.1016/j.chest.2018.03.003
   Iscimen R, 2008, CRIT CARE MED, V36, P1518, DOI 10.1097/CCM.0b013e31816fc2c0
   Iwamura H, 2004, J PHARMACOL EXP THER, V311, P1256, DOI 10.1124/jpet.104.072421
   Langlois RA, 2010, ALCOHOL CLIN EXP RES, V34, P1425, DOI 10.1111/j.1530-0277.2010.01226.x
   Lee JM, 2017, J ANESTH, V31, P397, DOI 10.1007/s00540-017-2311-9
   Li GF, 2016, INT J MOL MED, V38, P767, DOI 10.3892/ijmm.2016.2665
   LIESCHKE GJ, 1994, BLOOD, V84, P1737
   Manicone AM, 2009, EXPERT REV CLIN IMMU, V5, P63, DOI 10.1586/1744666X.5.1.63
   Miyazaki Y, 1998, AM J RESP CRIT CARE, V157, P89, DOI 10.1164/ajrccm.157.1.9612021
   Morishita K, 2015, AM J PATHOL, V185, P1899, DOI 10.1016/j.ajpath.2015.03.018
   Okada H, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1841-8
   Passi A, 1998, AM J PHYSIOL-LUNG C, V275, pL631, DOI 10.1152/ajplung.1998.275.3.L631
   Schmidt EP, 2014, J BIOL CHEM, V289, P8194, DOI 10.1074/jbc.M113.539452
   Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Spight D, 2008, SHOCK, V30, P434, DOI 10.1097/SHK.0b013e3181673543
   Stephens DP, 2002, INTERN MED J, V32, P143, DOI 10.1046/j.1445-5994.2002.00195.x
   Suzuki K, 2016, SHOCK, V46, P270, DOI 10.1097/SHK.0000000000000619
   Vender RL, 1996, J INVEST MED, V44, P531
   Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959
   WEISS SJ, 1989, NEW ENGL J MED, V320, P365
   WIENERKRONISH JP, 1991, J CLIN INVEST, V88, P864, DOI 10.1172/JCI115388
   WIGGS BR, 1994, J APPL PHYSIOL, V77, P463, DOI 10.1152/jappl.1994.77.1.463
   Zeiher BG, 2004, CRIT CARE MED, V32, P1695, DOI 10.1097/01.CCM.0000133332.48386.85
   Zemans RL, 2009, AM J RESP CELL MOL, V40, P519, DOI 10.1165/rcmb.2008-0348TR
NR 35
TC 36
Z9 42
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD AUG
PY 2019
VL 189
IS 8
BP 1526
EP 1535
DI 10.1016/j.ajpath.2019.05.002
PG 10
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA IN5KE
UT WOS:000478713500006
PM 31108101
OA hybrid
DA 2023-08-21
ER

PT J
AU Fang, Y
   Wu, D
   Birukov, KG
AF Fang, Yun
   Wu, David
   Birukov, Konstantin G.
TI Mechanosensing and Mechanoregulation of Endothelial Cell Functions
SO COMPREHENSIVE PHYSIOLOGY
LA English
DT Article
ID SMOOTH-MUSCLE-CELLS; HEPATOCYTE GROWTH-FACTOR; FOCAL ADHESION KINASE;
   KRUPPEL-LIKE FACTOR-2; NF-KAPPA-B; HEMODYNAMIC SHEAR-STRESS; MONOCYTE
   CHEMOATTRACTANT PROTEIN-1; STRETCH-INDUCED APOPTOSIS; RHO-FAMILY
   GTPASES; HEPARAN-SULFATE PROTEOGLYCANS
AB Vascular endothelial cells (ECs) form a semiselective barrier for macromolecules and cell elements regulated by dynamic interactions between cytoskeletal elements and cell adhesion complexes. ECs also participate in many other vital processes including innate immune reactions, vascular repair, secretion, and metabolism of bioactive molecules. Moreover, vascular ECs represent a unique cell type exposed to continuous, time-dependent mechanical forces: different patterns of shear stress imposed by blood flow in macrovasculature and by rolling blood cells in the microvasculature; circumferential cyclic stretch experienced by the arterial vascular bed caused by heart propulsions; mechanical stretch of lung microvascular endothelium at different magnitudes due to spontaneous respiration or mechanical ventilation in critically ill patients. Accumulating evidence suggests that vascular ECs contain mechanosensory complexes, which rapidly react to changes in mechanical loading, process the signal, and develop context-specific adaptive responses to rebalance the cell homeostatic state. The significance of the interactions between specific mechanical forces in the EC microenvironment together with circulating bioactive molecules in the progression and resolution of vascular pathologies including vascular injury, atherosclerosis, pulmonary edema, and acute respiratory distress syndrome has been only recently recognized. This review will summarize the current understanding of EC mechanosensory mechanisms, modulation of EC responses to humoral factors by surrounding mechanical forces (particularly the cyclic stretch), and discuss recent findings of magnitude-specific regulation of EC functions by transcriptional, posttranscriptional and epigenetic mechanisms using -omics approaches. We also discuss ongoing challenges and future opportunities in developing new therapies targeting dysregulated mechanosensing mechanisms to treat vascular diseases. (C) 2019 American Physiological Society.
C1 [Fang, Yun; Wu, David] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637, United States.
   [Birukov, Konstantin G.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201, United States.
C3 University of Chicago; University System of Maryland; University of
   Maryland Baltimore
RP Fang, Y (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.
EM yfang1@medicine.bsd.uchicago.edu
RI Birukov, Konstantin/FJB-5755-2022
OI Wu, David/0000-0003-3162-3238
FU National Institutes of Health [HL138223, HL136765, T32 HL007605, T32
   F32HL134288, HL076259, HL087823]
FX This work was supported by National Institutes of Health Grants HL138223
   (Y. Fang), HL136765 (Y. Fang), T32 HL007605 (D. Wu), T32 F32HL134288 (D.
   Wu), HL076259 (K. G. Birukov), and HL087823 (K. G. Birukov).
CR Abdulnour REE, 2006, AM J PHYSIOL-LUNG C, V291, pL345, DOI 10.1152/ajplung.00453.2005
   Adyshev DM, 2014, AM J RESP CELL MOL, V50, P409, DOI 10.1165/rcmb.2013-0292OC
   Adyshev DM, 2013, AM J RESP CELL MOL, V49, P58, DOI 10.1165/rcmb.2012-0397OC
   Ahn SJ, 2017, J PHYSIOL-LONDON, V595, P2339, DOI 10.1113/JP273255
   Alenghat FJ, 2004, EXP CELL RES, V301, P23, DOI 10.1016/j.yexcr.2004.08.003
   Ali MH, 2004, AM J PHYSIOL-LUNG C, V287, pL486, DOI 10.1152/ajplung.00389.2003
   Ali MH, 2006, AM J PHYSIOL-LUNG C, V291, pL38, DOI 10.1152/ajplung.00287.2004
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335
   Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88
   Amma H, 2005, BRIT J PHARMACOL, V145, P364, DOI 10.1038/sj.bjp.0706182
   Ando J, 2011, ANTIOXID REDOX SIGN, V15, P1389, DOI 10.1089/ars.2010.3361
   ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9
   [Anonymous], PROTEOMICS
   Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a
   AWOLESI MA, 1995, J CLIN INVEST, V96, P1449, DOI 10.1172/JCI118181
   Babior BM, 2000, IUBMB LIFE, V50, P267, DOI 10.1080/15216540051080976
   Babu SS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003173
   Baeyens N, 2014, P NATL ACAD SCI USA, V111, P17308, DOI 10.1073/pnas.1413725111
   Bai K, 2014, BIOMECH MODEL MECHAN, V13, P303, DOI 10.1007/s10237-013-0502-3
   Baker AB, 2008, CIRC RES, V103, P289, DOI 10.1161/CIRCRESAHA.108.179465
   Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   BARBEE KA, 1994, CIRC RES, V74, P163, DOI 10.1161/01.RES.74.1.163
   Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4
   Becker PM, 2001, AM J PHYSIOL-LUNG C, V281, pL1500, DOI 10.1152/ajplung.2001.281.6.L1500
   Beckerle MC, 1997, BIOESSAYS, V19, P949, DOI 10.1002/bies.950191104
   Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537
   Belperio JA, 2006, SEMIN RESP CRIT CARE, V27, P350, DOI 10.1055/s-2006-948289
   Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011
   Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06
   Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002
   Birukov KG, 2002, AM J RESP CELL MOL, V26, P453, DOI 10.1165/ajrcmb.26.4.4725
   Birukov KG, 2009, ANTIOXID REDOX SIGN, V11, P1651, DOI [10.1089/ars.2008.2390, 10.1089/ARS.2008.2390]
   Birukov KG, 2009, MICROVASC RES, V77, P46, DOI 10.1016/j.mvr.2008.09.006
   Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007
   Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431
   Birukova AA, 2005, J CELL PHYSIOL, V204, P934, DOI 10.1002/jcp.20359
   Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055
   Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008
   Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354
   Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com
   Birukova AA, 2007, AM J PHYSIOL-LUNG C, V292, pL924, DOI 10.1152/ajplung.00395.2006
   Birukova AA, 2007, J CELL PHYSIOL, V211, P608, DOI 10.1002/jcp.20966
   Birukova AA, 2016, AM J RESP CELL MOL, V55, P476, DOI 10.1165/rcmb.2015-0328OC
   Birukova AA, 2013, MICROVASC RES, V87, P50, DOI 10.1016/j.mvr.2012.12.006
   Birukova AA, 2010, TRANSL RES, V155, P44, DOI 10.1016/j.trsl.2009.09.002
   Birukova AA, 2008, EXP CELL RES, V314, P3466, DOI 10.1016/j.yexcr.2008.09.003
   Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241
   Blitzer AL, 2011, P NATL ACAD SCI USA, V108, P2819, DOI 10.1073/pnas.1016702108
   Bochkov VN, 2006, CURR RESPIR MED REV, V2, P27, DOI 10.2174/157339806775486182
   Boitano S, 1998, CELL CALCIUM, V23, P1, DOI 10.1016/S0143-4160(98)90069-0
   Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799
   Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0
   Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002
   Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004
   Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590
   Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629
   BYSTREVSKAYA VB, 1992, J STRUCT BIOL, V109, P1, DOI 10.1016/1047-8477(92)90061-E
   Cabrales P, 2007, J APPL PHYSIOL, V102, P2251, DOI 10.1152/japplphysiol.01155.2006
   Carey DJ, 1997, BIOCHEM J, V327, P1
   Caro CG, 2009, ARTERIOSCL THROM VAS, V29, P158, DOI 10.1161/ATVBAHA.108.166736
   Cevallos M, 2006, DIFFERENTIATION, V74, P552, DOI 10.1111/j.1432-0436.2006.00089.x
   Chapman AB, 2010, ADV CHRONIC KIDNEY D, V17, P153, DOI 10.1053/j.ackd.2010.01.001
   Chaturvedi LS, 2007, J BIOL CHEM, V282, P14, DOI 10.1074/jbc.M605817200
   Chen H, 2000, TRENDS BIOCHEM SCI, V25, P19, DOI 10.1016/S0968-0004(99)01511-X
   Chen JX, 2001, AM J PHYSIOL-CELL PH, V280, pC1475, DOI 10.1152/ajpcell.2001.280.6.C1475
   Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393
   Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607
   Cheng JJ, 1998, HYPERTENSION, V31, P125, DOI 10.1161/01.HYP.31.1.125
   Cheng WP, 2008, CARDIOVASC RES, V77, P551, DOI 10.1093/cvr/cvm057
   Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006
   Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76
   Chung EJ, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400336
   Civelek M, 2014, NAT REV GENET, V15, P34, DOI 10.1038/nrg3575
   Clements RT, 2005, AM J PHYSIOL-LUNG C, V288, pL294, DOI 10.1152/ajplung.00213.2004
   Collins NT, 2006, ARTERIOSCL THROM VAS, V26, P62, DOI 10.1161/01.ATV.0000194097.92824.b3
   Conway DE, 2017, CURR BIOL, V27, P2727, DOI 10.1016/j.cub.2017.08.064
   Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987
   Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989
   Dahlman JE, 2014, NAT NANOTECHNOL, V9, P648, DOI [10.1038/NNANO.2014.84, 10.1038/nnano.2014.84]
   Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003
   Davies PF, 2013, CARDIOVASC RES, V99, P315, DOI 10.1093/cvr/cvt101
   Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397
   DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519
   Davies PF, 1995, J BIOMECH, V28, P1553, DOI 10.1016/0021-9290(95)00102-6
   De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094
   Deguchi S., 2005, Molecular & Cellular Biomechanics, V2, P205
   Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7
   Delmas P, 2004, BIOCHEM BIOPH RES CO, V322, P1374, DOI 10.1016/j.bbrc.2004.08.044
   Demicheva E, 2008, CIRC RES, V103, P477, DOI 10.1161/CIRCRESAHA.108.177782
   Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297
   DePaola N, 2001, ANN BIOMED ENG, V29, P648, DOI 10.1114/1.1385811
   Ding JJ, 2016, NATURE, V540, DOI 10.1038/nature20106
   Dinsmore C, 2016, EMBO REP, V17, P156, DOI 10.15252/embr.201541019
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dixon DL, 2008, EXP LUNG RES, V34, P37, DOI 10.1080/01902140701807928
   Du W, 1995, J BIOMECH, V28, P1485, DOI 10.1016/0021-9290(95)00096-8
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Dunn J, 2014, J CLIN INVEST, V124, P3187, DOI 10.1172/JCI74792
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Ebong EE, 2014, INTEGR BIOL-UK, V6, P338, DOI 10.1039/c3ib40199e
   Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268
   Ecder T, 2009, NAT REV NEPHROL, V5, P221, DOI 10.1038/nrneph.2009.13
   Emwas Abdul-Hamid M, 2015, Methods Mol Biol, V1277, P161, DOI 10.1007/978-1-4939-2377-9_13
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fancher IS, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007430
   Fang Y, 2006, CIRC RES, V98, P1064, DOI 10.1161/01.RES.0000218776.87842.43
   Fang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1134, DOI 10.1152/ajpcell.00077.2005
   Fang Y, 2012, ARTERIOSCL THROM VAS, V32, P979, DOI 10.1161/ATVBAHA.111.244053
   Fang Y, 2010, P NATL ACAD SCI USA, V107, P13450, DOI 10.1073/pnas.1002120107
   Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]
   Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919
   Feng S, 2017, ARTERIOSCL THROM VAS, V37, P2087, DOI 10.1161/ATVBAHA.117.309249
   Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529
   Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5
   Fu BMM, 2013, WIRES SYST BIOL MED, V5, P381, DOI 10.1002/wsbm.1211
   Fujiwara K, 2006, J INTERN MED, V259, P373, DOI 10.1111/j.1365-2796.2006.01623.x
   Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450
   Gawad C, 2016, NAT REV GENET, V17, P175, DOI 10.1038/nrg.2015.16
   Gawlak G, 2014, FASEB J, V28, P3249, DOI 10.1096/fj.13-245142
   Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   Gerhold KA, 2016, PHYSIOLOGY, V31, P359, DOI 10.1152/physiol.00007.2016
   Giantsos-Adams KM, 2013, CELL MOL BIOENG, V6, P160, DOI 10.1007/s12195-013-0273-z
   Gieni RS, 2008, J CELL BIOCHEM, V104, P1964, DOI 10.1002/jcb.21364
   Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011
   Gillette TG, 2015, CIRC RES, V116, P1245, DOI 10.1161/CIRCRESAHA.116.303630
   Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301
   Giordano RJ, 2008, J BIOL CHEM, V283, P29447, DOI 10.1074/jbc.M804595200
   Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506
   Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306
   Goettsch C, 2009, ANTIOXID REDOX SIGN, V11, P2385, DOI [10.1089/ars.2009.2561, 10.1089/ARS.2009.2561]
   Goetz JG, 2014, CELL REP, V6, P799, DOI 10.1016/j.celrep.2014.01.032
   Graham DM, 2016, CURR OPIN CELL BIOL, V40, P98, DOI 10.1016/j.ceb.2016.03.006
   GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937
   Grote K, 2003, CIRC RES, V92, pE80, DOI 10.1161/01.RES.0000077044.60138.7C
   Guilak F, 2000, BIOCHEM BIOPH RES CO, V269, P781, DOI 10.1006/bbrc.2000.2360
   Gurkan OU, 2003, AM J PHYSIOL-LUNG C, V285, pL710, DOI 10.1152/ajplung.00044.2003
   Haasper C, 2008, EXP TOXICOL PATHOL, V59, P355, DOI [10.1016/j.etp.2007.11.013, 10.1016/j.etp.2007.11.008]
   Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011
   Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Hammerschmidt S, 2003, BBA-MOL BASIS DIS, V1639, P17, DOI 10.1016/S0925-4439(03)00126-1
   Han B, 2004, J BIOL CHEM, V279, P54793, DOI 10.1074/jbc.M406880200
   Han Bing, 2005, Proc Am Thorac Soc, V2, P181, DOI 10.1513/pats.200501-008AC
   Han ZS, 2009, J PHARMACOL EXP THER, V329, P94, DOI 10.1124/jpet.108.145557
   Haseneen NA, 2003, AM J PHYSIOL-LUNG C, V284, pL541, DOI 10.1152/ajplung.00290.2002
   Hatch EM, 2016, J CELL BIOL, V215, P27, DOI 10.1083/jcb.201603053
   Henderson-Toth CE, 2012, DEV BIOL, V369, P330, DOI 10.1016/j.ydbio.2012.07.009
   Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320
   Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192
   Hirayama Y, 2007, ENDOTHELIUM-J ENDOTH, V14, P275, DOI 10.1080/10623320701746248
   Hishikawa K, 1997, CIRCULATION, V96, P3610
   Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x
   Hoger JH, 2002, P NATL ACAD SCI USA, V99, P7780, DOI 10.1073/pnas.102184999
   Hosokawa H, 2002, BIOL PHARM BULL, V25, P1588, DOI 10.1248/bpb.25.1588
   Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268
   Hu YH, 1998, FASEB J, V12, P1135, DOI 10.1096/fasebj.12.12.1135
   Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896
   Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311
   Hunter O, 2007, FASEB J, V21, pA751
   Ichimura H, 2003, J CLIN INVEST, V111, P691, DOI 10.1172/JCI200317271
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333
   Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359
   Ingber DE, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/4/046603
   Inoue N, 1998, AM J PHYSIOL-HEART C, V274, pH1928, DOI 10.1152/ajpheart.1998.274.6.H1928
   Iomini C, 2004, J CELL BIOL, V164, P811, DOI 10.1083/jcb.200312133
   Ito S, 2010, AM J RESP CELL MOL, V43, P26, DOI 10.1165/rcmb.2009-0073OC
   Iwaki M, 2009, BIOCHEM BIOPH RES CO, V389, P531, DOI 10.1016/j.bbrc.2009.09.020
   Iwasaki H, 2000, AM J PHYSIOL-HEART C, V278, pH521, DOI 10.1152/ajpheart.2000.278.2.H521
   Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597
   Jacobson JR, 2004, AM J RESP CELL MOL, V30, P662, DOI 10.1165/rcmb.2003-0267OC
   Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089
   Jafari B, 2004, RESPIROLOGY, V9, P43, DOI 10.1111/j.1440-1843.2003.00527.x
   Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721
   Jalali S, 2001, P NATL ACAD SCI USA, V98, P1042, DOI 10.1073/pnas.031562998
   Jia ZF, 2016, J BIOL CHEM, V291, P9087, DOI 10.1074/jbc.M115.692384
   Jiang YZ, 2014, CIRC RES, V115, P32, DOI 10.1161/CIRCRESAHA.115.303883
   Jo H, 1997, J BIOL CHEM, V272, P1395, DOI 10.1074/jbc.272.2.1395
   Jones CI, 2008, AM J PHYSIOL-CELL PH, V295, pC180, DOI 10.1152/ajpcell.00549.2007
   Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230
   Kallakuri S, 2015, J AM SOC NEPHROL, V26, P864, DOI 10.1681/ASN.2013121314
   Kaner RJ, 2001, MOL MED, V7, P240, DOI 10.1007/BF03401843
   Kaner RJ, 2000, AM J RESP CELL MOL, V22, P657, DOI 10.1165/ajrcmb.22.6.3779
   Karmpaliotis D, 2002, AM J PHYSIOL-LUNG C, V283, pL585, DOI 10.1152/ajplung.00048.2002
   Katanosaka Y, 2008, J BIOTECHNOL, V133, P82, DOI 10.1016/j.jbiotec.2007.09.017
   Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200
   Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105
   Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102
   KHACHIGIAN LM, 1995, J CLIN INVEST, V96, P1169, DOI 10.1172/JCI118106
   Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106
   Kheirolomoom A, 2015, ACS NANO, V9, P8885, DOI 10.1021/acsnano.5b02611
   Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831
   Ko K, 2000, AM J PHYSIOL-CELL PH, V279, pC147, DOI 10.1152/ajpcell.2000.279.1.C147
   Ko KS, 2001, J BIOL CHEM, V276, P35967, DOI 10.1074/jbc.M104106200
   Kobayashi S, 2003, BIOCHEM BIOPH RES CO, V308, P306, DOI 10.1016/S0006-291X(03)01362-7
   Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a
   Komuro I, 1996, FASEB J, V10, P631, DOI 10.1096/fasebj.10.5.8621062
   Koo A, 2013, BIOPHYS J, V104, P2295, DOI 10.1016/j.bpj.2013.03.052
   Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012
   Kook SH, 2011, J APPL PHYSIOL, V111, P1575, DOI 10.1152/japplphysiol.00348.2011
   Kou BJ, 2009, MICROVASC RES, V77, P125, DOI 10.1016/j.mvr.2008.08.001
   Krause MD, 2018, P NATL ACAD SCI USA, V115, pE11349, DOI 10.1073/pnas.1810568115
   Kuebler WM, 2003, AM J RESP CRIT CARE, V168, P1391, DOI 10.1164/rccm.200304-562OC
   Kuhn H, 2010, RESPIROLOGY, V15, P343, DOI 10.1111/j.1440-1843.2009.01701.x
   Kumagai R, 2009, FREE RADICAL BIO MED, V47, P600, DOI 10.1016/j.freeradbiomed.2009.05.034
   Kumar A, 2003, J BIOL CHEM, V278, P18868, DOI 10.1074/jbc.M212777200
   Kuo CH, 2014, J MATER CHEM B, V2, P8142, DOI 10.1039/c4tb00977k
   Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148
   LAMPUGNANI MG, 1990, LAB INVEST, V63, P521
   LAN QX, 1994, BIOCHEM BIOPH RES CO, V201, P950, DOI 10.1006/bbrc.1994.1794
   Lee DY, 2012, P NATL ACAD SCI USA, V109, P1967, DOI 10.1073/pnas.1121214109
   Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006
   LEE ME, 1991, J BIOL CHEM, V266, P19034
   Lehoux S, 2006, J INTERN MED, V259, P381, DOI 10.1111/j.1365-2796.2006.01624.x
   Lehoux S, 1998, HYPERTENSION, V32, P338, DOI 10.1161/01.HYP.32.2.338
   Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010
   Lemarie CA, 2006, CIRC RES, V99, P434, DOI 10.1161/01.RES.0000237388.89261.47
   Lewis AH, 2015, ELIFE, V4, DOI 10.7554/eLife.12088
   Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701
   Li LF, 2005, CRIT CARE MED, V33, P1913, DOI 10.1097/01.CCM.0000178179.48050.BC
   Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455
   Lim CS, 2011, J VASC SURG, V53, P764, DOI 10.1016/j.jvs.2010.09.018
   Lin ZY, 2010, ARTERIOSCL THROM VAS, V30, P1952, DOI 10.1161/ATVBAHA.110.211474
   Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1
   Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com
   Liu MY, 1996, J BIOL CHEM, V271, P7066, DOI 10.1074/jbc.271.12.7066
   Liu MY, 1999, AM J PHYSIOL-LUNG C, V277, pL667, DOI 10.1152/ajplung.1999.277.4.L667
   Liu WF, 2007, CIRC RES, V101, pE44, DOI 10.1161/CIRCRESAHA.107.158329
   Lo HM, 2014, ACTA PHARMACOL SIN, V35, P339, DOI 10.1038/aps.2013.182
   Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700
   Lovett DB, 2013, CELL MOL BIOENG, V6, P230, DOI 10.1007/s12195-013-0270-2
   Loyer X, 2014, CIRC RES, V114, P434, DOI 10.1161/CIRCRESAHA.114.302213
   Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203
   Macalma T, 1996, J BIOL CHEM, V271, P31470, DOI 10.1074/jbc.271.49.31470
   Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913
   Mack JJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01741-8
   Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895
   MAJNO G, 1969, J CELL BIOL, V42, P647, DOI 10.1083/jcb.42.3.647
   Mambetsariev I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092670
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Marconcini L, 1999, P NATL ACAD SCI USA, V96, P9671, DOI 10.1073/pnas.96.17.9671
   Martin T, 1997, EUR J IMMUNOL, V27, P1091, DOI 10.1002/eji.1830270508
   Mata-Greenwood E, 2005, AM J PHYSIOL-LUNG C, V289, pL288, DOI 10.1152/ajplung.00417.2004
   Matsushita H, 2001, J CELL BIOCHEM, P99
   Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463
   McClatchey PM, 2016, AM J PHYSIOL-HEART C, V311, pH168, DOI 10.1152/ajpheart.00132.2016
   McNally JS, 2003, AM J PHYSIOL-HEART C, V285, pH2290, DOI 10.1152/ajpheart.00515.2003
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200
   Methe H, 2007, AM J PHYSIOL-HEART C, V292, pH2167, DOI 10.1152/ajpheart.00403.2006
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Metzler SA, 2008, J HEART VALVE DIS, V17, P571
   Milkiewicz M, 2007, J CELL BIOCHEM, V100, P750, DOI 10.1002/jcb.21055
   MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776
   Mochizuki S, 2003, AM J PHYSIOL-HEART C, V285, pH722, DOI 10.1152/ajpheart.00691.2002
   Mohler ER, 2007, BIOCHEM BIOPH RES CO, V358, P317, DOI 10.1016/j.bbrc.2007.04.138
   Mokres LM, 2010, AM J PHYSIOL-LUNG C, V298, pL23, DOI 10.1152/ajplung.00251.2009
   Moldobaeva A, 2008, AM J PHYSIOL-LUNG C, V295, pL941, DOI 10.1152/ajplung.90447.2008
   Moon JJ, 2005, J CELL PHYSIOL, V203, P166, DOI 10.1002/jcp.20220
   Moore KA, 2005, DEV DYNAM, V232, P268, DOI 10.1002/dvdy.20237
   Morrow D, 2007, ARTERIOSCL THROM VAS, V27, P1289, DOI 10.1161/ATVBAHA.107.142778
   Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453
   Mullins RD, 2000, CURR OPIN CELL BIOL, V12, P91, DOI 10.1016/S0955-0674(99)00061-7
   Mura M, 2004, J APPL PHYSIOL, V97, P1605, DOI 10.1152/japplphysiol.00202.2004
   Nahrendorf M, 2006, CIRCULATION, V114, P1504, DOI 10.1161/CIRCULATIONAHA.106.646380
   Naruse K, 1998, AM J PHYSIOL-HEART C, V274, pH1532
   Naruse K, 1998, ONCOGENE, V17, P455, DOI 10.1038/sj.onc.1201950
   Naruse K, 1998, FEBS LETT, V441, P111, DOI 10.1016/S0014-5793(98)01528-2
   Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076
   Nava MM, 2016, BIOMECH MODEL MECHAN, V15, P983, DOI 10.1007/s10237-015-0737-2
   Nayebosadri A, 2013, AM J PHYSIOL-CELL PH, V305, pC309, DOI 10.1152/ajpcell.00293.2012
   Ngu H, 2010, ANN BIOMED ENG, V38, P208, DOI 10.1007/s10439-009-9826-7
   Nguyen KT, 2001, HYPERTENSION, V38, P1038, DOI 10.1161/hy1101.092840
   Ni CW, 2011, AM J PHYSIOL-HEART C, V300, pH1762, DOI 10.1152/ajpheart.00829.2010
   Nishimura K, 2006, AM J PHYSIOL-CELL PH, V290, pC812, DOI 10.1152/ajpcell.00347.2005
   Nonas S, 2006, AM J RESP CRIT CARE, V173, P1130, DOI 10.1164/rccm.200511-1737OC
   Nonas S, 2008, CRIT CARE, V12, DOI 10.1186/cc6805
   Numaguchi Yasushi, 2003, Angiogenesis, V6, P55, DOI 10.1023/A:1025821517679
   Ohya Y, 1998, HYPERTENSION, V31, P254, DOI 10.1161/01.HYP.31.1.254
   Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892
   Okada M, 1998, ARTERIOSCL THROM VAS, V18, P894, DOI 10.1161/01.ATV.18.6.894
   OLESEN SP, 1988, NATURE, V331, P168, DOI 10.1038/331168a0
   OOHIRA A, 1983, J BIOL CHEM, V258, P2014
   Oudin S, 2002, AM J RESP CELL MOL, V27, P107, DOI 10.1165/ajrcmb.27.1.4766
   Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104
   Pan J, 2005, J CELL PHYSIOL, V202, P536, DOI 10.1002/jcp.20151
   Papaiahgari S, 2007, AM J RESP CELL MOL, V36, P304, DOI 10.1165/rcmb.2006-0131OC
   Park H, 1998, J BIOL CHEM, V273, P32304, DOI 10.1074/jbc.273.48.32304
   Park JM, 1999, AM J PHYSIOL-CELL PH, V277, pC294, DOI 10.1152/ajpcell.1999.277.2.C294
   Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787
   Parmar KM, 2005, J BIOL CHEM, V280, P26714, DOI 10.1074/jbc.C500144200
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Pendurthi UR, 1997, ARTERIOSCL THROM VAS, V17, P3406, DOI 10.1161/01.ATV.17.12.3406
   Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC
   Petrache I, 2003, FASEB J, V17, P407, DOI 10.1096/fj.02-0672com
   Petrache I, 2003, BIOCHEM BIOPH RES CO, V306, P244, DOI 10.1016/S0006-291X(03)00945-8
   Peverali FA, 2001, MOL MED, V7, P68, DOI 10.1007/BF03401840
   Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615
   Ponts N, 2010, GENOME RES, V20, P228, DOI 10.1101/gr.101063.109
   Poon C, 2017, ACS BIOMATER SCI ENG, V3, P3273, DOI 10.1021/acsbiomaterials.7b00600
   Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307
   Pugin J, 1998, AM J PHYSIOL-LUNG C, V275, pL1040, DOI 10.1152/ajplung.1998.275.6.L1040
   Putnam AJ, 2003, AM J PHYSIOL-CELL PH, V284, pC627, DOI 10.1152/ajpcell.00137.2002
   Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002
   Qin XM, 2010, P NATL ACAD SCI USA, V107, P3240, DOI 10.1073/pnas.0914882107
   Quesnel C, 2008, AM J PHYSIOL-LUNG C, V294, pL334, DOI 10.1152/ajplung.00096.2007
   Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10
   Quinn TP, 2002, AM J PHYSIOL-LUNG C, V282, pL897, DOI 10.1152/ajplung.00044.2001
   Raaz U, 2009, MICROVASC RES, V77, P297, DOI 10.1016/j.mvr.2009.01.012
   Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54
   Rapraeger AC, 2000, J CELL BIOL, V149, P995, DOI 10.1083/jcb.149.5.995
   Reddy SP, 2007, ANTIOXID REDOX SIGN, V9, P2003, DOI 10.1089/ars.2007.1770
   Ricard JD, 2003, EUR RESPIR J, V22, p2S, DOI 10.1183/09031936.03.00420103
   Riehl BD, 2012, TISSUE ENG PART B-RE, V18, P288, DOI [10.1089/ten.teb.2011.0465, 10.1089/ten.TEB.2011.0465]
   Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175
   Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011
   ROBERTS WG, 1995, J CELL SCI, V108, P2369
   Rodriguez-Pascual F, 2003, CIRC RES, V92, P1288, DOI 10.1161/01.RES.0000078491.79697.7F
   Romanoski CE, 2015, NATURE, V518, P314, DOI 10.1038/518314a
   Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377
   Ross TD, 2013, CURR OPIN CELL BIOL, V25, P613, DOI 10.1016/j.ceb.2013.05.006
   SACKIN H, 1995, KIDNEY INT, V48, P1134, DOI 10.1038/ki.1995.397
   Sai XR, 1999, J CELL SCI, V112, P1365
   Salameh A, 2010, CIRC RES, V106, P1592, DOI 10.1161/CIRCRESAHA.109.214429
   Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6
   Sasamoto A, 2005, AM J PHYSIOL-CELL PH, V288, pC1012, DOI 10.1152/ajpcell.00314.2004
   Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068
   Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044
   Scheitlin CG, 2016, AM J PHYSIOL-CELL PH, V310, pC479, DOI 10.1152/ajpcell.00171.2015
   Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189
   Seebach J, 2000, LAB INVEST, V80, P1819, DOI 10.1038/labinvest.3780193
   Segurola RJ, 1997, J SURG RES, V69, P135, DOI 10.1006/jsre.1997.5050
   Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837
   Semenza GL, 2017, EMBO J, V36, P252, DOI 10.15252/embj.201695204
   Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774
   SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132
   Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131
   Shen B, 2009, J BIOL CHEM, V284, P35471, DOI 10.1074/jbc.M109.046813
   Shi F, 2007, CARDIOVASC RES, V73, P813, DOI 10.1016/j.cardiores.2006.12.014
   Shikata Y, 2005, EXP CELL RES, V304, P40, DOI 10.1016/j.yexcr.2004.11.001
   Shimizu N, 2008, J APPL PHYSIOL, V104, P766, DOI 10.1152/japplphysiol.00870.2007
   SHIRINSKY VP, 1989, J CELL BIOL, V109, P331, DOI 10.1083/jcb.109.1.331
   Shukla A, 2004, Mech Chem Biosyst, V1, P279
   Shuvaev VV, 2011, FASEB J, V25, P348, DOI 10.1096/fj.10-169789
   Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18
   Sidhu SS, 2007, CURR OPIN STRUC BIOL, V17, P481, DOI 10.1016/j.sbi.2007.08.007
   Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200
   Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200
   Slutsky AS, 2014, NEW ENGL J MED, V370, P980, DOI [10.1056/NEJMra1208707, 10.1056/NEJMc1400293]
   Smith JD, 2001, ENDOTHELIUM-J ENDOTH, V8, P41, DOI 10.3109/10623320109063156
   Smith MA, 2010, DEV CELL, V19, P365, DOI 10.1016/j.devcel.2010.08.008
   Smith PG, 2003, AM J RESP CELL MOL, V28, P436, DOI 10.1165/rcmb.4754
   SMITH PG, 1995, AM J PHYSIOL-LUNG C, V268, pL999, DOI 10.1152/ajplung.1995.268.6.L999
   Sokabe M, 1997, HEART VESSELS, P191
   SOKABE M, 1993, JPN J PHYSIOL, V43, pS197
   Son DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4000
   Song KH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23412
   Song Lingyun, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5384
   Sooranna SR, 2004, MOL HUM REPROD, V10, P109, DOI 10.1093/molehr/gah021
   Sotoudeh M, 2002, AM J PHYSIOL-HEART C, V282, pH1709, DOI 10.1152/ajpheart.00744.2001
   Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207
   Starr DA, 2009, J CELL SCI, V122, P577, DOI 10.1242/jcs.037622
   Stern JB, 2000, CRIT CARE MED, V28, P2326, DOI 10.1097/00003246-200007000-00024
   Stevens TJ, 2017, NATURE, V544, P59, DOI 10.1038/nature21429
   Sun HR, 2006, MICROCIRCULATION, V13, P237, DOI 10.1080/10739680600556944
   Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46
   Suzuki N, 1997, BIOCHEM BIOPH RES CO, V239, P372, DOI 10.1006/bbrc.1997.7364
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takeda H, 2006, LIFE SCI, V79, P233, DOI 10.1016/j.lfs.2005.12.051
   Tamura K, 2000, J BIOL CHEM, V275, P34619, DOI 10.1074/jbc.M004421200
   Tanabe Y, 2000, MOL CELL BIOCHEM, V215, P103, DOI 10.1023/A:1026506801659
   Tarbell JM, 2014, ANNU REV BIOMED ENG, V16, P505, DOI 10.1146/annurev-bioeng-071813-104908
   Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890
   Thi MM, 2004, P NATL ACAD SCI USA, V101, P16483, DOI 10.1073/pnas.0407474101
   Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930
   Thomas RA, 2006, RESP MED, V100, P1588, DOI 10.1016/j.rmed.2005.12.008
   Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8
   Tkachenko E, 2013, BIOL OPEN, V2, P1007, DOI 10.1242/bio.20134622
   Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259
   Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688
   Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952
   Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556
   Van der Heiden K, 2008, ATHEROSCLEROSIS, V196, P542, DOI 10.1016/j.atherosclerosis.2007.05.030
   van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864
   Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538
   Verghese GM, 1998, AM J RESP CRIT CARE, V158, P386, DOI 10.1164/ajrccm.158.2.9711111
   Versaevel M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07362
   Villar J, 2003, CRIT CARE MED, V31, pS272, DOI 10.1097/01.CCM.0000057903.11528.6D
   Villarreal G, 2010, BIOCHEM BIOPH RES CO, V391, P984, DOI 10.1016/j.bbrc.2009.12.002
   Vink H, 1996, CIRC RES, V79, P581, DOI 10.1161/01.RES.79.3.581
   Vouret-Craviari V, 1998, MOL BIOL CELL, V9, P2639, DOI 10.1091/mbc.9.9.2639
   Voyvodic PL, 2014, J BIOL CHEM, V289, P9547, DOI 10.1074/jbc.M113.541573
   Wagner AH, 2009, ARTERIOSCL THROM VAS, V29, P1894, DOI 10.1161/ATVBAHA.109.194738
   Wang BW, 2003, CARDIOVASC RES, V59, P460, DOI 10.1016/S0008-6363(03)00428-0
   Wang JG, 2005, LIFE SCI, V76, P2817, DOI 10.1016/j.lfs.2004.10.050
   Wang KC, 2016, P NATL ACAD SCI USA, V113, P11525, DOI 10.1073/pnas.1613121113
   Wang KC, 2010, P NATL ACAD SCI USA, V107, P3234, DOI 10.1073/pnas.0914825107
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Ware LB, 2005, EUR RESPIR J, V26, P101, DOI 10.1183/09031936.05.00106604
   Waters CM, 2004, AM J PHYSIOL-LUNG C, V287, pL484, DOI 10.1152/ajplung.00161.2004
   Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959
   Wernig F, 2003, HYPERTENSION, V41, P903, DOI 10.1161/01.HYP.0000062882.42265.88
   Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011
   Wojciak-Stothard B, 2003, J CELL BIOL, V161, P429, DOI 10.1083/jcb.200210135
   Wojtowicz A, 2010, CIRC RES, V107, P898, DOI 10.1161/CIRCRESAHA.110.227850
   Wu CQ, 2015, CIRC RES, V117, pE41, DOI 10.1161/CIRCRESAHA.117.306457
   Wu DD, 2016, AM J RESP CRIT CARE, V193
   Wu D, 2017, ELIFE, V6, DOI 10.7554/eLife.25217
   Wu W, 2011, CIRCULATION, V124, P633, DOI 10.1161/CIRCULATIONAHA.110.005108
   Wung BS, 1997, CIRC RES, V81, P1, DOI 10.1161/01.RES.81.1.1
   Wung BS, 1999, CIRC RES, V84, P804
   Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364
   Yamamoto H, 2001, RESP PHYSIOL, V127, P105, DOI 10.1016/S0034-5687(01)00244-4
   Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034
   YAMAZAKI T, 1993, J BIOL CHEM, V268, P12069
   Yang JH, 1998, J BIOL CHEM, V273, P6550, DOI 10.1074/jbc.273.11.6550
   Yang JJ, 2010, J BIOMED MATER RES A, V95A, P531, DOI 10.1002/jbm.a.32875
   Yano Y, 1996, BIOCHEM BIOPH RES CO, V224, P508, DOI 10.1006/bbrc.1996.1057
   Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007
   Yen WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117133
   Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018
   Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992
   Yung YC, 2009, P NATL ACAD SCI USA, V106, P15279, DOI 10.1073/pnas.0905891106
   Zeng Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086249
   Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470
   Zhang BF, 2007, CELL SIGNAL, V19, P1690, DOI 10.1016/j.cellsig.2007.03.005
   Zhao HG, 2009, BIOCHEM BIOPH RES CO, V389, P599, DOI 10.1016/j.bbrc.2009.09.028
   Zheng W, 2004, AM J PHYSIOL-HEART C, V287, pH2739, DOI 10.1152/ajpheart.00410.2004
   Zhou J, 2014, CELL MOL BIOENG, V7, P218, DOI 10.1007/s12195-014-0325-z
   Zhou RH, 2003, ARTERIOSCL THROM VAS, V23, P2015, DOI 10.1161/01.ATV.0000095161.06906.ED
   Zimmermann P, 1999, FASEB J, V13, pS91
NR 441
TC 73
Z9 76
U1 3
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 2040-4603
J9 COMPR PHYSIOL
JI Compr. Physiol.
PD APR
PY 2019
VL 9
IS 2
BP 873
EP 904
DI 10.1002/cphy.c180020
PG 32
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA KI4DZ
UT WOS:000511301100011
PM 30873580
OA Green Accepted
DA 2023-08-21
ER

PT J
AU Ke, YB
   Karki, P
   Zhang, CO
   Li, Y
   Nguyen, T
   Birukov, KG
   Birukova, AA
AF Ke, Yunbo
   Karki, Pratap
   Zhang, Chenou
   Li, Yue
   Trang Nguyen
   Birukov, Konstantin G.
   Birukova, Anna A.
TI Mechanosensitive Rap1 activation promotes barrier function of lung
   vascular endothelium under cyclic stretch
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID DIFFERENTIAL REGULATION; MECHANICAL STRETCH; SIGNALING PATHWAY; KEY
   REGULATOR; PERMEABILITY; PAXILLIN; AFADIN; ENHANCEMENT; EXPRESSION;
   ADHESION
AB Mechanical ventilation remains an imperative treatment for the patients with acute respiratory distress syndrome, but can also exacerbate lung injury. We have previously described a key role of RhoA GTPase in high cyclic stretch (CS)-induced endothelial cell (EC) barrier dysfunction. However, cellular mechanotransduction complexes remain to be characterized. This study tested a hypothesis that recovery of a vascular EC barrier after pathologic mechanical stress may be accelerated by cell exposure to physiologic CS levels and involves Rap1-dependent rearrangement of endothelial cell junctions. Using biochemical, molecular, and imaging approaches we found that EC pre-or postconditioning at physiologically relevant low-magnitude CS promotes resealing of cell junctions disrupted by pathologic, high-magnitude CS. Cytoskeletal remodeling induced by low CS was dependent on small GTPase Rap1. Protective effects of EC preconditioning at low CS were abolished by pharmacological or molecular inhibition of Rap1 activity. In vivo, using mice exposed to mechanical ventilation, we found that the protective effect of low tidal volume ventilation against lung injury caused by lipopolysaccharides and ventilation at high tidal volume was suppressed in Rap1 knockout mice. Taken together, our results demonstrate a prominent role of Rap1-mediated signaling mechanisms activated by low CS in acceleration of lung vascular EC barrier restoration.
C1 [Ke, Yunbo; Birukov, Konstantin G.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201, United States.
   [Karki, Pratap; Zhang, Chenou; Li, Yue; Trang Nguyen; Birukova, Anna A.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201, United States.
C3 University System of Maryland; University of Maryland Baltimore;
   University System of Maryland; University of Maryland Baltimore
RP Birukova, AA (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.
EM abirukova@som.umaryland.edu
RI Nguyen, Trang Thi Thu/CAI-9696-2022; Birukov, Konstantin/FJB-5755-2022
OI Nguyen, Trang Thi Thu/0000-0001-8747-9082; 
FU National Heart, Lung, and Blood Institute [HL076259, HL087823, HL107920,
   HL130431]; National Institute on Aging [AG048231]; National Institute of
   General Medical Sciences [GM122940, GM114171]
FX This work was supported by grants HL076259, HL087823, HL107920, and
   HL130431 from the National Heart, Lung, and Blood Institute; AG048231
   from the National Institute on Aging; and GM122940 and GM114171 from the
   National Institute of General Medical Sciences.
CR Ando K, 2013, J CELL BIOL, V202, P901, DOI 10.1083/jcb.201301115
   Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002
   Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007
   Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431
   Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL593, DOI 10.1152/ajplung.90257.2008
   Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036
   Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007
   Birukova AA, 2015, BBA-MOL BASIS DIS, V1852, P778, DOI 10.1016/j.bbadis.2014.12.016
   Birukova AA, 2013, MOL BIOL CELL, V24, P2678, DOI 10.1091/mbc.E13-02-0098
   Birukova AA, 2013, TRANSL RES, V161, P495, DOI 10.1016/j.trsl.2012.12.008
   Birukova AA, 2012, J CELL PHYSIOL, V227, P1883, DOI 10.1002/jcp.22916
   Birukova AA, 2011, EXP CELL RES, V317, P859, DOI 10.1016/j.yexcr.2010.11.011
   Birukova AA, 2011, J CELL PHYSIOL, V226, P2052, DOI 10.1002/jcp.22543
   Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009
   Birukova AA, 2010, TRANSL RES, V155, P44, DOI 10.1016/j.trsl.2009.09.002
   Birukova AA, 2009, J APPL PHYSIOL, V107, P1900, DOI 10.1152/japplphysiol.00462.2009
   Birukova AA, 2009, AM J RESP CELL MOL, V40, P99, DOI 10.1165/rcmb.2008-0099OC
   Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004
   Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009
   Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159
   Freeman SA, 2017, J CELL SCI, V130, P152, DOI 10.1242/jcs.180612
   Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808
   Garcia MC, 2009, J BIOL CHEM, V284, P20936, DOI 10.1074/jbc.M109.020271
   Gawlak G, 2014, FASEB J, V28, P3249, DOI 10.1096/fj.13-245142
   Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5
   Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254
   Hammerschmidt S, 2004, AM J RESP CELL MOL, V30, P396, DOI 10.1165/rcmb.2003-0136OC
   Jafari B, 2004, RESPIROLOGY, V9, P43, DOI 10.1111/j.1440-1843.2003.00527.x
   Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105
   Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200
   Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306
   Lakshmikanthan S, 2015, EMBO REP, V16, P628, DOI 10.15252/embr.201439846
   Matoba K, 2010, BIOCHEM BIOPH RES CO, V402, P725, DOI 10.1016/j.bbrc.2010.10.093
   Meliton A, 2015, AM J RESP CELL MOL B, V53, DOI [10.1165/rcmb.2014-03760C, DOI 10.1165/RCMB.2014-03760C]
   Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760
   Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615
   Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Sanchez-Esteban J, 2002, AM J PHYSIOL-LUNG C, V282, pL448, DOI 10.1152/ajplung.00399.2000
   Severson EA, 2009, ANN NY ACAD SCI, V1165, P10, DOI 10.1111/j.1749-6632.2009.04034.x
   Shikata Y, 2005, EXP CELL RES, V304, P40, DOI 10.1016/j.yexcr.2004.11.001
   Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367
   Storck J, 1996, THROMB RES, V81, P121, DOI 10.1016/0049-3848(95)00220-0
   Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167
   Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021
   Tian XY, 2015, MOL BIOL CELL, V26, P636, DOI 10.1091/mbc.E14-02-0725
   Tian YF, 2015, J BIOL CHEM, V290, P4097, DOI 10.1074/jbc.M114.620377
   Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259
   Villar J, 2003, CRIT CARE MED, V31, pS272, DOI 10.1097/01.CCM.0000057903.11528.6D
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Yan JL, 2008, MOL CELL BIOL, V28, P5803, DOI 10.1128/MCB.00393-08
   Yang GG, 2005, GENE, V363, P166, DOI 10.1016/j.gene.2005.08.006
NR 52
TC 16
Z9 16
U1 0
U2 6
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD APR 1
PY 2019
VL 30
IS 8
BP 959
EP 974
DI 10.1091/mbc.E18-07-0422
PG 16
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA HR0OH
UT WOS:000462827500003
PM 30759056
OA Green Published, hybrid, Green Submitted
DA 2023-08-21
ER

PT J
AU Xu, J
   Wei, GH
   Wang, JJ
   Zhu, JL
   Yu, M
   Zeng, XN
   Wang, H
   Xie, WP
   Kong, H
AF Xu, Jian
   Wei, Guihong
   Wang, Jingjing
   Zhu, Jiali
   Yu, Min
   Zeng, Xiaoning
   Wang, Hong
   Xie, Weiping
   Kong, Hui
TI Glucagon-like peptide-1 receptor activation alleviates
   lipopolysaccharide-induced acute lung injury in mice via maintenance of
   endothelial barrier function
SO LABORATORY INVESTIGATION
LA English
DT Article
ID BLOOD-RETINAL BARRIER; REPERFUSION INJURY; CELL-INTERACTIONS; RHO
   GTPASES; EXPRESSION; DYSFUNCTION; EXENDIN-4; PROTECTS; MODULATION;
   MECHANISMS
AB Glucagon-like peptide-1 (GLP-1), which is well known for regulating glucose homeostasis, exhibits multiple actions in cardiovascular disorders and renal injury. However, little is known about the effect of GLP-1 receptor (GLP-1R) activation on acute lung injury (ALI). In this study, we investigated the effect of GLP-1R on ALI and the potential underlying mechanisms with the selective agonist liraglutide. Our results show that GLP-1 levels decreased in serum, though they increased in bronchoalveolar lavage fluid (BALF) and lung tissue in a mouse model of lipopolysaccharide (LPS)-induced ALI. Liraglutide prevented LPS-induced polymorphonuclear neutrophil (PMN) extravasation, lung injury, and alveolar-capillary barrier dysfunction. In cultured human pulmonary microvascular endothelial cells (HPMECs), liraglutide protected against LPS-induced endothelial barrier injury by restoring intercellular tight junctions and adherens junctions. Moreover, liraglutide prevented PMN-endothelial adhesion by inhibiting the expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), and thereafter suppressed PMN transendothelial migration. Furthermore, liraglutide suppressed LPS-induced activation of Rho/NF-kappa B signaling in HPMECs. In conclusion, our results show that GLP-1R activation protects mice from LPS-induced ALI by maintaining functional endothelial barrier and inhibiting PMN extravasation. These results also suggest that GLP-1R may be a potential therapeutic target for the treatment of ALI.
C1 [Xu, Jian; Wang, Jingjing] Tongji Univ, Shanghai Pulm Hosp, Dept Resp Med, Sch Med, Shanghai 200433, China.
   [Wei, Guihong; Zhu, Jiali; Yu, Min; Zeng, Xiaoning; Wang, Hong; Xie, Weiping; Kong, Hui] Nanjing Med Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Nanjing 210029, Jiangsu, China.
C3 Tongji University; Nanjing Medical University
RP Xie, WP; Kong, H (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Nanjing 210029, Jiangsu, Peoples R China.
EM wpxie@njmu.edu.cn; konghui@njmu.edu.cn
FU National Natural Science Foundation of China [81273571, 81870054];
   Jiangsu Clinical Research Center for Respiratory Diseases Project
   [BL2012012]; Jiangsu Province Scientific Research Innovation Project of
   University graduate students [JX22013361]; Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD) [JX10231802]
FX This study was supported by the National Natural Science Foundation of
   China (No. 81273571, No. 81870054), the Jiangsu Clinical Research Center
   for Respiratory Diseases Project under Grant BL2012012, the Jiangsu
   Province Scientific Research Innovation Project of University graduate
   students (JX22013361), and by a project funded by the Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD)
   (JX10231802).
CR Abdelsameea AA, 2017, N-S ARCH PHARMACOL, V390, P311, DOI 10.1007/s00210-016-1330-7
   Bruen R, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0626-3
   Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3
   Cheang JY, 2018, CHEMMEDCHEM, V13, P662, DOI 10.1002/cmdc.201700781
   Chen P, 2018, DIABETES RES CLIN PR, V137, P173, DOI 10.1016/j.diabres.2017.09.006
   Dokken BB, 2011, HORM METAB RES, V43, P300, DOI 10.1055/s-0031-1271777
   Drucker DJ, 2018, CELL METAB, V27, P740, DOI 10.1016/j.cmet.2018.03.001
   Duluc L, 2014, CELL TISSUE RES, V355, P675, DOI 10.1007/s00441-014-1805-0
   Fan YC, 2014, EXP EYE RES, V127, P104, DOI 10.1016/j.exer.2014.05.004
   Fanelli Vito, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS3, DOI 10.1513/AnnalsATS.201407-340MG
   Fukuda S, 2016, J MOL NEUROSCI, V59, P211, DOI 10.1007/s12031-015-0696-1
   Garczorz W, 2018, CARDIOVASC THER, V36, DOI 10.1111/1755-5922.12317
   Goncalves A, 2016, INVEST OPHTH VIS SCI, V57, P2584, DOI 10.1167/iovs.15-19006
   Gumuslu E, 2016, MED SCI MONITOR, V22, P2664, DOI 10.12659/MSM.897401
   Herold S, 2013, AM J PHYSIOL-LUNG C, V305, pL665, DOI 10.1152/ajplung.00232.2013
   Hu SY, 2017, J GERIATR CARDIOL, V14, P57, DOI 10.11909/j.issn.1671-5411.2017.01.008
   Kim S, 2017, EXP NEUROBIOL, V26, P227, DOI 10.5607/en.2017.26.4.227
   Kong XC, 2014, ENDOCRINOLOGY, V155, P4676, DOI 10.1210/en.2014-1314
   Kosowska A, 2017, ENDOCR CONNECT, V6, P856, DOI 10.1530/EC-17-0294
   Krasner NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097554
   Kreuger J, 2016, NAT REV DRUG DISCOV, V15, P125, DOI 10.1038/nrd.2015.2
   Li Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06712-z
   Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST
   Mitchell PD, 2017, CLIN EXP ALLERGY, V47, P331, DOI 10.1111/cea.12860
   Moitra J, 2007, TRANSL RES, V150, P253, DOI 10.1016/j.trsl.2007.03.013
   Muller-Redetzky HC, 2014, CELL TISSUE RES, V355, P657, DOI 10.1007/s00441-014-1821-0
   Nozu T, 2018, J GASTROEN HEPATOL, V33, P232, DOI 10.1111/jgh.13808
   Oliveira SDS, 2017, AM J PHYSIOL-LUNG C, V312, P1760, DOI 10.1152/ajplung.00484.2016
   PETTY TL, 1971, CHEST, V60, P233, DOI 10.1378/chest.60.3.233
   Tang ST, 2016, ENDOCRINE, V53, P107, DOI 10.1007/s12020-015-0852-y
   Wang CS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193473
   Wang DJ, 2013, DIABETES, V62, P1697, DOI 10.2337/db12-1025
   Wang JJ, 2016, CARDIOVASC DRUG THER, V30, P587, DOI 10.1007/s10557-016-6702-1
   Wang JJ, 2018, EXP CELL RES, V365, P97, DOI 10.1016/j.yexcr.2018.02.026
   Xie ZY, 2018, NEUROPHARMACOLOGY, V128, P142, DOI 10.1016/j.neuropharm.2017.09.040
   Xu J, 2018, LAB INVEST, V98, P1333, DOI 10.1038/s41374-018-0080-1
   Xu J, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1864107
   Zhang Y, 2017, MOL CELL ENDOCRINOL, V448, P98, DOI 10.1016/j.mce.2017.03.029
   Zhang Y, 2016, FREE RADICAL BIO MED, V95, P278, DOI 10.1016/j.freeradbiomed.2016.03.035
NR 39
TC 24
Z9 25
U1 2
U2 10
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
EI 1530-0307
J9 LAB INVEST
JI Lab. Invest.
PD APR
PY 2019
VL 99
IS 4
BP 577
EP 587
DI 10.1038/s41374-018-0170-0
PG 11
WC Medicine, Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pathology
GA HQ1MH
UT WOS:000462161500011
PM 30659271
OA Bronze
DA 2023-08-21
ER

PT J
AU Zhu, M
   Wang, L
   Yang, J
   Xie, K
   Zhu, M
   Liu, S
   Xu, C
   Wang, J
   Gu, L
   Ni, Z
   Xu, G
   Che, M
AF Zhu, M.
   Wang, L.
   Yang, J.
   Xie, K.
   Zhu, M.
   Liu, S.
   Xu, C.
   Wang, J.
   Gu, L.
   Ni, Z.
   Xu, G.
   Che, M.
TI Erythropoietin Ameliorates Lung Injury by Accelerating Pulmonary
   Endothelium Cell Proliferation via Janus Kinase-Signal Transducer and
   Activator of Transcription 3 Pathway After Kidney Ischemia and
   Reperfusion Injury
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article
ID RENAL ISCHEMIA; MICE
AB Background/aims. Kidney ischemia and reperfusion injury could cause microvascular barrier dysfunction, lung inflammatory cascades activation, and programmed cell death of pulmonary endothelium, leading to acute lung injury. Our study aimed at determining whether erythropoietin (EPO) can ameliorate lung dysfunction following renal ischemia and reperfusion (IR) injury and explored the underlying mechanisms.
   Methods. In vivo, C57BL/6 mice received EPO (6000 U/kg) before right renal vascular pedicles clamping for 30 minutes, followed by 24 hours of reperfusion. The lung histopathologic changes and inflammatory cytokines expression were assessed. In vitro, cultured human umbilical vein endothelial cells were treated with EPO, and apoptosis rate, proliferation capacity, and phosphorylation status of the Janus kinase-signal transducer and activator of transcription 3 (Jak-STAT3) pathway were measured respectively in the presence or absence of lipopolysaccharide stimulation.
   Results. In vivo, EPO remarkably attenuated pulmonary interstitial and alveolar epithelial edema caused by renal IR injury. In vitro, the proliferation capacity of human umbilical vein endothelial cells was significantly increased under EPO stimulation, which correlated with changes in Jak-STAT3 signaling.
   Conclusion. Our data indicated that EPO is able to ameliorate acute lung tissue damage induced by renal IR, and at least in part, via the Jak-STAT3 pathway.
C1 [Zhu, M.; Wang, J.] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Crit Care Med, Shanghai, China.
   [Wang, L.] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Emergency, South Campus, Shanghai, China.
   [Yang, J.] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai, China.
   [Xie, K.; Xu, C.; Gu, L.; Ni, Z.; Che, M.] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nephrol,Mol Cell Lab Kidney Dis, 145 Shandong Rd, Shanghai 200001, China.
   [Zhu, M.; Liu, S.] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nephrol, South Campus, Shanghai, China.
   [Xu, G.] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Cardiovasc Surg, Shanghai, China.
C3 Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai
   Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong
   University; Shanghai Jiao Tong University
RP Che, M (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nephrol,Mol Cell Lab Kidney Dis, 145 Shandong Rd, Shanghai 200001, Peoples R China.; Xu, G (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Cardiovasc Surg, Shanghai, Peoples R China.
EM xugenxing@medmail.com.cn; cather1983@126.com
OI Xu, Chenqi/0000-0003-1496-0937
FU Shanghai Natural Science Foundation [15ZR1425900]; Shanghai Municipal
   Commission of Health and Family Planning Science and Research Fund
   (Youth) [20164Y0231]; Cultivating Funds of South Campus, Renji Hospital,
   School of Medicine, Shanghai Jiao Tong University
FX This study was supported by a scholarship provided to M.Z. by the
   Shanghai Natural Science Foundation (grant no. 15ZR1425900), a
   scholarship provided to M.Z. by the Shanghai Municipal Commission of
   Health and Family Planning Science and Research Fund (Youth)
   (20164Y0231), and a scholarship provided to S.L. by the Cultivating
   Funds of South Campus, Renji Hospital, School of Medicine, Shanghai Jiao
   Tong University.
CR Awad AS, 2009, KIDNEY INT, V75, P689, DOI 10.1038/ki.2008.648
   Basu RK, 2013, PEDIATR NEPHROL, V28, P2239, DOI 10.1007/s00467-012-2386-3
   Campanholle G, 2012, CELL PHYSIOL BIOCHEM, V29, P523, DOI 10.1159/000338506
   Chen Q, 2016, ONCOTARGET, V7, P55990, DOI 10.18632/oncotarget.10809
   Collett JA, 2017, AM J PHYSIOL-RENAL, V312, pF897, DOI 10.1152/ajprenal.00643.2016
   Farrell F, 2004, ONCOLOGIST, V9, P18, DOI 10.1634/theoncologist.9-90005-18
   Faubel S, 2016, NAT REV NEPHROL, V12, P48, DOI 10.1038/nrneph.2015.158
   Hassoun HT, 2007, AM J PHYSIOL-RENAL, V293, pF30, DOI 10.1152/ajprenal.00023.2007
   Hassoun HT, 2009, AM J PHYSIOL-RENAL, V297, pF125, DOI 10.1152/ajprenal.90666.2008
   Janmaat ML, 2010, BLOOD, V115, P1453, DOI 10.1182/blood-2009-07-230870
   Kakavas S, 2011, EUR J CLIN PHARMACOL, V67, P1, DOI 10.1007/s00228-010-0938-7
   Kramer AA, 1999, KIDNEY INT, V55, P2362, DOI 10.1046/j.1523-1755.1999.00460.x
   Lee SA, 2018, AM J KIDNEY DIS, V72, P846, DOI 10.1053/j.ajkd.2018.03.028
   Liu ZH, 2018, INFLAMMATION, V41, P1546, DOI 10.1007/s10753-018-0801-z
   Lopez TV, 2011, INT J CANCER, V129, P2566, DOI 10.1002/ijc.25935
   Ma T, 2015, MOL MED REP, V12, P1923, DOI 10.3892/mmr.2015.3619
   Mandelbaum T, 2011, CRIT CARE MED, V39, P2659, DOI 10.1097/CCM.0b013e3182281f1b
   Moeini M, 2013, INT J PREVENTIVE MED, V4, P648
   Moon SJ, 2018, J CELL PHYSIOL, V233, P7128, DOI 10.1002/jcp.26635
   Rabadi M, 2016, AM J PHYSIOL-RENAL, V311, pF437, DOI 10.1152/ajprenal.00254.2016
   Wei XB, 2014, ONCOL REP, V31, P335, DOI 10.3892/or.2013.2858
   White LE, 2012, SHOCK, V38, P320, DOI 10.1097/SHK.0b013e31826359d0
   Zhou B, 2014, J CLIN INVEST, V124, P553, DOI 10.1172/JCI69804
NR 23
TC 17
Z9 20
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0041-1345
EI 1873-2623
J9 TRANSPL P
JI Transplant. Proc.
PD APR
PY 2019
VL 51
IS 3
BP 972
EP 978
DI 10.1016/j.transproceed.2019.01.059
PG 7
WC Immunology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Surgery; Transplantation
GA HV5VU
UT WOS:000466054000052
PM 30979490
OA hybrid
DA 2023-08-21
ER

PT J
AU Zhao, JN
   Zhu, MY
   Jiang, H
   Shen, SM
   Su, X
   Shi, Y
AF Zhao, Jiangnan
   Zhu, Meiying
   Jiang, Hao
   Shen, Simen
   Su, Xin
   Shi, Yi
TI Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and
   antiviral drug: a potential therapy against pathogenic influenza virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PROTEIN-COUPLED RECEPTOR; A H1N1 VIRUS; NF-KAPPA-B; ENDOTHELIAL-CELLS;
   SPHINGOSINE 1-PHOSPHATE; IMMUNOPATHOLOGY; INFLAMMATION; FINGOLIMOD;
   ACTIVATION; PROTECTION
AB The pandemic 2009 influenza A H1N1 virus is associated with significant mortality. Targeting S1PR1, which is known to modulate the immune response, provides protection against pathogenic influenza virus. The functional role and molecular mechanism of S1PR1 were analysed by generating inducible endothelial cell-specific S1PR1 knockout mice and assessing the therapeutic efficacy of the selective S1PR1 agonist CYM5442 against acute lung injury (ALI) induced by the 2009 influenza A H1N1 virus. Immune-mediated pulmonary injury is aggravated by the absence of endothelial S1PR1 and alleviated by treatment with CYM-5442, suggesting a protective function of S1PR1 signaling during H1N1 infection. S1PR1 signaling does not affect viral clearance in mice infected with influenza. Mechanistically, the MAPK and NF-kB signaling pathways are involved in the ALI mediated by S1PR1 in infected mice. Combined administration of the S1PR1 agonist CYM-5442 and the antiviral drug oseltamivir provides maximum protection from ALI. Our current study provides insight into the molecular mechanism of S1PR1 mediating the ALI induced by H1N1 infection and indicates that the combination of S1PR1 agonist with antiviral drug could potentially be used as a therapeutic remedy for future H1N1 virus pandemics.
C1 [Zhao, Jiangnan; Zhu, Meiying; Su, Xin; Shi, Yi] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp & Crit Med, Nanjing 210002, Jiangsu, China.
   [Jiang, Hao] Southeast Univ, Affiliated Hosp 2, Dept Emergency Med, Nanjing 210002, Jiangsu, China.
   [Shen, Simen] First Peoples Hosp Nantong, Dept Resp Med, Nantong 226000, China.
C3 Nanjing University; Southeast University - China
RP Shi, Y (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp & Crit Med, Nanjing 210002, Jiangsu, Peoples R China.
EM yishi201607@163.com
RI Su, Xin/X-2589-2018; SHI, Yi/IXD-7826-2023
OI Su, Xin/0000-0002-3910-9156; 
FU National Natural Science Foundation of China [81470206]; Natural Science
   Foundation of Jiangsu Province [BK20151372]
FX This project was supported by the National Natural Science Foundation of
   China (81470206), and the Natural Science Foundation of Jiangsu Province
   (BK20151372).
CR Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460
   Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008
   Belongia EA, 2010, JAMA-J AM MED ASSOC, V304, P1091, DOI 10.1001/jama.2010.1277
   Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248
   Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4
   Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810
   Forde A, 2002, GENESIS, V33, P191, DOI 10.1002/gene.10117
   Gao W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030328
   Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com
   Hale JJ, 2004, BIOORG MED CHEM LETT, V14, P3501, DOI 10.1016/j.bmcl.2004.04.070
   Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020
   Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088
   Huwiler A, 2000, BBA-MOL CELL BIOL L, V1485, P63, DOI 10.1016/S1388-1981(00)00042-1
   Jiang H, 2018, NEUROCOMPUTING, V275, P192, DOI 10.1016/j.neucom.2017.05.086
   Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495
   Krump-Konvalinkova V, 2005, ARTERIOSCL THROM VAS, V25, P546, DOI 10.1161/01.ATV.0000154360.36106.d9
   La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905
   Marchant D, 2010, J VIROL, V84, P11359, DOI 10.1128/JVI.00804-10
   Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106
   Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663
   Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008
   Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691
   Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007
   Rosen H, 2013, ANNU REV BIOCHEM, V82, P637, DOI 10.1146/annurev-biochem-062411-130916
   Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733
   Sammani S, 2010, AM J RESP CELL MOL, V43, P394, DOI 10.1165/rcmb.2009-0223OC
   Schaphorst KL, 2003, AM J PHYSIOL-LUNG C, V285, pL258, DOI 10.1152/ajplung.00311.2002
   Takuwa N, 2010, CARDIOVASC RES, V85, P484, DOI 10.1093/cvr/cvp312
   Teijaro JR, 2014, VIROLOGY, V452, P152, DOI 10.1016/j.virol.2014.01.003
   Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015
   To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581
   Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845
   Walsh KB, 2011, IMMUNOL RES, V51, P15, DOI 10.1007/s12026-011-8240-z
   Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108
   Wang LC, 2009, MICROVASC RES, V77, P39, DOI 10.1016/j.mvr.2008.09.005
NR 37
TC 34
Z9 35
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 27
PY 2019
VL 9
AR 5272
DI 10.1038/s41598-019-41760-7
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA HQ5OP
UT WOS:000462462800038
PM 30918324
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Leonard, A
   Grose, V
   Paton, AW
   Paton, JC
   Yule, DI
   Rahman, A
   Fazal, F
AF Leonard, Antony
   Grose, Valerie
   Paton, Adrienne W.
   Paton, James C.
   Yule, David, I
   Rahman, Arshad
   Fazal, Fabeha
TI Selective Inactivation of Intracellular BiP/GRP78 Attenuates Endothelial
   Inflammation and Permeability in Acute Lung Injury
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ENDOPLASMIC-RETICULUM STRESS; NF-KAPPA-B; ACTIVATES CRAC CHANNELS; CELL
   INFLAMMATION; SUBTILASE CYTOTOXIN; PROTEIN-KINASE; BARRIER; STIM1;
   PHOSPHORYLATION; ALPHA
AB The role of Endoplasmic Reticulum Chaperone and Signaling Regulator BiP/GRP78 in acute inflammatory injury, particularly in the context of lung endothelium, is poorly defined. In his study, we monitored the effect of SubAB, a holoenzyme that cleaves and specifically inactivates BiP/GRP78 and its inactive mutant SubA(A272)B on lung inflammatory injury in an aerosolized LPS inhalation mouse model of acute lung injury (ALI). Analysis of lung homogenates and bronchoalveolar lavage (BAL) fluid showed that LPS-induced lung inflammation and injury were significantly inhibited in SubAB-but not in SubA(A272)B-treated mice. SubAB-treated mice were also protected from LPS-induced decrease in lung compliance. Gene transfer of dominant negative mutant of BiP in the lung endothelium protected against LPS-induced lung inflammatory responses. Consistent with this, stimulation of endothelial cells (EC) with thrombin caused an increase in BiP/GRP78 levels and inhibition of ER stress with 4-phenylbutyric acid (4-PBA) prevented this response as well as increase in VCAM-1, ICAM-1, IL-6, and IL-8 levels. Importantly, thrombin-induced Ca2+ signaling and EC permeability were also prevented upon BiP/GRP78 inactivation. The above EC responses are mediated by intracellular BiP/GRP78 and not by cell surface BiP/GRP78. Together, these data identify intracellular BiP/GRP78 as a novel regulator of endothelial dysfunction associated with ALI.
C1 [Leonard, Antony; Grose, Valerie; Rahman, Arshad; Fazal, Fabeha] Univ Rochester, Dept Pediat, Lung Biol & Dis Program, Sch Med & Dent, Rochester, NY 14642, United States.
   [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Dept Mol & Biomed Sci, Adelaide, SA, Australia.
   [Yule, David, I] Univ Rochester, Dept Pharmacol & Physiol, Sch Med & Dent, Rochester, NY 14642, United States.
C3 University of Rochester; University of Adelaide; University of Rochester
RP Fazal, F (corresponding author), Univ Rochester, Dept Pediat, Lung Biol & Dis Program, Sch Med & Dent, Rochester, NY 14642 USA.
EM Fabeha_Fazal@URMC.Rochester.edu
FU National Heart Lung and Blood Institute [HL130870, GM130463, HL116632]
FX We would like to thank Jane Malone, Research Scientist in the Department
   of Pediatrics, for assistance in measuring lung compliance in mice (Fig.
   1G). This work was supported by National Heart Lung and Blood Institute
   grants HL130870, GM130463 and HL116632.
CR Bello-Irizarry SN, 2014, J IMMUNOL, V192, P282, DOI 10.4049/jimmunol.1301431
   Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756
   Bijli KM, 2016, AM J PHYSIOL-LUNG C, V311, pL517, DOI 10.1152/ajplung.00069.2016
   Bijli KM, 2014, SHOCK, V42, P562, DOI 10.1097/SHK.0000000000000242
   Birukova AA, 2015, BBA-MOL BASIS DIS, V1852, P778, DOI 10.1016/j.bbadis.2014.12.016
   Birukova AA, 2014, MOL BIOL CELL, V25, P2006, DOI 10.1091/mbc.E13-12-0743
   Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008
   Carlisle RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084663
   Dejana E, 2013, PROG MOL BIOL TRANSL, V116, P119, DOI 10.1016/B978-0-12-394311-8.00006-6
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487
   Dvorin EL, 2003, J HEART VALVE DIS, V12, P617
   Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200
   Fazal F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059965
   Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010
   Gong HX, 2015, J CLIN INVEST, V125, P652, DOI 10.1172/JCI77701
   Gross CM, 2018, AM J RESP CELL MOL, V58, P614, DOI 10.1165/rcmb.2016-0390OC
   Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755
   Leonard A, 2018, CELL SIGNAL, V44, P103, DOI 10.1016/j.cellsig.2018.01.011
   Leonard A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110949
   Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014
   Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009
   Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9
   McLean JW, 1997, AM J PHYSIOL-HEART C, V273, pH387, DOI 10.1152/ajpheart.1997.273.1.H387
   Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174, DOI 10.1016/j.tcm.2005.06.002
   Mittal M, 2016, P NATL ACAD SCI USA, V113, pE8151, DOI 10.1073/pnas.1614935113
   Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569
   Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415
   Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136
   Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014
   Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124
   Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392
   Perl M, 2011, EXPERT REV RESP MED, V5, P115, DOI [10.1586/ers.10.92, 10.1586/ERS.10.92]
   Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08
   Rahman Arshad, 2011, Proc Am Thorac Soc, V8, P497, DOI 10.1513/pats.201101-009MW
   Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]
   Ray R, 2012, J BIOL CHEM, V287, P32755, DOI 10.1074/jbc.M112.399808
   Slavin SA, 2018, AM J PHYSIOL-LUNG C, V314, pL388, DOI 10.1152/ajplung.00555.2016
   SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9
   Sundivakkam PC, 2013, J BIOL CHEM, V288, P17030, DOI 10.1074/jbc.M112.411272
   Thurston G, 1998, J CLIN INVEST, V101, P1401, DOI 10.1172/JCI965
   Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373
   Xu N, 2000, CIRC RES, V87, P254, DOI 10.1161/01.RES.87.3.254
   Yazbeck P, 2017, SCI REP-UK, V7, DOI 10.1038/srep42758
   Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393
   Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147
NR 51
TC 30
Z9 32
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 14
PY 2019
VL 9
AR 2096
DI 10.1038/s41598-018-38312-w
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA HL3ML
UT WOS:000458619600096
PM 30765717
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Fawad, M
   Abbas, M
   Zhang, LM
   Zhang, YP
   Guo, YX
AF Fawad, Muhammad
   Abbas, Muhammad
   Zhang, Limin
   Zhang, Yuping
   Guo, Yaxiong
TI ASK1-p38 cascaded signal mediates pulmonary microvascular endothelial
   barrier injury induced by the return of PHSML in rats
SO RSC ADVANCES
LA English
DT Article
ID MESENTERIC LYMPH; LUNG INJURY; HEMORRHAGIC-SHOCK; TRAUMA; CELLS;
   DYSFUNCTION; LIPOPOLYSACCHARIDE; APOPTOSIS; PATHWAY; KINASE
AB The return of post-hemorrhagic shock mesenteric lymph (PHSML) induces pulmonary vascular endothelial barrier dysfunction, which results in acute lung injury. Activation of the apoptosis signal-regulated kinase 1 (ASK1) and p38 mitogen-activated protein kinase (p38 MAPK) pathway has been shown to trigger inflammatory responses. However, whether the ASK1-p38 MAPK pathway is involved in the PHSML-induced pulmonary endothelial barrier dysfunction remains unclear. In the present study, permeability changes of pulmonary capillaries were found in vivo, and activation of the ASK1-p38 MAPK pathway was determined in vitro. PMVEC barrier dysfunction was determined by measuring TEER. Furthermore, junctional and cytoskeletal protein expressions were analyzed. The results showed that hemorrhagic shock led to a marked increase in the permeability of pulmonary capillaries in vivo, which was markedly alleviated by PHSML drainage. In cultured pulmonary microvascular endothelial cells (PMVECs), PHSML reduced the endothelial barrier function accompanied by upregulated p-ASK1 and p-p38 MAPK protein expression, impaired the cytoskeletal protein structure, and down-regulated junction protein expression. These adverse effects were eliminated by applying either Trx1 (ASK1 inhibitor) or SB203580 (p38 MAPK inhibitor). These results indicated that the ASK1-p38 MAPK pathway mediates PHSML-induced pulmonary vascular endothelial barrier dysfunction during hemorrhagic shock.
C1 [Fawad, Muhammad; Abbas, Muhammad; Zhang, Limin; Zhang, Yuping; Guo, Yaxiong] Hebei North Univ, Inst Microcirculat, Zhangjiakou, Hebei, China.
C3 Hebei North University
RP Guo, YX (corresponding author), Hebei North Univ, Inst Microcirculat, Zhangjiakou, Hebei, Peoples R China.
EM yxguo2022@163.com
RI Abbas, Muhammad/AID-1435-2022; zhang, yu/HNS-5948-2023; Zhang,
   Yunxuan/IXD-9283-2023; Guo, Yaxiong/T-4866-2018
OI Guo, Yaxiong/0000-0001-5792-590X
FU National Natural Science Foundation of China [81500380]; Young Top
   Talent Science Research Project of Colleges and Universities in Hebei
   Province [BJ2014004]; High-level Talent Support Project in Hebei
   Province [A201803058]; Healthcare and Biomedicine Special Project of Key
   Research and Development Program of Hebei province [18277716D]
FX This work was supported by the National Natural Science Foundation of
   China (81500380), the Young Top Talent Science Research Project of
   Colleges and Universities in Hebei Province (BJ2014004), the High-level
   Talent Support Project in Hebei Province (A201803058), and the
   Healthcare and Biomedicine Special Project of Key Research and
   Development Program of Hebei province (18277716D). The authors thank Dr
   Zigang Zhao and Dr Chunyu Niu for the conception and design of this
   study.
CR Aggarwal S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00161
   Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495
   Brobey RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139914
   Coronado-Velazquez D, 2018, J EUKARYOT MICROBIOL, V65, P804, DOI 10.1111/jeu.12522
   Deitch EA, 2004, SHOCK, V22, P221, DOI 10.1097/01.shk.0000133592.55400.83
   Deitch EA, 2001, SURGERY, V129, P39, DOI 10.1067/msy.2001.109119
   Gill SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088501
   Greene C, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2015.1138017
   Gulati A, 2016, CURR VASC PHARMACOL, V14, P187, DOI 10.2174/1570161114666151202210221
   Hsu JT, 2007, AM J PHYSIOL-HEART C, V292, pH2982, DOI 10.1152/ajpheart.01303.2006
   Huber F, 2015, CURR OPIN CELL BIOL, V32, P39, DOI 10.1016/j.ceb.2014.10.005
   Jiang CY, 2014, BIOL TRACE ELEM RES, V158, P249, DOI 10.1007/s12011-014-9918-6
   Langness S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168322
   Levy G, 2013, SHOCK, V39, P39, DOI 10.1097/SHK.0b013e31827b450d
   Li W, 2015, J PERIODONTOL, V86, P917, DOI 10.1902/jop.2015.150030
   Lin F, 2013, SHOCK, V39, P317, DOI 10.1097/SHK.0b013e318283773e
   Liu ZF, 2016, APOPTOSIS, V21, P896, DOI 10.1007/s10495-016-1263-0
   Mooren OL, 2014, MOL BIOL CELL, V25, P4115, DOI 10.1091/mbc.E14-05-0976
   Nicklisch SCT, 2016, BIOCHEMISTRY-US, V55, P2022, DOI 10.1021/acs.biochem.6b00044
   Ray A, 2015, FREE RADICAL BIO MED, V87, P312, DOI 10.1016/j.freeradbiomed.2015.06.041
   Rodrigues SF, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.978720
   Sato H, 2008, MED SCI MONITOR, V14, pBR79
   Shao M, 2016, MOL MED REP, V13, P529, DOI 10.3892/mmr.2015.4521
   Soga Mayumi, 2012, Int J Cell Biol, V2012, P439587, DOI 10.1155/2012/439587
   Stamatovic SM, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1154641
   Sun GX, 2016, J SURG RES, V203, P47, DOI 10.1016/j.jss.2016.01.034
   Wilson CW, 2013, BLOOD, V122, P3678, DOI 10.1182/blood-2013-02-483156
   Wu JC, 2015, BIOCHEM BIOPH RES CO, V466, P155, DOI 10.1016/j.bbrc.2015.08.121
   Wu XW, 2016, SHOCK, V46, P108, DOI 10.1097/SHK.0000000000000652
   Yao H, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00120
   Zhang YM, 2014, WORLD J GASTROENTERO, V20, P4771, DOI 10.3748/wjg.v20.i16.4771
NR 31
TC 0
Z9 1
U1 0
U2 3
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PD FEB 11
PY 2019
VL 9
IS 9
BP 4870
EP 4875
DI 10.1039/c8ra08473d
PG 6
WC Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA HM1BV
UT WOS:000459183800026
PM 35514647
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Hough, RF
   Islam, MN
   Gusarova, GA
   Jin, GC
   Das, S
   Bhattacharya, J
AF Hough, Rebecca F.
   Islam, Mohammad N.
   Gusarova, Galina A.
   Jin, Guangchun
   Das, Shonit
   Bhattacharya, Jahar
TI Endothelial mitochondria determine rapid barrier failure in chemical
   lung injury
SO JCI INSIGHT
LA English
DT Article
ID UNCOUPLING PROTEIN-2; OXIDATIVE STRESS; CALCINEURIN; PROTECTS;
   ACTIVATION; APOPTOSIS; CELLS; RAT; INFLAMMATION; DISRUPTION
AB Acid aspiration, which can result from several etiologies, including postoperative complications, leads to direct contact of concentrated hydrochloric acid (HCl) with the alveolar epithelium. As a result, rapid endothelial activation induces alveolar inflammation, leading to life-threatening pulmonary edema. Because mechanisms underlying the rapid endothelial activation are not understood, here we determined responses in real time through optical imaging of alveoli of live mouse lungs. By alveolar micropuncture, we microinfused concentrated HCl in the alveolar lumen. As expected, acid contact with the epithelium caused rapid, but transient, apical injury. However, there was no concomitant membrane injury to the endothelium. Nevertheless, H2O2 mediated epithelial-endothelial paracrine signaling induced endothelial barrier failure, as detected by microvascular dextran leakage and lung water quantification. Remarkably, endothelial mitochondria regulated the barrier failure by activating uncoupling protein 2 (UCP2), thereby inducing transient mitochondrial depolarization that led to cofilin-induced actin depolymerization. Knockdown, or endothelium-targeted deletion of UCP2 expression, blocked these responses, including pulmonary edema. To our knowledge, these findings are the first to mechanistically implicate endothelial mitochondria in acid-induced barrier deterioration and pulmonary edema. We suggest endothelial UCP2 may be a therapeutic target for acid-induced acute lung injury.
C1 [Hough, Rebecca F.; Islam, Mohammad N.; Gusarova, Galina A.; Jin, Guangchun; Das, Shonit; Bhattacharya, Jahar] Columbia Univ, Dept Med, Lung Biol Lab, Vagelos Coll Phys & Surg, New York, NY, United States.
   [Hough, Rebecca F.] Columbia Univ, Dept Pediat, Vagelos Coll Phys & Surg, New York, NY, United States.
C3 Columbia University; Columbia University
RP Bhattacharya, J (corresponding author), Dept Med, 630 W 168th St,Room BB 8-812, New York, NY 10032 USA.
EM jb39@cumc.columbia.edu
RI Hough, Rebecca/AAE-4641-2021
OI Hough, Rebecca/0000-0002-0203-4146; Islam, Mohammad
   Naimul/0000-0001-7929-9444
FU Stony Wold - Herbert Fund, Inc. fellowship; NIH T32 Research Training
   Fellowship [HL105323]; NIH [HL36024, HL57556, HL122730]; American Heart
   Association [25740080]
FX The authors acknowledge M. Wei for assistance with genotyping. This work
   was supported by a Stony Wold - Herbert Fund, Inc. fellowship and NIH
   T32 Research Training Fellowship HL105323 to RFH, American Heart
   Association Grant-in-Aid 25740080 to MNI, and grants HL36024, HL57556,
   and HL122730 from the NIH to JB.
CR Alan L, 2009, J BIOENERG BIOMEMBR, V41, P71, DOI 10.1007/s10863-009-9201-2
   Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0
   Bai JX, 1999, J BIOL CHEM, V274, P26217, DOI 10.1074/jbc.274.37.26217
   Carroll RG, 2014, CELL REP, V9, P1538, DOI 10.1016/j.celrep.2014.10.046
   Descazeaud V, 2012, J CELL MOL MED, V16, P218, DOI 10.1111/j.1582-4934.2011.01398.x
   Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a
   Emin MT, 2012, AM J PHYSIOL-LUNG C, V302, pL1209, DOI 10.1152/ajplung.00189.2011
   Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269
   FOLKESSON HG, 1995, J CLIN INVEST, V96, P107, DOI 10.1172/JCI118009
   GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613
   Haslip M, 2015, ARTERIOSCL THROM VAS, V35, P1166, DOI 10.1161/ATVBAHA.114.304865
   Hidaka S, 1998, BBA-LIPID LIPID MET, V1389, P178, DOI 10.1016/S0005-2760(97)00188-4
   Hook JL, 2018, J CLIN INVEST, V128, P1074, DOI 10.1172/JCI95823
   Hosoda K, 1999, CLIN EXP PHARMACOL P, V26, P561, DOI 10.1046/j.1440-1681.1999.03088.x
   Ikezoe T, 2017, BONE MARROW TRANSPL, V52, P245, DOI 10.1038/bmt.2016.241
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Karpurapu Manjula, 2018, Oncotarget, V9, P10606, DOI 10.18632/oncotarget.24320
   Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106
   Kolozsvari B, 2012, CARDIOVASC RES, V96, P494, DOI 10.1093/cvr/cvs255
   Kolozsvari B, 2009, CYTOM PART A, V75A, P405, DOI 10.1002/cyto.a.20707
   Kong D, 2010, CELL METAB, V12, P545, DOI 10.1016/j.cmet.2010.09.013
   Kuebler WM, 2000, J CLIN INVEST, V105, P905, DOI 10.1172/JCI8604
   Lin ZJ, 2016, J CANCER RES CLIN, V142, P239, DOI 10.1007/s00432-015-2028-9
   Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022
   Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903
   McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Modelska K, 1999, AM J RESP CRIT CARE, V160, P1450, DOI 10.1164/ajrccm.160.5.9901096
   NANJO S, 1983, AM REV RESPIR DIS, V128, P884
   Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200
   Quadri SK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2107
   Raffaello A, 2012, CELL CALCIUM, V52, P16, DOI 10.1016/j.ceca.2012.04.006
   Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004
   Rhee S G, 2000, Sci STKE, V2000, ppe1
   Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412
   Rowlands DJ, 2011, J CLIN INVEST, V121, P1986, DOI 10.1172/JCI43839
   Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483
   SCHNEEBERGER EE, 1981, CIRC RES, V49, P1102, DOI 10.1161/01.RES.49.5.1102
   Tang SE, 2014, FREE RADICAL BIO MED, V71, P321, DOI 10.1016/j.freeradbiomed.2014.03.034
   Tang YF, 2010, GENESIS, V48, P563, DOI 10.1002/dvg.20654
   Tian XY, 2012, CIRC RES, V110, P1211, DOI [10.1161/CIRCRESAHA.111.262170, 10.1161/circresaha.111.262170]
   Vitolo MI, 2013, ONCOGENE, V32, P2200, DOI 10.1038/onc.2012.234
   Wang Q, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9154230
   Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415
   Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902
   Westphalen K, 2012, AM J PHYSIOL-LUNG C, V303, pL107, DOI 10.1152/ajplung.00206.2011
   Yu SX, 2015, SCI REP-UK, V5, DOI 10.1038/srep17935
   ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661
   Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499
   Zhang XF, 2012, MOL BIOL CELL, V23, P4833, DOI 10.1091/mbc.E12-10-0715
NR 50
TC 27
Z9 28
U1 0
U2 4
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD FEB 7
PY 2019
VL 4
IS 3
AR e124329
DI 10.1172/jci.insight.124329
PG 11
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA HK5VQ
UT WOS:000458037000005
PM 30728333
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Pooladanda, V
   Thatikonda, S
   Bale, S
   Pattnaik, B
   Sigalapalli, DK
   Bathini, NB
   Singh, SB
   Godugu, C
AF Pooladanda, Venkatesh
   Thatikonda, Sowjanya
   Bale, Swarna
   Pattnaik, Bijay
   Sigalapalli, Dilep Kumar
   Bathini, Nagendra Babu
   Singh, Shashi Bala
   Godugu, Chandraiah
TI Nimbolide protects against endotoxin-induced acute respiratory distress
   syndrome by inhibiting TNF-alpha mediated NF-kappa B and HDAC-3 nuclear
   translocation
SO CELL DEATH & DISEASE
LA English
DT Article
ID ACUTE LUNG INJURY; OXIDATIVE STRESS; INFLAMMATION; PATHOGENESIS;
   MACROPHAGES; EXPRESSION; DELIVERY; ERK1/2; ACID; NRF2
AB Acute respiratory distress syndrome (ARDS) is characterized by an excessive acute inflammatory response in lung parenchyma, which ultimately leads to refractory hypoxemia. One of the earliest abnormalities seen in lung injury is the elevated levels of inflammatory cytokines, among them, the soluble tumor necrosis factor (TNF-alpha) has a key role, which exerts cytotoxicity in epithelial and endothelial cells thus exacerbates edema. The bacterial lipopolysaccharide (LPS) was used both in vitro (RAW 264.7, THP-1, MLE-12, A549, and BEAS-2B) and in vivo (C57BL/6 mice), as it activates a plethora of overlapping inflammatory signaling pathways involved in ARDS. Nimbolide is a chemical constituent of Azadirachta indica, which contains multiple biological properties, while its role in ARDS is elusive. Herein, we have investigated the protective effects of nimbolide in abrogating the complications associated with ARDS. We showed that nimbolide markedly suppressed the nitrosative-oxidative stress, inflammatory cytokines, and chemokines expression by suppressing iNOS, myeloperoxidase, and nitrotyrosine expression. Moreover, nimbolide mitigated the migration of neutrophils and mast cells whilst normalizing the LPS-induced hypothermia. Also, nimbolide modulated the expression of epigenetic regulators with multiple HDAC inhibitory activity by suppressing the nuclear translocation of NF-kappa B and HDAC-3. We extended our studies using molecular docking studies, which demonstrated a strong interaction between nimbolide and TNF-alpha. Additionally, we showed that treatment with nimbolide increased GSH, Nrf-2, SOD-1, and HO-1 protein expression; concomitantly abrogated the LPS-triggered TNF-alpha, p38 MAPK, mTOR, and GSK-3 beta protein expression. Collectively, these results indicate that TNF-alpha-regulated NF-kappa B and HDAC-3 crosstalk was ameliorated by nimbolide with promising anti-nitrosative, antioxidant, and anti-inflammatory properties in LPS-induced ARDS.
C1 [Pooladanda, Venkatesh; Thatikonda, Sowjanya; Bale, Swarna; Singh, Shashi Bala; Godugu, Chandraiah] Natl Inst Pharmaceut Educ & Res, Dept Regulatory Toxicol, Hyderabad 500037, Telangana, India.
   [Pattnaik, Bijay] CSIR Inst Genom & Integrat Biol, Ctr Excellence Asthma & Lung Dis, New Delhi 110007, India.
   [Pattnaik, Bijay] CSIR Inst Genom & Integrat Biol, Mol Immunogenet Lab, New Delhi 110007, India.
   [Sigalapalli, Dilep Kumar; Bathini, Nagendra Babu] Natl Inst Pharmaceut Educ & Res, Dept Med Chem, Hyderabad 500037, Telangana, India.
C3 National Institute of Pharmaceutical Education & Research, Hyderabad;
   National Institute of Pharmaceutical Education & Research (NIPER);
   Council of Scientific & Industrial Research (CSIR) - India; CSIR -
   Institute of Genomics & Integrative Biology (IGIB); Council of
   Scientific & Industrial Research (CSIR) - India; CSIR - Institute of
   Genomics & Integrative Biology (IGIB); National Institute of
   Pharmaceutical Education & Research, Hyderabad; National Institute of
   Pharmaceutical Education & Research (NIPER)
RP Godugu, C (corresponding author), Natl Inst Pharmaceut Educ & Res, Dept Regulatory Toxicol, Hyderabad 500037, Telangana, India.
EM chandragodugu@gmail.com
RI Singh, Shashi Bala/AAS-9889-2021; Pattnaik, Bijay Ranjan/GOK-0878-2022;
   thatikonda, sowjanya/IQS-6420-2023; Bale, Swarna/IYI-9304-2023;
   Pooladanda, Venkatesh/ABF-9051-2021; Godugu, Chandraiah/F-4741-2018;
   Sigalapalli, Dilep Kumar/GXI-0204-2022
OI Pattnaik, Bijay Ranjan/0000-0003-3534-7410; thatikonda,
   sowjanya/0000-0002-5353-7202; Pooladanda, Venkatesh/0000-0002-2506-011X;
   Godugu, Chandraiah/0000-0001-5904-3134; Sigalapalli, Dilep
   Kumar/0000-0002-7286-0128
CR Anatoliotakis N, 2013, CURR TOP MED CHEM, V13, P115, DOI 10.2174/1568026611313020004
   Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001
   Bryant AH, 2017, BIOL REPROD, V96, P576, DOI 10.1095/biolreprod.116.145680
   Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621
   Cross LJM, 2011, CRIT CARE CLIN, V27, P355, DOI 10.1016/j.ccc.2010.12.005
   Dong WP, 2017, J ENDOCRINOL, V232, P71, DOI 10.1530/JOE-16-0322
   Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200
   GLINSUKON T, 1986, TOXICOL LETT, V30, P159, DOI 10.1016/0378-4274(86)90098-6
   Godugu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089919
   Godugu C, 2013, J CONTROL RELEASE, V172, P86, DOI 10.1016/j.jconrel.2013.06.036
   Gonneaud A, 2014, J INFLAMM-LOND, V11, DOI 10.1186/s12950-014-0043-2
   Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138
   Hanafy K A, 2001, Med Sci Monit, V7, P801
   He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304
   HIDALGO HA, 1992, TRANSPLANTATION, V53, P620, DOI 10.1097/00007890-199203000-00024
   Jain A, 2017, NANOMED-NANOTECHNOL, V13, P2251, DOI 10.1016/j.nano.2017.06.009
   Jeyaseelan S, 2005, INFECT IMMUN, V73, P1754, DOI 10.1128/IAI.73.3.1754-1763.2005
   Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775
   Kato A, 2013, J ALLERGY CLIN IMMUN, V131, P933, DOI 10.1016/j.jaci.2013.02.023
   Kaur J, 2013, BBA-MOL CELL RES, V1833, P1028, DOI 10.1016/j.bbamcr.2013.01.029
   Kerksick Chad, 2005, J Int Soc Sports Nutr, V2, P38, DOI 10.1186/1550-2783-2-2-38
   Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359
   Leus NGJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45047
   Leus NGJ, 2016, BIOCHEM PHARMACOL, V108, P58, DOI 10.1016/j.bcp.2016.03.010
   Li CC, 2015, NUTRIENTS, V7, P5572, DOI 10.3390/nu7075239
   Li YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27911
   Liu ZN, 2013, ACTA PHARMACOL SIN, V34, P1317, DOI 10.1038/aps.2013.65
   Lundblad LKA, 2005, AM J RESP CRIT CARE, V171, P1363, DOI 10.1164/rccm.200410-1349OC
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   Moldoveanu B, 2009, J INFLAMM RES, V2, P1
   Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125
   Nakagome K, 2011, AURIS NASUS LARYNX, V38, P555, DOI 10.1016/j.anl.2011.01.011
   Nekkanti S, 2017, CHEMISTRYSELECT, V2, P7210, DOI 10.1002/slct.201700620
   Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10
   Pohl CS, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13118
   Pooladanda V, 2018, TOXICOL IN VITRO, V51, P114, DOI 10.1016/j.tiv.2018.05.010
   Pushpakumar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06484-6
   Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378
   Ramana KV, 2006, J BIOL CHEM, V281, P33019, DOI 10.1074/jbc.M603819200
   Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Shi L, 2002, AM J PHYSIOL-CELL PH, V282, pC1205, DOI 10.1152/ajpcell.00511.2001
   Speyer CL, 2003, AM J PATHOL, V163, P2319, DOI 10.1016/S0002-9440(10)63588-2
   Usui T, 2012, AM J PHYSIOL-HEART C, V302, pH1894, DOI 10.1152/ajpheart.01039.2011
   Wang LZ, 2016, ONCOTARGET, V7, P44790, DOI 10.18632/oncotarget.8316
   West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973
   Whitehead GS, 2017, J CLIN INVEST, V127, P3319, DOI 10.1172/JCI90890
   Wilson Kevin C, 2004, J Intensive Care Med, V19, P183, DOI 10.1177/0885066604263918
   Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051
   Zhu HQ, 2010, J BIOL CHEM, V285, P9429, DOI 10.1074/jbc.M109.071274
   Zidi I, 2010, MED ONCOL, V27, P185, DOI 10.1007/s12032-009-9190-3
   Ziesche E, 2013, NUCLEIC ACIDS RES, V41, P90, DOI 10.1093/nar/gks916
NR 52
TC 87
Z9 90
U1 4
U2 19
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JAN 28
PY 2019
VL 10
AR 81
DI 10.1038/s41419-018-1247-9
PG 17
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA HJ2SP
UT WOS:000457020500007
PM 30692512
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Fan, QY
   Mao, H
   Xie, L
   Pi, XC
AF Fan, Qiying
   Mao, Hua
   Xie, Liang
   Pi, Xinchun
TI Prolyl Hydroxylase Domain-2 Protein Regulates Lipopolysaccharide-Induced
   Vascular Inflammation
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID NF-KAPPA-B; EPITHELIAL-CELL APOPTOSIS; ACUTE LUNG INJURY; P38 MAP
   KINASE; VE-CADHERIN; ENDOTHELIAL-CELLS; MURINE MODEL; HIF-ALPHA;
   HYPOXIA; PHD2
AB Acute lung injury and its more severe form, acute respiratory distress syndrome, are Life-threatening respiratory disorders. Overwhelming pulmonary inflammation and endothelium disruption are commonly observed. Endothelial cells (ECs) are well recognized as key regulators in leukocyte adhesion and migration in response to bacterial infection. Prolyl hydroxylase domain (PHD)-2 protein, a major PHD in ECs, plays a critical role in intracellular oxygen homeostasis, angiogenesis, and pulmonary hypertension. However, its role in endothelial inflammatory response is unclear. We investigated the role of PHD2 in ECs during endotoxin-induced lung inflammatory responses with EC-specific PHD2 inducible knockout mice. On lipopolysaccharide challenge, PHD2 depletion in ECs attenuates lipopolysaccharide-induced increases of Lung vascular permeability, edema, and inflammatory cell infiltration. Moreover, EC-specific PHD2 inducible knockout mice exhibit improved adherens junction integrity and endothelial barrier function. Mechanistically, PHD2 knockdown induces vascular endothelial cadherin in mouse lung microvascular primary endothelial cells. Moreover, PHD2 knockdown can increase hypoxia-inducible factor/vascular endothelial protein tyrosine phosphatase signaling and reactive oxygen species dependent p38 activation, leading to the induction of vascular endothelial cadherin. Data indicate that PHD2 depletion prevents the formation of leaky vessels and edema by regulating endothelial barrier function. It provides direct in vivo evidence to suggest that PHD2 plays a pivotal role in vascular inflammation. The inhibition of endothelial PHD2 activity may be a new therapeutic strategy for acute inflammatory diseases.
C1 [Fan, Qiying; Mao, Hua; Xie, Liang; Pi, Xinchun] Baylor Coll Med, Dept Med, Sect Athero & Lipo, Cardiovasc Res Inst, Houston, TX 77030, United States.
C3 Baylor College of Medicine
RP Xie, L; Pi, XC (corresponding author), Baylor Coll Med, Cardiovasc Res Inst, Houston, TX 77030 USA.; Xie, L; Pi, XC (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
EM liangx@bcm.edu; xpi@bcm.edu
FU NIH [HL112890, HL061656, HL122736]
FX Supported by NIH R01s HL112890 and HL061656 (X.P.) and HL122736 (L.X.).
CR Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200
   Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62
   Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346
   Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07
   Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525
   Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373
   Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012
   Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103
   Dai ZY, 2016, CIRCULATION, V133, P2447, DOI 10.1161/CIRCULATIONAHA.116.021494
   Dejana E, 2012, CURR OPIN HEMATOL, V19, P218, DOI 10.1097/MOH.0b013e3283523e1c
   Deleuze V, 2007, MOL CELL BIOL, V27, P2687, DOI 10.1128/MCB.00493-06
   Di Conza G, 2017, CELL REP, V18, P2836, DOI 10.1016/j.celrep.2017.02.081
   Duan LJ, 2011, AM J PATHOL, V178, P1881, DOI 10.1016/j.ajpath.2010.12.016
   Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283
   Fang Y, 2016, ONCOTARGET, V7, P54317, DOI 10.18632/oncotarget.11104
   Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10
   Fu J, 2013, MOL CELL BIOL, V33, P3050, DOI 10.1128/MCB.00273-13
   Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600
   Gill SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088501
   Gong HX, 2015, J CLIN INVEST, V125, P652, DOI 10.1172/JCI77701
   Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072
   Hams E, 2011, SHOCK, V36, P295, DOI 10.1097/SHK.0b013e318225ad7e
   Harnoss JM, 2015, HYPOXIA, V3, P1, DOI 10.2147/HP.S60872
   Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817
   Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796
   Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775
   Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009
   Khanna P, 2010, AM J PHYSIOL-CELL PH, V298, pC1140, DOI 10.1152/ajpcell.00242.2009
   Kiss J, 2012, J IMMUNOL, V189, P1955, DOI 10.4049/jimmunol.1103471
   Kobayashi S, 2015, GENES CELLS, V20, P224, DOI 10.1111/gtc.12215
   Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833
   Lakshmi SP, 2012, AM J PHYSIOL-LUNG C, V303, pL758, DOI 10.1152/ajplung.00107.2012
   Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566
   Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9
   Lockyer P, 2017, ARTERIOSCL THROM VAS, V37, P1524, DOI 10.1161/ATVBAHA.117.309521
   Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009
   Manresa MC, 2017, CELL MOL GASTROENTER, V3, P303, DOI 10.1016/j.jcmgh.2017.02.004
   Mao H, 2016, ARTERIOSCL THROM VAS, V36, P350, DOI 10.1161/ATVBAHA.115.306713
   Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812
   Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09
   Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406
   Nwariaku FE, 2002, SHOCK, V18, P82, DOI 10.1097/00024382-200207000-00015
   Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x
   Pi XC, 2004, CIRC RES, V94, P362, DOI 10.1161/01.RES.0000112406.27800.6F
   Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200
   Ragaller Maximillian, 2010, J Emerg Trauma Shock, V3, P43, DOI 10.4103/0974-2700.58663
   Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033
   Runkle EA, 2013, CANCER LETT, V337, P41, DOI 10.1016/j.canlet.2013.05.038
   Schneider M, 2010, GASTROENTEROLOGY, V138, P1143, DOI 10.1053/j.gastro.2009.09.057
   Son Y, 2013, METHOD ENZYMOL, V528, P27, DOI 10.1016/B978-0-12-405881-1.00002-1
   Sukriti S, 2014, PULM CIRC, V4, P535, DOI 10.1086/677356
   Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06
   Takeda K, 2009, ARTERIOSCL THROM VAS, V29, P2132, DOI 10.1161/ATVBAHA.109.196071
   Tambuwala MM, 2010, GASTROENTEROLOGY, V139, P2093, DOI 10.1053/j.gastro.2010.06.068
   VANDENBROUCKE ST, 2012, CIRC RES, V111, P739, DOI DOI 10.1161/CIRCRESAHA.112.269654
   Walmsley SR, 2011, J CLIN INVEST, V121, P1053, DOI 10.1172/JCI43273
   Wang S, 2016, ONCOTARGET, V7, P58848, DOI 10.18632/oncotarget.11585
   Xie L, 2015, J CLIN INVEST, V125, P2759, DOI 10.1172/JCI80369
   Xie L, 2015, J MOL CELL CARDIOL, V80, P156, DOI 10.1016/j.yjmcc.2015.01.007
   Xie L, 2012, J CLIN INVEST, V122, P2827, DOI 10.1172/JCI62374
   Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444
   Yi Y, 2010, CLIN CANCER RES, V16, P5142, DOI 10.1158/1078-0432.CCR-09-3416
NR 64
TC 10
Z9 10
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD JAN
PY 2019
VL 189
IS 1
BP 200
EP 213
DI 10.1016/j.ajpath.2018.09.012
PG 14
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA HG0XN
UT WOS:000454672700020
PM 30339838
OA Green Published, hybrid
DA 2023-08-21
ER

PT J
AU He, MY
   Shi, W
   Yu, M
   Li, X
   Xu, J
   Zhu, JL
   Jin, LL
   Xie, WP
   Kong, H
AF He, Mengyu
   Shi, Wen
   Yu, Min
   Li, Xiang
   Xu, Jian
   Zhu, Jiali
   Jin, Linling
   Xie, Weiping
   Kong, Hui
TI Nicorandil Attenuates LPS-Induced Acute Lung Injury by Pulmonary
   Endothelial Cell Protection via NF-kappa B and MAPK Pathways
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
AB Acute lung injury (ALI) is a devastating critical disease characterized by diffuse inflammation and endothelial dysfunction. Increasing evidence, including from our laboratory, has revealed that the opening of ATP-sensitive potassium (K-ATP) channels has promising anti-inflammation and endothelial protection activities in various disorders. However, the impacts of K-ATP channels on ALI remain obscure. In this study, we used nicorandil (Nico), a classic K-ATP channel opener, to investigate whether opening of K-ATP channels could alleviate ALI with an emphasis on human pulmonary artery endothelial cell (HPAEC) modulation. The results showed that Nico inhibited lipopolysaccharide- (LPS-) induced inflammatory response, protein accumulation, myeloperoxidase activity, and endothelial injury. In vitro, Nico reduced LPS-induced HPAEC apoptosis and the expression of cleaved-caspase-3, caspase-9, and CCAAT/enhancer-binding protein homologous protein (CHOP). Additionally, Nico inhibited inflammation by suppressing monocyte-endothelial adhesion and decreasing the expression of proinflammatory proteins. Moreover, Nico restored the expression and the distribution of adherens junction vascular endothelial- (VE-) cadherin. Further, Nico abolished the increase in intracellular reactive oxygen species (ROS) and the activation of NF-kappa B and mitogen-activated protein kinase (MAPK) in HPAECs. Glibenclamide (Gli), a nonselective K-ATP channel blocker, abrogated the effects of Nico, implying that opening of K-ATP channels contributes to the relief of ALI. Together, our findings indicated that Nico alleviated LPS-induced ALI by protecting ECs function via preventing apoptosis, suppressing endothelial inflammation and reducing oxidative stress, which may be attributed to the inhibition of NF-kappa B and MAPK signaling pathways.
C1 [He, Mengyu; Shi, Wen; Yu, Min; Li, Xiang; Xu, Jian; Zhu, Jiali; Jin, Linling; Xie, Weiping; Kong, Hui] Nanjing Med Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Nanjing 210029, Jiangsu, China.
C3 Nanjing Medical University
RP Xie, WP; Kong, H (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Nanjing 210029, Jiangsu, Peoples R China.
EM wpxie@njmu.edu.cn; konghui@njmu.edu.cn
RI li, xiang/GWM-6319-2022; Li, Xiang/HGF-3237-2022
FU National Natural Science Foundation of China (NSFC) [81273571, 81800090,
   8187010350]; Jiangsu Clinical Research Center for Respiratory Diseases
   Project [BL2012012]
FX This work was supported by the National Natural Science Foundation of
   China (NSFC) under Grant 81273571, 81800090, and 8187010350 and the
   Jiangsu Clinical Research Center for Respiratory Diseases Project under
   Grant BL2012012.
CR Abdel-Raheem IT, 2013, BASIC CLIN PHARMACOL, V113, P158, DOI 10.1111/bcpt.12078
   Ahmed LA, 2015, SCI REP-UK, V5, DOI 10.1038/srep14043
   Ali J, 1997, MICROCIRCULATION-LON, V4, P267, DOI 10.3109/10739689709146790
   AZIZ Q, 2002, THE JOURNAL OF BIOLO, V292, P17587, DOI DOI 10.1074/JBC.M117.810325
   Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106
   Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086
   Butt Y, 2016, ARCH PATHOL LAB MED, V140, P345, DOI 10.5858/arpa.2015-0519-RA
   Chatterjee S, 2008, CELL BIOCHEM BIOPHYS, V52, P125, DOI 10.1007/s12013-008-9030-7
   Di A, 2016, CELL CALCIUM, V60, P163, DOI 10.1016/j.ceca.2016.02.002
   Dong YF, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0527-5
   Dzeja PP, 1998, FASEB J, V12, P523, DOI 10.1096/fasebj.12.7.523
   Fanelli Vito, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS3, DOI 10.1513/AnnalsATS.201407-340MG
   Foletto VRS, 2013, ANESTH ANALG, V116, P232, DOI 10.1213/ANE.0b013e31826f5cc5
   Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020
   HONGO M, 2002, JOURNAL OF CARDIOVAS, V46, P452, DOI DOI 10.1097/01.FJC.0000176728.74690.09
   Kadowaki D, 2015, CLIN EXP NEPHROL, V19, P1007, DOI 10.1007/s10157-015-1111-5
   Kandasamy K, 2015, AM J PHYSIOL-LUNG C, V309, pL584, DOI 10.1152/ajplung.00211.2014
   Kim E. K., 1802, BIOCHIM BIOPHYS ACTA, V1802, P396, DOI DOI 10.1016/J.BBADIS.2009.12.009
   Kratzer E, 2012, AM J RESP CELL MOL, V47, P688, DOI 10.1165/rcmb.2012-0161OC
   Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312
   Libby P, 2002, NATURE, V420, P868, DOI [10.1038/nature01323, 10.1161/ATVBAHA.108.179705]
   Matsui TC, 2015, EUR J PHARMACOL, V769, P306, DOI 10.1016/j.ejphar.2015.11.034
   Mehta D, 2014, AM J PHYSIOL-LUNG C, V307, pL924, DOI 10.1152/ajplung.00318.2014
   Millar FR, 2016, THORAX, V71, P462, DOI 10.1136/thoraxjnl-2015-207461
   NISHITOH H, 2002, JOURNAL OF BIOCHEMIS, V151, P217, DOI DOI 10.1093/JB/MVR143
   Price LC, 2012, AM J PHYSIOL-LUNG C, V302, pL803, DOI 10.1152/ajplung.00355.2011
   Sahara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033367
   Sapru A, 2015, PEDIATR CRIT CARE ME, V16, pS6, DOI 10.1097/PCC.0000000000000431
   Sargsyan E, 2008, J ENDOCRINOL, V199, P41, DOI 10.1677/JOE-08-0251
   Seok SM, 2015, INT IMMUNOPHARMACOL, V26, P203, DOI 10.1016/j.intimp.2015.03.029
   Serizawa K, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-105
   Sohn JT, 2003, ANESTHESIOLOGY, V98, P104, DOI 10.1097/00000542-200301000-00019
   Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830
   TOMASHEFSKI J, 2002, CLINICS IN CHEST MED, V21, P435, DOI DOI 10.1016/S0272-5231(05)70158-1
   UBERTI F, 2002, THE JOURNAL OF CLINI, V99, P1367, DOI DOI 10.1210/JC.2013-2103
   Villar J, 2014, CURR OPIN CRIT CARE, V20, P3, DOI 10.1097/MCC.0000000000000057
   Wang H, 2013, INT J MOL MED, V32, P187, DOI 10.3892/ijmm.2013.1379
   Wang S, 2017, ACTA PHARMACOL SIN, V38, P41, DOI 10.1038/aps.2016.118
   Wanstall JC, 1996, EUR J PHARMACOL, V303, P71, DOI 10.1016/0014-2999(96)00110-0
   Wu F, 2016, J ANESTH, V30, P410, DOI 10.1007/s00540-015-2129-2
   Wu Y, 2017, J CELL MOL MED, V21, P609, DOI 10.1111/jcmm.13006
   Xu Y, 2013, MOL VIS, V19, P203
   Yang JJ, 2015, CELL MOL LIFE SCI, V72, P4849, DOI 10.1007/s00018-015-1973-4
   Yu YZ, 2013, MOL MED REP, V7, P816, DOI 10.3892/mmr.2013.1255
   Zhao JL, 2007, VASA-J VASCULAR DIS, V36, P175, DOI 10.1024/0301-1526.36.3.175
   Zhu R, 2015, MOL MED REP, V12, P2945, DOI 10.3892/mmr.2015.3695
NR 46
TC 29
Z9 29
U1 2
U2 8
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PY 2019
VL 2019
AR 4957646
DI 10.1155/2019/4957646
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA HQ5FJ
UT WOS:000462435100001
PM 30984337
OA Green Submitted, Green Published, gold
DA 2023-08-21
ER

PT J
AU Proudfoot, A
   Bayliffe, A
   O'Kane, CM
   Wright, T
   Serone, A
   Bareille, PJ
   Brown, V
   Hamid, UI
   Chen, YN
   Wilson, R
   Cordy, J
   Morley, P
   de Wildt, R
   Elborn, S
   Hind, M
   Chilvers, ER
   Griffiths, M
   Summers, C
   McAuley, DF
AF Proudfoot, Alastair G.
   Bayliffe, Andrew
   O'Kane, Cecilia M.
   Wright, Tracey
   Serone, Adrian
   Bareille, Philippe Jean
   Brown, Vanessa
   Hamid, Umar I.
   Chen, Younan
   Wilson, Robert
   Cordy, Joanna
   Morley, Peter
   de Wildt, Ruud
   Elborn, Stuart
   Hind, Matthew
   Chilvers, Edwin R.
   Griffiths, Mark J.
   Summers, Charlotte
   McAuley, Daniel Francis
TI Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody
   prevents pulmonary inflammation in experimental acute lung injury
SO THORAX
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; SEPTIC
   SHOCK; SEVERE SEPSIS; FACTOR-ALPHA; MONOCLONAL-ANTIBODY; FUSION PROTEIN;
   DOUBLE-BLIND; P55; PATHWAY
AB Background Tumour necrosis factor alpha (TNF-alpha) is a pleiotropic cytokine with both injurious and protective functions, which are thought to diverge at the level of its two cell surface receptors, TNFR1 and TNFR2. In the setting of acute injury, selective inhibition of TNFR1 is predicted to attenuate the cell death and inflammation associated with TNF-alpha, while sparing or potentiating the protective effects of TNFR2 signalling. We developed a potent and selective antagonist of TNFR1 (GSK1995057) using a novel domain antibody (dAb) therapeutic and assessed its efficacy in vitro, in vivo and in a clinical trial involving healthy human subjects.
   Methods We investigated the in vitro effects of GSK1995057 on human pulmonary microvascular endothelial cells (HMVEC-L) and then assessed the effects of pretreatment with nebulised GSK1995057 in a non-human primate model of acute lung injury. We then tested translation to humans by investigating the effects of a single nebulised dose of GSK1995057 in healthy humans (n=37) in a randomised controlled clinical trial in which subjects were subsequently exposed to inhaled endotoxin.
   Results Selective inhibition of TNFR1 signalling potently inhibited cytokine and neutrophil adhesion molecule expression in activated HMVEC-L monolayers in vitro (P<0.01 and P<0.001, respectively), and also significantly attenuated inflammation and signs of lung injury in non-human primates (P<0.01 in all cases). In a randomised, placebo-controlled trial of nebulised GSK1995057 in 37 healthy humans challenged with a low dose of inhaled endotoxin, treatment with GSK1995057 attenuated pulmonary neutrophilia, inflammatory cytokine release (P<0.01 in all cases) and signs of endothelial injury (P<0.05) in bronchoalveolar lavage and serum samples.
   Conclusion These data support the potential for pulmonary delivery of a selective TNFR1 dAb as a novel therapeutic approach for the prevention of acute respiratory distress syndrome.
C1 [Proudfoot, Alastair; Hind, Matthew; Griffiths, Mark] Imperial Coll, Natl Heart & Lung Inst, London, England, United Kingdom.
   [Bayliffe, Andrew; Wright, Tracey; Bareille, Philippe Jean; Wilson, Robert; Cordy, Joanna; Morley, Peter; de Wildt, Ruud] GlaxoSmithKline Res & Dev Ltd, Stevenage, Herts, England, United Kingdom.
   [O'Kane, Cecilia M.; Brown, Vanessa; Hamid, Umar I.; Elborn, Stuart; McAuley, Daniel Francis] Queens Univ Belfast, Ctr Med Expt, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland, United Kingdom.
   [Serone, Adrian; Chen, Younan] GlaxoSmithKline R&D, Philadelphia, PA, United States.
   [Hind, Matthew] Royal Brompton & Harefield NHS Fdn Trust, Natl Inst Hlth Res Resp Biomed Res Unit, London, England, United Kingdom.
   [Chilvers, Edwin R.; Griffiths, Mark; Summers, Charlotte] Univ Cambridge, Dept Med, Sch Clin Med, Cambridge, England, United Kingdom.
C3 Imperial College London; GlaxoSmithKline; Queens University Belfast;
   GlaxoSmithKline; Royal Brompton & Harefield NHS Foundation Trust;
   University of Cambridge
RP McAuley, DF (corresponding author), Queens Univ Belfast, Ctr Med Expt, Belfast BT9 7AE, Antrim, North Ireland.
EM d.f.mcauley@qub.ac.uk
RI Hind, Matthew/AAC-4384-2021; Serone, Adrian/AAF-1918-2020; Chen,
   Younan/AAK-1654-2021; Proudfoot, Alastair/AAG-3235-2021; O'Kane, Cecilia
   M/E-8843-2010; Summers, Charlotte/A-6973-2012
OI Serone, Adrian/0000-0002-4615-3438; Chen, Younan/0000-0002-0455-2473;
   Summers, Charlotte/0000-0002-7269-2873; Griffiths,
   Mark/0000-0002-1615-1896; O'Kane, Cecilia/0000-0002-7138-5396; McAuley,
   Daniel/0000-0002-3283-1947; Hind, Matthew/0000-0002-9966-9446; Chilvers,
   Edwin/0000-0002-4230-9677; Cordy, Joanna/0000-0002-4892-4785
FU GlaxoSmithKline; Wellcome Trust; Wellcome Trust Clinical Research
   Training Fellowship [WT097248MA]; Wellcome Trust Postdoctoral Training
   Fellowship for Clinician Scientists [WT101692MA]; DH/NI HSC R&D
   Clinician Scientist Fellowship; NIHR Cambridge Biomedical Research
   Centre; NIHR Respiratory Disease Biomedical Research Unit at the Royal
   Brompton and Harefield NHS Foundation Trust and Imperial College London;
   MRC [G0701690] Funding Source: UKRI
FX GlaxoSmithKline funded the clinical trial and animal study, and the
   human tissue work was completed with funding from the Wellcome Trust. AP
   held a Wellcome Trust Clinical Research Training Fellowship
   (WT097248MA), CS held a Wellcome Trust Postdoctoral Training Fellowship
   for Clinician Scientists (WT101692MA). CMO'K is funded by a DH/NI HSC
   R&D Clinician Scientist Fellowship. ERC receives support from the NIHR
   Cambridge Biomedical Research Centre. MG is funded by the NIHR
   Respiratory Disease Biomedical Research Unit at the Royal Brompton and
   Harefield NHS Foundation Trust and Imperial College London.
CR Abraham E, 1998, LANCET, V351, P929
   Abraham E, 1997, JAMA-J AM MED ASSOC, V277, P1531, DOI 10.1001/jama.277.19.1531
   Al-Lamki RS, 2005, FASEB J, V19, P1637, DOI 10.1096/fj.05-3841com
   Barr LC, 2013, AM J RESP CRIT CARE, V188, P449, DOI 10.1164/rccm.201212-2334OC
   Bernard GR, 2014, CRIT CARE MED, V42, P504, DOI 10.1097/CCM.0000000000000043
   Bertok S, 2012, THORAX, V67, P244, DOI 10.1136/thoraxjnl-2011-200590
   Bluml S, 2010, ANN RHEUM DIS, V69, DOI 10.1136/ard.2010.129627a
   Boyle AJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-166
   Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924
   Cohen J, 1996, CRIT CARE MED, V24, P1431, DOI 10.1097/00003246-199609000-00002
   Cowburn AS, 2008, CHEST, V134, P606, DOI 10.1378/chest.08-0422
   Ebach DR, 2005, SHOCK, V23, P311, DOI 10.1097/01.shk.0000157301.87051.77
   Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030
   Finsterbusch M, 2014, J EXP MED, V211, P1306, DOI 10.1084/jem.20132413
   Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603
   Frank JA, 2006, CHEST, V130, P1906, DOI 10.1378/chest.130.6.1906
   Guilleminault L, 2014, J CONTROL RELEASE, V196, P344, DOI 10.1016/j.jconrel.2014.10.003
   Holland MC, 2013, J CLIN IMMUNOL, V33, P1192, DOI 10.1007/s10875-013-9915-0
   Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007
   Imai Y, 1999, J APPL PHYSIOL, V87, P510, DOI 10.1152/jappl.1999.87.2.510
   Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65
   Luo DH, 2006, AM J PATHOL, V169, P1886, DOI 10.2353/ajpath.2006.060603
   Mac Sweeney R, 2016, LANCET, V388, P2416, DOI 10.1016/S0140-6736(16)00578-X
   Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   Michel O, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-60
   National Research Council (US) Institute for Laboratory Animal Research, 1996, GUIDE CARE USE LAB A
   Oakley CM, 2017, AM J RESP CRIT CARE, V195
   Panacek EA, 2004, CRIT CARE MED, V32, P2173, DOI 10.1097/01.CCM.0000145229.59014.6c
   Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013
   Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC
   Patel BV, 2013, J IMMUNOL, V190, P4274, DOI 10.4049/jimmunol.1202437
   Proudfoot AG, 2011, DIS MODEL MECH, V4, P145, DOI 10.1242/dmm.006213
   Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   SCHLAG G, 1994, SHOCK, V2, P10, DOI 10.1097/00024382-199407000-00002
   Shyamsundar M, 2014, AM J RESP CRIT CARE, V189, P1520, DOI 10.1164/rccm.201310-1892OC
   Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC
   Summers C, 2014, THORAX, V69, P623, DOI 10.1136/thoraxjnl-2013-204742
   Tomkinson A, 2010, ALLERGY, V65, P69, DOI 10.1111/j.1398-9995.2009.02156.x
   Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189
   Wilson MR, 2007, AM J PHYSIOL-LUNG C, V293, pL60, DOI 10.1152/ajplung.00284.2006
   Yoshikawa S, 2004, J APPL PHYSIOL, V97, P2190, DOI 10.1152/japplphysiol.00324.2004
NR 43
TC 50
Z9 52
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0040-6376
EI 1468-3296
J9 THORAX
JI Thorax
PD AUG
PY 2018
VL 73
IS 8
BP 723
EP 730
DI 10.1136/thoraxjnl-2017-210305
PG 8
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA GR3EP
UT WOS:000442473100007
PM 29382797
OA hybrid, Green Published
DA 2023-08-21
ER

PT J
AU Mahapatra, S
   Ying, LH
   Ho, PPK
   Kurnellas, M
   Rothbard, J
   Steinman, L
   Cornfield, DN
AF Mahapatra, Sidharth
   Ying, Lihua
   Ho, Peggy Pui-Kay
   Kurnellas, Michael
   Rothbard, Jonathan
   Steinman, Lawrence
   Cornfield, David N.
TI An amyloidogenic hexapeptide derived from amylin attenuates inflammation
   and acute lung injury in murine sepsis
SO PLOS ONE
LA English
DT Article
ID ALPHA-B-CRYSTALLIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS;
   CHAPERONE-LIKE ACTIVITY; MULTIPLE-SCLEROSIS; ALZHEIMER-DISEASE; BRAIN
   DISEASE; CELLS; MICE; APOPTOSIS; PROTEINS
AB Although the accumulation of amyloidogenic proteins in neuroinflammatory conditions is generally considered pathologic, in a murine model of multiple sclerosis, amyloid-forming fibrils, comprised of hexapeptides, are anti-inflammatory. Whether these molecules modulate systemic inflammatory conditions remains unknown. We hypothesized that an amylin hexapeptide that forms fibrils can attenuate the systemic inflammatory response in a murine model of sepsis. To test this hypothesis, mice were pre-treated with either vehicle or amylin hexapeptide (20 mu g) at 12 hours and 6 hours prior to intraperitoneal (i.p.) lipopolysaccharide (LPS, 20 mg/kg) administration. Illness severity and survival were monitored every 6 hours for 3 days. Levels of pro- (IL-6, TNF-alpha, IFN-gamma) and anti-inflammatory (IL-10) cytokines were measured via ELISA at 1, 3, 6, 12, and 24 hours after LPS (i.p.). As a metric of lung injury, pulmonary artery endothelial cell (PAEC) barrier function was tested 24 hours after LPS administration by comparing lung wet-to-dry ratios, Evan's blue dye (EBD) extravasation, lung histology and caspase-3 activity. Compared to controls, pretreatment with amylin hexapeptide significantly reduced mortality (p<0.05 at 72 h), illness severity (p<0.05), and pro-inflammatory cytokine levels, while IL-10 levels were elevated (p<0.05). Amylin pretreatment attenuated LPS-induced lung injury, as demonstrated by decreased lung water and caspase-3 activity (p<0.05, versus PBS). Hence, in a murine model of systemic inflammation, pretreatment with amylin hexapeptide reduced mortality, disease severity, and preserved lung barrier function. Amylin hexapeptide may represent a novel therapeutic tool to mitigate sepsis severity and lung injury.
C1 [Mahapatra, Sidharth] Univ Nebraska Med Ctr, Dept Pediat, Omaha, NE 68198, United States.
   [Ying, Lihua; Cornfield, David N.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305, United States.
   [Ho, Peggy Pui-Kay; Rothbard, Jonathan; Steinman, Lawrence] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305, United States.
   [Kurnellas, Michael] Alector, San Francisco, CA, United States.
C3 University of Nebraska System; University of Nebraska Medical Center;
   Stanford University; Stanford University
RP Mahapatra, S (corresponding author), Univ Nebraska Med Ctr, Dept Pediat, Omaha, NE 68198 USA.
EM sidharth.mahapatra@unmc.edu
RI Mahapatra, Sidharth/H-4697-2019
OI Mahapatra, Sidharth/0000-0002-2483-0610; Steinman,
   Lawrence/0000-0002-2437-2250; /0000-0002-6848-318X
FU National Multiple Sclerosis Society Grant [NMSS SPO 112677]
FX The work in this manuscript was supported by the National Multiple
   Sclerosis Society Grant (NMSS SPO 112677) to Lawrence Steinman. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Arac A, 2011, P NATL ACAD SCI USA, V108, P13287, DOI 10.1073/pnas.1107368108
   Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141
   Cao CZ, 2010, J CLIN INVEST, V120, P1971, DOI 10.1172/JCI40380
   Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022
   Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833
   FREUDENBERG M A, 1990, International Reviews of Immunology, V6, P207, DOI 10.3109/08830189009056632
   Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130
   Gourdain P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-25
   Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145
   GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611
   Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559
   Hoff J, 2000, LAB ANIMAL, V29, P47
   ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X
   Ji Z, 2012, IMMUNOL CELL BIOL, V90, P388, DOI 10.1038/icb.2011.51
   Kitamura Y, 2001, AM J RESP CRIT CARE, V163, P762, DOI 10.1164/ajrccm.163.3.2003065
   Kurnellas MP, 2014, J EXP MED, V211, P1847, DOI 10.1084/jem.20140107
   Kurnellas MP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005681
   Kurnellas MP, 2012, J BIOL CHEM, V287, P36423, DOI 10.1074/jbc.M112.371229
   Kurnellas MP, 2015, P NATL ACAD SCI USA, V112, P15016, DOI 10.1073/pnas.1521206112
   Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151
   Maseda D, 2013, J IMMUNOL, V191, P2780, DOI 10.4049/jimmunol.1300649
   Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293
   Mehta D, 2014, AM J PHYSIOL-LUNG C, V307, pL924, DOI 10.1152/ajplung.00318.2014
   Moitra J, 2007, TRANSL RES, V150, P253, DOI 10.1016/j.trsl.2007.03.013
   Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680
   Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935
   Pangratz-Fuehrer S, 2011, EYE, V25, P809, DOI 10.1038/eye.2011.42
   Penaloza HF, 2015, IMMUNOLOGY, V146, P100, DOI 10.1111/imm.12486
   Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004
   ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016
   Rothbard JB, 2012, J BIOL CHEM, V287, P9708, DOI 10.1074/jbc.M111.337691
   Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695
   Shrum Bradly, 2014, BMC Res Notes, V7, P233, DOI 10.1186/1756-0500-7-233
   Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022
   Skelly CL, 2007, P NATL ACAD SCI USA, V104, P12474, DOI 10.1073/pnas.0705429104
   Tanaka N, 2008, BIOCHEMISTRY-US, V47, P2961, DOI 10.1021/bi701823g
   Tedder TF, 2010, J ALLERGY CLIN IMMUN, V125, P1125, DOI 10.1016/j.jaci.2010.03.024
   Velotta JB, 2011, ANN THORAC SURG, V91, P1907, DOI 10.1016/j.athoracsur.2011.02.072
   Weinger JG, 2012, J NEUROPATH EXP NEUR, V71, P422, DOI 10.1097/NEN.0b013e3182540d2e
   Wekerle H, 2005, NEUROL SCI, V26, pS1, DOI 10.1007/s10072-005-0386-9
   Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003
   Yanai H, 2013, P NATL ACAD SCI USA, V110, P20699, DOI 10.1073/pnas.1320808110
NR 42
TC 3
Z9 4
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 10
PY 2018
VL 13
IS 7
AR e0199206
DI 10.1371/journal.pone.0199206
PG 15
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GM5IS
UT WOS:000438170300007
PM 29990318
OA gold, Green Published, Green Submitted
DA 2023-08-21
ER

PT J
AU Hsiao, HM
   Fernandez, R
   Tanaka, S
   Li, WJ
   Spahn, JH
   Chiu, S
   Akbarpour, M
   Ruiz-Perez, D
   Wu, Q
   Turam, C
   Scozzi, D
   Takahashi, T
   Luehmann, HP
   Puri, V
   Budinger, GRS
   Krupnick, AS
   Misharin, AV
   Lavine, KJ
   Liu, YJ
   Gelman, AE
   Bharat, A
   Kreisel, D
AF Hsiao, Hsi-Min
   Fernandez, Ramiro
   Tanaka, Satona
   Li, Wenjun
   Spahn, Jessica H.
   Chiu, Stephen
   Akbarpour, Mahzad
   Ruiz-Perez, Daniel
   Wu, Qiang
   Turam, Cem
   Scozzi, Davide
   Takahashi, Tsuyoshi
   Luehmann, Hannah P.
   Puri, Varun
   Budinger, G. R. Scott
   Krupnick, Alexander S.
   Misharin, Alexander V.
   Lavine, Kory J.
   Liu, Yongjian
   Gelman, Andrew E.
   Bharat, Ankit
   Kreisel, Daniel
TI Spleen-derived classical monocytes mediate lung ischemia-reperfusion
   injury through IL-beta
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID PRIMARY GRAFT DYSFUNCTION; NEUTROPHIL EXTRACELLULAR TRAPS;
   FLOW-CYTOMETRIC ANALYSIS; ALLOGRAFT DYSFUNCTION; CHRONIC INFLAMMATION;
   CHRONIC REJECTION; TRANSPLANTATION; MACROPHAGES; MICE; SUBSETS
AB lschemia-reperfusion injury, a form of sterile inflammation, is the leading risk factor for both short-term mortality following pulmonary transplantation and chronic lung allograft dysfunction. While it is well recognized that neutrophils are critical mediators of acute lung injury, processes that guide their entry into pulmonary tissue are not well understood. Here, we found that CCR2(+) classical monocytes are necessary and sufficient for mediating extravasation of neutrophils into pulmonary tissue during ischemia-reperfusion injury following hilar clamping or lung transplantation. The classical monocytes were mobilized from the host spleen, and splenectomy attenuated the recruitment of classical monocytes as well as the entry of neutrophils into injured lung tissue, which was associated with improved graft function. Neutrophil extravasation was mediated by MyD88-dependent IL-1 beta production by graft-infiltrating classical monocytes, which downregulated the expression of the tight junction-associated protein ZO-2 in pulmonary vascular endothelial cells. Thus, we have uncovered a crucial role for classical monocytes, mobilized from the spleen, in mediating neutrophil extravasation, with potential implications for targeting of recipient classical monocytes to ameliorate pulmonary ischemia-reperfusion injury in the clinic.
C1 [Hsiao, Hsi-Min; Tanaka, Satona; Li, Wenjun; Spahn, Jessica H.; Ruiz-Perez, Daniel; Turam, Cem; Scozzi, Davide; Takahashi, Tsuyoshi; Puri, Varun; Gelman, Andrew E.; Kreisel, Daniel] Washington Univ, Dept Surg, St Louis, MO 63110, United States.
   [Fernandez, Ramiro; Chiu, Stephen; Akbarpour, Mahzad; Wu, Qiang; Bharat, Ankit] Northwestern Univ, Dept Surg, Chicago, IL 60611, United States.
   [Luehmann, Hannah P.; Liu, Yongjian] Washington Univ, Dept Radiol, St Louis, MO 63110, United States.
   [Budinger, G. R. Scott; Misharin, Alexander V.; Bharat, Ankit] Northwestern Univ, Dept Med, 676 N St Clair Ave,Suite 650, Chicago, IL 60611, United States.
   [Krupnick, Alexander S.] Univ Virginia, Dept Surg, Charlottesville, VA, United States.
   [Lavine, Kory J.] Washington Univ, Dept Med, St Louis, MO 63110, United States.
   [Gelman, Andrew E.; Kreisel, Daniel] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110, United States.
C3 Washington University (WUSTL); Northwestern University; Washington
   University (WUSTL); Northwestern University; University of Virginia;
   Washington University (WUSTL); Washington University (WUSTL)
RP Bharat, A (corresponding author), Northwestern Univ, Dept Med, 676 N St Clair Ave,Suite 650, Chicago, IL 60611 USA.; Kreisel, D (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8234,660 South Euclid Ave, St Louis, MO 63110 USA.
EM abharat@nm.org; kreiseld@wustl.edu
RI Scozzi, Davide/M-1363-2019; Wu, Qiang/L-4420-2018; Misharin,
   Alexander/AAD-6456-2019; Li, Wen-Jun/ACA-8525-2022; Akbarpour,
   Mahzad/AAG-8506-2019; Tanaka, Satona/ABF-9932-2021
OI Wu, Qiang/0000-0002-3345-9905; Li, Wen-Jun/0000-0002-1233-736X; Tanaka,
   Satona/0000-0002-0789-2350; Hsiao, Hsi-Min Jim/0000-0003-1918-7381;
   Ruiz-Perez, Daniel/0000-0001-9388-8704; Fernandez,
   Ramiro/0000-0002-0590-3773
FU NIH [1P01AI116501, R01 HL094601, P01 AG049665, P01 HL071643, HL125940,
   R01 HL125655, R01 HL131908]; Veterans Administration Merit Review
   [1I01BX002730]; Foundation for Barnes-Jewish Hospital; NIH Transplant
   Scientist Training Program [T32 DK077662]; International Society of
   Heart and Lung Transplantation Research awards; Department of the Army
   [W81XWH-15-1-0215]; Thoracic Surgery Foundation; American Lung
   Association; Society of University Surgeons; Cancer Center support grant
   [NCI CA060553]
FX This work was supported by NIH 1P01AI116501 and R01 HL094601 (to DK and
   AEG), Veterans Administration Merit Review 1I01BX002730, the Foundation
   for Barnes-Jewish Hospital (to DK and AEG), the NIH Transplant Scientist
   Training Program (T32 DK077662 to RF and SC), International Society of
   Heart and Lung Transplantation Research awards (to HMH and RF), NIH P01
   AG049665, NIH P01 HL071643, Department of the Army W81XWH-15-1-0215 (to
   GRSB and AVM), and NIH HL125940, the Thoracic Surgery Foundation, the
   American Lung Association, and the Society of University Surgeons (to
   AB). The Northwestern University Flow Cytometry Core Facility is
   supported by a Cancer Center support grant (NCI CA060553). Flow
   cytometry cell sorting at Northwestern University was performed on a BD
   FACSAria SORP system, purchased through the support of NIH
   1S10OD011996-01. YL and HPL were supported by NIH R01 HL125655 and NIH
   R01 HL131908. We thank the Molecular Microbiology Imaging Facility at
   Washington University in St. Louis for their technical support.
CR Ahdieh M, 2001, AM J PHYSIOL-CELL PH, V281, pC2029, DOI 10.1152/ajpcell.2001.281.6.C2029
   Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883
   Baddoura FK, 2005, AM J TRANSPLANT, V5, P510, DOI 10.1111/j.1600-6143.2004.00714.x
   Belperio JA, 2005, J IMMUNOL, V175, P6931, DOI 10.4049/jimmunol.175.10.6931
   Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849
   Bharat A, 2008, ANN THORAC SURG, V86, P189, DOI 10.1016/j.athoracsur.2008.03.073
   Bharat A, 2016, AM J RESP CELL MOL, V54, P147, DOI 10.1165/rcmb.2015-0147LE
   Bharat A, 2010, ANN THORAC SURG, V90, P1094, DOI 10.1016/j.athoracsur.2010.06.009
   Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com
   Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010
   Chiu S, 2016, CURR OPIN ORGAN TRAN, V21, P239, DOI 10.1097/MOT.0000000000000313
   Christie JD, 2005, J HEART LUNG TRANSPL, V24, P1454, DOI 10.1016/j.healun.2004.11.049
   Collison JL, 2015, J IMMUNOL, V195, P1162, DOI 10.4049/jimmunol.1401806
   Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012
   Dagvadorj J, 2015, IMMUNITY, V42, P640, DOI 10.1016/j.immuni.2015.03.007
   Daud SA, 2007, AM J RESP CRIT CARE, V175, P507, DOI 10.1164/rccm.200608-1079OC
   Desch AN, 2016, AM J RESP CRIT CARE, V193, P614, DOI 10.1164/rccm.201507-1376OC
   Francis M, 2017, TOXICOL SCI, V155, P182, DOI 10.1093/toxsci/kfw192
   Gelman AE, 2010, AM J TRANSPLANT, V10, P1189, DOI 10.1111/j.1600-6143.2010.03101.x
   Hachem RR, 2009, CURR OPIN ORGAN TRAN, V14, P477, DOI 10.1097/MOT.0b013e32832fb981
   Hanna RN, 2015, SCIENCE, V350, P985, DOI 10.1126/science.aac9407
   Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463
   Hsiao HM, 2015, AM J PATHOL, V185, P3189, DOI 10.1016/j.ajpath.2015.08.008
   Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258
   Huston JM, 2008, J IMMUNOL, V181, P3535, DOI 10.4049/jimmunol.181.5.3535
   Koltsova EK, 2012, J CLIN INVEST, V122, P3114, DOI 10.1172/JCI61758
   Kreisel D, 2011, J CLIN INVEST, V121, P265, DOI 10.1172/JCI42596
   Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   Li W, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86660
   Lin HYH, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0037-0
   Liu Y, 2016, AM J TRANSPLANT, V16, P3016, DOI 10.1111/ajt.13907
   Liu YJ, 2017, RADIOLOGY, V283, P757, DOI 10.1148/radiol.2016161409
   Martin TR, 2002, J CLIN INVEST, V110, P1603, DOI 10.1172/JCI200217302
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152
   Misharin AV, 2014, CELL REP, V9, P591, DOI 10.1016/j.celrep.2014.09.032
   Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA
   Mori DN, 2014, IMMUNOL REV, V258, P132, DOI 10.1111/imr.12146
   Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885
   Okazaki M, 2007, AM J TRANSPLANT, V7, P1672, DOI 10.1111/j.1600-6143.2007.01819.x
   Porteous MK, 2015, CURR OPIN ORGAN TRAN, V20, P506, DOI 10.1097/MOT.0000000000000232
   Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914
   Sayah DM, 2015, AM J RESP CRIT CARE, V191, P455, DOI 10.1164/rccm.201406-1086OC
   Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006
   Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Sorensen OE, 2016, J CLIN INVEST, V126, P1612, DOI 10.1172/JCI84538
   Spahn JH, 2015, J IMMUNOL, V194, P4039, DOI 10.4049/jimmunol.1401415
   Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202
   Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497
   Thomas GD, 2017, ARTERIOSCL THROM VAS, V37, P1548, DOI 10.1161/ATVBAHA.117.309145
   Tsai KS, 2008, CURR OPIN PULM MED, V14, P260, DOI 10.1097/MCP.0b013e3282f76457
   Weimer R, 2003, TRANSPLANTATION, V75, P2090, DOI 10.1097/01.TP.0000058808.37349.23
   Zarbock A, 2008, BRIT J PHARMACOL, V155, P357, DOI 10.1038/bjp.2008.270
   Zheng ZK, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4508
   Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558
NR 57
TC 42
Z9 47
U1 0
U2 6
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD JUL 2
PY 2018
VL 128
IS 7
BP 2833
EP 2847
DI 10.1172/JCI98436
PG 15
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA GL5TR
UT WOS:000437234600022
PM 29781811
OA Green Published, Green Submitted, Bronze
DA 2023-08-21
ER

PT J
AU Zheng, X
   Zhang, W
   Hu, XT
AF Zheng, Xia
   Zhang, Wang
   Hu, Xiaotong
TI Different concentrations of lipopolysaccharide regulate barrier function
   through the PI3K/Akt signalling pathway in human pulmonary microvascular
   endothelial cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; NITRIC-OXIDE SYNTHASE; ACUTE LUNG INJURY;
   VE-CADHERIN; PERMEABILITY; MIGRATION; SEPSIS; PHOSPHORYLATION;
   PROLIFERATION; EXPRESSION
AB Lipopolysaccharide (LPS) can lead to vascular endothelial barrier dysfunction, which often results in acute lung injury and acute respiratory distress syndrome. However, the effects of different concentrations of LPS on human pulmonary microvascular endothelial barrier function and the involvement of the phosphatidylinositol-3-kinase-serine/threonine kinase (PI3K/Akt) pathway in this process remain unclear. Human pulmonary microvascular endothelial cells (HPMECs) were stimulated with different doses of LPS, and barrier function was examined by determining cell monolayer permeability, cell migration, and the expression of intercellular junction proteins (VE-Cadherin, Claudin-5, and Connexin-43). LY294002 was used to inhibit PI3K to verify the role of the PI3K/Akt pathway in the regulation of barrier function in HPMECs stimulated by LPS. Low doses of LPS increased HPMEC migration, up-regulated VE-Cadherin and Claudin-5 expression, down-regulated Connexin-43 expression, and promoted Akt phosphorylation, which could collectively decrease monolayer permeability. In contrast, high doses of LPS suppressed HPMEC migration, down-regulated the expression of VE-Cadherin and Claudin-5, up-regulated Connexin-43 expression, and reduced Akt phosphorylation, which could collectively increase monolayer permeability. LPS has a biphasic effect on HPMEC barrier function through the PI3K/Akt pathway, and this effect is concentration-dependent.
C1 [Zheng, Xia; Zhang, Wang] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Crit Care Med, Hangzhou 310003, Zhejiang, China.
   [Hu, Xiaotong] Zhejiang Univ, Affiliated Hosp 1, Coll Med, State Key Lab Diag & Treatment Infect Dis,Collabo, Hangzhou 310003, Zhejiang, China.
C3 Zhejiang University; Zhejiang University
RP Zheng, X (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Crit Care Med, Hangzhou 310003, Zhejiang, Peoples R China.
EM zxicu@zju.edu.cn
FU Young science foundation of National Natural Science Foundation of China
   [81101445]; Zhejiang Provincial Natural Science Foundation [LY16H150002]
FX The work was supported by Young science foundation of National Natural
   Science Foundation of China (81101445) and Zhejiang Provincial Natural
   Science Foundation (LY16H150002).
CR Akizuki R, 2017, BBA-MOL CELL RES, V1864, P293, DOI 10.1016/j.bbamcr.2016.11.018
   Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491
   Camire RB, 2014, J PHARMACOL EXP THER, V351, P654, DOI 10.1124/jpet.114.218339
   Chichger H, 2015, FASEB J, V29, P868, DOI 10.1096/fj.14-257212
   Edens HA, 2003, CURR OPIN HEMATOL, V10, P25, DOI 10.1097/00062752-200301000-00005
   Garrett JP, 2017, MOL BIOL CELL, V28, P85, DOI 10.1091/mbc.E16-08-0616
   Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486
   Gong HX, 2015, J CLIN INVEST, V125, P652, DOI 10.1172/JCI77701
   Guo CR, 2016, MOL MED, V22, DOI 10.2119/molmed.2015.00240
   Herwig MC, 2013, PATHOBIOLOGY, V80, P245, DOI 10.1159/000347062
   Huang LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160875
   Jian ZC, 2016, PHARMAZIE, V71, P588, DOI 10.1691/ph.2016.6576
   Kandasamy K, 2015, AM J PHYSIOL-LUNG C, V309, pL584, DOI 10.1152/ajplung.00211.2014
   Keck T, 2002, GASTROENTEROLOGY, V122, P188, DOI 10.1053/gast.2002.30348
   Kim DI, 2012, J CLIN IMMUNOL, V32, P340, DOI 10.1007/s10875-011-9628-1
   Laakkonen JP, 2017, ANGIOGENESIS, V20, P109, DOI 10.1007/s10456-016-9532-7
   Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65
   Liu H, 2015, INT IMMUNOPHARMACOL, V29, P937, DOI 10.1016/j.intimp.2015.10.010
   Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203
   Lv JW, 2017, MICROVASC RES, V109, P45, DOI 10.1016/j.mvr.2016.10.001
   Matsuda N, 2006, J PHARMACOL EXP THER, V319, P1348, DOI 10.1124/jpet.106.109785
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   O'Donnell JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100931
   PATTERSON CE, 1992, J APPL PHYSIOL, V72, P865, DOI 10.1152/jappl.1992.72.3.865
   Qi D, 2017, INT J MOL MED, V40, P1803, DOI 10.3892/ijmm.2017.3176
   Qi D, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.265
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Razavi HM, 2004, AM J RESP CRIT CARE, V170, P227, DOI 10.1164/rccm.200306-846OC
   Reddy NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129676
   Sarmiento D, 2014, INT J BIOCHEM CELL B, V55, P11, DOI 10.1016/j.biocel.2014.08.001
   Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288
   Sun HJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040844
   Sun YL, 2016, EXP CELL RES, V347, P274, DOI 10.1016/j.yexcr.2016.07.009
   Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752
   Xu H, 2013, INFLAMMATION, V36, P216, DOI 10.1007/s10753-012-9537-3
   Zhang J, 2015, AM J PHYSIOL-LUNG C, V309, pL1323, DOI 10.1152/ajplung.00016.2015
   Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044590
   Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106328
   Zhu MY, 2013, CIRC J, V77, P772, DOI 10.1253/circj.CJ-12-0310
NR 41
TC 49
Z9 53
U1 1
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 2
PY 2018
VL 8
AR 9963
DI 10.1038/s41598-018-28089-3
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GL2MG
UT WOS:000436955000018
PM 29967433
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Mitra, S
   Exline, M
   Habyarimana, F
   Gavrilin, MA
   Baker, PJ
   Masters, SL
   Wewers, MD
   Sarkar, A
AF Mitra, Srabani
   Exline, Matthew
   Habyarimana, Fabien
   Gavrilin, Mikhail A.
   Baker, Paul J.
   Masters, Seth L.
   Wewers, Mark D.
   Sarkar, Anasuya
TI Microparticulate Caspase 1 Regulates Gasdermin D and Pulmonary Vascular
   Endothelial Cell Injury
SO AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
LA English
DT Article
ID MEMBRANE MICROPARTICLES; GASTROINTESTINAL-TRACT; PYROPTOSIS; PORE;
   INTERLEUKIN-1-BETA; SECRETION; APOPTOSIS; RELEASE; GSDMD; MACROPHAGES
AB Lung endothelial cell apoptosis and injury occur throughout all stages of acute lung injury/acute respiratory distress syndrome and impact disease progression. Caspases 1, 4, and 5 are essential for completion of the apoptotic program known as pyroptosis that also involves proinflammatory cytokines. Because gasdermin D (GSDMD) mediates pyroptotic death and is essential for pore formation, we hypothesized that it might direct caspase 1-encapsulated microparticle (MP) release and mediate endothelial cell death. Our present work provides evidence that GSDMD is released by LPS-stimulated THP-1 monocytic cells, where it is packaged into microparticles together with active caspase 1. Furthermore, only MP released from stimulated monocytic cells that contain both cleaved GSDMD and active caspase 1 induce endothelial cell apoptosis. MPs pretreated with caspase 1 inhibitor Y-VAD or pan-caspase inhibitor Z-VAD do not contain cleaved GSDMD. MPs from caspase 1-knockout cells are also deficient in p30 active GSDMD, further confirming that caspase 1 regulates GSDMD function. Although control MPs contained cleaved GSDMD without caspase 1, these fractions were unable to induce cell death, suggesting that encapsulation of both caspase 1 and GSDMD is essential for cell death induction. Release of microparticulate active caspase 1 was abrogated in GSDMD knockout cells, although cytosolic caspase 1 activation was not impaired. Last, higher concentrations of microparticulate GSDMD were detected in the plasma of septic patients with acute respiratory distress syndrome than in that of healthy donors. Taken together, these findings suggest that GSDMD regulates the release of microparticulate active caspase 1 from monocytes essential for induction of cell death and thereby may play a critical role in sepsis-induced endothelial cell injury.
C1 [Mitra, Srabani; Sarkar, Anasuya] Ohio State Univ, Dept Physiol & Cell Biol, 473 West 12th Ave, Columbus, OH 43210, United States.
   [Mitra, Srabani; Exline, Matthew; Habyarimana, Fabien; Gavrilin, Mikhail A.; Wewers, Mark D.; Sarkar, Anasuya] Ohio State Univ, Dept Internal Med, 473 West 12th Ave, Columbus, OH 43210, United States.
   [Baker, Paul J.; Masters, Seth L.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.
   [Baker, Paul J.; Masters, Seth L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia.
C3 University System of Ohio; Ohio State University; University System of
   Ohio; Ohio State University; University of Melbourne; Walter & Eliza
   Hall Institute
RP Sarkar, A (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, 473 West 12th Ave, Columbus, OH 43210 USA.; Sarkar, A (corresponding author), Ohio State Univ, Dept Internal Med, 473 West 12th Ave, Columbus, OH 43210 USA.
EM anasuya.sarkar@osumc.edu
RI Wewers, Mark/AAB-6202-2021; Masters, Seth L/N-2886-2013; Gavrilin,
   Mikhail A/D-2469-2009
OI Masters, Seth L/0000-0003-4763-576X; Baker, Paul J./0000-0002-3642-2366;
   Gavrilin, Mikhail/0000-0003-2003-768X
FU National Institutes of Health (NIH) [R01HL24325, R01GM108928]
FX Supported by National Institutes of Health (NIH) grants R01HL24325
   (A.S.) and R01GM108928 (A.S. and M.D.W.).
CR Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113
   Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126
   Chen X, 2016, CELL RES, V26, P1007, DOI 10.1038/cr.2016.100
   Diamant M, 2004, EUR J CLIN INVEST, V34, P392, DOI 10.1111/j.1365-2362.2004.01355.x
   Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590
   Distler JHW, 2005, APOPTOSIS, V10, P731, DOI 10.1007/s10495-005-2941-5
   Distler JHW, 2006, AUTOIMMUNITY, V39, P683, DOI 10.1080/08916930601061538
   Exline MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090968
   Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033
   He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139
   Huber LC, 2007, APOPTOSIS, V12, P363, DOI 10.1007/s10495-006-0622-7
   Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004
   Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541
   Lin HY, 2015, EXP DERMATOL, V24, P897, DOI 10.1111/exd.12797
   Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629
   MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1
   Man SM, 2015, CELL RES, V25, P1183, DOI 10.1038/cr.2015.124
   Martin S, 2004, CIRCULATION, V109, P1653, DOI 10.1161/01.CIR.0000124065.31211.6E
   Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004
   McKechnie NM, 2006, EXP EYE RES, V83, P304, DOI 10.1016/j.exer.2005.11.028
   Mitra S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145607
   Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913
   Rowe SJ, 2002, J IMMUNOL, V169, P6401, DOI 10.4049/jimmunol.169.11.6401
   Russo HM, 2016, J IMMUNOL, V197, P1353, DOI 10.4049/jimmunol.1600699
   Saeki N, 2000, MAMM GENOME, V11, P718, DOI 10.1007/s003350010138
   Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC
   Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140
   Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696
   Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004
   Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514
   Tamura M, 2007, GENOMICS, V89, P618, DOI 10.1016/j.ygeno.2007.01.003
   Watanabe JJ, 2003, J BIOL CHEM, V278, P33161, DOI 10.1074/jbc.M305321200
   Wewers MD, 2004, P NATL ACAD SCI USA, V101, P10241, DOI 10.1073/pnas.0403971101
NR 33
TC 54
Z9 60
U1 1
U2 15
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1044-1549
EI 1535-4989
J9 AM J RESP CELL MOL
JI Am. J. Respir. Cell Mol. Biol.
PD JUL
PY 2018
VL 59
IS 1
BP 56
EP 64
DI 10.1165/rcmb.2017-0393OC
PG 9
WC Biochemistry & Molecular Biology; Cell Biology; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Respiratory System
GA GL3MN
UT WOS:000437040100011
PM 29365280
OA Green Published
DA 2023-08-21
ER

PT J
AU Otulakowski, G
   Engelberts, D
   Post, M
   Masterson, C
   Kavanagh, BP
AF Otulakowski, Gail
   Engelberts, Doreen
   Post, Martin
   Masterson, Claire
   Kavanagh, Brian P.
TI Mechanical Ventilation Induces Desensitization of Lung Axl Tyrosine
   Kinase Receptors
SO ANESTHESIOLOGY
LA English
DT Article
ID TAM RECEPTORS; INJURY; GAS6; STIMULATION; HYPERCAPNIA; EXPRESSION;
   STRETCH; TARGET; LIGAND; CELLS
AB Background: Lower tidal volumes are increasingly used in acute respiratory distress syndrome, but mortality has changed little in the last 20 yr. Therefore, in addition to ventilator settings, it is important to target molecular mediators of injury. Sepsis and other inflammatory states increase circulating concentrations of Gas6, a ligand for the antiinflammatory receptor Axl, and of a soluble decoy form of Axl. We investigated the effects of lung stretch on Axl signaling.
   Methods: We used a mouse model of early injury from high tidal volume and assessed the effects of inhibiting Axl on in vivo lung injury (using an antagonist R428, n=4/group). We further determined the effects of stretch on Axl activation using in vitro lung endothelial cells.
   Results: High tidal volume caused mild injury (compliance decreased 6%) as intended, and shedding of the Axl receptor (soluble Axl in bronchoalveolar fluid increased 77%). The Axl antagonist R428 blocked the principal downstream Axl target (suppressor of cytokine signaling 3 [SOCS3]) but did not worsen lung physiology or inflammation. Cyclic stretch in vitro caused Axl to become insensitive to activation by its agonist, Gas6. Finally, in vitro Axl responses were rescued by blocking stretch-activated calcium channels (using guanidinium chloride [GdCl3]), and the calcium ionophore ionomycin replicated the effect of stretch.
   Conclusions: These data suggest that lung endothelial cell overdistention activates ion channels, and the resultant influx of Ca2+ inactivates Axl. Downstream inactivation of Axl by stretch was not anticipated; preventing this would be required to exploit Axl receptors in reducing lung injury.
C1 [Otulakowski, Gail; Engelberts, Doreen; Post, Martin; Masterson, Claire; Kavanagh, Brian P.] Univ Toronto, Translat Med, Toronto, ON, Canada.
   [Kavanagh, Brian P.] Univ Toronto, Hosp Sick Children, Dept Crit Care Med, Toronto, ON, Canada.
   [Kavanagh, Brian P.] Univ Toronto, Hosp Sick Children, Dept Anesthesia, Toronto, ON, Canada.
   [Kavanagh, Brian P.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada.
C3 University of Toronto; University of Toronto; Hospital for Sick Children
   (SickKids); University of Toronto; Hospital for Sick Children
   (SickKids); University of Toronto
RP Kavanagh, BP (corresponding author), Hosp Sick Children, Dept Crit Care Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM brian.kavanagh@utoronto.ca
RI kavanagh, brian/HTQ-4160-2023
OI Masterson, Claire/0000-0002-9863-5324
FU Canadian Institutes of Health Research (Ottawa, Canada) [311394]
FX Supported by a Canadian Institutes of Health Research (Ottawa, Canada)
   Operating Grant (311394) to Dr. Kavanagh. Dr. Kavanagh holds the Dr.
   Geoffrey Barker Chair in Critical Care Research. Dr. Post holds a Canada
   Research Chair (Tier I) in Fetal, Neonatal and Maternal Health.
CR Avanzi GC, 1998, BLOOD, V91, P2334, DOI 10.1182/blood.V91.7.2334.2334_2334_2340
   Bellani G, 2011, AM J RESP CRIT CARE, V183, P1193, DOI 10.1164/rccm.201008-1318OC
   Birukova AA, 2012, AM J PHYSIOL-LUNG C, V302, pL965, DOI 10.1152/ajplung.00292.2011
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Curley GF, 2016, CHEST, V150, P1109, DOI 10.1016/j.chest.2016.07.019
   D'Arcangelo D, 2006, CARDIOVASC RES, V71, P754, DOI 10.1016/j.cardiores.2006.06.002
   Delos Santos RC, 2015, CELL SIGNAL, V27, P1963, DOI 10.1016/j.cellsig.2015.07.004
   Ekman C, 2010, CRIT CARE, V14, DOI 10.1186/cc9233
   Ekman C, 2010, CLIN BIOCHEM, V43, P873, DOI 10.1016/j.clinbiochem.2010.04.006
   Fujimori T, 2015, MUCOSAL IMMUNOL, V8, P1021, DOI 10.1038/mi.2014.129
   Gattinoni L, 2016, INTENS CARE MED, V42, P663, DOI 10.1007/s00134-015-4200-8
   Gruber RC, 2014, J NEUROSCI, V34, P16320, DOI 10.1523/JNEUROSCI.2449-14.2014
   Happonen KE, 2016, J BIOL CHEM, V291, P10586, DOI 10.1074/jbc.M115.699058
   Hasanbasic I, 2004, AM J PHYSIOL-HEART C, V287, pH1207, DOI 10.1152/ajpheart.00020.2004
   Hecquet CM, 2010, ADV EXP MED BIOL, V661, P155, DOI 10.1007/978-1-60761-500-2_10
   Henderson WR, 2017, AM J RESP CRIT CARE, V196, P822, DOI 10.1164/rccm.201612-2495CI
   Laurance S, 2014, J THROMB HAEMOST, V12, P395, DOI 10.1111/jth.12481
   Lee IJ, 2015, CLIN IMMUNOL, V158, P231, DOI 10.1016/j.clim.2015.01.012
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212
   Matthay MA, 2002, AM J PHYSIOL-LUNG C, V283, pL678, DOI 10.1152/ajplung.00154.2002
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   Mehta D, 2014, AM J PHYSIOL-LUNG C, V307, pL924, DOI 10.1152/ajplung.00318.2014
   Morty RE, 2014, AM J PHYSIOL-LUNG C, V307, pL817, DOI 10.1152/ajplung.00254.2014
   O'Gara B, 2015, SEMIN RESP CRIT CARE, V36, P823, DOI 10.1055/s-0035-1564889
   Otulakowski G, 2017, THORAX, V72, P538, DOI 10.1136/thoraxjnl-2016-209501
   Otulakowski G, 2014, J PHYSIOL-LONDON, V592, P4507, DOI 10.1113/jphysiol.2014.277616
   Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC
   Rodriguez-Palacios A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8577
   Rose F, 2002, AM J PHYSIOL-LUNG C, V282, pL207, DOI 10.1152/ajplung.00156.2001
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103
   Schwingshackl A, 2016, AM J PHYSIOL-LUNG C, V311, pL639, DOI 10.1152/ajplung.00458.2015
   Standiford TJ, 2016, TRANSL RES, V167, P183, DOI 10.1016/j.trsl.2015.04.015
   Tong LS, 2017, J CEREBR BLOOD F MET, V37, P1971, DOI 10.1177/0271678X16658490
   Tsou WI, 2014, J BIOL CHEM, V289, P25750, DOI 10.1074/jbc.M114.569020
   Tsuchida S, 2006, AM J RESP CRIT CARE, V174, P279, DOI 10.1164/rccm.200506-1006OC
   van den Brand BT, 2013, ARTHRITIS RHEUM-US, V65, P671, DOI 10.1002/art.37786
   van der Meer JHM, 2014, BLOOD, V123, P2460, DOI 10.1182/blood-2013-09-528752
   Wang T, 2017, AM J PHYSIOL-LUNG C, V312, pL452, DOI 10.1152/ajplung.00231.2016
   Wung BS, 1996, AM J PHYSIOL-HEART C, V270, pH1462, DOI 10.1152/ajpheart.1996.270.4.H1462
   Xiaoming J, 2008, CHEST, V133, P853, DOI DOI 10.1378/CHEST.07-1121.RISK
   Zheng SS, 2015, J IMMUNOL, V194, P1928, DOI 10.4049/jimmunol.1401933
NR 43
TC 5
Z9 5
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0003-3022
EI 1528-1175
J9 ANESTHESIOLOGY
JI Anesthesiology
PD JUL
PY 2018
VL 129
IS 1
BP 143
EP 153
DI 10.1097/ALN.0000000000002140
PG 11
WC Anesthesiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology
GA GJ7JU
UT WOS:000435563800018
PM 29474201
OA Bronze
DA 2023-08-21
ER

PT J
AU Ying, LH
   Alvira, CM
   Cornfield, DN
AF Ying, Lihua
   Alvira, Cristina M.
   Cornfield, David N.
TI Developmental differences in focal adhesion kinase expression modulate
   pulmonary endothelial barrier function in response to inflammation
SO AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
LA English
DT Article
ID ACUTE RESPIRATORY-DISTRESS; CAPILLARY LEAK SYNDROME; ACUTE LUNG INJURY;
   SPHINGOSINE 1-PHOSPHATE; ADHERENS JUNCTIONS; KAPPA-B; ENDOTOXIN; CELLS;
   PHOSPHORYLATION; PERMEABILITY
AB Compromised pulmonary endothelial cell (PEC) barrier function characterizes acute respiratory distress syndrome (ARDS), a cause of substantial morbidity and mortality. Survival from ARDS is greater in children compared with adults. Whether developmental differences intrinsic to PEC barrier function contribute to this survival advantage remains unknown. To test the hypothesis that PEC barrier function is more well-preserved in neonatal lungs compared with adult lungs in response to inflammation, we induced lung injury in neonatal and adult mice with systemic lipopolysaccharide (LPS). We assessed PEC barrier function in vivo and in vitro, evaluated changes in the expression of focal adhesion kinase 1 (FAK1) and phosphorylation in response to LPS, and determined the effect of FAK silencing and overexpression on PEC barrier function. We found that LPS induced a greater increase in lung permeability and PEC barrier disruption in the adult mice, despite similar degrees of inflammation and apoptosis. Although baseline expression was similar, LPS increased FAK1 expression in neonatal PEC but increased FAK1 phosphorylation and decreased FAK1 expression in adult PEC. Pharmacologic inhibition of FAK1 accentuated LPS-induced barrier disruption most in adult PEC. Finally, in response to LPS, FAK silencing markedly impaired neonatal PEC barrier function, whereas FAK overexpression preserved adult PEC barrier function. Thus, developmental differences in FAK expression during inflammatory injury serve to preserve neonatal pulmonary endothelial barrier function compared with that of adults and suggest that intrinsic differences in the immature versus pulmonary endothelium, especially relative to FAK1 phosphorylation, may contribute to the improved outcomes of children with ARDS.
C1 [Ying, Lihua; Cornfield, David N.] Stanford Univ, Dept Pediat, Sch Med, Div Pulm Med, Stanford, CA 94305, United States.
   [Alvira, Cristina M.] Stanford Univ, Dept Pediat, Sch Med, Div Crit Care Med, Stanford, CA 94305, United States.
C3 Stanford University; Stanford University
RP Cornfield, DN (corresponding author), Stanford Univ, Sch Med, Ctr Excellence Pulm Biol, 770 Welch Rd,Suite 350, Stanford, CA 94305 USA.
EM cornfield@stanford.edu
OI Alvira, Cristina/0000-0002-6921-0001
FU National Heart, Lung, and Blood Institute [HL-060784, HL-0706280,
   HL-122918]; Burroughs Wellcome Fund Preterm Birth Initiative; Stanford
   Child Health Research Institute Tashia; John Morgridge Faculty Scholar
   Award
FX This work has been supported by National Heart, Lung, and Blood
   Institute Grants HL-060784 (D. N. Cornfield), HL-0706280 (D. N.
   Cornfield), and HL-122918 (C. M. Alvira). Further support for this work
   derived from the Burroughs Wellcome Fund Preterm Birth Initiative and
   the Stanford Child Health Research Institute Tashia and John Morgridge
   Faculty Scholar Award.
CR ABMAN SH, 1991, AM J PHYSIOL, V260, pL280, DOI 10.1152/ajplung.1991.260.4.L280
   Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887
   ALBELDA SM, 1991, AM J RESP CELL MOL, V4, P195, DOI 10.1165/ajrcmb/4.3.195
   Alvira CM, 2007, AM J RESP CRIT CARE, V175, P805, DOI 10.1164/rccm.200608-1162OC
   ASHBAUGH DG, 1967, LANCET, V2, P319
   AYALON O, 1994, J CELL BIOL, V126, P247, DOI 10.1083/jcb.126.1.247
   Bannerman DD, 1999, LAB INVEST, V79, P1181
   Bannerman DD, 1998, J BIOL CHEM, V273, P35371, DOI 10.1074/jbc.273.52.35371
   Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630
   BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913
   Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002
   Farley KS, 2009, AM J PHYSIOL-LUNG C, V296, pL480, DOI 10.1152/ajplung.90201.2008
   FOLKESSON HG, 1991, J APPL PHYSIOL, V71, P1106, DOI 10.1152/jappl.1991.71.3.1106
   Frey EA, 1998, MICROB PATHOGENESIS, V24, P101, DOI 10.1006/mpat.1997.0178
   Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450
   Gozin A, 1998, FREE RADICAL BIO MED, V25, P1021, DOI 10.1016/S0891-5849(98)00134-8
   Guignabert C, 2009, AM J PHYSIOL-LUNG C, V297, pL1082, DOI 10.1152/ajplung.00199.2009
   Harju K, 2001, PEDIATR RES, V49, P81, DOI 10.1203/00006450-200101000-00018
   Hsu P, 2015, PEDIATRICS, V135, pE730, DOI 10.1542/peds.2014-2268
   Iosef C, 2012, AM J PHYSIOL-LUNG C, V302, pL1023, DOI 10.1152/ajplung.00230.2011
   Jiao H, 2013, J IMMUNOL, V191, P6191, DOI 10.4049/jimmunol.1300873
   Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534
   Liu E, 2003, EMBO J, V22, P5036, DOI 10.1093/emboj/cdg503
   MEYRICK BO, 1986, AM J PATHOL, V122, P140
   Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549
   Moitra J, 2007, TRANSL RES, V150, P253, DOI 10.1016/j.trsl.2007.03.013
   Munshi N, 2002, J IMMUNOL, V168, P5860, DOI 10.4049/jimmunol.168.11.5860
   Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC
   Quasney MW, 2015, PEDIATR CRIT CARE ME, V16, pS118, DOI 10.1097/PCC.0000000000000438
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Schmidt TT, 2013, AM J PHYSIOL-LUNG C, V305, pL291, DOI 10.1152/ajplung.00094.2013
   Skelly CL, 2007, P NATL ACAD SCI USA, V104, P12474, DOI 10.1073/pnas.0705429104
   Sonntag J, 1998, ANN THORAC SURG, V65, P525, DOI 10.1016/S0003-4975(97)01340-4
   Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419, DOI 10.1152/ajplung.2000.279.3.L419
   Stiller B, 2001, INTENS CARE MED, V27, P193, DOI 10.1007/s001340000704
   Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752
   Timmerman I, 2012, MOL BIOL CELL, V23, P4212, DOI 10.1091/mbc.E12-01-0038
   TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   WEIBEL ER, 1973, PHYSIOL REV, V53, P419, DOI 10.1152/physrev.1973.53.2.419
   Xie ZH, 2012, BLOOD, V119, P4321, DOI 10.1182/blood-2011-08-375816
NR 41
TC 12
Z9 12
U1 0
U2 6
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1040-0605
EI 1522-1504
J9 AM J PHYSIOL-LUNG C
JI Am. J. Physiol.-Lung Cell. Mol. Physiol.
PD JUL
PY 2018
VL 315
IS 1
BP L66
EP L77
DI 10.1152/ajplung.00363.2017
PG 12
WC Physiology; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Respiratory System
GA GP5XZ
UT WOS:000440952000007
PM 29597831
OA Green Published, Bronze
DA 2023-08-21
ER

PT J
AU Soni, D
   Wang, DM
   Regmi, SC
   Mittal, M
   Vogel, SM
   Schluter, D
   Tiruppathi, C
AF Soni, Dheeraj
   Wang, Dong-Mei
   Regmi, Sushil C.
   Mittal, Manish
   Vogel, Stephen M.
   Schlueter, Dirk
   Tiruppathi, Chinnaswamy
TI Deubiquitinase function of A20 maintains and repairs endothelial barrier
   after lung vascular injury
SO CELL DEATH DISCOVERY
LA English
DT Article
ID NF-KAPPA-B; RESPIRATORY-DISTRESS-SYNDROME; MODIFYING ENZYME A20;
   IN-VIVO; LEUKOCYTE EXTRAVASATION; VE-CADHERIN; RESTRICTS UBIQUITINATION;
   ADHERENS JUNCTIONS; PROTECTS CELLS; CA2+ ENTRY
AB Vascular endothelial cadherin (VE-cad) expression at endothelial adherens junctions (AJs) regulates vascular homeostasis. Here we show that endothelial A20 is required for VE-cad expression at AJs to maintain and repair the injured endothelial barrier. In endothelial cell (EC)-restricted Tnfaip3 (A20) knockout (A20(Delta EC))mice, LPS challenge caused uncontrolled lung vascular leak and persistent sequestration of polymorphonuclear neutrophil (PMNs). Importantly, A20(Delta EC) mice exhibited drastically reduced VE-cad expression in lungs compared with wild-type counterparts. Endothelial expression of wild-type A20 but not the deubiquitinase-inactive A20 mutant (A20(C103A)) prevented VE-cad ubiquitination, restored VE-cad expression, and suppressed lung vascular leak in A20(Delta EC) mice. Interestingly, IRAK-Mmediated nuclear factor-kappa B (NE-kappa B) signaling downstream of TLR4 was required for A20 expression in ECs. interleukin-1 receptor-associated kinase M (IRAK-M) knockdown suppressed basal and LPS-induced A20 expression in ECs. Further, in vivo silencing of IRAK-M in mouse lung vascular ECs through the CRISPR-Cas9 system prevented expression of A20 and VE-cad while augmenting lung vascular leak. These results suggest that targeting of endothelial A20 is a potential therapeutic strategy to restore endothelial barrier integrity in the setting of acute lung injury.
C1 [Soni, Dheeraj; Wang, Dong-Mei; Regmi, Sushil C.; Mittal, Manish; Vogel, Stephen M.; Tiruppathi, Chinnaswamy] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60607, United States.
   [Soni, Dheeraj; Wang, Dong-Mei; Regmi, Sushil C.; Mittal, Manish; Vogel, Stephen M.; Tiruppathi, Chinnaswamy] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60607, United States.
   [Schlueter, Dirk] Otto von Guericke Univ, Inst Med Microbiol & Hosp Hyg, Magdeburg, Germany.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital;
   Otto von Guericke University
RP Tiruppathi, C (corresponding author), Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60607 USA.; Tiruppathi, C (corresponding author), Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60607 USA.
EM tiruc@uic.edu
RI Soni, Dheeraj/P-5496-2017
OI Soni, Dheeraj/0000-0002-5555-2051
FU National Institutes of Health [R01HL128359, R01GM117028, R01HL122157]
FX This work was supported by National Institutes of Health Grants
   R01HL128359, R01GM117028, and R01HL122157.
CR Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110
   BREVIARIO F, 1995, ARTERIOSCL THROM VAS, V15, P1229, DOI 10.1161/01.ATV.15.8.1229
   Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200
   Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815
   Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357
   Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897
   Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054
   Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031
   Frye M, 2015, J EXP MED, V212, P2267, DOI 10.1084/jem.20150718
   Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011
   Gong HX, 2014, J EXP MED, V211, P579, DOI 10.1084/jem.20131190
   Gotsch U, 1997, J CELL SCI, V110, P583
   Herwig MC, 2013, PATHOBIOLOGY, V80, P245, DOI 10.1159/000347062
   Hovelmeyer N, 2011, EUR J IMMUNOL, V41, P595, DOI 10.1002/eji.201041313
   Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4
   Just S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39796
   Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9
   Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399
   Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833
   Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092
   Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313
   Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158
   Mittal M, 2017, CIRC RES, V121, P1081, DOI 10.1161/CIRCRESAHA.117.311747
   Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172
   OPIPARI AW, 1992, J BIOL CHEM, V267, P12424
   Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199
   Paria BC, 2003, J BIOL CHEM, V278, P37195, DOI 10.1074/jbc.M304287200
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Schlegel N, 2009, CRIT CARE MED, V37, P1735, DOI 10.1097/CCM.0b013e31819deb6a
   Schulte D, 2011, EMBO J, V30, P4157, DOI 10.1038/emboj.2011.304
   Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364
   Shen JK, 2014, J CLIN INVEST, V124, P4564, DOI 10.1172/JCI74527
   Soni D, 2017, AM J PHYSIOL-LUNG C, V312, pL1003, DOI 10.1152/ajplung.00008.2017
   Sundivakkam PC, 2013, J BIOL CHEM, V288, P17030, DOI 10.1074/jbc.M112.411272
   Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8
   TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919
   Tiruppathi C, 2014, NAT IMMUNOL, V15, P239, DOI 10.1038/ni.2823
   Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474
   Vestweber D, 2014, SEMIN IMMUNOPATHOL, V36, P177, DOI 10.1007/s00281-014-0419-7
   Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794
   Wertz IE, 2015, NATURE, V528, P370, DOI 10.1038/nature16165
   Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824
   Zhou H, 2013, EMBO J, V32, P583, DOI 10.1038/emboj.2013.2
   Zhou MY, 1998, J CLIN INVEST, V101, P2427, DOI 10.1172/JCI407
NR 48
TC 17
Z9 17
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2058-7716
J9 CELL DEATH DISCOV
JI Cell Death Discov.
PD MAY 16
PY 2018
VL 4
AR 60
DI 10.1038/s41420-018-0056-3
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA HR4WB
UT WOS:000463147000001
PM 29796309
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Gross, CM
   Kellner, M
   Wang, T
   Lu, Q
   Sun, XT
   Zemskov, EA
   Noonepalle, S
   Kangath, A
   Kumar, S
   Gonzalez-Garay, M
   Desai, AA
   Aggarwal, S
   Gorshkov, B
   Klinger, C
   Verin, AD
   Catravas, JD
   Jacobson, JR
   Yuan, JXJ
   Rafikov, R
   Garcia, JGN
   Black, SM
AF Gross, Christine M.
   Kellner, Manuela
   Wang, Ting
   Lu, Qing
   Sun, Xutong
   Zemskov, Evgeny A.
   Noonepalle, Satish Kumar
   Kangath, Archana
   Kumar, Sanjiv
   Gonzalez-Garay, Manuel
   Desai, Ankit A.
   Aggarwal, Saurabh
   Gorshkov, Boris A.
   Klinger, Christina
   Verin, Alexander D.
   Catravas, John D.
   Jacobson, Jeffrey R.
   Yuan, Jason X-J.
   Rafikov, Ruslan
   Garcia, Joe G. N.
   Black, Stephen M.
TI LPS-induced Acute Lung Injury Involves NF-kappa B-mediated
   Downregulation of SOX18
SO AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
LA English
DT Article
ID BLOOD-BRAIN-BARRIER; RESPIRATORY-DISTRESS-SYNDROME; ENDOTHELIAL-CELLS;
   GENE-EXPRESSION; DNA METHYLATION; CLAUDIN-5 GENE; ALPHA; KINASE;
   PHOSPHORYLATION; TRANSCRIPTION
AB One of the early events in the progression of LPS-mediated acute lung injury in mice is the disruption of the pulmonary endothelial barrier resulting in lung edema. However, the molecular mechanisms by which the endothelial barrier becomes compromised remain unresolved. The SRY (sex-determining region on the Y chromosome)-related high-mobility group box (Sox) group F family member, SOX18, is a barrier-protective protein through its ability to increase the expression of the tight junction protein CLDN5. Thus, the purpose of this study was to determine if downregulation of the SOX18-CLDN5 axis plays a role in the pulmonary endothelial barrier disruption associated with LPS exposure. Our data indicate that both SOX18 and CLDN5 expression is decreased in two models of in vivo LPS exposure (intraperitoneal, intratracheal). A similar downregulation was observed in cultured human lung microvascular endothelial cells (HLMVECs) exposed to LPS. SOX18 overexpression in HLMVECs or in the mouse lung attenuated the LPS-mediated vascular barrier disruption. Conversely, reduced CLDN5 expression (siRNA) reduced the HLMVEC barrier-protective effects of SOX18 overexpression. The mechanism by which LPS decreases SOX18 expression was identified as transcriptional repression through binding of NF-kappa B (p65) to a SOX18 promoter sequence located between -1,082 and -1,073 bp with peroxynitrite contributing to LPS-mediated NF-kappa B activation. We conclude that NF-kappa B-dependent decreases in the SOX18-CLDN5 axis are essentially involved in the disruption of human endothelial cell barrier integrity associated with LPS-mediated acute lung injury.
C1 [Gross, Christine M.; Kumar, Sanjiv; Gorshkov, Boris; Verin, Alexander D.] Augusta Univ, Vasc Biol Ctr, Augusta, GA, United States.
   [Kellner, Manuela; Wang, Ting; Lu, Qing; Sun, Xutong; Zemskov, Evgeny A.; Noonepalle, Satish; Kangath, Archana; Gonzalez-Garay, Manuel; Desai, Ankit A.; Klinger, Christina; Yuan, Jason X-J; Rafikov, Ruslan; Garcia, Joe G. N.; Black, Stephen M.] Univ Arizona Hlth Sci, Dept Med, Tucson, AZ 85724, United States.
   [Aggarwal, Saurabh] Univ Alabama Birmingham, Sch Med, Dept Anesthesiol & Perioperat Med, Birmingham, AL, United States.
   [Catravas, John D.] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA, United States.
   [Jacobson, Jeffrey R.] Univ Illinois, Coll Med, Dept Med, Chicago, IL, United States.
C3 University System of Georgia; Augusta University; University of Arizona;
   University of Arizona Health Sciences; University of Alabama System;
   University of Alabama Birmingham; Old Dominion University; University of
   Illinois System; University of Illinois Chicago; University of Illinois
   Chicago Hospital
RP Black, SM (corresponding author), Univ Arizona Hlth Sci, Div Translat & Regenerat Med, Steele Childrens Res Ctr, Off 7341A,1501N Campbell Ave POB 245002, Tucson, AZ 85724 USA.
EM steveblack@e-mail.arizona.edu
RI Garcia, Joe GN/E-8862-2010; Noonepalle, Satish/ABD-6753-2021; Rafikov,
   Ruslan/AAG-9352-2019
OI Gonzalez-Garay, Manuel/0000-0003-3412-0353; Lu,
   Qing/0000-0002-1000-3884; Desai, Ankit/0000-0001-6427-616X; Rafikov,
   Ruslan/0000-0001-5950-4076; Noonepalle, Satish
   kumar/0000-0002-0346-3882; Black, Stephen M./0000-0002-4524-6544; Verin,
   Alexander/0000-0003-0627-7185
FU National Institutes of Health (NIH) [HL60190, HL67841, HL101902,
   P01HL134610, HL126609, HL115014, HL096887, HL132918]; American Heart
   Association National Office [14SDG20480354]
FX Supported in part by grants HL60190 (S.M.B.), HL67841 (S.M.B.), HL101902
   (S.M.B.), P01HL134610 (S.M.B.), HL126609 (J.G.N.G.), HL115014
   (J.X.-J.Y.), HL096887 (J.R.J.), and HL132918 (R.R.), all from the
   National Institutes of Health (NIH), and by a Scientist Development
   Grant (14SDG20480354 [R.R.]) from the American Heart Association
   National Office.
CR Aggarwal S, 2014, AM J RESP CELL MOL, V50, P614, DOI 10.1165/rcmb.2013-0193OC
   Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106
   Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001
   Aslam M, 2012, CYTOKINE, V57, P269, DOI 10.1016/j.cyto.2011.10.016
   Baeuerle PA, 1998, CURR BIOL, V8, pR19, DOI 10.1016/S0960-9822(98)70010-7
   Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3
   Basilio J, 2013, BIOCHEM BIOPH RES CO, V442, P221, DOI 10.1016/j.bbrc.2013.11.030
   BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706
   Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5
   Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473
   Catravas JD, 2010, VASC PHARMACOL, V52, P175, DOI 10.1016/j.vph.2009.12.009
   Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7
   Choy MK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-519
   Di Ruscio A, 2013, NATURE, V503, P371, DOI 10.1038/nature12598
   Fontijn RD, 2008, AM J PHYSIOL-HEART C, V294, pH891, DOI 10.1152/ajpheart.01248.2007
   Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225
   Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1
   Gross CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119918
   Gross CM, 2014, J CELL PHYSIOL, V229, P1802, DOI 10.1002/jcp.24633
   Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983
   HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182
   Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614
   Ishizaki T, 2003, EXP CELL RES, V290, P275, DOI 10.1016/S0014-4827(03)00354-9
   Kim S, 2004, J BIOL CHEM, V279, P4285, DOI 10.1074/jbc.M308383200
   Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7
   Kouba DJ, 1999, J IMMUNOL, V162, P4226
   Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541
   Liu Y, 2012, ONCOGENE, V31, P1143, DOI 10.1038/onc.2011.308
   Luczak MW, 2006, FOLIA HISTOCHEM CYTO, V44, P143
   Ma J, 2014, J CELL PHYSIOL, V229, P916, DOI 10.1002/jcp.24523
   Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3
   Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764
   Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070
   Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301
   Pittet JF, 1997, AM J RESP CRIT CARE, V155, P1187, DOI 10.1164/ajrccm.155.4.9105054
   Rafikov R, 2014, J BIOL CHEM, V289, P4710, DOI 10.1074/jbc.M114.547596
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6
   Sharma S, 2010, VASC PHARMACOL, V52, P182, DOI 10.1016/j.vph.2009.11.010
   Shaw J, 2006, CIRC RES, V99, P1347, DOI 10.1161/01.RES.0000251744.06138.50
   Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200
   Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752
   VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200
   Yakovlev VA, 2007, BIOCHEMISTRY-US, V46, P11671, DOI 10.1021/bi701107z
   Yamamoto M, 2008, AM J PATHOL, V172, P521, DOI 10.2353/ajpath.2008.070076
   Yuan L, 2012, J BIOL CHEM, V287, P6582, DOI 10.1074/jbc.M111.300236
   Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X
NR 49
TC 54
Z9 58
U1 0
U2 12
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1044-1549
EI 1535-4989
J9 AM J RESP CELL MOL
JI Am. J. Respir. Cell Mol. Biol.
PD MAY
PY 2018
VL 58
IS 5
BP 614
EP 624
DI 10.1165/rcmb.2016-0390OC
PG 11
WC Biochemistry & Molecular Biology; Cell Biology; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Respiratory System
GA GE4PN
UT WOS:000431198400015
PM 29115856
OA Green Published
DA 2023-08-21
ER

PT J
AU Lu, HL
   Huang, XY
   Luo, YF
   Tan, WP
   Chen, PF
   Guo, YB
AF Lu, Hui-Lun
   Huang, Xin-Yan
   Luo, Yi-Feng
   Tan, Wei-Ping
   Chen, Pei-Fen
   Guo, Yu-Biao
TI Activation of M1 macrophages plays a critical role in the initiation of
   acute lung injury
SO BIOSCIENCE REPORTS
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; ISCHEMIA-REPERFUSION INJURY; NF-KAPPA-B;
   POLARIZATION; INFLAMMATION; INHIBITION; RESOLUTION; LIPOPOLYSACCHARIDE;
   POPULATIONS; DEPLETION
AB The goal of the present study was to investigate the role of M1 macrophages in acute lung injury (ALI). To address this, we used lipopolysaccharide (LPS)-treated wild-type and CD11b-DTR mice, and examined their M1 macrophage levels, and the extent of their inflammation and pulmonary injuries. In addition, we evaluated pulmonary function by measuring the expressions of SP-A and SP-B in infiltrated M1 macrophages. Finally, we co-cultured the mouse type II-like alveolar epithelial cells (AT-II) and mouse pulmonary microvascular endothelial cells (PMECs) with M1 macrophages in the presence of TNF-alpha or H2O2 and assessed them for viability and apoptosis. After LPS treatment, we observed that the number of pulmonary M1/M2 macrophages and the serum levels of interleukin-1 beta (IL-1 beta), tumor necrosis factor a (TNF-alpha), and reactive oxygen species (ROS) significantly increased. Furthermore, the increase in cytokines was accompanied with the initiation of lung injury indicated by the decreased levels of SP-A and SP-B. In macrophage-depleted CD11b-DTR mice, ALI was attenuated, serum levels of IL-1 beta, TNF-alpha and ROS were reduced, and lung levels of monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-2) were decreased. After administering TNF-alpha and H2O2, the proapoptotic effect of M1 macrophages on AT-II or PMECs significantly increased, the cell viabilities significantly decreased, and apoptosis significantly increased. Our results suggest that M1 macrophages are recruited to the lungs where they significantly contribute to an increase in TNF-alpha and ROS production, thus initiating ALI.
C1 [Lu, Hui-Lun] Second Peoples Hosp Longgang Dist, Dept Resp Med, Shenzhen, China.
   [Huang, Xin-Yan; Luo, Yi-Feng; Tan, Wei-Ping; Guo, Yu-Biao] Sun Yat Sen Univ, Div Pulm & Crit Care Med, Affiliated Hosp 1, Guangzhou, China.
   [Huang, Xin-Yan; Luo, Yi-Feng; Tan, Wei-Ping; Guo, Yu-Biao] Sun Yat Sen Univ, Inst Resp Dis, Guangzhou, China.
   [Chen, Pei-Fen] Third Peoples Hosp Shenzhen, Dept Internal Med 2, Shenzhen, China.
C3 Sun Yat Sen University; Sun Yat Sen University; The Third People's
   Hospital of Shenzhen
RP Guo, YB (corresponding author), Sun Yat Sen Univ, Div Pulm & Crit Care Med, Affiliated Hosp 1, Guangzhou, Peoples R China.; Guo, YB (corresponding author), Sun Yat Sen Univ, Inst Resp Dis, Guangzhou, Peoples R China.
EM guoyubiao@hotmail.com
RI Chen, Pei-Fen/K-8584-2013; Huang, Xinyan/ABB-8442-2021
OI Chen, Pei-Fen/0000-0001-5470-321X; Huang, Xinyan/0000-0003-2775-6409
FU Science and Technology plan project of Shenzhen [JCYJ20150402092653975]
FX This work was supported by grants from the Science and Technology plan
   project of Shenzhen [JCYJ20150402092653975].
CR Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013
   Amano H, 2004, J IMMUNOL, V172, P398, DOI 10.4049/jimmunol.172.1.398
   Antonios JK, 2013, CELL MOL IMMUNOL, V10, P471, DOI 10.1038/cmi.2013.39
   Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891
   Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491
   Bhatia M, 2000, GUT, V47, P838, DOI 10.1136/gut.47.6.838
   Cabanski M, 2009, AM J PHYSIOL-LUNG C, V297, pL608, DOI 10.1152/ajplung.90433.2008
   Chow CW, 2003, AM J RESP CELL MOL, V29, P427, DOI 10.1165/rcmb.F278
   Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305
   Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249
   Fialkow L, 1997, J IMMUNOL, V158, P5409
   FIALKOW L, 1993, J BIOL CHEM, V268, P17131
   Fisher AB, 2005, J LIPID RES, V46, P1248, DOI 10.1194/jlr.M400499-JLR200
   Frieler RA, 2015, BRAIN RES, V1624, P103, DOI 10.1016/j.brainres.2015.07.011
   Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067
   Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5
   Haddad JJE, 2000, J BIOL CHEM, V275, P21130, DOI 10.1074/jbc.M000737200
   Johnston LK, 2012, AM J RESP CELL MOL, V47, P417, DOI 10.1165/rcmb.2012-0090OC
   Krishnadasan B, 2003, J THORAC CARDIOV SUR, V125, P261, DOI 10.1067/mtc.2003.16
   Liu SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep37252
   Manicone AM, 2009, EXPERT REV CLIN IMMU, V5, P63, DOI 10.1586/1744666X.5.1.63
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Mukaida N, 1998, INFLAMM RES, V47, pS151
   Nomura J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075527
   Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO
   Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013
   Patel BV, 2013, J IMMUNOL, V190, P4274, DOI 10.4049/jimmunol.1202437
   Schnyder-Candrian S, 2005, J IMMUNOL, V175, P262, DOI 10.4049/jimmunol.175.1.262
   Sone Y, 1999, J APPL PHYSIOL, V87, P1354, DOI 10.1152/jappl.1999.87.4.1354
   Song Y, 2001, AM J PHYSIOL-LUNG C, V281, pL677, DOI 10.1152/ajplung.2001.281.3.L677
   Tsushima K, 2009, INTERNAL MED, V48, P621, DOI 10.2169/internalmedicine.48.1741
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Weisser SB, 2012, JOVE-J VIS EXP, DOI 10.3791/4105
   Zhao MQ, 2006, AM J PHYSIOL-LUNG C, V291, pL1018, DOI 10.1152/ajplung.00086.2006
NR 35
TC 61
Z9 61
U1 1
U2 17
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0144-8463
EI 1573-4935
J9 BIOSCIENCE REP
JI Biosci. Rep.
PD APR 27
PY 2018
VL 38
AR BSR20171555
DI 10.1042/BSR20171555
PN 2
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA GE8TN
UT WOS:000431504200043
PM 29531017
OA Green Published, gold, Green Submitted
DA 2023-08-21
ER

PT J
AU Huertas, A
   Guignabert, C
   Barbera, JA
   Bartsch, P
   Bhattacharya, J
   Bhattacharya, S
   Bonsignore, MR
   Dewachter, L
   Dinh-Xuan, AT
   Dorfmuller, P
   Gladwin, MT
   Humbert, M
   Kotsimbos, T
   Vassilakopoulos, T
   Sanchez, O
   Savale, L
   Testa, U
   Wilkins, MR
AF Huertas, Alice
   Guignabert, Christophe
   Barbera, Joan A.
   Baertsch, Peter
   Bhattacharya, Jahar
   Bhattacharya, Sunita
   Bonsignore, Maria R.
   Dewachter, Laurence
   Anh Tuan Dinh-Xuan
   Dorfmuller, Peter
   Gladwin, Mark T.
   Humbert, Marc
   Kotsimbos, Tom
   Vassilakopoulos, Theodoros
   Sanchez, Olivier
   Savale, Laurent
   Testa, Ugo
   Wilkins, Martin R.
TI Pulmonary vascular endothelium: the orchestra conductor in respiratory
   diseases
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Review
ID STRESS DOPPLER-ECHOCARDIOGRAPHY; FIBROBLAST GROWTH FACTOR-2; SOLUBLE
   GUANYLATE-CYCLASE; EXHALED NITRIC-OXIDE; CELL-FREE HEMOGLOBIN;
   HIGH-ALTITUDE; PROGENITOR CELLS; ARTERIAL-HYPERTENSION; SMOOTH-MUSCLE;
   RHO-KINASE
AB The European Respiratory Society (ERS) Research Seminar entitled "Pulmonary vascular endothelium: orchestra conductor in respiratory diseases - highlights from basic research to therapy" brought together international experts in dysfunctional pulmonary endothelium, from basic science to translational medicine, to discuss several important aspects in acute and chronic lung diseases. This review will briefly sum up the different topics of discussion from this meeting which was held in Paris, France on October 27-28, 2016. It is important to consider that this paper does not address all aspects of endothelial dysfunction but focuses on specific themes such as: 1) the complex role of the pulmonary endothelium in orchestrating the host response in both health and disease (acute lung injury, chronic obstructive pulmonary disease, high-altitude pulmonary oedema and pulmonary hypertension); and 2) the potential value of dysfunctional pulmonary endothelium as a target for innovative therapies.
C1 [Huertas, Alice; Guignabert, Christophe; Dorfmuller, Peter; Humbert, Marc; Savale, Laurent] Univ Paris Sud, Univ Paris Saclay,INSERM UMR S 999, Hop Bicetre,Ctr Reference Hypertens Pulmonaire Se, Hop Marie Lannelongue,AP HP,Serv Pneumol,DHU Thor, Le Plessis Robinson, France.
   [Huertas, Alice; Guignabert, Christophe; Dorfmuller, Peter; Humbert, Marc; Savale, Laurent] Univ Paris Sud, Univ Paris Saclay,INSERM UMR S 999, Hop Bicetre,Ctr Reference Hypertens Pulmonaire Se, Hop Marie Lannelongue,AP HP,Serv Pneumol,DHU Thor, Le Kremlin Bicetre, France.
   [Barbera, Joan A.] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Hosp Clin, Dept Pulm Med, Barcelona, Spain.
   [Barbera, Joan A.] CIBERES, Madrid, Spain.
   [Baertsch, Peter] Univ Clin Heidelberg, Dept Internal Med, Heidelberg, Germany.
   [Bhattacharya, Jahar; Bhattacharya, Sunita] Columbia Univ, Med Ctr, Dept Med, Lung Biol Lab, New York, NY, United States.
   [Bonsignore, Maria R.] Univ Palermo, Inst Biomed & Mol Immunol IBIM, Biomed Dept Internal & Specialist Med DiBiMIS, Natl Res Council CNR, Palermo, Italy.
   [Dewachter, Laurence] Univ Libre Bruxelles, Lab Physiol & Pharmacol, Campus Erasme, Brussels, Belgium.
   [Anh Tuan Dinh-Xuan] Paris Descartes Univ, Cochin Hosp, Cardiothorac Dept, Resp Physiol Unit, Paris, France.
   [Gladwin, Mark T.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA, United States.
   [Kotsimbos, Tom] Monash Univ, Alfred Hlth, Melbourne, Vic, Australia.
   [Vassilakopoulos, Theodoros] Natl & Kapodistrian Univ Athens, Med Sch, Pulm & Crit Care Med, Athens, Greece.
   [Sanchez, Olivier] Paris Descartes Univ, Georges Pompidou European Hosp, AP HP, Med Sch,Sorbonne Paris City,Dept Pulmonol, Paris, France.
   [Testa, Ugo] Ist Super Sanita, Dept Hematol Oncol & Mol Med, Rome, Italy.
   [Wilkins, Martin R.] Imperial Coll London, Dept Med, Fac Med, London, England, United Kingdom.
C3 Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre
   - APHP; Hopital Universitaire Paul-Brousse - APHP; Hopital Marie
   Lannelongue; Institut National de la Sante et de la Recherche Medicale
   (Inserm); UDICE-French Research Universities; Universite Paris Cite;
   Hopital Universitaire Hotel-Dieu - APHP; Universite Paris Saclay;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Antoine-Beclere - APHP; Hopital Universitaire Bicetre - APHP; Hopital
   Universitaire Paul-Brousse - APHP; Hopital Marie Lannelongue; Institut
   National de la Sante et de la Recherche Medicale (Inserm); UDICE-French
   Research Universities; Universite Paris Cite; Hopital Universitaire
   Hotel-Dieu - APHP; Universite Paris Saclay; University of Barcelona;
   Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion
   Biomedica en Red; CIBERES; Ruprecht Karls University Heidelberg;
   Columbia University; Consiglio Nazionale delle Ricerche (CNR); Istituto
   di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR);
   University of Palermo; Universite Libre de Bruxelles; UDICE-French
   Research Universities; Universite Paris Cite; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Broca - APHP; Hopital
   Universitaire Cochin - APHP; Hopital Universitaire Necker-Enfants
   Malades - APHP; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Monash University; National &
   Kapodistrian University of Athens; Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research
   Universities; Universite Paris Cite; Hopital Universitaire Cochin -
   APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; Hopital
   Universitaire Hotel-Dieu - APHP; Hopital Universitaire Saint-Louis -
   APHP; Istituto Superiore di Sanita (ISS); Imperial College London
RP Huertas, A (corresponding author), Hop Marie Lannelongue, Inserm UMR S 999, 133 Ave Resistance, F-92350 Paris, France.
EM alice.huertas@inserm.fr
RI Huertas, Alice/E-8244-2017; Humbert, Marc/ABD-5112-2021; Testa,
   Ugo/J-6472-2016; DINH-XUAN, Anh Tuan/A-9691-2008; Savale,
   Laurent/AAJ-9781-2020; Bonsignore, Maria/U-6440-2017; Wilkins,
   Martin/ABH-1140-2021; GUIGNABERT, Christophe/G-3873-2013; Bonsignore,
   Maria/T-3983-2019; Humbert, Marc/AAC-8459-2019
OI Huertas, Alice/0000-0001-8545-747X; Testa, Ugo/0000-0001-7900-8942;
   DINH-XUAN, Anh Tuan/0000-0001-8651-5176; Bonsignore,
   Maria/0000-0002-4875-7796; Wilkins, Martin/0000-0003-3926-1171;
   GUIGNABERT, Christophe/0000-0002-8545-4452; Humbert,
   Marc/0000-0003-0703-2892; Dorfmuller, Peter/0000-0003-2499-6829
FU European Respiratory Society (ERS); Association de Recherche en
   Physiopathologie Respiratoire; Elivie; GlaxoSmithKline; Miltenyi Biotec;
   Oxyvie; Teva; Vivisol
FX The research seminar was sponsored by the European Respiratory Society
   (ERS) with the financial support of unrestricted grants from Association
   de Recherche en Physiopathologie Respiratoire, Elivie, GlaxoSmithKline,
   Miltenyi Biotec, Oxyvie, Teva and Vivisol. Funding information for this
   article has been deposited with the Crossref Funder Registry.
CR Abe K, 2016, CARDIOVASC RES, V111, P16, DOI 10.1093/cvr/cvw070
   Adir Y, 2012, CHEST, V142, P1654, DOI 10.1378/chest.11-2816
   Ahluwalia A, 2004, P NATL ACAD SCI USA, V101, P1386, DOI 10.1073/pnas.0304264101
   Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x
   Bartsch P, 2013, NEW ENGL J MED, V368, P2294, DOI 10.1056/NEJMcp1214870
   Bailey DM, 2010, J PHYSIOL-LONDON, V588, P4837, DOI 10.1113/jphysiol.2010.194704
   Barbera JA, 2001, AM J RESP CRIT CARE, V164, P709, DOI 10.1164/ajrccm.164.4.2101023
   Bartsch P, 2005, J APPL PHYSIOL, V98, P1101, DOI 10.1152/japplphysiol.01167.2004
   Bartsch P, 2002, LANCET, V360, P571, DOI 10.1016/S0140-6736(02)09723-4
   BARTSCH P, 1991, NEW ENGL J MED, V325, P1284, DOI 10.1056/NEJM199110313251805
   Basile David P., 2014, Cardiovascular & Hematological Disorders - Drug Targets, V14, P3
   Bei Y, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.105
   Blanco I, 2016, RESPIROLOGY, V21, P984, DOI 10.1111/resp.12772
   Busch T, 2001, AM J RESP CRIT CARE, V163, P368, DOI 10.1164/ajrccm.163.2.2001134
   Chaouat A, 2005, AM J RESP CRIT CARE, V172, P189, DOI 10.1164/rccm.200401-006OC
   De Castro LM, 2008, AM J HEMATOL, V83, P19, DOI 10.1002/ajh.21058
   de Man FS, 2012, AM J RESP CRIT CARE, V186, P780, DOI 10.1164/rccm.201203-0411OC
   Dehnert C, 2006, AM J RESP CRIT CARE, V174, P1132, DOI 10.1164/rccm.200606-780OC
   Dehnert C, 2015, HIGH ALT MED BIOL, V16, P11, DOI 10.1089/ham.2014.1117
   DINHXUAN AT, 1992, EUR RESPIR J, V5, P757
   DINHXUAN AT, 1991, NEW ENGL J MED, V324, P1539, DOI 10.1056/NEJM199105303242203
   Herrera MD, 2010, AGEING RES REV, V9, P142, DOI 10.1016/j.arr.2009.07.002
   Dominguez-Fandos D, 2015, EUR RESPIR J, V46, P346, DOI 10.1183/09031936.00139914
   Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698
   Duong-Quy S, 2011, EUR RESPIR J, V37, P349, DOI 10.1183/09031936.00056610
   Duong-Quy S, 2013, PHARMACOL THERAPEUT, V137, P352, DOI 10.1016/j.pharmthera.2012.12.003
   Duplain H, 2000, AM J RESP CRIT CARE, V162, P221, DOI 10.1164/ajrccm.162.1.9908039
   El Assar M, 2013, FREE RADICAL BIO MED, V65, P380, DOI 10.1016/j.freeradbiomed.2013.07.003
   Eldridge MW, 1996, J APPL PHYSIOL, V81, P911, DOI 10.1152/jappl.1996.81.2.911
   Emin MT, 2012, AM J PHYSIOL-LUNG C, V302, pL1209, DOI 10.1152/ajplung.00189.2011
   Fadini GP, 2006, STEM CELLS, V24, P1806, DOI 10.1634/stemcells.2005-0440
   Feng B, 2010, ATHEROSCLEROSIS, V208, P264, DOI 10.1016/j.atherosclerosis.2009.06.037
   Ferrer E, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-76
   Gibson GJ, 2013, EUR RESPIR J, V42, P559, DOI 10.1183/09031936.00105513
   Gladwin MT, 2016, LANCET, V387, P2565, DOI 10.1016/S0140-6736(16)00647-4
   Gladwin MT, 2014, BLOOD, V123, P3689, DOI 10.1182/blood-2014-03-563874
   Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477
   Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC
   Grunig E, 2009, CIRCULATION, V119, P1747, DOI 10.1161/CIRCULATIONAHA.108.800938
   Grunig E, 2000, J AM COLL CARDIOL, V35, P980, DOI 10.1016/S0735-1097(99)00633-6
   Guignabert C, 2015, CHEST, V147, P529, DOI 10.1378/chest.14-0862
   Guignabert C, 2013, SEMIN RESP CRIT CARE, V34, P551, DOI 10.1055/s-0033-1356496
   Hilde JM, 2013, EUR RESPIR J, V41, P1031, DOI 10.1183/09031936.00085612
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Hoffmann J, 2001, CIRC RES, V89, P709, DOI 10.1161/hh2001.097796
   HOHENHAUS E, 1995, EUR RESPIR J, V8, P1825, DOI 10.1183/09031936.95.08111825
   Hopkins SR, 2005, AM J RESP CRIT CARE, V171, P83, DOI 10.1164/rccm.200406-707OC
   Huertas A, 2016, CHEST, V149, P1482, DOI 10.1016/j.chest.2016.01.004
   Huertas A, 2015, EUR RESPIR J, V45, P1066, DOI 10.1183/09031936.00193014
   Huertas A, 2014, CIRCULATION, V129, P1332, DOI 10.1161/CIRCULATIONAHA.113.004555
   Huertas A, 2013, AM J RESP CELL MOL, V48, P78, DOI 10.1165/rcmb.2011-0402OC
   Huertas A, 2012, EUR RESPIR J, V40, P895, DOI 10.1183/09031936.00159911
   Huertas A, 2010, RESP PHYSIOL NEUROBI, V170, P23, DOI 10.1016/j.resp.2009.10.003
   HULTGREN HN, 1971, CIRCULATION, V44, P759, DOI 10.1161/01.CIR.44.5.759
   Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818
   Ichimura H, 2003, J CLIN INVEST, V111, P691, DOI 10.1172/JCI200317271
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Kiefmann R, 2009, AM J PHYSIOL-LUNG C, V296, pL901, DOI 10.1152/ajplung.90549.2008
   Kubo K, 1998, RESP PHYSIOL, V111, P301, DOI 10.1016/S0034-5687(98)00006-1
   Kuebler WM, 1999, J CLIN INVEST, V104, P495, DOI 10.1172/JCI6872
   Kuebler WM, 2000, J CLIN INVEST, V105, P905, DOI 10.1172/JCI8604
   Le Hiress M, 2015, AM J RESP CRIT CARE, V192, P983, DOI 10.1164/rccm.201402-0322OC
   Llinas L, 2011, PULM PHARMACOL THER, V24, P32, DOI 10.1016/j.pupt.2010.10.010
   Tu L, 2012, AM J RESP CRIT CARE, V186, P666, DOI 10.1164/rccm.201202-0309OC
   Tu L, 2011, AM J RESP CELL MOL, V45, P311, DOI 10.1165/rcmb.2010-0317OC
   Machado RF, 2006, JAMA-J AM MED ASSOC, V296, P310, DOI 10.1001/jama.296.3.310
   Maggiorini M, 2001, CIRCULATION, V103, P2078
   Maggiorini M, 2006, ANN INTERN MED, V145, P497, DOI 10.7326/0003-4819-145-7-200610030-00007
   Marijic J, 2001, CIRC RES, V88, P210
   McLaughlin VV, 2015, J AM COLL CARDIOL, V65, P1976, DOI 10.1016/j.jacc.2015.03.540
   Mehta D, 2004, AM J PHYSIOL-LUNG C, V287, pL1081, DOI 10.1152/ajplung.00268.2004
   Montani D, 2014, PHARMACOL THERAPEUT, V141, P172, DOI 10.1016/j.pharmthera.2013.10.002
   Nana-Sinkam SP, 2007, AM J RESP CRIT CARE, V175, P676, DOI 10.1164/rccm.200605-724OC
   OELZ O, 1989, LANCET, V2, P1241
   Palange P, 2006, EUR RESPIR J, V27, P529, DOI 10.1183/09031936.06.00120604
   Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565
   Peinado VI, 2006, AM J RESP CELL MOL, V34, P257, DOI 10.1165/rcmb.2005-0255OC
   Peinado VI, 1998, AM J PHYSIOL-LUNG C, V274, pL908, DOI 10.1152/ajplung.1998.274.6.L908
   Peinado VI, 2008, CHEST, V134, P808, DOI 10.1378/chest.08-0820
   Peinado VI, 2013, J HEART LUNG TRANSPL, V32, P1262, DOI 10.1016/j.healun.2013.09.007
   Pelosi E, 2014, BLOOD CELL MOL DIS, V52, P186, DOI 10.1016/j.bcmd.2013.11.004
   Petousi N, 2014, J APPL PHYSIOL, V116, P875, DOI 10.1152/japplphysiol.00605.2013
   Pizarro S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106163
   Portillo K, 2015, INT J CHRONIC OBSTR, V10, P1313, DOI 10.2147/COPD.S78180
   Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799
   Ricard N, 2014, CIRCULATION, V129, P1586, DOI 10.1161/CIRCULATIONAHA.113.007469
   Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653
   Rowlands DJ, 2011, J CLIN INVEST, V121, P1986, DOI 10.1172/JCI43839
   RYAN US, 1984, CIRCULATION, V70, P46
   RYAN US, 1986, CLIN INVEST MED, V9, P124
   Santos S, 2002, EUR RESPIR J, V19, P632, DOI 10.1183/09031936.02.00245902
   Sartori C, 1999, CIRCULATION, V99, P2665, DOI 10.1161/01.CIR.99.20.2665
   Scherrer U, 1996, NEW ENGL J MED, V334, P624, DOI 10.1056/NEJM199603073341003
   SCHOENE RB, 1988, J APPL PHYSIOL, V64, P2605, DOI 10.1152/jappl.1988.64.6.2605
   Seimetz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129327
   Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035
   Simonneau G, 2013, J AM COLL CARDIOL, V62, pD34, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]
   Soria R, 2016, J APPL PHYSIOL, V121, P1151, DOI 10.1152/japplphysiol.00394.2016
   Stenmark KR, 2005, CIRC RES, V97, P95, DOI 10.1161/01.RES.00000175934.68087.29
   Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f
   Sweatt AJ, 2014, CLIN CHEST MED, V35, P609, DOI 10.1016/j.ccm.2014.08.002
   Swenson ER, 2002, JAMA-J AM MED ASSOC, V287, P2228, DOI 10.1001/jama.287.17.2228
   Swenson ER, 2012, COMPR PHYSIOL, V2, P2753, DOI 10.1002/cphy.c100029
   Sylvester JT, 2012, PHYSIOL REV, V92, P367, DOI 10.1152/physrev.00041.2010
   Takahashi T, 2014, INT J CHRONIC OBSTR, V9, P303, DOI 10.2147/COPD.S38931
   Thomashow MA, 2013, AM J RESP CRIT CARE, V188, P60, DOI 10.1164/rccm.201209-1697OC
   Vanhoutte PM, 2016, CIRC RES, V119, P375, DOI 10.1161/CIRCRESAHA.116.306531
   VISWANATHAN R, 1969, AM REV RESPIR DIS, V100, P334, DOI 10.1164/arrd.1969.100.3.334
   VOCK P, 1991, CHEST, V100, P1306, DOI 10.1378/chest.100.5.1306
   Weissmann N, 2001, AM J PHYSIOL-LUNG C, V280, pL638, DOI 10.1152/ajplung.2001.280.4.L638
   Weissmann N, 2014, AM J RESP CRIT CARE, V189, P1359, DOI 10.1164/rccm.201311-2037OC
   WEST JB, 1974, ANESTHESIOLOGY, V41, P124, DOI 10.1097/00000542-197408000-00004
   Westphalen K, 2012, AM J PHYSIOL-LUNG C, V303, pL107, DOI 10.1152/ajplung.00206.2011
   Wilkins MR, 2015, CIRCULATION, V131, P582, DOI 10.1161/CIRCULATIONAHA.114.006977
   Wilkins MR, 2014, CIRC-CARDIOVASC GENE, V7, P920, DOI 10.1161/CIRCGENETICS.114.000763
   Wright JL, 2011, AM J RESP CRIT CARE, V183, P50, DOI 10.1164/rccm.201003-0399OC
   Ying XY, 1996, CIRC RES, V79, P898, DOI 10.1161/01.RES.79.4.898
   Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471
   Zhao L, 2015, NATURE, V524, P356, DOI 10.1038/nature14620
NR 120
TC 92
Z9 96
U1 3
U2 20
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD APR 1
PY 2018
VL 51
IS 4
AR 1700745
DI 10.1183/13993003.00745-2017
PG 13
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA GC8BH
UT WOS:000430017400014
PM 29545281
OA Bronze, Green Submitted
DA 2023-08-21
ER

PT J
AU Lam, FW
   Da, Q
   Guillory, B
   Cruz, MA
AF Lam, Fong W.
   Da, Qi
   Guillory, Bobby
   Cruz, Miguel A.
TI Recombinant Human Vimentin Binds to P-Selectin and Blocks Neutrophil
   Capture and Rolling on Platelets and Endothelium
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID ACUTE LUNG INJURY; VON-WILLEBRAND-FACTOR; GLYCOPROTEIN LIGAND-1;
   TRANSENDOTHELIAL MIGRATION; PULMONARY RECRUITMENT; ABDOMINAL SEPSIS;
   CELL-ADHESION; SEPTIC SHOCK; AGGREGATION; ALPHA
AB Leukocyte adhesion to vascular endothelium and platelets is an early step in the acute inflammatory response. The initial process is mediated through P-selectin glycoprotein ligand-1 (PSGL-1) on leukocytes binding to platelets adhered to endothelium and the endothelium itself via P-selectin. Although these interactions are generally beneficial, pathologic inflammation may occur in undesirable circumstances, such as in acute lung injury (ALI) and ischemia and reperfusion injury. Therefore, the development of novel therapies to attenuate inflammation may be beneficial. In this article, we describe the potential benefit of using a recombinant human vimentin (rhVim) on reducing human leukocyte adhesion to vascular endothelium and platelets under shear stress. The addition of rhVim to whole blood and isolated neutrophils decreased leukocyte adhesion to endothelial and platelet monolayers. Furthermore, rhVim blocked neutrophil adhesion to P-selectin-coated surfaces. Binding assays showed that rhVim binds specifically to P-selectin and not to its counterreceptor, PSGL-1. Finally, in an endotoxin model of ALI in C57BL/ 6J mice, treatment with rhVim significantly decreased histologic findings of ALI. These data suggest a potential role for rhVim in attenuating inflammation through blocking P-selectin-PSGL-1 interactions.
C1 [Lam, Fong W.; Da, Qi; Guillory, Bobby; Cruz, Miguel A.] Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX 77030, United States.
   [Lam, Fong W.; Da, Qi] Baylor Coll Med, Dept Pediat, 6621 Fannin St,WT-6006,One Baylor Plaza, Houston, TX 77030, United States.
   [Guillory, Bobby; Cruz, Miguel A.] Baylor Coll Med, Dept Med, Houston, TX 77030, United States.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine
RP Lam, FW (corresponding author), Baylor Coll Med, Dept Pediat, 6621 Fannin St,WT-6006,One Baylor Plaza, Houston, TX 77030 USA.
EM flam@bcm.edu
OI Lam, Fong/0000-0003-2034-2625
FU National Institutes of Health/National Heart, Lung, and Blood Institute
   [HL-116524]; National Institutes of Health/National Institute of General
   Medical Sciences [GM-112806, GM-123261]; National Institutes of
   Health/National Institute of Neurological Disorders and Stroke
   [NS-094280]; U.S. Department of Veterans Affairs Biomedical Laboratory
   Research and Development Service [I01 BX002551]
FX This work was supported by National Institutes of Health/National Heart,
   Lung, and Blood Institute Grant HL-116524, National Institutes of
   Health/National Institute of General Medical Sciences Grants GM-112806
   and GM-123261, National Institutes of Health/National Institute of
   Neurological Disorders and Stroke Grant NS-094280, and a Merit Review
   Award (I01 BX002551) from the U.S. Department of Veterans Affairs
   Biomedical Laboratory Research and Development Service.
CR ALTIERI DC, 1990, J BIOL CHEM, V265, P12119
   Asaduzzaman M, 2009, CRIT CARE MED, V37, P1389, DOI 10.1097/CCM.0b013e31819ceb71
   Asaduzzaman M, 2009, BRIT J PHARMACOL, V156, P307, DOI 10.1111/j.1476-5381.2008.00021.x
   Bay-Jensen AC, 2013, ARTHRITIS RHEUM-US, V65, P972, DOI 10.1002/art.37843
   Brentville VA, 2016, CANCER RES, V76, P548, DOI 10.1158/0008-5472.CAN-15-1085
   Chernyatina AA, 2012, P NATL ACAD SCI USA, V109, P13620, DOI 10.1073/pnas.1206836109
   Da Q, 2015, BLOOD, V126, P2338, DOI 10.1182/blood-2015-05-648030
   Da Q, 2014, BLOOD, V123, P2715, DOI 10.1182/blood-2013-10-530428
   Diacovo TG, 1996, BLOOD, V88, P146
   Dong JF, 2003, J BIOL CHEM, V278, P29633, DOI 10.1074/jbc.M301385200
   Fernandes LS, 2003, THROMB RES, V111, P171, DOI 10.1016/j.thromres.2003.08.017
   Fortenberry JD, 1996, J PEDIATR-US, V128, P670, DOI 10.1016/S0022-3476(96)80133-8
   Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067
   Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje
   Huet O, 2013, SHOCK, V39, P488, DOI 10.1097/SHK.0b013e3182939831
   Ise H, 2010, GLYCOBIOLOGY, V20, P843, DOI 10.1093/glycob/cwq039
   Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040
   JONES DA, 1993, BIOPHYS J, V65, P1560, DOI 10.1016/S0006-3495(93)81195-0
   Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014
   Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568
   Konstantopoulos K, 1998, CIRCULATION, V98, P873, DOI 10.1161/01.CIR.98.9.873
   Kumar A, 1996, J EXP MED, V183, P949, DOI 10.1084/jem.183.3.949
   Lam FW, 2013, THROMB RES, V132, P69, DOI 10.1016/j.thromres.2013.04.018
   Lam FW, 2011, AM J PHYSIOL-HEART C, V300, pH468, DOI 10.1152/ajpheart.00491.2010
   Lerman YV, 2014, BLOOD, V124, P3515, DOI 10.1182/blood-2014-01-552943
   Li FJ, 2017, J IMMUNOL, V199, P1596, DOI 10.4049/jimmunol.1700473
   Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P4794, DOI 10.1167/iovs.06-0381
   Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008
   McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556
   MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175
   MciLwain RB, 2010, LAB INVEST, V90, P128, DOI 10.1038/labinvest.2009.119
   MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445
   MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661
   Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898
   Mor-Vaknin N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01045
   Murohara T, 1996, J IMMUNOL, V156, P3550
   Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355
   Pall T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029305
   Satelli A, 2016, J CANCER, V7, P1824, DOI 10.7150/jca.15622
   SMITH CW, 1988, J CLIN INVEST, V82, P1746, DOI 10.1172/JCI113788
   Thorlacius H, 1997, AM J PHYSIOL-HEART C, V272, pH1725, DOI 10.1152/ajpheart.1997.272.4.H1725
   Wilkins PP, 1996, J BIOL CHEM, V271, P18732, DOI 10.1074/jbc.271.31.18732
   Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81
   Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499
NR 44
TC 34
Z9 34
U1 0
U2 9
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAR 1
PY 2018
VL 200
IS 5
BP 1718
EP 1726
DI 10.4049/jimmunol.1700784
PG 9
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA FW8NA
UT WOS:000425591000021
PM 29335256
OA Bronze, Green Accepted
DA 2023-08-21
ER

PT J
AU Shaver, CM
   Wickersham, N
   McNeil, JB
   Nagata, H
   Miller, A
   Landstreet, SR
   Kuck, JL
   Diamond, JM
   Lederer, DJ
   Kawut, SM
   Palmer, SM
   Wille, KM
   Weinacker, A
   Lama, VN
   Crespo, MM
   Orens, JB
   Shah, PD
   Hage, CA
   Cantu, E
   Porteous, MK
   Dhillon, G
   McDyer, J
   Bastarache, JA
   Christie, JD
   Ware, LB
AF Shaver, Ciara M.
   Wickersham, Nancy
   McNeil, J. Brennan
   Nagata, Hiromasa
   Miller, Adam
   Landstreet, Stuart R.
   Kuck, Jamie L.
   Diamond, Joshua M.
   Lederer, David J.
   Kawut, Steven M.
   Palmer, Scott M.
   Wille, Keith M.
   Weinacker, Ann
   Lama, Vibha N.
   Crespo, Maria M.
   Orens, Jonathan B.
   Shah, Pali D.
   Hage, Chadi A.
   Cantu, Edward, III
   Porteous, Mary K.
   Dhillon, Gundeep
   McDyer, John
   Bastarache, Julie A.
   Christie, Jason D.
   Ware, Lorraine B.
CA Lung Transplant Outcomes Grp LTOG
TI Cell-free hemoglobin promotes primary graft dysfunction through
   oxidative lung endothelial injury
SO JCI INSIGHT
LA English
DT Article
ID CLINICAL RISK-FACTORS; ISCHEMIA-REPERFUSION INJURY;
   VASCULAR-PERMEABILITY; LIPID-PEROXIDATION; PULMONARY-EDEMA; DONOR
   SMOKING; TRANSPLANTATION; ACETAMINOPHEN; INCREASES; SEPSIS
AB Primary graft dysfunction (PGD) is acute lung injury within 72 hours of lung transplantation. We hypothesized that cell-free hemoglobin (CFH) contributes to PGD by increasing lung microvascular permeability and tested this in patients, ex vivo human lungs, and cultured human lung microvascular endothelial cells. In a nested case control study of 40 patients with severe PGD at 72 hours and 80 matched controls without PGD, elevated preoperative CFH was independently associated with increased PGD risk (odds ratio [OR] 2.75, 95% CI, 1.23-6.16, P = 0.014). The effect of CFH on PGD was magnified by reperfusion fraction of inspired oxygen (FiO(2)) = 0.40 (OR 3.41, P = 0.031). Isolated perfused human lungs exposed to intravascular CFH (100 mg/dl) developed increased vascular permeability as measured by lung weight (CFH 14.4% vs. control 0.65%, P = 0.047) and extravasation of Evans blue-labeled albumin dye (EBD) into the airspace (P = 0.027). CFH (1 mg/dl) also increased paracellular permeability of human pulmonary microvascular endothelial cell monolayers (hPMVECs). Hyperoxia (FiO(2) = 0.95) increased human lung and hPMVEC permeability compared with normoxia (FiO(2) = 0.21). Treatment with acetaminophen (15 mu g/ml), a specific hemoprotein reductant, prevented CFH-dependent permeability in human lungs (P = 0.046) and hPMVECs (P = 0.037). In summary, CFH may mediate PGD through oxidative effects on microvascular permeability, which are augmented by hyperoxia and abrogated by acetaminophen.
C1 [Shaver, Ciara M.; Wickersham, Nancy; McNeil, J. Brennan; Landstreet, Stuart R.; Kuck, Jamie L.; Bastarache, Julie A.; Ware, Lorraine B.] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN, United States.
   [Nagata, Hiromasa] Keio Univ, Sch Med, Dept Anesthesiol, Tokyo, Japan.
   [Miller, Adam] Tennessee Donor Serv, Nashville, TN, United States.
   [Diamond, Joshua M.; Kawut, Steven M.; Crespo, Maria M.; Porteous, Mary K.; Christie, Jason D.] Univ Penn, Dept Med, Perelman Sch Med, Div Pulm & Crit Care Med, Philadelphia, PA 19104, United States.
   [Lederer, David J.] Columbia Univ, Sch Med, Div Pulm Allergy & Crit Care Med, New York, NY, United States.
   [Palmer, Scott M.] Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Durham, NC, United States.
   [Wille, Keith M.] Univ Alabama Birmingham, Div Pulm & Crit Care Med, Birmingham, AL, United States.
   [Weinacker, Ann; Dhillon, Gundeep] Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Palo Alto, CA 94304, United States.
   [Lama, Vibha N.] Univ Michigan, Med Ctr, Div Pulm & Crit Care Med, Ann Arbor, MI, United States.
   [Orens, Jonathan B.; Shah, Pali D.] Johns Hopkins Univ, Med Ctr, Div Pulm & Crit Care Med, Baltimore, MD 21218, United States.
   [Hage, Chadi A.] Indiana Univ Sch Med, Div Pulm Allergy Crit Care & Occupat Med, Indianapolis, IN 46202, United States.
   [Cantu, Edward, III] Univ Penn, Perelman Sch Med, Div Cardiovasc Surg, Philadelphia, PA 19104, United States.
   [McDyer, John] Univ Pittsburgh, Div Pulm Allergy & Crit Care, Pittsburgh, PA, United States.
   [Bastarache, Julie A.; Ware, Lorraine B.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN, United States.
C3 Vanderbilt University; Keio University; University of Pennsylvania;
   Pennsylvania Medicine; Columbia University; Duke University; University
   of Alabama System; University of Alabama Birmingham; Stanford
   University; University of Michigan System; University of Michigan; Johns
   Hopkins University; University System of Maryland; University of
   Maryland Baltimore; Indiana University System; Indiana University
   Bloomington; University of Pennsylvania; Pennsylvania Medicine;
   Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Vanderbilt University
RP Ware, LB (corresponding author), 1161 21st Ave South,Med Ctr North,T-1218, Nashville, TN 37232 USA.
EM lorraine.ware@vanderbilt.edu
RI Ware, Lorraine/AAJ-9307-2021; Hage, Chadi/Z-4903-2019; Hage,
   Chadi/HMP-3255-2023
OI Ware, Lorraine/0000-0002-9429-4702; Palmer, Scott/0000-0002-1370-3771;
   Christie, Jason/0000-0003-0519-218X; Weinacker, Ann/0000-0003-4869-2854;
   Dhillon, Gundeep/0000-0003-0440-1138; Shaver, Ciara/0000-0002-5677-0288;
   McNeil, Joel/0000-0002-9200-1881
FU NIH [HL135849, HL103836, HL087115, HL126176, HL126671, HL117676,
   HL121406, HL136888]; Vanderbilt Faculty Research Scholars; American
   Thoracic Society; Parker B. Francis Family Foundation
FX These studies were funded by NIH HL135849 (LBW, JAB), HL103836 (LBW),
   HL087115 (JDC), HL126176 (LBW), HL126671 (JAB), HL117676 (JAB), HL121406
   (JMD), HL136888 (CMS), Vanderbilt Faculty Research Scholars (CMS),
   American Thoracic Society (CMS), and the Parker B. Francis Family
   Foundation (CMS). We would like to thank Tennessee Donor Services for
   their invaluable assistance in obtaining donor lungs for research. We
   thank the donor families for their gift to research.
CR Baldwin AL, 1999, AM J PHYSIOL-HEART C, V277, pH650, DOI 10.1152/ajpheart.1999.277.2.H650
   Bastarache JA, 2012, THORAX, V67, P1032, DOI 10.1136/thoraxjnl-2012-201781
   Ben Moussa S, 2014, LIBYAN J MED, V9, DOI 10.3402/ljm.v9.23873
   Boutaud O, 2010, P NATL ACAD SCI USA, V107, P2699, DOI 10.1073/pnas.0910174107
   Brittain EL, 2014, CHEST, V146, P1478, DOI 10.1378/chest.14-0809
   Calfee CS, 2007, BIOMARK MED, V1, P285, DOI 10.2217/17520363.1.2.285
   Cantu E, 2016, AM J TRANSPLANT, V16, P833, DOI 10.1111/ajt.13525
   Christie JD, 2007, AM J RESP CRIT CARE, V175, P69, DOI 10.1164/rccm.200606-827OC
   Christie JD, 2009, AM J RESP CRIT CARE, V180, P1010, DOI 10.1164/rccm.200901-0118OC
   Christie JD, 2005, J HEART LUNG TRANSPL, V24, P1454, DOI 10.1016/j.healun.2004.11.049
   Christie JD, 2003, CHEST, V124, P1232, DOI 10.1378/chest.124.4.1232
   Diamond JM, 2011, AM J TRANSPLANT, V11, P561, DOI 10.1111/j.1600-6143.2010.03431.x
   Diamond JM, 2016, J HEART LUNG TRANSPL, V35, P500, DOI 10.1016/j.healun.2015.12.012
   Diamond JM, 2013, CURR OPIN ORGAN TRAN, V18, P518, DOI 10.1097/MOT.0b013e3283651994
   Diamond JM, 2013, AM J RESP CRIT CARE, V187, P527, DOI 10.1164/rccm.201210-1865OC
   Diamond JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051932
   Fessel Joshua P, 2012, Pulm Circ, V2, P201, DOI 10.4103/2045-8932.97606
   Frank JA, 2007, AM J PHYSIOL-LUNG C, V293, pL52, DOI 10.1152/ajplung.00256.2006
   Godzich M, 2006, FASEB J, V20, P1519, DOI 10.1096/fj.05-4708fje
   Hashimoto K, 2016, AM J RESP CRIT CARE, V194, P97, DOI 10.1164/rccm.201510-2115OC
   Hoffman SA, 2009, AM J TRANSPLANT, V9, P389, DOI 10.1111/j.1600-6143.2008.02497.x
   Janz DR, 2015, CRIT CARE MED, V43, P534, DOI 10.1097/CCM.0000000000000718
   Janz DR, 2013, CRIT CARE MED, V41, P784, DOI 10.1097/CCM.0b013e3182741a54
   Krenn K, 2007, AM J TRANSPLANT, V7, P700, DOI 10.1111/j.1600-6143.2006.01673.x
   Krenn K, 2007, EUR J CARDIO-THORAC, V32, P35, DOI 10.1016/j.ejcts.2007.04.006
   Kuntz CL, 2009, CLIN TRANSPLANT, V23, P819, DOI 10.1111/j.1399-0012.2008.00951.x
   Lederer DJ, 2011, AM J RESP CRIT CARE, V184, P1055, DOI 10.1164/rccm.201104-0728OC
   Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106
   Lisk C, 2013, AM J RESP CELL MOL, V49, P619, DOI 10.1165/rcmb.2012-0440OC
   Liu Yu-Qiang, 2014, J Anal Methods Chem, V2014, P617367, DOI 10.1155/2014/617367
   Lowery EM, 2014, ALCOHOL CLIN EXP RES, V38, P2853, DOI 10.1111/acer.12553
   Mallavia B, 2016, AM J TRANSPLANT, V16, P1306, DOI 10.1111/ajt.13605
   Nosotti M, 2014, TRANSPL P, V46, P2329, DOI 10.1016/j.transproceed.2014.07.042
   Ouellet M, 2001, ARCH BIOCHEM BIOPHYS, V387, P273, DOI 10.1006/abbi.2000.2232
   Porteous MK, 2016, AM J RESP CRIT CARE, V193, P1392, DOI 10.1164/rccm.201508-1522OC
   Porteous MK, 2015, CURR OPIN ORGAN TRAN, V20, P506, DOI 10.1097/MOT.0000000000000232
   Potor L, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/676425
   Reeder BJ, 2005, CURR MED CHEM, V12, P2741, DOI 10.2174/092986705774463021
   Risbano MG, 2015, AM J RESP CRIT CARE, V192, P1223, DOI 10.1164/rccm.201501-0145OC
   Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653
   Rusak T, 2014, FREE RADICAL RES, V48, P230, DOI 10.3109/10715762.2013.860225
   Sayah DM, 2015, AM J RESP CRIT CARE, V191, P455, DOI 10.1164/rccm.201406-1086OC
   Schaer DJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a013433
   Shah RJ, 2014, AM J RESP CRIT CARE, V189, P1564, DOI 10.1164/rccm.201312-2121LE
   Shah RJ, 2012, TRANSL RES, V160, P435, DOI 10.1016/j.trsl.2012.08.003
   Shaver CM, 2016, AM J PHYSIOL-LUNG C, V310, pL532, DOI 10.1152/ajplung.00155.2015
   Silva G, 2009, J BIOL CHEM, V284, P29582, DOI 10.1074/jbc.M109.045344
   Somers J, 2015, J HEART LUNG TRANSPL, V34, P941, DOI 10.1016/j.healun.2015.03.009
   Su G, 2007, AM J RESP CELL MOL, V36, P377, DOI 10.1165/rcmb.2006-0238OC
   Su G, 2013, CRIT CARE MED, V41, P546, DOI 10.1097/CCM.0b013e3182711b1e
   Suzuki Y, 2013, SEMIN RESP CRIT CARE, V34, P305, DOI 10.1055/s-0033-1348474
   Ware LB, 2014, AM J TRANSPLANT, V14, P2295, DOI 10.1111/ajt.12853
   Ware LB, 2002, LANCET, V360, P619, DOI 10.1016/S0140-6736(02)09774-X
   Whitson BA, 2006, J THORAC CARDIOV SUR, V131, P73, DOI 10.1016/j.jtcvs.2005.08.039
   Windsant ICV, 2011, J THORAC CARDIOV SUR, V142, P1, DOI 10.1016/j.jtcvs.2011.02.012
NR 55
TC 23
Z9 23
U1 0
U2 5
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD JAN 25
PY 2018
VL 3
IS 2
AR e98546
DI 10.1172/jci.insight.98546
PG 12
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA FT7MU
UT WOS:000423337400013
PM 29367464
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Oskolkova, O
   Sarich, N
   Tian, YF
   Gawlak, G
   Meng, F
   Bochkov, VN
   Berdyshev, E
   Birukova, AA
   Birukov, KG
AF Oskolkova, Olga
   Sarich, Nicolene
   Tian, Yufeng
   Gawlak, Grzegorz
   Meng, Fanyong
   Bochkov, Valery N.
   Berdyshev, Evgeny
   Birukova, Anna A.
   Birukov, Konstantin G.
TI Incorporation of iloprost in phospholipase-resistant phospholipid
   scaffold enhances its barrier protective effects on pulmonary
   endothelium
SO SCIENTIFIC REPORTS
LA English
DT Article
ID INDUCED LUNG INJURY; OXIDIZED PHOSPHOLIPIDS; ACTIVATION; PERMEABILITY;
   RECEPTOR; KINASE; CELLS; RAP1; RAC; PHARMACOKINETICS
AB Correction of barrier dysfunction and inflammation in acute lung injury (ALI) represents an important problem. Previous studies demonstrate barrier-protective and anti-inflammatory effects of bioactive lipid prostacyclin and its stable analog iloprost (ILO). We generated a phospholipase resistant synthetic phospholipid with iloprost attached at the sn-2 position (ILO-PC) and investigated its biological effects. In comparison to free ILO, ILO-PC caused sustained endothelial cell (EC) barrier enhancement, linked to more prolonged activation of Rap1 and Rac1 GTPases and their cytoskeletal and cell junction effectors: cortactin, PAK1, p120-catenin and VE-cadherin. ILO and ILO-PC equally efficiently suppressed acute, Rho GTPase-dependent EC hyper-permeability caused by thrombin. However, ILO-PC exhibited more sustained barrier-protective and anti-inflammatory effects in the model of chronic EC dysfunction caused by bacterial wall lipopolysacharide (LPS). ILO-PC was also more potent inhibitor of NF kappa B signaling and lung vascular leak in the murine model of LPS-induced ALI. Treatment with ILO-PC showed more efficient ALI recovery over 3 days after LPS challenge than free ILO. In conclusion, this study describes a novel synthetic phospholipid with barrier-enhancing and anti-inflammatory properties superior to existing prostacyclin analogs, which may be used as a prototype for future development of more efficient treatment for ALI and other vascular leak syndromes.
C1 [Oskolkova, Olga; Sarich, Nicolene; Tian, Yufeng; Gawlak, Grzegorz; Meng, Fanyong] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637, United States.
   [Oskolkova, Olga; Bochkov, Valery N.] Graz Univ, Dept Pharmaceut Chem, Inst Pharmaceut Sci, A-8010 Graz, Austria.
   [Berdyshev, Evgeny] Natl Jewish Hlth, Denver, CO 80206, United States.
   [Birukova, Anna A.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201, United States.
   [Birukov, Konstantin G.] Univ Maryland, Sch Med, Dept Anesthesia, Baltimore, MD 21201, United States.
C3 University of Chicago; ARQUS; University of Graz; National Jewish
   Health; University System of Maryland; University of Maryland Baltimore;
   University System of Maryland; University of Maryland Baltimore
RP Birukov, KG (corresponding author), Univ Maryland, Sch Med, Dept Anesthesia, Baltimore, MD 21201 USA.
EM kbirukov@som.umaryland.edu
RI Bochkov, Valery/HNR-8336-2023; Birukov, Konstantin/FJB-5755-2022;
   Sarich, Nicolene/IWV-3869-2023
OI Oskolkova, Olga/0000-0001-9443-8705
FU NHLBI NIH HHS [R01 HL076259, R01 HL087823, R01 HL146829, R01 HL130431]
   Funding Source: Medline; NIGMS NIH HHS [R01 GM122940, R01 GM114171]
   Funding Source: Medline
CR Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335
   Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P765, DOI 10.1007/s00418-008-0422-y
   Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06
   Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005
   Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com
   Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036
   Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007
   Birukova AA, 2015, BBA-MOL BASIS DIS, V1852, P778, DOI 10.1016/j.bbadis.2014.12.016
   Birukova AA, 2014, MOL BIOL CELL, V25, P2006, DOI 10.1091/mbc.E13-12-0743
   Birukova AA, 2013, MOL BIOL CELL, V24, P2678, DOI 10.1091/mbc.E13-02-0098
   Birukova AA, 2013, TRANSL RES, V161, P495, DOI 10.1016/j.trsl.2012.12.008
   Birukova AA, 2013, EUR RESPIR J, V41, P165, DOI 10.1183/09031936.00148311
   Birukova AA, 2010, TRANSL RES, V155, P44, DOI 10.1016/j.trsl.2009.09.002
   Birukova AA, 2009, J APPL PHYSIOL, V107, P1900, DOI 10.1152/japplphysiol.00462.2009
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bochkov VN, 2002, BLOOD, V99, P199, DOI 10.1182/blood.V99.1.199
   Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742
   Bos CL, 2004, INT J BIOCHEM CELL B, V36, P1187, DOI 10.1016/j.biocel.2003.08.006
   BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6
   CAWELLO W, 1994, EUR J CLIN PHARMACOL, V46, P275
   Dejana E, 2009, CELL TISSUE RES, V335, P17, DOI 10.1007/s00441-008-0694-5
   Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159
   Essler M, 2000, J IMMUNOL, V164, P6543, DOI 10.4049/jimmunol.164.12.6543
   Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808
   Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005
   Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.E02-11-0753
   Hildebrand M, 1997, EUR J CLIN PHARMACOL, V53, P51, DOI 10.1007/s002280050336
   Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200
   Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080
   Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010
   McIntyre TM, 2012, BBA-BIOMEMBRANES, V1818, P2456, DOI 10.1016/j.bbamem.2012.03.004
   Melian EB, 2002, DRUGS, V62, P107, DOI 10.2165/00003495-200262010-00005
   Meliton A., 2015, AM J PHYSIOL-LUNG C
   Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200
   Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010
   Tian YF, 2015, J BIOL CHEM, V290, P4097, DOI 10.1074/jbc.M114.620377
   Togbe D, 2007, INT J EXP PATHOL, V88, P387, DOI 10.1111/j.1365-2613.2007.00566.x
   Watanabe Y, 1999, TETRAHEDRON, V55, P9743, DOI 10.1016/S0040-4020(99)00551-7
   Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597
NR 39
TC 12
Z9 14
U1 1
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 17
PY 2018
VL 8
AR 879
DI 10.1038/s41598-018-19197-1
PG 15
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FS9DR
UT WOS:000422716900013
PM 29343759
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Cao, Z
   Liu, JL
   Wu, S
   Wang, Q
AF Cao, Zheng
   Liu, Jing-Lan
   Wu, Shen
   Wang, Qiao
TI Mechanism of MCP-1 in Acute Lung Injury and Advanced Therapy by
   Drug-Loaded Dextrin Nanoparticle
SO INTERNATIONAL JOURNAL OF POLYMER SCIENCE
LA English
DT Article
ID MACROPHAGES; CHEMOATTRACTANT; INFLAMMATION; INHIBITION; OUTCOMES; RATS;
   PAIN
AB Objective. To observe the expression of monocyte chemotactic protein 1 (MCP-1) in acute lung injury (ALI) rat model, to characterize its effect on the development and progression of ALI, and to identify the potential new drug delivery approach during in vivo experiment. Method. The effects of different doses of lipopolysaccharide (LPS) on human pulmonary artery endothelial cells (HPAEC) were tested. For the animal experiments, thirty Sprague-Dawley (SD) rats were divided into physiological saline control group (NC group), the LPS model group (L group), the antagonist RS102895 combined with LPS group (R+ L group), and the antagonist RS102895-loaded polyaldehyde dextran nanoparticles combined with LPS group (DNPR +L group). The blood gas analysis and dry/wet weight ratio were detected 24 hours after interventions. The levels of inflammatory factors, tumor necrosis factor-alpha (TNF-alpha) and interleuldn-1 beta (IL-1 beta), were tested by ELISA. The expression of monocyte chemoattractant protein-1 (MCP-1) in lung tissues was examined through Western blot, and the change of MCP-1 mRNA expression level was detected by performing RT-PCR. Result. LPS was responsible for inducing ALI in rats, and the degree of cell damage was dose-dependent. Blood gas analysis of L group showed that PaO2 and PaO2/FiO2 levels were significantly lower than those of the NC group (P < 0.05), while the dry/wet weight ratio of lung tissues in L group increased (P < 0.05). Inflammatory factors including TNF-alpha and IL-1 beta and the expression of MCP-1 in both protein and mRNA levels were higher in L group than in the NC group (P < 0.05). The inhibition of the interaction between MCP-1 and chemokines receptor 2 (CCR2) by antagonist RS102895 can significantly alleviate the ALI in rats, which is accompanied by a significant decrease of inflammatory factors and MCP-1 expression (P < 0.05). Compared with R + L group, treatment with DNPR and LPS combination significantly improved the condition of rats and decreased the level of TNF-alpha, IL-1 beta, and MCP-1 expression (P < 0.05). Conclusion. In ALI, RS102895 can inhibit the MCP-1/CCR2 interaction, therefore, retarding the progress of ALI. Because of the high transfection efficiency of inhibitor RS102895packgaed by polyaldehyde dextran nanoparticles, this phenomenon particularly reached a significant level. The results imply new insights for the treatment of ALI.
C1 [Cao, Zheng; Wu, Shen; Wang, Qiao] Shanghai Jiao Tong Univ, Emergency Dept, Shanghai Peoples Hosp 9, Sch Med, Shanghai, China.
   [Liu, Jing-Lan] Int Peace Matern & Child Hlth Hosp, China Welf Inst, Shanghai, China.
C3 Shanghai Jiao Tong University
RP Wang, Q (corresponding author), Shanghai Jiao Tong Univ, Emergency Dept, Shanghai Peoples Hosp 9, Sch Med, Shanghai, Peoples R China.
EM wangqiao1298@126.com
FU National Natural Science Foundation of China [51673190]
FX The article is supported by grant 51673190 from the National Natural
   Science Foundation of China, and the data and materials used to support
   the findings of this study are included in the published article.
CR Al-Mazidi S, 2018, EUR J PAIN, V22, P810, DOI 10.1002/ejp.1169
   Bostrom EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134608
   Cao YM, 2016, BIOMED REP, V4, P523, DOI 10.3892/br.2016.620
   Deng GM, 2017, BIOMED PHARMACOTHER, V96, P148, DOI 10.1016/j.biopha.2017.09.094
   Dias-Freitas F, 2016, RESP MED, V119, P23, DOI 10.1016/j.rmed.2016.08.010
   Ding XB, 2017, SCI REP-UK, V7, DOI 10.1038/srep34278
   Gibon E, 2012, J ORTHOP RES, V30, P547, DOI 10.1002/jor.21548
   Guo SX, 2017, BIOMED PHARMACOTHER, V95, P1743, DOI 10.1016/j.biopha.2017.09.034
   Han CH, 2017, MED GAS RES, V7, P220, DOI 10.4103/2045-9912.215753
   He Y, 2017, CELL PHYSIOL BIOCHEM, V42, P1303, DOI 10.1159/000478959
   Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065
   Hilda JN, 2016, HUM IMMUNOL, V77, P63, DOI 10.1016/j.humimm.2015.10.005
   Hu YH, 2017, MOLECULES, V22, DOI 10.3390/molecules22060937
   Kalliomaki J, 2013, SCAND J PAIN, V4, P17, DOI 10.1016/j.sjpain.2012.08.004
   Kalnins A, 2015, SCAND J IMMUNOL, V82, P102, DOI 10.1111/sji.12310
   Lei JJ, 2018, EUR J PHARMACOL, V818, P110, DOI 10.1016/j.ejphar.2017.10.029
   Lomis N, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6060116
   Luo YP, 2017, INT J MOL MED, V39, P297, DOI 10.3892/ijmm.2016.2828
   Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009
   Mutlu GM, 2006, NEW ENGL J MED, V354, P416
   Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018
   Proudfoot AG, 2011, DIS MODEL MECH, V4, P145, DOI 10.1242/dmm.006213
   Rajasekaran S, 2016, J CELL PHYSIOL, V231, P2097, DOI 10.1002/jcp.25316
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Sormann P, 2017, INJURY, V48, P2400, DOI 10.1016/j.injury.2017.08.041
   Toy P, 2012, BLOOD, V119, P1757, DOI 10.1182/blood-2011-08-370932
   von Dossow-Hanfstingl Vera, 2012, Anesthesiol Clin, V30, P629, DOI 10.1016/j.anclin.2012.08.008
   Wang Y., 2018, MOL PAIN, V14
   Wang YL, 2017, MICROB PATHOGENESIS, V110, P375, DOI 10.1016/j.micpath.2017.07.019
   Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006
   Yang MD, 2017, THERANOSTICS, V7, P97, DOI 10.7150/thno.16844
   Yu NB, 2016, J ACUTE DIS, V5, P382, DOI 10.1016/j.joad.2016.08.003
   Zhang HM, 2016, J PAIN, V17, P775, DOI 10.1016/j.jpain.2016.02.011
   Zhang Y, 2018, ADV SCI, V5, DOI 10.1002/advs.201700821
NR 34
TC 5
Z9 6
U1 0
U2 11
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-9422
EI 1687-9430
J9 INT J POLYM SCI
JI Int. J. Polym. Sci.
PY 2018
VL 2018
AR 9269154
DI 10.1155/2018/9269154
PG 7
WC Polymer Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Polymer Science
GA GW4IQ
UT WOS:000446876600001
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Zhou, WJ
   Shi, GC
   Bai, JJ
   Ma, SM
   Liu, QF
   Ma, XG
AF Zhou, Wenjie
   Shi, Guocui
   Bai, Jijia
   Ma, Shenmao
   Liu, Qinfu
   Ma, Xigang
TI Colquhounia Root Tablet Protects Rat Pulmonary Microvascular Endothelial
   Cells against TNF-alpha-Induced Injury by Upregulating the Expression of
   Tight Junction Proteins Claudin-5 and ZO-1
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID ACUTE LUNG INJURY; NF-KAPPA-B; TRIPTERYGIUM-HYPOGLAUCUM; PERMEABILITY;
   INHIBITION; TRIPTOLIDE; DYSFUNCTION; ACTIVATION; COMPLEX; NRF2
AB Background. There are currently limited effective pharmacotherapy agents for acute lung injury (ALI). Inflammatory response in the lungs is the main pathophysiological process of ALI. Our preliminary data have shown that colquhounia root tablet (CRT), a natural herbal medicine, alleviates the pulmonary inflammatory responses and edema in a rat model with oleic acid-induced ALI. However, the potential molecular action mechanisms underlining its protective effects against ALI are poorly understood. This study aimed to investigate the effects and mechanism of CRT in rat pulmonary microvascular endothelial cells (PMEC) with TNF-alpha-induced injury. Methods. PMECs were divided into 6 groups: normal control, TNF-alpha (10 ng/mL TNF-alpha), Dex (1x10(-6) M Dex + 10 ng/mL TNF-alpha), CRT high (1000 ng/mL CRT + 10 ng/mL TNF-alpha), CRT medium (500 ng/mL CRT + 10 ng/mL TNF-alpha), and CRT low group (250 ng/mL CRT + 10 ng/mL TNF-alpha). Cell proliferation and apoptosis were detected by MTT assay and flow cytometry. Cell micromorphology was observed under transmission electron microscope. The localization and expression of tight junction proteins Claudin-5 and ZO-1 were analyzed by immunofluorescence staining and Western blot, respectively. Results. TNF-a had successfully induced an acute endothelial cell injury model. Dex and CRT treatments had significantly stimulated the growth and reduced the apoptosis of PMECs (all p < 0.05 or 0.01) and alleviated the TNF-alpha-induced cell injury. The expression of Claudin-5 and ZO-1 in Dex and all 3 CRT groups was markedly increased compared with TNF-a group (all p < 0.05 or 0.01). Conclusion. CRT effectively protects PMECs from TNF-alpha-induced injury, which might be mediated via stabilizing the structure of tight junction. CRT might be a promising, effective, and safe therapeutic agent for the treatment of ALI.
C1 [Zhou, Wenjie; Bai, Jijia; Liu, Qinfu; Ma, Xigang] Ningxia Med Univ, Gen Hosp, Dept Crit Care Med, Yinchuan 750004, Ningxia, China.
   [Shi, Guocui] Cangzhou Peoples Hosp, Dept Resp Med, Cangzhou 061000, Hebei, China.
   [Ma, Shenmao] Ningxia Med Univ, Resident Standardized Training Base, Gen Hosp, Yinchuan 750004, Ningxia, China.
C3 Ningxia Medical University; Ningxia Medical University
RP Ma, XG (corresponding author), Ningxia Med Univ, Gen Hosp, Dept Crit Care Med, Yinchuan 750004, Ningxia, Peoples R China.
EM xigangma19560812@hotmail.com
FU Natural Science Foundation of Ningxia Hui Autonomous Region [NZ17151];
   National Natural Science Foundation of China [81260583]
FX This study was supported by the Natural Science Foundation of Ningxia
   Hui Autonomous Region (NZ17151) and the National Natural Science
   Foundation of China (81260583).
CR Al-Harbi NO, 2016, IMMUNOL INVEST, V45, P349, DOI 10.3109/08820139.2016.1157814
   Al-Sadi R, 2016, AM J PATHOL, V186, P1151, DOI 10.1016/j.ajpath.2015.12.016
   Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606
   Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200
   Chen XY, 2017, INT IMMUNOPHARMACOL, V50, P270, DOI 10.1016/j.intimp.2017.07.001
   Geng P, 2018, HUM EXP TOXICOL, V37, P626, DOI 10.1177/0960327117721961
   Han R, 2012, BRIT J CLIN PHARMACO, V74, P424, DOI 10.1111/j.1365-2125.2012.04221.x
   Han SH, 2015, J IMMUNOL, V194, P855, DOI 10.4049/jimmunol.1402513
   Haseloff RF, 2015, SEMIN CELL DEV BIOL, V38, P16, DOI 10.1016/j.semcdb.2014.11.004
   Hegeman MA, 2011, BRIT J PHARMACOL, V163, P1048, DOI 10.1111/j.1476-5381.2011.01314.x
   Herrero R, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2017.12.18
   Holopainen R, 2001, PEDIATR RES, V49, P162, DOI 10.1203/00006450-200102000-00006
   Jang AS, 2011, AM J RESP CELL MOL, V44, P483, DOI 10.1165/rcmb.2009-0391OC
   Jia W, 2014, MOL MED REP, V9, P779, DOI 10.3892/mmr.2013.1875
   Koval M, 2013, ANNU REV PHYSIOL, V75, P551, DOI 10.1146/annurev-physiol-030212-183809
   Krug SM, 2014, SEMIN CELL DEV BIOL, V36, P166, DOI 10.1016/j.semcdb.2014.09.002
   Kubo Y, 2018, EXPERT OPIN DRUG MET, V14, P513, DOI 10.1080/17425255.2018.1472764
   Liu YZ, 2015, IMMUNOPHARM IMMUNOT, V37, P527, DOI 10.3109/08923973.2015.1107574
   Ma X. G., 2014, J NINGXIA MED U, V36, P248
   Macconi D, 2000, J AM SOC NEPHROL, V11, P477, DOI 10.1681/ASN.V113477
   Mazzon E, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-75
   Morrison M, 2014, ATHEROSCLEROSIS, V233, P149, DOI 10.1016/j.atherosclerosis.2013.12.027
   Oray M, 2016, EXPERT OPIN DRUG SAF, V15, P457, DOI 10.1517/14740338.2016.1140743
   Peng Anping, 2014, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V30, P635
   Reno TA, 2015, ANN THORAC SURG, V100, P1817, DOI 10.1016/j.athoracsur.2015.05.074
   Shao P, 2018, INT J CLIN EXP MED, V11, P6634
   Shay J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/181260
   Shen HT, 2017, LIFE SCI, V170, P25, DOI 10.1016/j.lfs.2016.11.021
   Tsushima K, 2009, INTERNAL MED, V48, P621, DOI 10.2169/internalmedicine.48.1741
   Tu GW, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1284-7
   Turnage RH, 2002, WORLD J SURG, V26, P848, DOI 10.1007/s00268-002-4063-3
   Wang HB, 2012, DIGEST DIS SCI, V57, P3126, DOI 10.1007/s10620-012-2259-4
   Wang LC, 2015, MICROVASC RES, V99, P102, DOI 10.1016/j.mvr.2015.03.007
   Wei D, 2014, INFLAMMATION, V37, P1307, DOI 10.1007/s10753-014-9858-5
   Wen SH, 2014, INT IMMUNOPHARMACOL, V23, P709, DOI 10.1016/j.intimp.2014.10.027
   Wu Xin-lin, 2002, Zhongguo Zhong Xi Yi Jie He Za Zhi, V22, P30
   Yang L., 2018, MOL MED REPORTS
   Yang YQ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00999
   Zhang Y., 2008, PEOPLE MIL SURG, V51, P463
   Zhao P, 2014, BIOSCI BIOTECH BIOCH, V78, P370, DOI 10.1080/09168451.2014.890035
   Zheng He-zhong, 2012, Zhejiang Da Xue Xue Bao Yi Xue Ban, V41, P425
   Zhou Jian-hua, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P418
NR 42
TC 7
Z9 10
U1 2
U2 7
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2018
VL 2018
AR 1024634
DI 10.1155/2018/1024634
PG 11
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA HC5GW
UT WOS:000451832500001
PM 30581478
OA Green Published, gold, Green Submitted
DA 2023-08-21
ER

PT J
AU Meyer, NJ
   Reilly, JP
   Feng, R
   Christie, JD
   Hazen, SL
   Albert, CJ
   Franke, JD
   Hartman, CL
   McHowat, J
   Ford, DA
AF Meyer, Nuala J.
   Reilly, John P.
   Feng, Rui
   Christie, Jason D.
   Hazen, Stanley L.
   Albert, Carolyn J.
   Franke, Jacob D.
   Hartman, Celine L.
   McHowat, Jane
   Ford, David A.
TI Myeloperoxidase-derived 2-chlorofatty acids contribute to human sepsis
   mortality via acute respiratory distress syndrome
SO JCI INSIGHT
LA English
DT Article
ID ACUTE LUNG INJURY; CHLORINATED LIPIDS; CRITICALLY-ILL; NEUTROPHIL;
   IDENTIFICATION; TRAUMA; PLASMALOGENS; ACTIVATION; PREDICTION; TARGET
AB Sepsis-associated acute respiratory distress syndrome (ARDS) is characterized by neutrophilic inflammation and poor survival. Since neutrophil myeloperoxidase (MPO) activity leads to increased plasma 2-chlorofatty acid (2-ClFA) levels, we hypothesized that plasma concentrations of 2-ClFAs would associate with ARDS and mortality in subjects with sepsis. In sequential consenting patients with sepsis, free 2-ClFA levels were significantly associated with ARDS, and with 30-day mortality, for each log increase in free 2-chlorostearic acid. Plasma MPO was not associated with either ARDS or 30-day mortality but was correlated with 2-ClFA levels. Addition of plasma 2-ClFA levels to the APACHE III score improved prediction for ARDS. Plasma 2-ClFA levels correlated with plasma levels of angiopoietin-2, E selectin, and soluble thrombomodulin. Endothelial cells treated with 2-ClFA responded with increased adhesion molecule surface expression, increased angiopoietin-2 release, and dose-dependent endothelial permeability. Our results suggest that 2-ClFAs derived from neutrophil MPO-catalyzed oxidation contribute to pulmonary endothelial injury and have prognostic utility in sepsis-associated ARDS.
C1 [Meyer, Nuala J.; Reilly, John P.; Christie, Jason D.] Univ Penn, Perelman Sch Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104, United States.
   [Meyer, Nuala J.; Reilly, John P.; Christie, Jason D.] Univ Penn, Perelman Sch Med, Ctr Translat Lung Biol, Philadelphia, PA 19104, United States.
   [Feng, Rui; Christie, Jason D.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104, United States.
   [Hazen, Stanley L.] Cleveland Clin, Ctr Microbiome & Human Hlth, Dept Cellular & Mol Med, Cleveland, OH 44106, United States.
   [Hazen, Stanley L.] Cleveland Clin, Inst Heart & Vasc, Dept Cardiovasc Med, Cleveland, OH 44106, United States.
   [Albert, Carolyn J.; Franke, Jacob D.; Hartman, Celine L.; Ford, David A.] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104, United States.
   [Albert, Carolyn J.; Franke, Jacob D.; Hartman, Celine L.; McHowat, Jane; Ford, David A.] St Louis Univ, Sch Med, Ctr Cardiovasc Res, St Louis, MO, United States.
   [McHowat, Jane] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104, United States.
C3 University of Pennsylvania; Pennsylvania Medicine; University of
   Pennsylvania; Pennsylvania Medicine; University of Pennsylvania;
   Pennsylvania Medicine; Cleveland Clinic Foundation; Cleveland Clinic
   Foundation; Saint Louis University; Saint Louis University; Saint Louis
   University
RP Ford, DA (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, Doisy Res Ctr, 1100 South Grand Ave, St Louis, MO 63104 USA.
EM fordda@slu.edu
RI Hazen, Stanley L/ABD-5845-2021
OI Young, Celine Hartman/0000-0002-6956-3966
FU NIH [R01GM115553, R01HL122474, P01HL076491]
FX This study was supported by NIH grants R01GM115553 (to DAF and JM),
   R01HL122474 (to NJM), and P01HL076491 (to SLH).
CR Adams JM, 2001, J TRAUMA, V51, P452, DOI 10.1097/00005373-200109000-00005
   Albert CJ, 2001, J BIOL CHEM, V276, P23733, DOI 10.1074/jbc.M101447200
   Anbukumar DS, 2010, J LIPID RES, V51, P1085, DOI 10.1194/jlr.M003673
   Anderson BJ, 2016, J CRIT CARE, V36, P18, DOI 10.1016/j.jcrc.2016.06.012
   [Anonymous], 2012, JAMA, DOI DOI 10.1001/JAMA.2012.5669
   Aziz M, 2013, J LEUKOCYTE BIOL, V93, P329, DOI 10.1189/jlb.0912437
   Beckett CS, 2007, THROMB RES, V120, P259, DOI 10.1016/j.thromres.2006.09.005
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Brahmbhatt VV, 2010, J BIOL CHEM, V285, P41255, DOI 10.1074/jbc.M110.147157
   Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008
   Brealey D, 2000, J ROY COLL PHYS LOND, V34, P428
   Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3
   Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9
   Cepinskas G, 2008, J CLIN BIOCHEM NUTR, V42, P175, DOI 10.3164/jcbn.2008026
   CHILTON FH, 1988, J BIOL CHEM, V263, P5260
   David S, 2012, CRIT CARE MED, V40, P3034, DOI 10.1097/CCM.0b013e31825fdc31
   DORMAN RV, 1977, BIOCHIM BIOPHYS ACTA, V486, P55, DOI 10.1016/0005-2760(77)90069-8
   Famous KR, 2017, AM J RESP CRIT CARE, V195, P331, DOI 10.1164/rccm.201603-0645OC
   Fang WF, 2007, AM J PHYSIOL-LUNG C, V293, pL336, DOI 10.1152/ajplung.00011.2007
   FERRANTE A, 1980, J IMMUNOL METHODS, V36, P109, DOI 10.1016/0022-1759(80)90036-8
   Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685
   FORD DA, 1989, P NATL ACAD SCI USA, V86, P3479, DOI 10.1073/pnas.86.10.3479
   Ford DA, 2016, J LIPID RES, V57, P1529, DOI 10.1194/jlr.M069005
   Ford DA, 2010, CLIN LIPIDOL, V5, P835, DOI 10.2217/CLP.10.68
   Gajic O, 2011, AM J RESP CRIT CARE, V183, P462, DOI 10.1164/rccm.201004-0549OC
   Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298
   Graler MH, 2012, AM J CLIN EXP IMMUNO, V1, P90
   Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138
   HARRISON JE, 1976, J BIOL CHEM, V251, P1371
   HAZEN SL, 1993, J CLIN INVEST, V91, P2513, DOI 10.1172/JCI116487
   Hsu FF, 2003, J MASS SPECTROM, V38, P752, DOI 10.1002/jms.491
   Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761
   Iwata K, 2010, INTERNAL MED, V49, P2423, DOI 10.2169/internalmedicine.49.4010
   Kangelaris KN, 2015, AM J PHYSIOL-LUNG C, V308, pL1102, DOI 10.1152/ajplung.00380.2014
   KLEBANOFF SJ, 1980, ANN INTERN MED, V93, P480, DOI 10.7326/0003-4819-93-3-480
   KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619
   Kothari N, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.09.001
   McHowat J, 1997, J CHROMATOGR B, V702, P21, DOI 10.1016/S0378-4347(97)00386-1
   Messner MC, 2008, LIPIDS, V43, P581, DOI 10.1007/s11745-008-3189-y
   Mokart D, 2008, CRIT CARE, V12, DOI 10.1186/cc6791
   MURPHY EJ, 1992, LIPIDS, V27, P150, DOI 10.1007/BF02535816
   Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785
   NUYTINCK HKS, 1988, ARCH SURG-CHICAGO, V123, P1519
   Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046
   Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC
   Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929
   Pepe MS, 2006, BIOMETRICS, V62, P221, DOI 10.1111/j.1541-0420.2005.00420.x
   PEPE PE, 1982, AM J SURG, V144, P124, DOI 10.1016/0002-9610(82)90612-2
   Pittet JF, 1997, AM J RESP CRIT CARE, V155, P1187, DOI 10.1164/ajrccm.155.4.9105054
   PORTILLA D, 1995, KIDNEY INT, V47, P1087, DOI 10.1038/ki.1995.155
   Prescott SM, 1999, J CLIN INVEST, V104, P1019, DOI 10.1172/JCI8506
   Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54
   Reilly JP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1398-y
   Reilly JP, 2015, CLIN J AM SOC NEPHRO, V10, P1911, DOI 10.2215/CJN.12201214
   Reilly JP, 2014, CHEST, V145, P753, DOI 10.1378/chest.13-1962
   Robinson-Cohen C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1385-3
   Shah CV, 2010, CHEST, V138, P1054, DOI 10.1378/chest.09-2697
   Shapiro NI, 2010, CRIT CARE, V14, DOI 10.1186/cc9290
   Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
   Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541
   Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2
   Suratt BT, 2009, CRIT CARE MED, V37, P1322, DOI 10.1097/CCM.0b013e31819c14fa
   Suwa T, 2001, AM J RESP CRIT CARE, V163, P970, DOI 10.1164/ajrccm.163.4.2005132
   Teixeira-da-Cunha MGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074567
   Thijs A, 1998, KIDNEY INT, V53, pS34
   Thukkani AK, 2005, AM J PHYSIOL-HEART C, V288, pH2955, DOI 10.1152/ajpheart.00834.2004
   Thukkani AK, 2003, J BIOL CHEM, V278, P36365, DOI 10.1074/jbc.M305449200
   Thukkani AK, 2002, J BIOL CHEM, V277, P3842, DOI 10.1074/jbc.M109489200
   Verheul HMW, 2000, BLOOD, V96, P4216, DOI 10.1182/blood.V96.13.4216
   Wacker BK, 2013, FREE RADICAL BIO MED, V59, P92, DOI 10.1016/j.freeradbiomed.2012.06.013
   Wang WY, 2014, ARTERIOSCL THROM VAS, V34, P526, DOI 10.1161/ATVBAHA.113.302544
   Ware LB, 2011, SHOCK, V36, P12, DOI 10.1097/SHK.0b013e318217025a
   WEISS SJ, 1989, NEW ENGL J MED, V320, P365
   Wiedemann HP, 2002, CRIT CARE MED, V30, P1
   Wildsmith KR, 2006, J BIOL CHEM, V281, P16849, DOI 10.1074/jbc.M602505200
   WINDSOR ACJ, 1993, BRIT J SURG, V80, P10, DOI 10.1002/bjs.1800800106
   Zeiher BG, 2004, CRIT CARE MED, V32, P1695, DOI 10.1097/01.CCM.0000133332.48386.85
NR 77
TC 35
Z9 35
U1 0
U2 1
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD DEC 7
PY 2017
VL 2
IS 23
AR e96432
DI 10.1172/jci.insight.96432
PG 12
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA FP0QI
UT WOS:000417307600007
PM 29212955
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Silliman, CC
   Kelher, MR
   Khan, SY
   West, FB
   McLaughlin, NJD
   Elzi, DJ
   England, K
   Bjornsen, J
   Kuldanek, SA
   Banerjee, A
AF Silliman, Christopher C.
   Kelher, Marguerite R.
   Khan, Samina Y.
   West, F. Bernadette
   McLaughlin, Nathan J. D.
   Elzi, David J.
   England, Kelly
   Bjornsen, Jason
   Kuldanek, Susan A.
   Banerjee, Anirban
TI Supernatants and lipids from stored red blood cells activate pulmonary
   microvascular endothelium through the BLT2 receptor and protein kinase C
   activation
SO TRANSFUSION
LA English
DT Article
ID ACUTE LUNG INJURY; MULTIPLE-ORGAN FAILURE; ROUTINE STORAGE; MEMBRANE
   TRANSLOCATION; NEUTROPHIL ADHESION; TRANSFUSED BLOOD; EARLY PREDICTORS;
   TEMPORAL TRENDS; OLDER BLOOD; P38 MAPK
AB BACKGROUNDAlthough transfusion is a lifesaving intervention, it may be associated with significant morbidity in injured patients. We hypothesize that stored red blood cells (RBCs) induce proinflammatory activation of human pulmonary microvascular endothelial cells (HMVECs) resulting in neutrophil (PMN) adhesion and predisposition to acute lung injury (ALI).
   STUDY DESIGN AND METHODSTen units of RBCs were collected; 50% (by weight) were leukoreduced (LR-RBCs) and the remainder was unmodified and stored in additive solution-5 (AS-5). An additional 10 units of RBCs were collected, leukoreduced, and stored in AS-3. HMVECs were incubated with [10%-40%](FINAL) of the supernatants on Day (D)1 to D42 of storage, lipid extracts, and purified lipids. Endothelial surface expression of intercellular adhesion molecule-1 (ICAM-1), interleukin (IL)-8 release, and PMN adhesion to HMVECs were measured. HMVEC signaling via the BLT2 receptor was evaluated. Supernatants and lipids were also employed as the first event in a two-event model of ALI.
   RESULTSThe supernatants [10%-40%](FINAL) from D21 LR-RBCs and D42 RBCs and LR-RBCs and the lipids from D42 stored in AS-5 induced increased ICAM-1 surface expression on endothelium, IL-8 release, and PMN adhesion. In addition, the supernatants [20%-40%](FINAL) from D21 and D42 RBCs in AS-5 also increased endothelial surface expression of ICAM-1. D42 supernatants and lipids also caused coprecipitation of -arrestin-1 with BLT2, protein kinase C (PKC)(I), and PKC and served as the first event in a two-event rodent model of ALI.
   CONCLUSIONLipids that accumulate during RBC storage activate endothelium and predispose to ALI, which may explain some of the adverse events associated with the transfusion of critically injured patients.
C1 [Silliman, Christopher C.; Kelher, Marguerite R.; Khan, Samina Y.; West, F. Bernadette; McLaughlin, Nathan J. D.; Elzi, David J.; England, Kelly; Bjornsen, Jason; Kuldanek, Susan A.] Bonfils Blood Ctr, Res Lab, 717 Yosemite St, Denver, CO 80230, United States.
   [Silliman, Christopher C.; Kelher, Marguerite R.; Elzi, David J.; England, Kelly; Banerjee, Anirban] Univ Colorado Denver, Sch Med, Dept Surg, Aurora, CO, United States.
   [Silliman, Christopher C.; Khan, Samina Y.; McLaughlin, Nathan J. D.; Kuldanek, Susan A.] Univ Colorado Denver, Sch Med, Dept Pediat, Denver, CO, United States.
C3 Children's Hospital Colorado; University of Colorado System; University
   of Colorado Anschutz Medical Campus; Children's Hospital Colorado;
   University of Colorado System; University of Colorado Anschutz Medical
   Campus; University of Colorado Denver
RP Silliman, CC (corresponding author), Bonfils Blood Ctr, Res Lab, 717 Yosemite St, Denver, CO 80230 USA.
EM christopher.silliman@ucdenver.edu
OI Elzi, David/0000-0002-6637-7607
FU NHLBI NIH HHS [R01 HL059355] Funding Source: Medline; NIGMS NIH HHS [P50
   GM049222] Funding Source: Medline
CR ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668
   Balvers- K, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00024
   Bayat B, 2013, ARTERIOSCL THROM VAS, V33, P2538, DOI 10.1161/ATVBAHA.113.301206
   Bock A, 2015, SHOCK, V44, P137, DOI 10.1097/SHK.0000000000000394
   Brattstrom O, 2010, ACTA ANAESTH SCAND, V54, P1007, DOI 10.1111/j.1399-6576.2010.02266.x
   Brown LM, 2011, AM J SURG, V201, P486, DOI 10.1016/j.amjsurg.2010.02.003
   Chaiwat O, 2009, ANESTHESIOLOGY, V110, P351, DOI 10.1097/ALN.0b013e3181948a97
   Chinthamani S, 2012, AM J PHYSIOL-CELL PH, V302, pC968, DOI 10.1152/ajpcell.00259.2011
   Cho KJ, 2010, AM J RESP CELL MOL, V42, P294, DOI 10.1165/rcmb.2008-0445OC
   Ciesla DJ, 2005, ARCH SURG-CHICAGO, V140, P432, DOI 10.1001/archsurg.140.5.432
   Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451
   Cryer HG, 2014, J TRAUMA ACUTE CARE, V76, P592
   D'Alessandro A, 2015, VOX SANG, V108, P131, DOI 10.1111/vox.12193
   D'Alessandro A, 2015, TRANSFUSION, V55, P1155, DOI 10.1111/trf.12975
   D'Alessandro A, 2012, HAEMATOL-HEMATOL J, V97, P107, DOI 10.3324/haematol.2011.051789
   D'Amici GM, 2012, BLOOD TRANSFUS-ITALY, V10, pS46, DOI 10.2450/2012.008S
   DASILVA AMT, 1993, NEW ENGL J MED, V328, P1457, DOI 10.1056/NEJM199305203282005
   DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129
   Dudek SM, 2011, AM J RESP CELL MOL, V44, P361, DOI 10.1165/rcmb.2009-0446OC
   Dzieciatkowska M, 2013, VOX SANG, V105, P210, DOI 10.1111/vox.12042
   El Azreq MA, 2011, MOL IMMUNOL, V48, P1408, DOI 10.1016/j.molimm.2011.03.018
   Eun JC, 2011, SHOCK, V35, P240, DOI 10.1097/SHK.0b013e3181faceb3
   Fisher AB, 2011, ANTIOXID REDOX SIGN, V15, P831, DOI 10.1089/ars.2010.3412
   Gevi F, 2012, J PROTEOMICS, V76, P168, DOI 10.1016/j.jprot.2012.03.012
   GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662, DOI 10.1002/jlb.55.5.662
   Hassan M, 2011, SHOCK, V35, P3, DOI 10.1097/SHK.0b013e3181e76274
   Hicks A, 2007, EXPERT OPIN INV DRUG, V16, P1909, DOI 10.1517/13543784.16.12.1909
   Holena DN, 2012, J TRAUMA ACUTE CARE, V73, P825, DOI 10.1097/TA.0b013e318256de38
   Howard BM, 2015, J TRAUMA ACUTE CARE, V78, P735, DOI 10.1097/TA.0000000000000583
   Johansson AS, 2010, EXP CELL RES, V316, P2790, DOI 10.1016/j.yexcr.2010.07.016
   Juffermans NP, 2012, BLOOD TRANSFUS-ITALY, V10, P290, DOI 10.2450/2012.0068-11
   Kelher MR, 2017, J LEUKOCYTE BIOL, V101, P261, DOI 10.1189/jlb.3A0813-420RRR
   Kelher MR, 2009, BLOOD, V113, P2079, DOI 10.1182/blood-2008-09-177857
   Kim EY, 2010, FREE RADICAL BIO MED, V49, P1072, DOI 10.1016/j.freeradbiomed.2010.06.023
   Kim GY, 2010, J IMMUNOL, V184, P3946, DOI 10.4049/jimmunol.0901735
   Kim GY, 2009, ARTERIOSCL THROM VAS, V29, P915, DOI 10.1161/ATVBAHA.109.185793
   Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403
   Lee JW, 2013, J BIOL CHEM, V288, P30054, DOI 10.1074/jbc.M113.481283
   Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237
   Lelubre C, 2009, TRANSFUSION, V49, P1384, DOI 10.1111/j.1537-2995.2009.02211.x
   Long K, 2013, AM SURGEON, V79, P810
   Mack JP, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.96.96
   McLaughlin NJD, 2008, J IMMUNOL, V180, P8192, DOI 10.4049/jimmunol.180.12.8192
   McLaughlin NJD, 2006, J IMMUNOL, V176, P7039, DOI 10.4049/jimmunol.176.11.7039
   Mostafa G, 2004, AM SURGEON, V70, P357
   Murrell Z, 2005, AM SURGEON, V71, P781
   Offner PJ, 2004, CRIT CARE, V8, pS24, DOI 10.1186/cc2405
   Offner PJ, 2002, ARCH SURG-CHICAGO, V137, P711, DOI 10.1001/archsurg.137.6.711
   Partrick D A, 1996, New Horiz, V4, P194
   Patel SV, 2014, INJURY, V45, P1522, DOI 10.1016/j.injury.2014.05.015
   Peters AL, 2016, VOX SANG, V112, P25
   Peters AL, 2016, CRIT CARE MED, V44, pE412, DOI 10.1097/CCM.0000000000001614
   Roback JD, 2014, TRANSFUS MED REV, V28, P41, DOI 10.1016/j.tmrv.2014.01.003
   Sadjadi J, 2009, AM SURGEON, V75, P307
   SALZER WL, 1990, J CLIN INVEST, V85, P1135, DOI 10.1172/JCI114545
   Sauaia A, 1998, J TRAUMA, V45, P291, DOI 10.1097/00005373-199808000-00014
   SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39
   Sauaia A, 2014, J TRAUMA ACUTE CARE, V76, P582, DOI 10.1097/TA.0000000000000147
   SAUTER C, 1980, LANCET, V2, P852
   Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054
   Sharpe JP, 2013, J TRAUMA ACUTE CARE, V75, P32, DOI 10.1097/TA.0b013e318294672d
   Silliman CC, 2010, VOX SANG, V98, P525, DOI 10.1111/j.1423-0410.2009.01289.x
   Silliman CC, 1998, J CLIN INVEST, V101, P1458, DOI 10.1172/JCI1841
   SILLIMAN CC, 1994, J LAB CLIN MED, V124, P684
   Silliman CC, 1996, TRANSFUSION, V36, P133, DOI 10.1046/j.1537-2995.1996.36296181925.x
   Silliman CC, 2017, BLOOD TRANSFUS-ITALY, V15, P131, DOI 10.2450/2017.0314-16
   Silliman CC, 2014, BLOOD, V123, P3488, DOI 10.1182/blood-2013-10-532424
   Silliman CC, 2012, TRANSFUSION, V52, P1155, DOI 10.1111/j.1537-2995.2012.03564.x
   Silliman CC, 2011, TRANSFUSION, V51, P2549, DOI 10.1111/j.1537-2995.2011.03186.x
   Smith CW, 2008, J ALLERGY CLIN IMMUN, V121, pS375, DOI 10.1016/j.jaci.2007.07.030
   Sparrow RL, 2012, BLOOD TRANSFUS-ITALY, V10, pS7, DOI [10.2450/20/2.003S, 10.2450/2012.003S]
   Spinella PC, 2009, CRIT CARE, V13, DOI 10.1186/cc8050
   STARZL TE, 1985, SEMIN LIVER DIS, V5, P334, DOI 10.1055/s-2008-1040630
   STARZL TE, 1982, HEPATOLOGY, V2, P614
   WALL WJ, 1988, CAN MED ASSOC J, V139, P21
   Wang D, 2012, TRANSFUSION, V52, P1184, DOI 10.1111/j.1537-2995.2011.03466.x
   Warren HS, 2010, J INFECT DIS, V201, P223, DOI 10.1086/649557
   Watkins TR, 2008, CRIT CARE MED, V36, P1493, DOI 10.1097/CCM.0b013e318170a9ce
   Weinberg JA, 2008, J TRAUMA, V65, P279, DOI 10.1097/TA.0b013e31817c9687
   Weinberg JA, 2011, TRANSFUSION, V51, P867, DOI 10.1111/j.1537-2995.2011.03098.x
   Weinberg JA, 2010, J TRAUMA, V69, P1427, DOI 10.1097/TA.0b013e3181fa0019
   Wyman TH, 2002, AM J PHYSIOL-CELL PH, V283, pC1592, DOI 10.1152/ajpcell.00540.2001
   Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942
   Zallen G, 1999, AM J SURG, V178, P570, DOI 10.1016/S0002-9610(99)00239-1
NR 84
TC 12
Z9 12
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD NOV
PY 2017
VL 57
IS 11
BP 2690
EP 2700
DI 10.1111/trf.14271
PG 11
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA FL9WY
UT WOS:000414611800020
PM 28880373
OA Green Accepted
DA 2023-08-21
ER

PT J
AU Zhang, SJ
   Wu, Y
   Xuan, ZA
   Chen, XM
   Zhang, JJ
   Ge, DY
   Wang, XD
AF Zhang, Shujing
   Wu, Ying
   Xuan, Zinan
   Chen, Xiaoming
   Zhang, Junjie
   Ge, Dongyu
   Wang, Xudan
TI Screening differential miRNAs responsible for permeability increase in
   HUVECs infected with influenza A virus
SO PLOS ONE
LA English
DT Article
ID ENDOTHELIAL-CELLS; ACTIVATION; KINASE; H1N1; HYPERPERMEABILITY;
   PATHOGENESIS
AB Severe influenza infections are featured by acute lung injury, a syndrome of increased pulmonary microvascular permeability. A growing number of evidences have shown that influenza A virus induces cytoskeletal rearrangement and permeability increase in endothelial cells. Although miRNA's involvement in the regulation of influenza virus infection and endothelial cell (EC) function has been well documented, little is known about the miRNA profiles in influenza-infected endothelial cells. Using human umbilical vein endothelial cells (HUVECs) as cell models, the present study aims to explore the differential miRNAs in influenza virus-infected ECs and analyze their target genes involved in EC permeability regulation. As the results showed, permeability increased and F-actin cytoskeleton reorganized after HUVECs infected with influenza A virus (CA07 or PR8) at 30 MOI. MicroRNA microarray revealed a multitude of miRNAs differentially expressed in HUVECs after influenza virus infection. Through target gene prediction, we found that a series of miRNAs were involved in PKC, Rho/ROCK, HRas/Raf/MEK/ERK, and Ca-2+/CaM pathways associated with permeability regulation, and most of these miRNAs were down-regulated after flu infection. It has been reported that PKC, Rho/ROCK, HRas/Raf/MEK/ERK, and Ca-2+/CaM pathways are activated by flu infection and play important roles in permeability regulation. Therefore, the cumulative effects of these down-regulated miRNAs which synergistically enhanced activation of PKC, Rho/ROCK, Ras/Raf/MEK/ERK, and Ca-2+/CaM pathways, can eventually lead to actin rearrangement and hyperpermeability in flu-infected HUVECs.
C1 [Zhang, Shujing; Ge, Dongyu] Beijing Univ Chinese Med, Sci Res Ctr, Beijing, China.
   [Wu, Ying; Xuan, Zinan; Chen, Xiaoming; Zhang, Junjie; Wang, Xudan] Beijing Univ Chinese Med, Sch Life Sci, Dept Microbiol & Immunol, Beijing, China.
C3 Beijing University of Chinese Medicine; Beijing University of Chinese
   Medicine
RP Wu, Y (corresponding author), Beijing Univ Chinese Med, Sch Life Sci, Dept Microbiol & Immunol, Beijing, Peoples R China.
EM aqiwuying@hotmail.com
RI chen, xin/IQW-3432-2023; chen, xia/GXM-5435-2022; chen,
   xi/GXH-3653-2022; chen, xia/GYR-3948-2022
FU National Natural Science Foundation of China [81473520]
FX This work was supported by grants from the National Natural Science
   Foundation of China (No. 81473520) to YW.; This work was supported by
   grants from the National Natural Science Foundation of China (No.
   81473520). We thank Chenyue Zhang, PhD, at the Department of Integrative
   Oncology in Fudan University Shanghai Cancer Center, for language
   proofreading.
CR Alexy T, 2014, PHYSIOL GENOMICS, V46, P833, DOI 10.1152/physiolgenomics.00079.2014
   Armstrong SM, 2013, VIRULENCE, V4, P537, DOI 10.4161/viru.25779
   Armstrong SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047323
   Arora DJS, 1998, ARCH VIROL, V143, P2029, DOI 10.1007/s007050050439
   Szretter Kristy J, 2006, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g01s29, 10.1002/0471729256.mc15g01s3]
   Bogatcheva NV, 2011, J CELL PHYSIOL, V226, P3132, DOI 10.1002/jcp.22669
   Buggele WA, 2012, J BIOL CHEM, V287, P31027, DOI 10.1074/jbc.M112.387670
   Chan LY, 2011, J ETHNOPHARMACOL, V137, P1542, DOI 10.1016/j.jep.2011.08.022
   Chowell G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041069
   Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536
   Haidari M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021444
   Haidari M, 2009, PHYTOMEDICINE, V16, P1127, DOI 10.1016/j.phymed.2009.06.002
   HARTSHORN KL, 1990, BLOOD, V75, P218
   HARTSHORN KL, 1992, BLOOD, V79, P1049
   Hwang HW, 2006, BR J CANC S, V96, pR40
   Kalani M, 2016, PROBIOTICS ANTIMICRO, V8, P61, DOI 10.1007/s12602-016-9214-1
   Lipatov AS, 2004, J VIROL, V78, P8951, DOI 10.1128/JVI.78.17.8951-8959.2004
   Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11
   Ma YJ, 2012, J CELL MOL MED, V16, P2539, DOI 10.1111/j.1582-4934.2012.01572.x
   NUGENT KM, 1984, ARCH VIROL, V81, P163, DOI 10.1007/BF01309305
   OCHIAI H, 1991, ANTIVIR RES, V15, P149, DOI 10.1016/0166-3542(91)90032-M
   Pepini T, 2010, J VIROL, V84, P11929, DOI 10.1128/JVI.01658-10
   Perkins LEL, 2001, VET PATHOL, V38, P149, DOI 10.1354/vp.38-2-149
   Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098
   Root CN, 2000, J GEN VIROL, V81, P2697, DOI 10.1099/0022-1317-81-11-2697
   Ruan W, 2012, CARDIOVASC RES, V93, P623, DOI 10.1093/cvr/cvr290
   Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144
   Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10
   Sun XJ, 2007, CELL MICROBIOL, V9, P1672, DOI 10.1111/j.1462-5822.2007.00900.x
   Tambyah PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076811
   Wang SY, 2010, J INFECT DIS, V202, P991, DOI 10.1086/656044
   Zeng J, 2013, EXP CLIN ENDOCR DIAB, V121, P425, DOI 10.1055/s-0033-1345169
   Zhang CY, 2014, VIRUS RES, V192, P6, DOI 10.1016/j.virusres.2014.07.027
NR 33
TC 1
Z9 1
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 23
PY 2017
VL 12
IS 10
AR e0186477
DI 10.1371/journal.pone.0186477
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FK3RE
UT WOS:000413403000026
PM 29059211
OA gold, Green Published, Green Submitted
DA 2023-08-21
ER

PT J
AU Barnthaler, T
   Maric, J
   Platzer, W
   Konya, V
   Theiler, A
   Hasenohrl, C
   Gottschalk, B
   Trautmann, S
   Schreiber, Y
   Graier, WF
   Schicho, R
   Marsche, G
   Olschewski, A
   Thomas, D
   Schuligoi, R
   Heinemann, A
AF Barnthaler, Thomas
   Maric, Jovana
   Platzer, Wolfgang
   Konya, Viktoria
   Theiler, Anna
   Hasenohrl, Carina
   Gottschalk, Benjamin
   Trautmann, Sandra
   Schreiber, Yannick
   Graier, Wolfgang F.
   Schicho, Rudolf
   Marsche, Gunther
   Olschewski, Andrea
   Thomas, Dominique
   Schuligoi, Rufina
   Heinemann, Akos
TI The Role of PGE(2) in Alveolar Epithelial and Lung Microvascular
   Endothelial Crosstalk
SO SCIENTIFIC REPORTS
LA English
DT Article
ID INDUCED NEUTROPHIL INFILTRATION; RESPIRATORY-DISTRESS-SYNDROME;
   PROSTAGLANDIN-E RECEPTORS; BARRIER FUNCTION; CYCLOOXYGENASE-2
   EXPRESSION; FIBROBLAST PROLIFERATION; AIRWAY FUNCTION; CELL-LINE;
   TNF-ALPHA; II CELLS
AB Disruption of the blood-air barrier, which is formed by lung microvascular endothelial and alveolar epithelial cells, is a hallmark of acute lung injury. It was shown that alveolar epithelial cells release an unidentified soluble factor that enhances the barrier function of lung microvascular endothelial cells. In this study we reveal that primarily prostaglandin (PG) E-2 accounts for this endothelial barrier-promoting activity. Conditioned media from alveolar epithelial cells (primary ATI-like cells) collected from BALB/c mice and A549 cells increased the electrical resistance of pulmonary human microvascular endothelial cells, respectively. This effect was reversed by pretreating alveolar epithelial cells with a cyclooxygenase-2 inhibitor or by blockade of EP4 receptors on endothelial cells, and in A549 cells also by blocking the sphingosine-1-phosphate1 receptor. Cyclooxygenase-2 was constitutively expressed in A549 cells and in primary ATI-like cells, and was upregulated by lipopolysaccharide treatment. This was accompanied by enhanced PGE(2) secretion into conditioned media. Therefore, we conclude that epithelium-derived PGE(2) is a key regulator of endothelial barrier integrity via EP4 receptors under physiologic and inflammatory conditions. Given that pharmacologic treatment options are still unavailable for diseases with compromised air-blood barrier, like acute lung injury, our data thus support the therapeutic potential of selective EP4 receptor agonists.
C1 [Barnthaler, Thomas; Maric, Jovana; Platzer, Wolfgang; Konya, Viktoria; Theiler, Anna; Hasenohrl, Carina; Schicho, Rudolf; Marsche, Gunther; Schuligoi, Rufina; Heinemann, Akos] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria.
   [Gottschalk, Benjamin; Graier, Wolfgang F.] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria.
   [Olschewski, Andrea] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria.
   [Trautmann, Sandra; Thomas, Dominique] Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES Inst Clin Pharmacol, Frankfurt, Germany.
   [Schreiber, Yannick] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp TMP, Frankfurt, Germany.
C3 Medical University of Graz; Medical University of Graz; Ludwig Boltzmann
   Institute; Goethe University Frankfurt; Fraunhofer Gesellschaft
RP Heinemann, A (corresponding author), Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria.
EM akos.heinemann@medunigraz.at
RI Graier, Wolfgang F/B-7052-2008
OI Graier, Wolfgang F/0000-0003-1871-3298; Olschewski,
   Andrea/0000-0002-8189-3634; Barnthaler, Thomas/0000-0002-4988-3700;
   Gottschalk, Benjamin/0000-0001-5588-7698; Schuligoi,
   Rufina/0000-0002-9338-6904; Marsche, Gunther/0000-0002-2422-5381
FU Austrian Science Fund FWF [P22521-B18, P25531-B23, P25633-B19,
   P22976-B18, P26185-B19]; Jubilaumsfonds of the Austrian National Bank
   [14263]; DK-MOLIN [FWF - W1241]; DOC Fellowship of the Austrian Academy
   of Science at the Institute of Experimental and Clinical Pharmacology;
   DK-MCD (DKplus Metabolic and Cardiovascular Disease) [W 1226-B18];
   Austrian Science Fund (FWF) [P25531, P26185, KLI521, W1241] Funding
   Source: Austrian Science Fund (FWF)
FX We thank Markus Absenger-Novak and Eleonore Frohlich from the core
   facility for microscopy of the Medical University Graz, for their expert
   assistance in image acquisition. We are particularly grateful to Ilse
   Lanz and Martina Ofner for their excellent technical assistance that
   they provided with numerous assays. This work was supported by the
   Austrian Science Fund FWF (Grant P22521-B18 to A.H., P25531-B23 to V.K.,
   P25633-B19 to R.Schi., P22976-B18 to G.M. and P26185-B19 to R. Schu.)
   and the Jubilaumsfonds of the Austrian National Bank (14263 to A. H.).
   T.B. and J.M. were funded by the PhD Program DK-MOLIN (FWF - W1241).
   A.T. is a recipient of a DOC Fellowship of the Austrian Academy of
   Science at the Institute of Experimental and Clinical Pharmacology. C.H.
   was trained within the frame of the PhD Program Molecular Medicine of
   the Medical University of Graz. Benjamin Gottschalk was funded by the
   PhD Program DK-MCD (W 1226-B18, DKplus Metabolic and Cardiovascular
   Disease).
CR BEISKER W, 1987, CYTOMETRY, V8, P235, DOI 10.1002/cyto.990080218
   Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005
   Birrell MA, 2015, THORAX, V70, P740, DOI 10.1136/thoraxjnl-2014-206592
   Birukova AA, 2013, EUR RESPIR J, V41, P165, DOI 10.1183/09031936.00148311
   Cheng J, 2016, FASEB J, V30, P160, DOI 10.1096/fj.14-268458
   Cheng SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054125
   Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933
   CROXTALL JD, 1992, P NATL ACAD SCI USA, V89, P3571, DOI 10.1073/pnas.89.8.3571
   DeMaio L, 2009, AM J PHYSIOL-LUNG C, V296, pL1051, DOI 10.1152/ajplung.00021.2009
   deMoraes VLG, 1996, BRIT J PHARMACOL, V117, P1792
   Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930
   EVANS MJ, 1973, AM J PATHOL, V70, P175
   Fanelli V, 2013, J THORAC DIS, V5, P326, DOI 10.3978/j.issn.2072-1439.2013.04.05
   Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36
   Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200
   Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450
   Grill M, 2008, J NEUROCHEM, V104, P1345, DOI 10.1111/j.1471-4159.2007.05078.x
   GRIMMINGER F, 1992, AM J RESP CELL MOL, V6, P9, DOI 10.1165/ajrcmb/6.1.9
   Hattar K, 2013, CANCER IMMUNOL IMMUN, V62, P309, DOI 10.1007/s00262-012-1341-2
   Hermanns MI, 2004, LAB INVEST, V84, P736, DOI 10.1038/labinvest.3700081
   Herold S, 2013, AM J PHYSIOL-LUNG C, V305, pL665, DOI 10.1152/ajplung.00232.2013
   Ikegami R, 2001, J IMMUNOL, V166, P4689, DOI 10.4049/jimmunol.166.7.4689
   Jandl K, 2016, J ALLERGY CLIN IMMUN, V137, P833, DOI 10.1016/j.jaci.2015.11.012
   Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694
   Katsuyama M, 1998, BIOCHEM BIOPH RES CO, V251, P727, DOI 10.1006/bbrc.1998.9540
   Konya V, 2015, BRIT J PHARMACOL, V172, P4454, DOI 10.1111/bph.13229
   Konya V, 2013, PHARMACOL THERAPEUT, V138, P485, DOI 10.1016/j.pharmthera.2013.03.006
   Konya V, 2013, J ALLERGY CLIN IMMUN, V131, P532, DOI 10.1016/j.jaci.2012.05.008
   Konya V, 2010, J ALLERGY CLIN IMMUN, V125, P1105, DOI 10.1016/j.jaci.2009.12.002
   Lama V, 2002, AM J RESP CELL MOL, V27, P752, DOI 10.1165/rcmb.4857
   Lappi-Blanco E, 2006, AM J CLIN PATHOL, V126, P717, DOI 10.1309/PFGXCLNG2N17PJX9
   Lasa M, 2001, MOL CELL BIOL, V21, P771, DOI 10.1128/MCB.21.3.771-780.2001
   Lullmann-Rauch R., 2008, HISTOLOGIE
   Mao P, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12288
   Marsh LM, 2009, AM J PHYSIOL-LUNG C, V296, pL442, DOI 10.1152/ajplung.00525.2007
   Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158
   Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008
   MITCHELL JA, 1994, BRIT J PHARMACOL, V113, P1008, DOI 10.1111/j.1476-5381.1994.tb17093.x
   Moore BB, 2003, AM J PHYSIOL-LUNG C, V284, pL342, DOI 10.1152/ajplung.00168.2002
   Mura M, 2010, AM J PATHOL, V176, P1725, DOI 10.2353/ajpath.2010.090209
   Neuhaus W, 2012, DIFFERENTIATION, V84, P294, DOI 10.1016/j.diff.2012.08.006
   Parent R.A., 2015, COMP BIOL NORMAL LUN
   Pfister R, 2012, INT J CARDIOL, V155, P268, DOI 10.1016/j.ijcard.2010.10.013
   Radnai B, 2016, J CROHNS COLITIS, V10, P1087, DOI 10.1093/ecco-jcc/jjw061
   Ren YL, 2013, MICROVASC RES, V85, P59, DOI 10.1016/j.mvr.2012.10.004
   Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804
   Schmidt H, 2006, PROSTAG OTH LIPID M, V81, P162, DOI 10.1016/j.prostaglandins.2006.09.003
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schnitzer SE, 2009, MOL CANCER RES, V7, P393, DOI 10.1158/1541-7786.MCR-08-0156
   Sukriti S, 2014, PULM CIRC, V4, P535, DOI 10.1086/677356
   Sun Y, 2011, ARCH PATHOL LAB MED, V135, P1335, DOI 10.5858/arpa.2010-0549-OA
   Theiler A, 2016, VASC PHARMACOL, V87, P180, DOI 10.1016/j.vph.2016.09.008
   Tornehave D, 2000, HISTOCHEM CELL BIOL, V113, P19
   Torres R, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-72
   Ueki T, 2012, BIOL PHARM BULL, V35, P1041, DOI 10.1248/bpb.b110709
   Ulcar R, 2004, EUR J PHARMACOL, V501, P9, DOI 10.1016/j.ejphar.2004.08.003
   Vancheri C, 2004, TRENDS IMMUNOL, V25, P40, DOI 10.1016/j.it.2003.11.001
   Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016
   Wang LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055311
   Wardlaw SA, 2000, CARCINOGENESIS, V21, P1371, DOI 10.1093/carcin/21.7.1371
   Weibel E. R., 1984, PATHWAY OXYGEN STRUC
   Wu SJ, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-27
   Xiong YQ, 2014, CURR TOP MICROBIOL, V378, P85, DOI 10.1007/978-3-319-05879-5_4
   Zhang YS, 2011, BLOOD, V118, P5355, DOI 10.1182/blood-2011-04-350587
NR 64
TC 27
Z9 28
U1 1
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 11
PY 2017
VL 7
AR 7923
DI 10.1038/s41598-017-08228-y
PG 17
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FD3OO
UT WOS:000407442500063
PM 28801643
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Khoy, K
   Nguyen, MVC
   Masson, D
   Bardy, B
   Drouet, C
   Paclet, MH
AF Khoy, Kathy
   Minh Vu Chuong Nguyen
   Masson, Dominique
   Bardy, Beatrice
   Drouet, Christian
   Paclet, Marie-Helene
TI Transfusion-related acute lung injury: critical neutrophil activation by
   anti-HLA-A2 antibodies for endothelial permeability
SO TRANSFUSION
LA English
DT Article
ID PHAGOCYTE NADPH OXIDASE; IN-VITRO MODEL; MYELOID-LEUKEMIA; PATHOGENESIS;
   MATURATION; TRALI
AB BACKGROUND: Transfusion-related acute lung injury (TRALI) is a major complication of hemotherapy that may occur after the transfusion of any blood type component. Several clinical reports have suggested the presence of anti-HLA antibodies in the blood product. This study sought to examine the role of anti-HLA-A2 antibodies in polymorphonuclear neutrophil (PMN) activation and thus in endothelial permeability.
   STUDY DESIGN AND METHODS: PMN activation was assessed by both nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase) activity and reactive oxygen species (ROS) production. A coculture assay of EA.hy926 endothelial cells with PMNs or differentiated-PLB-985 cells, a model of neutrophil-like cells, was performed to estimate the impact of ROS on endothelial permeability.
   RESULTS: Anti-HLA-A2 antibodies significantly increased PMN activation, with subsequent endothelial dysfunction. Phagocyte NADPH oxidase (NOX2) activity was shown to be involved in this process and ROS themselves were demonstrated to induce VE-cadherin cleavage and endothelial permeability.
   CONCLUSION: Our data may support the existence of a critical anti-HLA-A2 antibody threshold for PMN activation, with NOX2 activity and subsequent endothelial permeability in the two-hit model of TRALI.
C1 [Khoy, Kathy; Minh Vu Chuong Nguyen; Drouet, Christian; Paclet, Marie-Helene] Univ Grenoble Alpes, GREPI EA 7408, Grenoble, France.
   [Khoy, Kathy] Univ Caen Normandie, CHU Caen, Caen, France.
   [Masson, Dominique; Bardy, Beatrice] EFS Rhone Alpes, Site Grenoble, Grenoble, France.
   [Drouet, Christian; Paclet, Marie-Helene] CHU Grenoble Alpes, Grenoble, France.
C3 Communaute Universite Grenoble Alpes; UDICE-French Research
   Universities; Universite Grenoble Alpes (UGA); CHU de Caen NORMANDIE;
   Universite de Caen Normandie; CHU Grenoble Alpes
RP Paclet, MH (corresponding author), Univ Grenoble Alpes, GREPI EA 7408, EFS Site Grenoble, 29 Ave Maquis Gresivaudan,BP35, F-38701 La Tronche, France.
EM mhpaclet@chu-grenoble.fr
RI Paclet, Marie-Hélène/AAS-5029-2020; DROUET, Christian/AAE-5682-2020
OI DROUET, Christian/0000-0003-1318-4278
FU Etablissement Francais du Sang (EFS call 2011)
FX This article was supported by a program conducted within the
   Etablissement Francais du Sang (EFS call 2011; C. Drouet, coordinator).
CR Baillet A, 2011, FASEB J, V25, P2333, DOI 10.1096/fj.10-173807
   Bouis Diane, 2001, Angiogenesis, V4, P91, DOI 10.1023/A:1012259529167
   Bux J, 2007, BRIT J HAEMATOL, V136, P788, DOI 10.1111/j.1365-2141.2007.06492.x
   Campion Y, 2007, BIOCHIMIE, V89, P1145, DOI 10.1016/j.biochi.2007.01.010
   Curtis BR, 2006, CRIT CARE MED, V34, pS118, DOI 10.1097/01.CCM.0000214293.72918.D8
   Gajic O, 2007, AM J RESP CRIT CARE, V176, P886, DOI 10.1164/rccm.200702-271OC
   Gavard Julie, 2014, Cell Adh Migr, V8, P158
   Goldman M, 2005, TRANSFUS MED REV, V19, P2, DOI 10.1016/j.tmrv.2004.10.001
   Holness L, 2004, TRANSFUS MED REV, V18, P184, DOI 10.1016/j.tmrv.2004.03.004
   Kleinman S, 2004, TRANSFUSION, V44, P1774, DOI 10.1111/j.0041-1132.2004.04347.x
   LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8
   Leach M, 1998, TRANSFUSION MED, V8, P333
   Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238
   Marik PE, 2008, CRIT CARE MED, V36, P3080, DOI 10.1097/CCM.0b013e31818c3801
   Middelburg RA, 2008, TRANSFUSION, V48, P2167, DOI 10.1111/j.1537-2995.2008.01810.x
   Peters AL, 2015, BRIT J HAEMATOL, V170, P597, DOI 10.1111/bjh.13459
   POPOVSKY MA, 1985, TRANSFUSION, V25, P573, DOI 10.1046/j.1537-2995.1985.25686071434.x
   Sachs UJH, 2006, BLOOD, V107, P1217, DOI 10.1182/blood-2005-04-1744
   SCHARF SJ, 1991, HUM IMMUNOL, V30, P190, DOI 10.1016/0198-8859(91)90034-7
   SEEGER W, 1990, BLOOD, V76, P1438
   Silliman CC, 2014, VOX SANG, V107, P76, DOI 10.1111/vox.12129
   Silliman CC, 2006, CRIT CARE MED, V34, pS124, DOI 10.1097/01.CCM.0000214292.62276.8E
   TERASAKI PI, 1964, NATURE, V204, P998, DOI 10.1038/204998b0
   TUCKER KA, 1987, BLOOD, V70, P372
   Vilgrain I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080056
   Vlaar APJ, 2013, LANCET, V382, P984, DOI 10.1016/S0140-6736(12)62197-7
   Vlaar APJ, 2011, BLOOD, V117, P4218, DOI 10.1182/blood-2010-10-313973
   Win N, 2001, TRANSFUSION, V41, P1421, DOI 10.1046/j.1537-2995.2001.41111421.x
   Wyman TH, 2002, AM J PHYSIOL-CELL PH, V283, pC1592, DOI 10.1152/ajpcell.00540.2001
   Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288
   Zhou YJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/374963
NR 31
TC 14
Z9 15
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JUL
PY 2017
VL 57
IS 7
BP 1699
EP 1708
DI 10.1111/trf.14134
PG 10
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA VI4AP
UT WOS:000482988100032
PM 28608441
OA Bronze
DA 2023-08-21
ER

PT J
AU Ohmura, T
   Tian, YF
   Sarich, N
   Ke, YB
   Meliton, A
   Shah, AS
   Andreasson, K
   Birukov, KG
   Birukova, AA
AF Ohmura, Tomomi
   Tian, Yufeng
   Sarich, Nicolene
   Ke, Yunbo
   Meliton, Angelo Y.
   Shah, Alok S.
   Andreasson, Katrin
   Birukov, Konstantin G.
   Birukova, Anna A.
TI Regulation of lung endothelial permeability and inflammatory responses
   by prostaglandin A2: role of EP4 receptor
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID NF-KAPPA-B; SIGNAL-TRANSDUCTION; OXIDIZED PHOSPHOLIPIDS; BARRIER
   DYSFUNCTION; INTERCELLULAR-ADHESION; PROSTANOID RECEPTORS; RHO; PATHWAY;
   ACTIVATION; CELLS
AB The role of prostaglandin A2 (PGA2) in modulation of vascular endothelial function is unknown. We investigated effects of PGA2 on pulmonary endothelial cell (EC) permeability and inflammatory activation and identified a receptor mediating these effects. PGA2 enhanced the EC barrier and protected against barrier dysfunction caused by vasoactive peptide thrombin and proinflammatory bacterial wall lipopolysaccharide (LPS). Receptor screening using pharmacological and molecular inhibitory approaches identified EP4 as a novel PGA2 receptor. EP4 mediated barrier-protective effects of PGA2 by activating Rap1/Rac1 GTPase and protein kinase A targets at cell adhesions and cytoskeleton: VE-cadherin, p120-catenin, ZO-1, cortactin, and VASP. PGA2 also suppressed LPS-induced inflammatory signaling by inhibiting the NF.B pathway and expression of EC adhesion molecules ICAM1 and VCAM1. These effects were abolished by pharmacological or molecular inhibition of EP4. In vivo, PGA2 was protective in two distinct models of acute lung injury (ALI): LPS-induced inflammatory injury and two-hit ALI caused by suboptimal mechanical ventilation and injection of thrombin receptor-activating peptide. These protective effects were abolished in mice with endothelial-specific EP4 knockout. The results suggest a novel role for the PGA2-EP4 axis in vascular EC protection that is critical for improvement of pathological states associated with increased vascular leakage and inflammation.
C1 [Ohmura, Tomomi; Tian, Yufeng; Sarich, Nicolene; Ke, Yunbo; Meliton, Angelo; Shah, Alok S.; Birukov, Konstantin G.; Birukova, Anna A.] Univ Chicago, Dept Med, Sect Pulm & Crit Med, Lung Injury Ctr, Chicago, IL 60637, United States.
   [Andreasson, Katrin] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305, United States.
   [Birukov, Konstantin G.; Birukova, Anna A.] Univ Maryland, Sch Med, Baltimore, MD 21201, United States.
C3 University of Chicago; Stanford University; University System of
   Maryland; University of Maryland Baltimore
RP Birukova, AA (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Med, Lung Injury Ctr, Chicago, IL 60637 USA.; Birukova, AA (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
EM abirukova@som.umaryland.edu
RI Birukov, Konstantin/FJB-5755-2022; Sarich, Nicolene/IWV-3869-2023
FU National Heart, Lung, and Blood Institute [HL076259, HL087823, HL107920,
   HL130431]; National Institute of General Medical Sciences [GM114171]
FX This work was supported by Grants HL076259, HL087823, HL107920, and
   HL130431 from the National Heart, Lung, and Blood Institute and GM114171
   from the National Institute of General Medical Sciences.
CR Alfranca A, 2006, CARDIOVASC RES, V70, P446, DOI 10.1016/j.cardiores.2005.12.020
   Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003
   Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007
   Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com
   Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055
   Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com
   Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007
   Birukova AA, 2013, MOL BIOL CELL, V24, P2678, DOI 10.1091/mbc.E13-02-0098
   Birukova AA, 2013, EUR RESPIR J, V41, P165, DOI 10.1183/09031936.00148311
   Birukova AA, 2012, J CELL PHYSIOL, V227, P1883, DOI 10.1002/jcp.22916
   Birukova AA, 2011, EXP CELL RES, V317, P859, DOI 10.1016/j.yexcr.2010.11.011
   Birukova AA, 2011, J CELL PHYSIOL, V226, P2052, DOI 10.1002/jcp.22543
   Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009
   Bos CL, 2004, INT J BIOCHEM CELL B, V36, P1187, DOI 10.1016/j.biocel.2003.08.006
   Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002
   Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661
   Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje
   Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159
   Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808
   Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068
   Guo F, 2012, MOL IMMUNOL, V50, P98, DOI 10.1016/j.molimm.2011.12.009
   Guo F, 2012, CYTOKINE, V57, P417, DOI 10.1016/j.cyto.2011.12.009
   Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003
   Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.E02-11-0753
   Howard Luke S G E, 2005, Paediatr Respir Rev, V6, P285, DOI 10.1016/j.prrv.2005.09.006
   Khakpour S, 2015, INNATE IMMUN-LONDON, V21, P827, DOI 10.1177/1753425915606525
   Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433
   Leduc M, 2009, J PHARMACOL EXP THER, V331, P297, DOI 10.1124/jpet.109.156398
   Liang XB, 2011, J CLIN INVEST, V121, P4362, DOI 10.1172/JCI46279
   Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006
   Matoba K, 2010, BIOCHEM BIOPH RES CO, V402, P725, DOI 10.1016/j.bbrc.2010.10.093
   Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008
   Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982
   MUALLEM S, 1989, BIOCHEM J, V263, P769, DOI 10.1042/bj2630769
   Musiek ES, 2005, J BIOL CHEM, V280, P35562, DOI 10.1074/jbc.M504785200
   Nwariaku FE, 2003, J APPL PHYSIOL, V95, P1889, DOI 10.1152/japplphysiol.00225.2003
   Rahman A, 2004, AM J PHYSIOL-LUNG C, V287, pL1017, DOI 10.1152/ajplung.00072.2004
   Schlegel N, 2014, CELL TISSUE RES, V355, P587, DOI 10.1007/s00441-013-1755-y
   Schlegel N, 2009, CRIT CARE MED, V37, P1735, DOI 10.1097/CCM.0b013e31819deb6a
   SMITH CW, 1993, SEMIN HEMATOL, V30, P45
   Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086
   Storer PD, 2005, J NEUROSCI RES, V80, P66, DOI 10.1002/jnr.20413
   Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200
   Tian YF, 2015, J BIOL CHEM, V290, P4097, DOI 10.1074/jbc.M114.620377
   Tian YF, 2014, MOL CELL BIOL, V34, P3546, DOI 10.1128/MCB.00248-14
   Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046
   Yagami T, 2016, MOL NEUROBIOL, V53, P4754, DOI 10.1007/s12035-015-9355-3
NR 47
TC 26
Z9 26
U1 0
U2 9
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD JUN 15
PY 2017
VL 28
IS 12
BP 1622
EP 1635
DI 10.1091/mbc.E16-09-0639
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA FA4SF
UT WOS:000405432800004
PM 28428256
OA hybrid, Green Submitted, Green Published
DA 2023-08-21
ER

PT J
AU Seo, J
   Conegliano, D
   Farrell, M
   Cho, M
   Ding, XT
   Seykora, T
   Qing, D
   Mangalmurti, NS
   Huh, D
AF Seo, Jeongyun
   Conegliano, David
   Farrell, Megan
   Cho, Minseon
   Ding, Xueting
   Seykora, Thomas
   Qing, Danielle Y.
   Mangalmurti, Nilam S.
   Huh, Dongeun
TI A microengineered model of RBC transfusion-induced pulmonary vascular
   injury
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ACUTE LUNG INJURY; RED-BLOOD-CELLS; RESPIRATORY-DISTRESS-SYNDROME;
   GLYCATION END-PRODUCTS; SHEAR-STRESS; ENDOTHELIAL-CELLS; CRITICALLY-ILL;
   CYCLIC STRETCH; FLOW; INFLAMMATION
AB Red blood cell (RBC) transfusion poses significant risks to critically ill patients by increasing their susceptibility to acute respiratory distress syndrome. While the underlying mechanisms of this life-threatening syndrome remain elusive, studies suggest that RBC-induced microvascular injury in the distal lung plays a central role in the development of lung injury following blood transfusion. Here we present a novel microengineering strategy to model and investigate this key disease process. Specifically, we created a microdevice for culturing primary human lung endothelial cells under physiological flow conditions to recapitulate the morphology and hemodynamic environment of the pulmonary microvascular endothelium in vivo. Perfusion of the microengineered vessel with human RBCs resulted in abnormal cytoskeletal rearrangement and release of intracellular molecules associated with regulated necrotic cell death, replicating the characteristics of acute endothelial injury in transfused lungs in vivo. Our data also revealed the significant effect of hemodynamic shear stress on RBC-induced microvascular injury. Furthermore, we integrated the microfluidic endothelium with a computer-controlled mechanical stretching system to show that breathing-induced physiological deformation of the pulmonary microvasculature may exacerbate vascular injury during RBC transfusion. Our biomimetic microsystem provides an enabling platform to mechanistically study transfusion-associated pulmonary vascular complications in susceptible patient populations.
C1 [Seo, Jeongyun; Conegliano, David; Farrell, Megan; Cho, Minseon; Ding, Xueting; Seykora, Thomas; Huh, Dongeun] Univ Penn, Dept Bioengn, Philadelphia, PA 19104, United States.
   [Qing, Danielle; Mangalmurti, Nilam S.] Perelman Sch Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104, United States.
C3 University of Pennsylvania; University of Pennsylvania; Pennsylvania
   Medicine
RP Huh, D (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
EM huhd@seas.upenn.edu
RI Seykora, Thomas/AAD-4942-2021
OI Seykora, Thomas/0000-0001-7779-6906; Huh, Dongeun/0000-0002-5718-6884;
   Qing, Danielle/0000-0001-5511-5196; Mangalmurti,
   Nilam/0000-0002-9146-1608
FU National Research Foundation of Korea [2012M3A7B4035374]; National
   Institutes of Health [R01 HL126788]; Department of Defense [PR141324];
   University of Pennsylvania; National Institutes of Health (NIH)
   Director's New Innovator Award [1DP2HL127720-01]; National Research
   Foundation of Korea [2012M3A7B4035374] Funding Source: Korea Institute
   of Science & Technology Information (KISTI), National Science &
   Technology Information Service (NTIS)
FX We thank G.A. for helpful discussion. This research was supported by
   grants from the National Research Foundation of Korea
   (2012M3A7B4035374), the National Institutes of Health (R01 HL126788),
   the Department of Defense (PR141324), and the University of
   Pennsylvania. D.H. is a recipient of the National Institutes of Health
   (NIH) Director's New Innovator Award (1DP2HL127720-01).
CR Anniss AM, 2007, AM J HEMATOL, V82, P439, DOI 10.1002/ajh.20837
   Baeyens N, 2015, ELIFE, V4, DOI 10.7554/eLife.04645
   Baeyens N, 2016, J CLIN INVEST, V126, P821, DOI 10.1172/JCI83083
   Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002
   Birukov KG, 2002, AM J RESP CELL MOL, V26, P453, DOI 10.1165/ajrcmb.26.4.4725
   Birukov KG, 2009, ANTIOXID REDOX SIGN, V11, P1651, DOI [10.1089/ars.2008.2390, 10.1089/ARS.2008.2390]
   Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008
   Bux J, 2005, VOX SANG, V89, P1, DOI 10.1111/j.1423-0410.2005.00648.x
   Chatterjee S, 2003, AM J PHYSIOL-CELL PH, V285, pC959, DOI 10.1152/ajpcell.00511.2002
   Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009
   Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79
   Croce MA, 2005, J TRAUMA, V59, P19, DOI 10.1097/01.TA.0000171459.21450.DC
   Donati A, 2014, CRIT CARE, V18, DOI 10.1186/cc13730
   Dos Santos CC, 2000, J APPL PHYSIOL, V89, P1645, DOI 10.1152/jappl.2000.89.4.1645
   ELLSWORTH ML, 1986, AM J PHYSIOL, V251, pH869, DOI 10.1152/ajpheart.1986.251.4.H869
   Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529
   Galbraith CG, 1998, CELL MOTIL CYTOSKEL, V40, P317, DOI 10.1002/(SICI)1097-0169(1998)40:4<317::AID-CM1>3.0.CO;2-8
   Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596
   Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601
   Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   I.W.B, 2011, 2011 NATL BLOOD COLL
   Kiefmann R, 2008, BLOOD, V111, P5205, DOI 10.1182/blood-2007-09-113902
   Kopko P M, 2004, Immunohematology, V20, P103
   Koutsiaris AG, 2007, BIORHEOLOGY, V44, P375
   Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050
   Liu MY, 1999, AM J PHYSIOL-LUNG C, V277, pL667, DOI 10.1152/ajplung.1999.277.4.L667
   Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594
   Malone DL, 2003, J TRAUMA, V54, P898, DOI 10.1097/01.TA.0000060261.10597.5C
   Mangalmurti NS, 2013, AM J PHYSIOL-LUNG C, V304, pL250, DOI 10.1152/ajplung.00278.2012
   Mangalmurti NS, 2010, TRANSFUSION, V50, P2353, DOI 10.1111/j.1537-2995.2010.02689.x
   Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9
   Nakano A, 2003, CLIN HEMORHEOL MICRO, V29, P445
   Nowak P, 2012, ANTICANCER RES, V32, P4067
   Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x
   Popel AS, 2005, ANNU REV FLUID MECH, V37, P43, DOI 10.1146/annurev.fluid.37.042604.133933
   POPOVSKY MA, 1985, TRANSFUSION, V25, P573, DOI 10.1046/j.1537-2995.1985.25686071434.x
   Qing DY, 2014, AM J RESP CRIT CARE, V190, P1243, DOI 10.1164/rccm.201406-1095OC
   Sakr Y, 2007, CRIT CARE MED, V35, P1639, DOI 10.1097/01.CCM.0000269936.73788.32
   Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Shaz BH, 2011, BLOOD, V117, P1463, DOI 10.1182/blood-2010-04-278135
   Silliman CC, 2005, BLOOD, V105, P2266, DOI 10.1182/blood-2004-07-2929
   Song JW, 2005, ANAL CHEM, V77, P3993, DOI 10.1021/ac050131o
   Strilic B, 2016, NATURE, V536, P215, DOI 10.1038/nature19076
   Tarbell JM, 2010, CARDIOVASC RES, V87, P320, DOI 10.1093/cvr/cvq146
   Uhlig S, 2002, AM J PHYSIOL-LUNG C, V282, pL892, DOI 10.1152/ajplung.00124.2001
   Vlaar APJ, 2013, LANCET, V382, P984, DOI 10.1016/S0140-6736(12)62197-7
   Ware LB, 2014, AM J RESP CRIT CARE, V190, P1331, DOI 10.1164/rccm.201411-2047ED
   Wei ZH, 2004, MICROCIRCULATION, V11, P517, DOI 10.1080/10739680490476367
   Wirtz HR, 2000, RESP PHYSIOL, V119, P1, DOI 10.1016/S0034-5687(99)00092-4
   Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010
   Zilberberg MD, 2007, CRIT CARE, V11, DOI 10.1186/cc5934
NR 53
TC 12
Z9 13
U1 0
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 13
PY 2017
VL 7
AR 3413
DI 10.1038/s41598-017-03597-w
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EX3NV
UT WOS:000403140000084
PM 28611413
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Matthay, MA
   McAuley, DF
   Ware, LB
AF Matthay, Michael A.
   McAuley, Daniel Francis
   Ware, Lorraine B.
TI Clinical trials in acute respiratory distress syndrome: challenges and
   opportunities
SO LANCET RESPIRATORY MEDICINE
LA English
DT Review
ID ACUTE LUNG INJURY; END-EXPIRATORY PRESSURE; INTENSIVE-CARE UNITS;
   CELL-FREE HEMOGLOBIN; DEAD-SPACE FRACTION; STEM STROMAL CELLS;
   FLUID-MANAGEMENT; DOUBLE-BLIND; NEUROMUSCULAR BLOCKERS; RANDOMIZED-TRIAL
AB This year is the 50th anniversary of the first description of acute respiratory distress syndrome (ARDS). Since then, much has been learned about the pathogenesis of lung injury in ARDS, with an emphasis on the mechanisms of injury to the lung endothelium and the alveolar epithelium. In terms of treatment, major progress has been made in reducing mortality from ARDS with lung-protective ventilation, using a tidal volume of 6 mL per kg of predicted bodyweight and a plateau airway pressure of less than 30 cm H2O. In more severely hypoxaemic patients with ARDS, neuromuscular blockade and prone positioning have further reduced mortality, probably by extending the therapeutic effects of lung protective ventilation. Fluid-conservative therapy has also increased ventilator-free days in patients with ARDS. The lack of success of pharmacological therapies for ARDS, however, presents a continued challenge in the field. In addition to presenting a brief summary of previous experience with clinical trials in ARDS, we focus in this Review on future opportunities to improve clinical trial design to maximise the likelihood of identifying beneficial pharmacological therapies. In view of the heterogeneity in ARDS, both prognostic and predictive enrichment strategies are needed that target therapies toward specific subgroups of patients with ARDS on the basis of both severity and biology. Approaches to reducing heterogeneity in ARDS clinical trials include using physiological, radiographic, and biological criteria to select patients for both phase 2 and 3 trials. Additionally, interest is growing in the design of preventive clinical trials in ARDS and to initiate early treatment of patients with acute lung injury before the need for endotracheal intubation. We also present promising new approaches to treating ARDS, including combination therapies, cell-based therapies, and generic pharmacological compounds with low-risk profiles that are already in routine clinical use for other clinical indications.
C1 [Matthay, Michael A.] Univ Calif San Francisco, Dept Med, San Francisco, CA, United States.
   [Matthay, Michael A.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA, United States.
   [Matthay, Michael A.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA, United States.
   [McAuley, Daniel F.] Queens Univ Belfast, Ctr Expt Med, Belfast, Antrim, North Ireland, United Kingdom.
   [McAuley, Daniel F.] Belfast Hlth & Social Care Trust, Reg Intens Care Unit, Belfast, Antrim, North Ireland, United Kingdom.
   [Ware, Lorraine B.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212, United States.
   [Ware, Lorraine B.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212, United States.
C3 University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   Queens University Belfast; Vanderbilt University; Vanderbilt University
RP Matthay, MA (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.
EM michael.matthay@ucsf.edu
RI Ware, Lorraine/AAJ-9307-2021
OI Ware, Lorraine/0000-0002-9429-4702; McAuley, Daniel/0000-0002-3283-1947
FU NHBLI [R37 HL51856, U01 HL108713]; Courtney's Race for the Cure;
   Courtney Charneco Family; NIH [HL103836, HL126176]
FX This Review was supported by NHBLI R37 HL51856 and U01 HL108713 (MAM),
   as well as Courtney's Race for the Cure, The Courtney Charneco Family,
   NIH HL103836, and NIH HL126176 (LBW). We thank Andrew Manies for
   assistance with preparation of the manuscript and Diana Lim for her work
   on the figure.
CR Abraham E, 1999, CRIT CARE MED, V27, P1478, DOI 10.1097/00003246-199908000-00013
   Adhikari NKJ, 2007, BMJ-BRIT MED J, V334, P779, DOI 10.1136/bmj.39139.716794.55
   Antonelli M, 2007, CRIT CARE MED, V35, P18, DOI 10.1097/01.CCM.0000251821.44259.F3
   ASHBAUGH DG, 1967, LANCET, V2, P319
   Beitler JR, 2016, CRIT CARE MED, V44, P91, DOI 10.1097/CCM.0000000000001355
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Bernard GR, 1997, CHEST, V112, P164, DOI 10.1378/chest.112.1.164
   BERNARD GR, 1987, NEW ENGL J MED, V317, P1565, DOI 10.1056/NEJM198712173172504
   BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706
   Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927
   Blackwood B, 2014, AM J RESP CRIT CARE, V189, P886, DOI 10.1164/rccm.201309-1645PP
   Boutaud O, 2010, P NATL ACAD SCI USA, V107, P2699, DOI 10.1073/pnas.0910174107
   Boyle AJ, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0846-4
   Boyle AJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-166
   Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015
   Brower RG, 2004, NEW ENGL J MED, V351, P327
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Calfee CS, 2007, CRIT CARE MED, V35, P2243, DOI 10.1097/01.CCM.0000280434.33451.87
   Calfee CS, 2015, CHEST, V147, P1539, DOI 10.1378/chest.14-2454
   Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9
   Chen W, 2015, CRIT CARE MED, V43, P801, DOI 10.1097/CCM.0000000000000789
   Famous KR, 2017, AM J RESP CRIT CARE, V195, P331, DOI 10.1164/rccm.201603-0645OC
   Festic E, 2017, CRIT CARE MED, V45, P798, DOI 10.1097/CCM.0000000000002284
   Flori HR, 2005, AM J RESP CRIT CARE, V171, P995, DOI 10.1164/rccm.200404-544OC
   Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326
   Gainnier M, 2004, CRIT CARE MED, V32, P113, DOI 10.1097/01.CCM.0000104114.72614.BC
   Gajic O, 2011, AM J RESP CRIT CARE, V183, P462, DOI 10.1164/rccm.201004-0549OC
   Gattinoni L, 2001, NEW ENGL J MED, V345, P568, DOI 10.1056/NEJMoa010043
   Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052
   Gattinoni L, 2010, MINERVA ANESTESIOL, V76, P448
   Gattinoni L, 2013, AM J RESP CRIT CARE, V188, P1286, DOI 10.1164/rccm.201308-1532CI
   Gotts JE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1585
   Guerin C, 2004, JAMA-J AM MED ASSOC, V292, P2379, DOI 10.1001/jama.292.19.2379
   Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103
   Guervilly C, 2017, INTENS CARE MED, V43, P408, DOI 10.1007/s00134-016-4653-4
   HALLMAN M, 1985, J PEDIATR-US, V106, P963, DOI 10.1016/S0022-3476(85)80253-5
   Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8
   Hough CL, 2014, CLIN CHEST MED, V35, P781, DOI 10.1016/j.ccm.2014.08.014
   Huang DT, 2017, ANN AM THORAC SOC, V14, P124, DOI 10.1513/AnnalsATS.201608-629OT
   Iwashyna TJ, 2015, AM J RESP CRIT CARE, V192, P1045, DOI 10.1164/rccm.201411-2125CP
   Janz DR, 2015, CRIT CARE MED, V43, P534, DOI 10.1097/CCM.0000000000000718
   Janz DR, 2013, CRIT CARE MED, V41, P784, DOI 10.1097/CCM.0b013e3182741a54
   Kallet RH, 2014, RESP CARE, V59, P1611, DOI 10.4187/respcare.02593
   Kangelaris KN, 2016, CRIT CARE MED, V44, P120, DOI 10.1097/CCM.0000000000001359
   Kor DJ, 2016, JAMA-J AM MED ASSOC, V315, P2406, DOI 10.1001/jama.2016.6330
   Levitt JE, 2013, CRIT CARE MED, V41, P1929, DOI 10.1097/CCM.0b013e31828a3d99
   Levitt JE, 2009, CHEST, V135, P936, DOI 10.1378/chest.08-2346
   Lipsky AM, 2013, STAT MED, V32, P3752, DOI 10.1002/sim.5807
   Liu KD, 2008, AM J RESP CRIT CARE, V178, P618, DOI 10.1164/rccm.200803-419OC
   Liu KD, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0022-z
   Luo L, 2017, CHEST, V151, P755, DOI 10.1016/j.chest.2016.09.004
   Mancebo J, 2006, AM J RESP CRIT CARE, V173, P1233, DOI 10.1164/rccm.200503-353OC
   Matthay MA, 2017, STEM CELLS, V35, P316, DOI 10.1002/stem.2551
   Matthay MA, 2016, CHEST, V150, P989, DOI 10.1016/j.chest.2016.05.013
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC
   McAuley DF, 2014, NEW ENGL J MED, V371, P1695, DOI 10.1056/NEJMoa1403285
   Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637
   Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159
   Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646
   Meyer NJ, 2017, LANCET RESP MED, V5, P512, DOI 10.1016/S2213-2600(17)30187-X
   Mrozek S, 2016, CHEST, V150, P998, DOI 10.1016/j.chest.2016.03.016
   MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720
   Nuckton TJ, 2002, NEW ENGL J MED, V346, P1281, DOI 10.1056/NEJMoa012835
   Paine R, 2012, CRIT CARE MED, V40, P90, DOI 10.1097/CCM.0b013e31822d7bf0
   Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372
   Pelosi P, 2001, SEM RESP CRIT CARE M, V22, P259, DOI 10.1055/s-2001-15783
   Prescott HC, 2016, AM J RESP CRIT CARE, V194, P147, DOI 10.1164/rccm.201512-2544CP
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Rice TW, 2011, JAMA-J AM MED ASSOC, V306, P1574, DOI 10.1001/jama.2011.1435
   Rouby JJ, 2000, INTENS CARE MED, V26, P1046, DOI 10.1007/s001340051317
   Rubenfeld GD, 2015, AM J RESP CRIT CARE, V191, P255, DOI 10.1164/rccm.201408-1574CP
   Neto AS, 2016, LANCET RESP MED, V4, P882, DOI 10.1016/S2213-2600(16)30305-8
   SHAPIRO DL, 1985, PEDIATRICS, V76, P593
   Shaver CM, 2016, AM J PHYSIOL-LUNG C, V310, pL532, DOI 10.1152/ajplung.00155.2015
   Shaver CM, 2014, CLIN CHEST MED, V35, P639, DOI 10.1016/j.ccm.2014.08.004
   Silversides JA, 2017, INTENS CARE MED, V43, P155, DOI 10.1007/s00134-016-4573-3
   Smith FG, 2012, LANCET, V379, P229, DOI 10.1016/S0140-6736(11)61623-1
   Spragg RG, 2004, NEW ENGL J MED, V351, P884, DOI 10.1056/NEJMoa033181
   Steinberg KP, 2006, NEW ENGL J MED, V354, P1671
   Taccone P, 2009, JAMA-J AM MED ASSOC, V302, P1977, DOI 10.1001/jama.2009.1614
   Taylor RW, 2004, JAMA-J AM MED ASSOC, V291, P1603, DOI 10.1001/jama.291.13.1603
   Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520
   Vieillard-Baron A, 2000, AM J RESP CRIT CARE, V161, P1597
   Vincent JL, 2009, CRIT CARE MED, V37, P1874, DOI 10.1097/CCM.0b013e31819fff2c
   Walter J, 2014, LANCET RESP MED, V2, P1016, DOI 10.1016/S2213-2600(14)70217-6
   Wang CY, 2014, INTENS CARE MED, V40, P388, DOI 10.1007/s00134-013-3186-3
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Ware LB, 2010, CHEST, V137, P288, DOI 10.1378/chest.09-1484
   Warren MA, 2017, AM J RESP C IN PRESS
   Wheeler AP, 2006, NEW ENGL J MED, V354, P2213
   Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564
   Wiedemann HP, 2000, JAMA-J AM MED ASSOC, V283, P1995
   Wiedemann HP, 2002, CRIT CARE MED, V30, P1
   Willson DF, 2015, CHEST, V148, P356, DOI 10.1378/chest.14-1139
   Wilson JG, 2015, LANCET RESP MED, V3, P24, DOI [10.1016/s2213-2600(14)70291-7, 10.1016/S2213-2600(14)70291-7]
   Yadav H, 2015, AM J PHYSIOL-LUNG C, V309, pL915, DOI 10.1152/ajplung.00266.2015
   Zeiher BG, 2004, CRIT CARE MED, V32, P1695, DOI 10.1097/01.CCM.0000133332.48386.85
   Zeyed YF, 2012, AM J PHYSIOL-LUNG C, V303, pL550, DOI 10.1152/ajplung.00190.2012
NR 99
TC 180
Z9 193
U1 4
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2213-2600
J9 LANCET RESP MED
JI Lancet Resp. Med.
PD JUN
PY 2017
VL 5
IS 6
BP 524
EP 534
DI 10.1016/S2213-2600(17)30188-1
PG 11
WC Critical Care Medicine; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Respiratory System
GA EV9FR
UT WOS:000402091700023
PM 28664851
DA 2023-08-21
ER

PT J
AU Wu, ZY
   Hu, ZP
   Cai, X
   Ren, W
   Dai, FF
   Liu, HG
   Chang, JX
   Li, BW
AF Wu, Zhiyong
   Hu, Zhipeng
   Cai, Xin
   Ren, Wei
   Dai, Feifeng
   Liu, Huagang
   Chang, Jinxing
   Li, Bowen
TI Interleukin 22 attenuated angiotensin II induced acute lung injury
   through inhibiting the apoptosis of pulmonary microvascular endothelial
   cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ACUTE AORTIC DISSECTION; NATURAL-KILLER-CELLS; POTENTIAL-ROLE; INDUCIBLE
   FACTOR; RECEPTOR COMPLEXES; VIRUS-INFECTION; HOST-DEFENSE; MOUSE MODEL;
   IL-TIF; IL-22
AB Apoptosis of pulmonary microvascular endothelial cells (PMVECs) was considered to be closely related to the pathogenesis of acute lung injury (ALI). We aim to investigate whether IL-22 plays protective roles in lung injury through inhibiting the apoptosis of PMVECs. ALI model was induced through subcutaneous infusion of angiotensin II (Ang II). Lung injury and infiltration of inflammatory cells were evaluated by determining the PaO2/FiO(2), calculation of dry to weight ratio in lung, and immunohistochemisty analysis. Apoptosis of PMVECs was determined using TUNEL assay and flow cytometry, respectively. Immunofluorescence and Western blot analysis were used to determine the expression and localization of STAT3, as well as the nucleus transmission of STAT3 from cytoplasm after IL22 treatment. Pathological findings showed ALI was induced 1 week after AngII infusion. IL22 inhibited the AngII-induced ALI, attenuated the edema in lung and the infiltration of inflammatory cells. Also, it contributed to the apoptosis of PMVECs induced by AngII. Meanwhile, significant increase was noticed in the expression of STAT3, phosphorylation of Y705-STAT3, and migration from cytoplasm to the nucleus after IL-22 treatment (P < 0.05). The activation of STAT3 by IL22 showed significant attenuation after AG490 treatment. Our data indicated that IL22 showed protective effects on lung injury through inhibiting the AngII-induced PMVECs apoptosis and PMVEC barrier injury by activating the JAK2/STAT3 signaling pathway.
C1 [Wu, Zhiyong; Hu, Zhipeng; Cai, Xin; Ren, Wei; Dai, Feifeng; Liu, Huagang; Chang, Jinxing; Li, Bowen] Wuhan Univ, Dept Cardiovasc Surg, Renmin Hosp, Jiefang Rd 238, Wuhan 430060, China.
C3 Wuhan University
RP Wu, ZY (corresponding author), Wuhan Univ, Dept Cardiovasc Surg, Renmin Hosp, Jiefang Rd 238, Wuhan 430060, Peoples R China.
EM zhiyongwu889@sina.com
OI Hu, Zhipeng/0000-0002-6384-0037
FU Hubei Province health and family planning scientific research
   [WJ2017M013]
FX This study was supported by the Hubei Province health and family
   planning scientific research project (WJ2017M013).
CR Alvarez DF, 2008, AM J PHYSIOL-LUNG C, V294, pL419, DOI 10.1152/ajplung.00314.2007
   Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071
   Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710
   Besnard AG, 2011, AM J RESP CRIT CARE, V183, P1153, DOI 10.1164/rccm.201008-1383OC
   Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465
   Chang H, 2006, J IMMUNOL, V177, P3635, DOI 10.4049/jimmunol.177.6.3635
   Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008
   Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697
   Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814
   Dumoutier L, 2009, J BIOL CHEM, V284, P26377, DOI 10.1074/jbc.M109.007955
   Farina F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056636
   Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220
   Gill SE, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0266-7
   Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10
   Hasegawa Y, 1999, J CARDIOVASC SURG, V40, P191
   Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965
   Jokela TA, 2014, J BIOL CHEM, V289, P18569, DOI 10.1074/jbc.M114.551804
   Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200
   Kurabayashi M, 2010, CIRC J, V74, P2066, DOI 10.1253/circj.CJ-10-0336
   Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200
   Logsdon NJ, 2002, J INTERF CYTOK RES, V22, P1099, DOI 10.1089/10799900260442520
   Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263
   Menden H, 2015, J BIOL CHEM, V290, P5449, DOI 10.1074/jbc.M114.600692
   Mikawa K, 2003, ANESTH ANALG, V97, P1751, DOI 10.1213/01.ANE.0000086896.90343.13
   Mitra A, 2012, CYTOKINE, V60, P38, DOI 10.1016/j.cyto.2012.06.316
   Nagem RAP, 2002, STRUCTURE, V10, P1051, DOI 10.1016/S0969-2126(02)00797-9
   Naher L, 2012, INT J ONCOL, V41, P1577, DOI 10.3892/ijo.2012.1594
   Neto MDO, 2008, BIOPHYS J, V94, P1754, DOI 10.1529/biophysj.107.112664
   Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857
   Paget C, 2012, J BIOL CHEM, V287, P8816, DOI 10.1074/jbc.M111.304758
   Qiao YY, 2016, WORLD J GASTROENTERO, V22, P5023, DOI 10.3748/wjg.v22.i21.5023
   Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176
   Sakaguchi R, 2016, INT IMMUNOL, V28, P233, DOI 10.1093/intimm/dxv070
   Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001
   Sestito R, 2011, FASEB J, V25, P916, DOI 10.1096/fj.10-172288
   Shang WQ, 2015, AM J TRANSL RES, V7, P1782
   Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061
   Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]
   Takahashi K, 2011, J ALLERGY CLIN IMMUN, V128, P1067, DOI 10.1016/j.jaci.2011.06.018
   Taube C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021799
   Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007
   Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503
   Wu ZY, 2016, AM J TRANSL RES, V8, P1426
   Wu ZY, 2016, AM J TRANSL RES, V8, P28
   Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166
   Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001
   Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720
   Zhu XF, 2012, MOL CELL BIOCHEM, V369, P255, DOI 10.1007/s11010-012-1389-5
NR 48
TC 16
Z9 17
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 19
PY 2017
VL 7
AR 2210
DI 10.1038/s41598-017-02056-w
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EV2VP
UT WOS:000401614900068
PM 28526849
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Hayashi, K
   Yoshida, H
   Sato, Y
   Tobiume, M
   Suzuki, Y
   Ariyoshi, K
   Hasegawa, H
   Nakajima, N
AF Hayashi, Kentaro
   Yoshida, Hiroshi
   Sato, Yuko
   Tobiume, Minoru
   Suzuki, Yoshio
   Ariyoshi, Koya
   Hasegawa, Hideki
   Nakajima, Noriko
TI Histopathological Findings of Lung with A/H1N1pdm09 Infection-Associated
   Acute Respiratory Distress Syndrome in the Post-Pandemic Season
SO JAPANESE JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID INFLUENZA-A H1N1; VIRUS-INFECTION; PATHOGENESIS; CELLS
AB We herein report the pulmonary histopathological findings of an autopsy case of post pandemic season A/H1N1pdm09 infection-associated acute respiratory distress syndrome (ARDS). The lung histology predominantly exhibited findings indicative of the exudative phase of diffuse alveolar damage, with similar inflammation severity observed in all sections. Furthermore, the lung sections only showed a few A/H1N1pdm09 antigen-positive cells along with a low viral RNA copy number. The sequence of the viral hemagglutinin receptor binding site identified a preference for alpha-2,6 linked sialic acid, suggesting low alveolar epithelial cell infectivity. The pathological findings, in this case, differed in several aspects from those of the first autopsy case of A/H1N1pdm09 infection-associated ARDS in Japan, reported during the 2009 pandemic season. In conclusion, pathological and molecular biological examinations suggested that in the post-pandemic season A/H1N1pdm09 infection, the infection associated ARDS was not caused by direct infection-induced damage to the alveolar epithelial cells but was rather a result of indirect sepsis-mediated endothelial cell damage.
C1 [Hayashi, Kentaro; Sato, Yuko; Tobiume, Minoru; Hasegawa, Hideki; Nakajima, Noriko] Natl Inst Infect Dis, Dept Pathol, Tokyo 1628640, Japan.
   [Hayashi, Kentaro; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 8528523, Japan.
   [Yoshida, Hiroshi; Suzuki, Yoshio] Asahi Gen Hosp, Dept Pathol, Chiba 2892511, Japan.
C3 National Institute of Infectious Diseases (NIID); Nagasaki University
RP Nakajima, N (corresponding author), Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
EM tenko@nih.go.jp
RI Hasegawa, Hideki/C-7978-2014; Yoshida, Hiroshi/J-2900-2019
FU MEXT KAKENHI [26460447]
FX We thank Drs. Noriyo Nagata, Tadaki Suzuki, and Tetsutaro Sata for their
   valuable discussions. This work was supported by MEXT KAKENHI Grant
   Number 26460447.
CR Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091
   Guarner J, 2006, CLIN INFECT DIS, V43, P132, DOI 10.1086/505122
   Kuroda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010256
   Liem NT, 2008, JPN J INFECT DIS, V61, P157
   Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10
   Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158
   Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC
   Nakajima N, 2012, MODERN PATHOL, V25, P1, DOI 10.1038/modpathol.2011.125
   Nakajima N, 2010, JPN J INFECT DIS, V63, P67
   Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252
   Rao S, 2015, J CLIN VIROL, V71, P44, DOI 10.1016/j.jcv.2015.07.308
   Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115
   Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X
NR 13
TC 1
Z9 1
U1 0
U2 0
PU NATL INST INFECTIOUS DISEASES
PI TOKYO
PA JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1,
   SHINJUKU-KU, TOKYO, 162-8640, JAPAN
SN 1344-6304
EI 1884-2836
J9 JPN J INFECT DIS
JI Jpn. J. Infect. Dis.
PD MAR
PY 2017
VL 70
IS 2
BP 197
EP 200
DI 10.7883/yoken.JJID.2016.120
PG 4
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA EQ8KX
UT WOS:000398335400015
PM 27357984
OA Green Submitted, gold
DA 2023-08-21
ER

PT J
AU Letsiou, E
   Sammani, S
   Wang, HS
   Belvitch, P
   Dudek, SM
AF Letsiou, Eleftheria
   Sammani, Saad
   Wang, Huashan
   Belvitch, Patrick
   Dudek, Steven M.
TI Parkin regulates lipopolysaccharide-induced proinflammatory responses in
   acute lung injury
SO TRANSLATIONAL RESEARCH
LA English
DT Article
ID FACTOR-KAPPA-B; MEDIATED TYROSINE PHOSPHORYLATION; VASCULAR LEAK;
   MITOPHAGY; INFLAMMATION; ASSOCIATION; DYSFUNCTION; IMATINIB; SEPSIS;
   ACTIVATION
AB The acute respiratory distress syndrome (ARDS) is a serious condition resulting from direct or indirect lung injury that is associated with high mortality and morbidity. A key biological event in the pathogenesis of the acute lung injury (ALI) that causes acute respiratory distress syndrome is activation of the lung endothelium cells (ECs), which is triggered by a variety of inflammatory insults leading to barrier disruption and excessive accumulation of neutrophils. Recently, we demonstrated that imatinib protects against lipopolysaccharide (LPS)-induced EC activation by inhibiting c-Abl kinase. In the present study, we explored the role of parkin, a novel c-Abl substrate, in ALI. Parkin is an E3 ubiquitin ligase originally characterized in the pathogenesis of Parkinson disease; however, its potential role in acute inflammatory processes and lung EC function remains largely unknown. Using parkin deficient (PARK2-/-) mice, we now demonstrate that parkin mediates LPS-induced ALI. After LPS, PARK2-/- mice have reduced total protein and cell levels in bronchoalveolar lavage (BAL) compared to wild type. Moreover, in LPS-treated PARK2-/- lungs, the sequestration and activation of neutrophils and release of inflammatory cytokines (interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha)) are significantly reduced. The BAL levels of soluble VCAM-1 and ICAM- I are also decreased in LPS-treated PARK2-/- mice compared to wild type. In cultured human lung endothelial cells, downregulation of parkin by small interfering RNA decreases LPS-induced VCAM- I expression, IL-8 and IL-6 secretion, and NF-kappa B phosphorylation. These results suggest a previously unidentified role of parkin in mediating endotoxin-induced endothelial proinflammatory signaling and indicate that it may play a critical role in acute inflammation.
C1 Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Chicago, IL, United States.
   Univ Arizona, Arizona Hlth Sci Ctr, Tucson, AZ 85721, United States.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Arizona;
   University of Arizona Health Sciences
RP Letsiou, E (corresponding author), Univ Illinois Hosp & Hlth Sci Syst, Div Pulm Crit Care Sleep & Allergy, COMRB, Room 3160, Chicago, IL 60612 USA.
EM eletsiou@gmail.com
FU American Heart Association Postdoctoral fellowship [13POST17110042]
FX Eleftheria Letsiou was supported by an American Heart Association
   Postdoctoral fellowship (13POST17110042).
CR Aman J, 2012, CIRCULATION, V126, P2728, DOI 10.1161/CIRCULATIONAHA.112.134304
   Attia EF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149687
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142
   Calfee C, 2009, INTENS CARE MED, V35, P248, DOI 10.1007/s00134-008-1235-0
   Chen BB, 2014, CELL REP, V7, P476, DOI 10.1016/j.celrep.2014.02.048
   Chian CF, 2014, TRANSL RES, V163, P211, DOI 10.1016/j.trsl.2013.10.002
   Chislock EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085231
   de Leseleuc L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002015
   deJong R, 1997, ONCOGENE, V14, P507, DOI 10.1038/sj.onc.1200885
   Elliott CL, 2001, MOL HUM REPROD, V7, P787, DOI 10.1093/molehr/7.8.787
   Fu PF, 2015, AM J PHYSIOL-LUNG C, V308, pL1025, DOI 10.1152/ajplung.00306.2014
   Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007
   Imam SZ, 2011, J NEUROSCI, V31, P157, DOI 10.1523/JNEUROSCI.1833-10.2011
   Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849
   Kim IK, 2013, CRIT CARE, V17, DOI 10.1186/cc12786
   Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107
   Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001
   Letsiou E, 2015, AM J PHYSIOL-LUNG C, V308, pL259, DOI 10.1152/ajplung.00323.2014
   Letsiou E, 2015, AM J RESP CELL MOL, V52, P193, DOI 10.1165/rcmb.2013-0347OC
   Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005
   Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103
   Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009
   Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9
   Mannam P, 2014, AM J PHYSIOL-LUNG C, V306, pL604, DOI 10.1152/ajplung.00272.2013
   Manning AM, 1995, J INFLAMM, V45, P283
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749
   Moreno-Vinasco L, 2014, AM J RESP CELL MOL, V51, P223, DOI 10.1165/rcmb.2012-0519OC
   Piquereau J, 2013, AUTOPHAGY, V9, P1837, DOI 10.4161/auto.26502
   Rizzo AN, 2015, AM J PHYSIOL-LUNG C, V309, pL1294, DOI 10.1152/ajplung.00031.2015
   Rizzo AN, 2015, ARTERIOSCL THROM VAS, V35, P1071, DOI 10.1161/ATVBAHA.115.305085
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Seirafi M, 2015, FEBS J, V282, P2076, DOI 10.1111/febs.13249
   Shapiro NI, 2010, CRIT CARE, V14, DOI 10.1186/cc9290
   Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060
   Singleton PA, 2009, J BIOL CHEM, V284, P34964, DOI 10.1074/jbc.M109.013771
   Standiford TJ, 2016, TRANSL RES, V167, P183, DOI 10.1016/j.trsl.2015.04.015
   Stephens RS, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12589
   Stephens RS, 2014, AM J PHYSIOL-CELL PH, V306, pC559, DOI 10.1152/ajpcell.00375.2012
   Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830
   Tanaka A, 2010, FEBS LETT, V584, P1386, DOI 10.1016/j.febslet.2010.02.060
   Tong HB, 2013, J LEUKOCYTE BIOL, V93, P611, DOI 10.1189/jlb.1012487
   Tran TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023660
   Williams JA, 2015, PHARMACOL RES, V102, P264, DOI 10.1016/j.phrs.2015.09.020
   Xu L, 2014, J MOL MED, V92, P31, DOI 10.1007/s00109-013-1107-0
   Zanon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078648
   Zhang XC, 2014, AM J PATHOL, V184, P2730, DOI 10.1016/j.ajpath.2014.06.017
   Zhang Y, 2014, J IMMUNOL, V192, P5296, DOI 10.4049/jimmunol.1400653
   Zhao J, 2015, TRANSL RES, V166, P80, DOI 10.1016/j.trsl.2015.01.008
NR 50
TC 27
Z9 29
U1 5
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1931-5244
EI 1878-1810
J9 TRANSL RES
JI Transl. Res.
PD MAR
PY 2017
VL 181
BP 71
EP 82
DI 10.1016/j.trsl.2016.09.002
PG 12
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA EP4LZ
UT WOS:000397353300006
PM 27693468
DA 2023-08-21
ER

PT J
AU Ren, W
   Wang, ZW
   Wu, ZY
   Hu, ZP
   Dai, FF
   Chang, JX
   Li, BW
   Liu, HG
   Ruan, YL
AF Ren, Wei
   Wang, Zhiwei
   Wu, Zhiyong
   Hu, Zhipeng
   Dai, Feifeng
   Chang, Jinxing
   Li, Bowen
   Liu, Huagang
   Ruan, Yongle
TI JAK2/STAT3 Pathway Was Associated with the Protective Effects of IL-22
   On Aortic Dissection with Acute Lung Injury
SO DISEASE MARKERS
LA English
DT Article
ID MICROVASCULAR ENDOTHELIAL-CELLS; ANGIOTENSIN-II; PROLIFERATION;
   INFLAMMATION; ACTIVATION; EXPRESSION; RECEPTOR; STAT3
AB Patients with aortic dissection (AD) may present acute lung injury (ALI) that may affect the prognosis. In this study, we aim to investigate the roles and mechanism of IL-22 in the pathogenesis of AD complicated with ALI. Six hundred and twenty-one AD patients were included, and the incidence of ALI and pulmonary CT findings were analyzed. Mouse ALI model was established through AngII, and then IL-22 injection and AG490 were given. The pathological changes, infiltration of inflammatory cells, and expression of STAT3 were determined. For the in vitro experiment, cultivated pulmonary microvascular endothelial cells (PMVECs) were treated by angiotensin II (AngII), followed by treating with IL-22 and/or AG490. The expression and migration of STAT3 was determined. Flow cytometry was carried out to evaluate the apoptosis. IL-22 contributed to the expression of STAT3 in lung tissues and attenuation of ALI. IL-22 obviously inhibited the apoptosis of PMVECs mediated by AngII and downregulated the expression and intranuclear transmission of STAT3. Such phenomenon was completely inhibited upon administration of AG490, an inhibitor of JAK2. Our data showed IL-22 contributed to the inhibition of PMVEC apoptosis mediated by AngII through activating the JAK2/STAT3 signaling pathway, which may attenuate the ALI induced by AngII.
C1 [Ren, Wei; Wang, Zhiwei; Wu, Zhiyong; Hu, Zhipeng; Dai, Feifeng; Chang, Jinxing; Li, Bowen; Liu, Huagang; Ruan, Yongle] Wuhan Univ, Renmin Hosp, Dept Cardiovasc Surg, Wuhan 430060, Hubei, China.
   [Ren, Wei; Wang, Zhiwei; Wu, Zhiyong; Hu, Zhipeng; Dai, Feifeng; Chang, Jinxing; Li, Bowen; Liu, Huagang; Ruan, Yongle] Hubei Key Lab Cardiol, Wuhan 430060, Hubei, China.
C3 Wuhan University
RP Wang, ZW; Wu, ZY (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiovasc Surg, Wuhan 430060, Hubei, Peoples R China.; Wang, ZW; Wu, ZY (corresponding author), Hubei Key Lab Cardiol, Wuhan 430060, Hubei, Peoples R China.
EM wangzhiwei@whu.edu.cn; zhiyongwu889@sina.com
OI Hu, Zhipeng/0000-0002-6384-0037
FU National Natural Science Foundation [81570428, 81501376]; Hubei Province
   Health and Family Planning Scientific Research Project [WJ2017M013]
FX This study was supported by the National Natural Science Foundation
   (nos. 81570428 and 81501376) and Hubei Province Health and Family
   Planning Scientific Research Project (no. WJ2017M013).
CR Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012
   Bae ON, 2015, TOXICOL APPL PHARM, V283, P147, DOI 10.1016/j.taap.2015.01.008
   Bai XZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10277
   Benham H, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4317
   Bhargava M., TRANSLATIONAL RES, V159, P205
   Cambi GE, 2012, MOL BIOSYST, V8, P2351, DOI 10.1039/c2mb25120e
   Chen D, 2014, BBA-MOL CELL RES, V1843, P454, DOI 10.1016/j.bbamcr.2013.11.024
   Del Porto F, 2010, ANN MED, V42, P622, DOI 10.3109/07853890.2010.518156
   Della Penna S. L., 2011, J PHYSL BIOCH, V70, P465
   Deng J, 2012, CAN RESPIR J, V19, P311, DOI 10.1155/2012/951025
   Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814
   Han S, 2015, J IMMUNOL, V194, P5569, DOI 10.4049/jimmunol.1500741
   Kim KW, 2012, ARTHRITIS RHEUM-US, V64, P1015, DOI 10.1002/art.33446
   Leifheit-Nestler M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-170
   Lin J, 2014, SCAND J IMMUNOL, V79, P131, DOI 10.1111/sji.12135
   Lu Z., 2011, CELL IMMUNOL, V304-305, P1
   Luo HY, 2009, PERFUSION-UK, V24, P199, DOI 10.1177/0267659109346671
   Ma WG, 2013, ANN CARDIOTHORAC SUR, V2, P621, DOI 10.3978/j.issn.2225-319X.2013.09.06
   Moriwaki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140750
   Podowski M, 2012, J CLIN INVEST, V122, P229, DOI 10.1172/JCI46215
   Rattik S, 2015, ATHEROSCLEROSIS, V242, P506, DOI 10.1016/j.atherosclerosis.2015.08.006
   Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176
   Savan R, 2011, BLOOD, V117, P575, DOI 10.1182/blood-2010-05-285908
   Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]
   Sun LZ, 2011, ANN THORAC SURG, V91, P1147, DOI 10.1016/j.athoracsur.2010.12.005
   Supe S, 2016, BRIT J PHARMACOL, V173, P1618, DOI 10.1111/bph.13462
   Talla K, 2017, INT J CARDIOVAS IMAG, V33, P259, DOI 10.1007/s10554-016-0989-7
   Wang LG, 2015, MOL MED REP, V12, P8261, DOI 10.3892/mmr.2015.4471
   Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x
   Wu ZY, 2016, AM J TRANSL RES, V8, P1426
   Wu ZY, 2016, AM J TRANSL RES, V8, P28
   Xia Q, 2012, INT J CARDIOL, V154, P187, DOI 10.1016/j.ijcard.2011.10.093
   Yang Y, 2013, J PINEAL RES, V55, P275, DOI 10.1111/jpi.12070
   Yue PB, 2016, CANCER RES, V76, P652, DOI 10.1158/0008-5472.CAN-14-3558
   Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001
   Zhang H, 2005, ARCH BIOCHEM BIOPHYS, V441, P75, DOI 10.1016/j.abb.2005.06.022
   Zhang H, 2006, J SURG RES, V134, P190, DOI 10.1016/j.jss.2006.01.026
   Zhao L, 2013, INT J RHEUM DIS, V16, P518, DOI 10.1111/1756-185X.12099
NR 38
TC 8
Z9 9
U1 0
U2 8
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0278-0240
EI 1875-8630
J9 DIS MARKERS
JI Dis. Markers
PY 2017
VL 2017
AR 1917804
DI 10.1155/2017/1917804
PG 9
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine; Pathology
GA FD8HE
UT WOS:000407765000001
PM 28827891
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Tsangaris, I
   Tsantes, A
   Vrigkou, E
   Kopterides, P
   Pelekanou, A
   Zerva, K
   Antonakos, G
   Konstantonis, D
   Mavrou, I
   Tsaknis, G
   Kyriazopoulou, E
   Mouktaroudi, M
   Kokori, S
   Orfanos, SE
   Giamarellos-Bourboulis, EJ
   Armaganidis, A
AF Tsangaris, Iraklis
   Tsantes, Argirios
   Vrigkou, Eleni
   Kopterides, Petros
   Pelekanou, Aimilia
   Zerva, Katerina
   Antonakos, George
   Konstantonis, Dimitrios
   Mavrou, Irini
   Tsaknis, Georgios
   Kyriazopoulou, Evdoxia
   Mouktaroudi, Maria
   Kokori, Styliani
   Orfanos, Stylianos E.
   Giamarellos-Bourboulis, Evangelos J.
   Armaganidis, Apostolos
TI Angiopoietin-2 Levels as Predictors of Outcome in Mechanically
   Ventilated Patients with Acute Respiratory Distress Syndrome
SO DISEASE MARKERS
LA English
DT Article
ID ACUTE LUNG INJURY; MORTALITY; INFLAMMATION; ENDOTHELIUM; COAGULATION;
   ACTIVATION; SEVERITY; MARKER; EDEMA
AB Pulmonary endothelium dysfunction is a key characteristic of ARDS. The aim of this study was to investigate endothelium-derived markers, such as angiopoietin-2 (Ang-2) and endothelial cell-specific molecule-1 (endocan), at the vascular and alveolar compartments as outcome predictors in ARDS. Fifty-three consecutive ARDS patients were studied. The primary outcome was 28-day mortality. Secondary endpoints were days of unassisted ventilation and days with organ failure other than ARDS, during the 28-day study period. Nonsurvivors presented higher lung injury scores and epithelial lining fluid (ELF) Ang-2 levels compared to survivors, with no significant differences in plasma Ang-2, endocan, and protein C concentrations between the two groups. In logistic regression analysis, ELF Ang-2 levels > 705 pg/ml were the only independent variable for 28-day mortality among the previous four. Plasma endocan values > 13 ng/pg were the only parameter predictive against days of unassisted ventilation during the 28-day study period. Finally, lung injury score > 2.25 and ELF Ang-2 levels > 705 pg/ml were associated with increased number of days with organ failure, other than ARDS. Our findings suggest that Ang-2 levels are increased in the alveolar compartment of ARDS patients, and this may be associated both with increased mortality and organ failure besides lung.
C1 [Tsangaris, Iraklis; Vrigkou, Eleni; Kopterides, Petros; Konstantonis, Dimitrios; Mavrou, Irini; Tsaknis, Georgios; Orfanos, Stylianos E.; Armaganidis, Apostolos] Natl & Kapodistrian Univ Athens, Med Sch, Dept Crit Care Med 2, Athens, Greece.
   [Tsantes, Argirios; Kokori, Styliani] Natl & Kapodistrian Univ Athens, Med Sch, Lab Hematol, Athens, Greece.
   [Tsantes, Argirios; Kokori, Styliani] Natl & Kapodistrian Univ Athens, Med Sch, Blood Bank Unit, Athens, Greece.
   [Pelekanou, Aimilia; Kyriazopoulou, Evdoxia; Mouktaroudi, Maria; Giamarellos-Bourboulis, Evangelos J.] Natl & Kapodistrian Univ Athens, Med Sch, Dept Internal Med 4, Athens, Greece.
   [Zerva, Katerina; Antonakos, George] Natl & Kapodistrian Univ Athens, Med Sch, Athens Univ Hosp Attikon, Dept Biochem, Athens, Greece.
C3 National & Kapodistrian University of Athens; National & Kapodistrian
   University of Athens; National & Kapodistrian University of Athens;
   National & Kapodistrian University of Athens; National & Kapodistrian
   University of Athens; University Hospital Attikon
RP Tsangaris, I (corresponding author), Natl & Kapodistrian Univ Athens, Med Sch, Dept Crit Care Med 2, Athens, Greece.
EM itsagkaris@med.uoa.gr
RI Kokoris, Stella/GYA-1957-2022; Giamarellos-Bourboulis,
   Evangelos/AAD-7155-2019; Tsaknis, Georgios/AAD-2109-2022; Kyriazopoulou,
   Evdoxia/AAT-9746-2021; Tsangaris, Iraklis/AAA-3627-2020
OI Tsaknis, Georgios/0000-0001-8927-9631; Kyriazopoulou,
   Evdoxia/0000-0002-9585-517X; Tsangaris, Iraklis/0000-0003-4395-0471;
   Kokoris, Styliani/0000-0002-1635-7309
CR Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Chambers Rachel C, 2012, Proc Am Thorac Soc, V9, P96, DOI 10.1513/pats.201201-006AW
   Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002
   Frantzeskaki F, 2017, RESPIRATION, V93, P212, DOI 10.1159/000453002
   Freitas C. N. D., 2013, J PHARMACEUT BIOMED, V78-79, P45
   Gallagher DC, 2008, SHOCK, V29, P656, DOI 10.1097/SHK.0b013e31815dd92f
   Ganter MT, 2008, ANN SURG, V247, P320, DOI 10.1097/SLA.0b013e318162d616
   IDELL S, 1991, AM J PHYSIOL, V261, pL240, DOI 10.1152/ajplung.1991.261.4.L240
   Ioakeimidou A., 2017, EUROPEAN J CLIN MICR
   KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009
   Kumpers P, 2008, CRIT CARE, V12, DOI 10.1186/cc7130
   Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9
   Matthay MA, 2004, CRIT CARE MED, V32, pS229, DOI 10.1097/01.CCM.0000126121.56990.D3
   Millar FR, 2016, THORAX, V71, P462, DOI 10.1136/thoraxjnl-2015-207461
   Ong T, 2010, CRIT CARE MED, V38, P1845, DOI 10.1097/CCM.0b013e3181eaa5bf
   Orfanos SE, 2007, CRIT CARE MED, V35, P199, DOI 10.1097/01.CCM.0000251640.77679.D7
   Ozolina A, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00064
   Pauly D, 2016, J CRIT CARE, V31, P68, DOI 10.1016/j.jcrc.2015.09.019
   Prabhakaran P, 2003, AM J PHYSIOL-LUNG C, V285, pL20, DOI 10.1152/ajplung.00312.2002
   Roviezzo F, 2005, J PHARMACOL EXP THER, V314, P738, DOI 10.1124/jpet.105.086553
   Sapru A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1330-5
   Sarrazin S, 2006, BBA-REV CANCER, V1765, P25, DOI 10.1016/j.bbcan.2005.08.004
   Tang L, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/625180
   Tsangaris I., 2011, INTENSIVE CARE ME S1, V37
   Tsangaris I, 2009, THROMB RES, V123, P832, DOI 10.1016/j.thromres.2008.07.018
   van der Heijden M, 2008, THORAX, V63, P903, DOI 10.1136/thx.2007.087387
   Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016
   Ware LB, 2010, CHEST, V137, P288, DOI 10.1378/chest.09-1484
NR 29
TC 14
Z9 15
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0278-0240
EI 1875-8630
J9 DIS MARKERS
JI Dis. Markers
PY 2017
VL 2017
AR 6758721
DI 10.1155/2017/6758721
PG 6
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine; Pathology
GA FG5JB
UT WOS:000410349100001
PM 28947844
OA Green Published, Green Submitted, gold
DA 2023-08-21
ER

PT J
AU Wang, LF
   Mehta, S
   Brock, M
   Gill, SE
AF Wang, Lefeng
   Mehta, Sanjay
   Brock, Michael
   Gill, Sean E.
TI Inhibition of Murine Pulmonary Microvascular Endothelial Cell Apoptosis
   Promotes Recovery of Barrier Function under Septic Conditions
SO MEDIATORS OF INFLAMMATION
LA English
DT Article
ID NITRIC-OXIDE SYNTHASE; ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME;
   TNF-ALPHA; IN-VITRO; PLASMA ANGIOPOIETIN-2; CORNEAL ENDOTHELIUM;
   OXIDATIVE STRESS; MEDICAL PROGRESS; PROGENITOR CELLS
AB Sepsis is characterized by injury of the pulmonary microvasculature and the pulmonary microvascular endothelial cells (PMVEC), leading to barrier dysfunction and acute respiratory distress syndrome (ARDS). Our recent work identified a strong correlation between PMVEC apoptosis and microvascular leak in septic mice in vivo, but the specific role of apoptosis in septic PMVEC barrier dysfunction remains unclear. Thus, we hypothesize that PMVEC apoptosis is likely required for PMVEC barrier dysfunction under septic conditions in vitro. Septic stimulation (mixture of tumour necrosis factor alpha, interleukin 1 beta, and interferon gamma [cytomix]) of isolated murine PMVEC resulted in a significant loss of barrier function as early as 4 h after stimulation, which persisted until 24 h. PMVEC apoptosis, as reflected by caspase activation, DNA fragmentation, and loss of membrane polarity, was first apparent at 8 h after cytomix. Pretreatment of PMVEC with the pan-caspase inhibitor Q-VD significantly decreased septic PMVEC apoptosis and was associated with reestablishment of PMVEC barrier function at 16 and 24 h after stimulation but had no effect on septic PMVEC barrier dysfunction over the first 8 h. Collectively, our data suggest that early septic murine PMVEC barrier dysfunction driven by proinflammatory cytokines is not mediated through apoptosis, but PMVEC apoptosis contributes to late septic PMVEC barrier dysfunction.
C1 [Wang, Lefeng; Mehta, Sanjay; Brock, Michael; Gill, Sean E.] Lawson Hlth Res Inst, Ctr Crit Illness Res, London, ON, Canada.
   [Wang, Lefeng; Mehta, Sanjay; Gill, Sean E.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med, London, ON, Canada.
   [Mehta, Sanjay; Gill, Sean E.] Univ Western Ontario, Schulich Sch Med & Dent, Div Respirol, London, ON, Canada.
   [Brock, Michael; Gill, Sean E.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada.
C3 Western University (University of Western Ontario); Western University
   (University of Western Ontario); Western University (University of
   Western Ontario); Western University (University of Western Ontario)
RP Gill, SE (corresponding author), Lawson Hlth Res Inst, Ctr Crit Illness Res, London, ON, Canada.; Gill, SE (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Med, London, ON, Canada.; Gill, SE (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Div Respirol, London, ON, Canada.; Gill, SE (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada.
EM sgill8@uwo.ca
RI wang, le/HKN-3406-2023; Mehta, Sanjay/G-3332-2011; Gill, Sean
   E/G-4057-2012
OI Mehta, Sanjay/0000-0002-7707-1056; Brock, Michael/0000-0002-8624-8378;
   Gill, Sean/0000-0003-4791-1576
FU Ontario Thoracic Society; Lawson Health Research Institute Internal
   Research Fund; Program of Experimental Medicine; Heart & Stroke
   Foundation of Ontario/Canada [G-13-0003039]
FX The authors would like to thank the members of the Lung Research Group
   at Western University, especially Drs. Ruud Veldhuizen and Lisa Cameron,
   for helpful discussions. This work was supported by research funding
   from the Ontario Thoracic Society (S. Gill), Lawson Health Research
   Institute Internal Research Fund (S. Gill), the Program of Experimental
   Medicine (S. Gill and S. Mehta), and the Heart & Stroke Foundation of
   Ontario/Canada Grant no. G-13-0003039 (S. Mehta).
CR Abdullah Z, 2014, MOL CELL NEUROSCI, V61, P72, DOI 10.1016/j.mcn.2014.06.002
   Agrawal A, 2013, AM J RESP CRIT CARE, V187, P736, DOI 10.1164/rccm.201208-1460OC
   Lopez-Ramirez MA, 2012, J IMMUNOL, V189, P3130, DOI 10.4049/jimmunol.1103460
   Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002
   Arpino V, 2016, AM J PHYSIOL-HEART C, V310, pH1455, DOI 10.1152/ajpheart.00796.2015
   Bannerman DD, 1998, J BIOL CHEM, V273, P35371, DOI 10.1074/jbc.273.52.35371
   Bechelli J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138830
   Bull TM, 2010, AM J RESP CRIT CARE, V182, P1123, DOI 10.1164/rccm.201002-0250OC
   Burnham EL, 2005, AM J RESP CRIT CARE, V172, P854, DOI 10.1164/rccm.200410-1325OC
   Calfee CS, 2012, CRIT CARE MED, V40, P1731, DOI 10.1097/CCM.0b013e3182451c87
   Cardoso FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035919
   Cines DB, 1998, BLOOD, V91, P3527
   Curley GF, 2016, CHEST, V150, P1109, DOI 10.1016/j.chest.2016.07.019
   De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC
   De Backer D, 2014, VIRULENCE, V5, P73, DOI 10.4161/viru.26482
   Dejana E, 1996, J CLIN INVEST, V98, P1949, DOI 10.1172/JCI118997
   Dente CJ, 2001, J SURG RES, V97, P85, DOI 10.1006/jsre.2001.6117
   Drakopanagiotakis F, 2008, EUR RESPIR J, V32, P1631, DOI 10.1183/09031936.00176807
   Edelman DA, 2006, J SURG RES, V135, P305, DOI 10.1016/j.jss.2006.06.010
   ENDO S, 1995, RES COMMUN MOL PATH, V90, P277
   Farley KS, 2006, AM J PHYSIOL-LUNG C, V290, pL1164, DOI 10.1152/ajplung.00248.2005
   Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137
   Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96
   GERRITSEN ME, 1987, BIOCHEM PHARMACOL, V36, P2701, DOI 10.1016/0006-2952(87)90252-8
   Gill SE, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0266-7
   Gill SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088501
   GLASSBERG MK, 1992, J APPL PHYSIOL, V72, P1681, DOI 10.1152/jappl.1992.72.5.1681
   Glauser MP, 2000, CRIT CARE MED, V28, pS4, DOI 10.1097/00003246-200009001-00002
   GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662, DOI 10.1002/jlb.55.5.662
   Groeneveld ABJ, 2002, VASC PHARMACOL, V39, P247, DOI 10.1016/S1537-1891(03)00013-2
   Handa O, 2008, AM J PHYSIOL-HEART C, V295, pH1712, DOI 10.1152/ajpheart.00476.2008
   Hotchkiss RS, 2002, CRIT CARE MED, V30, pS225, DOI 10.1097/00003246-200205001-00009
   Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333
   Husak Liudmila, 2010, Healthc Q, V13 Spec No, P35
   Kuckleburg CJ, 2008, THROMB HAEMOSTASIS, V99, P363, DOI 10.1160/TH07-07-0474
   LAM C, 1994, J CLIN INVEST, V94, P2077, DOI 10.1172/JCI117562
   Liu DX, 2005, BLOOD, V105, P2350, DOI 10.1182/blood-2004-05-1963
   Liu ZH, 1996, AM J PHYSIOL-CELL PH, V270, pC1595, DOI 10.1152/ajpcell.1996.270.6.C1595
   Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC
   Matsuda N, 2007, CARDIOVASC RES, V76, P132, DOI 10.1016/j.cardiores.2007.05.024
   Matsuda N, 2010, AM J PHYSIOL-HEART C, V298, pH92, DOI 10.1152/ajpheart.00069.2009
   Matsuda N, 2009, AM J RESP CRIT CARE, V179, P806, DOI 10.1164/rccm.200804-534OC
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008
   McDonnell CJ, 2016, J THROMB HAEMOST, V14, P2536, DOI 10.1111/jth.13501
   Meguro T, 2001, STROKE, V32, P561, DOI 10.1161/01.STR.32.2.561
   Mutunga M, 2001, AM J RESP CRIT CARE, V163, P195, DOI 10.1164/ajrccm.163.1.9912036
   Nuckton TJ, 2002, NEW ENGL J MED, V346, P1281, DOI 10.1056/NEJMoa012835
   Petrache I, 2003, FASEB J, V17, P407, DOI 10.1096/fj.02-0672com
   Petrache I, 2001, AM J PHYSIOL-LUNG C, V280, pL1168, DOI 10.1152/ajplung.2001.280.6.L1168
   POLUNOVSKY VA, 1994, EXP CELL RES, V214, P584, DOI 10.1006/excr.1994.1296
   Potter DR, 2008, CIRC RES, V102, P770, DOI 10.1161/CIRCRESAHA.107.160226
   Razavi HM, 2004, AM J RESP CRIT CARE, V170, P227, DOI 10.1164/rccm.200306-846OC
   Reinhart K, 2002, CRIT CARE MED, V30, pS302, DOI 10.1097/00003246-200205001-00021
   Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153
   Sagoo P, 2004, INVEST OPHTH VIS SCI, V45, P3964, DOI 10.1167/iovs.04-0439
   Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F
   Sapru A, 2015, INTENS CARE MED, V41, P470, DOI 10.1007/s00134-015-3648-x
   Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013
   Seynhaeve ALB, 2006, CELL BIOCHEM BIOPHYS, V44, P157, DOI 10.1385/CBB:44:1:157
   Shapiro NI, 2011, CRIT CARE, V15, DOI 10.1186/cc10044
   Shelton JL, 2008, MICROVASC RES, V76, P80, DOI 10.1016/j.mvr.2008.06.001
   Shelton JL, 2006, MICROVASC RES, V71, P40, DOI 10.1016/j.mvr.2005.11.003
   Shivanna M, 2010, INVEST OPHTH VIS SCI, V51, P1575, DOI 10.1167/iovs.09-4343
   Skibsted S, 2013, SHOCK, V39, P427, DOI 10.1097/SHK.0b013e3182903f0d
   Spanos A, 2010, SHOCK, V33, P387, DOI 10.1097/SHK.0b013e3181c6be04
   Subbanna S, 2013, NEUROBIOL DIS, V54, P475, DOI 10.1016/j.nbd.2013.01.022
   Terpstra ML, 2014, CRIT CARE MED, V42, P691, DOI 10.1097/01.ccm.0000435669.60811.24
   Townsley MI, 2012, COMPR PHYSIOL, V2, P675, DOI 10.1002/cphy.c100081
   Trzeciak S, 2007, ANN EMERG MED, V49, P88, DOI 10.1016/j.annemergmed.2006.08.021
   Tyml K, 2011, MICROCIRCULATION, V18, P152, DOI 10.1111/j.1549-8719.2010.00080.x
   Wagner JG, 1999, J LEUKOCYTE BIOL, V66, P10, DOI 10.1002/jlb.66.1.10
   Wagner N.-M., 2016, ANESTHESIA ANALGESIA
   Wang JH, 1997, AM J PHYSIOL-CELL PH, V272, pC1543, DOI 10.1152/ajpcell.1997.272.5.C1543
   Wang LF, 2012, SHOCK, V37, P539, DOI 10.1097/SHK.0b013e31824dcb5a
   Wang LF, 2002, AM J RESP CRIT CARE, V165, P1634, DOI 10.1164/rccm.2110017
   Wang Q, 2002, AM J RESP CRIT CARE, V166, P872, DOI 10.1164/rccm.2201007
   Ware LB, 2004, AM J RESP CRIT CARE, V170, P766, DOI 10.1164/rccm.200310-1434OC
   WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]
   Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7
   Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537
   Xu C, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12636
   Yang Y., 2015, IEEE T PARALL DISTR, P1, DOI DOI 10.18632/0NC0TARGET.3970
   Yang YM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23494
   Yoder Mervin C, 2011, Proc Am Thorac Soc, V8, P466, DOI 10.1513/pats.201101-006MW
   ZETTER BR, 1981, DIABETES, V30, P24, DOI 10.2337/diab.30.2.S24
   Zhu XJ, 2016, J SURG RES, V204, P288, DOI 10.1016/j.jss.2016.04.067
NR 87
TC 15
Z9 17
U1 0
U2 12
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0962-9351
EI 1466-1861
J9 MEDIAT INFLAMM
JI Mediat. Inflamm.
PY 2017
VL 2017
AR 3415380
DI 10.1155/2017/3415380
PG 15
WC Cell Biology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Immunology
GA EL9RX
UT WOS:000394958900001
PM 28250575
OA gold, Green Submitted, Green Published
DA 2023-08-21
ER

PT J
AU Xi, X
   Liu, Y
   Zhu, GF
   Huang, Y
   Li, K
   Wu, CT
AF Xi Xin
   Liu Yan
   Zhu Guangfa
   Huang Yan
   Li Keng
   Wu Chunting
TI Mesenchymal Stem Cells Promoted Lung Wound Repair through Hox A9 during
   Endotoxemia-Induced Acute Lung Injury
SO STEM CELLS INTERNATIONAL
LA English
DT Article
ID THERAPY; GENES
AB Objectives. Acute lung injury (ALI) is a common clinical critical disease. Stem cells transplantation is recognized as an effective way to repair injured lung tissues. The present study was designed to evaluate the effects of mesenchymal stem cells (MSCs) on repair of lung and its mechanism. Methods. MSCs carrying GFP were administrated via trachea into wild-type SD rats 4 hours later after LPS administration. The lung histological pathology and the distribution of MSCs were determined by HE staining and fluorescence microscopy, respectively. Next, differentially expressed HOX genes were screened by using real-time PCR array and abnormal expression and function of Hox A9 were analyzed in the lung and the cells. Results. MSCs promoted survival rate of ALI animals. The expression levels of multiple HOX genes had obvious changes after MSCs administration and HOX A9 gene increased by 5.94-fold after MSCs administration into ALI animals. HOX A9 was distributed in endothelial cells and epithelial cells in animal models and overexpression of Hox A9 can promote proliferation and inhibit inflammatory adhesion of MSCs. Conclusion. HoxA9 overexpression induced by MSCs may be closely linked with lung repair after endotoxin shock.
C1 [Xi Xin; Zhu Guangfa; Huang Yan; Li Keng; Wu Chunting] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Pulm & Crit Care Med, Beijing 100029, China.
   [Liu Yan; Zhu Guangfa] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Infect Dis, Beijing 100029, China.
C3 Capital Medical University; Capital Medical University
RP Zhu, GF (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Pulm & Crit Care Med, Beijing 100029, Peoples R China.; Zhu, GF (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Infect Dis, Beijing 100029, Peoples R China.
EM guangfa-zhu@yahoo.com
FU Capital Health Development Research and Special Projects of Beijing
   (Risk Factors and Prediction Score of Acute Respiratory Distress
   Syndrome after Cardiac Surgery) [SF-2016-21052]
FX This study was partly supported by a Grant (SF-2016-21052) from the
   Capital Health Development Research and Special Projects of Beijing
   (Risk Factors and Prediction Score of Acute Respiratory Distress
   Syndrome after Cardiac Surgery).
CR Banerjee ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033165
   Bein T, 2016, INTENS CARE MED, V42, P699, DOI 10.1007/s00134-016-4325-4
   Blazquez R, 2016, ACTA BIOMATER, V31, P221, DOI 10.1016/j.actbio.2015.11.057
   Bruhl T, 2004, CIRC RES, V94, P743, DOI 10.1161/01.RES.0000120861.27064.09
   Chistiakov DA, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-92
   Hrycaj SM, 2015, CELL REP, V12, P903, DOI 10.1016/j.celrep.2015.07.020
   Inamdar AC, 2013, EXP LUNG RES, V39, P315, DOI 10.3109/01902148.2013.816803
   Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106
   Lin X, 2016, GENE THER, V23, P489, DOI 10.1038/gt.2016.19
   Morgan R, 2016, CURR MOL MED, V16, P322, DOI 10.2174/1566524016666160316145715
   Pinto PB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005412
   Qin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101469
   Seifert A, 2015, WORLD J STEM CELLS, V7, P583, DOI 10.4252/wjsc.v7.i3.583
   Sun ZR, 2014, J CELL PHYSIOL, V229, P213, DOI 10.1002/jcp.24436
   Takyar S, 2016, FASEB J, V30, P1317, DOI 10.1096/fj.15-275024
   Tan YR, 2013, MOL BIOL REP, V40, P675, DOI 10.1007/s11033-012-2107-9
   van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC
   Yu SL, 2016, MOL CARCINOGEN, V55, P1915, DOI 10.1002/mc.22439
NR 18
TC 7
Z9 8
U1 0
U2 3
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-966X
EI 1687-9678
J9 STEM CELLS INT
JI Stem Cells Int.
PY 2017
VL 2017
AR 3648020
DI 10.1155/2017/3648020
PG 8
WC Cell & Tissue Engineering
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA EQ8ER
UT WOS:000398318200001
PM 28465690
OA gold, Green Published, Green Submitted
DA 2023-08-21
ER

PT J
AU Kovacs-Kasa, A
   Gorshkov, BA
   Kim, KM
   Kumar, S
   Black, SM
   Fulton, DJ
   Dimitropoulou, C
   Catravas, JD
   Verin, AD
AF Kovacs-Kasa, Anita
   Gorshkov, Boris A.
   Kim, Kyung-mi
   Kumar, Sanjiv
   Black, Stephen M.
   Fulton, David J. R.
   Dimitropoulou, Christiana
   Catravas, John D.
   Verin, Alexander D.
TI The protective role of MLCP-mediated ERM dephosphorylation in
   endotoxin-induced lung injury in vitro and in vivo
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CELL BARRIER ENHANCEMENT; PROTEIN-KINASE-C; LIGHT-CHAIN PHOSPHORYLATION;
   MYOSIN-BINDING SUBUNIT; RHO-ASSOCIATED KINASE; EZRIN/RADIXIN/MOESIN
   PROTEINS; ENDOTHELIAL-CELLS; CYTOSKELETAL REARRANGEMENT; PHOSPHATASE;
   MOESIN
AB The goal of this study was to investigate the role of MLC phosphatase (MLCP) in a LPS model of acute lung injury (ALI). We demonstrate that ectopic expression of a constitutively-active (C/A) MLCP regulatory subunit (MYPT1) attenuates the ability of LPS to increase endothelial (EC) permeability. Down-regulation of MYPT1 exacerbates LPS-induced expression of ICAM1 suggesting an anti-inflammatory role of MLCP. To determine whether MLCP contributes to LPS-induced ALI in vivo, we utilized a nanoparticle DNA delivery method to specifically target lung EC. Expression of a C/A MYPT1 reduced LPS-induced lung inflammation and vascular permeability. Further, increased expression of the CS1 beta (MLCP catalytic subunit) also reduced LPS-induced lung inflammation, whereas the inactive CS1 beta mutant increased vascular leak. We next examined the role of the cytoskeletal targets of MLCP, the ERM proteins (Ezrin/Radixin/Moesin), in mediating barrier dysfunction. LPS-induced increase in EC permeability was accompanied by PKC-mediated increase in ERM phosphorylation, which was more prominent in CS1 beta-depleted cells. Depletion of Moesin and Ezrin, but not Radixin attenuated LPS-induced increases in permeability. Further, delivery of a Moesin phospho-null mutant into murine lung endothelium attenuated LPS-induced lung inflammation and vascular leak suggesting that MLCP opposes LPS-induced ALI by mediating the dephosphorylation of Moesin and Ezrin.
C1 [Kovacs-Kasa, Anita; Gorshkov, Boris A.; Kim, Kyung-Mi; Kumar, Sanjiv; Fulton, David J.; Verin, Alexander D.] Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912, United States.
   [Black, Stephen M.] Univ Arizona, Ctr Lung Vasc Pathobiol, Phoenix, AZ, United States.
   [Dimitropoulou, Christiana; Catravas, John D.] Old Dominion Univ, Frank Reidy Ctr Bioelect, Norfolk, VA, United States.
C3 University System of Georgia; Augusta University; University of Arizona;
   Old Dominion University
RP Verin, AD (corresponding author), Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA.
EM averin@augusta.edu
OI Black, Stephen M./0000-0002-4524-6544; Verin,
   Alexander/0000-0003-0627-7185
FU NIH [HL101902]
FX The authors would like to thank Dr. M. Eto (Thomas Jefferson University,
   Philadelphia, PA) for providing C/A MYPT1 plasmid and acknowledge the
   financial support from NIH Program Project Grant HL101902.
CR Adyshev DM, 2013, AM J PHYSIOL-LUNG C, V305, P1240, DOI 10.1152/ajplung.00355.2012
   Adyshev DM, 2011, CELL SIGNAL, V23, P2086, DOI 10.1016/j.cellsig.2011.08.003
   Aggarwal S, 2014, AM J RESP CELL MOL, V50, P614, DOI 10.1165/rcmb.2013-0193OC
   Altavilla D, 2002, CARDIOVASC RES, V54, P684, DOI 10.1016/S0008-6363(02)00276-6
   Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246
   Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106
   Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055
   Bogatcheva NV, 2008, MICROVASC RES, V76, P202, DOI 10.1016/j.mvr.2008.06.003
   Bogatcheva NV, 2011, AM J RESP CELL MOL, V45, P1185, DOI 10.1165/rcmb.2011-0092OC
   Bogatcheva NV, 2009, J CELL PHYSIOL, V221, P750, DOI 10.1002/jcp.21913
   Bono P, 2005, EXP CELL RES, V308, P177, DOI 10.1016/j.yexcr.2005.04.017
   Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882
   Canals D, 2012, J BIOL CHEM, V287, P10145, DOI 10.1074/jbc.M111.306456
   Chatterjee A, 2007, AM J RESP CRIT CARE, V176, P667, DOI 10.1164/rccm.200702-291OC
   Clucas J, 2014, J CELL SCI, V127, P267, DOI 10.1242/jcs.133108
   Csortos C, 2007, AM J PHYSIOL-LUNG C, V293, pL843, DOI 10.1152/ajplung.00120.2007
   Dubois T, 2003, BIOCHEM BIOPH RES CO, V302, P186, DOI 10.1016/S0006-291X(03)00130-X
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487
   Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf
   Essler M, 2000, J IMMUNOL, V164, P6543, DOI 10.4049/jimmunol.164.12.6543
   ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993
   Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866
   Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409
   Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0
   GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311
   GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061
   Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018
   Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064
   He F, 2012, BIOCHEM BIOPH RES CO, V425, P182, DOI 10.1016/j.bbrc.2012.07.063
   Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200
   Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00
   Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x
   Ivetic A, 2002, J BIOL CHEM, V277, P2321, DOI 10.1074/jbc.M109460200
   Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775
   Joshi AD, 2014, AM J RESP CELL MOL, V50, P170, DOI 10.1165/rcmb.2012-0496OC
   Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200
   Kasa A, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974448
   Kasa A, 2013, MICROVASC RES, V89, P86, DOI 10.1016/j.mvr.2013.05.003
   Kim KM, 2012, J CELL PHYSIOL, V227, P1701, DOI 10.1002/jcp.22894
   Knezevic N, 2007, MOL CELL BIOL, V27, P6323, DOI 10.1128/MCB.00523-07
   Kolosova IA, 2005, CIRC RES, V97, P115, DOI 10.1161/01.RES.0000175561.55761.69
   Kolosova IA, 2008, AM J PHYSIOL-LUNG C, V294, pL319, DOI 10.1152/ajplung.00283.2007
   Koss M, 2006, J IMMUNOL, V176, P1218, DOI 10.4049/jimmunol.176.2.1218
   Lorenowicz MJ, 2007, ARTERIOSCL THROM VAS, V27, P1014, DOI 10.1161/ATVBAHA.106.132282
   Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006
   Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647
   Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090
   McClatchey AI, 2014, J CELL SCI, V127, P3199, DOI 10.1242/jcs.098343
   Mirzapolazova T, 2007, EUR RESPIR J, V30, P429, DOI 10.1183/09031936.00154206
   Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012
   Parameswaran N, 2013, IMMUNOL REV, V256, P63, DOI 10.1111/imr.12104
   Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3
   Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594
   Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565
   Ramachandran G, 2014, VIRULENCE, V5, P213, DOI 10.4161/viru.27024
   SHIMIZU H, 1994, J BIOL CHEM, V269, P30407
   Umapathy NS, 2010, VASC PHARMACOL, V52, P199, DOI 10.1016/j.vph.2009.12.008
   Umapathy NS, 2010, J CELL PHYSIOL, V223, P215, DOI 10.1002/jcp.22029
   Umapathy NS, 2012, EXP LUNG RES, V38, P223, DOI 10.3109/01902148.2012.673049
   Xu H, 2013, INFLAMMATION, V36, P216, DOI 10.1007/s10753-012-9537-3
NR 60
TC 16
Z9 18
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 15
PY 2016
VL 6
AR 39018
DI 10.1038/srep39018
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EH9KE
UT WOS:000392089400001
PM 27976727
OA Green Published, gold, Green Accepted
DA 2023-08-21
ER

PT J
AU Kelher, MR
   Banerjee, A
   Gamboni, F
   Anderson, C
   Silliman, CC
AF Kelher, Marguerite R.
   Banerjee, Anirban
   Gamboni, Fabia
   Anderson, Cameron
   Silliman, Christopher C.
TI Antibodies to major histocompatibility complex class II antigens
   directly prime neutrophils and cause acute lung injury in a two-event in
   vivo rat model
SO TRANSFUSION
LA English
DT Article
ID MHC CLASS-II; COLONY-STIMULATING FACTOR; RED-BLOOD-CELLS; HUMAN
   POLYMORPHONUCLEAR NEUTROPHILS; MICROVASCULAR ENDOTHELIAL-CELLS; HLA-DR;
   INTERFERON-GAMMA; T-CELLS; WEGENERS-GRANULOMATOSIS; RESTRICTED ANTIGEN
AB BACKGROUNDTransfusion-related acute lung injury (TRALI) is a significant cause of mortality, especially after transfusions containing antibodies to major histocompatibility complex (MHC) class II antigens. We hypothesize that a first event induces both 1) polymorphonuclear neutrophils (PMNs) to express MHC class II antigens, and 2) activation of the pulmonary endothelium, leading to PMN sequestration, so that the infusion of specific MHC class II antibodies to these antigens causes PMN-mediated acute lung injury (ALI).
   STUDY DESIGN AND METHODSRats were treated with saline (NS), endotoxin (lipopolysaccharide [LPS]), or cytokines (interferon- [IFN], macrophage colony-stimulating factor [MCSF], tumor necrosis factor- [TNF]); the PMNs were isolated; and the surface expression of the MHC class II antigen OX6 and priming by OX6 antibodies were measured by flow cytometry or priming assays.
   RESULTSA two-event model of ALI was completed with NS, LPS, or IFN/MCSF/TNF (first events) and the infusion of OX6 (second event). Compared with NS incubation, rats treated with either LPS or IFN/MCSF/TNF exhibited OX6 PMN surface expression, OX6 antibodies primed the formyl-methionyl-leucyl phenylalanine (fMLF)-activated respiratory burst, and PMN sequestration was increased. OX6 antibody infusion into LPS-incubated or IFN/MCSF/TNF-incubated rats elicited ALI, the OX6 antibody was present on the PMNs, and PMN depletion abrogated ALI.
   CONCLUSIONProinflammatory first events induce PMN MHC class II surface expression, activation of the pulmonary endothelium, and PMN sequestration such that the infusion of cognate antibodies precipitates TRALI.
C1 [Kelher, Marguerite R.; Silliman, Christopher C.] Bonfils Blood Ctr, Res Lab, 717 Yosemite St, Denver, CO 80230, United States.
   [Kelher, Marguerite R.; Banerjee, Anirban; Gamboni, Fabia; Anderson, Cameron; Silliman, Christopher C.] Univ Colorado Denver, Dept Surg, Sch Med, Aurora, CO, United States.
   [Silliman, Christopher C.] Univ Colorado Denver, Dept Pediat, Sch Med, Aurora, CO, United States.
C3 Children's Hospital Colorado; University of Colorado System; University
   of Colorado Anschutz Medical Campus; Children's Hospital Colorado;
   University of Colorado System; University of Colorado Anschutz Medical
   Campus
RP Silliman, CC (corresponding author), Bonfils Blood Ctr, Res Lab, 717 Yosemite St, Denver, CO 80230 USA.
EM christopher.silliman@ucdenver.edu
FU Bonfils Blood Center; National Heart, Lung, and Blood Institute,
   National Institutes of Health [HL59355]; National Institute of General
   Medical Sciences, National Institutes of Health [P50 GM049222]
FX These studies were supported by Bonfils Blood Center and by grant
   HL59355 from the National Heart, Lung, and Blood Institute, National
   Institutes of Health, and grant P50 GM049222 from the National Institute
   of General Medical Sciences, National Institutes of Health.
CR Abdel-Salam BKA, 2012, ALLERGOL IMMUNOPATH, V40, P81, DOI 10.1016/j.aller.2011.02.012
   Abe S, 2010, BLOOD PURIFICAT, V29, P321, DOI 10.1159/000287232
   AKIYAMA H, 1988, J NEUROSCI RES, V20, P147, DOI 10.1002/jnr.490200202
   Aysola AE, 2005, TRANSFUSION, V45, p83A
   Beauvillain C, 2007, BLOOD, V110, P2965, DOI 10.1182/blood-2006-12-063826
   Burg J, 2002, AM J PHYSIOL-LUNG C, V283, pL460, DOI 10.1152/ajplung.00249.2001
   Bux J, 2011, VOX SANG, V100, P122, DOI 10.1111/j.1423-0410.2010.01392.x
   Cao YL, 2011, J AM SOC NEPHROL, V22, P1161, DOI 10.1681/ASN.2010101058
   CHANG SC, 1990, TRANSPLANTATION, V49, P1158, DOI 10.1097/00007890-199006000-00026
   Chapman CE, 2009, TRANSFUSION, V49, P440, DOI 10.1111/j.1537-2995.2008.01948.x
   Culshaw S, 2008, IMMUNOL LETT, V118, P49, DOI 10.1016/j.imlet.2008.02.008
   Curtis BR, 2011, BLOOD, V117, P378, DOI 10.1182/blood-2010-11-317180
   Davey MS, 2014, J IMMUNOL, V193, P3704, DOI 10.4049/jimmunol.1401018
   Drifte G, 2013, CRIT CARE MED, V41, P820, DOI 10.1097/CCM.0b013e318274647d
   Eder AF, 2013, TRANSFUSION, V53, P1442, DOI 10.1111/j.1537-2995.2012.03935.x
   Eder AF, 2010, TRANSFUSION, V50, P1732, DOI 10.1111/j.1537-2995.2010.02652.x
   Eder AF, 2009, J CLIN APHERESIS, V24, P122, DOI 10.1002/jca.20198
   Fanger NA, 1997, BLOOD, V89, P4128, DOI 10.1182/blood.V89.11.4128
   Fung YL, 2009, TRANSFUS MED REV, V23, P266, DOI 10.1016/j.tmrv.2009.06.001
   Geng S, 2013, BLOOD, V121, P1690, DOI 10.1182/blood-2012-07-445197
   GOSSELIN EJ, 1993, J IMMUNOL, V151, P1482
   Hansch GM, 1999, KIDNEY INT, V55, P1811, DOI 10.1046/j.1523-1755.1999.00446.x
   Hendrickson JE, 2009, ANESTH ANALG, V108, P759, DOI 10.1213/ane.0b013e3181930a6e
   Holness L, 2004, TRANSFUS MED REV, V18, P184, DOI 10.1016/j.tmrv.2004.03.004
   IBRAHIM L, 1993, IMMUNOLOGY, V79, P119
   Iking-Konert C, 2001, KIDNEY INT, V60, P2247, DOI 10.1046/j.1523-1755.2001.00068.x
   Kao GS, 2003, TRANSFUSION, V43, P185, DOI 10.1046/j.1537-2995.2003.00285.x
   Kelher MR, 2009, BLOOD, V113, P2079, DOI 10.1182/blood-2008-09-177857
   Keller-Stanislawski B, 2010, VOX SANG, V98, P70, DOI 10.1111/j.1423-0410.2009.01232.x
   Khan SY, 2006, BLOOD, V108, P2455, DOI 10.1182/blood-2006-04-017251
   Kittur DS, 2002, J HEART LUNG TRANSPL, V21, P882, DOI 10.1016/S1053-2498(02)00407-2
   Kopko PM, 2001, TRANSFUSION, V41, P1244, DOI 10.1046/j.1537-2995.2001.41101244.x
   Lei L, 2001, J LEUKOCYTE BIOL, V70, P80
   McDouall RM, 1997, TRANSPLANTATION, V64, P1175, DOI 10.1097/00007890-199710270-00016
   MUDZINSKI SP, 1995, BLOOD, V86, P2452, DOI 10.1182/blood.V86.6.2452a.bloodjournal8662452a
   NELSON DJ, 1994, J EXP MED, V179, P203, DOI 10.1084/jem.179.1.203
   Nicolle AL, 2004, TRANSFUSION MED, V14, P225, DOI 10.1111/j.0958-7578.2004.00504.x
   Nishimura M, 2007, VOX SANG, V93, P78, DOI 10.1111/j.1423-0410.2007.00925.x
   Nishimura M, 2007, TRANSFUSION MED, V17, P129, DOI 10.1111/j.1365-3148.2006.00721.x
   Nishimura M, 2003, TRANSFUSION MED, V13, P141, DOI 10.1046/j.1365-3148.2003.00434.x
   Oehler L, 1998, J EXP MED, V187, P1019, DOI 10.1084/jem.187.7.1019
   Oliveira R, 2014, CLIN HEMORHEOL MICRO, V56, P175, DOI 10.3233/CH-131725
   POPOVSKY MA, 1985, TRANSFUSION, V25, P573, DOI 10.1046/j.1537-2995.1985.25686071434.x
   Porretti L, 2004, EUR J HAEMATOL, V73, P295, DOI 10.1111/j.1600-0609.2004.00279.x
   Radsak M, 2000, IMMUNOLOGY, V101, P521, DOI 10.1046/j.1365-2567.2000.00140.x
   Reinisch W, 2003, CLIN EXP IMMUNOL, V133, P476, DOI 10.1046/j.1365-2249.2003.02245.x
   Sachs UJH, 2011, BLOOD, V117, P669, DOI 10.1182/blood-2010-05-286146
   Salazar JC, 2003, J IMMUNOL, V171, P2660, DOI 10.4049/jimmunol.171.5.2660
   Sandilands GP, 2006, IMMUNOLOGY, V119, P562, DOI 10.1111/j.1365-2567.2006.02471.x
   Sandilands GP, 2005, IMMUNOLOGY, V114, P354, DOI 10.1111/j.1365-2567.2004.02114.x
   Silliman CC, 1998, J CLIN INVEST, V101, P1458, DOI 10.1172/JCI1841
   Silliman CC, 2003, J LEUKOCYTE BIOL, V73, P511, DOI 10.1189/jlb.0402179
   Silliman CC, 2003, TRANSFUSION, V43, P633, DOI 10.1046/j.1537-2995.2003.00385.x
   Silliman CC, 2014, BLOOD, V123, P3488, DOI 10.1182/blood-2013-10-532424
   Silliman CC, 2011, TRANSFUSION, V51, P2549, DOI 10.1111/j.1537-2995.2011.03186.x
   SPAGNOLI GC, 1995, HUM IMMUNOL, V43, P45, DOI 10.1016/0198-8859(94)00131-9
   SUDA T, 1995, LUNG, V173, P127, DOI 10.1007/BF02981472
   Tvinnereim AR, 2004, J IMMUNOL, V173, P1994, DOI 10.4049/jimmunol.173.3.1994
   Varela M, 2002, TRANSFUSION, V42, P1102, DOI 10.1046/j.1537-2995.2002.00225.x
   Vella A, 2002, INFLAMMATION, V26, P143, DOI 10.1023/A:1016514927365
   Win N, 2003, TRANSFUSION, V43, P545, DOI 10.1046/j.1537-2995.2003.00363.x
   Wyman TH, 2002, AM J PHYSIOL-CELL PH, V283, pC1592, DOI 10.1152/ajpcell.00540.2001
   Yamashiro S, 2000, BLOOD, V96, P3958, DOI 10.1182/blood.V96.12.3958.h8003958_3958_3963
   Zarco MA, 1998, HAEMATOLOGICA, V83, P573
NR 64
TC 13
Z9 14
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD DEC
PY 2016
VL 56
IS 12
BP 3004
EP 3011
DI 10.1111/trf.13817
PG 8
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA EF8KS
UT WOS:000390578300016
PM 27667662
OA Green Accepted
DA 2023-08-21
ER

PT J
AU Sun, XJ
   Zeng, H
   Kumar, A
   Belser, JA
   Maines, TR
   Tumpey, TM
AF Sun, Xiangjie
   Zeng, Hui
   Kumar, Amrita
   Belser, Jessica A.
   Maines, Taronna R.
   Tumpey, Terrence M.
TI Constitutively Expressed IFITM3 Protein in Human Endothelial Cells Poses
   an Early Infection Block to Human Influenza Viruses
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; WEST NILE VIRUS; EPITHELIAL-CELLS;
   RECEPTOR-BINDING; DENGUE VIRUS; LUNG INJURY; PATHOGENESIS; H5N1; PH;
   TRACT
AB A role for pulmonary endothelial cells in the orchestration of cytokine production and leukocyte recruitment during influenza virus infection, leading to severe lung damage, has been recently identified. As the mechanistic pathway for this ability is not fully known, we extended previous studies on influenza virus tropism in cultured human pulmonary endothelial cells. We found that a subset of avian influenza viruses, including potentially pandemic H5N1, H7N9, and H9N2 viruses, could infect human pulmonary endothelial cells (HULEC) with high efficiency compared to human H1N1 or H3N2 viruses. In HULEC, human influenza viruses were capable of binding to host cellular receptors, becoming internalized and initiating hemifusion but failing to uncoat the viral nucleocapsid and to replicate in host nuclei. Unlike numerous cell types, including epithelial cells, we found that pulmonary endothelial cells constitutively express a high level of the restriction protein IFITM3 in endosomal compartments. IFITM3 knockdown by small interfering RNA (siRNA) could partially rescue H1N1 virus infection in HULEC, suggesting IFITM3 proteins were involved in blocking human influenza virus infection in endothelial cells. In contrast, selected avian influenza viruses were able to escape IFITM3 restriction in endothelial cells, possibly by fusing in early endosomes at higher pH or by other, unknown mechanisms. Collectively, our study demonstrates that the human pulmonary endothelium possesses intrinsic immunity to human influenza viruses, in part due to the constitutive expression of IFITM3 proteins. Notably, certain avian influenza viruses have evolved to escape this restriction, possibly contributing to virus-induced pneumonia and severe lung disease in humans.
   IMPORTANCE
   Avian influenza viruses, including H5N1 and H7N9, have been associated with severe respiratory disease and fatal outcomes in humans. Although acute respiratory distress syndrome (ARDS) and progressive pulmonary endothelial damage are known to be present during severe human infections, the role of pulmonary endothelial cells in the pathogenesis of avian influenza virus infections is largely unknown. By comparing human seasonal influenza strains to avian influenza viruses, we provide greater insight into the interaction of influenza virus with human pulmonary endothelial cells. We show that human influenza virus infection is blocked during the early stages of virus entry, which is likely due to the relatively high expression of the host antiviral factors IFITMs (interferon-induced transmembrane proteins) located in membrane-bound compartments inside cells. Overall, this study provides a mechanism by which human endothelial cells limit replication of human influenza virus strains, whereas avian influenza viruses overcome these restriction factors in this cell type.
C1 [Sun, Xiangjie; Zeng, Hui; Kumar, Amrita; Belser, Jessica A.; Maines, Taronna R.; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Immunol & Pathogenesis Branch, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333, United States.
C3 Centers for Disease Control & Prevention - USA
RP Tumpey, TM (corresponding author), Ctr Dis Control & Prevent, Immunol & Pathogenesis Branch, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
EM tft9@cdc.gov
RI Sun, Xiangjie/AAP-5409-2020
FU HHS | Centers for Disease Control and Prevention (CDC)
FX This work, including the efforts of Xiangjie Sun, was funded by HHS |
   Centers for Disease Control and Prevention (CDC).
CR Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006
   Armstrong SM, 2013, VIRULENCE, V4, P537, DOI 10.4161/viru.25779
   Armstrong SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047323
   Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909
   Banerjee I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068450
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Chan MCW, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-102
   Chesarino NM, 2014, FUTURE MICROBIOL, V9, P1151, DOI [10.2217/fmb.14.65, 10.2217/FMB.14.65]
   Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048
   Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921
   Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337
   FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8
   Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016
   Gao RB, 2013, AM J PATHOL, V183, P1258, DOI 10.1016/j.ajpath.2013.06.023
   Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3
   Herold S, 2015, EUR RESPIR J, V45, P1463, DOI 10.1183/09031936.00186214
   Hickford D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-155
   Hiyoshi M, 2015, ARCH VIROL, V160, P225, DOI 10.1007/s00705-014-2270-5
   Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258
   Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861
   Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09
   Kuiken T, 2012, CURR OPIN VIROL, V2, P276, DOI 10.1016/j.coviro.2012.02.013
   Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124
   Liu Q, 2013, ACTA PHARMACOL SIN, V34, P1257, DOI 10.1038/aps.2013.121
   MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x
   MARTIN K, 1991, J VIROL, V65, P232, DOI 10.1128/JVI.65.1.232-244.1991
   MURPHY RF, 1984, J CELL BIOL, V98, P1757, DOI 10.1083/jcb.98.5.1757
   Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013
   Ocana-Macchi M, 2009, J VIROL, V83, P12947, DOI 10.1128/JVI.00468-09
   PALESE P, 2007, FIELDS VIROLOGY, P1647
   Perrone Lucy A., 2007, Infectious Disorders - Drug Targets, V7, P294, DOI 10.2174/187152607783018772
   Piantadosi CA, 2004, ANN INTERN MED, V141, P460, DOI 10.7326/0003-4819-141-6-200409210-00012
   Poovorawan Y, 2013, PATHOG GLOB HEALTH, V107, P217, DOI 10.1179/2047773213Y.0000000103
   Ramos I, 2011, J VIROL, V85, P4421, DOI 10.1128/JVI.02356-10
   Razinkov VI, 1999, BIOPHYS J, V77, P3144, DOI 10.1016/S0006-3495(99)77144-4
   Rybak SL, 1998, J CELL PHYSIOL, V176, P216, DOI 10.1002/(SICI)1097-4652(199807)176:1<216::AID-JCP23>3.0.CO;2-3
   Sakai T, 2006, J VIROL, V80, P2013, DOI 10.1128/JVI.80.4.2013-2018.2006
   Shelton H, 2013, J GEN VIROL, V94, P1220, DOI 10.1099/vir.0.050526-0
   Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X
   Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883
   Stauffer S, 2014, J VIROL, V88, P13029, DOI 10.1128/JVI.01430-14
   Sun XJ, 2007, CELL MICROBIOL, V9, P1672, DOI 10.1111/j.1462-5822.2007.00900.x
   Sun XJ, 2014, VIROLOGY, V464, P156, DOI 10.1016/j.virol.2014.07.004
   Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006
   Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015
   Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111
   Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10
   WHO, 2016, MONTHLY RISK ASSESSM
   Yeh E, 2010, CLIN INFECT DIS, V50, P391, DOI 10.1086/649875
   Zeng H, 2012, J VIROL, V86, P667, DOI 10.1128/JVI.06348-11
   Zeng H, 2011, J VIROL, V85, P686, DOI 10.1128/JVI.01568-10
NR 51
TC 28
Z9 31
U1 0
U2 15
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD DEC
PY 2016
VL 90
IS 24
BP 11157
EP 11167
DI 10.1128/JVI.01254-16
PG 11
WC Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Virology
GA EF2BL
UT WOS:000390129300016
PM 27707929
OA Green Published, Bronze
DA 2023-08-21
ER

PT J
AU Shigematsu, M
   Koga, T
   Ishimori, A
   Saeki, K
   Ishii, Y
   Taketomi, Y
   Ohba, M
   Jo-Watanabe, A
   Okuno, T
   Harada, N
   Harayama, T
   Shindou, H
   Li, JD
   Murakami, M
   Hoka, S
   Yokomizo, T
AF Shigematsu, Misako
   Koga, Tomoaki
   Ishimori, Ayako
   Saeki, Kazuko
   Ishii, Yumiko
   Taketomi, Yoshitaka
   Ohba, Mai
   Jo-Watanabe, Airi
   Okuno, Toshiaki
   Harada, Norihiro
   Harayama, Takeshi
   Shindou, Hideo
   Li, Jian-Dong
   Murakami, Makoto
   Hoka, Sumio
   Yokomizo, Takehiko
TI Leukotriene B-4 receptor type 2 protects against pneumolysin-dependent
   acute lung injury
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NONSTEROIDAL ANTIINFLAMMATORY DRUGS; STREPTOCOCCUS-PNEUMONIAE;
   12-HYDROXYHEPTADECATRIENOIC ACID; BLT2; INFLAMMATION;
   HYPERRESPONSIVENESS; MECHANISMS; MORTALITY; MIGRATION; GPR17
AB Although pneumococcal infection is a serious problem worldwide and has a high mortality rate, the molecular mechanisms underlying the lethality caused by pneumococcus remain elusive. Here, we show that BLT2, a G protein-coupled receptor for leukotriene B4 and 12(S)-hydroxyheptadecatrienoic acid (12-HHT), protects mice from lung injury caused by a pneumococcal toxin, pneumolysin (PLY). Intratracheal injection of PLY caused lethal acute lung injury (ALI) in BLT2-deficient mice, with evident vascular leakage and bronchoconstriction. Large amounts of cysteinyl leukotrienes (cysLTs), classically known as a slow reactive substance of anaphylaxis, were detected in PLY-treated lungs. PLY-dependent vascular leakage, bronchoconstriction, and death were markedly ameliorated by treatment with a CysLT1 receptor antagonist. Upon stimulation by PLY, mast cells produced cysLTs that activated CysLT1 expressed in vascular endothelial cells and bronchial smooth muscle cells, leading to lethal vascular leakage and bronchoconstriction. Treatment of mice with aspirin or loxoprofen inhibited the production of 12-HHT and increased the sensitivity toward PLY, which was also ameliorated by the CysLT1 antagonist. Thus, the present study identifies the molecular mechanism underlying PLY-dependent ALI and suggests the possible use of CysLT1 antagonists as a therapeutic tool to protect against ALI caused by pneumococcal infection.
C1 [Shigematsu, Misako; Koga, Tomoaki; Saeki, Kazuko; Ohba, Mai; Jo-Watanabe, Airi; Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Sch Med, Dept Biochem, Tokyo, Japan.
   [Shigematsu, Misako; Hoka, Sumio] Kyushu Univ, Grad Sch Med Sci, Dept Anesthesiol & Crit Care Med, Fukuoka, Japan.
   [Ishimori, Ayako; Harada, Norihiro] Juntendo Univ, Sch Med, Dept Resp Med, Tokyo, Japan.
   [Ishii, Yumiko] Kyushu Univ, Chest Dis Res Inst, Grad Sch Med Sci, Fukuoka, Japan.
   [Taketomi, Yoshitaka; Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Tokyo, Japan.
   [Harayama, Takeshi; Shindou, Hideo] Natl Ctr Global Hlth & Med, Lipid Signaling Project, Tokyo, Japan.
   [Harayama, Takeshi] Univ Geneva, Dept Biochem, Geneva, Switzerland.
   [Li, Jian-Dong] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303, United States.
C3 Juntendo University; Kyushu University; Juntendo University; Kyushu
   University; Tokyo Metropolitan Institute of Medical Science; National
   Center for Global Health & Medicine - Japan; University of Geneva;
   University System of Georgia; Georgia State University
RP Yokomizo, T (corresponding author), Juntendo Univ, Sch Med, Dept Biochem, Tokyo, Japan.
EM yokomizo-tky@umin.ac.jp
RI Harada, Norihiro/N-8827-2019; Jo-watanabe, Airi/W-3308-2019; Yokomizo,
   Takehiko/P-5673-2016; Harayama, Takeshi/AAD-8852-2022
OI Harada, Norihiro/0000-0002-0962-5731; Yokomizo,
   Takehiko/0000-0002-5219-1553; Harayama, Takeshi/0000-0003-2255-4197; Li,
   Jian-Dong/0000-0002-5593-050X; Ishii, Yumiko/0000-0002-7438-3695
FU MEXT/JSPS KAKENHI [22116001, 22116002, 15H05901, 15H05904, 15H04708,
   15H06604, 25860223, 15K19032, 24590386, 15K08316, 25460374]; Naito
   Foundation; Ono Medical Research Foundation; Uehara Memorial Foundation;
   Mitsubishi Foundation; Nakatomi Foundation; Takeda Science Foundation;
   Foundation of Strategic Research Projects in Private Universities from
   the MEXT [S1311011]; Institute for Environmental and Gender-Specific
   Medicine; Grants-in-Aid for Scientific Research [15KK0320, 15K19032,
   15H04708, 15H05904, 15K08316, 24590386, 16K08596, 25860223, 16K15122,
   15H06604, 15H05897, 16H02613] Funding Source: KAKEN
FX This work was supported by MEXT/JSPS KAKENHI Grant Numbers, 22116001,
   22116002, 15H05901, 15H05904, 15H04708, 15H06604, 25860223, 15K19032,
   24590386, 15K08316, and 25460374, and grants from the Naito Foundation,
   the Ono Medical Research Foundation, the Uehara Memorial Foundation, the
   Mitsubishi Foundation, the Nakatomi Foundation and the Takeda Science
   Foundation. This study was supported in part by a Grant-in-Aid
   (S1311011) from the Foundation of Strategic Research Projects in Private
   Universities from the MEXT and a grant from the Institute for
   Environmental and Gender-Specific Medicine. We thank Dr. Atsushi
   Furuhata (Division of Biomedical Imaging Research, Juntendo University),
   Dr. Yukari Asai (Research Institute for Diseases of the Chest, Graduate
   School of Medical Sciences, Kyushu University) and the Support Center
   for Education and Research (Kyushu University) for technical supports.
CR Abdulnour REE, 2014, P NATL ACAD SCI USA, V111, P16526, DOI 10.1073/pnas.1407123111
   Austen KF, 2009, J ALLERGY CLIN IMMUN, V124, P406, DOI 10.1016/j.jaci.2009.05.046
   Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]
   Brandenburg JA, 2000, J GEN INTERN MED, V15, P638, DOI 10.1046/j.1525-1497.2000.04429.x
   Cho KJ, 2010, J IMMUNOL, V185, P6329, DOI 10.4049/jimmunol.1001213
   Cockeran R, 2002, CURR OPIN INFECT DIS, V15, P235, DOI 10.1097/00001432-200206000-00004
   Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933
   Dewi BE, 2004, J VIROL METHODS, V121, P171, DOI 10.1016/j.jviromet.2004.06.013
   ESPOSITO AL, 1984, AM REV RESPIR DIS, V130, P857
   Eum SY, 2003, AM J RESP CELL MOL, V28, P25, DOI 10.1165/rcmb.4532
   GREEN TP, 1988, J LAB CLIN MED, V111, P173
   Hamaguchi M, 2010, J CLIN BIOCHEM NUTR, V47, P138, DOI 10.3164/jcbn.10-33
   Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019
   Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262
   Hollingshead SK, 2001, CURR OPIN MICROBIOL, V4, P71, DOI 10.1016/S1369-5274(00)00167-3
   Iizuka Y, 2005, J BIOL CHEM, V280, P24816, DOI 10.1074/jbc.M413257200
   Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050
   Ishii Y., 2015, FASEB J IN PRESS, DOI [10.1096/fj.1015-279653, DOI 10.1096/FJ.1015-279653]
   Jefferies S, 2012, POSTGRAD MED J, V88, P21, DOI 10.1136/postgradmedj-2011-130217
   Jiang Y, 2007, BLOOD, V110, P3263, DOI 10.1182/blood-2007-07-100453
   Kanaoka Y, 2013, J BIOL CHEM, V288, P10967, DOI 10.1074/jbc.C113.453704
   Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408
   Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011
   Liu M, 2014, J EXP MED, V211, P1063, DOI 10.1084/jem.20132063
   Lynch KR, 1999, NATURE, V399, P789
   Maekawa A, 2010, J IMMUNOL, V185, P1846, DOI 10.4049/jimmunol.1001131
   Maekawa A, 2009, P NATL ACAD SCI USA, V106, P11685, DOI 10.1073/pnas.0905364106
   Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159
   Matsunobu T, 2013, J LIPID RES, V54, P2979, DOI 10.1194/jlr.M037754
   Messika J, 2014, J CRIT CARE, V29, P733, DOI 10.1016/j.jcrc.2014.05.021
   Musher DM, 2014, NEW ENGL J MED, V371, P1619, DOI 10.1056/NEJMra1312885
   Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329
   Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371
   Rossjohn J, 1998, J MOL BIOL, V284, P449, DOI 10.1006/jmbi.1998.2167
   RUBINS JB, 1993, INFECT IMMUN, V61, P1352, DOI 10.1128/IAI.61.4.1352-1358.1993
   Sobczak Magdalena, 2010, J Vis Exp, DOI 10.3791/2316
   STANDIFORD TJ, 1995, J IMMUNOL, V155, P1515
   Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586
   Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217
   Voiriot G, 2011, CHEST, V139, P387, DOI 10.1378/chest.09-3102
   WEISS JW, 1982, SCIENCE, V216, P196, DOI 10.1126/science.7063880
   Witzenrath M, 2006, CRIT CARE MED, V34, P1947, DOI 10.1097/01.CCM.0000220496.48295.A9
   Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421
   Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506
NR 44
TC 21
Z9 21
U1 0
U2 5
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 5
PY 2016
VL 6
AR 34560
DI 10.1038/srep34560
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DX8TN
UT WOS:000384662500001
PM 27703200
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Di, A
   Mehta, D
   Malik, AB
AF Di, Anke
   Mehta, Dolly
   Malik, Asrar B.
TI ROS-activated calcium signaling mechanisms regulating endothelial
   barrier function
SO CELL CALCIUM
LA English
DT Review
ID PROTEIN-KINASE-C; NF-KAPPA-B; INCREASED VASCULAR-PERMEABILITY;
   VON-WILLEBRAND-FACTOR; OXIDATIVE STRESS; CA2+ ENTRY; NADPH OXIDASE; TRP
   CHANNELS; HYDROGEN-PEROXIDE; ANGIOTENSIN-II
AB Increased vascular permeability is a common pathogenic feature in many inflammatory diseases. For example in acute lung injury (ALI) and its most severe form, the acute respiratory distress syndrome (ARDS), lung microvessel endothelia lose their junctional integrity resulting in leakiness of the endothelial barrier and accumulation of protein rich edema. Increased reactive oxygen species (ROS) generated by neutrophils (PMNs) and other inflammatory cells play an important role in increasing endothelial permeability. In essence, multiple inflammatory syndromes are caused by dysfunction and compromise of the barrier properties of the endothelium as a consequence of unregulated acute inflammatory response. This review focuses on the role of ROS signaling in controlling endothelial permeability with particular focus on ALI. We summarize below recent progress in defining signaling events leading to increased endothelial permeability and ALI. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Di, Anke; Mehta, Dolly; Malik, Asrar B.] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612, United States.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital
RP Malik, AB (corresponding author), Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA.
EM abmalik@uic.edu
OI Malik, Asrar/0000-0002-8205-7128
FU NIH grant [P01HL77806]
FX This work was supported by NIH grant P01HL77806.
CR Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495
   Ahmmed GU, 2005, PFLUG ARCH EUR J PHY, V451, P131, DOI 10.1007/s00424-005-1461-z
   Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053
   Barandier C, 2003, BIOCHEM BIOPH RES CO, V304, P714, DOI 10.1016/S0006-291X(03)00668-5
   BARNARD ML, 1992, J APPL PHYSIOL, V72, P1724, DOI 10.1152/jappl.1992.72.5.1724
   Bates DO, 2002, VASC PHARMACOL, V39, P225, DOI 10.1016/S1537-1891(03)00011-9
   Baumeister U, 2005, EMBO J, V24, P1686, DOI 10.1038/sj.emboj.7600647
   Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005
   Bendall JK, 2007, CIRC RES, V100, P1016, DOI 10.1161/01.RES.0000263381.83835.7b
   BIRCH KA, 1994, J CELL PHYSIOL, V160, P545, DOI 10.1002/jcp.1041600318
   Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022
   Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928
   Birukov KG, 2001, J BIOL CHEM, V276, P8567, DOI 10.1074/jbc.M005270200
   Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007
   Bogeski I, 2011, CELL CALCIUM, V50, P407, DOI 10.1016/j.ceca.2011.07.006
   Bumstock G, 2008, NEUROCHEM INT, V52, P14, DOI 10.1016/j.neuint.2007.03.007
   Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669
   Chow CW, 2003, AM J RESP CELL MOL, V29, P427, DOI 10.1165/rcmb.F278
   Cioffi DL, 2009, ANTIOXID REDOX SIGN, V11, P765, DOI [10.1089/ars.2008.2221, 10.1089/ARS.2008.2221]
   Cleator JH, 2006, BLOOD, V107, P2736, DOI 10.1182/blood-2004-07-2698
   Datla SR, 2007, ARTERIOSCL THROM VAS, V27, P2319, DOI 10.1161/ATVBAHA.107.149450
   DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160
   Dietrich A, 2008, CIRC RES, V102, P275, DOI 10.1161/CIRCRESAHA.107.170548
   Ding YF, 2011, J BIOL CHEM, V286, P31799, DOI 10.1074/jbc.M111.248344
   Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Erent A, 2007, J PHYSIOL-LONDON, V583, P195, DOI 10.1113/jphysiol.2007.132993
   Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499
   Fink K, 2008, J IMMUNOL, V180, P6911, DOI 10.4049/jimmunol.180.10.6911
   Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914
   Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s
   Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]
   Fu J, 2005, J BIOL CHEM, V280, P3178, DOI 10.1074/jbc.M410044200
   Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486
   Gianni D, 2008, MOL BIOL CELL, V19, P2984, DOI 10.1091/mbc.E08-02-0138
   Gianni D, 2010, MOL BIOL CELL, V21, P4287, DOI 10.1091/mbc.E10-08-0685
   Graham S, 2010, J BIOL CHEM, V285, P23464, DOI 10.1074/jbc.M109.093500
   Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5
   Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5
   Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152
   Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704
   Hecquet C.M., 2009, THROMB HAEMOST, V101
   Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176
   Hecquet CM, 2014, CIRC RES, V114, P469, DOI 10.1161/CIRCRESAHA.114.302414
   Hecquet CM, 2010, ADV EXP MED BIOL, V661, P155, DOI 10.1007/978-1-60761-500-2_10
   Hordijk PL, 2003, CELL BIOCHEM BIOPHYS, V38, P305, DOI 10.1385/CBB:38:3:305
   Hu G, 2008, CIRC RES, V102, pE120, DOI 10.1161/CIRCRESAHA.107.167486
   Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454
   JOHNSON A, 1989, AM J PHYSIOL, V256, pH1012, DOI 10.1152/ajpheart.1989.256.4.H1012
   Kakkar AK, 2004, CURR OPIN PHARMACOL, V4, P154, DOI 10.1016/j.coph.2004.01.003
   Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034
   Klarenbach SW, 2003, CIRC RES, V92, P272, DOI 10.1161/01.RES.0000057386.15390.A3
   Knowles H, 2013, IMMUNOL RES, V55, P241, DOI 10.1007/s12026-012-8373-8
   Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833
   Konior A, 2014, ANTIOXID REDOX SIGN, V20, P2794, DOI 10.1089/ars.2013.5607
   Konstantoulaki M, 2003, AM J PHYSIOL-LUNG C, V285, pL434, DOI 10.1152/ajplung.00075.2003
   Kuhn FJP, 2005, PFLUG ARCH EUR J PHY, V451, P212, DOI 10.1007/s00424-005-1446-y
   Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312
   LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4
   Lesur O, 1999, Can Respir J, V6, P71
   Li DY, 2013, INVEST OPHTH VIS SCI, V54, P5661, DOI 10.1167/iovs.13-12473
   Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200
   Li PF, 1999, CIRCULATION, V100, P967, DOI 10.1161/01.CIR.100.9.967
   Lin CH, 2006, J IMMUNOL, V177, P3427, DOI 10.4049/jimmunol.177.5.3427
   Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719
   LYNCH JJ, 1990, J CLIN INVEST, V85, P1991, DOI 10.1172/JCI114663
   Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68
   Massullo P, 2006, SEMIN CELL DEV BIOL, V17, P654, DOI 10.1016/j.semcdb.2006.11.006
   Matsushita K, 2005, J CELL BIOL, V170, P73, DOI 10.1083/jcb.200502031
   Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544
   Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200
   Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3
   Ming XF, 2004, CIRCULATION, V110, P3708, DOI 10.1161/01.CIR.0000142867.26182.32
   Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0
   Moskovitz J, 2002, ARCH BIOCHEM BIOPHYS, V397, P354, DOI 10.1006/abbi.2001.2692
   Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551
   O'Donnell RW, 2003, ENDOTHELIUM-J ENDOTH, V10, P291, DOI 10.1080/10623320390272280
   Panday A, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.89
   Paria BC, 2004, AM J PHYSIOL-LUNG C, V287, pL1303, DOI 10.1152/ajplung.00240.2004
   Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028
   Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200
   Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100
   Peshavariya H, 2009, N-S ARCH PHARMACOL, V380, P193, DOI 10.1007/s00210-009-0413-0
   Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354
   Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473
   Pocock TM, 2004, AM J PHYSIOL-HEART C, V286, pH1015, DOI 10.1152/ajpheart.00826.2003
   Polgar J, 2005, J THROMB HAEMOST, V3, P1590, DOI 10.1111/j.1538-7836.2005.01373.x
   Poteser M, 2006, J BIOL CHEM, V281, P13588, DOI 10.1074/jbc.M512205200
   Prins D, 2011, EMBO REP, V12, P1182, DOI 10.1038/embor.2011.173
   Putney JW, 2010, MOL INTERV, V10, P209, DOI 10.1124/mi.10.4.4
   PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6
   Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385
   Rodriguez EM, 2009, J CELL PHYSIOL, V221, P171, DOI 10.1002/jcp.21841
   Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473
   Satpathy M, 2004, EXP EYE RES, V79, P477, DOI 10.1016/j.exer.2004.06.018
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16
   Shimizu S, 2014, HANDB EXP PHARMACOL, V223, P767, DOI 10.1007/978-3-319-05161-1_3
   SiflingerBirnboim A, 1996, AM J PHYSIOL-LUNG C, V270, pL973, DOI 10.1152/ajplung.1996.270.6.L973
   SIFLINGERBIRNBOIM A, 1992, LAB INVEST, V67, P24
   Simon F, 2013, CELL SIGNAL, V25, P1614, DOI 10.1016/j.cellsig.2013.03.023
   Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200
   Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414
   Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419, DOI 10.1152/ajplung.2000.279.3.L419
   Sundivakkam PC, 2013, J BIOL CHEM, V288, P17030, DOI 10.1074/jbc.M112.411272
   Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008
   Takahashi N, 2011, CELL CALCIUM, V50, P279, DOI 10.1016/j.ceca.2011.04.006
   Takano M, 2002, AM J PHYSIOL-HEART C, V283, pH2054, DOI 10.1152/ajpheart.01001.2001
   Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787
   Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355
   Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8
   Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7
   Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347
   Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983
   Ushio-Fukai M, 2007, ANTIOXID REDOX SIGN, V9, P731, DOI 10.1089/ars.2007.1556
   WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355
   WAGNER DD, 1993, THROMB HAEMOSTASIS, V70, P105
   Wang G, 2006, HYPERTENSION, V48, P482, DOI 10.1161/01.HYP.0000236647.55200.07
   Wang Q, 2000, J IMMUNOL, V164, P6487, DOI 10.4049/jimmunol.164.12.6487
   Wang Q, 2002, ANTIOXID REDOX SIGN, V4, P39, DOI 10.1089/152308602753625843
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Weber EW, 2015, J EXP MED, V212, P1883, DOI 10.1084/jem.20150353
   Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200
   WEIBEL ER, 1964, J CELL BIOL, V23, P101, DOI 10.1083/jcb.23.1.101
   Weissmann N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1660
   Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012
   Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725
   Xue JP, 2009, PHYSIOL GENOMICS, V38, P42, DOI 10.1152/physiolgenomics.00012.2009
   Yamamoto S, 2010, PROG BIOPHYS MOL BIO, V103, P18, DOI 10.1016/j.pbiomolbio.2010.05.005
   Yao XQ, 2005, CIRC RES, V97, P853, DOI 10.1161/01.RES.0000187473.85419.3e
   Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198
   ZANG Q, 1995, CELL GROWTH DIFFER, V6, P1367
   Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200
   Zhang WY, 2006, AM J PHYSIOL-CELL PH, V290, pC1146, DOI 10.1152/ajpcell.00205.2005
   Zheng HZ, 2003, BURNS, V29, P820, DOI 10.1016/j.burns.2003.08.004
   Zupancic G, 2002, J PHYSIOL-LONDON, V544, P741, DOI 10.1113/jphysiol.2002.027490
NR 137
TC 57
Z9 63
U1 1
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0143-4160
EI 1532-1991
J9 CELL CALCIUM
JI Cell Calcium
PD SEP
PY 2016
VL 60
IS 3
SI SI
BP 163
EP 171
DI 10.1016/j.ceca.2016.02.002
PG 9
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA DW8YB
UT WOS:000383940300003
PM 26905827
OA Green Accepted
DA 2023-08-21
ER

PT J
AU Qi, D
   Tang, XM
   He, J
   Wang, DX
   Zhao, Y
   Deng, W
   Deng, XY
   Zhou, GQ
   Xia, J
   Zhong, X
   Pu, SL
AF Qi, Di
   Tang, Xumao
   He, Jing
   Wang, Daoxin
   Zhao, Yan
   Deng, Wang
   Deng, Xinyu
   Zhou, Guoqi
   Xia, Jing
   Zhong, Xi
   Pu, Shenglan
TI Omentin protects against LPS-induced ARDS through suppressing pulmonary
   inflammation and promoting endothelial barrier via an Akt/eNOS-dependent
   mechanism
SO CELL DEATH & DISEASE
LA English
DT Article
ID ACUTE LUNG INJURY; SYSTEMIC INFLAMMATION; METABOLIC SYNDROME; SERUM
   OMENTIN-1; OBESITY; ADIPOKINES; KINASE; CELLS; FAT; ADIPOCYTOKINE
AB Acute respiratory distress syndrome (ARDS) is characterized by increased pulmonary inflammation and endothelial barrier permeability. Omentin has been shown to benefit obesity-related systemic vascular diseases; however, its effects on ARDS are unknown. In the present study, the level of circulating omentin in patients with ARDS was assessed to appraise its clinical significance in ARDS. Mice were subjected to systemic administration of adenoviral vector expressing omentin (Ad-omentin) and one-shot treatment of recombinant human omentin (rh-omentin) to examine omentin's effects on lipopolysaccharide (LPS)-induced ARDS. Pulmonary endothelial cells (ECs) were treated with rh-omentin to further investigate its underlying mechanism. We found that a decreased level of circulating omentin negatively correlated with white blood cells and procalcitonin in patients with ARDS. Ad-omentin protected against LPS-induced ARDS by alleviating the pulmonary inflammatory response and endothelial barrier injury in mice, accompanied by Akt/eNOS pathway activation. Treatment of pulmonary ECs with rh-omentin attenuated inflammatory response and restored adherens junctions (AJs), and cytoskeleton organization promoted endothelial barrier after LPS insult. Moreover, the omentin-mediated enhancement of EC survival and differentiation was blocked by the Akt/eNOS pathway inactivation. Therapeutic rh-omentin treatment also effectively protected against LPS-induced ARDS via the Akt/eNOS pathway. Collectively, these data indicated that omentin protects against LPS-induced ARDS by suppressing inflammation and promoting the pulmonary endothelial barrier, at least partially, through an Akt/eNOS-dependent mechanism. Therapeutic strategies aiming to restore omentin levels may be valuable for the prevention or treatment of ARDS.
C1 [Qi, Di; Tang, Xumao; He, Jing; Wang, Daoxin; Zhao, Yan; Deng, Wang; Deng, Xinyu; Zhou, Guoqi; Xia, Jing; Zhong, Xi; Pu, Shenglan] Chongqing Med Univ, Affiliated Hosp 2, Dept Resp Med, 76 L, Chongqing 400010, China.
C3 Chongqing Medical University
RP Wang, DX (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Resp Med, 76 L, Chongqing 400010, Peoples R China.
EM wangdaoxin0163@163.com
OI Wang, Daoxin/0000-0001-8327-3650; Qi, Di/0000-0002-8267-9832
FU National Natural Science Foundation of China [81270141]
FX We thank all the members of Wang's laboratory for full cooperation and
   to Zhui Li, PhD, for his generous help and valuable advice in this
   study. This study was supported by the National Natural Science
   Foundation of China (grant no. 81270141).
CR Anzueto A, 2011, THORAX, V66, P66, DOI 10.1136/thx.2010.145086
   Atkinson RL, 2014, TRENDS ENDOCRIN MET, V25, P283, DOI 10.1016/j.tem.2014.03.003
   Dias-Junior Carlos Alan, 2008, J. bras. pneumol., V34, P412, DOI 10.1590/S1806-37132008000600012
   Duan XY, 2011, AMINO ACIDS, V41, P1223, DOI 10.1007/s00726-010-0800-3
   El-Mesallamy HO, 2011, DIABETIC MED, V28, P1194, DOI 10.1111/j.1464-5491.2011.03353.x
   Fan XF, 2015, CHEST, V147, P969, DOI 10.1378/chest.14-1426
   Gando S, 2004, INFLAMMATION, V28, P237, DOI 10.1023/B:IFLA.0000049049.81688.fe
   Gong MN, 2010, THORAX, V65, P44, DOI 10.1136/thx.2009.117572
   He J, 2015, EXP CELL RES, V331, P164, DOI 10.1016/j.yexcr.2014.09.024
   Hiramatsu-Ito M, 2016, CARDIOVASC RES, V110, P107, DOI 10.1093/cvr/cvv282
   Hu GC, 2009, MICROVASC RES, V77, P21, DOI 10.1016/j.mvr.2008.10.002
   Jaikanth C, 2013, EXP CLIN ENDOCR DIAB, V121, P377, DOI 10.1055/s-0033-1345123
   Kasa A, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974448
   Kataoka Y, 2014, J AM COLL CARDIOL, V63, P2722, DOI 10.1016/j.jacc.2014.03.032
   Katsi V, 2014, HEART LUNG CIRC, V23, P802, DOI 10.1016/j.hlc.2014.03.013
   Kazama K, 2014, BIOCHEM BIOPH RES CO, V452, P142, DOI 10.1016/j.bbrc.2014.08.070
   Konter J, 2013, PULM PHARMACOL THER, V26, P427, DOI 10.1016/j.pupt.2012.03.003
   Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426
   Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200
   Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014
   Manukyan MC, 2010, SHOCK, V34, P442, DOI 10.1097/SHK.0b013e3181e14ea9
   Moreno-Navarrete JM, 2011, OBESITY, V19, P1552, DOI 10.1038/oby.2010.351
   Maruyama S, 2012, J BIOL CHEM, V287, P408, DOI 10.1074/jbc.M111.261818
   Matsuzawa Y, 2011, J ATHEROSCLER THROMB, V18, P629, DOI 10.5551/jat.7922
   Mattu HS, 2013, J ENDOCRINOL, V216, pT17, DOI 10.1530/JOE-12-0232
   Meduri GU, 2009, CHEST, V136, P1631, DOI 10.1378/chest.08-2408
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Muller-Redetzky HC, 2014, CELL TISSUE RES, V355, P657, DOI 10.1007/s00441-014-1821-0
   Ohashi K, 2014, TRENDS ENDOCRIN MET, V25, P348, DOI 10.1016/j.tem.2014.03.009
   Qi D, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0159-1
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Shah D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11362
   Shibata R, 2014, CYTOKINE GROWTH F R, V25, P483, DOI 10.1016/j.cytogfr.2014.07.005
   Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F
   Stapleton RD, 2014, CLIN CHEST MED, V35, P655, DOI 10.1016/j.ccm.2014.08.005
   Tan BK, 2010, TRENDS CARDIOVAS MED, V20, P143, DOI 10.1016/j.tcm.2010.12.002
   Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487
   Wang C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/978463
   Wang QY, 2013, ANN CLIN BIOCHEM, V50, P230, DOI 10.1177/0004563212473275
   Wu SS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/368970
   Yamawaki H, 2011, BIOCHEM BIOPH RES CO, V408, P339, DOI 10.1016/j.bbrc.2011.04.039
   Yamawaki Hideyuki, 2011, Folia Pharmacologica Japonica, V137, P131, DOI 10.1254/fpj.137.131
   Yamawaki H, 2010, BIOCHEM BIOPH RES CO, V393, P668, DOI 10.1016/j.bbrc.2010.02.053
   Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004
   Zhao LR, 2015, MOL MED REP, V11, P1859, DOI 10.3892/mmr.2014.2937
   Zhong X, 2012, BIOCHEM BIOPH RES CO, V425, P401, DOI 10.1016/j.bbrc.2012.07.110
   Zhou JY, 2014, CURR VASC PHARMACOL, V12, P136, DOI 10.2174/1570161112999140217095038
NR 48
TC 57
Z9 66
U1 1
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD SEP
PY 2016
VL 7
AR e2360
DI 10.1038/cddis.2016.265
PG 16
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA EC2QF
UT WOS:000387968100010
PM 27607575
OA gold, Green Published
DA 2023-08-21
ER

PT J
AU Yang, J
   Zhao, YF
   Zhang, P
   Li, YH
   Yang, Y
   Yang, Y
   Zhu, JJ
   Song, X
   Jiang, GN
   Fan, J
AF Yang, Jie
   Zhao, Yanfeng
   Zhang, Peng
   Li, Yuehua
   Yang, Yong
   Yang, Yang
   Zhu, Junjie
   Song, Xiao
   Jiang, Gening
   Fan, Jie
TI Hemorrhagic shock primes for lung vascular endothelial cell pyroptosis:
   role in pulmonary inflammation following LPS
SO CELL DEATH & DISEASE
LA English
DT Article
ID NLRP3 INFLAMMASOME; INTRACELLULAR LPS; MACROPHAGE DEATH;
   ENDOTOXIC-SHOCK; INNATE IMMUNITY; GASDERMIN D; CASPASE 1; ACTIVATION;
   INJURY; MECHANISMS
AB Hemorrhagic shock (HS) often renders patients more susceptible to lung injury by priming for an exaggerated response to a second infectious stimulus. Acute lung injury (ALI) is a major component of multiple organ dysfunction syndrome following HS and regularly serves as a major cause of patient mortality. The lung vascular endothelium is an active organ that has a central role in the development of ALI through synthesizing and releasing of a number of inflammatory mediators. Cell pyroptosis is a caspase-1-dependent regulated cell death, which features rapid plasma membrane rupture and release of proinflammatory intracellular contents. In this study, we demonstrated an important role of HS in priming for LPS-induced lung endothelial cell (EC) pyroptosis. We showed that LPS through TLR4 activates Nlrp3 (NACHT, LRR, and PYD domains containing protein 3) inflammasome in mouse lung vascular EC, and subsequently induces caspase-1 activation. However, HS induced release of high-mobility group box 1 (HMGB1), which acting through the receptor for advanced glycation end products initiates EC endocytosis of HMGB1, and subsequently triggers a cascade of molecular events, including cathepsin B release from ruptured lysosomes followed by pyroptosome formation and caspase-1 activation. These HS-induced events enhance LPS-induced EC pyroptosis. We further showed that lung vascular EC pyroptosis significantly exaggerates lung inflammation and injury. The present study explores a novel mechanism underlying HS-primed ALI and thus presents a potential therapeutic target for post-HS ALI.
C1 [Yang, Jie; Zhao, Yanfeng; Zhang, Peng; Yang, Yong; Yang, Yang; Zhu, Junjie; Song, Xiao; Jiang, Gening; Fan, Jie] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Thorac Surg, 507 Zhengmin Rd, Shanghai 200433, China.
   [Yang, Jie; Li, Yuehua; Yang, Yong; Fan, Jie] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213, United States.
   [Li, Yuehua; Fan, Jie] Vet Affairs Pittsburgh Healthcare Syst, Res & Dev, Pittsburgh, PA 15240, United States.
   [Fan, Jie] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219, United States.
C3 Tongji University; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); VA Pittsburgh Healthcare System;
   Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh
RP Jiang, GN; Fan, J (corresponding author), Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Thorac Surg, 507 Zhengmin Rd, Shanghai 200433, Peoples R China.; Fan, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, VAPHS, Bldg 1,1W142,151U,Univ Dr, Pittsburgh, PA 15213 USA.
EM jgnwp@aliyun.com; jif7@pitt.edu
RI LI, Yue/GRS-8071-2022; li, yueyue/IVH-9846-2023; li, yue/HSF-7296-2023
FU National Institutes of Health [HL-079669, HL-123882, HL076179]; VA Merit
   Award [1I01BX002729]; National Natural Science Foundation of China
   [81470262, 81400056]; Shanghai Rising-Star Program [14QA1403200];
   Shanghai Medical New Excellent Youth [XYQ2013115]
FX This work was supported by the National Institutes of Health Grant
   HL-079669 (JF), National Institutes of Health Grant HL-123882 (JF),
   National Institutes of Health Grant HL076179 (JF), VA Merit Award
   1I01BX002729 (JF), National Natural Science Foundation of China 81470262
   (JF), National Natural Science Foundation of China 81400056 (YZ),
   Shanghai Rising-Star Program 14QA1403200 (PZ), and Shanghai Medical New
   Excellent Youth XYQ2013115 (PZ).
CR Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751
   Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323
   Bergsbaken T, 2007, PLOS PATHOG, V3, P1570, DOI 10.1371/journal.ppat.0030161
   Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070
   Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x
   Cotter MJ, 2001, AM J PATHOL, V159, P473, DOI 10.1016/S0002-9440(10)61719-1
   Daniel TO, 2000, ANNU REV PHYSIOL, V62, P649, DOI 10.1146/annurev.physiol.62.1.649
   Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590
   Fan J, 2002, J BIOL CHEM, V277, P3404, DOI 10.1074/jbc.M110054200
   Fan J, 2007, J IMMUNOL, V178, P6573, DOI 10.4049/jimmunol.178.10.6573
   Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105
   Galluzzi L, 2016, IMMUNITY, V44, P221, DOI 10.1016/j.immuni.2016.01.020
   Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988
   He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139
   Hilbi H, 1997, INFECT IMMUN, V65, P5165, DOI 10.1128/IAI.65.12.5165-5170.1997
   HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752
   Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631
   Iivanainen E, 2003, MICROSC RES TECHNIQ, V60, P13, DOI 10.1002/jemt.10238
   Jiang RZ, 2014, J IMMUNOL, V193, P5000, DOI 10.4049/jimmunol.1303445
   Jones LJ, 1997, ANAL BIOCHEM, V251, P144, DOI 10.1006/abio.1997.2259
   Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541
   Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248
   Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558
   Kepp O, 2010, EUR J IMMUNOL, V40, P627, DOI 10.1002/eji.200940160
   Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune
   Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007
   Laubach VE, 2016, CURR OPIN ORGAN TRAN, V21, P246, DOI 10.1097/MOT.0000000000000304
   Liu YJ, 2009, J IMMUNOL, V182, P572, DOI 10.4049/jimmunol.182.1.572
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Man SM, 2016, NAT REV IMMUNOL, V16, P7, DOI 10.1038/nri.2015.7
   Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977
   Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS
   Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157
   Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x
   Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960
   Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659
   Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833
   Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514
   Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683
   Stapleton RD, 2005, CHEST, V128, P525, DOI 10.1378/chest.128.2.525
   Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154
   Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x
   Sun Q, 2013, J BIOL CHEM, V288, P15947, DOI 10.1074/jbc.M112.426791
   Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8
   Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725
   Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248
   Xiang M, 2011, J IMMUNOL, V187, P4809, DOI 10.4049/jimmunol.1102093
   Xu J, 2014, CELL DEATH DIFFER, V21, P1229, DOI 10.1038/cdd.2014.40
   Xu P, 2013, J IMMUNOL, V190, P5247, DOI 10.4049/jimmunol.1203182
   Yang DH, 2015, IMMUNITY, V43, P923, DOI 10.1016/j.immuni.2015.10.009
   Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603
NR 55
TC 86
Z9 95
U1 2
U2 27
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD SEP
PY 2016
VL 7
AR e2363
DI 10.1038/cddis.2016.274
PG 16
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA EC2QF
UT WOS:000387968100014
PM 27607578
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Bocharov, AV
   Wu, TH
   Baranova, IN
   Birukova, AA
   Sviridov, D
   Vishnyakova, TG
   Remaley, AT
   Eggerman, TL
   Patterson, AP
   Birukov, KG
AF Bocharov, Alexander V.
   Wu, Tinghuai
   Baranova, Irina N.
   Birukova, Anna A.
   Sviridov, Denis
   Vishnyakova, Tatyana G.
   Remaley, Alan T.
   Eggerman, Thomas L.
   Patterson, Amy P.
   Birukov, Konstantin G.
TI Synthetic Amphipathic Helical Peptides Targeting CD36 Attenuate
   Lipopolysaccharide-Induced Inflammation and Acute Lung Injury
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; RECEPTOR CLASS-B;
   SERUM-AMYLOID-A; MIMETIC PEPTIDE; SR-BI; BACTERIAL RECOGNITION;
   SCAVENGER RECEPTORS; CHOLESTEROL EFFLUX; WESTERN DIET
AB Synthetic amphipathic helical peptides (SAHPs) designed as apolipoprotein A-I mimetics are known to bind to class B scavenger receptors (SR-Bs), SR-BI, SR-BII, and CD36, receptors that mediate lipid transport and facilitate pathogen recognition. In this study, we evaluated SAHPs, selected for targeting human CD36, by their ability to attenuate LPS-induced inflammation, endothelial barrier dysfunction, and acute lung injury (ALI). L37pA, which targets CD36 and SR-BI equally, inhibited LPS-induced IL-8 secretion and barrier dysfunction in cultured endothelial cells while reducing lung neutrophil infiltration by 40% in a mouse model of LPS-induced ALI. A panel of 20 SAHPs was tested in HEK293 cell lines stably transfected with various SR-Bs to identify SAHPs with preferential selectivity toward CD36. Among several SAHPs targeting both SR-BI/BII and CD36 receptors, ELK-B acted predominantly through CD36. Compared with L37pA, 5A, and ELK SAHPs, ELK-B was most effective in reducing the pulmonary barrier dysfunction, neutrophil migration into the lung, and lung inflammation induced by LPS. We conclude that SAHPs with relative selectivity toward CD36 are more potent at inhibiting acute pulmonary inflammation and dysfunction. These data indicate that therapeutic strategies using SAHPs targeting CD36, but not necessarily mimicking all apolipoprotein A-I functions, may be considered a possible new treatment approach for inflammation-induced ALI and pulmonary edema.
C1 [Bocharov, Alexander V.; Baranova, Irina N.; Vishnyakova, Tatyana G.; Eggerman, Thomas L.; Patterson, Amy P.] NIH, Dept Lab Med, Ctr Clin, Bldg 9,Room 1N128,8800 Rockville Pike, Bethesda, MD 20892, United States.
   [Bocharov, Alexander V.; Remaley, Alan T.] NHLBI, Bldg 10, Bethesda, MD 20892, United States.
   [Wu, Tinghuai; Birukova, Anna A.; Birukov, Konstantin G.] Univ Chicago, Lung Injury Ctr, Chicago, IL 60637, United States.
   [Sviridov, Denis; Eggerman, Thomas L.] NIDDK, Bethesda, MD 20892, United States.
   [Patterson, Amy P.] NIH, Off Sci Policy, Off Director, Bldg 10, Bethesda, MD 20892, United States.
C3 National Institutes of Health (NIH) - USA; NIH Clinical Center (CC);
   National Institutes of Health (NIH) - USA; NIH National Heart Lung &
   Blood Institute (NHLBI); University of Chicago; National Institutes of
   Health (NIH) - USA; NIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA
RP Bocharov, AV (corresponding author), NIH, Dept Lab Med, Ctr Clin, Bldg 9,Room 1N128,8800 Rockville Pike, Bethesda, MD 20892 USA.
EM abocharov@mail.cc.nih.gov
RI Baranova, Irina/IQR-8854-2023; Birukov, Konstantin/FJB-5755-2022
FU National Institutes of Health Intramural Research Programs at the
   Clinical Center; National Institute of Diabetes, Digestive, and Kidney
   Diseases; National Institutes of Allergy and Infectious Diseases;
   National Heart, Lung, and Blood Institute; National Institutes of Health
FX This work was supported by the National Institutes of Health Intramural
   Research Programs at the Clinical Center, National Institute of
   Diabetes, Digestive, and Kidney Diseases, National Institutes of Allergy
   and Infectious Diseases, and National Heart, Lung, and Blood Institute,
   as well as by National Institutes of Health grants to the Lung Injury
   Center, The University of Chicago.
CR BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558
   Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200
   Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147
   Baranova IN, 2016, J IMMUNOL, V196, P3135, DOI 10.4049/jimmunol.1501709
   Baranova IN, 2012, J IMMUNOL, V188, P1371, DOI 10.4049/jimmunol.1100350
   Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526
   Barter Philip J, 2007, Curr Cardiol Rep, V9, P493, DOI 10.1007/BF02938394
   Barth H, 2008, J VIROL, V82, P3466, DOI 10.1128/JVI.02478-07
   Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007
   Bloedon LT, 2008, J LIPID RES, V49, P1344, DOI 10.1194/jlr.P800003-JLR200
   Bocharov AV, 2004, J BIOL CHEM, V279, P36072, DOI 10.1074/jbc.M314264200
   Buga GM, 2008, J LIPID RES, V49, P192, DOI 10.1194/jlr.M700433-JLR200
   Buga GM, 2006, J LIPID RES, V47, P2148, DOI 10.1194/jlr.M600214-JLR200
   Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200
   Cai L, 2008, J CLIN INVEST, V118, P364, DOI 10.1172/JCI31539
   Charles-Schoeman C, 2008, CLIN IMMUNOL, V127, P234, DOI 10.1016/j.clim.2008.01.016
   D'Souza W, 2010, CIRC RES, V107, P217, DOI 10.1161/CIRCRESAHA.110.216507
   Di Bartolo BA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-224
   Feng H, 2011, ARTERIOSCL THROM VAS, V31, P2543, DOI 10.1161/ATVBAHA.111.234716
   Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806
   Gao DT, 2015, METHODS MOL BIOL, V1208, P29, DOI 10.1007/978-1-4939-1441-8_3
   Gao DT, 2010, J BIOL CHEM, V285, P4447, DOI 10.1074/jbc.M109.082800
   Getz GS, 2009, CURR OPIN LIPIDOL, V20, P171, DOI 10.1097/MOL.0b013e32832ac051
   Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001
   Hoekstra M, 2010, WORLD J GASTROENTERO, V16, P5916, DOI 10.3748/wjg.v16.i47.5916
   Hu GC, 2010, CRIT CARE MED, V38, P194, DOI 10.1097/CCM.0b013e3181bc7c17
   Kerkela E, 2001, BRIT J CANCER, V84, P659, DOI 10.1054/bjoc.2000.1634
   Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011
   Kwon WY, 2012, J TRAUMA ACUTE CARE, V72, P1576, DOI 10.1097/TA.0b013e3182493ab4
   Leelahavanichkul A, 2012, J IMMUNOL, V188, P2749, DOI 10.4049/jimmunol.1003445
   LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040
   Meliton AY, 2013, AM J PHYSIOL-LUNG C, V304, pL689, DOI 10.1152/ajplung.00047.2013
   Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08
   Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061
   Navab M, 2000, J LIPID RES, V41, P1481
   Navab M, 2005, TRENDS CARDIOVAS MED, V15, P158, DOI 10.1016/j.tcm.2005.05.008
   Navab M, 2006, NAT CLIN PRACT CARD, V3, P540, DOI 10.1038/ncpcardio0661
   Nicholls SJ, 2005, CIRCULATION, V111, P1543, DOI 10.1161/01.CIR.0000159351.95399.50
   Nofer JR, 2006, J LIPID RES, V47, P794, DOI 10.1194/jlr.M500502-JLR200
   Okamura DM, 2009, J AM SOC NEPHROL, V20, P495, DOI 10.1681/ASN.2008010009
   PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607
   Puranik R, 2008, ATHEROSCLEROSIS, V196, P240, DOI 10.1016/j.atherosclerosis.2007.05.008
   Remaley AT, 2003, J LIPID RES, V44, P828, DOI 10.1194/jlr.M200475-JLR200
   Robbesyn F, 2005, ARTERIOSCL THROM VAS, V25, P1206, DOI 10.1161/01.ATV.0000164805.73558.80
   Robbesyn F, 2003, FASEB J, V17, P743, DOI 10.1096/fj.02-0240fje
   Rodrigues CD, 2008, CELL HOST MICROBE, V4, P271, DOI 10.1016/j.chom.2008.07.012
   SEGREST JP, 1992, J LIPID RES, V33, P141
   Sethi AA, 2008, J BIOL CHEM, V283, P32273, DOI 10.1074/jbc.M804461200
   Sethi AA, 2007, CURR OPIN INVEST DR, V8, P201
   Sharifov OF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064486
   Souza ACP, 2016, KIDNEY INT, V89, P809, DOI 10.1016/j.kint.2015.12.043
   Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001
   Van Lenten BJ, 2004, CIRCULATION, V110, P3252, DOI 10.1161/01.CIR.0000147232.75456.B3
   Van Lenten BJ, 2008, J LIPID RES, V49, P2302, DOI 10.1194/jlr.M800075-JLR200
   Vaziri ND, 2009, KIDNEY INT, V76, P437, DOI 10.1038/ki.2009.177
   Vishnyakova TG, 2006, P NATL ACAD SCI USA, V103, P16888, DOI 10.1073/pnas.0602126103
   Williams DL, 2000, J BIOL CHEM, V275, P18897, DOI 10.1074/jbc.M002411200
   Wu JX, 2015, ANTIOXID REDOX SIGN, V22, P308, DOI 10.1089/ars.2013.5743
   Xia P, 1999, J BIOL CHEM, V274, P33143, DOI 10.1074/jbc.274.46.33143
   Yao XL, 2011, J IMMUNOL, V186, P576, DOI 10.4049/jimmunol.1001534
NR 60
TC 24
Z9 27
U1 2
U2 12
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD JUL 15
PY 2016
VL 197
IS 2
BP 611
EP 619
DI 10.4049/jimmunol.1401028
PG 9
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA DQ8ZL
UT WOS:000379500100019
PM 27316682
OA Bronze
DA 2023-08-21
ER

PT J
AU Lee, JY
   Linge, HM
   Ochani, K
   Lin, K
   Miller, EJ
AF Lee, Ji Young
   Linge, Helena M.
   Ochani, Kanta
   Lin, Ke
   Miller, Edmund J.
TI N-Ethylmaleimide Sensitive Factor (NSF) Inhibition Prevents Vascular
   Instability following Gram-Positive Pulmonary Challenge
SO PLOS ONE
LA English
DT Article
ID WEIBEL-PALADE BODIES; ENDOTHELIAL-CELLS; ANGIOPOIETIN-2; EXOCYTOSIS;
   MORTALITY; SEPSIS; CARE
AB Background
   The Acute Respiratory Distress Syndrome (ARDS), remains a significant source of morbidity and mortality in critically ill patients. Pneumonia and sepsis are leading causes of ARDS, the pathophysiology of which includes increased pulmonary microvascular permeability and hemodynamic instability resulting in organ dysfunction. We hypothesized that N-ethylmaleimide sensitive factor (NSF) regulates exocytosis of inflammatory mediators, such as Angiopoietin-2 (Ang-2), and cytoskeletal stability by modulating myosin light chain (MLC) phosphorylation. Therefore, we challenged pulmonary cells, in vivo and in vitro, with Gram Positive bacterial cell wall components, lipoteichoic acid (LTA), and peptidoglycan (PGN) and examined the effects of NSF inhibition.
   Methods
   Mice were pre-treated with an inhibitor of NSF, TAT-NSF700 (to prevent Ang-2 release). After 30min, LTA and PGN (or saline alone) were instilled intratracheally. Pulse oximetry was assessed in awake mice prior to, and 6 hour post instillation. Post mortem, tissues were collected for studies of inflammation and Ang-2. In vitro, pulmonary endothelial cells were assessed for their responses to LTA and PGN.
   Results
   Pulmonary challenge induced signs of airspace and systemic inflammation such as changes in neutrophil counts and protein concentration in bronchoalveolar lavage fluid and tissue Ang-2 concentration, and decreased physiological parameters including oxygen saturation and pulse distention. TAT-NSF700 pre-treatment reduced LTA-PGN induced changes in lung tissue Ang-2, oxygen saturation and pulse distention. In vitro, LTA-PGN induced a rapid (<2 min) release of Ang-2, which was significantly attenuated by TAT-NSF700 or anti TLR2 antibody. Furthermore, TAT-NSF700 reduced LTA-PGN-induced MLC phosphorylation at low concentrations of 1-10 nM.
   Conclusions
   TAT-NSF700 decreased Ang-2 release, improved oxygen saturation and pulse distention following pulmonary challenge by inhibiting MLC phosphorylation, an important component of endothelial cell retraction. The data suggest that inhibition of NSF in pneumonia and sepsis may be beneficial to prevent the pulmonary microvascular and hemodynamic instability associated with ARDS.
C1 [Lee, Ji Young; Miller, Edmund J.] Elmezzi Grad Sch Mol Med, Manhasset, NY 11030, United States.
   [Linge, Helena M.; Ochani, Kanta; Lin, Ke; Miller, Edmund J.] Feinstein Inst Med Res, Ctr Heart & Lung Res, Manhasset, NY, United States.
   [Miller, Edmund J.] Hofstra North Shore LIJ Med Sch, Hempstead, NY, United States.
   [Lee, Ji Young] Univ S Alabama, Dept Pulm & Crit Care Med, Mobile, AL 36688, United States.
C3 Northwell Health; Northwell Health; Hofstra University; University of
   South Alabama
RP Lee, JY (corresponding author), Elmezzi Grad Sch Mol Med, Manhasset, NY 11030 USA.; Lee, JY (corresponding author), Univ S Alabama, Dept Pulm & Crit Care Med, Mobile, AL 36688 USA.
EM jiyounglee98@gmail.com
OI Linge, Helena/0000-0002-8919-0300; Lee, Ji Young/0000-0002-8005-2446
FU Elmezzi Graduate School of Molecular Medicine; Feinstein Institute for
   Medical Research
FX This study was supported by funds from The Elmezzi Graduate School of
   Molecular Medicine and The Feinstein Institute for Medical Research.
CR Aikawa N, 1996, Nihon Geka Gakkai Zasshi, V97, P771
   Aird WC, ROLE ENDOTHELIUM SEV, P3765
   Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359
   Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291
   Calvert JW, 2007, CIRC RES, V101, P1247, DOI 10.1161/CIRCRESAHA.107.162610
   Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685
   Friedman G, 1998, INTENS CARE MED, V24, P118, DOI 10.1007/s001340050531
   GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311
   Goel A, 2010, CIRC RES, V107, P242, DOI 10.1161/CIRCRESAHA.109.210229
   Linge HM, 2015, EXP LUNG RES, V41, P216, DOI 10.3109/01902148.2014.999174
   Linge HM, 2010, CRITICAL CARE S2, V14, pP8
   Matsushita K, 2005, MOL PHARMACOL, V67, P1137, DOI 10.1124/mol.104.004275
   Morrell CN, 2005, J PHARMACOL EXP THER, V314, P155, DOI 10.1124/jpet.104.082529
   National Institutes of Health. National Heart LaBI, 2007, NAT HEART LABI AC RE
   Oynebraten I, 2004, BLOOD, V104, P314, DOI 10.1182/blood-2003-08-2891
   Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046
   Pittoni GM, 2009, CURR OPIN ANESTHESIO, V22, P232, DOI 10.1097/ACO.0b013e328323f9a8
   Ricciuto DR, 2011, CRIT CARE MED, V39, P702, DOI 10.1097/CCM.0b013e318206d285
   Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c
   Roviezzo F, 2005, J PHARMACOL EXP THER, V314, P738, DOI 10.1124/jpet.105.086553
   Sheldon R, 1993, ROLE MYOSIN LIGHT CH, pL606
   Shen Q, 2010, MYOSIN LIGHT CHAIN K, P272
   Siner JM, 2009, SHOCK, V31, P348, DOI 10.1097/SHK.0b013e318188bd06
   SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2
   Tran Q. -K., 2006, V176, P145
   Valentijn KM, 2011, BLOOD, V117, P5033, DOI 10.1182/blood-2010-09-267492
   Valentijn KM, 2010, MULTIGRANULAR EXOCYT
   Vincent JL, 1998, J ANTIMICROB CHEMOTH, V41, P9, DOI 10.1093/jac/41.suppl_1.9
   Wu SW, 2014, PULM CIRC, V4, P110, DOI 10.1086/674879
   Yamakuchi Munekazu, 2008, V440, P203, DOI 10.1007/978-1-59745-178-9_15
   Ziegler T, 2013, J CLIN INVEST, V123, P3436, DOI 10.1172/JCI66549
   Zupancic G, 2002, J PHYSIOL-LONDON, V544, P741, DOI 10.1113/jphysiol.2002.027490
NR 32
TC 5
Z9 5
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 29
PY 2016
VL 11
IS 6
AR e0157837
DI 10.1371/journal.pone.0157837
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DQ0AM
UT WOS:000378859400021
PM 27355324
OA Green Published, gold, Green Submitted
DA 2023-08-21
ER

PT J
AU Zhang, Y
   Shan, PY
   Srivastava, A
   Jiang, G
   Zhang, XC
   Lee, PJ
AF Zhang, Yi
   Shan, Peiying
   Srivastava, Anup
   Jiang, Ge
   Zhang, Xuchen
   Lee, Patty J.
TI An Endothelial Hsp70-TLR4 Axis Limits Nox3 Expression and Protects
   Against Oxidant Injury in Lungs
SO ANTIOXIDANTS & REDOX SIGNALING
LA English
DT Article
ID NADPH OXIDASE; CUTTING EDGE; TLR4; DEFICIENCY; CELLS; ROS; FLUORESCENCE;
   DYSFUNCTION; ACTIVATION; RESISTANCE
AB Aims: Oxidants play a critical role in the pathogenesis of acute lung injury (ALI). Nox3 is a novel member of the NADPH oxidase (Nox) family of oxidant-generating enzymes, which our laboratory had previously identified to be induced in the lungs of TLR4(-/-) mice. However, the physiologic role of Nox3 induction in lungs and its precise relationship to TLR4 are unknown. Furthermore, the cell compartment involved and the signaling mechanisms of Nox3 induction are unknown. Results: We identified that Nox3 is regulated by heat shock protein 70 (Hsp70) signaling via a TLR4-Trif-signal transducer and activator of transcription 3 (Stat3) pathway and that Nox3 induction leads to increased oxidant injury and death in mice and lung endothelial cells. We generated Nox3(-/-)/TLR4(-/-) double knockout mice, endothelial-targeting lentiviral silencing constructs, and endothelial-targeted Stat3(-/-) mice to specifically demonstrate that Nox3 induction is responsible for the pro-oxidant, proapoptotic phenotype of TLR4(-/-) mice. We also show that an endothelial Hsp70-TLR4-Trif-Stat3 axis is required to suppress deleterious Nox3 induction. Innovation: To date, a physiologic role for Nox3 in oxidant-induced ALI has not been identified. In addition, we generated unique double knockout mice and endothelial-targeted lentiviral silencing constructs to specifically demonstrate the role of a TLR4 signaling pathway in regulating pro-oxidant generation. Conclusions: We identified an endothelial TLR4-Trif antioxidant pathway that leads to the inhibition of a novel NADPH oxidase, Nox3, in lungs and lung endothelial cells. We also identified the role of a TLR4 ligand, Hsp70, in suppressing Nox3 in basal and pro-oxidant conditions. These studies identify potentially new therapeutic targets in oxidant-induced ALI.
C1 [Zhang, Yi; Shan, Peiying; Srivastava, Anup; Jiang, Ge; Lee, Patty J.] Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, POB 208057, New Haven, CT 06520, United States.
   [Zhang, Xuchen] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520, United States.
   [Zhang, Xuchen] VA Connecticut Healthcare Syst, New Haven, CT, United States.
C3 Yale University; Yale University; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); VA Connecticut Healthcare System
RP Lee, PJ (corresponding author), Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, POB 208057, New Haven, CT 06520 USA.
EM patty.lee@yale.edu
RI zhang, xu/GYE-3558-2022
OI Zhang, Xuchen/0000-0002-1484-4672
FU NIH [HL 071595, HL 090660, FAMRI 82384]
FX The authors thank Dr. Tej Pandita for the Hsp70<SUP>-/-</SUP> mice, Dr.
   S. Akira for TLR4<SUP>-/-</SUP> mice, and Dr. X. Fu for endothelial
   Stat3-deficient mice (Stat3<SUP>E-/-</SUP>). P.J.L. was supported by NIH
   Grants, HL 071595, HL 090660, and FAMRI 82384.
CR Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200
   Benipal B, 2015, REDOX BIOL, V4, P321, DOI 10.1016/j.redox.2015.01.011
   Cai Hua, 2007, V139, P293
   Cantu E, 2015, J THORAC CARDIOV SUR, V149, P596, DOI 10.1016/j.jtcvs.2014.09.077
   Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8
   Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886
   Frame FM, 2010, EXP CELL RES, V316, P3161, DOI 10.1016/j.yexcr.2010.08.004
   Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694
   Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200
   Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182
   Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004
   Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077
   Konior A, 2014, ANTIOXID REDOX SIGN, V20, P2794, DOI 10.1089/ars.2013.5607
   Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028
   Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312
   Liu XY, 2015, TUMOR BIOL, V36, P1493, DOI 10.1007/s13277-014-2639-9
   Montezano AC, 2015, CAN J CARDIOL, V31, P631, DOI 10.1016/j.cjca.2015.02.008
   Morimoto H, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127647
   Paffenholz R, 2004, GENE DEV, V18, P486, DOI 10.1101/gad.1172504
   Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589
   Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354
   Qureshi ST, 2006, J IMMUNOL, V176, P4950, DOI 10.4049/jimmunol.176.8.4950
   Ruwanpura SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078095
   Rybak LP, 2012, CELL MOL LIFE SCI, V69, P2429, DOI 10.1007/s00018-012-1016-3
   Sanders YY, 2015, FREE RADICAL BIO MED, V79, P197, DOI 10.1016/j.freeradbiomed.2014.12.008
   Siner JM, 2007, FASEB J, V21, P1422, DOI 10.1096/fj.06-6661com
   Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]
   Takyar S, 2016, FASEB J, V30, P1317, DOI 10.1096/fj.15-275024
   Valente AJ, 2007, FREE RADICAL BIO MED, V43, P384, DOI 10.1016/j.freeradbiomed.2007.04.022
   Wojtala A, 2014, METHOD ENZYMOL, V542, P243, DOI 10.1016/B978-0-12-416618-9.00013-3
   Wu F, 2014, AM J PHYSIOL-LUNG C, V307, pL987, DOI 10.1152/ajplung.00063.2014
   Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834
   Zhang XC, 2004, J BIOL CHEM, V279, P10677, DOI 10.1074/jbc.M312941200
   Zhang XC, 2006, FASEB J, V20, P2156, DOI 10.1096/fj.06-5668fje
   Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139
   Zhang Y, 2014, J IMMUNOL, V192, P5296, DOI 10.4049/jimmunol.1400653
   Zhang Y, 2013, FASEB J, V27, P4041, DOI 10.1096/fj.13-231225
   Zhang Y, 2013, J IMMUNOL, V191, P1393, DOI 10.4049/jimmunol.1300052
NR 38
TC 13
Z9 17
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1523-0864
EI 1557-7716
J9 ANTIOXID REDOX SIGN
JI Antioxid. Redox Signal.
PD JUN 10
PY 2016
VL 24
IS 17
BP 991
EP 1012
DI 10.1089/ars.2015.6505
PG 22
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA DO8PO
UT WOS:000378045800003
PM 26905942
OA Green Published
DA 2023-08-21
ER

PT J
AU Millar, FR
   Summers, C
   Griffiths, MJ
   Toshner, MR
   Proudfoot, AG
AF Millar, Fraser R.
   Summers, Charlotte
   Griffiths, Mark J.
   Toshner, Mark R.
   Proudfoot, Alastair G.
TI The pulmonary endothelium in acute respiratory distress syndrome:
   insights and therapeutic opportunities
SO THORAX
LA English
DT Review
ID ACUTE LUNG INJURY; ACTIVATED PROTEIN-C; NEUTROPHIL EXTRACELLULAR TRAPS;
   ATRIAL-NATRIURETIC-PEPTIDE; ENZYME 2 ACE2; PROGENITOR CELLS; VASCULAR
   LEAK; BARRIER FUNCTION; IN-VIVO; PHENOTYPIC HETEROGENEITY
AB The pulmonary endothelium is a dynamic, metabolically active layer of squamous endothelial cells ideally placed to mediate key processes involved in lung homoeostasis. Many of these are disrupted in acute respiratory distress syndrome (ARDS), a syndrome with appreciable mortality and no effective pharmacotherapy. In this review, we consider the role of the pulmonary endothelium as a key modulator and orchestrator of ARDS, highlighting advances in our understanding of endothelial pathobiology and their implications for the development of endothelial-targeted therapeutics including cell-based therapies. We also discuss mechanisms to facilitate the translation of preclinical data into effective therapies including the application of biomarkers to phenotype patients with ARDS with a predominance of endothelial injury and emerging biotechnologies that could enhance delivery, discovery and testing of lung endothelial-specific therapeutics.
C1 [Millar, Fraser R.; Griffiths, Mark J.; Proudfoot, Alastair G.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Leukocyte Biol Sect, London, England, United Kingdom.
   [Summers, Charlotte] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge CB2 2QQ, England, United Kingdom.
   [Summers, Charlotte; Toshner, Mark R.] Papworth Hosp NHS Fdn Trust, Cambridge, England, United Kingdom.
   [Griffiths, Mark J.] NHS Fdn Trust, Royal Brompton & Harefield Hosp, NIHR Resp Biomed Res Unit, London, England, United Kingdom.
   [Proudfoot, Alastair G.] Spectrum Hlth, Frederick Meijer Heart & Vasc Inst, 100 Michigan St NE, Grand Rapids, MI 49503, United States.
C3 Imperial College London; University of Cambridge; Papworth Hospital;
   Oxford University Hospitals NHS Foundation Trust; Royal Brompton &
   Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton
   Hospital; Michigan State University; Michigan State University College
   of Human Medicine
RP Proudfoot, AG (corresponding author), Spectrum Hlth, Frederick Meijer Heart & Vasc Inst, 100 Michigan St NE, Grand Rapids, MI 49503 USA.
EM Alastair.Proudfoot@spectrumhealth.org
RI Proudfoot, Alastair/AAG-3235-2021; Summers, Charlotte/A-6973-2012
OI Summers, Charlotte/0000-0002-7269-2873; Griffiths,
   Mark/0000-0002-1615-1896; Toshner, Mark/0000-0002-3969-6143; Millar,
   Fraser/0000-0002-0740-5436
FU Wellcome Trust [WT101692MA]
FX CS is a Wellcome Trust Postdoctoral Clinical Research Training Fellow
   (WT101692MA).
CR Agrawal A, 2013, AM J RESP CRIT CARE, V187, P736, DOI 10.1164/rccm.201208-1460OC
   Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a
   Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae
   Alfieri A, 2012, CRIT CARE, V16, DOI 10.1186/cc11666
   Aman J, 2013, AM J RESP CRIT CARE, V188, P1171, DOI 10.1164/rccm.201301-0136LE
   Aman J, 2012, CIRCULATION, V126, P2728, DOI 10.1161/CIRCULATIONAHA.112.134304
   Ando K, 2013, J CELL BIOL, V202, P901, DOI 10.1083/jcb.201301115
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Azoulay E, 2002, CRIT CARE MED, V30, P781, DOI 10.1097/00003246-200204000-00010
   BACHOFEN M, 1977, AM REV RESPIR DIS, V116, P589, DOI 10.1164/arrd.1977.116.4.589
   Barry DM, 2015, DEVELOPMENT, V142, P3058, DOI 10.1242/dev.125260
   Bellingan G, 2014, LANCET RESP MED, V2, P98, DOI 10.1016/S2213-2600(13)70259-5
   Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007
   Birukova AA, 2012, AM J PHYSIOL-LUNG C, V302, pL965, DOI 10.1152/ajplung.00292.2011
   Birukova AA, 2010, AM J PHYSIOL-LUNG C, V299, pL652, DOI 10.1152/ajplung.00202.2009
   Birukova AA, 2009, NANOMED-NANOTECHNOL, V5, P30, DOI 10.1016/j.nano.2008.07.002
   Birukova AA, 2008, EXP CELL RES, V314, P3466, DOI 10.1016/j.yexcr.2008.09.003
   Boueiz A, 2009, MICROVASC RES, V77, P26, DOI 10.1016/j.mvr.2008.10.005
   Broman MT, 2007, TRENDS CARDIOVAS MED, V17, P151, DOI 10.1016/j.tcm.2007.03.004
   Burnham EL, 2005, AM J RESP CRIT CARE, V172, P854, DOI 10.1164/rccm.200410-1325OC
   Cabrera-Benitez NE, 2015, CRIT CARE MED, V43, pE551, DOI 10.1097/CCM.0000000000001280
   Calfee CS, 2015, CHEST, V147, P1539, DOI 10.1378/chest.14-2454
   Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9
   Calfee CS, 2012, CRIT CARE MED, V40, P1731, DOI 10.1097/CCM.0b013e3182451c87
   Carnevale-Schianca F, 2011, J CLIN ONCOL, V29, pE691, DOI 10.1200/JCO.2011.35.6733
   Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303
   Chambers Rachel C, 2012, Proc Am Thorac Soc, V9, P96, DOI 10.1513/pats.201201-006AW
   Chen WG, 2012, AM J PHYSIOL-LUNG C, V303, pL279, DOI 10.1152/ajplung.00361.2011
   CHOLLETMARTIN S, 1992, AM REV RESPIR DIS, V146, P990, DOI 10.1164/ajrccm/146.4.990
   Christiaans SC, 2013, AM J PHYSIOL-LUNG C, V305, pL455, DOI 10.1152/ajplung.00093.2013
   Cioffi DL, 2012, AM J PHYSIOL-LUNG C, V302, pL1067, DOI 10.1152/ajplung.00190.2011
   Collins SR, 2013, ANESTH ANALG, V117, P664, DOI 10.1213/ANE.0b013e3182975b85
   Cornet AD, 2013, J THROMB HAEMOST, V11, P894, DOI 10.1111/jth.12179
   Cornet AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090983
   Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987
   Daneshjou N, 2015, J CELL BIOL, V208, P23, DOI 10.1083/jcb.201409108
   David S, 2012, CRIT CARE MED, V40, P3034, DOI 10.1097/CCM.0b013e31825fdc31
   de Stoppelaar SF, 2014, BLOOD, V124, P3781, DOI 10.1182/blood-2014-05-573915
   Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003
   Doerschuk C M, 2000, Respir Res, V1, P136, DOI 10.1186/rr24
   DOERSCHUK CM, 1992, AM J RESP CELL MOL, V7, P140, DOI 10.1165/ajrcmb/7.2.140
   Doyle NA, 1997, J CLIN INVEST, V99, P526, DOI 10.1172/JCI119189
   Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487
   Emin MT, 2012, AM J PHYSIOL-LUNG C, V302, pL1209, DOI 10.1152/ajplung.00189.2011
   Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf
   Esch EW, 2015, NAT REV DRUG DISCOV, V14, P248, DOI 10.1038/nrd4539
   Ferrer MCC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102329
   Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351
   Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200
   Frye M, 2015, J EXP MED, V212, P2267, DOI 10.1084/jem.20150718
   Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450
   Goldenberg NM, 2015, COMPR PHYSIOL, V5, P531, DOI 10.1002/cphy.c140024
   Gong HX, 2014, J EXP MED, V211, P579, DOI 10.1084/jem.20131190
   Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200
   Gorbunov NV, 2007, ANTIOXID REDOX SIGN, V9, P483, DOI 10.1089/ars.2006.1296
   Greineder CF, 2015, FASEB J, V29, P3483, DOI 10.1096/fj.15-271213
   Griffin JH, 2015, BLOOD, V125, P2898, DOI 10.1182/blood-2015-02-355974
   Hager DN, 2015, CLIN CHEST MED, V36, P481, DOI 10.1016/j.ccm.2015.05.002
   HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831
   Hamanaka K, 2010, AM J PHYSIOL-LUNG C, V299, pL353, DOI 10.1152/ajplung.00315.2009
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012
   Horvath L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07974
   Huang FM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4595
   Huang LS, 2015, THORAX, V70, P1138, DOI 10.1136/thoraxjnl-2014-206684
   Huh D, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004249
   Huh Dongeun Dan, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS42, DOI 10.1513/AnnalsATS.201410-442MG
   HURLEY JV, 1982, ANN NY ACAD SCI, V384, P269, DOI 10.1111/j.1749-6632.1982.tb21378.x
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Itoh T, 2007, AM J PHYSIOL-LUNG C, V293, pL446, DOI 10.1152/ajplung.00412.2005
   Iwaki M, 2009, BIOCHEM BIOPH RES CO, V389, P531, DOI 10.1016/j.bbrc.2009.09.020
   Jacobson JR, 2005, AM J PHYSIOL-LUNG C, V288, pL1026, DOI 10.1152/ajplung.00354.2004
   Jia HP, 2005, J VIROL, V79, P14614, DOI 10.1128/JVI.79.23.14614-14621.2005
   Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315
   Jose RJ, 2015, J IMMUNOL, V194, P6024, DOI 10.4049/jimmunol.1500124
   Joshi AD, 2014, AM J RESP CELL MOL, V50, P170, DOI 10.1165/rcmb.2012-0496OC
   Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200
   Kangelaris KN, 2015, AM J PHYSIOL-LUNG C, V308, pL1102, DOI 10.1152/ajplung.00380.2014
   Kawasaki T, 2015, AM J RESP CELL MOL, V53, P500, DOI 10.1165/rcmb.2014-0185OC
   Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Kuck JL, 2015, AM J PHYSIOL-LUNG C, V308, pL1078, DOI 10.1152/ajplung.00015.2015
   Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039
   Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001
   Letourneau M, 2013, J NUCL MED, V54, P1789, DOI 10.2967/jnumed.112.118984
   Letsiou E, 2015, AM J PHYSIOL-LUNG C, V308, pL259, DOI 10.1152/ajplung.00323.2014
   Letsiou E, 2015, AM J RESP CELL MOL, V52, P193, DOI 10.1165/rcmb.2013-0347OC
   Li LF, 2015, SCI REP-UK, V5, DOI 10.1038/srep08895
   Lin MT, 2015, PULM CIRC, V5, P279, DOI 10.1086/680166
   Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com
   Liu KD, 2008, AM J RESP CRIT CARE, V178, P618, DOI 10.1164/rccm.200803-419OC
   Looney MR, 2014, ANNU REV PHYSIOL, V76, P431, DOI 10.1146/annurev-physiol-021113-170331
   Marshall RP, 2002, AM J RESP CRIT CARE, V166, P646, DOI 10.1164/rccm.2108086
   Mathew B, 2011, FASEB J, V25, P3388, DOI 10.1096/fj.11-183970
   McAuley DF, 2014, NEW ENGL J MED, V371, P1695, DOI 10.1056/NEJMoa1403285
   McVey M, 2012, AM J PHYSIOL-LUNG C, V303, pL364, DOI 10.1152/ajplung.00354.2011
   Mehta D, 2005, J BIOL CHEM, V280, P17320, DOI 10.1074/jbc.M411674200
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Meng FY, 2015, AM J PHYSIOL-LUNG C, V308, pL452, DOI 10.1152/ajplung.00170.2014
   Mitaka C, 1998, CHEST, V114, P223, DOI 10.1378/chest.114.1.223
   Muller HC, 2010, CRIT CARE, V14, DOI 10.1186/cc9209
   Muller HC, 2010, THORAX, V65, P1077, DOI 10.1136/thx.2010.135996
   Muller-Redetzky HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035832
   Naikawadi RP, 2012, CIRC RES, V111, P1517, DOI 10.1161/CIRCRESAHA.112.273078
   Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Natarajan V, 2013, AM J RESP CELL MOL, V49, P6, DOI 10.1165/rcmb.2012-0411TR
   Nuckton TJ, 2002, NEW ENGL J MED, V346, P1281, DOI 10.1056/NEJMoa012835
   Ormiston ML, 2010, AM J RESP CELL MOL, V43, P546, DOI 10.1165/rcmb.2009-0152OC
   Pannekoek WJ, 2014, CELL ADHES MIGR, V8, P100, DOI 10.4161/cam.27352
   Parikh SM, 2013, VIRULENCE, V4, P517, DOI 10.4161/viru.24906
   Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046
   Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691
   Perlot T, 2013, MICROBES INFECT, V15, P866, DOI 10.1016/j.micinf.2013.08.003
   Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC
   Pfeil U, 2009, AM J PHYSIOL-LUNG C, V297, pL837, DOI 10.1152/ajplung.90608.2008
   Phillipson M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001649
   Proudfoot AG, 2014, AM J RESP CRIT CARE, V189
   Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002
   RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4
   Rafat N, 2013, AM J RESP CELL MOL, V48, P399, DOI 10.1165/rcmb.2011-0132TR
   Rafii S, 2015, NAT CELL BIOL, V17, P123, DOI 10.1038/ncb3096
   Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701
   Rizzo AN, 2015, AM J PHYSIOL-LUNG C, V309, pL1294, DOI 10.1152/ajplung.00031.2015
   Rogers AJ, 2014, AM J PHYSIOL-LUNG C, V306, pL957, DOI 10.1152/ajplung.00376.2013
   ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z
   Rowlands DJ, 2011, J CLIN INVEST, V121, P1986, DOI 10.1172/JCI43839
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Sapru A, 2015, INTENS CARE MED, V41, P470, DOI 10.1007/s00134-015-3648-x
   Sayah DM, 2015, AM J RESP CRIT CARE, V191, P455, DOI 10.1164/rccm.201406-1086OC
   Sayner SL, 2011, AM J PHYSIOL-LUNG C, V300, pL667, DOI 10.1152/ajplung.00433.2010
   Schmidt EP, 2014, J BIOL CHEM, V289, P8194, DOI 10.1074/jbc.M113.539452
   Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843
   Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020
   Schmidt TT, 2013, AM J PHYSIOL-LUNG C, V305, pL291, DOI 10.1152/ajplung.00094.2013
   Schulte D, 2011, EMBO J, V30, P4157, DOI 10.1038/emboj.2011.304
   Shea BS, 2010, AM J RESP CELL MOL, V43, P662, DOI 10.1165/rcmb.2009-0345OC
   Shen JK, 2014, J CLIN INVEST, V124, P4564, DOI 10.1172/JCI74527
   Shuvaev VV, 2011, FASEB J, V25, P348, DOI 10.1096/fj.10-169789
   Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC
   Singla Sunit, 2012, Pulm Circ, V2, P397, DOI 10.4103/2045-8932.105028
   Stephens RS, 2014, AM J PHYSIOL-CELL PH, V306, pC559, DOI 10.1152/ajpcell.00375.2012
   Sugiyama MG, 2015, SCI REP-UK, V5, DOI 10.1038/srep11030
   Sukriti S, 2014, PULM CIRC, V4, P535, DOI 10.1086/677356
   Summers C, 2014, THORAX, V69, P623, DOI 10.1136/thoraxjnl-2013-204742
   Sun SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059989
   Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673
   Suratt BT, 2003, AM J RESP CRIT CARE, V168, P318, DOI 10.1164/rccm.200301-145OC
   Szczepaniak WS, 2008, TRANSL RES, V152, P213, DOI 10.1016/j.trsl.2008.09.002
   Tauseef M, 2012, J EXP MED, V209, P1953
   Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015
   Terpstra ML, 2014, CRIT CARE MED, V42, P691, DOI 10.1097/01.ccm.0000435669.60811.24
   Tian YF, 2015, J BIOL CHEM, V290, P4097, DOI 10.1074/jbc.M114.620377
   Tian YF, 2015, BBA-MOL BASIS DIS, V1852, P104, DOI 10.1016/j.bbadis.2014.10.012
   Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520
   Uhlig S, 2014, CELL PHYSIOL BIOCHEM, V34, P1, DOI 10.1159/000362980
   VANDENBROUCKE ST, 2012, CIRC RES, V111, P739, DOI DOI 10.1161/CIRCRESAHA.112.269654
   Vincent JL, 2009, CRIT CARE MED, V37, P1874, DOI 10.1097/CCM.0b013e31819fff2c
   Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100
   Wang CS, 2015, AM J RESP CELL MOL, V53, P459, DOI 10.1165/rcmb.2014-0373OC
   Wang LC, 2015, MICROVASC RES, V99, P102, DOI 10.1016/j.mvr.2015.03.007
   Wang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep11097
   Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824
   Weyrich AS, 2013, ANNU REV PHYSIOL, V75, P569, DOI 10.1146/annurev-physiol-030212-183752
   Wilson JG, 2015, LANCET RESP MED, V3, P24, DOI [10.1016/s2213-2600(14)70291-7, 10.1016/S2213-2600(14)70291-7]
   Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343
   Xing JJ, 2010, MICROVASC RES, V79, P56, DOI 10.1016/j.mvr.2009.11.006
   Yadav H, 2015, AM J PHYSIOL-LUNG C, V309, pL915, DOI 10.1152/ajplung.00266.2015
   Yamada M, 2005, THORAX, V60, P410, DOI 10.1136/thx.2004.034058
   Yang PH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07027
   Ye XF, 1999, BIOCHEM BIOPH RES CO, V259, P671, DOI 10.1006/bbrc.1999.0846
   Yiming MT, 2008, AM J RESP CELL MOL, V39, P569, DOI 10.1165/rcmb.2007-0332OC
   Yin J, 2008, CIRC RES, V102, P966, DOI 10.1161/CIRCRESAHA.107.168724
   Yin J, 2016, AM J RESP CELL MOL, V54, P370, DOI 10.1165/rcmb.2014-0225OC
   Yoder Mervin C, 2011, Proc Am Thorac Soc, V8, P466, DOI 10.1513/pats.201101-006MW
   Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499
   Zhang KJ, 2014, MOL BIOL REP, V41, P4253, DOI 10.1007/s11033-014-3296-1
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zimmerman GA, 1999, CHEST, V116, p18S, DOI 10.1378/chest.116.suppl_1.18S
   Zou Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4594
NR 181
TC 127
Z9 138
U1 1
U2 14
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0040-6376
EI 1468-3296
J9 THORAX
JI Thorax
PD MAY
PY 2016
VL 71
IS 5
BP 462
EP 473
DI 10.1136/thoraxjnl-2015-207461
PG 12
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA DK6ZR
UT WOS:000375075000013
PM 26968969
OA Bronze, Green Accepted
DA 2023-08-21
ER

PT J
AU Yi, L
   Huang, XQ
   Guo, F
   Zhou, ZD
   Dou, Y
   Huan, JN
AF Yi, Lei
   Huang, Xiaoqin
   Guo, Feng
   Zhou, Zengding
   Dou, Yi
   Huan, Jingning
TI Yes-associated protein (YAP) signaling regulates
   lipopolysaccharide-induced tissue factor expression in human endothelial
   cells
SO SURGERY
LA English
DT Article
ID ACUTE LUNG INJURY; FACTOR-ALPHA EXPRESSION; NF-KAPPA-B; HIPPO PATHWAY;
   FIBRIN DEPOSITION; MEDICAL PROGRESS; BAX EXPRESSION; SEVERE SEPSIS;
   UP-REGULATION; RHO-KINASE
AB Background. Sepsis-induced acute lung injury (ALI) is characterized by fibrin deposition, which indicates the local activation of coagulation. Tissue factor (TF), expressed in the pulmonary microvasculature, acts as a critical initiator of blood coagulation and ALI in sepsis. The molecular mechanism of lipopolysaccharide (LPS)-induced TF expression in endothelial cells (ECs), however, has not been determined. In this study, we implicate the Rho-associated protein kinase (ROCK)/Yes associated protein (YAP)/early growth response (Egr-1) signaling pathway in LPS-induced TF expression in vitro and in sepsis-induced ALI in vivo.
   Methods. Human umbilical vein ECs incubated with LPS were pretreated with or without the ROCK inhibitor Y-27632, a YAP small, interfering RNA (siRNA) and an Egr-1 siRNA. ROCK, YAP and Egr-1 signaling induced protein expression was investigated by Western blot. The LPS-induced activation of YAP was analyzed by an immunofluorescent assay. Furthermore, we intratracheally injected YAP siRNA to assess septic ALI in mice by hematoxylin and eosin staining.
   Results. I,PS rapidly induced ROCK activation and increased TF expression in ECs. LPS caused YAP shuttling into the nuclei of ECs and combined with Egr-1 via the activation of ROCK Furthermore, the I PS-mediated TF expression increase was prevented by ROCK inactivation, YAP knockdown and Egr-1 depletion, suggesting that LPS-induced TF expression is closely associated with the ROCK/YAP/Egr-1 signaling pathway in ECs. Finally, an intratracheal injection of YAP siRNA relieved lung injury in septic mice.
   Conclusion. This study not only suggests that ROCK/YAP/Egr-1 signaling regulates TF expression after stimulation with LPS in ECs, but it also indicates that LPS-induced activation of YAP signaling plays an important role in septic ALI in mice. Our findings provide a new insight into the pathogenic mechanism of TF expression, which is closely linked to septic ALI, and YAP signaling is considered to be a novel target for therapeutic intervention under septic conditions.
C1 [Yi, Lei; Huang, Xiaoqin; Guo, Feng; Zhou, Zengding; Dou, Yi; Huan, Jingning] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Burn & Plast Surg, Shanghai 230022, China.
C3 Shanghai Jiao Tong University
RP Huan, JN (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Burn & Plast Surg, Shanghai 230022, Peoples R China.
EM friendshiper@live.cn
RI Yi, Lei/AAI-6290-2020; huang, xiaoqin/HZL-4359-2023
FU National Science Foundation of China [81272094, 81471867, 81301633,
   81401590]; Doctoral Innovation Fund Projects from the Shanghai Jiao Tong
   University School of Medicine
FX This study was supported by the National Science Foundation of China
   (nos. 81272094, 81471867, 81301633, and 81401590) and the Doctoral
   Innovation Fund Projects from the Shanghai Jiao Tong University School
   of Medicine.
CR Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002
   Bannerman DD, 1998, J BIOL CHEM, V273, P35371, DOI 10.1074/jbc.273.52.35371
   Bode M, 2014, VASC PHARMACOL, V62, P57, DOI 10.1016/j.vph.2014.05.005
   Camino-Lopez S, 2007, CARDIOVASC RES, V73, P208, DOI 10.1016/j.cardiores.2006.10.017
   CAO XM, 1993, J BIOL CHEM, V268, P16949
   Carraway MS, 2003, AM J RESP CRIT CARE, V167, P1200, DOI 10.1164/rccm.200204-287OC
   Chu AJ, 2005, ARCH BIOCHEM BIOPHYS, V440, P123, DOI 10.1016/j.abb.2005.06.005
   Ding L, 2011, J BIOL CHEM, V286, P27027, DOI 10.1074/jbc.M111.235176
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Eto M, 2002, CIRCULATION, V105, P1756, DOI 10.1161/01.CIR.0000015465.73933.3B
   Farivar AS, 2005, J HEART LUNG TRANSPL, V24, P2235, DOI 10.1016/j.healun.2005.06.005
   Gando S, 1999, J TRAUMA, V47, P719, DOI 10.1097/00005373-199910000-00017
   Gordon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075483
   Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429
   Guo F, 2012, SHOCK, V37, P531, DOI 10.1097/SHK.0b013e31824caa96
   Guo F, 2012, MOL IMMUNOL, V50, P98, DOI 10.1016/j.molimm.2011.12.009
   Guo F, 2012, CYTOKINE, V57, P417, DOI 10.1016/j.cyto.2011.12.009
   Guo LW, 2015, INT J ONCOL, V46, P1444, DOI 10.3892/ijo.2015.2877
   Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z
   Hofstra JJH, 2008, CURR MED CHEM, V15, P588, DOI 10.2174/092986708783769696
   Hong WJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004573
   Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333
   Hsueh YJ, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.14
   Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB
   Idell S, 1994, New Horiz, V2, P566
   Kim J, 2010, CIRC RES, V107, P871, DOI 10.1161/CIRCRESAHA.110.221168
   Kono K, 2014, DEV BIOL, V394, P142, DOI 10.1016/j.ydbio.2014.06.023
   Letsiou E, 2015, AM J PHYSIOL-LUNG C, V308, pL259, DOI 10.1152/ajplung.00323.2014
   Levi M, 2006, SEMIN THROMB HEMOST, V32, P33, DOI 10.1055/s-2006-933338
   LEVI M, 1994, J CLIN INVEST, V93, P114, DOI 10.1172/JCI116934
   Mackman N, 2009, J THROMB HAEMOST, V7, P136, DOI 10.1111/j.1538-7836.2009.03368.x
   Mali RS, 2011, CANCER CELL, V20, P357, DOI 10.1016/j.ccr.2011.07.016
   Mana-Capelli S, 2014, MOL BIOL CELL, V25, P1676, DOI 10.1091/mbc.E13-11-0701
   Marti P, 2015, HEPATOLOGY, V62, P1497, DOI 10.1002/hep.27992
   Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005
   Mishra S, 2006, P NATL ACAD SCI USA, V103, P5191, DOI 10.1073/pnas.0600241103
   Mizumura K, 2010, INT IMMUNOPHARMACOL, V10, P1062, DOI 10.1016/j.intimp.2010.06.006
   Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112
   Moroishi T, 2015, GENE DEV, V29, P1271, DOI 10.1101/gad.262816.115
   Noma K, 2012, J CARDIOL, V60, P1, DOI 10.1016/j.jjcc.2012.03.005
   Nukuda A, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.24
   PARRY GCN, 1995, ARTERIOSCL THROM VAS, V15, P612, DOI 10.1161/01.ATV.15.5.612
   Regue L, 2013, BIOESSAYS, V35, P430, DOI 10.1002/bies.201200163
   Ruf W, 2003, CRIT CARE MED, V31, pS231, DOI 10.1097/01.CCM.0000057848.27456.04
   Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031
   Sebag SC, 2011, CURR PHARM BIOTECHNO, V12, P1481
   Simmons J, 2015, CURR OPIN ANESTHESIO, V28, P227, DOI 10.1097/ACO.0000000000000163
   Slotta JE, 2008, J INVEST MED, V56, P720, DOI 10.2310/JIM.0b013e31816c3e81
   Sun Q, 2012, INT IMMUNOPHARMACOL, V12, P88, DOI 10.1016/j.intimp.2011.10.018
   Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228
   Tasaka S, 2005, AM J RESP CELL MOL, V32, P504, DOI 10.1165/rcmb.2004-0009OC
   Tsuneki M, 2014, J BIOL CHEM, V289, P5357, DOI 10.1074/jbc.M113.529313
   Valencia-Sama I, 2015, J BIOL CHEM, V290, P16906, DOI 10.1074/jbc.M115.642363
   Vandenbroucke RE, 2011, EMBO MOL MED, V3, P367, DOI 10.1002/emmm.201100146
   Vincent JL, 2003, CRIT CARE MED, V31, pS296, DOI 10.1097/01.CCM.0000057906.89552.8F
   WADA H, 1995, BLOOD COAGUL FIBRIN, V6, pS26, DOI 10.1097/00001721-199506001-00005
   WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]
   Welty-Wolf KE, 2002, THROMB HAEMOSTASIS, V88, P17
   Welty-Wolf KE, 2001, AM J RESP CRIT CARE, V164, P1988, DOI 10.1164/ajrccm.164.10.2105027
   Welty-Wolf KE, 2006, AM J PHYSIOL-LUNG C, V290, pL21, DOI 10.1152/ajplung.00155.2005
   Welty-Wolf KE, 2001, SEMIN HEMATOL, V38, P35, DOI 10.1016/S0037-1963(01)90145-3
   Xue MM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0518-9
   Yan SF, 1998, P NATL ACAD SCI USA, V95, P8298, DOI 10.1073/pnas.95.14.8298
   Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112
   Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037
   Zagurovskaya M, 2009, ONCOGENE, V28, P1121, DOI 10.1038/onc.2008.461
   Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216
   Zhang H, 2011, APOPTOSIS, V16, P808, DOI 10.1007/s10495-011-0608-y
   Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106328
   Zhang Y, 2014, J BIOL CHEM, V289, P12876, DOI 10.1074/jbc.M113.535831
   Zhang YC, 2014, CELL SIGNAL, V26, P2504, DOI 10.1016/j.cellsig.2014.07.031
   Zhou ZD, 2015, SURGERY, V157, P590, DOI 10.1016/j.surg.2014.10.007
   Zhou ZD, 2013, SURGERY, V154, P621, DOI 10.1016/j.surg.2013.04.009
   Zhu C, 2015, ACTA BIOCH BIOPH SIN, V47, P16, DOI 10.1093/abbs/gmu110
NR 74
TC 21
Z9 23
U1 5
U2 32
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0039-6060
J9 SURGERY
JI Surgery
PD MAY
PY 2016
VL 159
IS 5
BP 1436
EP 1448
DI 10.1016/j.surg.2015.12.008
PG 13
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA DJ4WI
UT WOS:000374208400024
PM 26791271
OA hybrid
DA 2023-08-21
ER

PT J
AU Cai, YQ
   Bolte, C
   Le, T
   Goda, C
   Xu, Y
   Kalin, TV
   Kalinichenko, VV
AF Cai, Yuqi
   Bolte, Craig
   Le, Tien
   Goda, Chinmayee
   Xu, Yan
   Kalin, Tanya V.
   Kalinichenko, Vladimir V.
TI FOXF1 maintains endothelial barrier function and prevents edema after
   lung injury
SO SCIENCE SIGNALING
LA English
DT Article
ID FOXM1 TRANSCRIPTION FACTOR; FORKHEAD BOX F1;
   RESPIRATORY-DISTRESS-SYNDROME; MICE HETEROZYGOUS NULL; SPHINGOSINE
   1-PHOSPHATE; PULMONARY VASCULATURE; EPITHELIAL-CELLS; RECEPTOR S1P(1);
   GENE; EXPRESSION
AB Multiple signaling pathways, structural proteins, and transcription factors are involved in the regulation of endothelial barrier function. The forkhead protein FOXF1 is a key transcriptional regulator of embryonic lung development, and we used a conditional knockout approach to examine the role of FOXF1 in adult lung homeostasis, injury, and repair. Tamoxifen-regulated deletion of both Foxf1 alleles in endothelial cells of adult mice (Pdgfb-iCreER/Foxf1(-/-)) caused lung inflammation and edema, leading to respiratory insufficiency and death. Deletion of a single Foxf1 allele made heterozygous Pdgfb-iCreER/Foxf1(+/-) mice more susceptible to acute lung injury. FOXF1 abundance was decreased in pulmonary endothelial cells of human patients with acute lung injury. Gene expression analysis of pulmonary endothelial cells with homozygous FOXF1 deletion indicated reduced expression of genes critical for maintenance and regulation of adherens junctions. FOXF1 knockdown in vitro and in vivo disrupted adherens junctions, enhanced lung endothelial permeability, and increased the abundance of the mRNA and protein for sphingosine 1-phosphate receptor 1 (S1PR1), a key regulator of endothelial barrier function. Chromatin immunoprecipitation and luciferase reporter assays demonstrated that FOXF1 directly bound to and induced the transcriptional activity of the S1pr1 promoter. Pharmacological administration of S1P to injured Pdgfb-iCreER/Foxf1(+/-) mice restored endothelial barrier function, decreased lung edema, and improved survival. Thus, FOXF1 promotes normal lung homeostasis and repair, in part, by enhancing endothelial barrier function through activation of the S1P/S1PR1 signaling pathway.
C1 [Cai, Yuqi; Bolte, Craig; Le, Tien; Goda, Chinmayee; Xu, Yan; Kalin, Tanya V.; Kalinichenko, Vladimir V.] Cincinnati Childrens Res Fdn, Div Pulm Biol, 3333 Burnet Ave, Cincinnati, OH 45229, United States.
   [Kalin, Tanya V.; Kalinichenko, Vladimir V.] Cincinnati Childrens Res Fdn, Perinatal Inst, Cincinnati, OH 45229, United States.
C3 Cincinnati Children's Hospital Medical Center; Cincinnati Children's
   Hospital Research Foundation; Cincinnati Children's Hospital Medical
   Center; Cincinnati Children's Hospital Research Foundation
RP Kalin, TV; Kalinichenko, VV (corresponding author), Cincinnati Childrens Res Fdn, Div Pulm Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.; Kalin, TV; Kalinichenko, VV (corresponding author), Cincinnati Childrens Res Fdn, Perinatal Inst, Cincinnati, OH 45229 USA.
EM tatiana.kalin@cchmc.org; vladimir.kalinichenko@cchmc.org
RI Goda, Chinmayee/AAQ-5215-2021
OI Goda, Chinmayee/0000-0002-3718-585X; , Yan/0000-0003-2025-027X
FU NIH [HL84151, HL123490, CA142724]
FX This work was supported by NIH grants HL84151 (V.V.K.), HL123490
   (V.V.K.), and CA142724 (T.V.K.).
CR Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111
   Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632
   Balli D, 2012, ONCOGENE, V31, P3875, DOI 10.1038/onc.2011.549
   Balli D, 2013, EMBO J, V32, P231, DOI 10.1038/emboj.2012.336
   Balli D, 2011, CANCER RES, V71, P40, DOI 10.1158/0008-5472.CAN-10-2004
   Birukov KG, 2013, COMPR PHYSIOL, V3, P429, DOI 10.1002/cphy.c100066
   Cai YQ, 2013, J BIOL CHEM, V288, P22527, DOI 10.1074/jbc.M113.455089
   Camerer E, 2009, J CLIN INVEST, V119, P1871, DOI 10.1172/JCI38575
   Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427
   Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372
   Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367
   Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357
   Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200
   Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005
   Galvani S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2581
   Gurkan OU, 2011, EXP LUNG RES, V37, P575, DOI 10.3109/01902148.2011.620680
   Hoggatt AM, 2013, J BIOL CHEM, V288, P28477, DOI 10.1074/jbc.M113.478974
   Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015
   Kalin TV, 2008, AM J RESP CELL MOL, V39, P390, DOI 10.1165/rcmb.2008-0044OC
   Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105
   Kalinichenko VV, 2003, HEPATOLOGY, V37, P107, DOI 10.1053/jhep.2003.50005
   Kalinichenko VV, 2002, J BIOL CHEM, V277, P12369, DOI 10.1074/jbc.M112162200
   Kalinichenko VV, 2002, AM J PHYSIOL-LUNG C, V282, pL1253, DOI 10.1152/ajplung.00463.2001
   Kalinichenko VV, 2001, DEV BIOL, V235, P489, DOI 10.1006/dbio.2001.0322
   Kim IM, 2005, J BIOL CHEM, V280, P37908, DOI 10.1074/jbc.M506531200
   Kim IM, 2005, J BIOL CHEM, V280, P22278, DOI 10.1074/jbc.M500936200
   Krump-Konvalinkova V, 2005, ARTERIOSCL THROM VAS, V25, P546, DOI 10.1161/01.ATV.0000154360.36106.d9
   Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250
   Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905
   Mahlapuu M, 2001, DEVELOPMENT, V128, P2397
   Mahlapuu M, 2001, DEVELOPMENT, V128, P155
   Malin D, 2007, MOL CELL BIOL, V27, P2486, DOI 10.1128/MCB.01736-06
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   McVerry BJ, 2004, J CELL BIOCHEM, V92, P1075, DOI 10.1002/jcb.20088
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Pradhan A, 2016, ONCOTARGET, V7, P1912, DOI 10.18632/oncotarget.6422
   Ren XM, 2014, CIRC RES, V115, P709, DOI 10.1161/CIRCRESAHA.115.304382
   Ren XM, 2013, MOL CELL BIOL, V33, P371, DOI 10.1128/MCB.00934-12
   Ren XM, 2010, MOL CELL BIOL, V30, P5381, DOI 10.1128/MCB.00876-10
   Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804
   Shelton JL, 2006, MICROVASC RES, V71, P40, DOI 10.1016/j.mvr.2005.11.003
   Ustiyan V, 2012, DEV BIOL, V370, P198, DOI 10.1016/j.ydbio.2012.07.028
   Wang IC, 2012, MOL CELL BIOL, V32, P3838, DOI 10.1128/MCB.00355-12
   Wang IC, 2010, DEV BIOL, V347, P301, DOI 10.1016/j.ydbio.2010.08.027
   Wang IC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006609
   Wang LC, 2014, CRIT CARE MED, V42, pE189, DOI 10.1097/CCM.0000000000000097
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
NR 47
TC 59
Z9 61
U1 1
U2 5
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1945-0877
EI 1937-9145
J9 SCI SIGNAL
JI Sci. Signal.
PD APR 19
PY 2016
VL 9
IS 424
AR ra40
DI 10.1126/scisignal.aad1899
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA DJ8YS
UT WOS:000374501100003
PM 27095594
OA Bronze
DA 2023-08-21
ER

PT J
AU Sugiyama, MG
   Gamage, A
   Zyla, R
   Armstrong, SM
   Advani, S
   Advani, A
   Wang, CS
   Lee, WL
AF Sugiyama, Michael G.
   Gamage, Asela
   Zyla, Roman
   Armstrong, Susan M.
   Advani, Suzanne
   Advani, Andrew
   Wang, Changsen
   Lee, Warren L.
TI Influenza Virus Infection Induces Platelet-Endothelial Adhesion Which
   Contributes to Lung Injury
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID NEUTROPHIL EXTRACELLULAR TRAPS; ALVEOLAR EPITHELIAL-CELLS; NF-KAPPA-B;
   MICROVASCULAR ENDOTHELIUM; ACETYLSALICYLIC-ACID; IN-VIVO; INFLAMMATION;
   AGGREGATION; FIBRONECTIN; ACTIVATION
AB Lung injury after influenza infection is characterized by increased permeability of the lung microvasculature, culminating in acute respiratory failure. Platelets interact with activated endothelial cells and have been implicated in the pathogenesis of some forms of acute lung injury. Autopsy studies have revealed pulmonary microthrombi after influenza infection, and epidemiological studies suggest that influenza vaccination is protective against pulmonary thromboembolism; however, the effect of influenza infection on platelet-endothelial interactions is unclear. We demonstrate that endothelial infection with both laboratory and clinical strains of influenza virus increased the adhesion of human platelets to primary human lung microvascular endothelial cells. Platelets adhered to infected cells as well as to neighboring cells, suggesting a paracrine effect. Influenza infection caused the upregulation of von Willebrand factor and ICAM-1, but blocking these receptors did not prevent platelet-endothelial adhesion. Instead, platelet adhesion was inhibited by both RGDS peptide and a blocking antibody to platelet integrin alpha(5)beta(1), implicating endothelial fibronectin. Concordantly, lung histology from infected mice revealed viral dose-dependent colocalization of viral nucleoprotein and the endothelial marker PECAM-1, while platelet adhesion and fibronectin deposition also were observed in the lungs of influenza-infected mice. Inhibition of platelets using acetylsalicylic acid significantly improved survival, a finding confirmed using a second antiplatelet agent. Thus, influenza infection induces platelet-lung endothelial adhesion via fibronectin, contributing to mortality from acute lung injury. The inhibition of platelets may constitute a practical adjunctive strategy to the treatment of severe infections with influenza.
C1 [Sugiyama, Michael G.; Gamage, Asela; Zyla, Roman; Armstrong, Susan M.; Advani, Suzanne; Advani, Andrew; Wang, Changsen; Lee, Warren L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada.
   [Gamage, Asela; Armstrong, Susan M.; Lee, Warren L.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada.
   [Sugiyama, Michael G.; Lee, Warren L.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.
   [Lee, Warren L.] Univ Toronto, Div Crit Care Med, Div Resp Interdept, Toronto, ON, Canada.
C3 University of Toronto; Li Ka Shing Knowledge Institute; Saint Michaels
   Hospital Toronto; University of Toronto; University of Toronto;
   University of Toronto
RP Lee, WL (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada.; Lee, WL (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Lee, WL (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Lee, WL (corresponding author), Univ Toronto, Div Crit Care Med, Div Resp Interdept, Toronto, ON, Canada.
EM leew@smh.ca
OI Lee, Warren/0000-0002-1788-6587
FU Government of Ontario Early Researcher Award [ERA-07]; Gouvernement du
   Canada \ Canadian Institutes of Health Research (CIHR) [MOP130564, OCN
   126577]
FX Government of Ontario Early Researcher Award provided funding to Warren
   Lester Lee under grant number ERA-07. This work was funded by
   Gouvernement du Canada vertical bar Canadian Institutes of Health
   Research (CIHR) under grant MOP130564. This work was funded by
   Gouvernement du Canada vertical bar Canadian Institutes of Health
   Research (CIHR) under grant OCN 126577.
CR Adachi M, 1997, INT ARCH ALLERGY IMM, V113, P307, DOI 10.1159/000237584
   Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645
   Agarwal PP, 2009, AM J ROENTGENOL, V193, P1488, DOI 10.2214/AJR.09.3599
   Armstrong SM, 2013, ANTIVIR RES, V99, P113, DOI 10.1016/j.antiviral.2013.05.003
   Armstrong SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047323
   Azizi PM, 2015, MOL BIOL CELL, V26, P740, DOI 10.1091/mbc.E14-08-1307
   Bagamery K, 2005, CYTOM PART A, V65A, P84, DOI 10.1002/cyto.a.20133
   Szretter Kristy J, 2006, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g01s29, 10.1002/0471729256.mc15g01s3]
   Bombeli T, 1999, BLOOD, V93, P3831, DOI 10.1182/blood.V93.11.3831
   Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070
   Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013
   Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303
   Chan MCW, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-102
   Chen RH, 2000, AM J PHYSIOL-LUNG C, V279, pL161, DOI 10.1152/ajplung.2000.279.1.L161
   Cho J, 2006, J THROMB HAEMOST, V4, P1461, DOI 10.1111/j.1538-7836.2006.01943.x
   Coulombe F, 2014, IMMUNITY, V40, P554, DOI 10.1016/j.immuni.2014.02.013
   Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536
   FINE KM, 1976, AM J PATHOL, V84, P11
   Fortier ME, 2004, AM J PHYSIOL-REG I, V287, pR759, DOI 10.1152/ajpregu.00293.2004
   Getie-Kebtie M, 2013, INFLUENZA OTHER RESP, V7, P521, DOI 10.1111/irv.12001
   Grauslund M, 2007, MOL PHARMACOL, V72, P1003, DOI 10.1124/mol.107.036970
   Ito Y, 2015, AM J PHYSIOL-LUNG C, V308, pL1178, DOI 10.1152/ajplung.00290.2014
   Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025
   Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040
   Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432
   LOURIA DB, 1959, J CLIN INVEST, V38, P213, DOI 10.1172/JCI103789
   Lumadue JA, 1996, AM J CLIN PATHOL, V106, P795
   Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024
   Mazur I, 2007, CELL MICROBIOL, V9, P1683, DOI 10.1111/j.1462-5822.2007.00902.x
   McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584
   Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708
   MORI I, 1995, J GEN VIROL, V76, P2869, DOI 10.1099/0022-1317-76-11-2869
   Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013
   Nguyen JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031006
   Pan H, 2014, AM J PHYSIOL-LUNG C, V306, pL183, DOI 10.1152/ajplung.00147.2013
   Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Rondina MT, 2013, CIRC RES, V112, P1506, DOI 10.1161/CIRCRESAHA.113.300512
   Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab
   Schanzer DL, 2007, EPIDEMIOL INFECT, V135, P1109, DOI 10.1017/S0950268807007923
   Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478
   Sugiyama MG, 2015, SCI REP-UK, V5, DOI 10.1038/srep11030
   SUZUKA H, 1995, J CARDIOVASC PHARM, V25, P9, DOI 10.1097/00005344-199501000-00003
   Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618
   Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179
   TOIVANEN J, 1985, THROMB RES, V37, P493, DOI 10.1016/0049-3848(85)90095-7
   van den Boogaard FE, 2015, CRIT CARE MED, V43, pE75, DOI 10.1097/CCM.0000000000000853
   van der Vries E, 2011, CURR OPIN INFECT DIS, V24, P599, DOI 10.1097/QCO.0b013e32834cfb43
   Le VB, 2015, AM J RESP CRIT CARE, V191, P804, DOI 10.1164/rccm.201406-1031OC
   Wang CS, 2015, AM J RESP CELL MOL, V53, P459, DOI 10.1165/rcmb.2014-0373OC
   Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339
   WEIBEL ER, 1964, J CELL BIOL, V21, P367, DOI 10.1083/jcb.21.3.367
   Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499
   Zhu TN, 2009, THROMB HAEMOSTASIS, V102, P1259, DOI 10.1160/TH09-04-0222
NR 54
TC 48
Z9 52
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2016
VL 90
IS 4
BP 1812
EP 1823
DI 10.1128/JVI.02599-15
PG 12
WC Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Virology
GA DC3XL
UT WOS:000369152700010
PM 26637453
OA Green Published, Bronze
DA 2023-08-21
ER

PT J
AU Preira, P
   Forel, JM
   Robert, P
   Negre, P
   Biarnes-Pelicot, M
   Xeridat, F
   Bongrand, P
   Papazian, L
   Theodoly, O
AF Preira, Pascal
   Forel, Jean-Marie
   Robert, Philippe
   Negre, Paulin
   Biarnes-Pelicot, Martine
   Xeridat, Francois
   Bongrand, Pierre
   Papazian, Laurent
   Theodoly, Olivier
TI The leukocyte-stiffening property of plasma in early acute respiratory
   distress syndrome (ARDS) revealed by a microfluidic single-cell study:
   the role of cytokines and protection with antibodies
SO CRITICAL CARE
LA English
DT Article
ID NEUTROPHIL ELASTASE INHIBITOR; TUMOR-NECROSIS-FACTOR; LUNG INJURY;
   DEFORMABILITY; SEPSIS; ADHESION; SEQUESTRATION; EXPRESSION; SIVELESTAT;
   INCREASES
AB Background: Leukocyte-mediated pulmonary inflammation is a key pathophysiological mechanism involved in acute respiratory distress syndrome (ARDS). Massive sequestration of leukocytes in the pulmonary microvasculature is a major triggering event of the syndrome. We therefore investigated the potential role of leukocyte stiffness and adhesiveness in the sequestration of leukocytes in microvessels.
   Methods: This study was based on in vitro microfluidic assays using patient sera. Cell stiffness was assessed by measuring the entry time (ET) of a single cell into a microchannel with a 6 x 9-mu m cross-section under a constant pressure drop (Delta P = 160 Pa). Primary neutrophils and monocytes, as well as the monocytic THP-1 cell line, were used. Cellular adhesiveness to human umbilical vein endothelial cells was examined using the laminar flow chamber method. We compared the properties of cells incubated with the sera of healthy volunteers (n = 5), patients presenting with acute cardiogenic pulmonary edema (ACPE; n = 6), and patients with ARDS (n = 22), of whom 13 were classified as having moderate to severe disease and the remaining 9 as having mild disease.
   Results: Rapid and strong stiffening of primary neutrophils and monocytes was induced within 30 minutes (mean ET > 50 seconds) by sera from the ARDS group compared with both the healthy subjects and the ACPE groups (mean ET <1 second) (p < 0.05). Systematic measurements with the THP-1 cell line allowed for the establishment of a strong correlation between stiffening and the severity of respiratory status (mean ET 0.82 +/- 0.08 seconds for healthy subjects, 1.6 +/- 1.0 seconds for ACPE groups, 10.5 +/- 6.1 seconds for mild ARDS, and 20.0 +/- 8.1 seconds for moderate to severe ARDS; p < 0.05). Stiffening correlated with the cytokines interleukin IL-1 beta, IL-8, tumor necrosis factor TNF-alpha, and IL-10 but not with interferon-gamma, transforming growth factor-beta, IL-6, or IL-17. Strong stiffening was induced by IL-1 alpha, IL-8, and TNF-alpha but not by IL-10, and incubations with sera and blocking antibodies against IL-1 beta, IL-8, or TNF-alpha significantly diminished the stiffening effect of serum. In contrast, the measurements of integrin expression (CD11b, CD11a, CD18, CD49d) and leukocyte-endothelium adhesion showed a weak and slow response after incubation with the sera of patients with ARDS (several hours), suggesting a lesser role of leukocyte adhesiveness compared with leukocyte stiffness in early ARDS.
   Conclusions: The leukocyte stiffening induced by cytokines in the sera of patients might play a role in the sequestration of leukocytes in the lung capillary beds during early ARDS. The inhibition of leukocyte stiffening with blocking antibodies might inspire future therapeutic strategies.
C1 [Preira, Pascal; Robert, Philippe; Negre, Paulin; Biarnes-Pelicot, Martine; Bongrand, Pierre; Theodoly, Olivier] Univ Aix Marseille, Adhes & Inflammat, INSERM U1067, CNRS UMR7333, F-13009 Marseille, France.
   [Preira, Pascal; Robert, Philippe; Negre, Paulin; Biarnes-Pelicot, Martine; Bongrand, Pierre; Theodoly, Olivier] Assistance Publ Hop Marseille, Lab Immunol, F-13285 Marseille 05, France.
   [Forel, Jean-Marie; Xeridat, Francois; Papazian, Laurent] Hop Nord Marseille, Assistance Publ Hop Marseille, Reanimat Detresses Resp & Infect Severes, F-13015 Marseille, France.
   [Forel, Jean-Marie; Xeridat, Francois; Papazian, Laurent] Aix Marseille Univ, Fac Med, URMITE UMR CNRS 7278, F-13005 Marseille, France.
C3 Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of
   Physics (INP); Institut National de la Sante et de la Recherche Medicale
   (Inserm); UDICE-French Research Universities; Aix-Marseille Universite;
   UDICE-French Research Universities; Aix-Marseille Universite; Assistance
   Publique-Hopitaux de Marseille; UDICE-French Research Universities;
   Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille;
   Centre National de la Recherche Scientifique (CNRS); CNRS - National
   Institute for Biology (INSB); Institut National de la Sante et de la
   Recherche Medicale (Inserm); UDICE-French Research Universities;
   Aix-Marseille Universite
RP Theodoly, O (corresponding author), Univ Aix Marseille, Adhes & Inflammat, INSERM U1067, CNRS UMR7333, 163 Ave Luminy, F-13009 Marseille, France.
EM olivier.theodoly@inserm.fr
RI Robert, Philippe/P-9597-2016; Bongrand, Pierre/C-4456-2013; theodoly,
   olivier/P-5402-2016
OI Robert, Philippe/0000-0002-1343-994X; Bongrand,
   Pierre/0000-0001-6185-6572; theodoly, olivier/0000-0001-8787-3709
FU Provence Alpes Cote d'Azur region and Capsum; Labex INFORM
FX The authors thank the Provence Alpes Cote d'Azur region and Capsum SAS
   for their financial support of PP's doctoral grant; the Solvay company
   (LOF, Pessac, France), and F. Bedu and I. Ozerov (CINaM, CNRS UPR 3118,
   Marseilles, France) for technical support with microfabrication; Labex
   INFORM for financial support; Cyrille Mionnet for support with cytometry
   experiments; C. Farnarier (Laboratoire d'immunologie - Hopital de la
   Conception, Marseille, France) for initial treatment of the sera
   library; and the cell culture platform of INSERM at Marseille-Luminy.
CR Abraham E, 1998, LANCET, V351, P929
   Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510
   [Anonymous], 2003, CRIT CARE MED, DOI DOI 10.1097/01.CCM.0000050454.01978.3B
   Azoulay E, 2011, AM J RESP CRIT CARE, V183, P279, DOI 10.1164/ajrccm.183.2.279b
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Deree J, 2007, J SURG RES, V143, P99, DOI 10.1016/j.jss.2007.03.083
   Drost EM, 2002, EUR J IMMUNOL, V32, P393, DOI 10.1002/1521-4141(200202)32:2<393::AID-IMMU393>3.0.CO;2-5
   Hayakawa M, 2010, SHOCK, V33, P14, DOI 10.1097/SHK.0b013e3181aa95c4
   Hirsh M, 2001, SHOCK, V16, P102, DOI 10.1097/00024382-200116020-00003
   HOGG JC, 1987, PHYSIOL REV, V67, P1249, DOI 10.1152/physrev.1987.67.4.1249
   Ibbotson GC, 2001, NAT MED, V7, P465, DOI 10.1038/86539
   Inoue Y, 2006, J TRAUMA, V60, P936, DOI 10.1097/01.ta.0000217271.25809.a0
   Iyer SS, 2006, J IMMUNOL, V176, P3686, DOI 10.4049/jimmunol.176.6.3686
   Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107
   Lam WA, 2007, BLOOD, V109, P3505, DOI 10.1182/blood-2006-08-043570
   Lautenschlager F, 2009, P NATL ACAD SCI USA, V106, P15696, DOI 10.1073/pnas.0811261106
   Lavkan AH, 1998, CRIT CARE MED, V26, P1677, DOI 10.1097/00003246-199810000-00021
   Lewis SM, 2009, AM J RESP CELL MOL, V40, P724, DOI 10.1165/rcmb.2008-0252OC
   Linden A, 2005, EUR RESPIR J, V25, P159, DOI 10.1183/09031936.04.00032904
   Maniatis NA, 2012, SHOCK, V38, P381, DOI 10.1097/SHK.0b013e3182690ea2
   Mokart D, 2003, CHEST, V124, P644, DOI 10.1378/chest.124.2.644
   Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919
   Ng JMK, 2002, ELECTROPHORESIS, V23, P3461, DOI 10.1002/1522-2683(200210)23:20<3461::AID-ELPS3461>3.0.CO;2-8
   Nishino M, 2005, J TRAUMA, V59, P1425, DOI 10.1097/01.ta.0000197356.83144.72
   O'Dea KP, 2011, AM J PHYSIOL-LUNG C, V301, pL812, DOI 10.1152/ajplung.00092.2011
   Okayama Naoko, 2006, J Anesth, V20, P6, DOI 10.1007/s00540-005-0362-9
   Preira P, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4802272
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Robert P, 2011, J IMMUNOL, V186, P5273, DOI 10.4049/jimmunol.1003141
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   SHYY YJ, 1993, J CLIN INVEST, V92, P1745, DOI 10.1172/JCI116762
   Skoutelis AT, 2000, CYTOKINE, V12, P1737, DOI 10.1006/cyto.2000.0761
   Skoutelis AT, 2000, CRIT CARE MED, V28, P2355, DOI 10.1097/00003246-200007000-00029
   Slotman GJ, 2011, J TRAUMA, V71, P1406, DOI 10.1097/TA.0b013e3182159c61
   Volpe S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010159
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   WESTLIN WF, 1992, J LEUKOCYTE BIOL, V52, P43, DOI 10.1002/jlb.52.1.43
   WORTHEN GS, 1989, SCIENCE, V245, P183, DOI 10.1126/science.2749255
   Yang SC, 2013, J IMMUNOL, V190, P6511, DOI 10.4049/jimmunol.1202215
   Yen YT, 2006, J VIROL, V80, P2684, DOI 10.1128/JVI.80.6.2684-2693.2006
   Yodice PC, 1997, AM J RESP CRIT CARE, V155, P38, DOI 10.1164/ajrccm.155.1.9001286
   Yoshida K, 2006, AM J RESP CRIT CARE, V174, P689, DOI 10.1164/rccm.200502-276OC
NR 42
TC 26
Z9 27
U1 1
U2 20
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1466-609X
EI 1364-8535
J9 CRIT CARE
JI Crit. Care
PD JAN 12
PY 2016
VL 20
AR 8
DI 10.1186/s13054-015-1157-5
PG 11
WC Critical Care Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA DA9IA
UT WOS:000368121000001
PM 26757701
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Ben-Mahdi, MH
   Dang, PMC
   Gougerot-Pocidalo, MA
   O'Dowd, Y
   El-Benna, J
   Pasquier, C
AF Ben-Mahdi, Meriem H.
   Dang, Pham My-Chan
   Gougerot-Pocidalo, Marie-Anne
   O'Dowd, Yvonne
   El-Benna, Jamel
   Pasquier, Catherine
TI Xanthine Oxidase-Derived ROS Display a Biphasic Effect on Endothelial
   Cells Adhesion and FAK Phosphorylation
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID PROTEIN-TYROSINE-PHOSPHATASE; PEROXIDE-INDUCED APOPTOSIS; MAP KINASE;
   OXIDATIVE STRESS; SURVIVAL; FAMILY; INACTIVATION; NEUTROPHILS;
   INHIBITION; ACTIVATION
AB In pathological situations such as ischemia-reperfusion and acute respiratory distress syndrome, reactive oxygen species (ROS) are produced by different systems which are involved in endothelial cells injury, ultimately leading to severe organ dysfunctions. The aim of this work was to study the effect of ROS produced by hypoxanthine-xanthine oxidase (Hx-XO) on the adhesion of human umbilical vein endothelial cells (HUVEC) and on the signaling pathways involved. Results show that Hx-XO-derived ROS induced an increase in HUVEC adhesion in the early stages of the process (less than 30 min), followed by a decrease in adhesion in the later stages of the process. Interestingly, Hx-XO-derived ROS induced the same biphasic effect on the phosphorylation of the focal adhesion kinase (FAK), a nonreceptor tyrosine kinase critical for cell adhesion, but not on ERK1/2 phosphorylation. The biphasic effect was not seen with ERK1/2 where a decrease in phosphorylation only was observed. Wortmannin, a PI3-kinase inhibitor, inhibited ROS-induced cell adhesion and FAK phosphorylation. Orthovanadate, a protein tyrosine phosphatase inhibitor, and Resveratrol (Resv), an antioxidant agent, protected FAK and ERK1/2 from dephosphorylation and HUVEC from ROS-induced loss of adhesion. This study shows that ROS could have both stimulatory and inhibitory effects on HUVEC adhesion and FAK phosphorylation and suggests that PI3-kinase and tyrosine phosphatase control these effects.
C1 [Ben-Mahdi, Meriem H.] Vet Natl Super Sch Algiers, BP 161, Algiers 16200, Algeria.
   [Ben-Mahdi, Meriem H.; Dang, Pham My-Chan; Gougerot-Pocidalo, Marie-Anne; O'Dowd, Yvonne; El-Benna, Jamel; Pasquier, Catherine] CNRS ERL 8252, Ctr Rech IInflammat, INSERM U1149, F-75018 Paris, France.
   [Ben-Mahdi, Meriem H.; Dang, Pham My-Chan; Gougerot-Pocidalo, Marie-Anne; O'Dowd, Yvonne; El-Benna, Jamel; Pasquier, Catherine] Univ Paris Diderot, Fac Med, Lab Excellence Inflamex, Sorbonne Paris Cite,DHU FIRE, Site Xavier Bichat, F-75018 Paris, France.
C3 Ecole Nationale Superieure Veterinaire; Centre National de la Recherche
   Scientifique (CNRS); CNRS - National Institute for Biology (INSB);
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   UDICE-French Research Universities; Universite Paris Cite; UDICE-French
   Research Universities; Universite Paris Cite; Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard -
   APHP
RP Ben-Mahdi, MH (corresponding author), Vet Natl Super Sch Algiers, BP 161, Algiers 16200, Algeria.; Ben-Mahdi, MH; El-Benna, J (corresponding author), CNRS ERL 8252, Ctr Rech IInflammat, INSERM U1149, F-75018 Paris, France.; Ben-Mahdi, MH; El-Benna, J (corresponding author), Univ Paris Diderot, Fac Med, Lab Excellence Inflamex, Sorbonne Paris Cite,DHU FIRE, Site Xavier Bichat, F-75018 Paris, France.
EM mhbenmahdi@gmail.com; jamel.elbenna@inserm.fr
CR ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5
   Belambri SA, 2014, METHODS MOL BIOL, V1124, P427, DOI 10.1007/978-1-62703-845-4_25
   Ben-Mahdi MH, 2000, ANTIOXID REDOX SIGN, V2, P789, DOI 10.1089/ars.2000.2.4-789
   Burdon RH, 1996, BIOCHEM SOC T, V24, P1028, DOI 10.1042/bst0241028
   Cai WJ, 1997, ATHEROSCLEROSIS, V131, P177, DOI 10.1016/S0021-9150(97)06099-1
   Chan PC, 1999, J BIOL CHEM, V274, P26901, DOI 10.1074/jbc.274.38.26901
   Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329
   Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497
   Cuda G, 2002, CIRCULATION, V105, P968, DOI 10.1161/hc0802.104324
   Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404
   FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499
   FRANKEL EN, 1993, LANCET, V341, P1103, DOI 10.1016/0140-6736(93)92472-6
   Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793
   GRANGER DN, 1989, AM J PHYSIOL, V257, pG683, DOI 10.1152/ajpgi.1989.257.5.G683
   GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0
   Hoyt DG, 1996, AM J PHYSIOL-LUNG C, V270, pL689, DOI 10.1152/ajplung.1996.270.4.L689
   Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383
   Ilic D, 1998, J CELL BIOL, V143, P547
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7
   KEYSE SM, 1995, BBA-MOL CELL RES, V1265, P152, DOI 10.1016/0167-4889(94)00211-V
   Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1
   Le Gall M, 2000, MOL BIOL CELL, V11, P1103, DOI 10.1091/mbc.11.3.1103
   LEWIS T, 1995, J CELL SCI, V108, P2885
   Lin TH, 1997, J CELL BIOL, V136, P1385, DOI 10.1083/jcb.136.6.1385
   Mian MF, 2008, CHEM-BIOL INTERACT, V171, P57, DOI 10.1016/j.cbi.2007.08.009
   Muda M, 1996, J BIOL CHEM, V271, P4319
   Nguyen KT, 2002, J BIOL CHEM, V277, P11107, DOI 10.1074/jbc.M108166200
   POLUNOVSKY VA, 1993, J CLIN INVEST, V92, P388, DOI 10.1172/JCI116578
   Qin SF, 1996, EUR J BIOCHEM, V236, P443, DOI 10.1111/j.1432-1033.1996.00443.x
   Rotondo S, 1998, BRIT J PHARMACOL, V123, P1691, DOI 10.1038/sj.bjp.0701784
   SCHIEVEN GL, 1993, J BIOL CHEM, V268, P16688
   SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337
   SELLAK H, 1994, BLOOD, V83, P2669
   Sonoda Y, 1997, BIOCHEM BIOPH RES CO, V241, P769, DOI 10.1006/bbrc.1997.7895
   Sonoda Y, 1999, J BIOL CHEM, V274, P10566, DOI 10.1074/jbc.274.15.10566
   Sonoda Y., 2004, BIOCHIM BIOPHYS ACTA, V1683, P22
   SUZUKI M, 1989, AM J PHYSIOL, V257, pH1740, DOI 10.1152/ajpheart.1989.257.5.H1740
   Suzuki Y, 1996, IMMUNOLOGY, V87, P396, DOI 10.1046/j.1365-2567.1996.431546.x
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326
NR 41
TC 14
Z9 14
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PY 2016
VL 2016
AR 9346242
DI 10.1155/2016/9346242
PG 9
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA DT0RY
UT WOS:000381191900001
PM 27528888
OA Green Published, Green Submitted, gold
DA 2023-08-21
ER

PT J
AU Guo, CR
   Goodwin, A
   Buie, JNJ
   Cook, J
   Halushka, P
   Argraves, K
   Zingarelli, B
   Zhang, X
   Wang, LP
   Fan, HK
AF Guo, Changrun
   Goodwin, Andrew J.
   Buie, Joy N. Jones
   Cook, James A.
   Halushka, Perry V.
   Argraves, Kelley
   Zingarelli, Basilia
   Zhang, Xian
   Wang, Liping
   Fan, Hongkuan
TI A Stromal Cell-Derived Factor 1 alpha Analogue Improves Endothelial Cell
   Function in Lipopolysaccharide-Induced Acute Respiratory Distress
   Syndrome
SO MOLECULAR MEDICINE
LA English
DT Article
ID LUNG VASCULAR-PERMEABILITY; BARRIER-ENHANCEMENT; PROGENITOR CELLS;
   MICRORNAS; CONTRIBUTES; DYSFUNCTION; INTEGRITY; PROTECTS; RECOVERY;
   RECEPTOR
AB Endothelial cell (EC) dysfunction is a critical mediator of the acute respiratory distress syndrome (ARDS). Recent studies have demonstrated that stromal cell-derived factor 1 alpha (SDF-1 alpha) promotes EC barrier integrity. Our previous studies used a SDF-1 alpha analogue CTCE-0214 (CTCE) in experimental sepsis and demonstrated that it attenuated vascular leak and modulated microRNA (miR) levels. We examined the hypothesis that CTCE improves EC function in lipopolysaccharide (LPS)-induced ARDS through increasing miR-126 expression. Human microvascular endothelial cells (HMVECs) were treated with thrombin to disrupt the EC integrity followed by incubation with CTCE or SDF-1 alpha. Barrier function was determined by trans-endothelial electrical resistance assay. CTCE-induced alterations in miRNA expression and signaling pathways involved in barrier function were determined. Thrombin-induced vascular leak was abrogated by both CTCE and SDF-1 alpha. CTCE also prevented thrombin-induced decreases of vascular endothelial (VE)-cadherin cell surface expression and expansion of the intercellular space. CTCE increased miR-126 levels and induced activation of AKT/Rac 1 signaling. Cotreatment with a miR-126 inhibitor blocked the protective effects of CTCE on AKT activation and endothelial permeability. In subsequent in vivo studies, ARDS was induced by intratracheal instillation of LPS. Intravenous injection of CTCE diminished the injury severity as evidenced by significant reductions in protein, immune cells, inflammatory cytokines and chemokines in the bronchoalveolar lavage fluid, increased miR-126 expression and decreased pulmonary vascular leak and alveolar edema. Taken together, our data show that CTCE improves endothelial barrier integrity through increased expression of miR-126 and activation of Rac 1 signaling and represents an important potential therapeutic strategy in ARDS.
C1 [Guo, Changrun; Buie, Joy N. Jones; Cook, James; Fan, Hongkuan] Med Univ South Carolina, Dept Neurosci, Charleston, SC, United States.
   [Goodwin, Andrew] Med Univ South Carolina, Pulm Crit Care Allergy & Sleep Med, Charleston, SC, United States.
   [Halushka, Perry] Med Univ South Carolina, Med, Charleston, SC, United States.
   [Halushka, Perry] Med Univ South Carolina, Pharmacol, Charleston, SC, United States.
   [Argraves, Kelley] Med Univ South Carolina, Regenerat Med & Cell Biol, Charleston, SC, United States.
   [Zhang, Xian] Med Univ South Carolina, Div Rheumatol & Immunol, Charleston, SC, United States.
   [Fan, Hongkuan] Med Univ South Carolina, Pathol & Lab Med, Charleston, SC, United States.
   [Guo, Changrun; Wang, Liping] Jilin Univ, Coll Life Sci, Changchun, China.
   [Zingarelli, Basilia] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229, United States.
C3 Medical University of South Carolina; Medical University of South
   Carolina; Medical University of South Carolina; Medical University of
   South Carolina; Medical University of South Carolina; Medical University
   of South Carolina; Medical University of South Carolina; Jilin
   University; Cincinnati Children's Hospital Medical Center
RP Fan, HK (corresponding author), Dept Pathol & Lab Med, 173 Ashley Ave,CRI Room 605B, Charleston, SC 29425 USA.
EM fanhong@musc.edu
RI , Basilia/AAV-7582-2021; , B/HZK-8896-2023
OI Fan, Hongkuan/0000-0002-9441-9405
FU [GM113995];  [GM27673];  [GM67202];  [KL2 TR000060];  [UL1 TR 000062]; 
   [UL1TR001450]
FX The authors acknowledge the technical support of Ms Sarah Ashton. This
   work was supported in part by GM113995 (H Fan), GM27673 (J Cook, P
   Halushka), GM67202 (B Zingarelli), KL2 TR000060, UL1 TR 000062 (A
   -Goodwin) and UL1TR001450 -(P Halushka).
CR Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887
   [Anonymous], 2013, P WORLD C ENG, DOI DOI 10.1039/C3RA43480J
   Barabutis N, 2015, AM J PHYSIOL-LUNG C, V308, pL776, DOI 10.1152/ajplung.00334.2014
   D'Ambrosi N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00279
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487
   Fan HK, 2014, AM J RESP CRIT CARE, V189, P1509, DOI 10.1164/rccm.201312-2163OC
   Fan HK, 2012, INFLAMMATION, V35, P130, DOI 10.1007/s10753-011-9297-5
   Gerrits H, 2008, GENESIS, V46, P235, DOI 10.1002/dvg.20387
   Gong HX, 2015, J CLIN INVEST, V125, P652, DOI 10.1172/JCI77701
   Guan SW, 2015, IMMUNOLOGY, V144, P405, DOI 10.1111/imm.12382
   Gunduz D, 2010, ARTERIOSCL THROM VAS, V30, P1237, DOI 10.1161/ATVBAHA.110.203901
   Kane NM, 2010, ARTERIOSCL THROM VAS, V30, P1389, DOI 10.1161/ATVBAHA.110.204800
   Kasa A, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974448
   Kobayashi K, 2014, ARTERIOSCL THROM VAS, V34, P1716, DOI 10.1161/ATVBAHA.114.303890
   Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Lorenzen JM, 2015, J PHYSIOL-LONDON, V593, P1777, DOI 10.1113/JP270318
   Lu Q, 2012, AM J RESP CELL MOL, V47, P604, DOI 10.1165/rcmb.2012-0012OC
   Ma HY, 2014, BIOCHEM BIOPH RES CO, V450, P1560, DOI 10.1016/j.bbrc.2014.07.024
   Marques-Rocha JL, 2015, FASEB J, V29, P3595, DOI 10.1096/fj.14-260323
   Meng S, 2012, J MOL CELL CARDIOL, V53, P64, DOI 10.1016/j.yjmcc.2012.04.003
   Nie ZC, 2015, INT J CLIN EXP PATHO, V8, P4745
   Pepini T, 2010, J VIROL, V84, P11929, DOI 10.1128/JVI.01658-10
   Petruzziello-Pellegrini TN, 2012, J CLIN INVEST, V122, P759, DOI 10.1172/JCI57313
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Shah D, 2014, AM J PHYSIOL-LUNG C, V306, pL152, DOI 10.1152/ajplung.00229.2013
   Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367
   Spragg RG, 2011, AM J RESP CRIT CARE, V183, P1055, DOI 10.1164/rccm.201009-1424OC
   Staszel T, 2011, POL ARCH MED WEWN, V121, P361, DOI 10.20452/pamw.1093
   Suurna MV, 2006, AM J PHYSIOL-RENAL, V290, pF1398, DOI 10.1152/ajprenal.00194.2005
   Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355
   Tian XY, 2015, MOL BIOL CELL, V26, P636, DOI 10.1091/mbc.E14-02-0725
   Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520
   Trzeciak S, 2008, ACAD EMERG MED, V15, P399, DOI 10.1111/j.1553-2712.2008.00109.x
   Umapathy NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059733
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75
   Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Wei YY, 2013, ARTERIOSCL THROM VAS, V33, P449, DOI 10.1161/ATVBAHA.112.300279
   Wilkerson BA, 2012, J BIOL CHEM, V287, P44645, DOI 10.1074/jbc.M112.423426
   Young JA, 2013, BLOOD, V122, P2911, DOI 10.1182/blood-2012-12-473017
NR 42
TC 14
Z9 18
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1076-1551
EI 1528-3658
J9 MOL MED
JI Mol. Med.
PY 2016
VL 22
DI 10.2119/molmed.2015.00240
PG 9
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA DT5KW
UT WOS:000381523100001
PM 27031787
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Wu, W
   Luo, RJ
   Lin, ZQ
   Xia, Q
   Xue, P
AF Wu, Wei
   Luo, Ruijie
   Lin, Ziqi
   Xia, Qing
   Xue, Ping
TI Key Molecular Mechanisms of Chaiqinchengqi Decoction in Alleviating the
   Pulmonary Albumin Leakage Caused by Endotoxemia in Severe Acute
   Pancreatitis Rats
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID CHENGQI DECOCTION; IN-VITRO; KAPPA-B; LUNG INJURY; C-SRC; EXPRESSION;
   INFLAMMATION; PERMEABILITY; APOPTOSIS; BARRIER
AB To reveal the key molecular mechanisms of Chaiqinchengqi decoction (CQCQD) in alleviating the pulmonary albumin leakage caused by endotoxemia in severe acute pancreatitis (SAP) rats. Rats models of SAP endotoxemia-induced acute lung injury were established, the studies in vivo provided the important evidences that the therapy of CQCQD significantly ameliorated the increases in plasma levels of lipopolysaccharide (LPS), sCd14, and Lbp, the elevation of serum amylase level, the enhancements of systemic and pulmonary albumin leakage, and the depravation of airways indicators, thus improving respiratory dysfunction and also pancreatic and pulmonary histopathological changes. According to the analyses of rats pulmonary tissue microarray and protein-protein interaction network, c-Fos, c-Src, and p85 alpha were predicted as the target proteins for CQCQD in alleviating pulmonary albumin leakage. To confirm these predictions, human umbilical vein endothelial cells were employed in in vitro studies, which provide the evidences that (1) LPS-induced paracellular leakage and proinflammatory cytokines release were suppressed by pretreatment with inhibitors of c-Src (PP1) or PI3K (LY294002) or by transfection with siRNAs of c-Fos; (2) fortunately, CQCQD imitated the actions of these selective inhibitions agents to inhibit LPS-induced high expressions of p-Src, p-p85 alpha, and c-Fos, therefore attenuating paracellular leakage and proinflammatory cytokines release.
C1 [Wu, Wei; Luo, Ruijie; Lin, Ziqi; Xia, Qing; Xue, Ping] Sichuan Univ, Dept Integrated Tradit Chinese & Western Med, West China Hosp, Chengdu 610041, China.
C3 Sichuan University
RP Xue, P (corresponding author), Sichuan Univ, Dept Integrated Tradit Chinese & Western Med, West China Hosp, Chengdu 610041, Peoples R China.
EM weijunhr001@163.com
FU National Natural Science Foundation of China [81573766]; Science and
   Technology Support Program of Sichuan [2011SZ0291]; Remeadjohn
   Technology Co., Ltd., Chengdu, China
FX This project was supported by National Natural Science Foundation of
   China (no. 81573766), Science and Technology Support Program of Sichuan
   (no. 2011SZ0291), and Remeadjohn Technology Co., Ltd., Chengdu 610044,
   China.
CR Armstrong SM, 2012, AM J PATHOL, V180, P1308, DOI 10.1016/j.ajpath.2011.12.002
   Ben DF, 2012, J SURG RES, V174, P326, DOI 10.1016/j.jss.2010.12.005
   Cao XF, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0191-9
   dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236
   Deng Li-Hui, 2008, Zhong Xi Yi Jie He Xue Bao, V6, P176, DOI 10.3736/jcim20080214
   Deng LH, 2009, WORLD J GASTROENTERO, V15, P4439, DOI 10.3748/wjg.15.4439
   Du Anqing, 2012, Hua Xi Kou Qiang Yi Xue Za Zhi, V30, P430
   Gill SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088501
   Guo J, 2015, CHIN J INTEGR MED, V21, P29, DOI 10.1007/s11655-014-1750-5
   Guo J, 2013, CHIN J INTEGR MED, V19, P913, DOI 10.1007/s11655-013-1653-x
   Guo Jia, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P704
   Gustems M, 2014, NUCLEIC ACIDS RES, V42, P3059, DOI 10.1093/nar/gkt1323
   Hermanns MI, 2014, IN VITRO CELL DEV-AN, V50, P287, DOI 10.1007/s11626-013-9707-0
   Hu X, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/825805
   HUANG L, 2012, CHIN J INTEGR MED
   Huang L, 2013, TURK J GASTROENTEROL, V24, P502, DOI 10.4318/tjg.2013.0544
   Huang YJ, 2015, VASC PHARMACOL, V72, P43, DOI 10.1016/j.vph.2015.04.012
   Jia G., 2015, J TRADITIONAL CHINES, V35, P434, DOI DOI 10.1016/S0254-6272(15)30121-7
   Kamisoglu K, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0783-2
   Kim JY, 2015, BIOL PHARM BULL, V38, P66, DOI 10.1248/bpb.b14-00567
   Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001
   Kondrikov D, 2014, J BIOL CHEM, V289, P33355, DOI 10.1074/jbc.M114.585356
   Kourtidis A, 2015, NAT CELL BIOL, V17, P1145, DOI 10.1038/ncb3227
   Lee TH, 2014, BIOCHEM BIOPH RES CO, V445, P615, DOI 10.1016/j.bbrc.2014.02.046
   Li Y. H., 2006, ZHONG XI YI JIE HE X, V6, P180
   Lim HA, 2012, BIOGERONTOLOGY, V13, P133, DOI 10.1007/s10522-011-9361-4
   Lin ZQ, 2014, J TRADIT CHIN MED, V34, P178, DOI 10.1016/S0254-6272(14)60075-3
   Liu MW, 2014, INT J MOL MED, V34, P1492, DOI 10.3892/ijmm.2014.1943
   Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218
   Ma LQ, 2014, MICROCIRCULATION, V21, P649, DOI 10.1111/micc.12144
   Okkenhaug K, 2001, Sci STKE, V2001, ppe1
   Pan CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126640
   Pfannkuche A, 2011, HEPATOLOGY, V53, P1127, DOI 10.1002/hep.24214
   Singh N, 2014, PANCREAS, V43, P867, DOI 10.1097/MPA.0000000000000124
   Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025
   Stopa B, 2006, INT J BIOL MACROMOL, V40, P1, DOI 10.1016/j.ijbiomac.2006.05.002
   Wang L, 2011, J ZHEJIANG UNIV-SC B, V12, P1034, DOI 10.1631/jzus.B1000406
   Wang Zhong-Chao, 2009, Zhongguo Zhong Xi Yi Jie He Za Zhi, V29, P322
   Wu W, 2012, ASIAN PAC J TROP MED, V5, P901, DOI 10.1016/S1995-7645(12)60168-0
   Wu YL, 2010, CHEM-BIOL INTERACT, V188, P526, DOI 10.1016/j.cbi.2010.09.008
   Xiong Y., 2016, J INNATE IMMUNITY, V8
   Xiong YB, 2016, J INNATE IMMUN, V8, P171, DOI 10.1159/000440838
   Xu XF, 2013, INT J CLIN EXP MED, V6, P524
   Xue GD, 2013, JNCI-J NATL CANCER I, V105, P393, DOI 10.1093/jnci/djs648
   Xue Ping, 2005, Zhong Xi Yi Jie He Xue Bao, V3, P263
   Xue P, 2008, WORLD J GASTROENTERO, V14, P2343, DOI 10.3748/wjg.14.2343
   Xue P, 2014, CHIN J INTEGR MED, V20, P770, DOI 10.1007/s11655-013-1661-x
   Xue Ping, 2006, Sichuan Da Xue Xue Bao Yi Xue Ban, V37, P66
   Zarzycka M, 2015, ANDROLOGY-US, V3, P569, DOI 10.1111/andr.12028
   Zhou Lin, 2014, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V30, P151
   Zhu J, 2013, EXP THER MED, V5, P1345, DOI 10.3892/etm.2013.988
   Zou ZY, 2015, FITOTERAPIA, V105, P139, DOI 10.1016/j.fitote.2015.06.005
NR 52
TC 8
Z9 9
U1 0
U2 12
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2016
VL 2016
AR 3265368
DI 10.1155/2016/3265368
PG 14
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA DQ2QH
UT WOS:000379047100001
PM 27413385
OA gold, Green Published, Green Submitted
DA 2023-08-21
ER

PT J
AU Wu, ZY
   Wang, ZW
   Dai, FF
   Liu, HG
   Ren, W
   Chang, JX
   Li, BW
AF Wu, Zhiyong
   Wang, Zhiwei
   Dai, Feifeng
   Liu, Huagang
   Ren, Wei
   Chang, Jinxing
   Li, Bowen
TI Dephosphorylation of Y685-VE-Cadherin Involved in Pulmonary
   Microvascular Endothelial Barrier Injury Induced by Angiotensin II
SO MEDIATORS OF INFLAMMATION
LA English
DT Article
ID ACUTE AORTIC DISSECTION; VE-CADHERIN; VASCULAR-PERMEABILITY; LUNG
   INJURY; TYROSINE PHOSPHORYLATION; BETA-CATENIN; IN-VIVO; JUNCTIONS;
   ADHESION; CELLS
AB Angiotensin II (AngII) caused pulmonary microvascular endothelial barrier injury, which induced acute aortic dissection (AAD) combined with acute lung injury (ALI). However, the exact mechanism is unclear. We investigated the role of dephosphorylation of Y685-VE-cadherin in the AngII induced pulmonary microvascular endothelial barrier injury. Mice or pulmonary microvascular endothelial cells (PMVECs) were divided into control group, AngII group, AngII+PP2 (Src kinase inhibitor) group, and PP2 group. PP2 was used to inhibit the phosphorylation of Y685-VE-cadherin. Pathological changes, infiltration of macrophages and neutrophils, and pulmonary microvascular permeability were used to determine the pulmonary microvascular endothelial barrier function. Flow cytometry was used to determine the apoptosis of PMVECs, and immunofluorescence was used to determine the skeletal arrangement. Transendothelial resistance was used to detect the permeability of endothelial barrier. Phosphorylation of Y685-VE-cadherin was significantly reduced after AngII stimulation (p < 0.05), together with skeletal rearrangement, and elevation of endothelial permeability which finally induced endothelial barrier injury. After PP2 interference, the phosphorylation of Y685-VE- cadherin was further reduced and the endothelial permeability was further elevated. These data indicated that AngII could induce pulmonary injury by triggering endothelial barrier injury, and such process may be related to the dephosphorylation of Y685-VE-cadherin and the endothelial skeletal rearrangement.
C1 [Wu, Zhiyong; Wang, Zhiwei; Dai, Feifeng; Liu, Huagang; Ren, Wei; Chang, Jinxing; Li, Bowen] Wuhan Univ, Renmin Hosp, Dept Cardiovasc Surg, Wuhan 430060, China.
C3 Wuhan University
RP Wu, ZY (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiovasc Surg, Wuhan 430060, Peoples R China.
EM zhiyongwu889@sina.com
CR Alvarez DF, 2008, AM J PHYSIOL-LUNG C, V294, pL419, DOI 10.1152/ajplung.00314.2007
   Artigas A, 1998, AM J RESP CRIT CARE, V157, P1332, DOI 10.1164/ajrccm.157.4.ats2-98
   Audia JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081792
   Birukov KG, 2002, AM J RESP CELL MOL, V26, P453, DOI 10.1165/ajrcmb.26.4.4725
   Birukova AA, 2012, AM J PHYSIOL-LUNG C, V302, pL965, DOI 10.1152/ajplung.00292.2011
   Farina F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056636
   Feng G, 2015, J CELL SCI, V128, P576, DOI 10.1242/jcs.159053
   Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179
   Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486
   Gavard Julie, 2014, Cell Adh Migr, V8, P158
   Griffiths GS, 2011, J CELL PHYSIOL, V226, P2287, DOI 10.1002/jcp.22565
   Haidari M, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-105
   Haines RJ, 2015, BIOCHEM BIOPH RES CO, V456, P190, DOI 10.1016/j.bbrc.2014.11.057
   Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006
   Hasegawa Y, 1999, J CARDIOVASC SURG, V40, P191
   He HL, 2015, J CELL PHYSIOL, V230, P691, DOI 10.1002/jcp.24794
   Kamberi Lulzim S, 2011, Med Arh, V65, P89
   Konstantoulaki M, 2003, AM J PHYSIOL-LUNG C, V285, pL434, DOI 10.1152/ajplung.00075.2003
   Kurabayashi M, 2010, CIRC J, V74, P2066, DOI 10.1253/circj.CJ-10-0336
   Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924
   Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894
   Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298
   Onken MD, 2014, CYTOSKELETON, V71, P695, DOI 10.1002/cm.21203
   Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199
   Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200
   Sheng W, 2015, SAUDI MED J, V36, P940, DOI 10.15537/smj.2015.8.11583
   Sidibe A, 2014, AM J PHYSIOL-HEART C, V307, pH455, DOI 10.1152/ajpheart.00774.2013
   Sugano Y, 2005, INT J CARDIOL, V102, P39, DOI 10.1016/j.ijcard.2004.03.076
   Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014
   Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855
   Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003
   Weidemann A, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-80
   Weidert E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108092
   Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824
   Wu ZY, 2016, AM J TRANSL RES, V8, P1426
   Wu ZY, 2016, AM J TRANSL RES, V8, P28
   Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020
   Yu XB, 2016, CELL PHYSIOL BIOCHEM, V38, P1055, DOI 10.1159/000443056
NR 38
TC 10
Z9 10
U1 0
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0962-9351
EI 1466-1861
J9 MEDIAT INFLAMM
JI Mediat. Inflamm.
PY 2016
VL 2016
AR 8696481
DI 10.1155/2016/8696481
PG 10
WC Cell Biology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Immunology
GA EH8IL
UT WOS:000392015300001
PM 28119542
OA Green Submitted, Green Published, gold
DA 2023-08-21
ER

PT J
AU Yang, Y
   Hu, SL
   Xu, XP
   Li, JZ
   Liu, AR
   Han, JB
   Liu, SQ
   Liu, L
   Qiu, HB
AF Yang, Yi
   Hu, Shuling
   Xu, Xiuping
   Li, Jinze
   Liu, Airan
   Han, Jibin
   Liu, Songqiao
   Liu, Ling
   Qiu, Haibo
TI The Vascular Endothelial Growth Factors-Expressing Character of
   Mesenchymal Stem Cells Plays a Positive Role in Treatment of Acute Lung
   Injury In Vivo
SO MEDIATORS OF INFLAMMATION
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; STROMAL CELLS; EPITHELIAL-CELLS;
   PROMOTES; INFLAMMATION; MANAGEMENT; RECOVERY; REPAIR; PHASE
AB Recently, mesenchymal stemcells (MSC) have been proved to be beneficial in acute respiratory distress syndrome (ARDS). Vascular endothelial growth factor (VEGF) is an important angiogenesis factor that MSC release. However, the precise role of VEGF-expressing character of MSC in the MSC treatment for ARDS remains obscure. Here, we firstly knocked down the gene VEGF in MSC (MSC-ShVEGF) with lentiviral transduction. Then we injected the MSC-ShVEGF to rats with lipopolysaccharide-induced acute lung injury (ALI) via the tail vein. Data showed that MSC transplantation significantly increased VEGF levels in the lung, reduced lung permeability, protected lung endothelium from apoptosis, facilitated VE-cadherin recovery, controlled inflammation, and attenuated lung injury. However, VEGF gene knockdown in MSC led to relatively insufficient VEGF expression in the injured lung and significantly diminished the therapeutic effects of MSC on ALI, suggesting an important role of VEGF-expressing behavior of MSC in the maintenance of VEGF in the lung and the MSC treatment for ALI. Hence, we conclude that MSC restores the lung permeability and attenuates lung injury in rats with ALI in part by maintaining a "sufficient" VEGF level in the lung and the VEGF-expressing character of MSC plays a positive role in the therapeutic effects of MSC on ARDS.
C1 [Yang, Yi; Liu, Airan; Liu, Songqiao; Liu, Ling; Qiu, Haibo] Southeast Univ, Sch Med, Zhongda Hosp, Dept Crit Care Med, 87 Dingjiaqiao Rd, Nanjing 210009, Jiangsu, China.
   [Hu, Shuling; Xu, Xiuping; Li, Jinze; Han, Jibin] Southeast Univ, Sch Med, 87 Dingjiaqiao Rd, Nanjing 210009, Jiangsu, China.
C3 Southeast University - China; Southeast University - China
RP Qiu, HB (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Dept Crit Care Med, 87 Dingjiaqiao Rd, Nanjing 210009, Jiangsu, Peoples R China.
EM haiboq2000@163.com
RI yang, yang/GVT-5210-2022; Qiu, Haibo/AAS-9047-2021; 刘, 松桥/ACA-6923-2022;
   Lang, Ming/HIK-0758-2022; Xu, Xiuping/W-5865-2019; yang,
   yang/HGT-7999-2022
OI Qiu, Haibo/0000-0001-8589-4717; 刘, 松桥/0000-0002-1875-1131; Xu,
   Xiuping/0000-0003-3950-3425; 
FU National Natural Science Foundation of China [81571874, 81372093,
   81170057, 81300060]
FX The authors would like to thank Yanli An for her assistance with the
   lentiviral transduction experiment techniques. In addition, the authors
   are grateful for the financial support from the National Natural Science
   Foundation of China (Grants nos. 81571874, 81372093, 81170057, and
   81300060).
CR Barratt S, 2014, RESPIRATION, V87, P329, DOI 10.1159/000356034
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Brown KRS, 2001, AM J PHYSIOL-LUNG C, V281, pL1001, DOI 10.1152/ajplung.2001.281.4.L1001
   Buregeya E, 2014, GLOB HEART, V9, P289, DOI 10.1016/j.gheart.2014.08.003
   Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721
   Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007
   Cruz FF, 2015, STEM CELL TRANSL MED, V4, P1302, DOI 10.5966/sctm.2014-0280
   Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103
   He HL, 2015, CELL TRANSPLANT, V24, P1699, DOI 10.3727/096368914X685087
   Ho MSH, 2015, J CELL PHYSIOL, V230, P2606, DOI 10.1002/jcp.25028
   Hu SL, 2014, CRIT CARE, V18, DOI 10.1186/cc13896
   Kaner RJ, 2000, AM J RESP CELL MOL, V22, P657, DOI 10.1165/ajrcmb.22.6.3779
   Karihaloo A, 2005, MOL CELL BIOL, V25, P7441, DOI 10.1128/MCB.25.17.7441-7448.2005
   Kim YG, 2000, KIDNEY INT, V58, P2390, DOI 10.1046/j.1523-1755.2000.00422.x
   Kim Y, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0236-5
   Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57
   Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643
   Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709
   Liu AR, 2013, J CELL PHYSIOL, V228, P1270, DOI 10.1002/jcp.24282
   Liu C, 2015, INT J CARDIOL, V188, P22, DOI 10.1016/j.ijcard.2015.03.425
   Madonna R, 2015, CARDIOVASC RES, V108, P39, DOI 10.1093/cvr/cvv197
   Maitre B, 2001, EUR RESPIR J, V18, P100, DOI 10.1183/09031936.01.00074701
   Matthay Michael A, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS54, DOI 10.1513/AnnalsATS.201406-254MG
   Mura M, 2004, J APPL PHYSIOL, V97, P1605, DOI 10.1152/japplphysiol.00202.2004
   Okazaki T, 2008, NEUROSCI LETT, V430, P109, DOI 10.1016/j.neulet.2007.10.046
   Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372
   Perkins GD, 2005, THORAX, V60, P153, DOI 10.1136/thx.2004.027912
   Pers YM, 2015, OSTEOARTHR CARTILAGE, V23, P2027, DOI 10.1016/j.joca.2015.07.004
   Song JF, 2015, LUNG, V193, P1029, DOI 10.1007/s00408-015-9803-x
   Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053
   Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004
   Thickett DR, 2002, AM J RESP CRIT CARE, V166, P1332, DOI 10.1164/rccm.2105057
   Wang SP, 2012, MOL MED REP, V6, P848, DOI 10.3892/mmr.2012.997
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Zhang L, 2015, EUR REV MED PHARMACO, V19, P2621
NR 37
TC 44
Z9 51
U1 2
U2 14
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0962-9351
EI 1466-1861
J9 MEDIAT INFLAMM
JI Mediat. Inflamm.
PY 2016
VL 2016
AR 2347938
DI 10.1155/2016/2347938
PG 12
WC Cell Biology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Immunology
GA DO0CD
UT WOS:000377446100001
PM 27313398
OA Green Submitted, Green Published, gold
DA 2023-08-21
ER

PT J
AU Mitra, S
   Wewers, MD
   Sarkar, A
AF Mitra, Srabani
   Wewers, Mark D.
   Sarkar, Anasuya
TI Mononuclear Phagocyte-Derived Microparticulate Caspase-1 Induces
   Pulmonary Vascular Endothelial Cell Injury
SO PLOS ONE
LA English
DT Article
ID IL-1-BETA-CONVERTING ENZYME; ACUTE LUNG; MEMBRANE MICROPARTICLES;
   EPITHELIAL-CELLS; FAS-LIGAND; APOPTOSIS; ACTIVATION; DEATH; IL-1-BETA;
   INFLAMMASOME
AB Lung endothelial cell apoptosis and injury occurs throughout all stages of acute lung injury (ALI/ARDS) and impacts disease progression. Lung endothelial injury has traditionally been focused on the role of neutrophil trafficking to lung vascular integrin receptors induced by proinflammatory cytokine expression. Although much is known about the pathogenesis of cell injury and death in ALI/ARDS, gaps remain in our knowledge; as a result of which there is currently no effective pharmacologic therapy. Enzymes known as caspases are essential for completion of the apoptotic program and secretion of pro-inflammatory cytokines. We hypothesized that caspase-1 may serve as a key regulator of human pulmonary microvascular endothelial cell (HPMVEC) apoptosis in ALI/ARDS. Our recent experiments confirm that microparticles released from stimulated monocytic cells (THP1) induce lung endothelial cell apoptosis. Microparticles pretreated with the caspase-1 inhibitor, YVAD, or pan-caspase inhibitor, ZVAD, were unable to induce cell death of HPMVEC, suggesting the role of caspase-1 or its substrate in the induction of HPMVEC cell death. Neither un-induced microparticles (control) nor direct treatment with LPS induced apoptosis of HPMVEC. Further experiments showed that caspase-1 uptake into HPMVEC and the induction of HPMVEC apoptosis was facilitated by caspase-1 interactions with microparticulate vesicles. Altering vesicle integrity completely abrogated apoptosis of HPMVEC suggesting an encapsulation requirement for target cell uptake of active caspase-1. Taken together, we confirm that microparticle centered caspase-1 can play a regulator role in endothelial cell injury.
C1 [Mitra, Srabani; Wewers, Mark D.; Sarkar, Anasuya] Ohio State Univ, Dept Internal Med, Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210, United States.
C3 University System of Ohio; Ohio State University
RP Sarkar, A (corresponding author), Ohio State Univ, Dept Internal Med, Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.
EM anasuya.sarkar@osumc.edu
RI Wewers, Mark/AAB-6202-2021
FU NHLBI [RO1-HL076278, R21-HL102629]; AAT Foundation
FX This work was supported by NHLBI RO1-HL076278 to MDW; NHLBI R21-HL102629
   and AAT Foundation grant to AS.
CR Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479
   Baroni M, 2007, FASEB J, V21, P1926, DOI 10.1096/fj.06-7238com
   BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366
   Braddock M, 2004, NAT REV DRUG DISCOV, V3, P1, DOI 10.1038/nrd1342
   Cacquevel M, 2004, CURR DRUG TARGETS, V5, P529, DOI 10.2174/1389450043345308
   Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126
   Diamant M, 2004, EUR J CLIN INVEST, V34, P392, DOI 10.1111/j.1365-2362.2004.01355.x
   Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1
   Dinarello CA, 2001, ANN RHEUM DIS, V60, pIII18
   Distler JHW, 2005, APOPTOSIS, V10, P731, DOI 10.1007/s10495-005-2941-5
   Distler JHW, 2006, AUTOIMMUNITY, V39, P683, DOI 10.1080/08916930601061538
   Exline MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090968
   Fahy RJ, 2008, AM J RESP CRIT CARE, V177, P983, DOI 10.1164/rccm.200703-418OC
   GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301
   Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067
   Hamacher J, 2002, AM J RESP CRIT CARE, V166, P651, DOI 10.1164/rccm.2109004
   Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943
   Huber LC, 2007, APOPTOSIS, V12, P363, DOI 10.1007/s10495-006-0622-7
   Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004
   Imanishi T, 2002, ATHEROSCLEROSIS, V161, P143, DOI 10.1016/S0021-9150(01)00631-1
   Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793
   Kahlenberg JM, 2004, J LEUKOCYTE BIOL, V76, P676, DOI 10.1189/jlb.0404221
   Kim HJ, 2004, J IMMUNOL, V172, P4948, DOI 10.4049/jimmunol.172.8.4948
   Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833
   Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0
   Kurtovic Jelica, 2004, Trop Gastroenterol, V25, P9
   LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5
   MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1
   Mallat Z, 2000, BRIT J PHARMACOL, V130, P947, DOI 10.1038/sj.bjp.0703407
   Mangan DF, 1991, J IMMUNOL, V163, P1755
   Martin S, 2004, CIRCULATION, V109, P1653, DOI 10.1161/01.CIR.0000124065.31211.6E
   Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Matute-Bello G, 2005, J IMMUNOL, V175, P4069, DOI 10.4049/jimmunol.175.6.4069
   Matute-Bello G, 2003, CRIT CARE, V7, P355, DOI 10.1186/cc1861
   McKechnie NM, 2006, EXP EYE RES, V83, P304, DOI 10.1016/j.exer.2005.11.028
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A
   Nakamura M, 2004, AM J PATHOL, V164, P1949, DOI 10.1016/S0002-9440(10)63755-8
   Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913
   Santos RL, 2001, INFECT IMMUN, V69, P2293, DOI 10.1128/IAI.69.4.2293-2301.2001
   Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC
   Sarkar A, 2006, J IMMUNOL, V176, P4979, DOI 10.4049/jimmunol.176.8.4979
   Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140
   Sue W, 2006, AM J CLIN NUTR, V83, p470S
   Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788
   Tiwary R, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3063
   van der Velden AWM, 2003, J IMMUNOL, V171, P6742, DOI 10.4049/jimmunol.171.12.6742
   Wang J, 2000, J CELL SCI, V113, P753
   Watanabe JJ, 2003, J BIOL CHEM, V278, P33161, DOI 10.1074/jbc.M305321200
   Wewers MD, 2004, P NATL ACAD SCI USA, V101, P10241, DOI 10.1073/pnas.0403971101
   WIENERKRONISH JP, 1991, J CLIN INVEST, V88, P864, DOI 10.1172/JCI115388
   Wilson HL, 2004, J IMMUNOL, V173, P1202, DOI 10.4049/jimmunol.173.2.1202
   Zimmerman GA, 1999, CHEST, V116, p18S, DOI 10.1378/chest.116.suppl_1.18S
NR 54
TC 33
Z9 35
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 28
PY 2015
VL 10
IS 12
AR e0145607
DI 10.1371/journal.pone.0145607
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CZ9XO
UT WOS:000367451400065
PM 26710067
OA gold, Green Submitted, Green Published
DA 2023-08-21
ER

PT J
AU Gill, SE
   Rohan, M
   Mehta, S
AF Gill, Sean E.
   Rohan, Marta
   Mehta, Sanjay
TI Role of pulmonary microvascular endothelial cell apoptosis in murine
   sepsis-induced lung injury in vivo
SO RESPIRATORY RESEARCH
LA English
DT Article
ID NITRIC-OXIDE SYNTHASE; RESPIRATORY-DISTRESS-SYNDROME; MICROCIRCULATORY
   ALTERATIONS; BARRIER DYSFUNCTION; ORGAN DYSFUNCTION; OXIDATIVE STRESS;
   MEDICAL PROGRESS; SEPTIC SHOCK; PROTEIN LEAK; BLOOD-FLOW
AB Background: Sepsis remains a common and serious condition with significant morbidity and mortality due to multiple organ dysfunction, especially acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Sepsis-induced ALI is characterized by injury and dysfunction of the pulmonary microvasculature and pulmonary microvascular endothelial cells (PMVEC), resulting in enhanced pulmonary microvascular sequestration and pulmonary infiltration of polymorphonuclear leukocytes (PMN) as well as disruption of the normal alveolo-capillary permeability barrier with leak of albumin-rich edema fluid into pulmonary interstitium and alveoli. The role of PMVEC death and specifically apoptosis in septic pulmonary microvascular dysfunction in vivo has not been established.
   Methods: In a murine cecal ligation/perforation (CLP) model of sepsis, we quantified and correlated time-dependent changes in pulmonary microvascular Evans blue (EB)-labeled albumin permeability with (1) PMVEC death (propidium iodide [PI]-staining) by both fluorescent intravital videomicroscopy (IVVM) and histology, and (2) PMVEC apoptosis using histologic fluorescent microscopic assessment of a panel of 3 markers: cell surface phosphatidylserine (detected by Annexin V binding), caspase activation (detected by FLIVO labeling), and DNA fragmentation (TUNEL labeling).
   Results: Compared to sham mice, CLP-sepsis resulted in pulmonary microvascular barrier dysfunction, quantified by increased EB-albumin leak, and PMVEC death (PI+ staining) as early as 2 h and more marked by 4 h after CLP. Septic PMVEC also exhibited increased presence of all 3 markers of apoptosis (Annexin V+, FLIVO+, TUNEL+) as early as 30 mins - 1 h after CLP-sepsis, which all similarly increased markedly until 4 h. The time-dependent changes in septic pulmonary microvascular albumin-permeability barrier dysfunction were highly correlated with PMVEC death (PI+; r = 0.976, p < 0.01) and PMVEC apoptosis (FLIVO+; r = 0.991, p < 0.01). Treatment with the pan-caspase inhibitor Q-VD prior to CLP reduced PMVEC death/apoptosis and attenuated septic pulmonary microvascular dysfunction, including both albumin-permeability barrier dysfunction and pulmonary microvascular PMN sequestration (p < 0.05). Septic PMVEC apoptosis and pulmonary microvascular dysfunction were also abrogated following CLP-sepsis in mice deficient in iNOS (Nos2(-/-)) or NADPH oxidase (p47(phox-/-) or gp91(phox-/-)) and in wild-type mice treated with the NADPH oxidase inhibitor, apocynin.
   Conclusions: Septic murine pulmonary microvascular dysfunction in vivo is due to PMVEC death, which is mediated through caspase-dependent apoptosis and iNOS/NADPH-oxidase dependent signaling.
C1 [Gill, Sean E.; Rohan, Marta; Mehta, Sanjay] London Hlth Sci Ctr, Lawson Hlth Res Inst, Ctr Crit Illness Res, London, ON, Canada.
   [Gill, Sean E.; Mehta, Sanjay] Univ Western Ontario, Div Respirol, Schulich Sch Med & Dent, London, ON, Canada.
   [Gill, Sean E.; Mehta, Sanjay] Univ Western Ontario, Dept Med, Schulich Sch Med & Dent, London, ON, Canada.
   [Gill, Sean E.] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada.
   [Mehta, Sanjay] Victoria Hosp, London Hlth Sci Ctr, Div Respirol, London, ON N6A 5W9, Canada.
C3 London Health Sciences Centre; Western University (University of Western
   Ontario); Western University (University of Western Ontario); Western
   University (University of Western Ontario); Western University
   (University of Western Ontario); London Health Sciences Centre;
   University of Victoria; Western University (University of Western
   Ontario)
RP Mehta, S (corresponding author), London Hlth Sci Ctr, Lawson Hlth Res Inst, Ctr Crit Illness Res, London, ON, Canada.
EM Sanjay.Mehta@lhsc.on.ca
RI Gill, Sean E/G-4057-2012; Mehta, Sanjay/G-3332-2011
OI Mehta, Sanjay/0000-0002-7707-1056
FU Heart & Stroke Foundation of Ontario/Canada [G-13-0003039]; Ontario
   Thoracic Society; Lawson Health Research Institute
FX This work was supported by Heart & Stroke Foundation of Ontario/Canada
   grant #G-13-0003039, the Ontario Thoracic Society, and the Lawson Health
   Research Institute.
CR Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359
   [Anonymous], CRIT CARE MED
   Bastarache JA, 2009, AM J PHYSIOL-LUNG C, V297, pL1035, DOI 10.1152/ajplung.00214.2009
   Boerma EC, 2007, CRIT CARE MED, V35, P1055, DOI 10.1097/01.CCM.0000259527.89927.F9
   Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429
   Boos CJ, 2006, J THROMB HAEMOST, V4, P2509, DOI 10.1111/j.1538-7836.2006.02172.x
   Cines DB, 1998, BLOOD, V91, P3527
   Darwish I, 2013, VIRULENCE, V4, P572, DOI 10.4161/viru.25740
   De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC
   De Backer D, 2014, VIRULENCE, V5, P73, DOI 10.4161/viru.26482
   De Backer D, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-27
   Dellinger R, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8
   Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001
   DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012
   Farley KS, 2008, MICROVASC RES, V76, P208, DOI 10.1016/j.mvr.2008.07.004
   Farley KS, 2009, AM J PHYSIOL-LUNG C, V296, pL480, DOI 10.1152/ajplung.90201.2008
   Farley KS, 2006, AM J PHYSIOL-LUNG C, V290, pL1164, DOI 10.1152/ajplung.00248.2005
   Ferrer R, 2009, AM J RESP CRIT CARE, V180, P861, DOI 10.1164/rccm.200812-1912OC
   Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005
   Fujita M, 1998, INT ARCH ALLERGY IMM, V117, P202, DOI 10.1159/000024011
   Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137
   Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96
   Gill SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088501
   Glauser MP, 2000, CRIT CARE MED, V28, pS4, DOI 10.1097/00003246-200009001-00002
   GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662, DOI 10.1002/jlb.55.5.662
   Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545
   Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138
   HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831
   Hasleton PS, 1999, HISTOPATHOLOGY, V34, P285
   Hebert MJ, 1998, AM J PATHOL, V152, P523
   Hemmer CJ, 2008, CRIT CARE MED, V36, P2562, DOI 10.1097/CCM.0b013e31818441ee
   Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214
   Hotchkiss RS, 2002, CRIT CARE MED, V30, pS225, DOI 10.1097/00003246-200205001-00009
   Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333
   Hu HX, 2009, MICROVASC RES, V78, P33, DOI 10.1016/j.mvr.2009.04.005
   Husak Liudmila, 2010, Healthc Q, V13 Spec No, P35
   Joussen AM, 2002, FASEB J, V16, P76, DOI 10.1096/fj.02-0157fje
   Edul VSK, 2012, CRIT CARE MED, V40, P1443, DOI 10.1097/CCM.0b013e31823dae59
   Kasa A, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974448
   KINDT GC, 1991, J APPL PHYSIOL, V70, P1575, DOI 10.1152/jappl.1991.70.4.1575
   King EG, 2014, LAB INVEST, V94, P4, DOI 10.1038/labinvest.2013.110
   Kovarova M, 2012, J IMMUNOL, V189, P2006, DOI 10.4049/jimmunol.1201065
   LAM C, 1994, J CLIN INVEST, V94, P2077, DOI 10.1172/JCI117562
   Lang JD, 2002, CHEST, V122, p314S, DOI 10.1378/chest.122.6_suppl.314S
   Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121
   Li JM, 2007, FREE RADICAL BIO MED, V43, P976, DOI 10.1016/j.freeradbiomed.2007.06.001
   Liaudet L, 2013, CURR VASC PHARMACOL, V11, P196
   Manicone AM, 2009, EXPERT REV CLIN IMMU, V5, P63, DOI 10.1586/1744666X.5.1.63
   Matsuda N, 2007, CARDIOVASC RES, V76, P132, DOI 10.1016/j.cardiores.2007.05.024
   Matsuda N, 2010, AM J PHYSIOL-HEART C, V298, pH92, DOI 10.1152/ajpheart.00069.2009
   Maurer K, 2015, CELL HOST MICROBE, V17, P429, DOI 10.1016/j.chom.2015.03.001
   Mehta D, 2014, AM J PHYSIOL-LUNG C, V307, pL924, DOI 10.1152/ajplung.00318.2014
   Mehta S, 2005, VASC PHARMACOL, V43, P390, DOI 10.1016/j.vph.2005.08.013
   Nguyen HB, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-6
   Opal SM, 2015, J INTERN MED, V277, P277, DOI 10.1111/joim.12331
   Perl M, 2011, EXPERT REV RESP MED, V5, P115, DOI [10.1586/ers.10.92, 10.1586/ERS.10.92]
   Qing DY, 2014, AM J RESP CRIT CARE, V190, P1243, DOI 10.1164/rccm.201406-1095OC
   Razavi HM, 2005, CRIT CARE MED, V33, P1333, DOI 10.1097/01.CCM.0000165445.48350.4F
   Razavi HM, 2004, AM J RESP CRIT CARE, V170, P227, DOI 10.1164/rccm.200306-846OC
   Razavi HM, 2002, CRIT CARE MED, V30, P868, DOI 10.1097/00003246-200204000-00026
   Reinhart K, 2002, CRIT CARE MED, V30, pS302, DOI 10.1097/00003246-200205001-00021
   Rudkowski JC, 2004, AM J PHYSIOL-LUNG C, V286, pL793, DOI 10.1152/ajplung.00266.2003
   Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F
   Sandrock CE, 2010, SEMIN RESP CRIT CARE, V31, P66, DOI 10.1055/s-0029-1246290
   Schmidt EP, 2011, PHYSIOLOGY, V26, P334, DOI 10.1152/physiol.00011.2011
   Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013
   Shapiro NI, 2011, CRIT CARE, V15, DOI 10.1186/cc10044
   Sharma S, 2010, VASC PHARMACOL, V52, P182, DOI 10.1016/j.vph.2009.11.010
   Shelton JL, 2008, MICROVASC RES, V76, P80, DOI 10.1016/j.mvr.2008.06.001
   Shelton JL, 2007, MICROVASC RES, V74, P23, DOI 10.1016/j.mvr.2007.02.008
   Shelton JL, 2006, MICROVASC RES, V71, P40, DOI 10.1016/j.mvr.2005.11.003
   Skibsted S, 2013, SHOCK, V39, P427, DOI 10.1097/SHK.0b013e3182903f0d
   Starr A, 2008, CARDIOVASC RES, V78, P139, DOI 10.1093/cvr/cvn012
   Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327
   Subbanna S, 2013, NEUROBIOL DIS, V54, P475, DOI 10.1016/j.nbd.2013.01.022
   Sukriti S, 2014, PULM CIRC, V4, P535, DOI 10.1086/677356
   Trzeciak S, 2007, ANN EMERG MED, V49, P88, DOI 10.1016/j.annemergmed.2006.08.021
   Tyml K, 2011, MICROCIRCULATION, V18, P152, DOI 10.1111/j.1549-8719.2010.00080.x
   Vallet B, 2002, CRIT CARE MED, V30, pS229, DOI 10.1097/00003246-200205001-00010
   Wang LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055311
   Wang LF, 2012, SHOCK, V37, P539, DOI 10.1097/SHK.0b013e31824dcb5a
   Wang LF, 2010, BIOCHEM BIOPH RES CO, V401, P207, DOI 10.1016/j.bbrc.2010.09.029
   Wang LF, 2002, AM J RESP CRIT CARE, V165, P1634, DOI 10.1164/rccm.2110017
   Wang L, 2007, AM J RESP CELL MOL, V36, P497, DOI 10.1165/rcmb.2005-0425OC
   Wang Q, 2002, AM J RESP CRIT CARE, V166, P872, DOI 10.1164/rccm.2201007
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035
   Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7
   Wu F, 2014, AM J PHYSIOL-LUNG C, V307, pL987, DOI 10.1152/ajplung.00063.2014
   Xing K, 2012, CRIT CARE, V16, DOI 10.1186/cc11145
   Zhao JL, 2015, AM J TRANSL RES, V7, P474
   Zhou M, 2004, ANN SURG, V240, P321, DOI 10.1097/01.sla.0000133253.45591.5b
NR 92
TC 126
Z9 144
U1 0
U2 21
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1465-993X
J9 RESP RES
JI Respir. Res.
PD SEP 16
PY 2015
VL 16
AR 109
DI 10.1186/s12931-015-0266-7
PG 13
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA CR6KD
UT WOS:000361454600001
PM 26376777
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Konya, V
   Maric, J
   Jandl, K
   Luschnig, P
   Aringer, I
   Lanz, I
   Platzer, W
   Theiler, A
   Barnthaler, T
   Frei, R
   Marsche, G
   Marsh, LM
   Olschewski, A
   Lippe, IT
   Heinemann, A
   Schuligoi, R
AF Konya, Viktoria
   Maric, J.
   Jandl, Katharina
   Luschnig, P.
   Aringer, I.
   Lanz, I.
   Platzer, Wolfgang
   Theiler, Anna
   Baernthaler, T.
   Frei, R.
   Marsche, Gunther
   Marsh, Leigh M.
   Olschewski, Andrea
   Lippe, I. T.
   Heinemann, Akos
   Schuligoi, Rufina
TI Activation of EP4 receptors prevents endotoxin-induced neutrophil
   infiltration into the airways and enhances microvascular barrier
   function
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Article
ID TUMOR-NECROSIS-FACTOR; PROSTAGLANDIN E-2; LUNG INFLAMMATION; PULMONARY;
   OUTCOMES; ASTHMA; PGE(2); PERMEABILITY; PHARMACOLOGY; ASSOCIATION
AB Background and PurposePulmonary vascular dysfunction is a key event in acute lung injury. We recently demonstrated that PGE(2), via activation of E-prostanoid (EP)(4) receptors, strongly enhances microvascular barrier function in vitro. The aim of this study was to investigate the beneficial effects of concomitant EP4 receptor activation in murine models of acute pulmonary inflammation.
   Experimental ApproachPulmonary inflammation in male BALB/c mice was induced by LPS (20 g per mouse intranasally) or oleic acid (0.15 Lg(-1), i.v(.)). In-vitro, endothelial barrier function was determined by measuring electrical impedance.
   Key ResultsPGE(2) activation of EP4 receptors reduced neutrophil infiltration, pulmonary vascular leakage and TNF- concentration in bronchoalveolar lavage fluid from LPS-induced pulmonary inflammation. Similarly, pulmonary vascular hyperpermeability induced by oleic acid was counteracted by EP4 receptor activation. In lung function assays, the EP4 agonist ONO AE1-329 restored the increased resistance and reduced compliance upon methacholine challenge in mice treated with LPS or oleic acid. In agreement with these findings, EP4 receptor activation increased the in vitro vascular barrier function of human and mouse pulmonary microvascular endothelial cells and diminished the barrier disruption induced by LPS. The EP2 agonist ONO AE1-259 likewise reversed LPS-induced lung dysfunction without enhancing vascular barrier function.
   Conclusion and ImplicationsOur results show that activation of the EP4 receptor strengthens the microvascular barrier function and thereby ameliorates the pathology of acute lung inflammation, including neutrophil infiltration, vascular oedema formation and airway dysfunction. This suggests a potential benefit for EP4 agonists in acute pulmonary inflammation.
C1 [Konya, V.; Maric, J.; Jandl, K.; Luschnig, P.; Aringer, I.; Lanz, I.; Platzer, W.; Theiler, A.; Baernthaler, T.; Frei, R.; Marsche, G.; Lippe, I. T.; Heinemann, A.; Schuligoi, R.] Med Univ Graz, Inst Expt & Clin Pharmacol, A-8010 Graz, Austria.
   [Aringer, I.] Med Univ Graz, Dept Internal Med, Clin Div Nephrol, Graz, Austria.
   [Marsh, L. M.; Olschewski, A.] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria.
C3 Medical University of Graz; Medical University of Graz; Ludwig Boltzmann
   Institute
RP Heinemann, A (corresponding author), Med Univ Graz, Inst Expt & Clin Pharmacol, Univ Pl 4, A-8010 Graz, Austria.
EM akos.heinemann@medunigraz.at
RI Marsh, Leigh/AAB-5125-2021
OI Marsh, Leigh/0000-0002-1754-9249; Heinemann, Akos/0000-0002-8554-2372;
   Jandl, Katharina/0000-0002-7892-6618; Schuligoi,
   Rufina/0000-0002-9338-6904; Olschewski, Andrea/0000-0002-8189-3634;
   Barnthaler, Thomas/0000-0002-4988-3700; Konya,
   Viktoria/0000-0002-7999-9093; Marsche, Gunther/0000-0002-2422-5381
FU Austrian Science Fund FWF [P22521-B18, P25531-B23, P26185-B19,
   P21004-B02, P22976-B18]; Jubilaumsfonds of Austrian National Bank
   [14263, 14853]; DK-MOLIN [FWF - W1241]; Austrian Science Fund (FWF)
   [P21004, P22976, P25531, P26185, W1241] Funding Source: Austrian Science
   Fund (FWF); Austrian Science Fund (FWF) [P 22521, P 22976, P 21004]
   Funding Source: researchfish
FX This work was supported by the Austrian Science Fund FWF (Grant
   P22521-B18 to A. H., P25531-B23 to V. K., P26185-B19 to R. S. and
   P21004-B02, P22976-B18 to G. M.) and the Jubilaumsfonds of the Austrian
   National Bank (14263 to A. H. and 14853 to G. M.). K. J., I. A. and J.
   M. were funded by the PhD Program DK-MOLIN (FWF - W1241). The authors
   appreciate the excellent technical assistance of Martina Ofner and Iris
   Red.
CR Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8
   af Forselles KJ, 2011, BRIT J PHARMACOL, V164, P1847, DOI 10.1111/j.1476-5381.2011.01495.x
   Aggarwal S, 2010, CLIN EXP ALLERGY, V40, P85, DOI 10.1111/j.1365-2222.2009.03386.x
   Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445
   Amann R, 1999, INFLAMM RES, V48, P632, DOI 10.1007/s000110050514
   Benyahia C, 2012, PULM PHARMACOL THER, V25, P115, DOI 10.1016/j.pupt.2011.12.012
   Bhargava R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061405
   Birrell MA, 2015, THORAX, V70, P740, DOI 10.1136/thoraxjnl-2014-206592
   Birukov KG, 2013, COMPR PHYSIOL, V3, P429, DOI 10.1002/cphy.c100066
   Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036
   Birukova AA, 2013, EUR RESPIR J, V41, P165, DOI 10.1183/09031936.00148311
   Birukova AA, 2012, AM J PHYSIOL-LUNG C, V302, pL965, DOI 10.1152/ajplung.00292.2011
   Birukova AA, 2010, TRANSL RES, V155, P44, DOI 10.1016/j.trsl.2009.09.002
   Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028
   Buckley J, 2011, THORAX, V66, P1029, DOI 10.1136/thx.2010.158568
   Bull TM, 2010, AM J RESP CRIT CARE, V182, P1123, DOI 10.1164/rccm.201002-0250OC
   deMoraes VLG, 1996, BRIT J PHARMACOL, V117, P1792
   El-Gamal D, 2012, ANTIOXID REDOX SIGN, V16, P129, DOI 10.1089/ars.2011.4090
   Goldman JL, 2014, PULM CIRC, V4, P280, DOI 10.1086/675991
   Haegens A, 2009, J IMMUNOL, V182, P7990, DOI 10.4049/jimmunol.0800377
   HOCKING DC, 1990, CIRC RES, V67, P68, DOI 10.1161/01.RES.67.1.68
   HORVATH CJ, 1988, P NATL ACAD SCI USA, V85, P9219, DOI 10.1073/pnas.85.23.9219
   Jacobson JR, 2007, CURR DRUG TARGETS, V8, P509, DOI 10.2174/138945007780362719
   Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI200214459
   Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI [10.1038/jcbfm.2010.220, 10.1111/j.1476-5381.2010.00872.x]
   Konya V, 2013, PHARMACOL THERAPEUT, V138, P485, DOI 10.1016/j.pharmthera.2013.03.006
   Konya V, 2013, J ALLERGY CLIN IMMUN, V131, P532, DOI 10.1016/j.jaci.2012.05.008
   Konya V, 2010, J ALLERGY CLIN IMMUN, V125, P1105, DOI 10.1016/j.jaci.2009.12.002
   Lee IT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072783
   Lesur I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011485
   Lin JY, 1996, INT IMMUNOL, V8, P499, DOI 10.1093/intimm/8.4.499
   Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009
   Maruyama T, 2000, Tanpakushitsu Kakusan Koso, V45, P1001
   McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x
   McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006
   MILLAR AB, 1989, LANCET, V2, P712, DOI 10.1016/S0140-6736(89)90772-1
   Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200
   Nemmar A, 2011, BRIT J PHARMACOL, V164, P1871, DOI 10.1111/j.1476-5381.2011.01442.x
   PAVORD ID, 1993, AM REV RESPIR DIS, V148, P87, DOI 10.1164/ajrccm/148.1.87
   Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143
   Peters T, 2010, J PHARMACOL EXP THER, V335, P424, DOI 10.1124/jpet.109.163253
   Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976
   Sturm EM, 2008, J IMMUNOL, V181, P7273, DOI 10.4049/jimmunol.181.10.7273
   Tilley SL, 2003, AM J PHYSIOL-LUNG C, V284, pL599, DOI 10.1152/ajplung.00324.2002
   van Rijt LS, 2004, J IMMUNOL METHODS, V288, P111, DOI 10.1016/j.jim.2004.03.004
   Vancheri C, 2004, TRENDS IMMUNOL, V25, P40, DOI 10.1016/j.it.2003.11.001
   Wang LF, 2002, AM J RESP CRIT CARE, V165, P1634, DOI 10.1164/rccm.2110017
   Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288
   Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368
   Xu S, 2014, CELL BIOCHEM BIOPHYS, V70, P521, DOI 10.1007/s12013-014-9951-2
   Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195
   Zaslona Z, 2014, J ALLERGY CLIN IMMUN, V133, P379, DOI 10.1016/j.jaci.2013.07.037
NR 54
TC 16
Z9 17
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1188
EI 1476-5381
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PD SEP
PY 2015
VL 172
IS 18
BP 4454
EP 4468
DI 10.1111/bph.13229
PG 15
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA CQ3GT
UT WOS:000360490800002
PM 26103450
OA Green Published, Bronze
DA 2023-08-21
ER

PT J
AU Hoegl, S
   Brodsky, KS
   Blackburn, MR
   Karmouty-Quintana, H
   Zwissler, B
   Eltzschig, HK
AF Hoegl, Sandra
   Brodsky, Kelley S.
   Blackburn, Michael R.
   Karmouty-Quintana, Harry
   Zwissler, Bernhard
   Eltzschig, Holger K.
TI Alveolar Epithelial A2B Adenosine Receptors in Pulmonary Protection
   during Acute Lung Injury
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; HYPOXIA-INDUCIBLE FACTOR; INFLAMMATION;
   CELLS; DISEASE; MODEL; MICE; IDENTIFICATION; MECHANISMS; CLEARANCE
AB Acute lung injury (ALI) is an acute inflammatory lung disease that causes morbidity and mortality in critically ill patients. However, there are many instances where ALI resolves spontaneously through endogenous pathways that help to control excessive lung inflammation. Previous studies have implicated the extracellular signaling molecule adenosine and signaling events through the A2B adenosine receptor in lung protection. In this context, we hypothesized that tissue-specific expression of the A2B adenosine receptor is responsible for the previously described attenuation of ALI. To address this hypothesis, we exposed mice with tissue-specific deletion of Adora2b to ALI, utilizing a two-hit model where intratracheal LPS treatment is followed by injurious mechanical ventilation. Interestingly, a head-to-head comparison of mice with deletion of Adora2b in the myeloid lineage (Adora2b(loxP/loxP) LysM Cre(+)), endothelial cells (Adora2b(loxP/loxP) VE-cadherin Cre(+)), or alveolar epithelial cells (Adora2b(loxP/loxP) SPC Cre(+)) revealed a selective increase in disease susceptibility in Adora2b(loxP/loxP) SPC Cre(+) mice. More detailed analysis of Adora2b(loxP/loxP) SPC Cre(+) mice confirmed elevated lung inflammation and attenuated alveolar fluid clearance. To directly deliver an A2B adenosine receptor-specific agonist to alveolar epithelial cells, we subsequently performed studies with inhaled BAY 60-6583. Indeed, aerosolized BAY 60-6583 treatment was associated with attenuated pulmonary edema, improved histologic lung injury, and dampened lung inflammation. Collectively, these findings suggest that alveolar epithelial A2B adenosine receptor signaling contributes to lung protection, and they implicate inhaled A2B adenosine receptor agonists in ALI treatment.
C1 [Hoegl, Sandra; Brodsky, Kelley S.; Eltzschig, Holger K.] Univ Colorado, Sch Med, Dept Anesthesiol, Organ Protect Program, Aurora, CO 80045, United States.
   [Hoegl, Sandra; Zwissler, Bernhard] Univ Munich, Univ Hosp, German Ctr Lung Res, Dept Anesthesiol,Comprehens Pneumol Ctr Munich, D-81377 Munich, Germany.
   [Blackburn, Michael R.; Karmouty-Quintana, Harry] Univ Texas Houston, Hlth Sci Ctr Houston, Houston, TX 77030, United States.
C3 University of Colorado System; University of Colorado Anschutz Medical
   Campus; University of Munich; University of Texas System; University of
   Texas Health Science Center Houston
RP Hoegl, S (corresponding author), Univ Munich, Univ Hosp, Dept Anesthesiol, Marchioninistr 15, D-81377 Munich, Germany.
EM Sandra.Hoegl@med.uni-muenchen.de
RI Karmouty-Quintana, Harry/ABC-9144-2020
OI Karmouty-Quintana, Harry/0000-0003-4753-9823; Blackburn,
   Michael/0000-0002-1394-9966; Frank, Sandra/0000-0002-1749-0339
FU Leopoldina-Postdoc-Stipendium from the Deutsche Akademie der
   Naturforscher Leopoldina-German National Academy of Science [LPDS
   2012-02]; National Institutes of Health [HL114457, R01 DK097075, R01
   HL0921, R01 DK083385, R01 HL098294, POIHL114457-01]; Crohn's and Colitis
   Foundation of America
FX This work was supported by research funding by the
   Leopoldina-Postdoc-Stipendium (LPDS 2012-02) from the Deutsche Akademie
   der Naturforscher Leopoldina-German National Academy of Science (to
   S.H.), National Institutes of Health Program Project Grant HL114457 (to
   M.R.B.), National Institutes of Health Grants R01 DK097075, R01 HL0921,
   R01 DK083385, R01 HL098294, and POIHL114457-01, and by a grant from the
   Crohn's and Colitis Foundation of America (to H.K.E.).
CR Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643
   Belikoff BG, 2011, J IMMUNOL, V186, P2444, DOI 10.4049/jimmunol.1001567
   Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159
   Cagnina RE, 2009, AM J PHYSIOL-LUNG C, V297, pL467, DOI 10.1152/ajplung.90553.2008
   Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960
   Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5
   Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295
   Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203
   Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127
   Eckle T, 2014, J IMMUNOL, V192, P1249, DOI 10.4049/jimmunol.1100593
   Eckle T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001665
   Eckle T, 2013, FASEB J, V27, P3078, DOI 10.1096/fj.13-228551
   Eckle T, 2009, PHYSIOLOGY, V24, P298, DOI 10.1152/physiol.00022.2009
   Ehrentraut H, 2013, FASEB J, V27, P2207, DOI 10.1096/fj.12-225201
   Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750
   Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283
   Grenz A, 2012, J IMMUNOL, V189, P4566, DOI 10.4049/jimmunol.1201651
   Hardiman KM, 2001, AM J PHYSIOL-LUNG C, V281, pL722, DOI 10.1152/ajplung.2001.281.3.L722
   Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802
   Hoegl S, 2011, AM J RESP CELL MOL, V44, P369, DOI 10.1165/rcmb.2009-0440OC
   Hoegl S, 2009, RESP MED, V103, P463, DOI 10.1016/j.rmed.2008.09.020
   HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182
   Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085
   Jackson EK, 2009, J BIOL CHEM, V284, P33097, DOI 10.1074/jbc.M109.053876
   Karmouty-Quintana H, 2012, FASEB J, V26, P2546, DOI 10.1096/fj.11-200907
   Krombach F, 1996, EUR RESPIR J, V9, P984, DOI 10.1183/09031936.96.09050984
   Linden J, 2012, ARTERIOSCL THROM VAS, V32, P2097, DOI 10.1161/ATVBAHA.111.226837
   Manzo ND, 2012, AM J RESP CELL MOL, V47, P349, DOI 10.1165/rcmb.2011-0257OC
   Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST
   Messier EM, 2012, EXP LUNG RES, V38, P363, DOI 10.3109/01902148.2012.713077
   Mikkelsen ME, 2013, SHOCK, V40, P375, DOI 10.1097/SHK.0b013e3182a64682
   Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a
   Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009
   Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Schelling G, 2000, INTENS CARE MED, V26, P1304, DOI 10.1007/s001340051342
   Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035
   Schneider T, 1996, J IMMUNOL METHODS, V198, P1, DOI 10.1016/0022-1759(96)00143-3
   Singer K., 2011, AM J RESP CRIT CARE, V183, pA5105
   Skuli N, 2009, BLOOD, V114, P469, DOI 10.1182/blood-2008-12-193581
   SMEDIRA N, 1991, J APPL PHYSIOL, V70, P1827, DOI 10.1152/jappl.1991.70.4.1827
   Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303
   Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669
   Taylor CT, 2010, PHYSIOLOGY, V25, P272, DOI 10.1152/physiol.00029.2010
   Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Yang D, 2008, P NATL ACAD SCI USA, V105, P792, DOI 10.1073/pnas.0705563105
   Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933
   Zhou Y, 2011, J IMMUNOL, V186, P1097, DOI 10.4049/jimmunol.1002907
NR 51
TC 67
Z9 68
U1 0
U2 6
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD AUG 15
PY 2015
VL 195
IS 4
BP 1815
EP 1824
DI 10.4049/jimmunol.1401957
PG 10
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA CP6QO
UT WOS:000360013200051
PM 26188061
OA Green Accepted, Bronze
DA 2023-08-21
ER

PT J
AU Shah, D
   Romero, F
   Duong, M
   Wang, ND
   Paudyal, B
   Suratt, BT
   Kallen, CB
   Sun, JX
   Zhu, Y
   Walsh, K
   Summer, R
AF Shah, Dilip
   Romero, Freddy
   Duong, Michelle
   Wang, Nadan
   Paudyal, Bishnuhari
   Suratt, Benjamin T.
   Kallen, Caleb B.
   Sun, Jianxin
   Zhu, Ying
   Walsh, Kenneth
   Summer, Ross
TI Obesity-induced adipokine imbalance impairs mouse pulmonary vascular
   endothelial function and primes the lung for injury
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PHENOTYPIC HETEROGENEITY; NEUTROPHIL RECRUITMENT; ADIPOSE-TISSUE;
   INFLAMMATION; DYSFUNCTION; MECHANISMS; JUNCTIONS; RESPONSES
AB Obesity is a risk factor for the development of acute respiratory distress syndrome (ARDS) but mechanisms mediating this association are unknown. While obesity is known to impair systemic blood vessel function, and predisposes to systemic vascular diseases, its effects on the pulmonary circulation are largely unknown. We hypothesized that the chronic low grade inflammation of obesity impairs pulmonary vascular homeostasis and primes the lung for acute injury. The lung endothelium from obese mice expressed higher levels of leukocyte adhesion markers and lower levels of cell-cell junctional proteins when compared to lean mice. We tested whether systemic factors are responsible for these alterations in the pulmonary endothelium; treatment of primary lung endothelial cells with obese serum enhanced the expression of adhesion proteins and reduced the expression of endothelial junctional proteins when compared to lean serum. Alterations in pulmonary endothelial cells observed in obese mice were associated with enhanced susceptibility to LPS-induced lung injury. Restoring serum adiponectin levels reversed the effects of obesity on the lung endothelium and attenuated susceptibility to acute injury. Our work indicates that obesity impairs pulmonary vascular homeostasis and enhances susceptibility to acute injury and provides mechanistic insight into the increased prevalence of ARDS in obese humans.
C1 [Shah, Dilip; Romero, Freddy; Duong, Michelle; Wang, Nadan; Sun, Jianxin; Zhu, Ying; Summer, Ross] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107, United States.
   [Shah, Dilip; Romero, Freddy; Duong, Michelle; Wang, Nadan; Zhu, Ying; Summer, Ross] Thomas Jefferson Univ, Jane & Leonard Korman Lung Ctr, Philadelphia, PA 19107, United States.
   [Paudyal, Bishnuhari] Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107, United States.
   [Suratt, Benjamin T.] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405, United States.
   [Kallen, Caleb B.] Thomas Jefferson Univ, Dept Obstet & Gynecol, Philadelphia, PA 19107, United States.
   [Zhu, Ying] Second Mil Med Univ, Changhai Hosp, Dept Resp Med, Shanghai, China.
   [Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118, United States.
C3 Jefferson University; Jefferson University; Jefferson University;
   University of Vermont; Jefferson University; Naval Medical University;
   Boston University
RP Summer, R (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA.
EM Ross.Summer@jefferson.edu
RI , Ben/L-5749-2019
OI Shah, Dilip/0000-0002-4248-5611; Kallen, Caleb/0000-0002-4156-6719;
   Wang, Nadan/0000-0002-1682-080X; Paudyal, Ben/0000-0002-8388-9057
FU National Institute of Health (NIH) [R01HL105490]
FX Funding for this work was provided by the National Institute of Health
   (NIH) R01HL105490. The authors would like to thank Drs. Steven McKenzie
   and Shaji Abrabram, Cardeza Foundation for Hematologic Research and
   Department of Medicine, Thomas Jefferson University, for providing
   equipment for performing complete blood counts.
CR Ahasic AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089170
   Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a
   Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae
   Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110
   Boschetto P, 2012, RESPIROLOGY, V17, P422, DOI 10.1111/j.1440-1843.2011.02118.x
   Cohen TS, 2013, J CLIN INVEST, V123, P1630, DOI 10.1172/JCI66142
   Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008
   Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897
   Gajic O, 2011, AM J RESP CRIT CARE, V183, P462, DOI 10.1164/rccm.201004-0549OC
   Gong MN, 2010, THORAX, V65, P44, DOI 10.1136/thx.2009.117572
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Gu WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090426
   Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568
   Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X
   Ikeda Y, 2005, J BIOL CHEM, V280, P29661, DOI 10.1074/jbc.M411694200
   Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245
   Koh GCKW, 2012, CRIT CARE MED, V40, P1835, DOI 10.1097/CCM.0b013e31824e1696
   Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399
   Konter J, 2013, PULM PHARMACOL THER, V26, P427, DOI 10.1016/j.pupt.2012.03.003
   Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426
   Kordonowy LL, 2012, AM J RESP CELL MOL, V47, P120, DOI 10.1165/rcmb.2011-0334OC
   Lu FL, 2006, AM J PHYSIOL-LUNG C, V290, pL856, DOI 10.1152/ajplung.00386.2005
   Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881
   Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008
   Orrington-Myers J, 2006, AM J PHYSIOL-LUNG C, V291, pL764, DOI 10.1152/ajplung.00502.2005
   Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921
   Ouedraogo R, 2007, J CLIN INVEST, V117, P1718, DOI 10.1172/JCI29623
   Parker-Duffen JL, 2014, J BIOL CHEM, V289, P16200, DOI 10.1074/jbc.M114.548115
   Qin FZ, 2012, CIRCULATION, V125, P1757, DOI 10.1161/CIRCULATIONAHA.111.067801
   Raghavendran K, 2011, CRIT CARE MED, V39, P818, DOI 10.1097/CCM.0b013e31820a856b
   Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701
   Romero F., 2014, AM J RESP CELL MOL B
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   SAYE JA, 1989, AM J PHYSIOL, V256, pC448, DOI 10.1152/ajpcell.1989.256.2.C448
   Shah D, 2014, AM J PHYSIOL-LUNG C, V306, pL152, DOI 10.1152/ajplung.00229.2013
   Stapleton RD, 2010, CHEST, V138, P568, DOI 10.1378/chest.10-0014
   Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937
   Ubags ND, 2014, CRIT CARE MED, V42, pE143, DOI 10.1097/CCM.0000000000000048
   Van Eeden S, 2012, AM J RESP CRIT CARE, V186, P11, DOI 10.1164/rccm.201203-0455PP
   Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487
   van Meurs M, 2012, SHOCK, V37, P392, DOI 10.1097/SHK.0b013e318248225e
   Vernooy JHJ, 2013, PULM PHARMACOL THER, V26, P464, DOI 10.1016/j.pupt.2013.03.016
NR 44
TC 62
Z9 66
U1 0
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 12
PY 2015
VL 5
AR 11362
DI 10.1038/srep11362
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CK3YK
UT WOS:000356152600001
PM 26068229
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Bai, XZ
   Fan, L
   He, T
   Jia, WB
   Yang, LL
   Zhang, J
   Liu, Y
   Shi, JH
   Su, LL
   Hu, DH
AF Bai, Xiaozhi
   Fan, Lei
   He, Ting
   Jia, Wenbin
   Yang, Longlong
   Zhang, Jun
   Liu, Yang
   Shi, Jihong
   Su, Linlin
   Hu, Dahai
TI SIRT1 protects rat lung tissue against severe burn-induced remote ALI by
   attenuating the apoptosis of PMVECs via p38 MAPK signaling
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PERIODONTAL-LIGAMENT CELLS; OXIDATIVE STRESS; ENDOTHELIAL-CELLS;
   INFLAMMATORY RESPONSE; VASCULAR-PERMEABILITY; RESVERATROL PROTECTS;
   OVINE MODEL; IN-VIVO; INJURY; SEPSIS
AB Silent information regulator type-1 (SIRT1) has been reported to be involved in the cardiopulmonary protection. However, its role in the pathogenesis of burn-induced remote acute lung injury (ALI) is currently unknown. The present study aims to investigate the role of SIRT1 in burn-induced remote ALI and the involved signaling pathway. We observed that SIRT1 expression in rat lung tissue after burn injury appeared an increasing trend after a short period of suppression. The upregulation of SIRT1 stimulated by resveratrol exhibited remission of histopathologic changes, reduction of cell apoptosis, and downregulation of pro-inflammatory cytokines in rat pulmonary tissues suffering from severe burn. We next used primary pulmonary microvascular endothelial cells (PMVECs) challenged by burn serum (BS) to simulate in vivo rat lung tissue after burn injury, and found that BS significantly suppressed SIRT1 expression, increased cell apoptosis, and activated p38 MAPK signaling. The use of resveratrol reversed these effects, while knockdown of SIRT1 by shRNA further augmented BS-induced increase of cell apoptosis and activation of p38 MAPK. Taken together, these results indicate that SIRT1 might protect lung tissue against burn-induced remote ALI by attenuating PMVEC apoptosis via p38 MAPK signaling, suggesting its potential therapeutic effects on the treatment of ALI.
C1 [Bai, Xiaozhi; Fan, Lei; He, Ting; Jia, Wenbin; Yang, Longlong; Liu, Yang; Shi, Jihong; Su, Linlin; Hu, Dahai] Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shaanxi, China.
   [Zhang, Jun] 205 Hosp Chinese Peoples Liberat Army, Dept Burn & Plast Surg, Jinzhou, Liaoning, China.
C3 Air Force Military Medical University
RP Hu, DH (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shaanxi, Peoples R China.
EM linlinsu@fmmu.edu.cn; burnlab@fmmu.edu.cn
OI Hu, Dahai/0000-0001-5543-092X
FU National Natural Science Foundation of China [81372069]; Xijing Hospital
   Natural Science Funds for Distinguished Young Scientists [XJZT14J06]
FX This study was supported by National Natural Science Foundation of China
   (grant no: 81372069 to D.H.) and Xijing Hospital Natural Science Funds
   for Distinguished Young Scientists (grant no: XJZT14J06 to L.S.)
CR Bao XM, 2009, ACTA PHARMACOL SIN, V30, P1392, DOI 10.1038/aps.2009.135
   Bardales RH, 1996, AM J PATHOL, V149, P845
   Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   Becatti M, 2012, CELL MOL LIFE SCI, V69, P2245, DOI 10.1007/s00018-012-0925-5
   Brakenhielm E, 2001, FASEB J, V15, P1798, DOI 10.1096/fj.01-0028fje
   Burns AR, 2003, PHYSIOL REV, V83, P309, DOI 10.1152/physrev.00023.2002
   CHEN SF, 1995, MICROVASC RES, V50, P119, DOI 10.1006/mvre.1995.1044
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, pH2721, DOI 10.1152/ajpheart.00235.2008
   Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101
   Du G, 2014, INT J MOL MED, V34, P177, DOI 10.3892/ijmm.2014.1740
   Fang Y, 2011, J TRAUMA, V71, P1297, DOI 10.1097/TA.0b013e3182127d48
   Fang Y, 2011, J BURN CARE RES, V32, pE82, DOI 10.1097/BCR.0b013e318217f84f
   Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197
   FRANKEL EN, 1993, LANCET, V341, P1103, DOI 10.1016/0140-6736(93)92472-6
   Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000
   Galani V, 2010, PATHOL RES PRACT, V206, P145, DOI 10.1016/j.prp.2009.12.002
   Gloor B, 2000, PANCREAS, V21, P414, DOI 10.1097/00006676-200011000-00013
   Guo F, 2009, BURNS, V35, P210, DOI 10.1016/j.burns.2008.05.021
   Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250
   Hoshi T, 1998, ANTICANCER RES, V18, P4347
   Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002
   Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218
   Jonkam CC, 2009, CRIT CARE, V13, DOI 10.1186/cc7720
   Kao CL, 2010, J ATHEROSCLER THROMB, V17, P970, DOI 10.5551/jat.4333
   Kawasaki M, 2000, AM J PATHOL, V157, P597, DOI 10.1016/S0002-9440(10)64570-1
   Kim YS, 2010, J CELL BIOCHEM, V111, P1310, DOI 10.1002/jcb.22858
   Kitamura Y, 2010, NEUROL MED-CHIR, V50, P456, DOI 10.2176/nmc.50.456
   Knobloch J, 2014, BASIC CLIN PHARMACOL, V114, P202, DOI 10.1111/bcpt.12129
   Lange M, 2008, CRIT CARE MED, V36, P1284, DOI 10.1097/CCM.0b013e318169ef74
   Lee SI, 2011, J ENDODONT, V37, P1525, DOI 10.1016/j.joen.2011.07.006
   Lee YM, 2011, J PERIODONTAL RES, V46, P712, DOI 10.1111/j.1600-0765.2011.01394.x
   Liang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068786
   Marko Peter, 2003, Curr Opin Anaesthesiol, V16, P183, DOI 10.1097/00001503-200304000-00012
   Maybauer MO, 2009, ANAESTHESIST, V58, P805, DOI 10.1007/s00101-009-1560-x
   Monafo WW, 1996, NEW ENGL J MED, V335, P1581, DOI 10.1056/NEJM199611213352108
   Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x
   Parihar A, 2008, BURNS, V34, P6, DOI 10.1016/j.burns.2007.04.009
   Park GJ, 2013, J PERIODONTAL RES, V48, P483, DOI 10.1111/jre.12030
   Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013
   Rieder SA, 2012, BRIT J PHARMACOL, V167, P1244, DOI 10.1111/j.1476-5381.2012.02063.x
   Rudkowski JC, 2004, AM J PHYSIOL-LUNG C, V286, pL793, DOI 10.1152/ajplung.00266.2003
   Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604
   Schmid E, 1997, SHOCK, V8, P119, DOI 10.1097/00024382-199708000-00010
   Turnage RH, 2002, WORLD J SURG, V26, P848, DOI 10.1007/s00268-002-4063-3
   Uruno A, 2008, HYPERTENS RES, V31, P2085, DOI 10.1291/hypres.31.2085
   Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X
   Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6
   Winnik S, 2012, CURR VASC PHARMACOL, V10, P693, DOI 10.2174/157016112803520756
   Xia L, 2011, HUM CELL, V24, P127, DOI 10.1007/s13577-011-0031-2
   Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006
   You QH, 2010, J SURG RES, V162, P110, DOI 10.1016/j.jss.2009.01.019
   Zhang JP, 2008, J TRAUMA, V65, P401, DOI 10.1097/TA.0b013e31817cf732
   Zhang WF, 2011, J BURN CARE RES, V32, pE51, DOI 10.1097/BCR.0b013e318217f8ae
NR 56
TC 42
Z9 46
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 20
PY 2015
VL 5
AR 10277
DI 10.1038/srep10277
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CJ3OC
UT WOS:000355392700001
PM 25992481
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Hecker, M
   Linder, T
   Ott, J
   Walmrath, HD
   Lohmeyer, J
   Vadasz, I
   Marsh, LM
   Herold, S
   Reichert, M
   Buchbinder, A
   Morty, RE
   Bausch, B
   Fischer, T
   Schulz, R
   Grimminger, F
   Witzenrath, M
   Barnes, M
   Seeger, W
   Mayer, K
AF Hecker, Matthias
   Linder, Tomke
   Ott, Juliane
   Walmrath, Hans-Dieter
   Lohmeyer, Juergen
   Vadasz, Istvan
   Marsh, Leigh M.
   Herold, Susanne
   Reichert, Martin
   Buchbinder, Anja
   Morty, Rory Edward
   Bausch, Britta
   Fischer, Tobias
   Schulz, Richard
   Grimminger, Friedrich
   Witzenrath, Martin
   Barnes, Matt
   Seeger, Werner
   Mayer, Konstantin
TI Immunomodulation by lipid emulsions in pulmonary inflammation: a
   randomized controlled trial
SO CRITICAL CARE
LA English
DT Article
ID ACUTE LUNG INJURY; POLYUNSATURATED FATTY-ACIDS;
   RESPIRATORY-DISTRESS-SYNDROME; CONTROLLED CLINICAL-TRIAL; CRITICALLY-ILL
   PATIENTS; TUMOR-NECROSIS-FACTOR; FISH-OIL; PARENTERAL-NUTRITION;
   ENDOTHELIAL-CELLS; HUMAN MONOCYTES
AB Introduction: Acute respiratory distress syndrome (ARDS) is a major cause of mortality in intensive care units. As there is rising evidence about immuno-modulatory effects of lipid emulsions required for parenteral nutrition of ARDS patients, we sought to investigate whether infusion of conventional soybean oil (SO)-based or fish oil (FO)-based lipid emulsions rich in either n-6 or n-3 fatty acids, respectively, may influence subsequent pulmonary inflammation.
   Methods: In a randomized controlled, single-blinded pilot study, forty-two volunteers received SO, FO, or normal saline for two days. Thereafter, volunteers inhaled pre-defined doses of lipopolysaccharide (LPS) followed by bronchoalveolar lavage (BAL) 8 or 24 h later. In the murine model of LPS-induced lung injury a possible involvement of resolvin E1 (RvE1) receptor ChemR23 was investigated. Wild-type and ChemR23 knockout mice were infused with both lipid emulsions and challenged with LPS intratracheally.
   Results: In volunteers receiving lipid emulsions, the fatty acid profile in the plasma and in isolated neutrophils and monocytes was significantly changed. Adhesion of isolated monocytes to endothelial cells was enhanced after infusion of SO and reduced by FO, however, no difference of infusion on an array of surface adhesion molecules was detected. In neutrophils and monocytes, LPS-elicited generation of pro-inflammatory cytokines increased in the SO and decreased in the FO group. LPS inhalation in volunteers evoked an increase in neutrophils in BAL fluids, which decreased faster in the FO group. While TNF-alpha in the BAL was increased in the SO group, IL-8 decreased faster in the FO group. In the murine model of lung injury, effects of FO similar to the volunteer group observed in wild-type mice were abrogated in ChemR23 knockout mice.
   Conclusions: After infusion of conventional lipid emulsions, leukocytes exhibited increased adhesive and pro-inflammatory features. In contrast, FO-based lipid emulsions reduced monocyte adhesion, decreased pro-inflammatory cytokines, and neutrophil recruitment into the alveolar space possibly mediated by ChemR23-signaling. Lipid emulsions thus exert differential effects in human volunteers and mice in vivo.
C1 [Hecker, Matthias; Linder, Tomke; Ott, Juliane; Walmrath, Hans-Dieter; Lohmeyer, Juergen; Vadasz, Istvan; Marsh, Leigh M.; Herold, Susanne; Reichert, Martin; Buchbinder, Anja; Bausch, Britta; Fischer, Tobias; Schulz, Richard; Grimminger, Friedrich; Seeger, Werner; Mayer, Konstantin] Univ Giessen, D-35392 Giessen, Germany.
   [Hecker, Matthias; Linder, Tomke; Ott, Juliane; Walmrath, Hans-Dieter; Lohmeyer, Juergen; Vadasz, Istvan; Marsh, Leigh M.; Herold, Susanne; Reichert, Martin; Buchbinder, Anja; Bausch, Britta; Fischer, Tobias; Schulz, Richard; Grimminger, Friedrich; Seeger, Werner; Mayer, Konstantin] Univ Giessen, Marburg Lung Ctr UGMLC, D-35392 Giessen, Germany.
   [Morty, Rory Edward] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodelling, Bad Nauheim, Germany.
   [Witzenrath, Martin] Charite, Med Klin Schwerpunkt Infektiol & Pneumol, D-13353 Berlin, Germany.
   [Barnes, Matt] Takeda Cambridge Ltd, Cambridge, England, United Kingdom.
   [Mayer, Konstantin] Univ Giessen, Marburg Lung Ctr UGMLC, Med Clin 2, D-35392 Giessen, Germany.
C3 Justus Liebig University Giessen; Justus Liebig University Giessen; Max
   Planck Society; Free University of Berlin; Humboldt University of
   Berlin; Charite Universitatsmedizin Berlin; Justus Liebig University
   Giessen
RP Mayer, K (corresponding author), Univ Giessen, Klinikstr 33, D-35392 Giessen, Germany.
EM konstantin.mayer@innere.med.uni-giessen.de
RI Vadasz, Istvan/AAO-8288-2021; Marsh, Leigh/AAB-5125-2021
OI Marsh, Leigh/0000-0002-1754-9249; Vadasz, Istvan/0000-0003-1370-9783;
   Seeger, Werner/0000-0003-1946-0894; Herold, Susanne/0000-0001-6343-0911
FU Deutsche Forschungsgemeinschaft (Project C3) [SFB Transregio 84];
   Bundesministerium fur Bildung und Forschung (Klinische Forschergruppe
   Pneumonie, Project A); German Center for Lung Research (DZL)
FX The great technical assistance of Andrea Mohr and Juliane Mest is
   greatfully acknowledged. This study has been funded by Deutsche
   Forschungsgemeinschaft (SFB Transregio 84, Project C3),
   Bundesministerium fur Bildung und Forschung (Klinische Forschergruppe
   Pneumonie, Project A), and German Center for Lung Research (DZL). The
   funding bodies played no role in the design, collection, analysis and
   interpretation of data or in writing of the manuscript, or in the
   decision to submit the manuscript for publication.
CR Adrie C, 2001, AM J RESP CRIT CARE, V164, P389, DOI 10.1164/ajrccm.164.3.2009088
   Alexis NE, 2003, J ALLERGY CLIN IMMUN, V112, P353, DOI 10.1067/mai.2003.1651
   Barbosa VM, 2010, CRIT CARE, V14, DOI 10.1186/cc8844
   Calder PC, 2007, PROSTAG LEUKOTR ESS, V77, P327, DOI 10.1016/j.plefa.2007.10.015
   Calfee CS, 2007, CHEST, V131, P913, DOI 10.1378/chest.06-1743
   Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601
   Caughey GE, 1997, J IMMUNOL, V158, P351
   Chabot F, 1998, EUR RESPIR J, V11, P745
   Chen B, 2010, JPEN-PARENTER ENTER, V34, P387, DOI 10.1177/0148607110362532
   ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501
   Grau-Carmona T, 2015, CRIT CARE MED, V43, P31, DOI 10.1097/CCM.0000000000000612
   Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627
   Hecker M, 2014, CRIT CARE, V18, DOI 10.1186/cc13850
   Hoogerwerf JJ, 2008, AM J RESP CRIT CARE, V178, P34, DOI 10.1164/rccm.200708-1261OC
   Hughes DA, 1996, AM J CLIN NUTR, V63, P267, DOI 10.1093/ajcn/63.2.267
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kline JN, 1999, AM J RESP CRIT CARE, V160, P297, DOI 10.1164/ajrccm.160.1.9808144
   Marik PE, 2008, INTENS CARE MED, V34, P1980, DOI 10.1007/s00134-008-1213-6
   Maris NA, 2005, AM J RESP CRIT CARE, V172, P878, DOI 10.1164/rccm.200503-451OC
   Torrinhas RSMD, 2013, CLIN NUTR, V32, P503, DOI 10.1016/j.clnu.2012.12.008
   Mayer K, 2006, CURR OPIN CLIN NUTR, V9, P140, DOI 10.1097/01.mco.0000214573.75062.0a
   Mayer K, 2003, J IMMUNOL, V171, P4837, DOI 10.4049/jimmunol.171.9.4837
   Mayer K, 2003, INTENS CARE MED, V29, P1472, DOI 10.1007/s00134-003-1900-2
   Mayer K, 2003, AM J RESP CRIT CARE, V167, P1321, DOI 10.1164/rccm.200207-674OC
   Mayer K, 2008, CURR OPIN CLIN NUTR, V11, P121, DOI 10.1097/MCO.0b013e3282f4cdc6
   Mayer K, 2009, AM J RESP CRIT CARE, V179, P474, DOI 10.1164/rccm.200807-1064OC
   Pradelli L, 2012, CRIT CARE, V16, DOI 10.1186/cc11668
   Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004
   Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137
   Rustan AC, 1998, BBA-LIPID LIPID MET, V1390, P245, DOI 10.1016/S0005-2760(97)00194-X
   Schaefer MB, 2008, ATHEROSCLEROSIS, V197, P630, DOI 10.1016/j.atherosclerosis.2007.09.004
   Schaefer MB, 2007, CRIT CARE MED, V35, P544, DOI 10.1097/01.CCM.0000253811.74112.B6
   Schober A, 2005, ANTIOXID REDOX SIGN, V7, P1249, DOI 10.1089/ars.2005.7.1249
   Schutte H, 1996, EUR RESPIR J, V9, P1858, DOI 10.1183/09031936.96.09091858
   Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294
   Sibelius U, 2002, CRIT CARE MED, V30, P2306, DOI 10.1097/00003246-200210000-00020
   Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024
   Smith DF, 2005, AM J PHYSIOL-HEART C, V289, pH1976, DOI 10.1152/ajpheart.00153.2005
   SPERLING RI, 1993, J CLIN INVEST, V91, P651, DOI 10.1172/JCI116245
   Stapleton RD, 2011, CRIT CARE MED, V39, P1655, DOI 10.1097/CCM.0b013e318218669d
   Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288
NR 41
TC 29
Z9 30
U1 0
U2 18
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1466-609X
EI 1364-8535
J9 CRIT CARE
JI Crit. Care
PD MAY 12
PY 2015
VL 19
AR 226
DI 10.1186/s13054-015-0933-6
PG 13
WC Critical Care Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA CI6GC
UT WOS:000354855700001
PM 25962383
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Herold, S
   Becker, C
   Ridge, KM
   Budinger, GRS
AF Herold, Susanne
   Becker, Christin
   Ridge, Karen M.
   Budinger, G. R. Scott
TI Influenza virus-induced lung injury: pathogenesis and implications for
   treatment
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Article
ID N-LINKED GLYCOSYLATION; RECEPTOR-BINDING SPECIFICITY; ALVEOLAR
   EPITHELIAL-CELLS; COLONY-STIMULATING FACTOR; AIRWAY STEM-CELLS; A VIRUS;
   PANDEMIC INFLUENZA; DENDRITIC CELLS; T-CELLS; NEURAMINIDASE INHIBITORS
AB The influenza viruses are some of the Most important human pathogens, causing substantial seasonal and pandemic morbidity and mortality. In humans, infection of the lower respiratory tract of can result in flooding of the alveolar compartment, development of acute respiratory distress syndrome and death from respiratory failure. Influenza-mediated damage of the airway, alveolar epithelium and alveolar endothelium results from a combination of: 1) intrinsic viral pathogenicity, attributable to its tropism for host airway and alveolar epithelial cells; and 2) a robust host innate immune response, which, while contributing to viral clearance, can worsen the severity of lung injury. In this review, we summarise the molecular events at the virus host interface during influenza virus infection, highlighting some of the important cellular responses. We discuss immune-mediated viral clearance, the mechanisms promoting or perpetuating lung injury, lung regeneration after influenza-induced injury, and recent advances in influenza prevention and therapy.
C1 [Herold, Susanne; Becker, Christin] Univ Giessen, Univ Giessen & Marburg Lung Ctr, Dept Internal Med 2, D-35390 Giessen, Germany.
   [Ridge, Karen M.; Budinger, G. R. Scott] Northwestern Univ, Pulm & Crit Care Med, Chicago, IL 60611, United States.
C3 Justus Liebig University Giessen; Northwestern University
RP Herold, S (corresponding author), Univ Giessen & Marburg Lung Ctr, Dept Internal Med 2, Klin Str 33, D-35392 Giessen, Germany.
EM susanne.herold@innere.med.uni-giessen.de
OI Peteranderl, Christin/0000-0003-3799-8268; Herold,
   Susanne/0000-0001-6343-0911
FU NHLBI NIH HHS [R01 HL124664, P01 HL071643] Funding Source: Medline
CR Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004
   Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106
   Anikina AG, 2014, B EXP BIOL MED+, V156, P833, DOI 10.1007/s10517-014-2463-7
   [Anonymous], 2014, Wkly Epidemiol Rec, V89, P93
   Antunes I, 2010, J VIROL, V84, P12564, DOI 10.1128/JVI.01559-10
   Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710
   Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449
   Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918
   Belser JA, 2007, J INFECT DIS, V196, P1493, DOI 10.1086/522609
   Belshe RB, 2009, NEW ENGL J MED, V360, P2667, DOI 10.1056/NEJMe0903995
   Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000
   Berri F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003229
   Beyleveld G, 2013, ANTIVIR RES, V100, P120, DOI 10.1016/j.antiviral.2013.07.018
   Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058
   Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06
   Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166
   Bradel-Tretheway BG, 2011, J VIROL, V85, P8569, DOI 10.1128/JVI.00496-11
   Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013
   Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020
   Brincks EL, 2008, J IMMUNOL, V181, P4918, DOI 10.4049/jimmunol.181.7.4918
   Cakarova L, 2009, AM J RESP CRIT CARE, V180, P521, DOI 10.1164/rccm.200812-1837OC
   Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08
   Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612
   Capelozzi VL, 2010, CLINICS, V65, P1229, DOI 10.1590/S1807-59322010001200003
   Carlson CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001136
   Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797
   Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10
   Monsalvo AC, 2011, NAT MED, V17, P195, DOI 10.1038/nm.2262
   Cortes Garcia M, 2012, J INFECTION, V64, P218
   Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407
   Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526
   Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864
   Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7
   De Clercq E, 2007, BIOCHEM PHARMACOL, V73, P911, DOI 10.1016/j.bcp.2006.09.014
   Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930
   Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538
   Droebner K, 2011, ANTIVIR RES, V92, P195, DOI 10.1016/j.antiviral.2011.08.002
   Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101
   Enserink M, 2005, SCIENCE, V309, P1976
   Estenssoro E, 2010, AM J RESP CRIT CARE, V182, P41, DOI [10.1164/201001-0037OC, 10.1164/rccm.201001-0037OC]
   Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921
   Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006
   Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005
   Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459
   GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365
   Ghoneim HE, 2013, J IMMUNOL, V191, P1250, DOI 10.4049/jimmunol.1300014
   Ghosh S, 2011, AM J RESP CELL MOL, V45, P1036, DOI 10.1165/rcmb.2010-0349OC
   Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137
   Grohskopf LA, 2014, MMWR-MORBID MORTAL W, V63, P691
   Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10
   Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448
   Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774
   Helft J, 2012, J CLIN INVEST, V122, P4037, DOI 10.1172/JCI60659
   Herold S, 2014, AM J RESP CRIT CARE, V189, P609, DOI 10.1164/rccm.201311-2041LE
   Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065
   Herold S, 2011, AM J RESP CRIT CARE, V183, P1380, DOI 10.1164/rccm.201009-1431OC
   Herold S, 2008, J EXP MED, V205, P3065, DOI 10.1084/jem.20080201
   Hillaire MLB, 2013, J INNATE IMMUN, V5, P197, DOI 10.1159/000346374
   Hogner K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003188
   Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012
   Huang FM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4595
   Hufford MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046581
   Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850
   Hui DSC, 2013, INFLUENZA OTHER RESP, V7, P52, DOI 10.1111/irv.12171
   Ichikawa A, 2013, AM J RESP CRIT CARE, V187, P65, DOI 10.1164/rccm.201203-0508OC
   Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110
   Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108
   Igarashi M, 2008, VIROLOGY, V376, P323, DOI 10.1016/j.virol.2008.03.036
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   Ivanov S, 2013, J VIROL, V87, P6911, DOI 10.1128/JVI.02943-12
   Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665
   Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695
   Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632
   Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC
   Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]
   Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106
   Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927
   Karlstrom A, 2009, J INFECT DIS, V199, P311, DOI 10.1086/596051
   Karupiah G, 1998, J EXP MED, V188, P1541, DOI 10.1084/jem.188.8.1541
   KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989
   Khoufache K, 2013, J CLIN INVEST, V123, P206, DOI 10.1172/JCI61667
   Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07
   Kim TS, 2014, IMMUNITY, V40, P400, DOI 10.1016/j.immuni.2014.02.004
   Kim TS, 2011, TRENDS IMMUNOL, V32, P225, DOI 10.1016/j.it.2011.02.006
   Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204
   Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951
   Kohlmeier JE, 2010, IMMUNITY, V33, P96, DOI 10.1016/j.immuni.2010.06.016
   Korteweg C, 2008, AM J PATHOL, V172, P1155, DOI 10.2353/ajpath.2008.070791
   Kourtis AP, 2014, NEW ENGL J MED, V371, P1077, DOI [10.1056/NEJMra1213566, 10.1056/NEJMc1408436]
   Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025
   Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013
   Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001
   Lackenby A, 2008, CURR OPIN INFECT DIS, V21, P626, DOI 10.1097/QCO.0b013e3283199797
   Lazrak A, 2009, FASEB J, V23, P3829, DOI 10.1096/fj.09-135590
   Leeman KT, 2014, CURR TOP DEV BIOL, V107, P207, DOI 10.1016/B978-0-12-416022-4.00008-1
   Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617
   Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005
   Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673
   Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562
   Lin KL, 2011, J IMMUNOL, V186, P508, DOI 10.4049/jimmunol.1001002
   Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10
   Ljungman P, 2011, HAEMATOL-HEMATOL J, V96, P1231, DOI 10.3324/haematol.2011.041913
   Londino JD, 2013, AM J PHYSIOL-LUNG C, V304, pL582, DOI 10.1152/ajplung.00314.2012
   Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636
   Ludwig S, 2014, INT J MED MICROBIOL, V304, P894, DOI 10.1016/j.ijmm.2014.08.016
   Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161
   Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI [10.1056/NEJMoa1401480, 10.1056/NEJMc1412050]
   Maelfait J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002570
   Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238
   Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC
   MASON RJ, 1994, AM J RESP CELL MOL, V11, P561, DOI 10.1165/ajrcmb.11.5.7524567
   Mazur I, 2007, CELL MICROBIOL, V9, P1683, DOI 10.1111/j.1462-5822.2007.00902.x
   McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014
   McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314
   McGill J, 2010, J EXP MED, V207, P521, DOI 10.1084/jem.20091711
   Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906
   Mock JR, 2014, MUCOSAL IMMUNOL, V7, P1440, DOI 10.1038/mi.2014.33
   Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]
   Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708
   Morens DM, 2012, NATURE, V486, P335, DOI 10.1038/nature11170
   Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694
   Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027
   Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740
   Moser EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004315
   Moss RB, 2012, J INFECT DIS, V206, P1844, DOI 10.1093/infdis/jis622
   Narasaraju T, 2010, AM J RESP CELL MOL, V42, P732, DOI 10.1165/rcmb.2008-0423OC
   Ortiz JR, 2013, AM J RESP CRIT CARE, V188, P710, DOI 10.1164/rccm.201212-2341OC
   Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196
   Pinto LH, 2007, MOL BIOSYST, V3, P18, DOI 10.1039/b611613m
   Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200
   Pociask DA, 2013, AM J PATHOL, V182, P1286, DOI 10.1016/j.ajpath.2012.12.007
   Pothlichet J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003256
   Radigan KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035788
   Rajsbaum R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003059
   Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945
   Reading PC, 2007, ADV EXP MED BIOL, V598, P279
   Riscili BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018166
   Rodrigue-Gervais IG, 2014, CELL HOST MICROBE, V15, P23, DOI 10.1016/j.chom.2013.12.003
   Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003
   ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U
   Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137
   Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769
   Sakai S, 2000, J VIROL, V74, P2472, DOI 10.1128/JVI.74.5.2472-2476.2000
   Santesso N, 2013, INFLUENZA OTHER RESP, V7, P76, DOI 10.1111/irv.12085
   Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681
   SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8
   Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412
   Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a
   Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118
   Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X
   Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012
   Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637
   Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025
   Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054
   Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350
   Sturrock A, 2012, AM J PHYSIOL-LUNG C, V302, pL343, DOI 10.1152/ajplung.00276.2011
   Sun J, 2013, CURR OPIN VIROL, V3, P425, DOI 10.1016/j.coviro.2013.05.001
   Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929
   Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765
   Sun SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022844
   Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06
   Tarnow C, 2014, J VIROL, V88, P4744, DOI 10.1128/JVI.03799-13
   Tate MD, 2014, VIRUSES-BASEL, V6, P1294, DOI 10.3390/v6031294
   Tate MD, 2011, J IMMUNOL, V187, P1884, DOI 10.4049/jimmunol.1100295
   Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618
   Taubenberger J, 2006, P AM PHILOS SOC, V150, P1
   Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230
   Teijaro JR, 2014, P NATL ACAD SCI USA, V111, P3799, DOI 10.1073/pnas.1400593111
   Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015
   Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006
   Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057
   Thorlund K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-134
   Topham DJ, 1997, J IMMUNOL, V159, P5197
   Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520
   Tsai SY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003848
   Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212
   Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005
   Uhlendorff J, 2009, ARCH VIROL, V154, P945, DOI 10.1007/s00705-009-0393-x
   Unkel B, 2012, J CLIN INVEST, V122, P3652, DOI 10.1172/JCI62139
   Uyeki TM, 2014, NEW ENGL J MED, V370, P789, DOI 10.1056/NEJMp1400034
   van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248
   van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949
   Ventetuolo CE, 2014, AM J RESP CRIT CARE, V190, P497, DOI 10.1164/rccm.201404-0736CI
   Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07
   Waffarn EE, 2011, J IMMUNOL, V186, P3823, DOI 10.4049/jimmunol.1002090
   Wang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3106
   Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879
   Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000
   Worobey M, 2014, NATURE, V508, P254, DOI 10.1038/nature13016
   Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165
   Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713
   Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40
   Zhang W, 2013, J VIROL, V87, P5949, DOI 10.1128/JVI.00545-13
   Zou Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4594
   Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903
NR 200
TC 262
Z9 271
U1 9
U2 61
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD MAY
PY 2015
VL 45
IS 5
BP 1463
EP 1478
DI 10.1183/09031936.00186214
PG 16
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA CH6KI
UT WOS:000354145100030
PM 25792631
OA Bronze
DA 2023-08-21
ER

PT J
AU Xie, RF
   Hu, P
   Wang, ZC
   Yang, J
   Yang, YM
   Gao, L
   Fan, HH
   Zhu, YM
AF Xie, Ru Feng
   Hu, Ping
   Wang, Zhi Cheng
   Yang, Jie
   Yang, Yi Ming
   Gao, Li
   Fan, Hua Hua
   Zhu, Yong Ming
TI Platelet-derived microparticles induce polymorphonuclear
   leukocyte-mediated damage of human pulmonary microvascular endothelial
   cells
SO TRANSFUSION
LA English
DT Article
ID ACUTE LUNG INJURY; BLOOD; STORAGE; CD154; CD40
AB BackgroundPlatelets (PLTs) stored at 22 degrees C accumulate microparticles and biologic response modifiers (BRMs) that induce inflammatory reactions in transfusion recipients. However, soluble BRMs are fully diluted in the recipient's blood circulation. The mechanisms by which BRMs exert their effects have not been elucidated. The objectives of this study were to determine the effect of PLT microparticles (PMPs) on polymorphonuclear leukocyte (PMN)-mediated human pulmonary microvascular endothelial cell (HMVEC) damage and determine the role of soluble CD40 ligand (sCD40L).
   Study Design and MethodsPMPs were isolated from apheresis PLT concentrates. We used a two-insult in vitro model of HMVEC damage to investigate the effects of PMP and sCD40L and role of apocynin, an inhibitor of PMN respiratory burst. Their priming activities were measured using hydrogen peroxide production. The expression of intercellular cell adhesion molecule-1 (ICAM-1) and integrin M (CD11b) were also determined.
   ResultsLipopolysaccharide (LPS)-activated HMVEC damage and PMN respiratory burst depend on the presence of PMP and the concentration of sCD40L. PMP-induced PMN-mediated HMVEC damage was significantly reduced by apocynin-treated PMNs (p<0.05). The surface expression of ICAM-1 on HMVEC was increased by LPS stimulation. The expression of CD11b on PMNs was increased by PMP priming. Blocking ICAM-1 with a monoclonal antibody (MoAb) CD54 significantly reduced HMVEC damage (p<0.05). The treatment of endothelial cells but not PMN with a MoAb targeting CD40 failed to prevent the HMVEC damage caused by PMPs (p>0.05).
   ConclusionPMPs carry a concentrated CD40L signal, promote PMN-mediated HMVEC damage, and may affect the development of transfusion-related acute lung injury.
C1 [Xie, Ru Feng; Yang, Jie; Yang, Yi Ming; Gao, Li; Fan, Hua Hua; Zhu, Yong Ming] Shanghai Blood Ctr, Shanghai 200051, China.
   [Hu, Ping] E China Normal Univ, Inst Life Sci, Shanghai 200062, China.
   [Wang, Zhi Cheng] Huashan Hosp, Shanghai, China.
C3 East China Normal University; Fudan University
RP Xie, RF (corresponding author), Shanghai Blood Ctr, Blood Engn Lab, Room 701,1191 Hong Qiao Rd, Shanghai 200051, Peoples R China.
EM rufeng33@hotmail.com; zhuyongming@sbc.org.cn
FU National Science Foundation of China [81270650]; Shanghai Municipal
   Health Bureau [20114294]
FX This study was supported by the research funds of National Science
   Foundation of China 81270650 and funds of Shanghai Municipal Health
   Bureau 20114294.
CR Cardo LJ, 2008, TRANSFUS APHER SCI, V38, P117, DOI 10.1016/j.transci.2008.01.004
   GEORGE JN, 1986, BLOOD, V68, P307
   Jin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064631
   Jy W, 2011, TRANSFUSION, V51, P886, DOI 10.1111/j.1537-2995.2011.03099.x
   Kaufman J, 2007, J THROMB HAEMOST, V5, P788, DOI 10.1111/j.1538-7836.2007.02412.x
   Khan SY, 2006, BLOOD, V108, P2455, DOI 10.1182/blood-2006-04-017251
   Middelburg RA, 2012, TRANSFUSION, V52, P658, DOI 10.1111/j.1537-2995.2011.03352.x
   Rank A, 2011, VOX SANG, V100, P179, DOI 10.1111/j.1423-0410.2010.01385.x
   Silliman CC, 2003, BLOOD, V101, P454, DOI 10.1182/blood-2002-03-0958
   Sprague DL, 2008, BLOOD, V111, P5028, DOI 10.1182/blood-2007-06-097410
   Tanaka S, 2010, TRANSFUSION, V50, P1096, DOI 10.1111/j.1537-2995.2009.02547.x
   Tung JP, 2012, CRIT CARE, V16, DOI 10.1186/cc11178
   Urner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033403
   Vanichakarn P, 2008, THROMB RES, V122, P346, DOI 10.1016/j.thromres.2007.12.019
   Vlaar APJ, 2013, LANCET, V382, P984, DOI 10.1016/S0140-6736(12)62197-7
   Vlaar APJ, 2010, BLOOD, V116, P1360, DOI 10.1182/blood-2009-10-248732
   Wozniak MJ, 2013, CIRCULATION, V128
   Wyman TH, 2002, AM J PHYSIOL-CELL PH, V283, pC1592, DOI 10.1152/ajpcell.00540.2001
   Xie RF, 2014, VOX SANG, V106, P234, DOI 10.1111/vox.12092
NR 19
TC 38
Z9 40
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAY
PY 2015
VL 55
IS 5
BP 1051
EP 1057
DI 10.1111/trf.12952
PG 7
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA CH8JB
UT WOS:000354281500021
PM 25565376
DA 2023-08-21
ER

PT J
AU Dagvadorj, J
   Shimada, K
   Chen, S
   Jones, HD
   Tumurkhuu, G
   Zhang, WX
   Wawrowsky, KA
   Crother, TR
   Arditi, M
AF Dagvadorj, Jargalsaikhan
   Shimada, Kenichi
   Chen, Shuang
   Jones, Heather D.
   Tumurkhuu, Gantsetseg
   Zhang, Wenxuan
   Wawrowsky, Kolja A.
   Crother, Timothy R.
   Arditi, Moshe
TI Lipopolysaccharide Induces Alveolar Macrophage Necrosis via CD14 and the
   P2X7 Receptor Leading to Interleukin-1 alpha Release
SO IMMUNITY
LA English
DT Article
ID ACUTE LUNG INJURY; INFLAMMATORY RESPONSE; BACTERIAL LIPOPOLYSACCHARIDE;
   ENDOTHELIAL-CELLS; MOUSE MODEL; IN-VIVO; STERILE INFLAMMATION; SIGNALING
   PATHWAY; P2X(7) RECEPTORS; ALPHA PRODUCTION
AB Acute lung injury (ALI) remains a serious health issue with little improvement in our understanding of the pathophysiology and therapeutic approaches. We investigated the mechanism that lipopolysaccharide (LPS) induces early neutrophil recruitment to lungs and increases pulmonary vascular permeability during ALI. Intratracheal LPS induced release of pro-interleukin-1 alpha (IL-1 alpha) from necrotic alveolar macrophages (AM), which activated endothelial cells (EC) to induce vascular leakage via loss of vascular endothelial (VE)-cadherin. LPS triggered the AM purinergic receptor P2X7(R) to induce Ca2+ influx and ATP depletion, which led to necrosis. P2X7R deficiency significantly reduced necrotic death of AM and release of pro-IL-1 alpha into the lung. CD14 was required for LPS binding to P2X7R, as CD14 neutralization significantly diminished LPS induced necrotic death of AM and pro-IL-1 alpha release. These results demonstrate a key role for pro-IL-1 alpha from necrotic alveolar macrophages in LPS-mediated ALI, as a critical initiator of increased vascular permeability and early neutrophil infiltration.
C1 [Dagvadorj, Jargalsaikhan; Shimada, Kenichi; Chen, Shuang; Tumurkhuu, Gantsetseg; Zhang, Wenxuan; Crother, Timothy R.; Arditi, Moshe] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048, United States.
   [Dagvadorj, Jargalsaikhan; Shimada, Kenichi; Chen, Shuang; Tumurkhuu, Gantsetseg; Zhang, Wenxuan; Crother, Timothy R.; Arditi, Moshe] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048, United States.
   [Dagvadorj, Jargalsaikhan; Shimada, Kenichi; Chen, Shuang; Tumurkhuu, Gantsetseg; Zhang, Wenxuan; Crother, Timothy R.; Arditi, Moshe] Cedars Sinai Med Ctr, Dept Pediat, Div Infect Dis, Los Angeles, CA 90048, United States.
   [Dagvadorj, Jargalsaikhan; Shimada, Kenichi; Chen, Shuang; Tumurkhuu, Gantsetseg; Zhang, Wenxuan; Crother, Timothy R.; Arditi, Moshe] Cedars Sinai Med Ctr, Div Immunol, Los Angeles, CA 90048, United States.
   [Shimada, Kenichi; Chen, Shuang; Jones, Heather D.; Crother, Timothy R.; Arditi, Moshe] Cedars Sinai Med Ctr, Infect & Immunol Dis Res Ctr, Los Angeles, CA 90048, United States.
   [Jones, Heather D.] Cedars Sinai Med Ctr, Div Pulm & Crit Care Med, Los Angeles, CA 90048, United States.
   [Wawrowsky, Kolja A.] Cedars Sinai Med Ctr, Confocal Core, Los Angeles, CA 90048, United States.
   [Arditi, Moshe] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90048, United States.
C3 Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai
   Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical
   Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA
RP Arditi, M (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA.
EM moshe.arditi@cshs.org
RI Crother, Timothy R/E-2879-2010
OI Crother, Timothy R/0000-0001-8465-6127
FU National Institutes of Health (NIH) [RO1AI-067995, 2R56AI067995-06];
   American Heart Association [13BGIA17220050]
FX This work was supported by National Institutes of Health (NIH) grants
   RO1AI-067995 and 2R56AI067995-06 to M.A. K.S. is supported by the
   American Heart Association 13BGIA17220050. The authors would like to
   thank Ganghua Huang and Polly Sun for technical support and Bill Parks
   for his help in the editing of this manuscript.
CR Aggarwal S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00161
   Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411
   Barry KC, 2013, J IMMUNOL, V190, P6329, DOI 10.4049/jimmunol.1300100
   Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111
   Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004
   Brunn GJ, 2008, CIRC RES, V102, P823, DOI 10.1161/CIRCRESAHA.107.165332
   Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603
   Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873
   Costa HM, 2011, PURINERG SIGNAL, V7, P7, DOI 10.1007/s11302-011-9215-1
   De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002
   Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897
   Denlinger LC, 2001, J IMMUNOL, V167, P1871, DOI 10.4049/jimmunol.167.4.1871
   Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417
   Eigenbrod T, 2008, J IMMUNOL, V181, P8194, DOI 10.4049/jimmunol.181.12.8194
   Garcia-Marcos M, 2006, J LIPID RES, V47, P705, DOI 10.1194/jlr.M500408-JLR200
   Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018
   Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978
   Han JL, 2013, THROMB RES, V132, pE42, DOI 10.1016/j.thromres.2013.03.010
   HARMSEN AG, 1988, INFECT IMMUN, V56, P1858, DOI 10.1128/IAI.56.8.1858-1863.1988
   Herold S, 2011, AM J RESP CRIT CARE, V183, P1380, DOI 10.1164/rccm.201009-1431OC
   Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016
   Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207
   Jun DJ, 2007, J BIOL CHEM, V282, P37350, DOI 10.1074/jbc.M707915200
   Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106
   Kitchens RL, 1998, J IMMUNOL, V161, P5534
   Kitchens RL, 1998, J IMMUNOL, V160, P1920
   KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475
   Leiva-Salcedo E, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/152625
   Lemaire I, 2003, DRUG DEVELOP RES, V59, P118, DOI 10.1002/ddr.10209
   London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678
   Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC
   Makinde TO, 2011, AM J RESP CELL MOL, V44, P384, DOI 10.1165/rcmb.2009-0330OC
   Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515
   Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST
   MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015
   Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803
   Mishra A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-26
   Moncao-Ribeiro LC, 2011, RESP PHYSIOL NEUROBI, V179, P314, DOI 10.1016/j.resp.2011.09.015
   MOSLEY B, 1987, J BIOL CHEM, V262, P2941
   Myrtek D, 2008, J IMMUNOL, V181, P2181, DOI 10.4049/jimmunol.181.3.2181
   Naiki Y, 2005, J BIOL CHEM, V280, P29242, DOI 10.1074/jbc.M503225200
   Noulin N, 2005, J IMMUNOL, V175, P6861, DOI 10.4049/jimmunol.175.10.6861
   Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011
   Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x
   Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171
   Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7
   Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048
   ROYALL JA, 1989, AM J PHYSIOL, V257, pL399, DOI 10.1152/ajplung.1989.257.6.L399
   SALGADO A, 1994, HAEMOSTASIS, V24, P132
   Schlegel N, 2009, CRIT CARE MED, V37, P1735, DOI 10.1097/CCM.0b013e31819deb6a
   Seabra V, 1998, J LEUKOCYTE BIOL, V64, P615, DOI 10.1002/jlb.64.5.615
   Tachado SD, 2010, BLOOD, V115, P3606, DOI 10.1182/blood-2009-10-250787
   Tanabe M, 2005, J MED MICROBIOL, V54, P7, DOI 10.1099/jmm.0.45736-0
   Triantafilou M, 2002, J CELL SCI, V115, P2603
   Tsushima K, 2009, INTERNAL MED, V48, P621, DOI 10.2169/internalmedicine.48.1741
   ULICH TR, 1991, AM J PATHOL, V138, P521
   ULICH TR, 1991, AM J PATHOL, V138, P1097
   Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137
   WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311
   Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200
   Xing JJ, 2012, MICROVASC RES, V83, P194, DOI 10.1016/j.mvr.2011.09.012
   Zanoni I, 2010, IMMUNOBIOLOGY, V215, P709, DOI 10.1016/j.imbio.2010.05.026
   Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118
   Zhao YT, 2011, AM J RESP CELL MOL, V45, P426, DOI 10.1165/rcmb.2010-0422OC
   Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200
   Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603
   Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506
NR 69
TC 88
Z9 92
U1 2
U2 20
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD APR 21
PY 2015
VL 42
IS 4
BP 640
EP 653
DI 10.1016/j.immuni.2015.03.007
PG 14
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA CG5QF
UT WOS:000353347500011
PM 25862090
OA Green Published, Green Accepted, Bronze
DA 2023-08-21
ER

PT J
AU Hahn, CS
   Scott, DW
   Xu, X
   Roda, MA
   Payne, GA
   Wells, JM
   Viera, L
   Winstead, CJ
   Bratcher, P
   Sparidans, RW
   Redegeld, FA
   Jackson, PL
   Folkerts, G
   Blalock, JE
   Patel, RP
   Gaggar, A
AF Hahn, Cornelia S.
   Scott, David W.
   Xu, Xin
   Roda, Mojtaba Abdul
   Payne, Gregory A.
   Wells, J. Michael
   Viera, Liliana
   Winstead, Colleen J.
   Bratcher, Preston
   Sparidans, Rolf W.
   Redegeld, Frank A.
   Jackson, Patricia L.
   Folkerts, Gert
   Blalock, J. Edwin
   Patel, Rakesh P.
   Gaggar, Amit
TI The matrikine N-alpha-PGP couples extracellular matrix fragmentation to
   endothelial permeability
SO SCIENCE ADVANCES
LA English
DT Article
AB The compartmentalization and transport of proteins and solutes across the endothelium is a critical biologic function altered during inflammation and disease, leading to pathology inmultiple disorders. The impact of tissue damage and subsequent extracellularmatrix (ECM) fragmentation in regulating this process is unknown. We demonstrate that the collagen-derived matrikine acetylated proline-glycine-proline (N-alpha-PGP) serves as a critical regulator of endothelial permeability. N-alpha-PGP activates human endothelial cells via CXC-chemokine receptor 2 (CXCR2), triggeringmonolayer permeability through a discrete intracellular signaling pathway. In vivo, N-alpha-PGP induces local vascular leak after subcutaneous administration and pulmonary vascular permeability after systemic administration. Furthermore, neutralization of N-alpha-PGP attenuates lipopolysaccharide-induced lung leak. Finally, we demonstrate that plasma from patients with acute respiratory distress syndrome (ARDS) induces VE-cadherin phosphorylation in human endothelial cells, and this activation is attenuated by N-alpha-PGP blockade with a concomitant improvement in endothelial monolayer impedance. These results identify N-alpha-PGP as a novel ECM-derivedmatrikine regulating paracellular permeability during inflammatory disease and demonstrate the potential to target this ligand in various disorders characterized by excessive matrix turnover and vascular leak such as ARDS.
C1 [Hahn, Cornelia S.] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC 27599, United States.
   [Hahn, Cornelia S.; Xu, Xin; Roda, Mojtaba Abdul; Payne, Gregory A.; Wells, J. Michael; Viera, Liliana; Bratcher, Preston; Jackson, Patricia L.; Blalock, J. Edwin; Gaggar, Amit] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294, United States.
   [Scott, David W.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599, United States.
   [Scott, David W.] Univ N Carolina, Lineberger Canc Res Ctr, Chapel Hill, NC 27599, United States.
   [Scott, David W.; Winstead, Colleen J.; Patel, Rakesh P.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294, United States.
   [Xu, Xin; Wells, J. Michael; Viera, Liliana; Bratcher, Preston; Jackson, Patricia L.; Blalock, J. Edwin; Patel, Rakesh P.; Gaggar, Amit] Univ Alabama Birmingham, Program Protease & Matrix Biol, Birmingham, AL 35294, United States.
   [Roda, Mojtaba Abdul; Sparidans, Rolf W.; Redegeld, Frank A.; Folkerts, Gert] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, NL-3508 TB Utrecht, Netherlands.
   [Wells, J. Michael; Blalock, J. Edwin; Gaggar, Amit] Univ Alabama Birmingham, Lung Hlth Ctr, Birmingham, AL 35294, United States.
   [Wells, J. Michael; Gaggar, Amit] Birmingham VA Med Ctr, Med Serv, Birmingham, AL 35233, United States.
   [Blalock, J. Edwin; Gaggar, Amit] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294, United States.
C3 University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina School of Medicine; University of Alabama
   System; University of Alabama Birmingham; University of North Carolina;
   University of North Carolina Chapel Hill; University of North Carolina;
   University of North Carolina Chapel Hill; University of Alabama System;
   University of Alabama Birmingham; University of Alabama System;
   University of Alabama Birmingham; Utrecht University; University of
   Alabama System; University of Alabama Birmingham; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs
   Medical Center - Birmingham; University of Alabama System; University of
   Alabama Birmingham
RP Gaggar, A (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.
EM agaggar1@uab.edu
RI Wells, James Michael/ABA-2755-2021; Redegeld, Frank A/O-6534-2016
OI Redegeld, Frank A/0000-0001-8830-7960; Patel,
   Rakesh/0000-0002-1526-4303; Payne, Gregory/0000-0002-8525-8603
FU American Heart Association predoctoral fellowship; Howard Hughes Medical
   Institute Med-to-Grad fellowship; NIH [3T32CA009156]; Netherlands
   Organization for Scientific Research [017.008.029]; National Heart,
   Lung, and Blood Institute [HL07783, HL090999, HL087824, HL92624,
   HL102371]; Veterans Administration [1 I01 BX001756]; Ismail Moustapha
   Scholar Fund; NIH; Family Smoking Prevention and Tobacco Control Act
FX This work was supported by an American Heart Association predoctoral
   fellowship (D.W.S.), a Howard Hughes Medical Institute Med-to-Grad
   fellowship (D.W.S.), and NIH training grant 3T32CA009156 (D.W.S.).
   M.A.R. was supported by a Mosaic grant from the Netherlands Organization
   for Scientific Research (017.008.029). Additional funding from the
   National Heart, Lung, and Blood Institute (HL07783, HL090999, and
   HL087824 to J.E.B.; HL92624 to R.P.P.; and HL102371 to A. G.), the
   Veterans Administration (1 I01 BX001756 to A.G.), and the Ismail
   Moustapha Scholar Fund (to A.G.). Research reported in this publication
   was supported by the NIH and the Family Smoking Prevention and Tobacco
   Control Act. The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the NIH or the Food
   and Drug Administration.
CR Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269
   Braber S, 2011, EUR J PHARMACOL, V668, P443, DOI 10.1016/j.ejphar.2011.03.025
   Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159
   Dwyer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045562
   Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662
   Gaggar A, 2006, CLIN CHIM ACTA, V372, P24, DOI 10.1016/j.cca.2006.04.019
   Gandhirajan RK, 2013, J CLIN INVEST, V123, P887, DOI 10.1172/JCI65647
   Gavard J, 2009, MOL CELL BIOL, V29, P2469, DOI 10.1128/MCB.01304-08
   Hardison MT, 2009, J IMMUNOL, V182, P4423, DOI 10.4049/jimmunol.0802457
   Hardison Matthew Thomas, 2012, Front Biosci (Elite Ed), V4, P2402
   Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200
   Jozwiak M, 2013, CRIT CARE MED, V41, P472, DOI 10.1097/CCM.0b013e31826ab377
   Kantrow SP, 2009, AM J PHYSIOL-LUNG C, V297, pL738, DOI 10.1152/ajplung.00045.2009
   Kim KH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/863892
   Koelink PJ, 2014, GUT, V63, P578, DOI 10.1136/gutjnl-2012-303252
   Kong MYF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022596
   Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369
   Lin M, 2008, AM J PATHOL, V173, P144, DOI 10.2353/ajpath.2008.080081
   Monaghan-Benson E, 2013, METHODS MOL BIOL, V1046, P335, DOI 10.1007/978-1-62703-538-5_20
   O'Reilly P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-38
   O'Reilly PJ, 2009, J NEUROIMMUNOL, V217, P51, DOI 10.1016/j.jneuroim.2009.09.020
   Overbeek SA, 2011, EUR J PHARMACOL, V668, P428, DOI 10.1016/j.ejphar.2011.03.022
   Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC
   Petreaca ML, 2007, MOL BIOL CELL, V18, P5014, DOI 10.1091/mbc.E07-01-0004
   PFISTER RR, 1995, INVEST OPHTH VIS SCI, V36, P1306
   POSTLETHWAITE AE, 1976, J EXP MED, V143, P1299, DOI 10.1084/jem.143.6.1299
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Reddy AT, 2012, J IMMUNOL, V189, P5411, DOI 10.4049/jimmunol.1201487
   Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009
   Schraufstatter IU, 2001, AM J PHYSIOL-LUNG C, V280, pL1094, DOI 10.1152/ajplung.2001.280.6.L1094
   Scott DW, 2013, GLYCOBIOLOGY, V23, P622, DOI 10.1093/glycob/cwt014
   Scott DW, 2012, ARTERIOSCL THROM VAS, V32, pE51, DOI 10.1161/ATVBAHA.112.253203
   Singh S, 2011, MICROVASC RES, V82, P318, DOI 10.1016/j.mvr.2011.06.011
   Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594
   Stockton R, 2007, MOL BIOL CELL, V18, P2346, DOI 10.1091/mbc.E06-07-0584
   van Houwelingen AH, 2008, FASEB J, V22, P3403, DOI 10.1096/fj.07-096230
   Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361
   Wells JM, 2014, AM J RESP CRIT CARE, V190, P51, DOI 10.1164/rccm.201401-0145OC
   White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095
   Xu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015781
NR 40
TC 34
Z9 38
U1 0
U2 2
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD APR
PY 2015
VL 1
IS 3
AR e1500175
DI 10.1126/sciadv.1500175
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA V0V3L
UT WOS:000216592400017
PM 26229981
OA Green Published, Green Accepted, gold
DA 2023-08-21
ER

PT J
AU Li, LF
   Hu, JY
   He, T
   Zhang, Q
   Yang, X
   Lan, XD
   Zhang, DX
   Mei, H
   Chen, B
   Huang, YS
AF Li, Lingfei
   Hu, Jiongyu
   He, Ting
   Zhang, Qiong
   Yang, Xu
   Lan, Xiaodong
   Zhang, Dongxia
   Mei, Hao
   Chen, Bing
   Huang, Yuesheng
TI P38/MAPK contributes to endothelial barrier dysfunction via MAP4
   phosphorylation-dependent microtubule disassembly in
   inflammation-induced acute lung injury
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VASCULAR-PERMEABILITY; CELL PERMEABILITY; INDUCED APOPTOSIS; DYNAMICS;
   NECROSIS; KINASE; PROTEINS; PATHWAY; P38; DESTABILIZATION
AB Excessive activation of inflammation and the accompanying lung vascular endothelial barrier disruption are primary pathogenic features of acute lung injury (ALI). Microtubule-associated protein 4 (MAP4), a tubulin assembly-promoting protein, is important for maintaining the microtubule (MT) cytoskeleton and cell-cell junctional structures. However, both the involvement and exact mechanism of MAP4 in the development of endothelial barrier disruption in ALI remains unknown. In this study, lipopolysaccharide (LPS) and tumour necrosis factor-a (TNF-alpha) were applied to human pulmonary microvascular endothelial cells (HPMECs) to mimic the endothelial damage during inflammation in vitro. We demonstrated that the MAP4 (Ser696 and Ser787) phosphorylation increased concomitantly with the p38/MAPK pathway activation by the LPS and TNF-a stimulation of HPMECs, which induced MT disassembly followed by hyperpermeability. Moreover, the application of taxol, the overexpression of a MAP4 (Ala) mutant, or the application of the p38/MAPK inhibitor SB203580 inhibited the MT disruption and the intracellular junction dysfunction. In contrast, MKK6 (Glu), which constitutively activated p38/MAPK, resulted in microtubule depolymerisation and, subsequently, hyperpermeability. Our findings reveal a novel role of MAP4 in endothelial barrier dysfunction.
C1 [Li, Lingfei; He, Ting; Zhang, Qiong; Lan, Xiaodong; Zhang, Dongxia; Huang, Yuesheng] Third Mil Med Univ, Southwest Hosp, State Key Lab Trauma Burns & Combined Injury, Inst Burn Res, Chongqing, China.
   [Hu, Jiongyu; Chen, Bing] Third Mil Med Univ, Southwest Hosp, Dept Endocrinol, Chongqing, China.
   [Yang, Xu] Third Mil Med Univ, Xinqiao Hosp, Inst Resp Dis, Chongqing, China.
   [Mei, Hao] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06520, United States.
C3 Army Medical University; Army Medical University; Army Medical
   University; Yale University
RP Huang, YS (corresponding author), Third Mil Med Univ, Southwest Hosp, State Key Lab Trauma Burns & Combined Injury, Inst Burn Res, Chongqing, Peoples R China.
EM chenbing3@medmail.com.cn; yshuang.tmmu@gmail.com
FU National Natural Science Foundation of China [81270030]; State Key
   Laboratory of Trauma, Burns and Combined Injury Research Foundation
   [2012ZZII05, SKLZZ201103]; National Programme on Key Basic Research
   Project of China (973 Programme) [2012CB518101]
FX This work was supported by the National Natural Science Foundation of
   China (No. 81270030), State Key Laboratory of Trauma, Burns and Combined
   Injury Research Foundation (No. 2012ZZII05, No. SKLZZ201103), and
   National Programme on Key Basic Research Project of China (973
   Programme; No. 2012CB518101).
CR Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411
   Bannerman DD, 1998, J BIOL CHEM, V273, P35371, DOI 10.1074/jbc.273.52.35371
   Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com
   Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004
   Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009
   Bogatcheva NV, 2007, AM J PHYSIOL-LUNG C, V292, pL487, DOI 10.1152/ajplung.00217.2006
   Chang W, 2001, J CELL SCI, V114, P2879
   Chu ZG, 2010, SHOCK, V34, P222, DOI [10.1097/SHK.0b013e3181d75a66, 10.1097/SHK.0b013e3181d8e357]
   Curry FRE, 2010, CARDIOVASC RES, V87, P218, DOI 10.1093/cvr/cvq115
   Diaz JV, 2010, CRIT CARE MED, V38, P1644, DOI 10.1097/CCM.0b013e3181e795ee
   Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6
   Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.3.CO;2-W
   Gorovoy M, 2005, J BIOL CHEM, V280, P26533, DOI 10.1074/jbc.M502921200
   Hu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.369
   Hu JY, 2010, CELL MOL LIFE SCI, V67, P321, DOI 10.1007/s00018-009-0187-z
   Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834
   Joel R., 1996, MOL CELL BIO, V16, P1247
   Juskewitch JE, 2012, SCI REP-UK, V2, DOI 10.1038/srep00918
   Kitazawa H, 2000, CELL STRUCT FUNCT, V25, P33, DOI 10.1247/csf.25.33
   Kratzer E, 2012, AM J RESP CELL MOL, V47, P688, DOI 10.1165/rcmb.2012-0161OC
   Lee JSY, 2002, CARDIOVASC PATHOL, V11, P135, DOI 10.1016/S1054-8807(01)00080-1
   Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320
   Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014
   Miki Y, 2013, BIOL PHARM BULL, V36, P215, DOI 10.1248/bpb.b12-00567
   Monaghan-Benson E, 2011, METHODS MOL BIOL, V763, P281, DOI 10.1007/978-1-61779-191-8_19
   Nwariaku FE, 2002, SHOCK, V18, P82, DOI 10.1097/00024382-200207000-00015
   Ortiz-Ferron G, 2006, CELL DEATH DIFFER, V13, P1857, DOI 10.1038/sj.cdd.4401875
   Patel BV, 2013, J IMMUNOL, V190, P4274, DOI 10.4049/jimmunol.1202437
   Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC
   Putnam AJ, 1998, J CELL SCI, V111, P3379
   Samora CP, 2011, NAT CELL BIOL, V13, P1040, DOI 10.1038/ncb2297
   Stagg HW, 2013, AM J SURG, V205, P419, DOI 10.1016/j.amjsurg.2012.10.027
   Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355
   Tian XY, 2012, FASEB J, V26, P3862, DOI 10.1096/fj.12-207746
   Walczak CE, 2000, CURR OPIN CELL BIOL, V12, P52, DOI 10.1016/S0955-0674(99)00056-3
   Wang Y, 1996, P NATL ACAD SCI USA, V93, P3932, DOI 10.1073/pnas.93.9.3932
   Webster DR, 2006, CELL MOTIL CYTOSKEL, V63, P512, DOI 10.1002/cm.20140
   Yang D, 2010, CARDIOVASC RES, V85, P520, DOI 10.1093/cvr/cvp323
   Zhang LY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01681
NR 39
TC 55
Z9 60
U1 0
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 9
PY 2015
VL 5
AR 8895
DI 10.1038/srep08895
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CC7ME
UT WOS:000350551100004
PM 25746230
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU He, HL
   Liu, L
   Chen, QH
   Cai, SX
   Han, JB
   Hu, SL
   Chun, P
   Yang, Y
   Guo, FM
   Huang, YZ
   Qiu, HB
AF He, Hongli
   Liu, Ling
   Chen, Qihong
   Cai, Shixia
   Han, Jibin
   Hu, Shuling
   Chun, Pan
   Yang, Yi
   Guo, Fengmei
   Huang, Yingzi
   Qiu, Haibo
TI MSCs Modified With ACE2 Restore Endothelial Function Following LPS
   Challenge by Inhibiting the Activation of RAS
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
ID ACUTE LUNG INJURY; MESENCHYMAL STEM-CELLS; ANGIOTENSIN-CONVERTING
   ENZYME-2; GENE-THERAPY; LIPOPOLYSACCHARIDE; PERMEABILITY; MECHANISMS;
   RECEPTOR; PATHWAY; SEPSIS
AB Angiotensin (Ang) II plays an important role in the process of endothelial dysfunction in acute lung injury (ALI) and is degraded by angiotensin-converting enzyme2 (ACE2). However, treatments that target ACE2 to injured endothelium and promote endothelial repair of ALI are lacking. Mesenchymal stem cells (MSCs) are capable of homing to the injured site and delivering a protective gene. Our study aimed to evaluate the effects of genetically modified MSCs, which overexpress the ACE2 protein in a sustained manner via a lentiviral vector, on Ang II production in endothelium and in vitro repair of lipopolysaccharide (LPS)-induced endothelial injury. We found that the efficiency of lentiviral vector transduction of MSCs was as high as 97.8% and was well maintained over 30 passages. MSCs modified with ACE2 showed a sustained high expression of ACE2 mRNA and protein. The modified MSCs secreted soluble ACE2 protein into the culture medium, which reduced the concentration of Ang II and increased the production of Ang 1-7. MSCs modified with ACE2 were more effective at restoring endothelial function than were unmodified MSCs, as shown by the enhanced survival of endothelial cells; the downregulated production of inflammatory mediators, including ICAM-1, VCAM-1, TNF-, and IL-6; reduced paracellular permeability; and increased expression of VE-cadherin. These data demonstrate that MSCs modified to overexpress the ACE2 gene can produce biologically active ACE2 protein over a sustained period of time and have an enhanced ability to promote endothelial repair after LPS challenge. These results encourage further testing of the beneficial effects of ACE2-modified MSCs in an ALI animal model. J. Cell. Physiol. 230: 691-701, 2015. (c) 2014 Wiley Periodicals, Inc., A Wiley Company
C1 [He, Hong-li; Liu, Ling; Chen, Qi-hong; Cai, Shi-xia; Han, Ji-bin; Hu, Shu-ling; Chun, Pan; Yang, Yi; Guo, Feng-mei; Huang, Ying-zi; Qiu, Hai-bo] Southeast Univ, Sch Med, Zhong Da Hosp, Dept Crit Care Med, Nanjing 210009, Jiangsu, China.
C3 Southeast University - China
RP Qiu, HB (corresponding author), Southeast Univ, Sch Med, Zhong Da Hosp, Dept Crit Care Med, 87 Ding Jiaqiao, Nanjing 210009, Jiangsu, Peoples R China.
EM haiboq2000@gmail.com
RI chen, qian/HKE-2403-2023; CHEN, QING/IXN-5937-2023; Qiu,
   Haibo/AAS-9047-2021; Chen, QH/GXH-3158-2022
OI CHEN, QING/0000-0001-5250-1710; Qiu, Haibo/0000-0001-8589-4717; 
FU National Natural Science Foundation of China [81000828, 81070049,
   81170057, 81372093]; Natural Science Foundation of Jiangsu Province of
   China [BK20131302]; Graduate Innovation Project in Jiangsu Province of
   China [CXLX_0151, CXLX_0153]
FX Contract grant sponsor: National Natural Science Foundation of China;;
   Contract grant numbers: 81000828, 81070049, 81170057, 81372093.;
   Contract grant sponsor: Natural Science Foundation of Jiangsu Province
   of China;; Contract grant number: BK20131302.; Contract grant sponsor:
   Graduate Innovation Project in Jiangsu Province of China;; Contract
   grant numbers: CXLX_0151, CXLX_0153.
CR Bannerman DD, 2003, AM J PHYSIOL-LUNG C, V284, pL899, DOI 10.1152/ajplung.00338.2002
   Campbell AIM, 2001, CIRCULATION, V104, P2242, DOI 10.1161/hc4201.097838
   Clarke NE, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/307315
   Dandona P, 2007, J HUM HYPERTENS, V21, P20, DOI 10.1038/sj.jhh.1002101
   Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897
   Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006
   Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000
   Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217
   Imai Y, 2007, CELL MOL LIFE SCI, V64, P2006, DOI 10.1007/s00018-007-6228-6
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Imai Y, 2008, EXP PHYSIOL, V93, P543, DOI 10.1113/expphysiol.2007.040048
   Imai Y, 2010, CIRC J, V74, P405, DOI 10.1253/circj.CJ-10-0045
   Kanki-Horimoto S, 2006, CIRCULATION, V114, pI181, DOI 10.1161/CIRCULATIONAHA.105.001487
   Kim YC, 2012, AM J PHYSIOL-LUNG C, V303, pL228, DOI 10.1152/ajplung.00087.2012
   Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3
   Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643
   Lee YH, 2010, J CELL SCI, V123, P1634, DOI 10.1242/jcs.063545
   Lin X, 2011, CRIT CARE CLIN, V27, P705, DOI 10.1016/j.ccc.2011.04.002
   Liu AR, 2013, J CELL PHYSIOL, V228, P1270, DOI 10.1002/jcp.24282
   Liu L, 2009, ARCH BIOCHEM BIOPHYS, V481, P131, DOI 10.1016/j.abb.2008.09.019
   Lund DD, 2007, AM J PHYSIOL-HEART C, V293, pH3726, DOI 10.1152/ajpheart.01116.2007
   Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   McGinley L, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt53
   Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269
   Molthen RC, 2012, RESPIROLOGY, V17, P1261, DOI 10.1111/j.1440-1843.2012.02247.x
   MORRISON DC, 1978, AM J PATHOL, V93, P526
   Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905
   Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x
   Pati S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025171
   Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013
   Pittet JF, 1997, AM J RESP CRIT CARE, V155, P1187, DOI 10.1164/ajrccm.155.4.9105054
   Rentzsch B, 2008, HYPERTENSION, V52, P967, DOI 10.1161/HYPERTENSIONAHA.108.114322
   SCHALLER MD, 1985, AM J PHYSIOL, V249, P1086, DOI 10.1152/ajpheart.1985.249.6.H1086
   Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016
   Wang HL, 2007, J IMMUNOL, V179, P1834, DOI 10.4049/jimmunol.179.3.1834
   WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]
   Wiel E, 2004, INTENS CARE MED, V30, P1652, DOI 10.1007/s00134-004-2198-4
   Wort SJ, 1999, BRIT MED BULL, V55, P30, DOI 10.1258/0007142991902286
   Xu J, 2008, J PATHOL, V214, P472, DOI 10.1002/path.2302
   Xu JG, 2007, AM J PHYSIOL-LUNG C, V293, pL131, DOI 10.1152/ajplung.00431.2006
   Zhang H, 2005, ARCH BIOCHEM BIOPHYS, V441, P75, DOI 10.1016/j.abb.2005.06.022
   Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b
   Zhao YDD, 2009, CIRC RES, V105, P696, DOI 10.1161/CIRCRESAHA.109.199778
NR 44
TC 30
Z9 36
U1 1
U2 44
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD MAR
PY 2015
VL 230
IS 3
BP 691
EP 701
DI 10.1002/jcp.24794
PG 11
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA AU3JI
UT WOS:000345508400023
PM 25200929
DA 2023-08-21
ER

PT J
AU Xu, QL
   Liu, JX
   Wang, ZL
   Guo, XH
   Zhou, GB
   Liu, YA
   Huang, QB
   Su, L
AF Xu, Qiulin
   Liu, Jingxian
   Wang, Zhenglian
   Guo, Xiaohua
   Zhou, Gengbiao
   Liu, Yanan
   Huang, Qiaobing
   Su, Lei
TI Heat Stress-Induced Disruption of Endothelial Barrier Function Is via
   PAR1 Signaling and Suppressed by Xuebijing Injection
SO PLOS ONE
LA English
DT Article
ID GLYCATION END-PRODUCTS; EZRIN/RADIXIN/MOESIN PROTEINS; MOESIN
   PHOSPHORYLATION; CELLS; PERMEABILITY; MICE; STROKE; INCREASES; INJURY
AB Increased vascular permeability leading to acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) is central to the pathogenesis of heatstroke. Protease-activated receptor 1 (PAR1), the receptor for thrombin, plays a key role in disruption of endothelial barrier function in response to extracellular stimuli. However, the role of PAR1 in heat stress-induced endothelial hyper-permeability is unknown. In this study, we measured PAR1 protein expression in heat-stressed human umbilical venous endothelial cells (HUVECs), investigated the influences of PAR1 on endothelial permeability, F-actin rearrangement, and moesin phosphorylation by inhibiting PAR1 with its siRNA, neutralizing antibody (anti-PAR1), specific inhibitor(RWJ56110), and Xuebijing injection (XBJ), a traditional Chinese medicine used for sepsis treatment, and evaluated the role of PAR1 in heatstroke- related ALI/ARDS in mice by suppressing PAR1 with RWJ56110, anti-PAR1and XBJ. We found that heat stress induced PAR1 protein expression 2h after heat stress in endothelial cells, caused the release of endothelial matrix metalloprotease 1, an activator of PAR1, after 60 or 120 min of heat stimulation, as well as promoted endothelial hyper-permeability and F-actin rearrangement, which were inhibited by suppressing PAR1 with RWJ56110, anti-PAR1 and siRNA. PAR1 mediated moesin phosphorylation, which caused F-actin rearrangement and disruption of endothelial barrier function. To corroborate findings from in vitro experiments, we found that RWJ56110 and the anti-PAR1 significantly decreased lung edema, pulmonary microvascular permeability, protein exudation, and leukocytes infiltrations in heatstroke mice. Additionally, XBJ was found to suppress PAR1-moesin signal pathway and confer protective effects on maintaining endothelial barrier function both in vitro and in vivo heat-stressed model, similar to those observed above with the inhibition of PAR1. These results suggest that PAR1 is a potential therapeutic target in heatstroke.
C1 [Xu, Qiulin; Su, Lei] Guangzhou Mil Command, Gen Hosp, Dept ICU, Key Lab Trop Zone Trauma Care & Tissue Repair PLA, Guangzhou, Guangdong, China.
   [Xu, Qiulin] Huabo Biopharmaceut Res Inst, Postdoctoral Workstn, Guangzhou, Guangdong, China.
   [Liu, Jingxian; Liu, Yanan] Southern Med Univ, Guangzhou, Guangdong, China.
   [Wang, Zhenglian; Zhou, Gengbiao] Guangzhou Univ Chinese Med, Guangzhou, Guangdong, China.
   [Guo, Xiaohua; Huang, Qiaobing] Southern Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, China.
C3 Southern Theater Command General Hospital; Southern Medical University -
   China; Guangzhou University of Chinese Medicine; Southern Medical
   University - China
RP Huang, QB (corresponding author), Southern Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.
EM bing@smu.edu.cn; slei_icu@163.com
OI Xu, Qiulin/0000-0002-1592-6434
FU Natural Science Foundation of Guangdong Province, China
   [S2013040015661]; China Postdoctoral Science Foundation [2014M552180];
   National Natural Science Foundation of China [31300950]; Project of
   Medical Research of People's Liberation Army [BWS12J108]
FX This work was supported by the PhD Start-up Fund of Natural Science
   Foundation of Guangdong Province, China (S2013040015661,
   http://pro.gdstc.gov.cn/egrantweb/), China Postdoctoral Science
   Foundation(2014M552180,
   http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx), National
   Natural Science Foundation of China (31300950, http://www.nsfc.gov.cn/),
   and Project of Medical Research of People's Liberation Army (BWS12J108).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adyshev DM, 2013, AM J PHYSIOL-LUNG C, V305, P1240, DOI 10.1152/ajplung.00355.2012
   Asehnoune K, 2013, CRIT CARE, V17, DOI 10.1186/cc12502
   Austin KM, 2013, BLOOD, V121, P431, DOI 10.1182/blood-2012-09-355958
   Broquet A, 2014, CRIT CARE MED, V42, pE441, DOI 10.1097/CCM.0000000000000311
   Chen Y, 2013, J TRADIT CHIN MED, V33, P243, DOI 10.1016/S0254-6272(13)60133-8
   Chui A., 2014, PLACENTA
   Dematte JE, 1998, ANN INTERN MED, V129, P173, DOI 10.7326/0003-4819-129-3-199808010-00001
   Guo XH, 2009, AM J PHYSIOL-HEART C, V297, pH238, DOI 10.1152/ajpheart.00196.2009
   Helwig BG, 2011, PHYSIOL GENOMICS, V43, P1096, DOI 10.1152/physiolgenomics.00076.2011
   Hirano Katsuya, 2003, J Atheroscler Thromb, V10, P211
   Jeon S, 2010, NEUROCHEM INT, V56, P810, DOI 10.1016/j.neuint.2010.03.005
   Ji J, 2014, EXP THER MED, V7, P1745, DOI 10.3892/etm.2014.1639
   Juncker-Jensen A, 2013, CANCER RES, V73, P4196, DOI 10.1158/0008-5472.CAN-12-4495
   Kim HS, 2010, J NEUROCHEM, V113, P1565, DOI 10.1111/j.1471-4159.2010.06713.x
   Koss M, 2006, J IMMUNOL, V176, P1218, DOI 10.4049/jimmunol.176.2.1218
   Li QQ, 2011, BRAIN RES, V1373, P1, DOI 10.1016/j.brainres.2010.12.032
   Ng KY, 2004, J PHARM SCI-US, V93, P896, DOI 10.1002/jps.20015
   Pirot N, 2014, AM J PHYSIOL-LUNG C, V306, pL775, DOI 10.1152/ajplung.00200.2013
   SHARMA HS, 1990, ACT NEUR S, V51, P383
   Tressel SL, 2011, EMBO MOL MED, V3, P370, DOI 10.1002/emmm.201100145
   Varghese GM, 2005, EMERG MED J, V22, P185, DOI 10.1136/emj.2003.009365
   Wang JP, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-7
   Wang LJ, 2012, ACTA DIABETOL, V49, P47, DOI 10.1007/s00592-011-0267-z
   Wang LQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090472
   WIJSMAN JA, 1993, ACTA NEUROPATHOL, V86, P49, DOI 10.1007/BF00454898
   Zhang YL, 2013, J MOL MED, V91, P117, DOI 10.1007/s00109-012-0940-x
NR 26
TC 11
Z9 18
U1 1
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 18
PY 2015
VL 10
IS 2
AR e0118057
DI 10.1371/journal.pone.0118057
PG 17
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CC0WZ
UT WOS:000350061500092
PM 25693178
OA Green Published, gold, Green Submitted
DA 2023-08-21
ER

PT J
AU Tian, XY
   Tian, YF
   Gawlak, G
   Meng, FY
   Kawasaki, Y
   Akiyama, T
   Birukova, AA
AF Tian, Xinyong
   Tian, Yufeng
   Gawlak, Grzegorz
   Meng, Fanyong
   Kawasaki, Yoshihiro
   Akiyama, Tetsu
   Birukova, Anna A.
TI Asef controls vascular endothelial permeability and barrier recovery in
   the lung
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID HEPATOCYTE GROWTH-FACTOR; ADENOMATOUS POLYPOSIS-COLI; OXIDIZED
   PHOSPHOLIPIDS; SPHINGOSINE 1-PHOSPHATE; RHO GTPASES; RAC ACTIVATION;
   CELL-CELL; THROMBIN; CORTACTIN; ENHANCEMENT
AB Increased levels of hepatocyte growth factor (HGF) in injured lungs may reflect a compensatory response to diminish acute lung injury (ALI). HGF-induced activation of Rac1 GTPase stimulates endothelial barrier protective mechanisms. This study tested the involvement of Rac-specific guanine nucleotide exchange factor Asef in HGF-induced endothelial cell (EC) cytoskeletal dynamics and barrier protection in vitro and in a two-hit model of ALI. HGF induced membrane translocation of Asef and stimulated Asef Rac1-specific nucleotide exchange activity. Expression of constitutively activated Asef mutant mimicked HGF-induced peripheral actin cytoskeleton enhancement. In contrast, siRNA-induced Asef knockdown or expression of dominant-negative Asef attenuated HGF-induced Rac1 activation evaluated by Rac-GTP pull down and FRET assay with Rac1 biosensor. Molecular inhibition of Asef attenuated HGF-induced peripheral accumulation of cortactin, formation of lamellipodia-like structures, and enhancement of VE-cadherin adherens junctions and compromised HGF-protective effect against thrombin-induced RhoA GTPase activation, Rho-dependent cytoskeleton remodeling, and EC permeability. Intravenous HGF injection attenuated lung inflammation and vascular leak in the two-hit model of ALI induced by excessive mechanical ventilation and thrombin signaling peptide TRAP6. This effect was lost in Asef(-/-) mice. This study shows for the first time the role of Asef in HGF-mediated protection against endothelial hyperpermeability and lung injury.
C1 [Tian, Xinyong; Tian, Yufeng; Gawlak, Grzegorz; Meng, Fanyong; Birukova, Anna A.] Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637, United States.
   [Kawasaki, Yoshihiro; Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo 1130032, Japan.
C3 University of Chicago; University of Tokyo
RP Birukova, AA (corresponding author), Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA.
EM abirukov@medicine.bsd.uchicago.edu
FU National Heart, Lung, and Blood Institute [HL89257, HL107920]; Ministry
   of Education, Culture, Sports, Science and Technology, Japan;
   Grants-in-Aid for Scientific Research [22112004] Funding Source: KAKEN
FX We thank Katalin Szaszi (St. Michael's Hospital, Toronto, Canada) for
   sharing the RacG15A construct. This work was supported by grants from
   the National Heart, Lung, and Blood Institute (HL89257 and HL107920) to
   A.B. and Grants-in-Aid for Scientific Research on Innovative Areas
   (Integrative Research on Cancer Microenvironment Network), Ministry of
   Education, Culture, Sports, Science and Technology, Japan, to T.A.
CR Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296
   Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588
   Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016
   Baumer Y, 2009, J CELL PHYSIOL, V220, P716, DOI 10.1002/jcp.21819
   Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06
   Birukov KG, 2013, COMPR PHYSIOL, V3, P429, DOI 10.1002/cphy.c100066
   Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007
   Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com
   Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com
   Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036
   Birukova AA, 2007, AM J PHYSIOL-LUNG C, V292, pL924, DOI 10.1152/ajplung.00395.2006
   Birukova AA, 2012, J CELL PHYSIOL, V227, P3405, DOI 10.1002/jcp.24041
   Birukova AA, 2011, EXP CELL RES, V317, P859, DOI 10.1016/j.yexcr.2010.11.011
   Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009
   Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241
   Blank R, 2011, CRIT CARE CLIN, V27, P439, DOI 10.1016/j.ccc.2011.05.005
   BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0
   Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Cheng HT, 2013, J INVEST MED, V61, P1097, DOI 10.2310/JIM.0b013e3182a32fdb
   Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159
   Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200
   Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867
   Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200
   Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808
   Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005
   Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450
   Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9
   Geiser T, 2003, SWISS MED WKLY, V133, P586
   Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.E02-11-0753
   Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937
   Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194
   Kawasaki Y, 2013, CANCER SCI, V104, P1135, DOI 10.1111/cas.12180
   Kawasaki Y, 2010, J BIOL CHEM, V285, P1199, DOI 10.1074/jbc.M109.040691
   Kawasaki Y, 2009, J BIOL CHEM, V284, P22436, DOI 10.1074/jbc.M109.020768
   Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com
   Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591
   Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS
   Meliton AY, 2013, AM J PHYSIOL-LUNG C, V304, pL689, DOI 10.1152/ajplung.00047.2013
   Moitra J, 2007, TRANSL RES, V150, P253, DOI 10.1016/j.trsl.2007.03.013
   Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938
   Nonas S, 2008, CRIT CARE, V12, DOI 10.1186/cc6805
   Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200
   Poh YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007886
   Quesnel C, 2008, AM J PHYSIOL-LUNG C, V294, pL334, DOI 10.1152/ajplung.00096.2007
   Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200
   Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200
   Stern JB, 2000, CRIT CARE MED, V28, P2326, DOI 10.1097/00003246-200007000-00024
   Storck J, 1996, THROMB RES, V81, P121, DOI 10.1016/0049-3848(95)00220-0
   Stultiens Audrey, 2012, Commun Integr Biol, V5, P99
   Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51
   Tian YF, 2014, MOL CELL BIOL, V34, P3546, DOI 10.1128/MCB.00248-14
   Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051
   Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7
   Verghese GM, 1998, AM J RESP CRIT CARE, V158, P386, DOI 10.1164/ajrccm.158.2.9711111
   Vouret-Craviari V, 2002, J CELL SCI, V115, P2475
   Waheed F, 2013, MOL BIOL CELL, V24, P1068, DOI 10.1091/mbc.E12-09-0661
   Ware LB, 2002, AM J PHYSIOL-LUNG C, V282, pL924, DOI 10.1152/ajplung.00439.2001
   Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783
   Weed SA, 1998, J CELL SCI, V111, P2433
   Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X
   Zebda N, 2013, J BIOL CHEM, V288, P18290, DOI 10.1074/jbc.M112.432757
   Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9
NR 63
TC 21
Z9 23
U1 2
U2 6
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD FEB 15
PY 2015
VL 26
IS 4
BP 636
EP 650
DI 10.1091/mbc.E14-02-0725
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA CE6KJ
UT WOS:000351945000005
PM 25518936
OA Green Published, hybrid
DA 2023-08-21
ER

PT J
AU Li, YC
   Cao, YM
   Zeng, Z
   Liang, MF
   Xue, Y
   Xi, CH
   Zhou, M
   Jiang, W
AF Li, Yingchuan
   Cao, Yongmei
   Zeng, Zhen
   Liang, Mengfan
   Xue, Ying
   Xi, Caihua
   Zhou, Ming
   Jiang, Wei
TI Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents
   lipopolysaccharide-induced apoptosis of pulmonary microvascular
   endothelial cells by inhibiting JNK/NF-kappa B pathways
SO SCIENTIFIC REPORTS
LA English
DT Article
ID LUNG INJURY INVOLVEMENT; TOLL-LIKE RECEPTOR; ALDOSTERONE SYSTEM;
   ACTIVATION; EXPRESSION; PROTECTS; FIBROSIS; ACE2; P38; CONTRIBUTES
AB ACE2 and Ang-(1-7) have important roles in preventing acute lung injury. However, it is not clear whether upregulation of the ACE2/Ang-(1-7)/Mas axis prevents LPS-induced injury in pulmonary microvascular endothelial cells (PMVECs) by inhibiting the MAPKs/NF-kappa B pathways. Primary cultured rat PMVECs were transduced with lentiviral-borne Ace2 or shRNA-Ace2, and then treated or not with Mas receptor blocker (A779) before exposure to LPS. LPS stimulation resulted in the higher levels of AngII, Ang-(1-7), cytokine secretion, and apoptosis rates, and the lower ACE2/ACE ratio. Ace2 reversed the ACE2/ACE imbalance and increased Ang-(1-7) levels, thus reducing LPS-induced apoptosis and inflammation, while inhibition of Ace2 reversed all these effects. A779 abolished these protective effects of Ace2. LPS treatment was associated with activation of the ERK, p38, JNK, and NF-kappa B pathways, which were aggravated by A779. Pretreatment with A779 prevented the Ace2-induced blockade of p38, JNK, and NF-kappa B phosphorylation. However, only JNK inhibitor markedly reduced apoptosis and cytokine secretion in PMVECs with Ace2 deletion and A779 pretreatment. These results suggest that the ACE2/Ang-(1-7)/Mas axis has a crucial role in preventing LPS-induced apoptosis and inflammation of PMVECs, by inhibiting the JNK/NF-kappa B pathways.
C1 [Li, Yingchuan; Cao, Yongmei; Zeng, Zhen; Liang, Mengfan; Xue, Ying; Xi, Caihua; Zhou, Ming; Jiang, Wei] Shanghai Jiao Tong Univ, Dept Anesthesiol, Peoples Hosp 6, Shanghai 200233, China.
C3 Shanghai Jiao Tong University
RP Jiang, W (corresponding author), Shanghai Jiao Tong Univ, Dept Anesthesiol, Peoples Hosp 6, Shanghai 200233, Peoples R China.
EM jiangw@sjtu.edu.cn
RI Zhou, Ming/HSD-2621-2023
FU National Nature Science Foundation of China [81272145]
FX This work was supported by the National Nature Science Foundation of
   China (No. 81272145).
CR Abraham E, 2003, J INFECT DIS, V187, pS364, DOI 10.1086/374750
   [Anonymous], 2012, EUR J PHARMACOL
   Asaduzzaman M, 2008, CRIT CARE MED, V36, P482, DOI 10.1097/01.CCM.0B013E31816204FA
   Badiei A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/848570
   BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380
   BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913
   Chen LN, 2013, SHOCK, V40, P420, DOI 10.1097/SHK.0b013e3182a6953e
   Cheng C, 2007, MOL CELL BIOCHEM, V305, P1, DOI 10.1007/s11010-007-9521-7
   Choi MS, 2007, EUR J PHARMACOL, V556, P181, DOI 10.1016/j.ejphar.2006.10.054
   Chou CH, 2013, MOL CELL ENDOCRINOL, V366, P21, DOI 10.1016/j.mce.2012.11.004
   de Man FS, 2012, AM J RESP CRIT CARE, V186, P780, DOI 10.1164/rccm.201203-0411OC
   Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1
   Faffe DS, 2000, EUR RESPIR J, V15, P85, DOI 10.1034/j.1399-3003.2000.15a16.x
   Fan J, 2001, AM J PHYSIOL-LUNG C, V281, pL1037, DOI 10.1152/ajplung.2001.281.5.L1037
   Ferrario CM, 2010, AM J PHYSIOL-RENAL, V298, pF1297, DOI 10.1152/ajprenal.00110.2010
   Ferreira AJ, 2011, EXP PHYSIOL, V96, P287, DOI 10.1113/expphysiol.2010.055277
   Gallagher PE, 2008, AM J PHYSIOL-CELL PH, V295, pC1169, DOI 10.1152/ajpcell.00145.2008
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   Jia HP, 2005, J VIROL, V79, P14614, DOI 10.1128/JVI.79.23.14614-14621.2005
   Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047
   Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621
   Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006
   Klein N, 2013, CRIT CARE MED, V41, pE334, DOI 10.1097/CCM.0b013e31828a6688
   Lee VY, 2005, AM J PHYSIOL-LUNG C, V289, pL521, DOI 10.1152/ajplung.00340.2004
   Liu S, 2008, EUR J PHARMACOL, V584, P159, DOI 10.1016/j.ejphar.2008.02.009
   Meng Y, 2014, AM J RESP CELL MOL, V50, P723, DOI 10.1165/rcmb.2012-0451OC
   Phillips M Ian, 2002, Curr Opin Investig Drugs, V3, P569
   Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC
   Rice GI, 2004, BIOCHEM J, V383, P45, DOI 10.1042/BJ20040634
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341
   Schuh K, 2009, BIOCHEM PHARMACOL, V77, P1827, DOI 10.1016/j.bcp.2009.03.012
   Shen WF, 2009, PHARMACOL RES, V60, P296, DOI 10.1016/j.phrs.2009.04.007
   Shenoy V, 2010, AM J RESP CRIT CARE, V182, P1065, DOI 10.1164/rccm.200912-1840OC
   Siddiqui SS, 2007, AM J PHYSIOL-LUNG C, V292, pL114, DOI 10.1152/ajplung.00257.2005
   Song B, 2013, CIRC J, V77, P2997, DOI 10.1253/circj.CJ-13-0805
   Sukumaran V, 2011, INT J BIOL SCI, V7, P1077, DOI 10.7150/ijbs.7.1077
   Sun SX, 2011, CELL BIOCHEM BIOPHYS, V61, P123, DOI 10.1007/s12013-011-9168-6
   Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6
   Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200
   Togbe D, 2007, INT J EXP PATHOL, V88, P387, DOI 10.1111/j.1365-2613.2007.00566.x
   Uhal BD, 2011, AM J PHYSIOL-LUNG C, V301, pL269, DOI 10.1152/ajplung.00222.2010
   Wang YL, 2014, INT IMMUNOPHARMACOL, V23, P205, DOI 10.1016/j.intimp.2014.09.002
   Weir MR, 1999, AM J HYPERTENS, V12, p205S
   Wosten-van Asperen RM, 2011, J PATHOL, V225, P618, DOI 10.1002/path.2987
   Zhang H, 2005, ARCH BIOCHEM BIOPHYS, V441, P75, DOI 10.1016/j.abb.2005.06.022
   Zhong JC, 2010, CIRCULATION, V122, P717, DOI 10.1161/CIRCULATIONAHA.110.955369
   Zhou ZG, 2007, CELL SIGNAL, V19, P1238, DOI 10.1016/j.cellsig.2006.12.013
NR 49
TC 59
Z9 67
U1 2
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 3
PY 2015
VL 5
AR 8209
DI 10.1038/srep08209
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CA1XW
UT WOS:000348703200020
PM 25644821
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Gong, HX
   Rehman, J
   Tang, HY
   Wary, K
   Mittal, M
   Chatturvedi, P
   Zhao, YY
   Komorova, YA
   Vogel, SM
   Malik, AB
AF Gong, Haixia
   Rehman, Jalees
   Tang, Haiyang
   Wary, Kishore
   Mittal, Manish
   Chatturvedi, Pallavi
   Zhao, Youyang
   Komorova, Yulia A.
   Vogel, Stephen M.
   Malik, Asrar B.
TI HIF2 alpha signaling inhibits adherens junctional disruption in acute
   lung injury
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID HYPOXIA-INDUCIBLE FACTOR; RESPIRATORY-DISTRESS-SYNDROME; VE-CADHERIN;
   ENDOTHELIAL-CELLS; LEUKOCYTE EXTRAVASATION; VASCULAR-PERMEABILITY;
   ALVEOLAR HYPOXIA; BARRIER FUNCTION; FACTOR 1-ALPHA; IN-VIVO
AB Vascular endothelial barrier dysfunction underlies diseases such as acute respiratory distress syndrome (ARDS), characterized by edema and inflammatory cell infiltration. The transcription factor HIF2 alpha is highly expressed in vascular endothelial cells (ECs) and may regulate endothelial barrier function. Here, we analyzed promoter sequences of genes encoding proteins that regulate adherens junction (AJ) integrity and determined that vascular endothelial protein tyrosine phosphatase (VE-PTP) is a HIF2 alpha target HIF2 alpha-induced VE-PTP expression enhanced dephosphorylation of VE-cadherin, which reduced VE-cadherin endocytosis and thereby augmented AJ integrity and endothelial barrier function. Mice harboring an EC-specific deletion of Hif2 alpha exhibited decreased VE-PTP expression and increased VE-cadherin phosphorylation, resulting in defective AJs. Mice lacking HIF2 alpha in ECs had increased lung vascular permeability and water content, both of which were further exacerbated by endotoxin-mediated injury. Treatment of these mice with Fg4497, a prolyl hydroxylase domain 2 (PHD2) inhibitor, activated HIF2 alpha-mediated transcription in a hypoxia-independent manner. HIF2 alpha activation increased VE-PTP expression, decreased VE-cadherin phosphorylation, promoted AJ integrity, and prevented the loss of endothelial barrier function. These findings demonstrate that HIF2 alpha enhances endothelial barrier integrity, in part through VE-PTP expression and the resultant VE-cadherin dephosphorylation-mediated assembly of AJs. Moreover, activation of HIF2 alpha/VE-PTP signaling via PHD2 inhibition has the potential to prevent the formation of leaky vessels and edema in inflammatory diseases such as ARDS.
C1 [Gong, Haixia; Rehman, Jalees; Tang, Haiyang; Wary, Kishore; Mittal, Manish; Chatturvedi, Pallavi; Zhao, Youyang; Komorova, Yulia A.; Vogel, Stephen M.; Malik, Asrar B.] Univ Illinois, Dept Pharmacol, Chicago, IL 60612, United States.
   [Gong, Haixia; Rehman, Jalees; Tang, Haiyang; Wary, Kishore; Mittal, Manish; Chatturvedi, Pallavi; Zhao, Youyang; Komorova, Yulia A.; Vogel, Stephen M.; Malik, Asrar B.] Univ Illinois, Ctr Lung & Vasc Biol, Chicago, IL 60612, United States.
   [Rehman, Jalees] Univ Illinois, Dept Med, Cardiol Sect, Chicago, IL 60612, United States.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital;
   University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital
RP Malik, AB (corresponding author), Univ Illinois, Dept Pharmacol, 835 South Wolcott Ave, Chicago, IL 60612 USA.
EM jalees@uic.edu; abmalik@uic.edu
RI Rehman, Jalees/GVU-1981-2022; TANG, HAIYANG/J-4006-2013; Rehman,
   Jalees/J-8258-2012
OI Rehman, Jalees/0000-0002-2787-9292; Rehman, Jalees/0000-0002-2787-9292;
   ZHAO, YOU-YANG/0000-0002-0041-0339; Wary, Kishore/0000-0001-8851-8565;
   Malik, Asrar/0000-0002-8205-7128
FU NIH [P01 HL60678, R01 HL45638, R01HL118068, R01 GM094220]; AHA
   [13SDG16910050]
FX The studies were supported by NIH grants P01 HL60678, R01 HL45638,
   R01HL118068, and R01 GM094220, and by AHA grant 13SDG16910050.
CR Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200
   Bernhardt WM, 2010, J AM SOC NEPHROL, V21, P2151, DOI 10.1681/ASN.2010010116
   BLAND RD, 1977, CIRC RES, V40, P269, DOI 10.1161/01.RES.40.3.269
   Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427
   BRESSACK MA, 1980, CIRC RES, V46, P111, DOI 10.1161/01.RES.46.1.111
   Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373
   Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721
   Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4
   Farahani RM, 2012, J COMP NEUROL, V520, P3803, DOI 10.1002/cne.23162
   Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019
   Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486
   Goel S, 2013, JNCI-J NATL CANCER I, V105, P1188, DOI 10.1093/jnci/djt164
   Gong HX, 2014, J EXP MED, V211, P579, DOI 10.1084/jem.20131190
   Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779
   Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001
   Hayashi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2683
   He K, 2014, KIDNEY INT, V85, P276, DOI 10.1038/ki.2013.342
   Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200
   Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324
   Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817
   Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149
   Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009
   Kapitsinou PP, 2014, J CLIN INVEST, V124, P2396, DOI 10.1172/JCI69073
   Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300
   Komarova Yulia A, 2007, Sci STKE, V2007, pre8
   Korhonen H, 2009, J EXP MED, V206, P411, DOI 10.1084/jem.20082150
   Kuppers V, 2014, CELL TISSUE RES, V355, P577, DOI 10.1007/s00441-014-1812-1
   Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566
   Linke S, 2004, J BIOL CHEM, V279, P14391, DOI 10.1074/jbc.M313614200
   Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406
   OGAWA S, 1990, J CLIN INVEST, V85, P1090, DOI 10.1172/JCI114540
   Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199
   Pipeling MR, 2010, JAMA-J AM MED ASSOC, V304, P2521, DOI 10.1001/jama.2010.1752
   Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033
   Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266
   Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187
   Semenza GL, 2009, ANN NY ACAD SCI, V1177, P2, DOI 10.1111/j.1749-6632.2009.05032.x
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Shen JK, 2014, J CLIN INVEST, V124, P4564, DOI 10.1172/JCI74527
   Skuli N, 2009, BLOOD, V114, P469, DOI 10.1182/blood-2008-12-193581
   Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026
   Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320
   Vestweber D, 2014, SEMIN IMMUNOPATHOL, V36, P177, DOI 10.1007/s00281-014-0419-7
   Vockel M, 2013, BLOOD, V122, P2512, DOI 10.1182/blood-2013-04-499228
   Vogel SM, 2000, PHYSIOL GENOMICS, V4, P137, DOI 10.1152/physiolgenomics.2000.4.2.137
   Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824
   Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159
   Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001
   Yacyshyn OK, 2009, ANGIOGENESIS, V12, P25, DOI 10.1007/s10456-008-9126-0
   Yuan GX, 2013, P NATL ACAD SCI USA, V110, pE1788, DOI 10.1073/pnas.1305961110
   Ziegler T, 2013, J CLIN INVEST, V123, P3436, DOI 10.1172/JCI66549
NR 54
TC 92
Z9 93
U1 1
U2 22
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD FEB
PY 2015
VL 125
IS 2
BP 652
EP 664
DI 10.1172/JCI77701
PG 13
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA CA5QK
UT WOS:000348962700022
PM 25574837
OA Bronze, Green Published
DA 2023-08-21
ER

PT J
AU Sakaguchi, M
   Marutani, E
   Shin, HS
   Chen, W
   Hanaoka, K
   Xian, M
   Ichinose, F
AF Sakaguchi, Masahiro
   Marutani, Eizo
   Shin, Hae-sook
   Chen, Wei
   Hanaoka, Kenjiro
   Xian, Ming
   Ichinose, Fumito
TI Sodium Thiosulfate Attenuates Acute Lung Injury in Mice
SO ANESTHESIOLOGY
LA English
DT Article
ID HYDROGEN-SULFIDE; PROTECTS; INFLAMMATION; ACTIVATION; CISPLATIN;
   FAILURE; SEPSIS
AB Background: Acute lung injury is characterized by neutrophilic inflammation and increased lung permeability. Thiosulfate is a stable metabolite of hydrogen sulfide, a gaseous mediator that exerts antiinflammatory effects. Although sodium thiosulfate (STS) has been used as an antidote, the effect of STS on acute lung injury is unknown. The authors assessed the effects of STS on mice lung and vascular endothelial cells subjected to acute inflammation.
   Methods: Lung injury was assessed in mice challenged with intratracheal lipopolysaccharide or subjected to cecal ligation and puncture with or without STS. Effects of STS on endothelial permeability and the production of inflammatory cytokines and reactive oxygen species were examined in cultured endothelial cells incubated with lipopolysaccharide or tumor necrosis factor-a. Levels of sulfide and sulfane sulfur were measured using novel fluorescence probes.
   Results: STS inhibited lipopolysaccharide-induced production of cytokines (interleukin-6 [pg/ml]; 313 +/- 164, lipopolysaccharide; 79 +/- 27, lipopolysaccharide + STS [n = 10]), lung permeability, histologic lung injury, and nuclear factor-kappa B activation in the lung. STS also prevented up-regulation of interleukin-6 in the mouse lung subjected to cecal ligation and puncture. In endothelial cells, STS increased intracellular levels of sulfide and sulfane sulfur and inhibited lipopolysaccharide or tumor necrosis factor-alpha-induced production of cytokines and reactive oxygen species. The beneficial effects of STS were associated with attenuation of the lipopolysaccharide-induced nuclear factor-kappa B activation through the inhibition of tumor necrosis factor receptor-associated factor 6 ubiquitination.
   Conclusions: STS exerts robust antiinflammatory effects in mice lung and vascular endothelium. The results suggest a therapeutic potential of STS in acute lung injury.
C1 [Sakaguchi, Masahiro; Marutani, Eizo; Shin, Hae-sook; Ichinose, Fumito] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114, United States.
   [Sakaguchi, Masahiro; Marutani, Eizo; Shin, Hae-sook; Ichinose, Fumito] Harvard Univ, Sch Med, Boston, MA, United States.
   [Chen, Wei; Xian, Ming] Washington State Univ, Dept Chem, Pullman, WA 99164, United States.
   [Hanaoka, Kenjiro] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan.
C3 Harvard University; Massachusetts General Hospital; Harvard University;
   Harvard Medical School; Washington State University; University of Tokyo
RP Ichinose, F (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St, Boston, MA 02114 USA.
EM fichinose@mgh.harvard.edu
OI Chen, Wei/0000-0001-5567-7463
FU National Institutes of Health (Bethesda, Maryland) [R01HL101930]
FX This study was supported by a National Institutes of Health (Bethesda,
   Maryland) grant R01HL101930 (to Dr. Ichinose).
CR Adirekkiat S, 2010, NEPHROL DIAL TRANSPL, V25, P1923, DOI 10.1093/ndt/gfp755
   Bernard GR, 2005, AM J RESP CRIT CARE, V172, P798, DOI 10.1164/rccm.200504-663OE
   Chen W, 2013, CHEM SCI, V4, P2892, DOI 10.1039/c3sc50754h
   Chung JY, 2002, J CELL SCI, V115, P679
   Cicone JS, 2004, AM J KIDNEY DIS, V43, P1104, DOI 10.1053/j.ajkd.2004.03.018
   Faller S, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-26
   Francis RC, 2011, ANESTHESIOLOGY, V115, P1012, DOI 10.1097/ALN.0b013e31823306cf
   GOEL R, 1989, J NATL CANCER I, V81, P1552, DOI 10.1093/jnci/81.20.1552
   Ichinose F, 2001, CIRC RES, V88, P832, DOI 10.1161/hh0801.089177
   Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345
   Koh H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-60
   Kondo K, 2013, CIRCULATION, V127, P1116, DOI 10.1161/CIRCULATIONAHA.112.000855
   Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170
   MARKMAN M, 1985, CANCER, V56, P2364, DOI 10.1002/1097-0142(19851115)56:10<2364::AID-CNCR2820561003>3.0.CO;2-4
   Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008
   Menden H, 2013, AM J PHYSIOL-LUNG C, V304, pL445, DOI 10.1152/ajplung.00261.2012
   Neuwelt EA, 1998, J PHARMACOL EXP THER, V286, P77
   Olson KR, 2011, AM J PHYSIOL-REG I, V301, pR297, DOI 10.1152/ajpregu.00045.2011
   Pan LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019766
   Pasch A, 2008, KIDNEY INT, V74, P1444, DOI 10.1038/ki.2008.455
   Peters K, 2003, CARDIOVASC RES, V60, P49, DOI 10.1016/S0008-6363(03)00397-3
   PETTERSEN JC, 1985, TOXICOL APPL PHARM, V81, P265, DOI 10.1016/0041-008X(85)90163-2
   Reddy AT, 2012, J IMMUNOL, V189, P5411, DOI 10.4049/jimmunol.1201487
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Sasakura K, 2011, J AM CHEM SOC, V133, P18003, DOI 10.1021/ja207851s
   Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021
   Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364
   Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111
   Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]
   Shirozu K, 2014, ANTIOXID REDOX SIGN, V20, P204, DOI 10.1089/ars.2013.5354
   Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108
   Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425
   Tokuda K, 2012, ANTIOXID REDOX SIGN, V17, P11, DOI 10.1089/ars.2011.4363
   Toohey JI, 2011, ANAL BIOCHEM, V413, P1, DOI 10.1016/j.ab.2011.01.044
   Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899
   Zhang XF, 2013, CELL RES, V23, P366, DOI 10.1038/cr.2013.21
   Zou L, 2011, SHOCK, V36, P370, DOI 10.1097/SHK.0b013e3182279868
NR 37
TC 58
Z9 60
U1 1
U2 20
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0003-3022
EI 1528-1175
J9 ANESTHESIOLOGY
JI Anesthesiology
PD DEC
PY 2014
VL 121
IS 6
BP 1248
EP 1257
DI 10.1097/ALN.0000000000000456
PG 10
WC Anesthesiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology
GA AU2FB
UT WOS:000345430700016
PM 25260144
OA Green Accepted, Bronze
DA 2023-08-21
ER

PT J
AU Kondrikov, D
   Gross, C
   Black, SM
   Su, YC
AF Kondrikov, Dmitry
   Gross, Christine M.
   Black, Stephen M.
   Su, Yunchao
TI Novel Peptide for Attenuation of Hyperoxia-induced Disruption of Lung
   Endothelial Barrier and Pulmonary Edema via Modulating Peroxynitrite
   Formation
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID NITRIC-OXIDE SYNTHASE; OXYGEN-INDUCED RETINOPATHY; INJURY; APOPTOSIS;
   ENOS; PERMEABILITY; MONOLAYERS; TOXICITY; CELLS; NO
AB Pulmonary damages of oxygen toxicity include vascular leakage and pulmonary edema. We have previously reported that hyperoxia increases the formation of NO and peroxynitrite in lung endothelial cells via increased interaction of endothelial nitric oxide (eNOS) with beta-actin. A peptide (P326TAT) with amino acid sequence corresponding to the actin binding region of eNOS residues 326-333 has been shown to reduce the hyperoxia-induced formation of NO and peroxynitrite in lung endothelial cells. In the present study, we found that exposure of pulmonary artery endothelial cells to hyperoxia (95% oxygen and 5% CO2) for 48 h resulted in disruption of monolayer barrier integrity in two phases, and apoptosis occurred in the second phase. NOS inhibitor NG-nitro-L-arginine methyl ester attenuated the endothelial barrier disruption in both phases. Peroxynitrite scavenger uric acid did not affect the first phase but ameliorated the second phase of endothelial barrier disruption and apoptosis. P326TAT inhibited hyperoxia-induced disruption of monolayer barrier integrity in two phases and apoptosis in the second phase. More importantly, injection of P326TAT attenuated vascular leakage, pulmonary edema, and endothelial apoptosis in the lungs of mice exposed to hyperoxia. P326TAT also significantly reduced the increase in eNOS-beta-actin association and protein tyrosine nitration. Together, these results indicate that peptide P326TAT ameliorates barrier dysfunction of hyperoxic lung endothelial monolayer and attenuates eNOS-beta-actin association, peroxynitrite formation, endothelial apoptosis, and pulmonary edema in lungs of hyperoxic mice. P326TAT can be a novel therapeutic agent to treat or prevent acute lung injury in oxygen toxicity.
C1 [Kondrikov, Dmitry; Su, Yunchao] Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912, United States.
   [Su, Yunchao] Georgia Regents Univ, Med Coll Georgia, Dept Med, Augusta, GA 30912, United States.
   [Gross, Christine; Black, Stephen M.; Su, Yunchao] Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912, United States.
   [Su, Yunchao] Georgia Regents Univ, Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912, United States.
C3 University System of Georgia; Augusta University; University System of
   Georgia; Augusta University; University System of Georgia; Augusta
   University; University System of Georgia; Augusta University
RP Su, YC (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, 1120 15th St, Augusta, GA 30912 USA.
EM ysu@gru.edu
OI Black, Stephen M./0000-0002-4524-6544
FU National Institutes of Health [HL088261, HL115078, HL0101902]; Flight
   Attendants Medical Research Institute [113018_CIA]
FX This work was supported, in whole or in part, by National Institutes of
   Health Grants HL088261 and HL115078 (to Y. S.) and HL0101902 (to S. M.
   B.). This work was also supported by Flight Attendants Medical Research
   Institute Grant 113018_CIA (to Y. S.).
CR Abdelsaid MA, 2010, J PHARMACOL EXP THER, V332, P125, DOI 10.1124/jpet.109.157941
   Allen BW, 2009, J APPL PHYSIOL, V106, P662, DOI 10.1152/japplphysiol.91109.2008
   Beauchamp MH, 2004, FREE RADICAL BIO MED, V37, P1885, DOI 10.1016/j.freeradbiomed.2004.09.008
   Bhandari V, 2006, FREE RADICAL BIO MED, V41, P4, DOI 10.1016/j.freeradbiomed.2006.01.027
   Bove K, 2001, AM J PHYSIOL-LUNG C, V280, pL914, DOI 10.1152/ajplung.2001.280.5.L914
   BRASCH RC, 1993, PEDIATR RADIOL, V23, P495, DOI 10.1007/BF02012128
   Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222
   Christofidou-Solomidou Melpo, 2006, Treat Respir Med, V5, P47, DOI 10.2165/00151829-200605010-00004
   Delavallee L, 2011, IUBMB LIFE, V63, P221, DOI 10.1002/iub.432
   Gu XL, 2003, AM J PHYSIOL-CELL PH, V285, pC546, DOI 10.1152/ajpcell.00424.2002
   Gustafsson AB, 2005, METH MOLEC MED, V112, P81
   Klings ES, 2009, AM J PATHOL, V175, P2309, DOI 10.2353/ajpath.2009.081017
   Kondrikov D, 2011, FREE RADICAL BIO MED, V50, P1689, DOI 10.1016/j.freeradbiomed.2011.03.020
   Kondrikov D, 2010, J BIOL CHEM, V285, P35479, DOI 10.1074/jbc.M110.140269
   Kondrikov D, 2010, J BIOL CHEM, V285, P4319, DOI 10.1074/jbc.M109.063172
   Li LF, 2007, CRIT CARE, V11, DOI 10.1186/cc6101
   McGrath-Morrow SA, 2001, AM J RESP CELL MOL, V25, P150, DOI 10.1165/ajrcmb.25.2.4362
   Modol T, 2011, BIOCHEM PHARMACOL, V81, P451, DOI 10.1016/j.bcp.2010.10.017
   NOZIK ES, 1995, RESP PHYSIOL, V100, P63, DOI 10.1016/0034-5687(94)00116-H
   Payne DK, 1996, FREE RADICAL RES, V25, P229, DOI 10.3109/10715769609149048
   PHILLIPS PG, 1988, J APPL PHYSIOL, V64, P1196, DOI 10.1152/jappl.1988.64.3.1196
   Radomski A, 1998, BRIT J PHARMACOL, V125, P1455, DOI 10.1038/sj.bjp.0702216
   Sanchez FA, 2009, P NATL ACAD SCI USA, V106, P6849, DOI 10.1073/pnas.0812694106
   Su YC, 2003, AM J PHYSIOL-CELL PH, V284, pC1542, DOI 10.1152/ajpcell.00248.2002
   Veress LA, 2010, AM J RESP CRIT CARE, V182, P1352, DOI 10.1164/rccm.200910-1618OC
   WEIR KLI, 1994, AM J RESP CRIT CARE, V150, P784, DOI 10.1164/ajrccm.150.3.8087353
NR 26
TC 10
Z9 10
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 28
PY 2014
VL 289
IS 48
BP 33355
EP 33363
DI 10.1074/jbc.M114.585356
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA AU5HC
UT WOS:000345636600026
PM 25315770
OA Green Published, hybrid
DA 2023-08-21
ER

PT J
AU Leonard, A
   Paton, AW
   El-Quadi, M
   Paton, JC
   Fazal, F
AF Leonard, Antony
   Paton, Adrienne W.
   El-Quadi, Monaliza
   Paton, James C.
   Fazal, Fabeha
TI Preconditioning with Endoplasmic Reticulum Stress Ameliorates
   Endothelial Cell Inflammation
SO PLOS ONE
LA English
DT Article
ID NF-KAPPA-B; RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; RELA/P65
   NUCLEAR TRANSLOCATION; UNFOLDED PROTEIN RESPONSE; TISSUE-FACTOR;
   RHEUMATOID-ARTHRITIS; SIGNALING PATHWAYS; ICAM-1 EXPRESSION; INDUCED
   INCREASE
AB Endoplasmic Reticulum (ER) stress, caused by disturbance in ER homeostasis, has been implicated in several pathological conditions such as ischemic injury, neurodegenerative disorders, metabolic diseases and more recently in inflammatory conditions. Our present study aims at understanding the role of ER stress in endothelial cell (EC) inflammation, a critical event in the pathogenesis of acute lung injury (ALI). We found that preconditioning human pulmonary artery endothelial cells (HPAEC) to ER stress either by depleting ER chaperone and signaling regulator BiP using siRNA, or specifically cleaving (inactivating) BiP using subtilase cytotoxin (SubAB), alleviates EC inflammation. The two approaches adopted to abrogate BiP function induced ATF4 protein expression and the phosphorylation of eIF2 alpha, both markers of ER stress, which in turn resulted in blunting the activation of NF-kappa B, and restoring endothelial barrier integrity. Pretreatment of HPAEC with BiP siRNA inhibited thrombin-induced IkB alpha degradation and its resulting downstream signaling pathway involving NF-kappa B nuclear translocation, DNA binding, phosphorylation at serine536, transcriptional activation and subsequent expression of adhesion molecules. However, TNF alpha-mediated NF-kappa B signaling was unaffected upon BiP knockdown. In an alternative approach, SubAB-mediated inactivation of NF-kappa B was independent of IkB alpha degradation. Mechanistic analysis revealed that pretreatment of EC with SubAB interfered with the binding of the liberated NF-kappa B to the DNA, thereby resulting in reduced expression of adhesion molecules, cytokines and chemokines. In addition, both knockdown and inactivation of BiP stimulated actin cytoskeletal reorganization resulting in restoration of endothelial permeability. Together our studies indicate that BiP plays a central role in EC inflammation and injury via its action on NF-kappa B activation and regulation of vascular permeability.
C1 [Leonard, Antony; El-Quadi, Monaliza; Fazal, Fabeha] Univ Rochester, Sch Med & Dent, Dept Pediat, Lung Biol & Dis Program, Rochester, NY 14627, United States.
   [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA, Australia.
C3 University of Rochester; University of Adelaide
RP Fazal, F (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pediat, Lung Biol & Dis Program, Rochester, NY 14627 USA.
EM Fabeha_Fazal@URMC.Rochester.edu
FU National Heart, Lung and Blood Institute [HL096907]
FX This work was supported by National Heart, Lung and Blood Institute
   Grant HL096907. The funder had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Adachi T, 2012, ARCH BIOCHEM BIOPHYS, V520, P30, DOI 10.1016/j.abb.2012.01.014
   Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a
   Anthoni C, 2007, J EXP MED, V204, P1595, DOI 10.1084/jem.20062354
   Bair AM, 2009, J BIOL CHEM, V284, P563, DOI 10.1074/jbc.M803984200
   Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060
   Bijli KM, 2012, AM J RESP CELL MOL, V47, P660, DOI 10.1165/rcmb.2012-0047OC
   Contrino J, 1996, NAT MED, V2, P209, DOI 10.1038/nm0296-209
   Dong DZ, 2011, CANCER RES, V71, P2848, DOI 10.1158/0008-5472.CAN-10-3151
   Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487
   Fazal F, 2005, MOL CELL BIOL, V25, P6259, DOI 10.1128/MCB.25.14.6259-6266.2005
   Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200
   Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444
   Finigan JH, 2009, MICROVASC RES, V77, P35, DOI 10.1016/j.mvr.2008.09.002
   Gando S, 1999, J TRAUMA, V47, P719, DOI 10.1097/00005373-199910000-00017
   Gunther A, 2000, AM J RESP CRIT CARE, V161, P454
   Harama D, 2009, J IMMUNOL, V183, P1368, DOI 10.4049/jimmunol.0804066
   Hayakawa K, 2010, J AM SOC NEPHROL, V21, P73, DOI 10.1681/ASN.2009040432
   Hayakawa K, 2009, J IMMUNOL, V182, P1182, DOI 10.4049/jimmunol.182.2.1182
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Hu CCA, 2009, J EXP MED, V206, P2429, DOI 10.1084/jem.20090782
   Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200
   Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB
   Inagi R, 2008, J AM SOC NEPHROL, V19, P915, DOI 10.1681/ASN.2007070745
   Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211
   Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755
   Kitamura M, 2009, ANTIOXID REDOX SIGN, V11, P2353, DOI [10.1089/ars.2008.2391, 10.1089/ARS.2008.2391]
   LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933
   Levitt JE, 2006, SEMIN RESP CRIT CARE, V27, P426, DOI 10.1055/s-2006-948296
   Li JM, 2011, J BIOL CHEM, V286, P4912, DOI 10.1074/jbc.M110.199729
   Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007
   Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434
   Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006
   Minhajuddin M, 2005, J IMMUNOL, V174, P5823, DOI 10.4049/jimmunol.174.9.5823
   Nakajima S, 2011, MOL CELL BIOL, V31, P1710, DOI 10.1128/MCB.00939-10
   Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124
   Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392
   Prell T, 2014, J NEUROIMMUNOL, V270, P29, DOI 10.1016/j.jneuroim.2014.03.005
   Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488
   Rahman A, 1999, J IMMUNOL, V162, P5466
   Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001
   Rath E, 2011, EUR J NUTR, V50, P219, DOI 10.1007/s00394-011-0197-0
   Sabit R, 2010, CHEST, V138, P47, DOI 10.1378/chest.09-2764
   SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X
   Shenderov K, 2014, J IMMUNOL, V192, P2029, DOI 10.4049/jimmunol.1302549
   Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078
   Undas A, 2010, THROMB HAEMOSTASIS, V104, P224, DOI 10.1160/TH10-02-0091
   Usuki F, 2013, SCI REP-UK, V3, DOI 10.1038/srep02346
   Vaidyula VR, 2009, THROMB RES, V124, P259, DOI 10.1016/j.thromres.2008.12.030
   van der Poll T, 2008, CRIT CARE, V12, DOI 10.1186/cc7026
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739
   Wolfson JJ, 2008, CELL MICROBIOL, V10, P1775, DOI 10.1111/j.1462-5822.2008.01164.x
   Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373
   Yoo SA, 2012, J EXP MED, V209, P871, DOI 10.1084/jem.20111783
NR 57
TC 35
Z9 36
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 30
PY 2014
VL 9
IS 10
AR e110949
DI 10.1371/journal.pone.0110949
PG 18
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AX2HU
UT WOS:000346765000033
PM 25356743
OA Green Published, Green Submitted, gold
DA 2023-08-21
ER

PT J
AU Liu, TG
   Ghamloush, MM
   Aldawood, A
   Warburton, R
   Toksoz, D
   Hill, NS
   Tang, DD
   Kayyali, US
AF Liu, Tiegang
   Ghamloush, Maher M.
   Aldawood, Ali
   Warburton, Rod
   Toksoz, Deniz
   Hill, Nicholas S.
   Tang, Dale D.
   Kayyali, Usamah S.
TI Modulating Endothelial Barrier Function by Targeting Vimentin
   Phosphorylation
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
ID INTERMEDIATE-FILAMENTS; P21-ACTIVATED KINASE; CELLS; PERMEABILITY;
   HYPOXIA; ALTERS; PATHWAYS; INVITRO; SER-56
AB Vimentin is a major intermediate filament protein in vascular endothelial cells which might be involved in their function as a barrier tissue. It is proposed to dynamically maintain integrity of the endothelium as a tightly regulated permeability barrier that is subjected to a variety of shear and contractile forces. The results described in this report demonstrate that vimentin plays that role through mechanisms that are dependent on its phosphorylation state. Withaferin A (WFA), a vimentin targeting drug is shown to disrupt endothelial barrier function through its effects on vimentin filament distribution and physical properties. These effects are related to WFA's ability to increase vimentin phosphorylation. Through overexpressing a non-phosphorylatable vimentin mutant we can block the effects of WFA on vimentin distribution and barrier permeability. The barrier augmentation effect appears to extend to endothelial cells that do not express detectable mutant vimentin which might suggest transmissible effects across cells. Blocking vimentin phosphorylation also protects the endothelial barrier against LPS endotoxin, implicating it as a target for drug development against pulmonary edema and acute respiratory distress syndrome (ARDS). (C) 2014 Wiley Periodicals, Inc.
C1 [Liu, Tiegang; Ghamloush, Maher M.; Aldawood, Ali; Warburton, Rod; Toksoz, Deniz; Hill, Nicholas S.; Kayyali, Usamah S.] Tufts Univ, Sch Med, Dept Med, Pulm & Crit Care Div,Tupper Res Inst,Tufts Med Ct, Boston, MA 02111, United States.
   [Tang, Dale D.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208, United States.
C3 Tufts Medical Center; Tufts University; Albany Medical College
RP Kayyali, US (corresponding author), Tufts Med Ctr, Pulm & Crit Care Div, 800 Washington St 257, Boston, MA 02111 USA.
EM ukayyali@tuftsmedicalcenter.org
RI T, Dale/AAE-9643-2020
OI T, Dale/0000-0002-7339-9249
FU NIH [AI096087, HL089671-04]
FX Contract grant sponsor: NIH;; Contract grant numbers: AI096087,
   HL089671-04.
CR An SS, 2005, AM J PHYSIOL-CELL PH, V289, pC521, DOI 10.1152/ajpcell.00429.2004
   Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010
   Cote CG, 1996, AM J PHYSIOL-LUNG C, V271, pL869, DOI 10.1152/ajplung.1996.271.5.L869
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487
   ERIKSSON J E, 1992, Current Opinion in Cell Biology, V4, P99, DOI 10.1016/0955-0674(92)90065-K
   Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906
   EVANS RM, 1989, J CELL BIOL, V108, P67, DOI 10.1083/jcb.108.1.67
   GARCIA JGN, 1995, J INVEST MED, V43, P117
   Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065
   INAGAKI M, 1988, J BIOL CHEM, V263, P5970
   Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200
   Ku NO, 1996, CANCER METAST REV, V15, P429, DOI 10.1007/BF00054011
   Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200
   Liu TG, 2010, AM J PHYSIOL-CELL PH, V299, pC363, DOI 10.1152/ajpcell.00057.2010
   Liu T, 2009, J CELL PHYSIOL, V220, P600, DOI 10.1002/jcp.21773
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3
   Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355
   Shasby DM, 2002, AM J PHYSIOL-LUNG C, V282, pL1330, DOI 10.1152/ajplung.00329.2001
   Tang DD, 2005, BIOCHEM J, V388, P773, DOI 10.1042/BJ20050065
   Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938
NR 21
TC 19
Z9 19
U1 0
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD OCT
PY 2014
VL 229
IS 10
BP 1484
EP 1493
DI 10.1002/jcp.24590
PG 10
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA AJ9MC
UT WOS:000338034300022
PM 24648251
DA 2023-08-21
ER

PT J
AU Storch, EK
   Hillyer, CD
   Shaz, BH
AF Storch, Emily K.
   Hillyer, Christopher D.
   Shaz, Beth H.
TI Spotlight on pathogenesis of TRALI: HNA-3a (CTL2) antibodies
SO BLOOD
LA English
DT Article
ID ACUTE LUNG INJURY; TRANSPORTER-LIKE PROTEIN-2; TRANSFECTED CELL-LINES;
   ENDOTHELIAL-CELLS; DONOR PLASMA; TRANSFUSION; ALLOANTIBODIES; MODEL;
   RISK; PREVENTION
AB Human neutrophil antigen-3a (HNA-3a) antibodies contained in donor plasma can result in severe, sometimes fatal transfusion-related acute lung injury (TRALI). Recent developments in TRALI secondary to antibodies to HNA-3a antigen span diagnosis, pathophysiology, treatment, and prevention resulting in improved understanding, potential treatments, and mitigation strategies. First, on the molecular level, characterization of HNA-3 antigen has allowed for genotyping methods that clarify population prevalence. Related work has led to generation of multiple antibody detection assays. These assays aid in determining potential populations at risk and potential mitigation strategies. Second, the development of TRALI requires a hit from the patient and from the product. Anti-HNA-3a is one of the product-derived factors and appears to result in TRALI by binding directly to pulmonary endothelium as well as to neutrophils expressing the corresponding antigen. Finally, potential mitigation strategies include red blood cell product filtration to remove anti-HNA-3a as well as other antibodies.
C1 [Storch, Emily K.; Hillyer, Christopher D.; Shaz, Beth H.] New York Blood Ctr, New York, NY 10065, United States.
   [Hillyer, Christopher D.] Weill Cornell Med Coll, Dept Med, New York, NY, United States.
   [Shaz, Beth H.] Emory Univ, Dept Pathol & Lab Med, Ctr Transfus & Cellular Therapies, Atlanta, GA 30322, United States.
C3 New York Blood Center; Cornell University; Weill Cornell Medicine; Emory
   University
RP Shaz, BH (corresponding author), New York Blood Ctr, 310 East 67th St, New York, NY 10065 USA.
EM bshaz@nybloodcenter.org
OI Shaz, Beth/0000-0002-2270-4821
CR [Anonymous], FAT REP FDA FOLL BLO
   Bayat B, 2013, ARTERIOSCL THROM VAS, V33, P2538, DOI 10.1161/ATVBAHA.113.301206
   Bayat B, 2012, TRANSFUSION, V52, P613, DOI 10.1111/j.1537-2995.2011.03303.x
   Berthold T, 2011, TRANSFUSION, V51, P2160, DOI 10.1111/j.1537-2995.2011.03115.x
   Bierling P, 2009, VOX SANG, V96, P266, DOI 10.1111/j.1423-0410.2008.01144.x
   Bougie DW, 2013, BLOOD, V122
   Bowens KL, 2012, TRANSFUSION, V52, P2368, DOI 10.1111/j.1537-2995.2012.03600.x
   Bux J, 2011, VOX SANG, V100, P122, DOI 10.1111/j.1423-0410.2010.01392.x
   Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303
   Chapman CE, 2009, TRANSFUSION, V49, P440, DOI 10.1111/j.1537-2995.2008.01948.x
   Curtis BR, 2011, TRANSFUSION, V51, P2168, DOI 10.1111/j.1537-2995.2011.03145.x
   Curtis BR, 2010, BLOOD, V115, P2073, DOI 10.1182/blood-2009-11-248336
   Davoren A, 2003, TRANSFUSION, V43, P641, DOI 10.1046/j.1537-2995.2003.00374.x
   Eder AF, 2013, TRANSFUSION, V53, P1442, DOI 10.1111/j.1537-2995.2012.03935.x
   Fadeyi EA, 2007, TRANSFUSION, V47, P545, DOI 10.1111/j.1537-2995.2006.01148.x
   Flesch BK, 2013, TRANSFUSION, V53, P3217, DOI 10.1111/trf.12160
   Flesland O, 2007, Intensive Care Med, V33 Suppl 1, pS17, DOI 10.1007/s00134-007-2875-1
   Greinacher A, 2010, NAT MED, V16, P45, DOI 10.1038/nm.2070
   GRIMMINGER F, 1991, CIRC RES, V68, P503, DOI 10.1161/01.RES.68.2.503
   Kanack AJ, 2012, TRANSFUSION, V52, P1112, DOI 10.1111/j.1537-2995.2011.03411.x
   Keller-Stanislawski B, 2010, VOX SANG, V98, P70, DOI 10.1111/j.1423-0410.2009.01232.x
   Kleinman S, 2004, TRANSFUSION, V44, P1774, DOI 10.1111/j.0041-1132.2004.04347.x
   Kleinman S, 2010, TRANSFUSION, V50, P1312, DOI 10.1111/j.1537-2995.2010.02659.x
   Kommareddi PK, 2010, PROTEIN J, V29, P417, DOI 10.1007/s10930-010-9268-y
   Kommareddi PK, 2009, LARYNGOSCOPE, V119, P924, DOI 10.1002/lary.20136
   Kopko PM, 2002, JAMA-J AM MED ASSOC, V287, P1968, DOI 10.1001/jama.287.15.1968
   Lin YL, 2012, TRANSFUSION, V52, P567, DOI 10.1111/j.1537-2995.2011.03330.x
   Reil A, 2008, VOX SANG, V95, P313, DOI 10.1111/j.1423-0410.2008.01092.x
   Reil A, 2011, TRANSFUSION, V51, P18, DOI 10.1111/j.1537-2995.2010.02751.x
   Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366
   SEEGER W, 1990, BLOOD, V76, P1438
   Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538
   Shaz BH, 2011, BLOOD, V117, P1463, DOI 10.1182/blood-2010-04-278135
   Silliman CC, 2007, BLOOD, V109, P1752, DOI 10.1182/blood-2006-05-025106
   Silliman CC, 2014, BLOOD, V123, P3488, DOI 10.1182/blood-2013-10-532424
   Thomas GM, 2012, BLOOD, V119, P6335, DOI 10.1182/blood-2012-01-405183
   Toy P, 2012, BLOOD, V119, P1757, DOI 10.1182/blood-2011-08-370932
   Wiersum-Osselton JC, 2011, TRANSFUSION, V51, P1278, DOI 10.1111/j.1537-2995.2010.02969.x
   Wozniak MJ, 2012, TRANSFUSION, V52, P1458, DOI 10.1111/j.1537-2995.2011.03490.x
NR 39
TC 15
Z9 18
U1 0
U2 3
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD SEP 18
PY 2014
VL 124
IS 12
BP 1868
EP 1872
DI 10.1182/blood-2014-05-538181
PG 5
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA AQ4JT
UT WOS:000342762800007
PM 25006121
OA Bronze
DA 2023-08-21
ER

PT J
AU Kumar, S
   Xu, JY
   Kumar, RS
   Lakshmikanthan, S
   Kapur, R
   Kofron, M
   Chrzanowska-Wodnicka, M
   Filippi, MD
AF Kumar, Sachin
   Xu, Juying
   Kumar, Rupali Sani
   Lakshmikanthan, Sribalaji
   Kapur, Reuben
   Kofron, Matthew
   Chrzanowska-Wodnicka, Magdalena
   Filippi, Marie-Dominique
TI The small GTPase Rap1b negatively regulates neutrophil chemotaxis and
   transcellular diapedesis by inhibiting Akt activation
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID NECROSIS-FACTOR-ALPHA; ACUTE LUNG INJURY; MATRIX-METALLOPROTEINASE;
   VASCULAR ENDOTHELIUM; CELL FUNCTIONS; MIGRATION; ADHESION; PROTEIN;
   INFLAMMATION; CYTOTOXICITY
AB Neutrophils are the first line of cellular defense in response to infections and inflammatory injuries. However, neutrophil activation and accumulation into tissues trigger tissue damage due to release of a plethora of toxic oxidants and proteases, a cause of acute lung injury (ALI). Despite its clinical importance, the molecular regulation of neutrophil migration is poorly understood. The small GTPase Rap1b is generally viewed as a positive regulator of immune cell functions by controlling bidirectional integrin signaling. However, we found that Rap1b-deficient mice exhibited enhanced neutrophil recruitment to inflamed lungs and enhanced susceptibility to endotoxin shock. Unexpectedly, Rap1b deficiency promoted the transcellular route of diapedesis through endothelial cell. Increased transcellular migration of Rap1b-deficient neutrophils in vitro was selectively mediated by enhanced PI3K-Akt activation and invadopodia-like protrusions. Akt inhibition in vivo suppressed excessive Rap1b-deficient neutrophil migration and associated endotoxin shock. The inhibitory action of Rap1b on PI3K signaling may be mediated by activation of phosphatase SHP-1. Thus, this study reveals an unexpected role for Rap1b as a key suppressor of neutrophil migration and lung inflammation.
C1 [Kumar, Sachin; Xu, Juying; Kumar, Rupali Sani; Filippi, Marie-Dominique] Cincinnati Childrens Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229, United States.
   [Kumar, Sachin; Xu, Juying; Kumar, Rupali Sani; Filippi, Marie-Dominique] Univ Cincinnati, Coll Med, Cincinnati, OH 45229, United States.
   [Lakshmikanthan, Sribalaji; Chrzanowska-Wodnicka, Magdalena] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI 53214, United States.
   [Kapur, Reuben] Indiana Univ Sch Med, Canc Res Inst, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202, United States.
   [Kofron, Matthew] Cincinnati Childrens Res Fdn, Div Dev Biol, Cincinnati, OH 45229, United States.
C3 Cincinnati Children's Hospital Medical Center; Cincinnati Children's
   Hospital Research Foundation; University System of Ohio; University of
   Cincinnati; Versiti Blood Center of Wisconsin; Indiana University
   System; Indiana University Bloomington; Cincinnati Children's Hospital
   Medical Center; Cincinnati Children's Hospital Research Foundation
RP Filippi, MD (corresponding author), Cincinnati Childrens Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.
EM Marie-Dominique.Filippi@cchmc.org
RI Lakshmikanthan, Sribalaji/J-6882-2015; Kumar, Sachin/AAB-8679-2019
OI Lakshmikanthan, Sribalaji/0000-0002-1112-3730; kumar,
   sachin/0000-0002-3835-8935; Kofron, Matthew/0000-0001-6427-4148;
   Chrzanowska, Magdalena/0000-0003-4182-2126
FU National Institutes of Health [HL090676, HL111582, R01HL077177,
   R01HL081111, R01CA173852, R01CA134777]
FX The work was supported by National Institutes of Health (HL090676 to
   M.-D. Filippi; HL111582 to M. Chrzanowska-Wodnicka,; and R01HL077177,
   R01HL081111, R01CA173852, and R01CA134777 to R. Kapur).
CR Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137
   Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177
   Awasthi A, 2010, J EXP MED, V207, P1923, DOI 10.1084/jem.20100040
   Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004
   Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3
   Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436
   Carbo C, 2010, J LEUKOCYTE BIOL, V88, P313, DOI 10.1189/jlb.0110049
   Carman CV, 2008, CURR OPIN CELL BIOL, V20, P533, DOI 10.1016/j.ceb.2008.05.007
   Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015
   Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129
   Carman CV, 2003, J IMMUNOL, V171, P6135, DOI 10.4049/jimmunol.171.11.6135
   Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238
   Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2
   Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015
   Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973
   Cicchetti G, 2002, CRIT REV ORAL BIOL M, V13, P220, DOI 10.1177/154411130201300302
   Delacourt C, 2002, AM J RESP CELL MOL, V26, P290, DOI 10.1165/ajrcmb.26.3.4611
   Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903
   Filippi MD, 2007, BLOOD, V109, P1257, DOI 10.1182/blood-2006-04-017731
   Gerard A, 2009, BLOOD, V113, P6138, DOI 10.1182/blood-2008-07-167668
   Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138
   Hamacher J, 2002, AM J RESP CRIT CARE, V166, P651, DOI 10.1164/rccm.2109004
   HEWETT JA, 1992, LAB INVEST, V66, P347
   Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939
   Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012
   Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950
   Katagiri K, 2011, METHODS MOL BIOL, V757, P279, DOI 10.1007/978-1-61779-166-6_18
   Kumar S, 2012, BLOOD, V120, P3563, DOI 10.1182/blood-2012-04-426981
   Lakshmikanthan S, 2011, BLOOD, V118, P2015, DOI 10.1182/blood-2011-04-349282
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   Li Y, 2007, J IMMUNOL, V179, P8322, DOI 10.4049/jimmunol.179.12.8322
   Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4
   Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258
   Lou LG, 2002, J BIOL CHEM, V277, P32799, DOI 10.1074/jbc.M201491200
   M'Rabet L, 1998, BLOOD, V92, P2133, DOI 10.1182/blood.V92.6.2133.418k19_2133_2140
   Mamdouh Z, 2009, J EXP MED, V206, P2795, DOI 10.1084/jem.20082745
   McMillan SJ, 2013, BLOOD, V121, P2084, DOI 10.1182/blood-2012-08-449983
   Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224
   Nusrat A, 1997, GASTROENTEROLOGY, V113, P1489, DOI 10.1053/gast.1997.v113.pm9352851
   Nystrom A, 2009, BLOOD, V114, P4897, DOI 10.1182/blood-2009-02-207134
   OKRENT DG, 1990, AM REV RESPIR DIS, V141, P179, DOI 10.1164/ajrccm/141.1.179
   Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC
   Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925
   Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514
   Plitas G, 2003, J AM COLL SURGEONS, V196, P761, DOI 10.1016/S1072-7515(03)00134-0
   Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200
   Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9
   Sage PT, 2009, FRONT BIOSCI-LANDMRK, V14, P5066, DOI 10.2741/3587
   Sasawatari S, 2010, IMMUNITY, V32, P200, DOI 10.1016/j.immuni.2010.01.012
   Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295
   Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133
   Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020
   SIKORSKI EE, 1993, J IMMUNOL, V151, P5239
   Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3
   Szczur K, 2009, BLOOD, V114, P4527, DOI 10.1182/blood-2008-12-195164
   Tremblay GM, 2002, CHEST, V121, P582, DOI 10.1378/chest.121.2.582
   Tsui FWL, 2006, IMMUNOL RES, V35, P127, DOI 10.1385/IR:35:1:127
   von Wedel-Parlow M, 2011, BRAIN RES, V1367, P62, DOI 10.1016/j.brainres.2010.09.076
   Wittchen Erika S, 2011, Small GTPases, V2, P65
   Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942
   Zemans RL, 2009, AM J RESP CELL MOL, V40, P519, DOI 10.1165/rcmb.2008-0348TR
   Zhang H, 2005, IMMUNITY, V22, P235, DOI 10.1016/j.immuni.2005.01.004
   Zhang H, 2006, IMMUNITY, V25, P285, DOI 10.1016/j.immuni.2006.06.014
NR 63
TC 48
Z9 50
U1 1
U2 18
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD AUG 25
PY 2014
VL 211
IS 9
BP 1741
EP 1758
DI 10.1084/jem.20131706
PG 18
WC Immunology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Research & Experimental Medicine
GA AQ4EA
UT WOS:000342744500007
PM 25092872
OA Green Published, Green Submitted, hybrid
DA 2023-08-21
ER

PT J
AU Zhang, ML
   Dong, MQ
   Liu, W
   Wang, L
   Luo, YC
   Li, ZC
   Jin, FG
AF Zhang, Minlong
   Dong, Mingqing
   Liu, Wei
   Wang, Li
   Luo, Ying
   Li, Zhichao
   Jin, Faguang
TI 1 alpha, 25-Dihydroxyvitamin D-3 Ameliorates Seawater Aspiration-Induced
   Acute Lung Injury via NF-kappa B and RhoA/Rho Kinase Pathways
SO PLOS ONE
LA English
DT Article
ID VITAMIN-D-RECEPTOR; RHO-KINASE; ENDOTHELIAL-CELLS;
   1-ALPHA,25-DIHYDROXYVITAMIN D-3; INHIBITION; ACTIVATION; EXPRESSION;
   MYOSIN; PHOSPHORYLATION; PREVENTION
AB Introduction: Inflammation and pulmonary edema are involved in the pathogenesis of seawater aspiration-induced acute injury (ALI). Although several studies have reported that 1 alpha, 25-Dihydroxyvitamin D-3 (calcitriol) suppresses inflammation, it has not been confirmed to be effective in seawater aspiration-induced ALI. Thus, we investigated the effect of calcitriol on seawater aspiration-induced ALI and explored the probable mechanism.
   Methods: Male SD rats receiving different doses of calcitriol or not, underwent seawater instillation. Then lung samples were collected at 4 h for analysis. In addition, A549 cells and rat pulmonary microvascular endothelial cells (RPMVECs) were cultured with calcitriol or not and then stimulated with 25% seawater for 40 min. After these treatments, cells samples were collected for analysis.
   Results: Results from real-time PCR showed that seawater stimulation up-regulated the expression of vitamin D receptor in lung tissues, A549 cells and RPMVECs. Seawater stimulation also activates NF-kappa B and RhoA/Rho kinase pathways. However, we found that pretreatment with calcitriol significantly inhibited the activation of NF-kappa B and RhoA/Rho kinase pathways. Meanwhile, treatment of calcitriol also improved lung histopathologic changes, reduced inflammation, lung edema and vascular leakage.
   Conclusions: These results demonstrated that NF-kappa B and RhoA/Rho kinase pathways are critical in the development of lung inflammation and pulmonary edema and that treatment with calcitriol could ameliorate seawater aspiration-induced ALI, which was probably through the inhibition of NF-kappa B and RhoA/Rho kinase pathways.
C1 [Zhang, Minlong; Liu, Wei; Wang, Li; Jin, Faguang] Fourth Mil Med Univ, Tangdu Hosp, Dept Respirat, Xian 710032, China.
   [Dong, Mingqing; Luo, Ying; Li, Zhichao] Fourth Mil Med Univ, Dept Pathol & Pathophysiol, Xian 710032, China.
   [Dong, Mingqing; Liu, Wei; Luo, Ying; Li, Zhichao; Jin, Faguang] Fourth Mil Med Univ, Lung Injury & Repair Ctr, Xian 710032, China.
C3 Air Force Military Medical University; Air Force Military Medical
   University; Air Force Military Medical University
RP Li, ZC (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Respirat, Xian 710032, Peoples R China.
EM lizhic@fmmu.edu.cn; jinfag@fmmu.edu.cn
RI dong, ming-qing/HTO-3001-2023
OI dong, ming-qing/0000-0001-9720-535X
FU National Nature Science Foundation of China [81270124]
FX This work was supported by National Nature Science Foundation of China
   (No. 81270124). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308
   Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246
   BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294
   Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891
   Birukova AA, 2007, AM J PHYSIOL-LUNG C, V292, pL924, DOI 10.1152/ajplung.00395.2006
   CHEN SF, 1995, MICROVASC RES, V50, P119, DOI 10.1006/mvre.1995.1044
   Chen WG, 2008, AM J PHYSIOL-LUNG C, V295, pL575, DOI 10.1152/ajplung.00428.2007
   Clements RT, 2005, AM J PHYSIOL-LUNG C, V288, pL294, DOI 10.1152/ajplung.00213.2004
   Ding XM, 2006, PHARMACOL RES, V53, P372, DOI 10.1016/j.phrs.2006.01.006
   Dong XY, 2003, J BIOL CHEM, V278, P49378, DOI 10.1074/jbc.M308448200
   Ecklund MM, 2012, CRIT CARE NURS CLIN, V24, P601, DOI 10.1016/j.ccell.2012.07.002
   Essler M, 2000, J IMMUNOL, V164, P6543, DOI 10.4049/jimmunol.164.12.6543
   Fan QX, 2011, PULM PHARMACOL THER, V24, P673, DOI 10.1016/j.pupt.2011.07.002
   Fukuoka M, 1998, BRIT J PHARMACOL, V124, P1433, DOI 10.1038/sj.bjp.0701988
   Gorovoy M, 2007, CIRC RES, V101, P50, DOI 10.1161/CIRCRESAHA.106.145847
   Han F, 2012, RESP PHYSIOL NEUROBI, V182, P71, DOI 10.1016/j.resp.2012.05.012
   Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13
   Ibsen LM, 2002, CRIT CARE MED, V30, pS402, DOI 10.1097/00003246-200211001-00004
   Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210
   Konrad FM, 2012, AM J PHYSIOL-LUNG C, V303, pL425, DOI 10.1152/ajplung.00387.2011
   Li JH, 2011, RESP PHYSIOL NEUROBI, V176, P39, DOI 10.1016/j.resp.2011.01.005
   Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910
   Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016
   Ma LJ, 2013, RESP PHYSIOL NEUROBI, V185, P608, DOI 10.1016/j.resp.2012.11.016
   Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090
   Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779
   Penna G, 2009, PROSTATE, V69, P480, DOI 10.1002/pros.20896
   Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463
   Rostkowska-Nadolska B, 2010, ADV MED SCI-POLAND, V55, P86, DOI 10.2478/v10039-010-0012-9
   Salomez F, 2004, RESUSCITATION, V63, P261, DOI 10.1016/j.resuscitation.2004.06.007
   Schmeck B, 2003, INFLAMMATION, V27, P89, DOI 10.1023/A:1023278600596
   Segain JP, 2003, GASTROENTEROLOGY, V124, P1180, DOI 10.1016/S0016-5085(03)00283-X
   Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366
   Takahashi K, 2002, IMMUNOPHARM IMMUNOT, V24, P1, DOI 10.1081/IPH-120003399
   Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153
   Takano Y, 2011, STEROIDS, V76, P1305, DOI 10.1016/j.steroids.2011.06.009
   Tasaka S, 2005, AM J RESP CELL MOL, V32, P504, DOI 10.1165/rcmb.2004-0009OC
   van Beeck EF, 2005, B WORLD HEALTH ORGAN, V83, P853
   VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295
   Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2
   Xie XY, 2011, EXP LUNG RES, V37, P482, DOI 10.3109/01902148.2011.594144
   You QH, 2010, J SURG RES, V162, P110, DOI 10.1016/j.jss.2009.01.019
   Zhang Y, 2011, BIOL PHARM BULL, V34, P1052, DOI 10.1248/bpb.34.1052
   Zheng C, 2011, CELL RES, V21, P183, DOI 10.1038/cr.2010.171
NR 44
TC 20
Z9 28
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 13
PY 2014
VL 9
IS 8
AR e104507
DI 10.1371/journal.pone.0104507
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AN9BM
UT WOS:000340900600063
PM 25118599
OA Green Published, gold, Green Submitted
DA 2023-08-21
ER

PT J
AU Thangavel, J
   Malik, AB
   Elias, HK
   Rajasingh, S
   Simpson, AD
   Sundivakkam, PK
   Vogel, SM
   Xuan, YT
   Dawn, B
   Rajasingh, J
AF Thangavel, Jayakumar
   Malik, Asrar B.
   Elias, Harold K.
   Rajasingh, Sheeja
   Simpson, Andrew D.
   Sundivakkam, Premanand K.
   Vogel, Stephen M.
   Xuan, Yu-Ting
   Dawn, Buddhadeb
   Rajasingh, Johnson
TI Combinatorial Therapy with Acetylation and Methylation Modifiers
   Attenuates Lung Vascular Hyperpermeability in Endotoxemia-Induced Mouse
   Inflammatory Lung Injury
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID HISTONE DEACETYLASE INHIBITOR; DNA METHYLATION; TRICHOSTATIN-A;
   STEM-CELLS; 5-AZACYTIDINE; TRANSCRIPTION; PERMEABILITY; MODEL;
   NEUTROPHILS; DISRUPTION
AB Impairment of tissue fluid homeostasis and migration of inflammatory cells across the vascular endothelial barrier are crucial factors in the pathogenesis of acute lung injury (ALI). The goal for treatment of ALI is to target pathways that Lead to profound dysregulation of the lung endothelial barrier. Although studies have shown that chemical epigenetic modifiers can limit lung inflammation in experimental ALI models, studies to date have not examined efficacy of a combination of DNA methyl transferase inhibitor 5-Aza 2-deoxycytidine and histone deacetylase inhibitor trichostatin A (herein referred to as Aza+TSA) after endotoxemia-induced mouse lung injury. We tested the hypothesis that treatment with Aza+TSA after Lipopolysaccharide induction of ALI through epigenetic modification of Lung endothelial cells prevents inflammatory lung injury. Combinatorial treatment with Aza+TSA mitigated the increased endothelial permeability response after lipopolysaccharide challenge. In addition, we observed reduced lung inflammation and lung injury. Aza+TSA also significantly reduced mortality in the ALI model. The protection was ascribed to inhibition of the eN0S-Cav1-MLC2 signaling pathway and enhanced acetylation of histone markers on the vascular endothelial-cadherin promoter. In summary, these data show for the first time the efficacy of combinatorial Aza+TSA therapy in preventing ALI in lipopolysaccharide-induced endotoxemia and raise the possibility of an essential role of DNA methyl transferase and histone deacetylase in the mechanism of ALI.
C1 [Thangavel, Jayakumar; Elias, Harold K.; Rajasingh, Sheeja; Simpson, Andrew D.; Xuan, Yu-Ting; Dawn, Buddhadeb; Rajasingh, Johnson] Univ Kansas, Med Ctr, Dept Internal Med, Div Cardiovasc Dis, Kansas City, KS 66160, United States.
   [Rajasingh, Johnson] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Cardiovasc Res Inst, Kansas City, KS 66160, United States.
   [Malik, Asrar B.; Sundivakkam, Premanand K.; Vogel, Stephen M.] Univ Illinois, Dept Pharmacol, Chicago, IL, United States.
C3 University of Kansas; University of Kansas Medical Center; University of
   Kansas; University of Kansas Medical Center; University of Illinois
   System; University of Illinois Chicago; University of Illinois Chicago
   Hospital
RP Rajasingh, J (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Cardiovasc Res Inst,Dept Internal Med, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.
EM rjohnson9@kumc.edu
RI Rajasingh, Johnson/AAT-1985-2021; Elias, Harold/F-6457-2015
OI Rajasingh, Johnson/0000-0002-6172-4083; Elias,
   Harold/0000-0002-6189-4752; Malik, Asrar/0000-0002-8205-7128
FU American Heart Association grant-Jon Holden DeHaan Foundation grant
   [10SDG2630181]; NIH; NIH [R21HL97349, R01 HL-117730]
FX Supported in part by American Heart Association grant-Jon Holden DeHaan
   Foundation grant 10SDG2630181, and NIH-supported clinical and
   translational science award Frontiers Pilot grant (J.R.), and NIH grants
   R21HL97349 (J.R.) and R01 HL-117730 (B.D.).
CR Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137
   Atochin DN, 2010, PFLUG ARCH EUR J PHY, V460, P965, DOI 10.1007/s00424-010-0867-4
   Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562
   Blanchard F, 2005, DRUG DISCOV TODAY, V10, P197, DOI 10.1016/S1359-6446(04)03309-4
   Butt MU, 2009, J SURG RES, V156, P290, DOI 10.1016/j.jss.2009.04.012
   Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540
   Chen ZL, 2012, MOL BIOL CELL, V23, P1388, DOI 10.1091/mbc.E11-09-0811
   Choi Y, 2008, EXP MOL MED, V40, P574, DOI 10.3858/emm.2008.40.5.574
   Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699
   Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A
   Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41
   Dhawan S, 2011, DEV CELL, V20, P419, DOI 10.1016/j.devcel.2011.03.012
   Di AK, 2010, J BIOL CHEM, V285, P15848, DOI 10.1074/jbc.M109.075549
   Furumai R, 2011, CANCER SCI, V102, P1081, DOI 10.1111/j.1349-7006.2011.01904.x
   Garcia AN, 2011, METHODS MOL BIOL, V763, P333, DOI 10.1007/978-1-61779-191-8_23
   Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158
   Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST
   Iwata K, 2002, CELL IMMUNOL, V218, P26, DOI 10.1016/S0008-8749(02)00523-3
   Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127
   Kaminskas E, 2005, ONCOLOGIST, V10, P176, DOI 10.1634/theoncologist.10-3-176
   Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello
   Lin T, 2007, SURGERY, V141, P784, DOI 10.1016/j.surg.2007.01.014
   Lindbom L, 2003, CHEM IMMUNOL, V83, P146
   LO SK, 1992, J CLIN INVEST, V89, P981, DOI 10.1172/JCI115681
   Maniatis NA, 2008, AM J PHYSIOL-LUNG C, V294, pL865, DOI 10.1152/ajplung.00079.2007
   MATTHAY MA, 1990, AM REV RESPIR DIS, V142, P1250, DOI 10.1164/ajrccm/142.6_Pt_1.1250
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Miyawaki-Shimizu K, 2006, AM J PHYSIOL-LUNG C, V290, pL405, DOI 10.1152/ajplung.00292.2005
   Nemeth K, 2010, J MOL MED, V88, P5, DOI 10.1007/s00109-009-0523-7
   O'Connor OA, 2006, J CLIN ONCOL, V24, P166, DOI 10.1200/JCO.2005.01.9679
   Price LC, 2012, AM J PHYSIOL-LUNG C, V302, pL803, DOI 10.1152/ajplung.00355.2011
   Qian Q, 2012, STEM CELLS DEV, V21, P67, DOI 10.1089/scd.2010.0519
   Rahman I, 2002, BIOCHEM PHARMACOL, V64, P935, DOI 10.1016/S0006-2952(02)01153-X
   Rajasingh J, 2008, CIRC RES, V102, pE107, DOI 10.1161/CIRCRESAHA.108.176115
   Rajasingh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022550
   Sassi FD, 2014, J MOL NEUROSCI
   Schaefer MB, 2008, EUR RESPIR J, V32, P1344, DOI 10.1183/09031936.00035808
   SCHWARTZ RS, 1992, J AM COLL CARDIOL, V20, P1284, DOI 10.1016/0735-1097(92)90389-5
   Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049
   Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144
   Siddiqui MR, 2011, J CELL BIOL, V193, P841, DOI 10.1083/jcb.201012129
   Song Y, 2001, AM J PHYSIOL-LUNG C, V281, pL677, DOI 10.1152/ajplung.2001.281.3.L677
   Suzuki T, 2005, CURR MED CHEM, V12, P2867, DOI 10.2174/092986705774454706
   Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7
   Wu CJ, 2013, INT ARCH ALLERGY IMM, V160, P356, DOI 10.1159/000343030
   Wunderlich C, 2006, BIOCHEM BIOPH RES CO, V340, P702, DOI 10.1016/j.bbrc.2005.12.058
   Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91
   Zhang L, 2010, WORLD J SURG, V34, P1676, DOI 10.1007/s00268-010-0493-5
   Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154
NR 51
TC 39
Z9 39
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD AUG
PY 2014
VL 184
IS 8
BP 2237
EP 2249
DI 10.1016/j.ajpath.2014.05.008
PG 13
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA AM0JY
UT WOS:000339533100010
PM 24929240
OA Green Published, hybrid
DA 2023-08-21
ER

PT J
AU Chen, F
   Kumar, S
   Yu, YF
   Aggarwal, S
   Gross, C
   Wang, YS
   Chakraborty, T
   Verin, AD
   Catravas, JD
   Lucas, R
   Black, SM
   Fulton, DJR
AF Chen, Feng
   Kumar, Sanjiv
   Yu, Yanfang
   Aggarwal, Saurabh
   Gross, Christine M.
   Wang, Yusi
   Chakraborty, Trinad
   Verin, Alexander D.
   Catravas, John D.
   Lucas, Rudolf
   Black, Stephen M.
   Fulton, David J. R.
TI PKC-Dependent Phosphorylation of eNOS at T495 Regulates eNOS Coupling
   and Endothelial Barrier Function in Response to G(+) -Toxins
SO PLOS ONE
LA English
DT Article
ID NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; ACUTE LUNG INJURY;
   MICROVASCULAR PERMEABILITY; SUPEROXIDE ANION; STREPTOCOCCUS-PNEUMONIAE;
   PNEUMOCOCCAL PNEUMONIA; VASCULAR-PERMEABILITY; PORE FORMATION;
   PNEUMOLYSIN
AB Gram positive (G(+)) infections make up similar to 50% of all acute lung injury cases which are characterized by extensive permeability edema secondary to disruption of endothelial cell (EC) barrier integrity. A primary cause of increased permeability are cholesterol-dependent cytolysins (CDCs) of G(+)-bacteria, such as pneumolysin (PLY) and listeriolysin-O (LLO) which create plasma membrane pores, promoting Ca2+-influx and activation of PKC alpha. In human lung microvascular endothelial cells (HLMVEC), pretreatment with the nitric oxide synthase (NOS) inhibitor, ETU reduced the ability of LLO to increase microvascular cell permeability suggesting an endothelial nitric oxide synthase (eNOS)-dependent mechanism. LLO stimulated superoxide production from HLMVEC and this was prevented by silencing PKC alpha or NOS inhibition suggesting a link between these pathways. Both LLO and PLY stimulated eNOS T495 phosphorylation in a PKC-dependent manner. Expression of a phosphomimetic T495D eNOS (human isoform) resulted in increased superoxide and diminished nitric oxide (NO) production. Transduction of HLMVEC with an active form of PKC alpha resulted in the robust phosphorylation of T495 and increased peroxynitrite production, indicative of eNOS uncoupling. To determine the mechanisms underlying eNOS uncoupling, HLMVEC were stimulated with LLO and the amount of hsp90 and caveolin-1 bound to eNOS determined. LLO stimulated the dissociation of hsp90, and in particular, caveolin-1 from eNOS. Both hsp90 and caveolin-1 have been shown to influence eNOS uncoupling and a peptide mimicking the scaffolding domain of caveolin-1 blocked the ability of PKC alpha to stimulate eNOS-derived superoxide. Collectively, these results suggest that the G(+) pore-forming toxins promote increased EC permeability via activation of PKC alpha, phosphorylation of eNOS-T495, loss of hsp90 and caveolin-1 binding which collectively promote eNOS uncoupling and the production of barrier disruptive superoxide.
C1 [Chen, Feng] Nanjing Med Univ, Dept Forens Med, Nanjing, Jiangsu, China.
   [Chen, Feng; Kumar, Sanjiv; Yu, Yanfang; Aggarwal, Saurabh; Gross, Christine; Wang, Yusi; Verin, Alexander D.; Lucas, Rudolf; Black, Stephen M.; Fulton, David J. R.] Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30901, United States.
   [Lucas, Rudolf; Fulton, David J. R.] Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol, Augusta, GA, United States.
   [Chakraborty, Trinad] Univ Giessen, Inst Med Microbiol, D-35390 Giessen, Germany.
   [Catravas, John D.] Old Dominion Univ, Norfolk, VA, United States.
C3 Nanjing Medical University; University System of Georgia; Augusta
   University; University System of Georgia; Augusta University; Justus
   Liebig University Giessen; Old Dominion University
RP Fulton, DJR (corresponding author), Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30901 USA.
EM dfulton@gru.edu
RI Lucas, Rudolf/ABA-3011-2020; Chen, Feng/E-1133-2011
OI Chen, Feng/0000-0003-3508-8834; Verin, Alexander/0000-0003-0627-7185;
   Black, Stephen M./0000-0002-4524-6544; Lucas, Rudolf/0000-0003-3805-8868
FU National Institutes of Health [RO1 HL085827, P01 HL101902-01A1,
   R01HL092446, R01HL094609]; AHA
FX This work was supported by the National Institutes of Health RO1
   HL085827, P01 HL101902-01A1 (DJRF), R01HL092446 (DF), R01HL094609 (RL)
   and by a Postdoctoral Fellowship from the AHA (FC). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR ANANTHRAMAN A, 1983, RESPIRATION, V44, P153, DOI 10.1159/000194542
   Bonev BB, 2001, J BIOL CHEM, V276, P5714, DOI 10.1074/jbc.M005126200
   Cai L, 2014, AM J PHYSL LUNG CELL
   Catravas JD, 2010, VASCUL PHARM
   Chatterjee A, 2008, AM J PHYSIOL-LUNG C, V294, pL755, DOI 10.1152/ajplung.00350.2007
   Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200
   Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0
   Chiasson VL, 2011, J PHARMACOL EXP THER, V337, P718, DOI 10.1124/jpet.110.178095
   Church JE, 2006, J BIOL CHEM, V281, P1477, DOI 10.1074/jbc.M505968200
   Cockeran R, 2001, J INFECT DIS, V183, P604, DOI 10.1086/318536
   DRAIJER R, 1995, CIRC RES, V76, P199, DOI 10.1161/01.RES.76.2.199
   Duran WN, 2010, CARDIOVASC RES, V87, P254, DOI 10.1093/cvr/cvq139
   Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125
   Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810
   Ferro TJ, 1997, AM J PHYSIOL-LUNG C, V272, pL979, DOI 10.1152/ajplung.1997.272.5.L979
   Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677
   Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s
   Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532
   Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198
   Fulton D, 2005, J BIOL CHEM, V280, P35943, DOI 10.1074/jbc.M504606200
   Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934
   GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237
   GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437
   GUICE KS, 1989, ANN SURG, V210, P740, DOI 10.1097/00000658-198912000-00008
   Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200
   Iliev AI, 2007, P NATL ACAD SCI USA, V104, P2897, DOI 10.1073/pnas.0608213104
   Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939
   Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522
   Karuppiah K, 2011, AM J PHYSIOL-HEART C, V301, pH903, DOI 10.1152/ajpheart.00936.2010
   Knepler JL, 2001, AM J PHYSIOL-CELL PH, V281, pC1064, DOI 10.1152/ajpcell.2001.281.3.C1064
   KUROSE I, 1995, CIRC RES, V76, P30, DOI 10.1161/01.RES.76.1.30
   Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200
   Lucas R, 2012, AM J RESP CELL MOL, V47, P445, DOI 10.1165/rcmb.2011-0332OC
   McElroy MC, 1997, AM J PHYSIOL-LUNG C, V272, pL631, DOI 10.1152/ajplung.1997.272.4.L631
   McQuaid KE, 1997, EXP PHYSIOL, V82, P369, DOI 10.1113/expphysiol.1997.sp004032
   Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200
   NAUSEEF WM, 1991, J BIOL CHEM, V266, P5911
   Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004
   Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200
   PRITCHARD KA, 1995, CIRC RES, V77, P510, DOI 10.1161/01.RES.77.3.510
   Qian J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00347
   Qian J, 2012, FREE RADICAL BIO MED, V52, P1806, DOI 10.1016/j.freeradbiomed.2012.02.029
   Repp H, 2002, CELL MICROBIOL, V4, P483, DOI 10.1046/j.1462-5822.2002.00207.x
   RUBINS JB, 1994, INFECT IMMUN, V62, P3829, DOI 10.1128/IAI.62.9.3829-3836.1994
   RUBINS JB, 1995, J CLIN INVEST, V95, P142, DOI 10.1172/JCI117631
   Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200
   SOUTHAN GJ, 1995, BRIT J PHARMACOL, V114, P510, DOI 10.1111/j.1476-5381.1995.tb13256.x
   Sprague RS, 1998, J PHARMACOL EXP THER, V284, P443
   Stringaris AK, 2002, NEUROBIOL DIS, V11, P355, DOI 10.1006/nbdi.2002.0561
   Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007
   Sugimoto M, 2007, BIOCHEM BIOPH RES CO, V361, P462, DOI 10.1016/j.bbrc.2007.07.030
   Sun X, 2014, AM J RESP CELL MOL B
   Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918
   Tanita T, 1999, SURG TODAY, V29, P755, DOI 10.1007/BF02482321
   TERADA LS, 1992, P NATL ACAD SCI USA, V89, P3362, DOI 10.1073/pnas.89.8.3362
   Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033
   TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919
   WALKER JA, 1987, INFECT IMMUN, V55, P1184, DOI 10.1128/IAI.55.5.1184-1189.1987
   Weycker D, 2010, VACCINE, V28, P4955, DOI 10.1016/j.vaccine.2010.05.030
   Witzenrath M, 2006, CRIT CARE MED, V34, P1947, DOI 10.1097/01.CCM.0000220496.48295.A9
   Witzenrath M, 2007, CRIT CARE MED, V35, P1756, DOI 10.1097/01.CCM.0000269212.84709.23
   Wright JK, 1999, ARCH SURG-CHICAGO, V134, P293, DOI 10.1001/archsurg.134.3.293
   Xiong C, 2010, VASCUL PHARM
   Xiong CL, 2010, VASC PHARMACOL, V52, P207, DOI 10.1016/j.vph.2009.12.010
   Yamashita T, 2000, CIRCULATION, V101, P931, DOI 10.1161/01.CIR.101.8.931
   Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338
NR 66
TC 50
Z9 51
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 14
PY 2014
VL 9
IS 7
AR e99823
DI 10.1371/journal.pone.0099823
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AM1PC
UT WOS:000339618600004
PM 25020117
OA Green Published, Green Submitted, gold
DA 2023-08-21
ER

PT J
AU O'Donnell, JJ
   Birukova, AA
   Beyer, EC
   Birukov, KG
AF O'Donnell, James J., III
   Birukova, Anna A.
   Beyer, Eric C.
   Birukov, Konstantin G.
TI Gap Junction Protein Connexin43 Exacerbates Lung Vascular Permeability
SO PLOS ONE
LA English
DT Article
ID ENDOTHELIAL-CELLS; DIFFERENTIAL REGULATION; BARRIER FUNCTION;
   EXPRESSION; LIPOPOLYSACCHARIDE; INFLAMMATION; ACTIVATION; STRETCH;
   INJURY; RHO
AB Increased vascular permeability causes pulmonary edema that impairs arterial oxygenation and thus contributes to morbidity and mortality associated with Acute Respiratory Distress Syndrome and sepsis. Although components of intercellular adhesive and tight junctions are critical for maintaining the endothelial barrier, there has been limited study of the roles of gap junctions and their component proteins (connexins). Since connexins can modulate inflammatory signaling in other systems, we hypothesized that connexins may also regulate pulmonary endothelial permeability. The relationships between connexins and the permeability response to inflammatory stimuli were studied in cultured human pulmonary endothelial cells. Prolonged treatment with thrombin, lipopolysaccharide, or pathological cyclic stretch increased levels of mRNA and protein for the major connexin, connexin43 (Cx43). Thrombin and lipopolysaccharide both increased intercellular communication assayed by transfer of microinjected Lucifer yellow. Although thrombin decreased transendothelial resistance in these cells, the response was attenuated by pretreatment with the connexin inhibitor carbenoxolone. Additionally, the decreases of transendothelial resistance produced by either thrombin or lipopolysaccharide were attenuated by reducing Cx43 expression by siRNA knockdown. Both carbenoxolone and Cx43 knockdown also abrogated thrombin-induced phosphorylation of myosin light chain. Taken together, these data suggest that increased lung vascular permeability induced by inflammatory conditions may be amplified via increased expression of Cx43 and intercellular communication among pulmonary endothelial cells.
C1 [O'Donnell, James J., III; Birukova, Anna A.; Birukov, Konstantin G.] Univ Chicago, Dept Med, Sect Pulm & Crit Care, Chicago, IL 60637, United States.
   [O'Donnell, James J., III; Birukova, Anna A.; Birukov, Konstantin G.] Univ Chicago, Dept Med, Lung Injury Ctr, Chicago, IL 60637, United States.
   [Beyer, Eric C.] Univ Chicago, Dept Pediat, Chicago, IL 60637, United States.
C3 University of Chicago; University of Chicago; University of Chicago
RP Birukov, KG (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Care, 5841 S Maryland Ave, Chicago, IL 60637 USA.
EM kbirukov@medicine.bsd.uchicago.edu
RI Birukov, Konstantin/FJB-5755-2022
OI Beyer, Eric/0000-0001-8044-1356
FU National Institutes of Health [NHLBI HL089257]; NIH [NHLBI HL087823]; 
   [T32HL007605];  [HL59199]
FX Funding sources that supported this work include: T32HL007605, HL59199,
   National Institutes of Health NHLBI HL089257, and NIH NHLBI HL087823.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Agrawal A, 2012, AM J PHYSIOL-LUNG C, V303, pL634, DOI 10.1152/ajplung.00195.2012
   Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002
   Baker SM, 2008, FEBS LETT, V582, P4039, DOI 10.1016/j.febslet.2008.10.043
   Bastarache JA, 2006, SEMIN RESP CRIT CARE, V27, P365, DOI 10.1055/s-2006-948290
   Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002
   Birukov KG, 2013, COMPR PHYSIOL, V3, P429, DOI 10.1002/cphy.c100066
   Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007
   Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431
   Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008
   Birukova AA, 2007, AM J PHYSIOL-LUNG C, V292, pL924, DOI 10.1152/ajplung.00395.2006
   Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007
   Birukova AA, 2012, J CELL PHYSIOL, V227, P3405, DOI 10.1002/jcp.24041
   Birukova AA, 2012, AM J PHYSIOL-LUNG C, V302, pL965, DOI 10.1152/ajplung.00292.2011
   Birukova AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030957
   Bolon ML, 2007, J CELL PHYSIOL, V211, P159, DOI 10.1002/jcp.20928
   Chadjichristos CE, 2010, CIRCULATION, V121, P123, DOI 10.1161/CIRCULATIONAHA.109.867176
   Davey A, 2011, EUR RESPIR J, V38, P959, DOI 10.1183/09031936.00032111
   De Vuyst E, 2007, MOL BIOL CELL, V18, P34, DOI 10.1091/mbc.E06-03-0182
   Fernandez-Cobo M, 1999, CYTOKINE, V11, P216, DOI 10.1006/cyto.1998.0422
   Fernandez-Cobo M, 1998, SHOCK, V10, P97, DOI 10.1097/00024382-199808000-00003
   Gemel J, 2012, J MEMBRANE BIOL, V245, P231, DOI 10.1007/s00232-012-9444-4
   Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705
   Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011
   JARA PI, 1995, P NATL ACAD SCI USA, V92, P7011, DOI 10.1073/pnas.92.15.7011
   Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014
   Kwak BR, 2003, CIRCULATION, V107, P1033, DOI 10.1161/01.CIR.0000051364.70064.D1
   LARSON DM, 1990, CIRC RES, V66, P1074, DOI 10.1161/01.RES.66.4.1074
   Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372
   Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014
   LUM H, 1994, AM J PHYSIOL, V267, pL223, DOI 10.1152/ajplung.1994.267.3.L223
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Meliton AY, 2013, AM J PHYSIOL-LUNG C, V304, pL689, DOI 10.1152/ajplung.00047.2013
   Nagasawa K, 2006, J CELL PHYSIOL, V208, P123, DOI 10.1002/jcp.20647
   Parthasarathi K, 2006, J CLIN INVEST, V116, P2193, DOI 10.1172/JCI26605
   Parthasarathi K, 2012, AM J PHYSIOL-LUNG C, V303, pL33, DOI 10.1152/ajplung.00219.2011
   Rignault S, 2007, SHOCK, V28, P78, DOI 10.1097/shk.0b013e3180310bd1
   Salameh A, 2013, BBA-BIOMEMBRANES, V1828, P147, DOI 10.1016/j.bbamem.2011.12.030
   Sarieddine MZR, 2009, J CELL MOL MED, V13, P4560, DOI 10.1111/j.1582-4934.2008.00654.x
   Seminario-Vidal L, 2009, J BIOL CHEM, V284, P20638, DOI 10.1074/jbc.M109.004762
   Starosta V, 2012, AM J RESP CELL MOL, V46, P331, DOI 10.1165/rcmb.2011-0153OC
   Tyml K, 2011, CAN J PHYSIOL PHARM, V89, P1, DOI 10.1139/y10-099
   Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441
   Yeager M, 2007, CURR OPIN CELL BIOL, V19, P521, DOI 10.1016/j.ceb.2007.09.001
   Zhou XH, 2012, FRONT BIOSCI-LANDMRK, V17, P2278, DOI 10.2741/4051
   Ziliene Violeta, 2004, Medicina (Kaunas), V40, P1124
NR 45
TC 52
Z9 53
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 26
PY 2014
VL 9
IS 6
AR e100931
DI 10.1371/journal.pone.0100931
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AK2WP
UT WOS:000338280800085
PM 24967639
OA Green Published, gold, Green Submitted
DA 2023-08-21
ER

PT J
AU Mitra, S
   Wade, MS
   Sun, XG
   Moldobaeva, N
   Flores, C
   Ma, SF
   Zhang, W
   Garcia, JGN
   Jacobson, JR
AF Mitra, Sumegha
   Wade, Michael S.
   Sun, Xiaoguang
   Moldobaeva, Nurgul
   Flores, Carlos
   Ma, Shwu Fan
   Zhang, Wei
   Garcia, Joe G. N.
   Jacobson, Jeffrey R.
TI GADD45a Promoter Regulation by a Functional Genetic Variant Associated
   with Acute Lung Injury
SO PLOS ONE
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; COLONY-ENHANCING FACTOR; POLYMORPHISMS;
   SEPSIS; EXPRESSION; RISK; SUSCEPTIBILITY; TRANSCRIPTION; DEFINITIONS;
   HAPLOTYPE
AB Rationale: Growth arrest DNA damage inducible alpha (GADD45a) is a stress-induced gene we have shown to participate in the pathophysiology of ventilator-induced lung injury (VILI) via regulation of mechanical stress-induced Akt ubiquitination and phosphorylation. The regulation of GADD45a expression by mechanical stress and its relationship with acute lung injury (ALI) susceptibility and severity, however, remains unknown.
   Objectives: We examined mechanical stress-dependent regulatory elements (MSRE) in the GADD45a promoter and the contribution of promoter polymorphisms in GADD45a expression and ALI susceptibility.
   Methods and Results: Initial studies in GADD45a knockout and heterozygous mice confirmed the relationship of GADD45a gene dose to VILI severity. Human lung endothelial cells (EC) transfected with a luciferase vector containing the full length GADD45a promoter sequence (-771 to +223) demonstrated a >4 fold increase in GADD45a expression in response to 18% cyclic stretch (CS, 4 h) compared to static controls while specific promoter regions harboring CS-dependent MSRE were identified using vectors containing serial deletion constructs of the GADD45a promoter. In silico analyses of GADD45a promoter region (-371 to -133) revealed a potential binding site for specificity protein 1 (SP1), a finding supported by confirmed SP1 binding with the GADD45a promoter and by the significant attenuation of CS-dependent GADD45a promoter activity in response to SP1 silencing. Separately, case-control association studies revealed a significant association of a GADD45a promoter SNP at -589 (rs581000, G>C) with reduced ALI susceptibility. Subsequently, we found allelic variation of this SNP is associated with both differential GADD45a expression in mechanically stressed EC (18% CS, 4 h) and differential binding site of interferon regulatory factor 7 (IRF7) at this site.
   Conclusion: These results strongly support a functional role for GADD45a in ALI/VILI and identify a specific gene variant that confers risk for ALI.
C1 [Mitra, Sumegha; Wade, Michael S.; Sun, Xiaoguang; Moldobaeva, Nurgul; Zhang, Wei; Jacobson, Jeffrey R.] Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60607, United States.
   [Flores, Carlos] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain.
   [Flores, Carlos] Hosp Univ Nuestra Senora Candelaria, Res Unit, Tenerife, Spain.
   [Ma, Shwu-Fan] Univ Illinois, Div Pulm Crit Care & Sleep, Chicago, IL, United States.
   [Zhang, Wei] Univ Illinois, Dept Pediat, Chicago, IL, United States.
   [Garcia, Joe G. N.] Univ Arizona, Arizona Hlth Sci Ctr, Tucson, AZ, United States.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; CIBER - Centro de Investigacion
   Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of
   Illinois System; University of Illinois Chicago; University of Illinois
   Chicago Hospital; University of Illinois System; University of Illinois
   Chicago; University of Illinois Chicago Hospital; University of Arizona;
   University of Arizona Health Sciences
RP Jacobson, JR (corresponding author), Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA.
EM jrjacob@uic.edu
RI SUN, XIAOGUANG/ACA-5558-2022; Flores, Carlos/R-1159-2019; Garcia, Joe
   GN/E-8862-2010
OI Flores, Carlos/0000-0001-5352-069X; Mitra, Sumegha/0000-0002-5567-3347
FU NCATS NIH HHS [UL1 TR000430] Funding Source: Medline
CR Altemeier WA, 2005, J IMMUNOL, V175, P3369, DOI 10.4049/jimmunol.175.5.3369
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706
   Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002
   BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644
   Cao YX, 2003, J CELL BIOCHEM, V89, P887, DOI 10.1002/jcb.10555
   Flores C, 2008, TRANSL RES, V152, P11, DOI 10.1016/j.trsl.2008.05.006
   Gao L, 2006, AM J RESP CELL MOL, V34, P487, DOI 10.1165/rcmb.2005-0404OC
   Gao L, 2007, TRANSL RES, V150, P18, DOI 10.1016/j.trsl.2007.02.007
   Grigoryev DN, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r34
   Han YJ, 2012, J MOL MED, V90, P299, DOI 10.1007/s00109-011-0820-9
   Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802
   Hong SB, 2008, AM J RESP CRIT CARE, V178, P605, DOI 10.1164/rccm.200712-1822OC
   Lin Z, 2000, CLIN GENET, V58, P181, DOI 10.1034/j.1399-0004.2000.580305.x
   Liu YX, 2012, CLIN CHEM LAB MED, V50, P1917, DOI 10.1515/cclm-2012-0238
   Ma SF, 2011, AM J RESP CELL MOL, V45, P1203, DOI 10.1165/rcmb.2011-0179OC
   Marshall RP, 2002, AM J RESP CRIT CARE, V166, P646, DOI 10.1164/rccm.2108086
   Meyer NJ, 2009, FASEB J, V23, P1325, DOI 10.1096/fj.08-119073
   Mitra S, 2006, MATURITAS, V55, P27, DOI 10.1016/j.maturitas.2006.01.003
   Mitra S, 2011, AM J RESP CRIT CARE, V184, P1030, DOI 10.1164/rccm.201103-0447OC
   Moss M, 2002, CRIT CARE MED, V30, P1679, DOI 10.1097/00003246-200208000-00001
   Nemeth E, 2000, AM J OBSTET GYNECOL, V182, P50, DOI 10.1016/S0002-9378(00)70490-X
   Ney L, 2000, NEW ENGL J MED, V343, P812
   O'Mahony DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051104
   Pino-Yanes M, 2011, AM J RESP CELL MOL, V45, P740, DOI 10.1165/rcmb.2010-0292OC
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Seefried L, 2010, EUR CELLS MATER, V20, P344
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268
   Song ZJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-168
   Tejera P, 2012, J MED GENET, V49, P671, DOI 10.1136/jmedgenet-2012-100972
   Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098
   Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864
   Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC
NR 35
TC 12
Z9 12
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 18
PY 2014
VL 9
IS 6
AR e100169
DI 10.1371/journal.pone.0100169
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AK6AC
UT WOS:000338508200080
PM 24940746
OA Green Published, gold, Green Submitted
DA 2023-08-21
ER

PT J
AU Mambetsariev, I
   Tian, YF
   Wu, TH
   Lavoie, T
   Solway, J
   Birukov, KG
   Birukova, AA
AF Mambetsariev, Isa
   Tian, Yufeng
   Wu, Tinghuai
   Lavoie, Tera
   Solway, Julian
   Birukov, Konstantin G.
   Birukova, Anna A.
TI Stiffness-Activated GEF-H1 Expression Exacerbates LPS-Induced Lung
   Inflammation
SO PLOS ONE
LA English
DT Article
ID VASCULAR-PERMEABILITY; INJURY; MICROTUBULES; INHIBITION
AB Acute lung injury (ALI) is accompanied by decreased lung compliance. However, a role of tissue mechanics in modulation of inflammation remains unclear. We hypothesized that bacterial lipopolysacharide (LPS) stimulates extracellular matrix (ECM) production and vascular stiffening leading to stiffness-dependent exacerbation of endothelial cell (EC) inflammatory activation and lung barrier dysfunction. Expression of GEF-H1, ICAM-1, VCAM-1, ECM proteins fibronectin and collagen, lysyl oxidase (LOX) activity, interleukin-8 and activation of Rho signaling were analyzed in lung samples and pulmonary EC grown on soft (1.5 or 2.8 kPa) and stiff (40 kPa) substrates. LPS induced EC inflammatory activation accompanied by expression of ECM proteins, increase in LOX activity, and activation of Rho signaling. These effects were augmented in EC grown on stiff substrate. Stiffness-dependent enhancement of inflammation was associated with increased expression of Rho activator, GEF-H1. Inhibition of ECM crosslinking and stiffening by LOX suppression reduced EC inflammatory activation and GEF-H1 expression in response to LPS. In vivo, LOX inhibition attenuated LPS-induced expression of GEF-H1 and lung dysfunction. These findings present a novel mechanism of stiffness-dependent exacerbation of vascular inflammation and escalation of ALI via stimulation of GEF-H1 - Rho pathway. This pathway represents a fundamental mechanism of positive feedback regulation of inflammation.
C1 [Mambetsariev, Isa; Tian, Yufeng; Wu, Tinghuai; Lavoie, Tera; Solway, Julian; Birukov, Konstantin G.; Birukova, Anna A.] Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, Chicago, IL 60637, United States.
C3 University of Chicago
RP Birukova, AA (corresponding author), Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.
EM abirukov@medicine.bsd.uchicago.edu
RI Birukov, Konstantin/FJB-5755-2022
FU NIH [HL89257, HL107920, HL76259]
FX Funding was provided by NIH HL89257, HL107920, HL76259. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Aratyn-Schaus Y, 2011, MOL BIOL CELL, V22, P1330, DOI 10.1091/mbc.E10-11-0891
   Aratyn-Schaus Yvonne, 2010, J Vis Exp, DOI 10.3791/2173
   Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208
   Berg JT, 1997, J APPL PHYSIOL, V83, P120, DOI 10.1152/jappl.1997.83.1.120
   Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001
   Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431
   Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005
   Birukova AA, 2013, MICROVASC RES, V87, P50, DOI 10.1016/j.mvr.2012.12.006
   Birukova AA, 2012, AM J PHYSIOL-LUNG C, V302, pL965, DOI 10.1152/ajplung.00292.2011
   Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009
   Chandler EM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015008
   Deng XL, 2011, BRAIN RES, V1387, P1, DOI 10.1016/j.brainres.2011.02.059
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808
   Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254
   Guo F, 2012, MOL IMMUNOL, V50, P98, DOI 10.1016/j.molimm.2011.12.009
   Guo F, 2012, CYTOKINE, V57, P417, DOI 10.1016/j.cyto.2011.12.009
   Heck JN, 2012, MOL BIOL CELL, V23, P2583, DOI 10.1091/mbc.E11-10-0876
   Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC
   Karsdal MA, 2013, ASSAY DRUG DEV TECHN, V11, P70, DOI 10.1089/adt.2012.474
   Kratzer E, 2012, AM J RESP CELL MOL, V47, P688, DOI 10.1165/rcmb.2012-0161OC
   Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773
   Lavoie TL, 2012, AM J RESP CRIT CARE, V186, P225, DOI 10.1164/rccm.201202-0368OC
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Ly DL, 2013, AM J PHYSIOL-CELL PH, V304, pC115, DOI 10.1152/ajpcell.00290.2012
   Mammoto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2774
   Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108
   Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Rocco PRM, 2009, MINERVA ANESTESIOL, V75, P730
   Rodriguez C, 2008, DRUG NEWS PERSPECT, V21, P218, DOI 10.1358/dnp.2008.21.4.1213351
   Schmeck B, 2003, INFLAMMATION, V27, P89, DOI 10.1023/A:1023278600596
   Tasaka S, 2005, AM J RESP CELL MOL, V32, P504, DOI 10.1165/rcmb.2004-0009OC
   Togbe D, 2007, INT J EXP PATHOL, V88, P387, DOI 10.1111/j.1365-2613.2007.00566.x
   Wang Q, 2002, ANTIOXID REDOX SIGN, V4, P39, DOI 10.1089/152308602753625843
   Xing JJ, 2010, MICROVASC RES, V79, P56, DOI 10.1016/j.mvr.2009.11.006
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 37
TC 28
Z9 30
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 16
PY 2014
VL 9
IS 4
AR e92670
DI 10.1371/journal.pone.0092670
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AI4VW
UT WOS:000336863900012
PM 24739883
OA Green Published, gold, Green Submitted
DA 2023-08-21
ER

PT J
AU Shikata, F
   Sakaue, T
   Nakashiro, K
   Okazaki, M
   Kurata, M
   Okamura, T
   Okura, M
   Ryugo, M
   Nakamura, Y
   Yasugi, T
   Higashiyama, S
   Izutani, H
AF Shikata, Fumiaki
   Sakaue, Tomohisa
   Nakashiro, Koh-ichi
   Okazaki, Mikio
   Kurata, Mie
   Okamura, Toru
   Okura, Masahiro
   Ryugo, Masahiro
   Nakamura, Yuki
   Yasugi, Takumi
   Higashiyama, Shigeki
   Izutani, Hironori
TI Pathophysiology of Lung Injury Induced by Common Bile Duct Ligation in
   Mice
SO PLOS ONE
LA English
DT Article
ID ENDOTHELIN-B RECEPTOR; NITRIC-OXIDE SYNTHASE; HEPATOPULMONARY-SYNDROME;
   RAT MODEL; ARTERIOVENOUS-MALFORMATIONS; PORTAL-HYPERTENSION; POTENTIAL
   ROLE; MATRIX-METALLOPROTEINASE-9; PATHOGENESIS; EXPRESSION
AB Background: Liver dysfunction and cirrhosis affect vasculature in several organ systems and cause impairment of organ functions, thereby increasing morbidity and mortality. Establishment of a mouse model of hepatopulmonary syndrome (HPS) would provide greater insights into the genetic basis of the disease. Our objectives were to establish a mouse model of lung injury after common bile duct ligation (CBDL) and to investigate pulmonary pathogenesis for application in future therapeutic approaches.
   Methods: Eight-week-old Balb/c mice were subjected to CBDL. Immunohistochemical analyses and real-time quantitative reverse transcriptional polymerase chain reaction were performed on pulmonary tissues. The presence of HPS markers was detected by western blot and microarray analyses.
   Results: We observed extensive proliferation of CD31-positive pulmonary vascular endothelial cells at 2 weeks after CBDL and identified 10 upregulated and 9 down-regulated proteins that were associated with angiogenesis. TNF-a and MMP-9 were highly expressed at 3 weeks after CBDL and were less expressed in the lungs of the control group.
   Conclusions: We constructed a mouse lung injury model by using CBDL. Contrary to our expectation, lung pathology in our mouse model exhibited differences from that of rat models, and the mechanisms responsible for these differences are unknown. This phenomenon may be explained by contrasting processes related to TNF induction of angiogenic signaling pathways in the inflammatory phase. Thus, we suggest that our mouse model can be applied to pulmonary pathological analyses in the inflammatory phase, i.e., to systemic inflammatory response syndrome, acute lung injury, and multiple organ dysfunction syndrome.
C1 [Shikata, Fumiaki; Okazaki, Mikio; Okamura, Toru; Okura, Masahiro; Ryugo, Masahiro; Nakamura, Yuki; Yasugi, Takumi; Izutani, Hironori] Ehime Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Matsuyama, Ehime 790, Japan.
   [Sakaue, Tomohisa; Higashiyama, Shigeki] Ehime Univ, Dept Cell Growth & Tumor Regulat, Proteo Sci Ctr, Matsuyama, Ehime 790, Japan.
   [Sakaue, Tomohisa; Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Matsuyama, Ehime 790, Japan.
   [Nakashiro, Koh-ichi] Ehime Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Matsuyama, Ehime 790, Japan.
   [Kurata, Mie] Ehime Univ, Grad Sch Med, Dept Pathol, Div Pathogen, Matsuyama, Ehime 790, Japan.
C3 Ehime University; Ehime University; Ehime University; Ehime University;
   Ehime University
RP Izutani, H (corresponding author), Ehime Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Matsuyama, Ehime 790, Japan.
EM izutani@m.ehime-u.ac.jp
RI Nakamura, Yuki/N-4234-2019; Nakashiro, Koichi/AAV-6317-2020; OKAZAKI,
   MIKIO/AGN-1218-2022
OI Nakamura, Yuki/0000-0003-0023-4985; OKAZAKI, MIKIO/0000-0002-7202-244X;
   Nakashiro, Koh-ichi/0000-0002-9975-902X; Kurata, Mie/0000-0001-6596-2436
FU JSPS KAKENHI [11008958]; Grants-in-Aid for Scientific Research
   [24390457] Funding Source: KAKEN
FX This work was supported in part by JSPS KAKENHI grant number 11008958
   (http://www.jsps.go.jp/english/index.html). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript. No additional external funding received
   for this study.
CR Alaish SM, 2005, SHOCK, V24, P412, DOI 10.1097/01.shk.0000183392.83272.97
   Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR
   Beierle EA, 1996, AM J SURG, V171, P202, DOI 10.1016/S0002-9610(99)80100-7
   Bendeck MP, 2004, CIRC RES, V94, P138, DOI 10.1161/01.RES.0000117525.23089.1A
   Chakrabarti S, 2006, J LEUKOCYTE BIOL, V79, P214, DOI 10.1189/jlb.0605353
   Chakrabarti S, 2005, EXP LUNG RES, V31, P599, DOI 10.1080/019021490944232
   CHANG SW, 1992, AM REV RESPIR DIS, V145, P798, DOI 10.1164/ajrccm/145.4_Pt_1.798
   Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599
   Fallon MB, 1997, GASTROENTEROLOGY, V113, P606, DOI 10.1053/gast.1997.v113.pm9247483
   Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242
   Giraudo E, 1998, J BIOL CHEM, V273, P22128, DOI 10.1074/jbc.273.34.22128
   Gonzalez-Lopez A, 2012, CRIT CARE, V16, DOI 10.1186/cc11224
   Johnson C, 2004, CIRC RES, V94, P262, DOI 10.1161/01.RES.0000111527.42357.62
   Kato T, 1999, BREAST CANCER RES TR, V53, P19, DOI 10.1023/A:1006193024382
   Keck T, 2006, PANCREATOLOGY, V6, P316, DOI 10.1159/000092797
   Keck T, 2002, GASTROENTEROLOGY, V122, P188, DOI 10.1053/gast.2002.30348
   Kim JH, 2006, AM J PHYSIOL-LUNG C, V291, pL580, DOI 10.1152/ajplung.00270.2005
   Kirkland JG, 2010, J SURG RES, V164, P221, DOI 10.1016/j.jss.2009.08.010
   Kochar R, 2011, PULMONARY MANIFESTAT, P381
   Kong MYF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022596
   Kong MYF, 2009, INT J MED SCI, V6, P9
   Ling YQ, 2004, HEPATOLOGY, V39, P1593, DOI 10.1002/hep.20244
   Liu LC, 2001, HEPATOLOGY, V33, P722, DOI 10.1053/jhep.2001.22701
   Luo B, 2004, AM J PHYSIOL-GASTR L, V286, pG294, DOI 10.1152/ajpgi.00298.2003
   Machicao VI, 2012, SEMIN RESP CRIT CARE, V33, P11, DOI 10.1055/s-0032-1301730
   Miniati D, 2010, AM J PHYSIOL-LUNG C, V298, pL169, DOI 10.1152/ajplung.00188.2009
   Oggionni T, 2006, EUR J HISTOCHEM, V50, P317
   Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514
   Roberts KE, 2010, GASTROENTEROLOGY, V139, P130, DOI 10.1053/j.gastro.2010.03.044
   Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597
   Sari S, 2012, DIGEST DIS SCI, V57, P175, DOI 10.1007/s10620-011-1832-6
   Schranz D, 2004, LANCET, V364, P26, DOI 10.1016/S0140-6736(04)16582-3
   Sugiyama M, 1997, ARCH SURG-CHICAGO, V132, P1129
   Tang LP, 2007, AM J PHYSIOL-LUNG C, V292, pL1467, DOI 10.1152/ajplung.00446.2006
   Tanikella R, 2008, LIVER TRANSPLANT, V14, P1199, DOI 10.1002/lt.21482
   Thenappan T, 2011, AM J RESP CRIT CARE, V183, P1080, DOI 10.1164/rccm.201008-1303OC
   Tipps RS, 2008, J THORAC CARDIOV SUR, V136, P283, DOI 10.1016/j.jtcvs.2008.02.011
   Van Steenkiste C, 2010, LAB INVEST, V90, P1558, DOI 10.1038/labinvest.2010.138
   Walkin L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-18
   Wang BL, 2011, MOL MED REP, V4, P243, DOI 10.3892/mmr.2011.425
   Zhang JL, 2012, NAT REV GASTRO HEPAT, V9, P539, DOI 10.1038/nrgastro.2012.123
   Zhang JL, 2009, GASTROENTEROLOGY, V136, P1070, DOI 10.1053/j.gastro.2008.12.001
   Zhang R, 2003, J BIOL CHEM, V278, P51267, DOI 10.1074/jbc.M310678200
NR 43
TC 22
Z9 23
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 14
PY 2014
VL 9
IS 4
AR e94550
DI 10.1371/journal.pone.0094550
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AI6GP
UT WOS:000336970400051
PM 24733017
OA Green Published, Green Submitted, gold
DA 2023-08-21
ER

PT J
AU Valbuena, G
   Halliday, H
   Borisevich, V
   Goez, Y
   Rockx, B
AF Valbuena, Gustavo
   Halliday, Hailey
   Borisevich, Viktoriya
   Goez, Yenny
   Rockx, Barry
TI A Human Lung Xenograft Mouse Model of Nipah Virus Infection
SO PLOS PATHOGENS
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; HENIPAVIRUS INFECTION; ENDOTHELIAL-CELLS;
   SCID MICE; IN-VIVO; BANGLADESH; PATHOGENESIS; MALAYSIA; TRANSMISSION;
   ENCEPHALITIS
AB Nipah virus (NiV) is a member of the genus Henipavirus (family Paramyxoviridae) that causes severe and often lethal respiratory illness and encephalitis in humans with high mortality rates (up to 92%). NiV can cause Acute Lung Injury (ALI) in humans, and human-to-human transmission has been observed in recent outbreaks of NiV. While the exact route of transmission to humans is not known, we have previously shown that NiV can efficiently infect human respiratory epithelial cells. The molecular mechanisms of NiV-associated ALI in the human respiratory tract are unknown. Thus, there is an urgent need for models of henipavirus infection of the human respiratory tract to study the pathogenesis and understand the host responses. Here, we describe a novel human lung xenograft model in mice to study the pathogenesis of NiV. Following transplantation, human fetal lung xenografts rapidly graft and develop mature structures of adult lungs including cartilage, vascular vessels, ciliated pseudostratified columnar epithelium, and primitive "air'' spaces filled with mucus and lined by cuboidal to flat epithelium. Following infection, NiV grows to high titers (10(7) TCID50/gram lung tissue) as early as 3 days post infection (pi). NiV targets both the endothelium as well as respiratory epithelium in the human lung tissues, and results in syncytia formation. NiV infection in the human lung results in the production of several cytokines and chemokines including IL-6, IP-10, eotaxin, G-CSF and GM-CSF on days 5 and 7 pi. In conclusion, this study demonstrates that NiV can replicate to high titers in a novel in vivo model of the human respiratory tract, resulting in a robust inflammatory response, which is known to be associated with ALI. This model will facilitate progress in the fundamental understanding of henipavirus pathogenesis and virus-host interactions; it will also provide biologically relevant models for other respiratory viruses.
C1 [Valbuena, Gustavo; Halliday, Hailey; Borisevich, Viktoriya; Goez, Yenny; Rockx, Barry] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555, United States.
   [Valbuena, Gustavo; Borisevich, Viktoriya; Rockx, Barry] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555, United States.
   [Rockx, Barry] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555, United States.
C3 University of Texas System; University of Texas Medical Branch
   Galveston; University of Texas System; University of Texas Medical
   Branch Galveston; University of Texas System; University of Texas
   Medical Branch Galveston
RP Rockx, B (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM barry.rockx@utmb.edu
OI Rockx, Barry/0000-0003-2463-027X
FU Department of Pathology, University of Texas Medical Branch; Institute
   of Human Infections and Immunity, University of Texas Medical Branch;
   NIAID/NIH [U54 AI057156]
FX This study was financially supported by start-up funds by the Department
   of Pathology and Institute of Human Infections and Immunity, University
   of Texas Medical Branch to BR and by NIAID/NIH U54 AI057156 to GV. Its
   contents are solely the responsibility of the authors and do not
   necessarily represent the official views of the RCE Programs Office,
   NIAID, or NIH. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Abele-Ohl S, 2012, AM J TRANSPLANT, V12, P1720, DOI 10.1111/j.1600-6143.2012.04018.x
   Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106
   Bossart KN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004241
   Bossart KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000642
   Calderon VE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063331
   Cameron MJ, 2008, VIRUS RES, V133, P13, DOI 10.1016/j.virusres.2007.02.014
   Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3
   Clayton BA, 2012, EMERG INFECT DIS, V18, P1983, DOI 10.3201/eid1812.120875
   DeBuysscher BL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002024
   Dhondt KP, 2013, J INFECT DIS, V207, P142, DOI 10.1093/infdis/jis653
   Dups J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040308
   Erbar S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-142
   Escaffre O, 2013, J INFECT DEV COUNTR, V7, P308, DOI 10.3855/jidc.3648
   Gao RB, 2013, AM J PATHOL, V183, P1258, DOI 10.1016/j.ajpath.2013.06.023
   Geisbert TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010690
   Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128
   Headley AS, 1997, CHEST, V111, P1306, DOI 10.1378/chest.111.5.1306
   Hossain MJ, 2008, CLIN INFECT DIS, V46, P977, DOI 10.1086/529147
   Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701
   Kollmann TR, 1996, P NATL ACAD SCI USA, V93, P3126, DOI 10.1073/pnas.93.7.3126
   Lo MK, 2010, VIROLOGY, V404, P78, DOI 10.1016/j.virol.2010.05.005
   Maisner A, 2009, THROMB HAEMOSTASIS, V102, P1014, DOI 10.1160/TH09-05-0310
   Mathieu C, 2011, J VIROL, V85, P7863, DOI 10.1128/JVI.00549-11
   Medford ARL, 2006, THORAX, V61, P621, DOI 10.1136/thx.2005.040204
   MEDURI GU, 1995, CHEST, V107, P1062, DOI 10.1378/chest.107.4.1062
   Paton NI, 1999, LANCET, V354, P1253, DOI 10.1016/S0140-6736(99)04379-2
   Podesta JE, 2009, SMALL, V5, P1176, DOI 10.1002/smll.200801572
   Rockx B, 2012, ANTIVIR RES, V95, P135, DOI 10.1016/j.antiviral.2012.05.008
   Rockx B, 2011, J VIROL, V85, P7658, DOI 10.1128/JVI.00473-11
   Rockx B, 2009, J VIROL, V83, P7062, DOI 10.1128/JVI.00127-09
   Savidge TC, 2003, GASTROENTEROLOGY, V125, P413, DOI 10.1016/S0016-5085(03)00902-8
   SAVIDGE TC, 1995, DIFFERENTIATION, V58, P361, DOI 10.1046/j.1432-0436.1995.5850361.x
   SHULTZ LD, 1995, J IMMUNOL, V154, P180
   Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248
   Wong KT, 2003, AM J PATHOL, V163, P2127, DOI 10.1016/S0002-9440(10)63569-9
   Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8
NR 36
TC 31
Z9 32
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD APR
PY 2014
VL 10
IS 4
AR e1004063
DI 10.1371/journal.ppat.1004063
PG 11
WC Microbiology; Parasitology; Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology; Parasitology; Virology
GA AP4FW
UT WOS:000342033600029
PM 24699832
OA Green Submitted, Green Published, gold
DA 2023-08-21
ER

PT J
AU Wang, ZJ
   Li, J
   Cho, J
   Malik, AB
AF Wang, Zhenjia
   Li, Jing
   Cho, Jaehyung
   Malik, Asrar B.
TI Prevention of vascular inflammation by nanoparticle targeting of
   adherent neutrophils
SO NATURE NANOTECHNOLOGY
LA English
DT Article
ID FC-GAMMA RECEPTOR; EXPRESSION; MONOCYTES; INTEGRIN; DELIVERY; THERAPY;
   DISEASE; INJURY
AB Inflammatory diseases such as acute lung injury and ischaemic tissue injury are caused by the adhesion of a type of white blood cell-polymorphonuclear neutrophils-to the lining of the circulatory system or vascular endothelium and unchecked neutrophil transmigration(1),(2). Nanoparticle-mediated targeting of activated neutrophils on vascular endothelial cells at the site of injury may be a useful means of directly inactivating neutrophil transmigration and hence mitigating vascular inflammation(3). Here, we report a method employing drug-loaded albumin nanoparticles, which efficiently deliver drugs into neutrophils adherent to the surface of the inflamed endothelium. Using intravital microscopy of tumour necrosis factor-a-challenged mouse cremaster post-capillary venules, we demonstrate that fluorescently tagged albumin nanoparticles are largely internalized by neutrophils adherent to the activated endothelium via cell surface Fc gamma receptors. Administration of albumin nanoparticles loaded with the spleen tyrosine kinase inhibitor, piceatannol, which blocks `outside- in' beta 2 integrin signalling in leukocytes, detached the adherent neutrophils and elicited their release into the circulation. Thus, internalization of drug-loaded albumin nanoparticles into neutrophils inactivates the pro-inflammatory function of activated neutrophils, thereby offering a promising approach for treating inflammatory diseases resulting from inappropriate neutrophil sequestration and activation.
C1 [Wang, Zhenjia; Li, Jing; Cho, Jaehyung; Malik, Asrar B.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612, United States.
   [Wang, Zhenjia; Cho, Jaehyung; Malik, Asrar B.] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612, United States.
   [Cho, Jaehyung] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60612, United States.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital;
   University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital
RP Malik, AB (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA.
EM abmalik@uic.edu
OI Malik, Asrar/0000-0002-8205-7128; Cho, Jaehyung/0000-0003-2404-3446
FU American Heart Association [11SDG7490013]; National Institutes of Health
   [K25HL111157, R01 HL109439, P01 P01HL77806]
FX This work was supported by grant no. 11SDG7490013 from the American
   Heart Association and National Institutes of Health grants K25HL111157
   to Z. W., R01 HL109439 to J.C. and P01 P01HL77806 to A.B.M.
CR BULL HB, 1978, BIOPOLYMERS, V17, P2121, DOI 10.1002/bip.1978.360170907
   Chen K, 2012, BLOOD, V120, P4421, DOI 10.1182/blood-2011-12-401133
   Evans R, 2011, BLOOD, V117, P3331, DOI 10.1182/blood-2010-06-289140
   Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m
   GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7
   Hahm E, 2013, BLOOD, V121, P3789, DOI 10.1182/blood-2012-11-467985
   Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939
   Hu GC, 2010, CRIT CARE MED, V38, P194, DOI 10.1097/CCM.0b013e3181bc7c17
   INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389
   LO SK, 1992, J CLIN INVEST, V89, P981, DOI 10.1172/JCI115681
   Lockwood CM, 1999, CLIN IMMUNOL, V93, P93, DOI 10.1006/clim.1999.4764
   Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158
   Nakatani K, 1999, CLIN EXP IMMUNOL, V117, P418
   Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591
   Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514
   Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180
   SHARAR SR, 1991, SURGERY, V110, P213
   Sumagin R, 2010, J IMMUNOL, V185, P7057, DOI 10.4049/jimmunol.1001638
   Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720
   Wagner DD, 2008, BLOOD, V111, P5271, DOI 10.1182/blood-2008-01-078204
   Wang ZJ, 2011, IUBMB LIFE, V63, P659, DOI 10.1002/iub.485
   Wang ZJ, 2009, ACS NANO, V3, P4110, DOI 10.1021/nn9012274
   Weber C, 2000, INT J PHARM, V196, P197, DOI 10.1016/S0378-5173(99)00420-2
   Wisel S, 2009, J PHARMACOL EXP THER, V329, P543, DOI 10.1124/jpet.109.150839
   Wong CHY, 2010, CARDIOVASC RES, V86, P183, DOI 10.1093/cvr/cvq040
   Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628
   Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011
NR 27
TC 201
Z9 205
U1 10
U2 178
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1748-3387
EI 1748-3395
J9 NAT NANOTECHNOL
JI Nat. Nanotechnol.
PD MAR
PY 2014
VL 9
IS 3
BP 204
EP 210
DI 10.1038/NNANO.2014.17
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics; Materials Science
GA AC6MI
UT WOS:000332637200014
PM 24561355
OA Green Accepted
DA 2023-08-21
ER

PT J
AU Allen, TC
   Kurdowska, A
AF Allen, Timothy Craig
   Kurdowska, Anna
TI Interleukin 8 and Acute Lung Injury
SO ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
LA English
DT Review
ID RESPIRATORY-DISTRESS-SYNDROME; FC-GAMMA-RIIA; IMMUNE-COMPLEXES; IGG
   RECEPTORS; AUTOANTIBODY; CONTRACTILITY; INFLAMMATION; CELLS; FLUID; MICE
AB Acute lung injury is a complex clinical syndrome involving acute inflammation, microvascular damage, and increased pulmonary vascular and epithelial permeability, frequently resulting in acute respiratory failure culminating in often-fatal acute respiratory distress syndrome. Interleukin 8 (IL-8), a potent neutrophil attractant and activator, plays a significant role in acute lung injury via the formation of anti-IL-8 autoantibody: IL-8 complexes and those complexes' interaction with Fc gamma RIIa receptors, leading to the development of acute lung injury by, among other possible mechanisms, effecting neutrophil apoptosis. These complexes may also interact with lung endothelial cells in patients with acute respiratory distress syndrome. Continuing research of the role of neutrophils, IL-8, anti-IL-8 autoantibody: IL-8 complexes, and Fc gamma RIIa receptors may ultimately provide molecular therapies that could lower acute respiratory distress syndrome mortality, as well as reduce or even prevent the development of acute lung injury altogether.
C1 [Allen, Timothy Craig] Univ Texas Tyler, Hlth Sci Ctr, Dept Pathol, Tyler, TX 75799, United States.
   [Kurdowska, Anna] Univ Texas Tyler, Hlth Sci Ctr, Dept Biochem, Tyler, TX 75799, United States.
C3 University of Texas System; University of Texas at Tyler; University of
   Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas
   System; University of Texas at Tyler; University of Texas-Health
   Sciences Center at Tyler (UTHSCT)
RP Allen, TC (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM tcallen@utmb.edu
CR Allen TC, 2007, ARCH PATHOL LAB MED, V131, P452
   ASHBAUGH DG, 1967, LANCET, V2, P319
   Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC
   Bhandary YP, 2009, AM J RESP CRIT CARE, V179, P288, DOI 10.1164/rccm.200712-1787OC
   Chen CY, 2009, AM J RESP CRIT CARE, V180, P751, DOI 10.1164/rccm.200902-0222OC
   Fudala R, 2008, CLIN SCI, V114, P403, DOI 10.1042/CS20070272
   Fudala R, 2007, AM J PHYSIOL-LUNG C, V293, pL364, DOI 10.1152/ajplung.00179.2006
   Fudala R, 2011, ARCH PATHOL LAB MED, V135, P647, DOI 10.1043/2009-0660-OAR1.1
   Huang FF, 2011, AM J RESP CRIT CARE, V184, P259, DOI 10.1164/rccm.201012-2036OC
   Krupa A, 2004, AM J PHYSIOL-LUNG C, V286, pL1105, DOI 10.1152/ajplung.00277.2003
   Krupa A, 2007, AM J RESP CELL MOL, V37, P532, DOI 10.1165/rcmb.2006-0395OC
   Krupa A, 2009, AM J RESP CELL MOL, V41, P155, DOI 10.1165/rcmb.2008-0183OC
   Kurdowska A, 1996, J IMMUNOL, V157, P2699
   Kurdowska A, 2002, CRIT CARE MED, V30, P2335, DOI 10.1097/00003246-200210000-00024
   Kurdowska A, 2001, AM J RESP CRIT CARE, V163, P463, DOI 10.1164/ajrccm.163.2.2005109
   Matthay MA, 2010, AM J RESP CRIT CARE, V181, P1027, DOI 10.1164/rccm.201001-0074UP
   Midde KK, 2011, SHOCK, V36, P128, DOI 10.1097/SHK.0b013e31821d60a4
   MILLER EJ, 1992, AM REV RESPIR DIS, V146, P427, DOI 10.1164/ajrccm/146.2.427
   MONTGOMERY AB, 1991, CHEST, V99, P261, DOI 10.1378/chest.99.1.261
   Nassar T, 2011, AM J RESP CELL MOL, V45, P1015, DOI 10.1165/rcmb.2010-0302OC
   Nassar T, 2011, AM J PHYSIOL-LUNG C, V301, pL307, DOI 10.1152/ajplung.00429.2010
   Nassar T, 2010, AM J RESP CELL MOL, V43, P703, DOI 10.1165/rcmb.2009-0257OC
   Paul-Clark MJ, 2009, AM J RESP CRIT CARE, V179, P299, DOI 10.1164/rccm.200707-1019OC
   Sardjono CT, 2003, IMMUNOL CELL BIOL, V81, P374, DOI 10.1046/j.1440-1711.2003.01182.x
   Sloggett AT, 1915, MEMORANDUM TREATMENT, P115
   VANDEWINKEL JGJ, 1993, IMMUNOL TODAY, V14, P215, DOI 10.1016/0167-5699(93)90166-I
   Ware LB, 2010, CHEST, V137, P288, DOI 10.1378/chest.09-1484
   Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053
NR 28
TC 88
Z9 92
U1 0
U2 22
PU COLL AMER PATHOLOGISTS
PI NORTHFIELD
PA C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 USA
SN 0003-9985
EI 1543-2165
J9 ARCH PATHOL LAB MED
JI Arch. Pathol. Lab. Med.
PD FEB
PY 2014
VL 138
IS 2
BP 266
EP 269
DI 10.5858/arpa.2013-0182-RA
PG 4
WC Medical Laboratory Technology; Medicine, Research & Experimental;
   Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology; Research & Experimental Medicine;
   Pathology
GA AM0QF
UT WOS:000339550000021
PM 23782136
DA 2023-08-21
ER

PT J
AU Hou, SK
   Ding, H
   Lv, Q
   Yin, XF
   Song, JQ
   Landen, NX
   Fan, HJ
AF Hou, Shike
   Ding, Hui
   Lv, Qi
   Yin, Xiaofeng
   Song, Jianqi
   Landen, Ning Xu
   Fan, Haojun
TI Therapeutic Effect of Intravenous Infusion of Perfluorocarbon Emulsion
   on LPS-Induced Acute Lung Injury in Rats
SO PLOS ONE
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; LIQUID
   VENTILATION; OXYGEN CARRIERS; IN-VITRO; INHIBITION; RELEASE; ARDS
AB Acute lung injury (ALI) and its more severe form, acute respiratory distress syndrome (ARDS) are the leading causes of death in critical care. Despite extensive efforts in research and clinical medicine, mortality remains high in these diseases. Perfluorocarbon (PFC), a chemical compound known as liquid ventilation medium, is capable of dissolving large amounts of physiologically important gases (mainly oxygen and carbon dioxide). In this study we aimed to investigate the effect of intravenous infusion of PFC emulsion on lipopolysaccharide (LPS) induced ALI in rats and elucidate its mechanism of action. Forty two Wistar rats were randomly divided into three groups: 6 rats were treated with saline solution by intratracheal instillation (control group), 18 rats were treated with LPS by intratracheal instillation (LPS group) and the other 18 rats received PFC through femoral vein prior to LPS instillation (LPS+ PFC group). The rats in the control group were sacrificed 6 hours later after saline instillation. At 2, 4 and 6 hours of exposure to LPS, 6 rats in the LPS group and 6 rats in LPS+ PFC group were sacrificed at each time point. By analyzing pulmonary pathology, partial pressure of oxygen in the blood (PaO2) and lung wet-dry weight ratio (W/D) of each rat, we found that intravenous infusion of PFC significantly alleviated acute lung injury induced by LPS. Moreover, we showed that the expression of pulmonary myeloperoxidase (MPO), intercellular adhesion molecule-1 (ICAM-1) of endothelial cells and CD11b of polymorphonuclear neutrophils (PMN) induced by LPS were significantly decreased by PFC treatment in vivo. Our results indicate that intravenous infusion of PFC inhibits the infiltration of PMNs into lung tissue, which has been shown as the core pathogenesis of ALI/ARDS. Thus, our study provides a theoretical foundation for using intravenous infusion of PFC to prevent and treat ALI/ARDS in clinical practice.
C1 [Hou, Shike; Ding, Hui; Lv, Qi; Yin, Xiaofeng; Song, Jianqi; Fan, Haojun] Logist Univ Chinese Peoples Armed Police Forces, Affiliated Hosp, Rescue Med Res Inst, Tianjin, China.
   [Landen, Ning Xu] Karolinska Univ Hosp, Mol Dermatol Res Grp, CMM, Stockholm, Sweden.
C3 Karolinska Institutet; Karolinska University Hospital
RP Fan, HJ (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Affiliated Hosp, Rescue Med Res Inst, Tianjin, Peoples R China.
EM haojunfan86@163.com
RI Landén, Ning Xu/AFL-2883-2022
OI Landén, Ning Xu/0000-0003-4868-3798; Lv, Qi/0000-0001-9076-7042; Fan,
   Haojun/0000-0003-1111-0232
FU capital development fund [2009-3091]; Key program of PAPF [WJHQ2010-08]
FX This work was supported by grants from the capital development fund
   (2009-3091), Key program of PAPF (WJHQ2010-08). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Albaghdadi AS, 2010, RESUSCITATION, V81, P353, DOI 10.1016/j.resuscitation.2009.11.018
   Angus DC, 2006, CRIT CARE MED, V34, P2885, DOI 10.1097/01.CCM.0000248727.29055.25
   ASHBAUGH DG, 1967, LANCET, V2, P319
   Baba A, 2000, CRIT CARE MED, V28, P1113, DOI 10.1097/00003246-200004000-00034
   Bernard GR, 1999, CHEST, V116, p260S
   Bollen CW, 2005, CRIT CARE, V9, pR430, DOI 10.1186/cc3737
   Brower RG, 2004, NEW ENGL J MED, V351, P327
   BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8
   Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x
   Chang H, 2005, INTENS CARE MED, V31, P977, DOI 10.1007/s00134-005-2652-y
   Chopra M, 2009, EXP BIOL MED, V234, P361, DOI 10.3181/0811-MR-318
   Dickinson S, 2011, CRIT CARE CLIN, V27, P511, DOI 10.1016/j.ccc.2011.05.010
   Doerschuk CM, 1996, J IMMUNOL, V157, P4609
   Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995
   Faithfull NS, 1998, VOX SANG, V74, P243, DOI 10.1111/j.1423-0410.1998.tb05426.x
   Gale SC, 2007, J SURG RES, V138, P135, DOI 10.1016/j.jss.2006.08.029
   Garber BG, 1996, CRIT CARE MED, V24, P687, DOI 10.1097/00003246-199604000-00023
   Gardinali M, 2000, AM J RESP CRIT CARE, V161, P1022, DOI 10.1164/ajrccm.161.3.9901066
   GREENSPAN JS, 1990, J PEDIATR-US, V117, P106, DOI 10.1016/S0022-3476(05)82457-6
   Greenspan JS, 2000, SEMIN PERINATOL, V24, P396, DOI 10.1053/sper.2000.20092
   Hadjiliadis D, 2000, SEM RESP CRIT CARE M, V21, P175, DOI 10.1055/s-2000-9852
   Hale DF, 2012, J TRAUMA ACUTE CARE, V72, P1634, DOI 10.1097/TA.0b013e318247cd4f
   Keipert PE, 2001, ANASTH INTENSIV NOTF, V36, pS104
   KERINS DM, 1994, AM J MED SCI, V307, P218, DOI 10.1097/00000441-199403000-00009
   Lu YM, 2004, INTENS CARE MED, V30, P2197, DOI 10.1007/s00134-004-2479-y
   [马希刚 MA Xigang], 2006, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V26, P363
   Michetti C, 2003, J SURG RES, V115, P92, DOI 10.1016/S0022-4804(03)00219-1
   Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC
   Riess JG, 2006, ARTIF CELL BLOOD SUB, V34, P567, DOI 10.1080/10731190600973824
   Sharma J, 2009, J IMMUNOL METHODS, V351, P30, DOI 10.1016/j.jim.2009.09.008
   Shashikant BN, 2005, CRIT CARE MED, V33, P1096, DOI 10.1097/01.CCM.0000163218.79770.29
   Shen Y, 2011, EXPERT REV RESP MED, V5, P107, DOI [10.1586/ers.10.80, 10.1586/ERS.10.80]
   Smith FG, 2012, LANCET, V379, P229, DOI 10.1016/S0140-6736(11)61623-1
   Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200
   Spahn DR, 1999, CRIT CARE, V3, pR93, DOI 10.1186/cc364
   Spiess BD, 2009, J APPL PHYSIOL, V106, P1444, DOI 10.1152/japplphysiol.90995.2008
   Taut FJH, 2008, CHEST, V134, P724, DOI 10.1378/chest.08-0362
   Taylor RW, 2004, JAMA-J AM MED ASSOC, V291, P1603, DOI 10.1001/jama.291.13.1603
   Thompson BT, 2003, CRIT CARE MED, V31, pS253, DOI 10.1097/01.CCM.0000057900.19201.55
   Tsushima K, 2009, INTERNAL MED, V48, P621, DOI 10.2169/internalmedicine.48.1741
   Wang X, 2013, CLIN RESPIR  J, DOI [10.1111/crj.12053, DOI 10.1111/CRJ.12053.[]
   Wolfson MR, 2004, PAEDIATR ANAESTH, V14, P15, DOI 10.1046/j.1460-9592.2003.01206.x
   Wyman TH, 2002, AM J PHYSIOL-CELL PH, V283, pC1592, DOI 10.1152/ajpcell.00540.2001
   Young D, 2013, NEW ENGL J MED, V368, P806, DOI 10.1056/NEJMoa1215716
   Yoxall CW, 1997, THORAX, V52, pS3, DOI 10.1136/thx.52.2008.S3
   Zhang XP, 2009, J PANCREAS, V10, P8
   Zhou XH, 2012, FRONT BIOSCI-LANDMRK, V17, P2278, DOI 10.2741/4051
NR 47
TC 31
Z9 38
U1 1
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 28
PY 2014
VL 9
IS 1
AR e87826
DI 10.1371/journal.pone.0087826
PG 7
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 301CJ
UT WOS:000330510000152
PM 24489970
OA gold, Green Published, Green Submitted
DA 2023-08-21
ER

PT J
AU Braach, N
   Buschmann, K
   Pflaum, J
   Hudalla, H
   Koch, L
   Ryschich, E
   Poeschl, J
   Frommhold, D
AF Braach, Natascha
   Buschmann, Kirsten
   Pflaum, Johanna
   Hudalla, Hannes
   Koch, Lutz
   Ryschich, Eduard
   Poeschl, Johannes
   Frommhold, David
TI Anti-Inflammatory Functions of Protein C Require RAGE and ICAM-1 in a
   Stimulus-Dependent Manner
SO MEDIATORS OF INFLAMMATION
LA English
DT Article
ID GLYCATION END-PRODUCTS; LEUKOCYTE RECRUITMENT; ACUTE-INFLAMMATION;
   ENDOTHELIAL-CELLS; IMPROVES SURVIVAL; LUNG INJURY; RECEPTOR; ADHESION;
   ANTICOAGULANT; ENDOTOXEMIA
AB By binding beta(2)-integrins both ICAM-1 and the receptor for advanced glycation end products (RAGE) mediate leukocyte recruitment in a stimulus-dependent manner. Using different inflammatory mouse models we investigated how RAGE and ICAM-1 are involved in anti-inflammatory functions of protein C (PC; Ceprotin, 100 U/kg). We found that, depending on the stimulus, RAGE and ICAM-1 are cooperatively involved in PC-induced inhibition of leukocyte recruitment in cremaster models of inflammation. During short-term proinflammatory stimulation (trauma, fMLP, and CXCL1), ICAM-1 is more important for mediation of anti-inflammatory effects of PC, whereas RAGE plays a major role after longer proinflammatory stimulation (TNF alpha). In contrast to WT and Icam-1(-/-) mice, PC had no effect on bronchoalveolar neutrophil emigration in RAGE(-/-) mice during LPS-induced acute lung injury, suggesting that RAGE critically mediates PC effects during acute lung inflammation. In parallel, PC treatment effectively blocked leukocyte recruitment and improved survival of WT mice and Icam-1-deficient mice in LPS-induced endotoxemia, but failed to do so in RAGE-deficient mice. Exploring underlying mechanisms, we found that PC is capable of downregulating intracellular RAGE and extracellular ICAM-1 in endothelial cells. Taken together, our data show that RAGE and ICAM-1 are required for the anti-inflammatory functions of PC.
C1 [Braach, Natascha; Buschmann, Kirsten; Pflaum, Johanna; Hudalla, Hannes; Koch, Lutz; Poeschl, Johannes; Frommhold, David] Ruprecht Karls Univ Hosp Heidelberg, Dept Neonatol, D-69120 Heidelberg, Germany.
   [Ryschich, Eduard] Ruprecht Karls Univ Hosp Heidelberg, Dept Surg, D-69120 Heidelberg, Germany.
C3 Ruprecht Karls University Heidelberg; Ruprecht Karls University
   Heidelberg
RP Frommhold, D (corresponding author), Ruprecht Karls Univ Hosp Heidelberg, Dept Neonatol, D-69120 Heidelberg, Germany.
EM david.frommhold@med.uni-heidelberg.de
RI Koch, Lutz/H-2166-2011
OI Koch, Lutz/0000-0003-3683-2274
FU Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg
FX The authors thank Melitta Weissinger for her excellent technical
   assistance in performing intravital microscopy and Professor Peter
   Nawroth (Department of Medicine I & Clinical Chemistry, University
   Heidelberg) for providing RAGE<SUP>-/-</SUP> and Icam-1<SUP>-/-</SUP>
   mice and MAECs. In addition, they thank Professor Berend Isermann and
   Dr. Hongjie Wang (both from University Magdeburg, Germany) for
   assistance in performing the APC capture assay and Dr. Sandra Ehrle
   (Baxter, Unterschleissheim, Germany) for providing the Ceprotin. In
   addition, we acknowledge the financial support of the Deutsche
   Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within
   the funding programme Open Access Publishing.
CR Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782
   Bae JS, 2011, BLOOD, V118, P3952, DOI 10.1182/blood-2011-06-360701
   Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005
   Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9
   BRETT J, 1993, AM J PATHOL, V143, P1699
   Buschmann K, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/739176
   Cao CZ, 2010, J CLIN INVEST, V120, P1971, DOI 10.1172/JCI40380
   Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800
   Dinarvand P, 2014, BLOOD, V123, P935, DOI 10.1182/blood-2013-09-529602
   Elphick GF, 2009, BLOOD, V113, P4078, DOI 10.1182/blood-2008-09-180968
   Foy DS, 2000, MICROVASC RES, V60, P249, DOI 10.1006/mvre.2000.2272
   Frommhold D, 2011, AM J PATHOL, V179, P2637, DOI 10.1016/j.ajpath.2011.07.023
   Frommhold D, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-56
   Frommhold D, 2010, BLOOD, V116, P841, DOI 10.1182/blood-2009-09-244293
   Frommhold D, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-31
   Guitton C, 2011, AM J PHYSIOL-CELL PH, V300, pC833, DOI 10.1152/ajpcell.00003.2010
   Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667
   Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9
   Jackson CJ, 2008, INT J BIOCHEM CELL B, V40, P2692, DOI 10.1016/j.biocel.2007.12.013
   Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200
   Kau JH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-98
   Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404
   Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138
   Lange-Sperandio B, 2007, CURR PEDIATR REV, V3, P1, DOI 10.2174/157339607779941598
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   Liaw PCY, 2003, J THROMB HAEMOST, V1, P662, DOI 10.1046/j.1538-7836.2003.00153.x
   Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704
   Luo Y, 2013, BIOCHEM BIOPH RES CO, V438, P732, DOI 10.1016/j.bbrc.2013.07.098
   Messaris E, 2010, CRIT CARE MED, V38, P209, DOI 10.1097/CCM.0b013e3181b4a972
   Ramsgaard L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020132
   Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004
   Reynolds PR, 2010, AM J RESP CELL MOL, V42, P545, DOI 10.1165/rcmb.2008-0265OC
   Rezaie AR, 2010, CURR MED CHEM, V17, P2059, DOI 10.2174/092986710791233706
   Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699
   Scaldaferri F, 2007, J CLIN INVEST, V117, P1951, DOI 10.1172/JCI31027
   Sopel MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045663
   SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143
   Sturn DH, 2003, BLOOD, V102, P1499, DOI 10.1182/blood-2002-12-3880
   Su X, 2009, AM J PHYSIOL-LUNG C, V297, pL1, DOI 10.1152/ajplung.90546.2008
   Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC
   van Zoelen Marieke A D, 2011, Front Biosci (Schol Ed), V3, P1119
   Wang J, 2012, INFLAMMATION, V35, P859, DOI 10.1007/s10753-011-9387-4
   Weiler H, 2001, ARTERIOSCL THROM VAS, V21, P1531, DOI 10.1161/hq0901.094496
   Weiler H, 2010, CRIT CARE MED, V38, pS18, DOI 10.1097/CCM.0b013e3181c9cbb5
   XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95
   Xu X, 2013, CLIN EXP IMMUNOL, V173, P523, DOI 10.1111/cei.12139
   Yamamoto Y, 2011, J IMMUNOL, V186, P3248, DOI 10.4049/jimmunol.1002253
   Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942
NR 48
TC 4
Z9 5
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0962-9351
EI 1466-1861
J9 MEDIAT INFLAMM
JI Mediat. Inflamm.
PY 2014
VL 2014
AR 743678
DI 10.1155/2014/743678
PG 12
WC Cell Biology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Immunology
GA AH4UW
UT WOS:000336125200001
PM 24876676
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Mondrinos, MJ
   Zhang, T
   Sun, S
   Kennedy, PA
   King, DJ
   Wolfson, MR
   Knight, LC
   Scalia, R
   Kilpatric, LE
AF Mondrinos, Mark J.
   Zhang, Ting
   Sun, Shuang
   Kennedy, Paul A.
   King, Devon J.
   Wolfson, Marla R.
   Knight, Linda C.
   Scalia, Rosario
   Kilpatric, Laurie E.
TI Pulmonary Endothelial Protein Kinase C-Delta (PKC delta) Regulates
   Neutrophil Migration in Acute Lung Inflammation
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; NF-KAPPA-B; TNF-ALPHA;
   STREPTOCOCCUS-PNEUMONIAE; ADHESION MOLECULE-1; LEUKOCYTE ADHESION;
   GENE-EXPRESSION; RECRUITMENT; CELLS; ACTIVATION
AB Excessive neutrophil migration across the pulmonary endothelium into the lung and release of oxidants and proteases are key elements in pathogenesis of acute lung injury. Previously, we identified protein kinase C-delta (PKC delta) as an important regulator of proinflammatory signaling in human neutrophils and demonstrated that intratracheal instillation of a TAT-conjugated PKC delta inhibitory peptide (PKC delta-TAT) is lung protective in a rat model of sepsis-induced indirect pulmonary injury (cecal ligation and puncture). In the present study, intratracheal instillation of this PKC delta inhibitor resulted in peptide distribution throughout the lung parenchyma and pulmonary endothelium and decreased neutrophil influx, with concomitant attenuation of sepsis-induced endothelial ICAM-1 and VCAM-1 expression in this model. To further delineate the role of PKC delta in regulating neutrophil migration, we used an in vitro transmigration model with human pulmonary microvascular endothelial cells (PMVECs). Consistent with in vivo findings, inhibition of PMVEC PKC delta decreased IL-1 beta-mediated neutrophil transmigration. PKC delta regulation was stimulus-dependent; PKC delta was required for transmigration mediated by IL-1 beta and fMLP (integrin-dependent), but not IL-8 (integrin-independent). PKC delta was essential for IL-1 beta-mediated neutrophil adherence and NF-kappa B-dependent expression of ICAM-1 and VCAM-1. In PMVECs, IL-1 beta-mediated production of ROS and activation of redox-sensitive NF-kappa B were PKC delta dependent, suggesting an upstream signaling role. Thus, PKC delta has an important role in regulating neutrophil-endothelial cell interactions and recruitment to the inflamed lung.
C1 [Mondrinos, Mark J.; Zhang, Ting; Sun, Shuang; Kennedy, Paul A.; King, Devon J.; Wolfson, Marla R.; Scalia, Rosario; Kilpatric, Laurie E.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140, United States.
   [Mondrinos, Mark J.; Zhang, Ting; Sun, Shuang; Kennedy, Paul A.; King, Devon J.; Wolfson, Marla R.; Kilpatric, Laurie E.] Temple Univ, Sch Med, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19140, United States.
   [Mondrinos, Mark J.; Knight, Linda C.; Kilpatric, Laurie E.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140, United States.
   [Knight, Linda C.] Temple Univ, Sch Med, Dept Radiol, Philadelphia, PA 19140, United States.
   [Scalia, Rosario] Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19140, United States.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple
   University; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher
   Education (PCSHE); Temple University; Pennsylvania Commonwealth System
   of Higher Education (PCSHE); Temple University; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); Temple University
RP Kilpatric, LE (corresponding author), Temple Univ, Sch Med, Ctr Inflammat Translat & Clin Lung Res, Broad St,Room 1153 MERB, Philadelphia, PA 19140 USA.
EM laurie.kilpatrick@temple.edu
OI Scalia, Rosario/0000-0002-1829-943X
FU NIH [RO1 HL111552, R01 DK064344, 5T32-HL007777]; DoD/ONR
   [N00014-12-1-0597]
FX Supported in part by NIH grants RO1 HL111552 (L.E.K.), R01 DK064344
   (R.S.), 5T32-HL007777 (M.J.M.) and DoD/ONR N00014-12-1-0597 (M.R.W.).
CR Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8
   Aghajanian A, 2008, J THROMB HAEMOST, V6, P1453, DOI 10.1111/j.1538-7836.2008.03087.x
   Aldridge AJ, 2002, EUR J SURG, V168, P204, DOI 10.1080/11024150260102807
   Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002
   Asaduzzaman M, 2008, SHOCK, V30, P254, DOI 10.1097/shk.0b013e318162c567
   Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121
   Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200
   Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Burns AR, 2003, PHYSIOL REV, V83, P309, DOI 10.1152/physrev.00023.2002
   Cai WJ, 2010, AM J PHYSIOL-CELL PH, V298, pC624, DOI 10.1152/ajpcell.00463.2009
   Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098
   Chichger H, 2012, AM J PHYSIOL-LUNG C, V303, pL880, DOI 10.1152/ajplung.00169.2012
   Chou WH, 2004, J CLIN INVEST, V114, P49, DOI 10.1172/JC1200421655
   Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015
   Cummings R, 2004, J BIOL CHEM, V279, P41085, DOI 10.1074/jbc.M404045200
   de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83
   Doerschuk CM, 2001, MICROCIRCULATION, V8, P71, DOI 10.1038/sj.mn.7300151
   Doerschuk CM, 2000, AM J RESP CELL MOL, V23, P133, DOI 10.1165/ajrcmb.23.2.f193
   Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s
   Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829
   Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011
   Guo RF, 2002, FREE RADICAL BIO MED, V33, P303, DOI 10.1016/S0891-5849(02)00823-7
   Guo RF, 2002, J IMMUNOL, V169, P307, DOI 10.4049/jimmunol.169.1.307
   Hu R, 2013, FRONT BIOSCI-LANDMRK, V18, P1244, DOI 10.2741/4176
   Ibbotson GC, 2001, NAT MED, V7, P465, DOI 10.1038/86539
   Kadioglu A, 2011, J IMMUNOL, V186, P5907, DOI 10.4049/jimmunol.1001533
   Kilpatrick LE, 2006, J LEUKOCYTE BIOL, V80, P1512, DOI 10.1189/jlb.0406284
   Kilpatrick LE, 2011, J LEUKOCYTE BIOL, V89, P3, DOI 10.1189/jlb.0510281
   Kilpatrick LE, 2010, J LEUKOCYTE BIOL, V87, P153, DOI 10.1189/jlb.0408230
   Kilpatrick LE, 2004, AM J PHYSIOL-CELL PH, V287, pC633, DOI 10.1152/ajpcell.00486.2003
   Kilpatrick LE, 2002, AM J PHYSIOL-CELL PH, V283, pC48, DOI 10.1152/ajpcell.00385.2001
   Kilpatrick LE, 2000, AM J PHYSIOL-CELL PH, V279, pC2011, DOI 10.1152/ajpcell.2000.279.6.C2011
   Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399
   Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006
   Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719
   Mackarel AJ, 2001, J IMMUNOL, V167, P2839, DOI 10.4049/jimmunol.167.5.2839
   Mackarel AJ, 2000, AM J RESP CELL MOL, V23, P154, DOI 10.1165/ajrcmb.23.2.3853
   Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9
   Martins JO, 2011, J LEUKOCYTE BIOL, V89, P1, DOI 10.1189/jlb.0810452
   Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331
   Minami T, 2003, J BIOL CHEM, V278, P6976, DOI 10.1074/jbc.M208974200
   Minhajuddin M, 2009, J BIOL CHEM, V284, P4052, DOI 10.1074/jbc.M805032200
   Mondrinos MJ, 2013, SHOCK, V39, P467, DOI 10.1097/SHK.0b013e318294f85a
   Moreland JG, 2004, J IMMUNOL, V172, P426, DOI 10.4049/jimmunol.172.1.426
   Muller S, 2010, EXPERT OPIN DRUG DIS, V5, P867, DOI 10.1517/17460441.2010.504203
   Muller AM, 2002, J PATHOL, V198, P270, DOI 10.1002/path.1186
   O'Brien CD, 2003, BLOOD, V101, P2816, DOI 10.1182/blood-2002-08-2396
   Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x
   Page K, 2003, J IMMUNOL, V170, P5681, DOI 10.4049/jimmunol.170.11.5681
   Pelosi P, 2003, EUR RESPIR J, V22, p48S, DOI 10.1183/09031936.03.00420803
   Perl M, 2011, EXPERT REV RESP MED, V5, P115, DOI [10.1586/ers.10.92, 10.1586/ERS.10.92]
   Qin Y, 2012, J DRUG TARGET, V20, P235, DOI 10.3109/1061186X.2011.639022
   Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001
   Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]
   Ramnath RD, 2010, J MOL MED, V88, P1055, DOI 10.1007/s00109-010-0647-9
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004
   Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881
   Rossaint J, 2013, J INNATE IMMUN, V5, P348, DOI 10.1159/000345943
   Sevransky JE, 2008, CHEST, V134, P534, DOI 10.1378/chest.08-0309
   Sheu CC, 2010, INTENS CARE MED, V36, P963, DOI 10.1007/s00134-010-1851-3
   Shukla A, 2007, AM J PATHOL, V170, P140, DOI 10.2353/ajpath.2007.060381
   Steinberg KP, 2006, NEW ENGL J MED, V354, P1671
   STEINBERG KP, 1994, AM J RESP CRIT CARE, V150, P113, DOI 10.1164/ajrccm.150.1.8025736
   Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]
   WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]
   Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7
   Woo CH, 2005, AM J PHYSIOL-LUNG C, V288, pL307, DOI 10.1152/ajplung.00105.2004
   Yan SR, 2004, IMMUNOL CELL BIOL, V82, P435, DOI 10.1111/j.0818-9641.2004.01268.x
NR 72
TC 33
Z9 36
U1 0
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD JAN
PY 2014
VL 184
IS 1
BP 200
EP 213
DI 10.1016/j.ajpath.2013.09.010
PG 14
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 278DU
UT WOS:000328870100021
PM 24211111
OA Green Published, hybrid
DA 2023-08-21
ER

PT J
AU Moraes, L
   Santos, CL
   Santos, RS
   Cruz, FF
   Saddy, F
   Morales, MM
   Capelozzi, VL
   Silva, PL
   de Abreu, MG
   Garcia, CSNB
   Pelosi, P
   Rocco, PRM
AF Moraes, Lillian
   Santos, Cintia Lourenco
   Santos, Raquel Souza
   Cruz, Fernanda Ferreira
   Saddy, Felipe
   Morales, Marcelo Marcos
   Capelozzi, Vera Luiza
   Silva, Pedro Leme
   de Abreu, Marcelo Gama
   Nascimento Baez Garcia, Cristiane Sousa
   Pelosi, Paolo
   Macedo Rocco, Patricia Rieken
TI Effects of sigh during pressure control and pressure support ventilation
   in pulmonary and extrapulmonary mild acute lung injury
SO CRITICAL CARE
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; IMPROVES GAS-EXCHANGE; RECRUITMENT
   MANEUVERS; VARIABILITY; STRATEGIES; MECHANICS; FREQUENCY; ETIOLOGY
AB Introduction: Sigh improves oxygenation and lung mechanics during pressure control ventilation (PCV) and pressure support ventilation (PSV) in patients with acute respiratory distress syndrome. However, so far, no study has evaluated the biological impact of sigh during PCV or PSV on the lung and distal organs in experimental pulmonary (p) and extrapulmonary (exp) mild acute lung injury (ALI).
   Methods: In 48 Wistar rats, ALI was induced by Escherichia coli lipopolysaccharide either intratracheally (ALIp) or intraperitoneally (ALlexp). After 24 hours, animals were anesthetized and mechanically ventilated with PCV or PSV with a tidal volume of 6 mL/kg, FiO(2)=0.4, and PEEP = 5 cmH(2)O for 1 hour. Both ventilator strategies were then randomly assigned to receive periodic sighs (10 sighs/hour, Sigh) or not (non-Sigh, NS). Ventilatory and mechanical parameters, arterial blood gases, lung histology, interleukin (IL)-1 beta, IL-6, caspase-3, and type III procollagen (PCIII) mRNA expression in lung tissue, and number of apoptotic cells in lung, liver, and kidney specimens were analyzed.
   Results: In both ALI etiologies: (1) PCV-Sigh and PSV-Sigh reduced transpulmonary pressure, and (2) PSV-Sigh reduced the respiratory drive compared to PSV-NS. In ALIp: (1) PCV-Sigh and PSV-Sigh decreased alveolar collapse as well as IL-1 beta, IL-6, caspase-3, and PCIII expressions in lung tissue, (2) PCV-Sigh increased alveolar-capillary membrane and endothelial cell damage, and (3) abnormal myofibril with Z-disk edema was greater in PCV-NS than PSV-NS. In ALlexp: (1) PSV-Sigh reduced alveolar collapse, but led to damage to alveolar-capillary membrane, as well as type II epithelial and endothelial cells, (2) PCV-Sigh and PSV-Sigh increased IL-1 beta IL-6, caspase-3, and PCIII expressions, and (3) PCV-Sigh increased the number of apoptotic cells in the lung compared to PCV-NS.
   Conclusions: In these models of mild ALIp and ALlexp, sigh reduced alveolar collapse and transpulmonary pressures during both PCV and PSV; however, improved lung protection only during PSV in ALIp.
C1 [Moraes, Lillian; Santos, Cintia Lourenco; Santos, Raquel Souza; Cruz, Fernanda Ferreira; Saddy, Felipe; Silva, Pedro Leme; Nascimento Baez Garcia, Cristiane Sousa; Macedo Rocco, Patricia Rieken] Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, Lab Pulm Invest, Ctr Ciencias Saude,Ilha Fundao, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Santos, Cintia Lourenco] Univ Fed Rio de Janeiro, Fac Med, Expt Surg Lab, BR-21941901 Rio De Janeiro, RJ, Brazil.
   [Saddy, Felipe] Hosp Procardiaco, BR-22280003 Rio De Janeiro, RJ, Brazil.
   [Saddy, Felipe] Hosp Copa DOr, BR-22031011 Rio De Janeiro, RJ, Brazil.
   [Morales, Marcelo Marcos] Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, Lab Cellular & Mol Physiol, BR-21941901 Rio De Janeiro, RJ, Brazil.
   [Capelozzi, Vera Luiza] Univ Sao Paulo, Sch Med, Dept Pathol, BR-05508070 Sao Paulo, Brazil.
   [de Abreu, Marcelo Gama] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Anesthesiol & Intens Care Therapy, Pulm Engn Grp, D-01069 Dresden, Germany.
   [Nascimento Baez Garcia, Cristiane Sousa] Rio de Janeiro Fed Inst Educ Sci & Technol, BR-25715000 Rio De Janeiro, RJ, Brazil.
   [Pelosi, Paolo] Univ Genoa, IRCCS AOU San Martino IST, Dept Surg Sci & Integrated Diagnost, I-16132 Genoa, Italy.
C3 Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de
   Janeiro; Universidade Federal do Rio de Janeiro; Universidade de Sao
   Paulo; Technische Universitat Dresden; Carl Gustav Carus University
   Hospital; University of Genoa; IRCCS AOU San Martino IST
RP Rocco, PRM (corresponding author), Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, Lab Pulm Invest, Ctr Ciencias Saude,Ilha Fundao, Ave Carlos Chagas Filho S-N,Bloco G-014, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM prmrocco@gmail.com
RI , Capelozzi/N-1737-2019; Cruz, Fernanda F/P-1193-2016; Capelozzi, Vera
   Luiza/C-6363-2013; Rocco, Patricia/I-7460-2012; Silva, Pedro
   Leme/AAD-8236-2019
OI , Capelozzi/0000-0001-9732-5853; Cruz, Fernanda F/0000-0001-9443-3648;
   Rocco, Patricia/0000-0003-1412-7136; Silva, Pedro
   Leme/0000-0001-5838-4949; delmonte, samuel/0000-0002-3289-4577; Gama de
   Abreu, Marcelo/0000-0002-3554-883X; Pelosi, Paolo/0000-0001-5055-3023
FU Centers of Excellence Program (PRONEX-FAPERJ); Brazilian Council for
   Scientific and Technological Development (CNPq); Rio de Janeiro State
   Research Foundation (FAPERJ); Sao Paulo State Research Foundation
   (FAPESP); National Institute of Science and Technology of Drugs and
   Medicine (INCT-INOFAR); Coordination for the Improvement of Higher Level
   Personnel (CAPES); European Community
FX This study was supported by the Centers of Excellence Program
   (PRONEX-FAPERJ), the Brazilian Council for Scientific and Technological
   Development (CNPq), the Rio de Janeiro State Research Foundation
   (FAPERJ), the Sao Paulo State Research Foundation (FAPESP), the National
   Institute of Science and Technology of Drugs and Medicine (INCT-INOFAR),
   the Coordination for the Improvement of Higher Level Personnel (CAPES),
   and the European Community Seventh Framework Programme (TARKINAID,
   FP7-2007-2013).
CR BAYDUR A, 1982, AM REV RESPIR DIS, V126, P788
   Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756
   Brack T, 2002, AM J RESP CRIT CARE, V165, P1260, DOI 10.1164/rccm.2201018
   Brander L, 2006, CRIT CARE, V10, DOI 10.1186/cc3953
   Chesnutt AN, 1997, AM J RESP CRIT CARE, V156, P840, DOI 10.1164/ajrccm.156.3.9701124
   Fan E, 2008, AM J RESP CRIT CARE, V178, P1156, DOI 10.1164/rccm.200802-335OC
   Fanelli V, 2009, CRIT CARE MED, V37, P1046, DOI 10.1097/CCM.0b013e3181968e7e
   Foti G, 2000, INTENS CARE MED, V26, P501, DOI 10.1007/s001340051196
   Galletly D, 1999, BRIT J ANAESTH, V83, P552, DOI 10.1093/bja/83.4.552
   Guerin C, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-9
   Laffey JG, 2004, INTENS CARE MED, V30, P347, DOI 10.1007/s00134-003-2051-1
   Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST
   Nacoti M, 2012, MINERVA ANESTESIOL, V78, P920
   Oliveira GP, 2009, CRIT CARE, V13, DOI 10.1186/cc7888
   Passaro CP, 2009, CRIT CARE MED, V37, P1011, DOI 10.1097/CCM.0b013e3181962d85
   Patroniti N, 2002, ANESTHESIOLOGY, V96, P788, DOI 10.1097/00000542-200204000-00004
   Pelosi P, 1999, AM J RESP CRIT CARE, V159, P872, DOI 10.1164/ajrccm.159.3.9802090
   Pelosi P, 2001, AM J RESP CRIT CARE, V164, P122, DOI 10.1164/ajrccm.164.1.2007010
   Perlman CE, 2007, J APPL PHYSIOL, V103, P1037, DOI 10.1152/japplphysiol.00160.2007
   Putensen C, 2009, ANN INTERN MED, V151, P566, DOI 10.7326/0003-4819-151-8-200910200-00011
   Riva DR, 2008, CRIT CARE MED, V36, P1900, DOI 10.1097/CCM.0b013e3181760e5d
   Saddy F, 2013, CRIT CARE, V17, DOI 10.1186/cc13051
   Saddy F, 2010, INTENS CARE MED, V36, P1417, DOI 10.1007/s00134-010-1808-6
   Santiago VR, 2010, CRIT CARE MED, V38, P2207, DOI 10.1097/CCM.0b013e3181f3e076
   Santos CL, 2012, INTENS CARE MED, V38, P499, DOI 10.1007/s00134-011-2451-6
   Silva PL, 2013, CRIT CARE MED, V41, pE256, DOI 10.1097/CCM.0b013e31828a3c13
   Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281
   Steimback PW, 2009, INTENS CARE MED, V35, P1120, DOI 10.1007/s00134-009-1439-y
   Suki B, 2014, CURR OPIN CRIT CARE, V20, P17, DOI 10.1097/MCC.0000000000000043
   Weibel ER, 1990, MODELS LUNG DIS MICR, V47, P199
NR 30
TC 21
Z9 23
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1466-609X
EI 1364-8535
J9 CRIT CARE
JI Crit. Care
PY 2014
VL 18
IS 4
AR 474
DI 10.1186/s13054-014-0474-4
PG 13
WC Critical Care Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA CA4MJ
UT WOS:000348878200052
PM 25113136
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Short, KR
   Kroeze, EJBV
   Fouchier, RAM
   Kuiken, T
AF Short, Kirsty R.
   Kroeze, Edwin J. B. Veldhuis
   Fouchier, Ron A. M.
   Kuiken, Thijs
TI Pathogenesis of influenza-induced acute respiratory distress syndrome
SO LANCET INFECTIOUS DISEASES
LA English
DT Review
ID ALVEOLAR EPITHELIAL-CELLS; VIRUS-INDUCED PNEUMONIA;
   TUMOR-NECROSIS-FACTOR; DOUBLE-STRANDED-RNA; A H5N1 VIRUSES; AVIAN
   INFLUENZA; PANDEMIC INFLUENZA; HUMAN MACROPHAGES; CYTOKINE RESPONSES;
   ENDOTHELIAL-CELLS
AB Acute respiratory distress syndrome (ARDS) is a fatal complication of influenza infection. In this Review we provide an integrated model for its pathogenesis. ARDS involves damage to the epithelial endothelial barrier, fluid leakage into the alveolar lumen, and respiratory insufficiency. The most important part of the epithelial endothelial barrier is the alveolar epithelium, strengthened by tight junctions. Influenza virus targets these epithelial cells, reducing sodium pump activity, damaging tight junctions, and killing infected cells. Infected epithelial cells produce cytokines that attract leucocytes-neutrophils and macrophages and activate adjacent endothelial cells. Activated endothelial cells and infiltrated leucocytes stimulate further infiltration, and leucocytes induce production of reactive oxygen species and nitric oxide that damage the barrier. Activated macrophages also cause direct apoptosis of epithelial cells. This model for influenza-induced ARDS differs from the dassic model, which is centred on endothelial damage, and provides a rationale for therapeutic intervention to moderate host response in influenza-induced ARDS.
C1 [Short, Kirsty R.; Kroeze, Edwin J. B. Veldhuis; Fouchier, Ron A. M.; Kuiken, Thijs] Erasmus MC, Dept Virosci, NL-3015 GE Rotterdam, Zuid Holland, Netherlands.
C3 Erasmus University Rotterdam; Erasmus MC
RP Kuiken, T (corresponding author), Erasmus MC, Dept Virosci, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Zuid Holland, Netherlands.
EM t.kuiken@erasmusmc.nl
RI Fouchier, Ron A/A-1911-2014
OI Fouchier, Ron A/0000-0001-8095-2869; Short, Kirsty/0000-0003-4963-6184;
   Kuiken, Thijs/0000-0001-5501-9049
FU NHMRC CJ Martin postdoctoral fellowship [1054081]; NIH/NIAID
   [HHSN266200700010C]; European Union FP7 ANTIGONE [278976]
FX We thank Lonneke Leijten for doing Pankeratin and von Willebrand factor
   staining. We thank Judith van den Brand for the provision of histology
   sections and Debby van Riel for the provision of histology sections and
   critical reading of the Review. KRS is supported by an NHMRC CJ Martin
   postdoctoral fellowship (1054081). RAMF is supported by NIH/NIAID
   contract HHSN266200700010C. TK is supported by European Union FP7
   ANTIGONE contract 278976.
CR Adachi M, 1997, INT ARCH ALLERGY IMM, V113, P307, DOI 10.1159/000237584
   Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448
   Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7
   Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942
   Armstrong SM, 2013, VIRULENCE, V4, P537, DOI 10.4161/viru.25779
   Armstrong SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047323
   Arndt U, 2002, J VIROL, V76, P9298, DOI 10.1128/JVI.76.18.9298-9306.2002
   Bandyopadhyay U, 1999, CURR SCI INDIA, V77, P658
   Bannerman DD, 2003, AM J PHYSIOL-LUNG C, V284, pL899, DOI 10.1152/ajplung.00338.2002
   Basler CF, 2008, ANTIVIR RES, V79, P166, DOI 10.1016/j.antiviral.2008.04.006
   Bellingan GJ, 2002, THORAX, V57, P540, DOI 10.1136/thorax.57.6.540
   Bemasconi D, 2005, J BIOL CHEM, V280, P24127
   Berthiaume Y, 2007, RESP PHYSIOL NEUROBI, V159, P350, DOI 10.1016/j.resp.2007.05.010
   Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313
   Brunkhorst FM, 1999, CRIT CARE MED, V27, P2172, DOI 10.1097/00003246-199910000-00016
   Brydon EWA, 2003, J GEN VIROL, V84, P2389, DOI 10.1099/vir.0.18913-0
   Budinger GRS, 2006, CLIN CHEST MED, V27, P655, DOI 10.1016/j.ccm.2006.06.007
   Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08
   Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135
   Chan MCW, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-102
   Chen XJ, 2004, AM J PHYSIOL-LUNG C, V287, pL366, DOI 10.1152/ajplung.00011.2004
   Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7
   Chien YW, 2009, NEW ENGL J MED, V361, P2582, DOI 10.1056/NEJMc0908216
   Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797
   CHOI AMK, 1992, FEBS LETT, V309, P327, DOI 10.1016/0014-5793(92)80799-M
   Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061
   Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09
   Darwish I, 2011, EXPERT REV ANTI-INFE, V9, P807, DOI [10.1586/eri.11.56, 10.1586/ERI.11.56]
   Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4
   Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7
   Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004
   Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030
   Folkesson HG, 2006, AM J RESP CELL MOL, V35, P10, DOI 10.1165/rcmb.2006-0080SF
   Friesenhagen J, 2012, J LEUKOCYTE BIOL, V92, P11, DOI 10.1189/jlb.0911479
   Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459
   Geiler J, 2011, MED MICROBIOL IMMUN, V200, P53, DOI 10.1007/s00430-010-0173-y
   Golebiewski L, 2011, J VIROL, V85, P10639, DOI 10.1128/JVI.05070-11
   GORIN AB, 1979, J APPL PHYSIOL, V47, P1315, DOI 10.1152/jappl.1979.47.6.1315
   Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3
   Guarner J, 2009, ARCH MED RES, V40, P655, DOI 10.1016/j.arcmed.2009.10.001
   Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200
   Hale BG, 2010, FUTURE MICROBIOL, V5, P23, DOI 10.2217/FMB.09.108
   Hemmers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022043
   Herold S, 2006, J IMMUNOL, V177, P1817, DOI 10.4049/jimmunol.177.3.1817
   Herold S, 2008, J EXP MED, V205, P3065, DOI 10.1084/jem.20080201
   Hogner K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003188
   HOLT PG, 1986, CLIN EXP IMMUNOL, V63, P261
   Horby P, 2013, NATURE, V496, P399, DOI 10.1038/496399a
   Huber D, 1999, INVAS METAST, V18, P70
   Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088
   Husain AN, 2010, ROBBINS COTRAN PATHO, P715
   Ichikawa A, 2013, AM J RESP CRIT CARE, V187, P65, DOI 10.1164/rccm.201203-0508OC
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   Ishiguro N, 2004, ARCH VIROL, V149, P17, DOI 10.1007/s00705-003-0208-4
   Jaeschke H, 1997, J LEUKOCYTE BIOL, V61, P647, DOI 10.1002/jlb.61.6.647
   Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022
   Karupiah G, 1998, J EXP MED, V188, P1541, DOI 10.1084/jem.188.8.1541
   Kash JC, 2006, VIRUS RES, V119, P111, DOI 10.1016/j.virusres.2005.10.013
   Koval M, 2013, ANNU REV PHYSIOL, V75, P551, DOI 10.1146/annurev-physiol-030212-183809
   Kuiken T, 2010, VET PATHOL, V47, P893, DOI 10.1177/0300985810378651
   Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025
   Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997
   Lam WY, 2008, J VIROL, V82, P2741, DOI 10.1128/JVI.01712-07
   Lazrak A, 2009, FASEB J, V23, P3829, DOI 10.1096/fj.09-135590
   LEFKOWITZ DL, 1995, MED HYPOTHESES, V44, P58, DOI 10.1016/0306-9877(95)90303-8
   Lehmann C, 1996, RES VIROLOGY, V147, P123, DOI 10.1016/0923-2516(96)80226-3
   MARTIN TR, 1989, J CLIN INVEST, V84, P1609, DOI 10.1172/JCI114338
   Matikainen S, 2000, VIROLOGY, V276, P138, DOI 10.1006/viro.2000.0542
   Matsukura S, 1996, J ALLERGY CLIN IMMUN, V98, P1080, DOI 10.1016/S0091-6749(96)80195-3
   Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158
   Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC
   Michaelis M, 2010, MED MICROBIOL IMMUN, V199, P291, DOI 10.1007/s00430-010-0155-0
   Mok KP, 2009, J INFECT DIS, V200, P1104, DOI 10.1086/605606
   Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708
   Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989
   MULLIN JM, 1990, CANCER RES, V50, P2172
   Nakajima N, 2013, MODERN PATHOL, V26, P357, DOI 10.1038/modpathol.2012.193
   Narasaraju T, 2010, AM J RESP CELL MOL, V42, P732, DOI 10.1165/rcmb.2008-0423OC
   Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013
   Ocana-Macchi M, 2009, J VIROL, V83, P12947, DOI 10.1128/JVI.00468-09
   ODA T, 1989, SCIENCE, V244, P974, DOI 10.1126/science.2543070
   Okada T, 2011, J STRENGTH COND RES, V25, P252, DOI 10.1519/JSC.0b013e3181b22b3e
   Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09
   Padalko E, 2004, P NATL ACAD SCI USA, V101, P11731, DOI 10.1073/pnas.0400518101
   Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540
   Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004
   Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5
   Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115
   Piantadosi CA, 2004, ANN INTERN MED, V141, P460, DOI 10.7326/0003-4819-141-6-200409210-00012
   PINKERTON KE, 1992, COMP BIOL NORMAL LUN, P121
   Pirhonen J, 1999, J IMMUNOL, V162, P7322
   Ramsey C, 2011, CURR OPIN CRIT CARE, V17, P64, DOI 10.1097/MCC.0b013e3283427259
   Reperant LA, 2012, J VIROL, V86, P1158, DOI 10.1128/JVI.06375-11
   Roux J, 2005, J BIOL CHEM, V280, P18579, DOI 10.1074/jbc.M410561200
   Sakai S, 2000, J VIROL, V74, P2472, DOI 10.1128/JVI.74.5.2472-2476.2000
   Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104
   SchultzCherry S, 1996, J VIROL, V70, P8624, DOI 10.1128/JVI.70.12.8624-8629.1996
   Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757
   Sevransky JE, 2009, CRIT CARE, V13, DOI 10.1186/cc8048
   Sheu CC, 2010, CHEST, V138, P559, DOI 10.1378/chest.09-2933
   Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115
   Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a
   Snelgrove RJ, 2006, EUR J IMMUNOL, V36, P1364, DOI 10.1002/eji.200635977
   Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002
   Stinchcombe JC, 1999, J CELL BIOL, V147, P1, DOI 10.1083/jcb.147.1.1
   Sugamata R, 2012, MICROBIOL IMMUNOL, V56, P171, DOI 10.1111/j.1348-0421.2011.00424.x
   Sumikoshi M, 2008, J MED VIROL, V80, P1072, DOI 10.1002/jmv.21185
   Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6
   Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06
   Takizawa T, 1996, J VIROL, V70, P8128, DOI 10.1128/JVI.70.11.8128-8132.1996
   Tapper H, 1996, J LEUKOCYTE BIOL, V59, P613, DOI 10.1002/jlb.59.5.613
   Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10
   Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497
   Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316
   Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015
   To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581
   Uiprasertkui M, 2007, EMERG INFECT DIS, V13, P708, DOI 10.3201/eid1305.060572
   Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313
   Valberg PA, 1992, COMP BIOL NORMAL LUN, P681
   van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548
   van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248
   van Riel D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002099
   Visseren FLJ, 1999, J LAB CLIN MED, V134, P623, DOI 10.1016/S0022-2143(99)90103-8
   Vissers MCM, 1999, BIOCHEM J, V344, P443, DOI 10.1042/0264-6021:3440443
   Vlahos R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001271
   von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0
   WALKER DC, 1995, MICROVASC RES, V50, P397, DOI 10.1006/mvre.1995.1067
   Wang JP, 2008, BLOOD, V112, P2028, DOI 10.1182/blood-2008-01-132860
   Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024
   WEILAND JE, 1986, AM REV RESPIR DIS, V133, P218
   WIENERKRONISH JP, 1991, J CLIN INVEST, V88, P864, DOI 10.1172/JCI115388
   Wolk KE, 2008, AM J RESP CRIT CARE, V178, P969, DOI 10.1164/rccm.200803-455OC
   Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785
   Wyble CW, 1997, J SURG RES, V73, P107, DOI 10.1006/jsre.1997.5207
   YAMAMOTO K, 1991, J INFECT DIS, V164, P8, DOI 10.1093/infdis/164.1.8
   Yu WCL, 2011, J VIROL, V85, P6844, DOI 10.1128/JVI.02200-10
   Zeng H, 2013, J VIROL, V87, P2597, DOI 10.1128/JVI.02885-12
   Zeng H, 2012, J VIROL, V86, P667, DOI 10.1128/JVI.06348-11
   Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105
NR 139
TC 334
Z9 362
U1 10
U2 63
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JAN
PY 2014
VL 14
IS 1
BP 57
EP 69
DI 10.1016/S1473-3099(13)70286-X
PG 13
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA 281DC
UT WOS:000329079100022
PM 24239327
DA 2023-08-21
ER

PT J
AU Villar, J
   Muros, M
   Cabrera-Benitez, NE
   Valladares, F
   Lopez-Hernandez, M
   Flores, C
   Martin-Barrasa, JL
   Blanco, J
   Liu, MY
   Kacmarek, RM
AF Villar, Jesus
   Muros, Mercedes
   Cabrera-Benitez, Nuria E.
   Valladares, Francisco
   Lopez-Hernandez, Milagros
   Flores, Carlos
   Martin-Barrasa, Jose L.
   Blanco, Jesus
   Liu, Mingyao
   Kacmarek, Robert M.
TI Soluble platelet-endothelial cell adhesion molecule-1, a biomarker of
   ventilator-induced lung injury
SO CRITICAL CARE
LA English
DT Article
ID MECHANICAL VENTILATION; PECAM-1; MICROPARTICLES; PRESSURE; SEPSIS;
   INFLAMMATION; DYSFUNCTION; EXPRESSION; PROTECTION; CORRELATE
AB Introduction: Endothelial cell injury is an important component of acute lung injury. Platelet-endothelial cell adhesion molecule-1 (PECAM1) is a transmembrane protein that connects endothelial cells to one another and can be detected as a soluble, truncated protein (sPECAM1) in serum. We hypothesized that injurious mechanical ventilation (MV) leads to shedding of PECAM1 from lung endothelial cells resulting in increasing sPECAM1 levels in the systemic circulation.
   Methods: We studied 36 Sprague-Dawley rats in two prospective, randomized, controlled studies (healthy and septic) using established animal models of ventilator-induced lung injury. Animals (n = 6 in each group) were randomized to spontaneous breathing or two MV strategies: low tidal volume (V-T) (6 ml/kg) and high-V-T (20 ml/kg) on 2 cmH(2)O of positive end-expiratory pressure (PEEP). In low-V-T septic animals, 10 cmH(2)O of PEEP was applied. We performed pulmonary histological and physiological evaluation and measured lung PECAM1 protein content and serum sPECAM1 levels after four hours ventilation period.
   Results: High-V-T MV caused severe lung injury in healthy and septic animals, and decreased lung PECAM1 protein content (P < 0.001). Animals on high-V-T had a four-to six-fold increase of mean sPECAM1 serum levels than the unventilated counterpart (35.4 +/- 10.4 versus 5.6 +/- 1.7 ng/ml in healthy rats; 156.8 +/- 47.6 versus 35.6 +/- 12.6 ng/ml in septic rats) (P < 0.0001). Low-V-T MV prevented these changes. Levels of sPECAM1 in healthy animals on high-V-T MV paralleled the sPECAM1 levels of non-ventilated septic animals.
   Conclusions: Our findings suggest that circulating sPECAM1 may represent a promising biomarker for the detection and monitoring of ventilator-induced lung injury.
C1 [Villar, Jesus; Muros, Mercedes; Cabrera-Benitez, Nuria E.; Valladares, Francisco; Flores, Carlos; Martin-Barrasa, Jose L.; Blanco, Jesus] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.
   [Villar, Jesus; Cabrera-Benitez, Nuria E.; Martin-Barrasa, Jose L.] Hosp Univ Dr Negrin, Res Unit, Multidisciplinary Organ Dysfunct Evaluat Res Net, Las Palmas Gran Canaria, Spain.
   [Villar, Jesus] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada.
   [Muros, Mercedes] Hosp Univ NS de Candelaria, Dept Clin Biochem, Tenerife, Spain.
   [Valladares, Francisco; Lopez-Hernandez, Milagros] Univ La Laguna, Dept Anat Pathol & Histol, Tenerife, Spain.
   [Flores, Carlos] Hosp Univ NS de Candelaria, Res Unit, Santa Cruz De Tenerife, Spain.
   [Blanco, Jesus] Hosp Univ Rio Hortega, Intens Care Unit, Valladolid, Spain.
   [Liu, Mingyao] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada.
   [Liu, Mingyao] Univ Hlth Network, Toronto Gen Res Inst, Resp & Crit Care Res Grp, Toronto, ON, Canada.
   [Kacmarek, Robert M.] Massachusetts Gen Hosp, Dept Resp Care, Boston, MA 02114, United States.
   [Kacmarek, Robert M.] Harvard Univ, Dept Anesthesiol, Boston, MA 02115, United States.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de
   Salud Carlos III; University of Toronto; Li Ka Shing Knowledge
   Institute; Saint Michaels Hospital Toronto; Universidad de la Laguna;
   Hospital del Rio Hortega; University of Toronto; University of Toronto;
   University Health Network Toronto; Toronto General Hospital; Harvard
   University; Massachusetts General Hospital; Harvard University
RP Villar, J (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.
EM jesus.villar54@gmail.com
RI Villar, Jesús/R-4526-2019; Martín-Barrasa, José Luis/GLR-3921-2022;
   Flores, Carlos/R-1159-2019
OI Villar, Jesús/0000-0001-5687-3562; Martín-Barrasa, José
   Luis/0000-0002-3280-9838; Flores, Carlos/0000-0001-5352-069X; Liu,
   Mingyao/0000-0002-9188-8417
FU Instituto de Salud Carlos III, Madrid, Spain [PI10/0393, CB06/06/1088]
FX Supported in part by grants (PI10/0393, CB06/06/1088) from Instituto de
   Salud Carlos III, Madrid, Spain.
CR Amabile N, 2008, AM J RESP CRIT CARE, V177, P1268, DOI 10.1164/rccm.200710-1458OC
   Bhatia RK, 2005, INJURY, V36, P956, DOI 10.1016/j.injury.2005.03.009
   Bhatt AJ, 2001, AM J RESP CRIT CARE
   Bhattacharya S, 2003, AM J RESP CELL MOL, V28, P218, DOI 10.1165/rcmb.4763
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854
   Burns KEA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014623
   Chiumello D, 2008, AM J RESP CRIT CARE, V178, P346, DOI 10.1164/rccm.200710-1589OC
   Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009
   Densmore JC, 2006, SHOCK, V26, P464, DOI 10.1097/01.shk.0000228791.10550.36
   Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014
   Fornasa G, 2010, J IMMUNOL, V184, P5485, DOI 10.4049/jimmunol.0902219
   FU ZX, 1992, J APPL PHYSIOL, V73, P123, DOI 10.1152/jappl.1992.73.1.123
   GOLDBERGER A, 1994, J BIOL CHEM, V269, P17183
   Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI200213595
   Hegeman MA, 2009, CRIT CARE, V13, DOI 10.1186/cc8168
   Herrera MT, 2003, INTENS CARE MED, V29, P1345, DOI 10.1007/s00134-003-1756-5
   Ilan N, 2001, FASEB J, V15, P362, DOI 10.1096/fj.00-0372com
   Krauss T, 1997, AM J OBSTET GYNECOL, V177, P443, DOI 10.1016/S0002-9378(97)70213-8
   Lopez-Aguilar J, 2006, CRIT CARE MED, V34, P1106, DOI 10.1097/01.CCM.0000205757.66971.DA
   Maas M, 2005, AM J PHYSIOL-HEART C, V288, pH159, DOI 10.1152/ajpheart.00500.2004
   Mahooti S, 2000, AM J PATHOL, V157, P75, DOI 10.1016/S0002-9440(10)64519-1
   Muller AM, 2002, J PATHOL, V198, P270, DOI 10.1002/path.1186
   MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449
   Newman PJ, 1997, J CLIN INVEST, V100, pS25
   NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453
   Nonas SA, 2007, AM J PHYSIOL-LUNG C, V293, pL292, DOI 10.1152/ajplung.00481.2006
   PARKER JC, 1993, CRIT CARE MED, V21, P131, DOI 10.1097/00003246-199301000-00024
   Pinhu L, 2003, LANCET, V361, P332, DOI 10.1016/S0140-6736(03)12329-X
   Privratsky JR, 2011, J CELL SCI, V124, P1477, DOI 10.1242/jcs.082271
   Protti A, 2011, AM J RESP CRIT CARE, V183, P1354, DOI 10.1164/rccm.201010-1757OC
   Pugin J, 2002, INTENS CARE MED, V28, P817, DOI 10.1007/s00134-002-1320-8
   Shehabi Y, 2008, CRIT CARE, V12, DOI 10.1186/cc6860
   Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478
   Slutsky AS, 2014, NEW ENGL J MED, V370, P980, DOI [10.1056/NEJMra1208707, 10.1056/NEJMc1400293]
   Soriano AO, 2005, CRIT CARE MED, V33, P2540, DOI 10.1097/01.CCM.0000186414.86162.03
   Tremblay LN, 2006, INTENS CARE MED, V32, P24, DOI 10.1007/s00134-005-2817-8
   TSUKIMOTO K, 1991, J APPL PHYSIOL, V71, P573, DOI 10.1152/jappl.1991.71.2.573
   Villar J, 2011, MINERVA ANESTESIOL, V77, P647
   Villar J, 2011, INTENS CARE MED, V37, P1201, DOI 10.1007/s00134-011-2234-0
   Villar J, 2010, INTENS CARE MED, V36, P1049, DOI 10.1007/s00134-010-1799-3
   Villar J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-27
   Villar J, 2009, ANESTHESIOLOGY, V110, P1341, DOI 10.1097/ALN.0b013e31819fcba9
   WEBB HH, 1974, AM REV RESPIR DIS, V110, P556
   Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456
NR 45
TC 8
Z9 9
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1466-609X
EI 1364-8535
J9 CRIT CARE
JI Crit. Care
PY 2014
VL 18
IS 2
AR R41
DI 10.1186/cc13754
PG 9
WC Critical Care Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA AM1SA
UT WOS:000339627400059
PM 24588994
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Kong, J
   Zhu, XD
   Shi, YY
   Liu, TJ
   Chen, YZ
   Bhan, I
   Zhao, Q
   Thadhani, R
   Li, YC
AF Kong, Juan
   Zhu, Xiangdong
   Shi, Yongyan
   Liu, Tianjing
   Chen, Yunzi
   Bhan, Ishir
   Zhao, Qun
   Thadhani, Ravi
   Li, Yan Chun
TI VDR Attenuates Acute Lung Injury by Blocking Ang-2-Tie-2 Pathway and
   Renin-Angiotensin System
SO MOLECULAR ENDOCRINOLOGY
LA English
DT Article
ID VITAMIN-D-RECEPTOR; LIGHT-CHAIN PHOSPHORYLATION; SMOOTH-MUSCLE-CELLS;
   1,25-DIHYDROXYVITAMIN D-3; DIABETIC-NEPHROPATHY; GAP FORMATION; MICE;
   EXPRESSION; ASTHMA; LIPOPOLYSACCHARIDE
AB Acute lung injury (ALI) is a hallmark of systemic inflammation associated with high mortality. Although the vitamin D receptor (VDR) is highly expressed in the lung, its role in lung physiology remains unclear. We investigated the effect of VDR deletion on ALI using a lipopolysaccharide (LPS)-induced sepsis model. After LPS challenge VDR-null mice exhibited more severe ALI and higher mortality compared with wild-type (WT) counterparts, manifested by increased pulmonary vascular leakiness, pulmonary edema, apoptosis, neutrophil infiltration, and pulmonary inflammation, which was accompanied by excessive induction of angiopoietin (Ang)-2 and myosin light chain (MLC) phosphorylation in the lung. 1,25-Dihydroxyvitamin D blocked LPS-induced Ang-2 expression by blocking nuclear factor-kappa B activation in human pulmonary artery endothelial cells. The severity of lung injury seen in VDR-null mice was ameliorated by pretreatment with L1-10, an antagonist of Ang-2, suggesting that VDR signaling protects the pulmonary vascular barrier by targeting the Ang-2-Tie-2-MLC kinase cascade. Severe ALI in VDR-null mice was also accompanied by an increase in pulmonary renin and angiotensin II levels, and pretreatment of VDR-null mice with angiotensin II type 1 receptor blocker losartan partially ameliorated the severity of LPS-induced lung injury. Taken together, these observations provide evidence that the vitamin D-VDR signaling prevents lung injury by blocking the Ang-2-Tie-2-MLC kinase cascade and the renin-angiotensin system.
C1 [Kong, Juan; Zhu, Xiangdong; Shi, Yongyan; Liu, Tianjing; Chen, Yunzi; Li, Yan Chun] Univ Chicago, Dept Med, Div Biol Sci, Chicago, IL 60637, United States.
   [Kong, Juan; Chen, Yunzi; Li, Yan Chun] China Med Univ, Shengjing Hosp, Lab Metab Dis Res & Drug Dev, Shenyang 110000, China.
   [Shi, Yongyan] China Med Univ, Shengjing Hosp, Dept Pediat, Shenyang 110000, China.
   [Liu, Tianjing; Zhao, Qun] China Med Univ, Shengjing Hosp, Key Lab Congenital Malformat, Minist Hlth, Shenyang 110000, China.
   [Bhan, Ishir; Thadhani, Ravi] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Nephrol, Boston, MA 02114, United States.
C3 University of Chicago; China Medical University; China Medical
   University; China Medical University; Harvard University; Harvard
   Medical School; Massachusetts General Hospital
RP Kong, J (corresponding author), China Med Univ, Lab Metab Dis Res & Drug Dev, Shenyang 110000, Peoples R China.
EM kong_juan@hotmail.com; thadhani.ravi@mgh.harvard.edu;
   cyan@medicine.bsd.uchicago.edu
RI chen, yunzi/B-2964-2011; ZHAO, QUN/HMP-0262-2023
OI zhu, xiangdong/0000-0002-5627-8082
FU American Heart Association [10SDG4280066]; National Institutes of Health
   [R01HL085793, R01DK092143, R01DK84974]; CTSA from National Center for
   Research Resources [UL1 RR024999]; National Natural Science Foundation
   of China [30971401, 81170065]
FX This work was supported by American Heart Association Scientist
   Development Grant 10SDG4280066 (to J.K.), National Institutes of Health
   grants R01HL085793 (to Y.C.L.), R01DK092143, and R01DK84974 (to R.T.),
   CTSA grant UL1 RR024999 from National Center for Research Resources, as
   well as by National Natural Science Foundation of China (Grants 30971401
   and 81170065).
CR Banerjee A, 2008, BRIT J PHARMACOL, V155, P84, DOI 10.1038/bjp.2008.232
   Beck-Schimmer B, 2004, NEWS PHYSIOL SCI, V19, P129, DOI 10.1152/nips.01508.2003
   Bhatt AJ, 2001, AM J RESP CRIT CARE, V164, P1971, DOI 10.1164/ajrccm.164.10.2101140
   Bosse Y, 2007, PHYSIOL GENOMICS, V29, P161, DOI 10.1152/physiolgenomics.00134.2006
   Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004
   Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12
   Chen Y, 2013, J BIOL CHEM, V288, P19450, DOI 10.1074/jbc.M113.467670
   Chen YZ, 2013, J IMMUNOL, V190, P3687, DOI 10.4049/jimmunol.1203273
   Deb DK, 2009, AM J PHYSIOL-RENAL, V296, pF1212, DOI 10.1152/ajprenal.00002.2009
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487
   Eutamene H, 2005, EUR RESPIR J, V25, P789, DOI 10.1183/09031936.05.00064704
   GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311
   Ginde AA, 2009, CURR ALLERGY ASTHM R, V9, P81, DOI 10.1007/s11882-009-0012-7
   Grant WB, 2008, PHOTOCHEM PHOTOBIOL, V84, P356, DOI 10.1111/j.1751-1097.2007.00266.x
   Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325
   Hypponen E, 2004, ANN NY ACAD SCI, V1037, P84, DOI 10.1196/annals.1337.013
   Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712
   Kawasaki M, 2000, AM J PATHOL, V157, P597, DOI 10.1016/S0002-9440(10)64570-1
   Kitamura Y, 2001, AM J RESP CRIT CARE, V163, P762, DOI 10.1164/ajrccm.163.3.2003065
   Klaff LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049076
   Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831
   Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391
   Li YC, 2002, J CLIN INVEST, V110, P229, DOI [10.1172/JCI200215219, 10.1172/JCI0215219]
   Li YC, 2001, AM J PHYSIOL-ENDOC M, V281, pE558, DOI 10.1152/ajpendo.2001.281.3.E558
   Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028
   Liu L, 2009, ARCH BIOCHEM BIOPHYS, V481, P131, DOI 10.1016/j.abb.2008.09.019
   Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008
   Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269
   Mofarrahi M, 2008, AM J PHYSIOL-LUNG C, V294, pL955, DOI 10.1152/ajplung.00449.2007
   Orfanos SE, 2007, CRIT CARE MED, V35, P199, DOI 10.1097/01.CCM.0000251640.77679.D7
   Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046
   Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC
   Podowski M, 2012, J CLIN INVEST, V122, P229, DOI 10.1172/JCI46215
   Poon AH, 2004, AM J RESP CRIT CARE, V170, P967, DOI 10.1164/rccm.200403-412oc
   Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290
   Raby BA, 2004, AM J RESP CRIT CARE, V170, P1057, DOI 10.1164/rccm.200404-447OC
   Rojas M, 2005, AM J PHYSIOL-LUNG C, V288, pL333, DOI 10.1152/ajplung.00334.2004
   Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725
   Tinsley JH, 2004, AM J PHYSIOL-LUNG C, V286, pL841, DOI 10.1152/ajplung.00341.2003
   Tsiani E, 2002, AM J PHYSIOL-ENDOC M, V282, pE161, DOI 10.1152/ajpendo.2002.282.1.E161
   VERIN AD, 1995, AM J PHYSIOL-LUNG C, V269, pL99, DOI 10.1152/ajplung.1995.269.1.L99
   Wang F, 2009, CYTOKINE, V48, P246, DOI 10.1016/j.cyto.2009.08.001
   Wang HL, 2007, J IMMUNOL, V179, P1834, DOI 10.4049/jimmunol.179.3.1834
   Wang YL, 2012, J AM SOC NEPHROL, V23, P1977, DOI 10.1681/ASN.2012040383
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Wittke A, 2004, J IMMUNOL, V173, P3432, DOI 10.4049/jimmunol.173.5.3432
   Wittke A, 2007, ARCH BIOCHEM BIOPHYS, V460, P306, DOI 10.1016/j.abb.2006.12.011
   Wjst M, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-2
   Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567
   Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200
   Zhang Z, 2008, KIDNEY INT, V73, P163, DOI 10.1038/sj.ki.5002572
   Zhang Z, 2007, KIDNEY INT, V72, P193, DOI 10.1038/sj.ki.5002296
NR 52
TC 105
Z9 110
U1 2
U2 23
PU ENDOCRINE SOC
PI CHEVY CHASE
PA 8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA
SN 0888-8809
J9 MOL ENDOCRINOL
JI Mol. Endocrinol.
PD DEC
PY 2013
VL 27
IS 12
BP 2116
EP 2125
DI 10.1210/me.2013-1146
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 262LZ
UT WOS:000327738200012
PM 24196349
OA Green Published
DA 2023-08-21
ER

PT J
AU Greineder, CF
   Chacko, AM
   Zaytsev, S
   Zern, BJ
   Carnemolla, R
   Hood, ED
   Han, JY
   Ding, BS
   Esmon, CT
   Muzykantov, VR
AF Greineder, Colin F.
   Chacko, Ann Marie
   Zaytsev, Sergei
   Zern, Blaine J.
   Carnemolla, Ronald
   Hood, Elizabeth D.
   Han, Jingyan
   Ding, Bi-Sen
   Esmon, Charles T.
   Muzykantov, Vladimir R.
TI Vascular Immunotargeting to Endothelial Determinant ICAM-1 Enables
   Optimal Partnering of Recombinant scFv-Thrombomodulin Fusion with
   Endogenous Cofactor
SO PLOS ONE
LA English
DT Article
ID ACTIVATED PROTEIN-C; DISSEMINATED INTRAVASCULAR COAGULATION; SOLUBLE
   THROMBOMODULIN; CARDIAC-ARREST; SEVERE SEPSIS; RECEPTOR; DYSFUNCTION;
   THROMBOSIS; EXPRESSION; PECAM-1
AB The use of targeted therapeutics to replenish pathologically deficient proteins on the luminal endothelial membrane has the potential to revolutionize emergency and cardiovascular medicine. Untargeted recombinant proteins, like activated protein C (APC) and thrombomodulin (TM), have demonstrated beneficial effects in acute vascular disorders, but have failed to have a major impact on clinical care. We recently reported that TM fused with an scFv antibody fragment to platelet endothelial cell adhesion molecule-1 (PECAM-1) exerts therapeutic effects superior to untargeted TM. PECAM-1 is localized to cell-cell junctions, however, whereas the endothelial protein C receptor (EPCR), the key co-factor of TM/APC, is exposed in the apical membrane. Here we tested whether anchoring TM to the intercellular adhesion molecule (ICAM-1) favors scFv/TM collaboration with EPCR. Indeed: i) endothelial targeting scFv/TM to ICAM-1 provides similar to 15-fold greater activation of protein C than its PECAM-targeted counterpart; ii) blocking EPCR reduces protein C activation by scFv/TM anchored to endothelial ICAM-1, but not PECAM-1; and iii) anti-ICAM scFv/TM fusion provides more profound anti-inflammatory effects than anti-PECAM scFv/TM in a mouse model of acute lung injury. These findings, obtained using new translational constructs, emphasize the importance of targeting protein therapeutics to the proper surface determinant, in order to optimize their microenvironment and beneficial effects.
C1 [Greineder, Colin F.; Zaytsev, Sergei; Zern, Blaine J.; Carnemolla, Ronald; Hood, Elizabeth D.; Han, Jingyan; Ding, Bi-Sen; Muzykantov, Vladimir R.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104, United States.
   [Greineder, Colin F.; Chacko, Ann-Marie; Zaytsev, Sergei; Zern, Blaine J.; Carnemolla, Ronald; Hood, Elizabeth D.; Han, Jingyan; Ding, Bi-Sen; Muzykantov, Vladimir R.] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Ctr Targeted Therapeut & Translat Nanomed, Philadelphia, PA 19104, United States.
   [Chacko, Ann-Marie] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104, United States.
   [Greineder, Colin F.] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104, United States.
   [Esmon, Charles T.] Oklahoma Med Res Fdn, Howard Hughes Med Inst, Cardiovasc Biol Res Program, Oklahoma City, OK 73104, United States.
C3 University of Pennsylvania; Pennsylvania Medicine; University of
   Pennsylvania; Pennsylvania Medicine; University of Pennsylvania;
   Pennsylvania Medicine; University of Pennsylvania; Pennsylvania
   Medicine; Howard Hughes Medical Institute; Oklahoma Medical Research
   Foundation
RP Muzykantov, VR (corresponding author), Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA.
EM muzykant@mail.med.upenn.edu
RI han, jingyan/HJG-6568-2022
OI Greineder, Colin/0000-0001-9740-7672; Chacko,
   Ann-Marie/0000-0001-5140-2622
FU Institute of Translational Medicine and Therapeutics (ITMAT) at the
   University of Pennsylvania; American Heart Association [10FTF4150053];
   National Institutes of Health [R01-HL091950]
FX This work was supported by a Junior Investigator Preliminary/Feasibility
   Grant from the Institute of Translational Medicine and Therapeutics
   (ITMAT) at the University of Pennsylvania (CFG), as well as an American
   Heart Association Fellow to Faculty grant 10FTF4150053 (CFG), and
   National Institutes of Health Grant R01-HL091950 (VRM). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Adrie C, 2005, J AM COLL CARDIOL, V46, P21, DOI 10.1016/j.jacc.2005.03.046
   Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887
   ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059
   Bae JS, 2007, P NATL ACAD SCI USA, V104, P2867, DOI 10.1073/pnas.0611493104
   Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001
   Chacko AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034958
   Chrastina A, 2010, J VASC RES, V47, P531, DOI 10.1159/000313880
   Christofidou-Solomidou M, 2002, AM J PATHOL, V160, P1155, DOI 10.1016/S0002-9440(10)64935-8
   CROWE JS, 1989, NUCLEIC ACIDS RES, V17, P7992, DOI 10.1093/nar/17.19.7992
   Danilov SM, 2001, AM J PHYSIOL-LUNG C, V280, pL1335, DOI 10.1152/ajplung.2001.280.6.L1335
   Ding BS, 2009, AM J RESP CRIT CARE, V180, P247, DOI 10.1164/rccm.200809-1433OC
   DUBEL S, 1994, J IMMUNOL METHODS, V175, P89, DOI 10.1016/0022-1759(94)90334-4
   Esmon CT, 2001, CRIT CARE, V5, pS7, DOI 10.1186/cc1333
   ESMON CT, 1989, J BIOL CHEM, V264, P4743
   Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603
   Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985
   Finigan JH, 2009, MICROVASC RES, V77, P35, DOI 10.1016/j.mvr.2008.09.002
   FUKUDOME K, 1995, J BIOL CHEM, V270, P5571, DOI 10.1074/jbc.270.10.5571
   Gentry CA, 2009, CRIT CARE MED, V37, P19, DOI 10.1097/CCM.0b013e318192843b
   GLASER CB, 1992, J CLIN INVEST, V90, P2565, DOI 10.1172/JCI116151
   Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404
   Kim AY, 2002, CIRC RES, V90, P205, DOI 10.1161/hh0202.105097
   Kowalski PS, 2011, IUBMB LIFE, V63, P648, DOI 10.1002/iub.487
   Laszik ZG, 2001, AM J PATHOL, V159, P797, DOI 10.1016/S0002-9440(10)61753-1
   Li W, 2005, J THROMB HAEMOST, V3, P1351, DOI 10.1111/j.1538-7836.2005.01385.x
   Lin SM, 2008, CRIT CARE MED, V36, P683, DOI 10.1097/CCM.0B013E31816537D8
   Liu KD, 2008, AM J RESP CRIT CARE, V178, P618, DOI 10.1164/rccm.200803-419OC
   MacGregor IR, 1997, AM J RESP CRIT CARE, V155, P47, DOI 10.1164/ajrccm.155.1.9001288
   MOORE KL, 1989, BLOOD, V73, P159
   Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367
   Muro Silvia, 2004, Current Vascular Pharmacology, V2, P281, DOI 10.2174/1570161043385736
   Muzykantov Vladimir R, 2005, Expert Opin Drug Deliv, V2, P909, DOI 10.1517/17425247.2.5.909
   NAWROTH PP, 1986, P NATL ACAD SCI USA, V83, P3460, DOI 10.1073/pnas.83.10.3460
   Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652
   Newby AC, 1999, CURR OPIN CARDIOL, V14, P489, DOI 10.1097/00001573-199911000-00007
   NEWMAN PJ, 1994, ANN NY ACAD SCI, V714, P165, DOI 10.1111/j.1749-6632.1994.tb12041.x
   Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129
   Pasqualini R, 2000, CANCER RES, V60, P722
   Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171
   Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x
   SIDO B, 1995, TRANSPLANTATION, V60, P462, DOI 10.1097/00007890-199509000-00010
   Simone E, 2009, CELL TISSUE RES, V335, P283, DOI 10.1007/s00441-008-0676-7
   STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O
   StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212
   Su EJ, 2011, J THROMB HAEMOST, V9, P1174, DOI 10.1111/j.1538-7836.2011.04269.x
   Tabuchi N, 2004, EUR J CARDIO-THORAC, V26, P995, DOI 10.1016/j.ejcts.2004.07.028
   TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902
   TEASDALE MS, 1994, IMMUNOL CELL BIOL, V72, P480, DOI 10.1038/icb.1994.72
   Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735
   van Buul JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011336
   Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92
   Waugh JM, 1999, CIRC RES, V84, P84
   Weiler H, 2001, ARTERIOSCL THROM VAS, V21, P1531, DOI 10.1161/hq0901.094496
   Zhang N, 2008, BIOCONJUGATE CHEM, V19, P145, DOI 10.1021/bc700227z
NR 54
TC 40
Z9 40
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 14
PY 2013
VL 8
IS 11
AR e80110
DI 10.1371/journal.pone.0080110
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 254DJ
UT WOS:000327143800123
PM 24244621
OA gold, Green Published, Green Submitted
DA 2023-08-21
ER

PT J
AU Aires, RD
   Capettini, LSA
   Silva, JF
   Rodrigues-Machado, MD
   Pinho, V
   Teixeira, MM
   Cortes, SF
   Lemos, VS
AF Aires, Rosaria D.
   Capettini, Luciano S. A.
   Silva, Josiane F.
   Rodrigues-Machado, Maria da Gloria
   Pinho, Vanessa
   Teixeira, Mauro M.
   Cortes, Steyner F.
   Lemos, Virginia S.
TI Paraquat Poisoning Induces TNF-alpha-Dependent iNOS/NO Mediated
   Hyporesponsiveness of the Aorta to Vasoconstrictors in Rats
SO PLOS ONE
LA English
DT Article
ID SYNTHASE GENE-EXPRESSION; RESPIRATORY-DISTRESS-SYNDROME; INDUCED
   OXIDATIVE STRESS; NITRIC-OXIDE; HYDROGEN-PEROXIDE; LUNG TOXICITY;
   DYSFUNCTION; MECHANISM; ANGIOTENSIN-(1-7); ACCUMULATION
AB Paraquat is a toxic herbicide that may induce acute lung injury, circulatory failure and death. The present work aimed at investigating whether there is systemic inflammation and vascular dysfunction after paraquat exposure and whether these parameters were related. There was neutrophilia and accumulation of neutrophils in lung and bronchoalveolar lavage of animals given paraquat. This was associated with an increase in serum levels of TNF-alpha. In rats given paraquat, the relaxant response of aortic rings to acetylcholine was not modified but the contractile response to phenylephrine was greatly reduced. Endothelium removal or treatment with non-selective (L-NAME) or selective (L-NIL) inhibitors of inducible nitric oxide synthase (iNOS) restored contraction of aortas. There was greater production of nitric oxide (NO), which was restored to basal level by L-NIL, and greater expression of iNOS in endothelial cells, as seen by Western blot analyses and confocal microscopy. Blockade of TNF-alpha reduced pulmonary and systemic inflammation and vascular dysfunction. Together, our results clearly show that paraquat causes pulmonary and systemic inflammation, and vascular dysfunction in rats. Vascular dysfunction is TNF-alpha dependent, associated with enhanced expression of iNOS in aortic endothelial cells and greater NO production, which accounts for the decreased responsiveness of aortas to vasoconstrictors. Blockers of TNF-alpha may be useful in patients with paraquat poisoning.
C1 [Aires, Rosaria D.; Silva, Josiane F.; Rodrigues-Machado, Maria da Gloria; Lemos, Virginia S.] Univ Fed Minas Gerais, Dept Physiol & Biophys, ICB, Belo Horizonte, MG, Brazil.
   [Capettini, Luciano S. A.; Cortes, Steyner F.] Univ Fed Minas Gerais, Dept Pharmacol, ICB, Belo Horizonte, MG, Brazil.
   [Pinho, Vanessa] Univ Fed Minas Gerais, Dept Morphol, ICB, Belo Horizonte, MG, Brazil.
   [Teixeira, Mauro M.] Univ Fed Minas Gerais, Dept Biochem & Immunol, ICB, Belo Horizonte, MG, Brazil.
C3 Universidade Federal de Minas Gerais; Universidade Federal de Minas
   Gerais; Universidade Federal de Minas Gerais; Universidade Federal de
   Minas Gerais
RP Lemos, VS (corresponding author), Univ Fed Minas Gerais, Dept Physiol & Biophys, ICB, Belo Horizonte, MG, Brazil.
EM vslemos@icb.ufmg.br
RI Pinho, Vanessa/GXM-8532-2022; Teixeira, Mauro M/A-4587-2008; Cortes,
   Steyner Franca/F-5449-2010; da Glória Rodrigues-Machado,
   Maria/H-1484-2019; Lemos, Virginia S/B-7305-2018; Pinho,
   Vanessa/AAR-1686-2021; Silva, Josiane/AAC-8361-2019; pinho,
   vanessa/AAC-8437-2020
OI Pinho, Vanessa/0000-0003-1038-2324; Teixeira, Mauro
   M/0000-0002-6944-3008; Cortes, Steyner Franca/0000-0002-4340-2574;
   Lemos, Virginia S/0000-0003-1234-9325; Silva,
   Josiane/0000-0002-6623-7946; pinho, vanessa/0000-0003-1038-2324;
   Capettini, Luciano/0000-0002-6487-9558
FU FAPEMIG (Fundacao de Apoio a Pesquisa do Estado de Minas Gerais)/PRONEX;
   CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)/Brazil
FX FAPEMIG (Fundacao de Apoio a Pesquisa do Estado de Minas Gerais)/PRONEX
   and CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)/Brazil. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adachi J, 2003, ARCH TOXICOL, V77, P353, DOI 10.1007/s00204-003-0449-8
   Barcelos LS, 2009, MICROVASC RES, V78, P148, DOI 10.1016/j.mvr.2009.04.009
   BERISHA HI, 1994, P NATL ACAD SCI USA, V91, P7445, DOI 10.1073/pnas.91.16.7445
   BUS JS, 1976, ENVIRON HEALTH PERSP, V16, P139, DOI 10.2307/3428594
   Capettini LSA, 2011, BRIT J PHARMACOL, V164, P1738, DOI 10.1111/j.1476-5381.2011.01500.x
   Capettini LSA, 2008, AM J PHYSIOL-HEART C, V295, pH2503, DOI 10.1152/ajpheart.00731.2008
   Chan MMY, 1998, BIOCHEM PHARMACOL, V55, P1955, DOI 10.1016/S0006-2952(98)00114-2
   Day BJ, 1999, P NATL ACAD SCI USA, V96, P12760, DOI 10.1073/pnas.96.22.12760
   Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959
   Dinis-Oliveira RJ, 2006, TOXICOLOGY, V227, P73, DOI 10.1016/j.tox.2006.07.025
   Dinis-Oliveira RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007149
   Gil HW, 2008, CLIN TOXICOL, V46, P515, DOI 10.1080/15563650701549403
   Gocgeldi E, 2008, EXP BIOL MED, V233, P1133, DOI 10.3181/0802-RM-65
   Hecker M, 1999, GEN PHARMACOL, V32, P9, DOI 10.1016/S0306-3623(98)00082-2
   HOFFER E, 1993, TOXICOL APPL PHARM, V120, P8, DOI 10.1006/taap.1993.1080
   Hong SY, 2000, TOXICOL LETT, V118, P53, DOI 10.1016/S0378-4274(00)00264-2
   HSU KS, 1995, EUR J PHARM-ENVIRON, V292, P315
   Jo YH, 2011, RESUSCITATION, V82, P487, DOI 10.1016/j.resuscitation.2010.11.028
   Kang YJ, 2003, BIOCHEM PHARMACOL, V65, P457, DOI 10.1016/S0006-2952(02)01549-6
   Koo JR, 2002, AM J KIDNEY DIS, V39, P55, DOI 10.1053/ajkd.2002.29880
   Lemos VS, 2002, BRIT J PHARMACOL, V135, P1743, DOI 10.1038/sj.bjp.0704630
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Luh Shi-Ping, 2007, Journal of Zhejiang University-Science B, V8, P60, DOI 10.1631/jzus.2007.B0060
   Mainwaring G, 2006, TOXICOLOGY, V225, P157, DOI 10.1016/j.tox.2006.05.017
   Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009
   Margolis AS, 2000, BBA-GEN SUBJECTS, V1524, P253, DOI 10.1016/S0304-4165(00)00167-7
   Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305
   Mitra S, 2006, BBA-MOL BASIS DIS, V1762, P732, DOI 10.1016/j.bbadis.2006.06.011
   Moran JM, 2010, J BIOCHEM MOL TOXIC, V24, P402, DOI 10.1002/jbt.20348
   Nandi J, 2010, MOL CELL BIOCHEM, V336, P17, DOI 10.1007/s11010-009-0259-2
   ROSE MS, 1976, BIOCHEM PHARMACOL, V25, P419, DOI 10.1016/0006-2952(76)90344-0
   ROSE MS, 1974, NATURE, V252, P314, DOI 10.1038/252314b0
   Russo RC, 2009, AM J RESP CELL MOL, V40, P410, DOI 10.1165/rcmb.2007-0364OC
   Silva DMR, 2007, PEPTIDES, V28, P702, DOI 10.1016/j.peptides.2006.10.007
   Soares AC, 2006, MICROBES INFECT, V8, P1321, DOI 10.1016/j.micinf.2005.12.017
   Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7
   Suratt BT, 2006, CLIN CHEST MED, V27, P579, DOI 10.1016/j.ccm.2006.06.005
   Takizawa M, 2007, TOXICOL IN VITRO, V21, P355, DOI 10.1016/j.tiv.2006.09.003
   Tsukamoto M, 2002, TOXICOL APPL PHARM, V178, P82, DOI 10.1006/taap.2001.9325
   Venkatesan N, 1999, LIFE SCI, V66, pPL21, DOI 10.1016/S0024-3205(99)00576-7
   Zerin T, 2012, TOXICOL LETT, V208, P101, DOI 10.1016/j.toxlet.2011.10.019
   Zocrato LBR, 2010, TOXICOL IN VITRO, V24, P1019, DOI 10.1016/j.tiv.2009.12.003
NR 42
TC 26
Z9 29
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 9
PY 2013
VL 8
IS 9
AR e73562
DI 10.1371/journal.pone.0073562
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 244QV
UT WOS:000326405300092
PM 24039983
OA gold, Green Published, Green Submitted
DA 2023-08-21
ER

PT J
AU Collins, SR
   Blank, RS
   Deatherage, LS
   Dull, RO
AF Collins, Stephen R.
   Blank, Randal S.
   Deatherage, Lindy S.
   Dull, Randal O.
TI The Endothelial Glycocalyx: Emerging Concepts in Pulmonary Edema and
   Acute Lung Injury
SO ANESTHESIA AND ANALGESIA
LA English
DT Article
ID CATECHOLAMINE-INDUCED INCREASE; RESPIRATORY-DISTRESS-SYNDROME;
   MOLECULAR-WEIGHT HYALURONAN; ISOLATED RAT LUNGS; NITRIC-OXIDE;
   CAPILLARY-PERMEABILITY; HYDRAULIC CONDUCTIVITY; VASCULAR PRESSURE;
   SURFACE-LAYER; SHEAR-STRESS
AB The endothelial glycocalyx is a dynamic layer of macromolecules at the luminal surface of vascular endothelium that is involved in fluid homeostasis and regulation. Its role in vascular permeability and edema formation is emerging but is still not well understood. In this special article, we highlight key concepts of endothelial dysfunction with regards to the glycocalyx and provide new insights into the glycocalyx as a mediator of processes central to the development of pulmonary edema and lung injury.
C1 [Collins, Stephen R.; Blank, Randal S.] Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA, United States.
   [Deatherage, Lindy S.] Univ Utah, Dept Anesthesiol, Salt Lake City, UT, United States.
   [Dull, Randal O.] Univ Illinois, Coll Med, Dept Anesthesiol & Bioengn, Chicago, IL 60612, United States.
C3 University of Virginia; Utah System of Higher Education; University of
   Utah; University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital
RP Dull, RO (corresponding author), Univ Illinois, Coll Med, Dept Anesthesiol & Bioengn, 1740 W Taylor St,Suite 3200,M-C 515, Chicago, IL 60612 USA.
EM rdull@uic.edu
RI Collins, Stephen/M-1568-2019
FU NHLBI NIH HHS [R01 HL085255] Funding Source: Medline
CR ABRAHAMSSON T, 1992, CIRC RES, V70, P264, DOI 10.1161/01.RES.70.2.264
   Adamson RH, 2004, J PHYSIOL-LONDON, V557, P889, DOI 10.1113/jphysiol.2003.058255
   ADAMSON RH, 1990, J PHYSIOL-LONDON, V428, P1
   Anglade D, 1998, J APPL PHYSIOL, V84, P1011, DOI 10.1152/jappl.1998.84.3.1011
   Becker BF, 2010, CARDIOVASC RES, V87, P300, DOI 10.1093/cvr/cvq137
   Briot R, 2009, CRIT CARE, V13, DOI 10.1186/cc8137
   Broccard AF, 2002, CRIT CARE MED, V30, P2183, DOI 10.1097/00003246-200210000-00002
   Broccard AF, 1998, AM J RESP CRIT CARE, V157, P1935, DOI 10.1164/ajrccm.157.6.9612006
   Bruegger D, 2008, CRIT CARE, V12, DOI 10.1186/cc6913
   Bruegger D, 2009, J THORAC CARDIOV SUR, V138, P1445, DOI 10.1016/j.jtcvs.2008.07.063
   Bucci M, 2005, P NATL ACAD SCI USA, V102, P904, DOI 10.1073/pnas.0408906102
   Chappell D, 2009, CARDIOVASC RES, V83, P388, DOI 10.1093/cvr/cvp097
   Chappell D, 2009, BASIC RES CARDIOL, V104, P78, DOI 10.1007/s00395-008-0749-5
   Chen EP, 1996, CIRCULATION, V94, P412
   Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D
   CROUCH JD, 1987, ANN THORAC SURG, V43, P613, DOI 10.1016/S0003-4975(10)60231-7
   CURRY FE, 1980, MICROVASC RES, V20, P96, DOI 10.1016/0026-2862(80)90024-2
   Curry FRE, 2010, CARDIOVASC RES, V87, P195, DOI 10.1093/cvr/cvq188
   Czarnowska E, 1996, FOLIA HISTOCHEM CYTO, V34, P25
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487
   Dull RO, 2007, AM J PHYSIOL-LUNG C, V292, pL1452, DOI 10.1152/ajplung.00376.2006
   Dull RO, 2012, AM J PHYSIOL-LUNG C, V302, pL816, DOI 10.1152/ajplung.00080.2011
   DULL RO, 1991, MICROVASC RES, V41, P390, DOI 10.1016/0026-2862(91)90037-C
   Dull RO, 2003, AM J PHYSIOL-LUNG C, V285, pL986, DOI 10.1152/ajplung.00022.2003
   Effros RM, 2009, MICROVASC RES, V78, P71, DOI 10.1016/j.mvr.2009.03.004
   EHRHART IC, 1994, J APPL PHYSIOL, V76, P2342, DOI 10.1152/jappl.1994.76.6.2342
   EHRHART IC, 1992, J APPL PHYSIOL, V72, P211, DOI 10.1152/jappl.1992.72.1.211
   Fernandez ER, 2005, CHEST, V128, p129S, DOI 10.1378/chest.128.4_MeetingAbstracts.129S-a
   Filaire M, 2007, J THORAC CARDIOV SUR, V133, P770, DOI 10.1016/j.jtcvs.2006.09.052
   Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5
   Gao LJ, 2010, MICROVASC RES, V80, P394, DOI 10.1016/j.mvr.2010.06.005
   Garcia-Delgado M, 2001, CRIT CARE MED, V29, P931, DOI 10.1097/00003246-200105000-00003
   Giantsos KM, 2009, BIOMATERIALS, V30, P5885, DOI 10.1016/j.biomaterials.2009.06.048
   Giantsos-Adams K, 2011, BIOMATERIALS, V32, P288, DOI 10.1016/j.biomaterials.2010.08.092
   Grichnik Katherine P, 2004, Semin Cardiothorac Vasc Anesth, V8, P317, DOI 10.1177/108925320400800405
   Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508
   Henry CBS, 2000, AM J PHYSIOL-HEART C, V279, pH2815, DOI 10.1152/ajpheart.2000.279.6.H2815
   HIRATA A, 1995, AM J PHYSIOL-LUNG C, V269, pL403, DOI 10.1152/ajplung.1995.269.3.L403
   Hotchkiss JR, 2000, AM J RESP CRIT CARE, V161, P463, DOI 10.1164/ajrccm.161.2.9811008
   Hotchkiss JR, 2001, CRIT CARE MED, V29, P1593, DOI 10.1097/00003246-200108000-00016
   Huxley VH, 2000, AM J PHYSIOL-HEART C, V278, pH1177, DOI 10.1152/ajpheart.2000.278.4.H1177
   Jacob M, 2007, CARDIOVASC RES, V73, P575, DOI 10.1016/j.cardiores.2006.11.021
   Jordan S, 2000, EUR RESPIR J, V15, P790, DOI 10.1034/j.1399-3003.2000.15d26.x
   KASLOVSKY RA, 1990, CIRC RES, V67, P795, DOI 10.1161/01.RES.67.4.795
   Kuebler WM, 2003, AM J RESP CRIT CARE, V168, P1391, DOI 10.1164/rccm.200304-562OC
   Kuebler WM, 2002, AM J PHYSIOL-LUNG C, V282, pL917, DOI 10.1152/ajplung.00275.2001
   Kurzelewski M, 2005, J PHYSIOL PHARMACOL, V56, P163
   Landis EM, 1927, AM J PHYSIOL, V82, P217, DOI 10.1152/ajplegacy.1927.82.2.217
   LANDOLT CC, 1983, CIRC RES, V52, P335, DOI 10.1161/01.RES.52.3.335
   Levick JR, 2004, J PHYSIOL-LONDON, V557, P704, DOI 10.1113/jphysiol.2004.066118
   Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6
   Licker M, 2003, ANESTH ANALG, V97, P1558, DOI 10.1213/01.ANE.0000087799.85495.8A
   Lipowsky HH, 2012, ANN BIOMED ENG, V40, P840, DOI 10.1007/s10439-011-0427-x
   Liu YY, 2008, CRIT CARE, V12, DOI 10.1186/cc6982
   Lopez-Quintero SV, 2009, AM J PHYSIOL-HEART C, V296, pH1451, DOI 10.1152/ajpheart.00894.2008
   MAJNO G, 1961, J BIOPHYS BIOCHEM CY, V11, P571, DOI 10.1083/jcb.11.3.571
   Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9
   MATHRU M, 1990, CHEST, V98, P1216, DOI 10.1378/chest.98.5.1216
   Michel CC, 1997, EXP PHYSIOL, V82, P1
   Mochizuki S, 2003, AM J PHYSIOL-HEART C, V285, pH722, DOI 10.1152/ajpheart.00691.2002
   Motosugi H, 1998, AM J RESP CRIT CARE, V157, P192, DOI 10.1164/ajrccm.157.1.9602095
   Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003
   Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002
   NETTELBLADT O, 1989, AM REV RESPIR DIS, V140, P1028, DOI 10.1164/ajrccm/140.4.1028
   Nieuwdorp M, 2008, J APPL PHYSIOL, V104, P845, DOI 10.1152/japplphysiol.00440.2007
   NOGAE C, 1995, J MOL CELL CARDIOL, V27, P2091, DOI 10.1016/S0022-2828(95)91155-3
   O'Callaghan R, 2011, AM J PHYSIOL-LUNG C, V301, pL353, DOI 10.1152/ajplung.00342.2010
   OHKUDA K, 1978, CIRC RES, V43, P152, DOI 10.1161/01.RES.43.2.152
   PAPPENHEIMER JR, 1948, AM J PHYSIOL, V152, P471, DOI 10.1152/ajplegacy.1948.152.3.471
   Park BJ, 2007, SEMIN THORAC CARDIOV, V19, P374, DOI 10.1053/j.semtcvs.2007.10.003
   Parker JC, 1997, J APPL PHYSIOL, V83, P1962, DOI 10.1152/jappl.1997.83.6.1962
   Parker JC, 2002, AM J PHYSIOL-LUNG C, V283, pL1203, DOI 10.1152/ajplung.00488.2001
   PARKER RE, 1981, CIRC RES, V49, P1164, DOI 10.1161/01.RES.49.5.1164
   Parquin F, 1996, EUR J CARDIO-THORAC, V10, P929, DOI 10.1016/S1010-7940(96)80392-7
   Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852
   Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8
   RIPPE B, 1984, J APPL PHYSIOL, V57, P233, DOI 10.1152/jappl.1984.57.1.233
   Rubio-Gayosso I, 2006, AM J PHYSIOL-HEART C, V290, pH2247, DOI 10.1152/ajpheart.00796.2005
   Schilling T, 2005, ANESTH ANALG, V101, P957, DOI 10.1213/01.ane.0000172112.02902.77
   Schreiber T, 2006, INTENS CARE MED, V32, P740, DOI 10.1007/s00134-006-0117-6
   Schreiber T, 2007, CRIT CARE MED, V35, P1741, DOI 10.1097/01.CCM.0000269374.85160.BF
   SHIMADA K, 1991, JPN CIRC J, V55, P1016, DOI 10.1253/jcj.55.1016
   SHIRLEY HH, 1957, AM J PHYSIOL, V190, P189, DOI 10.1152/ajplegacy.1957.190.2.189
   Singleton PA, 2010, AM J PHYSIOL-LUNG C, V299, pL639, DOI 10.1152/ajplung.00405.2009
   Slinger PD, 2006, ANESTHESIOLOGY, V105, P2, DOI 10.1097/00000542-200607000-00003
   Starling E H, 1896, J Physiol, V19, P312
   Tarbell JM, 1999, J APPL PHYSIOL, V87, P261, DOI 10.1152/jappl.1999.87.1.261
   Tarbell JM, 2010, CARDIOVASC RES, V87, P320, DOI 10.1093/cvr/cvq146
   Thi MM, 2004, P NATL ACAD SCI USA, V101, P16483, DOI 10.1073/pnas.0407474101
   TOWNSLEY MI, 1987, J APPL PHYSIOL, V63, P2460, DOI 10.1152/jappl.1987.63.6.2460
   TURNAGE WS, 1993, CHEST, V103, P1646, DOI 10.1378/chest.103.6.1646
   Ueda A, 2004, AM J PHYSIOL-HEART C, V287, pH2287, DOI 10.1152/ajpheart.00808.2003
   Van den Berg B, 2006, AM J PHYSIOL-HEART C, V290, pH2174, DOI 10.1152/ajpheart.00197.2006
   van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75
   van Haaren PMA, 2005, AM J PHYSIOL-HEART C, V289, pH2503, DOI 10.1152/ajpheart.00587.2005
   van Haaren PMA, 2003, AM J PHYSIOL-HEART C, V285, pH2848, DOI 10.1152/ajpheart.00117.2003
   vanderWerff YD, 1997, CHEST, V111, P1278, DOI 10.1378/chest.111.5.1278
   VanTeeffelen JWGE, 2005, AM J PHYSIOL-HEART C, V289, pH2508, DOI 10.1152/ajpheart.00446.2005
   Vink H, 2000, CIRCULATION, V101, P1500, DOI 10.1161/01.CIR.101.13.1500
   Vink H, 2000, AM J PHYSIOL-HEART C, V278, pH285, DOI 10.1152/ajpheart.2000.278.1.H285
   Vink H, 1996, CIRC RES, V79, P581, DOI 10.1161/01.RES.79.3.581
   Waller DA, 1996, ANN THORAC SURG, V61, P1435, DOI 10.1016/0003-4975(96)00103-8
   Wang SF, 2012, WORLD J GASTROENTERO, V18, P4771, DOI 10.3748/wjg.v18.i34.4771
   WASSERMAN K, 1955, CIRC RES, V3, P594, DOI 10.1161/01.RES.3.6.594
   Weinbaum S, 1998, ANN BIOMED ENG, V26, P627, DOI 10.1114/1.134
   Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959
   Williams EA, 1999, EUR RESPIR J, V14, P745, DOI 10.1034/j.1399-3003.1999.14d04.x
   Williams EA, 1998, EUR RESPIR J, V11, P1028, DOI 10.1183/09031936.98.11051028
   Wrigge H, 2004, ANESTH ANALG, V98, P775
   ZELDIN RA, 1984, J THORAC CARDIOV SUR, V87, P359
   Zhang XB, 2006, AM J PHYSIOL-HEART C, V291, pH2950, DOI 10.1152/ajpheart.01160.2005
   Zharikov SI, 2001, AM J PHYSIOL-LUNG C, V280, pL465, DOI 10.1152/ajplung.2001.280.3.L465
NR 114
TC 59
Z9 62
U1 0
U2 19
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0003-2999
EI 1526-7598
J9 ANESTH ANALG
JI Anesth. Analg.
PD SEP
PY 2013
VL 117
IS 3
BP 664
EP 674
DI 10.1213/ANE.0b013e3182975b85
PG 11
WC Anesthesiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology
GA 248JJ
UT WOS:000326695200019
PM 23835455
OA Bronze, Green Accepted
DA 2023-08-21
ER

PT J
AU Li, H
   Qiang, Y
   Wang, L
   Wang, GM
   Yi, J
   Jing, H
   Wu, HW
AF Li, Hao
   Qiang, Yong
   Wang, Lian
   Wang, Gaoming
   Yi, Jun
   Jing, Hua
   Wu, Haiwei
TI Repair of Lipopolysaccharide-Induced Acute Lung Injury in Mice by
   Endothelial Progenitor Cells, Alone and in Combination With Simvastatin
SO CHEST
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; STEM-CELLS; IMPROVES SURVIVAL; STATIN
   THERAPY; MURINE MODEL; INFLAMMATION; SEPSIS; TRANSPLANTATION; ISCHEMIA;
   PROTECTS
AB Background: Endothelial progenitor cells (EPCs) are involved in endothelium repair of acute lung injury (ALI). Numerous studies have demonstrated that statins can promote EPC function in vitro and in vivo; therefore, the purpose of this study was to determine whether simvastatin enhances the function of EPCs participating in the repair of ALI.
   Methods: BALB/C mice were initially pretreated with simvastatin by intraperitoneal administration 24 h before, and again at the time of, intratracheal instillation of lipopolysaccharide (LPS) and subsequently treated with EPCs by IV transplantation 2 h later. The effects of capillary permeability, endothelium repair, and inflammatory cytokines were measured.
   Results: This study revealed that both simvastatin administration and EPC transplantation can reduce the severity of LPS-induced ALI in mice, and the effect can be further improved by combining the two therapies.
   Conclusions: The administration of simvastatin and EPC transplantation can reduce the severity of LPS-induced ALI in mice, and improvement is moderately enhanced in some respects when EPC transplantation is combined with simvastatin administration. The beneficial role of simvastatin on EPCs may be a component of its pleiotropic effects. Although the exact mechanism remains unknown, the combined administration of simvastatin and EPC transplantation may be a potentially important, cell-based, inflammation-mediated therapy for patients with ALI/ARDS.
C1 [Li, Hao; Qiang, Yong; Wang, Lian; Yi, Jun; Jing, Hua; Wu, Haiwei] Nanjing Univ, Sch Clin Med, Jinling Hosp, Dept Cardiothorac Surg, Nanjing 210008, Jiangsu, China.
   [Wang, Gaoming] Xuzhou Cent Hosp, Dept Cardiothorac Surg, Xuzhou, China.
C3 Nanjing University
RP Wu, HW (corresponding author), 305 Zhongshan E Rd, Nanjing, Jiangsu, Peoples R China.
EM wuhaiweicts@163.com
OI Wang, Lian/0000-0001-9201-6517
FU Natural Science Foundation of China [30972969]
FX This study was supported by research grant from the Natural Science
   Foundation of China [30972969].
CR Aguilar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008013
   Aliotta JM, 2009, STEM CELLS DEV, V18, P773, DOI 10.1089/scd.2008.0237
   Alm AS, 2010, RESP PHYSIOL NEUROBI, V171, P157, DOI 10.1016/j.resp.2010.02.009
   Aslam M, 2009, AM J RESP CRIT CARE, V180, P1122, DOI 10.1164/rccm.200902-0242OC
   Chen Hong, 2010, Expert Rev Respir Med, V4, P773, DOI 10.1586/ers.10.71
   Chen WG, 2008, AM J PHYSIOL-LUNG C, V295, pL575, DOI 10.1152/ajplung.00428.2007
   Comellas AP, 2009, TRANSL RES, V153, P263, DOI 10.1016/j.trsl.2009.02.007
   Cribbs SK, 2012, INTENS CARE MED, V38, P429, DOI 10.1007/s00134-012-2480-9
   Cui X, 2009, NEUROBIOL DIS, V36, P35, DOI 10.1016/j.nbd.2009.06.012
   Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI200113152
   Donnelly SC, 1996, ANN INTERN MED, V125, P191, DOI 10.7326/0003-4819-125-3-199608010-00005
   Fujita M, 1998, INT ARCH ALLERGY IMM, V117, P202, DOI 10.1159/000024011
   Gao XF, 2011, INT IMMUNOPHARMACOL, V11, P1584, DOI 10.1016/j.intimp.2011.05.019
   Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5
   Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855
   Hu ZL, 2008, J BIOMED SCI, V15, P509, DOI 10.1007/s11373-008-9243-1
   Huang YQ, 2008, CRIT CARE MED, V36, P262, DOI 10.1097/01.CCM.0000297955.02633.A4
   Infusino GA, 2012, MICROVASC RES, V83, P89, DOI 10.1016/j.mvr.2011.09.011
   Jacobson JR, 2005, AM J PHYSIOL-LUNG C, V288, pL1026, DOI 10.1152/ajplung.00354.2004
   Janet CG, 2011, GUIDE CARE USE LAB A, P1
   Jeon O, 2007, J BIOMED SCI, V14, P323, DOI 10.1007/s11373-007-9145-7
   Kawamoto A, 2001, CIRCULATION, V103, P634
   Kim YS, 2009, TISSUE ENG REGEN MED, V6, P1072
   Kupatt C, 2005, CIRCULATION, V112, pI117, DOI 10.1161/CIRCULATIONAHA.104.524801
   Lam CF, 2011, ANESTH ANALG, V112, P620, DOI 10.1213/ANE.0b013e3182075da4
   LI XY, 1995, AM J RESP CELL MOL, V13, P185, DOI 10.1165/ajrcmb.13.2.7626286
   Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131
   Mao M, 2010, SHOCK, V34, P196, DOI 10.1097/SHK.0b013e3181d49457
   Mathew B, 2011, AM J RESP CELL MOL, V44, P415, DOI 10.1165/rcmb.2010-0122OC
   O'Neal HR, 2011, CRIT CARE MED, V39, P1343, DOI 10.1097/CCM.0b013e3182120992
   Rafat N, 2012, ANASTH INTENSIVMED, V53, P196
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Sadeghi NM, 2000, J IMMUNOL, V165, P2712, DOI 10.4049/jimmunol.165.5.2712
   Serikov VB, 2008, LUNG, V186, P179, DOI 10.1007/s00408-008-9078-6
   Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC
   Takahashi S, 2008, AM J PHYSIOL-LUNG C, V294, pL882, DOI 10.1152/ajplung.00238.2007
   Takano K, 2011, J PHARMACOL EXP THER, V336, P381, DOI 10.1124/jpet.110.171462
   Toya SP, 2011, AM J PATHOL, V178, P313, DOI 10.1016/j.ajpath.2010.09.041
   Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816
   Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55
   Weil BR, 2009, ANN SURG, V250, P19, DOI 10.1097/SLA.0b013e3181a77b9c
   Wu BJ, 2009, ARTERIOSCL THROM VAS, V29, P1537, DOI 10.1161/ATVBAHA.109.184713
   Xu J, 2008, J PATHOL, V214, P472, DOI 10.1002/path.2302
NR 43
TC 22
Z9 28
U1 1
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0012-3692
J9 CHEST
JI Chest
PD SEP
PY 2013
VL 144
IS 3
BP 876
EP 886
DI 10.1378/chest.12-2429
PG 11
WC Critical Care Medicine; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Respiratory System
GA 241JC
UT WOS:000326161700023
PM 23539119
DA 2023-08-21
ER

PT J
AU Anidi, IU
   Servinsky, LE
   Rentsendorj, O
   Stephens, RS
   Scott, AL
   Pearse, DB
AF Anidi, Ifeanyi U.
   Servinsky, Laura E.
   Rentsendorj, Otgonchimeg
   Stephens, R. Scott
   Scott, Alan L.
   Pearse, David B.
TI CD36 and Fyn Kinase Mediate Malaria-Induced Lung Endothelial Barrier
   Dysfunction in Mice Infected with Plasmodium berghei
SO PLOS ONE
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; PARASITE SEQUESTRATION;
   VASCULAR-PERMEABILITY; HYDROGEN-PEROXIDE; TYROSINE KINASE;
   CELL-ADHESION; IN-VITRO; FALCIPARUM; INJURY; OXYGEN
AB Severe malaria can trigger acute lung injury characterized by pulmonary edema resulting from increased endothelial permeability. However, the mechanism through which lung fluid conductance is altered during malaria remains unclear. To define the role that the scavenger receptor CD36 may play in mediating this response, C57BL/6J (WT) and CD36-/- mice were infected with P. berghei ANKA and monitored for changes in pulmonary endothelial barrier function employing an isolated perfused lung system. WT lungs demonstrated a >10-fold increase in two measures of paracellular fluid conductance and a decrease in the albumin reflection coefficient (sigma alb) compared to control lungs indicating a loss of barrier function. In contrast, malaria-infected CD36-/- mice had near normal fluid conductance but a similar reduction in sigma alb. In WT mice, lung sequestered iRBCs demonstrated production of reactive oxygen species (ROS). To determine whether knockout of CD36 could protect against ROS-induced endothelial barrier dysfunction, mouse lung microvascular endothelial monolayers (MLMVEC) from WT and CD36-/- mice were exposed to H2O2. Unlike WT monolayers, which showed dose-dependent decreases in transendothelial electrical resistance (TER) from H2O2 indicating loss of barrier function, CD36-/- MLMVEC demonstrated dose-dependent increases in TER. The differences between responses in WT and CD36-/- endothelial cells correlated with important differences in the intracellular compartmentalization of the CD36-associated Fyn kinase. Malaria infection increased total lung Fyn levels in CD36-/- lungs compared to WT, but this increase was due to elevated production of the inactive form of Fyn further suggesting a dysregulation of Fyn-mediated signaling. The importance of Fyn in CD36-dependent endothelial signaling was confirmed using in vitro Fyn knockdown as well as Fyn-/- mice, which were also protected from H2O2- and malaria-induced lung endothelial leak, respectively. Our results demonstrate that CD36 and Fyn kinase are critical mediators of the increased lung endothelial fluid conductance caused by malaria infection.
C1 [Anidi, Ifeanyi U.; Scott, Alan L.] Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD, United States.
   [Servinsky, Laura E.; Rentsendorj, Otgonchimeg; Stephens, R. Scott; Pearse, David B.] Johns Hopkins Med Inst, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205, United States.
C3 Johns Hopkins University; Johns Hopkins Bloomberg School of Public
   Health; Johns Hopkins University; Johns Hopkins Medicine
RP Pearse, DB (corresponding author), Johns Hopkins Med Inst, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA.
EM dpearse@jhmi.edu
FU NIH [HL075236]; Johns Hopkins Malaria Research Institute; Johns Hopkins
   MD/PhD training program [T32 GM007309]; Johns Hopkins University
   Libraries
FX This work was supported by NIH grant HL075236 (DBP), a grant from the
   Johns Hopkins Malaria Research Institute (DBP), a predoctoral fellowship
   from the Johns Hopkins Malaria Research Institute (IUA) and the Johns
   Hopkins MD/PhD training program (T32 GM007309). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript. Publication of this article was funded in
   part by the Open Access Promotion Fund of the Johns Hopkins University
   Libraries.
CR APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z
   ATAMNA H, 1993, MOL BIOCHEM PARASIT, V61, P231, DOI 10.1016/0166-6851(93)90069-A
   Bolcato-Bellemin AL, 2007, P NATL ACAD SCI USA, V104, P16050, DOI 10.1073/pnas.0707831104
   BULL HA, 1994, FEBS LETT, V351, P41, DOI 10.1016/0014-5793(94)00814-0
   Butzloff S, 2012, CYTOM PART A, V81A, P698, DOI 10.1002/cyto.a.22081
   Cambos M, 2010, INT J PARASITOL, V40, P1003, DOI 10.1016/j.ijpara.2010.02.007
   Chang WL, 2001, INFECT IMMUN, V69, P7341, DOI 10.1128/IAI.69.12.7341-7348.2001
   Cox-Singh J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-10
   Cunha-Rodrigues M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-32
   Curry FRE, 2010, CARDIOVASC RES, V87, P218, DOI 10.1093/cvr/cvq115
   Davis SP, 2012, FASEB J, V26, P1119, DOI 10.1096/fj.11-196923
   Deroost K, 2013, AM J RESP CELL MOL, V48, P589, DOI 10.1165/rcmb.2012-0450OC
   Dodd-O JM, 2008, AM J PHYSIOL-LUNG C, V294, pL714, DOI 10.1152/ajplung.00185.2007
   Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055
   Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI14006
   Filby A, 2007, J IMMUNOL, V179, P4635, DOI 10.4049/jimmunol.179.7.4635
   Fonager J, 2012, J EXP MED, V209, P93, DOI 10.1084/jem.20110762
   Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779
   Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102
   Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189
   Gamain B, 2007, INT J PARASITOL, V37, P273, DOI 10.1016/j.ijpara.2006.11.011
   Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005
   Gillrie MR, 2007, BLOOD, V110, P3426, DOI 10.1182/blood-2007-04-084582
   Gillrie MR, 2012, AM J PATHOL, V180, P1028, DOI 10.1016/j.ajpath.2011.11.037
   Graewe Stefanie, 2009, Biotechnology Journal, V4, P895, DOI 10.1002/biot.200900035
   Gruring C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1169
   Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913
   Han JY, 2011, J PHARMACOL EXP THER, V338, P82, DOI 10.1124/jpet.111.180620
   Hu GC, 2009, MICROVASC RES, V77, P21, DOI 10.1016/j.mvr.2008.10.002
   JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2
   Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517
   Lovegrove FE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000068
   Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703
   Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a
   Mishra Neerad C., 1994, Indian Journal of Malariology, V31, P77
   Mohan Alladi, 2008, Journal of Vector Borne Diseases, V45, P179
   Moldobaeva A, 2006, AM J PHYSIOL-LUNG C, V290, pL919, DOI 10.1152/ajplung.00434.2005
   Moldobaeva A, 2005, AM J PHYSIOL-LUNG C, V288, pL1117, DOI 10.1152/ajplung.00370.2004
   MONS B, 1985, PARASITOLOGY, V91, P423, DOI 10.1017/S0031182000062673
   Mota MM, 2000, INFECT IMMUN, V68, P4135, DOI 10.1128/IAI.68.7.4135-4144.2000
   Pearse DB, 2003, ENDOTHELIUM-J ENDOTH, V10, P309, DOI 10.1080/10623320390272307
   Pearse DB, 2001, AM J PHYSIOL-HEART C, V280, pH918, DOI 10.1152/ajpheart.2001.280.2.H918
   Pearse DB, 1996, AM J RESP CRIT CARE, V153, P196, DOI 10.1164/ajrccm.153.1.8542116
   Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992
   Postma NS, 1996, PHARM WORLD SCI, V18, P121, DOI 10.1007/BF00717727
   Qin Y, 2008, CELL BIOL INT, V32, P224, DOI 10.1016/j.cellbi.2007.08.028
   Rentsendorj O, 2008, AM J PHYSIOL-LUNG C, V294, pL686, DOI 10.1152/ajplung.00417.2007
   Rentsendorj O, 2011, AM J PHYSIOL-LUNG C, V301, pL161, DOI 10.1152/ajplung.00073.2011
   SAKURADA H, 1992, ARCH DERMATOL RES, V284, P114, DOI 10.1007/BF00373382
   Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843
   Schmidt EP, 2008, AM J PHYSIOL-LUNG C, V295, pL1056, DOI 10.1152/ajplung.90329.2008
   Seydel KB, 2006, J INFECT DIS, V194, P208, DOI 10.1086/505078
   Sherman IW, 2003, MICROBES INFECT, V5, P897, DOI 10.1016/S1286-4579(03)00162-X
   Siracusa MC, 2008, J LEUKOCYTE BIOL, V84, P1422, DOI 10.1189/jlb.0308199
   Smith JD, 1998, MOL BIOCHEM PARASIT, V97, P133, DOI 10.1016/S0166-6851(98)00145-5
   Sponaas AM, 2009, BLOOD, V114, P5522, DOI 10.1182/blood-2009-04-217489
   STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y
   Stephens RS, 2010, AM J PHYSIOL-LUNG C, V299, pL323, DOI 10.1152/ajplung.00442.2009
   Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311
   Taylor Walter R J, 2006, Treat Respir Med, V5, P419, DOI 10.2165/00151829-200605060-00007
   van der Heyde HC, 2001, INFECT IMMUN, V69, P3460, DOI 10.1128/IAI.69.5.3460-3465.2001
NR 61
TC 17
Z9 17
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 15
PY 2013
VL 8
IS 8
AR e71010
DI 10.1371/journal.pone.0071010
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 204OU
UT WOS:000323378000027
PM 23967147
OA Green Published, Green Submitted, gold
DA 2023-08-21
ER

PT J
AU Wu, TH
   Xing, JJ
   Birukova, AA
AF Wu, Tinghuai
   Xing, Junjie
   Birukova, Anna A.
TI Cell-type-specific crosstalk between p38 MAPK and Rho signaling in lung
   micro- and macrovascular barrier dysfunction induced by Staphylococcus
   aureus-derived pathogens
SO TRANSLATIONAL RESEARCH
LA English
DT Article
ID NF-KAPPA-B; ENDOTHELIAL BARRIER; DIFFERENTIAL REGULATION; LIPOTEICHOIC
   ACID; OXIDIZED PHOSPHOLIPIDS; KINASE INHIBITOR; INJURY; ACTIVATION;
   PEPTIDOGLYCAN; PERMEABILITY
AB Lung inflammation and alterations in endothelial cell (EC) micro- and macrovascular permeability are key events to development of acute lung injury. Using ECs derived from human pulmonary artery and lung microvasculature, we investigated the interplay between p38 stress mitogen-activated protein kinase (MAPK) and Rho guanosine triphosphatase signaling in inflammatory and hyperpermeability responses. Both cell types were treated with Staphylococcus aureus-derived peptidoglycan (PepG) and lipoteichoic acid (LTA) with or without pretreatment with p38 MAPK or Rho kinase inhibitors. LTA and PepG increased permeability markedly in both pulmonary macrovascular and microvascular ECs. Agonist-induced hyperpermeability was accompanied by cytoskeletal remodeling, disruption of cell-cell contacts, formation of paracellular gaps, and activation of p38 MAPK, nuclear factor kappa-B (NF kappa B), and Rho/Rho kinase signaling. In macrovascular ECs, pharmacologic inhibition of Rho kinase with Y27632 suppressed p38 MAP kinase cascade activation significantly, whereas inhibition of p38 MAPK with SB203580 had no effect on Rho activation. In contrast, inhibition of p38 MAPK in microvascular ECs suppressed LTA/PepG-induced activation of Rho, whereas the Rho inhibitor suppressed activation of p38 MAPK. Inhibition of either p38 MAPK or Rho kinase attenuated activation of NF kappa B signaling substantially. These results demonstrate cell-type-specific differences in signaling induced by Staphylococcus aureus-derived pathogens in pulmonary endothelium. Thus, although Gram-positive bacterial compounds caused barrier dysfunction in both EC types, it was induced by a different pattern of crosstalk between Rho, p38 MAPK, and NF kappa B signaling. These observations may have important implications in defining microvasculature-specific therapeutic strategies aimed at the treatment of sepsis and acute lung injury induced by Gram-positive bacterial pathogens.
C1 [Wu, Tinghuai; Xing, Junjie; Birukova, Anna A.] Univ Chicago, Dept Med, Sect Pulm & Crit Med, Lung Injury Ctr, Chicago, IL 60637, United States.
C3 University of Chicago
RP Birukova, AA (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Med, 5841 S Maryland Ave,MC-6026,Off N-613, Chicago, IL 60637 USA.
EM abirukov@medicine.bsd.uchicago.edu
FU National Heart, Lung, and Blood Institutes [HL89257, HL107920]
FX The authors' work was funded by the National Heart, Lung, and Blood
   Institutes (grants HL89257 and HL107920).
CR Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335
   Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797
   Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06
   Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007
   Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431
   Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004
   Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008
   Birukova AA, 2007, AM J PHYSIOL-LUNG C, V292, pL924, DOI 10.1152/ajplung.00395.2006
   Birukova AA, 2012, AM J PHYSIOL-LUNG C, V302, pL965, DOI 10.1152/ajplung.00292.2011
   Birukova AA, 2010, AM J PHYSIOL-LUNG C, V299, pL652, DOI 10.1152/ajplung.00202.2009
   Birukova AA, 2009, AM J RESP CELL MOL, V40, P99, DOI 10.1165/rcmb.2008-0099OC
   Cioffi DL, 2009, ANTIOXID REDOX SIGN, V11, P765, DOI [10.1089/ars.2008.2221, 10.1089/ARS.2008.2221]
   Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366
   DEKIMPE SJ, 1995, P NATL ACAD SCI USA, V92, P10359, DOI 10.1073/pnas.92.22.10359
   Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808
   Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0
   Gacouin A, 2009, ANESTH ANALG, V109, P1584, DOI 10.1213/ANE.0b013e3181b6e9b6
   Hayashida A, 2009, AM J PATHOL, V174, P509, DOI 10.2353/ajpath.2009.080394
   He F, 2011, NEUROSCIENCE, V188, P35, DOI 10.1016/j.neuroscience.2011.04.025
   Hocke AC, 2006, HISTOCHEM CELL BIOL, V126, P305, DOI 10.1007/s00418-006-0174-5
   Hortal J, 2009, INTENS CARE MED, V35, P1518, DOI 10.1007/s00134-009-1523-3
   Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014
   Kielian T, 2005, INFECT IMMUN, V73, P7428, DOI 10.1128/IAI.73.11.7428-7435.2005
   Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3
   LECHNER AJ, 1993, MICROSC RES TECHNIQ, V26, P444, DOI 10.1002/jemt.1070260512
   Leemans JC, 2002, AM J RESP CRIT CARE, V165, P1445, DOI 10.1164/rccm.2106045
   Liu S, 2008, EUR J PHARMACOL, V584, P159, DOI 10.1016/j.ejphar.2008.02.009
   Lowe K, 2007, J SURG RES, V143, P70, DOI 10.1016/j.jss.2007.03.047
   Manukyan M, 2009, J IMMUNOL, V182, P3522, DOI 10.4049/jimmunol.0802280
   Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS
   Mayer AK, 2007, J IMMUNOL, V178, P3134, DOI 10.4049/jimmunol.178.5.3134
   Melamed A, 2009, CRIT CARE, V13, DOI 10.1186/cc7733
   Netea MG, 2004, J LEUKOCYTE BIOL, V75, P749, DOI 10.1189/jlb.1103543
   Nwariaku FE, 2002, SHOCK, V18, P82, DOI 10.1097/00024382-200207000-00015
   Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189
   Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33
   Schmeck B, 2003, INFLAMMATION, V27, P89, DOI 10.1023/A:1023278600596
   Shibolet O, 2007, J BIOL CHEM, V282, P35308, DOI 10.1074/jbc.M704426200
   Slotta JE, 2006, INFLAMM RES, V55, P364, DOI 10.1007/s00011-006-6013-2
   Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003
   Tasaka S, 2005, AM J RESP CELL MOL, V32, P504, DOI 10.1165/rcmb.2004-0009OC
   Teusch N, 2004, J IMMUNOL, V173, P507, DOI 10.4049/jimmunol.173.1.507
   Vouret-Craviari V, 1998, MOL BIOL CELL, V9, P2639, DOI 10.1091/mbc.9.9.2639
   Wang JE, 2003, SHOCK, V20, P402, DOI 10.1097/01.shk.0000092268.01859.0d
   Xing JJ, 2011, J APPL PHYSIOL, V110, P213, DOI 10.1152/japplphysiol.00284.2010
   Xing JJ, 2010, MICROVASC RES, V79, P56, DOI 10.1016/j.mvr.2009.11.006
NR 46
TC 17
Z9 19
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1931-5244
EI 1878-1810
J9 TRANSL RES
JI Transl. Res.
PD JUL
PY 2013
VL 162
IS 1
BP 45
EP 55
DI 10.1016/j.trsl.2013.03.005
PG 11
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA 173OU
UT WOS:000321089600005
PM 23571093
OA Green Accepted
DA 2023-08-21
ER

PT J
AU Birukova, AA
   Starosta, V
   Tian, XY
   Higginbotham, K
   Koroniak, L
   Berliner, JA
   Birukov, KG
AF Birukova, Anna A.
   Starosta, Vitaliy
   Tian, Xinyong
   Higginbotham, Katherine
   Koroniak, Lukas
   Berliner, Judith A.
   Birukov, Konstantin G.
TI Fragmented oxidation products define barrier disruptive endothelial cell
   response to OxPAPC
SO TRANSLATIONAL RESEARCH
LA English
DT Article
ID ACUTE LUNG INJURY; MONOCYTE CHEMOTACTIC PROTEIN-1; OXIDIZED
   PHOSPHOLIPIDS; VE-CADHERIN; IN-VIVO; VASCULAR LEAK; RHO KINASE;
   RECEPTOR; IDENTIFICATION; INFLAMMATION
AB Excessive concentrations of oxidized phospholipids (OxPL), the products of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphatidylcholine (PAPC) oxidation have been detected in atherosclerosis, septic inflammation, and acute lung injury (ALI) and have been shown to induce vascular barrier dysfunction. In contrast, oxidized PAPC (OxPAPC) at low concentrations exhibit potent barrier protective effects. The nature of such biphasic effects remains unclear. We tested the hypothesis that barrier-disruptive effects of high OxPAPC doses on endothelial cell (EC) monolayer are defined by fragmented products of PAPC oxidation (lysophosphatidyl choline (lyso-PC), 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-phosphatidylcholine (POVPC), 1-palmitoyl-2-glutaroyl-sn-glycero-phosphatidylcholine (PGPC)), whereas barrier enhancing effects are mediated by full length oxidated PAPC products and may be reproduced by single compounds contained in the OxPAPC such as 1-palmitoyl-2-(5,6-epoxyisoprostane E2)-sn-glycero-3-phosphatidyl choline (PEIPC). All 3 fragmented OxPAPC products increased EC permeability in a dose-dependent manner, whereas PEIPC decreased it and reversed barrier disruptive effects of lyso-PC, POVPC, and PGPC monitored by measurements of transendothelial electrical resistance. Immunofluorescence staining and western blot analysis showed that PGPC mimicked the cytoskeletal remodeling and tyrosine phosphorylation of adherens junction (AJ) protein vascular endothelial (VE)-cadherin leading to EC barrier dysfunction induced by high OxPAPC concentrations. Barrier-disruptive effects of PGPC were abrogated by reactive oxygen species (ROS) inhibitor, N-acetyl cysteine, or Src kinase inhibitor, PP-2. The results of this study show that barrier disruptive effects of fragmented OxPAPC constituents (lyso-PC, POVPC, PGPC) are balanced by barrier enhancing effects of full length oxygenated products (PEIPC). These data strongly suggest that barrier disruptive effects of OxPAPC at higher concentrations are dictated by predominant effects of fragmented phospholipids such as PGPC, which promote ROS-dependent activation of Src kinase and VE-cadherin phosphorylation at Tyr(658) and Tyr(731) leading to disruption of endothelial cell AJs.
C1 [Birukov, Konstantin G.] Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, Chicago, IL 60637, United States.
   Univ Calif Los Angeles, Dept Chem, Los Angeles, CA 90024, United States.
   Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90024, United States.
C3 University of Chicago; University of California System; University of
   California Los Angeles; University of California System; University of
   California Los Angeles
RP Birukov, KG (corresponding author), Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.
EM kbirukov@medicine.bsd.uchicago.edu
RI Birukov, Konstantin/FJB-5755-2022
FU  [HL087823];  [HL076259];  [HL107920];  [HL064731]
FX Supported by HL087823, HL076259 (K.G.B.); HL107920 (A.A.B.) and HL064731
   (L.K., J.A.B.).
CR Alcaide P, 2008, BLOOD, V112, P2770, DOI 10.1182/blood-2008-03-147181
   Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335
   Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06
   Birukov Konstantin G, 2006, Curr Atheroscler Rep, V8, P223, DOI 10.1007/s11883-006-0077-x
   Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007
   Birukova AA, 2007, AM J PHYSIOL-LUNG C, V292, pL924, DOI 10.1152/ajplung.00395.2006
   Birukova AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030957
   Birukova AA, 2011, EXP CELL RES, V317, P859, DOI 10.1016/j.yexcr.2010.11.011
   Birukova AA, 2011, J CELL PHYSIOL, V226, P2052, DOI 10.1002/jcp.22543
   Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597
   Bochkov VN, 2003, J MOL MED, V81, P613, DOI 10.1007/s00109-003-0467-2
   Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023
   Carpenter CT, 1998, CHEST, V114, P1653, DOI 10.1378/chest.114.6.1653
   Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487
   Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200
   Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867
   Furnkranz A, 2004, CURR PHARM DESIGN, V10, P915
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   Jerlich A, 2003, FREE RADICAL RES, V37, P645, DOI 10.1080/1071576031000091720
   Jung ME, 2008, ORG LETT, V10, P4207, DOI 10.1021/ol8014804
   Lee H, 2000, CIRC RES, V87, P516
   Li RS, 2006, CIRC RES, V98, P642, DOI 10.1161/01.RES.0000207394.39249.fc
   Ma Z, 2004, AM J PHYSIOL-LUNG C, V286, pL808, DOI 10.1152/ajplung.00220.2003
   Montuschi P, 2000, AM J RESP CRIT CARE, V162, P1175, DOI 10.1164/ajrccm.162.3.2001063
   Nonas S, 2006, AM J RESP CRIT CARE, V173, P1130, DOI 10.1164/rccm.200511-1737OC
   Nonas S, 2008, CRIT CARE, V12, DOI 10.1186/cc6805
   Oskolkova OV, 2010, J IMMUNOL, V185, P7706, DOI 10.4049/jimmunol.0903594
   Pegorier S, 2006, ATHEROSCLEROSIS, V188, P433, DOI 10.1016/j.atherosclerosis.2005.11.015
   Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200
   Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200
   Qiao J, 2006, AM J PHYSIOL-LUNG C, V291, pL91, DOI 10.1152/ajplung.00508.2005
   Quinlan GJ, 1996, CRIT CARE MED, V24, P241, DOI 10.1097/00003246-199602000-00010
   Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367
   Starosta V, 2012, AM J RESP CELL MOL, V46, P331, DOI 10.1165/rcmb.2011-0153OC
   Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248
   Subbanagounder G, 2002, J BIOL CHEM, V277, P7271, DOI 10.1074/jbc.M107602200
   Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597
   Zimman A, 2007, ARTERIOSCL THROM VAS, V27, P332, DOI 10.1161/01.ATV.0000252842.57585.df
   Zmijewski JW, 2005, BIOCHEM SOC T, V33, P1385, DOI 10.1042/BST0331385
NR 40
TC 56
Z9 57
U1 0
U2 24
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1931-5244
J9 TRANSL RES
JI Transl. Res.
PD JUN
PY 2013
VL 161
IS 6
BP 495
EP 504
DI 10.1016/j.trsl.2012.12.008
PG 10
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA 152NC
UT WOS:000319537400005
PM 23305708
OA Green Accepted
DA 2023-08-21
ER

PT J
AU Kandasamy, K
   Bezavada, L
   Escue, RB
   Parthasarathi, K
AF Kandasamy, Kathirvel
   Bezavada, Lavanya
   Escue, Rachel B.
   Parthasarathi, Kaushik
TI Lipopolysaccharide Induces Endoplasmic Store Ca2+-Dependent Inflammatory
   Responses in Lung Microvessels
SO PLOS ONE
LA English
DT Article
ID NF-KAPPA-B; INDUCED CYTOKINE PRODUCTION; ENDOTHELIAL-CELLS;
   PROINFLAMMATORY RESPONSES; CALCIUM OSCILLATION; SIGNALING PATHWAY;
   GENE-EXPRESSION; ACTIVATION; RECEPTOR; PROTEIN
AB The pulmonary microvasculature plays a critical role in endotoxin-induced acute lung injury. However, the relevant signaling remain unclear. Specifically the role of endothelial Ca2+ in the induction of endotoxin-mediated responses in lung microvessels remains undefined. Toward elucidating this, we used the isolated blood-perfused rat lung preparation. We loaded microvessels with the Ca2+ indicator, Fura 2 AM and then determined Ca2+ responses to infusions of lipopolysaccharide (LPS) into the microvessels. LPS induced a more than two-fold increase in the amplitude of cytosolic Ca2+ oscillations. Inhibiting inositol 1,4,5 trisphosphate receptors on endoplasmic reticulum (ER) Ca2+ stores with Xestospongin C (XeC), blocked the LPS-induced increase in the Ca2+ oscillation amplitude. However, XeC did not affect entry of external Ca2+ via plasma membrane Ca2+ channels in lung microvascular endothelial cells. This suggested that LPS augmented the oscillations via release of Ca2+ from ER stores. In addition, XeC also blocked LPS-mediated activation and nuclear translocation of nuclear factor-kappa B in lung microvessels. Further, inhibiting ER Ca2+ release blunted increases in intercellular adhesion molecule-1 expression and retention of naive leukocytes in LPS-treated microvessels. Taken together, the data suggest that LPS-mediated Ca2+ release from ER stores underlies nuclear factor-kappa B activation and downstream inflammatory signaling in lung microvessels. Thus, we show for the first time a role for inositol 1,4,5 trisphosphate-mediated ER Ca2+ release in the induction of LPS responses in pulmonary microvascular endothelium. Mechanisms that blunt this signaling may mitigate endotoxin-induced morbidity.
C1 [Kandasamy, Kathirvel; Bezavada, Lavanya; Escue, Rachel B.; Parthasarathi, Kaushik] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163, United States.
   [Parthasarathi, Kaushik] Univ Tennessee, Ctr Hlth Sci, Dept Orthoped Surg & Biomed Engn, Memphis, TN 38163, United States.
C3 University of Tennessee System; University of Tennessee Health Science
   Center; University of Tennessee System; University of Tennessee Health
   Science Center
RP Parthasarathi, K (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA.
EM kparthas@uthsc.edu
OI Bezavada, Lavanya/0000-0001-8434-3323; Kandasamy,
   Kathirvel/0000-0002-4966-4604; Helms, Rachel/0000-0001-5027-7153
FU National Heart, Lung, and Blood Institute, National Institutes of Health
   [HL75503]
FX This study was funded by the National Heart, Lung, and Blood Institute,
   National Institutes of Health, grant number HL75503. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Adachi T, 1997, HEPATOLOGY, V26, P295, DOI 10.1002/hep.510260207
   Antonsson A, 2003, MOL CELL BIOL, V23, P1418, DOI 10.1128/MCB.23.4.1418-1427.2003
   Aul R, 2012, BRIT J CLIN PHARMACO, V74, P1023, DOI 10.1111/j.1365-2125.2012.04287.x
   BADER MF, 1994, GLIA, V11, P336, DOI 10.1002/glia.440110406
   Beck A, 2008, J PHYSIOL-LONDON, V586, P427, DOI 10.1113/jphysiol.2007.145151
   Berendji-Grun D, 2001, MOL MED, V7, P748, DOI 10.1007/BF03401964
   BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0
   Chin ER, 2005, J APPL PHYSIOL, V99, P414, DOI 10.1152/japplphysiol.00015.2005
   Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366
   Guo F, 2012, CYTOKINE, V57, P417, DOI 10.1016/j.cyto.2011.12.009
   Hoffmann A, 2003, J NEUROSCI, V23, P4410
   Hu QH, 2002, BIOCHEM BIOPH RES CO, V292, P325, DOI 10.1006/bbrc.2002.6675
   Hughes K, 2001, J BIOL CHEM, V276, P36008, DOI 10.1074/jbc.M106125200
   Ichimura H, 2003, J CLIN INVEST, V111, P691, DOI 10.1172/JCI200317271
   Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799
   Kandasamy K, 2012, MICROVASC RES, V83, P323, DOI 10.1016/j.mvr.2012.01.006
   Karpurapu M, 2011, BLOOD, V118, P5255, DOI 10.1182/blood-2011-03-341123
   Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200
   Kiefmann R, 2009, AM J PHYSIOL-LUNG C, V296, pL901, DOI 10.1152/ajplung.90549.2008
   Kojima S, 2000, BLOOD, V95, P1309
   Lai DZ, 2009, P NATL ACAD SCI USA, V106, P1169, DOI 10.1073/pnas.0811274106
   Lawson C, 1999, J IMMUNOL, V162, P2990
   Lowry MAR, 1999, DEV COMP IMMUNOL, V23, P253, DOI 10.1016/S0145-305X(99)00004-X
   Lu ZY, 2012, ARTERIOSCL THROM VAS, V32, P1696, DOI 10.1161/ATVBAHA.112.251181
   Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813
   May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550
   Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110
   Otterson MF, 2012, LIFE SCI, V91, P771, DOI 10.1016/j.lfs.2012.08.018
   Parthasarathi K, 2002, J IMMUNOL, V169, P7078, DOI 10.4049/jimmunol.169.12.7078
   Parthasarathi K, 2006, J CLIN INVEST, V116, P2193, DOI 10.1172/JCI26605
   Rahman A, 2000, AM J PHYSIOL-CELL PH, V279, pC906, DOI 10.1152/ajpcell.2000.279.4.C906
   Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2
   Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206
   Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351
   Scharbrodt W, 2009, J CEREBR BLOOD F MET, V29, P57, DOI 10.1038/jcbfm.2008.87
   SCHUMANN MA, 1993, J BIOL CHEM, V268, P2134
   Segura BJ, 2005, MOL BRAIN RES, V133, P325, DOI 10.1016/j.molbrainres.2004.10.016
   Shinji H, 1997, J IMMUNOL, V158, P1370
   Song YX, 2013, EUR J PHARMACOL, V705, P49, DOI 10.1016/j.ejphar.2013.02.008
   Stevens Troy, 2011, Proc Am Thorac Soc, V8, P453, DOI 10.1513/pats.201101-004MW
   Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355
   Thompson PW, 2002, J IMMUNOL, V169, P1007, DOI 10.4049/jimmunol.169.2.1007
   Thor D, 2012, VASCUL PHARM, V53, P230
   Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200
   Valdes JA, 2007, AM J PHYSIOL-CELL PH, V292, pC1960, DOI 10.1152/ajpcell.00320.2006
   Wang Q, 2005, AM J PHYSIOL-LUNG C, V288, pL359, DOI 10.1152/ajplung.00292.2004
   Wehrhahn J, 2010, J IMMUNOL, V184, P2386, DOI 10.4049/jimmunol.0902474
   Wildner O, 1992, Exp Dermatol, V1, P191, DOI 10.1111/j.1600-0625.1992.tb00188.x
   Wurster AL, 2011, MOL IMMUNOL, V48, P2178, DOI 10.1016/j.molimm.2011.07.016
   Xie YC, 1997, J LEUKOCYTE BIOL, V61, P745, DOI 10.1002/jlb.61.6.745
   Yamashiro K, 2010, BIOCHEM BIOPH RES CO, V398, P284, DOI 10.1016/j.bbrc.2010.06.082
   Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200
NR 54
TC 32
Z9 33
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 10
PY 2013
VL 8
IS 5
AR e63465
DI 10.1371/journal.pone.0063465
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 143FO
UT WOS:000318852400041
PM 23675486
OA Green Submitted, gold, Green Published
DA 2023-08-21
ER

PT J
AU Fazal, F
   Bijli, KM
   Murrill, M
   Leonard, A
   Minhajuddin, M
   Anwar, KN
   Finkelstein, JN
   Watterson, DM
   Rahman, A
AF Fazal, Fabeha
   Bijli, Kaiser M.
   Murrill, Matthew
   Leonard, Antony
   Minhajuddin, Mohammad
   Anwar, Khandaker N.
   Finkelstein, Jacob N.
   Watterson, D. Martin
   Rahman, Arshad
TI Critical Role of Non-Muscle Myosin Light Chain Kinase in
   Thrombin-Induced Endothelial Cell Inflammation and Lung PMN Infiltration
SO PLOS ONE
LA English
DT Article
ID NF-KAPPA-B; INTERCELLULAR-ADHESION MOLECULE-1;
   RESPIRATORY-DISTRESS-SYNDROME; RELA/P65 NUCLEAR TRANSLOCATION;
   NEUTROPHIL ADHESION; ACTIN CYTOSKELETON; ICAM-1 EXPRESSION; VASCULAR
   INJURY; TISSUE-FACTOR; COAGULATION
AB The pathogenesis of acute lung injury (ALI) involves bidirectional cooperation and close interaction between inflammatory and coagulation pathways. A key molecule linking coagulation and inflammation is the procoagulant thrombin, a serine protease whose concentration is elevated in plasma and lavage fluids of patients with ALI and acute respiratory distress syndrome (ARDS). However, little is known about the mechanism by which thrombin contributes to lung inflammatory response. In this study, we developed a new mouse model that permits investigation of lung inflammation associated with intravascular coagulation. Using this mouse model and in vitro approaches, we addressed the role of non-muscle myosin light chain kinase (nmMLCK) in thrombin-induced endothelial cell (EC) inflammation and lung neutrophil (PMN) infiltration. Our in vitro experiments revealed a key role of nmMLCK in ICAM-1 expression by its ability to control nuclear translocation and transcriptional capacity of RelA/p65 in EC. When subjected to intraperitoneal thrombin challenge, wild type mice showed a marked increase in lung PMN infiltration via expression of ICAM-1. However, these responses were markedly attenuated in mice deficient in nmMLCK. These results provide mechanistic insight into lung inflammatory response associated with intravascular coagulation and identify nmMLCK as a critical target for modulation of lung inflammation.
C1 [Fazal, Fabeha; Bijli, Kaiser M.; Murrill, Matthew; Leonard, Antony; Minhajuddin, Mohammad; Finkelstein, Jacob N.; Rahman, Arshad] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642, United States.
   [Anwar, Khandaker N.] Univ Illinois, Coll Med, Dept Med, Chicago, IL, United States.
   [Watterson, D. Martin] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Chicago, IL 60611, United States.
C3 University of Rochester; University of Illinois System; University of
   Illinois Chicago; University of Illinois Chicago Hospital; Northwestern
   University
RP Fazal, F (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA.
EM Fabeha_Fazal@URMC.Rochester.edu
RI Minhajuddin, Mohammad/AAC-9227-2022
OI Murrill, Matthew/0000-0001-7567-7727; Watterson, Daniel
   Martin/0000-0001-7605-5866
FU National Heart, Lung, and Blood Institute [HL67424, HL096907]; National
   Institute of Environmental Health Sciences Center (EHSC) [ES-01247];
   Biomedical Research Grant from American Lung Association
FX This work was supported by National Heart, Lung, and Blood Institute
   Grants HL67424 and HL096907. This study was also supported in part by
   National Institute of Environmental Health Sciences Center (EHSC) Grant
   ES-01247, and a Biomedical Research Grant from American Lung
   Association. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR ADELSTEIN RS, 1983, J CLIN INVEST, V72, P1863, DOI 10.1172/JCI111148
   Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965
   Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005
   Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3
   Cirino G, 2006, CURR OPIN PHARMACOL, V6, P428, DOI 10.1016/j.coph.2006.05.001
   COLOTTA F, 1994, AM J PATHOL, V144, P975
   Conway EM, 2002, J EXP MED, V196, P565, DOI 10.1084/jem.20020077
   COOPER JA, 1984, J APPL PHYSIOL, V57, P826, DOI 10.1152/jappl.1984.57.3.826
   Delekta PC, 2010, J BIOL CHEM, V285, P41432, DOI 10.1074/jbc.M110.158949
   DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487
   Dudek SM, 2002, BIOCHEM BIOPH RES CO, V298, P511, DOI 10.1016/S0006-291X(02)02492-0
   Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200
   Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444
   Finigan JH, 2009, MICROVASC RES, V77, P35, DOI 10.1016/j.mvr.2008.09.002
   Gando S, 1999, J TRAUMA, V47, P719, DOI 10.1097/00005373-199910000-00017
   Gao XP, 2001, J IMMUNOL, V167, P2895, DOI 10.4049/jimmunol.167.5.2895
   Gunther A, 2000, AM J RESP CRIT CARE, V161, P454
   Hu G, 2008, CIRC RES, V102, pE120, DOI 10.1161/CIRCRESAHA.107.167486
   Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB
   Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200
   Knezevic N, 2012, J EXP MED
   Kudryashov DS, 1999, FEBS LETT, V463, P67, DOI 10.1016/S0014-5793(99)01591-4
   Kumasaka T, 1996, J CLIN INVEST, V97, P2362, DOI 10.1172/JCI118679
   Levi M, 2005, TRENDS CARDIOVAS MED, V15, P254, DOI 10.1016/j.tcm.2005.07.004
   Levitt JE, 2006, SEMIN RESP CRIT CARE, V27, P426, DOI 10.1055/s-2006-948296
   Li XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1193, DOI 10.1152/ajplung.00408.2006
   Lin T, 2003, CIRC RES, V92, P1296, DOI 10.1161/01.RES.0000078780.65824.8B
   MALIK AB, 1987, AM REV RESPIR DIS, V136, P467, DOI 10.1164/ajrccm/136.2.467
   MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174, DOI 10.1016/j.tcm.2005.06.002
   Mirzapoiazova T, 2011, AM J RESP CELL MOL, V44, P40, DOI 10.1165/rcmb.2009-0197OC
   Niessen F, 2009, BLOOD, V113, P2859, DOI 10.1182/blood-2008-12-192385
   Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065
   Rahman A, 1999, J IMMUNOL, V162, P5466
   Rahman A, 2012, AM J RESP CELL MOL B
   Rahman Arshad, 2011, Proc Am Thorac Soc, V8, P497, DOI 10.1513/pats.201101-009MW
   Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]
   Ranaivo HR, 2007, AM J PATHOL, V170, P439, DOI 10.2353/ajpath.2007.060219
   Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699
   SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111
   Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092
   Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641
   van der Poll T, 2008, CRIT CARE, V12, DOI 10.1186/cc7026
   Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7
   Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998
   Wu Z, 2012, BLOOD, V119, P2422, DOI 10.1182/blood-2011-04-350413
   Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628
   Xu N, 2002, AM J PHYSIOL-LUNG C, V282, pL796, DOI 10.1152/ajplung.00298.2001
   Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393
NR 53
TC 18
Z9 18
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 21
PY 2013
VL 8
IS 3
AR e59965
DI 10.1371/journal.pone.0059965
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 111UM
UT WOS:000316546400072
PM 23555849
OA Green Published, gold, Green Submitted
DA 2023-08-21
ER

PT J
AU Sun, SQ
   Sursal, T
   Adibnia, Y
   Zhao, C
   Zheng, Y
   Li, HP
   Otterbein, LE
   Hauser, CJ
   Itagaki, K
AF Sun, Shiqin
   Sursal, Tolga
   Adibnia, Yasaman
   Zhao, Cong
   Zheng, Yi
   Li, Haipeng
   Otterbein, Leo E.
   Hauser, Carl J.
   Itagaki, Kiyoshi
TI Mitochondrial DAMPs Increase Endothelial Permeability through Neutrophil
   Dependent and Independent Pathways
SO PLOS ONE
LA English
DT Article
ID OPERATED CALCIUM-ENTRY; SPHINGOSINE 1-PHOSPHATE; GENE-EXPRESSION; DANGER
   SIGNALS; MAP KINASE; DNA; CELLS; INFLAMMATION; ACTIVATION; INFLUX
AB Trauma and sepsis can cause acute lung injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) in part by triggering neutrophil (PMN)-mediated increases in endothelial cell (EC) permeability. We had shown that mitochondrial (mt) damage-associated molecular patterns (DAMPs) appear in the blood after injury or shock and activate human PMN. So we now hypothesized that mitochondrial DAMPs (MTD) like mitochondrial DNA (mtDNA) and peptides might play a role in increased EC permeability during systemic inflammation and proceeded to evaluate the underlying mechanisms. MtDNA induced changes in EC permeability occurred in two phases: a brief, PMN-independent 'spike' in permeability was followed by a prolonged PMN-dependent increase in permeability. Fragmented mitochondria (MTD) caused PMN-independent increase in EC permeability that were abolished with protease treatment. Exposure to mtDNA caused PMN-EC adherence by activating expression of adherence molecule expression in both cell types. Cellular activation was manifested as an increase in PMN calcium flux and EC MAPK phosphorylation. Permeability and PMN adherence were attenuated by endosomal TLR inhibitors. EC lacked formyl peptide receptors but were nonetheless activated by mt-proteins, showing that non-formylated mt-protein DAMPs can activate EC. Mitochondrial DAMPs can be released into the circulation by many processes that cause cell injury and lead to pathologic endothelial permeability. We show here that mitochondria contain multiple DAMP motifs that can act on EC and/or PMN via multiple pathways. This can enhance PMN adherence to EC, activate PMN-EC interactions and subsequently increase systemic endothelial permeability. Mitochondrial DAMPs may be important therapeutic targets in conditions where inflammation pathologically increases endothelial permeability.
C1 [Sun, Shiqin; Sursal, Tolga; Adibnia, Yasaman; Zhao, Cong; Zheng, Yi; Li, Haipeng; Otterbein, Leo E.; Hauser, Carl J.; Itagaki, Kiyoshi] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215, United States.
   [Li, Haipeng] Beijing Army Gen Hosp, Dept Orthoped Surg, Beijing, China.
C3 Harvard University; Beth Israel Deaconess Medical Center; Harvard
   Medical School
RP Hauser, CJ (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA.
EM cjhauser@bidmc.harvard.edu; kitagaki@bidmc.harvard.edu
RI Itagaki, Kiyoshi/M-5501-2015; Sursal, Tolga/AAN-8585-2021; Hauser, Carl
   J./Y-1189-2019
OI Itagaki, Kiyoshi/0000-0002-6033-1122; Hauser, Carl/0000-0003-3167-1846
FU NIGMS/NIH [5R01GM089711-02]; Department of Defense
   [W81XWH-09-1-0472/DR0809]; Center for Integration of Medicine and
   Innovative Technology [W81XWH-09-2-0001]
FX 5R01GM089711-02 (NIGMS/NIH, CJH), W81XWH-09-1-0472/DR0809 (Department of
   Defense, CJH), W81XWH-09-2-0001 (Center for Integration of Medicine and
   Innovative Technology, CJH). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896
   Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636
   Hauser CJ, 2010, J ORTHOP TRAUMA, V24, P534, DOI 10.1097/BOT.0b013e3181ec4991
   Hauser CJ, 2000, J TRAUMA, V48, P592, DOI 10.1097/00005373-200004000-00003
   Hauser CJ, 2001, J LEUKOCYTE BIOL, V69, P63
   Hopson KP, 2011, AM J PHYSIOL-CELL PH, V300, pC919, DOI 10.1152/ajpcell.00350.2010
   Itagaki K, 2003, J BIOL CHEM, V278, P27540, DOI 10.1074/jbc.M301763200
   Itagaki K, 2002, J IMMUNOL, V168, P4063, DOI 10.4049/jimmunol.168.8.4063
   Itagaki K, 2011, SHOCK, V36, P548, DOI 10.1097/SHK.0b013e3182369fb2
   Itagaki K, 2010, SHOCK, V33, P381, DOI 10.1097/SHK.0b013e3181c6bb75
   Krieg AM, 1998, P NATL ACAD SCI USA, V95, P12631, DOI 10.1073/pnas.95.21.12631
   Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116
   Lucke S, 2010, CELL PHYSIOL BIOCHEM, V26, P87, DOI 10.1159/000315109
   Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059
   McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002
   Peltz ED, 2009, SHOCK, V32, P17, DOI 10.1097/SHK.0b013e3181997173
   Raoof M, 2010, J TRAUMA, V68, P1328, DOI 10.1097/TA.0b013e3181dcd28d
   Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876
   Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993
   Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603
   Strub GM, 2010, ADV EXP MED BIOL, V688, P141
   Tornquist K, 2012, ACTA PHYSIOL, V204, P151, DOI 10.1111/j.1748-1716.2011.02265.x
   Vazquez G, 2001, P NATL ACAD SCI USA, V98, P11777, DOI 10.1073/pnas.201238198
   Wang LC, 2009, MICROVASC RES, V77, P39, DOI 10.1016/j.mvr.2008.09.005
   Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010
   Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
NR 31
TC 152
Z9 156
U1 1
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 20
PY 2013
VL 8
IS 3
AR e59989
DI 10.1371/journal.pone.0059989
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 125SW
UT WOS:000317562600109
PM 23527291
OA Green Published, Green Submitted, gold
DA 2023-08-21
ER

PT J
AU Davidson, BA
   Vethanayagam, RR
   Grimm, MJ
   Mullan, BA
   Raghavendran, K
   Blackwell, TS
   Freeman, ML
   Ayyasamy, V
   Singh, KK
   Sporn, MB
   Itagaki, K
   Hauser, CJ
   Knight, PR
   Segal, BH
AF Davidson, Bruce A.
   Vethanayagam, R. Robert
   Grimm, Melissa J.
   Mullan, Barbara A.
   Raghavendran, Krishnan
   Blackwell, Timothy S.
   Freeman, Michael L.
   Ayyasamy, Vanniarajan
   Singh, Keshav K.
   Sporn, Michael B.
   Itagaki, Kiyoshi
   Hauser, Carl J.
   Knight, Paul R.
   Segal, Brahm H.
TI NADPH Oxidase and Nrf2 Regulate Gastric Aspiration-Induced Inflammation
   and Acute Lung Injury
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID NEUTROPHIL EXTRACELLULAR TRAPS; REACTIVE OXYGEN; ACID ASPIRATION;
   ADAPTIVE RESPONSE; HYPOCHLOROUS ACID; HOST-DEFENSE; CELL-DEATH;
   ACTIVATION; PATHOGENESIS; PROTECTION
AB Recruitment of neutrophils and release of reactive oxygen species are considered to be major pathogenic components driving acute lung injury (ALI). However, NADPH oxidase, the major source of reactive oxygen species in activated phagocytes, can paradoxically limit inflammation and injury. We hypothesized that NADPH oxidase protects against ALI by limiting neutrophilic inflammation and activating Nrf2, a transcriptional factor that induces antioxidative and cytoprotective pathways. Our objective was to delineate the roles of NADPH oxidase and Nrf2 in modulating acute lung inflammation and injury in clinically relevant models of acute gastric aspiration injury, a major cause of ALI. Acid aspiration caused increased ALI (as assessed by bronchoalveolar lavage fluid albumin concentration) in both NADPH oxidase-deficient mice and Nrf2(-/-) mice compared with wild-type mice. NADPH oxidase reduced airway neutrophil accumulation, but Nrf2 decreased ALI without affecting neutrophil recovery. Acid injury resulted in a 120-fold increase in mitochondrial DNA, a proinflammatory and injurious product of cellular necrosis, in cell-free bronchoalveolar lavage fluid. Pharmacologic activation of Nrf2 by the triterpenoid 1-[2-cyano-3-, 12-dioxooleana-1,9 (11)-dien-28-oyl]imidazole limited aspiration-induced ALI in wild-type mice and reduced endothelial cell injury caused by mitochondrial extract-primed human neutrophils, leading to the conclusion that NADPH oxidase and Nrf2 have coordinated, but distinct, functions in modulating inflammation and injury. These results also point to Nrf2 as a therapeutic target to limit ALI by attenuating neutrophil-induced cellular injury. The Journal of Immunology, 2013, 190: 1714-1724.
C1 [Davidson, Bruce A.; Mullan, Barbara A.; Knight, Paul R.] SUNY Buffalo, Dept Anesthesiol, Sch Med, Buffalo, NY 14214, United States.
   [Davidson, Bruce A.] SUNY Buffalo, Dept Pathol & Anat Sci, Sch Med, Buffalo, NY 14214, United States.
   [Davidson, Bruce A.; Mullan, Barbara A.; Knight, Paul R.] Vet Adm Western New York Healthcare Syst, Dept Anesthesiol, Buffalo, NY 14215, United States.
   [Vethanayagam, R. Robert; Grimm, Melissa J.; Segal, Brahm H.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263, United States.
   [Raghavendran, Krishnan] Univ Michigan Hlth Syst, Dept Surg, Ann Arbor, MI 48109, United States.
   [Blackwell, Timothy S.] Vanderbilt Univ, Dept Med, Sch Med, Nashville, TN 37232, United States.
   [Freeman, Michael L.] Vanderbilt Univ, Dept Radiat Oncol, Sch Med, Nashville, TN 37232, United States.
   [Ayyasamy, Vanniarajan] Roswell Pk Canc Inst, Dept Genet, Buffalo, NY 14263, United States.
   [Singh, Keshav K.] Univ Alabama Birmingham, Dept Genet, Sch Med, Birmingham, AL 35294, United States.
   [Sporn, Michael B.] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755, United States.
   [Itagaki, Kiyoshi; Hauser, Carl J.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215, United States.
   [Segal, Brahm H.] SUNY Buffalo, Dept Med, Sch Med, Buffalo, NY 14214, United States.
   [Segal, Brahm H.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263, United States.
C3 State University of New York (SUNY) System; State University of New York
   (SUNY) Buffalo; State University of New York (SUNY) System; State
   University of New York (SUNY) Buffalo; Roswell Park Comprehensive Cancer
   Center; University of Michigan System; University of Michigan;
   Vanderbilt University; Vanderbilt University; Roswell Park Comprehensive
   Cancer Center; University of Alabama System; University of Alabama
   Birmingham; Dartmouth College; Harvard University; Beth Israel Deaconess
   Medical Center; State University of New York (SUNY) System; State
   University of New York (SUNY) Buffalo; Roswell Park Comprehensive Cancer
   Center
RP Segal, BH (corresponding author), Roswell Pk Canc Inst, Elm & Carlton St, Buffalo, NY 14263 USA.
EM brahm.segal@roswellpark.org
RI Davidson, Bruce/AAW-5753-2021; Segal, Brahm/AAW-2706-2020; Itagaki,
   Kiyoshi/M-5501-2015; raghavendran, krishnan/J-4662-2013; Hauser, Carl
   J./Y-1189-2019; Vanniarajan, A./AAB-4896-2022
OI Itagaki, Kiyoshi/0000-0002-6033-1122; Hauser, Carl/0000-0003-3167-1846;
   Davidson, Bruce/0000-0001-8223-1870
FU National Institutes of Health [AI079253, CA016056, HL048889, AI084410,
   CA116430, NIGMS 5 R01 GM089711-03]; Department of Defense
   [W81XWH-09-1-0472]
FX This work was supported by grants from the National Institutes of Health
   (AI079253 to B.H.S., CA016056 [Center Support Grant to Roswell Park
   Cancer Institute], HL048889 to B.A.D. and P.R.K., AI084410 to B.A.D. and
   P.R.K., CA116430 to K.K.S., and NIGMS 5 R01 GM089711-03 to C.J.H.) and
   Department of Defense Hypothesis Grant award W81XWH-09-1-0472 (to
   C.J.H.).
CR Adhikari N., 2004, COCHRANE DB SYST REV, V4, DOI [DOI 10.1002/14651858.CD004477.PUB2, 10.1002/14651858.CD004477.pub2]
   Agata N, 2008, CANCER RES, V68, P6136, DOI 10.1158/0008-5472.CAN-08-0464
   Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710
   Brower RG, 2004, NEW ENGL J MED, V351, P327
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303
   Chan JY, 2000, BBA-GENE STRUCT EXPR, V1517, P19, DOI 10.1016/S0167-4781(00)00238-4
   Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501
   Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC
   Cooke CR, 2009, CRIT CARE MED, V37, P1913, DOI 10.1097/CCM.0b013e3181a009b4
   Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2
   Davidson BA, 2005, AM J PHYSIOL-LUNG C, V288, pL699, DOI 10.1152/ajplung.00229.2004
   Davidson BA, 1999, ANESTHESIOLOGY, V91, P486, DOI 10.1097/00000542-199908000-00024
   Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   Eisner MD, 2001, AM J RESP CRIT CARE, V164, P231, DOI 10.1164/ajrccm.164.2.2011093
   Estenssoro E, 2002, CRIT CARE MED, V30, P2450, DOI 10.1097/00003246-200211000-00008
   Fernandez-Boyanapalli R, 2010, BLOOD, V116, P4512, DOI 10.1182/blood-2010-02-272005
   Fernandez-Boyanapalli RF, 2009, BLOOD, V113, P2047, DOI 10.1182/blood-2008-05-160564
   Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030
   FOWLER AA, 1983, ANN INTERN MED, V98, P593, DOI 10.7326/0003-4819-98-5-593
   Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027
   Gao XP, 2002, J IMMUNOL, V168, P3974, DOI 10.4049/jimmunol.168.8.3974
   GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896
   GOLDMAN G, 1992, J APPL PHYSIOL, V73, P571, DOI 10.1152/jappl.1992.73.2.571
   HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182
   Inci I, 2007, ANN THORAC SURG, V84, P240, DOI 10.1016/j.athoracsur.2007.03.082
   Itagaki K, 2011, SHOCK, V36, P548, DOI 10.1097/SHK.0b013e3182369fb2
   Itagaki K, 2010, SHOCK, V33, P381, DOI 10.1097/SHK.0b013e3181c6bb75
   JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751
   Jang JS, 2009, J CLIN BIOCHEM NUTR, V45, P37, DOI 10.3164/jcbn.08-262
   KENNEDY TP, 1989, ANESTH ANALG, V69, P87
   Knight PR, 2004, EXP LUNG RES, V30, P535, DOI 10.1080/01902140490489162
   KNIGHT PR, 1992, ANESTHESIOLOGY, V77, P772, DOI 10.1097/00000542-199210000-00023
   KNIGHT PR, 1993, ANESTH ANALG, V77, P754
   Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215
   Kubo H, 1996, J CLIN INVEST, V97, P2680, DOI 10.1172/JCI118718
   Liby K, 2005, CANCER RES, V65, P4789, DOI 10.1158/0008-5472.CAN-04-4539
   Marciano BE, 2004, PEDIATRICS, V114, P462, DOI 10.1542/peds.114.2.462
   Nader ND, 2005, ANESTH ANALG, V101, P213, DOI 10.1213/01.ANE.0000152188.65226.FE
   Nader-Djalal N, 1998, ANESTH ANALG, V87, P127, DOI 10.1097/00000539-199807000-00028
   Phadke AP, 2005, MED MYCOL, V43, pS173, DOI 10.1080/13693780500052099
   Quinlan GJ, 1997, AM J RESP CRIT CARE, V155, P479, DOI 10.1164/ajrccm.155.2.9032182
   Raghavendran K, 2005, AM J PHYSIOL-LUNG C, V289, pL134, DOI 10.1152/ajplung.00390.2004
   Rahman I, 2006, CURR DRUG TARGETS, V7, P707, DOI 10.2174/138945006777435254
   Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a
   Ruchaud-Sparagano MH, 1998, EUR J IMMUNOL, V28, P80, DOI 10.1002/(SICI)1521-4141(199801)28:01<80::AID-IMMU80>3.0.CO;2-7
   Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004
   Segal BH, 2000, INFECT IMMUN, V68, P2374, DOI 10.1128/IAI.68.4.2374-2378.2000
   Segal BH, 2007, AM J PHYSIOL-LUNG C, V292, pL760, DOI 10.1152/ajplung.00281.2006
   Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631
   Sheu CC, 2010, CHEST, V138, P559, DOI 10.1378/chest.09-2933
   Siddiqui S., 2007, CLIN INFECT DIS, V45, P673, DOI [10.1086/520985, DOI 10.1086/520985]
   Tasaka S, 2008, ANTIOXID REDOX SIGN, V10, P739, DOI 10.1089/ars.2007.1940
   Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102
   Thimmulappa RK, 2002, CANCER RES, V62, P5196
   van Bruggen R, 2010, BLOOD, V115, P5398, DOI 10.1182/blood-2009-10-250803
   Ware LB, 2010, CHEST, V137, P288, DOI 10.1378/chest.09-1484
   Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919
   Woods CG, 2009, TOXICOL APPL PHARM, V238, P27, DOI 10.1016/j.taap.2009.04.007
   Yamada M, 2011, AM J RESP CRIT CARE, V183, P1391, DOI 10.1164/rccm.201004-0592OC
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhang XC, 2003, AM J RESP CELL MOL, V28, P305, DOI 10.1165/rcmb.2002-0156OC
   Zhu LX, 2008, AM J PHYSIOL-LUNG C, V294, pL469, DOI 10.1152/ajplung.00310.2007
   Zmijewski JW, 2009, AM J RESP CRIT CARE, V179, P694, DOI 10.1164/rccm.200806-851OC
NR 69
TC 43
Z9 44
U1 0
U2 9
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD FEB 15
PY 2013
VL 190
IS 4
BP 1714
EP 1724
DI 10.4049/jimmunol.1202410
PG 11
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 088HS
UT WOS:000314825400035
PM 23296708
OA Bronze, Green Accepted
DA 2023-08-21
ER

PT J
AU Wang, LF
   Taneja, R
   Wang, W
   Yao, LJ
   Veldhuizen, RAW
   Gill, SE
   Fortin, D
   Inculet, R
   Malthaner, R
   Mehta, S
AF Wang, Lefeng
   Taneja, Ravi
   Wang, Wei
   Yao, Li-Juan
   Veldhuizen, Ruud A. W.
   Gill, Sean E.
   Fortin, Dalilah
   Inculet, Richard
   Malthaner, Richard
   Mehta, Sanjay
TI Human Alveolar Epithelial Cells Attenuate Pulmonary Microvascular
   Endothelial Cell Permeability under Septic Conditions
SO PLOS ONE
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; NITRIC-OXIDE SYNTHASE;
   MURINE SEPSIS; PROTEIN LEAK; IN-VITRO; MIGRATION; KINASE; MODEL;
   PATHOGENESIS
AB Acute lung injury (ALI) and its most severe form, acute respiratory distress syndrome (ARDS), are characterised by high-protein pulmonary edema and severe hypoxaemic respiratory failure due to increased permeability of pulmonary microvascular endothelial cells (PMVEC). Alveolar epithelial cells (AEC) contribute importantly to normal alveolar function, and AEC dysfunction in ALI/ARDS is associated with worse outcomes. We hypothesized that AEC can modulate human PMVEC barrier function, and investigated the effects of AEC presence on human PMVEC barrier under septic conditions in vitro. PMVEC isolated from human lung were treated in vitro with septic stimulation (lipopolysaccharide [LPS], a mixture of clinically-relevant cytokines [cytomix], or plasma from patients with severe sepsis), and the trans-PMVEC leak of Evans Blue dye-labeled albumin assessed. PMVEC septic responses were compared in the presence/absence of co-cultured A549 epithelial cell line or primary human AEC. Septic stimulation with LPS, cytomix, or septic plasma induced marked PMVEC hyper-permeability (10.2 +/- 1.8, 8.9 +/- 2.2, and 3.7 +/- 0.2 fold-increase vs. control, respectively, p<0.01 for all). The presence of A549 cells or primary human AEC in a non-contact co-culture model attenuated septic PMVEC hyper-permeability by 39 +/- 4% to 100 +/- 3%, depending on the septic stimulation (p<0.05). Septic PMVEC hyper-permeability was also attenuated following treatment with culture medium conditioned by previous incubation with either naive or cytomix-treated A549 cells (p<0.05), and this protective effect of A549 cell-conditioned medium was both heat-stable and transferable following lipid extraction. Cytomix-stimulated PMN-dependent PMVEC hyper-permeability and trans-PMVEC PMN migration were also inhibited in the presence of A549 cells or A549 cell-conditioned medium (p<0.05). Human AEC appear to protect human PMVEC barrier function under septic conditions in vitro, through release of a soluble mediator(s), which are at least partly lipid in nature. This study suggests a scientific and potential clinical therapeutic importance of epithelial-endothelial cross talk in maintaining alveolar integrity in ALI/ARDS.
C1 [Wang, Lefeng; Taneja, Ravi; Wang, Wei; Yao, Li-Juan; Veldhuizen, Ruud A. W.; Gill, Sean E.; Mehta, Sanjay] London Hlth Sci Ctr, Lawson Hlth Res Inst, Ctr Crit Illness Res, Div Respirol, London, ON, Canada.
   [Wang, Lefeng; Wang, Wei; Veldhuizen, Ruud A. W.; Gill, Sean E.; Mehta, Sanjay] Univ Western Ontario, Schulich Fac Med & Dent, Dept Med, London, ON, Canada.
   [Taneja, Ravi] Univ Western Ontario, Schulich Fac Med & Dent, Dept Anesthesia, London, ON, Canada.
   [Taneja, Ravi; Fortin, Dalilah] Univ Western Ontario, Schulich Fac Med & Dent, Dept Crit Care Med, London, ON, Canada.
   [Fortin, Dalilah; Inculet, Richard; Malthaner, Richard] Univ Western Ontario, Schulich Fac Med & Dent, Dept Thorac Surg, London, ON, Canada.
C3 London Health Sciences Centre; Western University (University of Western
   Ontario); Western University (University of Western Ontario); Western
   University (University of Western Ontario); Western University
   (University of Western Ontario); Western University (University of
   Western Ontario)
RP Mehta, S (corresponding author), London Hlth Sci Ctr, Lawson Hlth Res Inst, Ctr Crit Illness Res, Div Respirol, London, ON, Canada.
EM Sanjay.Mehta@lhsc.on.ca
RI Mehta, Sanjay/G-3332-2011; wang, le/HKN-3406-2023; Veldhuizen,
   Ruud/G-3352-2011; Gill, Sean E/G-4057-2012
OI Mehta, Sanjay/0000-0002-7707-1056; Veldhuizen, Ruud/0000-0002-8802-1580;
   
FU Heart & Stroke Foundation of Ontario/Canada [T6461]; Ontario Thoracic
   Society; Lawson Health Research Institute; LHSC Department of Medicine
   Program of Experimental Medicine
FX Funding support by Heart & Stroke Foundation of Ontario/Canada grant
   #T6461, Ontario Thoracic Society, Lawson Health Research Institute, LHSC
   Department of Medicine Program of Experimental Medicine. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Bastarache JA, 2009, AM J PHYSIOL-LUNG C, V297, pL1035, DOI 10.1152/ajplung.00214.2009
   Berthiaume Y, 2007, RESP PHYSIOL NEUROBI, V159, P350, DOI 10.1016/j.resp.2007.05.010
   Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491
   BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481
   Breslin JW, 2004, AM J PHYSIOL-HEART C, V286, pH1057, DOI 10.1152/ajpheart.00841.2003
   Burns AR, 2003, PHYSIOL REV, V83, P309, DOI 10.1152/physrev.00023.2002
   Clerici C, 2011, AM J PHYSIOL-LUNG C, V301, pL20, DOI 10.1152/ajplung.00126.2011
   DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012
   Ehrhardt Carsten, 2005, Methods Mol Med, V107, P207
   Farley KS, 2006, AM J PHYSIOL-LUNG C, V290, pL1164, DOI 10.1152/ajplung.00248.2005
   GORIN AB, 1979, J APPL PHYSIOL, V47, P1315, DOI 10.1152/jappl.1979.47.6.1315
   Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138
   Hermanns MI, 2009, CELL TISSUE RES, V336, P91, DOI 10.1007/s00441-008-0750-1
   Jacobs ER, 2001, AM J PHYSIOL-HEART C, V280, pH1, DOI 10.1152/ajpheart.2001.280.1.H1
   Manicone AM, 2009, EXPERT REV CLIN IMMU, V5, P63, DOI 10.1586/1744666X.5.1.63
   Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x
   Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158
   Moss M, 1996, CRIT CARE MED, V24, P1782, DOI 10.1097/00003246-199611000-00004
   Ochoa CD, 2012, AM J PHYSIOL-LUNG C, V302, pL275, DOI [10.1152/ajplung.00215.2011, 10.1152/ajplung.00215.2011.]
   Orgeig S, 2010, RESP PHYSIOL NEUROBI, V173, pS43, DOI 10.1016/j.resp.2010.04.023
   Perl M, 2011, EXPERT REV RESP MED, V5, P115, DOI [10.1586/ers.10.92, 10.1586/ERS.10.92]
   Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155
   Razavi HM, 2005, CRIT CARE MED, V33, P1333, DOI 10.1097/01.CCM.0000165445.48350.4F
   Razavi HM, 2004, AM J RESP CRIT CARE, V170, P227, DOI 10.1164/rccm.200306-846OC
   Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976
   Schnitzer SE, 2009, MOL CANCER RES, V7, P393, DOI 10.1158/1541-7786.MCR-08-0156
   Shelton JL, 2008, MICROVASC RES, V76, P80, DOI 10.1016/j.mvr.2008.06.001
   Shelton JL, 2007, MICROVASC RES, V74, P23, DOI 10.1016/j.mvr.2007.02.008
   Shelton JL, 2006, MICROVASC RES, V71, P40, DOI 10.1016/j.mvr.2005.11.003
   Singh LS, 2007, JNCI-J NATL CANCER I, V99, P1313, DOI 10.1093/jnci/djm107
   Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com
   Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC
   Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463
   Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1
   Wang LF, 2012, SHOCK, V37, P539, DOI 10.1097/SHK.0b013e31824dcb5a
   Wang LF, 2002, AM J RESP CRIT CARE, V165, P1634, DOI 10.1164/rccm.2110017
   Wang L, 2007, AM J RESP CELL MOL, V36, P497, DOI 10.1165/rcmb.2005-0425OC
   Ware LB, 2004, AM J RESP CRIT CARE, V170, P766, DOI 10.1164/rccm.200310-1434OC
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Weppler A, 2006, EXP LUNG RES, V32, P455, DOI 10.1080/01902140601059463
   Witherden IR, 2004, AM J RESP CELL MOL, V30, P500, DOI 10.1165/rcmb.4890
   Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528
NR 42
TC 32
Z9 38
U1 1
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 5
PY 2013
VL 8
IS 2
AR e55311
DI 10.1371/journal.pone.0055311
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 086NV
UT WOS:000314692800022
PM 23393568
OA Green Published, Green Submitted, gold
DA 2023-08-21
ER

PT J
AU Gandhirajan, RK
   Meng, S
   Chandramoorthy, HC
   Mallilankaraman, K
   Mancarella, S
   Gao, H
   Razmpour, R
   Yang, XF
   Houser, SR
   Chen, J
   Koch, WJ
   Wang, H
   Soboloff, J
   Gill, DL
   Madesh, M
AF Gandhirajan, Rajesh Kumar
   Meng, Shu
   Chandramoorthy, Harish C.
   Mallilankaraman, Karthik
   Mancarella, Salvatore
   Gao, Hui
   Razmpour, Roshanak
   Yang, Xiao-Feng
   Houser, Steven R.
   Chen, Ju
   Koch, Walter J.
   Wang, Hong
   Soboloff, Jonathan
   Gill, Donald L.
   Madesh, Muniswamy
TI Blockade of NOX2 and STIM1 signaling limits lipopolysaccharide-induced
   vascular inflammation
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID CALCIUM SENSORS STIM1; ENDOTHELIAL-CELLS; CA2+ INFLUX; INOSITOL
   1,4,5-TRISPHOSPHATE; S-GLUTATHIONYLATION; GENE-EXPRESSION;
   UNITED-STATES; TNF-ALPHA; ACTIVATION; PROTEIN
AB During sepsis, acute lung injury (ALI) results from activation of innate immune cells and endothelial cells by endotoxins, leading to systemic inflammation through proinflammatory cytokine overproduction, oxidative stress, and intracellular Ca2+ overload. Despite considerable investigation, the underlying molecular mechanism(s) leading to LPS-induced ALI remain elusive. To determine whether stromal interaction molecule 1-dependent (STIM1-dependent) signaling drives endothelial dysfunction in response to LPS, we investigated oxidative and STIM1 signaling of EC-specific Stim1-knockout mice. Here we report that LPS-mediated Ca2+ oscillations are ablated in ECs deficient in Nox2, Stim1, and type II inositol triphosphate receptor (Itpr2). LPS-induced nuclear factor of activated T cells (NEAT) nuclear accumulation was abrogated by either antioxidant supplementation or Ca2+ chelation. Moreover, ECs lacking either Nox2 or Stim1 failed to trigger store-operated Ca2+ entry (SOCe) and NFAT nuclear accumulation. LPS-induced vascular permeability changes were reduced in EC-specific Stim1(-/-) mice, despite elevation of systemic cytokine levels. Additionally, inhibition of STIM1 signaling prevented receptor-interacting protein 3-dependent (RIP3-dependent) EC death. Remarkably, BTP2, a small-molecule calcium release-activated calcium (CRAC) channel blocker administered after insult, halted LPS-induced vascular leakage and pulmonary edema. These results indicate that ROS-driven Ca2+ signaling promotes vascular barrier dysfunction and that the SOCe machinery may provide crucial therapeutic targets to limit sepsis-induced ALI.
C1 [Gandhirajan, Rajesh Kumar; Chandramoorthy, Harish C.; Mallilankaraman, Karthik; Mancarella, Salvatore; Soboloff, Jonathan; Gill, Donald L.; Madesh, Muniswamy] Temple Univ, Dept Biochem, Philadelphia, PA 19140, United States.
   [Gandhirajan, Rajesh Kumar; Chandramoorthy, Harish C.; Mallilankaraman, Karthik; Koch, Walter J.; Madesh, Muniswamy] Temple Univ, Ctr Translat Med, Philadelphia, PA 19140, United States.
   [Meng, Shu; Yang, Xiao-Feng; Koch, Walter J.; Wang, Hong] Temple Univ, Dept Pharmacol, Philadelphia, PA 19140, United States.
   [Gao, Hui; Houser, Steven R.] Temple Univ, Dept Physiol, Cardiovasc Res Ctr, Philadelphia, PA 19140, United States.
   [Razmpour, Roshanak] Temple Univ, Dept Anat & Cell Biol, Philadelphia, PA 19140, United States.
   [Chen, Ju] UCSD, Dept Med, La Jolla, CA, United States.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple
   University; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher
   Education (PCSHE); Temple University; Pennsylvania Commonwealth System
   of Higher Education (PCSHE); Temple University; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); Temple University;
   University of California System; University of California San Diego
RP Madesh, M (corresponding author), Temple Univ, Ctr Translat Med, 950 MERB,3500 N Broad St, Philadelphia, PA 19140 USA.
EM madeshm@temple.edu
RI Soboloff, Jonathan/I-6995-2012; Chandramoorthy, Harish C/A-6533-2019;
   Chen, Ju/E-5579-2011
OI Soboloff, Jonathan/0000-0001-5192-1297; MALLILANKARAMAN,
   KARTHIK/0000-0002-9492-9050; Chinna Konda Chandramoorthy,
   Harish/0000-0002-8780-8971; Gandhirajan, Rajesh
   Kumar/0000-0002-0039-771X
FU NIH [HL086699, 1S10RR027327-01, 1R21HL109920-01]
FX This work was supported by NIH grants HL086699 (to M. Madesh),
   1S10RR027327-01 (to M. Madesh), and 1R21HL109920-01 (to M. Madesh and J.
   Soboloff). We thank Anjana Rao (La Jolla Institute for Allergy and
   Immunology, La Jolla, California, USA), Suresh Joseph (Thomas Jefferson
   University, Philadelphia, Pennsylvania, USA), and Gary Koretzky
   (University of Pennsylvania, Philadelphia, Pennsylvania, USA) for
   providing the Stim1<SUP>fl/fl</SUP> mice, InsP<INF>3</INF>RI antibody,
   and NFAT-luciferase plasmid construct, respectively. We are grateful to
   Aron B. Fisher, G. Scott Worthen, and Troy Stevens for critical comments
   on the results.
CR Aird WC, 2007, CURR DRUG TARGETS, V8, P501, DOI 10.2174/138945007780362782
   Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510
   Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002
   Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040
   Baluk P, 2009, J CLIN INVEST, V119, P2954, DOI 10.1172/JCI37626
   Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866
   Bergner A, 2002, J GEN PHYSIOL, V119, P187, DOI 10.1085/jgp.119.2.187
   Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522
   Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155
   Bogeski I, 2011, CELL CALCIUM, V50, P407, DOI 10.1016/j.ceca.2011.07.006
   Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025
   Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028
   Craige SM, 2011, CIRCULATION, V124, P731, DOI 10.1161/CIRCULATIONAHA.111.030775
   Czermak BJ, 1999, AM J PATHOL, V154, P1057, DOI 10.1016/S0002-9440(10)65358-8
   Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960
   Dupont G., 2011, COLD SPRING HARB PER, V3
   Estrada IA, 2012, CIRC RES, V111, P1166, DOI 10.1161/CIRCRESAHA.112.275743
   Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702
   GOLDBLUM SE, 1994, J CLIN INVEST, V93, P692, DOI 10.1172/JCI117022
   Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400
   Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200
   Hawkins BJ, 2007, MOL CELL BIOL, V27, P7582, DOI 10.1128/MCB.00493-07
   Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830
   Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152
   He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200
   Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333
   Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200
   Hu QH, 2000, J BIOL CHEM, V275, P15749, DOI 10.1074/jbc.M000381200
   Hu QH, 2002, J BIOL CHEM, V277, P32546, DOI 10.1074/jbc.M201550200
   Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454
   Kar P, 2011, J BIOL CHEM, V286, P14795, DOI 10.1074/jbc.M111.220582
   Krapivinsky G, 2011, P NATL ACAD SCI USA, V108, P19234, DOI 10.1073/pnas.1117231108
   Lamb FS, 2012, J BIOL CHEM, V287, P12395, DOI 10.1074/jbc.M111.306530
   Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106
   Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055
   Lock JT, 2011, AM J PHYSIOL-HEART C, V300, pH493, DOI 10.1152/ajpheart.01073.2010
   Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065
   Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022
   Mallilankaraman K, 2011, JOVE-J VIS EXP, DOI 10.3791/3511
   Mancarella S, 2011, J BIOL CHEM, V286, P44788, DOI 10.1074/jbc.M111.303081
   Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139
   Matsumoto M, 2011, IMMUNITY, V34, P703, DOI 10.1016/j.immuni.2011.03.016
   Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818
   Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574
   Ohga K, 2008, INT IMMUNOPHARMACOL, V8, P1787, DOI 10.1016/j.intimp.2008.08.016
   Palty R, 2012, CELL, V149, P425, DOI 10.1016/j.cell.2012.01.055
   Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013
   Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589
   Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514
   Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082
   Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053
   Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019
   Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632
   Simon F, 2009, J HYPERTENS, V27, P1202, DOI 10.1097/HJH.0b013e328329e31c
   Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414
   Soboloff J, 2011, NAT CHEM BIOL, V7, P488, DOI 10.1038/nchembio.619
   Srikanth S, 2012, P NATL ACAD SCI USA, V109, P8682, DOI 10.1073/pnas.1200667109
   Srikanth S, 2010, NAT CELL BIOL, V12, P436, DOI 10.1038/ncb2045
   Takezawa R, 2006, MOL PHARMACOL, V69, P1413, DOI 10.1124/mol.105.021154
   Tiruppathi C, 2008, J BIOL CHEM, V283, P4210, DOI 10.1074/jbc.M703153200
   VARANI J, 1994, SHOCK, V2, P311, DOI 10.1097/00024382-199411000-00001
   Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302
   Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883
   Wada Y, 2005, FASEB J, V19, P1914, DOI 10.1096/fj.05-4037fje
   Wu SQ, 2005, AM J PHYSIOL-HEART C, V289, pH873, DOI 10.1152/ajpheart.00993.2004
   Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/nchembio.558, 10.1038/NCHEMBIO.558]
   Zhang L, 2011, J CELL PHYSIOL, V226, P1694, DOI 10.1002/jcp.22500
   Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103
   Zhu LP, 2008, J CELL SCI, V121, P2511, DOI 10.1242/jcs.031997
   Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200
NR 72
TC 163
Z9 168
U1 1
U2 44
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD FEB
PY 2013
VL 123
IS 2
BP 887
EP 902
DI 10.1172/JCI65647
PG 16
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 084QG
UT WOS:000314553600041
PM 23348743
OA Green Published
DA 2023-08-21
ER

PT J
AU Mannam, P
   Zhang, XC
   Shan, PY
   Zhang, Y
   Shinn, AS
   Zhang, YT
   Lee, PJ
AF Mannam, Praveen
   Zhang, Xuchen
   Shan, Peiying
   Zhang, Yi
   Shinn, Amanda S.
   Zhang, Yitao
   Lee, Patty J.
TI Endothelial MKK3 Is a Critical Mediator of Lethal Murine Endotoxemia and
   Acute Lung Injury
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID NF-KAPPA-B; PROTEIN-KINASE PATHWAY; MITOCHONDRIAL SUPEROXIDE;
   GENE-EXPRESSION; ACTIVATION; MICE; RESISTANCE; ICAM-1; SHOCK; AP-1
AB Sepsis is a leading cause of intensive care unit admissions, with high mortality and morbidity. Although outcomes have improved with better supportive care, specific therapies are limited. Endothelial activation and oxidant injury are key events in the pathogenesis of sepsis-induced lung injury. The signaling pathways leading to these events remain poorly defined. We sought to determine the role of MAPK kinase 3 (MKK3), a kinase of the p38 group, in the pathogenesis of sepsis. We used a murine i.p. LPS model of systemic inflammation to mimic sepsis. Lung injury parameters were assessed in lung tissue and bronchoalveolar lavage specimens. Primary lung endothelial cells were cultured and assessed for mediators of inflammation and injury, such as ICAM-1, AP-1, NF-kappa B, and mitochondrial reactive oxygen species. Our studies demonstrate that MKK3 deficiency confers virtually complete protection against organ injury after i.p. LPS. Specifically, MKK3(-/-) mice were protected against acute lung injury, as assessed by reduced inflammation, mitochondrial reactive oxygen species generation, endothelial injury, and ICAM-1 expression after LPS administration. Our results show that endothelial MKK3 is required for inflammatory cell recruitment to the lungs, mitochondrial oxidant-mediated AP-1, NF-kappa B activation, and ICAM-1 expression during LPS challenge. Collectively, these studies identify a novel role for MKK3 in lethal LPS responses and provide new therapeutic targets against sepsis and acute lung injury. The Journal of Immunology, 2013, 190: 1264-1275.
C1 [Mannam, Praveen; Shan, Peiying; Zhang, Yi; Shinn, Amanda S.; Zhang, Yitao; Lee, Patty J.] Yale Univ, Dept Internal Med, Sch Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT 06520, United States.
   [Zhang, Xuchen] Yale Univ, Dept Pathol, Sch Med, New Haven, CT 06520, United States.
C3 Yale University; Yale University
RP Lee, PJ (corresponding author), Yale Univ, Dept Internal Med, Sch Med, Sect Pulm Crit Care & Sleep Med, 333 Cedar St,POB 208057, New Haven, CT 06520 USA.
EM patty.lee@yale.edu
RI zhang, xu/GYE-3558-2022
OI Zhang, Xuchen/0000-0002-1484-4672
FU American Heart Association [AHA 09FTF2090019]; National Institutes of
   Health/National Heart, Lung, and Blood Institute [R01 HL090660, R01
   HL071595]
FX This work was supported by American Heart Association Grant AHA
   09FTF2090019 (to P.M.) and by National Institutes of Health/National
   Heart, Lung, and Blood Institute, Grants R01 HL090660 and R01 HL071595
   (to P.J.L.).
CR Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002
   Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522
   Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X
   Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC
   De Plaen IG, 2006, IMMUNOLOGY, V118, P153, DOI 10.1111/j.1365-2567.2006.02344.x
   Deans KJ, 2005, J TRAUMA, V58, P867, DOI 10.1097/01.TA.0000158244.69179.94
   DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144
   Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601
   Dolinay T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001601
   Fan HY, 2002, AM J PHYSIOL-HEART C, V282, pH1778, DOI 10.1152/ajpheart.00796.2000
   Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004
   Fukuda K, 2008, LAB INVEST, V88, P398, DOI 10.1038/labinvest.2008.10
   HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033
   Han JH, 1997, FEBS LETT, V403, P19, DOI 10.1016/S0014-5793(97)00021-5
   Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X
   Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333
   Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5
   Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2
   Kepp O, 2011, NAT IMMUNOL, V12, P199, DOI 10.1038/ni0311-199
   Kisseleva T, 2006, J CLIN INVEST, V116, P2955, DOI 10.1172/JCI27392
   Kuhlencordt PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1195, DOI 10.1152/ajpcell.00546.2002
   Lee JH, 2004, J IMMUNOL, V172, P608, DOI 10.4049/jimmunol.172.1.608
   LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5
   Lim AKH, 2009, DIABETOLOGIA, V52, P347, DOI 10.1007/s00125-008-1215-5
   Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845
   Ma FY, 2007, AM J PHYSIOL-RENAL, V293, pF1556, DOI 10.1152/ajprenal.00010.2007
   Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008
   McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491
   Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106
   Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446
   Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6
   Otterbein LE, 2003, AM J PATHOL, V163, P2555, DOI 10.1016/S0002-9440(10)63610-3
   Panes J, 1995, AM J PHYSIOL-HEART C, V269, pH1955, DOI 10.1152/ajpheart.1995.269.6.H1955
   Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791
   Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]
   Roebuck KA, 1999, INT J MOL MED, V4, P223
   SCHMIDT KN, 1995, CHEM BIOL, V2, P13, DOI 10.1016/1074-5521(95)90076-4
   Sen CK, 1997, BIOCHEM BIOPH RES CO, V237, P645, DOI 10.1006/bbrc.1997.7206
   Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830
   Wang Y, 2009, REDOX REP, V14, P243, DOI 10.1179/135100009X12525712409896
   Warn PA, 2003, LAB ANIM-UK, V37, P126, DOI 10.1258/00236770360563769
   Wysk M, 1999, P NATL ACAD SCI USA, V96, P3763, DOI 10.1073/pnas.96.7.3763
   XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhang XC, 2005, J BIOL CHEM, V280, P8714, DOI 10.1074/jbc.M408092200
   Zhang XC, 2003, J BIOL CHEM, V278, P22061, DOI 10.1074/jbc.M301858200
   Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139
NR 49
TC 34
Z9 39
U1 0
U2 5
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD FEB 1
PY 2013
VL 190
IS 3
BP 1264
EP 1275
DI 10.4049/jimmunol.1202012
PG 12
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 074AM
UT WOS:000313784200044
PM 23275604
OA Bronze, Green Accepted
DA 2023-08-21
ER

PT J
AU Ma, LJ
   Li, YY
   Zhao, YL
   Wang, QW
   Nan, YD
   Mu, DG
   Li, WP
   Sun, RL
   Jin, FG
   Liu, XY
AF Ma, Lijie
   Li, Yanyan
   Zhao, Yilin
   Wang, Qingwei
   Nan, Yandong
   Mu, Deguang
   Li, Wangping
   Sun, Ruilin
   Jin, Faguang
   Liu, Xueying
TI 3,5,4 '-tri-O-acetylresveratrol Ameliorates Seawater Exposure-Induced
   Lung Injury by Upregulating Connexin 43 Expression in Lung
SO MEDIATORS OF INFLAMMATION
LA English
DT Article
ID GAP-JUNCTION CHANNEL; PERMEABILITY; RESVERATROL; PATHWAYS
AB The aim of the present study was to examine the effects of 3,5,4'-tri-O-acetylresveratrol on connexin 43 (Cx43) in acute lung injury (ALI) in rats induced by tracheal instillation of artificial seawater. Different doses (50, 150, and 450 mg/kg) of 3,5,4'-tri-O-acetylresveratrol were administered orally for 7 days before modeling. Four hours after seawater inhalation, histological changes, contents of TNF-alpha, IL-1 beta and IL-10, and the expression of Cx43 in lungs were detected. Besides, the gap junction communication in A549 cells and human umbilical vein endothelial cells (HUVECs) challenged by seawater was also evaluated. Histological changes, increased contents of inflammatory factors, upregulation in gene level, and deregulation in protein level of Cx43 in lungs stimulated by seawater were observed. On the other hand, pretreatment with 3,5,4'-tri-O-acetylresveratrol significantly inhibited infiltration of inflammation, development of pulmonary edema, and contents of inflammatory mediators in lungs. Above all, 3,5,4'-tri-Oacetylresveratrol upregulated the expression of Cx43 in both gene and protein levels, and its intermediate metabolite, resveratrol, also enhanced the gap junction communication in the two cell lines. The results of the present study suggested that administration of 3,5,4'-tri-O-acetylresveratrol may be beneficial for treatment of inflammatorycells in lung.
C1 [Ma, Lijie; Li, Yanyan; Zhao, Yilin; Nan, Yandong; Mu, Deguang; Li, Wangping; Sun, Ruilin; Jin, Faguang] Fourth Mil Med Univ, Dept Respirat, Tangdu Hosp, Xian 710038, China.
   [Wang, Qingwei] Fourth Mil Med Univ, Dept Pharm, Tangdu Hosp, Xian 710038, China.
   [Liu, Xueying] Fourth Mil Med Univ, Dept Med Chem, Sch Pharm, Xian 710032, China.
C3 Air Force Military Medical University; Air Force Military Medical
   University; Air Force Military Medical University
RP Jin, FG (corresponding author), Fourth Mil Med Univ, Dept Respirat, Tangdu Hosp, Xian 710038, Peoples R China.
EM jinfag@fmmu.edu.cn; weiyingxuan427@163.com
RI ma, li/HOH-7275-2023
FU G&k gold surface project: the mechanisms of hypoxia-inducible factor
   1alpha (HIF-1alpha) in seawater drowning-induced acute lung injury
   (SWD-ALI) [81270124]
FX This work was supported by Grants from the 2012 G&k gold surface
   project: the mechanisms of hypoxia-inducible factor 1 alpha (HIF-1
   alpha) in seawater drowning-induced acute lung injury (SWD-ALI),
   (Project 81270124). Besides, the copyright of this paper has nothing to
   do with those corporations mentioned above who provided the experimental
   materials.
CR Brink PR, 2006, J UROLOGY, V175, P381, DOI 10.1016/S0022-5347(05)00007-8
   Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6
   Ecklund MM, 2012, CRIT CARE NURS CLIN, V24, P601, DOI 10.1016/j.ccell.2012.07.002
   Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20
   Fragopoulou E, 2007, J AGR FOOD CHEM, V55, P80, DOI 10.1021/jf0627221
   Gregorakos L, 2009, LUNG, V187, P93, DOI 10.1007/s00408-008-9132-4
   Koide K, 2011, ACS MED CHEM LETT, V2, P270, DOI 10.1021/ml100159p
   Li JH, 2011, CLIN EXP PHARMACOL P, V38, P269, DOI 10.1111/j.1440-1681.2011.05498.x
   Li JH, 2011, RESP PHYSIOL NEUROBI, V176, P39, DOI 10.1016/j.resp.2011.01.005
   Li L., 2011, STUDY PHARMACOKINETI
   Li Q, 2010, J TRAUMA, V68, P802, DOI 10.1097/TA.0b013e3181bb80ea
   Mann Ashley, 2012, Mo Med, V109, P371
   Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770
   Neves AR, 2012, CURR MED CHEM, V19, P1663
   Scheckenbach KEL, 2011, J VASC RES, V48, P91, DOI 10.1159/000316942
   Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366
   van Beeck EF, 2005, B WORLD HEALTH ORGAN, V83, P853
   Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885
   Zhang JZ, 2010, RESPIRATION, V80, P236, DOI 10.1159/000274384
   Zhang Y, 2011, BIOL PHARM BULL, V34, P1052, DOI 10.1248/bpb.34.1052
NR 20
TC 12
Z9 13
U1 0
U2 13
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0962-9351
EI 1466-1861
J9 MEDIAT INFLAMM
JI Mediat. Inflamm.
PY 2013
VL 2013
AR 182132
DI 10.1155/2013/182132
PG 8
WC Cell Biology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Immunology
GA 112PD
UT WOS:000316603600001
PM 23576849
OA Green Published, gold, Green Submitted
DA 2023-08-21
ER

PT J
AU Huang, XJ
   Zhao, YY
AF Huang, Xiaojia
   Zhao, You-Yang
TI Transgenic Expression of FoxM1 Promotes Endothelial Repair following
   Lung Injury Induced by Polymicrobial Sepsis in Mice
SO PLOS ONE
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; M1B TRANSCRIPTION FACTOR; BETA-CATENIN;
   CELLS; LIVER; PROLIFERATION; PERMEABILITY; REGENERATION; MECHANISMS;
   JUNCTIONS
AB Enhancing endothelial barrier integrity for the treatment of acute lung injury (ALI) is an emerging novel therapeutic strategy. Our previous studies have demonstrated the essential role of FoxM1 in mediating endothelial regeneration and barrier repair following lipopolysaccharide-induced lung injury. However, it remains unclear whether FoxM1 expression is sufficient to promote endothelial repair in experimental models of sepsis. Here, employing the FoxM1 transgenic (FoxM1 Tg) mice, we showed that transgenic expression of FoxM1 promoted rapid recovery of endothelial barrier function and survival in a clinically relevant model of sepsis induced by cecal ligation and puncture (CLP). We observed lung vascular permeability was rapidly recovered and returned to levels similar to baseline at 48 h post-CLP challenge in FoxM1 Tg mice whereas it remained markedly elevated in WT mice. Lung edema and inflammation were resolved only in FoxM1 Tg mice at 24 h post-CLP. 5-bromo-2-deoxyuridine incorporation assay revealed a drastic induction of endothelial proliferation in FoxM1 Tg lungs at 24h post-CLP, correlating with early induction of expression of FoxM1 target genes essential for cell cycle progression. Additionally, deletion of FoxM1 in endothelial cells, employing the mouse model with endothelial cell-restricted disruption of FoxM1 (FoxM1 CKO) resulted in impaired endothelial repair following CLP challenge. Together, these data suggest FoxM1 expression in endothelial cells is necessary and sufficient to mediate endothelial repair and thereby promote survival following sepsis challenge.
C1 [Huang, Xiaojia; Zhao, You-Yang] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607, United States.
   [Huang, Xiaojia; Zhao, You-Yang] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL, United States.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital
RP Zhao, YY (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA.
EM yyzhao@uic.edu
OI ZHAO, YOU-YANG/0000-0002-0041-0339
FU National Institutes of Health [R01HL085462, P01HL077806]
FX This study was supported by National Institutes of Health grants
   R01HL085462 and P01HL077806 to YYZ. The funders had no role in design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a
   Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854
   Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157
   Cines DB, 1998, BLOOD, V91, P3527
   CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0
   Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357
   Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011
   Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200
   Kaestner KH, 2000, GENE DEV, V14, P142
   Kalinichenko VV, 2003, J BIOL CHEM, V278, P37888, DOI 10.1074/jbc.M305555200
   Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704
   Kolosova IA, 2008, AM J PHYSIOL-LUNG C, V294, pL319, DOI 10.1152/ajplung.00283.2007
   Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217
   Liu YR, 2011, J EXP MED, V208, P1473, DOI 10.1084/jem.20102041
   Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004
   Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Minamino T, 2006, J CLIN INVEST, V116, P2316, DOI 10.1172/JCI29637
   Mirza MK, 2010, J EXP MED, V207, P1675, DOI 10.1084/jem.20091857
   Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC
   Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51
   Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005
   Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2
   Ye HG, 1999, MOL CELL BIOL, V19, P8570
   Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626
   Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154
NR 31
TC 24
Z9 24
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 20
PY 2012
VL 7
IS 11
AR e50094
DI 10.1371/journal.pone.0050094
PG 8
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 043II
UT WOS:000311535700068
PM 23185540
OA Green Submitted, Green Published, gold
DA 2023-08-21
ER

PT J
AU Chichger, H
   Grinnell, KL
   Casserly, B
   Chung, CS
   Braza, J
   Lomas-Neira, J
   Ayala, A
   Rounds, S
   Klinger, JR
   Harrington, EO
AF Chichger, Havovi
   Grinnell, Katie L.
   Casserly, Brian
   Chung, Chun-Shiang
   Braza, Julie
   Lomas-Neira, Joanne L.
   Ayala, Alfred
   Rounds, Sharon
   Klinger, James R.
   Harrington, Elizabeth O.
TI Genetic disruption of protein kinase C delta reduces endotoxin-induced
   lung injury
SO AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
LA English
DT Article
ID KAPPA-B ACTIVATION; PKC-DELTA; ENDOTHELIAL-CELLS; BARRIER FUNCTION;
   PULMONARY-EDEMA; IN-VIVO; EXPRESSION; PHOSPHORYLATION; PROLIFERATION;
   INVOLVEMENT
AB Chichger H, Grinnell KL, Casserly B, Chung C, Braza J, Lomas-Neira J, Ayala A, Rounds S, Klinger JR, Harrington EO. Genetic disruption of protein kinase C delta reduces endotoxin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 303: L880-L888, 2012. First published September 14, 2012; doi:10.1152/ajplung.00169.2012.-The pathogenesis of acute lung injury and acute respiratory distress syndrome is characterized by sequestration of leukocytes in lung tissue, disruption of capillary integrity, and pulmonary edema. PKC delta plays a critical role in RhoA-mediated endothelial barrier function and inflammatory responses. We used mice with genetic deletion of PKC delta (PKC delta(-/-)) to assess the role of PKC delta in susceptibility to LPS-induced lung injury and pulmonary edema. Under baseline conditions or in settings of increased capillary hydrostatic pressures, no differences were noted in the filtration coefficients (k(f)) or wet-to-dry weight ratios between PKC delta(-/-) and PKC delta(-/-) mice. However, at 24 h after exposure to LPS, the kf values were significantly higher in lungs isolated from PKC delta(-/-) than PKC delta(-/-) mice. In addition, bronchoalveolar lavage fluid obtained from LPS-exposed PKC delta(-/-) mice displayed increased protein and cell content compared with LPS-exposed PKC delta(-/-) mice, but similar changes in inflammatory cytokines were measured. Histology indicated elevated LPS-induced cellularity and inflammation within PKC delta(-/-) mouse lung parenchyma relative to PKC delta(-/-) mouse lungs. Transient overexpression of catalytically inactive PKC delta cDNA in the endothelium significantly attenuated LPS-induced endothelial barrier dysfunction in vitro and increased k(f) lung values in PKC delta(-/-) mice. However, transient overexpression of wild-type PKC delta cDNA in PKC delta(-/-) mouse lung vasculature did not alter the protective effects of PKC delta deficiency against LPS-induced acute lung injury. We conclude that PKC delta plays a role in the pathological progression of endotoxin-induced lung injury, likely mediated through modulation of inflammatory signaling and pulmonary vascular barrier function.
C1 [Chichger, Havovi; Grinnell, Katie L.; Casserly, Brian; Braza, Julie; Rounds, Sharon; Klinger, James R.; Harrington, Elizabeth O.] Providence Vet Affairs Med Ctr, Vasc Res Lab, Providence, RI, United States.
   [Chichger, Havovi; Grinnell, Katie L.; Casserly, Brian; Braza, Julie; Rounds, Sharon; Klinger, James R.; Harrington, Elizabeth O.] Brown Univ, Dept Med, Alpert Med Sch, Providence, RI 02912, United States.
   [Chung, Chun-Shiang; Lomas-Neira, Joanne; Ayala, Alfred] Brown Univ, Dept Surg, Alpert Med Sch, Providence, RI 02912, United States.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Providence VA Medical Center; Brown University; Brown University
RP Harrington, EO (corresponding author), Providence VA Med Ctr, Res Serv, 151 830 Chalkstone Ave, Providence, RI 02908 USA.
EM Elizabeth_Harrington@brown.edu
RI Chichger, Havovi/Y-7117-2019; Rounds, Sharon/AAF-7380-2020; Chichger,
   Havovi/M-5129-2015
OI Chichger, Havovi/0000-0002-8549-7583; Chichger,
   Havovi/0000-0002-8549-7583; Harrington, Elizabeth/0000-0002-3207-5301;
   Ayala, Alfred/0000-0002-5034-2995
FU National Heart, Lung, and Blood Institute [R01 HL-67795, T32 HL-094300];
   American Heart Association [10GRNT4160055]
FX This material is the result of work supported with resources and the use
   of facilities at the Providence Veterans Affairs Medical Center and
   supported by National Heart, Lung, and Blood Institute Grant R01
   HL-67795 and American Heart Association Grant 10GRNT4160055 to E. O.
   Harrington. K. L. Grinnell was supported by National Heart, Lung, and
   Blood Institute Grant T32 HL-094300.
CR Bai X, 2010, ARTERIOSCL THROM VAS, V30, P2467, DOI 10.1161/ATVBAHA.110.215723
   Bair AM, 2009, J BIOL CHEM, V284, P563, DOI 10.1074/jbc.M803984200
   Bey EA, 2004, J IMMUNOL, V173, P5730, DOI 10.4049/jimmunol.173.9.5730
   BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913
   Bright R, 2004, J NEUROSCI, V24, P6880, DOI 10.1523/JNEUROSCI.4474-03.2004
   Bright R, 2007, BRAIN RES, V1144, P146, DOI 10.1016/j.brainres.2007.01.113
   Chou WH, 2004, J CLIN INVEST, V114, P49, DOI 10.1172/JC1200421655
   Garcia JGN, 1998, J APPL PHYSIOL, V84, P1817, DOI 10.1152/jappl.1998.84.5.1817
   Gaudreault N, 2008, ARTERIOSCL THROM VAS, V28, P1527, DOI 10.1161/ATVBAHA.108.166975
   Grinnell KL, 2010, AM J PHYSIOL-LUNG C, V298, pL361, DOI 10.1152/ajplung.00374.2009
   Grinnell K, 2012, J CELL PHYSIOL, V227, P1899, DOI 10.1002/jcp.22918
   Grinnell KL, 2012, AM J RESP CELL MOL, V46, P623, DOI 10.1165/rcmb.2011-0271OC
   Harrington EO, 2005, EXP CELL RES, V308, P407, DOI 10.1016/j.yexcr.2005.05.005
   Harrington EO, 2003, AM J RESP CELL MOL, V28, P626, DOI 10.1165/rcmb.2002-0085OC
   Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200
   Kamochi M, 1999, AM J PHYSIOL-LUNG C, V277, pL310, DOI 10.1152/ajplung.1999.277.2.L310
   Kandasamy K, 2012, MICROVASC RES, V83, P323, DOI 10.1016/j.mvr.2012.01.006
   Kilpatrick LE, 2011, J LEUKOCYTE BIOL, V89, P3, DOI 10.1189/jlb.0510281
   Kim YA, 2010, NEUROSCI LETT, V468, P254, DOI 10.1016/j.neulet.2009.11.007
   Klinger JR, 2007, J APPL PHYSIOL, V103, P2084, DOI 10.1152/japplphysiol.00695.2007
   Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652
   Leitges M, 2001, J CLIN INVEST, V108, P1505
   Lu Q, 2009, AM J PHYSIOL-LUNG C, V296, pL825, DOI 10.1152/ajplung.90307.2008
   Martin K, 2008, LUNG, V186, P145, DOI 10.1007/s00408-008-9073-y
   Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158
   Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH946, DOI 10.1152/ajpheart.00878.2003
   Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH937, DOI 10.1152/ajpheart.00877.2003
   Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a
   Minami T, 2003, J BIOL CHEM, V278, P6976, DOI 10.1074/jbc.M208974200
   Minhajuddin M, 2009, J BIOL CHEM, V284, P4052, DOI 10.1074/jbc.M805032200
   Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a
   Qi X, 2008, J CLIN INVEST, V118, P173, DOI 10.1172/JCI32636
   Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001
   Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934
   Shukla A, 2007, AM J PATHOL, V170, P140, DOI 10.2353/ajpath.2007.060381
   Tinsley JH, 2004, AM J PHYSIOL-CELL PH, V286, pC105, DOI 10.1152/ajpcell.00340.2003
   Tiruppathi C, 2008, J BIOL CHEM, V283, P4210, DOI 10.1074/jbc.M703153200
   UHLIG S, 1994, J PHARMACOL TOXICOL, V31, P85, DOI 10.1016/1056-8719(94)90047-7
   Waki K, 2006, FREE RADICAL RES, V40, P359, DOI 10.1080/10715760500539121
   Zhao XX, 2005, J LEUKOCYTE BIOL, V77, P414, DOI 10.1189/jlb.0504284
   Zhou MY, 1998, J CLIN INVEST, V101, P2427, DOI 10.1172/JCI407
NR 41
TC 24
Z9 26
U1 0
U2 5
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1040-0605
EI 1522-1504
J9 AM J PHYSIOL-LUNG C
JI Am. J. Physiol.-Lung Cell. Mol. Physiol.
PD NOV
PY 2012
VL 303
IS 10
BP L880
EP L888
DI 10.1152/ajplung.00169.2012
PG 9
WC Physiology; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Respiratory System
GA 038XW
UT WOS:000311208400005
PM 22983354
OA Green Published
DA 2023-08-21
ER

PT J
AU Coulthard, MG
   Morgan, M
   Woodruff, TM
   Arumugam, TV
   Taylor, SM
   Carpenter, TC
   Lackmann, M
   Boyd, AW
AF Coulthard, Mark G.
   Morgan, Michael
   Woodruff, Trent M.
   Arumugam, Thiruma V.
   Taylor, Stephen M.
   Carpenter, Todd C.
   Lackmann, Martin
   Boyd, Andrew W.
TI Eph/Ephrin Signaling in Injury and Inflammation
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Review
ID RECEPTOR TYROSINE KINASE; FACTOR-ALPHA INDUCTION; EPH RECEPTORS;
   ENDOTHELIAL-CELLS; UP-REGULATION; RETINAL NEOVASCULARIZATION; AXONAL
   REGENERATION; SUPERIOR COLLICULUS; ASTROCYTIC GLIOSIS; REPERFUSION
   INJURY
AB The Eph/ephrin receptor-ligand system plays an important role in embryogenesis and adult life, principally by influencing cell behavior through signaling pathways, resulting in modification of the cell cytoskeleton and cell adhesion. There are 10 EphA receptors, and six EphB receptors, distinguished on sequence difference and binding preferences, that interact with the six glycosylphosphatidylinositol-linked ephrin-A ligands and the three transmembrane ephrin-B ligands, respectively. The Eph/ephrin proteins, originally described as developmental regulators that are expressed at low levels postembryonically, are re-expressed after injury to the optic nerve, spinal cord, and brain in fish, amphibians, rodents, and humans. In rodent spinal cord injury, the upregulation of EphA4 prevents recovery by inhibiting axons from crossing the injury site. Eph/ephrin proteins may be partly responsible for the phenotypic changes to the vascular endothelium in inflammation, which, allows fluid and inflammatory cells to pass from the vascular space into the interstitial tissues. Specifically, EphA2/ephrin-A1 signaling in the lung may be responsible for pulmonary inflammation in acute lung injury. A role in T-cell maturation and chronic inflammation (heart failure, inflammatory bowel disease, and rheumatoid arthritis) is also reported. Although there remains much to learn about Eph/ephrin signaling in human disease, and specifically in injury and inflammation, this area of research raises the exciting prospect that novel therapies will be developed that precisely target these pathways. (Am J Pathol 2012, 181:1493-1503; http://dx.doi.org/10.1016/j.ajpath.2012.06.043)
C1 [Coulthard, Mark G.] Royal Childrens Hosp, Paediat Intens Care Unit, Herston, Qld 4029, Australia.
   [Coulthard, Mark G.; Boyd, Andrew W.] Royal Childrens Hosp, Queensland Childrens Med Res Inst, Herston, Qld 4029, Australia.
   [Coulthard, Mark G.] Univ Queensland, Acad Discipline Paediat & Child Hlth, Herston, Qld, Australia.
   [Coulthard, Mark G.; Boyd, Andrew W.] Queensland Inst Med Res, Leukaemia Fdn Lab, Herston, Qld 4006, Australia.
   [Morgan, Michael; Woodruff, Trent M.; Arumugam, Thiruma V.; Taylor, Stephen M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.
   [Carpenter, Todd C.] Univ Colorado Denver, Pediat Crit Care Sect, Aurora, CO, United States.
   [Lackmann, Martin] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia.
   [Boyd, Andrew W.] Univ Queensland, Royal Brisbane Womens Hosp, Acad Discipline Med, Herston, Qld, Australia.
C3 Royal Children's Hospital Brisbane; Royal Children's Hospital Brisbane;
   University of Queensland; QIMR Berghofer Medical Research Institute;
   University of Queensland; Children's Hospital Colorado; University of
   Colorado System; University of Colorado Anschutz Medical Campus; Monash
   University; Royal Brisbane & Women's Hospital; University of Queensland
RP Coulthard, MG (corresponding author), Royal Childrens Hosp, Paediat Intens Care Unit, Herston, Qld 4029, Australia.
EM mark_coulthard@health.qld.gov.au
RI Morgan, Michael/AAC-2044-2021; Arumugam, Thiruma/AAG-6958-2019;
   Woodruff, Trent M/B-4861-2009; Coulthard, Mark G/AAT-7735-2021;
   Coulthard, Mark Graeme/E-9444-2010; Carpenter, Todd/A-7503-2011;
   Arumugam, Thiruma Valavan/B-4898-2011; Morgan, Michael/C-1323-2015;
   Woodruff, Trent/AAS-4629-2020
OI Morgan, Michael/0000-0002-3641-2774; Woodruff, Trent
   M/0000-0003-1382-911X; Coulthard, Mark G/0000-0001-7400-5582; Coulthard,
   Mark Graeme/0000-0001-7400-5582; Carpenter, Todd/0000-0002-9855-0021;
   Morgan, Michael/0000-0002-3641-2774; Woodruff,
   Trent/0000-0003-1382-911X; Arumugam, Thiruma/0000-0002-3377-0939
CR Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875
   Afshari FT, 2010, J NEUROSCI, V30, P4246, DOI 10.1523/JNEUROSCI.3351-09.2010
   Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae
   Ait-Oufella H, 2010, INTENS CARE MED, V36, P1286, DOI 10.1007/s00134-010-1893-6
   Arocho LC, 2011, CELL MOL NEUROBIOL, V31, P1057, DOI 10.1007/s10571-011-9705-2
   Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408
   Baldwin C, 2006, AM J PHYSIOL-RENAL, V291, pF960, DOI 10.1152/ajprenal.00020.2006
   Baum CL, 2005, DERMATOL SURG, V31, P674
   Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403
   Bernhardt RR, 1999, EXP NEUROL, V157, P223, DOI 10.1006/exnr.1999.7059
   Blits-Huizinga CT, 2004, IUBMB LIFE, V56, P257, DOI 10.1080/15216540412331270076
   Bundesen LQ, 2003, J NEUROSCI, V23, P7789
   Cannon RO, 2005, NAT CLIN PRACT CARD, V2, P88, DOI 10.1038/ncpcardio0096
   Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027
   Carmichael ST, 2003, CURR OPIN NEUROL, V16, P699, DOI 10.1097/00019052-200312000-00009
   Carpenter TC, 2012, AM J RESP CELL MOL, V46, P40, DOI 10.1165/rcmb.2011-0044OC
   Cercone MA, 2009, AM J PHYSIOL-LUNG C, V297, pL856, DOI 10.1152/ajplung.00118.2009
   Chan B, 2009, THROMB RES, V123, P745, DOI 10.1016/j.thromres.2008.07.010
   Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007
   Chen J, 2006, EXP EYE RES, V82, P664, DOI 10.1016/j.exer.2005.09.004
   Cheng N, 2001, J BIOL CHEM, V276, P13771, DOI 10.1074/jbc.M009147200
   Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019
   Cruz-Orengo L, 2006, EXP NEUROL, V202, P421, DOI 10.1016/j.expneurol.2006.07.005
   Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   DIXIT VM, 1990, J BIOL CHEM, V265, P2973
   Dries JL, 2011, J PHYSIOL-LONDON, V589, P1725, DOI 10.1113/jphysiol.2010.202366
   Fabes J, 2007, EUR J NEUROSCI, V26, P2496, DOI 10.1111/j.1460-9568.2007.05859.x
   Fang BW, 2008, J CELL SCI, V121, P358, DOI 10.1242/jcs.017145
   Flanagan JG, 1997, CELL, V90, P403
   Frugier T, 2012, J NEUROPATH EXP NEUR, V71, P242, DOI 10.1097/NEN.0b013e3182496149
   Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048
   Giger RJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001867
   Goichberg P, 2011, CIRC RES, V108, P1071, DOI 10.1161/CIRCRESAHA.110.239459
   Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011
   Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004
   Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006
   Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636
   Goldshmit Y, 2010, J NEUROTRAUM, V27, P1321, DOI 10.1089/neu.2010.1294
   Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849
   Hafner C, 2005, WORLD J GASTROENTERO, V11, P4511, DOI 10.3748/wjg.v11.i29.4511
   Hafner C, 2005, WORLD J GASTROENTERO, V11, P4024, DOI 10.3748/wjg.v11.i26.4024
   Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237
   Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107
   Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004
   Hui SP, 2010, DEV DYNAM, V239, P2962, DOI 10.1002/dvdy.22438
   Hwan AY, 2006, BIOCHEM BIOPH RES CO, V348, P560, DOI 10.1016/j.bbrc.2006.07.105
   Irizarry-Ramirez M, 2005, J NEUROTRAUM, V22, P929, DOI 10.1089/neu.2005.22.929
   Islam S, 2010, DIGEST DIS SCI, V55, P2478, DOI 10.1007/s10620-009-1102-z
   Ivanov AI, 2005, PHYSIOL GENOMICS, V21, P152, DOI 10.1152/physiolgenomics.00043.2004
   Ivanov AI, 2006, IUBMB LIFE, V58, P389, DOI 10.1080/15216540600756004
   Janes PW, 2012, SEMIN CELL DEV BIOL, V23, P43, DOI 10.1016/j.semcdb.2012.01.001
   Janes PW, 2011, J CELL BIOL, V195, P1033, DOI 10.1083/jcb.201104037
   Janes PW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000215
   Munoz JJ, 2011, NEUROIMMUNOMODULAT, V18, P271, DOI 10.1159/000329490
   Kitamura T, 2008, AM J PHYSIOL-CELL PH, V294, pC189, DOI 10.1152/ajpcell.00314.2007
   Knoll B, 2001, MECH DEVELOP, V106, P119, DOI 10.1016/S0925-4773(01)00431-2
   Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389
   Kume T, 2010, HISTOL HISTOPATHOL, V25, P637, DOI 10.14670/HH-25.637
   Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2
   Larson J, 2008, AM J PHYSIOL-LUNG C, V295, pL431, DOI 10.1152/ajplung.90256.2008
   Li YY, 1998, AM J PHYSIOL-HEART C, V274, pH331, DOI 10.1152/ajpheart.1998.274.1.H331
   Liu X, 2006, J NEUROSCI, V26, P3087, DOI 10.1523/JNEUROSCI.4797-05.2006
   London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678
   Maeda S, 2011, CELL MOL LIFE SCI, V68, P1115, DOI 10.1007/s00018-010-0551-z
   Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020
   Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Miao H, 2012, SEMIN CELL DEV BIOL, V23, P16, DOI 10.1016/j.semcdb.2011.10.013
   Miranda JD, 1999, EXP NEUROL, V156, P218, DOI 10.1006/exnr.1998.7012
   Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625
   Nievergall E, 2012, CELL MOL LIFE SCI, V69, P1813, DOI 10.1007/s00018-011-0900-6
   Ojima T, 2006, AM J PATHOL, V168, P331, DOI 10.2353/ajpath.2006.050435
   Okazaki T, 2009, AM J PATHOL, V174, P2388, DOI 10.2353/ajpath.2009.080949
   Orsulic S, 2000, J CELL SCI, V113, P1793
   PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959
   Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011
   Pfaff D, 2008, J CELL SCI, V121, P3842, DOI 10.1242/jcs.030627
   Pitulescu ME, 2010, GENE DEV, V24, P2480, DOI 10.1101/gad.1973910
   Robbins SL, 1999, ROBBINS PATHOLOGIC B, P52
   Rodger J, 2001, EUR J NEUROSCI, V14, P1929, DOI 10.1046/j.0953-816x.2001.01822.x
   Rosas OR, 2011, DEV NEUROBIOL, V71, P595, DOI 10.1002/dneu.20848
   Ruan JP, 2010, ANESTHESIOLOGY, V112, P1234, DOI 10.1097/ALN.0b013e3181d3e0df
   Schruefer R, 2006, J VASC RES, V43, P1, DOI 10.1159/000088975
   Scicolone G, 2009, BRAIN RES BULL, V79, P227, DOI 10.1016/j.brainresbull.2009.03.008
   Sharfe N, 2008, MOL IMMUNOL, V45, P1208, DOI 10.1016/j.molimm.2007.09.019
   Sobel RA, 2005, BRAIN PATHOL, V15, P35
   Sohl M, 2010, BIOCHEM BIOPH RES CO, V391, P24, DOI 10.1016/j.bbrc.2009.10.146
   Tanaka M, 2005, J BIOL CHEM, V280, P42375, DOI 10.1074/jbc.M503786200
   Tat SK, 2008, ARTHRITIS RHEUM-US, V58, P3820, DOI 10.1002/art.24029
   Ting MJ, 2010, EXP HEMATOL, V38, P1087, DOI 10.1016/j.exphem.2010.07.007
   Trinidad EM, 2010, CELL ADHES MIGR, V4, P363, DOI 10.4161/cam.4.3.11586
   Vearing CJ, 2005, GROWTH FACTORS, V23, P67, DOI 10.1080/08977190500055869
   Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje
   Wilkinson DG, 2000, INT REV CYTOL, V196, P177
   Willson CA, 2006, J MOL HISTOL, V37, P369, DOI 10.1007/s10735-006-9067-0
   Wong SY, 2010, J R SOC INTERFACE, V7, pS351, DOI 10.1098/rsif.2010.0018.focus
   Wykosky J, 2008, ONCOGENE, V27, P7260, DOI 10.1038/onc.2008.328
   Yamashita T, 2008, J BIOL CHEM, V283, P18926, DOI 10.1074/jbc.M709133200
   Zamora DO, 2006, CELL IMMUNOL, V242, P99, DOI 10.1016/j.cellimm.2006.10.001
   Zhang R, 2010, PSYCHIAT RES, V180, P5, DOI 10.1016/j.psychres.2010.04.037
   Zhou N, 2011, MICROVASC RES, V82, P113, DOI 10.1016/j.mvr.2011.06.005
NR 102
TC 151
Z9 153
U1 4
U2 35
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD NOV
PY 2012
VL 181
IS 5
BP 1493
EP 1503
DI 10.1016/j.ajpath.2012.06.043
PG 11
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 031QK
UT WOS:000310656800002
PM 23021982
OA hybrid
DA 2023-08-21
ER

PT J
AU Armstrong, SM
   Wang, CS
   Tigdi, J
   Si, XE
   Dumpit, C
   Charles, S
   Gamage, A
   Moraes, TJ
   Lee, WL
AF Armstrong, Susan M.
   Wang, Changsen
   Tigdi, Jayesh
   Si, Xiaoe
   Dumpit, Carlo
   Charles, Steffany
   Gamage, Asela
   Moraes, Theo J.
   Lee, Warren L.
TI Influenza Infects Lung Microvascular Endothelium Leading to
   Microvascular Leak: Role of Apoptosis and Claudin-5
SO PLOS ONE
LA English
DT Article
ID TIGHT JUNCTION STRANDS; BLOOD-BRAIN-BARRIER; CELLS; VIRUS; INJURY;
   EXPRESSION; HOSPITALIZATION; PERMEABILITY; DYSFUNCTION; MECHANISMS
AB Severe influenza infections are complicated by acute lung injury, a syndrome of pulmonary microvascular leak. The pathogenesis of this complication is unclear. We hypothesized that human influenza could directly infect the lung microvascular endothelium, leading to loss of endothelial barrier function. We infected human lung microvascular endothelium with both clinical and laboratory strains of human influenza. Permeability of endothelial monolayers was assessed by spectrofluorimetry and by measurement of the transendothelial electrical resistance. We determined the molecular mechanisms of flu-induced endothelial permeability and developed a mouse model of severe influenza. We found that both clinical and laboratory strains of human influenza can infect and replicate in human pulmonary microvascular endothelium, leading to a marked increase in permeability. This was caused by apoptosis of the lung endothelium, since inhibition of caspases greatly attenuated influenza-induced endothelial leak. Remarkably, replication-deficient virus also caused a significant degree of endothelial permeability, despite displaying no cytotoxic effects to the endothelium. Instead, replication-deficient virus induced degradation of the tight junction protein claudin-5; the adherens junction protein VE-cadherin and the actin cytoskeleton were unaffected. Over-expression of claudin-5 was sufficient to prevent replication-deficient virus-induced permeability. The barrier-protective agent formoterol was able to markedly attenuate flu-induced leak in association with dose-dependent induction of claudin-5. Finally, mice infected with human influenza developed pulmonary edema that was abrogated by parenteral treatment with formoterol. Thus, we describe two distinct mechanisms by which human influenza can induce pulmonary microvascular leak. Our findings have implications for the pathogenesis and treatment of acute lung injury from severe influenza.
C1 [Armstrong, Susan M.; Gamage, Asela; Moraes, Theo J.; Lee, Warren L.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada.
   [Wang, Changsen; Tigdi, Jayesh; Dumpit, Carlo; Charles, Steffany; Lee, Warren L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada.
   [Si, Xiaoe; Moraes, Theo J.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada.
   [Lee, Warren L.] Univ Toronto, Fac Med, Div Respirol, Toronto, ON, Canada.
   [Lee, Warren L.] Univ Toronto, Fac Med, Interdept Div Crit Care Med, Toronto, ON, Canada.
C3 University of Toronto; University of Toronto; Li Ka Shing Knowledge
   Institute; Saint Michaels Hospital Toronto; University of Toronto;
   Hospital for Sick Children (SickKids); University of Toronto; University
   of Toronto
RP Lee, WL (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada.
EM warren.lee@utoronto.ca
RI Moraes, Theo/CAJ-3254-2022
OI Moraes, Theo/0000-0001-9968-6601; Lee, Warren/0000-0002-1788-6587
FU Canadian Institutes of Health Research; Ontario Thoracic Society;
   Physician Services Incorporated Foundation; Government of Ontario; CIHR;
   McLaughlin Centre
FX WLL is supported by the Canadian Institutes of Health Research, the
   Ontario Thoracic Society, the Physician Services Incorporated Foundation
   and an Early Researcher Award from the Government of Ontario. SMA is
   supported by a MD/PhD Studentship award from the CIHR and an MD/PhD
   Studentship award from the McLaughlin Centre. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abe Y, 1999, J IMMUNOL, V163, P2867
   Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a
   Armstrong SM, 2012, AM J PATHOL, V180, P1308, DOI 10.1016/j.ajpath.2011.12.002
   Szretter Kristy J, 2006, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g01s29, 10.1002/0471729256.mc15g01s3]
   Beese M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-68
   COLDENSTANFIELD M, 1993, J IMMUNOL, V151, P310
   Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815
   Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42
   CRAWFORD DH, 1983, J GEN VIROL, V64, P697, DOI 10.1099/0022-1317-64-3-697
   Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536
   Feldmann A, 2000, J VIROL, V74, P8018, DOI 10.1128/JVI.74.17.8018-8027.2000
   Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486
   Gillrie MR, 2007, BLOOD, V110, P3426, DOI 10.1182/blood-2007-04-084582
   Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011
   Goto H, 2010, AM J RESP CRIT CARE, V181, P1336, DOI 10.1164/rccm.200907-1002OC
   HANASAKI K, 1994, J BIOL CHEM, V269, P10637
   Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943
   Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511
   Ishizaki T, 2003, EXP CELL RES, V290, P275, DOI 10.1016/S0014-4827(03)00354-9
   Jang AS, 2011, AM J RESP CELL MOL, V44, P483, DOI 10.1165/rcmb.2009-0391OC
   Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525
   Kawasaki M, 2000, AM J PATHOL, V157, P597, DOI 10.1016/S0002-9440(10)64570-1
   Klenk HD, 2005, THROMB HAEMOSTASIS, V94, P262, DOI 10.1160/TH05-04-0264
   KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415
   Kuster SP, 2010, EUR J CLIN MICROBIOL, V29, P835, DOI 10.1007/s10096-010-0935-x
   Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001
   Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040
   London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678
   Mandel I, 2012, J CELL BIOCHEM, V113, P2415, DOI 10.1002/jcb.24118
   McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185
   Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511
   Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070
   PATTERSON CE, 1992, J APPL PHYSIOL, V72, P865, DOI 10.1152/jappl.1992.72.3.865
   Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35
   Sartori C, 2002, NEW ENGL J MED, V346, P1631, DOI 10.1056/NEJMoa013183
   Sayner SL, 2011, AM J PHYSIOL-LUNG C, V300, pL667, DOI 10.1152/ajplung.00433.2010
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Smith FG, 2012, LANCET, V379, P229, DOI 10.1016/S0140-6736(11)61623-1
   Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015
   Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179
   Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344
   Visseren FLJ, 1999, J LAB CLIN MED, V134, P623, DOI 10.1016/S0022-2143(99)90103-8
   Wang SY, 2010, J INFECT DIS, V202, P991, DOI 10.1086/656044
   Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0
   WojtowiczPraga SM, 1997, INVEST NEW DRUG, V15, P61, DOI 10.1023/A:1005722729132
   Yao L, 2008, FASEB J, V22, P733, DOI 10.1096/fj.06-7880com
   Yuan L, 2012, J BIOL CHEM
NR 49
TC 85
Z9 90
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 24
PY 2012
VL 7
IS 10
AR e47323
DI 10.1371/journal.pone.0047323
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 026VC
UT WOS:000310310200034
PM 23115643
OA gold, Green Submitted, Green Published
DA 2023-08-21
ER

PT J
AU Tauseef, M
   Knezevic, N
   Chava, KR
   Smith, M
   Sukriti, S
   Gianaris, N
   Obukhov, AG
   Vogel, SM
   Schraufnagel, DE
   Dietrich, A
   Birnbaumer, L
   Malik, AB
   Mehta, D
AF Tauseef, Mohammad
   Knezevic, Nebojsa
   Chava, Koteswara Rao
   Smith, Monica
   Sukriti, Sukriti
   Gianaris, Nicholas
   Obukhov, Alexander G.
   Vogel, Stephen M.
   Schraufnagel, Dean E.
   Dietrich, Alexander
   Birnbaumer, Lutz
   Malik, Asrar B.
   Mehta, Dolly
TI TLR4 activation of TRPC6-dependent calcium signaling mediates
   endotoxin-induced lung vascular permeability and inflammation
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID LIGHT-CHAIN KINASE; NF-KAPPA-B; INCREASED ENDOTHELIAL PERMEABILITY;
   PATTERN-RECOGNITION RECEPTORS; C REGULATES ACTIVATION; TOLL-LIKE
   RECEPTOR-4; PHOSPHOLIPASE-C; CA2+ ENTRY; IN-VIVO; MICROVASCULAR
   PERMEABILITY
AB Lung vascular endothelial barrier disruption and the accompanying inflammation are primary pathogenic features of acute lung injury (ALI); however, the basis for the development of both remains unclear. Studies have shown that activation of transient receptor potential canonical (TRPC) channels induces Ca2+ entry, which is essential for increased endothelial permeability. Here, we addressed the role of Toll-like receptor 4 (TLR4) intersection with TRPC6-dependent Ca2+ signaling in endothelial cells (ECs) in mediating lung vascular leakage and inflammation. We find that the endotoxin (lipopolysaccharide; LPS) induces Ca2+ entry in ECs in a TLR4-dependent manner. Moreover, deletion of TRPC6 renders mice resistant to endotoxin-induced barrier dysfunction and inflammation, and protects against sepsis-induced lethality. TRPC6 induces Ca2+ entry in ECs, which is secondary to the generation of diacylglycerol (DAG) induced by LPS. Ca2+ entry mediated by TRPC6, in turn, activates the nonmuscle myosin light chain kinase (MYLK), which not only increases lung vascular permeability but also serves as a scaffold to promote the inter-action of myeloid differentiation factor 88 and IL-1R-associated kinase 4, which are required for NF-kappa B activation and lung inflammation. Our findings suggest that TRPC6-dependent Ca2+ entry into ECs, secondary to TLR4-induced DAG generation, participates in mediating both lung vascular barrier disruption and inflammation induced by endotoxin.
C1 [Tauseef, Mohammad; Knezevic, Nebojsa; Chava, Koteswara R.; Smith, Monica; Sukriti, Sukriti; Vogel, Stephen M.; Malik, Asrar B.; Mehta, Dolly] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 61605, United States.
   [Tauseef, Mohammad; Knezevic, Nebojsa; Chava, Koteswara R.; Smith, Monica; Sukriti, Sukriti; Vogel, Stephen M.; Malik, Asrar B.; Mehta, Dolly] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 61605, United States.
   [Schraufnagel, Dean E.] Univ Illinois, Coll Med, Dept Med, Chicago, IL 61605, United States.
   [Gianaris, Nicholas; Obukhov, Alexander G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202, United States.
   [Dietrich, Alexander] Univ Munich, Walther Straub Inst Pharmacol & Toxicol, D-80336 Munich, Germany.
   [Birnbaumer, Lutz] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC 27709, United States.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital;
   University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; Indiana University System;
   Indiana University Bloomington; University of Munich; National
   Institutes of Health (NIH) - USA; NIH National Institute of
   Environmental Health Sciences (NIEHS)
RP Mehta, D (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 61605 USA.
EM dmehta@uic.edu
RI Knezevic, MD, PhD, Nebojsa Nick/H-9921-2019; Dietrich,
   Alexander/G-8619-2013; Obukhov, Alexander G/C-7246-2008
OI Knezevic, MD, PhD, Nebojsa Nick/0000-0001-8028-1495; Dietrich,
   Alexander/0000-0002-1168-8707; Obukhov, Alexander G/0000-0002-3862-6004;
   Tauseef, Mohammad/0000-0001-5317-4379; Baweja,
   Sukriti/0000-0002-8677-9857; Schraufnagel, Dean/0000-0003-0063-7223;
   Malik, Asrar/0000-0002-8205-7128
FU National Institutes of Health [HL71794, HL84153, P01-HL60678]; American
   Heart Association postdoctoral fellowship [10POST2600336]; Intramural
   Research Division of the National Institutes of Health [Z01-ES-101684]
FX This work was supported by National Institutes of Health grants HL71794
   (D. Mehta), HL84153 (D. Mehta) and P01-HL60678 (D. Mehta and A.B.
   Malik), American Heart Association postdoctoral fellowship to M. Tauseef
   (10POST2600336), and in part by the Intramural Research Division of the
   National Institutes of Health (project Z01-ES-101684 to LB).
CR Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510
   Andonegui G, 2002, J IMMUNOL, V169, P2111, DOI 10.4049/jimmunol.169.4.2111
   Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411
   Bachmaier K, 2007, NAT MED, V13, P920, DOI 10.1038/nm1607
   BARNARD JW, 1995, J IMMUNOL, V155, P4876
   Bertocchi C, 2011, CELL PHYSIOL BIOCHEM, V28, P625, DOI 10.1159/000335758
   Blue EK, 2002, AM J PHYSIOL-CELL PH, V282, pC451, DOI 10.1152/ajpcell.00333.2001
   Cheng HW, 2006, ARTERIOSCL THROM VAS, V26, P1768, DOI 10.1161/01.ATV.0000231518.86795.0f
   Di AK, 2012, NAT IMMUNOL, V13, P29, DOI 10.1038/ni.2171
   Di AK, 2010, J BIOL CHEM, V285, P15848, DOI 10.1074/jbc.M109.075549
   Diaz JV, 2010, CRIT CARE MED, V38, P1644, DOI 10.1097/CCM.0b013e3181e795ee
   Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0
   Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005
   Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158
   Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995
   Gao XP, 2002, J IMMUNOL, V168, P3974, DOI 10.4049/jimmunol.168.8.3974
   GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311
   Garcia JGN, 1997, AM J RESP CELL MOL, V16, P489, DOI 10.1165/ajrcmb.16.5.9160829
   Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853
   Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3
   Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711
   Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200
   Into T, 2007, J BIOL CHEM, V282, P8134, DOI 10.1074/jbc.M609962200
   Karpurapu M, 2011, BLOOD, V118, P5255, DOI 10.1182/blood-2011-03-341123
   Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606
   Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598
   Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034
   Knezevic N, 2007, MOL CELL BIOL, V27, P6323, DOI 10.1128/MCB.00523-07
   Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652
   Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121
   Lloyd-Jones KL, 2008, J IMMUNOL, V181, P1446, DOI 10.4049/jimmunol.181.2.1446
   Loiarro M, 2009, J BIOL CHEM, V284, P28093, DOI 10.1074/jbc.M109.004465
   Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209
   Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Monick MM, 1999, J IMMUNOL, V162, P3005
   Nicholas C, 2007, J IMMUNOL, V179, P7121, DOI 10.4049/jimmunol.179.10.7121
   Obukhov AG, 2005, J NEUROSCI, V25, P1234, DOI 10.1523/JNEUROSCI.4451-04.2005
   Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC
   Pocock TM, 2004, AM J PHYSIOL-HEART C, V286, pH1015, DOI 10.1152/ajpheart.00826.2003
   Ranaivo HR, 2007, AM J PATHOL, V170, P439, DOI 10.2353/ajpath.2007.060219
   Rossi JL, 2007, AM J PHYSIOL-LUNG C, V292, pL1327, DOI 10.1152/ajplung.00380.2006
   SANDS WA, 1994, BIOCHEM BIOPH RES CO, V199, P461, DOI 10.1006/bbrc.1994.1251
   Sel S, 2008, CLIN EXP ALLERGY, V38, P1548, DOI 10.1111/j.1365-2222.2008.03043.x
   Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51
   Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8
   Toya SP, 2011, AM J PATHOL, V178, P313, DOI 10.1016/j.ajpath.2010.09.041
   Verin AD, 1998, AM J RESP CELL MOL, V19, P758, DOI 10.1165/ajrcmb.19.5.3125
   Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125
   Vogel SM, 2000, PHYSIOL GENOMICS, V4, P137, DOI 10.1152/physiolgenomics.2000.4.2.137
   Wadgaonkar R, 2005, J CELL BIOCHEM, V95, P849, DOI 10.1002/jcb.20472
   Wadgaonkar R, 2005, J CELL BIOCHEM, V94, P351, DOI 10.1002/jcb.20250
   Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100
   Wang YL, 2011, J IMMUNOL, V186, P3180, DOI 10.4049/jimmunol.1001252
   Weissmann N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1660
   Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628
   Xu SJ, 2005, ACTA PHARMACOL SIN, V26, P1497, DOI 10.1111/j.1745-7254.2005.00217.x
   Yamamoto H, 1997, BIOCHEM J, V325, P223, DOI 10.1042/bj3250223
   Zhang FH, 2001, J LEUKOCYTE BIOL, V69, P1060
   Zhang L, 2011, J CELL PHYSIOL, V226, P1694, DOI 10.1002/jcp.22500
   Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154
   Zhou H, 2009, J IMMUNOL, V183, P5244, DOI 10.4049/jimmunol.0901309
NR 66
TC 171
Z9 183
U1 3
U2 34
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD OCT 22
PY 2012
VL 209
IS 11
BP 1953
EP 1968
DI 10.1084/jem.20111355
PG 16
WC Immunology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Research & Experimental Medicine
GA 027QT
UT WOS:000310368800005
PM 23045603
OA Green Submitted, Green Published, hybrid
DA 2023-08-21
ER

PT J
AU Miyashita, H
   Watanabe, T
   Hayashi, H
   Suzuki, Y
   Nakamura, T
   Ito, S
   Ono, M
   Hoshikawa, Y
   Okada, Y
   Kondo, T
   Sato, Y
AF Miyashita, Hiroki
   Watanabe, Tatsuaki
   Hayashi, Hideki
   Suzuki, Yasuhiro
   Nakamura, Takanobu
   Ito, Soichi
   Ono, Manabu
   Hoshikawa, Yasushi
   Okada, Yoshinori
   Kondo, Takashi
   Sato, Yasufumi
TI Angiogenesis Inhibitor Vasohibin-1 Enhances Stress Resistance of
   Endothelial Cells via Induction of SOD2 and SIRT1
SO PLOS ONE
LA English
DT Article
ID OBSTRUCTIVE PULMONARY-DISEASE; NEGATIVE FEEDBACK REGULATOR; DNA-DAMAGE
   RESPONSE; SUPEROXIDE-DISMUTASE; DEACETYLASE SIRT1; OXIDATIVE STRESS;
   SENESCENCE; MICE; OVEREXPRESSION; PROTEIN
AB Vasohibin-1 (VASH1) is isolated as an endothelial cell (EC)-produced angiogenesis inhibitor. We questioned whether VASH1 plays any role besides angiogenesis inhibition, knocked-down or overexpressed VASH1 in ECs, and examined the changes of EC property. Knock-down of VASH1 induced premature senescence of ECs, and those ECs were easily killed by cellular stresses. In contrast, overexpression of VASH1 made ECs resistant to premature senescence and cell death caused by cellular stresses. The synthesis of VASH1 was regulated by HuR-mediated post-transcriptional regulation. We sought to define the underlying mechanism. VASH1 increased the expression of (superoxide dismutase 2) SOD2, an enzyme known to quench reactive oxygen species (ROS). Simultaneously, VASH1 augmented the synthesis of sirtuin 1 (SIRT1), an anti-aging protein, which improved stress tolerance. Paraquat generates ROS and causes organ damage when administered in vivo. More VASH1 (+/-) mice died due to acute lung injury caused by paraquat. Intratracheal administration of an adenovirus vector encoding human VASH1 augmented SOD2 and SIRT1 expression in the lungs and prevented acute lung injury caused by paraquat. Thus, VASH1 is a critical factor that improves the stress tolerance of ECs via the induction of SOD2 and SIRT1.
C1 [Miyashita, Hiroki; Watanabe, Tatsuaki; Hayashi, Hideki; Suzuki, Yasuhiro; Nakamura, Takanobu; Ito, Soichi; Ono, Manabu; Sato, Yasufumi] Tohoku Univ, Dept Vasc Biol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.
   [Watanabe, Tatsuaki; Hoshikawa, Yasushi; Okada, Yoshinori; Kondo, Takashi] Tohoku Univ, Dept Thorac Surg, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.
C3 Tohoku University; Tohoku University
RP Sato, Y (corresponding author), Tohoku Univ, Dept Vasc Biol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.
EM y-sato@idac.tohoku.ac.jp
RI Suzuki, Yasuhiro/GOE-4553-2022; Sato, Yasufumi/AAF-3367-2019
OI Suzuki, Yasuhiro/0000-0001-9046-5466; Ono, Manabu/0000-0003-3831-9773
FU Ministry of Education, Culture, Sports, Science, and Technology of Japan
   [22112006, 22590821]; Mitsubishi Foundation; Grants-in-Aid for
   Scientific Research [22590821, 22112006] Funding Source: KAKEN
FX This work was supported by grants from the programs Grant-in-Aid for
   Scientific Research on Innovative Areas "Integrative Research on Cancer
   Microenvironment Network" (22112006) and Grants-in-Aid for Scientific
   Research (C) [ 22590821] from the Ministry of Education, Culture,
   Sports, Science, and Technology of Japan, and by the 38th Research
   Grants in the Natural Sciences from the Mitsubishi Foundation. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299
   Andreassi MG, 2009, MUTAT RES-FUND MOL M, V667, P35, DOI 10.1016/j.mrfmmm.2008.10.018
   Bertram C, 2008, BIOL CHEM, V389, P211, DOI 10.1515/BC.2008.031
   Chen J, 2008, J NEPHROL, V21, P337
   de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO
   Didion SP, 2005, ARTERIOSCL THROM VAS, V25, P90, DOI 10.1161/01.ATV.0000149868.74075.5d
   DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95
   Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010
   Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197
   Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999
   Gorospe M, 2008, TRENDS CELL BIOL, V18, P77, DOI 10.1016/j.tcb.2007.11.007
   Gurevich F, 2009, AM J MED, V122, P322, DOI 10.1016/j.amjmed.2008.11.025
   Han MLK, 2011, AM J RESP CRIT CARE, V183, P1311, DOI 10.1164/rccm.201102-0280UP
   Heishi T, 2010, AM J PATHOL, V176, P1950, DOI 10.2353/ajpath.2010.090829
   Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6
   Hosaka T, 2009, AM J PATHOL, V175, P430, DOI 10.2353/ajpath.2009.080788
   Jang YC, 2009, J GERONTOL A-BIOL, V64, P1114, DOI 10.1093/gerona/glp100
   Jerkic M, 2011, CARDIOVASC RES, V92, P375, DOI 10.1093/cvr/cvr232
   Kimura H, 2009, BLOOD, V113, P4810, DOI 10.1182/blood-2008-07-170316
   Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054
   Minamino T, 2008, FRONT BIOSCI-LANDMRK, V13, P2971, DOI 10.2741/2902
   Miyashita H, 2011, PHARMACEUTICALS, V4, P782, DOI 10.3390/ph4060782
   Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367
   Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468
   Namba K, 2000, ONCOGENE, V19, P106, DOI 10.1038/sj.onc.1203257
   Nasu T, 2009, DIABETES, V58, P2365, DOI 10.2337/db08-1790
   O'Riordan E, 2007, AM J PHYSIOL-HEART C, V292, pH285, DOI 10.1152/ajpheart.00560.2006
   Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x
   Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694
   Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015
   Potente M, 2008, CELL CYCLE, V7, P2117, DOI 10.4161/cc.7.14.6267
   Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107
   Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001
   Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC
   Saito D, 2011, AM J PHYSIOL-RENAL, V300, pF873, DOI 10.1152/ajprenal.00503.2010
   Shibuya T, 2006, ARTERIOSCL THROM VAS, V26, P1051, DOI 10.1161/01.ATV.0000216747.66660.26
   Shimizu K, 2005, BIOCHEM BIOPH RES CO, V327, P700, DOI 10.1016/j.bbrc.2004.12.073
   Siedlinski M, 2009, EUR RESPIR J, V33, P986, DOI 10.1183/09031936.00171507
   Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107
   SUZUKI K, 1993, AM J PHYSIOL, V265, pH1173, DOI 10.1152/ajpheart.1993.265.4.H1173
   Suzuki Y, 2010, J CELL SCI, V123, P3094, DOI 10.1242/jcs.067538
   Takemura A, 2011, ARTERIOSCL THROM VAS, V31, P2054, DOI 10.1161/ATVBAHA.110.216739
   Tomita M, 2007, TOXICOLOGY, V231, P200, DOI 10.1016/j.tox.2006.12.005
   Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5
   Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152
   Yamashita H, 2006, BIOCHEM BIOPH RES CO, V345, P919, DOI 10.1016/j.bbrc.2006.04.176
   Zhan H, 2010, J BIOL CHEM, V285, P29662, DOI 10.1074/jbc.M110.125138
   Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224
NR 48
TC 54
Z9 56
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 8
PY 2012
VL 7
IS 10
AR e46459
DI 10.1371/journal.pone.0046459
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 020RP
UT WOS:000309831500042
PM 23056314
OA Green Published, Green Submitted, gold
DA 2023-08-21
ER

PT J
AU Cao, JP
   He, XY
   Xu, HT
   Zou, Z
   Shi, XY
AF Cao, Jian-Ping
   He, Xing-Ying
   Xu, Hai-Tao
   Zou, Zui
   Shi, Xue-Yin
TI Autologous Transplantation of Peripheral Blood-derived Circulating
   Endothelial Progenitor Cells Attenuates Endotoxin-induced Acute Lung
   Injury in Rabbits by Direct Endothelial Repair and Indirect
   Immunomodulation
SO ANESTHESIOLOGY
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; MESENCHYMAL STEM-CELLS; NITRIC-OXIDE
   SYNTHASE; SUPEROXIDE-DISMUTASE; CRITICALLY-ILL; ANGIOGENESIS;
   MOBILIZATION; EXPRESSION; ISCHEMIA; DISEASES
AB Background: Studies have demonstrated the role of circulating endothelial progenitor cells (EPCs) in maintaining normal endothelial function and in endothelial repairing. This study was aimed to observe the protective effects of autologous transplantation of circulating EPCs against endotoxin- induced acute lung injury in rabbits and to investigate the underlying mechanisms.
   Methods: One-hundred-and-fifty rabbits were enrolled. After acute lung injury was induced by endotoxin, autologous circulating EPCs, endothelial cell, or normal saline were transfused intravenously, respectively. PaO2/FiO(2) ratios, concentrations of plasma nitric oxide, malonyldialdehyde, and activity of superoxide dismutase were examined. The lung wet-to-dry weight ratios were counted; polymorphonuclear cell ratios and areas of hyaline membrane formation and hemorrhage were measured. The levels of interleukin-1 beta, E-selectin, intercellular adhesion molecule-1, interleukin-10, vascular endothelial growth factor protein, and inducible nitric oxide synthase protein were analyzed.
   Results: PaO2/FiO(2) ratios were significantly increased with EPC transfusion. Infiltration of polymorphonuclear cells, lung wet-to-dry weight ratios, and area of hyaline membrane and hemorrhage in lung tissue were significantly decreased after EPC transplantation. Plasma level of nitric oxide and malondialdehyde were significantly inhibited, and the activity of superoxide dismutase was enhanced in the EPC-treated animals. EPC transplantation significantly increased level of interleukin-10 and vascular endothelial growth factor protein and reduced levels of interleukin-1 beta, E-selectin, intercellular adhesion molecule-1, and inducible nitric oxide synthase in injury lung tissues.
   Conclusions: Autologous transplantation of circulating EPCs can partly restore the pulmonary endothelial function and effectively attenuate endotoxin-induced acute lung injury by direct endothelial repair and indirect immunomodulation of antioxidation and antiinflammation.
C1 [Cao, Jian-Ping; He, Xing-Ying; Xu, Hai-Tao; Zou, Zui; Shi, Xue-Yin] Second Mil Med Univ, Dept Anesthesiol, Changzheng Hosp, Shanghai, China.
   [Cao, Jian-Ping] PLA455 Hosp, Dept Anesthesiol, Shanghai, China.
C3 Naval Medical University
RP Shi, XY (corresponding author), Second Mil Med Univ, Dept Anesthesiol, Changzheng Hosp, 415 Fengyang Rd, Shanghai, Peoples R China.
EM shixueyin1128@yahoo.com.cn
RI Cao, Jianping/AFL-5468-2022
OI Cao, Jianping/0000-0002-1974-0047; Zou, Zui/0000-0002-8433-8388
FU National Nature Science Funds [30772092]; Military Science and
   Technology Funds [08G0712]; Key Basic Research Projects [09JC1405600];
   Science and Technology Commission, Shanghai Municipality, China
   [10411951300]
FX Received from the Department of Anesthesiology, Changzheng Hospital, The
   Second Military Medical University, Shanghai, China. Submitted for
   publication December 3, 2010. Accepted for publication February 9, 2012.
   Supported by National Nature Science Funds (grant no. 30772092),
   Military Science and Technology Funds (grant no. 08G0712), Key Basic
   Research Projects (grant no. 09JC1405600), and Key Medical Research
   Projects (grant no. 10411951300) from Science and Technology Commission,
   Shanghai Municipality, China. Drs. Jian-Ping Cao and Xing-Ying He
   contributed equally to this work.
CR Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
   Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Aslam M, 2009, AM J RESP CRIT CARE, V180, P1122, DOI 10.1164/rccm.200902-0242OC
   Asti C, 2000, PULM PHARMACOL THER, V13, P61, DOI 10.1006/pupt.2000.0231
   Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491
   Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657
   Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549
   He TR, 2004, ARTERIOSCL THROM VAS, V24, P2021, DOI 10.1161/01.ATV.0000142810.27849.8f
   He TR, 2004, STROKE, V35, P2378, DOI 10.1161/01.STR.0000141893.33677.5d
   Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Knepler JL, 2001, AM J PHYSIOL-CELL PH, V281, pC1064, DOI 10.1152/ajpcell.2001.281.3.C1064
   Kristof AS, 1998, AM J RESP CRIT CARE, V158, P1883, DOI 10.1164/ajrccm.158.6.9802100
   Lam CF, 2008, ANESTHESIOLOGY, V108, P392, DOI 10.1097/ALN.0b013e318164ca64
   LAMY M, 1976, AM REV RESPIR DIS, V114, P267
   Lee JW, 2009, EXPERT OPIN BIOL TH, V9, P1259, DOI 10.1517/14712590903213651
   Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904
   Liu Y, 2011, J BIOL CHEM, V286, P25007, DOI 10.1074/jbc.M110.213108
   Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238
   Mao M, 2010, SHOCK, V34, P196, DOI 10.1097/SHK.0b013e3181d49457
   Mikawa K, 2003, ANESTH ANALG, V97, P1751, DOI 10.1213/01.ANE.0000086896.90343.13
   Mikawa K, 1998, CRIT CARE MED, V26, P905, DOI 10.1097/00003246-199805000-00026
   Mutunga M, 2001, AM J RESP CRIT CARE, V163, P195, DOI 10.1164/ajrccm.163.1.9912036
   Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905
   Newman Robert E., 2009, Inflammation & Allergy Drug Targets, V8, P110
   Oberholzer A, 2000, CRIT CARE MED, V28, pN3, DOI 10.1097/00003246-200004001-00002
   OBERLEY LW, 1979, CANCER RES, V39, P1141
   Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x
   Phua J, 2008, CRIT CARE MED, V36, P2912, DOI 10.1097/CCM.0b013e31817d20bd
   Piantadosi CA, 2004, ANN INTERN MED, V141, P460, DOI 10.7326/0003-4819-141-6-200409210-00012
   Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434
   Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Weiss Daniel J, 2008, Proc Am Thorac Soc, V5, P637, DOI 10.1513/pats.200804-037DW
   Yamada M, 2005, THORAX, V60, P410, DOI 10.1136/thx.2004.034058
   Yamada M, 2004, J IMMUNOL, V172, P1266, DOI 10.4049/jimmunol.172.2.1266
NR 37
TC 41
Z9 47
U1 1
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0003-3022
EI 1528-1175
J9 ANESTHESIOLOGY
JI Anesthesiology
PD JUN
PY 2012
VL 116
IS 6
BP 1278
EP 1287
DI 10.1097/ALN.0b013e3182567f84
PG 10
WC Anesthesiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology
GA 946MR
UT WOS:000304356500018
PM 22546965
OA Bronze
DA 2023-08-21
ER

PT J
AU Birukova, AA
   Fu, PF
   Wu, TH
   Dubrovskyi, O
   Sarich, N
   Poroyko, V
   Birukov, KG
AF Birukova, Anna A.
   Fu, Panfeng
   Wu, Tinghuai
   Dubrovskyi, Oleksii
   Sarich, Nicolene
   Poroyko, Valery
   Birukov, Konstantin G.
TI Afadin controls p120-catenin-ZO-1 interactions leading to endothelial
   barrier enhancement by oxidized phospholipids
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
ID ACUTE LUNG INJURY; CELL JUNCTION FORMATION; IN-VIVO; PROTECTIVE
   RESPONSE; ADHERENS JUNCTIONS; EXCHANGE FACTORS; E-CADHERIN; NECTIN;
   RAP1; RAC
AB Afadin is a novel regulator of epithelial cell junctions assembly. However, its role in the formation of endothelial cell junctions and the regulation of vascular permeability remains obscure. We previously described protective effects of oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC) in the in vitro and in vivo models of lung endothelial barrier dysfunction and acute lung injury, which were mediated by Rac GTPase. This study examined a role of afadin in the OxPAPC-induced enhancement of interactions between adherens junctions and tight junctions as a novel mechanism of endothelial cell (EC) barrier preservation. OxPAPC induced Rap1-dependent afadin accumulation at the cell periphery and Rap1-dependent afadin interaction with adherens junction and tight junction proteins p120-catenin and ZO-1, respectively. Afadin knockdown using siRNA or ectopic expression of afadin mutant lacking Rap1 GTPase binding domain suppressed OxPAPC-induced EC barrier enhancement and abolished barrier protective effects of OxPAPC against thrombin-induced EC permeability. Afadin knockdown also abolished protective effects of OxPAPC against ventilator-induced lung injury in vivo. These results demonstrate for the first time a critical role of afadin in the regulation of vascular barrier function in vitro and in vivo via coordination of adherens junctiontight junction interactions. J. Cell. Physiol. 227: 1883-1890, 2012. (C) 2011 Wiley Periodicals, Inc.
C1 [Birukova, Anna A.; Fu, Panfeng; Wu, Tinghuai; Dubrovskyi, Oleksii; Sarich, Nicolene; Poroyko, Valery; Birukov, Konstantin G.] Univ Chicago, Sect Pulm & Crit Med, Lung Injury Ctr, Dept Med, Chicago, IL 60637, United States.
C3 University of Chicago
RP Birukov, KG (corresponding author), Univ Chicago, Sect Pulm & Crit Med, Lung Injury Ctr, Dept Med, 5841 S Maryland Ave,Off N-611, Chicago, IL 60637 USA.
EM kbirukov@medicine.bsd.uchicago.edu
RI Birukov, Konstantin/FJB-5755-2022; Fu, Panfeng/F-7345-2015; Sarich,
   Nicolene/IWV-3869-2023
OI Fu, Panfeng/0000-0001-8813-9258; 
FU National Heart, Lung, and Blood Institutes [HL87823, HL76259, HL58064,
   HL89257]; American Heart Association
FX Contract grant sponsor: National Heart, Lung, and Blood Institutes;;
   Contract grant numbers: HL87823, HL76259, HL58064, HL89257.; Contract
   grant sponsor: American Heart Association Midwest Affiliate
   Grant-in-Aid.
CR Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068
   Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06
   Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL593, DOI 10.1152/ajplung.90257.2008
   Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036
   Birukova AA, 2007, AM J PHYSIOL-LUNG C, V292, pL924, DOI 10.1152/ajplung.00395.2006
   Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007
   Birukova AA, 2007, MICROVASC RES, V73, P173, DOI 10.1016/j.mvr.2006.12.004
   Birukova AA, 2007, J CELL PHYSIOL, V211, P608, DOI 10.1002/jcp.20966
   Birukova AA, 2011, J CELL PHYSIOL, V226, P2052, DOI 10.1002/jcp.22543
   Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023
   Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004
   Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004
   Dejana E, 2009, CELL TISSUE RES, V335, P17, DOI 10.1007/s00441-008-0694-5
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487
   Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200
   Groeneveld ABJ, 2002, VASC PHARMACOL, V39, P247, DOI 10.1016/S1537-1891(03)00013-2
   Hopkins AM, 2003, J CELL SCI, V116, P725, DOI 10.1242/jcs.00300
   Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200
   Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306
   Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080
   Ma Z, 2004, AM J PHYSIOL-LUNG C, V286, pL808, DOI 10.1152/ajplung.00220.2003
   Maniatis NA, 2008, VASC PHARMACOL, V49, P119, DOI 10.1016/j.vph.2008.06.009
   Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS
   Matthay MA, 2002, AM J PHYSIOL-LUNG C, V283, pL678, DOI 10.1152/ajplung.00154.2002
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008
   Nonas S, 2008, CRIT CARE, V12, DOI 10.1186/cc6805
   Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010
   Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012
   Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200
   Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367
   Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167
   Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339
   Tawa H, 2010, CIRC RES, V106, P1731, DOI 10.1161/CIRCRESAHA.110.216747
   Tsukita S, 2009, ANN NY ACAD SCI, V1165, P44, DOI 10.1111/j.1749-6632.2009.04056.x
   Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016
   Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597
   Wittchen ES, 2005, J BIOL CHEM, V280, P11675, DOI 10.1074/jbc.M412595200
NR 38
TC 40
Z9 40
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0021-9541
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD MAY
PY 2012
VL 227
IS 5
BP 1883
EP 1890
DI 10.1002/jcp.22916
PG 8
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA 879ZS
UT WOS:000299373900012
PM 21732359
OA Green Accepted
DA 2023-08-21
ER

PT J
AU Kandasamy, K
   Sahu, G
   Parthasarathi, K
AF Kandasamy, Kathirvel
   Sahu, Geetaram
   Parthasarathi, Kaushik
TI Real-time imaging reveals endothelium-mediated leukocyte retention in
   LPS-treated lung microvessels
SO MICROVASCULAR RESEARCH
LA English
DT Article
ID INDUCED NEUTROPHIL RECRUITMENT; TOLL-LIKE RECEPTOR-4; PROINFLAMMATORY
   RESPONSES; BONE-MARROW; P-SELECTIN; MOUSE LUNG; SEQUESTRATION; INJURY;
   ICAM-1; PNEUMONIA
AB Endotoxemia, a major feature of sepsis, is a common cause of acute lung injury and initiates rapid accumulation of leukocytes in the lung vasculature. Endothelial mechanisms that underlie this accumulation remain unclear, as current experimental models of endotoxemia are less suitable for targeted activation of the endothelium. Toward elucidating this, we used the isolated blood-perfused rat lung preparation. With a micro-catheter inserted through a left atrial cannula, we cleared blood cells from a small lung region and then infused lipopolysaccharide (LPS) into microvessels. After a Ringer's wash to remove residual LPS, we infused fluorescently-labeled autologous leukocytes and imaged their transit through the treated microvessels. Image analysis revealed that leukocytes infused 90 min after LPS treatment were retained more in treated venules and capillaries than untreated vessels. Further, pretreatment with either the intercellular adhesion molecule-1 (ICAM-1) mAb or polymyxin-B blunted LPS-induced leukocyte retention in both microvessel segments. In addition, retention of leukocytes treated ex vivo with LPS in LPS-treated microvessels was higher compared to retention of untreated leukocytes. In situ immunofluorescence experiments revealed that LPS significantly increased microvessel ICAM-1 expression at 90 min post treatment. Polymyxin pretreatment inhibited this increase. Taken together, the data suggest that LPS increased leukocyte retention in both venules and capillaries and this response was mediated by the increased expression of endothelial ICAM-1. Thus, endothelial mechanisms may themselves play a major role in LPS-induced leukocyte retention in lung microvessels. Blunting the endothelial responses may mitigate endotoxin-induced morbidity. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Kandasamy, Kathirvel; Sahu, Geetaram; Parthasarathi, Kaushik] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163, United States.
   [Parthasarathi, Kaushik] Univ Tennessee, Ctr Hlth Sci, Dept Biomed Engn & Imaging, Memphis, TN 38163, United States.
C3 University of Tennessee System; University of Tennessee Health Science
   Center; University of Tennessee System; University of Tennessee Health
   Science Center
RP Parthasarathi, K (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave,Nash 207, Memphis, TN 38163 USA.
EM kparthas@uthsc.edu
OI Kandasamy, Kathirvel/0000-0002-4966-4604
FU  [HL75503]
FX This work was supported by HL75503 (KP).
CR Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510
   Aoki T, 1997, AM J PHYSIOL-HEART C, V273, pH2361, DOI 10.1152/ajpheart.1997.273.5.H2361
   Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005
   BURNS AR, 1994, J IMMUNOL, V153, P3189
   Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689
   Doerschuk CM, 2001, MICROCIRCULATION, V8, P71, DOI 10.1038/sj.mn.7300151
   DOHERTY DE, 1994, J IMMUNOL, V153, P241
   Doyle NA, 1997, J CLIN INVEST, V99, P526, DOI 10.1172/JCI119189
   Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf
   GEBB SA, 1995, J APPL PHYSIOL, V79, P493, DOI 10.1152/jappl.1995.79.2.493
   Grimminger F, 2000, AM J PHYSIOL-LUNG C, V278, pL268, DOI 10.1152/ajplung.2000.278.2.L268
   Hattar K, 2010, EUR RESPIR J, V36, P187, DOI 10.1183/09031936.00143308
   Hu GC, 2010, CRIT CARE MED, V38, P194, DOI 10.1097/CCM.0b013e3181bc7c17
   Ichimura H, 2005, AM J PHYSIOL-LUNG C, V289, pL407, DOI 10.1152/ajplung.00048.2005
   Kamochi M, 1999, AM J PHYSIOL-LUNG C, V277, pL310, DOI 10.1152/ajplung.1999.277.2.L310
   Kuebler WM, 2000, AM J RESP CRIT CARE, V161, P36, DOI 10.1164/ajrccm.161.1.9901039
   KUHNLE GEH, 1995, AM J RESP CRIT CARE, V152, P1221, DOI 10.1164/ajrccm.152.4.7551374
   Kumasaka T, 1996, J CLIN INVEST, V97, P2362, DOI 10.1172/JCI118679
   LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933
   Melamed A, 2009, CRIT CARE, V13, DOI 10.1186/cc7733
   Mizgerd Joseph P., 2004, BMC Immunology, V5
   NORMAN KE, 1995, BLOOD, V86, P4417, DOI 10.1182/blood.V86.12.4417.bloodjournal86124417
   Parthasarathi K, 2002, J IMMUNOL, V169, P7078, DOI 10.4049/jimmunol.169.12.7078
   Parthasarathi K, 2006, J CLIN INVEST, V116, P2193, DOI 10.1172/JCI26605
   Ploppa A, 2010, CRIT CARE, V14, DOI 10.1186/cc9322
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Rowlands DJ, 2011, J CLIN INVEST, V121, P1986, DOI 10.1172/JCI43839
   Saito H, 2002, BLOOD, V99, P2207, DOI 10.1182/blood.V99.6.2207
   Sato Y, 1998, CRIT CARE MED, V26, P501, DOI 10.1097/00003246-199803000-00022
   Sharma AK, 2011, AM J RESP CRIT CARE, V183, P1539, DOI 10.1164/rccm.201007-1173OC
   Van Putte BP, 2005, CRIT CARE, V9, pR1, DOI 10.1186/cc2992
   Wang Q, 2001, J IMMUNOL, V166, P6877, DOI 10.4049/jimmunol.166.11.6877
   Wang Q, 2001, BLOOD, V97, P660, DOI 10.1182/blood.V97.3.660
   WORTHEN GS, 1989, SCIENCE, V245, P183, DOI 10.1126/science.2749255
   Yiming MT, 2005, AM J RESP CELL MOL, V33, P549, DOI 10.1165/rcmb.2005-0133OC
   Yoshida K, 2006, AM J RESP CRIT CARE, V174, P689, DOI 10.1164/rccm.200502-276OC
NR 36
TC 10
Z9 10
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0026-2862
EI 1095-9319
J9 MICROVASC RES
JI Microvasc. Res.
PD MAY
PY 2012
VL 83
IS 3
BP 323
EP 331
DI 10.1016/j.mvr.2012.01.006
PG 9
WC Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 937VJ
UT WOS:000303690800009
PM 22342350
OA Green Accepted
DA 2023-08-21
ER

PT J
AU Xing, JJ
   Yakubov, B
   Poroyko, V
   Birukova, AA
AF Xing, Junjie
   Yakubov, Bakhtiyor
   Poroyko, Valery
   Birukova, Anna A.
TI Opposite effects of ANP receptors in attenuation of LPS-induced
   endothelial permeability and lung injury
SO MICROVASCULAR RESEARCH
LA English
DT Article
ID ATRIAL-NATRIURETIC-PEPTIDE; ACTIVATED PROTEIN-KINASE; DIFFERENTIAL
   REGULATION; OXIDIZED PHOSPHOLIPIDS; PLASMA-LEVELS; INHIBITION;
   EXPRESSION; CLEARANCE; FAILURE; MOUSE
AB Atrial natriuretic peptide (ANP) has been recently identified as a modulator of acute lung injury (ALI) induced by pro-inflammatory agonists. While previous studies tested effects of exogenous ANP administration, the role of endogenous ANP in the course of ALI remains unexplored. This study examined regulation of ANP and its receptors NPR-A, NPR-B and NPR-C by LPS and involvement of ANP receptors in the modulation of LPS-induced lung injury. Primary cultures of human pulmonary endothelial cells (EC) were used in the in vitro tests. Expression of ANP and its receptors was determined by quantitative RT-PCR analysis. Agonist-induced cytoskeletal remodeling was evaluated by immunofluorescence staining, and EC barrier function was characterized by measurements of transendothelial electrical resistance. In the murine model of ALI, LPS-induced lung injury was assessed by measurements of protein concentration and cell count in bronchoalveolar lavage fluid (BAL). LPS stimulation significantly increased mRNA expression levels of ANP and NPR-A in pulmonary EC. Pharmacological inhibition of NPR-A augmented LPS-induced EC permeability and blocked barrier protective effects of exogenous ANP on LPS-induced intercellular gap formation. In contrast, pharmacological inhibition of ANP clearance receptor NPR-C significantly attenuated LPS-induced barrier disruptive effects. Administration of NPR-A inhibitor in vivo exacerbated LPS-induced lung injury, whereas inhibition of NPR-C suppressed LPS-induced increases in BAL cell count and protein content. These results demonstrate for the first time opposite effects of NPR-A and NPR-C in the modulation of ALI and suggest a compensatory protective mechanism of endogenous ANP in the maintenance of lung vascular permeability in ALI. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Xing, Junjie; Yakubov, Bakhtiyor; Poroyko, Valeriy; Birukova, Anna A.] Univ Chicago, Dept Med, Sect Pulm & Crit Med, Lung Injury Ctr, Chicago, IL 60637, United States.
C3 University of Chicago
RP Birukova, AA (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Med, Lung Injury Ctr, 5841 S Maryland Ave,MC 6026, Chicago, IL 60637 USA.
EM abirukov@medicine.bsd.uchicago.edu
FU NHLBI [HL89257]; American Heart Association
FX Supported by NHLBI grant HL89257 and the American Heart Association
   Midwest Affiliate Grant-in-Aid.
CR Ahluwalia A, 2004, BASIC RES CARDIOL, V99, P83, DOI 10.1007/s00395-004-0459-6
   Anand-Srivastava MB, 2005, PEPTIDES, V26, P1044, DOI 10.1016/j.peptides.2004.09.023
   Baxter GF, 2004, BASIC RES CARDIOL, V99, P71, DOI 10.1007/s00395-004-0457-8
   Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06
   Birukova A. A., 2008, AM J RESP CELL MOL B
   Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431
   Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354
   Birukova AA, 2007, AM J PHYSIOL-LUNG C, V292, pL924, DOI 10.1152/ajplung.00395.2006
   Birukova AA, 2010, AM J PHYSIOL-LUNG C, V299, pL652, DOI 10.1152/ajplung.00202.2009
   Curry FRE, 2005, J CLIN INVEST, V115, P1458, DOI 10.1172/JCI25417
   DELPORTE C, 1992, EUR J PHARMACOL, V224, P183, DOI 10.1016/0014-2999(92)90803-C
   Doust JA, 2005, BRIT MED J, V330, P625, DOI 10.1136/bmj.330.7492.625
   EISON HB, 1988, CHEST, V94, P1040, DOI 10.1378/chest.94.5.1040
   Furst R, 2005, CIRC RES, V96, P43, DOI 10.1161/01.RES.0000151983.01148.06
   HOLLISTER AS, 1989, J CLIN INVEST, V83, P623, DOI 10.1172/JCI113926
   IMAMURA T, 1988, LIFE SCI, V42, P403, DOI 10.1016/0024-3205(88)90078-1
   Irwin DC, 2005, AM J PHYSIOL-LUNG C, V288, pL849, DOI 10.1152/ajplung.00294.2004
   Karmpaliotis D, 2007, CHEST, V131, P964, DOI 10.1378/chest.06-1247
   Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3
   Klinger JR, 2006, EXP CELL RES, V312, P401, DOI 10.1016/j.yexcr.2005.11.001
   Louzier V, 2001, HUM GENE THER, V12, P503, DOI 10.1089/104303401300042401
   Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403
   Mitaka C, 1998, CHEST, V114, P223, DOI 10.1378/chest.114.1.223
   MITAKA C, 1992, AM REV RESPIR DIS, V146, P43, DOI 10.1164/ajrccm/146.1.43
   Moro C, 2004, J PHARMACOL EXP THER, V308, P984, DOI 10.1124/jpet.103.060913
   Onuoha GN, 2000, BURNS, V26, P449, DOI 10.1016/S0305-4179(99)00187-4
   Pandey KN, 2000, BIOCHEM BIOPH RES CO, V271, P374, DOI 10.1006/bbrc.2000.2627
   Pedram A, 2002, J BIOL CHEM, V277, P44385, DOI 10.1074/jbc.M202391200
   Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014
   Potter LR, 2005, FRONT BIOSCI-LANDMRK, V10, P1205, DOI 10.2741/1613
   Rana R, 2006, CRIT CARE MED, V34, P1941, DOI 10.1097/01.CCM.0000220492.15645.47
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Sakurai H, 2005, BURNS, V31, P737, DOI 10.1016/j.burns.2005.03.002
   Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9
   Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101
   Ueda S, 2006, SHOCK, V26, P134, DOI 10.1097/01.shk.0000226266.99960.d0
   VOLLMAR AM, 1995, J CLIN INVEST, V95, P2442, DOI 10.1172/JCI117944
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Xing JJ, 2011, J APPL PHYSIOL, V110, P213, DOI 10.1152/japplphysiol.00284.2010
   Xing JJ, 2010, MICROVASC RES, V79, P56, DOI 10.1016/j.mvr.2009.11.006
NR 40
TC 7
Z9 10
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0026-2862
EI 1095-9319
J9 MICROVASC RES
JI Microvasc. Res.
PD MAR
PY 2012
VL 83
IS 2
BP 194
EP 199
DI 10.1016/j.mvr.2011.09.012
PG 6
WC Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 899MA
UT WOS:000300818800015
PM 22001395
OA Green Accepted
DA 2023-08-21
ER

PT J
AU Saffarzadeh, M
   Juenemann, C
   Queisser, MA
   Lochnit, G
   Barreto, G
   Galuska, SP
   Lohmeyer, J
   Preissner, KT
AF Saffarzadeh, Mona
   Juenemann, Christiane
   Queisser, Markus A.
   Lochnit, Guenter
   Barreto, Guillermo
   Galuska, Sebastian P.
   Lohmeyer, Juergen
   Preissner, Klaus T.
TI Neutrophil Extracellular Traps Directly Induce Epithelial and
   Endothelial Cell Death: A Predominant Role of Histones
SO PLOS ONE
LA English
DT Article
ID ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME;
   SYSTEMIC-LUPUS-ERYTHEMATOSUS; RECOMBINANT HUMAN DNASE; CYSTIC-FIBROSIS;
   NETTING NEUTROPHILS; MEDICAL PROGRESS; MYELOPEROXIDASE;
   LIPOPOLYSACCHARIDE; ENDOTOXIN
AB Neutrophils play an important role in innate immunity by defending the host organism against invading microorganisms. Antimicrobial activity of neutrophils is mediated by release of antimicrobial peptides, phagocytosis as well as formation of neutrophil extracellular traps (NET). These structures are composed of DNA, histones and granular proteins such as neutrophil elastase and myeloperoxidase. This study focused on the influence of NET on the host cell functions, particularly on human alveolar epithelial cells as the major cells responsible for gas exchange in the lung. Upon direct interaction with epithelial and endothelial cells, NET induced cytotoxic effects in a dose-dependent manner, and digestion of DNA in NET did not change NET-mediated cytotoxicity. Pre-incubation of NET with antibodies against histones, with polysialic acid or with myeloperoxidase inhibitor but not with elastase inhibitor reduced NET-mediated cytotoxicity, suggesting that histones and myeloperoxidase are responsible for NET-mediated cytotoxicity. Although activated protein C (APC) did decrease the histone-induced cytotoxicity in a purified system, it did not change NET-induced cytotoxicity, indicating that histone-dependent cytotoxicity of NET is protected against APC degradation. Moreover, in LPS-induced acute lung injury mouse model, NET formation was documented in the lung tissue as well as in the bronchoalveolar lavage fluid. These data reveal the important role of protein components in NET, particularly histones, which may lead to host cell cytotoxicity and may be involved in lung tissue destruction.
C1 [Saffarzadeh, Mona; Juenemann, Christiane; Queisser, Markus A.; Lochnit, Guenter; Galuska, Sebastian P.; Preissner, Klaus T.] Univ Giessen, Sch Med, Inst Biochem, Giessen, Germany.
   [Queisser, Markus A.] Northwestern Univ, Chicago, IL 60611, United States.
   [Barreto, Guillermo] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany.
   [Lohmeyer, Juergen] Univ Giessen, Dept Internal Med 2, Giessen, Germany.
C3 Justus Liebig University Giessen; Northwestern University; Max Planck
   Society; Justus Liebig University Giessen
RP Saffarzadeh, M (corresponding author), Univ Giessen, Sch Med, Inst Biochem, Giessen, Germany.
EM klaus.t.preissner@biochemie.med.uni-giessen.de
RI Queisser, Markus A/C-4426-2008; Barreto, Guillermo/U-5718-2017
OI Barreto, Guillermo/0000-0002-7777-4712; Galuska, Sebastian
   P./0000-0001-5565-0252
FU Bundesministerium fur Bildung und Forschung (Berlin, Germany); Clinical
   Research Group "Pneumonia" [01-KI-1004]; "Excellence Cluster
   Cardio-Pulmonary System" (ECCPS), Deutsche Forschungsgemeinschaft (Bonn,
   Germany)
FX This work was supported in part by the Bundesministerium fur Bildung und
   Forschung (Berlin, Germany), Clinical Research Group "Pneumonia"
   (01-KI-1004), and the "Excellence Cluster Cardio-Pulmonary System"
   (ECCPS), Deutsche Forschungsgemeinschaft (Bonn, Germany). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950
   Bergmann C, 2008, CLIN CANCER RES, V14, P3706, DOI 10.1158/1078-0432.CCR-07-5126
   BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706
   Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606
   BOTHA AJ, 1995, J TRAUMA, V39, P411
   Bozinovski S, 2004, AM J PHYSIOL-LUNG C, V286, pL877, DOI 10.1152/ajplung.00275.2003
   BRANDT T, 1995, THORAX, V50, P880, DOI 10.1136/thx.50.8.880
   BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   Cabanski M, 2009, AM J PHYSIOL-LUNG C, V297, pL608, DOI 10.1152/ajplung.90433.2008
   Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565
   Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933
   Costa D, 2006, FREE RADICAL BIO MED, V40, P632, DOI 10.1016/j.freeradbiomed.2005.09.017
   DeCoursey TE, 2005, CELL MOL LIFE SCI, V62, P2173, DOI 10.1007/s00018-005-5177-1
   Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201
   Faffe DS, 2000, EUR RESPIR J, V15, P85, DOI 10.1034/j.1399-3003.2000.15a16.x
   FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003
   Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027
   FUJISHIMA S, 1995, INTENS CARE MED, V21, P277, DOI 10.1007/BF01701489
   Gong Q, 2008, INT IMMUNOPHARMACOL, V8, P792, DOI 10.1016/j.intimp.2008.01.026
   Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106
   Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003
   Gupta A, 2006, ANN NY ACAD SCI, V1075, P118, DOI 10.1196/annals.1368.015
   Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006
   Haegens A, 2008, EUR RESPIR J, V31, P252, DOI 10.1183/09031936.00029307
   Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI [10.1038/nchembio.496, 10.1038/NCHEMBIO.496]
   Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107
   Hamutcu R, 2002, AM J RESP CRIT CARE, V165, P1172, DOI 10.1164/ajrccm.165.8.2104090
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Jones A, 2007, FASEB J, V21, P345, DOI 10.1096/fj.06-6675com
   Kanthack A. A., 1894, J PHYSL, V17, P80
   Kanthack AA, 1894, J PHYSL, V17, P81
   Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959
   Klebanoff SJ, 1999, P ASSOC AM PHYSICIAN, V111, P383, DOI 10.1111/paa.1999.111.5.383
   KOLLEF MH, 1995, NEW ENGL J MED, V332, P27, DOI 10.1056/NEJM199501053320106
   Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180
   Lee JS, 2005, AM J PHYSIOL-LUNG C, V289, pL731, DOI 10.1152/ajplung.00196.2005
   Lim MB, 2011, J LEUKOC BIOL
   Liu M, 1997, INTENS CARE MED, V23, P718, DOI 10.1007/s001340050400
   Liu MY, 2005, AM J RESP CRIT CARE, V171, P298, DOI 10.1164/rccm.2412002
   Manicone AM, 2009, EXPERT REV CLIN IMMU, V5, P63, DOI 10.1586/1744666X.5.1.63
   Manzenreiter R, 2011, J CYST FIBROS
   Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209
   Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184
   Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST
   Medina E, 2009, J INNATE IMMUN, V1, P176, DOI 10.1159/000203699
   Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010
   Myzak MC, 2002, REDOX REP, V7, P47, DOI 10.1179/135100002125000181
   Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013
   Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785
   Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052
   Patel S, 2010, NITRIC OXIDE-BIOL CH, V22, P226, DOI 10.1016/j.niox.2010.01.001
   Perl M, 2008, MOL MED, V14, P465, DOI 10.2119/2008-00011.Perl
   RAPTIS L, 1980, J CLIN INVEST, V66, P1391, DOI 10.1172/JCI109992
   Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150
   Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004
   Rotta AT, 1998, CRIT CARE MED, V26, P1707, DOI 10.1097/00003246-199810000-00026
   Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538
   Steinmuller M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-30
   Szarka RJ, 1997, J IMMUNOL METHODS, V202, P49, DOI 10.1016/S0022-1759(96)00236-0
   Tasaka S, 2003, AM J RESP CELL MOL, V29, P252, DOI 10.1165/rcmb.2002-0132OC
   Thulke S, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-77
   Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223
   Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x
   Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639
   Valeva A, 2008, MED MICROBIOL IMMUN, V197, P285, DOI 10.1007/s00430-007-0061-2
   van der Vliet A, 2000, AM J PHYSIOL-LUNG C, V279, pL537, DOI 10.1152/ajplung.2000.279.3.L537
   Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450
   Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7
   Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053
   Zhang D, 2001, J BIOL CHEM, V276, P3683, DOI 10.1074/jbc.M005390200
NR 73
TC 832
Z9 884
U1 6
U2 91
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 28
PY 2012
VL 7
IS 2
AR e32366
DI 10.1371/journal.pone.0032366
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 928RC
UT WOS:000302999600034
PM 22389696
OA Green Published, Green Submitted, gold
DA 2023-08-21
ER

PT J
AU Konter, JM
   Parker, JL
   Baez, E
   Li, SZ
   Ranscht, B
   Denzel, M
   Little, FF
   Nakamura, K
   Ouchi, N
   Fine, A
   Walsh, K
   Summer, RS
AF Konter, Jason M.
   Parker, Jennifer L.
   Baez, Elizabeth
   Li, Stephanie Z.
   Ranscht, Barbara
   Denzel, Martin
   Little, Frederic F.
   Nakamura, Kazuto
   Ouchi, Noriyuki
   Fine, Alan
   Walsh, Kenneth
   Summer, Ross S.
TI Adiponectin Attenuates Lipopolysaccharide-Induced Acute Lung Injury
   through Suppression of Endothelial Cell Activation
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID ISCHEMIA-REPERFUSION INJURY; PLASMA ADIPONECTIN; INSULIN-RESISTANCE;
   LEPTIN RESISTANCE; CRITICALLY-ILL; ADIPOSE-TISSUE; OBESITY; MICE;
   INFLAMMATION; ASSOCIATION
AB Adiponectin (APN) is an adipose tissue-derived factor with anti-inflammatory and vascular protective properties whose levels paradoxically decrease with increasing body fat. In this study, APN's role in the early development of ALI to LPS was investigated. Intratracheal LPS elicited an exaggerated systemic inflammatory response in APN-deficient (APN(-/-)) mice compared with wildtype (wt) littermates. Increased lung injury and inflammation were observed in APN(-/-) mice as early as 4 h after delivery of LPS. Targeted gene expression profiling performed on immune and endothelial cells isolated from lung digests 4 h after LPS administration showed increased proinflammatory gene expression (e. g., IL-6) only in endothelial cells of APN(-/-) mice when compared with wt mice. Direct effects on lung endothelium were demonstrated by APN's ability to inhibit LPS-induced IL-6 production in primary human endothelial cells in culture. Furthermore, T-cadherin-deficient mice that have significantly reduced lung airspace APN but high serum APN levels had pulmonary inflammatory responses after intratracheal LPS that were similar to those of wt mice. These findings indicate the importance of serum APN in modulating LPS-induced ALI and suggest that conditions leading to hypoadiponectinemia (e. g., obesity) predispose to development of ALI through exaggerated inflammatory response in pulmonary vascular endothelium. The Journal of Immunology, 2012, 188: 854-863.
C1 [Konter, Jason M.; Baez, Elizabeth; Li, Stephanie Z.; Little, Frederic F.; Fine, Alan; Summer, Ross S.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118, United States.
   [Parker, Jennifer L.; Nakamura, Kazuto; Ouchi, Noriyuki; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118, United States.
   [Ranscht, Barbara; Denzel, Martin] Sanford Burnham Med Res Inst, La Jolla, CA 92037, United States.
C3 Boston University; Boston University; Sanford Burnham Prebys Medical
   Discovery Institute
RP Summer, RS (corresponding author), Boston Univ, Sch Med, Ctr Pulm, 715 Albany St,R-304, Boston, MA 02118 USA.
EM rsummer@bu.edu
RI Denzel, Martin/C-9047-2014; OUCHI, Noriyuki/I-7306-2014
OI Denzel, Martin/0000-0002-5691-3349; Little,
   Frederic/0000-0003-4342-7007; Duffen, Jennifer/0000-0001-7797-037X;
   Fine, Alan/0000-0001-9351-3048
FU National Institutes of Health [K08 HL077138, AG15052, HL-59215,
   HL-105490]
FX This work was supported by National Institutes of Health Grants K08
   HL077138, AG15052, HL-59215, and HL-105490.
CR Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae
   Anzueto A, 2011, THORAX, V66, P66, DOI 10.1136/thx.2010.145086
   Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Bellmeyer A, 2007, AM J RESP CRIT CARE, V175, P587, DOI 10.1164/rccm.200603-312OC
   Chen B, 2009, BRAIN RES, V1273, P129, DOI 10.1016/j.brainres.2009.04.002
   Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464
   Durante-Mangoni E, 2006, ALIMENT PHARM THERAP, V24, P1349, DOI 10.1111/j.1365-2036.2006.03114.x
   Engeli S, 2003, DIABETES, V52, P942, DOI 10.2337/diabetes.52.4.942
   Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023
   Gajic O, 2011, AM J RESP CRIT CARE, V183, P462, DOI 10.1164/rccm.201004-0549OC
   Gong MN, 2010, THORAX, V65, P44, DOI 10.1136/thx.2009.117572
   Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277
   Krakoff J, 2003, DIABETES CARE, V26, P1745, DOI 10.2337/diacare.26.6.1745
   Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706
   Matsumoto H, 2006, WORLD J GASTROENTERO, V12, P3352, DOI 10.3748/wjg.v12.i21.3352
   Medoff BD, 2009, AM J RESP CELL MOL, V41, P397, DOI 10.1165/rcmb.2008-0415OC
   Munzberg H, 2010, FORUM NUTR, V63, P123, DOI 10.1159/000264400
   Nakagawa Y, 2009, BIOCHEM BIOPH RES CO, V382, P183, DOI 10.1016/j.bbrc.2009.03.004
   Nakanishi K, 2011, AM J RESP CRIT CARE, V183, P1164, DOI 10.1164/rccm.201007-1091OC
   Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09
   Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x
   Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003
   Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3
   Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295
   Sridulyakul P, 2003, CLIN HEMORHEOL MICRO, V29, P423
   Stapleton RD, 2010, CHEST, V138, P568, DOI 10.1378/chest.10-0014
   Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884
   Summer R, 2008, AM J PHYSIOL-LUNG C, V294, pL1035, DOI 10.1152/ajplung.00397.2007
   Summer R, 2009, AM J PHYSIOL-LUNG C, V297, pL432, DOI 10.1152/ajplung.90599.2008
   Takemura Yukihiro, 2007, Curr Atheroscler Rep, V9, P238, DOI 10.1007/s11883-007-0025-4
   Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709
   Tilg H, 2008, CLIN SCI, V114, P275, DOI 10.1042/CS20070196
   Towfigh S, 2009, J TRAUMA, V67, P1239, DOI 10.1097/TA.0b013e31818b1733
   Tsuchihashi H, 2006, J SURG RES, V134, P348, DOI 10.1016/j.jss.2006.01.001
   Tsushima K, 2009, INTERNAL MED, V48, P621, DOI 10.2169/internalmedicine.48.1741
   Uji Y, 2009, SURGERY, V145, P550, DOI 10.1016/j.surg.2009.01.010
   Walkey AJ, 2010, CRIT CARE MED, V38, P2329, DOI 10.1097/CCM.0b013e3181fa0561
   Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930
   Wyder L, 2000, CANCER RES, V60, P4682
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Zhu M, 2010, AM J RESP CELL MOL, V43, P487, DOI 10.1165/rcmb.2009-0086OC
NR 43
TC 81
Z9 87
U1 1
U2 11
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD JAN 15
PY 2012
VL 188
IS 2
BP 854
EP 863
DI 10.4049/jimmunol.1100426
PG 10
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 879IU
UT WOS:000299323700040
PM 22156343
OA Green Accepted, Bronze
DA 2023-08-21
ER

PT J
AU Chava, KR
   Tauseef, M
   Sharma, T
   Mehta, D
AF Chava, Koteswara Rao
   Tauseef, Mohammad
   Sharma, Tiffany
   Mehta, Dolly
TI Cyclic AMP response element-binding protein prevents endothelial
   permeability increase through transcriptional controlling p190RhoGAP
   expression
SO BLOOD
LA English
DT Article
ID THROMBIN-INDUCED INCREASE; NF-KAPPA-B; IN-VIVO; BARRIER DYSFUNCTION;
   VASCULAR LEAKAGE; RHOA ACTIVATION; P190 RHOGAP; CREB; ADENOSINE;
   MECHANISMS
AB Increased endothelial permeability contributes to the morbidity and mortality associated with chronic inflammatory diseases, including acute lung injury. Cyclic AMP response element-binding protein (CREB) transcriptional factor induces genes that regulate inflammation and vascular remodeling. However, the role of CREB in regulating endothelial barrier function is unknown. Here, we demonstrate that CREB maintains basal endothelial barrier function and suppresses endothelial permeability increase by diverse agonists such as thrombin, lipopolysaccharide, histamine, and VEGF. We show that CREB transcriptionally controls the expression of p190RhoGAP-A, a GTPase-activating protein that inhibits small GTPase RhoA. Impairing CREB function using small interfering RNA or dominant-negative (dn)-CREB mutant (dn-CREB) markedly suppressed p190RhoGAP-A expression, increased RhoA activity, induced actin stress fiber formation, and produced an amplified and protracted increase in endothelial permeability in response to thrombin. Rescuing p190RhoGAP-A expression restored the permeability defect in dn-CREB-transducing endothelial cells. These findings were recapitulated in vivo because dn-CREB expression in mice vasculature increased basal lung microvessel permeability and exaggerated permeability increase induced by thrombin and lipopolysaccharide. Inhibiting RhoA signaling restored endothelial barrier dysfunction in the dnCREB-expressing lung microvasculature. These results uncover a pivotal role of CREB in regulating endothelial barrier function by restricting RhoA signaling through controlling p190RhoGAP-A expression. (Blood. 2012; 119(1): 308-319)
C1 [Chava, Koteswara Rao; Tauseef, Mohammad; Sharma, Tiffany; Mehta, Dolly] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612, United States.
   [Chava, Koteswara Rao; Tauseef, Mohammad; Sharma, Tiffany; Mehta, Dolly] Univ Illinois, Ctr Lung & Vasc Biol, Coll Med, Chicago, IL 60612, United States.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital
RP Mehta, D (corresponding author), Univ Illinois, Dept Pharmacol, Coll Med, 835 S Wolcott Ave, Chicago, IL 60612 USA.
EM dmehta@uic.edu
OI Tauseef, Mohammad/0000-0001-5317-4379
FU National Institutes of Health [HL71794, HL84153, PO1HL060678]
FX This work was supported by National Institutes of Health grants HL71794,
   HL84153, and PO1HL060678.
CR Abraham E, 2001, J IMMUNOL, V166, P522, DOI 10.4049/jimmunol.166.1.522
   Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115
   Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711
   Barlow C, 2006, AM J RESP CELL MOL, V34, P7, DOI 10.1165/rcmb.2005-0153OC
   Baumer Y, 2009, J CELL PHYSIOL, V220, P716, DOI 10.1002/jcp.21819
   Birukova AA, 2011, EXP CELL RES, V317, P859, DOI 10.1016/j.yexcr.2010.11.011
   Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002
   Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777
   Chiappara G, 2007, ALLERGY, V62, P787, DOI 10.1111/j.1398-9995.2007.01417.x
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487
   Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044
   Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891
   Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283
   GARCIA JGN, 1986, J CELL PHYSIOL, V128, P96, DOI 10.1002/jcp.1041280115
   GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311
   Harrington EO, 2004, AM J PHYSIOL-LUNG C, V287, pL1091, DOI 10.1152/ajplung.00421.2003
   Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200
   Ichiki T, 2006, ARTERIOSCL THROM VAS, V26, P449, DOI 10.1161/01.ATV.0000196747.79349.d1
   Ichiki T, 2003, HYPERTENSION, V42, P177, DOI 10.1161/01.HYP.0000079791.26014.04
   Klein IK, 2009, J BIOL CHEM, V284, P25953, DOI 10.1074/jbc.M109.035071
   Knezevic N, 2007, MOL CELL BIOL, V27, P6323, DOI 10.1128/MCB.00523-07
   Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652
   Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112
   KVIETIKOVA I, 1995, NUCLEIC ACIDS RES, V23, P4542, DOI 10.1093/nar/23.22.4542
   Leonard MO, 2008, AM J RESP CRIT CARE, V178, P977, DOI 10.1164/rccm.200712-1890OC
   Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200
   Matheson SF, 2006, DEV NEUROSCI-BASEL, V28, P538, DOI 10.1159/000095116
   Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158
   Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D
   Minshall R. D., 2006, V176, P107
   Mroz RM, 2007, J PHYSIOL PHARMACOL, V58, P437
   Naoe H, 2010, MOL CELL BIOL, V30, P3994, DOI 10.1128/MCB.01358-09
   Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x
   Persengiev SP, 2003, APOPTOSIS, V8, P225, DOI 10.1023/A:1023633704132
   Reusch JEB, 2003, CIRCULATION, V108, P1164, DOI 10.1161/01.CIR.0000084296.45158.50
   Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481
   Schlegel N, 2009, CRIT CARE MED, V37, P1735, DOI 10.1097/CCM.0b013e31819deb6a
   Settleman J, 2000, NAT CELL BIOL, V2, pE7, DOI 10.1038/71390
   Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821
   Shenkar R, 1997, AM J RESP CELL MOL, V16, P145, DOI 10.1165/ajrcmb.16.2.9032121
   Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X
   Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086
   TAKAI Y, 1994, MOLECULAR AND CELLULAR BASIS FOR CELL TO CELL INTERACTION: ITS SIGNIFICANCE IN CANCER, P338
   Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51
   Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915
   Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200
   Vogel SM, 2000, PHYSIOL GENOMICS, V4, P137, DOI 10.1152/physiolgenomics.2000.4.2.137
   Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046
NR 50
TC 31
Z9 33
U1 0
U2 2
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD JAN 5
PY 2012
VL 119
IS 1
BP 308
EP 319
DI 10.1182/blood-2011-02-339473
PG 12
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA 875EE
UT WOS:000299012400037
PM 22049513
OA Bronze, Green Published
DA 2023-08-21
ER

PT J
AU Belvitch, P
   Dudek, SM
AF Belvitch, Patrick
   Dudek, Steven M.
TI Role of FAK in S1P-regulated endothelial permeability
SO MICROVASCULAR RESEARCH
LA English
DT Article
ID FOCAL ADHESION KINASE; MYOSIN LIGHT-CHAIN; CELL BARRIER ENHANCEMENT;
   ACUTE LUNG INJURY; SPHINGOSINE 1-PHOSPHATE; VE-CADHERIN; TYROSINE
   PHOSPHORYLATION; VASCULAR-PERMEABILITY; S1P(1) RECEPTOR; RHO-GTPASES
AB The vascular endothelium serves as a semi-selective barrier between the circulating contents of the blood and the tissues through which they flow. Disruption of this barrier results in significant organ dysfunction during devastating inflammatory syndromes such as sepsis and acute lung injury (ALI). Sphingosine 1-phosphate (S1P) is an endogenous lipid regulator of endothelial permeability that produces potent barrier enhancement via actin and junctional protein rearrangement and resultant cytoskeletal changes. A key effector protein in this S1P response is focal adhesion kinase (FAK), a highly conserved cytoplasmic tyrosine kinase involved in the engagement of integrins and assembly of focal adhesions (FA) through the catalysis of multiple downstream signals. After stimulation by S1P, endothelial FAK undergoes specific tyrosine phosphorylation that results in activation of the kinase and dynamic interactions with other effector molecules to improve the endothelial barrier. FAK participates in peripheral actin cytoskeletal rearrangement as well as cell-matrix (FA) and cell-cell (adherens junction) junctional complex strengthening that combine to decrease vascular permeability. This review summarizes the current knowledge of the role of FAK in mediating enhanced endothelial barrier function by S1P. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Belvitch, Patrick; Dudek, Steven M.] Univ Illinois, Sect Pulm Crit Care Sleep & Allergy, Inst Personalized Resp Med, Dept Med, Chicago, IL 60612, United States.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital
RP Dudek, SM (corresponding author), Univ Illinois, Sect Pulm Crit Care Sleep & Allergy, Inst Personalized Resp Med, Dept Med, COMRB 3143,MC 719,909 S Wolcott Ave, Chicago, IL 60612 USA.
EM sdudek@uic.edu
FU National Heart Lung Blood Institute NIH [P01 HL 58064, R01 HL 88144]
FX This work was supported by grants from the National Heart Lung Blood
   Institute NIH grant P01 HL 58064 and R01 HL 88144. The authors thank
   Lichun Wang, Ph.D. for helpful discussions.
CR Alghisi GC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004449
   Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296
   Arce FT, 2008, BIOPHYS J, V95, P886, DOI 10.1529/biophysj.107.127167
   Argraves KM, 2008, J BIOL CHEM, V283, P25074, DOI 10.1074/jbc.M801214200
   Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829
   Bazzoni G, 2006, THROMB HAEMOSTASIS, V95, P36, DOI 10.1160/TH05-07-0488
   Birukova AA, 2007, MICROVASC RES, V73, P173, DOI 10.1016/j.mvr.2006.12.004
   Birukova AA, 2009, NANOMED-NANOTECHNOL, V5, P30, DOI 10.1016/j.nano.2008.07.002
   Birukova AA, 2009, AM J RESP CELL MOL, V40, P99, DOI 10.1165/rcmb.2008-0099OC
   Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248
   Brown M, 2010, MICROVASC RES, V80, P75, DOI 10.1016/j.mvr.2009.12.010
   Camerer E, 2009, J CLIN INVEST, V119, P1871, DOI 10.1172/JCI38575
   Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110
   Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207
   Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815
   Dudek SM, 2007, CELL SIGNAL, V19, P1754, DOI 10.1016/j.cellsig.2007.03.011
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487
   Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200
   Dudek SM, 2010, MOL BIOL CELL, V21, P4042, DOI 10.1091/mbc.E09-10-0876
   Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200
   Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996
   Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450
   Golubovskaya VM, 2005, J BIOL CHEM, V280, P25008, DOI 10.1074/jbc.M414172200
   Guo MZ, 2005, MICROCIRCULATION, V12, P223, DOI 10.1080/10739680590905251
   Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007
   Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532
   Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200
   ILLC D, 1995, NATURE, V377, P539
   Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123
   Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652
   Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833
   Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200
   Lee JF, 2009, AM J PHYSIOL-HEART C, V296, pH33, DOI 10.1152/ajpheart.00097.2008
   Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X
   Lee OH, 2000, BIOCHEM BIOPH RES CO, V268, P47, DOI 10.1006/bbrc.2000.2087
   Young HL, 2007, AM J RESP CELL MOL, V37, P485, DOI 10.1165/rcmb.2006-0439OC
   Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031
   Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107
   McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc
   Mehta D, 2002, J PHYSIOL-LONDON, V539, P779, DOI 10.1113/jphysiol.2001.013289
   Miura Y, 2000, J BIOCHEM-TOKYO, V127, P909, DOI 10.1093/oxfordjournals.jbchem.a022686
   Orr AW, 2004, FRONT BIOSCI-LANDMRK, V9, P1254, DOI 10.2741/1239
   Ossovskaya V, 2008, FEBS LETT, V582, P2402, DOI 10.1016/j.febslet.2008.06.004
   Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093
   Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC
   Playford MP, 2008, EXP CELL RES, V314, P3187, DOI 10.1016/j.yexcr.2008.08.010
   Quadri SK, 2007, AM J PHYSIOL-LUNG C, V292, pL334, DOI 10.1152/ajplung.00228.2006
   Quadri SK, 2003, J BIOL CHEM, V278, P13342, DOI 10.1074/jbc.M209922200
   Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db
   Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733
   Sammani S, 2010, AM J RESP CELL MOL, V43, P394, DOI 10.1165/rcmb.2009-0223OC
   Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112
   Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623
   SCHLAEPFER DD, 1994, NATURE, V372, P786
   Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626
   Shan YL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000116
   Shikata Y, 2003, FASEB J, V17, P2240, DOI 10.1096/fj.03-0198com
   Shikata Y, 2003, J APPL PHYSIOL, V94, P1193, DOI 10.1152/japplphysiol.00690.2002
   Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com
   Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200
   Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367
   Strub GM, 2010, ADV EXP MED BIOL, V688, P141
   Sun XG, 2009, MICROVASC RES, V77, P304, DOI 10.1016/j.mvr.2008.12.004
   Tani M, 2007, CELL SIGNAL, V19, P229, DOI 10.1016/j.cellsig.2006.07.001
   Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51
   Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380
   Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006
   Troyanovsky B, 2008, AM J PHYSIOL-LUNG C, V294, pL266, DOI 10.1152/ajplung.00107.2007
   Turner CE, 2001, CURR OPIN CELL BIOL, V13, P593, DOI 10.1016/S0955-0674(00)00256-8
   Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016
   Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251
   Venkiteswaran K, 2002, AM J PHYSIOL-CELL PH, V283, pC811, DOI 10.1152/ajpcell.00417.2001
   Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001
   Wang L, 2011, EUR RESPIR J, V38, P78, DOI 10.1183/09031936.00047810
   Wang L, 2008, HISTOCHEM CELL BIOL, V129, P579, DOI 10.1007/s00418-008-0389-8
   Wang LC, 2009, MICROVASC RES, V77, P39, DOI 10.1016/j.mvr.2008.09.005
   Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094
   Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7
   Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9
   Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537
   Wu MH, 2003, J PHYSIOL-LONDON, V552, P691, DOI 10.1113/jphysiol.2003.048405
   Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200
   Xu M, 2007, AM J PHYSIOL-CELL PH, V293, pC1309, DOI 10.1152/ajpcell.00014.2007
   Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013
   YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193
   Yu JXA, 2009, MOL BIOL CELL, V20, P4706, DOI 10.1091/mbc.E09-07-0548
   Zhang GQ, 2010, AM J PHYSIOL-HEART C, V299, pH1494, DOI 10.1152/ajpheart.00462.2010
   Zhao J, 2009, CELL SIGNAL, V21, P1945, DOI 10.1016/j.cellsig.2009.09.002
   Zhao XF, 2010, J CELL BIOL, V189, P955, DOI 10.1083/jcb.200912094
   Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200
NR 90
TC 42
Z9 46
U1 0
U2 15
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0026-2862
EI 1095-9319
J9 MICROVASC RES
JI Microvasc. Res.
PD JAN
PY 2012
VL 83
IS 1
SI SI
BP 22
EP 30
DI 10.1016/j.mvr.2011.08.012
PG 9
WC Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 875WY
UT WOS:000299067100004
PM 21925517
OA Green Accepted
DA 2023-08-21
ER

PT J
AU Zeng, H
   Pappas, C
   Belser, JA
   Houser, KV
   Zhong, WM
   Wadford, DA
   Stevens, T
   Balczon, R
   Katz, JM
   Tumpey, TM
AF Zeng, Hui
   Pappas, Claudia
   Belser, Jessica A.
   Houser, Katherine V.
   Zhong, Weiming
   Wadford, Debra A.
   Stevens, Troy
   Balczon, Ron
   Katz, Jacqueline M.
   Tumpey, Terrence M.
TI Human Pulmonary Microvascular Endothelial Cells Support Productive
   Replication of Highly Pathogenic Avian Influenza Viruses: Possible
   Involvement in the Pathogenesis of Human H5N1 Virus Infection
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID ACUTE LUNG INJURY; A SUBTYPE H5N1; MYCOBACTERIUM-TUBERCULOSIS;
   COMPARATIVE PATHOLOGY; RECEPTOR SPECIFICITY; RESPIRATORY-TRACT; H7
   VIRUSES; CLEAVAGE; HEMAGGLUTININ; EXPRESSION
AB Highly pathogenic avian influenza (HPAI) H5N1 viruses continue to cause sporadic human infections with a high fatality rate. Respiratory failure due to acute respiratory distress syndrome (ARDS) is a complication among hospitalized patients. Since progressive pulmonary endothelial damage is the hallmark of ARDS, we investigated host responses following HPAI virus infection of human pulmonary microvascular endothelial cells. Evaluation of these cells for the presence of receptors preferred by influenza virus demonstrated that avian-like (alpha 2-3-linked) receptors were more abundant than human-like (alpha 2-6-linked) receptors. To test the permissiveness of pulmonary endothelial cells to virus infection, we compared the replication of selected seasonal, pandemic (2009 H1N1 and 1918), and potentially pandemic (H5N1) influenza virus strains. We observed that these cells support productive replication only of HPAI H5N1 viruses, which preferentially enter through and are released from the apical surface of polarized human endothelial monolayers. Furthermore, A/Thailand/16/2004 and A/Vietnam/1203/2004 (VN/1203) H5N1 viruses, which exhibit heightened virulence in mammalian models, replicated to higher titers than less virulent H5N1 strains. VN/1203 infection caused a significant decrease in endothelial cell proliferation compared to other subtype viruses. VN/1203 virus was also found to be a potent inducer of cytokines and adhesion molecules known to regulate inflammation during acute lung injury. Deletion of the H5 hemagglutinin (HA) multibasic cleavage site did not affect virus infectivity but resulted in decreased virus replication in endothelial cells. Our results highlight remarkable tropism and infectivity of the H5N1 viruses for human pulmonary endothelial cells, resulting in the potent induction of host inflammatory responses.
C1 [Zeng, Hui; Pappas, Claudia; Belser, Jessica A.; Houser, Katherine V.; Zhong, Weiming; Wadford, Debra A.; Katz, Jacqueline M.; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Immunol & Pathogenesis Branch, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333, United States.
   [Balczon, Ron] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688, United States.
   [Stevens, Troy] Univ S Alabama, Dept Pharmacol, Mobile, AL 36688, United States.
   [Stevens, Troy; Balczon, Ron] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688, United States.
C3 Centers for Disease Control & Prevention - USA; University of South
   Alabama; University of South Alabama; University of South Alabama
RP Tumpey, TM (corresponding author), Ctr Dis Control & Prevent, Immunol & Pathogenesis Branch, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
EM tft9@cdc.gov
OI Wadford, Debra/0000-0002-8630-427X
FU NIH [HL-60024, HL-66299]
FX This research was funded in part by NIH grants HL-60024 and HL-66299 to
   T.S.
CR Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279
   Alom-Ruiz SP, 2008, ANTIOXID REDOX SIGN, V10, P1089, DOI 10.1089/ars.2007.2007
   Azoulay E, 2002, CRIT CARE MED, V30, P781, DOI 10.1097/00003246-200204000-00010
   Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106
   Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105
   Belser JA, 2011, J INFECT DIS, V203, P40, DOI 10.1093/infdis/jiq018
   Belser JA, 2009, J VIROL, V83, P7075, DOI 10.1128/JVI.00535-09
   Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657
   Birkness KA, 1999, INFECT IMMUN, V67, P653, DOI 10.1128/IAI.67.2.653-658.1999
   Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10
   Chan MCW, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-102
   Chosewood L.C., 2009, BIOSAFETY MICROBIOLO, Vfifth
   Chutinimitkul S, 2006, EMERG INFECT DIS, V12, P1041, DOI 10.3201/eid1206.060227
   Cotran R. S., 1999, ROBBINS PATHOLOGIC B
   de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307
   de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477
   Decha P, 2008, BIOPHYS J, V95, P128, DOI 10.1529/biophysj.107.127456
   Deng R, 2008, J PATHOL, V216, P328, DOI 10.1002/path.2417
   Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3
   Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3
   Guo XL, 2008, AMINO ACIDS, V35, P375, DOI 10.1007/s00726-007-0611-3
   Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419
   Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05
   King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006
   Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6
   Korteweg C, 2008, AM J PATHOL, V172, P1155, DOI 10.2353/ajpath.2008.070791
   Kuiken T, 2010, VET PATHOL, V47, P893, DOI 10.1177/0300985810378651
   Kusters S, 1997, EUR J IMMUNOL, V27, P2870, DOI 10.1002/eji.1830271119
   La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026
   Lamb RA, 1996, FIELDS VIROLOGY
   Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999
   Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005
   Mehta PK, 2006, MICROB PATHOGENESIS, V41, P119, DOI 10.1016/j.micpath.2006.05.002
   Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625
   Ng WF, 2006, HUM PATHOL, V37, P381, DOI 10.1016/j.humpath.2006.01.015
   Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529
   Ocana-Macchi M, 2009, J VIROL, V83, P12947, DOI 10.1128/JVI.00468-09
   Park MS, 2006, P NATL ACAD SCI USA, V103, P8203, DOI 10.1073/pnas.0602566103
   Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5
   Perrone LA, 2010, J INFECT DIS, V202, P1161, DOI 10.1086/656365
   Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a
   Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716
   Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000
   To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N
   Tran TT, 2008, INT J BIOCHEM CELL B, V40, P2671, DOI 10.1016/j.biocel.2008.05.019
   Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392
   Uyeki TM, 2009, CLIN INFECT DIS, V49, P279, DOI 10.1086/600035
   van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548
   van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248
   Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016
   WALLS HH, 1986, J CLIN MICROBIOL, V23, P240, DOI 10.1128/JCM.23.2.240-245.1986
   Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288
   Yao L, 2008, FASEB J, V22, P733, DOI 10.1096/fj.06-7880com
   Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985
   Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07
   Zeng H, 2011, J VIROL, V85, P686, DOI 10.1128/JVI.01568-10
   Zhang ZF, 2009, HUM PATHOL, V40, P735, DOI 10.1016/j.humpath.2008.08.015
NR 57
TC 73
Z9 83
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JAN
PY 2012
VL 86
IS 2
BP 667
EP 678
DI 10.1128/JVI.06348-11
PG 12
WC Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Virology
GA 870MW
UT WOS:000298674600003
PM 22072765
OA Bronze, Green Published
DA 2023-08-21
ER

PT J
AU Zhang, LS
   Li, T
   Yu, DN
   Forman, BM
   Huang, WD
AF Zhang, Lisheng
   Li, Tao
   Yu, Donna
   Forman, Barry M.
   Huang, Wendong
TI FXR Protects Lung from Lipopolysaccharide-Induced Acute Injury
SO MOLECULAR ENDOCRINOLOGY
LA English
DT Article
ID FARNESOID-X-RECEPTOR; BILE-ACID; ACTIVATION; EXPRESSION; CELLS;
   PROLIFERATION; RECRUITMENT; DISRUPTION; BLOCKING; ADHESION
AB Acute lung injury and its more severe form, acute respiratory distress syndrome, are characterized by an acute inflammatory response in the airspaces and lung parenchyma. The nuclear receptor farnesoid X receptor (FXR) is expressed in pulmonary artery endothelial cells. Here, we report a protective role of FXR in a lipopolysaccharide-induced mouse model of acute lung injury. Uponintratracheal injection of lipopolysaccharide, FXR-/- mice showed higher lung endothelial permeability, released more bronchoalveolar lavage cells to the alveoli, and developed acute pneumonia. Cell adhesion molecules were expressed at higher levels in FXR-/- mice as compared with control mice. Furthermore, lung regeneration was much slower in FXR-/- mice. In vitro experiments showed that FXR activation blocked TNF alpha-induced expression of P-selectin but stimulated proliferation of lung microvascular endothelial cells through up-regulation of Foxm1b. In addition, expression of a constitutively active FXR repressed the expression of proinflammatory genes and improved lung permeability and lung regeneration in FXR-/- mice. This study demonstrates a critical role of FXR in suppressing the inflammatory response in lung and promoting lung repair after injury. (Molecular Endocrinology 26: 27-36, 2012)
C1 [Zhang, Lisheng; Li, Tao; Yu, Donna; Forman, Barry M.; Huang, Wendong] City Hope Natl Med Ctr, Beckman Res Inst, Div Gene Regulat & Drug Discovery, Duarte, CA 91010, United States.
C3 City of Hope; Beckman Research Institute of City of Hope
RP Huang, WD (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Gene Regulat & Drug Discovery, 1500 E Duarte Rd, Duarte, CA 91010 USA.
EM whuang@coh.org
FU National Cancer Institute [1R01CA139158-01A2]
FX This work was supported by the National Cancer Institute Grant
   1R01CA139158-01A2 (to W.H.).
CR Bishop-Bailey D, 2004, P NATL ACAD SCI USA, V101, P3668, DOI 10.1073/pnas.0400046101
   Chen WD, 2010, HEPATOLOGY, V51, P953, DOI 10.1002/hep.23390
   Das A, 2009, ARTERIOSCL THROM VAS, V29, P562, DOI 10.1161/ATVBAHA.108.182725
   Gong HBA, 2009, J BIOL CHEM, V284, P30113, DOI 10.1074/jbc.M109.047753
   He FT, 2006, CIRC RES, V98, P192, DOI 10.1161/01.RES.0000200400.55539.85
   Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435
   Kalinichenko VV, 2003, J BIOL CHEM, V278, P37888, DOI 10.1074/jbc.M305555200
   Kevil Christopher G., 2003, Pathophysiology, V9, P63, DOI 10.1016/S0928468002000834
   Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249
   Li YTY, 2007, ARTERIOSCL THROM VAS, V27, P2606, DOI 10.1161/ATVBAHA.107.152694
   Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014
   McMillan SJ, 2004, J IMMUNOL, V172, P2586, DOI 10.4049/jimmunol.172.4.2586
   Mencarelli A, 2009, J IMMUNOL, V183, P6657, DOI 10.4049/jimmunol.0901347
   Meng ZP, 2010, MOL ENDOCRINOL, V24, P886, DOI 10.1210/me.2009-0286
   Minamino T, 2006, J CLIN INVEST, V116, P2316, DOI 10.1172/JCI29637
   MULLIGAN MS, 1992, J CLIN INVEST, V90, P1600, DOI 10.1172/JCI116029
   Piqueras L, 2009, J LEUKOCYTE BIOL, V86, P115, DOI [10.1189/jlb.0508284, 10.1189/JLB.0508284]
   Ramirez SH, 2008, J IMMUNOL, V180, P1854, DOI 10.4049/jimmunol.180.3.1854
   Rudkowski JC, 2004, AM J PHYSIOL-LUNG C, V286, pL793, DOI 10.1152/ajplung.00266.2003
   Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3
   Singbartl K, 2000, FASEB J, V14, P48, DOI 10.1096/fasebj.14.1.48
   SUBRAMANIAM M, 1995, J EXP MED, V181, P2277, DOI 10.1084/jem.181.6.2277
   Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978
   Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519
   Wang YD, 2008, MOL ENDOCRINOL, V22, P1622, DOI 10.1210/me.2007-0527
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078
   Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499
   Zecca E, 2008, PEDIATRICS, V121, pE146, DOI 10.1542/peds.2007-1220
   Zhang LS, 2009, MOL ENDOCRINOL, V23, P137, DOI 10.1210/me.2008-0198
   Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154
NR 31
TC 28
Z9 36
U1 1
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0888-8809
EI 1944-9917
J9 MOL ENDOCRINOL
JI Mol. Endocrinol.
PD JAN
PY 2012
VL 26
IS 1
BP 27
EP 36
DI 10.1210/me.2011-0042
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 877RO
UT WOS:000299199800004
PM 22135065
OA Green Published, Bronze
DA 2023-08-21
ER

PT J
AU Xiang, M
   Shi, XL
   Li, YH
   Xu, J
   Yin, LH
   Xiao, GZ
   Scott, MJ
   Billiar, TR
   Wilson, MA
   Fan, J
AF Xiang, Meng
   Shi, Xiaolian
   Li, Yuehua
   Xu, Jia
   Yin, Lianhua
   Xiao, Guozhi
   Scott, Melanie J.
   Billiar, Timothy R.
   Wilson, Mark A.
   Fan, Jie
TI Hemorrhagic Shock Activation of NLRP3 Inflammasome in Lung Endothelial
   Cells
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID MOBILITY GROUP BOX-1; INTERLEUKIN-1 RECEPTOR ANTAGONIST;
   RESPIRATORY-DISTRESS-SYNDROME; NEUTROPHIL NADPH OXIDASE; MULTIPLE ORGAN
   FAILURE; SEVERE BLUNT TRAUMA; TLR2 UP-REGULATION; NAD(P)H OXIDASE;
   ISCHEMIA/REPERFUSION INJURY; ALVEOLAR MACROPHAGES
AB Hemorrhagic shock (HS) due to major trauma and surgery predisposes the host to the development of systemic inflammatory response syndrome (SIRS), including acute lung injury (ALI), through activating and exaggerating the innate immune response. IL-1 beta is a crucial proinflammatory cytokine that contributes to the development of SIRS and ALI. Lung endothelial cells (EC) are one important source of IL-1 beta, and the production of active IL-1 beta is controlled by the inflammasome. In this study, we addressed the mechanism underlying HS activation of the inflammasome in lung EC. We show that high mobility group box 1 acting through TLR4, and a synergistic collaboration with TLR2 and receptor for advanced glycation end products signaling, mediates HS-induced activation of EC NAD(P) H oxidase. In turn, reactive oxygen species derived from NAD(P) H oxidase promote the association of thioredoxin-interacting protein with the nucleotide-binding oligomerization domain-like receptor protein NLRP3 and subsequently induce inflammasome activation and IL-1 beta secretion from the EC. We also show that neutrophil-derived reactive oxygen species play a role in enhancing EC NAD(P) H oxidase activation and therefore an amplified inflammasome activation in response to HS. The present study explores a novel mechanism underlying HS activation of EC inflammasome and thus presents a potential therapeutic target for SIRS and ALI induced after HS. The Journal of Immunology, 2011, 187: 4809-4817.
C1 [Fan, Jie] Vet Affairs Pittsburgh Healthcare Syst, Dept Surg, Res & Dev, Pittsburgh, PA 15240, United States.
   [Xiang, Meng; Shi, Xiaolian; Li, Yuehua; Xu, Jia; Scott, Melanie J.; Billiar, Timothy R.; Wilson, Mark A.; Fan, Jie] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213, United States.
   [Xiang, Meng; Yin, Lianhua] Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai 200032, China.
   [Shi, Xiaolian] Xi An Jiao Tong Univ, Coll Med, Dept Pharmacol, Xian 710061, China.
   [Xu, Jia] So Med Univ, Dept Pathophysiol, Guangzhou 510515, Guangdong, China.
   [Xiao, Guozhi] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213, United States.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); University of Pittsburgh; Fudan University;
   Xi'an Jiaotong University; Southern Medical University - China;
   Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh
RP Fan, J (corresponding author), Vet Affairs Pittsburgh Healthcare Syst, Dept Surg, Res & Dev, Bldg 1,Room 2W109 151L-U,Univ Dr C, Pittsburgh, PA 15240 USA.
EM jif7@pitt.edu
RI li, yueyue/IVH-9846-2023; LI, Yue/GRS-8071-2022; li, yue/HSF-7296-2023
FU National Institutes of Health [R01-HL-079669]; National Institutes of
   Health Center [P50-GM-53789]; Veterans Administration
FX This work was supported by National Institutes of Health Grant
   R01-HL-079669 (to J.F. and M.A.W.), National Institutes of Health Center
   Grant P50-GM-53789 (to T.R.B. and J.F.), and a Veterans Administration
   Merit Award (to J.F.).
CR Abraham E, 1999, INTENS CARE MED, V25, P556, DOI 10.1007/s001340050903
   Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950
   ABRAHAM E, 1988, CIRC SHOCK, V25, P33
   Al-Mehdi AB, 1998, CIRC RES, V83, P730, DOI 10.1161/01.RES.83.7.730
   Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565
   Assier E, 2004, J IMMUNOL, V172, P7661, DOI 10.4049/jimmunol.172.12.7661
   Babior BM, 2000, IUBMB LIFE, V50, P267, DOI 10.1080/15216540051080976
   Cotter MJ, 2001, AM J PATHOL, V159, P473, DOI 10.1016/S0002-9440(10)61719-1
   Czura CJ, 2003, CRIT CARE MED, V31, pS46, DOI 10.1097/00003246-200301001-00007
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   Eckels P, 2008, SHOCK, V29, P17
   Fan J, 2006, AM J PHYSIOL-LUNG C, V290, pL738, DOI 10.1152/ajplung.00280.2005
   Fan J, 1998, J IMMUNOL, V161, P440
   Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696
   Fan J, 2007, SHOCK, V28, P213, DOI 10.1097/shk.0b013e318033ec9d
   Fan J, 2007, J IMMUNOL, V178, P6573, DOI 10.4049/jimmunol.178.10.6573
   FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836
   FISHER CJ, 1994, CIRC SHOCK, V44, P1
   FOWLER AA, 1983, ANN INTERN MED, V98, P593, DOI 10.7326/0003-4819-98-5-593
   GLAUSER MP, 1991, LANCET, V338, P732, DOI 10.1016/0140-6736(91)91452-Z
   Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494
   Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916
   HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752
   Huber TS, 2000, SHOCK, V13, P425, DOI 10.1097/00024382-200006000-00002
   Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919
   Huttunen HJ, 2002, CANCER RES, V62, P4805
   Impellizzeri D, 2011, BIOCHEM PHARMACOL, V81, P636, DOI 10.1016/j.bcp.2010.12.006
   Kaczorowski DJ, 2008, J LEUKOCYTE BIOL, V83, P546, DOI 10.1189/jlb.0607374
   Kim JY, 2005, AM J PHYSIOL-LUNG C, V288, pL958, DOI 10.1152/ajplung.00359.2004
   Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936
   Li YH, 2009, AM J PHYSIOL-REG I, V297, pR1670, DOI 10.1152/ajpregu.00445.2009
   Liu YJ, 2009, J IMMUNOL, V182, P572, DOI 10.4049/jimmunol.182.1.572
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS
   Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059
   Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010
   Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x
   Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552
   Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005
   Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200
   Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195
   Rao DA, 2007, J IMMUNOL, V179, P6536, DOI 10.4049/jimmunol.179.10.6536
   ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011
   ROUMEN RMH, 1995, CRIT CARE MED, V23, P474, DOI 10.1097/00003246-199503000-00010
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   SHENKAR R, 1994, AM J RESP CELL MOL, V10, P290, DOI 10.1165/ajrcmb.10.3.8117448
   SHENKAR R, 1993, LYMPHOKINE CYTOK RES, V12, P237
   Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8
   Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725
   Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661
   Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614
   Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248
   Wang HH, 2001, AM J RESP CRIT CARE, V164, P1768, DOI 10.1164/ajrccm.164.10.2106117
   Xiang M, 2011, AM J RESP CELL MOL, V44, P333, DOI 10.1165/rcmb.2009-0408OC
   Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100
   Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang
   Zanetti G, 1997, SCHWEIZ MED WSCHR, V127, P489
   Zeh HJ, 2005, J IMMUNOTHER, V28, P1, DOI 10.1097/00002371-200501000-00001
   Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831
   ZHU XL, 1995, CYTOKINE, V7, P8, DOI 10.1006/cyto.1995.1002
NR 61
TC 122
Z9 137
U1 0
U2 11
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD NOV 1
PY 2011
VL 187
IS 9
BP 4809
EP 4817
DI 10.4049/jimmunol.1102093
PG 9
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 841ET
UT WOS:000296496000046
PM 21940680
OA Green Accepted, Bronze
DA 2023-08-21
ER

PT J
AU Pati, S
   Gerber, MH
   Menge, TD
   Wataha, KA
   Zhao, YH
   Baumgartner, JA
   Zhao, J
   Letourneau, PA
   Huby, MP
   Baer, LA
   Salsbury, JR
   Kozar, RA
   Wade, CE
   Walker, PA
   Dash, PK
   Cox, CS
   Doursout, MF
   Holcomb, JB
AF Pati, Shibani
   Gerber, Michael H.
   Menge, Tyler D.
   Wataha, Kathryn A.
   Zhao, Yuhai
   Baumgartner, John Adam
   Zhao, Jing
   Letourneau, Phillip A.
   Huby, Maria P.
   Baer, Lisa A.
   Salsbury, John R.
   Kozar, Rosemary A.
   Wade, Charles E.
   Walker, Peter A.
   Dash, Pramod K.
   Cox, Charles S., Jr.
   Doursout, Marie-Francoise
   Holcomb, John B.
TI Bone Marrow Derived Mesenchymal Stem Cells Inhibit Inflammation and
   Preserve Vascular Endothelial Integrity in the Lungs after Hemorrhagic
   Shock
SO PLOS ONE
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; STROMAL CELLS; ADHERENS JUNCTIONS;
   KAPOSIS-SARCOMA; GROWTH-FACTORS; VE-CADHERIN; INJURY; PERMEABILITY;
   DISEASE; SEPSIS
AB Hemorrhagic shock (HS) and trauma is currently the leading cause of death in young adults worldwide. Morbidity and mortality after HS and trauma is often the result of multi-organ failure such as acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), conditions with few therapeutic options. Bone marrow derived mesenchymal stem cells (MSCs) are a multipotent stem cell population that has shown therapeutic promise in numerous pre-clinical and clinical models of disease. In this paper, in vitro studies with pulmonary endothelial cells (PECs) reveal that conditioned media (CM) from MSCs and MSC-PEC co-cultures inhibits PEC permeability by preserving adherens junctions (VE-cadherin and beta-catenin). Leukocyte adhesion and adhesion molecule expression (VCAM-1 and ICAM-1) are inhibited in PECs treated with CM from MSC-PEC co-cultures. Further support for the modulatory effects of MSCs on pulmonary endothelial function and inflammation is demonstrated in our in vivo studies on HS in the rat. In a rat "fixed volume" model of mild HS, we show that MSCs administered IV potently inhibit systemic levels of inflammatory cytokines and chemokines in the serum of treated animals. In vivo MSCs also inhibit pulmonary endothelial permeability and lung edema with concurrent preservation of the vascular endothelial barrier proteins: VE-cadherin, Claudin-1, and Occludin-1. Leukocyte infiltrates (CD68 and MPO positive cells) are also decreased in lungs with MSC treatment. Taken together, these data suggest that MSCs, acting directly and through soluble factors, are potent stabilizers of the vascular endothelium and inflammation. These data are the first to demonstrate the therapeutic potential of MSCs in HS and have implications for the potential use of MSCs as a cellular therapy in HS-induced lung injury.
C1 [Pati, Shibani; Gerber, Michael H.; Menge, Tyler D.; Wataha, Kathryn A.; Zhao, Yuhai; Baumgartner, John Adam; Letourneau, Phillip A.; Huby, Maria P.; Baer, Lisa A.; Salsbury, John R.; Kozar, Rosemary A.; Wade, Charles E.; Holcomb, John B.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX, United States.
   [Pati, Shibani; Gerber, Michael H.; Menge, Tyler D.; Wataha, Kathryn A.; Zhao, Yuhai; Baumgartner, John Adam; Letourneau, Phillip A.; Huby, Maria P.; Baer, Lisa A.; Salsbury, John R.; Kozar, Rosemary A.; Wade, Charles E.; Holcomb, John B.] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Houston, TX, United States.
   [Dash, Pramod K.] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX, United States.
   [Zhao, Jing; Walker, Peter A.; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX, United States.
   [Doursout, Marie-Francoise] Univ Texas Hlth Sci Ctr Houston, Dept Anesthesiol, Houston, TX, United States.
C3 University of Texas System; University of Texas Health Science Center
   Houston; University of Texas System; University of Texas Health Science
   Center Houston; University of Texas System; University of Texas Health
   Science Center Houston; University of Texas System; University of Texas
   Health Science Center Houston; University of Texas System; University of
   Texas Health Science Center Houston
RP Pati, S (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX USA.
EM shibani.pati@uth.tmc.edu
RI Dash, Pramod Kumar/F-5832-2011
OI Dash, Pramod Kumar/0000-0001-6746-1002; holcomb,
   john/0000-0001-8312-9157; Salsbury, John/0000-0002-6536-6420
FU Mission Connect: The Institute for Rehabilitation and Research; National
   Institutes of Health [T32GM008792-11]
FX This work was supported by funding from Mission Connect: The Institute
   for Rehabilitation and Research and the National Institutes of Health
   T32GM008792-11. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
   Aird WC, 2003, CRIT CARE MED, V31, pS221, DOI 10.1097/01.CCM.0000057847.32590.C1
   Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
   Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708
   Ball SG, 2007, J CELL MOL MED, V11, P1012, DOI 10.1111/j.1582-4934.2007.00120.x
   Ball SG, 2007, INT J BIOCHEM CELL B, V39, P379, DOI 10.1016/j.biocel.2006.09.005
   Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003
   Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6
   Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005
   Cinel I, 2007, CURR OPIN INFECT DIS, V20, P345, DOI 10.1097/QCO.0b013e32818be70a
   Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244
   Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68
   Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897
   DIAZFLORES L, 1991, HISTOL HISTOPATHOL, V6, P269
   Fang XH, 2010, J BIOL CHEM, V285, P26211, DOI 10.1074/jbc.M110.119917
   Fein AM, 2000, CRIT CARE CLIN, V16, P289, DOI 10.1016/S0749-0704(05)70111-1
   Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253
   FLECK A, 1985, LANCET, V1, P781
   GROTZ MRW, 1995, SHOCK, V3, P362
   Guidot DM, 2006, AM J PHYSIOL-LUNG C, V291, pL301, DOI 10.1152/ajplung.00153.2006
   Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855
   Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158
   Kamouchi M, 2010, CELL MOL NEUROBIOL
   Kerkar S, 2001, J TRAUMA, V51, P440, DOI 10.1097/00005373-200109000-00003
   Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921
   Lampugnani MG, 2007, THROMB RES, V120, pS1, DOI 10.1016/S0049-3848(07)70124-X
   Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7
   Lee CC, 2005, SHOCK, V24, P177, DOI 10.1097/01.shk.0000171870.42900.15
   London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678
   Matthay MA, 2010, CHEST, V138, P965, DOI 10.1378/chest.10-0518
   Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905
   Pati S, 2001, J VIROL, V75, P8660, DOI 10.1128/JVI.75.18.8660-8673.2001
   Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013
   Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4
   Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2
   Qian H, 2008, INT J MOL MED, V22, P325, DOI 10.3892/ijmm_00000026
   Rocco TR, 2001, ANN SURG, V233, P414, DOI 10.1097/00000658-200103000-00017
   SIMS DE, 1991, CAN J CARDIOL, V7, P431
   SINCLAIR DG, 1994, CHEST, V106, P535, DOI 10.1378/chest.106.2.535
   Sondeen JL, 2007, SHOCK, V28, P426, DOI 10.1097/shk.0b013e31804a5791
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   Veevers-Lowe J, 2011, J CELL SCI, V124, P1288, DOI 10.1242/jcs.076935
   Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005
   Ware LB, 2002, AM J PHYSIOL-LUNG C, V282, pL924, DOI 10.1152/ajplung.00439.2001
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Weiss Daniel J, 2008, Proc Am Thorac Soc, V5, P637, DOI 10.1513/pats.200804-037DW
   Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7
NR 47
TC 114
Z9 126
U1 0
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 28
PY 2011
VL 6
IS 9
AR e25171
DI 10.1371/journal.pone.0025171
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 834CT
UT WOS:000295936900029
PM 21980392
OA Green Published, gold, Green Submitted
DA 2023-08-21
ER

PT J
AU Krzyzaniak, MJ
   Peterson, CY
   Cheadle, G
   Loomis, W
   Wolf, P
   Kennedy, V
   Putnam, JG
   Bansal, V
   Eliceiri, B
   Baird, A
   Coimbra, R
AF Krzyzaniak, Michael J.
   Peterson, Carrie Y.
   Cheadle, Gerald
   Loomis, William
   Wolf, Paul
   Kennedy, Vince
   Putnam, James G.
   Bansal, Vishal
   Eliceiri, Brian
   Baird, Andrew
   Coimbra, Raul
TI Efferent vagal nerve stimulation attenuates acute lung injury following
   burn: The importance of the gut-lung axis
SO SURGERY
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; FACTOR-KAPPA-B; SYSTEMIC INFLAMMATORY
   RESPONSE; THERMAL-INJURY; PHOSPHODIESTERASE INHIBITION; INTESTINAL
   INJURY; MESENTERIC LYMPH; BARRIER INJURY; PENTOXIFYLLINE; NEUTROPHILS
AB Background. The purpose of this study was to assess acute lung injury when protection to the gut mucosal barrier offered by vagus nerve stimulation is eliminated by an abdominal vagotomy.
   Methods. Male balb/c mice were subjected to 30% total body surface area steam burn With and without electrical stimulation to the right cervical vagus nerve. A cohort of animals were subjected to abdominal vagotomy. Lung histology, myeloperoxidase and ICAM-1 immune staining, myeloperoxidase enzymatic assay, and tissue KC levels were analyzed 24 hours after burn. Additionally, lung IkB-alpha, NF-kB immunoblots, and NF-kB-DNA binding measured by photon emission analysis Using NF-kB-luc transgenic mice Were performed.
   Results. Six hours post burn, phosphorylation of both NF-kB p65 and IkB-alpha were observed. Increased photon emission signal was seen in the lungs of NF-kB-luc transgenic animals. Vagal nerve stimulation blunted NF-kB activation similar to sham animals whereas abdominal vagotomy eliminated the anti-inflammatory effect. After burn, MPO positive cells and ICAM-1 expression in the lung endothelium was increased, and lung histology demonstrated significant injury at 24 hours. Vagal nerve stimulation markedly decreased neutrophil infiltration as demonstrated by MPO immune staining and enzyme activity. Vagal stimulation also markedly attenuated acute lung injury at 24 hours. The protective effects of vagal nerve stimulation were reversed by performing an abdominal vagotomy.
   Conclusion. Vagal nerve stimulation is an effective strategy to protect against acute lung injury following burn. Moreover, the protective effects of vagal nerve stimulation, in the prevention of acute lung injury are eliminated by performing an abdominal vagotomy. These results establish the importance of the gut-lung axis after burn in the genesis of acute lung injury. (Surgery 2011;150:379-89.)
C1 [Krzyzaniak, Michael J.; Peterson, Carrie Y.; Cheadle, Gerald; Loomis, William; Kennedy, Vince; Putnam, James G.; Bansal, Vishal; Eliceiri, Brian; Baird, Andrew; Coimbra, Raul] Univ Calif San Diego, San Diego Sch Med, Dept Surg, Div Trauma Surg Crit Care & Burns, San Diego, CA 92103, United States.
   [Wolf, Paul] Univ Calif San Diego, San Diego Sch Med, Dept Pathol, San Diego, CA 92103, United States.
C3 University of California System; University of California San Diego;
   University of California System; University of California San Diego
RP Coimbra, R (corresponding author), 200 W Arbor Dr 8896, San Diego, CA 92103 USA.
EM rcoimbra@ncsd.edu
RI Coimbra, Raul/AAP-3019-2020; COimbra, Raul/HJP-1207-2023; Peterson,
   Carrie/AAF-8586-2021
OI Coimbra, Raul/0000-0002-3759-6851; COimbra, Raul/0000-0002-3759-6851;
   Peterson, Carrie/0000-0002-8448-4633; Baird, Andrew/0000-0003-0027-9905;
   Eliceiri, Brian/0000-0003-1811-1916
FU NIGMS NIH HHS [P20 GM078421, P20 GM078421-05] Funding Source: Medline
CR Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8
   Berger F, 2008, EUR J NUCL MED MOL I, V35, P2275, DOI 10.1007/s00259-008-0870-6
   Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124
   Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132
   Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070
   Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801
   Calkins CM, 2001, J SURG RES, V101, P232, DOI 10.1006/jsre.2001.6274
   CANNON JG, 1992, CRIT CARE MED, V20, P1414, DOI 10.1097/00003246-199210000-00009
   Christman JW, 1998, INTENS CARE MED, V24, P1131, DOI 10.1007/s001340050735
   Coimbra R, 2004, J TRAUMA, V57, P1157, DOI 10.1097/01.TA.0000151261.28640.F7
   Costantini TW, 2010, AM J PHYSIOL-GASTR L, V299, pG1308, DOI 10.1152/ajpgi.00156.2010
   Costantini TW, 2010, J TRAUMA, V68, P1349, DOI 10.1097/TA.0b013e3181dccea0
   Costantini TW, 2009, J TRAUMA, V67, P1162, DOI 10.1097/TA.0b013e3181ba3577
   Costantini TW, 2009, SHOCK, V31, P416, DOI 10.1097/SHK.0b013e3181863080
   Dancey DR, 1999, INTENS CARE MED, V25, P1231, DOI 10.1007/PL00003763
   Deitch E A, 2001, Curr Opin Crit Care, V7, P92, DOI 10.1097/00075198-200104000-00007
   DEMLING RH, 1984, SURGERY, V95, P136
   Deree J, 2007, J SURG RES, V143, P99, DOI 10.1016/j.jss.2007.03.083
   Estenssoro E, 2002, CRIT CARE MED, V30, P2450, DOI 10.1097/00003246-200211000-00008
   HARMS BA, 1982, MICROVASC RES, V23, P77, DOI 10.1016/0026-2862(82)90032-2
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362
   Ipaktchi K, 2006, J IMMUNOL, V177, P8065, DOI 10.4049/jimmunol.177.11.8065
   Lpaktchi K, 2007, CRIT CARE MED, V35, P2139, DOI 10.1097/01.CCM.0000280568.61217.26
   Magnotti LJ, 1999, ARCH SURG-CHICAGO, V134, P1333, DOI 10.1001/archsurg.134.12.1333
   MAINOUS MR, 1995, SHOCK, V4, P193, DOI 10.1097/00024382-199509000-00007
   PRUITT BA, 1975, J TRAUMA, V15, P369
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Sha WC, 1998, J EXP MED, V187, P143, DOI 10.1084/jem.187.2.143
   Song XM, 2010, BURNS, V36, P75, DOI 10.1016/j.burns.2009.02.002
   WALKER HL, 1968, J TRAUM, V8, P1049, DOI 10.1097/00005373-196811000-00006
   Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339
   WINDSOR ACJ, 1993, BRIT J SURG, V80, P10, DOI 10.1002/bjs.1800800106
   Zallen G, 1999, J SURG RES, V83, P83, DOI 10.1006/jsre.1999.5569
   Zambon M, 2008, CHEST, V133, P1120, DOI 10.1378/chest.07-2134
NR 35
TC 40
Z9 44
U1 0
U2 8
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0039-6060
J9 SURGERY
JI Surgery
PD SEP
PY 2011
VL 150
IS 3
BP 379
EP 389
DI 10.1016/j.surg.2011.06.008
PG 11
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA 823FQ
UT WOS:000295108300003
PM 21783215
OA Green Accepted
DA 2023-08-21
ER

PT J
AU van der Heijden, M
   Amerongen, GPV
   van Bezu, J
   Paul, MA
   Groeneveld, ABJ
   van Hinsbergh, VWM
AF van der Heijden, Melanie
   Amerongen, Geerten P. van Nieuw
   van Bezu, Jan
   Paul, Marinus A.
   Groeneveld, A. B. Johan
   van Hinsbergh, Victor W. M.
TI Opposing Effects of the Angiopoietins on the Thrombin-Induced
   Permeability of Human Pulmonary Microvascular Endothelial Cells
SO PLOS ONE
LA English
DT Article
ID ACUTE LUNG INJURY; VASCULAR-PERMEABILITY; INDUCED INCREASE; BARRIER
   FUNCTION; GENE-THERAPY; VE-CADHERIN; IN-VIVO; TIE2; JUNCTIONS; KINASE
AB Background: Angiopoietin-2 (Ang-2) is associated with lung injury in ALI/ARDS. As endothelial activation by thrombin plays a role in the permeability of acute lung injury and Ang-2 may modulate the kinetics of thrombin-induced permeability by impairing the organization of vascular endothelial (VE-) cadherin, and affecting small Rho GTPases in human pulmonary microvascular endothelial cells (HPMVECs), we hypothesized that Ang-2 acts as a sensitizer of thrombin-induced hyperpermeability of HPMVECs, opposed by Ang-1.
   Methodology/Principal Findings: Permeability was assessed by measuring macromolecule passage and transendothelial electrical resistance (TEER). Angiopoietins did not affect basal permeability. Nevertheless, they had opposing effects on the thrombin-induced permeability, in particular in the initial phase. Ang-2 enhanced the initial permeability increase (passage, P = 0.010; TEER, P = 0.021) in parallel with impairment of VE-cadherin organization without affecting VE-cadherin Tyr685 phosphorylation or increasing RhoA activity. Ang-2 also increased intercellular gap formation. Ang-1 preincubation increased Rac1 activity, enforced the VE-cadherin organization, reduced the initial thrombin-induced permeability (TEER, P = 0.027), while Rac1 activity simultaneously normalized, and reduced RhoA activity at 15 min thrombin exposure (P = 0.039), but not at earlier time points. The simultaneous presence of Ang-2 largely prevented the effect of Ang-1 on TEER and macromolecule passage.
   Conclusions/Significance: Ang-1 attenuated thrombin-induced permeability, which involved initial Rac1 activation-enforced cell-cell junctions, and later RhoA inhibition. In addition to antagonizing Ang-1, Ang-2 had also a direct effect itself. Ang-2 sensitized the initial thrombin-induced permeability accompanied by destabilization of VE-cadherin junctions and increased gap formation, in the absence of increased RhoA activity.
C1 [van der Heijden, Melanie; Groeneveld, A. B. Johan] Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Inst Cardiovasc Res, Amsterdam, Netherlands.
   [van der Heijden, Melanie; Amerongen, Geerten P. van Nieuw; van Bezu, Jan; van Hinsbergh, Victor W. M.] Vrije Univ Amsterdam, Med Ctr, Dept Physiol, Inst Cardiovasc Res, Amsterdam, Netherlands.
   [Paul, Marinus A.] Vrije Univ Amsterdam, Med Ctr, Dept Cardiothorac Surg, Amsterdam, Netherlands.
C3 Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije
   Universiteit Amsterdam
RP van der Heijden, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Inst Cardiovasc Res, Amsterdam, Netherlands.
EM nieuwamerongen@vumc.nl
FU Netherlands Heart Foundation [2003T032]; European Society of Intensive
   Care Medicine
FX GPvNA was supported by The Netherlands Heart Foundation (The Hague,
   grant 2003T032). MvdH was supported by the European Society of Intensive
   Care Medicine (ECCRN Levi Montalcini Biomedical Sciences Award 2007).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae
   Amerongen GPV, 2000, CIRCULATION, V102, P2803
   Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH107, DOI 10.1152/ajpheart.00542.2005
   Baumeister U, 2005, EMBO J, V24, P1686, DOI 10.1038/sj.emboj.7600647
   Baumer Y, 2009, J CELL PHYSIOL, V220, P716, DOI 10.1002/jcp.21819
   Beck GC, 1999, CLIN EXP IMMUNOL, V118, P298
   Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494
   Bogatcheva NV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P75, DOI 10.1023/A:1013904231324
   Cascone I, 2003, BLOOD, V102, P2482, DOI 10.1182/blood-2003-03-0670
   Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897
   Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487
   Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X
   Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351
   Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482
   Finigan JH, 2009, MICROVASC RES, V77, P35, DOI 10.1016/j.mvr.2008.09.002
   Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714
   Fukuhara S, 2010, YAKUGAKU ZASSHI, V130, P1413, DOI 10.1248/yakushi.130.1413
   Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603
   Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019
   Gorovoy M, 2007, CIRC RES, V101, P50, DOI 10.1161/CIRCRESAHA.106.145847
   Hoang MV, 2011, BLOOD, V117, P1751, DOI 10.1182/blood-2010-05-286831
   Huang YQ, 2008, CRIT CARE MED, V36, P262, DOI 10.1097/01.CCM.0000297955.02633.A4
   Jho D, 2005, CIRC RES, V96, P1282, DOI 10.1161/01.RES.0000171894.03801.03
   Kim KT, 2005, J BIOL CHEM, V280, P20126, DOI 10.1074/jbc.M500292200
   Kim SR, 2008, EXP MOL MED, V40, P320, DOI 10.3858/emm.2008.40.3.320
   Kinney CM, 2008, AM J PHYSIOL-CELL PH, V294, pC241, DOI 10.1152/ajpcell.00187.2007
   Kipnis E, 2004, SHOCK, V21, P444, DOI 10.1097/00024382-200405000-00008
   LANGELER EG, 1988, THROMB HAEMOSTASIS, V60, P240
   LEEMREIS JR, 2006, CYTOM PART A, V69, P873
   Li XC, 2004, BLOOD, V104, P1716, DOI 10.1182/blood-2003-11-3744
   Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143
   Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55
   Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200
   Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9
   Marcus BC, 1998, ANN VASC SURG, V12, P384, DOI 10.1007/s100169900173
   Marron MB, 2007, J BIOL CHEM, V282, P30509, DOI 10.1074/jbc.M702535200
   McCarter SD, 2007, AM J RESP CRIT CARE, V175, P1014, DOI 10.1164/rccm.200609-1370OC
   Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269
   Moy AB, 1996, J CLIN INVEST, V97, P1020, DOI 10.1172/JCI118493
   Oubaha M, 2009, BLOOD, V114, P3343, DOI 10.1182/blood-2008-12-196584
   Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046
   Peters S, 2007, CYTOKINE, V40, P144, DOI 10.1016/j.cyto.2007.09.001
   Pizurki L, 2003, BRIT J PHARMACOL, V139, P329, DOI 10.1038/sj.bjp.0705259
   Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488
   Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715
   Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653
   Schubert SY, 2011, ARTERIOSCL THROM VAS, V31, P870, DOI 10.1161/ATVBAHA.110.218255
   Seegar TCM, 2010, MOL CELL, V37, P643, DOI 10.1016/j.molcel.2010.02.007
   Shelton JL, 2006, MICROVASC RES, V71, P40, DOI 10.1016/j.mvr.2005.11.003
   van der Heijden M, 2008, THORAX, V63, P903, DOI 10.1136/thx.2007.087387
   van der Heijden M, 2008, APOPTOSIS, V13, P404, DOI 10.1007/s10495-007-0173-6
   van der Heijden M, 2009, INTENS CARE MED, V35, P1567, DOI 10.1007/s00134-009-1560-y
   Wang YH, 2004, J CELL PHYSIOL, V198, P53, DOI 10.1002/jcp.10386
   Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159
   Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E
   WYSOLMERSKI RB, 1990, P NATL ACAD SCI USA, V87, P16, DOI 10.1073/pnas.87.1.16
   Xu J, 2008, J PATHOL, V214, P472, DOI 10.1002/path.2302
   Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08
NR 58
TC 34
Z9 34
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 15
PY 2011
VL 6
IS 8
AR e23448
DI 10.1371/journal.pone.0023448
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 808CV
UT WOS:000293953700023
PM 21858121
OA Green Published, gold
DA 2023-08-21
ER

PT J
AU Makarova, AM
   Lebedeva, TV
   Nassar, T
   Higazi, AA
   Xue, J
   Carinato, ME
   Bdeir, K
   Cines, DB
   Stepanova, V
AF Makarova, Anastasia M.
   Lebedeva, Tatiana V.
   Nassar, Taher
   Higazi, Abd Al-Roof
   Xue, Jing
   Carinato, Maria E.
   Bdeir, Khalil
   Cines, Douglas B.
   Stepanova, Victoria
TI Urokinase-type Plasminogen Activator (uPA) Induces Pulmonary
   Microvascular Endothelial Permeability through Low Density Lipoprotein
   Receptor-related Protein (LRP)-dependent Activation of Endothelial
   Nitric-oxide Synthase
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; KINASE-A PHOSPHORYLATION;
   BLOOD-BRAIN-BARRIER; ACUTE LUNG INJURY; FIBRIN DEPOSITION;
   ADENYLYL-CYCLASE; CELL BARRIER; VASCULAR-PERMEABILITY; MEDIATED
   ENDOCYTOSIS; ISCHEMIA-REPERFUSION
AB Urokinase plasminogen activator (uPA) and PA inhibitor type 1 (PAI-1) are elevated in acute lung injury, which is characterized by a loss of endothelial barrier function and the development of pulmonary edema. Two-chain uPA and uPA-PAI-1 complexes (1-20 nM) increased the permeability of monolayers of human pulmonary microvascular endothelial cells (PMVECs) in vitro and lung permeability in vivo. The effects of uPA-PAI-1 were abrogated by the nitric-oxide synthase (NOS) inhibitor L-NAME (N-D-nitro-L-arginine methyl ester). Two-chain uPA (1-20 nM) and uPA-PAI-1 induced phosphorylation of endothelial NOS-Ser(1177) in PMVECs, which was followed by generation of NO and the nitrosylation and dissociation of beta-catenin from VE-cadherin. uPA-induced phosphorylation of eNOS was decreased by anti-low density lipoprotein receptor-related protein-1 (LRP) antibody and an LRP antagonist, receptor-associated protein (RAP), and when binding to the uPA receptor was blocked by the isolated growth factor-like domain of uPA. uPA-induced phosphorylation of eNOS was also inhibited by the protein kinase A (PKA) inhibitor, myristoylated PKI, but was not dependent on PI3K-Akt signaling. LRP blockade and inhibition of PKA prevented uPA- and uPA-PAI-1-induced permeability of PMVEC monolayers in vitro and uPA-induced lung permeability in vivo. These studies identify a novel pathway involved in regulating PMVEC permeability and suggest the utility of uPA-based approaches that attenuate untoward permeability following acute lung injury while preserving its salutary effects on fibrinolysis and airway remodeling.
C1 [Makarova, Anastasia M.; Lebedeva, Tatiana V.; Higazi, Abd Al-Roof; Xue, Jing; Carinato, Maria E.; Bdeir, Khalil; Cines, Douglas B.; Stepanova, Victoria] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104, United States.
   [Nassar, Taher; Higazi, Abd Al-Roof] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Clin Biochem, IL-91120 Jerusalem, Israel.
   [Xue, Jing] Tianjin Huanhu Hosp, Dept Lab Med, Tianjin 300060, China.
C3 University of Pennsylvania; Hebrew University of Jerusalem; Hadassah
   University Medical Center
RP Stepanova, V (corresponding author), 512 Stellar Chance Bldg,422 Curie Blvd, Philadelphia, PA 19104 USA.
EM vstepano@mail.med.upenn.edu
FU National Institutes of Health [HL-077760, 5T32 HL07971-07,
   NS053410-04S1, HD057355, HL076406, CA141228]
FX This work was supported, in whole or in part, by National Institutes of
   Health Grants HL-077760 (to A. A. H.), 5T32 HL07971-07, NS053410-04S1,
   HD057355, and HL076406 (to D. B. C.), and CA141228 (to V. S.).
CR Abraham E, 2003, J IMMUNOL, V170, P5644, DOI 10.4049/jimmunol.170.11.5644
   ANDREASEN PA, 1986, J BIOL CHEM, V261, P7644
   Armstead WM, 2008, J NEUROTRAUM, V25, P1375, DOI 10.1089/neu.2008.0666
   Armstead WM, 2005, STROKE, V36, P2265, DOI 10.1161/01.STR.0000181078.74698.b0
   Armstead WM, 2005, DEV BRAIN RES, V156, P139, DOI 10.1016/j.devbraines.2005.02.012
   BACHOFEN M, 1982, CLIN CHEST MED, V3, P35
   Barazzone C, 1996, J CLIN INVEST, V98, P2666, DOI 10.1172/JCI119089
   BARNATHAN ES, 1990, J BIOL CHEM, V265, P2865
   Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003
   Bdeir K, 2003, BLOOD, V102, P3600, DOI 10.1182/blood-2003-03-0949
   Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC
   Behzadian MA, 2003, FASEB J, V17, P752, DOI 10.1096/fj.02-0484fje
   Bindewald K, 2004, AM J PHYSIOL-CELL PH, V287, pC1246, DOI 10.1152/ajpcell.00132.2004
   Birukova AA, 2007, MICROVASC RES, V73, P173, DOI 10.1016/j.mvr.2006.12.004
   Birukova AA, 2010, AM J PHYSIOL-LUNG C, V299, pL652, DOI 10.1152/ajplung.00202.2009
   Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977
   Bogatcheva NV, 2009, J CELL PHYSIOL, V221, P750, DOI 10.1002/jcp.21913
   BONE RC, 1976, AM J MED, V61, P585, DOI 10.1016/0002-9343(76)90135-2
   Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095
   Bucci M, 2005, P NATL ACAD SCI USA, V102, P904, DOI 10.1073/pnas.0408906102
   Cate JM, 2007, CURR DRUG TARGETS, V8, P971, DOI 10.2174/138945007781662337
   Chen HI, 2003, J BIOMED SCI, V10, P588, DOI 10.1159/000073523
   Cioffi DL, 2002, J CELL BIOL, V157, P1267, DOI 10.1083/jcb.200204022
   CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609
   Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467
   Dear AE, 1998, EUR J BIOCHEM, V252, P185, DOI 10.1046/j.1432-1327.1998.2520185.x
   Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106
   Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224
   Duran WN, 2010, CARDIOVASC RES, V87, P254, DOI 10.1093/cvr/cvq139
   Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396
   Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198
   Goretzki L, 1998, BIOCHEM J, V336, P381, DOI 10.1042/bj3360381
   Goretzki L, 1997, J CELL SCI, V110, P1395
   Hardaway RM, 2001, AM SURGEON, V67, P377
   Herz J, 2003, J CLIN INVEST, V112, P1483, DOI 10.1172/JCI200320337
   Hiroi YK, 2008, FASEB J, V22, P1450, DOI 10.1096/fj.07-9309com
   Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB
   IDELL S, 1989, J CLIN INVEST, V84, P695, DOI 10.1172/JCI114217
   Idell S, 1994, New Horiz, V2, P566
   IDELL S, 1991, AM REV RESPIR DIS, V144, P187, DOI 10.1164/ajrccm/144.1.187
   ISCHIROPOULOS H, 1994, AM J RESP CRIT CARE, V150, P337, DOI 10.1164/ajrccm.150.2.8049812
   Jin SLC, 1998, J BIOL CHEM, V273, P19672, DOI 10.1074/jbc.273.31.19672
   Kao SJ, 2003, J BIOMED SCI, V10, P58, DOI 10.1159/000068090
   KASAI S, 1985, J BIOL CHEM, V260, P2377
   Klein RC, 1999, NEUROSCI LETT, V273, P171, DOI 10.1016/S0304-3940(99)00649-7
   Kondrikov D, 2006, AM J PHYSIOL-LUNG C, V290, pL41, DOI 10.1152/ajplung.00444.2004
   KUBES P, 1992, AM J PHYSIOL, V262, pH611, DOI 10.1152/ajpheart.1992.262.2.H611
   Kuramoto E, 2009, AM J PHYSIOL-LUNG C, V296, pL337, DOI 10.1152/ajplung.90434.2008
   Lardot CG, 1998, AM J RESP CRIT CARE, V157, P617, DOI 10.1164/ajrccm.157.2.9707052
   LASZLO F, 1995, EUR J PHARMACOL, V283, P47, DOI 10.1016/0014-2999(95)00281-O
   Lee NPY, 2003, ENDOCRINOLOGY, V144, P3114, DOI 10.1210/en.2002-0167
   LI H, 1994, J BIOL CHEM, V269, P8153
   Li YH, 2001, MOL CELL BIOL, V21, P1185, DOI 10.1128/MCB.21.4.1185-1195.2001
   Loskutoff DJ, 2000, J CLIN INVEST, V106, P1441, DOI 10.1172/JCI11765
   MAJNO G, 1969, J CELL BIOL, V42, P647, DOI 10.1083/jcb.42.3.647
   Martins-Green M, 2008, METHOD ENZYMOL, V443, P137, DOI 10.1016/S0076-6879(08)02008-9
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL203, DOI 10.1152/ajplung.1998.275.2.L203
   Mundy AL, 2000, BRIT J ANAESTH, V85, P570, DOI 10.1093/bja/85.4.570
   Nagata K, 2003, CHEST, V124, P2293, DOI 10.1378/chest.124.6.2293
   Namiki A, 1992, JPN J PHARM S2, V58, p326P
   Nassar T, 2002, J BIOL CHEM, V277, P40499, DOI 10.1074/jbc.M207172200
   Nassar T, 2010, AM J RESP CELL MOL, V43, P703, DOI 10.1165/rcmb.2009-0257OC
   NEUHOF H, 1986, RESUSCITATION, V14, P23, DOI 10.1016/0300-9572(86)90004-3
   NYKJAER A, 1994, J BIOL CHEM, V269, P25668
   NYKJAER A, 1992, J BIOL CHEM, V267, P14543
   Pinsky DJ, 1998, J CLIN INVEST, V102, P919, DOI 10.1172/JCI307
   PLOUG M, 1995, BIOCHEMISTRY-US, V34, P12524, DOI 10.1021/bi00039a006
   Polavarapu R, 2007, BLOOD, V109, P3270, DOI 10.1182/blood-2006-08-043125
   Quinn KA, 1997, J BIOL CHEM, V272, P23946, DOI 10.1074/jbc.272.38.23946
   Rampersad SN, 2010, J BIOL CHEM, V285, P33614, DOI 10.1074/jbc.M110.140004
   Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147
   Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013
   Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e
   SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4
   SEEKAMP A, 1993, AM J PATHOL, V142, P1217
   Shetty S, 2008, AM J PHYSIOL-LUNG C, V295, pL967, DOI 10.1152/ajplung.90349.2008
   STEFFENS GJ, 1982, H-S Z PHYSIOL CHEM, V363, P1043, DOI 10.1515/bchm2.1982.363.2.1043
   Stepanova V, 2008, BLOOD, V112, P100, DOI 10.1182/blood-2007-07-104455
   Sugiura H, 1999, AM J RESP CRIT CARE, V160, P663, DOI 10.1164/ajrccm.160.2.9807160
   Symons JD, 2009, CIRC RES, V104, P1085, DOI 10.1161/CIRCRESAHA.108.189316
   Tarui T, 2006, THROMB HAEMOSTASIS, V95, P524, DOI 10.1160/TH05-06-0457
   Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013
   Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200
   Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7
   Umapathy NS, 2010, J CELL PHYSIOL, V223, P215, DOI 10.1002/jcp.22029
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH2427, DOI 10.1152/ajpheart.00556.2004
   Webb DJ, 2001, J CELL BIOL, V152, P741, DOI 10.1083/jcb.152.4.741
   WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035
   Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212
   Zhu B, 2010, AM J PHYSIOL-LUNG C, V299, pL493, DOI 10.1152/ajplung.00431.2009
NR 92
TC 16
Z9 18
U1 0
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 1
PY 2011
VL 286
IS 26
BP 23044
EP 23053
DI 10.1074/jbc.M110.210195
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 782QP
UT WOS:000292025000039
PM 21540184
OA hybrid, Green Published
DA 2023-08-21
ER

PT J
AU Wakamoto, S
   Fujihara, M
   Takahashi, D
   Niwa, K
   Sato, S
   Kato, T
   Azuma, H
   Ikeda, H
AF Wakamoto, Shinobu
   Fujihara, Mitsuhiro
   Takahashi, Daisuke
   Niwa, Koichi
   Sato, Shinichiro
   Kato, Toshiaki
   Azuma, Hiroshi
   Ikeda, Hisami
TI Enhancement of endothelial permeability by coculture with peripheral
   blood mononuclear cells in the presence of HLA Class II antibody that
   was associated with transfusion-related acute lung injury
SO TRANSFUSION
LA English
DT Article
ID PLATELET-ACTIVATING-FACTOR; TUMOR-NECROSIS-FACTOR; FACTOR PAF;
   HUMAN-MONOCYTES; TRALI; RELEASE; PATHOPHYSIOLOGY; ALLOANTIBODY;
   LEUKOTRIENES; PATHOGENESIS
AB BACKGROUND: HLA Class II antibody-initiated activation of monocytes possessing the corresponding antigen is thought to participate in the pathogenesis of transfusion-related acute lung injury (TRALI). Pulmonary edema, a hallmark of TRALI, is caused by increasing vascular permeability.
   STUDY DESIGN AND METHODS: To investigate the contribution of HLA Class II antibody and monocytes to the development of pulmonary edema in TRALI, we studied whether the permeability of human lung microvascular endothelial cells (HMVECs) could be enhanced by coculturing HMVECs with peripheral blood mononuclear cells (PBMNCs) in the presence of HLA Class II antibody-containing plasma, which was implicated in TRALI (anti-HLA-DR plasma). In addition, similar experiments were performed with human umbilical vein endothelial cells (HUVECs). The endothelial permeability to fluoresceinated dextran, which was added from the start of coculture, was measured.
   RESULTS: The coculture of HMVECs or HUVECs with PBMNCs in the presence of anti-HLA-DR plasma resulted in the increase of endothelial permeability in the corresponding antigen-antibody-dependent manner. CV-3988, a platelet-activating factor (PAF) receptor antagonist, almost completely suppressed the increase in endothelial permeability. Neutralizing antibodies to tumor necrosis factor (TNF)-alpha alone and simultaneous addition of the antibodies to TNF-alpha and interleukin (IL)-1 beta to the coculture partially suppressed the permeability increase of HMVECs and HUVECs, respectively.
   CONCLUSIONS: HLA Class II antibody and monocytes in the corresponding antigen-antibody combination caused the enhancement of endothelial permeability. PAF, TNF-alpha, and/or IL-1 beta might be involved in the endothelial permeability increase. HLA Class II antibody-initiated monocyte activation could lead to the development of pulmonary edema in TRALI.
C1 [Fujihara, Mitsuhiro] Hokkaido Red Cross Blood Ctr, Nishi Ku, Sapporo, Hokkaido 0630002, Japan.
   Tokyo Univ Agr, Fac Bioind, Dept Food Sci & Technol, Abashiri, Japan.
C3 Tokyo University of Agriculture
RP Fujihara, M (corresponding author), Hokkaido Red Cross Blood Ctr, Nishi Ku, Yamanote 2-2, Sapporo, Hokkaido 0630002, Japan.
EM fujihara@hokkaido.bc.jrc.or.jp
FU Northern Advancement Center for Science & Technology of Hokkaido Japan
FX This study was supported in part by Grants-in-Aid for Regional R&D
   Proposal-Based Program from Northern Advancement Center for Science &
   Technology of Hokkaido Japan.
CR Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491
   Bossi F, 2004, J IMMUNOL, V173, P6921, DOI 10.4049/jimmunol.173.11.6921
   BUSSOLINO F, 1988, J BIOL CHEM, V263, P11856
   BUSSOLINO F, 1995, EUR J BIOCHEM, V229, P327, DOI 10.1111/j.1432-1033.1995.tb20472.x
   Bux J, 2007, BRIT J HAEMATOL, V136, P788, DOI 10.1111/j.1365-2141.2007.06492.x
   Calvijo LC, 2001, J APPL PHYSIOL, V90, P261, DOI 10.1152/jappl.2001.90.1.261
   CHANG SW, 1987, J CLIN INVEST, V79, P1498, DOI 10.1172/JCI112980
   Flesch BK, 2002, BRIT J HAEMATOL, V116, P673, DOI 10.1046/j.0007-1048.2001.03305.x
   Fujihara M, 2009, VASCULAR DIS PREVENT, V6, P170
   Fung YL, 2009, TRANSFUS MED REV, V23, P266, DOI 10.1016/j.tmrv.2009.06.001
   HENDERSON WR, 1994, ANN INTERN MED, V121, P684, DOI 10.7326/0003-4819-121-9-199411010-00010
   IMAIZUMI TA, 1995, J INTERN MED, V238, P5, DOI 10.1111/j.1365-2796.1995.tb00894.x
   Kao GS, 2003, TRANSFUSION, V43, P185, DOI 10.1046/j.1537-2995.2003.00285.x
   Kleinman S, 2004, TRANSFUSION, V44, P1774, DOI 10.1111/j.0041-1132.2004.04347.x
   Kopko PM, 2003, TRANSFUSION, V43, P177, DOI 10.1046/j.1537-2995.2003.00307.x
   Kopko PM, 2001, TRANSFUSION, V41, P1244, DOI 10.1046/j.1537-2995.2001.41101244.x
   Miotla JM, 1998, AM J RESP CELL MOL, V18, P197, DOI 10.1165/ajrcmb.18.2.2846
   Montrucchio G, 2000, PHYSIOL REV, V80, P1669, DOI 10.1152/physrev.2000.80.4.1669
   Moses LA, 2000, TRANSFUSION, V40, P861, DOI 10.1046/j.1537-2995.2000.40070861.x
   Nicolle AL, 2004, TRANSFUSION MED, V14, P225, DOI 10.1111/j.0958-7578.2004.00504.x
   Nishimura M, 2007, VOX SANG, V93, P78, DOI 10.1111/j.1423-0410.2007.00925.x
   Nishimura M, 2007, TRANSFUSION MED, V17, P129, DOI 10.1111/j.1365-3148.2006.00721.x
   Nishimura M, 2001, TRANSFUSION, V41, P1268, DOI 10.1046/j.1537-2995.2001.41101268.x
   Nothacker HP, 2000, MOL PHARMACOL, V58, P1601, DOI 10.1124/mol.58.6.1601
   POUBELLE PE, 1991, IMMUNOLOGY, V72, P181
   Sakagawa H, 2007, TRANSFUSION, V47, P154, DOI 10.1111/j.1537-2995.2007.01078.x
   SCHLEIMER RP, 1986, AM REV RESPIR DIS, V133, P614
   Seynhaeve ALB, 2006, CELL BIOCHEM BIOPHYS, V44, P157, DOI 10.1385/CBB:44:1:157
   SHIBATA Y, 1981, VOX SANG, V41, P25, DOI 10.1111/j.1423-0410.1981.tb01007.x
   Shigematsu A, 2004, TRANSFUSION MED, V50, P720
   Silliman CC, 2005, BLOOD, V105, P2266, DOI 10.1182/blood-2004-07-2929
   SISSON JH, 1987, J IMMUNOL, V138, P3918
   Sjostrom M, 2003, ARTERIOSCL THROM VAS, V23, pE37, DOI 10.1161/01.ATV.0000082689.46538.DF
   TERASHITA Z, 1983, LIFE SCI, V32, P1975, DOI 10.1016/0024-3205(83)90049-8
   TERASHITA ZI, 1985, BIOCHEM PHARMACOL, V34, P1491, DOI 10.1016/0006-2952(85)90689-6
   VALONE FH, 1988, J IMMUNOL, V141, P3945
   VENABLE ME, 1993, J LIPID RES, V34, P691
   Wakamoto S, 2008, TRANSFUSION, V48, P2060, DOI 10.1111/j.1537-2995.2008.01809.x
   Wallis JP, 2003, TRANSFUSION, V43, P1053, DOI 10.1046/j.1537-2995.2003.00466.x
NR 39
TC 12
Z9 14
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAY
PY 2011
VL 51
IS 5
BP 993
EP 1001
DI 10.1111/j.1537-2995.2010.02910.x
PG 9
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA 759SC
UT WOS:000290267700016
PM 20977481
DA 2023-08-21
ER

PT J
AU Zhang, WF
   Zhu, XX
   Hu, DH
   Xu, CF
   Wang, YC
   Lv, GF
AF Zhang, Wan-Fu
   Zhu, Xiong-Xiang
   Hu, Dahai
   Xu, Cheng-Feng
   Wang, Yun-Chuan
   Lv, Gen-Fa
TI Intensive Insulin Treatment Attenuates Burn-Initiated Acute Lung Injury
   in Rats: Role of the Protective Endothelium
SO JOURNAL OF BURN CARE & RESEARCH
LA English
DT Article
ID NITRIC-OXIDE; STRESS HYPERGLYCEMIA; GLUCOSE CONTROL; THERAPY; CELLS;
   APOPTOSIS; CYTOKINE; AKT
AB Nonmetabolic effects of intensive insulin therapy in critically ill patients have been reported, but the underlying mechanisms are unclear. This study was designed to test the hypothesis that intensive insulin treatment would attenuate burn-induced acute lung injury by protecting the pulmonary microvascular endothelium. The rat model of burn injury was achieved by exposure to 92 degrees C water for 18 seconds. The rats were randomly allocated into the sham, burn/normal saline (NS), and burn/intensive insulin treatment groups. Blood glucose level was maintained between 5 and 7 mmol/L in rats in the burn/intensive insulin treatment group. Pulmonary injury was assessed by hematoxylin and eosin staining, scanning electron microscopy, bronchoalveolar lavage fluid protein concentrations, the lung wet: dry weight ratio, and lung myeloperoxidase activity. Pulmonary microvascular endothelial cells were examined by transmission electron microscopy. Western blotting was used to determine the protein expression of caspase-3. Intensive insulin treatment markedly attenuated the acute lung injury, revealed by improvements in histological features and significant decreases in bronchoalveolar lavage fluid protein concentrations, pulmonary wet: dry weight ratio, and myeloperoxidase activity at 12 hours after injury (P < .05 or P < .01 vs burn/NS). Moreover, the injured pulmonary microvascular endothelial cells showed significant improvements, whereas caspase-3 was markedly downregulated in the burn/intensive insulin treatment group when compared with the burn/NS group. Overall, intensive insulin treatment efficiently attenuated pulmonary microvascular endothelial cell dysfunction, decreased cell apoptosis, and inhibited acute lung injury after a burn. These findings may be useful in preventing organ failure after burn injury. (J Burn Care Res 2011;32:e51-e58)
C1 [Zhang, Wan-Fu; Zhu, Xiong-Xiang; Hu, Da-Hai; Xu, Cheng-Feng; Wang, Yun-Chuan; Lv, Gen-Fa] Fourth Mil Med Univ, Dept Burns & Cutaneous Surg, Xijing Hosp, Xian 710032, Shaanxi, China.
C3 Air Force Military Medical University
RP Hu, DH (corresponding author), Fourth Mil Med Univ, Dept Burns & Cutaneous Surg, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China.
FU National Natural Science Foundation of China [30772249]
FX Supported by grant 30772249 from the National Natural Science Foundation
   of China.
CR Bochicchio GV, 2005, J TRAUMA, V58, P921, DOI 10.1097/01.TA.0000162141.26392.07
   Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9
   Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194
   Chaudhuri A, 2004, CIRCULATION, V109, P849, DOI 10.1161/01.CIR.0000116762.77804.FC
   Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553
   Dandona P, 2001, J CLIN ENDOCR METAB, V86, P3257, DOI 10.1210/jc.86.7.3257
   Dandona P, 2005, J CLIN INVEST, V115, P2069, DOI 10.1172/JCI26045
   Deng HP, 2009, INT IMMUNOPHARMACOL, V9, P1251, DOI 10.1016/j.intimp.2009.07.009
   Dhainaut JF, 2002, PHYS REV LETT, V30, pS179u348
   Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE
   Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F
   Gauglitz GG, 2008, J BURN CARE RES, V29, P683, DOI 10.1097/BCR.0b013e31818481ce
   Gore DC, 2002, CRIT CARE MED, V30, P2438, DOI 10.1097/00003246-200211000-00006
   Hemmila MR, 2008, SURGERY, V144, P629, DOI 10.1016/j.surg.2008.07.001
   Huang YS, 1998, BURNS, V24, P706, DOI 10.1016/S0305-4179(98)00123-5
   Ishii H, 2000, Respirology, V5, P325, DOI 10.1046/j.1440-1843.2000.00271.x
   Jeschke MG, 2010, AM J RESP CRIT CARE, V182, P351, DOI 10.1164/rccm.201002-0190OC
   Kim YM, 1998, J BIOL CHEM, V273, P31437, DOI 10.1074/jbc.273.47.31437
   Kim YM, 1999, CIRC RES, V84, P253, DOI 10.1161/01.RES.84.3.253
   Krinsley JS, 2004, MAYO CLIN P, V79, P992
   Langouche L, 2005, J CLIN INVEST, V115, P2277, DOI 10.1172/JCI25385
   Li J, 2009, J MOL CELL CARDIOL, V47, P512, DOI 10.1016/j.yjmcc.2009.07.010
   Murphy JT, 2003, J TRAUMA, V54, P81, DOI 10.1097/00005373-200301000-00011
   Murphy JT, 2001, SHOCK, V16, P227, DOI 10.1097/00024382-200116030-00010
   Pidcoke HF, 2007, CRIT CARE MED, V35, pS524, DOI 10.1097/01.CCM.0000278065.72486.31
   Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256
   Steinberg HO, 1997, J CLIN INVEST, V100, P1230, DOI 10.1172/JCI119636
   Thorell A, 1999, Curr Opin Clin Nutr Metab Care, V2, P69, DOI 10.1097/00075197-199901000-00012
   Van den Berghe G, 2004, J CLIN INVEST, V114, P1187, DOI 10.1172/JCI200423506
   Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521
   Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300
   Whaley JG, 2009, J BURN CARE RES, V30, P1018, DOI 10.1097/BCR.0b013e3181bfb825
   Yung M, 2008, PEDIATR CRIT CARE ME, V9, P147, DOI 10.1097/PCC.0b013e3181668c22
   Zhang JP, 2008, J TRAUMA, V65, P401, DOI 10.1097/TA.0b013e31817cf732
NR 34
TC 11
Z9 13
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1559-047X
EI 1559-0488
J9 J BURN CARE RES
JI J. Burn Care Res.
PD MAY-JUN
PY 2011
VL 32
IS 3
BP E51
EP E58
DI 10.1097/BCR.0b013e318217f8ae
PG 8
WC Critical Care Medicine; Dermatology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Dermatology; Surgery
GA 760EZ
UT WOS:000290308500003
PM 21436719
DA 2023-08-21
ER

PT J
AU Lam, CF
   Roan, JN
   Lee, CH
   Chang, PJ
   Huang, CC
   Liu, YC
   Jiang, MJ
   Tsai, YC
AF Lam, Chen-Fuh
   Roan, Jun-Neng
   Lee, Chou-Hwei
   Chang, Pei-Jung
   Huang, Chein-Chi
   Liu, Yen-Chin
   Jiang, Meei-Jyh
   Tsai, Yu-Chuan
TI Transplantation of Endothelial Progenitor Cells Improves Pulmonary
   Endothelial Function and Gas Exchange in Rabbits with Endotoxin-Induced
   Acute Lung Injury
SO ANESTHESIA AND ANALGESIA
LA English
DT Article
ID ACUTE RESPIRATORY-DISTRESS; ACUTE MYOCARDIAL-INFARCTION;
   LIPOPOLYSACCHARIDE; EXPRESSION; NEUTROPHILS; APOPTOSIS; STRESS; NUMBER
AB BACKGROUND: Circulating endothelial progenitor cells (EPCs) have been therapeutically applied to aid vascular repair and myocardial regeneration. The number of circulating EPCs also provides invaluable outcome prediction for fatal diseases such as acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). However, evidence for the therapeutic potential of EPCs in subjects with ALI/ADRS is limited.
   METHODS: Circulating EPCs were obtained from rabbits using Ficoll centrifugation. One week after culturing EPCs in endothelial growth medium-2, ALI was induced in rabbits by intratracheal instillation of lipopolysaccharide (500 mu g/kg). Autologous EPCs or saline were administered IV after induction of ALI and animals were killed 2 days later. Pulmonary artery endothelial function and gas exchange were determined. Degrees of lung injury were assessed by alveolocapillary permeability, lung hemoglobin content, and myeloperoxidase activity.
   RESULTS: In comparison with controls, Po-2 in arterial blood was significantly elevated and pulmonary artery endothelium-dependent relaxation response was restored in rabbits receiving EPC transplantation. Lung water, Evan's blue, and bronchoalveolar lavage protein contents were significantly reduced in the EPC transplanted group, indicating a better preservation of the alveolocapillary membrane. Transplantation of EPCs decreased the lung hemoglobin level. Furthermore, expressions of CD11b and myeloperoxidase activity were also suppressed after administration of EPCs.
   CONCLUSIONS: Transplantation of EPCs restored pulmonary endothelial function, preserved integrity of the alveolocapillary barrier and suppressed the lung inflammatory response, thereby improving pulmonary gas exchange in rabbits with intratracheal lipopolysaccharide-induced ALI. Transplantation of EPCs can be a novel cell-based, endothelium-targeted therapeutic strategy for prevention and treatment of ALI/ARDS. (Anesth Analg 2011;112:620-7)
C1 [Lam, Chen-Fuh; Lee, Chou-Hwei; Chang, Pei-Jung; Huang, Chein-Chi; Liu, Yen-Chin; Tsai, Yu-Chuan] Natl Cheng Kung Univ, Dept Anesthesiol, Med Coll & Hosp, Tainan 70101, Taiwan.
   [Lee, Chou-Hwei; Jiang, Meei-Jyh] Natl Cheng Kung Univ, Dept Cell Biol & Anat, Med Coll & Hosp, Tainan 70101, Taiwan.
   [Roan, Jun-Neng] Tainan Municipal Hosp, Div Cardiovasc Surg, Dept Surg, Tainan, Taiwan.
C3 National Cheng Kung University; National Cheng Kung University
RP Tsai, YC (corresponding author), Natl Cheng Kung Univ, Dept Anesthesiol, Med Coll & Hosp, 138 Sheng Li Rd, Tainan 70101, Taiwan.
EM yctsai@mail.ncku.edu.tw
RI Liu, Yen-Chin/HOC-8913-2023; Roan, Jun-Neng/AFK-1022-2022
OI Liu, Yen-Chin/0000-0002-5247-1678; Roan, Jun-Neng/0000-0002-0312-0628
FU National Science Council of Taiwan [97-2314-B-006-023]
FX This study was supported by a research grant from the National Science
   Council of Taiwan (grant number 97-2314-B-006-023 to CFL).
CR Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137
   Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948
   Alba-Loureiro TC, 2004, INFLAMM RES, V53, P658, DOI 10.1007/s00011-004-1308-7
   Asahara T, 2004, AM J PHYSIOL-CELL PH, V287, pC572, DOI 10.1152/ajpcell.00330.2003
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   ASHBAUGH DG, 1967, LANCET, V2, P319
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Asti C, 2000, PULM PHARMACOL THER, V13, P61, DOI 10.1006/pupt.2000.0231
   Battistini B, 1998, PULM PHARMACOL THER, V11, P165, DOI 10.1006/pupt.1998.0133
   Burnham EL, 2005, AM J RESP CRIT CARE, V172, P854, DOI 10.1164/rccm.200410-1325OC
   d'Uscio LV, 2003, CIRC RES, V92, P88, DOI 10.1161/01.RES.0000049166.33035.62
   DALLAL MM, 1994, J APPL PHYSIOL, V77, P1030, DOI 10.1152/jappl.1994.77.2.1030
   FAGON JY, 2003, EUR RESPIR J, V42, P77
   Frank JA, 2002, AM J RESP CRIT CARE, V165, P242, DOI 10.1164/ajrccm.165.2.2108087
   George J, 2003, ARTERIOSCL THROM VAS, V23, pE57, DOI 10.1161/01.ATV.0000107029.65274.db
   He TR, 2005, AM J PHYSIOL-HEART C, V289, pH968, DOI 10.1152/ajpheart.01166.2004
   He TR, 2004, ARTERIOSCL THROM VAS, V24, P2021, DOI 10.1161/01.ATV.0000142810.27849.8f
   He TR, 2004, STROKE, V35, P2378, DOI 10.1161/01.STR.0000141893.33677.5d
   HENDERSON RF, 1984, ENVIRON HEALTH PERSP, V56, P115, DOI 10.2307/3429841
   Hingorani AD, 2000, ENDOTHEL CELL RES S, V7, P3
   Imamura S, 1997, PATHOL INT, V47, P16, DOI 10.1111/j.1440-1827.1997.tb04430.x
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kawamoto A, 2001, CIRCULATION, V103, P634
   Kitamura Y, 2001, AM J RESP CRIT CARE, V163, P762, DOI 10.1164/ajrccm.163.3.2003065
   Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498
   Lam CF, 2008, ANESTHESIOLOGY, V108, P392, DOI 10.1097/ALN.0b013e318164ca64
   Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106
   Oettgen P, 2006, CIRCULATION, V114, P353, DOI 10.1161/CIRCULATIONAHA.106.639385
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Piantadosi CA, 2004, ANN INTERN MED, V141, P460, DOI 10.7326/0003-4819-141-6-200409210-00012
   Rezaiguia-Delclaux S, 2003, INTENS CARE MED, V29, P1151, DOI 10.1007/s00134-003-1809-9
   Sato K, 2002, FASEB J, V16, P1713, DOI 10.1096/fj.02-0331com
   Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388
   SOUKHOMOVSKAIA O, 2004, CIRCULATION, V110, P1209
   Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1
   Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434
   Tao J, 2007, J HUM HYPERTENS, V21, P353, DOI 10.1038/sj.jhh.1002147
   ULICH TR, 1994, INFLAMMATION, V18, P389, DOI 10.1007/BF01534436
   Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953
   Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814
   Yamamoto T, 1998, J IMMUNOL, V161, P5704
   Yip HK, 2008, STROKE, V39, P69, DOI 10.1161/STROKEAHA.107.489401
NR 44
TC 37
Z9 43
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0003-2999
J9 ANESTH ANALG
JI Anesth. Analg.
PD MAR
PY 2011
VL 112
IS 3
BP 620
EP 627
DI 10.1213/ANE.0b013e3182075da4
PG 8
WC Anesthesiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology
GA 726DG
UT WOS:000287698400026
PM 21233499
OA Bronze
DA 2023-08-21
ER

PT J
AU Wang, YL
   Malik, AB
   Sun, Y
   Hu, SY
   Reynolds, AB
   Minshall, RD
   Hu, GC
AF Wang, Yan-lei
   Malik, Asrar B.
   Sun, Yu
   Hu, Sanyuan
   Reynolds, Albert B.
   Minshall, Richard D.
   Hu, Guochang
TI Innate Immune Function of the Adherens Junction Protein p120-Catenin in
   Endothelial Response to Endotoxin
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID INTERCELLULAR-ADHESION MOLECULE-1; KAPPA-B ACTIVATION; ACUTE LUNG
   INJURY; P120 CATENIN; NEUTROPHIL SEQUESTRATION; CADHERIN EXPRESSION;
   SIGNALING PATHWAYS; KINASE-ACTIVITY; MUTANT MICE; IRAK FAMILY
AB Sepsis-induced acute lung injury is a common clinical disorder in critically ill patients that is associated with high mortality. In this study, we investigated the role of p120-catenin (p120), a constituent of endothelial adherens junctions, in regulating the innate immune function of lungs. In mice in which acute lung injury was induced by i.p. administration of LPS, we observed a rapid decrease in the expression of p120 in lungs. The p120 protein expression was correlated inversely with severity of inflammation. Suppression of p120 expression in lung endothelial cells in mice using small interfering RNA resulted in high sensitivity to endotoxin and greatly increased the mortality compared with controls. Knockdown of p120 also increased the expression of ICAM-1, neutrophil recruitment, production of cytokines TNF-alpha and IL-6, pulmonary transvascular protein permeability, and lung water content in response to LPS. We demonstrated that endothelial p120 modulates lung innate immune function by interfering with the association of TLR4 with its adaptor MyD88 to block TLR4 signaling and NF-kappa B activation in endothelial cells. In conclusion, these studies have uncovered a novel innate immune function of endothelial p120 in downregulating the lung inflammatory response to endotoxin through the suppression of TLR4 signaling. The Journal of Immunology, 2011, 186: 3180-3187.
C1 [Wang, Yan-lei; Malik, Asrar B.; Sun, Yu; Minshall, Richard D.; Hu, Guochang] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612, United States.
   [Wang, Yan-lei; Hu, Sanyuan] Shandong Univ, Dept Gen Surg, Qilu Hosp, Coll Med, Jinan 250012, China.
   [Malik, Asrar B.; Minshall, Richard D.] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612, United States.
   [Sun, Yu] Shandong Univ, Inst Pharmacol, Coll Med, Jinan 250012, China.
   [Reynolds, Albert B.] Vanderbilt Univ, Dept Canc Biol, Med Ctr, Nashville, TN 37203, United States.
   [Minshall, Richard D.; Hu, Guochang] Univ Illinois, Dept Anesthesiol, Coll Med, Chicago, IL 60612, United States.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; Shandong University; University
   of Illinois System; University of Illinois Chicago; University of
   Illinois Chicago Hospital; Shandong University; Vanderbilt University;
   University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital
RP Hu, GC (corresponding author), Univ Illinois, Dept Pharmacol Mc 868, 835 S Wolcott Ave, Chicago, IL 60612 USA.
EM gchu@uic.edu
OI Malik, Asrar/0000-0002-8205-7128
FU American Heart Association [0730331N]; National Institutes of Health
   National Heart, Lung, and Blood Institute [HL104092, HL071626, P01
   HL060678]
FX This work was supported by American Heart Association Scientist
   Development Grant 0730331N (to G.H.) and National Institutes of Health
   National Heart, Lung, and Blood Institute Grants HL104092 (to G.H.),
   HL071626 (to R.D.M.), and P01 HL060678 (to R.D.M. and A.B.M.).
CR Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137
   Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391
   Alcaide P, 2008, BLOOD, V112, P2770, DOI 10.1182/blood-2008-03-147181
   Anastasiadis PZ, 2000, J CELL SCI, V113, P1319
   Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510
   Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098
   Bannerman DD, 2003, AM J PHYSIOL-LUNG C, V284, pL899, DOI 10.1152/ajplung.00338.2002
   Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005
   BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706
   Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110
   Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0
   Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304
   Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366
   Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004
   Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111
   Doerschuk CM, 1996, J IMMUNOL, V157, P4609
   Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853
   Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200
   Hirano S, 1996, AM J PHYSIOL-LUNG C, V270, pL836, DOI 10.1152/ajplung.1996.270.5.L836
   Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889
   Hu G, 2008, CIRC RES, V102, pE120, DOI 10.1161/CIRCRESAHA.107.167486
   Hu GC, 2008, AM J PHYSIOL-LUNG C, V294, pL178, DOI 10.1152/ajplung.00263.2007
   Hu GC, 2010, CRIT CARE MED, V38, P194, DOI 10.1097/CCM.0b013e3181bc7c17
   Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115
   Iyer S, 2004, AM J PHYSIOL-LUNG C, V286, pL1143, DOI 10.1152/ajplung.00305.2003
   Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4
   Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315
   Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887
   Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325
   Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825
   Kumasaka T, 1996, J CLIN INVEST, V97, P2362, DOI 10.1172/JCI118679
   Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399
   Li XP, 2009, CARDIOVASC RES, V83, P72, DOI 10.1093/cvr/cvp100
   Lye E, 2004, J BIOL CHEM, V279, P40653, DOI 10.1074/jbc.M402666200
   Mamidipudi V, 2004, J BIOL CHEM, V279, P4161, DOI 10.1074/jbc.C300431200
   Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7
   Mo YY, 1996, CANCER RES, V56, P2633
   Moreland JG, 2002, AM J RESP CELL MOL, V27, P474, DOI 10.1165/rcmb.4694
   Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612
   Ohno H, 2007, BIOCHEM BIOPH RES CO, V353, P547, DOI 10.1016/j.bbrc.2006.12.061
   Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043
   Perez-Moreno M, 2008, P NATL ACAD SCI USA, V105, P15399, DOI 10.1073/pnas.0807301105
   Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019
   Sampson HW, 2007, J HISTOCHEM CYTOCHEM, V55, P845, DOI 10.1369/jhc.7A7184.2007
   Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673
   UHLIG S, 1995, AM J PATHOL, V146, P1235
   van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980
   Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001
   Zhou MY, 1998, J CLIN INVEST, V101, P2427, DOI 10.1172/JCI407
NR 49
TC 58
Z9 63
U1 0
U2 10
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAR 1
PY 2011
VL 186
IS 5
BP 3180
EP 3187
DI 10.4049/jimmunol.1001252
PG 8
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 721LT
UT WOS:000287356900057
PM 21278343
OA Green Accepted, Bronze
DA 2023-08-21
ER

PT J
AU Shaz, BH
   Stowell, SR
   Hillyer, CD
AF Shaz, Beth H.
   Stowell, Sean R.
   Hillyer, Christopher D.
TI Transfusion-related acute lung injury: from bedside to bench and back
SO BLOOD
LA English
DT Review
ID RED-BLOOD-CELLS; PULMONARY HYPERSENSITIVITY REACTION; RISK REDUCTION
   STRATEGY; UP-REGULATE CD11B; IN-VITRO MODEL; HUMAN NEUTROPHILS; ELASTASE
   RELEASE; CONCORDANT SUPEROXIDE; DONOR ANTIBODIES; ANIMAL-MODEL
AB Over the past 60 years, the transfusion medicine community has attained significant knowledge regarding transfusion-related acute lung injury (TRALI) through the bedside to bench and back to the bedside model. First, at the bedside, TRALI causes hypoxia and noncardiogenic pulmonary edema, typically within 6 hours of transfusion. Second, bedside studies showed a higher incidence in plasma and platelet products than in red blood cell products (the fatal TRALI incidence for plasma is 1:2-300 000 products; platelet, 1: 3-400 000; red blood cells, 1: 25 002 000), as well as an association with donor leukocyte antibodies (similar to 80% of cases). Third, at the bench, antibody-dependent and antibody-independent mechanisms have been described, requiring neutrophil and pulmonary endothelial cell activation. Antibodies, as well as alternate substances in blood products, result in neutrophil activation, which, in a susceptible patient, result in TRALI (2-hit hypothesis). Fourth, back to the bedside, policy changes based on results of these studies, such as minimizing use of plasma and platelet products from donors with leukocyte antibodies, have decreased the incidence of TRALI. Thus, steps to mitigate TRALI are in place, but a complete mechanistic understanding of the pathogenesis of TRALI and of which patients are at highest risk remains to be elucidated. (Blood. 2011; 117(5): 1463-1471)
C1 [Shaz, Beth H.; Hillyer, Christopher D.] New York Blood Ctr, New York, NY 10065, United States.
   [Shaz, Beth H.; Stowell, Sean R.] Emory Univ, Dept Pathol & Lab Med, Ctr Transfus & Cellular Therapies, Atlanta, GA 30322, United States.
   [Hillyer, Christopher D.] Weill Cornell Med Coll, Dept Med, Div Hematol Med Oncol, New York, NY, United States.
C3 New York Blood Center; Emory University; Cornell University; Weill
   Cornell Medicine
RP Shaz, BH (corresponding author), New York Blood Ctr, 310 E 67th St, New York, NY 10065 USA.
EM bshaz@nybloodcenter.org
OI Shaz, Beth/0000-0002-2270-4821
CR AABB, ASS B AABB
   Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8
   [Anonymous], NAT HEALTHC SAF NETW
   BERNARD GR, 1994, J CRIT CARE, V9, P72, DOI 10.1016/0883-9441(94)90033-7
   Bierling P, 2009, VOX SANG, V96, P266, DOI 10.1111/j.1423-0410.2008.01144.x
   Blood Products Advisory Committee, 2007, TOP 2 TRANSF REL AC
   BRITTINGHAM TE, 1957, JAMA-J AM MED ASSOC, V165, P819, DOI 10.1001/jama.1957.02980250053013
   Bux J, 2007, BRIT J HAEMATOL, V136, P788, DOI 10.1111/j.1365-2141.2007.06492.x
   Chapman CE, 2009, TRANSFUSION, V49, P440, DOI 10.1111/j.1537-2995.2008.01948.x
   Danielson C, 2008, TRANSFUSION, V48, P2401, DOI 10.1111/j.1537-2995.2008.01879.x
   DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442
   Doan CA, 1926, J AMER MED ASSOC, V86, P1593, DOI 10.1001/jama.1926.02670470001001
   Eder AF, 2007, TRANSFUSION, V47, P599, DOI 10.1111/j.1537-2995.2007.01102.x
   Eder AF, 2010, TRANSFUSION, V50, P1732, DOI 10.1111/j.1537-2995.2010.02652.x
   Flesland O, 2007, Intensive Care Med, V33 Suppl 1, pS17, DOI 10.1007/s00134-007-2875-1
   GRIMMINGER F, 1991, CIRC RES, V68, P503, DOI 10.1161/01.RES.68.2.503
   HAMBURGER SA, 1990, BLOOD, V75, P550
   Jensen HM, 2010, VOX SANG, V98, P130, DOI 10.1111/j.1423-0410.2009.01235.x
   JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3
   Kao GS, 2003, TRANSFUSION, V43, P185, DOI 10.1046/j.1537-2995.2003.00285.x
   Kelher MR, 2009, BLOOD, V113, P2079, DOI 10.1182/blood-2008-09-177857
   Keller-Stanislawski B, 2010, VOX SANG, V98, P70, DOI 10.1111/j.1423-0410.2009.01232.x
   KERNOFF PBA, 1972, BRIT J HAEMATOL, V23, P777, DOI 10.1111/j.1365-2141.1972.tb03492.x
   Khan SY, 2006, BLOOD, V108, P2455, DOI 10.1182/blood-2006-04-017251
   Kleinman S, 2004, TRANSFUSION, V44, P1774, DOI 10.1111/j.0041-1132.2004.04347.x
   Kleinman S, 2010, TRANSFUSION, V50, P1312, DOI 10.1111/j.1537-2995.2010.02659.x
   Koch C, 2009, ANN THORAC SURG, V88, P1410, DOI 10.1016/j.athoracsur.2009.07.020
   Kopko PM, 2002, JAMA-J AM MED ASSOC, V287, P1968, DOI 10.1001/jama.287.15.1968
   Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238
   Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432
   Mangalmurti NS, 2009, BLOOD, V113, P1158, DOI 10.1182/blood-2008-07-166264
   Maslanka K, 2007, VOX SANG, V92, P247, DOI 10.1111/j.1423-0410.2007.00890.x
   Middelburg RA, 2008, TRANSFUSION, V48, P2167, DOI 10.1111/j.1537-2995.2008.01810.x
   MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661
   Murphy MF, 2009, TRANSFUSION, V49, P1779, DOI 10.1111/j.1537-2995.2009.02340.x
   Nakajima F, 2008, VOX SANG, V95, P318, DOI 10.1111/j.1423-0410.2008.01095.x
   Nakazawa H, 2009, TRANSFUSION, V49, P2434, DOI 10.1111/j.1537-2995.2009.02321.x
   Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785
   Nishimura M, 2007, TRANSFUSION MED, V17, P129, DOI 10.1111/j.1365-3148.2006.00721.x
   Nishimura M, 2004, TRANSFUSION MED, V14, P359, DOI 10.1111/j.0958-7578.2004.00527.x
   Palfi M, 2001, TRANSFUSION, V41, P317, DOI 10.1046/j.1537-2995.2001.41030317.x
   Partrick DA, 1999, J SURG RES, V86, P42, DOI 10.1006/jsre.1999.5702
   Partrick DA, 1997, J TRAUMA, V43, P297, DOI 10.1097/00005373-199708000-00015
   Partrick DA, 1998, J TRAUMA, V44, P592, DOI 10.1097/00005373-199804000-00006
   PHILIPPS E, 1966, DIS CHEST, V50, P619, DOI 10.1378/chest.50.6.619
   POPOVSKY MA, 1985, TRANSFUSION, V25, P573, DOI 10.1046/j.1537-2995.1985.25686071434.x
   Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533
   Ramachandran V, 2004, P NATL ACAD SCI USA, V101, P13519, DOI 10.1073/pnas.0403608101
   Rana R, 2006, CRIT CARE MED, V34, P1892, DOI 10.1097/01.CCM.0000220766.13623.FE
   Reichel CA, 2009, ARTERIOSCL THROM VAS, V29, P1787, DOI 10.1161/ATVBAHA.109.193268
   Reil A, 2008, VOX SANG, V95, P313, DOI 10.1111/j.1423-0410.2008.01092.x
   Sachs UJ, 2010, VOX SANG, V99, P456
   Sachs U J H, 2007, Intensive Care Med, V33 Suppl 1, pS3, DOI 10.1007/s00134-007-2873-3
   Sachs UJH, 2006, BLOOD, V107, P1217, DOI 10.1182/blood-2005-04-1744
   Sachs UJH, 2005, TRANSFUSION, V45, P1628, DOI 10.1111/j.1537-2995.2005.00587.x
   SEEGER W, 1990, BLOOD, V76, P1438
   Silliman CC, 1998, J CLIN INVEST, V101, P1458, DOI 10.1172/JCI1841
   Silliman CC, 1997, TRANSFUSION, V37, P719, DOI 10.1046/j.1537-2995.1997.37797369448.x
   Silliman CC, 2003, TRANSFUSION, V43, P633, DOI 10.1046/j.1537-2995.2003.00385.x
   Silliman CC, 1996, TRANSFUSION, V36, P133, DOI 10.1046/j.1537-2995.1996.36296181925.x
   Silliman CC, 2007, BLOOD, V109, P1752, DOI 10.1182/blood-2006-05-025106
   Silliman CC, 2009, BLOOD REV, V23, P245, DOI 10.1016/j.blre.2009.07.005
   Sinnott P, 2004, EUR J IMMUNOGENET, V31, P271, DOI 10.1111/j.1365-2370.2004.00481.x
   Stainsby D, 2006, TRANSFUS MED REV, V20, P273, DOI 10.1016/j.tmrv.2006.05.002
   Stowell SR, 2007, BLOOD, V109, P219, DOI 10.1182/blood-2006-03-007153
   Stowell SR, 2009, MOL BIOL CELL, V20, P1408, DOI 10.1091/mbc.E08-07-0786
   Takahashi D, 2010, VOX SANG, V98, P560, DOI 10.1111/j.1423-0410.2010.01311.x
   TILL GO, 1982, J CLIN INVEST, V69, P1126, DOI 10.1172/JCI110548
   Toy P, 2005, CRIT CARE MED, V33, P721, DOI 10.1097/01.CCM.0000159849.94750.51
   Triulzi DJ, 2009, TRANSFUSION, V49, P1825, DOI 10.1111/j.1537-2995.2009.02206.x
   Triulzi DJ, 2009, ANESTH ANALG, V108, P770, DOI 10.1213/ane.0b013e31819029b2
   US Food and Drug Administration, 2010, FAT REP FDA FOLL BLO
   Vamvakas EC, 2009, BLOOD, V113, P3406, DOI 10.1182/blood-2008-10-167643
   VANBUREN NL, 1990, TRANSFUSION, V30, P42
   Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011
   Vlaar APJ, 2010, ANESTHESIOLOGY, V113, P92, DOI 10.1097/ALN.0b013e3181de6f25
   Wakamoto S, 2008, TRANSFUSION, V48, P2060, DOI 10.1111/j.1537-2995.2008.01809.x
   WARD HN, 1968, ARCH INTERN MED, V122, P362, DOI 10.1001/archinte.122.4.362
   Welsby IJ, 2010, J THORAC CARDIOV SUR, V140, P1353, DOI 10.1016/j.jtcvs.2009.12.035
   Wilson M, 1997, J TRAUMA, V43, P302
   WOLF CFW, 1976, TRANSFUSION, V16, P135, DOI 10.1046/j.1537-2995.1976.16276155107.x
   Woodfin A, 2010, CURR OPIN HEMATOL, V17, P9, DOI 10.1097/MOH.0b013e3283333930
   Wyman TH, 2002, AM J PHYSIOL-CELL PH, V283, pC1592, DOI 10.1152/ajpcell.00540.2001
   YOMTOVIAN R, 1984, LANCET, V1, P244
   Zarbock A, 2008, AM J PATHOL, V172, P1, DOI 10.2353/ajpath.2008.070502
   ZOON KC, 2001, TRANSFUSION RELATED
NR 86
TC 88
Z9 94
U1 1
U2 3
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD FEB 3
PY 2011
VL 117
IS 5
BP 1463
EP 1471
DI 10.1182/blood-2010-04-278135
PG 9
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA 715WV
UT WOS:000286925500011
PM 20944069
OA Bronze
DA 2023-08-21
ER

PT J
AU Sachs, UJH
   Wasel, W
   Bayat, B
   Bohle, RM
   Hattar, K
   Berghofer, H
   Reil, A
   Bux, J
   Bein, G
   Santoso, S
   Weissmann, N
AF Sachs, Ulrich J. H.
   Wasel, Wiebke
   Bayat, Behnaz
   Bohle, Rainer M.
   Hattar, Katja
   Berghoefer, Heike
   Reil, Angelika
   Bux, Juergen
   Bein, Gregor
   Santoso, Sentot
   Weissmann, Norbert
TI Mechanism of transfusion-related acute lung injury induced by HLA class
   II antibodies
SO BLOOD
LA English
DT Article
ID IN-VITRO MODEL; HUMAN NEUTROPHILS; DONOR ANTIBODIES; BLOOD-DONORS;
   TRALI; EXPRESSION; PATHOGENESIS; CELLS; VIVO; INTERLEUKIN-8
AB Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-associated mortality in the United States and other countries. In most TRALI cases, human leukocyte antigen (HLA) class II antibodies are detected in implicated donors. However, the corresponding antigens are not present on the cellular key players in TRALI: neutrophils and endothelium. In this study, we identify monocytes as a primary target in HLA class II-induced TRALI. Monocytes become activated when incubated with matched HLA class II antibodies and are capable of activating neutrophils, which, in turn, can induce disturbance of an endothelial barrier. In an ex vivo rodent model, HLA class II antibody-dependent monocyte activation leads to severe pulmonary edema in a relevant period of time, whenever neutrophils are present and the endothelium is preactivated. Our data suggest that in most TRALI cases, monocytes are cellular key players, because HLA class II antibodies induce TRALI by a reaction cascade initiated by monocyte activation. Furthermore, our data support the previous assumption that TRALI pathogenesis follows a threshold model. Having identified the biologic mechanism of HLA class II antibody-induced TRALI, strategies to avoid plasma from immunized donors, such as women with a history of pregnancy, appear to be justified preventive measures. (Blood. 2011;117(2):669-677)
C1 [Sachs, Ulrich J. H.; Wasel, Wiebke; Bayat, Behnaz; Berghoefer, Heike; Bein, Gregor; Santoso, Sentot] Univ Giessen, Inst Clin Immunol & Transfus Med, D-35392 Giessen, Germany.
   [Bohle, Rainer M.] Univ Saarland, Inst Pathol, D-6650 Homburg, Germany.
   [Hattar, Katja] Univ Giessen, Lung Ctr, Med Clin 5, D-35392 Giessen, Germany.
   [Reil, Angelika; Bux, Juergen] German Red Cross Blood Serv W, Hagen, Germany.
   [Weissmann, Norbert] Univ Giessen, Lung Ctr, ECCPS, D-35392 Giessen, Germany.
C3 Justus Liebig University Giessen; Saarland University; Justus Liebig
   University Giessen; Justus Liebig University Giessen
RP Sachs, UJH (corresponding author), Univ Giessen, Inst Clin Immunol & Transfus Med, Langhansstr 7, D-35392 Giessen, Germany.
EM ulrich.sachs@med.uni-giessen.de
RI Sachs, Ulrich/GSI-7824-2022; Hattar, Katja/HMW-1331-2023
OI Weissmann, Norbert/0000-0003-2675-3871; Hattar,
   Katja/0000-0001-6245-4663
FU Deutsche Forschungsgemeinschaft; University Medical Center Giessen and
   Marburg (UKGM) [10/2009GI]; Foundation for Hemotherapeutic Research,
   Bonn, Germany
FX This work was supported by the Deutsche Forschungsgemeinschaft
   (Excellence Cluster-Cardiopulmonary System; U.J.H.S. and N.W.), by the
   University Medical Center Giessen and Marburg (UKGM, research grant
   10/2009GI; S.S. and U.J.H.S.), and a fellowship from the Foundation for
   Hemotherapeutic Research, Bonn, Germany (U.J.H.S.).
CR ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668
   BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265
   BARNARD ML, 1992, J APPL PHYSIOL, V72, P1724, DOI 10.1152/jappl.1992.72.5.1724
   *BD BIOSC, 2008, TECHN B BD BIOSC, V413
   Bux J, 2007, BRIT J HAEMATOL, V136, P788, DOI 10.1111/j.1365-2141.2007.06492.x
   Chapman CE, 2009, TRANSFUSION, V49, P440, DOI 10.1111/j.1537-2995.2008.01948.x
   Crooks SW, 1998, INT J BIOCHEM CELL B, V30, P173, DOI 10.1016/S1357-2725(97)00123-4
   Eder AF, 2007, TRANSFUSION, V47, P599, DOI 10.1111/j.1537-2995.2007.01102.x
   Ermert L, 1998, J PHARMACOL EXP THER, V286, P1309
   Flesch BK, 2002, BRIT J HAEMATOL, V116, P673, DOI 10.1046/j.0007-1048.2001.03305.x
   Fung YL, 2009, TRANSFUS MED REV, V23, P266, DOI 10.1016/j.tmrv.2009.06.001
   Greinacher A, 2010, NAT MED, V16, P45, DOI 10.1038/nm.2070
   Hansch GM, 1999, KIDNEY INT, V55, P1811, DOI 10.1046/j.1523-1755.1999.00446.x
   HOLMAN RG, 1990, AM REV RESPIR DIS, V141, P134, DOI 10.1164/ajrccm/141.1.134
   JOHNSON A, 1989, AM J PHYSIOL, V256, pH1012, DOI 10.1152/ajpheart.1989.256.4.H1012
   Kao GS, 2003, TRANSFUSION, V43, P185, DOI 10.1046/j.1537-2995.2003.00285.x
   Kelher MR, 2009, BLOOD, V113, P2079, DOI 10.1182/blood-2008-09-177857
   Keller-Stanislawski B, 2010, VOX SANG, V98, P70, DOI 10.1111/j.1423-0410.2009.01232.x
   Kleinman S, 2004, TRANSFUSION, V44, P1774, DOI 10.1111/j.0041-1132.2004.04347.x
   Koike J, 2000, FEBS LETT, V477, P84, DOI 10.1016/S0014-5793(00)01765-8
   Kopko PM, 2003, TRANSFUSION, V43, P177, DOI 10.1046/j.1537-2995.2003.00307.x
   Kopko PM, 2001, TRANSFUSION, V41, P1244, DOI 10.1046/j.1537-2995.2001.41101244.x
   Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238
   Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432
   Lydaki E, 2005, TRANSFUS APHER SCI, V33, P107, DOI 10.1016/j.transci.2004.12.001
   METZNER B, 1995, J INVEST DERMATOL, V104, P789, DOI 10.1111/1523-1747.ep12606993
   Middelburg RA, 2008, TRANSFUSION, V48, P2167, DOI 10.1111/j.1537-2995.2008.01810.x
   MUDZINSKI SP, 1995, BLOOD, V86, P2452, DOI 10.1182/blood.V86.6.2452a.bloodjournal8662452a
   Nishimura M, 2007, TRANSFUSION MED, V17, P129, DOI 10.1111/j.1365-3148.2006.00721.x
   POBER JS, 1986, TRANSPLANTATION, V41, P141, DOI 10.1097/00007890-198602000-00001
   Porretti L, 2004, EUR J HAEMATOL, V73, P295, DOI 10.1111/j.1600-0609.2004.00279.x
   Reil A, 2008, VOX SANG, V95, P313, DOI 10.1111/j.1423-0410.2008.01092.x
   Reinisch W, 2003, CLIN EXP IMMUNOL, V133, P476, DOI 10.1046/j.1365-2249.2003.02245.x
   Sachs UJH, 2006, BLOOD, V107, P1217, DOI 10.1182/blood-2005-04-1744
   Sachs UJH, 2004, BLOOD, V104, P727, DOI 10.1182/blood-2003-11-3809
   SEEGER W, 1995, MICROVASC RES, V50, P1, DOI 10.1006/mvre.1995.1033
   SEEGER W, 1990, BLOOD, V76, P1438
   SEEGER W, 1986, J APPL PHYSIOL, V61, P1781, DOI 10.1152/jappl.1986.61.5.1781
   SHASBY DM, 1985, BLOOD, V65, P605
   Silliman CC, 2007, BLOOD, V109, P1752, DOI 10.1182/blood-2006-05-025106
   Triulzi DJ, 2009, TRANSFUSION, V49, P1825, DOI 10.1111/j.1537-2995.2009.02206.x
   Vamvakas EC, 2009, BLOOD, V113, P3406, DOI 10.1182/blood-2008-10-167643
   Varela M, 2002, TRANSFUSION, V42, P1102, DOI 10.1046/j.1537-2995.2002.00225.x
   Vassallo RR, 2010, TRANSFUSION, V50, P1766, DOI 10.1111/j.1537-2995.2010.02626.x
   Wallis JP, 2003, TRANSFUSION, V43, P1053, DOI 10.1046/j.1537-2995.2003.00466.x
   Wallis JP, 2009, ROSSIS PRINCIPLES TR, V4, P870
   Win N, 2003, TRANSFUSION, V43, P545, DOI 10.1046/j.1537-2995.2003.00363.x
   Win N, 2007, HEMATOLOGY, V12, P461, DOI 10.1080/10245330701562345
   Wyman TH, 2002, AM J PHYSIOL-CELL PH, V283, pC1592, DOI 10.1152/ajpcell.00540.2001
NR 49
TC 65
Z9 72
U1 0
U2 4
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD JAN 13
PY 2011
VL 117
IS 2
BP 669
EP 677
DI 10.1182/blood-2010-05-286146
PG 9
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA 705ZD
UT WOS:000286178700038
PM 21030555
OA Bronze
DA 2023-08-21
ER

PT J
AU Devaney, J
   Contreras, M
   Laffey, JG
AF Devaney, James
   Contreras, Maya
   Laffey, John G.
TI Clinical Review: Gene-based therapies for ALI/ARDS: where are we now?
SO CRITICAL CARE
LA English
DT Review
ID ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; ADENOVIRUS-MEDIATED
   TRANSFER; PLACEBO-CONTROLLED TRIAL; AIRWAY EPITHELIAL-CELLS;
   FACTOR-KAPPA-B; CYSTIC-FIBROSIS; IN-VIVO; RECOMBINANT ADENOVIRUS; CECAL
   LIGATION
AB Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) confer substantial morbidity and mortality, and have no specific therapy. The accessibility of the distal lung epithelium via the airway route, and the relatively transient nature of ALI/ARDS, suggest that the disease may be amenable to gene-based therapies. Ongoing advances in our understanding of the pathophysiology of ALI/ARDS have revealed multiple therapeutic targets for gene-based approaches. Strategies to enhance or restore lung epithelial and/or endothelial cell function, to strengthen lung defense mechanisms against injury, to speed clearance of infection and to enhance the repair process following ALI/ARDS have all demonstrated promise in preclinical models. Despite three decades of gene therapy research, however, the clinical potential for gene-based approaches to lung diseases including ALI/ARDS remains to be realized. Multiple barriers to effective pulmonary gene therapy exist, including the pulmonary architecture, pulmonary defense mechanisms against inhaled particles, the immunogenicity of viral vectors and the poor transfection efficiency of nonviral delivery methods. Deficits remain in our knowledge regarding the optimal molecular targets for gene-based approaches. Encouragingly, recent progress in overcoming these barriers offers hope for the successful translation of gene-based approaches for ALI/ARDS to the clinical setting.
C1 [Contreras, Maya; Laffey, John G.] Galway Univ Hosp, Dept Anaesthesia & Intens Care Med, Galway, Ireland.
   [Devaney, James; Contreras, Maya; Laffey, John G.] Natl Univ Ireland, Lung Biol Grp, Regenerat Med Inst, Natl Ctr Biomed Engn Sci, Galway, Ireland.
   [Laffey, John G.] Natl Univ Ireland Galway, Inst Clin Sci, Sch Med, Galway, Ireland.
C3 Ollscoil na Gaillimhe-University of Galway; Ollscoil na
   Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of
   Galway
RP Laffey, JG (corresponding author), Galway Univ Hosp, Dept Anaesthesia & Intens Care Med, Newcastle Rd, Galway, Ireland.
EM john.laffey@nuigalway.ie
RI Laffey, John/G-4204-2010
OI Laffey, John/0000-0002-1246-9573; Devaney, James/0000-0002-7489-5463
FU Health Research Board, Dublin, Ireland [RP/2008/193]; European Research
   Council, Brussels, Belgium [ERC-2007-StG 207777]; Health Research Board
   (HRB) [RP-2008-193] Funding Source: Health Research Board (HRB)
FX The present work was supported by funding from the Health Research
   Board, Dublin, Ireland (Grant No. RP/2008/193), and by the European
   Research Council, Brussels, Belgium, under the Framework 7 Programme
   (Grant No. ERC-2007-StG 207777).
CR Adir Y, 2008, AM J PHYSIOL-LUNG C, V294, pL1233, DOI 10.1152/ajplung.00076.2007
   Aguilar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008013
   Alton EWFW, 1999, LANCET, V353, P947, DOI 10.1016/S0140-6736(98)06532-5
   [Anonymous], 2000, NEW ENGL J MED
   Bromberg Z, 2008, CRIT CARE MED, V36, P246, DOI 10.1097/01.CCM.0000295473.56522.EF
   Buning H, 2008, J GENE MED, V10, P717, DOI 10.1002/jgm.1205
   Campbell AIM, 2001, CIRCULATION, V104, P2242, DOI 10.1161/hc4201.097838
   Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669
   Chen GH, 2000, J IMMUNOL, V165, P6496, DOI 10.4049/jimmunol.165.11.6496
   Christofidou-Solomidou M, 2003, AM J PHYSIOL-LUNG C, V285, pL283, DOI 10.1152/ajplung.00021.2003
   Chtarto A, 2003, GENE THER, V10, P84, DOI 10.1038/sj.gt.3301838
   Crystal RG, 2002, HUM GENE THER, V13, P65, DOI 10.1089/10430340152712647
   Danel C, 1998, HUM GENE THER, V9, P1487, DOI 10.1089/hum.1998.9.10-1487
   DUERR J, 2010, AM J RESP CELL MOL B, V178, P1245
   Dumasius V, 2002, CHEST, V121, p33S, DOI 10.1378/chest.121.3_suppl.33S
   Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067
   Gao CJ, 2011, J TRAUMA, V70, P210, DOI 10.1097/TA.0b013e3181e7432d
   Gao HW, 2006, J IMMUNOL, V177, P612, DOI 10.4049/jimmunol.177.1.612
   Garbuzenko OB, 2010, P NATL ACAD SCI USA, V107, P10737, DOI 10.1073/pnas.1004604107
   GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547
   Griesenbach U, 2009, ADV DRUG DELIVER REV, V61, P128, DOI 10.1016/j.addr.2008.09.010
   Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700
   Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001
   Harvey BG, 1999, J CLIN INVEST, V104, P1245, DOI 10.1172/JCI7935
   HAY JG, 1995, HUM GENE THER, V6, P1487, DOI 10.1089/hum.1995.6.11-1487
   Hendrickson B, 2007, AM J RESP CELL MOL, V37, P414, DOI 10.1165/rcmb.2006-0276OC
   Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450
   Huang YQ, 2008, CRIT CARE MED, V36, P262, DOI 10.1097/01.CCM.0000297955.02633.A4
   Hyde SC, 2008, NAT BIOTECHNOL, V26, P549, DOI 10.1038/nbt1399
   Joseph PM, 2001, HUM GENE THER, V12, P1369, DOI 10.1089/104303401750298535
   Kabay B, 2007, WORLD J SURG, V31, P105, DOI 10.1007/s00268-006-0066-9
   KATKIN JP, 1995, HUM GENE THER, V6, P985, DOI 10.1089/hum.1995.6.8-985
   Kida H, 2008, AM J PATHOL, V172, P1542, DOI 10.2353/ajpath.2008.071052
   Koehler DR, 2000, PEDIATR RES, V48, P184, DOI 10.1203/00006450-200008000-00011
   Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H
   Lamartina S, 2003, MOL THER, V7, P271, DOI 10.1016/S1525-0016(02)00051-5
   Leung K, 2007, J GENE MED, V9, P10, DOI 10.1002/jgm.987
   Li TB, 2006, AM J PHYSIOL-LUNG C, V290, pL649, DOI 10.1152/ajplung.00205.2005
   Li YT, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-79
   Li Y, 2008, EUR J PHARMACOL, V590, P417, DOI 10.1016/j.ejphar.2008.06.047
   Liu H, 2007, AM J TRANSPLANT, V7, P2291, DOI 10.1111/j.1600-6143.2007.01942.x
   Liu XM, 2009, MOL THER, V17, P285, DOI 10.1038/mt.2008.248
   Lomas-Neira JL, 2005, J LEUKOCYTE BIOL, V77, P846, DOI 10.1189/jlb.1004617
   MacLoughlin RJ, 2009, J AEROSOL MED PULM D, V22, P323, DOI 10.1089/jamp.2008.0717
   Manning E, 2010, HUM GENE THER, V21, P713, DOI 10.1089/hum.2009.147
   Matsuda N, 2005, MOL PHARMACOL, V67, P1018, DOI 10.1124/mol.104.005926
   McAuliffe PF, 2006, GENE THER, V13, P276, DOI 10.1038/sj.gt.3302600
   McCarter SD, 2007, AM J RESP CRIT CARE, V175, P1014, DOI 10.1164/rccm.200609-1370OC
   Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269
   Meng QH, 2004, J GENE MED, V6, P210, DOI 10.1002/jgm.483
   Moss RB, 2004, CHEST, V125, P509, DOI 10.1378/chest.125.2.509
   Moss RB, 2007, HUM GENE THER, V18, P726, DOI 10.1089/hum.2007.022
   Mustapa MFM, 2009, BIOCONJUGATE CHEM, V20, P518, DOI 10.1021/bc800450r
   Mutlu GM, 2007, AM J RESP CRIT CARE, V176, P582, DOI 10.1164/rccm.200608-1246OC
   Ostrowski LE, 2007, GENE THER, V14, P1492, DOI 10.1038/sj.gt.3302994
   Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2
   Perabo L, 2008, COMB CHEM HIGH T SCR, V11, P118
   Perl M, 2005, AM J PATHOL, V167, P1545, DOI 10.1016/S0002-9440(10)61240-0
   Perricone MA, 2001, HUM GENE THER, V12, P1383, DOI 10.1089/104303401750298544
   Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Rubenfeld GD, 2003, CRIT CARE MED, V31, pS276, DOI 10.1097/01.CCM.0000057904.62683.2B
   Saitoh H, 2002, EXP LUNG RES, V28, P219, DOI 10.1080/019021402753570518
   Scaria A, 1998, J VIROL, V72, P7302, DOI 10.1128/JVI.72.9.7302-7309.1998
   Shu Q, 2006, SHOCK, V26, P365, DOI 10.1097/01.shk.0000224722.65929.58
   Simpson AJ, 2001, J IMMUNOL, V167, P1778, DOI 10.4049/jimmunol.167.3.1778
   Sinn PL, 2003, J VIROL, V77, P5902, DOI 10.1128/JVI.77.10.5902-5910.2003
   Stern M, 2000, GENE THER, V7, P960, DOI 10.1038/sj.gt.3301193
   Strayer MS, 1998, AM J RESP CELL MOL, V18, P1
   Sud S, 2010, INTENS CARE MED, V36, P585, DOI 10.1007/s00134-009-1748-1
   Tagalakis AD, 2008, MOL THER, V16, P907, DOI 10.1038/mt.2008.38
   ter Horst Simone A J, 2006, BMC Pulm Med, V6, P8, DOI 10.1186/1471-2466-6-8
   Vandenberghe LH, 2009, GENE THER, V16, P311, DOI 10.1038/gt.2008.170
   Wagner JA, 1999, LARYNGOSCOPE, V109, P266, DOI 10.1097/00005537-199902000-00017
   Wang X, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-36
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Weiss Daniel J, 2008, Proc Am Thorac Soc, V5, P637, DOI 10.1513/pats.200804-037DW
   Weiss YG, 2001, ANESTHESIOLOGY, V95, P974, DOI 10.1097/00000542-200110000-00029
   Wheeler AP, 2006, NEW ENGL J MED, V354, P2213
   Writer M, 2006, J LIPOSOME RES, V16, P373, DOI 10.1080/08982100600992500
   Yan ZY, 2002, J VIROL, V76, P2043, DOI 10.1128/JVI.76.5.2043-2053.2002
   Zabner J, 2000, J VIROL, V74, P3852, DOI 10.1128/JVI.74.8.3852-3858.2000
   Zamora MR, 2011, AM J RESP CRIT CARE, V183, P531, DOI 10.1164/rccm.201003-0422OC
   Zhang YX, 2010, J THORAC CARDIOV SUR, V139, P758, DOI 10.1016/j.jtcvs.2009.09.027
   Zhao YD, 2006, AM J RESP CELL MOL, V35, P182, DOI 10.1165/rcmb.2005-0115OC
   Zhou J, 2006, GENE THER, V13, P974, DOI 10.1038/sj.gt.3302746
   Zhou R, 2007, GENE THER, V14, P775, DOI 10.1038/sj.gt.3302936
   Zuckerman JB, 1999, HUM GENE THER, V10, P2973, DOI 10.1089/10430349950016384
NR 88
TC 33
Z9 42
U1 3
U2 12
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1466-609X
J9 CRIT CARE
JI Crit. Care
PY 2011
VL 15
IS 3
AR 224
DI 10.1186/cc10216
PG 12
WC Critical Care Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 832JB
UT WOS:000295799700059
PM 21699743
OA Green Published, gold
DA 2023-08-21
ER

